Identifier,StructureData,,,,,,,,,,,,,,,Polymer EntityData,,,,,,
Entry ID,EM Resolution (Å),Experimental Method,Matthews Coefficient,Percent Solvent Content,Crystallization Method,pH,Crystal Growth Procedure,Temp (K),DOI,Ligand,PDB ID,Molecular Weight per Deposited Model,Resolution (Å),High Resolution Limit,Structure Title,Sequence,Source Organism,Gene Name,Macromolecule Name,Entity ID,Entry Id (Polymer Entity Identifiers),
"3OY6",,"X-RAY DIFFRACTION",1.99,38.07,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.05M SODIUM CITRATE, 1.95M (NH4)2SO4, 0.05% NAN3, 5% PEG 400, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.jmb.2011.07.028",,"3OY6",30.78,"2.31","2.31","The crystal structure of uPA complex with peptide inhibitor MH036 at pH4.6","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","3OY6"
,,,,,,,,,,,,,,,,"MGSADGACSWRGLENHRMCGAAG",,,"MH036","2","3OY6"
"3OY8",,"X-RAY DIFFRACTION",2.48,50.39,"VAPOR DIFFUSION, HANGING DROP",6.2,"4-8 microlitre drops consisting of equal volumes of protein solution (20 mM sodium potassium phosphate buffer, pH 7.0, and protein at concentration of 10 mg/mL) and reservoir solution (0.2 M ammonium sulphate, 25% w/v polyethylene glycol 4000, 0.1M sodium acetate trihydrate, pH 6.2), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.canlet.2010.08.005",,"3OY8",30.19,"2.19","2.19","Crystal structure of human galectin-1 in complex with lactobionic acid","ACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","1","3OY8"
,,,,,,,,,,,,,,,,"ACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","2","3OY8"
"3OYQ",,"X-RAY DIFFRACTION",2.08,40.91,"VAPOR DIFFUSION, HANGING DROP",8,"1.6M Sodium Citrate, 50mM Tris-Cl, detergent (Tween 20), pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm200209n","OYQ","3OYQ",29.81,"1.47","1.47","Structure of Human Carbonic Anhydrase II complexed with 5,6-DIHYDRO-BENZO[H]CINNOLIN-3-YLAMINE","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3OYQ"
"3OYS",,"X-RAY DIFFRACTION",2.09,41.26,"VAPOR DIFFUSION, HANGING DROP",8,"1.6M Sodium Citrate, 50mM Tris-Cl, detergent (Tween 20), pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm200209n","OYS","3OYS",29.82,"1.538","1.538","Human Carbonic Anhydrase II complexed with 2-{[4-AMINO-3-(3-HYDROXYPROP-1-YN-1-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]METHYL}-5-METHYL-3-(2-METHYLPHENYL)QUINAZOLIN-4(3H)-ONE","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3OYS"
"3OYW",,"X-RAY DIFFRACTION",2.46,49.91,"VAPOR DIFFUSION, HANGING DROP",6.2,"4-8 microlitre drops consisting of equal volumes of protein solution (20 mM sodium potassium phosphate buffer, pH 7.0, and protein at concentration of 10 mg/mL) and reservoir solution (0.2 M ammonium sulphate, 25% w/v polyethylene glycol 4000, 0.1M sodium acetate trihydrate, pH 6.2), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.canlet.2010.08.005",,"3OYW",30.19,"2.5","2.5","Crystal structure of human galectin-1 in complex with thiodigalactoside","ACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","1","3OYW"
,,,,,,,,,,,,,,,,"ACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","2","3OYW"
"3OZ0",,"X-RAY DIFFRACTION",2.4,48.85,"VAPOR DIFFUSION, SITTING DROP",8.5,"PEG, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmcl.2010.10.117","3OZ","3OZ0",33.17,"3","3","PPAR Delta in complex with azppard02","MGHHHHHHGSQYNPQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","3OZ0"
"3OZ1",,"X-RAY DIFFRACTION",2.65,53.63,"VAPOR DIFFUSION, SITTING DROP",8,"25% PEG 400, 0.1M Sodium Citrate, 0.1M Tris, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/pro.523","BMB","3OZ1",60.26,"3","3","cIAP1-BIR3 domain in complex with the Smac-mimetic compound Smac066","MENSLETLRFSISNLSMQTHAARMRTFMYWPSSVPVQPEQLASAGFYYVGRNDDVKCFCCDGGLRCWESGDDPWVEHAKWFPRCEFLIRMKGQEFVDEIQGRYPHLLEQLLSTSLEHHHHHH","Homo sapiens","BIRC2, API1, IAP2, MIHB, RNF48","Baculoviral IAP repeat-containing protein 2","1","3OZ1"
"3OZC",,"X-RAY DIFFRACTION",3.15,60.9,"VAPOR DIFFUSION, SITTING DROP",6.2,"0.2M NaCl, 0.1M phosphate buffer, 10% PEG 8000, pH 6.2, vapor diffusion, sitting drop, temperature 291K",291,,"4CT","3OZC",31.76,"1.93","1.93","Crystal Structure of human 5'-deoxy-5'-methyladenosine phosphorylase in complex with pCl-phenylthioDADMeImmA","MASGTTTTAVKIGIIGGTGLDDPEILEGRTEKYVDTPFGKPSDALILGKIKNVDCVLLARHGRQHTIMPSKVNYQANIWALKEEGCTHVIVTTACGSLREEIQPGDIVIIDQFIDRTTMRPQSFYDGSHSCARGVCHIPMAEPFCPKTREVLIETAKKLGLRCHSKGTMVTIEGPRFSSRAESFMFRTWGADVINMTTVPEVVLAKEAGICYASIAMATDYDCWKEHEEAVSVDRVLKTLKENANKAKSLLLTTIPQIGSTEWSETLHNLKNMAQFSVLLPRH","Homo sapiens","MTAP, MSAP","S-methyl-5'-thioadenosine phosphorylase","1","3OZC"
"3OZD",,"X-RAY DIFFRACTION",2.99,58.83,"VAPOR DIFFUSION, SITTING DROP",4.6,"2M NaCl, 0.1M sodium acetate, pH 4.6, vapor diffusion, sitting drop, temperature 291K",291,,"4CT","3OZD",63.33,"2.1","2.1","Crystal Structure of human 5'-deoxy-5'-methyladenosine phosphorylase in complex with pCl-phenylthioDADMeImmA","MASGTTTTAVKIGIIGGTGLDDPEILEGRTEKYVDTPFGKPSDALILGKIKNVDCVLLARHGRQHTIMPSKVNYQANIWALKEEGCTHVIVTTACGSLREEIQPGDIVIIDQFIDRTTMRPQSFYDGSHSCARGVCHIPMAEPFCPKTREVLIETAKKLGLRCHSKGTMVTIEGPRFSSRAESFMFRTWGADVINMTTVPEVVLAKEAGICYASIAMATDYDCWKEHEEAVSVDRVLKTLKENANKAKSLLLTTIPQIGSTEWSETLHNLKNMAQFSVLLPRH","Homo sapiens","MTAP, MSAP","S-methyl-5'-thioadenosine phosphorylase","1","3OZD"
"3OZE",,"X-RAY DIFFRACTION",2.26,45.52,"VAPOR DIFFUSION, SITTING DROP",7.5,"200mM NaCl, 0.1M Hepes, 20% PEG3000, pH 7.5, vapor diffusion, sitting drop, temperature 291K",291,,,"3OZE",188.23,"2","2","Crystal Structure of human 5'-deoxy-5'-methyladenosine phosphorylase","MASGTTTTAVKIGIIGGTGLDDPEILEGRTEKYVDTPFGKPSDALILGKIKNVDCVLLARHGRQHTIMPSKVNYQANIWALKEEGCTHVIVTTACGSLREEIQPGDIVIIDQFIDRTTMRPQSFYDGSHSCARGVCHIPMAEPFCPKTREVLIETAKKLGLRCHSKGTMVTIEGPRFSSRAESFMFRTWGADVINMTTVPEVVLAKEAGICYASIAMATDYDCWKEHEEAVSVDRVLKTLKENANKAKSLLLTTIPQIGSTEWSETLHNLKNMAQFSVLLPRH","Homo sapiens","MTAP, MSAP","S-methyl-5'-thioadenosine phosphorylase","1","3OZE"
"3OZK",,"X-RAY DIFFRACTION",2.14,42.61,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Hepes sodium pH 7.5, 28% PEG 400, 0.2 calcium chloride dihydrate, VAPOR DIFFUSION, HANGING DROP, temperature 293K, complex obtained by soaking crystal with ligand.",293,,"T44","3OZK",29.17,"1.9","1.9","Crystal structure of human transthyretin variant A25T in complex with thyroxine (T4)","GPTGTGESKCPLMVKVLDAVRGSPTINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3OZK"
"3OZL",,"X-RAY DIFFRACTION",2.22,44.61,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Hepes sodium pH 7.5, 28% PEG 400, 0.2 calcium chloride dihydrate, VAPOR DIFFUSION, HANGING DROP, temperature 293K, soaking for 1 h with ligand.",293,,"FLF","3OZL",28.18,"1.9","1.9","Crystal structure of human transthyretin variant A25T in complex with flufenamic acid.","GPTGTGESKCPLMVKVLDAVRGSPTINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3OZL"
"3P08",,"X-RAY DIFFRACTION",2.27,45.84,"VAPOR DIFFUSION, HANGING DROP",7,"equal volumes of well solution (0.2 M Na Malonate pH 7.0, 20% PEG 3350, 3% 6-aminocaproic acid) and protein solution (8 mg/mL in 100 mM NaCl, 10 mM Tris-HCL, pH8.5, 1mM TCEP) , VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"3P08",62.42,"2.3","2.3","Crystal structure of the human BTK kinase domain","GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","AGMX1, ATK, BPK, BTK","Tyrosine-protein kinase BTK","1","3P08"
"3P0C",,"X-RAY DIFFRACTION",2.49,50.57,"VAPOR DIFFUSION, SITTING DROP",9,"11% PEG monomethyl ether 2000, 0.3M NaCl, 0.1M Tris, 0.3M trimetylamine n-oxide, 1mM benzene 1,2,4-trisphosphate, pH 9.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3P0C",30.58,"2.273","2.273","Nischarin PX-domain","MHHHHHHSSGVDLGTENLYFQSMEARVVGSELVDTYTVYIIQVTDGSHEWTVKHRYSDFHDLHEKLVAERKIDKNLLPPKKIIGKNSRSLVEKREKDLEVYLQKLLAAFPGVTPRVLAHFLHFHFYEING","Homo sapiens","NISCH, IRAS, KIAA0975","Nischarin","1","3P0C"
"3P0E",,"X-RAY DIFFRACTION",2.72,54.83,"VAPOR DIFFUSION, HANGING DROP",5.5,"2.0M ammonium sulfate, 0.1 M Bis-Tris, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jsb.2011.08.002",,"3P0E",201.62,"2","2","Structure of hUPP2 in an active conformation with bound 5-benzylacyclouridine","GSSGKRFVHVKNPYLDLMDEDILYHLDLGTKTHNLPAMFGDVKFVCVGGSPNRMKAFALFMHKELGFEEAEEDIKDICAGTDRYCMYKTGPVLAISHGMGIPSISIMLHELIKLLHHARCCDVTIIRIGTSGGIGIAPGTVVITDIAVDSFFKPRFEQVILDNIVTRSTELDKELSEELFNCSKEIPNFPTLVGHTMCTYDFYEGQGRLDGALCSFSREKKLDYLKRAFKAGVRNIEMESTVFAAMCGLCGLKAAVVCVTLLDRLDCDQINLPHDVLVEYQQRPQLLISNFIRRRLG","Homo sapiens","UPP2","Uridine phosphorylase 2","1","3P0E"
"3P0F",,"X-RAY DIFFRACTION",2.54,51.53,"VAPOR DIFFUSION, HANGING DROP",8.5,"20% polyvinylpyrrolidone K15, 0.1M cobalt chloride, 0.1M Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jsb.2011.08.002",,"3P0F",33.65,"1.54","1.54","Structure of hUPP2 in an inactive conformation with bound 5-benzylacyclouridine","GSSGKRFVHVKNPYLDLMDEDILYHLDLGTKTHNLPAMFGDVKFVCVGGSPNRMKAFALFMHKELGFEEAEEDIKDICAGTDRYCMYKTGPVLAISHGMGIPSISIMLHELIKLLHHARCCDVTIIRIGTSGGIGIAPGTVVITDIAVDSFFKPRFEQVILDNIVTRSTELDKELSEELFNCSKEIPNFPTLVGHTMCTYDFYEGQGRLDGALCSFSREKKLDYLKRAFKAGVRNIEMESTVFAAMCGLCGLKAAVVCVTLLDRLDCDQINLPHDVLVEYQQRPQLLISNFIRRRLG","Homo sapiens","UPP2","Uridine phosphorylase 2","1","3P0F"
"3P0L",,"X-RAY DIFFRACTION",3.07,59.87,"VAPOR DIFFUSION",6.5,"200 mM Ca-acetate, 40 % PEG-300, 100 mM Na-Cacodylate, pH 6.5, VAPOR DIFFUSION, temperature 277K",277,"10.1371/journal.pone.0019521",,"3P0L",98.82,"3.4","3.4","Human steroidogenic acute regulatory protein","SMTLYSDQELAYLQQGEEAMQKALGILSNQEGWKKESQQDNGDKVMSKVVPDVGKVFRLEVVVDQPMERLYEELVERMEAMGEWNPNVKEIKVLQKIGKDTFITHELAAEAAGNLVGPRDFVSVRCAKRRGSTCVLAGMATDFGNMPEQKGVIRAEHGPTCMVLHPLAGSPSKTKLTWLLSIDLKGWLPKSIINQVLSQTQVDFANHLRKRLESHPASEAR","Homo sapiens","STAR, STARD1","Steroidogenic acute regulatory protein, mitochondrial","1","3P0L"
"3P0M",,"X-RAY DIFFRACTION",2.54,51.58,"VAPOR DIFFUSION, SITTING DROP",6.9,"5mM MES, 5mM BisTris-propane, 75mM LiCl, 1mM DTT, 0.1mM EDTA, equilibrated against water/ethanol, pH 6.9, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3P0M",43.41,"2.03","2.03","Human cAMP-dependent protein kinase in complex with an inhibitor","MGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF","Homo sapiens","PRKACA, PKACA","cAMP-dependent protein kinase catalytic subunit alpha","1","3P0M"
,,,,,,,,,,,,,,,,"TTYADFIASGRTGRRNAIHD",,,"cAMP-dependent protein kinase inhibitor alpha","2","3P0M"
"3P0N",,"X-RAY DIFFRACTION",2.44,49.52,"VAPOR DIFFUSION, SITTING DROP",8,"21% PEG3350, 0.2M ammonium sulfate, 0.1M Tris-HCl, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/nbt.2121",,"3P0N",55.83,"1.9","1.9","Human Tankyrase 2 - Catalytic PARP domain in complex with an inhibitor","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","3P0N"
"3P0P",,"X-RAY DIFFRACTION",2.4,48.78,"VAPOR DIFFUSION, SITTING DROP",8,"23% PEG3350, 0.2M ammonium sulfate, 0.1M Tris-HCl, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/nbt.2121",,"3P0P",55.69,"2.49","2.49","Human Tankyrase 2 - Catalytic PARP domain in complex with an inhibitor","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","3P0P"
"3P0Q",,"X-RAY DIFFRACTION",2.42,49.18,"VAPOR DIFFUSION, SITTING DROP",8.5,"21% PEG3350, 0.2M lithium sulfate, 0.1M Tris-HCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/nbt.2121",,"3P0Q",55.74,"1.9","1.9","Human Tankyrase 2 - Catalytic PARP domain in complex with an inhibitor","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","3P0Q"
"3P0U",,"X-RAY DIFFRACTION",3.75,67.22,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M (NH4)2SO4, 0.1M HEPES, 25% w/v PEG 3,350, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M110.168740",,"3P0U",56.2,"3","3","Crystal Structure of the ligand binding domain of human testicular receptor 4","RDQSTPIIEVEGPLLSDTHVTFKLTMPSPMPEYLNVHYICESASRLLFLSMHWARSIPAFQALGQDCNTSLVRACWNELFTLGLAQCAQVMSLSTILAAIVNHLQNSIQEDKLSGDRIKQVMEHIWKLQEFCNSMAKLDIDGYEYAYLKAIVLFSPDHPGLTSTSQIEKFQEAAQMELQDYVQATYSEDTYRLARILVRLPALRLMSSNITEELFFTGLIGNVSIDSIIPYILKMETAEYNGQITGASL","Homo sapiens","NR2C2, TAK1, TR4","Nuclear receptor subfamily 2 group C member 2","1","3P0U"
"3P0V",,"X-RAY DIFFRACTION",2.37,48.08,"VAPOR DIFFUSION, SITTING DROP",8.5,"MgCl/PEG3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.ccr.2011.09.003",,"3P0V",94.93,"2.85","2.85","anti-EGFR/HER3 Fab DL11 alone","DIQMTQSPSSLSASVGDRVTITCRASQDLATDVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSEPEPYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab DL11 light chain","1","3P0V"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVQPGGSLRLSCAASGFTLSGDWIHWVRQAPGKGLEWLGEISAAGGYTDYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARESRVSFEAAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTH","Homo sapiens",,"Fab DL11 heavy chain","2","3P0V"
"3P1A",,"X-RAY DIFFRACTION",2.12,42.09,"VAPOR DIFFUSION, SITTING DROP",6.5,"20% PEG 3350, 0.2M KSCN, 0.1M Bis-Tris Propane, pH 6.5, 10% Ethylene glycol , VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,,,"3P1A",35.28,"1.7","1.7","Structure of human Membrane-associated Tyrosine- and Threonine-specific cdc2-inhibitory kinase MYT1 (PKMYT1)","MHHHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP","Homo sapiens","MYT1, PKMYT1","Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase","1","3P1A"
"3P1C",,"X-RAY DIFFRACTION",2,38.54,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M KSCN 
25% PEG3350 
5% EtGly, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.cell.2012.02.013",,"3P1C",28.92,"1.82","1.82","Crystal structure of the bromodomain of human CREBBP in complex with acetylated lysine","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CBP, CREBBP","CREB-binding protein","1","3P1C"
"3P1D",,"X-RAY DIFFRACTION",2.01,38.82,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M KSCN 
20% PEG3350 
5% EtGly, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.cell.2012.02.013","MB3","3P1D",28.74,"1.86","1.86","Crystal structure of the bromodomain of human CREBBP in complex with N-Methyl-2-pyrrolidone (NMP)","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","3P1D"
"3P1E",,"X-RAY DIFFRACTION",2.04,39.6,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M KSCN  
25% PEG3350  
5% EtGly, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3P1E",28.7,"1.8","1.8","Crystal structure of the bromodomain of human CREBBP in complex with dimethyl sulfoxide (DMSO)","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","3P1E"
"3P1F",,"X-RAY DIFFRACTION",2.35,47.75,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.15M KSCN  
20% PEG3350  
10% EtGly, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,"3PF","3P1F",29.35,"1.63","1.63","Crystal structure of the bromodomain of human CREBBP in complex with a hydroquinazolin ligand","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","3P1F"
"3P1I",,"X-RAY DIFFRACTION",2.22,44.57,"VAPOR DIFFUSION, HANGING DROP",8,"1.6 M AMMONIUM SULFATE, 5% ISOPROPANOL, 0.1 M BIS-TRIS,PH 8.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291.1K",291.1,,,"3P1I",69.52,"2.1","2.1","Ligand binding domain of human ephrin type-B receptor 3","AAPEHHHHHHDYDIPTTENLYFQGAMDEETLMDTKWVTSELAWTSHPESGWEEVSGYDEAMNPIRTYQVCNVRESSQNNWLRTGFIWRRDVQRVYVELKFTVRDCNSIPNIPGSCKETFNLFYYEADSDVASASSPFWMENPYVKVDTIAPDESFSRLDAGRVNTKVRSFGPLSKAGFYLAFQDQGACMSLISVRAFYKK","Homo sapiens","EPHB3, ETK2, HEK2, TYR06, TYRO6","Ephrin type-B receptor 3","1","3P1I"
"3P1J",,"X-RAY DIFFRACTION",2.5,50.8,"VAPOR DIFFUSION, HANGING DROP",7.6,"5-fold molar excess of GDP was added to protein stock solution. 1.4M sodium citrate, 0.1M HEPES, pH 7.6, vapor diffusion, hanging drop, temperature 291K",291,,,"3P1J",92.72,"2.58","2.58","Crystal structure of human GTPase IMAP family member 2 in the nucleotide-free state","GSRSELRIILVGKTGTGKSAAGNSILRKQAFESKLGSQTLTKTCSKSQGSWGNREIVIIDTPDMFSWKDHCEALYKEVQRCYLLSAPGPHVLLLVTQLGRYTSQDQQAAQRVKEIFGEDAMGHTIVLFTHKEDLNGGSLMDYMHDSDNKALSKLVAACGGRICAFNNRAEGSNQDDQVKELMDCIEDLLMEKNGDHYTNGLYSLIQRSK","Homo sapiens","GIMAP2, IMAP2","GTPase IMAP family member 2","1","3P1J"
"3P1M",,"X-RAY DIFFRACTION",3.4,63.86,"VAPOR DIFFUSION, SITTING DROP",7.4,"1.75M Potassium Citrate (K3Cit), pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,,,"3P1M",120.18,"2.54","2.54","Crystal structure of human ferredoxin-1 (FDX1) in complex with iron-sulfur cluster","MSSSEDKITVHFINRDGETLTTKGKVGDSLLDVVVENNLDIDGFGACEGTLACSTCHLIFEDHIYEKLDAITDEENDMLDLAYGLTDRSRLGCQICLTKSMDNMTVRVPETVADARQSIDVGKTSAENLYFQ","Homo sapiens","ADX, FDX1","Adrenodoxin, mitochondrial","1","3P1M"
"3P1N",,"X-RAY DIFFRACTION",2.48,50.4,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.095M HEPES Na-Salt, 25.6% PEG 400, 0.19M CaCl2, 5% Glycerol, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.chembiol.2013.03.015",,"3P1N",27.47,"1.4","1.4","Crystal structure of human 14-3-3 sigma in complex with TASK-3 peptide","AMGSMERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSCEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTNPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWT","Homo sapiens","SFN, HME1","14-3-3 protein sigma","1","3P1N"
,,,,,,,,,,,,,,,,"KRRKSV",,,"6-mer peptide from Potassium channel subfamily K member 9","2","3P1N"
"3P1P",,"X-RAY DIFFRACTION",2.31,46.7,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.095M HEPES Na-Salt, 25.6% PEG 400, 0.19M CaCl2, 5% Glycerol, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 277.15K",277.15,"10.1016/j.chembiol.2013.03.015",,"3P1P",27.54,"1.95","1.95","Crystal structure of human 14-3-3 sigma C38N/N166H in complex with TASK-3 peptide","KRRKSV",,,"6-mer peptide from Potassium channel subfamily K member 9","2","3P1P"
,,,,,,,,,,,,,,,,"GAMGSMERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSNEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTHPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWT","Homo sapiens","SFN, HME1","14-3-3 protein sigma","1","3P1P"
"3P1Q",,"X-RAY DIFFRACTION",2.44,49.56,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.095M HEPES Na-Salt, 25.6% PEG 400, 0.19M CaCl2, 5% Glycerol, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 277.15K",277.15,"10.1016/j.chembiol.2013.03.015",,"3P1Q",28.24,"1.7","1.7","Crystal structure of human 14-3-3 sigma C38N/N166H in complex with TASK-3 Peptide and stabilizer fusicoccin A","GAMGSMERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSNEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTHPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWT","Homo sapiens","SFN, HME1","14-3-3 protein sigma","1","3P1Q"
,,,,,,,,,,,,,,,,"KRRKSV",,,"6-mer peptide from Potassium channel subfamily K member 9","2","3P1Q"
"3P1R",,"X-RAY DIFFRACTION",2.49,50.61,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.095M HEPES Na-Salt, 25.6% PEG 400, 0.19M CaCl2, 5% Glycerol, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.chembiol.2013.03.015",,"3P1R",27.7,"1.7","1.7","Crystal structure of human 14-3-3 sigma C38V/N166H in complex with TASK-3 peptide","GAMGSMERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSVEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTHPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWT","Homo sapiens","SFN, HME1","14-3-3 protein sigma","1","3P1R"
,,,,,,,,,,,,,,,,"KRRKSV",,,"6-mer peptide from Potassium channel subfamily K member 9","2","3P1R"
"3P1S",,"X-RAY DIFFRACTION",2.45,49.78,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.095M HEPES Na-Salt, 25.6% PEG 400, 0.19M CaCl2, 5% Glycerol, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 277.15K",277.15,"10.1016/j.chembiol.2013.03.015",,"3P1S",28.18,"1.65","1.65","Crystal structure of human 14-3-3 sigma C38N/N166H in complex with TASK-3 peptide and stabilizer fusicoccin A","GAMGSMERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSVEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTHPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWT","Homo sapiens","SFN, HME1","14-3-3 protein sigma","1","3P1S"
,,,,,,,,,,,,,,,,"KRRKSV",,,"6-mer peptide from Potassium channel subfamily K member 9","2","3P1S"
"3P1X",,"X-RAY DIFFRACTION",2.32,47.05,,8,"0.1M Sodium chloride, 0.1 M  Tris, pH (8, 24% (w/v) PEG 20K, microbatch under oil method, temperature 277K",277,,,"3P1X",16.82,"1.9","1.9","Crystal structure of DRBM 2 domain of Interleukin enhancer-binding factor 3 from Homo sapiens, Northeast Structural Genomics Consortium Target HR4527E","ILTKHGKNPVMELNEKRRGLKYELISETGGSHDKRFVMEVEVDGQKFQGAGSNKKVAKAYAALAALEKLFPDTPL","Homo sapiens","ILF3, DRBF, MPHOSPH4, NF90","Interleukin enhancer-binding factor 3","1","3P1X"
"3P23",,"X-RAY DIFFRACTION",2.67,53.98,"VAPOR DIFFUSION, HANGING DROP",7.5,"15% PEG 3350, 0.2M Ammonium Sulfate, pH7.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1038/emboj.2011.18","ADP","3P23",199.7,"2.7","2.7","Crystal structure of the Human kinase and RNase domains in complex with ADP","MGSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGTLPDDFVCYFTSRFPHLLAHTYRAMELCSHERLFQPYYFHEPPEPQPPVTPDAL","Homo sapiens","ERN1, IRE1","Serine/threonine-protein kinase/endoribonuclease IRE1","1","3P23"
"3P2B",,"X-RAY DIFFRACTION",2.24,45.03,"VAPOR DIFFUSION, HANGING DROP",8.5,"16-19% PEG 4000, 0.2M Sodium Acetate, 0.1M Sodium Citrate, 0.1M TRIS pH 8.5  
  
[Protein] ~6mg/mL in   
20mM Tris pH 7.2,   
50mM AmmSO4,   
1% Betaine,   
1% Ethylene Glycol,   
0.02% CHAPS,   
5mM DTT  
  
Drop: 1uL + 1uL, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.bmcl.2010.10.021",,"3P2B",111.11,"3.2","3.2","Crystal Structure of PI3K gamma with 3-(2-morpholino-6-(pyridin-3-ylamino)pyrimidin-4-yl)phenol","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVRLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG, PK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","3P2B"
"3P2T",,"X-RAY DIFFRACTION",2.54,51.64,"VAPOR DIFFUSION, HANGING DROP",8,"0.2M sodium sulfate heptahydrate, 20%(w/v) polyethylene glycol 3350, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M111.221028",,"3P2T",22.07,"1.699","1.699","Crystal Structure of Leukocyte Ig-like Receptor LILRB4 (ILT3/LIR-5/CD85k)","GPLPKPTLWAEPGSVISWGNSVTIWCQGTLEAREYRLDKEESPAPWDRQNPLEPKNKARFSIPSMTEDYAGRYRCYYRSPVGWSQPSDPLELVMTGAYSKPTLSALPSPLVTSGKSVTLLCQSRSPMDTFLLCKERAAHPLLCLRSEHGAQQHQAEFPMSPVTSVHGGTYRCFSSHGFSHYLLSHPSDPLELIVSG","Homo sapiens","LILRB4, ILT3, LIR5","Leukocyte immunoglobulin-like receptor subfamily B member 4","1","3P2T"
"3P2V",,"X-RAY DIFFRACTION",2.13,44.17,"VAPOR DIFFUSION, HANGING DROP",5,"20% PEG 6000, 120mM citrate buffer, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bbagen.2011.06.001","DOY","3P2V",37.27,"1.69","1.69","Novel Benzothiazepine Inhibitor in Complex with human Aldose Reductase","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","ALR2, AKR1B1, ALDR1","Aldose reductase","1","3P2V"
"3P2W",,"X-RAY DIFFRACTION",2.26,45.67,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM HEPES, 1.0-2.0M (NH4)2SO4, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/anie.201008019",,"3P2W",27.22,"1.66","1.66","Unliganded form of Polo-like kinase I Polo-box domain","GPLGSPEFDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSR","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","3P2W"
"3P2X",,"X-RAY DIFFRACTION",1.87,34.11,"VAPOR DIFFUSION, HANGING DROP",8.3,"0.05 M sodium citrate, 1% phenol, 0.04% zinc acetate, pH 8.3, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"3P2X",11.96,"2","2","Insulin fibrillation is the Janus face of induced fit. A chiaral clamp stabilizes the native state at the expense of activity","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","3P2X"
,,,,,,,,,,,,,,,,"FVNQHLCASHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin","2","3P2X"
"3P2Z",,"X-RAY DIFFRACTION",1.83,32.96,"VAPOR DIFFUSION, SITTING DROP",,"0.2M K/Na tartrate, 20% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/anie.201008019",,"3P2Z",27.58,"1.79","1.79","Polo-like kinase I Polo-box domain in complex with PLHSpTA phosphopeptide from PBIP1","GPLGSPEFDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSR","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","3P2Z"
,,,,,,,,,,,,,,,,"XPLHSTAX",,,"phosphopeptide","2","3P2Z"
"3P33",,"X-RAY DIFFRACTION",1.96,37.4,"VAPOR DIFFUSION, HANGING DROP",8.3,"0.05 M sodium citrate, 1% phenol, 0.04% zinc acetate, pH 8.3, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"3P33",24.05,"2.3","2.3","Insulin fibrillation is the Janus face of induced fit. A chiral clamp stabilizes the native state at the expense of activity","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","3P33"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin","2","3P33"
"3P34",,"X-RAY DIFFRACTION",2.33,47.2,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM HEPES, 1.0-2.0M (NH4)2SO4, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/anie.201008019",,"3P34",27.82,"1.4","1.4","Polo-like kinase I Polo-box domain in complex with MQSpTPL phosphopeptide","GPLGSPEFDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSR","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","3P34"
,,,,,,,,,,,,,,,,"XMQSTPLX",,,"phosphopeptide","2","3P34"
"3P35",,"X-RAY DIFFRACTION",2.1,41.42,"VAPOR DIFFUSION, SITTING DROP",,"0.2M potassium formate, 20% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/anie.201008019",,"3P35",82.26,"2.09","2.09","Polo-like kinase I Polo-box domain in complex with MQSpSPL phosphopeptide","GPLGSPEFDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSR","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","3P35"
,,,,,,,,,,,,,,,,"XMQSSPLX",,,"phosphopeptide","2","3P35"
"3P36",,"X-RAY DIFFRACTION",1.95,36.83,"VAPOR DIFFUSION, SITTING DROP",6.2,"100mM Na/K phosphate, 0.2M NaCl, 10% PEG 8000, pH 6.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/anie.201008019",,"3P36",27.88,"1.59","1.59","Polo-like kinase I Polo-box domain in complex with DPPLHSpTA phosphopeptide from PBIP1","GPLGSPEFDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSR","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","3P36"
,,,,,,,,,,,,,,,,"XDPPLHSTAX",,,"phosphopeptide","2","3P36"
"3P37",,"X-RAY DIFFRACTION",2,38.38,"VAPOR DIFFUSION, SITTING DROP",6.5,"100mM MES, 30% PEG 400, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/anie.201008019",,"3P37",83.9,"2.38","2.38","Polo-like kinase I Polo-box domain in complex with FDPPLHSpTA phosphopeptide from PBIP1","GPLGSPEFDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSR","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","3P37"
,,,,,,,,,,,,,,,,"XFDPPLHSTAX",,,"phosphopeptide","2","3P37"
"3P3H",,"X-RAY DIFFRACTION",2.1,41.54,"VAPOR DIFFUSION, HANGING DROP",9.5,"2.6M ammonium sulfate, 0.1M glycine, pH 9.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1039/c2cc15625c","84A","3P3H",29.85,"1.5","1.5","Human carbonic anhydrase II in complex with p-(5-ferrocenyl-1H-1,2,3-triazol-1-yl)benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3P3H"
"3P3J",,"X-RAY DIFFRACTION",2.11,41.82,"VAPOR DIFFUSION, HANGING DROP",6.5,"2.9M ammonium sulfate, 0.1M MES/NaOH, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1039/c2cc15625c","498","3P3J",29.89,"1.6","1.6","Human carbonic anhydrase II in complex with p-(5-ruthenocenyl-1H-1,2,3-triazol-1-yl)benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3P3J"
"3P3R",,"X-RAY DIFFRACTION",2.12,42.1,"VAPOR DIFFUSION, SITTING DROP",5.5,"The WT-TTR was concentrated to 4 mg/mL in 10 mM NaPi, 100 mM KCl, at pH 7.6 and co-crystallized at room temperature using the vapor-diffusion sitting drop method. Crystals were grown from 1.395 M sodium citrate, 3.5% v/v glycerol at pH 5.5. The crystals were frozen using a cryo-protectant solution of 1.395 M sodium citrate, pH 5.5, containing 10% v/v glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1126/scitranslmed.3002473","3M1","3P3R",28.11,"1.25","1.25","Transthyretin in complex with (3,4-dihydroxy-5-nitrophenyl)(2-fluorophenyl)methanone","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","PALB, TTR","Transthyretin","1","3P3R"
"3P3S",,"X-RAY DIFFRACTION",2.19,43.74,"VAPOR DIFFUSION, SITTING DROP",5.5,"The WT-TTR was concentrated to 4 mg/mL in 10 mM NaPi, 100 mM KCl, at pH 7.6 and co-crystallized at room temperature using the vapor-diffusion sitting drop method. Crystals were grown from 1.395 M sodium citrate, 3.5% v/v glycerol at pH 5.5. The crystals were frozen using a cryo-protectant solution of 1.395 M sodium citrate, pH 5.5, containing 10% v/v glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1126/scitranslmed.3002473","3M2","3P3S",29.05,"1.6","1.6","Human transthyretin (TTR) complexed with (Z)-5-(3,5-dibromo-4-hydroxybenzylidene)-imino-1-methylimidazolidin-4-one","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","PALB, TTR","Transthyretin","1","3P3S"
"3P3T",,"X-RAY DIFFRACTION",2.13,42.31,"VAPOR DIFFUSION, SITTING DROP",5.5,"The WT-TTR was concentrated to 4 mg/mL in 10 mM NaPi, 100 mM KCl, at pH 7.6 and co-crystallized at room temperature using the vapor-diffusion sitting drop method. Crystals were grown from 1.395 M sodium citrate, 3.5% v/v glycerol at pH 5.5. The crystals were frozen using a cryo-protectant solution of 1.395 M sodium citrate, pH 5.5, containing 10% v/v glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1126/scitranslmed.3002473","3M3","3P3T",28.05,"1.45","1.45","Human transthyretin (TTR) complexed with 4-(3-(2-flourophenoxy)propyl)-3,5-dimethyl-1H-pyrazole","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","PALB, TTR","Transthyretin","1","3P3T"
"3P3U",,"X-RAY DIFFRACTION",2.08,40.77,"VAPOR DIFFUSION, SITTING DROP",5.5,"The WT-TTR was concentrated to 4 mg/mL in 10 mM NaPi, 100 mM KCl, at pH 7.6 and co-crystallized at room temperature using the vapor-diffusion sitting drop method. Crystals were grown from 1.395 M sodium citrate, 3.5% v/v glycerol at pH 5.5. The crystals were frozen using a cryo-protectant solution of 1.395 M sodium citrate, pH 5.5, containing 10% v/v glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1126/scitranslmed.3002473","3M4","3P3U",28.09,"1.5","1.5","Human transthyretin (TTR) complexed with 5-(2-ethoxyphenyl)-3-(pyridin-4-yl)-1,2,4-oxadiazole","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","PALB, TTR","Transthyretin","1","3P3U"
"3P3Y",,"X-RAY DIFFRACTION",4.11,70.08,"VAPOR DIFFUSION, SITTING DROP",6.5,"1.4 ammonium sulfate, 0.1 M cacodylate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1074/jbc.M110.180281",,"3P3Y",45.51,"2.6","2.6","Crystal structure of neurofascin homophilic adhesion complex in space group p6522","IEIPMDPSIQNELTQPPTITKQSAKDHIVDPRDNILIECEAKGNPAPSFHWTRNSRFFNIAKDPRVSMRRRSGTLVIDFRSGGRPEEYEGEYQCFARNKFGTALSNRIRLQVSKSPLWPKENLDPVVVQEGAPLTLQCNPPPGLPSPVIFWMSSSMEPITQDKRVSQGHNGDLYFSNVMLQDMQTDYSCNARFHFTHTIQQKNPFTLKVLTTRGVAERTPSFMYPQGTASSQMVLRGMDLLLECIASGVPTPDIAWYKKGGDLPSDKAKFENFNKALRITNVSEEDSGEYFCLASNKMGSIRHTISVRVKAAPYWLDEPKNLILAPGEDGRLVCRANGNPKPTVQWMVNGEPLQSAPPNPNREVAGDTIIFRDTQISSRAVYQCNTSNEHGYLLANAFVSVLDV","Homo sapiens","NFASC, KIAA0756","Neurofascin","1","3P3Y"
"3P40",,"X-RAY DIFFRACTION",3.61,65.9,"VAPOR DIFFUSION, SITTING DROP",7.5,"30%(w/v) PEG400, 0.1 M HEPES, 0.2 lithium sulfate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M110.180281",,"3P40",45.51,"3.2","3.2","Crystal structure of neurofascin adhesion complex in space group p3221","IEIPMDPSIQNELTQPPTITKQSAKDHIVDPRDNILIECEAKGNPAPSFHWTRNSRFFNIAKDPRVSMRRRSGTLVIDFRSGGRPEEYEGEYQCFARNKFGTALSNRIRLQVSKSPLWPKENLDPVVVQEGAPLTLQCNPPPGLPSPVIFWMSSSMEPITQDKRVSQGHNGDLYFSNVMLQDMQTDYSCNARFHFTHTIQQKNPFTLKVLTTRGVAERTPSFMYPQGTASSQMVLRGMDLLLECIASGVPTPDIAWYKKGGDLPSDKAKFENFNKALRITNVSEEDSGEYFCLASNKMGSIRHTISVRVKAAPYWLDEPKNLILAPGEDGRLVCRANGNPKPTVQWMVNGEPLQSAPPNPNREVAGDTIIFRDTQISSRAVYQCNTSNEHGYLLANAFVSVLDV","Homo sapiens","NFASC, KIAA0756","Neurofascin","1","3P40"
"3P44",,"X-RAY DIFFRACTION",2.11,41.58,"VAPOR DIFFUSION, HANGING DROP",6.5,"2.9M ammonium sulfate, 0.1M MES/NaOH, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1039/c2cc15625c",,"3P44",29.98,"2.2","2.2","Human carbonic anhydrase II in complex with p-(4-ruthenocenyl-1H-1,2,3-triazol-1-yl)benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3P44"
"3P45",,"X-RAY DIFFRACTION",2.28,46.12,"VAPOR DIFFUSION, HANGING DROP",7.4,"3.3 M sodium nitrate, 0.1 M Tris, 0.5 % ethyl acetate, 5 mM THP, pH 7.4, vapor diffusion, hanging drop, temperature 293K",293,,,"3P45",263,"2.53","2.53","Crystal structure of apo-caspase-6 at physiological pH","MSSASGLRRGHPAGGEENMTETDAFYKREMFDPAEKYKMDHRRRGIALIFNHERFFWHLTLPERRGTCADRDNLTRRFSDLGFEVKCFNDLKAEELLLKIHEVSTVSHADADCFVCVFLSHGEGNHIYAYDAKIEIQTLTGLFKGDKCHSLVGKPKIFIIQACRGNQHDVPVIPLDVVD","Homo sapiens","CASP6, MCH2","caspase-6","1","3P45"
,,,,,,,,,,,,,,,,"DAASVYTLPAGADFLMCYSVAEGYYSHRETVNGSWYIQDLCEMLGKYGSSLEFTELLTLVNRKVSQRRVDFCKDPSAIGKKQVPCFASMLTKKLHFFPKSNRHHHHHH","Homo sapiens","CASP6, MCH2","caspase-6","2","3P45"
"3P4L",,"X-RAY DIFFRACTION",2.5,51,,8.5,"25% PEG-3350, 0.2m ammonium sulfate, 0.1m TRIS, pH 8.5, temperature 293k, VAPOR DIFFUSION, HANGING DROP",293,"10.1016/j.jsb.2010.10.005",,"3P4L",23.9,"1.8","1.8","Crystal structure of a hemojuvelin-binding fragment of neogenin","ADLPMMPPVGVQASILSHDTIRITWADNSLPKHQKITDSRYYTVRWKTNIPANTKYKNANATTLSYLVTGLKPNTLYEFSVMVTKGRRSSTWSMTAHGTTFELVPTSPPKDVTVVSKEGKPKTIIVNWQPPSEANGKITGYIIYYSTDVNAEIHDWVIEPVVGNRLTHQIQELTLDTPYYFKIQARNSKGMGPMSEAVQFRTPKAHHHHHH","Homo sapiens","NEO1, IGDCC2, NGN","Neogenin","1","3P4L"
"3P4U",,"X-RAY DIFFRACTION",2.05,40.06,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.05 M calcium acetate, 0.1 M sodium cacodylate pH 5.5 and 12% PEG 8000, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3P4U",63.04,"1.9","1.9","Crystal structure of active caspase-6 in complex with Ac-VEID-CHO inhibitor","DAFYKREMFDPAEKYKMDHRRRGIALIFNHERFFWHLTLPERRGTCADRDNLTRRFSDLGFEVKCFNDLKAEELLLKIHEVSTVSHADADCFVCVFLSHGEGNHIYAYDAKIEIQTLTGLFKGDKCHSLVGKPKIFIIQACRGNQHDVPVIPLDVVD","Homo sapiens","CASP6, MCH2","Caspase-6","1","3P4U"
,,,,,,,,,,,,,,,,"DAASVYTLPAGADFLMCYSVAEGYYSHRETVNGSWYIQDLCEMLGKYGSSLEFTELLTLVNRKVSQRRVDFCKDPSAIGKKQVPCFASMLTKKLHFFPKSNRHHHHHH","Homo sapiens","CASP6, MCH2","Caspase-6","2","3P4U"
,,,,,,,,,,,,,,,,"XVEIX",,,"Ac-VEID-CHO inhibitor","3","3P4U"
"3P4V",,"X-RAY DIFFRACTION",2.09,41.09,"VAPOR DIFFUSION, HANGING DROP",9.5,"3.2M (NH4)2SO4, 0.1M Glycine, pH 9.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1021/jm1013242","PMX","3P4V",29.68,"2","2","Human carbonic anhydrase II in complex with (+)-Xylariamide A","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3P4V"
"3P53",,"X-RAY DIFFRACTION",2.25,45.29,"VAPOR DIFFUSION, HANGING DROP",8,"24% PEG 3350, 0.2 M Lithium Acetate, 1mM DTT, 4% glycerol, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M111.251439",,"3P53",112.33,"2","2","Structure of fascin","AGHMTANGTAEAVQIQFGLINCGNKYLTAEAFGFKVNASASSLKKKQIWTLEQPPDEAGSAAVCLRSHLGRYLAADKDGNVTCEREVPGPDCRFLIVAHDDGRWSLQSEAHRRYFGGTEDRLSCFAQTVSPAEKWSVHIAMHPQVNIYSVTRKRYAHLSARPADEIAVDRDVPWGVDSLITLAFQDQRYSVQTADHRFLRHDGRLVARPEPATGYTLEFRSGKVAFRDCEGRYLAPSGPSGTLKAGKATKVGKDELFALEQSCAQVVLQAANERNVSTRQGMDLSANQDEETDQETFQLEIDRDTKKCAFRTHTGKYWTLTATGGVQSTASSKNASCYFDIEWRDRRITLRASNGKFVTSKKNGQLAASVETAGDSELFLMKLINRPIIVFRGEHGFIGCRKVTGTLDANRSSYDVFQLEFNDGAYNIKDSTGKYWTVGSDSAVTSSGDTPVDFFFEFCDYNKVAIKVGGRYLKGDHAGVLKASAETVDPASLWEY","Homo sapiens","FAN1, FSCN1, HSN, Human, SNL","Fascin","1","3P53"
"3P55",,"X-RAY DIFFRACTION",2.1,41.55,"VAPOR DIFFUSION, HANGING DROP",6.5,"2.9M ammonium sulfate, 0.1M MES/NaOH, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1039/c2cc15625c","670","3P55",29.94,"2","2","Human carbonic anhydrase II in complex with p-(4-ferrocenyl-1H-1,2,3-triazol-1-yl)benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3P55"
"3P58",,"X-RAY DIFFRACTION",2.06,40.43,"VAPOR DIFFUSION, HANGING DROP",8,"1.6M Sodium Citrate. 50mM Tris-Cl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1039/c2cc16395k","P58","3P58",29.55,"1.49","1.49","Human Carbonic Anhydrase in complex with Benzyl (Methyl) Carbamodithoic Acid","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3P58"
"3P5A",,"X-RAY DIFFRACTION",2.08,40.85,"VAPOR DIFFUSION, HANGING DROP",8,"1.6M Sodium Citrate, 50 mM Tris-Cl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm300031j","IT2","3P5A",29.6,"1.49","1.49","Human Carbonic Anhydrase complexed with Sodium morpholinocarbodithioate","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3P5A"
"3P5D",,"X-RAY DIFFRACTION",2.26,45.69,"VAPOR DIFFUSION, HANGING DROP",7,"protein solution: 5 mg/mL langerin CRD, 2.5 mM CaCl2, 10 mM Tris pH 8.0, 25 mM NaCl and 10 mM Man5. reservoir solution: 0.1 M Hepes pH 7.0, 0.25 M MgCl2 and 25% polyethylene glycol 4000, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jmb.2010.11.039",,"3P5D",63.35,"1.8013","1.8013","Structure of the carbohydrate-recognition domain of human Langerin with man5 (Man alpha1-3(Man alpha1-6)Man alpha1-6)(Man- alpha1-3)Man","QVVSQGWKYFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAGGLIYWIGLTKAGMEGDWSWVDDTPFNKVQSARFWIPGEPNNAGNNEHCGNIKAPSLQAWNDAPCDKTFLFICKRPYVPSEP","Homo sapiens","CD207, CLEC4K","C-type lectin domain family 4 member K","1","3P5D"
"3P5E",,"X-RAY DIFFRACTION",2.26,45.59,"VAPOR DIFFUSION, HANGING DROP",7,"protein solution: 5 mg/mL langerin CRD, 2.5 mM CaCl2, 10 mM Tris pH 8.0, 25 mM NaCl and 10 mM Man4. reservoir solution: 0.1 M Hepes pH 7.0, 0.25 M MgCl2 and 31% polyethylene glycol 4000, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jmb.2010.11.039",,"3P5E",63.19,"1.7012","1.7012","Structure of the carbohydrate-recognition domain of human Langerin with man4 (Man alpha1-3(Man alpha1-6)Man alpha1-6Man)","QVVSQGWKYFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAGGLIYWIGLTKAGMEGDWSWVDDTPFNKVQSARFWIPGEPNNAGNNEHCGNIKAPSLQAWNDAPCDKTFLFICKRPYVPSEP","Homo sapiens","CD207, CLEC4K","C-type lectin domain family 4 member K","1","3P5E"
"3P5F",,"X-RAY DIFFRACTION",2.31,46.76,"VAPOR DIFFUSION, HANGING DROP",7,"protein solution: 5 mg mL-1 langerin CRD, 2.5 mM CaCl2, 10 mM Tris pH 8.0, 25 mM NaCl and 30 mM Man5. reservoir solution: 0.1 M Hepes pH 7.0, 0.10 M MgCl2 and 25% polyethylene glycol 4000, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jmb.2010.11.039",,"3P5F",63.69,"1.7501","1.7501","Structure of the carbohydrate-recognition domain of human Langerin with man2 (Man alpha1-2 Man)","QVVSQGWKYFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAGGLIYWIGLTKAGMEGDWSWVDDTPFNKVQSARFWIPGEPNNAGNNEHCGNIKAPSLQAWNDAPCDKTFLFICKRPYVPSEP","Homo sapiens","CD207, CLEC4K","C-type lectin domain family 4 member K","1","3P5F"
"3P5G",,"X-RAY DIFFRACTION",2.31,46.69,"VAPOR DIFFUSION, HANGING DROP",7,"protein solution: 5 mg mL-1 langerin CRD, 2.5 mM CaCl2, 10 mM Tris pH 8.0, 25 mM NaCl and 5 mM GB. reservoir solution: 0.1 M Hepes pH 7.0, 0.25 M MgCl2 and 20% polyethylene glycol 4000, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jmb.2010.11.039",,"3P5G",63.78,"1.6027","1.6027","Structure of the carbohydrate-recognition domain of human Langerin with Blood group B trisaccharide (Gal alpha1-3(Fuc alpha1-2)Gal)","QVVSQGWKYFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAGGLIYWIGLTKAGMEGDWSWVDDTPFNKVQSARFWIPGEPNNAGNNEHCGNIKAPSLQAWNDAPCDKTFLFICKRPYVPSEP","Homo sapiens","CD207, CLEC4K","C-type lectin domain family 4 member K","1","3P5G"
"3P5H",,"X-RAY DIFFRACTION",2.34,47.34,"VAPOR DIFFUSION, HANGING DROP",7,"protein solution: 2.5 mg mL-1 langerin CRD, 1.25 mM CaCl2, 5 mM Tris pH 8.0, 12.5 mM NaCl and 15 mM Laminaritriose. reservoir solution: 0.1 M Hepes pH 7.0, 0.1 M MgCl2 and 20% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jmb.2010.11.039",,"3P5H",63.51,"1.6051","1.6051","Structure of the carbohydrate-recognition domain of human Langerin with Laminaritriose","QVVSQGWKYFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAGGLIYWIGLTKAGMEGDWSWVDDTPFNKVQSARFWIPGEPNNAGNNEHCGNIKAPSLQAWNDAPCDKTFLFICKRPYVPSEP","Homo sapiens","CD207, CLEC4K","C-type lectin domain family 4 member K","1","3P5H"
"3P5I",,"X-RAY DIFFRACTION",2.32,46.96,"VAPOR DIFFUSION, HANGING DROP",7,"protein solution: 2.5 mg/mL langerin CRD, 1.25 mM CaCl2, 5 mM Tris pH 8.0, 12.5 mM NaCl and 7.5 mM 6SO4-Gal-GlcNAc. reservoir solution: 0.1 M Hepes pH 7.0, 0.1 M MgCl2 and 25% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.jmb.2010.11.039",,"3P5I",64.32,"1.8","1.8","Structure of the carbohydrate-recognition domain of human Langerin with 6-SO4-Gal-GlcNAc","QVVSQGWKYFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAGGLIYWIGLTKAGMEGDWSWVDDTPFNKVQSARFWIPGEPNNAGNNEHCGNIKAPSLQAWNDAPCDKTFLFICKRPYVPSEP","Homo sapiens","CD207, CLEC4K","C-type lectin domain family 4 member K","1","3P5I"
"3P5L",,"X-RAY DIFFRACTION",2.09,41.03,"VAPOR DIFFUSION, HANGING DROP",8,"1.6M Sodium Citrate, 50mM Tris-Cl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1039/c2cc16395k","IT5","3P5L",29.69,"1.498","1.498","Human Carbonic Anhydrase complexed with sodium 4-cyano-4-phenylpiperidine-1-carbodithioate","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3P5L"
"3P5O",,"X-RAY DIFFRACTION",2.15,42.85,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M NaNO3, 20% PEG 3350, 10% ethylene glycol, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nature09589","EAM","3P5O",15.77,"1.6","1.6","Crystal Structure of the First Bromodomain of Human Brd4 in complex with IBET inhibitor","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","3P5O"
"3P6A",,"X-RAY DIFFRACTION",3.98,69.08,,,"2.7-3.0M sodium formate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3P6A",87.82,"2.5","2.5","Crystal Structure of the DH/PH domains of p115-RhoGEF (R399E mutant)","GIQTSPPGWEELVPPDTLHSLPKSQVKRQEVISELLVTEAAHVRMLRVLHDLFFQPMAECLFFPLEELQNIFPSLDELIEVHSLFLDRLMKRRQESGYLIEEIGDVLLARFDGAEGSWFQKISSRFCSRQSFALEQLKAKQRKDPRFCAFVQEAESRPRCRRLQLKDMIPTEMQRLTKYPLLLQSIGQNTEEPTEREKVELAAECCREILHHVNQAVRDMEDLLRLKDYQRRLDLSHLRQSSDPMLSEFKNLDITKKKLVHEGPLTWRVTKDKAVEVHVLLLDDLLLLLQRQDERLLLKSHSRTLTPTPDGKTMLRPVLRLTSAMTREVATDHKAFYVLFTWDQEAQIYELVAQTVSERKNWCALITETAGSLKVPA","Homo sapiens","ARHGEF1","Rho guanine nucleotide exchange factor 1","1","3P6A"
"3P6C",,"X-RAY DIFFRACTION",2.08,40.9,"VAPOR DIFFUSION",6.5,"1.6 M sodium citrate, pH 6.5, vapor diffusion, temperature 293K",293,"10.1107/S2053230X14027897",,"3P6C",15.68,"1.25","1.25","Human adipocyte lipid-binding protein FABP4 in complex with citric acid","QQMGRGSMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","3P6C"
"3P6D",,"X-RAY DIFFRACTION",2.08,41,"VAPOR DIFFUSION",6.5,"1.6 M sodium citrate, pH 6.5, vapor diffusion, temperature 293K",293,"10.1107/S2053230X14027897",,"3P6D",15.68,"1.06","1.06","Human adipocyte lipid-binding protein FABP4 in complex with 3-(4-methoxy-3-methylphenyl) propionic acid","QQMGRGSMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","3P6D"
"3P6E",,"X-RAY DIFFRACTION",2.07,40.45,"VAPOR DIFFUSION",6.5,"1.6 M sodium citrate, pH 6.5, vapor diffusion, temperature 293K",293,"10.1107/S2053230X14027897",,"3P6E",15.67,"1.08","1.08","Human adipocyte lipid-binding protein FABP4 in complex with 3-(4-methoxyphenyl) propionic acid","QQMGRGSMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","3P6E"
"3P6F",,"X-RAY DIFFRACTION",2.09,41.16,"VAPOR DIFFUSION",6.5,"1.6 M sodium citrate, pH 6.5, VAPOR DIFFUSION, temperature 293K",293,"10.1107/S2053230X14027897",,"3P6F",15.65,"1.2","1.2","Human adipocyte lipid-binding protein FABP4 in complex with (S)-3-phenyl butyric acid","QQMGRGSMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","3P6F"
"3P6G",,"X-RAY DIFFRACTION",2.09,41.19,"VAPOR DIFFUSION",6.5,"1.6 M sodium citrate, pH 6.5, vapor diffusion, temperature 293K",293,"10.1107/S2053230X14027897",,"3P6G",15.69,"1.2","1.2","Human adipocyte lipid-binding protein FABP4 in complex with (R)-ibuprofen","QQMGRGSMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","3P6G"
"3P6H",,"X-RAY DIFFRACTION",2.09,41.16,"VAPOR DIFFUSION",6.5,"1.6 M sodium citrate, pH 6.5, vapor diffusion, temperature 293K",293,"10.1107/S2053230X14027897",,"3P6H",15.69,"1.15","1.15","Human adipocyte lipid-binding protein FABP4 in complex with (S)-ibuprofen","QQMGRGSMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","3P6H"
"3P72",,"X-RAY DIFFRACTION",2.61,52.79,"VAPOR DIFFUSION, SITTING DROP",8.2,"1.9M ammonium sulfate, 80mM lithium sulfate, 100mM N-cyclohexyl-3-aminopropanesulfonic acid buffer. 1:1 mix buffer with 4mg/mL protein. lyophilised peptide added directly to crystallised protein drops., pH 8.2, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1182/blood-2009-05-224170",,"3P72",31.25,"1.9","1.9","structure of platelet Glycoprotein 1b alpha with a bound peptide inhibitor","HPICEVSKVASHLEVNCDKRQLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRCELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNQLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQDNAENVYVWKQGVDVKAMTSNVASVQCDNSDKFPVYKYPGKGCPLVPR","Homo sapiens","GP1BA","Platelet glycoprotein Ib alpha chain","1","3P72"
,,,,,,,,,,,,,,,,"CTERMALHNLC",,,"OS1 peptide","2","3P72"
"3P7F",,"X-RAY DIFFRACTION",2.14,42.59,"VAPOR DIFFUSION, SITTING DROP",6.9,"Protein: 10mg/ml Langerin in 10 mM Tris/HCl pH 7.5; Reservoir: 0.1 M Na-cacodylate, 13 %(w/v) PEG4000, 0.1 M MgCl2, 5mM CaCl2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.molimm.2007.10.030",,"3P7F",67.38,"2.5","2.5","Structure of the human Langerin carbohydrate recognition domain","QVVSQGWKYFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAGGLIYWIGLTKAGMEGDWSWVDDTPFNKVQSVRFWIPGEPNNAGNNEHCGNIKAPSLQAWNDAPCDKTFLFICKRPYVPSEPSAWSHPQFEK","Homo sapiens","CD207, CLEC4K, Leucocyte cDNA","C-type lectin domain family 4 member K","1","3P7F"
"3P7G",,"X-RAY DIFFRACTION",2.12,41.99,"VAPOR DIFFUSION, SITTING DROP",6.9,"Protein: 10mg/ml Langerin in 10 mM Tris/HCl pH 7.5, 5 mM Mannose; Reservoir: 0.1 M Na-cacodylate, 13 %(w/v) PEG4000, 0.1 M MgCl2, 5mM CaCl2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.molimm.2007.10.030",,"3P7G",68.29,"1.5","1.5","Structure of the human Langerin carbohydrate recognition domain in complex with mannose","QVVSQGWKYFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAGGLIYWIGLTKAGMEGDWSWVDDTPFNKVQSVRFWIPGEPNNAGNNEHCGNIKAPSLQAWNDAPCDKTFLFICKRPYVPSEPSAWSHPQFEK","Homo sapiens","CD207, CLEC4K, Leucocyte cDNA","C-type lectin domain family 4 member K","1","3P7G"
"3P7H",,"X-RAY DIFFRACTION",2.16,42.98,"VAPOR DIFFUSION, SITTING DROP",6.9,"Protein: 10mg/ml Langerin in 10 mM Tris/HCl pH 7.5, 5 mM Maltose; Reservoir: 0.1 M Na-cacodylate, 13 %(w/v) PEG4000, 0.1 M MgCl2, 5mM CaCl2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.molimm.2007.10.030",,"3P7H",68.94,"2.3","2.3","Structure of the human Langerin carbohydrate recognition domain in complex with maltose","QVVSQGWKYFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQEFLYKTAGGLIYWIGLTKAGMEGDWSWVDDTPFNKVQSVRFWIPGEPNNAGNNEHCGNIKAPSLQAWNDAPCDKTFLFICKRPYVPSEPSAWSHPQFEK","Homo sapiens","CD207, CLEC4K, Leucocyte cDNA","C-type lectin domain family 4 member K","1","3P7H"
"3P7Z",,"X-RAY DIFFRACTION",3.15,60.91,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES, 7.5% PEG 4000, 0.2M Na4P207, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1002/humu.21405",,"3P7Z",65.1,"2.65","2.65","Crystal structure of the Neurofibromin Sec14-PH module containing the patient derived mutation I1584V","GAMGSSKFEEFMTRHQVHEKEEFKALKTLSIFYQAGTSKAGNPVFYYVARRFKTGQINGDLLIYHVLLTLKPYYAKPYEIVVDLTHTGPSNRFKTDFLSKWFVVFPGFAYDNVSAVYIYNCNSWVREYTKYHERLLTGLKGSKRLVFIDCPGKLAEHIEHEQQKLPAATLALEEDLKVFHNALKLAHKDTKVSIKVGSTAVQVTSAERTKVLGQSVFLNDIYYASEIEEICLVDENQFTLTIANQGTPLTFMHQECEAIVQSIIHIRTRWELSQPD","Homo sapiens","NF1","Neurofibromin","1","3P7Z"
"3P8D",,"X-RAY DIFFRACTION",3.73,67.04,"VAPOR DIFFUSION, HANGING DROP",8.5,"12% PEG8000, 0.1 M Tris-HCl, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1038/nsmb.2353",,"3P8D",15.18,"2","2","Crystal structure of the second Tudor domain of human PHF20 (homodimer form)","GHMSSEFQINEQVLACWSDCRFYPAKVTAVNKDGTYTVKFYDGVVQTVKHIHVKAFSKDQNIVGNAR","Homo sapiens","PHF20, C20orf104, GLEA2, HCA58, NZF, TZP","Medulloblastoma antigen MU-MB-50.72","1","3P8D"
"3P8E",,"X-RAY DIFFRACTION",2.1,41.54,"VAPOR DIFFUSION, SITTING DROP",8.2,"20% polyethyleneglycol 6000, 0.1 M Tris-HCl, pH 8.2, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1002/cmdc.201000392","LN7","3P8E",67.68,"2.4946","2.4946","Crystal structure of human DIMETHYLARGININE DIMETHYLAMINOHYDROLASE-1 (DDAH-1) covalently bound with N5-(1-iminopentyl)-L-ornithine","MGSSHHHHHHSSGLVPRGSHMASMAGLGHPAAFGRATHAVVRALPESLGQHALRSAKGEEVDVARAERQHQLYVGVLGSKLGLQVVELPADESLPDCVFVEDVAVVCEETALITRPGAPSRRKEVDMMKEALEKLQLNIVEMKDENATLDGGDVLFTGREFFVGLSKRTNQRGAEILADTFKDYAVSTVPVADGLHLKSFCSMAGPNLIAIGSSESAQKALKIMQQMSDHRYDKLTVPDDIAANCIYLNIPNKGHVLLHRTPEEYPESAKVYEKLKDHMLIPVSMSELEKVDGLLTCCSVLINKKVDS","Homo sapiens","DDAH, DDAH1","N(G),N(G)-dimethylarginine dimethylaminohydrolase 1","1","3P8E"
"3P8G",,"X-RAY DIFFRACTION",2.33,47.13,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris.HCl, pH 8.0, 1.5M ammonium sulfate, 3% ethanol, vapor diffusion, hanging drop, temperature 297K",297,"10.1186/1472-6807-11-30",,"3P8G",27.44,"1.2","1.2","Crystal Structure of MT-SP1 in complex with benzamidine","VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTAFLGLHDQSQRSAPGVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVRPICLPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVIQQTTCENLLPQQITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKENTGV","Homo sapiens","ST14, PRSS14, SNC19, TADG15","ST14 protein","1","3P8G"
"3P8H",,"X-RAY DIFFRACTION",2.64,53.4,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG3350, 0.1M Ammonium sulfate, 0.1M Bis-Tris pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/jm200045v","P8H","3P8H",112.48,"2.55","2.55","Crystal structure of L3MBTL1 (MBT repeat) in complex with a nicotinamide antagonist","GEKKECWSWESYLEEQKAITAPVSLFQDSQAVTHNKNGFKLGMKLEGIDPQHPSMYFILTVAEVCGYRLRLHFDGYSECHDFWVNANSPDIHPAGWFEKTGHKLQPPKGYKEEEFSWSQYLRSTRAQAAPKHLFVSQSHSPPPLGFQVGMKLEAVDRMNPSLVCVASVTDVVDSRFLVHFDNWDDTYDYWCDPSSPYIHPVGWCQKQGKPLTPPQDYPDPDNFCWEKYLEETGASAVPTWAFKVRPPHSFLVNMKLEAVDRRNPALIRVASVEDVEDHRIKIHFDGWSHGYDFWIDADHPDIHPAGWCSKTGHPLQPPLGPRE","Homo sapiens","KIAA0681, L3MBT, L3MBTL, L3MBTL1","Lethal(3)malignant brain tumor-like protein","1","3P8H"
"3P8P",,"X-RAY DIFFRACTION",2.06,40.27,"VAPOR DIFFUSION, HANGING DROP",8,"23% polyethyleneglycol 6000, 0.1 M Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1002/cmdc.201000392","LN6","3P8P",67.65,"2.5","2.5","Crystal Structure of Human Dimethylarginine Dimethylaminohydrolase-1 (DDAH-1) variant C274S bound with N5-(1-iminopentyl)-L-ornithine","MGSSHHHHHHSSGLVPRGSHMASMAGLGHPAAFGRATHAVVRALPESLGQHALRSAKGEEVDVARAERQHQLYVGVLGSKLGLQVVELPADESLPDCVFVEDVAVVCEETALITRPGAPSRRKEVDMMKEALEKLQLNIVEMKDENATLDGGDVLFTGREFFVGLSKRTNQRGAEILADTFKDYAVSTVPVADGLHLKSFCSMAGPNLIAIGSSESAQKALKIMQQMSDHRYDKLTVPDDIAANCIYLNIPNKGHVLLHRTPEEYPESAKVYEKLKDHMLIPVSMSELEKVDGLLTSCSVLINKKVDS","Homo sapiens","DDAH, DDAH1","N(G),N(G)-dimethylarginine dimethylaminohydrolase 1","1","3P8P"
"3P8W",,"X-RAY DIFFRACTION",2.11,41.7,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Bis-Tris, 25% (w/v) PEG 2000 monomethyl ether, 0.02% azide, 1 mM DTT, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3P8W",26.93,"2","2","Crystal Structure Analysis of R29M/E81M double mutant of human CLIC1","MAEEQPQVELFVKAGSDGAKIGNCPFSQMLFMVLWLKGVTFNVTTVDTKRRTETVQKLCPGGQLPFLLYGTEVHTDTNKIMEFLEAVLCPPRYPKLAALNPESNTAGLDIFAKFSAYIKNSNPALNDNLEKGLLKALKVLDNYLTSPLPEEVDETSAEDEGVSQRKFLDGNELTLADCNLLPKLHIVQVVCKKYRGFTIPEAFRGVHRYLSNAYAREEFASTCPDDEEIELAYEQVAKALK","Homo sapiens","CLIC1, G6, NCC27","Chloride intracellular channel protein 1","1","3P8W"
"3P8X",,"X-RAY DIFFRACTION",2.37,48.09,"VAPOR DIFFUSION, HANGING DROP",6.5,"NH4 sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1002/cmdc.201100021",,"3P8X",32.3,"1.7","1.7","Synthesis, Structure, and Biological Activity of des-Side Chain Analogues of 1alpha,25-Dihydroxyvitamin D3 with Substituents at C-18","MGSSHHHHHHSSGLVPRGSHMDSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEIS","Homo sapiens","VDR, NR1I1","Vitamin D3 receptor","1","3P8X"
,,,,,,,,,,,,,,,,,"Homo sapiens","VDR, NR1I1"
"3P90",,"X-RAY DIFFRACTION",2.15,42.69,"hanging drop",6.5,"0.1 M Bis-Tris, 30% (v/v) PEG 550 monomethyl ether, 0.05 M calcium chloride, 5 mM DTT, pH 6.5, hanging drop, temperature 293K",293,"10.1021/bi201541w",,"3P90",26.96,"2.3","2.3","Crystal Structure Analysis of H207F Mutant of Human CLIC1","MAEEQPQVELFVKAGSDGAKIGNCPFSQRLFMVLWLKGVTFNVTTVDTKRRTETVQKLCPGGQLPFLLYGTEVHTDTNKIEEFLEAVLCPPRYPKLAALNPESNTAGLDIFAKFSAYIKNSNPALNDNLEKGLLKALKVLDNYLTSPLPEEVDETSAEDEGVSQRKFLDGNELTLADCNLLPKLHIVQVVCKKYRGFTIPEAFRGVFRYLSNAYAREEFASTCPDDEEIELAYEQVAKALK","Homo sapiens","CLIC1, G6, NCC27","Chloride intracellular channel protein 1","1","3P90"
"3P9G",,"X-RAY DIFFRACTION",1.95,36.91,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES-NAOH (PH7.5), 25% PEG 3350, 0.2M SODIUM NITRATE, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/ml1002579",,"3P9G",17.59,"1.8","1.8","Crystal structure of the TSG101 UEV domain in complex with FA459 peptide","GAMGSAVSESQLKKMVSKYKYRDLTVRETVNVITLYKDLKPVLDSYGGSRELMNLTGTIPVPYRGNTYNIPICLWLLDTYPYNPPICFVKPTSSMTIKTGKHVDANGKIYLPYLHEWKHPQSDLLGLIQVMIVVFGDEPPVFSRP","Homo sapiens","TSG101","Tumor susceptibility gene 101 protein","1","3P9G"
,,,,,,,,,,,,,,,,"XPEXTAPPEEX",,,"Gag polyprotein","2","3P9G"
"3P9H",,"X-RAY DIFFRACTION",1.89,35.07,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES-NAOH (PH7.5), 25% PEG 3350, 0.2M SODIUM NITRATE , VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/ml1002579",,"3P9H",17.57,"1.8","1.8","Crystal structure of the TSG101 UEV domain in complex with FA258 peptide","GAMGSAVSESQLKKMVSKYKYRDLTVRETVNVITLYKDLKPVLDSYGGSRELMNLTGTIPVPYRGNTYNIPICLWLLDTYPYNPPICFVKPTSSMTIKTGKHVDANGKIYLPYLHEWKHPQSDLLGLIQVMIVVFGDEPPVFSRP","Homo sapiens","TSG101","Tumor susceptibility gene 101 protein","1","3P9H"
,,,,,,,,,,,,,,,,"XPEXTAPPEEX",,,"Gag polyprotein","2","3P9H"
"3P9J",,"X-RAY DIFFRACTION",2.77,55.67,"VAPOR DIFFUSION, SITTING DROP",7,"PEG3350, pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm101346r","P9J","3P9J",31.37,"2.8","2.8","Aurora A kinase domain with phthalazinone pyrazole inhibitor","AKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS","Homo sapiens","AIK, ARK1, AURA, AURKA, BTAK, STK15, STK6, AIRK1, AYK1, IAK1","Serine/threonine-protein kinase 6","1","3P9J"
"3PA3",,"X-RAY DIFFRACTION",2.73,54.89,"hanging drop",7.5,"0.1 M Tris-Cl pH 7.5, 1% v/v n-butanol, 2.5% v/v DMSO, 25% v/v Glycerol, 6-12% PEG 3.25K, 2.5 mM TCEP-Cl, 10 mM Na2-Dithionite, hanging drop, temperature 298K",298,"10.1016/j.bmcl.2010.10.105","C70","3PA3",31.84,"1.4","1.4","X-ray crystal structure of compound 70 bound to human CHK1 kinase domain","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAK","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","3PA3"
"3PA4",,"X-RAY DIFFRACTION",2.52,51.27,"hanging drop",7.5,"0.1 M Tris-Cl pH 7.5, 1% v/v n-butanol, 2.5% v/v DMSO, 25% v/v Glycerol, 6-12% PEG 3.25K, 2.5 mM TCEP-Cl, 10 mM Na2-Dithionite, hanging drop, temperature 298K",298,"10.1016/j.bmcl.2010.10.105","C72","3PA4",32.12,"1.59","1.59","X-ray crystal structure of compound 2a bound to human CHK1 kinase domain","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAK","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","3PA4"
"3PA5",,"X-RAY DIFFRACTION",2.72,54.86,"hanging drop",7.5,"0.1 M Tris-Cl, pH 7.5, 1% v/v n-butanol, 2.5% v/v DMSO, 25% v/v Glycerol, 6-12% PEG 3.25K, 2.5 mM TCEP-Cl, 10 mM Na2-Dithionite, hanging drop, temperature 298K",298,"10.1016/j.bmcl.2010.10.105","C73","3PA5",32.11,"1.7","1.7","X-ray crystal structure of compound 1 bound to human CHK1 kinase domain","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAK","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","3PA5"
"3PA6",,"X-RAY DIFFRACTION",2.02,39.24,,7,"0.2M sodium succinate, 15% PEG 3350, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,,,"3PA6",36.3,"1.5","1.5","Structure of the N-terminal BRCT domain of human microcephalin (MCPH1)","GHMAAPILKDVVAYVEVWSSNGTENYSKTFTTQLVDMGAKVSKTFNKQVTHVIFKDGYQSTWDKAQKRGVKLVSVLWVEKCRTAGAHIDESLFPAANMNEHLSSLIK","Homo sapiens","MCPH1","Microcephalin","1","3PA6"
"3PAH",,"X-RAY DIFFRACTION",3.19,61,,6.8,"pH 6.8",,"10.1021/bi9815290",,"3PAH",35.94,"2","2","HUMAN PHENYLALANINE HYDROXYLASE CATALYTIC DOMAIN DIMER WITH BOUND ADRENALINE INHIBITOR","TVPWFPRTIQELDRFANQILSYGAELDADHPGFKDPVYRARRKQFADIAYNYRHGQPIPRVEYMEEEKKTWGTVFKTLKSLYKTHACYEYNHIFPLLEKYCGFHEDNIPQLEDVSQFLQTCTGFRLRPVAGLLSSRDFLGGLAFRVFHCTQYIRHGSKPMYTPEPDICHELLGHVPLFSDRSFAQFSQEIGLASLGAPDEYIEKLATIYWFTVEFGLCKQGDSIKAYGAGLLSSFGELQYCLSEKPKLLPLELEKTAIQNYTVTEFQPLYYVAESFNDAKEKVRNFAATIPRPFSVRYDPYTQRIEVL","Homo sapiens","PAH","PHENYLALANINE HYDROXYLASE","1","3PAH"
"3PB4",,"X-RAY DIFFRACTION",1.9,35.4,"VAPOR DIFFUSION, SITTING DROP",6,"30%(v/v) PEG 200, 5%(w/v) PEG 3000, 0.1M Mes, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M110.208595",,"3PB4",37.13,"1.13","1.13","Crystal structure of the catalytic domain of human Golgi-resident glutaminyl cyclase at pH 6.0","SGWHRRTEELPLGRELRVPLIGSLPEARLRRVVGQLDPQRLWSTYLRPLLVVRTPGSPGNLQVRKFLEATLRSLTAGWHVELDPFTASTPLGPVDFGNVVATLDPRAARHLTLACHYDSKLFPPGSTPFVGATDSAVPCALLLELAQALDLELSRAKKQAAPVTLQLLFLDGEEALKEWGPKDSLYGSRHLAQLMESIPHSPGPTRIQAIELFMLLDLLGAPNPTFYSHFPRTVRWFHRLRSIEKRLHRLNLLQSHPQEVMYFQPGEPFGSVEDDHIPFLRRGVPVLHLISTPFPAVWHTPADTEVNLHPPTVHNLCRILAVFLAEYLGL","Homo sapiens","QPCTL","Glutaminyl-peptide cyclotransferase-like protein","1","3PB4"
"3PB6",,"X-RAY DIFFRACTION",1.9,35.2,"VAPOR DIFFUSION, SITTING DROP",6.5,"50%(v/v) PEG 200, 0.2M MgCl2, 0.1M cacodylate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M110.208595",,"3PB6",37.27,"1.05","1.05","Crystal structure of the catalytic domain of human Golgi-resident glutaminyl cyclase at pH 6.5","SGWHRRTEELPLGRELRVPLIGSLPEARLRRVVGQLDPQRLWSTYLRPLLVVRTPGSPGNLQVRKFLEATLRSLTAGWHVELDPFTASTPLGPVDFGNVVATLDPRAARHLTLACHYDSKLFPPGSTPFVGATDSAVPCALLLELAQALDLELSRAKKQAAPVTLQLLFLDGEEALKEWGPKDSLYGSRHLAQLMESIPHSPGPTRIQAIELFMLLDLLGAPNPTFYSHFPRTVRWFHRLRSIEKRLHRLNLLQSHPQEVMYFQPGEPFGSVEDDHIPFLRRGVPVLHLISTPFPAVWHTPADTEVNLHPPTVHNLCRILAVFLAEYLGL","Homo sapiens","QPCTL","Glutaminyl-peptide cyclotransferase-like protein","1","3PB6"
"3PB7",,"X-RAY DIFFRACTION",1.95,36.86,"VAPOR DIFFUSION, SITTING DROP",6,"30%(v/v) PEG 200, 5%(w/v) PEG 3000, 0.1M Mes, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M110.208595","PBD","3PB7",37.45,"1.4","1.4","Crystal structure of the catalytic domain of human Golgi-resident glutaminyl cyclase in complex with PBD150","SGWHRRTEELPLGRELRVPLIGSLPEARLRRVVGQLDPQRLWSTYLRPLLVVRTPGSPGNLQVRKFLEATLRSLTAGWHVELDPFTASTPLGPVDFGNVVATLDPRAARHLTLACHYDSKLFPPGSTPFVGATDSAVPCALLLELAQALDLELSRAKKQAAPVTLQLLFLDGEEALKEWGPKDSLYGSRHLAQLMESIPHSPGPTRIQAIELFMLLDLLGAPNPTFYSHFPRTVRWFHRLRSIEKRLHRLNLLQSHPQEVMYFQPGEPFGSVEDDHIPFLRRGVPVLHLISTPFPAVWHTPADTEVNLHPPTVHNLCRILAVFLAEYLGL","Homo sapiens","QPCTL","Glutaminyl-peptide cyclotransferase-like protein","1","3PB7"
"3PB8",,"X-RAY DIFFRACTION",1.91,35.57,"VAPOR DIFFUSION, SITTING DROP",6,"30%(v/v) PEG 200, 5%(w/v) PEG 3000, 0.1M Mes, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M110.208595","AHN","3PB8",37.29,"1.13","1.13","Crystal structure of the catalytic domain of human Golgi-resident glutaminyl cyclase in complex with N-acetylhistamine","SGWHRRTEELPLGRELRVPLIGSLPEARLRRVVGQLDPQRLWSTYLRPLLVVRTPGSPGNLQVRKFLEATLRSLTAGWHVELDPFTASTPLGPVDFGNVVATLDPRAARHLTLACHYDSKLFPPGSTPFVGATDSAVPCALLLELAQALDLELSRAKKQAAPVTLQLLFLDGEEALKEWGPKDSLYGSRHLAQLMESIPHSPGPTRIQAIELFMLLDLLGAPNPTFYSHFPRTVRWFHRLRSIEKRLHRLNLLQSHPQEVMYFQPGEPFGSVEDDHIPFLRRGVPVLHLISTPFPAVWHTPADTEVNLHPPTVHNLCRILAVFLAEYLGL","Homo sapiens","QPCTL","Glutaminyl-peptide cyclotransferase-like protein","1","3PB8"
"3PB9",,"X-RAY DIFFRACTION",1.93,36.43,"VAPOR DIFFUSION, SITTING DROP",6,"30%(v/v) PEG 200, 5%(w/v) PEG 3000, 0.1M Mes, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M110.208595","1BN","3PB9",37.29,"1.12","1.12","Crystal structure of the catalytic domain of human Golgi-resident glutaminyl cyclase in complex with 1-benzylimidazole","SGWHRRTEELPLGRELRVPLIGSLPEARLRRVVGQLDPQRLWSTYLRPLLVVRTPGSPGNLQVRKFLEATLRSLTAGWHVELDPFTASTPLGPVDFGNVVATLDPRAARHLTLACHYDSKLFPPGSTPFVGATDSAVPCALLLELAQALDLELSRAKKQAAPVTLQLLFLDGEEALKEWGPKDSLYGSRHLAQLMESIPHSPGPTRIQAIELFMLLDLLGAPNPTFYSHFPRTVRWFHRLRSIEKRLHRLNLLQSHPQEVMYFQPGEPFGSVEDDHIPFLRRGVPVLHLISTPFPAVWHTPADTEVNLHPPTVHNLCRILAVFLAEYLGL","Homo sapiens","QPCTL","Glutaminyl-peptide cyclotransferase-like protein","1","3PB9"
"3PBA",,"X-RAY DIFFRACTION",2.56,51.89,"VAPOR DIFFUSION, HANGING DROP",7.5,"tri-sodium citrate, Hepes, 1,2-propanediol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1093/toxsci/kfr132",,"3PBA",65.95,"2.3","2.3","Crystal structure of PPARgamma ligand binding domain in complex with monosulfate tetrabromo-bisphenol A (MonoTBBPA)","GSHMEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3PBA"
"3PBB",,"X-RAY DIFFRACTION",2.5,50.84,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.7M (NH4)2SO4, 4%(v/v) dioxane, 100mM Mes, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M110.208595","PBD","3PBB",75.89,"1.95","1.95","Crystal structure of human secretory glutaminyl cyclase in complex with PBD150","ASAWPEEKNYHQPAILNSSALRQIAEGTSISEMWQNDLQPLLIERYPGSPGSYAARQHIMQRIQRLQADWVLEIDTFLSQTPYGYRSFSNIISTLNPTAKRHLVLACHYDSKYFSHWNNRVFVGATDSAVPCAMMLELARALDKKLLSLKTVSDSKPDLSLQLIFFDGEEAFLHWSPQDSLYGSRHLAAKMASTPHPPGARGTSQLHGMDLLVLLDLIGAPNPTFPNFFPNSARWFERLQAIEHELHELGLLKDHSLEGRYFQNYSYGGVIQDDHIPFLRRGVPVLHLIPSPFPEVWHTMDDNEENLDESTIDNLNKILQVFVLEYLHL","Homo sapiens","QPCT","Glutaminyl-peptide cyclotransferase","1","3PBB"
"3PBE",,"X-RAY DIFFRACTION",3,59.04,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.7M (NH4)2SO4, 4%(v/v) dioxane, 100mM Mes, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M110.208595",,"3PBE",75.36,"1.95","1.95","Crystal structure of the mutant W207F of human secretory glutaminyl cyclase","ASAWPEEKNYHQPAILNSSALRQIAEGTSISEMWQNDLQPLLIERYPGSPGSYAARQHIMQRIQRLQADWVLEIDTFLSQTPYGYRSFSNIISTLNPTAKRHLVLACHYDSKYFSHWNNRVFVGATDSAVPCAMMLELARALDKKLLSLKTVSDSKPDLSLQLIFFDGEEAFLHFSPQDSLYGSRHLAAKMASTPHPPGARGTSQLHGMDLLVLLDLIGAPNPTFPNFFPNSARWFERLQAIEHELHELGLLKDHSLEGRYFQNYSYGGVIQDDHIPFLRRGVPVLHLIPSPFPEVWHTMDDNEENLDESTIDNLNKILQVFVLEYLHL","Homo sapiens","QPCT","Glutaminyl-peptide cyclotransferase","1","3PBE"
"3PBH",,"X-RAY DIFFRACTION",2.27,46,,5.72,"PROTEIN WAS CRYSTALLIZED FROM 2 M AMMONIUM SULFATE, PH 5.72",,"10.1006/jmbi.1997.1218",,"3PBH",35.23,"2.5","2.5","REFINED CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN B AT 2.5 ANGSTROM RESOLUTION","MRSRPSFHPLSDELVNYVNKRNTTWQAGHNFYNVDMSYLKRLCGTFLGGPKPPQRVMFTEDLKLPASFDAREQWPQCPTIKEIRDQGSCGSCWAFGAVEAISDRICIHTNAHVSVEVSAEDLLTCCGSMCGDGCNGGYPAEAWNFWTRKGLVSGGLYESHVGCRPYSIPPCEHHVNGSRPPCTGEGDTPKCSKICEPGYSPTYKQDKHYGYNSYSVSNSEKDIMAEIYKNGPVEGAFSVYSDFLLYKSGVYQHVTGEMMGGHAIRILGWGVENGTPYWLVANSWNTDWGDNGFFKILRGQDHCGIESEVVAGIPRTD","Homo sapiens","CTSB, CPSB","PROCATHEPSIN B","1","3PBH"
"3PC7",,"X-RAY DIFFRACTION",1.92,35.8,"VAPOR DIFFUSION, HANGING DROP",6.5,"25 % polyethylene glycol 3350, 0.1 M BisTris, 0.25 M ammonium acetate , pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1093/nar/gkr419",,"3PC7",20,"1.65","1.65","X-ray crystal structure of the DNA ligase III-alpha BRCT domain.","GSADETLSQTKVLLDIFTGVRLYLPPSTPDFSRLRRYFVAFDGDLVQEFDMTSATHVLGSRDKNPAAQQVSPEWIWACIRKRRLVAPS","Homo sapiens","LIG3","DNA ligase 3","1","3PC7"
"3PCV",,"X-RAY DIFFRACTION",4.91,74.77,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M MES-NaOH (pH 6.5), 1.6M ammonium sulfate, 0.8M magnesium chloride, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M110.150177",,"3PCV",23.78,"1.9","1.9","Crystal structure analysis of human leukotriene C4 synthase at 1.9 angstrom resolution","MKDEVALLAAVTLLGVLLQAYFSLQVISARRAFRVSPPLTTGPPEFERVYRAQVNCSEYFPLFLATLWVAGIFFHEGAAALCGLVYLFARLRYFQGYARSAQLRLAPLYASARALWLLVALAALGLLAHFLPAALRAALLGRLRTLLPWAHHHHHH","Homo sapiens","LTC4S","Leukotriene C4 synthase","1","3PCV"
"3PCX",,"X-RAY DIFFRACTION",2.42,49.07,"VAPOR DIFFUSION, HANGING DROP",8.5,"Inhibitor, Ac-DEVD-CMK, reconstituted in DMSO, was added at a 5:1 inhibitor:protein ratio (w/w). Final buffer consisted of 10 mM Tris-HCl, 10 mM DTT, 3 mM NaN3, VAPOR DIFFUSION, HANGING DROP, pH 8.5, temperature 300K",300,"10.1016/j.abb.2011.01.011",,"3PCX",29.09,"1.5","1.5","Caspase-3 E246A, K242A Double Mutant","SGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRAVATAFESFSFDATFHAKKQIPCIVSMLTKELYFYHH","Homo sapiens","CASP3, CPP32","Caspase-3","1","3PCX"
,,,,,,,,,,,,,,,,"XDEVDX",,,"Inhibitor Ac-DEVD-CMK","2","3PCX"
"3PD0",,"X-RAY DIFFRACTION",2.34,47.52,"VAPOR DIFFUSION, HANGING DROP",8.5,"Inhibitor, Ac-DEVD-CMK, reconstituted in DMSO, was added at a 5:1 inhibitor:protein ratio (w/w). Final buffer consisted of 10 mM Tris-HCl, 10 mM DTT, 3 mM NaN3, VAPOR DIFFUSION, HANGING DROP, pH 8.5, temperature 291K",291,"10.1016/j.abb.2011.01.011",,"3PD0",29.17,"2","2","Caspase-3 E246A","SGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDSGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATAFESFSFDATFHAKKQIPCIVSMLTKELYFYHH","Homo sapiens","CASP3, CPP32","Caspase-3","1","3PD0"
,,,,,,,,,,,,,,,,"XDEVDX",,,"INHIBITOR AC-DEVD-CMK","2","3PD0"
"3PD1",,"X-RAY DIFFRACTION",2.4,48.65,"VAPOR DIFFUSION, HANGING DROP",8.5,"Inhibitor, Ac-DEVD-CMK, reconstituted in DMSO, was added at a 5:1 inhibitor:protein ratio (w/w). Final buffer consisted of 10 mM Tris-HCl (pH 8.5), 10 mM DTT, 3 mM NaN3., VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.abb.2011.01.011",,"3PD1",29.15,"1.62","1.62","Caspase-3 K242A","SGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRAVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYHH","Homo sapiens","CASP3, CPP32","Caspase-3","1","3PD1"
,,,,,,,,,,,,,,,,"XDEVDX",,,"Inhibitor Ac-DEVD-CMK","2","3PD1"
"3PD7",,"X-RAY DIFFRACTION",2.03,39.29,"VAPOR DIFFUSION, HANGING DROP",6.6,"20% PEG 4000, 0.2 M sodium acetate trihydrate, 0.1 M Tris-HCl, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,,,"3PD7",24.43,"1.26","1.26","Crystal Structure of the Sixth BRCT Domain of Human TopBP1","GHMEAQSEKEEAPKPLHKVVVCVSKKLSKKQSELNGIAASLGADYRRSFDETVTHFIYQGRPNDTNREYKSVKERGVHIVSEHWLLDCAQECKHLPESLYPHTYNGS","Homo sapiens","TOPBP1, KIAA0259","DNA topoisomerase 2-binding protein 1","1","3PD7"
"3PDC",,"X-RAY DIFFRACTION",2.11,41.75,"VAPOR DIFFUSION",7.4,"26-30% PEG6K, 0.1M sodium cacodylate, 0.07M ammonium acetate, 0.1M magnesium acetate, pH 7.4, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm101382t","ZYI","3PDC",79.18,"2.6","2.6","Crystal structure of hydrolase domain of human soluble epoxide hydrolase complexed with a benzoxazole inhibitor","MGSSHHHHHHSSGLVPRGSHMAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARN","Homo sapiens","EPHX2","Epoxide hydrolase 2","1","3PDC"
"3PDF",,"X-RAY DIFFRACTION",2.17,43.31,,,,,,,"3PDF",51.18,"1.85","1.85","Discovery of Novel Cyanamide-Based Inhibitors of Cathepsin C","DTPANCTYLDLLGTWVFQVGSSGSQRDVNCSVMGPQEKKVVVYLQKLDTAYDDLGNSGHFTIIYNQGFEIVLNDYKWFAFFKYKEEGSKVTTYCNETMTGWVHDVLGRNWACFTGKKVGTASENVYVNTAHLKNSQEKYSNRLYKYDHNFVKAINAIQKSWTATTYMEYETLTLGDMIRRSGGHSRKIPRPKPAPLTAEIQQKILFLPTSWDWRNVHGINFVSPVRNQASCGSCYSFASMGMLEARIRILTNNSQTPILSPQEVVSCSQYAQGCEGGFPYLIAGKYAQDFGLVEEACFPYTGTDSPCKMKEDCFRYYSSEYHYVGGFYGGCNEALMKLELVHHGPMAVAFEVYDDFLHYKKGIYHHTGLRDPFNPFELTNHAVLLVGYGTDSASGMDYWIVKNSWGTGWGENGYFRIRRGTDECAIESIAVAATPIPKLEN","Homo sapiens","CTSC, CPPI","Dipeptidyl peptidase 1","1","3PDF"
"3PDJ",,"X-RAY DIFFRACTION",3.65,66.31,"VAPOR DIFFUSION",6.4,"19% PEG 3350, 0.1 M MES 6.4, vapor diffusion, temperature 289K",289,"10.1016/j.bmcl.2010.10.129","3PJ","3PDJ",62.71,"2.3","2.3","Crystal Structure of Human 11-beta-Hydroxysteroid Dehydrogenase 1 (11b-HSD1) in Complex with 4,4-Disubstituted Cyclohexylbenzamide Inhibitor","QQPLNEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPMVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSLWTTLLIRNPSRKILEFLYSTSYNMDRFINK","Homo sapiens","HSD11, HSD11B1, HSD11L, SDR26C1","Corticosteroid 11-beta-dehydrogenase isozyme 1","1","3PDJ"
"3PDN",,"X-RAY DIFFRACTION",2.21,44.46,"VAPOR DIFFUSION, HANGING DROP",8,"13% PEG 3350, 50 mM Na Formate, 100 mM Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2010.12.014",,"3PDN",50.36,"1.7","1.7","Crystal structure of SmyD3 in complex with methyltransferase inhibitor sinefungin","MEPLKVEKFATANRGNGLRAVTPLRPGELLFRSDPLAYTVCKGSRGVVCDRCLLGKEKLMRCSQCRVAKYCSAKCQKKAWPDHKRECKCLKSCKPRYPPDSVRLLGRVVFKLMDGAPSESEKLYSFYDLESNINKLTEDRKEGLRQLVMTFQHFMREEIQDASQLPPAFDLFEAFAKVICNSFTICNAEMQEVGVGLYPSISLLNHSCDPNCSIVFNGPHLLLRAVRDIEVGEELTICYLDMLMTSEERRKQLRDQYCFECDCFRCQTQDKDADMLTGDEQVWKEVQESLKKIEELKAHWKWEQVLAMCQAIISSNSERLPDINIYQLKVLDCAMDACINLGLLEEALFYGTRTMEPYRIFFPGSHPVRGVQVMKVGKLQLHQGMFPQAMKNLRLAFDIMRVTHGREHSLIEDLILLLEECDANIRAS","Homo sapiens","SMYD3, ZMYND1, ZNFN3A1","SET and MYND domain-containing protein 3","1","3PDN"
"3PDQ",,"X-RAY DIFFRACTION",2.43,49.45,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M Citrate, 4mM NiCl2, 17.5% PEG 3350, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1002/cmdc.201100026","KC6","3PDQ",89.7,"1.989","1.989","Crystal structure of JMJD2A complexed with bipyridyl inhibitor","MHHHHHHSSGVDLGTENLYFQSMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","Lysine-specific demethylase 4A","1","3PDQ"
"3PDY",,"X-RAY DIFFRACTION",2.67,54.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES, 17% PEG 4000, 8% ISOPROPANOL, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 297K",297,"10.1074/jbc.M110.197467",,"3PDY",48.64,"2.2182","2.2182","Structure of the third and fourth spectrin repeats of the plakin domain of plectin","GSHMELEDSTLRYLQDLLAWVEENQHRVDGAEWGVDLPSVEAQLGSHRGLHQSIEEFRAKIERARSDEGQLSPATRGAYRDCLGRLDLQYAKLLNSSKARLRSLESLHSFVAAATKELMWLNEKEEEEVGFDWSDRNTNMTAKKESYSALMRELELKEKKIKELQNAGDRLLREDHPARPTVESFQAALQTQWSWMLQLCCCIEAHLKEN","Homo sapiens","PLEC, PLEC1","Plectin","1","3PDY"
"3PDZ",,"SOLUTION NMR",,,,,,,"10.1021/bi991913c",,"3PDZ",10.02,,,"SOLUTION STRUCTURE OF THE PDZ2 DOMAIN FROM HUMAN PHOSPHATASE HPTP1E","PKPGDIFEVELAKNDNSLGISVTGGVNTSVRHGGIYVKAVIPQGAAESDGRIHKGDRVLAVNGVSLEGATHKQAVETLRNTGQVVHLLLEKGQSPT","Homo sapiens","PTPN13, PNP1, PTP1E, PTPL1","PROTEIN (TYROSINE PHOSPHATASE (PTP-BAS, TYPE 1))","1","3PDZ"
"3PE0",,"X-RAY DIFFRACTION",3.42,64,"VAPOR DIFFUSION",7.2,"0.1 M imidazole, 0.2 M calcium acetate, 9% PEG 8000, 2 mM DTT, pH 7.2, VAPOR DIFFUSION, temperature 277K",277,"10.1074/jbc.M110.197467",,"3PE0",64.76,"2.95","2.95","Structure of the central region of the plakin domain of plectin","GSHMRSLESLHSFVAAATKELMWLNEKEEEEVGFDWSDRNTNMTAKKESYSALMRELELKEKKIKELQNAGDRLLREDHPARPTVESFQAALQTQWSWMLQLCCCIEAHLKENAAYFQFFSDVREAEGQLQKLQEALRRKYSCDRSATVTRLEDLLQDAQDEKEQLNEYKGHLSGLAKRAKAVVQLKPRHPAHPMRGRLPLLAVCDYKQVEVTVHKGDECQLVGPAQPSHWKVLSSSGSEAAVPSVCFLVPPPNQEAQEAVTRLEAQHQALVTLWHQLHVDMK","Homo sapiens","PLEC, PLEC1","Plectin","1","3PE0"
"3PE1",,"X-RAY DIFFRACTION",1.98,37.78,"VAPOR DIFFUSION, SITTING DROP",8.5,"32% PEG 4000, 0.2M Li2SO4, 0.1M Tris, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/bi2008382","3NG","3PE1",40.88,"1.6","1.6","Crystal structure of human protein kinase CK2 alpha subunit in complex with the inhibitor CX-4945","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3PE1"
"3PE2",,"X-RAY DIFFRACTION",1.99,38.32,"VAPOR DIFFUSION, SITTING DROP",8.5,"32% PEG 4000, 0.2M Li2SO4, 0.1M Tris pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/bi2008382","E1B","3PE2",40.87,"1.9","1.9","Crystal structure of human protein kinase CK2 in complex with the inhibitor CX-5011","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3PE2"
"3PE3",,"X-RAY DIFFRACTION",4.76,74.14,"VAPOR DIFFUSION, HANGING DROP",8.5,"1.45 M Potassium Phosphate Dibasic, 8 mM EDTA, 1% xylitol, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nature09638","UDP","3PE3",325.51,"2.78","2.78","Structure of human O-GlcNAc transferase and its complex with a peptide substrate","GPGSCPTHADSLNNLANIKREQGNIEEAVRLYRKALEVFPEFAAAHSNLASVLQQQGKLQEALMHYKEAIRISPTFADAYSNMGNTLKEMQDVQGALQCYTRAIQINPAFADAHSNLASIHKDSGNIPEAIASYRTALKLKPDFPDAYCNLAHCLQIVCDWTDYDERMKKLVSIVADQLEKNRLPSVHPHHSMLYPLSHGFRKAIAERHGNLCLDKINVLHKPPYEHPKDLKLSDGRLRVGYVSSDFGNHPTSHLMQSIPGMHNPDKFEVFCYALSPDDGTNFRVKVMAEANHFIDLSQIPCNGKAADRIHQDGIHILVNMNGYTKGARNELFALRPAPIQAMWLGYPGTSGALFMDYIITDQETSPAEVAEQYSEKLAYMPHTFFIGDHANMFPHLKKKAVIDFKSNGHIYDNRIVLNGIDLKAFLDSLPDVKIVKMKCPDGGDNADSSNTALNMPVIPMNTIAEAVIEMINRGQIQITINGFSISNGLATTQINNKAATGEEVPRTIIVTTRSQYGLPEDAIVYCNFNQLYKIDPSTLQMWANILKRVPNSVLWLLRFPAVGEPNIQQYAQNMGLPQNRIIFSPVAPKEEHVRRGQLADVCLDTPLCNGHTTGMDVLWAGTPMVTMPGETLASRVAASQLTCLGCLELIAKNRQEYEDIAVKLGTDLEYLKKVRGKVWKQRISSPLFNTKQYTMELERLYLQMWEHYAAGNKPDHMIKPVE","Homo sapiens","OGT","UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit","1","3PE3"
"3PE6",,"X-RAY DIFFRACTION",2.75,55.23,"VAPOR DIFFUSION, HANGING DROP",6,"PEGMME5000 
MES 
glucopyranoside, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1002/pro.596",,"3PE6",33.64,"1.35","1.35","Crystal Structure of a soluble form of human MGLL in complex with an inhibitor","MPEESSPRRTPQSIPYQDLPHLVNADGQYLFCRYWAPTGTPKALIFVSHGAGEHSGRYEELARMLMGLDLLVFAHDHVGHGQSEGERMVVSDFHVFVRDVLQHVDSMQKDYPGLPVFLLGHSMGGAIAILTAAERPGHFAGMVLISPLVLANPESATTFKVLAAKVLNSVLPNLSSGPIDSSVLSRNKTEVDIYNSDPLICRAGLKVCFGIQLLNAVSRVERALPKLTVPFLLLQGSADRLCDSKGAYLLMELAKSQDKTLKIYEGAYHVLHKELPEVTNSVFHEINMWVSQRTATAGTASPP","Homo sapiens","MGLL, hCG_40840","Monoglyceride lipase","1","3PE6"
"3PEC",,"X-RAY DIFFRACTION",3.15,61,"VAPOR DIFFUSION, HANGING DROP",4.5,"1.3M Ammonium sulfate, 0.2M Lithium sulfate, 50mM sodium chloride, 0.1M sodium acetate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"3PEC",63.49,"2.19","2.19","Siderocalin Recognitin of Carboxymycobactins: Interference by the immune system in intracellular iron acquisition by Mycobacteria tuberculosis","QDSTSDLIPAPPLSKVPLQQNFQDNQFQGKWYVVGLAGNAILREDKDPQKMYATIYELKEDKSYNVTSVLFRKKKCDYWIRTFVPGSQPGEFTLGNIKSYPGLTSYLVRVVSTNYNQHAMVFFKKVSQNREYFKITLYGRTKELTSELKENFIRFSKSLGLPENHIVFPVPIDQCIDG","Homo sapiens","LCN2, HNL, NGAL","Neutrophil gelatinase-associated lipocalin","1","3PEC"
"3PED",,"X-RAY DIFFRACTION",3.15,61,"VAPOR DIFFUSION, HANGING DROP",4.5,"1.3M Ammonium sulfate, 0.2M Lithium sulfate, 50mM sodium chloride, 0.1M sodium acetate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"3PED",64.21,"2.3","2.3","Siderocalin Recognitin of Carboxymycobactins: Interference by the immune system in intracellular iron acquisition by Mycobacteria tuberculosis","QDSTSDLIPAPPLSKVPLQQNFQDNQFQGKWYVVGLAGNAILREDKDPQKMYATIYELKEDKSYNVTSVLFRKKKCDYWIRTFVPGSQPGEFTLGNIKSYPGLTSYLVRVVSTNYNQHAMVFFKKVSQNREYFKITLYGRTKELTSELKENFIRFSKSLGLPENHIVFPVPIDQCIDG","Homo sapiens","LCN2, HNL, NGAL","Neutrophil gelatinase-associated lipocalin","1","3PED"
"3PEG",,"X-RAY DIFFRACTION",2.77,55.65,"VAPOR DIFFUSION, HANGING DROP",7,"0.05M HEPES, 39% PEG 400, 0.2M (NH4)2SO4, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289.15K",289.15,"10.1002/humu.21405",,"3PEG",34.34,"2.524","2.524","Crystal structure of Neurofibromins Sec14-PH module containing a patient derived duplication (TD)","GAMGSSKFEEFMTRHQVHEKEEFKALKTLSIFYQAGTSKAGNPIFYYVARRFKTGQINGDLLIYHVLLTLKPYYAKPYEIVVDLTHTGPSNRFKTDFLSKWFVVFPGFAYDNVSAVYIYNCNSWVREYTKYHERLLTGLKGSKRLVFIDCPGKLAEHIEHEQQKLPAATLALGHEQQKLPAATLALEEDLKVFHNALKLAHKDTKVSIKVGSTAVQVTSAERTKVLGQSVFLNDIYYASEIEEICLVDENQFTLTIANQGTPLTFMHQECEAIVQSIIHIRTRWELSQPD","Homo sapiens","NF1","Neurofibromin","1","3PEG"
,,,,,,,,,,,,,,,,,"Homo sapiens","NF1"
,,,,,,,,,,,,,,,,,"Homo sapiens","NF1"
"3PEQ",,"X-RAY DIFFRACTION",3.03,59.36,"VAPOR DIFFUSION, HANGING DROP",9,"100 mM potassium iodide, 20% PEG3350, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2011.02.077","3EQ","3PEQ",64.69,"2.4","2.4","PPARd complexed with a phenoxyacetic acid partial agonist","QVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","NR1C2, PPARB, PPARD","Peroxisome proliferator-activated receptor delta","1","3PEQ"
"3PFF",,"X-RAY DIFFRACTION",2.5,50.85,"VAPOR DIFFUSION, HANGING DROP",7,"12.5% polyethylene glycol 3350, 125 mM sodium tartrate, 100 mM Tris-HCl, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1107/S1744309111028363",,"3PFF",91.44,"2.3","2.3","Truncated human atp-citrate lyase with ADP and tartrate bound","MSAKAISEQTGKELLYKFICTTSAIQNRFKYARVTPDTDWARLLQDHPWLLSQNLVVKPDQLIKRRGKLGLVGVNLTLDGVKSWLKPRLGQEATVGKATGFLKNFLIEPFVPHSQAEEFYVCIYATREGDYVLFHHEGGVDVGDVDAKAQKLLVGVDEKLNPEDIKKHLLVHAPEDKKEILASFISGLFNFYEDLYFTYLEINPLVVTKDGVYVLDLAAKVDATADYICKVKWGDIEFPPPFGREAYPEEAYIADLDAKSGASLKLTLLNPKGRIWTMVAGGGASVVYSDTICDLGGVNELANYGEYSGAPSEQQTYDYAKTILSLMTREKHPDGKILIIGGSIANFTNVAATFKGIVRAIRDYQGPLKEHEVTIFVRRGGPNYQEGLRVMGEVGKTTGIPIHVFGTETHMTAIVGMALGHRPIPNQPPTAAHTANFLLNASGSTSTPAPSRTASFSESRADEVAPAKKAKPAMPQDSVPSPRSLQGKSTTLFSRHTKAIVWGMQTRAVQGMLDFDYVCSRDEPSVAAMVYPFTGDHKQKFYWGHKEILIPVFKNMADAMRKHPEVDVLINFASLRSAYDSTMETMNYAQIRTIAIIAEGIPEALTRKLIKKADQKGVTIIGPATVGGIKPGCFKIGNTGGMLDNILASKLYRPGSVAYVSRSGGMSNELNNIISRTTDGVYEGVAIGGDRYPGSTFMDHVLRYQDTPGVKMIVVLGEIGGTEEYKICRGIKEGRLTKPIVCWCIGTCATMFSSEVQFGHAGACANQASETAVAKNQALKEAGVFVPRSFDELGEIIQSVYEDLVANGVIVPAQEVPAALEHHHHHHHH","Homo sapiens","ACLY","ATP-citrate synthase","1","3PFF"
"3PFN",,"X-RAY DIFFRACTION",2.21,44.35,"VAPOR DIFFUSION, SITTING DROP",5.5,"21.4% PEG3350, 0.2M magnesium nitrate, pH 5.5, vapor diffusion, sitting drop, temperature 291K",291,,,"3PFN",162.48,"2.7","2.7","Crystal Structure of human NAD kinase","MPCPVTTFGPKACVLQNPQTIMHIQDPASQRLTWNKSPKSVLVIKKMRDASLLQPFKELCTHLMEENMIVYVEKKVLEDPAIASDESFGAVKKKFCTFREDYDDISNQIDFIICLGGDGTLLYASSLFQGSVPPVMAFHLGSLGFLTPFSFENFQSQVTQVIEGNAAVVLRSRLKVRVVKELRGKKTAVHNGLGEKGSQAAGLDMDVGKQAMQYQVLNEVVIDRGPSSYLSNVDVYLDGHLITTVQGDGVIVSTPTGSTAYAAAAGASMIHPNVPAIMITPICPHSLSFRPIVVPAGVELKIMLSPEARNTAWVSFDGRKRQEIRHGDSISITTSCYPLPSICVRDPVSDWFESLAQCLHHHHHH","Homo sapiens","NADK","NAD kinase","1","3PFN"
"3PFS",,"X-RAY DIFFRACTION",1.91,35.66,"VAPOR DIFFUSION, SITTING DROP",6.5,"30% PEG4000, 0.2M Ammonium Sulfate, 0.1M Sodium Cacodylate pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1371/journal.pone.0018919",,"3PFS",36.6,"1.9","1.9","PWWP Domain of Human Bromodomain and PHD finger-containing protein 3","MHHHHHHSSGRENLYFQGDYNGSGRSLLLPFEDRGDLEPLELVWAKCRGYPSYPALIIDPKMPREGLLHNGVPIPVPPLDVLKLGEQKQAEAGEKLFLVLFFDNKRTWQWLPRDKVLPLGVEDTVDKLKMLEGRKTSIRKSVQVAYDRAMIHLSRVRG","Homo sapiens","BRPF3, KIAA1286","Bromodomain and PHD finger-containing protein 3","1","3PFS"
"3PFW",,"X-RAY DIFFRACTION",2.31,46.75,,6.5,"20% PEG 3350, 0.2 M Na2SO4, 10% ethylene glycol and 0.1 M Bis-Tris propane pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,"10.1042/BJ20101442",,"3PFW",77.48,"2.15","2.15","Crystal structure of human sperm-specific glyceraldehyde-3-phosphate dehydrogenase (GAPDS) complex with NAD, a binary form","MVSVARELTVGINGFGRIGRLVLRACMEKGVKVVAVNDPFIDPEYMVYMFKYDSTHGRYKGSVEFRNGQLVVDNHEISVYQCKEPKQIPWRAVGSPYVVESTGVYLSIQAASDHISAGAQRVVISAPSPDAPMFVMGVNENDYNPGSMNIVSNASCTTNCLAPLAKVIHERFGIVEGLMTTVHSYTATQKTVDGPSRKAWRDGRGAHQNIIPASTGAAKAVTKVIPELKGKLTGMAFRVPTPDVSVVDLTCRLAQPAPYSAIKEAVKAAAKGPMAGILAYTEDEVVSTDFLGDTHSSIFDAKAGIALNDNFVKLISWYDNEYGYSHRVVDLLRYMFSRDAENLYFQ","Homo sapiens","GAPD2, GAPDH2, GAPDHS, GAPDS, HSD-35, HSD35","Glyceraldehyde-3-phosphate dehydrogenase, testis-specific","1","3PFW"
"3PFY",,"X-RAY DIFFRACTION",1.9,35.33,"VAPOR DIFFUSION, SITTING DROP",7.5,"2% PEG 400, 2 M AMMONIUM SULFATE, 0.1 M SODIUM HEPES, PH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"3PFY",22.82,"1.702","1.702","The catalytic domain of human OTUD5","MHHHHHHSSGRENLYFQGAGYNSEDEYEAAAARIEAMDPATVEQQEHWFEKALRDKKGFIIKQMKEDGACLFRAVADQVYGDQDMHEVVRKHCMDYLMKNADYFSNYVTEDFTTYINRKRKNNCHGNHIEMQAMAEMYNRPVEVYQYSTEPINTFHGIHQNEDEPIRVSYHRNIHYNSVVNPNKA","Homo sapiens","OTUD5","OTU domain-containing protein 5","1","3PFY"
"3PG3",,"X-RAY DIFFRACTION",2.19,43.71,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, 20-30% PEG4000, 50 mM n-BOG, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,"DG7","3PG3",42.02,"2","2","Human p38 MAP Kinase in Complex with RL182","GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSLESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","3PG3"
"3PG6",,"X-RAY DIFFRACTION",3.05,59.65,,6,"22% PEG3350, 0.2 M TRI-LITHIUM CITRATE PH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/prot.24054",,"3PG6",72.67,"1.7","1.7","The carboxyl terminal domain of human deltex 3-like","MGSSHHHHHHSSGLVPRGSTSYGIQKGNQPEGSMVFTVSRDSLPGYESFGTIVITYSMKAGIQTEEHPNPGKRYPGIQRTAYLPDNKEGRKVLKLLYRAFDQKLIFTVGYSRVLGVSDVITWNDIHHKTSRFGGPEMYGYPDPSYLKRVKEELKAKGIE","Homo sapiens","BBAP, DTX3L","E3 ubiquitin-protein ligase DTX3L","1","3PG6"
"3PG7",,"X-RAY DIFFRACTION",3.41,63.97,,,,,"10.1002/humu.21405",,"3PG7",60.48,"2.189","2.189","Crystal structure of the H. sapiens NF1 SEC-PH domain (del1750 mutant)","KEEFKALKTLSIFYQAGTSKAGNPIFYYVARRFKTGQINGDLLIYHVLLTLKPYYAKPYEIVVDLTHTGPSNRFKTDFLSKWFVVFPGFAYDNVSAVYIYNCNSWVREYTKYHERLLTGLKGSKRLVFIDCPGKLAEHIEHEQQKLPAATLALEEDLKVFHNALKLAHKDTKVSIKVGSTAVQVTSAERTVLGQSVFLNDIYYASEIEEICLVDENQFTLTIANQGTPLTFMHQECEAIVQSIIHIRTRWELSQPD","Homo sapiens","NF1","Neurofibromin","1","3PG7"
"3PGL",,"X-RAY DIFFRACTION",3.44,64.27,"VAPOR DIFFUSION, SITTING DROP",7,"30% PEG 3350, 0.2 M magnesium acetate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/cb100357t","RZX","3PGL",41.89,"2.35","2.35","Crystal structure of human small C-terminal domain phosphatase 1 (Scp1) bound to rabeprazole","QYLLPEAKAQDSDKICVVIDLDETLVHSSFKPVNNADFIIPVEIDGVVHQVYVLKRPHVDEFLQRMGELFECVLFTASLAKYADPVADLLDKWGAFRARLFRESCVFHRGNYVKDLSRLGRDLRRVLILDNSPASYVFHPDNAVPVASWFDNMSDTELHDLLPFFEQLSRVDDVYSVLRQ","Homo sapiens","CTDSP1, CTDSP1 or SCP1, NIF3, NLIIF, SCP1","Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1","1","3PGL"
"3PGT",,"X-RAY DIFFRACTION",2.07,40,,6.5,"pH 6.5",,"10.1021/bi990668u",,"3PGT",49.42,"2.14","2.14","CRYSTAL STRUCTURE OF HGSTP1-1[I104] COMPLEXED WITH THE GSH CONJUGATE OF (+)-ANTI-BPDE","MPPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPINGNGKQ","Homo sapiens","GTP_HUMAN, GSTP1, FAEES3, GST3","PROTEIN (GLUTATHIONE S-TRANSFERASE)","1","3PGT"
"3PH9",,"X-RAY DIFFRACTION",1.97,37.41,"VAPOR DIFFUSION, SITTING DROP",8.5,"25 % PEG 4000, 0.2 M MgCl2, 0.2 M NaCl, 0.1 M Tris-Cl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 295.15K",295.15,,,"3PH9",35.87,"1.83","1.83","Crystal structure of the human anterior gradient protein 3","MHHHHHHMIKKEKRPPQTLSRGWGDDITWVQTYEEGLFYAQKSKKPLMVIHHLEDCQYSQALKKVFAQNEEIQEMAQNKFIMLNLMHETTDKNLSPDGQYVPRIMFVDPSLTVRADIAGRYSNRLYTYEPRDLPLLIENMKKALRLIQSEL","Homo sapiens","AGR3, BCMP11, UNQ642/PRO1272, PDIA18","Anterior gradient protein 3 homolog","1","3PH9"
"3PHB",,"X-RAY DIFFRACTION",2.09,41.23,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M ammonium phosphate, 0.1M Tris, 25% PEG 3350, pH 8.5, vapor diffusion, sitting drop, temperature 291K",291,,"IM5","3PHB",219.7,"2.3","2.3","Crystal Structure of human purine nucleoside phosphorylase in complex with DADMe-ImmG","MRGSHHHHHHGMASMTGGQQMGRDLYDDDDKDPTLMENGYTYEDYKNTAEWLLSHTKHRPQVAIICGSGLGGLTDKLTQAQIFDYSEIPNFPRSTVPGHAGRLVFGFLNGRACVMMQGRFHMYEGYPLWKVTFPVRVFHLLGVDTLVVTNAAGGLNPKFEVGDIMLIRDHINLPGFSGQNPLRGPNDERFGDRFPAMSDAYDRTMRQRALSTWKQMGEQRELQEGTYVMVAGPSFETVAECRVLQKLGADAVGMSTVPEVIVARHCGLRVFGFSLITNKVIMDYESLEKANHEEVLAAGKQAAQKLEQFVSILMASIPLPDKAS","Homo sapiens","PNP, NP","Purine nucleoside phosphorylase","1","3PHB"
"3PI5",,"X-RAY DIFFRACTION",3.01,59.18,"VAPOR DIFFUSION, HANGING DROP",5.5,"1.0M Ammonium Sulfate in water, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2011.02.038","3P5","3PI5",135.77,"2.4","2.4","Crystal Structure of Human Beta Secretase in Complex with BFG356","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","3PI5"
"3PIQ",,"X-RAY DIFFRACTION",3.67,66.46,"VAPOR DIFFUSION, HANGING DROP",8.5,"17% PEG 8000, 0.1M Tris-Cl (pH 8.5), 0.1M NaCl, 3% galactose, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1128/JVI.02335-10",,"3PIQ",284.94,"3.325","3.325","Crystal structure of human 2909 Fab, a quaternary structure-specific antibody against HIV-1","EVQLVESGGNVVQPGGSLRLSCTASGFSFDDSTMHWVRQAPGKGLQWVSLISWNGGRTYYADSVKGRFTISRDNSKNSLYLQMNSLKTEDTAFYFCAKDKGDSDYDYNLGYSYFYYMDGWGKGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPK","Homo sapiens",,"Human monoclonal antibody 2909 Fab heavy chain","1","3PIQ"
,,,,,,,,,,,,,,,,"SYVLTQPPSVSVAPGKTARITCGGNNIANKNVHWYQQKPGQAPVLVIYYDDDRPSGIPDRFSGSNSGNTATLTISRVEAGDEADYYCQVWDSNSDHVVFGGGTQLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPT","Homo sapiens",,"Human monoclonal antibody 2909 Fab light chain","2","3PIQ"
"3PIX",,"X-RAY DIFFRACTION",2.18,43.58,"VAPOR DIFFUSION, HANGING DROP",8,"33% PEG3350, 0.1M HEPES, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/pro.575","027","3PIX",32.21,"1.85","1.85","Crystal structure of BTK kinase domain complexed with 2-Isopropyl-7-(4-methyl-piperazin-1-yl)-4-(5-methyl-2H-pyrazol-3-ylamino)-2H-phthalazin-1-one","GTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","AGMX1, ATK, BPK, BTK","Tyrosine-protein kinase BTK","1","3PIX"
"3PIY",,"X-RAY DIFFRACTION",2.23,44.73,"VAPOR DIFFUSION, HANGING DROP",8,"33% PEG3350, 0.1M HEPES, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/pro.575","585","3PIY",32.3,"2.55","2.55","Crystal structure of BTK kinase domain complexed with R406","GTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","AGMX1, ATK, BPK, BTK","Tyrosine-protein kinase BTK","1","3PIY"
"3PIZ",,"X-RAY DIFFRACTION",2.24,45.17,"VAPOR DIFFUSION, HANGING DROP",8,"33% PEG3350, 0.1M HEPES, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/pro.575","03C","3PIZ",32.27,"2.21","2.21","Crystal structure of BTK kinase domain complexed with (5-Amino-1-o-tolyl-1H-pyrazol-4-yl)-[3-(1-methanesulfonyl-piperidin-4-yl)-phenyl]-methanone","GTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","AGMX1, ATK, BPK, BTK","Tyrosine-protein kinase BTK","1","3PIZ"
"3PJ1",,"X-RAY DIFFRACTION",2.25,45.43,"VAPOR DIFFUSION, HANGING DROP",8,"33% PEG3350, 0.1M HEPES, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/pro.575","LHL","3PJ1",32.86,"2","2","Crystal structure of BTK kinase domain complexed with 3-(2,6-Dichloro-phenyl)-7-[4-(2-diethylamino-ethoxy)-phenylamino]-1-methyl-3,4-dihydro-1H-pyrimido[4,5-d]pyrimidin-2-one","GTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","AGMX1, ATK, BPK, BTK","Tyrosine-protein kinase BTK","1","3PJ1"
"3PJ2",,"X-RAY DIFFRACTION",2.23,44.9,"VAPOR DIFFUSION, HANGING DROP",8,"33% PEG3350, 0.1M HEPES, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/pro.575","04K","3PJ2",32.31,"1.75","1.75","Crystal structure of BTK kinase domain complexed with 2-[4-(2-Diethylamino-ethoxy)-phenylamino]-6-(4-fluoro-phenoxy)-8-methyl-8H-pyrido[2,3-d]pyrimidin-7-one","GTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","AGMX1, ATK, BPK, BTK","Tyrosine-protein kinase BTK","1","3PJ2"
"3PJ3",,"X-RAY DIFFRACTION",2.26,45.6,"VAPOR DIFFUSION, HANGING DROP",8,"33% PEG3350, 0.1M HEPES, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/pro.575","04L","3PJ3",32.3,"1.85","1.85","Crystal structure of BTK kinase domain complexed with 2-Methyl-5-[(E)-(3-phenyl-acryloyl)amino]-N-(2-phenyl-3H-imidazo[4,5-b]pyridin-6-yl)-benzamide","GTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","AGMX1, ATK, BPK, BTK","Tyrosine-protein kinase BTK","1","3PJ3"
"3PJ8",,"X-RAY DIFFRACTION",2.08,40.87,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 3350,  Na-HEPES, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1021/jm200064p","404","3PJ8",34.39,"1.96","1.96","Structure of CDK2 in complex with a Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine.","GMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cell division protein kinase 2","1","3PJ8"
"3PJC",,"X-RAY DIFFRACTION",2.27,45.76,"VAPOR DIFFUSION, SITTING DROP",6.5,"CO-CRYSTALLIZATION WITH COMPOUND NVP-BLZ295 ADDED BEFORE CONCENTRATION OF THE PROTEIN AT 3 FOLD MOLAR EXCESS. 8% PEG 4000, 0.05 M MES PH 6.5, 0.01 M MGCL2. PROTEIN AT 10.0 MG/ML. CRYOPROTECTION: 30% GLYCEROL + WELL SOLUTION, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/jm101157q","PJC","3PJC",36.15,"2.2","2.2","Crystal structure of JAK3 complexed with a potent ATP site inhibitor showing high selectivity within the Janus kinase family","GPQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","3PJC"
"3PJJ",,"X-RAY DIFFRACTION",2.26,45.68,"VAPOR DIFFUSION, HANGING DROP",8,"1.4 M ammonium sulfate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"3PJJ",29.42,"1.8","1.8","Synthetic Dimer of Human Carbonic Anhydrase II","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGCAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLESVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3PJJ"
"3PKI",,"X-RAY DIFFRACTION",2.04,39.7,,5.8,"2M NH4SO4, 2%PEG400, 0.1M BIS-TRIS pH5.8, temperature 297K",297,"10.1074/jbc.M111.218990",,"3PKI",240.6,"2.04","2.04","Human SIRT6 crystal structure in complex with ADP ribose","GSVNYAAGLSPYADKGKCGLPEIFDPPEELERKVWELARLVWQSSSVVFHTGAGISTASGIPDFRGPHGVWTMEERGLAPKFDTTFESARPTQTHMALVQLERVGLLRFLVSQNVDGLHVRSGFPRDKLAELHGNMFVEECAKCKTQYVRDTVVGTMGLKATGRLCTVAKARGLRACRGELRDTILDWEDSLPDRDLALADEASRNADLSITLGTSLQIRPSGNLPLATKRRGGRLVIVNLQPTKHDRHADLRIHGYVDEVMTRLMEHLGLEIPAWDGPRVLERALPPLPRPPTPKLEPKEESPTRINGSIPAGPKQEPCAQHNGSEPASPKRERPTSPAPHRPPKRVKAKAVPS","Homo sapiens","SIRT6, SIR2L6","NAD-dependent deacetylase sirtuin-6","1","3PKI"
"3PKJ",,"X-RAY DIFFRACTION",1.99,38.12,"VAPOR DIFFUSION, HANGING DROP",5.8,"2M NH4SO4, 2%PEG400, 0.1M BIS-TRIS PH 5.8, VAPOR DIFFUSION, HANGING DROP, temperature 297K",297,"10.1074/jbc.M111.218990",,"3PKJ",239.79,"2.12","2.12","Human SIRT6 crystal structure in complex with 2'-N-Acetyl ADP ribose","GSVNYAAGLSPYADKGKCGLPEIFDPPEELERKVWELARLVWQSSSVVFHTGAGISTASGIPDFRGPHGVWTMEERGLAPKFDTTFESARPTQTHMALVQLERVGLLRFLVSQNVDGLHVRSGFPRDKLAELHGNMFVEECAKCKTQYVRDTVVGTMGLKATGRLCTVAKARGLRACRGELRDTILDWEDSLPDRDLALADEASRNADLSITLGTSLQIRPSGNLPLATKRRGGRLVIVNLQPTKHDRHADLRIHGYVDEVMTRLMEHLGLEIPAWDGPRVLERALPPLPRPPTPKLEPKEESPTRINGSIPAGPKQEPCAQHNGSEPASPKRERPTSPAPHRPPKRVKAKAVPS","Homo sapiens","SIRT6, SIR2L6","NAD-dependent deacetylase sirtuin-6","1","3PKJ"
"3PKN",,"X-RAY DIFFRACTION",1.78,30.91,"VAPOR DIFFUSION, HANGING DROP",7,"0.25 M potassium iodide, 1.9 M ammonium sulfate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1128/MCB.01162-10",,"3PKN",11.19,"1.8","1.8","Crystal structure of MLLE domain of poly(A) binding protein in complex with PAM2 motif of La-related protein 4 (LARP4)","GPLGSPLTASMLASAPPQEQKQMLGERLFPLIQAMHPTLAGKITGMLLEIDNSELLHMLESPESLRSKVDEAVAVLQAHQAKEAAQKA","Homo sapiens","PABPC1, PAB1, PABP1, PABPC2, PABP","Polyadenylate-binding protein 1","1","3PKN"
,,,,,,,,,,,,,,,,"TGLNPNAKVWQEIA",,,"La-related protein 4","2","3PKN"
"3PLF",,"X-RAY DIFFRACTION",2.11,41.65,"hanging drop",6.5,"100mM Bis-tris propane, 50mM ammonium sulfate, pH 6.5, hanging drop, temperature 298K",298,"10.1016/j.febslet.2010.11.060",,"3PLF",79.36,"1.92","1.92","Reverse Binding Mode of MetRD peptide complexed with c-Cbl TKB domain","NESVRYDATFP",,,"MetRD peptide","1","3PLF"
,,,,,,,,,,,,,,,,"GSLIGLMKDAFQPHHHHHHHLSPHPPGTVDKKMVEKCWKLMDKVVRLCQNPKLALKNSPPYILDLLPDTYQHLRTILSRYEGKMETLGENEYFRVFMENLMKKTKQTISLFKEGKERMYEENSQPRRNLTKLSLIFSHMLAELKGIFPSGLFQGDTFRITKADAAEFWRKAFGEKTIVPWKSFRQALHEVHPISSGLEAMALKSTIDLTCNDYISVFEFDIFTRLFQPWSSLLRNWNSLAVTHPGYMAFLTYDEVKARLQKFIHKPGSYIFRLSCTRLGQWAIGYVTADGNILQTIPHNKPLFQALIDGFREGFYLFPDGRNQNPDLTG","Homo sapiens","c-Cbl, CBL, CBL2, RNF55","E3 ubiquitin-protein ligase CBL","2","3PLF"
"3PLS",,"X-RAY DIFFRACTION",3.29,62.59,"VAPOR DIFFUSION",7.5,"20% PEG2K and 2mM MgCl2, pH 7.5, VAPOR DIFFUSION",,"10.1021/bi100409w",,"3PLS",34.78,"2.24","2.24","RON in complex with ligand AMP-PNP","RDLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQLP","Homo sapiens","MST1R, PTK8, RON","Macrophage-stimulating protein receptor","1","3PLS"
"3PM0",,"X-RAY DIFFRACTION",2.42,49.2,"VAPOR DIFFUSION, HANGING DROP",5.1,"PEG-3350, ammonium dibasic citrate, potassium phosphate, NaCl, glycerol, beta-mercaptoethanol, alpha-naphthoflavone, CHAPS, pH 5.1, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M110.204420","BHF","3PM0",57.79,"2.7","2.7","Structural Characterization of the Complex between Alpha-Naphthoflavone and Human Cytochrome P450 1B1 (CYP1B1)","MAKKTSSKGKPPGPFAWPLIGNAAAVGQAAHLSFARLARRYGDVFQIRLGSCPIVVLNGERAIHQALVQQGSAFADRPSFASFRVVSGGRSMAFGHYSEHWKVQRRAAHSMMRNFFTRQPRSRQVLEGHVLSEARELVALLVRGSADGAFLDPRPLTVVAVANVMSAVCFGCRYSHDDPEFRELLSHNEEFGRTVGAGSLVDVMPWLQYFPNPVRTVFREFEQLNRNFSNFILDKFLRHCESLRPGAAPRDMMDAFILSAEKKAAGDSHGGGARLDLENVPATITDIFGASQDTLSTALQWLLLLFTRYPDVQTRVQAELDQVVGRDRLPCMGDQPNLPYVLAFLYEAMRFSSFVPVTIPHATTANTSVLGYHIPKDTVVFVNQWSVNHDPLKWPNPENFDPARFLDKDGLINKDLTSRVMIFSVGKRRCIGEELSKMQLFLFISILAHQCDFRANPNEPAKMNFSYGLTIKPKSFKVNVTLRESMELLDSAVQNLQAKETCQHHHH","Homo sapiens","CYP1B1","Cytochrome P450 1B1","1","3PM0"
"3PMI",,"X-RAY DIFFRACTION",2.37,48.07,"VAPOR DIFFUSION, SITTING DROP",7.5,"25% PEG3350, 0.1M Ammonium Sulfate, 0.1M HEPES pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1371/journal.pone.0018919",,"3PMI",63.03,"2.82","2.82","PWWP Domain of Human Mutated Melanoma-Associated Antigen 1","EPRSFEVGMLVWHKHKKYPFWPAVVKSVRQRDKKASVLYIEGHMNPKMKGFTVSLKSLKHFDCKEKQTLLNQAREDFNQDIGWCVSLITDYRVRLGCGSFAGSFLEYYAADISYPVRKSIQQDVLGTKLPQLSK","Homo sapiens","EXPAND1, MUM1, PWWP3A","PWWP domain-containing protein MUM1","1","3PMI"
"3PML",,"X-RAY DIFFRACTION",2.8,56,"VAPOR DIFFUSION, SITTING DROP",7.5,".1M NaCl, 0.1M Hepes pH 7.5 and 10%PEG4000, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.1012825108",,"3PML",87.35,"2.6","2.6","crystal structure of a polymerase lambda variant with a dGTP analog opposite a templating T","AQPSSQKATNHNLHITEKLEVLAKAYSVQGDKWRALGYAKAINALKSFHKPVTSYQEACSIPGIGKRMAEKIIEILESGHLRKLDHISESVPVLELFSNIWGAGTKTAQMWYQQGFRSLEDIRSQASLTTQQAIGLKHYSDFLERMPREEATEIEQTVQKAAQAFNSGLLCVACGSYRRGKATCGDVDVLITHPDGRSHRGIFSRLLDSLRQEGFLTDDLVKGETKYLGVCRLPGPGRRHRRLDIIVVPYSEFACALLYFTGSAHFNRSMRALAKTKGMSLSEHALSTAVVRNTHGCKVGPGRVLPTPTEKDVFRLLGLPYREPAERDW","Homo sapiens","POLL","DNA polymerase lambda","1","3PML"
,,,,,,,,,,,,,,,,"CGGCTGTACTG",,,"5'-D(*CP*GP*GP*CP*TP*GP*TP*AP*CP*TP*G)-3'","2","3PML"
,,,,,,,,,,,,,,,,"GCCG",,,"5'-D(P*GP*CP*CP*G)-3'","3","3PML"
,,,,,,,,,,,,,,,,"CAGTAC",,,"5'-D(*CP*AP*GP*TP*AP*C)-3'","4","3PML"
"3PMN",,"X-RAY DIFFRACTION",2.86,56.94,"VAPOR DIFFUSION, SITTING DROP",7.5,"2M formate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.1012825108",,"3PMN",43.9,"2.2","2.2","ternary crystal structure of polymerase lambda variant with a GT mispair at the primer terminus with Mn2+ in the active site","AQPSSQKATNHNLHITEKLEVLAKAYSVQGDKWRALGYAKAINALKSFHKPVTSYQEACSIPGIGKRMAEKIIEILESGHLRKLDHISESVPVLELFSNIWGAGTKTAQMWYQQGFRSLEDIRSQASLTTQQAIGLKHYSDFLERMPREEATEIEQTVQKAAQAFNSGLLCVACGSYRRGKATCGDVDVLITHPDGRSHRGIFSRLLDSLRQEGFLTDDLVKGETKYLGVCRLPGPGRRHRRLDIIVVPYSEFACALLYFTGSAHFNRSMRALAKTKGMSLSEHALSTAVVRNTHGCKVGPGRVLPTPTEKDVFRLLGLPYREPAERDW","Homo sapiens","POLL","DNA polymerase lambda","1","3PMN"
,,,,,,,,,,,,,,,,"CGGCCTTACTG",,,"5'-D(*CP*GP*GP*CP*CP*TP*TP*AP*CP*TP*G)-3'","2","3PMN"
,,,,,,,,,,,,,,,,"CAGTAG",,,"5'-D(*CP*AP*GP*TP*AP*G)-3'","3","3PMN"
,,,,,,,,,,,,,,,,"GCCG",,,"5'-D(*GP*CP*CP*G)-3'","4","3PMN"
"3PMR",,"X-RAY DIFFRACTION",2.69,54.35,"VAPOR DIFFUSION, SITTING DROP",5.6,"1.4M Na/K Phosphate, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi101846x",,"3PMR",51.02,"2.11","2.11","Crystal Structure of E2 domain of Human Amyloid Precursor-Like Protein 1","GSHMTPTPRPTDGVDIYFGMPGEISEHEGFLRAKMDLEERRMRQINEVMREWAMADNQSKNLPKADRQALNEHFQSILQTLEEQVSGERQRLVETHATRVIALINDQRRAALEGFLAALQADPPQAERVLLALRRYLRAEQKEQRHTLRHYQHVAAVDPEKAQQMRFQVHTHLQVIEERVNQSLGLLDQNPHLAQELRPQIQELLHSEHLGPSELEAPA","Homo sapiens","APLP1","Amyloid-like protein 1","1","3PMR"
"3PMT",,"X-RAY DIFFRACTION",2.18,43.68,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M Tris-HCl pH 8.5, 2.0M Ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1371/journal.pone.0030375",,"3PMT",7.08,"1.8","1.8","Crystal structure of the Tudor domain of human Tudor domain-containing protein 3","AKMWKPGDECFALYWEDNKFYRAEVEALHSSGMTAVVKFIDYGNYEEVLLSNIKPIQTE","Homo sapiens","TDRD3","Tudor domain-containing protein 3","1","3PMT"
"3PNC",,"X-RAY DIFFRACTION",2.84,56.64,,7.5,"2M formate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.1012825108",,"3PNC",43.81,"2","2","Ternary crystal structure of a polymerase lambda variant with a GT mispair at the primer terminus and sodium at catalytic metal site","AQPSSQKATNHNLHITEKLEVLAKAYSVQGDKWRALGYAKAINALKSFHKPVTSYQEACSIPGIGKRMAEKIIEILESGHLRKLDHISESVPVLELFSNIWGAGTKTAQMWYQQGFRSLEDIRSQASLTTQQAIGLKHYSDFLERMPREEATEIEQTVQKAAQAFNSGLLCVACGSYRRGKATCGDVDVLITHPDGRSHRGIFSRLLDSLRQEGFLTDDLVKGETKYLGVCRLPGPGRRHRRLDIIVVPYSEFACALLYFTGSAHFNRSMRALAKTKGMSLSEHALSTAVVRNTHGCKVGPGRVLPTPTEKDVFRLLGLPYREPAERDW","Homo sapiens","POLL","DNA polymerase lambda","1","3PNC"
,,,,,,,,,,,,,,,,"CAGTAG",,,"5'-D(*CP*AP*GP*TP*AP*G)-3'","2","3PNC"
,,,,,,,,,,,,,,,,"CGGCCTTACTG",,,"5'-D(*CP*GP*GP*CP*CP*TP*TP*AP*CP*TP*G)-3'","3","3PNC"
,,,,,,,,,,,,,,,,"GCCG",,,"5'-D(*GP*CP*CP*G)-3'","4","3PNC"
"3PO6",,"X-RAY DIFFRACTION",2.08,40.85,"VAPOR DIFFUSION, HANGING DROP",8.2,"0.1M Tris-Cl, 2.5M ammonium sulfate, 0.3M sodium chloride, pH 8.2, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm2000213","DT9, ACT","3PO6",30.22,"1.47","1.47","Crystal structure of human carbonic anhydrase II with 6,7-Dimethoxy-1-methyl-3,4-dihydroisoquinoline-2(1H)-sulfonamide","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3PO6"
"3PO7",,"X-RAY DIFFRACTION",2.68,54.07,"VAPOR DIFFUSION, SITTING DROP",6.5,"12% PEG 4000, 100mM ADA pH 6.5, 70mM Lithium sulphate, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm101359c","ZON","3PO7",119.67,"1.8","1.8","Human monoamine oxidase B in complex with zonisamide","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","Amine oxidase [flavin-containing] B","1","3PO7"
"3PO9",,"X-RAY DIFFRACTION",2.56,51.88,"VAPOR DIFFUSION, HANGING DROP",7,"1.2M tri-sodium citrate, 100mM Hepes, 3.5% 1,2-propanediol, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3PO9",65.94,"2.35","2.35","Crystal structure of PPARgamma ligand binding domain in complex with tripropyltin","GSHMEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3PO9"
"3POK",,"X-RAY DIFFRACTION",2.1,41.43,"VAPOR DIFFUSION, HANGING DROP",4.5,"100mM sodium acetate trihydrate pH 4.5, 3.0 M NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/ja104983t",,"3POK",18.99,"1.7","1.7","Interleukin-1-beta LBT L3 Mutant","MAPVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLGYIDTNNDGWIEGDELYPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","3POK"
,,,,,,,,,,,,,,,,,"Homo sapiens","IL1B, IL1F2"
"3POM",,"X-RAY DIFFRACTION",2.82,56.44,"VAPOR DIFFUSION, SITTING DROP",10.6,"100 mM CAPS, 10% PEG 3350, pH 10.6, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1002/prot.23007",,"3POM",82.43,"2.5","2.5","Crystal Structure of the Unliganded Retinoblastoma Protein Pocket Domain","GEFNTIQQLMMILNSASDQPSENLISYFNNCTVNPKESILKRVKDIGYIFKEKFAKAVGQGCVEIGSQRYKLGVRLYYRVMESMLKSEEERLSIQNFSKLLNDNIFHMSLLACALEVVMATYSRSTSQNLDSGTDLSFPWILNVLNLKAFDFYKVIESFIKAEGNLTREMIKHLERCEHRIMESLAWLSDSPLFDLIKQSKLVPRGSKSTSLSLFYKKVYRLAYLRLNTLCERLLSEHPELEHIIWTLFQHTLQNEYELMRDRHLDQIMMCSMYGICKVKNIDLKFKIIVTAYKDLPHAVQETFKRVLIKEEEYDSIIVFYNSVFMQRLKTNILQYASTRPPTLSPIPHIPR","Homo sapiens","RB1","Retinoblastoma-associated protein","1","3POM"
,,,,,,,,,,,,,,,,,"Homo sapiens","RB1"
"3POO",,"X-RAY DIFFRACTION",2.53,51.35,"VAPOR DIFFUSION, SITTING DROP",6.9,"5mM MES, 5mM BisTris-propane, 75mM LiCl, 1ml DTT, 0.1mM EDTA equilibrated against water/ethanol, pH 6.9, VAPOR DIFFUSION, SITTING DROP, temperature 277K, temperature 289K",289,,,"3POO",43.44,"1.6","1.6","human cAMP-dependent protein kinase in complex with an inhibitor","MGNAAAAKKGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF","Homo sapiens","PKACA, PRKACA","cAMP-dependent protein kinase catalytic subunit alpha","1","3POO"
,,,,,,,,,,,,,,,,"TTYADFIASGRTGRRNAIHD",,,"cAMP-dependent protein kinase inhibitor alpha","2","3POO"
"3POS",,"X-RAY DIFFRACTION",2.06,40.39,"VAPOR DIFFUSION, HANGING DROP",,"30% PEG 4000, 0.1M sodium acetate, 0.1M Tris, pH 8.5-9, VAPOR DIFFUSION, HANGING DROP, temperature 277.1K",277.1,"10.1371/journal.pone.0017886",,"3POS",90.56,"1.65","1.65","Crystal structure of the globular domain of human calreticulin","NKGSIEGREPAVYFKEQFLDGDGWTSRWIESKHKSDFGKFVLSSGKFYGDEEKDKGLQTSQDARFYALSASFEPFSNKGQTLVVQFTVKHEQNIDCGGGYVKLFPNSLDQTDMHGDSEYNIMFGPDICGPGTKKVHVIFNYKGKNVLINKDIRCKDDEFTHLYTLIVRPDNTYEVKIDNSQVESGSLEDDWDFLPGSGDPSIYAYDNFGVLGLDLWQVKSGTIFDNFLITNDEAYAEEFGNETWGVTKAAEKQMKDKQDEEQRLK","Homo sapiens","CALR, CRTC","Calreticulin","1","3POS"
,,,,,,,,,,,,,,,,,"Homo sapiens","CALR, CRTC"
"3POW",,"X-RAY DIFFRACTION",2.3,46.49,"VAPOR DIFFUSION",6,"30% PEG 4000, 0.2M ammonium acetate, 10mM magnesium acetate, and either 0.05M MES (pH 5.7 or 6.0), or 0.05M HEPES (pH 7.0), VAPOR DIFFUSION, temperature 277.1K",277.1,"10.1371/journal.pone.0017886",,"3POW",30.19,"1.55","1.55","Crystal structure of the globular domain of human calreticulin","NKGSIEGREPAVYFKEQFLDGDGWTSRWIESKHKSDFGKFVLSSGKFYGDEEKDKGLQTSQDARFYALSASFEPFSNKGQTLVVQFTVKHEQNIDCGGGYVKLFPNSLDQTDMHGDSEYNIMFGPDICGPGTKKVHVIFNYKGKNVLINKDIRCKDDEFTHLYTLIVRPDNTYEVKIDNSQVESGSLEDDWDFLPGSGDPSIYAYDNFGVLGLDLWQVKSGTIFDNFLITNDEAYAEEFGNETWGVTKAAEKQMKDKQDEEQRLK","Homo sapiens","CALR, CRTC","calreticulin","1","3POW"
,,,,,,,,,,,,,,,,,"Homo sapiens","CALR, CRTC"
"3POZ",,"X-RAY DIFFRACTION",2.25,45.28,,6.5,"pH 6.5, hanging drop vapor diffusion, temperature 20K, temperature 293K",293,"10.1074/jbc.M110.206193","03P","3POZ",38.14,"1.5","1.5","EGFR Kinase domain complexed with tak-285","GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB1, ERBB, HER1","Epidermal growth factor receptor","1","3POZ"
"3PP0",,"X-RAY DIFFRACTION",1.92,35.92,"VAPOR DIFFUSION, SITTING DROP",6.5,"20% PEG 3550, 200mM di-Ammonium Tartrate, 100 mM PIPES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1074/jbc.M110.206193","03Q","3PP0",77.45,"2.25","2.25","Crystal Structure of the Kinase domain of Human HER2 (erbB2).","MSGAAPNQALLRILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVSEFSRMARDPQRFVVIQNEDLGPASPLDSTFYRSLLEDDDMGDLVDAEEYLVPQQGAAASHHHHHH","Homo sapiens","ERBB2, HER2, MLN19, NEU, NGL","Receptor tyrosine-protein kinase erbB-2","1","3PP0"
"3PP1",,"X-RAY DIFFRACTION",3.43,64.15,"VAPOR DIFFUSION, SITTING DROP",6,"10% MPD, 0.1M MES, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2011.01.071","IZG","3PP1",37.73,"2.7","2.7","Crystal Structure of the Human Mitogen-activated protein kinase kinase 1 (MEK 1) in complex with ligand and MgATP","MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNHHHHHH","Homo sapiens","MAP2K1, Mapk/erk kinase 1, MEK1, PRKMK1","Dual specificity mitogen-activated protein kinase kinase 1","1","3PP1"
"3PP2",,"X-RAY DIFFRACTION",3.35,63.33,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.4 M sodium citrate, 0.1 M HEPES, 1:100 w/w endoproteinase Glu-C V8, pH 7.5, vapor diffusion, hanging drop, temperature 293K",293,,,"3PP2",28.93,"1.421","1.421","Crystal structure of the pleckstrin homology domain of ArhGAP27","MAVRTKTLDKAGVLHRTKTADKGKRLRKKHWSASWTVLEGGVLTFFKDSKTSAAGGLRQPSKFSTPEYTVELRGATLSWAPKDKSSRKNVLELRSRDGSEYLIQHDSEAIISTWHKAIAQGIQE","Homo sapiens","ARHGAP27, CAMGAP1, SH3D20, PP905","Rho GTPase-activating protein 27","1","3PP2"
"3PPA",,"X-RAY DIFFRACTION",2.82,56.33,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.5 M ammonium formate, 1.0 M lithium sulfate, 0.1 M citrate pH 5.6; 1 uM dispase added, VAPOR DIFFUSION, SITTING DROP, temperature 291.1K",291.1,,,"3PPA",27.9,"2.35","2.35","Structure of the Dusp-Ubl domains of Usp15","MGSSHHHHHHSSGLVPRGSAADLDTQRSDIATLLKTSLRKGDTWYLVDSRWFKQWKKYVGFDSWDKYQMGDQNVYPGPIDNSGLLKDGDAQSLKEHLIDELDYILLPTEGWNKLVSWYTLMEGQEPIARKVVEQGMFVKHCKVEVYLTELKLCENGNMNNVVTRRFSKADTIDTIEKEIRKIFSIPDEKETRLWNKYMSNTFEPLNKPDSTIQDAGLYQGQVLVIEQKNEDGTWPRG","Homo sapiens","KIAA0529, USP15","Ubiquitin carboxyl-terminal hydrolase 15","1","3PPA"
"3PPD",,"X-RAY DIFFRACTION",1.55,20.39,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES pH6.0, 0.2M Zn(OAc)2, 10%(w/v)PEG-8000, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nature10154",,"3PPD",0.68,"1.5","1.5","GGVLVN segment from Human Prostatic Acid Phosphatase Residues 260-265, involved in Semen-Derived Enhancer of Viral Infection","GGVLVN","Homo sapiens","ACP3, ACPP","GGVLVN peptide, amyloid forming segment","1","3PPD"
"3PPJ",,"X-RAY DIFFRACTION",2.91,57.7,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2010.12.061","FOI","3PPJ",71.11,"3.7","3.7","Human B-Raf Kinase in Complex with a Furopyridine Inhibitor","MDRGSHHHHHHGSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","3PPJ"
"3PPK",,"X-RAY DIFFRACTION",2.92,57.83,"VAPOR DIFFUSION, HANGING DROP",7.8,"PEG 3350, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2010.12.061","FNI","3PPK",71.23,"3","3","Human B-Raf Kinase in Complex with a Non-Oxime Furopyridine Inhibitor","MDRGSHHHHHHGSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","3PPK"
"3PPV",,"X-RAY DIFFRACTION",2.34,47.51,"VAPOR DIFFUSION, HANGING DROP",5.2,"0.1M sodium citrate, 1.6M (NH4)2SO4, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1182/blood-2010-11-321596",,"3PPV",22.2,"1.9","1.9","Crystal structure of an engineered VWF A2 domain (N1493C and C1670S)","MLGPKRCSMVLDVAFVLEGSDKIGEADFNRSKEFMEEVIQRMDVGQDSIHVTVLQYSYMVTVEYPFSEAQSKGDILQRVREIRYQGGNRTNTGLALRYLSDHSFLVSQGDREQAPNLVYMVTGNPASDEIKRLPGDIQVVPIGVGPNANVQELERIGWPNAPILIQDFETLPREAPDLVLQRCSSGEGLEHHHHHH","Homo sapiens","F8VWF, VWF","von Willebrand factor","1","3PPV"
"3PPW",,"X-RAY DIFFRACTION",2.6,52.61,"VAPOR DIFFUSION, HANGING DROP",5.2,"0.1M sodium citrate, 1.6M (NH4)2SO4, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1182/blood-2010-11-321596",,"3PPW",22.04,"1.9","1.9","Crystal structure of the D1596A mutant of an engineered VWF A2 domain (N1493C and C1670S)","MLGPKRCSMVLDVAFVLEGSDKIGEADFNRSKEFMEEVIQRMDVGQDSIHVTVLQYSYMVTVEYPFSEAQSKGDILQRVREIRYQGGNRTNTGLALRYLSDHSFLVSQGAREQAPNLVYMVTGNPASDEIKRLPGDIQVVPIGVGPNANVQELERIGWPNAPILIQDFETLPREAPDLVLQRCSSGEGLEHHHHHH","Homo sapiens","F8VWF, VWF","von Willebrand factor","1","3PPW"
"3PPX",,"X-RAY DIFFRACTION",2.6,52.7,"VAPOR DIFFUSION, HANGING DROP",5.2,"0.1M sodium citrate, 1.6M (NH4)2SO4, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1182/blood-2010-11-321596",,"3PPX",22.04,"1.91","1.91","Crystal structure of the N1602A mutant of an engineered VWF A2 domain (N1493C and C1670S)","MLGPKRCSMVLDVAFVLEGSDKIGEADFNRSKEFMEEVIQRMDVGQDSIHVTVLQYSYMVTVEYPFSEAQSKGDILQRVREIRYQGGNRTNTGLALRYLSDHSFLVSQGDREQAPALVYMVTGNPASDEIKRLPGDIQVVPIGVGPNANVQELERIGWPNAPILIQDFETLPREAPDLVLQRCSSGEGLEHHHHHH","Homo sapiens","F8VWF, VWF","von Willebrand factor","1","3PPX"
"3PPY",,"X-RAY DIFFRACTION",2.63,53.23,"VAPOR DIFFUSION, HANGING DROP",5.2,"0.1M sodium citrate, 1.6M (NH4)2SO4, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1182/blood-2010-11-321596",,"3PPY",22,"2","2","Crystal structure of the D1596A/N1602A double mutant of an engineered VWF A2 domain (N1493C and C1670S)","MLGPKRCSMVLDVAFVLEGSDKIGEADFNRSKEFMEEVIQRMDVGQDSIHVTVLQYSYMVTVEYPFSEAQSKGDILQRVREIRYQGGNRTNTGLALRYLSDHSFLVSQGAREQAPALVYMVTGNPASDEIKRLPGDIQVVPIGVGPNANVQELERIGWPNAPILIQDFETLPREAPDLVLQRCSSGEGLEHHHHHH","Homo sapiens","F8VWF, VWF","von Willebrand factor","1","3PPY"
"3PQ1",,"X-RAY DIFFRACTION",2.15,42.8,"MICROBATCH",,"The precipitant solution contained 100 mM MES (pH 6.0), 6% (v/v) PEG4000, 35 mM NaCl, and 5 mM MgSO4. The protein was at 20 mg/mL concentration, and 0.5 mM MgATP was included as an additive., microbatch, temperature 293K",293,"10.1016/j.molcel.2011.01.013",,"3PQ1",104.66,"3.1","3.1","Crystal structure of human mitochondrial poly(A) polymerase (PAPD1)","MGSSHHHHHHSSGLVPRGSHMEQPSGSVETGFEDKIPKRRFSEMQNERREQAQRTVLIHCPEKISENKFLKYLSQFGPINNHFFYESFGLYAVVEFCQKESIGSLQNGTHTPXXXXXXXSNKQLFELLCYAESIDDQLNTLLKEFQLTEENTKLRYLTCSLIEDMAAAYFPDCIVRPFGSSVNTFGKLGCDLDMFLDLDETRNLSAHKISGNFLMEFQVKNVPSERIATQKILSVLGECLDHFGPGCVGVQKILNARCPLVRFSHQASGFQCALTTNNRIALTSSELLYIYGALDSRVRALVFSVRCWARAHSLTSSIPGAWITNFSLTMMVIFFLQRRSPPILPTLDSLKTLADAEDKCVIEGNNCTFVRDLSRIKPSQNTETLELLLKEFFEYFGNFAXXXXXXXXXXXXXXXVSQSQLQKFVDLARESAWILQQEDTDRPSISSNRPWGLVSLLLPSAPNR","Homo sapiens","MTPAP, PAPD1","Poly(A) RNA polymerase","1","3PQ1"
,,,,,,,,,,,,,,,,,"Homo sapiens","MTPAP, PAPD1"
,,,,,,,,,,,,,,,,,"Homo sapiens","MTPAP, PAPD1"
"3PQZ",,"X-RAY DIFFRACTION",1.95,36.83,"VAPOR DIFFUSION, SITTING DROP",6.6,"17.5% PEG3350, 0.1M Glycine, 10% Glycerol, pH 6.6, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2011.07.030",,"3PQZ",56.67,"2.413","2.413","Grb7 SH2 with peptide","ASGTSLSAAIHRTQLWFHGRISREESQRLIGQQGLVDGLFLVRESQRNPQGFVLSLCHLQKVKHYLILPSEEEGRLYFSMDDGQTRFTDLLQLVEFHQLNRGILPCLLRHCCTRVAL","Homo sapiens","GRB7","Growth factor receptor-bound protein 7","1","3PQZ"
,,,,,,,,,,,,,,,,"WFEGYDNTFPC",,,"cyclic peptide","2","3PQZ"
"3PRE",,"X-RAY DIFFRACTION",2.31,46.77,"VAPOR DIFFUSION",8.2,"0.1M BIS-TRIS PROPANE, 0.2M (NH4)2SO4, 16-18% (W/V) PEG3350, 10% (V/V) ETHYLENE GLYCOL AND 10MM TCEP , pH 8.2, VAPOR DIFFUSION, temperature 286K",286,"10.1016/j.bmcl.2010.12.026",,"3PRE",111.08,"2.91","2.91","Quinazolines with intra-molecular hydrogen bonding scaffold (iMHBS) as PI3K/mTOR dual inhibitors.","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","3PRE"
"3PRF",,"X-RAY DIFFRACTION",2.93,58.05,"VAPOR DIFFUSION, HANGING DROP",7.8,"PEG 3350, Tris buffer, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2010.12.061","FP3","3PRF",71.11,"2.9","2.9","Crystal Structure of Human B-Raf Kinase Domain in Complex with a Non-Oxime Furopyridine Inhibitor","MDRGSHHHHHHGSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","3PRF"
"3PRG",,"X-RAY DIFFRACTION",2.7,54,,9.5,"pH 9.50",,"10.1074/jbc.273.47.31108",,"3PRG",31.79,"2.9","2.9","LIGAND BINDING DOMAIN OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR","AVHYLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA","1","3PRG"
"3PRI",,"X-RAY DIFFRACTION",2.92,57.88,"VAPOR DIFFUSION, HANGING DROP",8,"100 mM Tris, 10% PEG 4000, 0.2 M NDSB-256, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2010.12.061",,"3PRI",71.21,"3.5","3.5","Crystal Structure of Human B-Raf Kinase in Complex with a Non-Oxime Furopyridine Inhibitor","MDRGSHHHHHHGSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","3PRI"
"3PRJ",,"X-RAY DIFFRACTION",2.8,56.01,"VAPOR DIFFUSION, HANGING DROP",7,"10% PEG3350, 0.9 M hexanediol, 0.1 M HEPES pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi2005637",,"3PRJ",337.77,"3.1","3.1","Role of Packing Defects in the Evolution of Allostery and Induced Fit in Human UDP-Glucose Dehydrogenase.","MFEIKKICCIGAGYVGGPTCSVIAHMCPEIRVTVVDVNESRINAWNSPTLPIYEPGLKEVVESCRGKNLFFSTNIDDAIKEADLVFISVNTPTKTYGMGKGRAADLKYIEACARRIVQNSNGYKIVTEKSTVPVRAAESIRRIFDANTKPNLNLQVLSNPEFLAEGTAIKDLKNPDRVLIGGDETPEGQRAVQALCAVYEHWVPREKILTTNTWSSELSKLAANAFLAQRISSINSISALCEATGADVEEVATAIGMDQRIGNKFLKASVGFGGSCFQKDVLNLVYLCEALNLPEVARYWQQVIDMNDYQRRRFASRIIDSLFNTVTDKKIAILGFAFKKDTGDTRESSSIYISKYLMDEGAHLHIYDPKVPREQIVVDLSHPGVSEDDQVSRLVTISKDPYEACDGAHAVVICTEWDMFKELDYERIHKKMLKPAFIFDGRRVLDGLHNELQTIGFQIETIGKKVSSKRIPYAPSGEIPKFSLQDPPNKKPKV","Homo sapiens","UGDH","UDP-glucose 6-dehydrogenase","1","3PRJ"
"3PRY",,"X-RAY DIFFRACTION",2.45,49.76,"VAPOR DIFFUSION, SITTING DROP",7.5,"25.5% PEG3350, 0.17 M ammonium sulfate, 15% glycerol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,,,"3PRY",96.09,"2.28","2.28","Crystal structure of the middle domain of human HSP90-beta refined at 2.3 A resolution","MKTKPIWTRNPDDITQEEYGEFYKSLTNDWEDHLAVKHFSVEGQLEFRALLFIPRRAPFDLFENKKKKNNIKLYVRRVFIMDSCDELIPEYLNFIRGVVDSEDLPLNISREMLQQSKILKVIRKNIVKKCLELFSELAEDKENYKKFYEAFSKNLKLGIHEDSTNRRRLSELLRYHTSQSGDEMTSLSEYVSRMKETQKSIYYITGESKEQVANSAFVERVRKRGFEVVYMTEPIDEYCVQQLKEFDGKSLVSVTKEGLELAENLYFQ","Homo sapiens","HSP90AB1, HSP90B, HSPC2, HSPCB","Heat shock protein HSP 90-beta","1","3PRY"
"3PRZ",,"X-RAY DIFFRACTION",2.31,46.79,"VAPOR DIFFUSION",8.2,"0.1M BIS-TRIS PROPANE, 0.2M (NH4)2SO4, 16-18% (W/V) PEG3350, 10% (V/V) ETHYLENE GLYCOL AND 10MM TCEP , pH 8.2, VAPOR DIFFUSION, temperature 286K",286,"10.1016/j.bmcl.2010.12.026","3RZ","3PRZ",111,"2.6","2.6","Quinazolines with intra-molecular hydrogen bonding scaffold (iMHBS) as PI3K/mTOR dual inhibitors.","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","3PRZ"
"3PS4",,"X-RAY DIFFRACTION",2.26,45.69,"VAPOR DIFFUSION, SITTING DROP",6.1,"25 w/v PEG_MME_2000   
85 mM Imidazole pH 6.1, 15 mM Imidazole pH 8.1, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3PS4",45.38,"1.85","1.85","PDZ domain from Human microtubule-associated serine/threonine-protein kinase 1","YFQSMRSPITIQRSGKKYGFTLRAIRVYMGDTDVYSVHHIVWHVEEGGPAQEAGLCAGDLITHVNGEPVHGMVHPEVVELILKSGNKVAVTTTPFENTQSLV","Homo sapiens","MAST1, KIAA0973, SAST","Microtubule-associated serine/threonine-protein kinase 1","1","3PS4"
"3PS5",,"X-RAY DIFFRACTION",3.02,59.23,"VAPOR DIFFUSION, HANGING DROP",7,"2.5 ul of SHP-1 at 3.5 mg/ml in 25mM Tris-HCl,  beta-mercaptoethanol, 1mM EDTA mixed with 2.5 ul of 1.8M ammonium sulfate, 0.1M glycine, 0.1M Tris-HCl, with the addition of 0.5 ul 14mM deoxy Big Chap to form the final drop., pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1002/jcb.23125",,"3PS5",68.12,"3.1","3.1","Crystal structure of the full-length Human Protein Tyrosine Phosphatase SHP-1","MVRWFHRDLSGLDAETLLKGRGVHGSFLARPSRKNQGDFSLSVRVGDQVTHIRIQNSGDFYDLYGGEKFATLTELVEYYTQQQGVLQDRDGTIIHLKYPLNCSDPTSERWYHGHMSGGQAETLLQAKGEPWTFLVRESLSQPGDFVLSVLSDQPKAGPGSPLRVTHIKVMCEGGRYTVGGLETFDSLTDLVEHFKKTGIEEASGAFVYLRQPYYATRVNAADIENRVLELNKKQESEDTAKAGFWEEFESLQKQEVKNLHQRLEGQRPENKGKNRYKNILPFDHSRVILQGRDSNIPGSDYINANYIKNQLLGPDENAKTYIASQGCLEATVNDFWQMAWQENSRVIVMTTREVEKGRNKCVPYWPEVGMQRAYGPYSVTNCGEHDTTEYKLRTLQVSPLDNGDLIREIWHYQYLSWPDHGVPSEPGGVLSFLDQINQRQESLPHAGPIIVHSSAGIGRTGTIIVIDMLMENISTKGLDCDIDIQKTIQMVRAQRSGMVQTEAQYKFIYVAIAQFIETTKKKLEVLQSQKGQESEYGNITYPPAMKNAHAKASRTSSKHKEDVYENLHTKNKREEKVKKQRSADKEKSKGSLKRK","Homo sapiens","PTPN6, HCP, PTP1C","Tyrosine-protein phosphatase non-receptor type 6","1","3PS5"
"3PS6",,"X-RAY DIFFRACTION",2.33,47.21,"VAPOR DIFFUSION",8.2,"0.1M BIS-TRIS PROPANE, 0.2M (NH4)2SO4, 16-18% (W/V) PEG3350, 10% (V/V) ETHYLENE GLYCOL AND 10MM TCEP , pH 8.2, VAPOR DIFFUSION, temperature 286K",286,"10.1016/j.bmcl.2010.12.026","3PS","3PS6",111.04,"2.6","2.6","Quinazolines with intra-molecular hydrogen bonding scaffold (iMHBS) as PI3K/mTOR dual inhibitors.","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","3PS6"
"3PS8",,"X-RAY DIFFRACTION",4.26,71.15,"VAPOR DIFFUSION, HANGING DROP",4.6,"0.1M sodium acetate pH=4.6, 8% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3PS8",13.73,"2.55","2.55","Crystal structure of L68V mutant of human cystatin C","SSPGKPPRLVGGPMDASVEEEGVRRALDFAVGEYNKASNDMYHSRALQVVRARKQIVAGVNYFLDVEVGRTTCTKTQPNLDNCPFHDQPHLKRKAFCSFQIYAVPWQGTMTLSKSTCQDA","Homo sapiens","CST3","Cystatin-C","1","3PS8"
"3PSB",,"X-RAY DIFFRACTION",2.95,58.36,"VAPOR DIFFUSION, HANGING DROP",8,"10% PEG 8K 
100mM Hepes pH8.0 
3% aminocaproic acid 
10% glycerol 
2.6mg/ml protein 
500uM inhibitor, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2010.12.039","SM6","3PSB",71.17,"3.4","3.4","Furo[2,3-c]pyridine-based Indanone Oximes as Potent and Selective B-Raf Inhibitors","MDRGSHHHHHHGSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR","Homo sapiens","BRAF, BRAF1, RAFB1","B-RAF PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE","1","3PSB"
"3PSD",,"X-RAY DIFFRACTION",2.59,52.5,"VAPOR DIFFUSION, HANGING DROP",8,"7.5% PEG 3350 
100mM Tris pH8.0 
10% Tacsimate 
10% glycerol 
1.6mg/ml protein 
500uM inhibitor 
, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2010.12.038","SM7","3PSD",71.2,"3.6","3.6","Non-oxime pyrazole based inhibitors of B-Raf kinase","MDRGSHHHHHHGSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR","Homo sapiens","BRAF, BRAF1, RAFB1","B-RAF PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE","1","3PSD"
"3PSL",,"X-RAY DIFFRACTION",1.74,29.4,"VAPOR DIFFUSION, HANGING DROP",4.6,"50 mM NaAcetate, 100 mM NH4 SO4 , and 20% PEG4000, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1096/fj.10-171959",,"3PSL",70.85,"1.7","1.7","Fine-tuning the stimulation of MLL1 methyltransferase activity by a histone H3 based peptide mimetic","GAMGSSATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","3PSL"
,,,,,,,,,,,,,,,,"XARTKQ",,,"N-alpha acetylated form of histone H3","2","3PSL"
"3PSR",,"X-RAY DIFFRACTION",2.22,44.7,,7.7,"pH 7.7",,"10.1021/bi982483d",,"3PSR",22.83,"2.5","2.5","HUMAN PSORIASIN (S100A7) CA2+ BOUND FORM (CRYSTAL FORM I)","SNTQAERSIIGMIDMFHKYTRRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLGDIATDYHKQSHGAAPCSGGSQ","Homo sapiens","S100A7, PSOR1, S100A7C","PSORIASIN","1","3PSR"
"3PT3",,"X-RAY DIFFRACTION",1.84,33.1,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Bis-Tris, 0.2M NaCl, 25% PEG3350, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1107/S1744309112036937",,"3PT3",27.04,"1.97","1.97","Crystal structure of the C-terminal lobe of the human UBR5 HECT domain","GPLGSVQMLISFTSFNDESGENAEKLLQFKRWFWSIVEKMSMTERQDLVYFWTSSPSLPASEEGFQPMPSITIRPPDDQHLPTANTCISRLYVPLYSSKQILKQKLLLAIKTKNFGFV","Homo sapiens","UBR5, EDD, EDD1, HYD, KIAA0896","E3 ubiquitin-protein ligase UBR5","1","3PT3"
"3PTA",,"X-RAY DIFFRACTION",3.38,63.58,"VAPOR DIFFUSION, HANGING DROP",6.5,"6% PEG 20,000, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1126/science.1195380","SAH","3PTA",120.36,"3.6","3.6","Crystal structure of human DNMT1(646-1600) in complex with DNA","SNAFKRRRCGVCEVCQQPECGKCKACKDMVKFGGSGRSKQACQERRCPNMAMKEADDDEEVDDNIPEMPSPKKMHQGKKKKQNKNRISWVGEAVKTDGKKSYYKKVCIDAETLEVGDCVSVIPDDSSKPLYLARVTALWEDSSNGQMFHAHWFCAGTDTVLGATSDPLELFLVDECEDMQLSYIHSKVKVIYKAPSENWAMEGGMDPESLLEGDDGKTYFYQLWYDQDYARFESPPKTQPTEDNKFKFCVSCARLAEMRQKEIPRVLEQLEDLDSRVLYYSATKNGILYRVGDGVYLPPEAFTFNIKLSSPVKRPRKEPVDEDLYPEHYRKYSDYIKGSNLDAPEPYRIGRIKEIFCPKKSNGRPNETDIKIRVNKFYRPENTHKSTPASYHADINLLYWSDEEAVVDFKAVQGRCTVEYGEDLPECVQVYSMGGPNRFYFLEAYNAKSKSFEDPPNHARSPGNKGKGKGKGKGKPKSQACEPSEPEIEIKLPKLRTLDVFSGCGGLSEGFHQAGISDTLWAIEMWDPAAQAFRLNNPGSTVFTEDCNILLKLVMAGETTNSRGQRLPQKGDVEMLCGGPPCQGFSGMNRFNSRTYSKFKNSLVVSFLSYCDYYRPRFFLLENVRNFVSFKRSMVLKLTLRCLVRMGYQCTFGVLQAGQYGVAQTRRRAIILAAAPGEKLPLFPEPLHVFAPRACQLSVVVDDKKFVSNITRLSSGPFRTITVRDTMSDLPEVRNGASALEISYNGEPQSWFQRQLRGAQYQPILRDHICKDMSALVAARMRHIPLAPGSDWRDLPNIEVRLSDGTMARKLRYTHHDRKNGRSSSGALRGVCSCVEAGKACDPAARQFNTLIPWCLPHTGNRHNHWAGLYGRLEWDGFFSTTVTNPEPMGKQGRVLHPEQHRVVSVRECARSQGFPDTYRLFGNILDKHRQVGNAVPPPLAKAIGLEIKLCMLAKA","Homo sapiens","DNMT1, AIM, CXXC9, DNMT","DNA (cytosine-5)-methyltransferase 1","1","3PTA"
,,,,,,,,,,,,,,,,"TCCCGTGAGCCTCCGCAGG",,,"DNA (5'-D(*TP*CP*CP*CP*GP*TP*GP*AP*GP*CP*CP*TP*CP*CP*GP*CP*AP*GP*G)-3')","2","3PTA"
,,,,,,,,,,,,,,,,"CCTGCGGAGGCTCACGGGA",,,"DNA (5'-D(*CP*CP*TP*GP*CP*GP*GP*AP*GP*GP*CP*TP*CP*AP*CP*GP*GP*GP*A)-3')","3","3PTA"
"3PTR",,"X-RAY DIFFRACTION",2.56,51.88,"VAPOR DIFFUSION",6,"18-30% polyethylene glycol 3350 and 100 mM NaCitrate, pH 5.2-6.0, VAPOR DIFFUSION",,"10.1016/j.jmb.2010.12.013",,"3PTR",45.89,"1.954","1.954","PHF2 Jumonji domain","STLKKKRTWHKHGPGQAPDVKPVQNGSQLFIKELRSRTFPSAEDVVARVPGSQLTLGYMEEHGFTEPILVPKKDGLGLAVPAPTFYVSDVENYVGPERSVDVTDVTKQKDCKMKLKEFVDYYYSTNRKRVLNVTNLEFSDTRMSSFVEPPDIVKKLSWVENYWPDDALLAKPKVTKYCLICVKDSYTDFHIDSGGASAWYHVLKGEKTFYLIRPASANISLYERWRSASNHSEMFFADQVDKCYKCIVKQGQTLFIPSGWIYATLTPVDCLAFAGHFLHSLSVEMQMRAYEVERRLKLGSLTQFPNFETACWYMGKHLLEAFKGSHKSGKQLPPHLVQGAKILNGAFRSWTKKQALAEHEDELPEHFKPSQLIKDLAKEIRLSENASKAVRP","Homo sapiens","PHF2, KIAA0662, CENP-35","PHD finger protein 2","1","3PTR"
"3PTZ",,"X-RAY DIFFRACTION",2.75,55.25,"VAPOR DIFFUSION, HANGING DROP",7.5,"10% PEG3350, 6% heptanediol, 0.1 M HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi2005637",,"3PTZ",337.76,"2.5","2.5","Role of Packing Defects in the Evolution of Allostery and Induced Fit in Human UDP-Glucose Dehydrogenase.","MFEIKKICCIGAGYVGGPTCSVIAHMCPEIRVTVVDVNESRINAWNSPTLPIYEPGLKEVVESCRGKNLFFSTNIDDAIKEADLVFISVNTPTKTYGMGKGRAADLKYIEACARRIVQNSNGYKIVTEKSTVPVRAAESIRRIFDANTKPNLNLQVLSNPEFLAEGTAIKDLKNPDRVLIGGDETPEGQRAVQALCAVYEHWVPREKILTTNTWSSELSKLAANAFLAQRISSINSISALCEATGADVEEVATAIGMDQRIGNKFLKASVGFGGSCFQKDVLNLVYLCEALNLPEVARYWQQVIDMNDYQRRRFASRIIDSLFNTVTDKKIAILGFAFKKDTGDTRESSSIYISKYLMDEGAHLHIYDPKVPREQIVVDLSHPGVSEDDQVSRLVTISKDPYEACDGAHAVVICTEWDMFKELDYERIHKKMLKPAFIFDGRRVLDGLHNELQTIGFQIETIGKKVSSKRIPYAPSGEIPKFSLQDPPNKKPKV","Homo sapiens","UGDH","UDP-glucose 6-dehydrogenase","1","3PTZ"
"3PU3",,"X-RAY DIFFRACTION",2.36,47.8,"VAPOR DIFFUSION",6,"18-30% polyethylene glycol 3350 and 100 mM NaCitrate, pH 5.2-6.0, VAPOR DIFFUSION",,"10.1016/j.jmb.2010.12.013",,"3PU3",92.49,"1.95","1.95","PHF2 Jumonji domain-NOG complex","STLKKKRTWHKHGPGQAPDVKPVQNGSQLFIKELRSRTFPSAEDVVARVPGSQLTLGYMEEHGFTEPILVPKKDGLGLAVPAPTFYVSDVENYVGPERSVDVTDVTKQKDCKMKLKEFVDYYYSTNRKRVLNVTNLEFSDTRMSSFVEPPDIVKKLSWVENYWPDDALLAKPKVTKYCLICVKDSYTDFHIDSGGASAWYHVLKGEKTFYLIRPASANISLYERWRSASNHSEMFFADQVDKCYKCIVKQGQTLFIPSGWIYATLTPVDCLAFAGHFLHSLSVEMQMRAYEVERRLKLGSLTQFPNFETACWYMGKHLLEAFKGSHKSGKQLPPHLVQGAKILNGAFRSWTKKQALAEHEDELPEHFKPSQLIKDLAKEIRLSENASKAVRP","Homo sapiens","PHF2, KIAA0662, CENP-35","PHD finger protein 2","1","3PU3"
"3PU8",,"X-RAY DIFFRACTION",2.4,48.73,"VAPOR DIFFUSION",6,"18-30% polyethylene glycol 3350 and 100 mM NaCitrate, pH 5.2-6.0, VAPOR DIFFUSION",,"10.1016/j.jmb.2010.12.013",,"3PU8",91.47,"1.943","1.943","PHF2 Jumonji-NOG-Fe(II) complex","STLKKKRTWHKHGPGQAPDVKPVQNGSQLFIKELRSRTFPSAEDVVARVPGSQLTLGYMEEHGFTEPILVPKKDGLGLAVPAPTFYVSDVENYVGPERSVDVTDVTKQKDCKMKLKEFVDYYYSTNRKRVLNVTNLEFSDTRMSSFVEPPDIVKKLSWVENYWPDDALLAKPKVTKYCLICVKDSYTDFHIDSGGASAWYHVLKGEKTFYLIRPASANISLYERWRSASNHSEMFFADQVDKCYKCIVKQGQTLFIPSGWIYATLTPVDCLAFAGHFLHSLSVEMQMRAYEVERRLKLGSLTQFPNFETACWYMGKHLLEAFKGSHKSGKQLPPHLVQGAKILNGAFRSWTKKQALAEHEDELPEHFKPSQLIKDLAKEIRLSENASKAVRP","Homo sapiens","PHF2, KIAA0662, CENP-35","PHD finger protein 2","1","3PU8"
"3PUA",,"X-RAY DIFFRACTION",2.62,53.13,"VAPOR DIFFUSION",6,"18-30% polyethylene glycol 3350 and 100 mM NaCitrate, pH 5.2-6.0, VAPOR DIFFUSION",,"10.1016/j.jmb.2010.12.013",,"3PUA",45.64,"1.89","1.89","PHF2 Jumonji-NOG-Ni(II)","STLKKKRTWHKHGPGQAPDVKPVQNGSQLFIKELRSRTFPSAEDVVARVPGSQLTLGYMEEHGFTEPILVPKKDGLGLAVPAPTFYVSDVENYVGPERSVDVTDVTKQKDCKMKLKEFVDYYYSTNRKRVLNVTNLEFSDTRMSSFVEPPDIVKKLSWVENYWPDDALLAKPKVTKYCLICVKDSYTDFHIDSGGASAWYHVLKGEKTFYLIRPASANISLYERWRSASNHSEMFFADQVDKCYKCIVKQGQTLFIPSGWIYATLTPVDCLAFAGHFLHSLSVEMQMRAYEVERRLKLGSLTQFPNFETACWYMGKHLLEAFKGSHKSGKQLPPHLVQGAKILNGAFRSWTKKQALAEHEDELPEHFKPSQLIKDLAKEIRLSENASKAVRP","Homo sapiens","PHF2, KIAA0662, CENP-35","PHD finger protein 2","1","3PUA"
"3PUC",,"X-RAY DIFFRACTION",1.8,31.65,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris pH 8.0, 3.2M ammonium sulfate, 1mM TCEP, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3PUC",10.52,"0.96","0.96","Atomic resolution structure of titin domain M7","GPISSKPVIVTGLQDTTVSSDSVAKFAVKATGEPRPTAIWTKDGKAITQGGKYKLSEDKGGFFLEIHKTDTSDSGLYTCTVKNSAGSVSSSCKLTIKAI","Homo sapiens","TTN","Titin","1","3PUC"
"3PUP",,"X-RAY DIFFRACTION",3.34,63.19,"VAPOR DIFFUSION, HANGING DROP",7.4,"100 mM Tris pH 7.4  
20 % PEG 6000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/ja1112996","OS1","3PUP",94.75,"2.99","2.99","Structure of Glycogen Synthase Kinase 3 beta (GSK3B) in complex with a ruthenium octasporine ligand (OS1)","MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","3PUP"
"3PUS",,"X-RAY DIFFRACTION",2.35,47.56,"VAPOR DIFFUSION",6,"18-30% polyethylene glycol 3350 and 100 mM NaCitrate, pH 5.2-6.0, VAPOR DIFFUSION",,"10.1016/j.jmb.2010.12.013",,"3PUS",90.81,"2.08","2.08","PHF2 Jumonji-NOG-Ni(II)","STLKKKRTWHKHGPGQAPDVKPVQNGSQLFIKELRSRTFPSAEDVVARVPGSQLTLGYMEEHGFTEPILVPKKDGLGLAVPAPTFYVSDVENYVGPERSVDVTDVTKQKDCKMKLKEFVDYYYSTNRKRVLNVTNLEFSDTRMSSFVEPPDIVKKLSWVENYWPDDALLAKPKVTKYCLICVKDSYTDFHIDSGGASAWYHVLKGEKTFYLIRPASANISLYERWRSASNHSEMFFADQVDKCYKCIVKQGQTLFIPSGWIYATLTPVDCLAFAGHFLHSLSVEMQMRAYEVERRLKLGSLTQFPNFETACWYMGKHLLEAFKGSHKSGKQLPPHLVQGAKILNGAFRSWTKKQALAEHEDELPEHFKPSQLIKDLAKEIRLSENASKAVRP","Homo sapiens","PHF2, KIAA0662, CENP-35","PHD finger protein 2","1","3PUS"
"3PV1",,"X-RAY DIFFRACTION",3.01,59.09,"VAPOR DIFFUSION, SITTING DROP",7.2,"18% PEG  4000, 0.1M Tris, 0.1M magnesium acetate, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1016/j.febslet.2011.09.040",,"3PV1",51.97,"2.6","2.6","Crystal structure of the USP15 DUSP-UBL domains","GAMAEGGAADLDTQRSDIATLLKTSLRKGDTWYLVDSRWFKQWKKYVGFDSWDKYQMGDQNVYPGPIDNSGLLKDGDAQSLKEHLIDELDYILLPTEGWNKLVSWYTLMEGQEPIARKVVEQGMFVKHCKVEVYLTELKLCENGNMNNVVTRRFSKADTIDTIEKEIRKIFSIPDEKETRLWNKYMSNTFEPLNKPDSTIQDAGLYQGQVLVIEQKNEDGTWPRG","Homo sapiens","USP15, KIAA0529","Ubiquitin carboxyl-terminal hydrolase 15","1","3PV1"
"3PV7",,"X-RAY DIFFRACTION",2.94,58.18,"hanging drop",7,"PEG 3350, LiCl2, pH 7.0, hanging drop, temperature 298K",298,,,"3PV7",28.9,"2","2","Crystal structure of NKp30 ligand B7-H6","ADLKVEMMAGGTQITPLNDNVTIFCNIFYSQPLNITSMGITWFWKSLTFDKEVKVFEFFGDHQEAFRPGAIVSPWRLKSGDASLRLPGIQLEEAGEYRCEVVVTPLKAQGTVQLEVVASPASRLLLDQVGMKENEDKYMCESSGFYPEAINITWEKQTQKFPHPIEISEDVITGPTIKNMDGTFNVTSCLKLNSSQEDPGTVYQCVVRHASLHTPLRSNFTLTAARHSLSETEKTDNFSAAAHHHHHH","Homo sapiens","NCR3LG1, B7H6","Ig-like domain-containing protein DKFZp686O24166/DKFZp686I21167","1","3PV7"
"3PVN",,"X-RAY DIFFRACTION",2.41,48.99,"VAPOR DIFFUSION",8,"12% PEG 4000, 0.1M Tris-Hcl, 0.2M MgCl2, 0.05M LiCl, pH 8.0, VAPOR DIFFUSION, temperature 289K",289,"10.2174/0929866522666141231111226",,"3PVN",463.29,"1.98","1.98","Triclinic form of Human C-Reactive Protein in complex with Zinc","QTDMSRKAFVFPKESDTSYVSLKAPLTKPLKAFTVCLHFYTELSSTRGYSIFSYATKRQDNEILIFWSKDIGYSFTVGGSEILFEVPEVTVAPVHICTSWESASGIVEFWVDGKPRVRKSLKKGYTVGAEASIILGQEQDSFGGNFEGSQSLVGDIGNVNMWDFVLSPDEINTIYLGGPFSPNVLNWRALKYEVQGEVFTKPQLWP","Homo sapiens","CRP, PTX1","C-reactive protein","1","3PVN"
"3PVO",,"X-RAY DIFFRACTION",2.44,49.62,"VAPOR DIFFUSION",8,"12% PEG 4000, 0.1M Tris-HCl, 0.2M MgCl2, 0.05M LiCl, pH 8.0, VAPOR DIFFUSION, temperature 289K",289,"10.2174/0929866522666141231111226",,"3PVO",462.96,"3","3","Monoclinic form of Human C-Reactive Protein","QTDMSRKAFVFPKESDTSYVSLKAPLTKPLKAFTVCLHFYTELSSTRGYSIFSYATKRQDNEILIFWSKDIGYSFTVGGSEILFEVPEVTVAPVHICTSWESASGIVEFWVDGKPRVRKSLKKGYTVGAEASIILGQEQDSFGGNFEGSQSLVGDIGNVNMWDFVLSPDEINTIYLGGPFSPNVLNWRALKYEVQGEVFTKPQLWP","Homo sapiens","CRP, PTX1","C-Reactive Protein","1","3PVO"
"3PWH",,"X-RAY DIFFRACTION",5.425463,77.329124,"VAPOR DIFFUSION, SITTING DROP",8.1,"32-42% PEG1000, 0.25M MgCl2, 0.3% NG, 0.1%(w/v) 1-Butanol, 0.05% CYMAL-6, pH 8.1, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.str.2011.06.014","ZMA","3PWH",36.82,"3.296","3.296","Thermostabilised Adenosine A2A Receptor","MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADILVGVLAIPFAITISTGFCAACHGCLFIACFVLVLAQSSIFSLLAIAIDRYIAIAIPLRYNGLVTGTRAAGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFAAARRQLKQMESQPLPGERARSTLQKEVHAAKSAAIIAGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLAHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAAAHHHHHHHHHH","Homo sapiens","ADORA2A, ADORA2","Adenosine receptor A2a","1","3PWH"
"3PWY",,"X-RAY DIFFRACTION",2.9,57.64,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.1 M Tris pH 7.4, 2.1 M ammonium sulfate; 16 mg/ml protein in 50 mM Tris pH 8, 400 mM KCl, 3 mM DTT; supplemented with 20 mM DTT prior to addition of inhibitor, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2011.03.032",,"3PWY",35.73,"3.5","3.5","Crystal structure of an extender (SPD28345)-modified human PDK1 complex 2","GPMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDK1, PDPK1","3-phosphoinositide-dependent protein kinase 1","1","3PWY"
"3PXA",,"X-RAY DIFFRACTION",4.73,73.99,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.0M Li2SO4 
100mM Tris 
5mM CaCl2 
10mM NiCl2 
 
, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi2003795",,"3PXA",24.74,"2.55","2.55","Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: G1656D","VNKRMSMVVSDLTPEEFMLVYKFARKHHITLTNLITEETTHVVMKTDAEFVCERTLKYFLGIAGGKWVVSYFWVTQSIKERKMLNEHDFEVRGDVVNGRNHQGPKRARESQDRKIFRGLEICCYGPFTNMPTDQLEWMVQLCGASVVKELSSFTLGTGVHPIVVVQPDAWTEDNGFHAIGQMCEAPVVTREWVLDSVALYQCQELDTYLIPQIP","Homo sapiens","BRCA1, RNF53","Breast cancer type 1 susceptibility protein","1","3PXA"
"3PXB",,"X-RAY DIFFRACTION",4.71,73.91,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.8 M Li2SO4 
100 mM TRIS 
5mM CaCl2 
10 mM NiCl2, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi2003795",,"3PXB",24.66,"2.5","2.5","Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: T1700A","VNKRMSMVVSGLTPEEFMLVYKFARKHHITLTNLITEETTHVVMKTDAEFVCERALKYFLGIAGGKWVVSYFWVTQSIKERKMLNEHDFEVRGDVVNGRNHQGPKRARESQDRKIFRGLEICCYGPFTNMPTDQLEWMVQLCGASVVKELSSFTLGTGVHPIVVVQPDAWTEDNGFHAIGQMCEAPVVTREWVLDSVALYQCQELDTYLIPQIP","Homo sapiens","BRCA1, RNF53","Breast cancer type 1 susceptibility protein","1","3PXB"
"3PXC",,"X-RAY DIFFRACTION",4.73,73.97,"VAPOR DIFFUSION, HANGING DROP",8,"0.8M Li2SO4  
100mM Tris  
5mM CaCl2  
10mM NiCl2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi2003795",,"3PXC",24.66,"2.8","2.8","Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: R1699Q","VNKRMSMVVSGLTPEEFMLVYKFARKHHITLTNLITEETTHVVMKTDAEFVCEQTLKYFLGIAGGKWVVSYFWVTQSIKERKMLNEHDFEVRGDVVNGRNHQGPKRARESQDRKIFRGLEICCYGPFTNMPTDQLEWMVQLCGASVVKELSSFTLGTGVHPIVVVQPDAWTEDNGFHAIGQMCEAPVVTREWVLDSVALYQCQELDTYLIPQIP","Homo sapiens","BRCA1, RNF53","Breast cancer type 1 susceptibility protein","1","3PXC"
"3PXD",,"X-RAY DIFFRACTION",4.75,74.12,"VAPOR DIFFUSION, HANGING DROP",8,"0.8M Li2SO4 
100 mM Tris 
5mM CaCl2 
10mM NiCl2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi2003795",,"3PXD",24.63,"2.8","2.8","Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: R1835P","VNKRMSMVVSGLTPEEFMLVYKFARKHHITLTNLITEETTHVVMKTDAEFVCERTLKYFLGIAGGKWVVSYFWVTQSIKERKMLNEHDFEVRGDVVNGRNHQGPKRARESQDRKIFRGLEICCYGPFTNMPTDQLEWMVQLCGASVVKELSSFTLGTGVHPIVVVQPDAWTEDNGFHAIGQMCEAPVVTPEWVLDSVALYQCQELDTYLIPQIP","Homo sapiens","BRCA1, RNF53","Breast cancer type 1 susceptibility protein","1","3PXD"
"3PXE",,"X-RAY DIFFRACTION",3.33,63.09,"VAPOR DIFFUSION, HANGING DROP",6.5,"50mM MES       
0.15M (NH4)2SO4      
26% PEG 8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi2003795",,"3PXE",102.95,"2.85","2.85","Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: E1836K","VNKRMSMVVSGLTPEEFMLVYKFARKHHITLTNLITEETTHVVMKTDAEFVCERTLKYFLGIAGGKWVVSYFWVTQSIKERKMLNEHDFEVRGDVVNGRNHQGPKRARESQDRKIFRGLEICCYGPFTNMPTDQLEWMVQLCGASVVKELSSFTLGTGVHPIVVVQPDAWTEDNGFHAIGQMCEAPVVTRKWVLDSVALYQCQELDTYLIPQIP","Homo sapiens","BRCA1, RNF53","Breast cancer type 1 susceptibility protein","1","3PXE"
,,,,,,,,,,,,,,,,"SRSTSPTFNK",,,"phospho peptide","2","3PXE"
"3PXF",,"X-RAY DIFFRACTION",1.93,36.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2, 5 mM ANS, 15% (v/v) JEFFAMINE ED-2001, 50 mM HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb100410m","2AN","3PXF",35.67,"1.8","1.8","CDK2 in complex with two molecules of 8-anilino-1-naphthalene sulfonate","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cell division protein kinase 2","1","3PXF"
"3PXK",,"X-RAY DIFFRACTION",2.31,46.68,"VAPOR DIFFUSION, HANGING DROP",8.6,"0.1M Tris 
16% PEG 3350 
, pH 8.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3PXK",65.14,"1.79","1.79","FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH Pyrrolo[2,3-d]thiazole","GSGSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQEE","Homo sapiens","PTK2, FAK, FAK1","PTK2 protein","1","3PXK"
"3PXQ",,"X-RAY DIFFRACTION",1.91,35.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2, 15% (v/v) PEG3350, 50 mM HEPES/NaOH; soaked 24 hrs in 15 mM ANS, 50 mM HEPES, 50 mM Na/K phosphate, 7.5% (v/v) PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb100410m","2AN","3PXQ",35.72,"1.9","1.9","CDK2 in complex with 3 molecules of 8-anilino-1-naphthalene sulfonate","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cell division protein kinase 2","1","3PXQ"
"3PXR",,"X-RAY DIFFRACTION",1.99,38.33,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2, 15 % (v/v) Jeffamine ED-2001, 50 mM HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb100410m",,"3PXR",34.82,"2","2","Apo CDK2 crystallized from Jeffamine","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cell division protein kinase 2","1","3PXR"
"3PXY",,"X-RAY DIFFRACTION",1.96,37.37,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2, 1.5 mM JWS648, 15% (v/v) PEG3350, 50 mM HEPES/NaOH, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb100410m","JWS","3PXY",35.09,"1.8","1.8","CDK2 in complex with inhibitor JWS648","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cell division protein kinase 2","1","3PXY"
"3PXZ",,"X-RAY DIFFRACTION",1.93,36.32,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2, 3 mM JWS648, 15% (v/v) PEG3350, 50 mM HEPES/NaOH, soaked for 24 hrs in 15 mM ANS, 2 mM JWS648, 50 mM HEPES, 50 mM Na/K phosphate, 7.5% (v/v) PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb100410m","JWS, 2AN","3PXZ",35.59,"1.7","1.7","CDK2 ternary complex with JWS648 and ANS","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cell division protein kinase 2","1","3PXZ"
"3PY0",,"X-RAY DIFFRACTION",2,38.55,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2, 1.5 mM SU9516, 15% (v/v) PEG3350, 50 mM HEPES/NaOH, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb100410m","SU9","3PY0",35.16,"1.75","1.75","CDK2 in complex with inhibitor SU9516","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cell division protein kinase 2","1","3PY0"
"3PY1",,"X-RAY DIFFRACTION",1.93,36.1,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2, 1.5 mM SU9516, 15% (v/v) PEG3350, 50 mM HEPES/NaOH, soaked for 24 hrs in 15 mM ANS, 2 mM SU9516, 50 mM HEPES, 50 mM Na/K phosphate, 7.5% (v/v) PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb100410m","SU9, 2AN","3PY1",35.66,"2.05","2.05","CDK2 ternary complex with SU9516 and ANS","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cell division protein kinase 2","1","3PY1"
"3PYC",,"X-RAY DIFFRACTION",2.24,45.07,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M HEPES (pH 6.5), 2M ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3PYC",15.07,"1.96","1.96","Crystal structure of human SMURF1 C2 domain","GSEFIKIRLTVLCAKNLAKKDFFRLPDPFAKIVVDGSGQCHSTDTVKNTLDPKWNQHYDLYVGKTDSITISVWNHKKIHKKQGAGFLGCVRLLSNAISRLKDTGYQRLDLCKLNPSDTDAVRGQIVVSLQTR","Homo sapiens","SMURF1, KIAA1625","E3 ubiquitin-protein ligase SMURF1","1","3PYC"
"3PYK",,"X-RAY DIFFRACTION",2.09,41.24,"VAPOR DIFFUSION, HANGING DROP",8,"3 uL protein solution (20 mg/mL lyophilized hCAII in 50 mM Tris-sulfate, 1 mM methyl mercuric acetate) and 5 uL precipitating buffer (2.6 M ammonium sulfate, 50 mM Tris-sulfate were mixed and equilibrated against 500 uL precipitating buffer. Single crystals were transferred into a cross-linking buffer, which was prepared from 10 uL precipitating buffer and 5 uL glutaraldehyde solution (0.8 % glutaraldehyde, 4 M ammonium sulfate, 50 mM Tris-sulfate) and equilibrated for 18 h. Cross-linked crystals were transferred into soaking buffer (9 uL precipitating buffer, 0.5 uL 60 mM {(6-benzene)Ru(bispy 3)Cl}+ in DMSO) and equilibrated for 54 h, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1039/c1cc10345h","SO4","3PYK",30.32,"1.3","1.3","Human Carbonic Anhydrase II as Host for Pianostool Complexes Bearing a Sulfonamide Anchor","MAHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3PYK"
"3PYY",,"X-RAY DIFFRACTION",2.95,58.35,"VAPOR DIFFUSION, HANGING DROP",8,"20 mgs/ml protein in 20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 3 mM DTT and 5% (v/v) glycerol. Reservoir with 0.4 M ammonium phosphate. Cryo w/ 15%-30% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.chembiol.2010.12.013","STI, 3YY","3PYY",71.87,"1.85","1.85","Discovery and Characterization of a Cell-Permeable, Small-molecule c-Abl Kinase Activator that Binds to the Myristoyl Binding Site","MHHHHHHENLYFQGSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGK","Homo sapiens","ABL1, ABL, JTK7","V-abl Abelson murine leukemia viral oncogene homolog 1 isoform b variant","1","3PYY"
"3PZ7",,"X-RAY DIFFRACTION",2.07,40.46,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Sodium Cacodylate, 20% PEG 3350, 4% Ethylene Glycol, 0.2M Ammonium Acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 278.0K",278,,,"3PZ7",10.69,"2.441","2.441","Crystal structure of Ccd1-DIX domain","GPHMSSTCTKVLYFTDRSLTPFMVNIPKRLEEVTLKDFKAAIDREGNHRYHFKAMDPEFGTVKEEIFHDDDAIPGWEGKIVAWVEEDHGEN","Homo sapiens","DIXDC1, CCD1, KIAA1735","Dixin","1","3PZ7"
"3PZE",,"X-RAY DIFFRACTION",2.28,46.15,"EVAPORATION",7,"15% PEG2000 MME, 100 mM HEPES, 10 mM DTT, pH 7, EVAPORATION, temperature 298K",298,"10.1021/jm300025r",,"3PZE",41.99,"2","2","JNK1 in complex with inhibitor","DNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLE","Homo sapiens","MAPK8, JNK1, PRKM8, SAPK1, SAPK1C","Mitogen-activated protein kinase 8","1","3PZE"
"3PZP",,"X-RAY DIFFRACTION",3.61,65.88,"VAPOR DIFFUSION, HANGING DROP",7,"14% PEG 5000 monomethylether, 0.2M potassium acetate, 0.1M sodium chloride, 0.1M sodium cacodylate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jmb.2011.02.042",,"3PZP",137.75,"3.336","3.336","Human DNA polymerase kappa extending opposite a cis-syn thymine dimer","GPGGDPHMGLNDNKAGMEGLDKEKINKIIMEATKGSRFYGNELKKEKQVNQRIENMMQQKAQITSQQLRKAQLQVDRFAMELEQSRNLSNTIVHIDMDAFYAAVEMRDNPELKDKPIAVGSMSMLSTSNYHARRFGVRAAMPGFIAKRLCPQLIIVPPNFDKYRAVSKEVKEILADYDPNFMAMSLDEAYLNITKHLEERQNWPEDKRRYFIKMGSSVENDNPGKEVNKLSEHERSISPLLFEESPSDVQPPGDPFQVNFEEQNNPQILQNSVVFGTSAQEVVKEIRFRIEQKTTLTASAGIAPNTMLAKVCSDKNKPNGQYQILPNRQAVMDFIKDLPIRKVSGIGKVTEKMLKALGIITCTELYQQRALLSLLFSETSWHYFLHISLGLGSTHLTRDGERKSMSVERTFSEINKAEEQYSLCQELCSELAQDLQKERLKGRTVTIKLKNVNFEVKTRASTVSSVVSTAEEIFAIAKELLKTEIDADFPHPLRLRLMGVRISSFPNEEDRKHQQRS","Homo sapiens","POLK, DINB1","DNA polymerase kappa","1","3PZP"
,,,,,,,,,,,,,,,,"GGGGGAAGGACCA",,,"5'-D(*GP*GP*GP*GP*GP*AP*AP*GP*GP*AP*CP*CP*A)-3'","2","3PZP"
,,,,,,,,,,,,,,,,"TTCCTGGTCCTTCCCCC",,,"5'-D(*TP*TP*CP*CP*(TTD)P*GP*GP*TP*CP*CP*TP*TP*CP*CP*CP*CP*C)-3'","3","3PZP"
"3PZZ",,"X-RAY DIFFRACTION",1.68,26.79,"VAPOR DIFFUSION, HANGING DROP",,"reservoir contained 14.4% PEG 8000, 0.08 M Na Cacodylate pH 6.5, 0.16 M Calcium Acetate, 20% v/v Glycerol, vapor diffusion, hanging drop, temperature 291K",291,"10.1073/pnas.1112600108",,"3PZZ",1.09,"1.29","1.29","Structure of an amyloid forming peptide GAIIGL (29-34) from amyloid beta","GAIIGL","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","3PZZ"
"3Q01",,"X-RAY DIFFRACTION",2.59,52.58,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M ammonium acetate, 0.1M HEPES, pH 7.5, 45% v/v 2-Methyl-2,4-pentanediol, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/emboj.2011.127",,"3Q01",53.02,"2.1","2.1","An induced fit mechanism regulates p53 DNA binding kinetics to confer sequence specificity","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFVQLAKTVPVQLYVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERSSDSDGLAPPQHLIRVEGNLRAEYLDDPNTFRHSVVVPYEPPEVGSDYTTIYFKFMCNSSCMGGMNRRPILVIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKTMDGEYFTLQIRGRERFEQFRERNEALELKDAQAG","Homo sapiens","P53, TP53","Cellular tumor antigen p53","1","3Q01"
,,,,,,,,,,,,,,,,,"Homo sapiens","P53, TP53"
"3Q02",,"X-RAY DIFFRACTION",2.72,54.72,"VAPOR DIFFUSION, HANGING DROP",6.1,"1.7 - 3.0 M NaCl, 5 mM Mes pH 6.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M111.236554",,"3Q02",85.82,"2.3","2.3","Crystal structure of plasminogen activator inhibitor-1 in a metastable active conformation.","VHHPPSYVAHLASDFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDDKGMAPALRHLYKELMGPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIINDWVKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGQFKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAPYEKEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQADFTSLSDQEPLHVAQALQKVKIEVNESGTVASSSTAVIVSARMAPEEIIMDRPFLFVVRHNPTGTVLFMGQVMEP","Homo sapiens","PAI1, PLANH1, SERPINE1","Plasminogen activator inhibitor 1","1","3Q02"
"3Q03",,"X-RAY DIFFRACTION",2.7,54.41,"VAPOR DIFFUSION, HANGING DROP",6.1,"1.7 - 3.0 M NaCl, 5 mM Mes pH 6.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M111.236554",,"3Q03",85.76,"2.6401","2.6401","Crystal structure of plasminogen activator inhibitor-1 in a metastable active conformation.","VHHPPSYVAHLASDFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDDKGMAPALRHLYKELMGPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIINDWVKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGQFKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAPYEKEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQADFTSLSDQEPLHVAQALQKVKIEVNESGTVASSSTAVIVSARMAPEEIIMDRPFLFVVRHNPTGTVLFMGQVMEP","Homo sapiens","PAI1, PLANH1, SERPINE1","Plasminogen activator inhibitor 1","1","3Q03"
"3Q04",,"X-RAY DIFFRACTION",2.04,39.63,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% PEG 4000, 0.2M lithium sulfate, 0.1M TrisHCl, pH 8.5, vapor diffusion, sitting drop, temperature 293K",293,,,"3Q04",39.65,"1.8","1.8","Crystal structure of the apo-form of human CK2 alpha at pH 8.5","GPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3Q04"
"3Q05",,"X-RAY DIFFRACTION",3.15,60.96,"VAPOR DIFFUSION, HANGING DROP",7,"0.15M DL-Malic Acid [pH 7.0], 20% Polyethylene Glycol 3350, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/emboj.2011.127",,"3Q05",122.71,"2.4","2.4","An induced fit mechanism regulates p53 DNA binding kinetics to confer sequence specificity","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFVQLAKTVPVQLYVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERSSDSDGLAPPQHLIRVEGNLRAEYLDDPNTFRHSVVVPYEPPEVGSDYTTIYFKFMCNSSCMGGMNRRPILVIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKTMDGEYFTLQIRGRERFEQFRERNEALELKDAQAT","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","3Q05"
,,,,,,,,,,,,,,,,,"Homo sapiens","TP53, P53"
,,,,,,,,,,,,,,,,"TGAGACATGCCCAGACATGCCCGTTT",,,"DNA (26-MER)","2","3Q05"
,,,,,,,,,,,,,,,,"ACGGGCATGTCTGGGCATGTCTCAAA",,,"DNA (26-MER)","3","3Q05"
"3Q06",,"X-RAY DIFFRACTION",3.17,61.22,"VAPOR DIFFUSION, HANGING DROP",7,"0.15M DL-Malic Acid pH 7.0, 20% Polyethylene Glycol 3350, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/emboj.2011.127",,"3Q06",121.84,"3.2","3.2","An induced fit mechanism regulates p53 DNA binding kinetics to confer sequence specificity","SVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFVQLAKTVPVQLYVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERSSDSDGLAPPQHLIRVEGNLRAEYLDDPNTFRHSVVVPYEPPEVGSDYTTIYFKFMCNSSCMGGMNRRPILVIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKKTMDGEYFTLQIRGRERFEQFRERNEALELKDAQ","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","3Q06"
,,,,,,,,,,,,,,,,,"Homo sapiens","TP53, P53"
,,,,,,,,,,,,,,,,"TGAGACATGCCCAGACATGCCCGTTT",,,"DNA (26-MER)","2","3Q06"
,,,,,,,,,,,,,,,,"ACGGGCATGTCTGGGCATGTCTCAAA",,,"DNA (26-MER)","3","3Q06"
"3Q0H",,"X-RAY DIFFRACTION",2.54,51.57,"VAPOR DIFFUSION, SITTING DROP",6,"1.3M Ammonium Sulfate, 0.1M MES pH 6.0, Vapor diffusion, Sitting drop, temperature 298K",298,,,"3Q0H",25.43,"1.7","1.7","Structure of T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT)","MMMTGTIETTGNISAEKGGSIILQCHLSSTTAQVTQVNWEQQDQLLAICNADLGWHISPSFKDRVAPGPGLGLTLQSLTVNDTGEYFCIYHTYPDGTYTGRIFLEVLESSVAEHGAR","Homo sapiens","TIGIT, VSIG9, VSTM3","T cell immunoreceptor with Ig and ITIM domains","1","3Q0H"
"3Q0K",,"X-RAY DIFFRACTION",3.5,64.86,"VAPOR DIFFUSION, SITTING DROP",6.5,"100mM MgCl2, 100mM NaCacodylate pH 6.5, 18% PEG 3350 (w/v), VAPOR DIFFUSION, SITTING DROP, temperature 288K",288,,,"3Q0K",137.32,"2.6","2.6","Crystal structure of Human PACSIN 2 F-BAR","DSFWEVGNYKRTVKRIDDGHRLCSDLMNCLHERARIEKAYAQQLTEWARRWRQLVEKGPQYGTVEKAWMAFMSEAERVSELHLEVKASLMNDDFEKIKNWQKEAFHKQMMGGFKETKEAEDGFRKAQKPWAKKLKEVEAAKKAHHAACKEEKLAISREANSKADPSLNPEQLKKLQDKIEKCKQDVLKTKEKYEKSLKELDQGTPQYMENMEQVFEQCQQFEEKRLRFFREVLLEVQKHLDLSNVAGYKAIYHDLEQSIRAADAVEDLRWFRANHGPGMAMNWPQFEEW","Homo sapiens","PACSIN2","Protein kinase C and casein kinase substrate in neurons protein 2","1","3Q0K"
"3Q0L",,"X-RAY DIFFRACTION",2.3,46.54,"VAPOR DIFFUSION",5.5,"15-20% (w/v) PEG 3350, 100 mM Li2SO4, and 100 mM Na3Citrate pH 5.5-6.0, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.str.2010.12.019",,"3Q0L",85.8,"2.503","2.503","Crystal structure of the PUMILIO-homology domain from Human PUMILIO1 in complex with p38alpha NREa","GRSRLLEDFRNNRYPNLQLREIAGHIMEFSQDQHGSRFIQLKLERATPAERQLVFNEILQAAYQLMVDVFGNYVIQKFFEFGSLEQKLALAERIRGHVLSLALQMYGCRVIQKALEFIPSDQQNEMVRELDGHVLKCVKDQNGNHVVQKCIECVQPQSLQFIIDAFKGQVFALSTHPYGCRVIQRILEHCLPDQTLPILEELHQHTEQLVQDQYGNYVIQHVLEHGRPEDKSKIVAEIRGNVLVLSQHKFASNVVEKCVTHASRTERAVLIDEVCTMNDGPHSALYTMMKDQYANYVVQKMIDVAEPGQRKIVMHKIRPHIATLRKYTYGKHILAKLEKYYMKNGVDLG","Homo sapiens","PUM1, KIAA0099, PUMH1","Pumilio homolog 1","1","3Q0L"
,,,,,,,,,,,,,,,,"UGUAAAUA",,,"5'-R(UP*GP*UP*AP*AP*AP*UP*A)-3'","2","3Q0L"
"3Q0M",,"X-RAY DIFFRACTION",2.08,40.82,"VAPOR DIFFUSION",5.5,"15-20% (w/v) PEG 3350, 100 mM Li2SO4, and 100 mM Na3Citrate pH 5.5-6.0, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.str.2010.12.019",,"3Q0M",85.83,"2.705","2.705","Crystal structure of the PUMILIO-homology domain from Human PUMILIO1 in complex with p38alpha NREb","UGUAGAUA",,,"5'-R(UP*GP*UP*AP*GP*AP*UP*A)-3'","2","3Q0M"
,,,,,,,,,,,,,,,,"GRSRLLEDFRNNRYPNLQLREIAGHIMEFSQDQHGSRFIQLKLERATPAERQLVFNEILQAAYQLMVDVFGNYVIQKFFEFGSLEQKLALAERIRGHVLSLALQMYGCRVIQKALEFIPSDQQNEMVRELDGHVLKCVKDQNGNHVVQKCIECVQPQSLQFIIDAFKGQVFALSTHPYGCRVIQRILEHCLPDQTLPILEELHQHTEQLVQDQYGNYVIQHVLEHGRPEDKSKIVAEIRGNVLVLSQHKFASNVVEKCVTHASRTERAVLIDEVCTMNDGPHSALYTMMKDQYANYVVQKMIDVAEPGQRKIVMHKIRPHIATLRKYTYGKHILAKLEKYYMKNGVDLG","Homo sapiens","PUM1, KIAA0099, PUMH1","Pumilio homolog 1","1","3Q0M"
"3Q0N",,"X-RAY DIFFRACTION",2.32,46.89,"VAPOR DIFFUSION",5.5,"15-20% (w/v) PEG 3350, 100 mM Li2SO4, and 100 mM Na3Citrate pH 5.5-6.0 , VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.str.2010.12.019",,"3Q0N",85.7,"2.4","2.4","Crystal structure of the PUMILIO-homology domain from Human PUMILIO1 in complex with erk2 NRE","GRSRLLEDFRNNRYPNLQLREIAGHIMEFSQDQHGSRFIQLKLERATPAERQLVFNEILQAAYQLMVDVFGNYVIQKFFEFGSLEQKLALAERIRGHVLSLALQMYGCRVIQKALEFIPSDQQNEMVRELDGHVLKCVKDQNGNHVVQKCIECVQPQSLQFIIDAFKGQVFALSTHPYGCRVIQRILEHCLPDQTLPILEELHQHTEQLVQDQYGNYVIQHVLEHGRPEDKSKIVAEIRGNVLVLSQHKFASNVVEKCVTHASRTERAVLIDEVCTMNDGPHSALYTMMKDQYANYVVQKMIDVAEPGQRKIVMHKIRPHIATLRKYTYGKHILAKLEKYYMKNGVDLG","Homo sapiens","PUM1, KIAA0099, PUMH1","Pumilio homolog 1","1","3Q0N"
,,,,,,,,,,,,,,,,"UGUACAUC",,,"5'-R(UP*GP*UP*AP*CP*AP*UP*C)-3'","2","3Q0N"
"3Q0O",,"X-RAY DIFFRACTION",2.13,42.36,"VAPOR DIFFUSION",5.5,"15-20% (w/v) PEG 3350, 100 mM Li2SO4, and 100 mM Na3Citrate pH 5.5-6.0 , VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.str.2010.12.019",,"3Q0O",85.7,"2.804","2.804","Crystal structure of the PUMILIO-homology domain from Human PUMILIO1 in complex with erk2 NRE","GRSRLLEDFRNNRYPNLQLREIAGHIMEFSQDQHGSRFIQLKLERATPAERQLVFNEILQAAYQLMVDVFGNYVIQKFFEFGSLEQKLALAERIRGHVLSLALQMYGCRVIQKALEFIPSDQQNEMVRELDGHVLKCVKDQNGNHVVQKCIECVQPQSLQFIIDAFKGQVFALSTHPYGCRVIQRILEHCLPDQTLPILEELHQHTEQLVQDQYGNYVIQHVLEHGRPEDKSKIVAEIRGNVLVLSQHKFASNVVEKCVTHASRTERAVLIDEVCTMNDGPHSALYTMMKDQYANYVVQKMIDVAEPGQRKIVMHKIRPHIATLRKYTYGKHILAKLEKYYMKNGVDLG","Homo sapiens","PUM1, KIAA0099, PUMH1","Pumilio homolog 1","1","3Q0O"
,,,,,,,,,,,,,,,,"UGUACAUC",,,"5'-R(UP*GP*UP*AP*CP*AP*UP*C)-3'","2","3Q0O"
"3Q0P",,"X-RAY DIFFRACTION",2.3,46.53,"VAPOR DIFFUSION",5.5,"15-20% (w/v) PEG 3350, 100 mM Li2SO4, and 100 mM Na3Citrate pH 5.5-6.0 , VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.str.2010.12.019",,"3Q0P",85.83,"2.6","2.6","Crystal structure of the PUMILIO-homology domain from Human PUMILIO1 in complex with hunchback NRE","GRSRLLEDFRNNRYPNLQLREIAGHIMEFSQDQHGSRFIQLKLERATPAERQLVFNEILQAAYQLMVDVFGNYVIQKFFEFGSLEQKLALAERIRGHVLSLALQMYGCRVIQKALEFIPSDQQNEMVRELDGHVLKCVKDQNGNHVVQKCIECVQPQSLQFIIDAFKGQVFALSTHPYGCRVIQRILEHCLPDQTLPILEELHQHTEQLVQDQYGNYVIQHVLEHGRPEDKSKIVAEIRGNVLVLSQHKFASNVVEKCVTHASRTERAVLIDEVCTMNDGPHSALYTMMKDQYANYVVQKMIDVAEPGQRKIVMHKIRPHIATLRKYTYGKHILAKLEKYYMKNGVDLG","Homo sapiens","PUM1, KIAA0099, PUMH1","Pumilio homolog 1","1","3Q0P"
,,,,,,,,,,,,,,,,"UGUAUAUA",,,"5'-R(UP*GP*UP*AP*UP*AP*UP*A)-3'","2","3Q0P"
"3Q0Q",,"X-RAY DIFFRACTION",2.06,40.18,"VAPOR DIFFUSION",5,"17-20% (w/v) PEG 3000, 100 mM Na3Citrate pH 5.0-6.0, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.str.2010.12.019",,"3Q0Q",43.06,"2","2","Crystal structure of the PUMILIO-homology domain from Human PUMILIO2 in complex with p38alpha NREa","UGUAAAUA",,,"5'-R(UP*GP*UP*AP*AP*AP*UP*A)-3'","2","3Q0Q"
,,,,,,,,,,,,,,,,"GRSRLLEDFRNNRFPNLQLRDLIGHIVEFSQDQHGSRFIQQKLERATPAERQMVFNEILQAAYQLMTDVFGNYVIQKFFEFGSLDQKLALATRIRGHVLPLALQMYGCRVIQKALESISSDQQVISEMVKELDGHVLKCVKDQNGNHVVQKCIECVQPQSLQFIIDAFKGQVFVLSTHPYGCRVIQRILEHCTAEQTLPILEELHQHTEQLVQDQYGNYVIQHVLEHGRPEDKSKIVSEIRGKVLALSQHKFASNVVEKCVTHASRAERALLIDEVCCQNDGPHSALYTMMKDQYANYVVQKMIDMAEPAQRKIIMHKIRPHITTLRKYTYGKHILAKLEKYYLKNSPDLG","Homo sapiens","PUM2, KIAA0235, PUMH2","Pumilio homolog 2","1","3Q0Q"
"3Q0R",,"X-RAY DIFFRACTION",2.05,40.14,"VAPOR DIFFUSION",5,"17-20% (w/v) PEG 3000, 100 mM Na3Citrate pH 5.0-6.0 , VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.str.2010.12.019",,"3Q0R",43.08,"2","2","Crystal structure of the PUMILIO-homology domain from Human PUMILIO2 in complex with p38alpha NREb","GRSRLLEDFRNNRFPNLQLRDLIGHIVEFSQDQHGSRFIQQKLERATPAERQMVFNEILQAAYQLMTDVFGNYVIQKFFEFGSLDQKLALATRIRGHVLPLALQMYGCRVIQKALESISSDQQVISEMVKELDGHVLKCVKDQNGNHVVQKCIECVQPQSLQFIIDAFKGQVFVLSTHPYGCRVIQRILEHCTAEQTLPILEELHQHTEQLVQDQYGNYVIQHVLEHGRPEDKSKIVSEIRGKVLALSQHKFASNVVEKCVTHASRAERALLIDEVCCQNDGPHSALYTMMKDQYANYVVQKMIDMAEPAQRKIIMHKIRPHITTLRKYTYGKHILAKLEKYYLKNSPDLG","Homo sapiens","PUM2, KIAA0235, PUMH2","Pumilio homolog 2","1","3Q0R"
,,,,,,,,,,,,,,,,"UGUAGAUA",,,"5'-R(UP*GP*UP*AP*GP*AP*UP*A)-3'","2","3Q0R"
"3Q0S",,"X-RAY DIFFRACTION",2.43,49.39,"VAPOR DIFFUSION",5,"17-20% (w/v) PEG 3000, 100 mM Na3Citrate pH 5.0-6.0 , VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.str.2010.12.019",,"3Q0S",43.01,"2","2","Crystal structure of the PUMILIO-homology domain from Human PUMILIO2 in complex with erk2 NRE","GRSRLLEDFRNNRFPNLQLRDLIGHIVEFSQDQHGSRFIQQKLERATPAERQMVFNEILQAAYQLMTDVFGNYVIQKFFEFGSLDQKLALATRIRGHVLPLALQMYGCRVIQKALESISSDQQVISEMVKELDGHVLKCVKDQNGNHVVQKCIECVQPQSLQFIIDAFKGQVFVLSTHPYGCRVIQRILEHCTAEQTLPILEELHQHTEQLVQDQYGNYVIQHVLEHGRPEDKSKIVSEIRGKVLALSQHKFASNVVEKCVTHASRAERALLIDEVCCQNDGPHSALYTMMKDQYANYVVQKMIDMAEPAQRKIIMHKIRPHITTLRKYTYGKHILAKLEKYYLKNSPDLG","Homo sapiens","PUM2, KIAA0235, PUMH2","Pumilio homolog 2","1","3Q0S"
,,,,,,,,,,,,,,,,"UGUACAUC",,,"5'-R(UP*GP*UP*AP*CP*AP*UP*C)-3'","2","3Q0S"
"3Q0T",,"X-RAY DIFFRACTION",2.67,53.94,"VAPOR DIFFUSION, HANGING DROP",8.5,"CRYSTALS GROWN IN 2 UL EQUIVOLUME MIXTURE OF PROTEIN SOLUTION (0.1 M NACL, 20 MM TRIS-HCL BUFFER PH 7.8, 9.8 MG/ML PROTEIN) AND CRYSTALLIZATION SOLUTION (17% W/V PEG 3350, 15% W/V GLYCEROL, 200 MM MGCL2, 100 MM TRIS-HCL BUFFER PH 8.5).  SUFFICIENT. 100 MM LIGAND STOCK SOLUTION (NEAT DMSO) ADDED TO ACHIEVE 1 MM LIGAND CONCENTRATION.  SOAKED OVERNIGHT. HARVESTED DIRECTLY AND CRYO-STORED IN LN2. 
2. temperature 298K, VAPOR DIFFUSION, HANGING DROP",298,,"LGE","3Q0T",178.75,"2.401","2.401","Crystal structure of human dpp-iv in complex withsa-(+)- methyl2-(3-(aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl- 7-oxo-5h-pyrrolo[3,4-b]pyridin-6(7h)-yl)acetate","EFSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLPPLEQKLISEEDLNSAVDHHHHHH","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","3Q0T"
"3Q13",,"X-RAY DIFFRACTION",3.11,60.51,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M Lithium sulfate monohydrate, 
25% (w/v) PEG 3350, 
0.1M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1186/1472-6807-11-22",,"3Q13",29.9,"1.95","1.95","The Structure of the Ca2+-binding, Glycosylated F-spondin Domain of F-spondin, A C2-domain Variant from Extracellular Matrix","RSPWPGVTDKPILDCCACGTAKYRLTFYGNWSEKTHPKDYPRRANHWSAIIGGSHSKNYVLWEYGGYASEGVKQVAELGSPVKMEEEIRQQSDEVLTVIKAKAQWPAWQPLNVRAAPSAEFSVDRTRHLMSFLTMMGPSPDWNVGLSAEDLCTKECGWVQKVVQDLIPWDAGTDSGVTYESPNKPTIPQEKIRPLTSLDHPQSPFYDPEGGSITQVARVVIERIARKGEQCNIVPDNVDDIVADLAPEEKTGHHHHHH","Homo sapiens","Homo sapiens, KIAA0762, SPON1, VSGP","Spondin-1","1","3Q13"
"3Q18",,"X-RAY DIFFRACTION",2.16,43.16,"VAPOR DIFFUSION, HANGING DROP",9,"0.1M sodium chloride, 0.1M Bicine pH 9.0, 20% (v/v) PEGMME 2000, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.jmb.2012.04.014",,"3Q18",55.81,"1.7","1.7","Human Glutathione Transferase O2","MSGDATRTLGKGSQPPGPVPEGLIRIYSMRFCPYSHRTRLVLKAKDIRHEVVNINLRNKPEWYYTKHPFGHIPVLETSQSQLIYESVIACEYLDDAYPGRKLFPYDPYERARQKMLLELFSKVPHLTKECLVALRSGRESTNLKAALRQEFSNLEEILEYQNTTFFGGTSISMIDYLLWPWFERLDVYGILDCVSHTPALRLWISAMKWDPTVSALLMDKSIFQGFLNLYFQNNPNAFD","Homo sapiens","GSTO2","Glutathione S-transferase omega-2","1","3Q18"
"3Q19",,"X-RAY DIFFRACTION",2.14,42.5,"VAPOR DIFFUSION, HANGING DROP",9,"0.1M sodium chloride, 0.1M Bicine pH 9.0, 20% (v/v) PEGMME 2000, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.jmb.2012.04.014",,"3Q19",56.23,"1.9","1.9","Human Glutathione Transferase O2","MSGDATRTLGKGSQPPGPVPEGLIRIYSMRFCPYSHRTRLVLKAKDIRHEVVNINLRNKPEWYYTKHPFGHIPVLETSQSQLIYESVIACEYLDDAYPGRKLFPYDPYERARQKMLLELFSKVPHLTKECLVALRSGRESTNLKAALRQEFSNLEEILEYQNTTFFGGTSISMIDYLLWPWFERLDVYGILDCVSHTPALRLWISAMKWDPTVSALLMDKSIFQGFLNLYFQNNPNAFD","Homo sapiens","GSTO2","Glutathione S-transferase omega-2","1","3Q19"
"3Q1D",,"X-RAY DIFFRACTION",2.62,52.97,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.4M SODIUM CITRATE, 0.1M HEPES PH 7.5, 5% MPD, 0.57 MICROMOLAR TRYPSIN, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3Q1D",5.52,"2.15","2.15","The B-box domain of Trim54","QHLMCEEHEEEKINIYCLSCEVPTCSLCKVFGAHKDCEVAPLPTIYK","Homo sapiens","MURF, MURF3, RNF30, TRIM54","Tripartite motif-containing protein 54","1","3Q1D"
"3Q1I",,"X-RAY DIFFRACTION",1.85,33.64,"VAPOR DIFFUSION, SITTING DROP",6.5,"30% PEG400, 0.1M MES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/anie.201008019",,"3Q1I",28.35,"1.4","1.4","Polo-like kinase I Polo-box domain in complex with FMPPPMSpSM phosphopeptide from TCERG1","GPLGSPEFDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSR","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","3Q1I"
,,,,,,,,,,,,,,,,"XFMPPPMSSMX",,,"peptide from Transcription elongation regulator 1","2","3Q1I"
"3Q1J",,"X-RAY DIFFRACTION",2.03,39.43,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG-3350, 0.2M ammonium acetate, 0.1M bis-tris. Prior to freezing, a cluster of thin rods was transferred to a drop of paratone oil. A fragment of the cluster was frozen in a stream of cold nitrogen., pH 5.5, vapor diffusion, sitting drop, temperature 291K, VAPOR DIFFUSION, SITTING DROP",291,"10.1016/j.febslet.2012.02.012",,"3Q1J",8.21,"2.35","2.35","Crystal structure of tudor domain 1 of human PHD finger protein 20","HPPNRRGISFEVGAQLEARDRLKNWYPAHIEDIDYEEGKVLIHFKRWNHRYDEWFCWDSPYLRPLE","Homo sapiens","PHF20, C20orf104, GLEA2, HCA58, NZF, TZP","PHD finger protein 20","1","3Q1J"
"3Q2C",,"X-RAY DIFFRACTION",2.41,48.91,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.0M ammonium sulfate, 0.1M HEPES buffer (pH 7.5), 0.75% (w/v) PEG 8000, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1371/journal.pone.0019245",,"3Q2C",10.79,"2.5","2.5","Binding properties to HLA class I molecules and the structure of the leukocyte Ig-like receptor A3 (LILRA3/ILT6/LIR4/CD85e)","GPLPKPTLWAEPGSVITQGSPVTLRCQGSLETQEYHLYREKKTALWITRIPQELVKKGQFPILSITWEHAGRYCCIYGSHTVGLSESSDPLELVVTG","Homo sapiens","LILRA3, ILT6, LIR4","Leukocyte immunoglobulin-like receptor subfamily A member 3","1","3Q2C"
"3Q2E",,"X-RAY DIFFRACTION",2.02,39.04,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.2M (NH4)COOCH3, 0.1M BisTris, 25% PEG 3350 , pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.cell.2012.02.013",,"3Q2E",14.51,"1.74","1.74","Crystal structure of the second bromodomain of human bromodomain and WD repeat-containing protein 1 isoform A (WDR9)","SMATNYVESNWKKQCKELVNLIFQCEDSEPFRQPVDLVEYPDYRDIIDTPMDFGTVRETLDAGNYDSPLEFCKDIRLIFSNAKAYTPNKRSKIYSMTLRLSALFEEKMKKISSDFKIGQKFNE","Homo sapiens","BRWD1, C21orf107, WDR9","Bromodomain and WD repeat-containing protein 1","1","3Q2E"
"3Q2F",,"X-RAY DIFFRACTION",4.17,70.48,"VAPOR DIFFUSION, SITTING DROP",7.5,"24% PEG 1K 
20% glycerol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3Q2F",14.09,"2.06","2.06","Crystal Structure of the bromodomain of human BAZ2B in complex with a triazolo ligand","SMSVKKPKRDDSKDLALCSMILTEMETHEDAWPFLLPVNLKLVPGYKKVIKKPMDFSTIREKLSSGQYPNLETFALDVRLVFDNCETFNEDDSDIGRAGHNMRKYFEKKWTDTFKVS","Homo sapiens","BAZ2B, KIAA1476","Bromodomain adjacent to zinc finger domain protein 2B","1","3Q2F"
"3Q2G",,"X-RAY DIFFRACTION",2.87,57.13,,,,,"10.1016/j.bmcl.2011.01.036","QGF","3Q2G",67.85,"2.3","2.3","Adamts1 in complex with a novel N-hydroxyformamide inhibitors","SHRYVETMLVADQSMAEFHGSGLKHYLLTLFSVAARLYKHPSIRNSVSLVVVKILVIHDEQKGPEVTSNAALTLRNFCNWQKQHNPPSDRDAEHYDTAILFTRQDLCGSQTCDTLGMADVGTVCDPSRSCSVIEDDGLQAAFTTAHELGHVFNMPHDDAKQCASLNGVNQDSHMMASMLSNLDHSQPWSPCSAYMITSFLDNGHGECLMDKPQNPIQLPGDLPGTSYDANRQCQFTFGEDSKHCPDAASTCSTLWCTGTSGGVLVCQTKHFPWADGTSCGEGKWCINGKCVNKLVPR","Homo sapiens","ADAMTS1, KIAA1346, METH1","A disintegrin and metalloproteinase with thrombospondin motifs 1","1","3Q2G"
"3Q2H",,"X-RAY DIFFRACTION",2.74,55.09,,,,,"10.1016/j.bmcl.2011.01.036","QHF","3Q2H",67.75,"2.33","2.33","Adamts1 in complex with N-hydroxyformamide inhibitors of ADAM-TS4","SHRYVETMLVADQSMAEFHGSGLKHYLLTLFSVAARLYKHPSIRNSVSLVVVKILVIHDEQKGPEVTSNAALTLRNFCNWQKQHNPPSDRDAEHYDTAILFTRQDLCGSQTCDTLGMADVGTVCDPSRSCSVIEDDGLQAAFTTAHELGHVFNMPHDDAKQCASLNGVNQDSHMMASMLSNLDHSQPWSPCSAYMITSFLDNGHGECLMDKPQNPIQLPGDLPGTSYDANRQCQFTFGEDSKHCPDAASTCSTLWCTGTSGGVLVCQTKHFPWADGTSCGEGKWCINGKCVNKLVPR","Homo sapiens","ADAMTS1, KIAA1346, METH1","A disintegrin and metalloproteinase with thrombospondin motifs 1","1","3Q2H"
"3Q2R",,"X-RAY DIFFRACTION",2.85,56.78,,6.5,"0.085M sodium cacodylate, 25.5%w/v PEG8000, 0.17M Ammonium sulfate, 15% glycerol 0.2mM Zinc Chloride, pH 6.5, VAPOR DIFFUSION, temperature 293K",293,"10.1107/S0907444911028198",,"3Q2R",23.39,"2.2","2.2","crystal structure of sGLIPR1 soaked with zinc chloride","EAEAEFANILPDIENEDFIKDCVRIHNKFRSEVKPTASDMLYMTWDPALAQIAKAWASNCQFSHNTRLKPPHKLHPNFTSLGENIWTGSVPIFSVSSAITNWYDEIQDYDFKTRICKKVCGHYTQVVWADSYKVGCAVQFCPKVSGFDALSNGAHFICNYGPGGNYPTWPYKRGATCSACPNNDKCLDNLCVNRQRDQVKRYYSV","Homo sapiens","GLIPR, GLIPR1, RTVP1, synthesized","Glioma pathogenesis-related protein 1","1","3Q2R"
"3Q2U",,"X-RAY DIFFRACTION",2.82,56.35,"VAPOR DIFFUSION",6.5,"0.085M MES, 25.5% w/v PEG 5000 MME, 0.17M Ammonium sulfate 15% v/v glycerol, pH 6.5, VAPOR DIFFUSION, temperature 293K",293,"10.1107/S0907444911028198",,"3Q2U",23.69,"1.85","1.85","Structure of Human Glioma Pathogenesis-related Protein 1 Reveals Unique loops and surface motifs.","EAEAEFANILPDIENEDFIKDCVRIHNKFRSEVKPTASDMLYMTWDPALAQIAKAWASNCQFSHNTRLKPPHKLHPNFTSLGENIWTGSVPIFSVSSAITNWYDEIQDYDFKTRICKKVCGHYTQVVWADSYKVGCAVQFCPKVSGFDALSNGAHFICNYGPGGNYPTWPYKRGATCSACPNNDKCLDNLCVNRQRDQVKRYYSV","Homo sapiens","GLIPR, GLIPR1, RTVP1, synthesized","Glioma pathogenesis-related protein 1","1","3Q2U"
"3Q2X",,"X-RAY DIFFRACTION",1.42,13.11,"VAPOR DIFFUSION, HANGING DROP",,"reservoir contained 2.4M Sodium Malonate, 15% v/v Glycerol, vapor diffusion, hanging drop, temperature 291K",291,"10.1073/pnas.1112600108",,"3Q2X",0.62,"1.451","1.451","Structure of an amyloid forming peptide NKGAII (residues 27-32) from amyloid beta","NKGAII","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","3Q2X"
"3Q2Z",,"X-RAY DIFFRACTION",2.64,53.45,"VAPOR DIFFUSION",5,"seeding method, pH 5, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.bmc.2011.01.065",,"3Q2Z",39.84,"2","2","Human Squalene synthase in complex with N-[(3R,5S)-7-Chloro-5-(2,3-dimethoxyphenyl)-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetyl]-L-aspartic acid","MDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFAKPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKGAVKIRKGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSDPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3Q2Z"
"3Q30",,"X-RAY DIFFRACTION",2.48,50.33,"VAPOR DIFFUSION",5,"seeding method, pH 5, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.bmc.2011.01.065",,"3Q30",39.91,"2","2","Human Squalene synthase in complex with (2R,3R)-2-Carboxymethoxy-3-[5-(2-naphthalenyl)pentyl]aminocarbonyl-3-[5-(2-naphthalenyl)pentyloxy]propionic acid","MDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFAKPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKGAVKIRKGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSDPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3Q30"
"3Q32",,"X-RAY DIFFRACTION",3,58.95,,6.5,"35% PEG3350, 0.1 M sodium chloride, 0.1 M MES, pH 6.5",,"10.1016/j.bmcl.2011.01.022","J2I","3Q32",72.36,"2.5","2.5","Structure of Janus kinase 2 with a pyrrolotriazine inhibitor","MRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAGHHHHHH","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","3Q32"
"3Q36",,"X-RAY DIFFRACTION",2.83,56.46,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M magnesium acetate tetrahydrate, 0.05 M sodium cacodylate, 15% w/v PEG8000, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.4161/cc.10.6.15010",,"3Q36",44.93,"2.5","2.5","Crystal structure of the 4Fe-4S cluster domain of human DNA primase large subunit","GNVGKISLDQIDLLSTKSFPPCMRQLHKALRENHHLRHGGRMQYGLFLKGIGLTLEQALQFWKQEFIKGKMDPDKFDKGYSYNIRHSFGKEGKRTDYTPFSCLKIILSNPPSQGDYHGCPFRHSDPELLKQKLQSYKISPGGISQILDLVKGTHYQVACQKYFEMIHNVDDCGFSLNHPNQFFCESQRILNG","Homo sapiens","PRIM2, PRIM2A","DNA primase large subunit","1","3Q36"
"3Q3B",,"X-RAY DIFFRACTION",3.39,63.75,,,,,"10.1016/j.bmcl.2011.01.017","55E","3Q3B",94.72,"2.7","2.7","6-Amino-4-(pyrimidin-4-yl)pyridones: Novel Glycogen Synthase Kinase-3 Inhibitors","GPLGSSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","3Q3B"
"3Q3K",,"X-RAY DIFFRACTION",2.58,52.32,"VAPOR DIFFUSION, SITTING DROP",5,"macro-seeding, soak at pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmcl.2011.01.132","D90","3Q3K",32.74,"2","2","Factor Xa in complex with a phenylenediamine derivative","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMK","Homo sapiens","F10","Activated factor Xa heavy chain","1","3Q3K"
,,,,,,,,,,,,,,,,"TRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE","Homo sapiens","F10","Factor X light chain","2","3Q3K"
"3Q3T",,"X-RAY DIFFRACTION",2.64,53.4,"HANGING DROP",,"0.1 M Tris-HCl, 0.2 M ammonium sulfate, 18-26% w/v PEG3550, 5 mg/mL renin, 1 mm inhibitor, pH 7.0-8.0, HANGING DROP, temperature 278K",278,"10.1016/j.bmcl.2011.06.043","RX0","3Q3T",76.33,"2.6","2.6","Alkyl Amine Renin Inhibitors: Filling S1 from S3","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN, renin","Renin","1","3Q3T"
"3Q4B",,"X-RAY DIFFRACTION",2.69,54.25,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris-HCl, 0.2 M ammonium sulfate, 18-26% w/v PEG3350, 5 mg/ml renin, 1 mM inhibitor, pH 7.0-8.0, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1021/ml200137x","RX5","3Q4B",76.02,"2.19","2.19","Clinically Useful Alkyl Amine Renin Inhibitors","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN, renin","Renin","1","3Q4B"
"3Q4C",,"X-RAY DIFFRACTION",2.61,52.89,"MICROBATCH",6.5,"25mM magnesium acetate tetrahydrate, 100mM sodium cacodylate trihydrate, 20% PEG8K, pH 6.5, microbatch, temperature 298K",298,"10.1021/bi802067u","RSW","3Q4C",70.99,"3.2","3.2","Crystal Structure of Wild Type BRAF kinase domain in complex with organometallic inhibitor CNS292","MDRGSHHHHHHGSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","3Q4C"
"3Q4S",,"X-RAY DIFFRACTION",2.42,49.14,"VAPOR DIFFUSION, SITTING DROP",7,"20% PEG smears (PEG 2000, 3350, 4000, 5000MME), 0.1M PIPES, pH 7.0, 0.1M MgCl2, 0.1M KCl, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1073/pnas.1113921108",,"3Q4S",30.19,"1.98","1.98","Crystal Structure of Human Glycogenin-1 (GYG1), apo form","SMTDQAFVTLTTNDAYAKGALVLGSSLKQHRTTRRLVVLATPQVSDSMRKVLETVFDEVIMVDVLDSGDSAHLTLMKRPELGVTLTKLHCWSLTQYSKCVFMDADTLVLANIDDLFDREELSAAPDPGWPDCFNSGVFVYQPSVETYNQLLHLASEQGSFDGGDQGILNTFFSSWATTDIRKHLPFIYNLSSISIFSYLPAFKVFGASAKVVHFLGRVKPWNYTYDPKTKSVKSEAHDPNMTHPEFLILWWNIFTTNVLPLLQ","Homo sapiens","GYG, GYG1","Glycogenin-1","1","3Q4S"
"3Q4T",,"X-RAY DIFFRACTION",2.48,50.33,"VAPOR DIFFUSION, SITTING DROP",8.8,"28% PEG 3350, 0.2M LiSO4, 0.1M Tris, pH 8.8, 10% Ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1074/jbc.M114.604397",,"3Q4T",75.78,"1.96","1.96","Crystal structure of Activin receptor type-IIA (ACVR2A) kinase domain in complex with dorsomorphin","MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLTNI","Homo sapiens","ACVR2, ACVR2A","Activin receptor type-2A","1","3Q4T"
"3Q4U",,"X-RAY DIFFRACTION",2.22,44.66,"VAPOR DIFFUSION, SITTING DROP",5,"20% PEG 3350, 0.2M ammonium citrate dibasic pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1371/journal.pone.0062721","LDN","3Q4U",142.91,"1.82","1.82","Crystal structure of the ACVR1 kinase domain in complex with LDN-193189","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","3Q4U"
"3Q4Z",,"X-RAY DIFFRACTION",2.29,46.18,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Hepes pH 7.5, 25% PEG 3350, 0.2M Ammonium Sulphate, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1016/j.str.2011.10.013",,"3Q4Z",69.56,"1.887","1.887","Structure of unphosphorylated PAK1 kinase domain","MSDEEILEKLRIIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLKIAKPLSSLTPLIAAAKEATKNNHLEHHHHHH","Homo sapiens","PAK1","Serine/threonine-protein kinase PAK 1","1","3Q4Z"
"3Q52",,"X-RAY DIFFRACTION",2.4,48.83,"VAPOR DIFFUSION, HANGING DROP",7,"25% PEG 3350, 0.2M Na/K Tartrate, 0.1M NDSB256, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1016/j.str.2011.10.013",,"3Q52",34.57,"1.801","1.801","Structure of phosphorylated PAK1 kinase domain","MSDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLKIAKPLSSLTPLIAAAKEATKNNHLEHHHHHH","Homo sapiens","PAK1","Serine/threonine-protein kinase PAK 1","1","3Q52"
"3Q53",,"X-RAY DIFFRACTION",2.24,45.03,"VAPOR DIFFUSION, HANGING DROP",7,"25% PEG 3350, 0.2M Na/K Tartrate, 0.1M NDSB256, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1016/j.str.2011.10.013",,"3Q53",35.13,"2.09","2.09","Structure of phosphorylated PAK1 kinase domain in complex with ATP","MSDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLKIAKPLSSLTPLIAAAKEATKNNHLEHHHHHH","Homo sapiens","PAK1","Serine/threonine-protein kinase PAK 1","1","3Q53"
"3Q5D",,"X-RAY DIFFRACTION",3.07,59.89,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Bicine pH 8.5, 30% PEG-MME550, 0.1 M succinic acid pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1012792108",,"3Q5D",52.25,"2.699","2.699","crystal structure of human Atlastin-1 (residues 1-447) bound to GDP, crystal form 1","MAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAART","Homo sapiens","ATL1, atlastin-1 (residues 1-447), GBP3, SPG3A","Atlastin-1","1","3Q5D"
"3Q5E",,"X-RAY DIFFRACTION",2.99,58.8,"VAPOR DIFFUSION, HANGING DROP",8,"20% PEG3350 and 0.15 M ammonium phosphate dibasic, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1012792108",,"3Q5E",207.14,"3.013","3.013","crystal structure of human Atlastin-1 (residues 1-447) bound to GDP, crystal form 2","MAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAART","Homo sapiens","ATL1, GBP3, SPG3A","Atlastin-1","1","3Q5E"
"3Q5H",,"X-RAY DIFFRACTION",2.67,53.98,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris-HCl, 0.2 M ammonium sulfate, 18-26% PEG3550, 5 mg/mL renin, 1 mm inhibitor, pH 7.0-8.0, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1021/ml200137x","RX6","3Q5H",76.22,"2.16","2.16","Clinically Useful Alkyl Amine Renin Inhibitors","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN, renin","Renin","1","3Q5H"
"3Q5O",,"X-RAY DIFFRACTION",4.04,69.53,"VAPOR DIFFUSION, HANGING DROP",6.8,"0.1M bistris p 6.8, 55% MPD, 0.2M magnesium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"3Q5O",21.88,"2.05","2.05","Crystal structure of human titin domain M10","GPGIPPKIEALPSDISIDEGKVLTVACAFTGEPTPEVTWSCGGRKIHSQEQGRFHIENTDDLTTLIIMDVQKQDGGLYTLSLGNEFGSDSATVNIHIRSI","Homo sapiens","TTN","Titin","1","3Q5O"
"3Q65",,"X-RAY DIFFRACTION",2.64,53.46,"VAPOR DIFFUSION, SITTING DROP",7.5,"2.04 M Ammonium Sulfate, 0.1M HEPES pH 7.5, 7% polyethylene glycol 400, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1074/jbc.M110.154195",,"3Q65",74.24,"2.09","2.09","Human Aldose Reductase in Complex with NADP+ in Space Group P212121","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","3Q65"
"3Q67",,"X-RAY DIFFRACTION",2.62,53.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"2.04 M Ammonium Sulfate, 0.1M HEPES pH 7.5, 7% polyethylene glycol 400, vapor diffusion, sitting drop, temperature 277K",277,"10.1074/jbc.M110.154195",,"3Q67",74.02,"1.55","1.55","Human Aldose Reductase C298S mutant in Complex with NADP+ in Space Group P212121","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVSALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","3Q67"
"3Q6E",,"X-RAY DIFFRACTION",2.83,56.59,"EVAPORATION",7,"40 uM Q7, 40 uM insulin, 10 mM sodium phosphate, 4 mM EDTA, 1 mM lysine, EVAPORATION, temperature 298K, pH 7.0",298,"10.1021/ja201581x",,"3Q6E",12.8,"2.05","2.05","Human insulin in complex with cucurbit[7]uril","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","3Q6E"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","3Q6E"
"3Q6F",,"X-RAY DIFFRACTION",3.5,64.9,"EVAPORATION",6.8,"14% PEG 8000, 0.1M HEPES, pH6.8, 0.1M glycine, and 8% ethylene glycol, under the oil, temperature 296K, EVAPORATION",296,"10.1016/j.str.2011.02.012",,"3Q6F",288.9,"3.192","3.192","Crystal structure of Fab of human mAb 2909 specific for quaternary neutralizing epitope of HIV-1 gp120","SYVLTQPPSVSVAPGKTARITCGGNNIANKNVHWYQQKPGQAPVLVIYYDDDRPSGIPDRFSGSNSGNTATLTISRVEAGDEADYYCQVWDSNSDHVVFGGGTQLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTEC","Homo sapiens",,"Light chain of Fab of human mAb 2909","1","3Q6F"
,,,,,,,,,,,,,,,,"EVQLVESGGNVVQPGGSLRLSCTASGFSFDDSTMHWVRQAPGKGLQWVSLISWNGGRTYYADSVKGRFTISRDNSKNSLYLQMNSLKTEDTAFYFCAKDKGDSDYDYNLGYSYFYYMDGWGKGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"Heavy chain of Fab of human mAb 2909","2","3Q6F"
"3Q6L",,"X-RAY DIFFRACTION",1.96,37.27,"VAPOR DIFFUSION, SITTING DROP",7.4,"Sodium phosphate monobasic monohydrate/Potassium phosphate dibasic 2.2 - 2.6M, pH 7 - 7.4,  Protein concentration 17mg/ml., VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"3Q6L",16.91,"1.4","1.4","Crystal Structure of Human Adipocyte Fatty Acid Binding Protein (FABP4) at 1.4 Ang. Resolution","MGSSHHHHHHSSGLVPRGSHMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","3Q6L"
"3Q6M",,"X-RAY DIFFRACTION",3.45,64.39,"VAPOR DIFFUSION, SITTING DROP",,"2.5M ammonium sulfate, 0.1M Tris-sodium citrate, 0.1mM cis-dichloro(ethylenediamine)platinum (II), pH 5.4-5.8, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1371/journal.pone.0019961",,"3Q6M",157.4,"3","3","Crystal Structure of Human MC-HSP90 in C2221 Space Group","AATKPIWTRNPDDITNEEYGEFYKSLTNDWEDHLAVKHFSVEGQLEFRALLFVPRRAPFDLFENRKKKNNIKLYVRRVFIMDNCEELIPEYLNFIRGVVDSEDLPLNISREMLQQSKILKVIRKNLVKKCLELFTELAEDKENYKKFYEQFSKNIKLGIHEDSQNRKKLSELLRYYTSASGDEMVSLKDYCTRMKENQKHIYYITGETKDQVANSAFVERLRKHGLEVIYMIEPIDEYCVQQLKEFEGKTLVSVTKEGLELPEDEEEKKKQEEKKTKFENLCKIMKDILEKKVEKVVVSNRLVTSPCCIVTSTYGWTANMERIMKAQALRDNSTMGYMAAKKHLEINPDHSIIETLRQKAEADKNDKSVKDLVILLYETALLSSGFSLEDPQTHANRIYRMIKLGLGIDEDDPTADDTSAAVTEEMPPLEGDDDTSRMEEVDHHHHHH","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3Q6M"
"3Q6N",,"X-RAY DIFFRACTION",3.43,64.17,"VAPOR DIFFUSION, SITTING DROP",,"1.0M ammonium sulfate, 0.04M Tris-sodium citrate, 0.04 mM cisplatin, pH 5.4-5.8, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1371/journal.pone.0019961",,"3Q6N",314.81,"3.05","3.05","Crystal Structure of Human MC-HSP90 in P21 space group","AATKPIWTRNPDDITNEEYGEFYKSLTNDWEDHLAVKHFSVEGQLEFRALLFVPRRAPFDLFENRKKKNNIKLYVRRVFIMDNCEELIPEYLNFIRGVVDSEDLPLNISREMLQQSKILKVIRKNLVKKCLELFTELAEDKENYKKFYEQFSKNIKLGIHEDSQNRKKLSELLRYYTSASGDEMVSLKDYCTRMKENQKHIYYITGETKDQVANSAFVERLRKHGLEVIYMIEPIDEYCVQQLKEFEGKTLVSVTKEGLELPEDEEEKKKQEEKKTKFENLCKIMKDILEKKVEKVVVSNRLVTSPCCIVTSTYGWTANMERIMKAQALRDNSTMGYMAAKKHLEINPDHSIIETLRQKAEADKNDKSVKDLVILLYETALLSSGFSLEDPQTHANRIYRMIKLGLGIDEDDPTADDTSAAVTEEMPPLEGDDDTSRMEEVDHHHHHH","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3Q6N"
"3Q6O",,"X-RAY DIFFRACTION",2.31,46.87,"VAPOR DIFFUSION, HANGING DROP",8,"20% w/v PEG 3350, 0.2 M lithium sulfate monohydrate, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature11267",,"3Q6O",27.52,"2.05","2.05","Oxidoreductase Fragment of Human QSOX1","GSHMSALYSPSDPLTLLQADTVRGAVLGSRSAWAVEFFASWCGHCIAFAPTWKALAEDVKAWRPALYLAALDCAEETNSAVCRDFNIPGFPTVRFFKAFTKNGSGAVFPVAGADVQTLRERLIDALESHHDTWPPACPPLEPAKLEEIDGFFARNNEEYLALIFEKGGSYLAREVALDLSQHKGVAVRRVLNTEANVVRKFGVTDFPSCYLLFRNGSVSRVPVLMESRSFYTAYLQRLSGLTRE","Homo sapiens","QSCN6, QSOX1, QSOX1a, UNQ2520/PRO6013","Sulfhydryl oxidase 1","1","3Q6O"
"3Q6S",,"X-RAY DIFFRACTION",2.18,43.56,"VAPOR DIFFUSION",6.6,"0.1 M Bis-tris, 0.2 M NaCl, 21% (w/v) PEG 3350, pH 6.6, VAPOR DIFFUSION, temperature 293K",293,"10.1091/mbc.E11-01-0009",,"3Q6S",40.24,"1.93","1.93","The crystal structure of the heterochromatin protein 1 beta chromoshadow domain complexed with a peptide from Shugoshin 1","EKPRGFARGLEPERIIGATDSSGELMFLMKWKNSDEADLVPAKEANVKCPQVVISFYEERLTWHSYPSEDDDKKDDKN","Homo sapiens","CBX1, CBX","Chromobox protein homolog 1","1","3Q6S"
,,,,,,,,,,,,,,,,"TNVSLYPVVKIRRLSLSPK",,,"Shugoshin-like 1","2","3Q6S"
"3Q6U",,"X-RAY DIFFRACTION",2.03,39.46,"VAPOR DIFFUSION, SITTING DROP",7,"15.6 mg/ml protein mixed in 1:1 ratio with reservoir containing 150 mM malic acid, 20% PEG3350., pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M110.204404",,"3Q6U",35.13,"1.6","1.6","Structure of the apo MET receptor kinase in the dually-phosphorylated, activated state","XQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHHHHHHH","Homo sapiens","MET","Hepatocyte growth factor receptor","1","3Q6U"
"3Q6W",,"X-RAY DIFFRACTION",2.17,43.44,"VAPOR DIFFUSION, SITTING DROP",7,"15.6 mg/ml protein mixed 1:1 with a reservoir solution of 150 mM malic acid, 20% PEG3350.  2-fold molar excess of ligand was added for co-crystallization., pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M110.204404","Q6W","3Q6W",35.63,"1.75","1.75","Structure of dually-phosphorylated MET receptor kinase in complex with an MK-2461 analog with specificity for the activated receptor","QNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHHHHHHH","Homo sapiens","MET","Hepatocyte growth factor receptor","1","3Q6W"
"3Q6Z",,"X-RAY DIFFRACTION",1.93,36.39,,8.5,"30% PEGMME2000, 0.1M HEPES, 4mM ADP-RIBOSE, 4mM MAGNESIUM CHLORIDE, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.str.2012.12.019","APR","3Q6Z",24.07,"2.23","2.23","HUman PARP14 (ARTD8)-Macro domain 1 in complex with adenosine-5-diphosphoribose","MHHHHHHSSGVDLGTENLYFQSMGQKCFSRTVLAPGVVLIVQQGDLARLPVDVVVNASNEDLKHYGGLAAALSKAAGPELQADCDQIVKREGRLLPGNATISKAGKLPYHHVIHAVGPRWSGYEAPRCVYLLRRAVQLSLCLAEKYKYRSIAIPAISSGVFGFPLGRCVETIVSAIKENFQFKKDGHCLKEIYLVDVSEKTVEAFAEAVKTVFK","Homo sapiens","BAL2, KIAA1268, PARP14","Poly [ADP-ribose] polymerase 14","1","3Q6Z"
"3Q71",,"X-RAY DIFFRACTION",2.89,57.44,"VAPOR DIFFUSION, SITTING DROP",5.1,"1.4M Ammonium Sulfate, 0.1M Sodium Acetate, 0.4M Sodium Chloride, 4mM ADP-ribose, 4mM Magnesium Chloride, pH 5.1, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.str.2012.12.019","AR6","3Q71",24.9,"2.2","2.2","Human parp14 (artd8) - macro domain 2 in complex with adenosine-5-diphosphoribose","MHHHHHHSSGVDLGTENLYFQSMGKTSWEKGSLVSPGGLQMLLVKEGVQNAKTDVVVNSVPLDLVLSRGPLSKSLLEKAGPELQEELDTVGQGVAVSMGTVLKTSSWNLDCRYVLHVVAPEWRNGSTSSLKIMEDIIRECMEITESLSLKSIAFPAIGTGNLGFPKNIFAELIISEVFKFSSKNQLKTLQEVHFLLHPSDHENIQAFSDEFARRANGNLVS","Homo sapiens","BAL2, KIAA1268, PARP14","Poly [ADP-ribose] polymerase 14","1","3Q71"
"3Q72",,"X-RAY DIFFRACTION",1.87,34.24,"VAPOR DIFFUSION, SITTING DROP",5.7,"25% PEG 400, 5% ethylene glycol 0.1M MES, 0.2M calcium acetate,, pH 5.7, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1016/j.jmb.2011.08.017","GNP","3Q72",37.64,"1.655","1.655","Crystal Structure of Rad G-domain-GTP Analog Complex","SVYKVLLLGAPGVGKSALARIFGGVEDGPEAEAAGHTYDRSIVVDGEEASLMVYDIWEQDGGRWLPGHCMAMGDAYVIVYSVTDKGSFEKASELRVQLRRARQTDDVPIILVGNKSDLVRSREVSVDEGRACAVVFDCKFIETSAALHHNVQALFEGVVRQIRLRR","Homo sapiens","RRAD, RAD","GTP-binding protein RAD","1","3Q72"
"3Q74",,"X-RAY DIFFRACTION",2.28,46.09,"hanging drop",7.5,"0.1 M Tris, 20% PEG 3350, 2 mM DTT, 0.02% azide, pH 7.5, hanging drop, temperature 293K",293,,,"3Q74",50.99,"1.79","1.79","Crystal Structure Analysis of the L7A Mutant of the Apo Form of Human Alpha Class Glutathione Transferase","AEKPKAHYFNARGRMESTRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEIDGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYIEGIADLGEMILLLPVCPPEEKDAKLALIKEKIKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEEARKIFRF","Homo sapiens","GSTA1","Glutathione S-transferase A1","1","3Q74"
"3Q76",,"X-RAY DIFFRACTION",2.8,56.08,"VAPOR DIFFUSION, SITTING DROP",6.5,"1.9 M ammonium sulfate, 5% w/v PEG400, 0.1 M MES-NaOH, 20% v/v glycerol, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2011.04.047",,"3Q76",49.28,"1.861","1.861","Structure of human neutrophil elastase (uncomplexed)","IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQ","Homo sapiens","ELANE, ELA2","Neutrophil elastase","1","3Q76"
"3Q77",,"X-RAY DIFFRACTION",2.38,48.27,"VAPOR DIFFUSION, SITTING DROP",5,"20% w/v PEG3350, 0.2 M ammonium citrate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2011.04.047","2HY","3Q77",24.56,"1.998","1.998","Structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor","IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQ","Homo sapiens","ELANE, ELA2","Neutrophil elastase","1","3Q77"
"3Q7G",,"X-RAY DIFFRACTION",2.74,55.06,"MICROBATCH",6.5,"25% PEG 3350, 0.1 M bis-tris, 0.2 M Li2SO4, 25 mM ATP, pH 6.5, microbatch, temperature 298K",298,"10.1074/jbc.M111.219659",,"3Q7G",52.62,"2.3","2.3","Crystal Structure of E2 domain of Human Amyloid Precursor-Like Protein 1 in complex with SOS (sucrose octasulfate)","GSHMTPTPRPTDGVDIYFGMPGEISEHEGFLRAKMDLEERRMRQINEVMREWAMADNQSKNLPKADRQALNEHFQSILQTLEEQVSGERQRLVETHATRVIALINDQRRAALEGFLAALQADPPQAERVLLALRRYLRAEQKEQRHTLRHYQHVAAVDPEKAQQMRFQVHTHLQVIEERVNQSLGLLDQNPHLAQELRPQIQELLHSEHLGPSE","Homo sapiens","APLP1","Amyloid-like protein 1","1","3Q7G"
"3Q7L",,"X-RAY DIFFRACTION",2.72,54.79,"EVAPORATION",6.5,"25% PEG 3350, 0.1 M bis-tris, 0.2 M Li2SO4, 25 mM ATP, pH 6.5, EVAPORATION, temperature 298K",298,"10.1074/jbc.M111.219659",,"3Q7L",49.87,"2.2","2.2","Crystal structure of the E2 domain of amyloid precursor-like protein 1","GSHMTPTPRPTDGVDIYFGMPGEISEHEGFLRAKMDLEERRMRQINEVMREWAMADNQSKNLPKADRQALNEHFQSILQTLEEQVSGERQRLVETHATRVIALINDQRRAALEGFLAALQADPPQAERVLLALRRYLRAEQKEQRHTLRHYQHVAAVDPEKAQQMRFQVHTHLQVIEERVNQSLGLLDQNPHLAQELRPQIQELLHSEHLGPSE","Homo sapiens","APLP1","Amyloid-like protein 1","1","3Q7L"
"3Q7P",,"X-RAY DIFFRACTION",1.81,32.15,"VAPOR DIFFUSION, SITTING DROP",5.7,"25% PEG 400, 5% ethylene glycol 0.1M MES, 0.2M calcium acetate,, pH 5.7, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1016/j.jmb.2011.08.017","GNP","3Q7P",37.56,"2.5","2.5","Crystal Structure of Rad G-domain-GTP Analog Complex","SVYKVLLLGAPGVGKSALARIFGGVEDGPEAEAAGHTYDRSIVVDGEEASLMVYDIWEQDGGRWLPGHCMAMGDAYVIVYSVTDKGSFEKASELRVQLRRARQTDDVPIILVGNKSDLVRSREVSVDEGRACAVVFDCKFIETSAALHHNVQALFEGVVRQIRLRR","Homo sapiens","RRAD, RAD","GTP-binding protein RAD","1","3Q7P"
"3Q7Q",,"X-RAY DIFFRACTION",1.8,31.52,"VAPOR DIFFUSION, SITTING DROP",5.7,"12% PEG 8000, 0.1M MES, 0.2M calcium acetate, pH 5.7, VAPOR DIFFUSION, SITTING DROP, temperature 292.0K",292,"10.1016/j.jmb.2011.08.017","GNP","3Q7Q",37.6,"2.3","2.3","Crystal Structure of Rad G-domain Q148A-GTP Analog Complex","SVYKVLLLGAPGVGKSALARIFGGVEDGPEAEAAGHTYDRSIVVDGEEASLMVYDIWEQDGGRWLPGHCMAMGDAYVIVYSVTDKGSFEKASELRVQLRRARQTDDVPIILVGNKSDLVRSREVSVDEGRACAVVFDCKFIETSAALHHNVQALFEGVVRQIRLRR","Homo sapiens","RRAD, RAD","GTP-binding protein RAD","1","3Q7Q"
"3Q84",,"X-RAY DIFFRACTION",3.37,63.55,"VAPOR DIFFUSION, HANGING DROP",7.5,"200mM NH4H2PO4, 100mM HEPES pH 7.5, 16% PEG 3350 (w/v), 5% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 300K",300,,,"3Q84",213.07,"2.8","2.8","Crystal structure of human PACSIN 1 F-BAR domain","ETTDSFWEVGNYKRTVKRIDDGHRLCNDLMNCVQERAKIEKAYGQQLTDWAKRWRQLIEKGPQYGSLERAWGAIMTEADKVSELHQEVKNNLLNEDLEKVKNWQKDAYHKQIMGGFKETKEAEDGFRKAQKPWAKKMKELEAAKKAYHLACKEEKLAMTREMNSKTEQSVTPEQQKKLQDKVDKCKQDVQKTQEKYEKVLEDVGKTTPQYMENMEQVFEQCQQFEEKRLVFLKEVLLDIKRHLNLAENSSYIHVYRELEQAIRGADAQEDLRWFRSTSGPGMPMNWPQFEEWNPD","Homo sapiens","PACSIN1, KIAA1379","Protein kinase C and casein kinase substrate in neurons protein 1","1","3Q84"
"3Q8K",,"X-RAY DIFFRACTION",3.41,63.9,"VAPOR DIFFUSION",7,"16% mPEG 2k, 20% saturated KCl, 0.5 mM Sm2(SO4)3, 10 mM Mg(NO3)2, 100 mM Hepes pH 7.0, 5% ethylene glycol, VAPOR DIFFUSION, temperature 288K",288,"10.1016/j.cell.2011.03.004",,"3Q8K",50.14,"2.2001","2.2001","Crystal Structure of Human Flap Endonuclease FEN1 (WT) in complex with product 5'-flap DNA, SM3+, and K+","GIQGLAKLIADVAPSAIRENDIKSYFGRKVAIDASMSIYQFLIAVRQGGDVLQNEEGETTSHLMGMFYRTIRMMENGIKPVYVFDGKPPQLKSGELAKRSERRAEAEKQLQQAQAAGAEQEVEKFTKRLVKVTKQHNDECKHLLSLMGIPYLDAPSEAEASCAALVKAGKVYAAATEDMDCLTFGSPVLMRHLTASEAKKLPIQEFHLSRILQELGLNQEQFVDLCILLGSDYCESIRGIGPKRAVDLIQKHKSIEEIVRRLDPNKYPVPENWLHKEAHQLFLEPEVLDPESVELKWSEPNEEELIKFMCGEKQFSEERIRSGVKRLSKSRQGSTLEVLFQ","Homo sapiens","FEN1, RAD2","Flap endonuclease 1","1","3Q8K"
,,,,,,,,,,,,,,,,"ACTCTGCCTCAAGACGGT",,,"DNA (5'-D(*AP*CP*TP*CP*TP*GP*CP*CP*TP*CP*AP*AP*GP*AP*CP*GP*GP*T)-3')","2","3Q8K"
,,,,,,,,,,,,,,,,"TGAGGCAGAGT",,,"DNA (5'-D(P*TP*GP*AP*GP*GP*CP*AP*GP*AP*GP*T)-3')","3","3Q8K"
,,,,,,,,,,,,,,,,"ACCGTCC",,,"DNA (5'-D(*AP*CP*CP*GP*TP*CP*C)-3')","4","3Q8K"
"3Q8L",,"X-RAY DIFFRACTION",3.33,63.11,"VAPOR DIFFUSION",7,"17% mPEG 2k, 20% KCl, 0.5 mM Sm2(SO4)3, 50 mM Bis-Tris pH 7.0 and 5% Ethylene Glycol, vapor diffusion, temperature 288K",288,"10.1016/j.cell.2011.03.004",,"3Q8L",50.62,"2.319","2.319","Crystal Structure of Human Flap Endonuclease FEN1 (WT) in complex with substrate 5'-flap DNA, SM3+, and K+","GIQGLAKLIADVAPSAIRENDIKSYFGRKVAIDASMSIYQFLIAVRQGGDVLQNEEGETTSHLMGMFYRTIRMMENGIKPVYVFDGKPPQLKSGELAKRSERRAEAEKQLQQAQAAGAEQEVEKFTKRLVKVTKQHNDECKHLLSLMGIPYLDAPSEAEASCAALVKAGKVYAAATEDMDCLTFGSPVLMRHLTASEAKKLPIQEFHLSRILQELGLNQEQFVDLCILLGSDYCESIRGIGPKRAVDLIQKHKSIEEIVRRLDPNKYPVPENWLHKEAHQLFLEPEVLDPESVELKWSEPNEEELIKFMCGEKQFSEERIRSGVKRLSKSRQGSTLEVLFQ","Homo sapiens","FEN1, RAD2","Flap endonuclease 1","1","3Q8L"
,,,,,,,,,,,,,,,,"ACTCTGCCTCAAGACGGT",,,"DNA (5'-D(*AP*CP*TP*CP*TP*GP*CP*CP*TP*CP*AP*AP*GP*AP*CP*GP*GP*T)-3')","2","3Q8L"
,,,,,,,,,,,,,,,,"TTGAGGCAGAGT",,,"DNA (5'-D(*TP*TP*GP*AP*GP*GP*CP*AP*GP*AP*GP*T)-3')","3","3Q8L"
,,,,,,,,,,,,,,,,"ACCGTCC",,,"DNA (5'-D(*AP*CP*CP*GP*TP*CP*C)-3')","4","3Q8L"
"3Q8M",,"X-RAY DIFFRACTION",2.91,57.77,"VAPOR DIFFUSION",7.5,"20% mPEG 2k, 20% KCl, 10 mM CaCl2, 50 mM Bis-Tris pH 7.5, 5% ethylene glycol, vapor diffusion, temperature 288K",288,"10.1016/j.cell.2011.03.004",,"3Q8M",99.57,"2.6","2.6","Crystal Structure of Human Flap Endonuclease FEN1 (D181A) in complex with substrate 5'-flap DNA and K+","GIQGLAKLIADVAPSAIRENDIKSYFGRKVAIDASMSIYQFLIAVRQGGDVLQNEEGETTSHLMGMFYRTIRMMENGIKPVYVFDGKPPQLKSGELAKRSERRAEAEKQLQQAQAAGAEQEVEKFTKRLVKVTKQHNDECKHLLSLMGIPYLDAPSEAEASCAALVKAGKVYAAATEDMACLTFGSPVLMRHLTASEAKKLPIQEFHLSRILQELGLNQEQFVDLCILLGSDYCESIRGIGPKRAVDLIQKHKSIEEIVRRLDPNKYPVPENWLHKEAHQLFLEPEVLDPESVELKWSEPNEEELIKFMCGEKQFSEERIRSGVKRLSKSRQGSTLEVLFQ","Homo sapiens","FEN1, RAD2","Flap endonuclease 1","1","3Q8M"
,,,,,,,,,,,,,,,,"ACTCTGCCTCAAGACGGT",,,"DNA (5'-D(*AP*CP*TP*CP*TP*GP*CP*CP*TP*CP*AP*AP*GP*AP*CP*GP*GP*T)-3')","2","3Q8M"
,,,,,,,,,,,,,,,,"TTGAGGCAGAGT",,,"DNA (5'-D(*TP*TP*GP*AP*GP*GP*CP*AP*GP*AP*GP*T)-3')","3","3Q8M"
,,,,,,,,,,,,,,,,"ACCGTCC",,,"DNA (5'-D(*AP*CP*CP*GP*TP*CP*C)-3')","4","3Q8M"
"3Q8W",,"X-RAY DIFFRACTION",2.88,57.34,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M Tris pH 8.0, 22 % (w/v) PEG 4000, 0.3M NaAcetate , VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,,"AZV","3Q8W",171.27,"3.64","3.64","A b-aminoacyl containing thiazolidine derivative and DPPIV complex","SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSHHHHHH","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","3Q8W"
"3Q90",,"X-RAY DIFFRACTION",2.12,41.97,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% w/v PEG3350, 0.2M AMMONIUM ACETATE, 0.1M BIS-TRIS, VAPOR DIFFUSION, SITTING DROP, temperature 277K, pH 5.5",277,,,"3Q90",31.97,"1.7","1.7","Crystal structure of the NTF2 domain of Ras GTPase-activating protein-binding protein 1","SMVMEKPSPLLVGREFVRQYYTLLNQAPDMLHRFYGKNSSYVHGGLDSNGKPADAVYGQKEIHRKVMSQNFTNCHTKIRHVDAHATLNDGVVVQVMGLLSNNNQALRRFMQTFVLAPEGSVANKFYVHNDIFRYQDEVFG","Homo sapiens","G3BP, G3BP1","Ras GTPase-activating protein-binding protein 1","1","3Q90"
"3Q91",,"X-RAY DIFFRACTION",2.5,50.74,"VAPOR DIFFUSION, HANGING DROP",7.5,"20 % w/v PEG3350, 0.2 M AMMONIUM FORMATE, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3Q91",95.07,"2.7","2.7","Crystal Structure of Human Uridine Diphosphate Glucose Pyrophosphatase (NUDT14)","MHHHHHHSSGVDLGTENLYFQSMNGAQKSWDFMKTHDSVTVLLFNSSRRSLVLVKQFRPAVYAGEVERRFPGSLAAVDQDGPRELQPALPGSAGVTVELCAGLVDQPGLSLEEVACKEAWEECGYHLAPSDLRRVATYWSGVGLTGSRQTMFYTEVTDAQRSGPGGGLVEEGELIEVVHLPLEGAQAFADDPDIPKTLGVIFGVSWFLSQVAPNLDLQ","Homo sapiens","NUDT14, UGPP","Uridine diphosphate glucose pyrophosphatase","1","3Q91"
"3Q92",,"X-RAY DIFFRACTION",3.58,65.6,"VAPOR DIFFUSION, SITTING DROP",4.5,"17% PEG 8k, 0.1M Na-Citrate, 0.2M Ammonium Sulfate, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/ml200070g","XNB","3Q92",69.29,"2.8","2.8","X-ray Structure of ketohexokinase in complex with a pyrimidopyrimidine analog 1","MGSSHHHHHHSSGLVPRGSQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV","Homo sapiens","KHK","Ketohexokinase","1","3Q92"
"3Q93",,"X-RAY DIFFRACTION",2.07,40.51,,7.4,"0.26 M AMMONIUM SULFATE, 22 % w/v PEG4000, 13 % GLYCEROL, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3Q93",41.02,"1.8","1.8","Crystal Structure of Human 8-oxo-dGTPase (MTH1)","MGSSHHHHHHSSGLVPRGSHMGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","MTH1, NUDT1","7,8-dihydro-8-oxoguanine triphosphatase","1","3Q93"
"3Q96",,"X-RAY DIFFRACTION",2.84,56.7,"VAPOR DIFFUSION",,"14.025% PEG 8000, 0.8M NP Lithium Cl, 0.06M Tris base, 0.04M Tris Cl, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm101479y","0NF","3Q96",65.38,"3.1","3.1","B-Raf kinase domain in complex with a tetrahydronaphthalene inhibitor","SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRS","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","3Q96"
"3Q9P",,"X-RAY DIFFRACTION",2.94,58.21,"VAPOR DIFFUSION, HANGING DROP",5.5,"2.2M ammonium sulfate, 0.2M di-ammonium tartrate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jmb.2011.05.024",,"3Q9P",9.29,"2","2","HspB1 fragment","GGSHTADRWRVSLDVNHFAPDELTVKTKDGVVEITGKHAARQDEHGYISRCFTRKYTLPPGVDPTQVSSSLSPEGTLTVEAPMPK","Homo sapiens","HSPB1, HSP27, HSP28","Heat shock protein beta-1","1","3Q9P"
"3Q9Q",,"X-RAY DIFFRACTION",2.58,52.39,"VAPOR DIFFUSION, HANGING DROP",5.5,"2.2M ammonium sulfate, 0.2M di-ammonium tartrate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.jmb.2011.05.024",,"3Q9Q",18.58,"2.2","2.2","HspB1 fragment second crystal form","GGSHTADRWRVSLDVNHFAPDELTVKTKDGVVEITGKHAARQDEHGYISRCFTRKYTLPPGVDPTQVSSSLSPEGTLTVEAPMPK","Homo sapiens","HSPB1, HSP27, HSP28","Heat shock protein beta-1","1","3Q9Q"
"3Q9W",,"X-RAY DIFFRACTION",1.93,36.12,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% PEG 4000, 0.2M lithium sulfate, 0.1M TrisHCl, pH 8.5, vapor diffusion, sitting drop, temperature 293K",293,,"EMO","3Q9W",40.71,"1.7","1.7","Crystal structure of human CK2 alpha in complex with emodin at pH 8.5","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3Q9W"
"3Q9X",,"X-RAY DIFFRACTION",3.18,61.3,"VAPOR DIFFUSION, SITTING DROP",6.5,"20% PEG 5000 MME, 0.2M ammonium sulfate, 0.1M Mes, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,"EMO","3Q9X",82.06,"2.2","2.2","Crystal structure of human CK2 alpha in complex with emodin at pH 6.5","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3Q9X"
"3Q9Y",,"X-RAY DIFFRACTION",1.98,37.88,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% PEG 4000, 0.2M lithium sulfate, 0.1M TrisHCl, pH 8.5, vapor diffusion, sitting drop, temperature 293K",293,,,"3Q9Y",40.71,"1.8","1.8","Crystal structure of human CK2 alpha in complex with Quinalizarin at pH 8.5","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3Q9Y"
"3Q9Z",,"X-RAY DIFFRACTION",3.2,61.61,"VAPOR DIFFUSION, SITTING DROP",6.5,"20% PEG 5000 MME, 0.2M ammonium sulfate, 0.1M Mes pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3Q9Z",81.58,"2.2","2.2","Crystal structure of human CK2 alpha in complex with Quinalizarin at pH 6.5","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3Q9Z"
"3QA0",,"X-RAY DIFFRACTION",3.17,61.18,"VAPOR DIFFUSION, SITTING DROP",6.5,"20% PEG 5000 MME, 0.2M ammonium sulfate, 0.1M Mes pH 6.5, vapor diffusion, sitting drop, temperature 293K",293,,,"3QA0",81.29,"2.5","2.5","Crystal structure of the apo-form of human CK2 alpha at pH 6.5","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3QA0"
"3QA2",,"X-RAY DIFFRACTION",3.62,65.98,"VAPOR DIFFUSION, SITTING DROP",4.5,"17% PEG 8k, 0.1M Na-Citrate, 0.2M Ammonium Sulfate, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/ml200070g","XNA","3QA2",69.22,"2.519","2.519","X-ray Structure of ketohexokinase in complex with a pyrimidopyrimidine analog 2","MGSSHHHHHHSSGLVPRGSQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV","Homo sapiens","KHK","Ketohexokinase","1","3QA2"
"3QAG",,"X-RAY DIFFRACTION",2.59,52.44,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Hepes pH7.5, 2% v/v Polyethylene glycol 400, 2M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.jmb.2012.04.014",,"3QAG",28.35,"2","2","Human Glutathione Transferase O2 with glutathione -new crystal form","MSGDATRTLGKGSQPPGPVPEGLIRIYSMRFCPYSHRTRLVLKAKDIRHEVVNINLRNKPEWYYTKHPFGHIPVLETSQSQLIYESVIACEYLDDAYPGRKLFPYDPYERARQKMLLELFSKVPHLTKECLVALRSGRESTNLKAALRQEFSNLEEILEYQNTTFFGGTSISMIDYLLWPWFERLDVYGILDCVSHTPALRLWISAMKWDPTVSALLMDKSIFQGFLNLYFQNNPNAFD","Homo sapiens","GSTO2","Glutathione S-transferase omega-2","1","3QAG"
"3QAH",,"X-RAY DIFFRACTION",2.43,49.29,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M Bis-Tris, 0.2M MgCl2, 25% PEG 3350, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/cr.2011.105",,"3QAH",35.78,"2.1","2.1","Crystal structure of apo-form human MOF catalytic domain","MGSHHHHHHHHGSDYDIPTTENLYFQGSTKVKYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVYEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVACILTLPPYQRRGYGKFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSWVLLEILRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPPK","Homo sapiens","MOF, MYST1, PP7073, KAT8","Probable histone acetyltransferase MYST1","1","3QAH"
"3QAI",,"X-RAY DIFFRACTION",3.59,65.78,"VAPOR DIFFUSION, SITTING DROP",4.5,"17% PEG 8k, 0.1M Na-Citrate, 0.2M Ammonium Sulfate, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1021/ml200070g","XNN","3QAI",69.31,"2.7","2.7","X-ray Structure of ketohexokinase in complex with a pyrimidopyrimidine analog 3","MGSSHHHHHHSSGLVPRGSQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV","Homo sapiens","KHK","Ketohexokinase","1","3QAI"
"3QAQ",,"X-RAY DIFFRACTION",2.41,48.95,"VAPOR DIFFUSION",7.3,"21% PEG 3350, 0.1 M Tris pH 7.3, 245 mM ammonium sulfate, 5 mM EDTA, VAPOR DIFFUSION, temperature 298K",298,"10.1016/j.bmcl.2011.02.007","QAQ","3QAQ",110.47,"2.9","2.9","Crystal structure of PI3K-gamma in complex with triazine-benzimidazole 1","GSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA","Homo sapiens","PIK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","3QAQ"
"3QAR",,"X-RAY DIFFRACTION",2.35,47.68,"VAPOR DIFFUSION",7.3,"21% PEG 3350, 0.1 M Tris pH 7.3, 245 mM ammonium sulfate, 5 mM EDTA, VAPOR DIFFUSION, temperature 298K",298,"10.1016/j.bmcl.2011.02.007","QAR","3QAR",110.42,"2.65","2.65","Crystal structure of PI3K-gamma in complex with triazine-benzimidazole 32","GSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA","Homo sapiens","PIK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","3QAR"
"3QB1",,"X-RAY DIFFRACTION",2.34,47.34,"VAPOR DIFFUSION, SITTING DROP",7.2,"50 mM HEPES, 200 mM NaCl, 30% PEG-4000, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1038/nature10975",,"3QB1",125.82,"3.1","3.1","Interleukin-2 mutant D10","ADPAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAHSKNFHFDPRDVVSNINVFVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT","Homo sapiens","IL2","Interleukin-2","1","3QB1"
"3QBH",,"X-RAY DIFFRACTION",3.08,60.07,"VAPOR DIFFUSION, HANGING DROP",5,"1.0M Ammonium phosphate, 0.1M sodium citrate pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.bmcl.2011.02.038","QBH","3QBH",135.97,"2.24","2.24","Structure based design, synthesis and SAR of cyclic hydroxyethylamine (HEA) BACE-1 inhibitors","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","3QBH"
"3QBJ",,"X-RAY DIFFRACTION",2.78,55.79,,,,,,,"3QBJ",176.06,"2.21","2.21","Crystal structure of dipeptidyl peptidase IV in complex with inhibitor","GTDDATADSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPANTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILAETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLPLVPRGSHHHHHH","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","3QBJ"
"3QBN",,"X-RAY DIFFRACTION",2.67,53.86,"VAPOR DIFFUSION, HANGING DROP",4.5,"100 mM Na-citrate, 15-20% PEG8000, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/cb200112y","E9Z","3QBN",32.84,"3.5","3.5","Structure of Human Aurora A in Complex with a diaminopyrimidine","GKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNSQNKESASKQS","Homo sapiens","AURKA, AIK, ARK1, AURA, BTAK, STK15, STK6, AIRK1, AYK1, IAK1","Serine/threonine-protein kinase 6","1","3QBN"
"3QC3",,"X-RAY DIFFRACTION",2.48,50.48,"VAPOR DIFFUSION, SITTING DROP",6,"0.16M magnesium acetate, 10.0% polyethylene glycol 8000, 20.0% Glycerol, 0.1M sodium cacodylate pH 6.0, NANODROP', VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3QC3",51.03,"2.2","2.2","Crystal structure of a D-ribulose-5-phosphate-3-epimerase (NP_954699) from HOMO SAPIENS at 2.20 A resolution","GMASGCKIGPSILNSDLANLGAECLRMLDSGADYLHLDVMDGHFVPNITFGHPVVESLRKQLGQDPFFDMHMMVSKPEQWVKPMAVAGANQYTFHLEATENPGALIKDIRENGMKVGLAIKPGTSVEYLAPWANQIDMALVMTVEPGFGGQKFMEDMMPKVHWLRTQFPSLDIEVDGGVGPDTVHKCAEAGANMIVSGSAIMRSEDPRSVINLLRNVCSEAAQKR","Homo sapiens","RPE, HUSSY-17","D-ribulose-5-phosphate-3-epimerase","1","3QC3"
"3QC4",,"X-RAY DIFFRACTION",2.81,56.17,"VAPOR DIFFUSION, SITTING DROP",7,"2 M ammonium sulfate, pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmcl.2011.03.032","MP7","3QC4",72.48,"1.8","1.8","PDK1 in complex with DFG-OUT inhibitor xxx","GPLGSMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDPK1, PDK1","3-phosphoinositide-dependent protein kinase 1","1","3QC4"
"3QCA",,"X-RAY DIFFRACTION",2.87,57.2,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.0M Ammonium Sulfate, 0.1M Na Hepes, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bbrc.2011.03.052",,"3QCA",39.34,"2.9","2.9","Crystal Structure of FAF1 UBX Domain In Complex with p97/VCP N Domain Reveals The Conserved FcisP Touch-Turn Motif of UBX Domain Suffering Conformational Change","GSEFEPVSKLRIRTPSGEFLERRFLASNKLQIVFDFVASKGFPWDEYKLLSTFPRRDVTQLDPNKSLLEVKLFPQETLFLEAKE","Homo sapiens","FAF1, UBXD12, UBXN3A, CGI-03","FAS-associated factor 1","1","3QCA"
"3QCB",,"X-RAY DIFFRACTION",2.58,52.37,,6.5,"pH 6.5, vapor diffusion, temperature 277K",277,"10.1021/jm2003766",,"3QCB",71.99,"2.1","2.1","Human receptor protein tyrosine phosphatase gamma, domain 1, apo","GSHMGSMEAIPVKQFVKHIGELYSNNQHGFSEDFEEVQRCTADMNITAEHSNHPENKHKNRYINILAYDHSRVKLRPLPGKDSKHSDYINANYVDGYNKAKAYIATQGPLKSTFEDFWRMIWEQNTGIIVMITNLVEKGRRKCDQYWPTENSEEYGNIIVTLKSTKIHACYTVRRFSIRNTKVKKGQKGNPKGRQNERVVIQYHYTQWPDMGVPEYALPVLTFVRRSSAARMPETGPVLVHCSAGVGRTGTYIVIDSMLQQIKDKSTVNVLGFLKHIRTQRNYLVQTEEQYIFIHDALLEAILGKETEVS","Homo sapiens","PTPG, PTPRG","Receptor-type tyrosine-protein phosphatase gamma","1","3QCB"
"3QCC",,"X-RAY DIFFRACTION",2.52,51.19,,6.5,"pH 6.5, vapor diffusion, temperature 277K",277,"10.1021/jm2003766",,"3QCC",71.65,"2.1","2.1","Human receptor protein tyrosine phosphatase gamma, domain 1, in complex with vanadate, orthorhombic crystal form","GSHMGSMEAIPVKQFVKHIGELYSNNQHGFSEDFEEVQRCTADMNITAEHSNHPENKHKNRYINILAYDHSRVKLRPLPGKDSKHSDYINANYVDGYNKAKAYIATQGPLKSTFEDFWRMIWEQNTGIIVMITNLVEKGRRKCDQYWPTENSEEYGNIIVTLKSTKIHACYTVRRFSIRNTKVKKGQKGNPKGRQNERVVIQYHYTQWPDMGVPEYALPVLTFVRRSSAARMPETGPVLVHCSAGVGRTGTYIVIDSMLQQIKDKSTVNVLGFLKHIRTQRNYLVQTEEQYIFIHDALLEAILGKETEVS","Homo sapiens","PTPG, PTPRG","Receptor-type tyrosine-protein phosphatase gamma","1","3QCC"
"3QCD",,"X-RAY DIFFRACTION",3.47,64.55,,7,"pH 7.0, vapor diffusion, temperature 277K",277,"10.1021/jm2003766",,"3QCD",35.94,"1.8","1.8","Human receptor protein tyrosine phosphatase gamma, domain 1, in complex with vanadate, trigonal crystal form","GSHMGSMEAIPVKQFVKHIGELYSNNQHGFSEDFEEVQRCTADMNITAEHSNHPENKHKNRYINILAYDHSRVKLRPLPGKDSKHSDYINANYVDGYNKAKAYIATQGPLKSTFEDFWRMIWEQNTGIIVMITNLVEKGRRKCDQYWPTENSEEYGNIIVTLKSTKIHACYTVRRFSIRNTKVKKGQKGNPKGRQNERVVIQYHYTQWPDMGVPEYALPVLTFVRRSSAARMPETGPVLVHCSAGVGRTGTYIVIDSMLQQIKDKSTVNVLGFLKHIRTQRNYLVQTEEQYIFIHDALLEAILGKETEVS","Homo sapiens","PTPG, PTPRG","Receptor-type tyrosine-protein phosphatase gamma","1","3QCD"
"3QCE",,"X-RAY DIFFRACTION",2.75,55.23,"VAPOR DIFFUSION",6.5,"pH 6.5, vapor diffusion, temperature 277K",277,"10.1021/jm2003766","NXY","3QCE",72.44,"2.1","2.1","Human receptor protein tyrosine phosphatase gamma, domain 1, in complex with 3-[(3,4-dichlorobenzyl)sulfanyl]thiophene-2-carboxylic acid via soaking","GSHMGSMEAIPVKQFVKHIGELYSNNQHGFSEDFEEVQRCTADMNITAEHSNHPENKHKNRYINILAYDHSRVKLRPLPGKDSKHSDYINANYVDGYNKAKAYIATQGPLKSTFEDFWRMIWEQNTGIIVMITNLVEKGRRKCDQYWPTENSEEYGNIIVTLKSTKIHACYTVRRFSIRNTKVKKGQKGNPKGRQNERVVIQYHYTQWPDMGVPEYALPVLTFVRRSSAARMPETGPVLVHCSAGVGRTGTYIVIDSMLQQIKDKSTVNVLGFLKHIRTQRNYLVQTEEQYIFIHDALLEAILGKETEVS","Homo sapiens","PTPG, PTPRG","Receptor-type tyrosine-protein phosphatase gamma","1","3QCE"
"3QCF",,"X-RAY DIFFRACTION",2.74,55.05,,6.5,"pH 6.5, vapor diffusion, temperature 277K",277,"10.1021/jm2003766","NXY","3QCF",72.15,"2.5","2.5","Human receptor protein tyrosine phosphatase gamma, domain 1, in complex with 3-[(3,4-dichlorobenzyl)sulfanyl]thiophene-2-carboxylic acid via co-crystallization","GSHMGSMEAIPVKQFVKHIGELYSNNQHGFSEDFEEVQRCTADMNITAEHSNHPENKHKNRYINILAYDHSRVKLRPLPGKDSKHSDYINANYVDGYNKAKAYIATQGPLKSTFEDFWRMIWEQNTGIIVMITNLVEKGRRKCDQYWPTENSEEYGNIIVTLKSTKIHACYTVRRFSIRNTKVKKGQKGNPKGRQNERVVIQYHYTQWPDMGVPEYALPVLTFVRRSSAARMPETGPVLVHCSAGVGRTGTYIVIDSMLQQIKDKSTVNVLGFLKHIRTQRNYLVQTEEQYIFIHDALLEAILGKETEVS","Homo sapiens","PTPG, PTPRG","Receptor-type tyrosine-protein phosphatase gamma","1","3QCF"
"3QCG",,"X-RAY DIFFRACTION",3.5,64.9,,7,"pH 7.0, vapor diffusion, temperature 277K",277,"10.1021/jm2003766",,"3QCG",36.13,"2.05","2.05","Human receptor protein tyrosine phosphatase gamma, domain 1, in complex with 3-[(3-bromo-4-chlorobenzyl)sulfanyl]thiophene-2-carboxylic acid","GSHMGSMEAIPVKQFVKHIGELYSNNQHGFSEDFEEVQRCTADMNITAEHSNHPENKHKNRYINILAYDHSRVKLRPLPGKDSKHSDYINANYVDGYNKAKAYIATQGPLKSTFEDFWRMIWEQNTGIIVMITNLVEKGRRKCDQYWPTENSEEYGNIIVTLKSTKIHACYTVRRFSIRNTKVKKGQKGNPKGRQNERVVIQYHYTQWPDMGVPEYALPVLTFVRRSSAARMPETGPVLVHCSAGVGRTGTYIVIDSMLQQIKDKSTVNVLGFLKHIRTQRNYLVQTEEQYIFIHDALLEAILGKETEVS","Homo sapiens","PTPG, PTPRG","Receptor-type tyrosine-protein phosphatase gamma","1","3QCG"
"3QCH",,"X-RAY DIFFRACTION",3.55,65.36,,7,"pH 7.0, vapor diffusion, temperature 277K",277,"10.1021/jm2003766","NX2","3QCH",36.1,"2.4","2.4","Human receptor protein tyrosine phosphatase gamma, domain 1, in complex with 3-[(3,4-dichlorobenzyl)sulfanyl]-N-(methylsulfonyl)thiophene-2-carboxamide","GSHMGSMEAIPVKQFVKHIGELYSNNQHGFSEDFEEVQRCTADMNITAEHSNHPENKHKNRYINILAYDHSRVKLRPLPGKDSKHSDYINANYVDGYNKAKAYIATQGPLKSTFEDFWRMIWEQNTGIIVMITNLVEKGRRKCDQYWPTENSEEYGNIIVTLKSTKIHACYTVRRFSIRNTKVKKGQKGNPKGRQNERVVIQYHYTQWPDMGVPEYALPVLTFVRRSSAARMPETGPVLVHCSAGVGRTGTYIVIDSMLQQIKDKSTVNVLGFLKHIRTQRNYLVQTEEQYIFIHDALLEAILGKETEVS","Homo sapiens","PTPG, PTPRG","Receptor-type tyrosine-protein phosphatase gamma","1","3QCH"
"3QCI",,"X-RAY DIFFRACTION",3.53,65.2,"VAPOR DIFFUSION",7,"pH 7.0, vapor diffusion, temperature 277K",277,"10.1021/jm2003766","NX3","3QCI",36.18,"2.27","2.27","Human receptor protein tyrosine phosphatase gamma, domain 1, in complex with N-[(3-aminophenyl)sulfonyl]-3-[(3,4-dichlorobenzyl)sulfanyl]thiophene-2-carboxamide","GSHMGSMEAIPVKQFVKHIGELYSNNQHGFSEDFEEVQRCTADMNITAEHSNHPENKHKNRYINILAYDHSRVKLRPLPGKDSKHSDYINANYVDGYNKAKAYIATQGPLKSTFEDFWRMIWEQNTGIIVMITNLVEKGRRKCDQYWPTENSEEYGNIIVTLKSTKIHACYTVRRFSIRNTKVKKGQKGNPKGRQNERVVIQYHYTQWPDMGVPEYALPVLTFVRRSSAARMPETGPVLVHCSAGVGRTGTYIVIDSMLQQIKDKSTVNVLGFLKHIRTQRNYLVQTEEQYIFIHDALLEAILGKETEVS","Homo sapiens","PTPG, PTPRG","Receptor-type tyrosine-protein phosphatase gamma","1","3QCI"
"3QCJ",,"X-RAY DIFFRACTION",3.53,65.11,"VAPOR DIFFUSION",7,"pH 7.0, vapor diffusion, temperature 277K",277,"10.1021/jm2003766","NX4","3QCJ",36.24,"2.26","2.26","Human receptor protein tyrosine phosphatase gamma, domain 1, in complex with 5-[({3-[(3,4-dichlorobenzyl)sulfanyl]thiophen-2-yl}carbonyl)sulfamoyl]-2-methoxybenzoic acid","GSHMGSMEAIPVKQFVKHIGELYSNNQHGFSEDFEEVQRCTADMNITAEHSNHPENKHKNRYINILAYDHSRVKLRPLPGKDSKHSDYINANYVDGYNKAKAYIATQGPLKSTFEDFWRMIWEQNTGIIVMITNLVEKGRRKCDQYWPTENSEEYGNIIVTLKSTKIHACYTVRRFSIRNTKVKKGQKGNPKGRQNERVVIQYHYTQWPDMGVPEYALPVLTFVRRSSAARMPETGPVLVHCSAGVGRTGTYIVIDSMLQQIKDKSTVNVLGFLKHIRTQRNYLVQTEEQYIFIHDALLEAILGKETEVS","Homo sapiens","PTPG, PTPRG","Receptor-type tyrosine-protein phosphatase gamma","1","3QCJ"
"3QCK",,"X-RAY DIFFRACTION",3.5,64.9,,7,"pH 7.0, vapor diffusion, temperature 277K",277,"10.1021/jm2003766","NX5","3QCK",36.02,"2.05","2.05","Human receptor protein tyrosine phosphatase gamma, domain 1, in complex with 2-[(3,4-dichlorobenzyl)sulfanyl]benzoic acid","GSHMGSMEAIPVKQFVKHIGELYSNNQHGFSEDFEEVQRCTADMNITAEHSNHPENKHKNRYINILAYDHSRVKLRPLPGKDSKHSDYINANYVDGYNKAKAYIATQGPLKSTFEDFWRMIWEQNTGIIVMITNLVEKGRRKCDQYWPTENSEEYGNIIVTLKSTKIHACYTVRRFSIRNTKVKKGQKGNPKGRQNERVVIQYHYTQWPDMGVPEYALPVLTFVRRSSAARMPETGPVLVHCSAGVGRTGTYIVIDSMLQQIKDKSTVNVLGFLKHIRTQRNYLVQTEEQYIFIHDALLEAILGKETEVS","Homo sapiens","PTPG, PTPRG","Receptor-type tyrosine-protein phosphatase gamma","1","3QCK"
"3QCL",,"X-RAY DIFFRACTION",3.5,64.84,,8,"pH 8.0, vapor diffusion, temperature 277K",277,"10.1021/jm2003766","NXV","3QCL",36.09,"2.4","2.4","Human receptor protein tyrosine phosphatase gamma, domain 1, in complex with 2-[(3,4-dichlorobenzyl)sulfanyl]-4-(4-hydroxybut-1-yn-1-yl)benzoic acid","GSHMGSMEAIPVKQFVKHIGELYSNNQHGFSEDFEEVQRSTADMNITAEHSNHPENKHKNRYINILAYDHSRVKLRPLPGKDSKHSDYINANYVDGYNKAKAYIATQGPLKSTFEDFWRMIWEQNTGIIVMITNLVEKGRRKCDQYWPTENTEEYGNIIVTLKSTKIHACYTVRRFSIRNTKVKKGQKGNPKGRQNERVVIQYHYTQWPDMGVPEYALPVLTFVRRSSAARMPETGPVLVHCSAGVGRTGTYIVIDSMLQQIKDKSTVNVLGFLKHIRTQRNYLVQTEEQYIFIHDALLEAILGKETEVS","Homo sapiens","PTPG, PTPRG","Receptor-type tyrosine-protein phosphatase gamma","1","3QCL"
"3QCM",,"X-RAY DIFFRACTION",2.52,51.21,,6.7,"pH 6.7, vapor diffusion, temperature 277K",277,"10.1021/jm2003766",,"3QCM",72.95,"2.4","2.4","Human receptor protein tyrosine phosphatase gamma, domain 1, in complex with 2-[(3,4-dichlorobenzyl)sulfanyl]-4-{[3-({N-[2-(methylamino)ethyl]glycyl}amino)phenyl]ethynyl}benzoic acid","GSHMGSMEAIPVKQFVKHIGELYSNNQHGFSEDFEEVQRCTADMNITAEHSNHPENKHKNRYINILAYDHSRVKLRPLPGKDSKHSDYINANYVDGYNKAKAYIATQGPLKSTFEDFWRMIWEQNTGIIIMITNLVEKGRRKCDQYWPTENTEEYGNIIVTLKSTKIHACYTVRRFSIRNTKVKKGQKGNPKGRQNERVVIQYHYTQWPDMGVPEYALPVLTFVRRSSAARMPETGPVLVHCSAGVGRTGTYIVIDSMLQQIKDKSTVNVLGFLKHIRTQRNYLVQTEEQYIFIHDALLEAILGKETEVS","Homo sapiens","PTPG, PTPRG","Receptor-type tyrosine-protein phosphatase gamma","1","3QCM"
"3QCN",,"X-RAY DIFFRACTION",3.48,64.67,,7,"pH 7.0",,"10.1021/jm2003766",,"3QCN",35.71,"2.41","2.41","Human receptor protein tyrosine phosphatase gamma, domain 1, trigonal crystal form","GSHMGSMEAIPVKQFVKHIGELYSNNQHGFSEDFEEVQRSTADMNITAEHSNHPENKHKNRYINILAYDHSRVKLRPLPGKDSKHSDYINANYVDGYNKAKAYIATQGPLKSTFEDFWRMIWEQNTGIIVMITNLVEKGRRKCDQYWPTENTEEYGNIIVTLKSTKIHACYTVRRFSIRNTKVKKGQKGNPKGRQNERVVIQYHYTQWPDMGVPEYALPVLTFVRRSSAARMPETGPVLVHCSAGVGRTGTYIVIDSMLQQIKDKSTVNVLGFLKHIRTQRNYLVQTEEQYIFIHDALLEAILGKETEVS","Homo sapiens","PTPG, PTPRG","Receptor-type tyrosine-protein phosphatase gamma","1","3QCN"
"3QCQ",,"X-RAY DIFFRACTION",2.92,57.82,"VAPOR DIFFUSION, SITTING DROP",9,"1.9-2 M ammonium sulfate and 0.1 M tris pH 9 
 plus 15 - 30 % glycerol for freezing, VAPOR DIFFUSION, SITTING DROP, temperature 323K",323,"10.1021/jm101527u","3Q0","3QCQ",36.58,"2.501","2.501","Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with 6-(3-Amino-1H-indazol-6-yl)-N4-ethyl-2,4-pyrimidinediamine","GPAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDK1, PDPK1","3-phosphoinositide-dependent protein kinase 1","1","3QCQ"
"3QCR",,"X-RAY DIFFRACTION",2.89,57.37,"VAPOR DIFFUSION, HANGING DROP",6.5,"MPD, KCl, Na cacodylate, spermine, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1021/ja109767y",,"3QCR",4.6,"3.2","3.2","Incomplete structural model of a human telomeric DNA quadruplex-acridine complex.","TAGGGTTAGGGT","Homo sapiens",,"Human telomeric repeat deoxyribonucleic acid","1","3QCR"
"3QCS",,"X-RAY DIFFRACTION",2.92,57.89,"VAPOR DIFFUSION, SITTING DROP",9,"1.9-2 M ammonium sulfate,0.1 M tris pH 9. and 5mM ATP 
  
15-30% glycerol plus mother liquor mixed with inhibitor served as the cryo-protectant before being frozen in liquid nitrogen, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm101527u","3Q1","3QCS",36.81,"2.487","2.487","Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with 6-[2-Amino-6-(4-morpholinyl)-4-pyrimidinyl]-1H-indazol-3-amine","GPAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDPK1, PDK1","3-phosphoinositide-dependent protein kinase 1","1","3QCS"
"3QCX",,"X-RAY DIFFRACTION",2.89,57.48,"VAPOR DIFFUSION, SITTING DROP",9,"1.9-2 M ammonium sulfate,0.1 M tris pH 9. and 5mM ATP; 15-30% glycerol plus mother liquor mixed with inhibitor served as the cryo-protectant before being frozen in liquid nitrogen, Vapor diffusion. sitting drop, temperature 293K",293,"10.1021/jm101527u","3Q2","3QCX",37.02,"2.3","2.3","Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with 6-{2-Amino-6-[(3R)-3-methyl-4-morpholinyl]-4-pyrimidinyl}-1H-indazol-3-amine","GPAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDK1, PDPK1","3-phosphoinositide-dependent protein kinase 1","1","3QCX"
"3QCY",,"X-RAY DIFFRACTION",2.92,57.85,"VAPOR DIFFUSION, SITTING DROP",9,"1.9-2 M ammonium sulfate,0.1 M tris pH 9. and 5mM ATP; 15-30% glycerol plus mother liquor mixed with inhibitor served as the cryo-protectant before being frozen in liquid nitrogen, Vapor diffusion. sitting drop, temperature 293K",293,"10.1021/jm101527u","3Q3","3QCY",37.03,"2.2","2.2","Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with 4-[2-Amino-6-(3-amino-1H-indazol-6-yl)-4-pyrimidinyl]-N-phenyl-2-morpholinecarboxamide","GPAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDK1, PDPK1","3-phosphoinositide-dependent protein kinase 1","1","3QCY"
"3QD0",,"X-RAY DIFFRACTION",2.92,57.91,"VAPOR DIFFUSION, SITTING DROP",9,"1.9-2 M ammonium sulfate,0.1 M tris pH 9. and 5mM ATP; 15-30% glycerol plus mother liquor mixed with inhibitor served as the cryo-protectant before being frozen in liquid nitrogen, Vapor diffusion. sitting drop, temperature 293K",293,"10.1021/jm101527u","3Q4","3QD0",37.04,"1.99","1.99","Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with (2R,5S)-1-[2-Amino-6-(3-amino-1H-indazol-6-yl)-4-pyrimidinyl]-6-methyl-N-phenyl-3-piperidinecarboxamide","GPAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDK1, PDPK1","3-phosphoinositide-dependent protein kinase 1","1","3QD0"
"3QD3",,"X-RAY DIFFRACTION",2.9,57.52,"VAPOR DIFFUSION, SITTING DROP",9,"1.9-2 M ammonium sulfate,0.1 M tris pH 9. and 5mM ATP; 15-30% glycerol plus mother liquor mixed with inhibitor served as the cryo-protectant before being frozen in liquid nitrogen, Vapor diffusion. sitting drop, temperature 293K",293,"10.1021/jm101527u","3Q5","3QD3",36.37,"2","2","Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with 1,1-Dimethylethyl {(3R,6S)-1-[2-amino-6-(3-amino-1H-indazol-6-yl)-4-pyrimidinyl]-6-methyl-3-piperidinyl}carbamate","GPAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDK1, PDPK1","3-phosphoinositide-dependent protein kinase 1","1","3QD3"
"3QD4",,"X-RAY DIFFRACTION",2.94,58.19,"VAPOR DIFFUSION, SITTING DROP",9,"1.9-2 M ammonium sulfate,0.1 M tris pH 9. and 5mM ATP; 15-30% glycerol plus mother liquor mixed with inhibitor served as the cryo-protectant before being frozen in liquid nitrogen, Vapor diffusion. sitting drop, temperature 293K",293,"10.1021/jm101527u","3Q6","3QD4",36.19,"2.3","2.3","Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with 1,1-Dimethylethyl{(3R,5R)-1-[2-amino-6-(3-amino-1H-indazol-6-yl)-4-pyrimidinyl]-5-methyl-3-piperidinyl}carbamate","GPAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDK1, PDPK1","3-phosphoinositide-dependent protein kinase 1","1","3QD4"
"3QDA",,"X-RAY DIFFRACTION",2.2,44.06,"VAPOR DIFFUSION, HANGING DROP",6,"19-20% PEG4000, 20% glycerol, 0.2 M ammonium acetate, 0.1 M MES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1186/1471-2148-11-159",,"3QDA",11.96,"1.57","1.57","Crystal structure of W95L beta-2 microglobulin","MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKLDRDM","Homo sapiens","B2M, CDABP0092, HDCMA22P, NM_004048","Beta-2-microglobulin","1","3QDA"
"3QDD",,"X-RAY DIFFRACTION",2.81,56.28,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M sodium cacodylate, 20% PEG2000 MME, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm300810x","94M","3QDD",27.06,"1.79","1.79","HSP90A N-terminal domain in complex with BIIB021","HMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3QDD"
"3QE0",,"X-RAY DIFFRACTION",3.22,61.86,"VAPOR DIFFUSION, HANGING DROP",7,"Hanging drops were a 1:1 mixture of protein-peptide complex in buffer (50 mM HEPES pH 8.0, 10 mM magnesium chloride, 10 microM GppNHp, 1 mM EDTA, 5 mM DTT) and well solution (17% (w/v) PEG MME 5K, 200 mM magnesium chloride, 100 mM HEPES pH 7.0), VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1371/journal.ppat.1002553",,"3QE0",117.22,"3","3","A Galpha-i1 P-loop mutation prevents transition to the activated state","SNAEVKLLLLGARESGKSTIVKQMKIIHEAGYSEEECKQYKAVVYSNTIQSIIAIIRAMGRLKIDFGDSARADDARQLFVLAGAAEEGFMTAELAGVIKRLWKDSGVQACFNRSREYQLNDSAAYYLNDLDRIAQPNYIPTQQDVLRTRVKTTGIVETHFTFKDLHFKMFDVGGQRSERKKWIHCFEGVTAIIFCVALSDYDLVLAEDEEMNRMHESMKLFDSICNNKWFTDTSIILFLNKKDLFEEKIKKSPLTICYPEYAGSNTYEEAAAYIQCQFEDLNKRKDTKEIYTHFTCATDTKNVQFVFDAVTDVIIKNNLKDCGLF","Homo sapiens","GNAI1","Guanine nucleotide-binding protein G(i) subunit alpha-1","1","3QE0"
,,,,,,,,,,,,,,,,"SRVTWYDFLMEDTKSR",,,"KB752 peptide","2","3QE0"
"3QE2",,"X-RAY DIFFRACTION",2.3,46.55,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 50 mM calcium acetate, 0.5 M sodium chloride, 14% PEG4000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 292KK",292,"10.1073/pnas.1106632108",,"3QE2",144.27,"1.75","1.75","Crystal Structure of Human NADPH-Cytochrome P450 Reductase","GSHMVRESSFVEKMKKTGRNIIVFYGSQTGTAEEFANRLSKDAHRYGMRGMSADPEEYDLADLSSLPEIDNALVVFCMATYGEGDPTDNAQDFYDWLQETDVDLSGVKFAVFGLGNKTYEHFNAMGKYVDKRLEQLGAQRIFELGLGDDDGNLEEDFITWREQFWLAVCEHFGVEATGEESSIRQYELVVHTDIDAAKVYMGEMGRLKSYENQKPPFDAKNPFLAAVTTNRKLNQGTERHLMHLELDISDSKIRYESGDHVAVYPANDSALVNQLGKILGADLDVVMSLNNLDEESNKKHPFPCPTSYRTALTYYLDITNPPRTNVLYELAQYASEPSEQELLRKMASSSGEGKELYLSWVVEARRHILAILQDCPSLRPPIDHLCELLPRLQARYYSIASSSKVHPNSVHICAVVVEYETKAGRINKGVATNWLRAKEPVGENGGRALVPMFVRKSQFRLPFKATTPVIMVGPGTGVAPFIGFIQERAWLRQQGKEVGETLLYYGCRRSDEDYLYREELAQFHRDGALTQLNVAFSREQSHKVYVQHLLKQDREHLWKLIEGGAHIYVCGDARNMARDVQNTFYDIVAELGAMEHAQAVDYIKKLMTKGRYSLDVWS","Homo sapiens","POR, CYPOR","NADPH--cytochrome P450 reductase","1","3QE2"
"3QE9",,"X-RAY DIFFRACTION",2.37,48.06,"VAPOR DIFFUSION, SITTING DROP",7,"PEG6K, HEPES, CaCl2, KCl, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 290K",290,"10.1016/j.cell.2011.03.005",,"3QE9",93.18,"2.51","2.51","Crystal structure of human exonuclease 1 Exo1 (D173A) in complex with DNA (complex I)","MGIQGLLQFIKEASEPIHVRKYKGQVVAVDTYCWLHKGAIACAEKLAKGEPTDRYVGFCMKFVNMLLSHGIKPILVFDGCTLPSKKEVERSRRERRQANLLKGKQLLREGKVSEARECFTRSINITHAMAHKVIKAARSQGVDCLVAPYEADAQLAYLNKAGIVQAIITEDSALLAFGCKKVILKMDQFGNGLEIDQARLGMCRQLGDVFTEEKFRYMCILSGCDYLSSLRGIGLAKACKVLRLANNPDIVKVIKKIGHYLKMNITVPEDYINGFIRANNTFLYQLVFDPIKRKLIPLNAYEDDVDPETLSYAGQYVDDSIALQIALGNKDINTFEQIDDYNPDTAMPAHSR","Homo sapiens","EXO1, EXOI, HEX1","Exonuclease 1","1","3QE9"
,,,,,,,,,,,,,,,,"CGCTAGTCGACAT",,,"DNA (5'-D(*CP*GP*CP*TP*AP*GP*TP*CP*GP*AP*CP*AP*T)-3')","2","3QE9"
,,,,,,,,,,,,,,,,"TCGACTAGCG",,,"DNA (5'-D(P*TP*CP*GP*AP*CP*TP*AP*GP*CP*G)-3')","3","3QE9"
"3QEA",,"X-RAY DIFFRACTION",2.52,51.13,"VAPOR DIFFUSION, SITTING DROP",6,"MES, PEG 6K, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 290K",290,"10.1016/j.cell.2011.03.005",,"3QEA",47.11,"3.1","3.1","Crystal structure of human exonuclease 1 Exo1 (WT) in complex with DNA (complex II)","MGIQGLLQFIKEASEPIHVRKYKGQVVAVDTYCWLHKGAIACAEKLAKGEPTDRYVGFCMKFVNMLLSHGIKPILVFDGCTLPSKKEVERSRRERRQANLLKGKQLLREGKVSEARECFTRSINITHAMAHKVIKAARSQGVDCLVAPYEADAQLAYLNKAGIVQAIITEDSDLLAFGCKKVILKMDQFGNGLEIDQARLGMCRQLGDVFTEEKFRYMCILSGCDYLSSLRGIGLAKACKVLRLANNPDIVKVIKKIGHYLKMNITVPEDYINGFIRANNTFLYQLVFDPIKRKLIPLNAYEDDVDPETLSYAGQYVDDSIALQIALGNKDINTFEQIDDYNPDTAMPAHSR","Homo sapiens","EXO1, EXOI, HEX1","Exonuclease 1","1","3QEA"
,,,,,,,,,,,,,,,,"CGCTAGTCGACAT",,,"DNA (5'-D(P*CP*GP*CP*TP*AP*GP*TP*CP*GP*AP*CP*AP*T)-3')","2","3QEA"
,,,,,,,,,,,,,,,,"TCGACTAGCG",,,"DNA (5'-D(P*TP*CP*GP*AP*CP*TP*AP*GP*CP*G)-3')","3","3QEA"
"3QEB",,"X-RAY DIFFRACTION",2.43,49.47,"VAPOR DIFFUSION, SITTING DROP",6,"PEG 6K, MES, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 290K",290,"10.1016/j.cell.2011.03.005",,"3QEB",46.67,"3","3","Crystal structure of human exonuclease 1 Exo1 (WT) in complex with DNA and Mn2+ (complex III)","MGIQGLLQFIKEASEPIHVRKYKGQVVAVDTYCWLHKGAIACAEKLAKGEPTDRYVGFCMKFVNMLLSHGIKPILVFDGCTLPSKKEVERSRRERRQANLLKGKQLLREGKVSEARECFTRSINITHAMAHKVIKAARSQGVDCLVAPYEADAQLAYLNKAGIVQAIITEDSDLLAFGCKKVILKMDQFGNGLEIDQARLGMCRQLGDVFTEEKFRYMCILSGCDYLSSLRGIGLAKACKVLRLANNPDIVKVIKKIGHYLKMNITVPEDYINGFIRANNTFLYQLVFDPIKRKLIPLNAYEDDVDPETLSYAGQYVDDSIALQIALGNKDINTFEQIDDYNPDTAMPAHSR","Homo sapiens","EXO1, EXOI, HEX1","Exonuclease 1","1","3QEB"
,,,,,,,,,,,,,,,,"CGCTAGTCGACAT",,,"DNA (5'-D(*CP*GP*CP*TP*AP*GP*TP*CP*GP*AP*CP*AP*T)-3')","2","3QEB"
,,,,,,,,,,,,,,,,"TCGACTAGCG",,,"DNA (5'-D(P*TP*CP*GP*AP*CP*TP*AP*GP*CP*G)-3')","3","3QEB"
"3QEG",,"X-RAY DIFFRACTION",2.88,57.36,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.01 M Ni (II) chloride hexahydrate, 0.1 M Tris HCl, pH 8.5, 20% Polyethylene glycol monomethyl ether 2,000, , VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,,,"3QEG",49.09,"1.95","1.95","Crystal structure of human N12-i2 Fab, an ADCC and neutralizing anti-HIV-1 Env antibody","QVQLVQSGAEVKKPGSSVKVSCRASRGTFSSYGITWVRQAPGQGLEWMGGIIPIFDVTNYAQNFQGRVAITTDAEMSTAYMELRSLKSEDSAVYYCASDSRDFSYYEPGTSYSHYYNIMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTH","Homo sapiens",,"Fab fragment of human anti-HIV antibody N12-i2, heavy chain","1","3QEG"
,,,,,,,,,,,,,,,,"EIVMMQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPETFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab fragment of human anti-HIV antibody N12-i2, light chain","2","3QEG"
"3QEH",,"X-RAY DIFFRACTION",3,59.01,"VAPOR DIFFUSION, HANGING DROP",7.5,"01 M HEPES sodium, pH 7.5, 2% v/v PEG 400, 2 M Ammonium Sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,,,"3QEH",196.53,"2.59","2.59","Crystal structure of human N12-i15, an ADCC and non-neutralizing anti-HIV-1 Env antibody","QVQLVQSGAEVRKPGASVTVSCKTSGYTFVNFYIVWVRQAPGQGLEWMGVINPFRGDTYFAQKFKGRVTLTRDTSTSTVFMELSSLRSDDTAIYYCARDLEMRDGNNHGSHLEFWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTH","Homo sapiens",,"Fab fragment of human anti-HIV-1 Env antibody N12-i15, heavy chain","1","3QEH"
,,,,,,,,,,,,,,,,"DIVMTQSPLSLPVTPGEAASISCRSSQSLLHTNGFQYLDWYLQKPGQSPQLLIYLGSNRATGVPHRFSGSGSGTEFTLKISRVEAEDVGVYYCMQAKESPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab fragment of human anti-HIV-1 Env antibody N12-i15,light chain","2","3QEH"
"3QEJ",,"X-RAY DIFFRACTION",2.16,43.06,"VAPOR DIFFUSION",,"15 mg/ml protein mixed with 0.9-1.5M trisodium citrate di-hydrate and 100 mM Tris, pH 7.5, VAPOR DIFFUSION, temperature 298K",298,"10.1021/bi2001032",,"3QEJ",66.04,"2.49","2.49","S74E-dCK mutant in complex with UDP","MGSSHHHHHHSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMEQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","3QEJ"
"3QEN",,"X-RAY DIFFRACTION",2.18,43.54,"VAPOR DIFFUSION",7.5,"12 mg/ml protein mixed with 0.9-1.5M trisodium citrate di-hydrate and 100 mM Tris, pH 7.5, VAPOR DIFFUSION, temperature 298K",298,"10.1021/bi2001032",,"3QEN",66.65,"1.997","1.997","S74E dCK in complex with 5-bromodeoxycytidine and UDP","MGSSHHHHHHSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMEQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","3QEN"
"3QEO",,"X-RAY DIFFRACTION",2.19,43.83,"VAPOR DIFFUSION",7.5,"9 mg/ml protein was mixed with 0.9-1.5M trisodium citrate di-hydrate and 100 mM Tris, pH 7.5, VAPOR DIFFUSION, temperature 298K",298,"10.1021/bi2001032",,"3QEO",66.38,"1.897","1.897","S74E-R104M-D133A dCK variant in complex with L-deoxythymidine and UDP","MGSSHHHHHHSGLVPRGSHMATPPKRSSPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLSEDWEVVPEPVARWSNVQSTQDEFEELTMEQKNGGNVLQMMYEKPERWSFTFQTYACLSMIRAQLASLNGKLKDAEKPVLFFERSVYSARYIFASNLYESESMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL","Homo sapiens","DCK","Deoxycytidine kinase","1","3QEO"
"3QF2",,"X-RAY DIFFRACTION",2.44,49.57,"VAPOR DIFFUSION, HANGING DROP",4.6,"0.2M ammonium citrate, 0.1M sodium acetate pH4.6, 30% PEG MME 2000, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M111.278812",,"3QF2",25.41,"1.7","1.7","Crystal structure of NALP3 PYD","MASTRCKLARYLEDLEDVDLKKFKMHLEDYPPQKGCIPLPRGQTEKADHVDLATLMIDFNGEEKAWAMAVWIFAAINRRDLYEKAKRDEPKWGSDNARVSNPTVICQEDS","Homo sapiens","NALP3, NLRP3, C1orf7, CIAS1, PYPAF1","NACHT, LRR and PYD domains-containing protein 3","1","3QF2"
"3QFC",,"X-RAY DIFFRACTION",2.32,46.97,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 50 mM calcium acetate, 0.5 M sodium chloride, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 292KK",292,"10.1073/pnas.1106632108",,"3QFC",144.33,"1.8","1.8","Crystal Structure of Human NADPH-Cytochrome P450 (V492E mutant)","GSHMVRESSFVEKMKKTGRNIIVFYGSQTGTAEEFANRLSKDAHRYGMRGMSADPEEYDLADLSSLPEIDNALVVFCMATYGEGDPTDNAQDFYDWLQETDVDLSGVKFAVFGLGNKTYEHFNAMGKYVDKRLEQLGAQRIFELGLGDDDGNLEEDFITWREQFWLAVCEHFGVEATGEESSIRQYELVVHTDIDAAKVYMGEMGRLKSYENQKPPFDAKNPFLAAVTTNRKLNQGTERHLMHLELDISDSKIRYESGDHVAVYPANDSALVNQLGKILGADLDVVMSLNNLDEESNKKHPFPCPTSYRTALTYYLDITNPPRTNVLYELAQYASEPSEQELLRKMASSSGEGKELYLSWVVEARRHILAILQDCPSLRPPIDHLCELLPRLQARYYSIASSSKVHPNSVHICAVVVEYETKAGRINKGEATNWLRAKEPVGENGGRALVPMFVRKSQFRLPFKATTPVIMVGPGTGVAPFIGFIQERAWLRQQGKEVGETLLYYGCRRSDEDYLYREELAQFHRDGALTQLNVAFSREQSHKVYVQHLLKQDREHLWKLIEGGAHIYVCGDARNMARDVQNTFYDIVAELGAMEHAQAVDYIKKLMTKGRYSLDVWS","Homo sapiens","POR, CYPOR","NADPH--cytochrome P450 reductase","1","3QFC"
"3QFR",,"X-RAY DIFFRACTION",2.36,47.88,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM MES, 50 mM calcium acetate, 0.1 M sodium chloride, 14% PEG4000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1073/pnas.1106632108",,"3QFR",144.14,"2.4","2.4","Crystal Structure of Human NADPH-Cytochrome P450 Reductase (R457H Mutant)","GSHMVRESSFVEKMKKTGRNIIVFYGSQTGTAEEFANRLSKDAHRYGMRGMSADPEEYDLADLSSLPEIDNALVVFCMATYGEGDPTDNAQDFYDWLQETDVDLSGVKFAVFGLGNKTYEHFNAMGKYVDKRLEQLGAQRIFELGLGDDDGNLEEDFITWREQFWPAVCEHFGVEATGEESSIRQYELVVHTDIDAAKVYMGEMGRLKSYENQKPPFDAKNPFLAAVTTNRKLNQGTERHLMHLELDISDSKIRYESGDHVAVYPANDSALVNQLGKILGADLDVVMSLNNLDEESNKKHPFPCPTSYRTALTYYLDITNPPRTNVLYELAQYASEPSEQELLRKMASSSGEGKELYLSWVVEARRHILAILQDCPSLRPPIDHLCELLPRLQAHYYSIASSSKVHPNSVHICAVVVEYETKAGRINKGVATNWLRAKEPAGENGGRALVPMFVRKSQFRLPFKATTPVIMVGPGTGVAPFIGFIQERAWLRQQGKEVGETLLYYGCRRSDEDYLYREELAQFHRDGALTQLNVAFSREQSHKVYVQHLLKQDREHLWKLIEGGAHIYVCGDARNMARDVQNTFYDIVAELGAMEHAQAVDYIKKLMTKGRYSLDVWS","Homo sapiens","POR, CYPOR","NADPH--cytochrome P450 reductase","1","3QFR"
"3QFS",,"X-RAY DIFFRACTION",2,38.6,"VAPOR DIFFUSION, HANGING DROP",6.8,"100 mM magnesium chloride, 15% PEG5000 MME, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1073/pnas.1106632108",,"3QFS",53.53,"1.4","1.4","Crystal Structure of NADPH-Cytochrome P450 Reductase (FAD/NADPH domain)","MGSSHHHHHHSSGLVPRGSHMSIRQYELVVHTDIDAAKVYMGEMGRLKSYENQKPPFDAKNPFLAAVTTNRKLNQGTERHLMHLELDISDSKIRYESGDHVAVYPANDSALVNQLGKILGADLDVVMSLNNLDEESNKKHPFPCPTSYRTALTYYLDITNPPRTNVLYELAQYASEPSEQELLRKMASSSGEGKELYLSWVVEARRHILAILQDCPSLRPPIDHLCELLPRLQARYYSIASSSKVHPNSVHICAVVVEYETKAGRINKGVATNWLRAKEPVGENGGRALVPMFVRKSQFRLPFKATTPVIMVGPGTGVAPFIGFIQERAWLRQQGKEVGETLLYYGCRRSDEDYLYREELAQFHRDGALTQLNVAFSREQSHKVYVQHLLKQDREHLWKLIEGGAHIYVCGDARNMARDVQNTFYDIVAELGAMEHAQAVDYIKKLMTKGRYSLDVWS","Homo sapiens","POR, CYPOR","NADPH--cytochrome P450 reductase","1","3QFS"
"3QFT",,"X-RAY DIFFRACTION",2.01,38.85,"VAPOR DIFFUSION, HANGING DROP",6.8,"100 mM magnesium chloride, 15% PEG5000 MME, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1073/pnas.1106632108",,"3QFT",53.51,"1.4","1.4","Crystal Structure of NADPH-Cytochrome P450 Reductase (FAD/NADPH domain and R457H Mutant)","MGSSHHHHHHSSGLVPRGSHMSIRQYELVVHTDIDAAKVYMGEMGRLKSYENQKPPFDAKNPFLAAVTTNRKLNQGTERHLMHLELDISDSKIRYESGDHVAVYPANDSALVNQLGKILGADLDVVMSLNNLDEESNKKHPFPCPTSYRTALTYYLDITNPPRTNVLYELAQYASEPSEQELLRKMASSSGEGKELYLSWVVEARRHILAILQDCPSLRPPIDHLCELLPRLQAHYYSIASSSKVHPNSVHICAVVVEYETKAGRINKGVATNWLRAKEPVGENGGRALVPMFVRKSQFRLPFKATTPVIMVGPGTGVAPFIGFIQERAWLRQQGKEVGETLLYYGCRRSDEDYLYREELAQFHRDGALTQLNVAFSREQSHKVYVQHLLKQDREHLWKLIEGGAHIYVCGDARNMARDVQNTFYDIVAELGAMEHAQAVDYIKKLMTKGRYSLDVWS","Homo sapiens","POR, CYPOR","NADPH--cytochrome P450 reductase","1","3QFT"
"3QFV",,"X-RAY DIFFRACTION",2.43,49.42,"VAPOR DIFFUSION, HANGING DROP",5.5,"pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1371/journal.pone.0024825","NM7","3QFV",96.31,"2.65","2.65","MRCK beta in complex with TPCA-1","MSAKVRLKKLEQLLLDGPWRNESALSVETLLDVLVCLYTECSHSALRRDKYVAEFLEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLNWENIRNLEAPYIPDVSSPSDTSNFDVDDDVLRNTEILPPGSHTGFSGLHLPFIGFTFTTESCFSDRGSL","Homo sapiens","CDC42BPB, MRCK beta, KIAA1124","CDC42BPB protein","1","3QFV"
"3QGN",,"X-RAY DIFFRACTION",2.27,45.93,"VAPOR DIFFUSION, HANGING DROP",6.2,"0.2 M NH4I and 20 % PEG 3350, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/bi200878c",,"3QGN",34.43,"2.1","2.1","The allosteric E*-E equilibrium is a key property of the trypsin fold","EADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Thrombin light chain","1","3QGN"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGPLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin heavy chain","2","3QGN"
"3QGW",,"X-RAY DIFFRACTION",2.83,56.57,,,,,"10.1021/jm101499u","L7A","3QGW",65.71,"2.1","2.1","Crystal Structure of ITK kinase bound to an inhibitor","MGSSHHHHHHSSGLVPRGSLHMVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","3QGW"
"3QGY",,"X-RAY DIFFRACTION",2.83,56.57,,,,,"10.1021/jm101499u","L7O","3QGY",65.83,"2.1","2.1","Crystal structure of ITK inhibitor complex","MGSSHHHHHHSSGLVPRGSLHMVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","3QGY"
"3QH3",,"X-RAY DIFFRACTION",2.25,45.36,"VAPOR DIFFUSION, SITTING DROP",8.5,"PEG 30%, TRIS 0.1M, pH 8.5, vapor diffusion, sitting drop, temperature 297K",297,"10.1016/j.jmb.2011.10.006",,"3QH3",98.63,"2.19","2.19","The crystal structure of TCR A6","KEVEQNSGPLSVPEGAIASLNCTYSDRGSQSFFWYRQYSGKSPELIMSIYSNGDKEDGRFTAQLNKASQYVSLLIRDSQPSDSATYLCAVTTDSWGKLQFGAGTQVVVTPDIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPE","Homo sapiens",,"A6 alpha chain","1","3QH3"
,,,,,,,,,,,,,,,,"NAGVTQTPKFQVLKTGQSMTLQCAQDMNHEYMSWYRQDPGMGLRLIHYSVGAGITDQGEVPNGYNVSRSTTEDFPLRLLSAAPSQTSVYFCASRPGLAGGRPEQYFGPGTRLTVTEDLKNVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYALSSRLRVSATFWQDPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"A6 beta chain","2","3QH3"
"3QH9",,"X-RAY DIFFRACTION",2.15,42.8,"VAPOR DIFFUSION, HANGING DROP",8,"190 mM ammonium iodide, 23% PEG 3350, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi200141e",,"3QH9",9.98,"2.01","2.01","Human Liprin-beta2 Coiled-Coil","KLKLVGMEKEQREQEEKQRKAEELLQELRHLKIKVEELENERNQYEWKLKATKAEVAQLQEQVALKDAEIERLHSQLSRTA","Homo sapiens","PPFIBP2","Liprin-beta-2","1","3QH9"
"3QI1",,"X-RAY DIFFRACTION",2.41,48.96,,4.6,"BACE PROTEIN AT 10MG/ML IN 100MM SODIUM BORATE BUFFER PH 8.5. 1MM COMPOUND ADDED TO PROTEIN AND INCUBATED AT 4 C FOR 3 HOURS. HANGING DROP PLATES SET UP WITH RESERVOIR SOLUTION CONTAINING 4% PEG 8000, 100MM SODIUM ACETATE PH 4.6 THE DROPS WERE MIXED WITH 1:1 (V/V) RATIO OF PROTEIN/COMPOUND TO RESERVOIR AND INCUBATED AT ROOM TEMPERATURE FOR 2 WEEKS. VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K",295,"10.1016/j.bmcl.2013.06.006","C6A","3QI1",45.9,"2.3","2.3","Design and synthesis of hydroxyethylamine (hea) BACE-1 inhibitors: prime side chromane-containing inhibitors","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGAWAGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","3QI1"
"3QI2",,"X-RAY DIFFRACTION",2.8,56.07,"VAPOR DIFFUSION, HANGING DROP",5,"Hanging drops were a 1:1 mixture of protein-peptide complex in buffer (10 mM Tris pH 7.5, 1 mM magnesium chloride, 5% (w/v) glycerol, 5 mM DTT) and well solution (1.7 M ammonium sulfate, 100 mM sodium acetate pH 5.0, 200 mM magnesium 
chloride, 10% (w/v) glycerol), VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1371/journal.ppat.1002553",,"3QI2",84.42,"2.797","2.797","A Galpha P-loop mutation prevents transition to the activated state: G42R bound to RGS14 GoLoco","SNAGAREVKLLLLGARESGKSTIVKQMKIIHEAGYSEEECKQYKAVVYSNTIQSIIAIIRAMGRLKIDFGDSARADDARQLFVLAGAAEEGFMTAELAGVIKRLWKDSGVQACFNRSREYQLNDSAAYYLNDLDRIAQPNYIPTQQDVLRTRVKTTGIVETHFTFKDLHFKMFDVGGQRSERKKWIHCFEGVTAIIFCVALSDYDLVLAEDEEMNRMHESMKLFDSICNNKWFTDTSIILFLNKKDLFEEKIKKSPLTICYPEYAGSNTYEEAAAYIQCQFEDLNKRKDTKEIYTHFTCATDTKNVQFVFDAVTDVIIKNNLKDCGLF","Homo sapiens","GNAI1","Guanine nucleotide-binding protein G(i) subunit alpha-1","1","3QI2"
,,,,,,,,,,,,,,,,"DIEGLVELLNRVQSSGAHDQRGLLRKEDLVLPEFLQ",,,"Regulator of G-protein signaling 14","2","3QI2"
"3QI3",,"X-RAY DIFFRACTION",2.91,57.72,"VAPOR DIFFUSION, HANGING DROP",7.5,"The catalytic domain of the PDE9Q453E mutant (10-15 mg/mL, amino acids 181-506) was stored in a buffer of 50 mM NaCl, 20 mM Tris.HCl pH 7.5, 1 mM beta-mercaptoethanol, and 1 mM EDTA. After mixing with 2 mM IBMX, the PDE9Q453E-IBMX complex was crystallized by hanging drop vapor diffusion against the well buffer of 2.0 M Na formate, 0.1 M HEPES pH 7.5, 5% xylitol at 277K. Crystals of the PDE9Q453E-(S)-BAY73-6691 complex were prepared by soaking PDE9Q453E-IBMX co-crystals in the crystallization buffer plus 2 mM (S)-BAY73-6691 at 398K for 3 days, VAPOR DIFFUSION, HANGING DROP",277,"10.1371/journal.pone.0018092","PDB","3QI3",124.47,"2.3","2.3","Crystal structure of PDE9A(Q453E) in complex with inhibitor BAY73-6691","MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAEIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA","Homo sapiens","PDE, PDE9A","High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A","1","3QI3"
"3QI4",,"X-RAY DIFFRACTION",2.92,57.87,"VAPOR DIFFUSION, HANGING DROP",7.5,"The catalytic domain of the PDE9Q453E mutant (10-15 mg/mL, amino acids 181-506) was stored in a buffer of 50 mM NaCl, 20 mM Tris.HCl pH 7.5, 1 mM beta-mercaptoethanol, and 1 mM EDTA. After mixing with 2 mM IBMX, the PDE9Q453E-IBMX complex was crystallized by hanging drop vapor diffusion against the well buffer of 2.0 M Na formate, 0.1 M HEPES pH 7.5, 5% xylitol at 277K., VAPOR DIFFUSION, HANGING DROP",277,"10.1371/journal.pone.0018092","IBM","3QI4",124.2,"2.5","2.5","Crystal structure of PDE9A(Q453E) in complex with IBMX","MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAMVSIDPTMPANSERTPYKVRPVAIKQLSEREELIQSVLAQVAEQFSRAFKINELKAEVANHLAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAEIGFIKFVLIPMFETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA","Homo sapiens","PDE9A","High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A","1","3QI4"
"3QI5",,"X-RAY DIFFRACTION",2.14,42.41,"VAPOR DIFFUSION, HANGING DROP",,"The 3,N4-ethenocytosine (EDC) containing DNA duplex was prepared by annealing the EDC containing 13-mer crystallization oligonucleotide ('5-GAC ATG (EDC)TT GCC T-3') with its complementary strand that contained G opposite EDC (5'-GGC AAG CAT GTC A-3'). The delta79AAG-EDC complexes were prepared by mixing equimolar ratios of delta79AAG and EDC:G 13-mer DNA duplex at the final protein-DNA complex concentration of 0.3 mM in the complex buffer (20 mM Hepes-NaOH pH 7.5, 100 mM  NaCl, 0.1 mM EDTA, 5% v/v glycerol and 1 mM DTT). The complex was incubated on ice for 15 min and used for crystallization. The crystals were obtained upon mixing 1 uL of complex and 1 ul of the reservoir solution (100 mM sodium cacodylate pH 6.0, 200 mM manganese chloride and 20% polyethylene glycol (PEG)-3350) over 0.5 ml of the reservoir solution, followed by incubation for 2 days, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M110.192435",,"3QI5",64.67,"2.2","2.2","Crystal structure of human alkyladenine DNA glycosylase in complex with 3,N4-ethenocystosine containing duplex DNA","GPHMTRLGLEFFDQPAVPLARAFLGQVLVRRLPNGTELRGRIVETEAYLGPEDEAAHSRGGRQTPRNRGMFMKPGTLYVYIIYGMYFCMNISSQGDGACVLLRALEPLEGLETMRQLRSTLRKGTASRVLKDRELCSGPSKLCQALAINKSFDQRDLAQDEAVWLERGPLEPSEPAVVAAARVGVGHAGEWARKPLRFYVRGSPWVSVVDRVAEQDTQA","Homo sapiens","MPG, AAG, ANPG, MID1","DNA-3-methyladenine glycosylase","1","3QI5"
,,,,,,,,,,,,,,,,"GACATGXTTGCCT",,,"DNA (5'-D(*GP*AP*CP*AP*TP*GP*(EDC)P*TP*TP*GP*CP*CP*T)-3')","2","3QI5"
,,,,,,,,,,,,,,,,"GGCAAGCATGTCA",,,"DNA (5'-D(*GP*GP*CP*AP*AP*GP*CP*AP*TP*GP*TP*CP*A)-3')","3","3QI5"
"3QIC",,"X-RAY DIFFRACTION",2.74,55.09,"VAPOR DIFFUSION, SITTING DROP",7.3,"25% (w/v) PEG3350, 0.1M HEPES pH 7.3, 0.2M ammonium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.febslet.2011.03.026",,"3QIC",53.81,"2.2","2.2","The structure of human glucokinase E339K mutation","MGHHHHHHENLYFQGMKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVKSDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ","Homo sapiens","GCK","Glucokinase","1","3QIC"
"3QII",,"X-RAY DIFFRACTION",2.9,57.65,"VAPOR DIFFUSION, SITTING DROP",8.5,"25% PEG-8000, 0.2M sodium chloride, 0.1M TRIS, pH 8.5, vapor diffusion, sitting drop, temperature 291K",291,"10.1016/j.febslet.2012.02.012",,"3QII",9.82,"2.3","2.3","Crystal structure of tudor domain 2 of human PHD finger protein 20","MHHHHHHSSRENLYFQGGSSEFQINEQVLACWSDCRFYPAKVTAVNKDGTYTVKFYDGVVQTVKHIHVKAFSKDQNIVGNARPKE","Homo sapiens","PHF20, C20orf104, GLEA2, HCA58, NZF, TZP","PHD finger protein 20","1","3QII"
"3QIJ",,"X-RAY DIFFRACTION",2.04,39.81,"VAPOR DIFFUSION, SITTING DROP",7.5,"25% PEG3350, 0.2M magnesium chloride, 1% w/w dispase-I, pH 7.5, vapor diffusion, sitting drop, temperature 293K",293,,,"3QIJ",68.86,"1.8","1.8","Primitive-monoclinic crystal structure of the FERM domain of protein 4.1R","MHHHHHHSSGRENLYFQGHCKVSLLDDTVYECVVEKHAKGQDLLKRVCEHLNLLEEDYFGLAIWDNATSKTWLDSAKEIKKQVRGVPWNFTFNVKFYPPDPAQLTEDITRYYLCLQLRQDIVAGRLPCSFATLALLGSYTIQSELGDYDPELHGVDYVSDFKLAPNQTKELEEKVMELHKSYRSMTPAQADLEFLENAKKLSMYGVDLHKAKDLEGVDIILGVCSSGLLVYKDKLRINRFPWPKVLKISYKRSSFFIKIRPGEQEQYESTIGFKLPSYRAAKKLWKVCVEHHTFFR","Homo sapiens","EPB41, E41P","Protein 4.1","1","3QIJ"
"3QIK",,"X-RAY DIFFRACTION",4.2,70.4,"VAPOR DIFFUSION, SITTING DROP",6.2,"1.2M lithium sulfate, 0.5M ammonium sulfate, 0.1M sodium citrate, pH 6.2, vapor diffusion, sitting drop, temperature 293K",293,,,"3QIK",11.52,"2.285","2.285","Crystal structure of the first PDZ domain of PREX1","GKNKQLRNDFKLVENILAKRLLILPQEEDYGFDIEEKNKAVVVKSVQRGSLAEVAGLQVGRKIYSINEDLVFLRPFSEVESILNQSFCSRRPLRLLVATKA","Homo sapiens","PREX1, KIAA1415","Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein","1","3QIK"
,,,,,"VAPOR DIFFUSION, SITTING DROP",5.6,"1.2M lithium sulfate, 0.5M ammonium sulfate, 0.1M sodium citrate. Soaked for 6 hours in 0.01 M potassium hexaiodoplatin-(IV)-ate and mother liquor, pH 5.6, vapor diffusion, sitting drop, temperature 293K",293
"3QIR",,"X-RAY DIFFRACTION",2.33,47.31,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M NaI, 20% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 297K",297,,,"3QIR",69.7,"2.45","2.45","Crystal structure of PIWIL2 PAZ domain","RNDCVLDVMHAIYQQNKEHFQDECTKLLVGNIVITRYNNRTYRIDDVDWNKTPKDSFTMSDGKEITFLEYYSKNYGITVKEEDQPLLIHRPSERQDNHGMLLKGEILLLPELSFMTGIPEKMKKDFRAMKDLAQQINLSPKQHHSALE","Homo sapiens","PIWIL2, HILI","Piwi-like protein 2","1","3QIR"
"3QJ4",,"X-RAY DIFFRACTION",2.86,56.92,"VAPOR DIFFUSION, SITTING DROP",6.5,"30% PEG 8000, 0.2M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2011.06.010",,"3QJ4",77.6,"2.5","2.5","Crystal structure of Human Renalase (isoform 1)","MAQVLIVGAGMTGSLCAALLRRQTSGPLYLAVWDKADDSGGRMTTACSPHNPQCTADLGAQYITCTPHYAKKHQRFYDELLAYGVLRPLSSPIEGMVMKEGDCNFVAPQGISSIIKHYLKESGAEVYFRHRVTQINLRDDKWEVSKQTGSPEQFDLIVLTMPVPEILQLQGDITTLISECQRQQLEAVSYSSRYALGLFYEAGTKIDVPWAGQYITSNPCIRFVSIDNKKRNIESSEIGPSLVIHTTVPFGVTYLEHSIEDVQELVFQQLENILPGLPQPIATKCQKWRHSQVTNAAANCPGQMTLHHKPFLACGGDGFTQSNFDGCITSALCVLEALKNYI","Homo sapiens","RNLS, C10orf59","Renalase","1","3QJ4"
"3QJ5",,"X-RAY DIFFRACTION",3.03,59.45,"VAPOR DIFFUSION, SITTING DROP",7,"19% PEG 8000, 100MM K-PHOSPHATE PH 7.0, 100MM ZNSO4, 1MM DTT, 3% (W/V) BUTANEDIOL, TEMPERATURE 290K, VAPOR DIFFUSION, SITTING DROP",290,"10.1021/ml200045s","022","3QJ5",83.1,"1.9","1.9","S-nitrosoglutathione reductase (GSNOR) in complex with N6022","SANEVIKCKAAVAWEAGKPLSIEEIEVAPPKAHEVRIKIIATAVCHTDAYTLSGADPEGCFPVILGHEGAGIVESVGEGVTKLKAGDTVIPLYIPQCGECKFCLNPKTNLCQKIRVTQGKGLMPDGTSRFTCKGKTILHYMGTSTFSEYTVVADISVAKIDPLAPLDKVCLLGCGISTGYGAAVNTAKLEPGSVCAVFGLGGVGLAVIMGCKVAGASRIIGVDINKDKFARAKEFGATECINPQDFSKPIQEVLIEMTDGGVDYSFECIGNVKVMRAALEACHKGWGVSVVVGVAASGEEIATRPFQLVTGRTWKGTAFGGWKSVESVPKLVSEYMSKKIKVDEFVTHNLSFDEINKAFELMHSGKSIRTVVKI","Homo sapiens","ADH5, ADHX, FDH","Alcohol dehydrogenase class-3","1","3QJ5"
"3QJZ",,"X-RAY DIFFRACTION",2.26,45.67,"VAPOR DIFFUSION, HANGING DROP",8,"20% PEG 3350, 200 mM ammonium sulfate, 2 mM dithiothreitol, 100 mM Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm1014605",,"3QJZ",110.24,"2.9","2.9","Crystal structure of PI3K-gamma in complex with benzothiazole 1","GSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA","Homo sapiens","PIK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","3QJZ"
"3QK0",,"X-RAY DIFFRACTION",2.38,48.31,"VAPOR DIFFUSION, HANGING DROP",7.5,"21% PEG 3350, 240 mM ammonium sulfate, 2 mM dithiothreitol, 100 mM Tris, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm1014605","QK0","3QK0",110.59,"2.85","2.85","Crystal structure of PI3K-gamma in complex with benzothiazole 82","GSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA","Homo sapiens","PIK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","3QK0"
"3QK3",,"X-RAY DIFFRACTION",2,38.4,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES, 1.5M Li2SO4, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3QK3",65.15,"1.95","1.95","Crystal structure of human beta-crystallin B3","YFQSMGGSYKVILYELENFQGKRCELSAECPSLTDSLLEKVGSIQVESGPWLAFESRAFRGEQFVLEKGDYPRWDAWSNSRDSDSLLSLRPLNIDSPHHKLHLFENPAFSGRKMEIVDDDVPSLWAHGFQDRVASVRAINGTWVGYEFPGYRGRQYVFERGEYRHWNEWDASQPQLQSVRRIRD","Homo sapiens","CRYBB3, CRYB3","Beta-crystallin B3","1","3QK3"
"3QKD",,"X-RAY DIFFRACTION",2.58,52.29,"VAPOR DIFFUSION, HANGING DROP",8,"1.1M Sodium Citrate, 0.1M Tris pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1021/jm101596e","HI0","3QKD",43.41,"2.02","2.02","Crystal structure of Bcl-xL in complex with a Quinazoline sulfonamide inhibitor","MSMAMSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERLEHHHHHH","Homo sapiens","BCL2L1, BCL2L, BCLX","Bcl-2-like protein 1","1","3QKD"
"3QKG",,"X-RAY DIFFRACTION",2.32,47.06,"VAPOR DIFFUSION, SITTING DROP",7,"100 mM Tris-HCl, 1.1 M sodium citrate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1042/BJ20120448",,"3QKG",22.11,"2.3","2.3","Crystal structure of alpha-1-microglobulin at 2.3 A resolution","GPVPTPPDNIQVQENFNISRIYGKWYNLAIGSTSPWLKKIMDRMTVSTLVLGEGATEAEISMTSTRWRKGVCEETSGAYEKTDTDGKFLYHKSKWNITMESYVVHTNYDEYAIFLTKKFSRHHGPTITAKLYGRAPQLRETLLQDFRVVAQGVGIPEDSIFTMADRGECVPGEQEPEPILIPRSAWSHPQFEK","Homo sapiens","AMBP, HCP, ITIL","Protein AMBP","1","3QKG"
"3QKJ",,"X-RAY DIFFRACTION",3.84,67.93,"VAPOR DIFFUSION, SITTING DROP",6,"pH 6, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1371/journal.pone.0018919",,"3QKJ",68.44,"2.04","2.04","The PWWP domain of human DNA (CYTOSINE-5-)-METHYLTRANSFERASE 3 BETA in complex with a bis-tris molecule","GEADSGDGDSSEYQDGKEFGIGDLVWGKIKGFSWWPAMVVSWKATSKRQAMSGMRWVQWFGDGKFSEVSADKLVALGLFSQHFNLATFNKLVSYRKAMYHALEKARVRAGKTFPSSPGDSLEDQLKPMLEWAHGGFKPTGIEGLKPNNTQP","Homo sapiens","DNMT3B","DNA cytosine-5 methyltransferase 3 beta isoform 6 variant","1","3QKJ"
"3QKK",,"X-RAY DIFFRACTION",2.52,51.2,"Under oil",7.8,"8.1mg/ml protein, 0.6mM GSK-3 beta peptide, 5mM Mg-AMPPNP, 10mM DTT, 20% PEG 4K, 10% Isopropanol, 0.1M Hepes, pH 7.8, Under oil, temperature 293K",293,"10.1016/j.bmcl.2011.02.073","SMH","3QKK",41.14,"2.3","2.3","Spirochromane Akt Inhibitors","GRPRTTSFAE",,,"GSK-3 beta peptide","2","3QKK"
,,,,,,,,,,,,,,,,"GAMARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFDYSASSTA","Homo sapiens","AKT1, PKB, RAC","RAC-alpha serine/threonine-protein kinase","1","3QKK"
"3QKL",,"X-RAY DIFFRACTION",2.61,52.93,"Under oil",7.8,"9.7mg/ml protein, 0.6mM GSK-3 beta peptide, 1mM Mg-AMPPNP, 10mM DTT, 22% PEG 4K, 10% Isopropanol, 0.1M Hepes, pH 7.8, Under oil, temperature 293K",293,"10.1016/j.bmcl.2011.02.073","SMR","3QKL",41.15,"1.9","1.9","Spirochromane Akt Inhibitors","GAMARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFDYSASSTA","Homo sapiens","AKT1, PKB, RAC","RAC-alpha serine/threonine-protein kinase","1","3QKL"
,,,,,,,,,,,,,,,,"GRPRTTSFAE",,,"GSK-3 beta peptide","2","3QKL"
"3QKM",,"X-RAY DIFFRACTION",2.59,52.5,"Under oil",7.8,"9.7mg/ml protein, 0.6mM GSK-3 beta peptide, 1mM Mg-AMPPNP, 10mM DTT, 22% PEG 4K, 10% Isopropanol, 0.1M Hepes, pH 7.8, Under oil, temperature 293K",293,"10.1016/j.bmcl.2011.02.098","SM9","3QKM",40.05,"2.2","2.2","Spirocyclic sulfonamides as AKT inhibitors","GAMARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFDYSASSTA","Homo sapiens","AKT1, PKB, RAC","RAC-alpha serine/threonine-protein kinase","1","3QKM"
"3QKP",,"X-RAY DIFFRACTION",3.15,60.96,"VAPOR DIFFUSION, SITTING DROP",7.5,"2uL of protein solution (12 mg/mL PTP1B W179F in 10 mM Tris pH 7.5, 25 mM NaCl, 0.2 mM EDTA and 3 mM DTT), 0.5 uL sucrose 30 % (w/v) and 3 uL of precipitant solution (0.1 M Hepes pH 7.5, 0.2 M magnesium acetate and 15-20 % polyethylene glycol 8000). The well solution was 500 uL of precipitant solution., vapor diffusion, sitting drop, temperature 277K",277,"10.1016/j.abb.2012.06.002",,"3QKP",37.63,"2.05","2.05","Protein Tyrosine Phosphatase 1B - Apo W179F mutant with open WPD-loop","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTFPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTP1B, PTPN1","Tyrosine-protein phosphatase non-receptor type 1","1","3QKP"
"3QKQ",,"X-RAY DIFFRACTION",3.17,61.17,"VAPOR DIFFUSION, SITTING DROP",7.5,"2uL of protein solution, 0.5 uL sucrose 30 % (w/v) and 3 uL of precipitant solution (0.1 M Hepes pH 7.5, 0.2 M magnesium acetate and 15-20 % polyethylene glycol 8000). The protein solution was prepared with 15 uL of 12 mg/mL PTP1B W179F in 10 mM Tris pH 7.5, 25 mM NaCl, 0.2 mM EDTA and 3 mM DTT, and 0.5 uL of 60 mM of sodium vanadate. The well solution was 500 uL of precipitant solution., vapor diffusion, sitting drop, temperature 277K",277,"10.1016/j.abb.2012.06.002","VO4","3QKQ",37.84,"2.2","2.2","Protein Tyrosine Phosphatase 1B - W179F mutant bound with vanadate","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTFPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTP1B, PTPN1","Tyrosine-protein phosphatase non-receptor type 1","1","3QKQ"
"3QL8",,"X-RAY DIFFRACTION",1.97,37.72,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3QL8",35.04,"1.9","1.9","CDK2 in complex with inhibitor JWS-6-260","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QL8"
"3QLN",,"X-RAY DIFFRACTION",2.9,57.63,"VAPOR DIFFUSION, SITTING DROP",7.5,"25% (v/v) PEG 4000, 100mM HEPES-NaOH, 0.2M KCL, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/nsmb.2062",,"3QLN",29.98,"1.901","1.901","Crystal structure of ATRX ADD domain in free state","GPLGSMGIVSCTACGQQVNHFQKDSIYRHPSLQVLICKNCFKYYMSDDISRDSDGMDEQCRWCAEGGNLICCDFCHNAFCKKCILRNLGRRELSTIMDENNQWYCYICHPEPLLDLVTACNSVYENLEQ","Homo sapiens","ATRX, RAD54L, XH2","Transcriptional regulator ATRX","1","3QLN"
"3QLP",,"X-RAY DIFFRACTION",2.95,58.33,"VAPOR DIFFUSION, SITTING DROP",5.8,"20% w/v PEG 20000, 0.2M ammonium sulfate, 3% n-propanol, 0.1 M sodium acetate pH 5.8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1093/nar/gkr522",,"3QLP",39.36,"2.14","2.14","X-ray structure of the complex between human alpha thrombin and a modified thrombin binding aptamer (mTBA)","IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin heavy chain","1","3QLP"
,,,,,,,,,,,,,,,,"TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Thrombin light chain","2","3QLP"
,,,,,,,,,,,,,,,,"GGTTGGTGTGGTTGG",,,"modified thrombin binding DNA aptamer","3","3QLP"
"3QM4",,"X-RAY DIFFRACTION",2.57,52.18,"VAPOR DIFFUSION, HANGING DROP",7,"PEG-3350, ammonium sulphate, sodium cacodylate, potassium phosphate, NaCl, glycerol, beta-mercaptoethanol, prinomastat, HEGA-10, CHAPS, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M111.307918",,"3QM4",109.6,"2.85","2.85","Human Cytochrome P450 (CYP) 2D6 - Prinomastat Complex","MAKKTSSKGKLPPGPLPLPGLGNLLHVDFQNTPYCFDQLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVFLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDKAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKVLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVADLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVIHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHFLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGVFAFLVSPSPYELCAVPRHHHH","Homo sapiens","CYP2D6, CYP2DL1","Cytochrome P450 2D6","1","3QM4"
"3QMB",,"X-RAY DIFFRACTION",2.31,46.65,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES pH 7.5, 0.2M CaCl2, 28% PEG400, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/ncomms1237",,"3QMB",17.03,"2.06","2.06","Structural Basis of Selective Binding of Nonmethylated CpG Islands by the CXXC Domain of CFP1","MHHHHHHSSRENLYFQGQIKRSARMCGECEACRRTEDCGHCDFCRDMKKFGGPNKIRQKCRLRQCQLRARESYKYFPSS","Homo sapiens","CFP1, CGBP, CXXC1, PCCX1, PHF18","CpG-binding protein","1","3QMB"
,,,,,,,,,,,,,,,,"GCCACCGGTGGC",,,"5'-D(*GP*CP*CP*AP*CP*CP*GP*GP*TP*GP*GP*C)-3'","2","3QMB"
"3QMC",,"X-RAY DIFFRACTION",2.15,42.68,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES pH 7.5, 0.2M CaCl2, 28% PEG400, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/ncomms1237",,"3QMC",16.99,"2.1","2.1","Structural Basis of Selective Binding of Nonmethylated CpG Islands by the CXXC Domain of CFP1","MHHHHHHSSRENLYFQGQIKRSARMCGECEACRRTEDCGHCDFCRDMKKFGGPNKIRQKCRLRQCQLRARESYKYFPSS","Homo sapiens","CXXC1, CFP1, CGBP, PCCX1, PHF18","CpG-binding protein","1","3QMC"
,,,,,,,,,,,,,,,,"GCCACCGCTGGC",,,"5'-D(*GP*CP*CP*AP*CP*CP*GP*CP*TP*GP*GP*C)-3'","2","3QMC"
,,,,,,,,,,,,,,,,"GCCAGCGGTGGC",,,"5'-D(*GP*CP*CP*AP*GP*CP*GP*GP*TP*GP*GP*C)-3'","3","3QMC"
"3QMD",,"X-RAY DIFFRACTION",2.14,42.4,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Hepes pH 7.5, 0.1M MgCl2, 30% PEG550MME., VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/ncomms1237",,"3QMD",16.99,"1.9","1.9","Structural Basis of Selective Binding of Nonmethylated CpG Islands by the CXXC Domain of CFP1","MHHHHHHSSRENLYFQGQIKRSARMCGECEACRRTEDCGHCDFCRDMKKFGGPNKIRQKCRLRQCQLRARESYKYFPSS","Homo sapiens","CXXC1, CFP1, CGBP, PCCX1, PHF18","CpG-binding protein","1","3QMD"
,,,,,,,,,,,,,,,,"GCCAACGATGGC",,,"DNA (5'-D(*GP*CP*CP*AP*AP*CP*GP*AP*TP*GP*GP*C)-3')","2","3QMD"
,,,,,,,,,,,,,,,,"GCCATCGTTGGC",,,"DNA (5'-D(*GP*CP*CP*AP*TP*CP*GP*TP*TP*GP*GP*C)-3')","3","3QMD"
"3QMG",,"X-RAY DIFFRACTION",2.13,42.15,,,,,"10.1038/ncomms1237",,"3QMG",17.09,"2.3","2.3","Structural Basis of Selective Binding of Non-Methylated CpG islands by the CXXC Domain of CFP1","MHHHHHHSSRENLYFQGQIKRSARMCGECEACRRTEDCGHCDFCRDMKKFGGPNKIRQKCRLRQCQLRARESYKYFPSS","Homo sapiens","CFP1, CGBP, CXXC1, PCCX1, PHF18","CpG-binding protein","1","3QMG"
,,,,,,,,,,,,,,,,"GCCAACGGTGGC",,,"5'-D(*GP*CP*CP*AP*AP*CP*GP*GP*TP*GP*GP*C)-3'","2","3QMG"
,,,,,,,,,,,,,,,,"GCCACCGTTGGC",,,"5'-D(*GP*CP*CP*AP*CP*CP*GP*TP*TP*GP*GP*C)-3'","3","3QMG"
"3QMH",,"X-RAY DIFFRACTION",2.07,40.65,,,,,"10.1038/ncomms1237",,"3QMH",16.99,"2.5","2.5","Structural Basis of Selective Binding of Non-Methylated CpG islands (DNA-TCGA) by the CXXC Domain of CFP1","MHHHHHHSSRENLYFQGQIKRSARMCGECEACRRTEDCGHCDFCRDMKKFGGPNKIRQKCRLRQCQLRARESYKYFPSS","Homo sapiens","CFP1, CGBP, CXXC1, PCCX1, PHF18","CpG-binding protein","1","3QMH"
,,,,,,,,,,,,,,,,"GCCATCGATGGC",,,"5'-D(*GP*CP*CP*AP*TP*CP*GP*AP*TP*GP*GP*C)-3'","2","3QMH"
"3QMI",,"X-RAY DIFFRACTION",2.14,42.65,,,,,"10.1038/ncomms1237",,"3QMI",17.29,"2.1","2.1","Structural Basis of Selective Binding of Non-Methylated CpG islands (DNA-ACGT) by the CXXC Domain of CFP1","MHHHHHHSSRENLYFQGQIKRSARMCGECEACRRTEDCGHCDFCRDMKKFGGPNKIRQKCRLRQCQLRARESYKYFPSS","Homo sapiens","CFP1, CGBP, CXXC1, PCCX1, PHF18","CpG-binding protein","1","3QMI"
,,,,,,,,,,,,,,,,"GCCAACGTTGGC",,,"5'-D(*GP*CP*CP*AP*AP*CP*GP*TP*TP*GP*GP*C)-3'","2","3QMI"
"3QMK",,"X-RAY DIFFRACTION",2.78,55.69,"MICROBATCH",6.5,"25% PEG 3350, 0.1 M bis-tris, 0.2 M Li2SO4, 25 mM ATP, pH 6.5, microbatch, temperature 298K",298,"10.1073/pnas.1103407108",,"3QMK",51.14,"2.21","2.21","Crystal structure of the E2 domain of APLP1 in complex with heparin hexasaccharide","GSHMTPTPRPTDGVDIYFGMPGEISEHEGFLRAKMDLEERRMRQINEVMREWAMADNQSKNLPKADRQALNEHFQSILQTLEEQVSGERQRLVETHATRVIALINDQRRAALEGFLAALQADPPQAERVLLALRRYLRAEQKEQRHTLRHYQHVAAVDPEKAQQMRFQVHTHLQVIEERVNQSLGLLDQNPHLAQELRPQIQELLHSEHLGPSE","Homo sapiens","APLP1","Amyloid-like protein 1","1","3QMK"
"3QN7",,"X-RAY DIFFRACTION",2,38.46,"VAPOR DIFFUSION, HANGING DROP",4.3,"2M ammonium sulfate, 0.05M sodium citrate, 5%(v/v) PEG 400, pH 4.3, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/cb200478t",,"3QN7",30.59,"1.9","1.9","Potent and selective bicyclic peptide inhibitor (UK18) of human urokinase-type plasminogen activator(uPA)","IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL","Homo sapiens","PLAU","Urokinase-type plasminogen activator","1","3QN7"
,,,,,,,,,,,,,,,,"ACSRYEVDCRGRGSACG",,,"Bicyclic peptide inhibitor","2","3QN7"
"3QNF",,"X-RAY DIFFRACTION",2.31,46.66,"VAPOR DIFFUSION",7.5,"0.1M HEPES pH 7.5;  25% PEG 3350, VAPOR DIFFUSION, temperature 293K",293,"10.1073/pnas.1101262108",,"3QNF",329.04,"3","3","Crystal structure of the open state of human endoplasmic reticulum aminopeptidase 1 ERAP1","LRRRYTMVFLPLKWSLATMSFLLSSLLALLTVSTPSWCQSTEASPKRSDGTPFPWNKIRLPEYVIPVHYDLLIHANLTTLTFWGTTKVEITASQPTSTIILHSHHLQISRATLRKGAGERLSEEPLQVLEHPRQEQIALLAPEPLLVGLPYTVVIHYAGNLSETFHGFYKSTYRTKEGELRILASTQFEPTAARMAFPCFDEPAFKASFSIKIRREPRHLAISNMPLVKSVTVAEGLIEDHFDVTVKMSTYLVAFIISDFESVSKITKSGVKVSVYAVPDKINQADYALDAAVTLLEFYEDYFSIPYPLPKQDLAAIPDFQSGAMENWGLTTYRESALLFDAEKSSASSKLGITMTVAHELAHQWFGNLVTMEWWNDLWLNEGFAKFMEFVSVSVTHPELKVGDYFFGKCFDAMEVDALNSSHPVSTPVENPAQIREMFDDVSYDKGACILNMLREYLSADAFKSGIVQYLQKHSYKNTKNEDLWDSMASICPTDGVKGMDGFCSRSQHSSSSSHWHQEGVDVKTMMNTWTLQKGFPLITITVRGRNVHMKQEHYMKGSDGAPDTGYLWHVPLTFITSKSDMVHRFLLKTKTDVLILPEEVEWIKFNVGMNGYYIVHYEDDGWDSLTGLLKGTHTAVSSNDRASLINNAFQLVSIGKLSIEKALDLSLYLKHETEIMPVFQGLNELIPMYKLMEKRDMNEVETQFKAFLIRLLRDLIDKQTWTDEGSVSERMLRSQLLLLACVHNYQPCVQRAEGYFRKWKESNGNLSLPVDVTLAVFAVGAQSTEGWDFLYSKYQFSLSSTEKSQIEFALCRTQNKEKLQWLLDESFKGDKIKTQEFPQILTLIGRNPVGYPLAWQFLRKNWNKLVQKFELGSSSIAHMVMGTTNQFSTRTRLEEVKGFFSSLKENGSQLRCVQQTIETIEENIGWMDKNFDKIRVWLQSEKLERMAENLYFQ","Homo sapiens","ERAP1, APPILS, ARTS1, KIAA0525, UNQ584/PRO1154","Endoplasmic reticulum aminopeptidase 1","1","3QNF"
"3QNI",,"X-RAY DIFFRACTION",3.36,63.42,,,,,,,"3QNI",72.62,"2.8","2.8","Crystal structure of human PACSIN 1 F-BAR domain","MSSSYDEASLAPEETTDSFWEVGNYKRTVKRIDDGHRLCNDLMNCVQERAKIEKAYGQQLTDWAKRWRQLIEKGPQYGSLERAWGAIMTEADKVSELHQEVKNNLLNEDLEKVKNWQKDAYHKQIMGGFKETKEAEDGFRKAQKPWAKKMKELEAAKKAYHLACKEEKLAMTREMNSKTEQSVTPEQQKKLQDKVDKCKQDVQKTQEKYEKVLEDVGKTTPQYMENMEQVFEQCQQFEEKRLVFLKEVLLDIKRHLNLAENSSYIHVYRELEQAIRGADAQEDLRWFRSTSGPGMPMNWPQFEEWNP","Homo sapiens","PACSIN1, KIAA1379","Protein kinase C and casein kinase substrate in neurons protein 1","1","3QNI"
"3QNT",,"X-RAY DIFFRACTION",2.4,48.76,"VAPOR DIFFUSION, HANGING DROP",6.5,"pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1371/journal.pone.0018722",,"3QNT",28.52,"2.83","2.83","NPC1L1 (NTD) Structure","GAEPYTTIHQPGYCAFYDECGKNPELSGSLMTLSNVSCLSNTPARKITGDHLILLQKICPRLYTGPNTQACCSAKQLVSLEASLSITKALLTRCPACSDNFVNLHCHNTCSPNQSLFINVTRVAQLGAGQLPAVVAYEAFYQHSFAEQSYDSCSRVRVPAAATLAVGTMCGVYGSALCNAQRWLNFQGDTGNGLAPLDITFHLLEPGQAVGSGIQPLNEGVARCNESQGDDVATCSCQDCAASCPAIARPQALDSTFYLGQMPGS","Homo sapiens","NPC1L1","Niemann-Pick C1-like protein 1","1","3QNT"
"3QNU",,"X-RAY DIFFRACTION",2.98,58.72,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M Tris-HCl, pH8.5, 25%(w/v) PEG1500, 20%(v/v) Glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1101643108",,"3QNU",53.19,"2.8","2.8","Crystal structure of the cytosolic domain of human atlastin-1 in complex with GDP, hexagonal form","MHHHHHHGSHMASAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAART","Homo sapiens","ATL1, GBP3, SPG3A","Atlastin-1","1","3QNU"
"3QNX",,"X-RAY DIFFRACTION",2.69,54.33,"VAPOR DIFFUSION, SITTING DROP",3.8,"1.8M (NH4)2SO4, 0.1M PO4/citrate, pH 3.8, vapor diffusion, sitting drop, temperature 293K",293,"10.1107/S0907444912048664",,"3QNX",47.79,"2.2","2.2","Orthorhombic form of human IgA1 Fab fragment, sharing same Fv as IgG","DIVMTQSPLSLSVTPGEPASISCRSSQSLLRRDGHNDLEWYLQKPGQSPQPLIYLGSTRASGVPDRFSGSGSGTDFTLKIIRVEAEDAGTYYCMQNKQTPLTFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab fragment of IMMUNOGLOBULIN A1 LIGHT CHAIN","1","3QNX"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVQPGGSLKLSCAASGFTLSGSNVHWVRQASGKGLEWVGRIKRNAESDATAYAASMRGRLTISRDDSKNTAFLQMNSLKSDDTAMYYCVIRGDVYNRQWGQGTLVTVSSASPTSPKVFPLSLCSTQPDGNVVIACLVQGFFPQEPLSVTWSESGQGVTARNFPPSQDASGDLYTTSSQLTLPATQCLAGKSVTCHVKHYTNPSQDVTVPCP","Homo sapiens",,"Fab fragment of IMMUNOGLOBULIN A1 HEAVY CHAIN","2","3QNX"
"3QNY",,"X-RAY DIFFRACTION",2.4,48.68,"VAPOR DIFFUSION, SITTING DROP",8.2,"0.2M potassium sulfate, 20% PEG 3350, pH 8.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S0907444912048664",,"3QNY",95.22,"2.3","2.3","Monoclinic form of human IgA1 Fab fragment, sharing same Fv as IgG","DIVMTQSPLSLSVTPGEPASISCRSSQSLLRRDGHNDLEWYLQKPGQSPQPLIYLGSTRASGVPDRFSGSGSGTDFTLKIIRVEAEDAGTYYCMQNKQTPLTFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"FAB FRAGMENT OF IMMUNOGLOBULIN A1 LIGHT CHAIN","1","3QNY"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVQPGGSLKLSCAASGFTLSGSNVHWVRQASGKGLEWVGRIKRNAESDATAYAASMRGRLTISRDDSKNTAFLQMNSLKSDDTAMYYCVIRGDVYNRQWGQGTLVTVSSASPTSPKVFPLSLCSTQPDGNVVIACLVQGFFPQEPLSVTWSESGQGVTARNFPPSQDASGDLYTTSSQLTLPATQCLAGKSVTCHVKHYTNPSQDVTVPCP","Homo sapiens",,"FAB FRAGMENT OF IMMUNOGLOBULIN A1 HEAVY CHAIN","2","3QNY"
"3QNZ",,"X-RAY DIFFRACTION",2.52,51.27,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M Na citrate, 20% isopropanol, 16% PEG 4000, pH 5.5, vapor diffusion, sitting drop, temperature 293K",293,"10.1107/S0907444912048664",,"3QNZ",48.46,"2.2","2.2","Orthorhombic form of IgG1 Fab fragment (in complex with antigenic tubulin peptide) sharing same Fv as IgA","DIVMTQSPLSLSVTPGEPASISCRSSQSLLRRDGHNDLEWYLQKPGQSPQPLIYLGSTRASGVPDRFSGSGSGTDFTLKIIRVEAEDAGTYYCMQNKQTPLTFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab fragment of IMMUNOGLOBULIN G1 LIGHT CHAIN","1","3QNZ"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVQPGGSLKLSCAASGFTLSGSNVHWVRQASGKGLEWVGRIKRNAESDATAYAASMRGRLTISRDDSKNTAFLQMNSLKSDDTAMYYCVIRGDVYNRQWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPK","Homo sapiens",,"Fab fragment of IMMUNOGLOBULIN G1 HEAVY CHAIN","2","3QNZ"
,,,,,,,,,,,,,,,,"TAEEEEDFGE",,,"peptide from Tubulin beta chain","3","3QNZ"
"3QO0",,"X-RAY DIFFRACTION",2.43,49.3,"VAPOR DIFFUSION, SITTING DROP",6.1,"0.1M Na citrate, 20% isopropanol, 16% PEG 4000, pH 6.1, vapor diffusion, sitting drop, temperature 293K",293,,,"3QO0",49.78,"2.3","2.3","Monoclinic form of IgG1 Fab fragment (in complex with antigenic peptide) sharing same Fv as IgA","DIVMTQSPLSLSVTPGEPASISCRSSQSLLRRDGHNDLEWYLQKPGQSPQPLIYLGSTRASGVPDRFSGSGSGTDFTLKIIRVEAEDAGTYYCMQNKQTPLTFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab fragment of IMMUNOGLOBULIN G1 LIGHT CHAIN","1","3QO0"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVQPGGSLKLSCAASGFTLSGSNVHWVRQASGKGLEWVGRIKRNAESDATAYAASMRGRLTISRDDSKNTAFLQMNSLKSDDTAMYYCVIRGDVYNRQWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPK","Homo sapiens",,"Fab fragment of IMMUNOGLOBULIN G1 HEAVY CHAIN","2","3QO0"
,,,,,,,,,,,,,,,,"YQQYQDATAEEEEDFGEEAE",,,"Peptide from Tubulin beta chain","3","3QO0"
"3QO1",,"X-RAY DIFFRACTION",2.54,51.67,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M Na citrate, 20% isopropanol, 16% PEG 4000, pH 5.5, vapor diffusion, sitting drop, temperature 293K",293,"10.1107/S0907444912048664",,"3QO1",47.39,"2.4","2.4","Monoclinic form of IgG1 Fab fragment (apo form) sharing same Fv as IgA","DIVMTQSPLSLSVTPGEPASISCRSSQSLLRRDGHNDLEWYLQKPGQSPQPLIYLGSTRASGVPDRFSGSGSGTDFTLKIIRVEAEDAGTYYCMQNKQTPLTFGQGTRLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab fragment of IMMUNOGLOBULIN G1 LIGHT CHAIN","1","3QO1"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVQPGGSLKLSCAASGFTLSGSNVHWVRQASGKGLEWVGRIKRNAESDATAYAASMRGRLTISRDDSKNTAFLQMNSLKSDDTAMYYCVIRGDVYNRQWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPK","Homo sapiens",,"Fab fragment of IMMUNOGLOBULIN G1 HEAVY CHAIN","2","3QO1"
"3QO4",,"X-RAY DIFFRACTION",4.19,70.63,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.1 M Sodium citrate, 30% PEG4000, 0.5 M Ammoniumacetate 
, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2011.03.048",,"3QO4",19.8,"2.2","2.2","The Crystal Structure of Death Receptor 6","GSHMQPEQKASNLIGTYRHVDRATGQVLTCDKCPAGTYVSEHCTNTSLRVCSSCPVGTFTRHENGIEKCHDCSQPCPWPMIEKLPCAALTDRECTCPPGMFQSNATCAPHTVCPVGWGVRKKGTETEDVRCKQCARGTFSDVPSSVMKCKAYTDCLSQNLVVIKPGTKETDNVCGTLPSFS","Homo sapiens","TNFRSF21, DR6, UNQ437/PRO868","Tumor necrosis factor receptor superfamily member 21","1","3QO4"
"3QOA",,"X-RAY DIFFRACTION",3.13,60.75,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M Ammonium acetate, 0.1 M HEPES, 25% PEG 3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1124/mol.111.074427","3QO","3QOA",56.42,"2.1","2.1","Crystal structure of a human cytochrome P450 2B6 (Y226H/K262R) in complex with the inhibitor 4-Benzylpyridine.","MAKKTSSKGKLPPGPRPLPLLGNLLQMDRRGLLKSFLRFREKYGDVFTVHLGPRPVVMLCGVEAIREALVDKAEAFSGRGKIAMVDPFFRGYGVIFANGNRWKVLRRFSVTTMRDFGMGKRSVEERIQEEAQCLIEELRKSKGALMDPTFLFQSITANIICSIVFGKRFHYQDQEFLKMLNLFYQTFSLISSVFGQLFELFSGFLKHFPGAHRQVYKNLQEINAYIGHSVEKHRETLDPSAPRDLIDTYLLHMEKEKSNAHSEFSHQNLNLNTLSLFFAGTETTSTTLRYGFLLMLKYPHVAERVYREIEQVIGPHRPPELHDRAKMPYTEAVIYEIQRFSDLLPMGVPHIVTQHTSFRGYIIPKDTEVFLILSTALHDPHYFEKPDAFNPDHFLDANGALKKTEAFIPFSLGKRICLGEGIARAELFLFFTTILQNFSMASPVAPEDIDLTPQECGVGKIPPTYQIRFLPRHHHH","Homo sapiens","CYP2B6","Cytochrome P450 2B6","1","3QOA"
"3QOF",,"X-RAY DIFFRACTION",2.92,57.89,"VAPOR DIFFUSION, HANGING DROP",8.3,"0.1M Tris-HCl, pH8.3, 25%(w/v) PEG 3350, 0.1M (NH4)2HPO4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1101643108",,"3QOF",212.74,"2.802","2.802","Crystal structure of the cytosolic domain of human atlastin-1 in complex with GDP, orthorhombic form","MHHHHHHGSHMASAKNRRDRNSWGGFSEKTYEWSSEEEEPVKKAGPVQVLIVKDDHSFELDETALNRILLSEAVRDKEVVAVSVAGAFRKGKSFLMDFMLRYMYNQESVDWVGDYNEPLTGFSWRGGSERETTGIQIWSEIFLINKPDGKKVAVLLMDTQGTFDSQSTLRDSATVFALSTMISSIQVYNLSQNVQEDDLQHLQLFTEYGRLAMEETFLKPFQSLIFLVRDWSFPYEFSYGADGGAKFLEKRLKVSGNQHEELQNVRKHIHSCFTNISCFLLPHPGLKVATNPNFDGKLKEIDDEFIKNLKILIPWLLSPESLDIKEINGNKITCRGLVEYFKAYIKIYQGEELPHPKSMLQATAEANNLAAVATAKDTYNKKMEEICGGDKPFLAPNDLQTKHLQLKEESVKLFRGVKKMGGEEFSRRYLQQLESEIDELYIQYIKHNDSKNIFHAART","Homo sapiens","ATL1, GBP3, SPG3A","Atlastin-1","1","3QOF"
"3QOR",,"X-RAY DIFFRACTION",2.35,47.55,"VAPOR DIFFUSION, HANGING DROP",4.5,"25% PEG 3350, 0.2M sodium acetate, 0.1M lithium sulfate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1016/j.jmb.2011.04.018",,"3QOR",68.52,"1.753","1.753","Crystal structure of human nuclear migration protein NudC","GSSSKLKPNLGNGADLPNYRWTQTLSELDLAVPFCVNFRLKGKDMVVDIQRRHLRVGLKGQPAIIDGELYNEVKVEESSWLIADGAVVTVHLEKINKMEWWSRLVSSDPEINTKKINPENS","Homo sapiens","NUDC","Nuclear migration protein nudC","1","3QOR"
,,,,,,,,,,,,,,,,"GSSSKLKPNLGNGADLPNYRWTQTLSELDLAVPFCVNFRLKGKDMVVDIQRRHLRVGLKGQPAIIDGELYNEVKVEESSWLIADGAVVTVHLEKINKMEWWSRLVSSDPEINTKKINPENS","Homo sapiens","NUDC","Nuclear migration protein nudC","2","3QOR"
,,,,,,,,,,,,,,,,"GSSSKLKPNLGNGADLPNYRWTQTLSELDLAVPFCVNFRLKGKDMVVDIQRRHLRVGLKGQPAIIDGELYNEVKVEESSWLIADGAVVTVHLEKINKMEWWSRLVSSDPEINTKKINPENS","Homo sapiens","NUDC","Nuclear migration protein nudC","3","3QOR"
,,,,,,,,,,,,,,,,"GSSSKLKPNLGNGADLPNYRWTQTLSELDLAVPFCVNFRLKGKDMVVDIQRRHLRVGLKGQPAIIDGELYNEVKVEESSWLIADGAVVTVHLEKINKMEWWSRLVSSDPEINTKKINPENS","Homo sapiens","NUDC","Nuclear migration protein nudC","4","3QOR"
"3QOW",,"X-RAY DIFFRACTION",3.57,65.54,"VAPOR DIFFUSION, HANGING DROP",5.2,"2 M Ammonium Sulfate, 0.1 M Sodium Acetate, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1111/j.1747-0285.2011.01135.x",,"3QOW",49.29,"2.1","2.1","DOT1L Structure in complex with SAM","MHHHHHHSSGMGEKLELRLKSPVGAEPAVYPWPLPVYDKHHDAAHEIIETIRWVCEEIPDLKLAMENYVLIDYDTKSFESMQRLCDKYNRAIDSIHQLWKGTTQPMKLNTRPSTGLLRHILQQVYNHSVTDPEKLNNYEPFSPEVYGETSFDLVAQMIDEIKMTDDDLFVDLGSGVGQVVLQVAAATNCKHHYGVEKADIPAKYAETMDREFRKWMKWYGKKHAEYTLERGDFLSEEWRERIANTSVIFVNNFAFGPEVDHQLKERFANMKEGGRIVSSKPFAPLNFRINSRNLSDIGTIMRVVELSPLKGSVSWTGKPVSYYLHTIDRTILENYFSSLKNPKLREEQEAARRRQQRESKSNAATPTKGPEGKVAGPADAPMDSGAEEEKAGAATVKKPSPSKARKKKLNKKGRKMAGRKRGRPKK","Homo sapiens","DOT1L, KIAA1814, KMT4","Histone-lysine N-methyltransferase","1","3QOW"
"3QOX",,"X-RAY DIFFRACTION",3.55,65.32,"VAPOR DIFFUSION, HANGING DROP",5.3,"2 M Ammonium Sulfate, 2 mM TCEP, 0.1 M Sodium Acetate, pH 5.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1111/j.1747-0285.2011.01135.x","SAH","3QOX",49.47,"2.3","2.3","DOT1L structure in complex with SAH","MHHHHHHSSGMGEKLELRLKSPVGAEPAVYPWPLPVYDKHHDAAHEIIETIRWVCEEIPDLKLAMENYVLIDYDTKSFESMQRLCDKYNRAIDSIHQLWKGTTQPMKLNTRPSTGLLRHILQQVYNHSVTDPEKLNNYEPFSPEVYGETSFDLVAQMIDEIKMTDDDLFVDLGSGVGQVVLQVAAATNCKHHYGVEKADIPAKYAETMDREFRKWMKWYGKKHAEYTLERGDFLSEEWRERIANTSVIFVNNFAFGPEVDHQLKERFANMKEGGRIVSSKPFAPLNFRINSRNLSDIGTIMRVVELSPLKGSVSWTGKPVSYYLHTIDRTILENYFSSLKNPKLREEQEAARRRQQRESKSNAATPTKGPEGKVAGPADAPMDSGAEEEKAGAATVKKPSPSKARKKKLNKKGRKMAGRKRGRPKK","Homo sapiens","DOT1L, KIAA1814, KMT4","Histone-lysine N-methyltransferase","1","3QOX"
"3QP3",,"X-RAY DIFFRACTION",2.2,44,"VAPOR DIFFUSION, HANGING DROP",4,"0.2M Na-citrate pH 4.0, 1.2M (NH4)2SO4, 0.3M MgSO4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3QP3",35.32,"1.997","1.997","Crystal structure of titin domain M4, tetragonal form","GPFTLDHAPRITLRMRSHRVPCGQNTRFILNVQSKPTAEVKWYHNGVELQESSKIHYTNTSGVLTLEILDCHTDDSGTYRAVCTNYKGEASDYATLDVTGGDY","Homo sapiens","TTN","Titin","1","3QP3"
"3QPU",,"X-RAY DIFFRACTION",3.31,62.83,"VAPOR DIFFUSION, SITTING DROP",7.5,"100 mM Tris-HCl,20-25% ethylene glycol, 200-400mM Tartaric Acid, 5% glycerol, and 12% polyethylene glycol 4000, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1002/prot.24015",,"3QPU",60.65,"2.3","2.3","PFKFB3 in complex with PPi","MPLELTQSRVQKIWVPVDHRPSLPRSCGPKLTNSPTVIVMVGLPARGKTYISKKLTRYLNWIGVPTKVFNVGEYRREAVKQYSSYNFFRPDNEEAMKVRKQCALAALRDVKSYLAKEGGQIAVFDATNTTRERRHMILHFAKENDFKAFFIESVCDDPTVVASNIMEVKISSPDYKDCNSAEAMDDFMKRISCYEASYQPLDPDKCDRDLSLIKVIDVGRRFLVNRVQDHIQSRIVYYLMNIHVQPRTIYLCRHGENEHNLQGRIGGDSGLSSRGKKFASALSKFVEEQNLKDLRVWTSQLKSTIQTAEALRLPYEQWKALNEIDAGVCEELTYEEIRDTYPEEYALREQDKYYYRYPTGESYQDLVQRLEPVIMELERQENVLVICHQAVLRCLLAYFLDKSAEEMPYLKCPLHTVLKLTPVAYGCRVESIYLNVESVCTHRERSEDAKKGPNPLMRRNSVTPLASPEPTKKPRINSFEEHVASTSAALPSCLPPEVPTQLPGQNMKGSRSSADSSRKH","Homo sapiens","PFKFB3","6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3","1","3QPU"
"3QPV",,"X-RAY DIFFRACTION",3.27,62.42,"VAPOR DIFFUSION, SITTING DROP",7.5,"100 mM Tris-HCl,20-25% ethylene glycol, 200-400mM Tartaric Acid, 5% glycerol, and 12% polyethylene glycol 4000, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1002/prot.24015",,"3QPV",60.8,"2.5","2.5","PFKFB3 trapped in a phospho-enzyme intermediate state","MPLELTQSRVQKIWVPVDHRPSLPRSCGPKLTNSPTVIVMVGLPARGKTYISKKLTRYLNWIGVPTKVFNVGEYRREAVKQYSSYNFFRPDNEEAMKVRKQCALAALRDVKSYLAKEGGQIAVFDATNTTRERRHMILHFAKENDFKAFFIESVCDDPTVVASNIMEVKISSPDYKDCNSAEAMDDFMKRISCYEASYQPLDPDKCDRDLSLIKVIDVGRRFLVNRVQDHIQSRIVYYLMNIHVQPRTIYLCRHGENEHNLQGRIGGDSGLSSRGKKFASALSKFVEEQNLKDLRVWTSQLKSTIQTAEALRLPYEQWKALNEIDAGVCEELTYEEIRDTYPEEYALREQDKYYYRYPTGESYQDLVQRLEPVIMELERQENVLVICHQAVLRCLLAYFLDKSAEEMPYLKCPLHTVLKLTPVAYGCRVESIYLNVESVCTHRERSEDAKKGPNPLMRRNSVTPLASPEPTKKPRINSFEEHVASTSAALPSCLPPEVPTQLPGQNMKGSRSSADSSRKH","Homo sapiens","PFKFB3","6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3","1","3QPV"
"3QPW",,"X-RAY DIFFRACTION",3.28,62.48,"VAPOR DIFFUSION, SITTING DROP",7.5,"00 mM Tris-HCl, pH 7.5, 20-25% ethylene glycol, 200-400mM Tartaric Acid, 5% glycerol,12% polyethylene glycol 4000, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1002/prot.24015",,"3QPW",60.43,"2.25","2.25","PFKFB3 in complex with Aluminum Tetrafluoride","MPLELTQSRVQKIWVPVDHRPSLPRSCGPKLTNSPTVIVMVGLPARGKTYISKKLTRYLNWIGVPTKVFNVGEYRREAVKQYSSYNFFRPDNEEAMKVRKQCALAALRDVKSYLAKEGGQIAVFDATNTTRERRHMILHFAKENDFKAFFIESVCDDPTVVASNIMEVKISSPDYKDCNSAEAMDDFMKRISCYEASYQPLDPDKCDRDLSLIKVIDVGRRFLVNRVQDHIQSRIVYYLMNIHVQPRTIYLCRHGENEHNLQGRIGGDSGLSSRGKKFASALSKFVEEQNLKDLRVWTSQLKSTIQTAEALRLPYEQWKALNEIDAGVCEELTYEEIRDTYPEEYALREQDKYYYRYPTGESYQDLVQRLEPVIMELERQENVLVICHQAVLRCLLAYFLDKSAEEMPYLKCPLHTVLKLTPVAYGCRVESIYLNVESVCTHRERSEDAKKGPNPLMRRNSVTPLASPEPTKKPRINSFEEHVASTSAALPSCLPPEVPTQLPGQNMKGSRSSADSSRKH","Homo sapiens","PFKFB3","6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3","1","3QPW"
"3QQ7",,"X-RAY DIFFRACTION",3.2,61.55,"VAPOR DIFFUSION, HANGING DROP",4.5,"1 M Hexanediol, 0.1 M Na-acetate, 0.01 M CoCl2, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2011.03.018",,"3QQ7",21.21,"2.65","2.65","Crystal Structure of the p97 N-terminal domain","ASGADSKGDDLSTAILKQKNRPNRLIVDEAINEDNSVVSLSQPKMDELQLFRGDTVLLKGKKRREAVCIVLSDDTCSDEKIRMNRVVRNNLRVRLGDVISIQPCPDVKYGKRIHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIRKGDIFLVRGGMRAVEFKVVETDPSPYCIVAPDTVIHCEGE","Homo sapiens","VCP","Transitional endoplasmic reticulum ATPase","1","3QQ7"
"3QQD",,"X-RAY DIFFRACTION",1.94,36.61,"VAPOR DIFFUSION, HANGING DROP",8,"2.3 M AMMONIUM SULFATE, 0.1 M TRIS, TEMPERATURE 298K, pH 8.0, VAPOR DIFFUSION, HANGING DROP",,"10.1021/bi100314n",,"3QQD",32.13,"1.653","1.653","Human SOD1 H80R variant, P212121 crystal form","XATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERRVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","3QQD"
,,,,,,,,,,,,,,,,"XATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERRVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","2","3QQD"
"3QQF",,"X-RAY DIFFRACTION",2,38.46,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3QQF",35.1,"1.75","1.75","CDK2 in complex with inhibitor L1","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QQF"
"3QQG",,"X-RAY DIFFRACTION",2,38.39,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3QQG",35.16,"1.9","1.9","CDK2 in complex with inhibitor L2-5","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QQG"
"3QQH",,"X-RAY DIFFRACTION",1.91,35.63,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate , pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3QQH",35.42,"1.87","1.87","CDK2 in complex with inhibitor L2-2","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QQH"
"3QQJ",,"X-RAY DIFFRACTION",1.99,38.12,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3QQJ",35.12,"1.7","1.7","CDK2 in complex with inhibitor L2","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QQJ"
"3QQK",,"X-RAY DIFFRACTION",2.01,38.94,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","X02","3QQK",35.33,"1.86","1.86","CDK2 in complex with inhibitor L4","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QQK"
"3QQL",,"X-RAY DIFFRACTION",1.97,37.58,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3QQL",35.01,"1.85","1.85","CDK2 in complex with inhibitor L3","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QQL"
"3QQN",,"X-RAY DIFFRACTION",2.36,47.9,"VAPOR DIFFUSION, SITTING DROP",7,"0.2M Ammonium Sulfate, 20% PEG 3350, 0.1M spermidine tetrachloride, pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.jmb.2011.04.060",,"3QQN",30.94,"2.309","2.309","The retinal specific CD147 Ig0 domain: from molecular structure to biological activity","MGSSHHHHHHSSGLVPRGSHMAGFVQAPLSQQRWVGGSVELHCEAVGSPVPEIQWWFEGQGPNDIMSQLWDGARLDRVHIHATYHQHAASTISIDTLVEEDTGTYECRASNDPDRNHLTRAPRVKWVRAQAVVLVLE","Homo sapiens","BSG, UNQ6505/PRO21383","Basigin","1","3QQN"
"3QQP",,"X-RAY DIFFRACTION",2.54,51.54,"VAPOR DIFFUSION",6.5,"40% PEG300, 0.1M MES, pH 6.5, vapor diffusion, temperature 277K",277,"10.1016/j.bmcl.2011.02.111","S05","3QQP",131.57,"2.72","2.72","Crystal Structure of 11beta-Hydroxysteroid Dehydrogenase 1 (11b-HSD1) in Complex with Urea Inhibitor","MKHQHQHQHQHQHQQPLNEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPMVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSLWTTLLIRNPSRKILEFLYSTSYNMDRFINK","Homo sapiens","HSD11, HSD11B1, HSD11L, SDR26C1","Corticosteroid 11-beta-dehydrogenase isozyme 1","1","3QQP"
"3QQU",,"X-RAY DIFFRACTION",3.7,66.79,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2M Mg Acetate, 15%-17.5% PEG8K, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2011.02.075","01P","3QQU",139.11,"2.9","2.9","Cocrystal structure of unphosphorylated igf with pyrimidine 8","GSVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENK","Homo sapiens","IGF1R","Insulin-like growth factor 1 receptor","1","3QQU"
"3QR2",,"X-RAY DIFFRACTION",2.44,49.64,"VAPOR DIFFUSION, SITTING DROP",7,"0.2 Na2SO4, 20% w/v PEG sulfate, pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.jmb.2011.04.060",,"3QR2",30.6,"2.3","2.3","Wild type CD147 Ig0 domain","MGSSHHHHHHSSGLVPRGSHMAGFVQAPLSQQRWVGGSVELHCEAVGSPVPEIQWWFEGQGPNDICSQLWDGARLDRVHIHATYHQHAASTISIDTLVEEDTGTYECRASNDPDRNHLTRAPRVKWVRAQAVVLVLE","Homo sapiens","BSG, UNQ6505/PRO21383","Basigin","1","3QR2"
"3QR6",,"X-RAY DIFFRACTION",2.22,44.65,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris, 30% (v/v) PEG 550 monomethyl ether, 0.05 M calcium chloride, 2.5 mM DTT, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi201541w",,"3QR6",26.96,"1.78","1.78","Crystal Structure Analysis of H185F Mutant of Human CLIC1","MAEEQPQVELFVKAGSDGAKIGNCPFSQRLFMVLWLKGVTFNVTTVDTKRRTETVQKLCPGGQLPFLLYGTEVHTDTNKIEEFLEAVLCPPRYPKLAALNPESNTAGLDIFAKFSAYIKNSNPALNDNLEKGLLKALKVLDNYLTSPLPEEVDETSAEDEGVSQRKFLDGNELTLADCNLLPKLFIVQVVCKKYRGFTIPEAFRGVHRYLSNAYAREEFASTCPDDEEIELAYEQVAKALK","Homo sapiens","CLIC1, G6, NCC27","Chloride intracellular channel protein 1","1","3QR6"
"3QRD",,"X-RAY DIFFRACTION",2.7,54.49,"VAPOR DIFFUSION, HANGING DROP",8,"0.18M tri-Sodium citrate, 0.1M TrisHCl pH 8.0, 30% PEG, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3QRD",54.04,"2.19","2.19","Crystal structure of L68V mutant of human cystatin C","SSPGKPPRLVGGPMDASVEEEGVRRALDFAVGEYNKASNDMYHSRALQVVRARKQIVAGVNYFLDVEVGRTTCTKTQPNLDNCPFHDQPHLKRKAFCSFQIYAVPWQGTMTLSKSTCQDA","Homo sapiens","CST3","Cystatin-C","1","3QRD"
"3QRI",,"X-RAY DIFFRACTION",2.11,41.63,"VAPOR DIFFUSION, SITTING DROP",8.2,"32% PEG 3000, 100MM TRIS PH 8.2, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 290K",290,"10.1016/j.ccr.2011.03.003","919","3QRI",65.37,"2.1","2.1","The crystal structure of human abl1 kinase domain in complex with DCC-2036","TSMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE","Homo sapiens","ABL1, ABL, JTK7","Tyrosine-protein kinase ABL1","1","3QRI"
"3QRJ",,"X-RAY DIFFRACTION",1.84,33.06,"VAPOR DIFFUSION, SITTING DROP",7.1,"29% PEG 3350, 100MM BISTRIS PH 7.1, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 290K",290,"10.1016/j.ccr.2011.03.003","919","3QRJ",65.35,"1.82","1.82","The crystal structure of human abl1 kinase domain T315I mutant in complex with DCC-2036","TSMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE","Homo sapiens","ABL1, ABL, JTK7","Tyrosine-protein kinase ABL1","1","3QRJ"
"3QRK",,"X-RAY DIFFRACTION",2.15,42.66,"VAPOR DIFFUSION, SITTING DROP",8.2,"32% PEG 3000, 100MM TRIS PH 8.2, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 290K",290,"10.1016/j.ccr.2011.03.003","9DP","3QRK",32.61,"2.3","2.3","The crystal structure of human abl1 kinase domain in complex with DP-987","TSMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE","Homo sapiens","ABL1, ABL, JTK7","Tyrosine-protein kinase ABL1","1","3QRK"
"3QRT",,"X-RAY DIFFRACTION",2.01,38.85,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3QRT",35.29,"1.75","1.75","CDK2 in complex with inhibitor NSK-MC2-55","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QRT"
"3QRU",,"X-RAY DIFFRACTION",1.98,37.92,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3QRU",35.07,"1.95","1.95","CDK2 in complex with inhibitor NSK-MC1-12","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QRU"
"3QTE",,"X-RAY DIFFRACTION",1.88,34.47,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M imidazole, pH 6.5, 1M Na acetate trihydrate, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1126/science.1218831",,"3QTE",15.23,"1.949","1.949","Crystal structure of human alpha-defensin 6 (H27W mutant)","AFTCHCRRSCYSTEYSYGTCTVMGINWRFCCL","Homo sapiens","DEFA6, DEF6","Defensin-6","1","3QTE"
"3QTF",,"X-RAY DIFFRACTION",2.95,58.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"18.4% PEG3350, 0.2M MAGNESIUM NITRATE, PROTEIN @ 13.5 MG/ML, TEMPERATURE 277K; FROZEN BY 1-STEP TRANSFER TO 25% GLYCEROL, 14% PEG3350, 0.15M MAGNESIUM NITRATE, pH 7.5, VAPOR DIFFUSION, HANGING DROP",277,"10.1016/j.bmcl.2011.02.101","05S","3QTF",25.9,"1.5703","1.5703","Design and SAR of macrocyclic Hsp90 inhibitors with increased metabolic stability and potent cell-proliferation activity","QPMEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90A, HSP90AA1, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3QTF"
"3QTI",,"X-RAY DIFFRACTION",2.18,43.6,"VAPOR DIFFUSION, HANGING DROP",7.5,"Equal Volumes Protein and a Reservoir Solution composed of 100 mM Hepes pH 7.5, 16% PEG 4000, 8% isopropanol, and 3 mM TCEP were mixed with microseeds., VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1158/0008-5472.CAN-10-4433","3QT","3QTI",71.65,"2","2","c-Met Kinase in Complex with NVP-BVU972","GPGTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVK","Homo sapiens","MET","Hepatocyte growth factor receptor","1","3QTI"
"3QTK",,"X-RAY DIFFRACTION",2.55,51.8,"VAPOR DIFFUSION, HANGING DROP",5.5,"45% v/v MPD, 0.2 M ammonium acetate, 0.1 M Bis-Tris, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1002/anie.201103237",,"3QTK",73.22,"1.849","1.849","The crystal structure of chemically synthesized VEGF-A","GQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKD","Homo sapiens","VEGFA, VEGF","Vascular endothelial growth factor A","1","3QTK"
"3QTQ",,"X-RAY DIFFRACTION",1.98,37.76,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","X35","3QTQ",35.08,"1.8","1.8","CDK2 in complex with inhibitor RC-1-137","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QTQ"
"3QTR",,"X-RAY DIFFRACTION",2,38.56,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","X36","3QTR",35.06,"1.85","1.85","CDK2 in complex with inhibitor RC-1-148","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QTR"
"3QTS",,"X-RAY DIFFRACTION",2,38.48,,7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","X46","3QTS",35.09,"1.9","1.9","CDK2 in complex with inhibitor RC-2-12","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QTS"
"3QTU",,"X-RAY DIFFRACTION",2.03,39.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","X44","3QTU",35.21,"1.82","1.82","CDK2 in complex with inhibitor RC-2-132","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QTU"
"3QTW",,"X-RAY DIFFRACTION",2.01,38.9,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","X3A","3QTW",35.43,"1.85","1.85","CDK2 in complex with inhibitor RC-2-13","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QTW"
"3QTX",,"X-RAY DIFFRACTION",2.01,38.77,,7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","X43","3QTX",35.18,"1.95","1.95","CDK2 in complex with inhibitor RC-2-35","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QTX"
"3QTZ",,"X-RAY DIFFRACTION",1.98,37.88,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","X42","3QTZ",35.28,"2","2","CDK2 in complex with inhibitor RC-2-36","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QTZ"
"3QU0",,"X-RAY DIFFRACTION",1.99,38.24,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","X40","3QU0",35.39,"1.95","1.95","CDK2 in complex with inhibitor RC-2-38","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QU0"
"3QU6",,"X-RAY DIFFRACTION",2.38,48.35,"VAPOR DIFFUSION, HANGING DROP",6,"6% PEG 1K, 100 mM NaAc, 300 mM ZnCl2, 8% cadaverine, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1093/nar/gkr325",,"3QU6",41.15,"2.3","2.3","Crystal structure of IRF-3 DBD free form","GSHMGTPKPRILPWLVSQLDLGQLEGVAWVNKSRTRFRIPWKHGLRQDAQQEDFGIFQAWAEATGAYVPGRDKPDLPTWKRNFRSAMNRKEGLRLAEDRSKDPHDPHKIYEFVNSG","Homo sapiens","IRF3","IRF3 protein","1","3QU6"
"3QU8",,"X-RAY DIFFRACTION",2.74,55.06,,7,"0.15 M DL-Malic Acid, 20 % w/v PEG 3350, pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1124/mol.111.074427",,"3QU8",336.6,"2.8","2.8","Crystal structure of a human cytochrome P450 2B6 (Y226H/K262R) in complex with the inhibitor 4-(4-Nitrobenzyl)pyridine.","MAKKTSSKGKLPPGPRPLPLLGNLLQMDRRGLLKSFLRFREKYGDVFTVHLGPRPVVMLCGVEAIREALVDKAEAFSGRGKIAMVDPFFRGYGVIFANGNRWKVLRRFSVTTMRDFGMGKRSVEERIQEEAQCLIEELRKSKGALMDPTFLFQSITANIICSIVFGKRFHYQDQEFLKMLNLFYQTFSLISSVFGQLFELFSGFLKHFPGAHRQVYKNLQEINAYIGHSVEKHRETLDPSAPRDLIDTYLLHMEKEKSNAHSEFSHQNLNLNTLSLFFAGTETTSTTLRYGFLLMLKYPHVAERVYREIEQVIGPHRPPELHDRAKMPYTEAVIYEIQRFSDLLPMGVPHIVTQHTSFRGYIIPKDTEVFLILSTALHDPHYFEKPDAFNPDHFLDANGALKKTEAFIPFSLGKRICLGEGIARAELFLFFTTILQNFSMASPVAPEDIDLTPQECGVGKIPPTYQIRFLPRHHHH","Homo sapiens","CYP2B6","Cytochrome P450 2B6","1","3QU8"
"3QUD",,"X-RAY DIFFRACTION",2.36,47.93,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, 20-30% PEG 4000, 50mM n-BOG, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,"N3F","3QUD",42.14,"2","2","Human p38 MAP Kinase in Complex with 2-amino-phenylamino-benzophenone","GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","3QUD"
"3QUE",,"X-RAY DIFFRACTION",2.27,45.86,"VAPOR DIFFUSION, HANGING DROP",6,"100mM MES, 20-30% PEG 4000, 50mM n-BOG, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nchembio.761","3FF","3QUE",42.28,"2.7","2.7","Human p38 MAP Kinase in Complex with Skepinone-L","GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","3QUE"
"3QVB",,"X-RAY DIFFRACTION",2.4,48.66,"VAPOR DIFFUSION, SITTING DROP",8.5,"25% PEG 3350, 0.2M Ammonium sulfate, 0.1M Tris, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1073/pnas.1113921108",,"3QVB",30.37,"2.26","2.26","Crystal Structure of Human Glycogenin-1 (GYG1) complexed with manganese and UDP","SMTDQAFVTLTTNDAYAKGALVLGSSLKQHRTTRRLVVLATPQVSDSMRKVLETVFDEVIMVDVLDSGDSAHLTLMKRPELGVTLTKLHCWSLTQYSKCVFMDADTLVLANIDDLFDREELSAAPDPGWPDCFNSGVFVYQPSVETYNQLLHLASEQGSFDGGDQGILNTFFSSWATTDIRKHLPFIYNLSSISIFSYLPAFKVFGASAKVVHFLGRVKPWNYTYDPKTKSVKSEAHDPNMTHPEFLILWWNIFTTNVLPLLQ","Homo sapiens","GYG, GYG1","Glycogenin-1","1","3QVB"
"3QVE",,"X-RAY DIFFRACTION",4.09,69.91,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG 3350, 0.3M Ammonium sulfate, 0.1M Bis-Tris, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,,,"3QVE",48.93,"2.04","2.04","Crystal structure of human HMG box-containing protein 1, HBP1","SMSWPSTVWHCFLKGTRLCFHKGSNKEWQDVEDFARAEGCDNEEDLQMGIHKGYGSDGLKLLSHEESVSFGESVLKLTFDPGTVEDGLLTVECKLDHPFYVKNKGWSSFYPSLTVVQHGIPCCEVHIGDVCLPPGHPDA","Homo sapiens","HBP1","HMG box-containing protein 1","1","3QVE"
"3QVU",,"X-RAY DIFFRACTION",2.15,42.66,"VAPOR DIFFUSION, HANGING DROP",8,"The protein was concentrated to 33mg.mL-1. Condition: 18-22% (w/v) PEG 3350 and 50mM Tris-HCL buffer pH 8. Crystals appeared after two days at 293 K. 
, VAPOR DIFFUSION, HANGING DROP",293,"10.1016/j.jmb.2011.06.037","NPO","3QVU",69.69,"2.5","2.5","Crystal structure of Ancestral variant b9 of SULT 1A1 in complex with PAP and p-nitrophenol","MELIQDTSRQPLEYVKGVPLIKYFAEALGPLQSFQARPDDLLISTYPKSGTTWVSQILDMIYQGGDLEKCHRAPIFNRVPFLEFKAPGIPSGMETLKDTPAPRLLKTHLPLALLPQTLLDQKVKVVYVARNAKDVAVSYYHFYHMAKVHPDPGTWDSFLEKFMVGEVCYGSWYQHVQEWWELSRTHPVLYLFYEDMKENPKREIQKILEFVGHSLPEETVDFMVQHTSFKEMKKNPMTNYTTIPQEIMDHSISPFMRKGMAGDWKTTFTVAQNERFDADYAEKMAGCSLSFRSEL","Homo sapiens","SULT1A1, STP, STP1, OK/SW-cl.88","Sulfotransferase 1A1","1","3QVU"
"3QVV",,"X-RAY DIFFRACTION",2.3,46.5,"VAPOR DIFFUSION, HANGING DROP",8,"The protein was concentrated to 33mg.mL-1. Condition: 18-22% (w/v) PEG 3350 and 50mM Tris-HCL buffer pH 8. Crystals appeared after two days at 293 K. , VAPOR DIFFUSION, HANGING DROP",293,"10.1016/j.jmb.2011.06.037","3QV","3QVV",69.66,"2.35","2.35","Crystal structure of Ancestral variant b9 of SULT 1A1 in complex with PAP and 3-CyC","MELIQDTSRQPLEYVKGVPLIKYFAEALGPLQSFQARPDDLLISTYPKSGTTWVSQILDMIYQGGDLEKCHRAPIFNRVPFLEFKAPGIPSGMETLKDTPAPRLLKTHLPLALLPQTLLDQKVKVVYVARNAKDVAVSYYHFYHMAKVHPDPGTWDSFLEKFMVGEVCYGSWYQHVQEWWELSRTHPVLYLFYEDMKENPKREIQKILEFVGHSLPEETVDFMVQHTSFKEMKKNPMTNYTTIPQEIMDHSISPFMRKGMAGDWKTTFTVAQNERFDADYAEKMAGCSLSFRSEL","Homo sapiens","SULT1A1, STP, STP1, OK/SW-cl.88","Sulfotransferase 1A1","1","3QVV"
"3QWE",,"X-RAY DIFFRACTION",4,68.6,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG-1500, 0.2M sodium chloride, 0.1M HEPES, 5% ethylene glycol, 3% glucose monohydrate. Crystals were de-hydrated by addition of 5% glycerol to reservoir solution, incubation over-night, pH 7.5, vapor diffusion, sitting drop, temperature 293K, VAPOR DIFFUSION, SITTING DROP",293,,,"3QWE",32.18,"2.4","2.4","Crystal structure of the N-terminal domain of the GEM interacting protein","GGEELDLRLIRTKGGVDAALEYAKTWSRYAKELLAWTEKRASYELEFAKSTMKIAEAGKVSIQQQSHMPLQYIYTLFLEHDLSLGTLAMETVAQQKRDYYQPLAAKRTEIEKWRKEFKEQWMKEQKRMNEAVQALRRAQLQYVQRSEDLRARSQGSPEDSAPQASPGPSKQQERRRRSREEAQAKAQEAEALYQACVREANARQQDLEIAKQRIVSHVRKLVFQGDEVLRRVTLSLFGLRGAQAERGPRAFAALAECCAPFEPGQRYQEFVRALRPEAP","Homo sapiens","GMIP","GEM-interacting protein","1","3QWE"

"3QWJ",,"X-RAY DIFFRACTION",1.97,37.44,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3QWJ",35.15,"1.75","1.75","CDK2 in complex with inhibitor KVR-1-142","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QWJ"
"3QWK",,"X-RAY DIFFRACTION",1.99,38.09,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate , pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3QWK",35.35,"1.85","1.85","CDK2 in complex with inhibitor KVR-1-150","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QWK"
"3QWL",,"X-RAY DIFFRACTION",1.87,34.15,"VAPOR DIFFUSION, SITTING DROP",8.5,"20% PEG-1500, 0.2M magnesium chloride, 0.1M TRIS. 1:10 dispase-1 added in situ., pH 8.5, vapor diffusion, sitting drop, temperature 289K",289,,,"3QWL",34.08,"1.9","1.9","Crystal structure of human TBC1 domain family member 7","GMTEDSQRNFRSVYYEKVGFRGVEEKKSLEILLKDDRLDTEKLCTFSQRFPLPSMYRALVWKVLLGILPPHHESHAKVMMYRKEQYLDVLHALKVVRFVSDATPQAEVYLRMYQLESGKLPRSPSFPLEPDDEVFLAIAKAMEEMVEDSVDCYWITRRFVNQLNTKYRDSLPQLPKAFEQYLNLEDGRLLTHLRMCSAAPKLPYDLWFKRCFAGCLPESSLQRVWDKVVSGSCKILVFVAVEILLTFKIKVMALNSAEKITKFLENIPQDSSDAIVSKAIDLWHKHCGTPVHSS","Homo sapiens","TBC1D7, HSPC239, TBC7","TBC1 domain family member 7","1","3QWL"
,,,,,"VAPOR DIFFUSION, SITTING DROP",7.5,"Selenomethionyl derivative protein. 30% PEG-1500, 0.2M sodium chloride, 0.1M HEPES. 1:10 dispase-1 added in situ., pH 7.5, vapor diffusion, sitting drop, temperature 289K",289
"3QWM",,"X-RAY DIFFRACTION",3.31,62.82,"VAPOR DIFFUSION, SITTING DROP",8.25,"17.5%(w/v) PEG 3350, 0.20M Na nitrate, 10.0%(v/v) ethylene glycol, 0.1M Bis-Tris propane, pH 8.25, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3QWM",16.43,"2.39","2.39","Crystal Structure of GEP100, the plextrin homology domain of IQ motif and SEC7 domain-containing protein 1 isoform a","SMGCVLSLPHRRLVCYCRLFEVPDPNKPQKLGLHQREIFLFNDLLVVTKIFQKKKNSVTYSFRQSFSLYGMQVLLFENQYYPNGIRLTSSVPGADIKVLINFNAPNPQDRKKFTDDLRESIAEVQEMEKHRIESELEKQK","Homo sapiens","IQSEC1, ARFGEP100, BRAG2, KIAA0763","IQ motif and SEC7 domain-containing protein 1","1","3QWM"
"3QWP",,"X-RAY DIFFRACTION",2.21,44.42,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350, 0.2M CaCl2, VAPOR DIFFUSION, SITTING DROP, temperature 297K",297,,,"3QWP",50.57,"1.53","1.53","Crystal structure of SET and MYND domain containing 3; Zinc finger MYND domain-containing protein 1","GMEPLKVEKFATANRGNGLRAVTPLRPGELLFRSDPLAYTVCKGSRGVVCDRCLLGKEKLMRCSQCRVAKYCSAKCQKKAWPDHKRECKCLKSCKPRYPPDSVRLLGRVVFKLMDGAPSESEKLYSFYDLESNINKLTEDRKEGLRQLVMTFQHFMREEIQDASQLPPAFDLFEAFAKVICNSFTICNAEMQEVGVGLYPSISLLNHSCDPNCSIVFNGPHLLLRAVRDIEVGEELTICYLDMLMTSEERRKQLRDQYCFECDCFRCQTQDKDADMLTGDEQVWKEVQESLKKIEELKAHWKWEQVLAMCQAIISSNSERLPDINIYQLKVLDCAMDACINLGLLEEALFYGTRTMEPYRIFFPGSHPVRGVQVMKVGKLQLHQGMFPQAMKNLRLAFDIMRVTHGREHSLIEDLILLLEECDANIRAS","Homo sapiens","SMYD3, ZMYND1, ZNFN3A1","SET and MYND domain-containing protein 3","1","3QWP"
"3QX1",,"X-RAY DIFFRACTION",2.09,41.2,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG 3350, 0.2M Lithium sulfate, 0.1M HEPES pH7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,,,"3QX1",19.85,"1.6","1.6","Crystal structure of FAF1 UBX domain","GSHMEPVSKLRIRTPSGEFLERRFLASNKLQIVFDFVASKGFPWDEYKLLSTFPRRDVTQLDPNKSLLEVKLFPQETLFLEAKE","Homo sapiens","CGI-03, FAF1, UBXD12, UBXN3A","FAS-associated factor 1","1","3QX1"
"3QX2",,"X-RAY DIFFRACTION",2,38.54,,7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3QX2",35.17,"1.75","1.75","CDK2 in complex with inhibitor KVR-1-190","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QX2"
"3QX3",,"X-RAY DIFFRACTION",3.16,61.09,"VAPOR DIFFUSION, HANGING DROP",5.8,"0.1M magnesium acetate, 50mM 2-(N-morpholino)ethanesulfonic acid pH 5.8, 22% 2-methyl-2, 4-pentanediol (MPT), VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1126/science.1204117","EVP","3QX3",197.36,"2.162","2.162","Human topoisomerase IIbeta in complex with DNA and etoposide","MASWSHPQFEKGADDDDKVPDPTSVDSVKYSKIKGIPKLDDANDAGGKHSLECTLILTEGDSAKSLAVSGLGVIGRDRYGVFPLRGKILNVREASHKQIMENAEINNIIKIVGLQYKKSYDDAESLKTLRYGKIMIMTDQDQDGSHIKGLLINFIHHNWPSLLKHGFLEEFITPIVKASKNKQELSFYSIPEFDEWKKHIENQKAWKIKYYKGLGTSTAKEAKEYFADMERHRILFRYAGPEDDAAITLAFSKKKIDDRKEWLTNFMEDRRQRRLHGLPEQFLYGTATKHLTYNDFINKELILFSNSDNERSIPSLVDGFKPGQRKVLFTCFKRNDKREVKVAQLAGSVAEMSAYHHGEQALMMTIVNLAQNFVGSNNINLLQPIGQFGTRLHGGKDAASPRYIFTMLSTLARLLFPAVDDNLLKFLYDDNQRVEPEWYIPIIPMVLINGAEGIGTGWACKLPNYDAREIVNNVRRMLDGLDPHPMLPNYKNFKGTIQELGQNQYAVSGEIFVVDRNTVEITELPVRTWTQVYKEQVLEPMLNGTDKTPALISDYKEYHTDTTVKFVVKMTEEKLAQAEAAGLHKVFKLQTTLTCNSMVLFDHMGCLKKYETVQDILKEFFDLRLSYYGLRKEWLVGMLGAESTKLNNQARFILEKIQGKITIENRSKKDLIQMLVQRGYESDPVKAWKEAQEKAAEEDETQNQHDDSSSDSGTPSGPDFNYILNMSLWSLTKEKVEELIKQRDAKGREVNDLKRKSPSDLWKEDLAAFVEELDKVESQEREDGAPGFSSISAHHHHHHHHHH","Homo sapiens","TOP2B","DNA topoisomerase 2-beta","1","3QX3"
,,,,,,,,,,,,,,,,"AGCCGAGC",,,"DNA (5'-D(P*AP*GP*CP*CP*GP*AP*GP*C)-3')","2","3QX3"
,,,,,,,,,,,,,,,,"TGCAGCTCGGCT",,,"DNA (5'-D(P*TP*GP*CP*AP*GP*CP*TP*CP*GP*GP*CP*T)-3')","3","3QX3"
"3QX4",,"X-RAY DIFFRACTION",1.96,37.16,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3QX4",35.19,"1.92","1.92","CDK2 in complex with inhibitor KVR-1-78","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QX4"
"3QX8",,"X-RAY DIFFRACTION",2.61,52.93,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M imidazole, 0.2 M NaCl, 0.46 M NaH2PO4, 1.84 M K2HPO4, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/embor.2011.48","GTG","3QX8",48.39,"2.3","2.3","Crystal structure of MID domain from hAGO2 in complex with m7GpppG","SNKQFHTGIEIKVWAIACFAPQRQCTEVHLKSFTEQLRKISRDAGMPIQGQPCFCKYAQGADSVEPMFRHLKNTYAGLQLVVVILPGKTPVYAEVKRVGDTVLGMATQCVQMKNVQRTTPQTLSNLCLKINVKLGGVN","Homo sapiens","EIF2C2, AGO2","Protein argonaute-2","1","3QX8"
"3QX9",,"X-RAY DIFFRACTION",2.57,52.2,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M imidazole, 0.2 M NaCl, 0.46 M NaH2PO4, 1.84 M K2HPO4, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/embor.2011.48","ATP","3QX9",47.5,"2","2","Crystal structure of MID domain from hAGO2 in complex with ATP","SNKQFHTGIEIKVWAIACFAPQRQCTEVHLKSFTEQLRKISRDAGMPIQGQPCFCKYAQGADSVEPMFRHLKNTYAGLQLVVVILPGKTPVYAEVKRVGDTVLGMATQCVQMKNVQRTTPQTLSNLCLKINVKLGGVN","Homo sapiens","EIF2C2, AGO2","Protein argonaute-2","1","3QX9"
"3QXL",,"X-RAY DIFFRACTION",2.44,49.58,"VAPOR DIFFUSION, HANGING DROP",6.5,"200 mM KCl, 10 mM MgCl2, 50 mM sodium cacodylate and 8.5% (w/v) PEG 3350, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1007/s13238-011-1036-z",,"3QXL",62.3,"2.237","2.237","Crystal structure of the CDC25 Domain from Ral-specific Guanine-nucleotide Exchange Factor RalGPS1a","GPLGSSDSLEGQSCDYASKSYDAVVFDVLKVTPEEFASQITLMDIPVFKAIQPEELASCGWSKKEKHSLAPNVVAFTRRFNQVSFWVVREILTAQTLKIRAEILSHFVKIAKKLLELNNLHSLMSVVSALQSAPIFRLTKTWALLNRKDKTTFEKLDYLMSKEDNYKRTREYIRSLKMVPSIPYLGIYLLDLIYIDSAYPASGSIMENEQRSNQMNNILRIIADLQVSCSYDHLTTLPHVQKYLKSVRYIEELQKFVEDDNYKLSLRIEPG","Homo sapiens","RALGPS1, KIAA0351, RALGEF2","Ras-specific guanine nucleotide-releasing factor RalGPS1","1","3QXL"
"3QXM",,"X-RAY DIFFRACTION",2.37,48.1,"VAPOR DIFFUSION, HANGING DROP",6.5,"18-22% PEG4000, 2mM Tris, 1mM EDTA, 10mM NaCl, 10mM Sodium L-ascorbate monohydrate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 303K",303,"10.1016/j.jmb.2011.08.043","NDZ","3QXM",59.16,"1.65","1.65","Crystal Structure of Human GluK2 Ligand-Binding Core in Complex with Novel Marine-Derived Toxins, Neodysiherbaine A","SNRSLIVTTILEEPYVLFKKSDKPLYGNDRFEGYCIDLLRELSTILGFTYEIRLVEDGKYGAQDDANGQWNGMVRELIDHKADLAVAPLAITYVREKVIDFSKPFMTLGISILYRKGTPIDSADDLAKQTKIEYGAVEDGATMTFFKKSKISTYDKMWAFMSSRRQSVLVKSNEEGIQRVLTSDYAFLMESTTIEFVTQRNCNLTQIGGLIDSKGYGVGTPMGSPYRDKITIAILQLQEEGKLHMMKEKWWRGNGCPE","Homo sapiens","GRIK2, GLUR6","Glutamate receptor ionotropic, kainate 2","1","3QXM"
,,,,,,,,,,,,,,,,,"Homo sapiens","GRIK2, GLUR6"
"3QXO",,"X-RAY DIFFRACTION",2.01,38.73,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3QXO",35.17,"1.75","1.75","CDK2 in complex with inhibitor KVR-1-84","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QXO"
"3QXP",,"X-RAY DIFFRACTION",2.02,38.98,,7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","X64","3QXP",35.24,"1.75","1.75","CDK2 in complex with inhibitor RC-3-89","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QXP"
"3QXR",,"X-RAY DIFFRACTION",1.98,37.98,"VAPOR DIFFUSION, HANGING DROP",6.5,"MPD, potassium chloride, sodium chloride, sodium cacodylate, potassium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 283K",283,"10.1093/nar/gks023",,"3QXR",14.59,"1.62","1.62","Crystal structure of the brominated CKIT-1 proto-oncogene promoter quadruplex DNA","AGGGAGGGCGCUGGGAGGAGGG","Homo sapiens",,"5'-D(*AP*GP*GP*GP*AP*GP*GP*GP*CP*GP*CP*(BRU)P*GP*GP*GP*AP*GP*GP*AP*GP*GP*G)-3'","1","3QXR"
"3QYB",,"X-RAY DIFFRACTION",4.99,75.35,"VAPOR DIFFUSION",8.5,"5-8% PEG 8K, 0.1 TRIS pH 8.5 and 35% glycerol, VAPOR DIFFUSION, temperature 298KK",298,"10.1074/jbc.M110.217323",,"3QYB",35.16,"3.5","3.5","X-ray Crystal Structure of Human TBC1D4 (AS160) RabGAP domain","GSHMKVKLDYEEVGACQKEVLITWDKKLLNCRAKIRCDMEDIHTLLKEGVPKSRRGEIWQFLALQYRLRHRLPNKQQPPDISYKELLKQLTAQQHAILVDLGRTFPTHPYFSVQLGPGQLSLFNLLKAYSLLDKEVGYCQGISFVAGVLLLHMSEEQAFEMLKFLMYDLGFRKQYRPDMMSLQIQMYQLSRLLHDYHRDLYNHLEENEISPSLYAAPWFLTLFASQFSLGFVARVFDIIFLQGTEVIFKVALSLLSSQETLIMECESFENIVEFLKNTLPDMNTSEMEKIITQVFEMDISK","Homo sapiens","TBC1D4, AS160, KIAA0603","TBC1 domain family member 4","1","3QYB"
"3QYC",,"X-RAY DIFFRACTION",1.98,37.88,"VAPOR DIFFUSION, SITTING DROP",9,"20% PEG 6000, 0.1M Bicine, pH 9.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1371/journal.pone.0030149",,"3QYC",31.48,"1.6","1.6","Structure of a dimeric anti-HER2 single domain antibody","QAQVQLVESGGGLIKPGGSLRLSCAASGVRLSAYDMAWVRQAPGKGLEWVSAISSSGGSTYYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAVYYCVTLPDLCPGDNCTYPDASWGQGTMVTVSSGSEQKLISEEDLNHHHHHH","Homo sapiens",,"VH domain of IgG molecule","1","3QYC"
"3QYE",,"X-RAY DIFFRACTION",3.16,61.1,"VAPOR DIFFUSION",7.5,"2.0-3.2 M ammonium formate, 0.1 HEPES pH 7.5 and 20-25% ethylene glycol, VAPOR DIFFUSION, temperature 298 KK",298,"10.1074/jbc.M110.217323",,"3QYE",76.93,"2.2","2.2","Crystal Structure of Human TBC1D1 RabGAP domain","GSHMASENDLLNKRLKLDYEEITPCLKEVTTVWEKMLSTPGRSKIKFDMEKMHSAVGQGVPRHHRGEIWKFLAEQFHLKHQFPSKQQPKDVPYKELLKQLTSQQHAILIDLGRTFPTHPYFSAQLGAGQLSLYNILKAYSLLDQEVGYCQGLSFVAGILLLHMSEEEAFKMLKFLMFDMGLRKQYRPDMIILQIQMYQLSRLLHDYHRDLYNHLEEHEIGPSLYAAPWFLTMFASQFPLGFVARVFDMIFLQGTEVIFKVALSLLGSHKPLILQHENLETIVDFIKSTLPNLGLVQMEKTINQVFEMDIAKQLQAYEVEYHVLQEELIDSS","Homo sapiens","TBC1D1, KIAA1108","TBC1 domain family member 1","1","3QYE"
"3QYK",,"X-RAY DIFFRACTION",2.09,41.2,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6 M sodium citrate, 50 mM Tris-Cl, drug dissolved in DMSO, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"IE2","3QYK",29.79,"1.469","1.469","Human Carbonic Anhydrase II complexed with triple ring benzene sulfonamide inhibitor","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2, hCAII","Carbonic anhydrase 2","1","3QYK"
"3QYM",,"X-RAY DIFFRACTION",2.83,56.49,"VAPOR DIFFUSION, HANGING DROP",6.8,"10% PEG3350, 0.2 M ammonium formate, 0.1 M Bis-Tris, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.1013657108",,"3QYM",206.34,"3.2","3.2","Structure of p63 DNA Binding Domain in Complex with a 10 Base Pair A/T Rich Response Element Half Site","GSHMASPSNTDYPGPHSFDVSFQQSSTAKSATWTYSTELKKLYCQIAKTCPIQIKVMTPPPQGAVIRAMPVYKKAEHVTEVVKRCPNHELSREFNEGQIAPPSHLIRVEGNSHAQYVEDPITGRQSVLVPYEPPQVGTEFTTVLYNFMCNSSCVGGMNRRPILIIVTLETRDGQVLGRRCFEARICACPGRDRKADEDSIRKQ","Homo sapiens","KET, P63, P73H, P73L, TP63, TP73L","Tumor protein 63","1","3QYM"
,,,,,,,,,,,,,,,,"AAACATGTTT",,,"5'-D(*AP*AP*AP*CP*AP*TP*GP*TP*TP*T)-3'","2","3QYM"
"3QYN",,"X-RAY DIFFRACTION",3.28,62.56,"VAPOR DIFFUSION, HANGING DROP",6.8,"20% PEG3350, 0.2 M ammonium acetate, 0.1 M Bis-Tris, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.1013657108",,"3QYN",104.49,"2.5","2.5","Structure of p63 DNA Binding Domain in Complex with a 22 Base Pair A/T Rich Response Element Containing 2 Base Pair Spacer Between Half Sites","GSHMASPSNTDYPGPHSFDVSFQQSSTAKSATWTYSTELKKLYCQIAKTCPIQIKVMTPPPQGAVIRAMPVYKKAEHVTEVVKRCPNHELSREFNEGQIAPPSHLIRVEGNSHAQYVEDPITGRQSVLVPYEPPQVGTEFTTVLYNFMCNSSCVGGMNRRPILIIVTLETRDGQVLGRRCFEARICACPGRDRKADEDSIRKQ","Homo sapiens","KET, P63, P73H, P73L, TP63, TP73L","Tumor protein 63","1","3QYN"
,,,,,,,,,,,,,,,,"AAACATGTTTTAAAACATGTTT",,,"5'-D(*AP*AP*AP*CP*AP*TP*GP*TP*TP*TP*TP*AP*AP*AP*AP*CP*AP*TP*GP*TP*TP*T)-3'","2","3QYN"
"3QYT",,"X-RAY DIFFRACTION",2.49,50.61,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.01M HEPES, 15% PEG3000, pH 7.4, vapor diffusion, sitting drop, temperature 271K",271,"10.1038/srep00999",,"3QYT",76.05,"2.8","2.8","Diferric bound human serum transferrin","VPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVKKASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVVKKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPCADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRDQYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKEFQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKPVKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGKCGLVPVLAENYNKSDNCEDTPEAGYFAVAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWNIPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAFRCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLARAPNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKLHDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP","Homo sapiens","TF, PRO1400","Serotransferrin","1","3QYT"
"3QYU",,"X-RAY DIFFRACTION",2.1,41.53,"VAPOR DIFFUSION, SITTING DROP",7.3,"30% Peg 4000, pH 7.3, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1107/S0907444911023249",,"3QYU",17.65,"1.54","1.54","Crystal structure of human cyclophilin D at 1.54 A resolution at room temperature","GNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F","1","3QYU"
"3QZ2",,"X-RAY DIFFRACTION",3.93,68.7,"VAPOR DIFFUSION, HANGING DROP",7,"10-13% PEG MME 5000, 100 mM HEPES pH 7.0, 4-14% Tacsimate, 10% dioxane, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.ejmech.2014.04.009",,"3QZ2",229.25,"3.2","3.2","The structure of cysteine-free human insulin degrading enzyme","MHHHHHHAAGIPMNNPAIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFLEHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLSPLFDESAKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVVVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKEGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQELKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDEVIKKWQNADLNGKFKLPTKNEFIPTNFEILPLEKEATPYPALIKDTAMSKLWFKQDDKFFLPKANLNFEFFSPFAYVDPLHSNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEKRFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALDDVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLVRYREVQLPDRGWFVYQQRNEVHNNSGIEIYYQTDMQSTSENMFLELFAQIISEPAFNTLRTKEQLGYIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAESAKYWGEIISQQYNFDRDNTEVAYLKTLTKEDIIKFYKEMLAVDAPRRHKVSVHVLAREMDSNPVVGEFPAQNDINLSQAPALPQPEVIQNMTEFKRGLPLFPLVKPHINFMAAKL","Homo sapiens","IDE","Insulin-degrading enzyme","1","3QZ2"
"3QZF",,"X-RAY DIFFRACTION",1.94,36.7,,7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3QZF",34.98,"2","2","CDK2 in complex with inhibitor JWS-6-52","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QZF"
"3QZG",,"X-RAY DIFFRACTION",2,38.39,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3QZG",35.11,"1.75","1.75","CDK2 in complex with inhibitor JWS-6-76","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QZG"
"3QZH",,"X-RAY DIFFRACTION",2,38.62,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3QZH",35.13,"1.95","1.95","CDK2 in complex with inhibitor KVR-1-124","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QZH"
"3QZI",,"X-RAY DIFFRACTION",2.02,38.97,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3QZI",35.13,"1.75","1.75","CDK2 in complex with inhibitor KVR-1-126","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3QZI"
"3R00",,"X-RAY DIFFRACTION",3.23,61.88,"VAPOR DIFFUSION, SITTING DROP",6.4,"0.1M imidazole, 1-1.4 M sodium acetate anhydrous, pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2011.03.030","UNJ","3R00",34.79,"2.1","2.1","The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKAAALEHHHHHHHH","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase pim-1","1","3R00"
"3R01",,"X-RAY DIFFRACTION",3.24,62.07,"VAPOR DIFFUSION, SITTING DROP",6.4,"0.1M imidazole, 1-1.4 M sodium acetate anhydrous, pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2011.03.030","UNE","3R01",34.89,"2.6","2.6","The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKAAALEHHHHHHHH","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase pim-1","1","3R01"
"3R02",,"X-RAY DIFFRACTION",3.21,61.67,"VAPOR DIFFUSION, SITTING DROP",6.4,"0.1M imidazole, 1-1.4 M sodium acetate anhydrous, pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2011.03.030","UNM","3R02",35.04,"1.95","1.95","The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKAAALEHHHHHHHH","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase pim-1","1","3R02"
"3R04",,"X-RAY DIFFRACTION",3.24,62.01,"VAPOR DIFFUSION, SITTING DROP",6.4,"0.1M imidazole, 1-1.4 M sodium acetate anhydrous, pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2011.03.030","UNQ","3R04",35.04,"1.7","1.7","The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKAAALEHHHHHHHH","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase pim-1","1","3R04"
"3R0N",,"X-RAY DIFFRACTION",2.03,39.51,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M MgCl2.6H20, 0.1M TRIS hydrochloride pH 8.5, 30% PEG 4000, Vapor diffusion, Sitting drop, temperature 298K",298,"10.1073/pnas.1212912109",,"3R0N",14.01,"1.3","1.3","Crystal Structure of the Immunoglobulin variable domain of Nectin-2","MQDVRVQVLPEVRGQLGGTVELPCHLLPPVPGLYISLVTWQRPDAPANHQNVAAFHPKMGPSFPSPKPGSERLSFVSAKQSTGQDTEAELQDATLALHGLTVEDEGNYTCEFATFPKGSVRGMTWLRV","Homo sapiens","HVEB, PRR2, PVRL2, NECTIN2","Poliovirus receptor-related protein 2","1","3R0N"
"3R0T",,"X-RAY DIFFRACTION",1.97,37.63,"VAPOR DIFFUSION, SITTING DROP",8.5,"32% PEG 4000, 0.2M Li2SO4, 0.1M Tris pH 8.5, vapor diffusion, sitting drop, temperature 293K",293,"10.1021/bi2008382","FU9","3R0T",41.73,"1.75","1.75","Crystal structure of human protein kinase CK2 alpha subunit in complex with the inhibitor CX-5279","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSS","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3R0T"
"3R16",,"X-RAY DIFFRACTION",2.12,41.96,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M sodium citrate, tris buffer, pH 7.8, VAPOR DIFFUSION, HANGING DROP",,"10.1016/j.bmc.2011.05.006","5UN","3R16",29.56,"1.6","1.6","Human CAII bound to N-(4-sulfamoylphenyl)-2-(thiophen-2-yl) acetamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3R16"
"3R17",,"X-RAY DIFFRACTION",2.11,41.65,"VAPOR DIFFUSION, HANGING DROP",8,"1.6M Sodium Citrate, tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmc.2011.05.006","5UM","3R17",29.57,"1.7","1.7","hCarbonic anhydrase II bound to N-(2-fluoro.4-sulfamoylphenyl)-2-(thiophen-2-yl) acetamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3R17"
"3R1H",,"X-RAY DIFFRACTION",2.48,50.38,"VAPOR DIFFUSION, HANGING DROP",6,"50 mM sodium cacodylate, pH 6.0, 20 mM calcium acetate, 10 mM strontium acetate, 1mM spermine, 16-20% MPD, crystals in same conditions with 30% MPD were crushed and used as microseeding stocks, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1038/nsmb.2107",,"3R1H",112.29,"3.15","3.15","Crystal structure of the Class I ligase ribozyme-substrate preligation complex, C47U mutant, Ca2+ bound","MAVPETRPNHTIYINNLNEKIKKDELKKSLHAIFSRFGQILDILVSRSLKMRGQAFVIFKEVSSATNALRSMQGFPFYDKPMRIQYAKTDSDIIAKMK","Homo sapiens","SNRPA","U1 small nuclear ribonucleoprotein A","1","3R1H"
,,,,,,,,,,,,,,,,"UCCAGUA",,,"5'-R(*UP*CP*CP*AP*GP*UP*A)-3'","2","3R1H"
,,,,,,,,,,,,,,,,"GGAACACUAUACUACUGGAUAAUCAAAGACAAAUCUGCCCGAAGGGUUUGAGAACAUACCCAUUGCACUCCGGGUAUGCAGAGGUGGCAGCCUCCGGUGGGUUAAAACCCAACGUUCUCAACAAUAGUGA",,,"Class I ligase ribozyme","3","3R1H"
"3R1L",,"X-RAY DIFFRACTION",2.49,50.56,"VAPOR DIFFUSION, HANGING DROP",6,"50 mM sodium cacodylate, pH 6.0, 20 mM calcium chloride, 10 mM strontium chloride, 1 mM spermine, 26% MPD, crystals were crushed and used as microseeding stocks, calcium chloride was replaced with magnesium chloride prior to freezing, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1038/nsmb.2107",,"3R1L",112.37,"3.125","3.125","Crystal structure of the Class I ligase ribozyme-substrate preligation complex, C47U mutant, Mg2+ bound","MAVPETRPNHTIYINNLNEKIKKDELKKSLHAIFSRFGQILDILVSRSLKMRGQAFVIFKEVSSATNALRSMQGFPFYDKPMRIQYAKTDSDIIAKMK","Homo sapiens","SNRPA","U1 small nuclear ribonucleoprotein A","1","3R1L"
,,,,,,,,,,,,,,,,"UCCAGUA",,,"5'-R(*UP*CP*CP*AP*GP*UP*A)-3'","2","3R1L"
,,,,,,,,,,,,,,,,"GGAACACUAUACUACUGGAUAAUCAAAGACAAAUCUGCCCGAAGGGUUUGAGAACAUACCCAUUGCACUCCGGGUAUGCAGAGGUGGCAGCCUCCGGUGGGUUAAAACCCAACGUUCUCAACAAUAGUGA",,,"Class I ligase ribozyme","3","3R1L"
"3R1N",,"X-RAY DIFFRACTION",2.55,51.81,"VAPOR DIFFUSION, HANGING DROP",5,"0.1 M citrate/Bis-tris propane, 12 % PEG3350, 10 mM DTT, 1 mM Compound 5b, pH 5.0, vapor diffusion, hanging drop, temperature 293K",293,"10.1016/j.bmcl.2011.04.018",,"3R1N",36.83,"2.09","2.09","MK3 kinase bound to Compound 5b","EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWDEVKEEMTSALATMRVDYDQV","Homo sapiens","MAPKAPK3","MAP kinase-activated protein kinase 3","1","3R1N"
"3R1Q",,"X-RAY DIFFRACTION",2.01,38.67,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3R1Q",35.16,"1.85","1.85","CDK2 in complex with inhibitor KVR-1-102","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R1Q"
"3R1S",,"X-RAY DIFFRACTION",2,38.57,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3R1S",35.13,"1.8","1.8","CDK2 in complex with inhibitor KVR-1-127","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R1S"
"3R1Y",,"X-RAY DIFFRACTION",2.07,40.64,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3R1Y",35.05,"1.8","1.8","CDK2 in complex with inhibitor KVR-1-134","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R1Y"
"3R21",,"X-RAY DIFFRACTION",2.58,52.29,"VAPOR DIFFUSION, SITTING DROP",9,"10% Peg550 MME, 100mM Tris, 10% ethylene glycol, pH 9, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.bmcl.2011.06.129","D36","3R21",31.82,"2.9","2.9","Design, synthesis, and biological evaluation of pyrazolopyridine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (Part I)","GPLGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS","Homo sapiens","AIK, ARK1, AURA, AURKA, BTAK, STK15, STK6, AIRK1, AYK1, IAK1","Serine/threonine-protein kinase 6","1","3R21"
"3R22",,"X-RAY DIFFRACTION",2.54,51.52,"VAPOR DIFFUSION, SITTING DROP",9,"10% Peg550 MME, 0.1M Tris pH 9, 10% ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.bmcl.2011.06.129","D37","3R22",31.75,"2.9","2.9","Design, synthesis, and biological evaluation of pyrazolopyridine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (Part I)","GPLGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS","Homo sapiens","AURKA, AIK, ARK1, AURA, BTAK, STK15, STK6, AIRK1, AYK1, IAK1","Serine/threonine-protein kinase 6","1","3R22"
"3R27",,"X-RAY DIFFRACTION",1.9,35.35,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES, 25%w/v Polyethylene glycol 3,350, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 287K",287,,,"3R27",22.67,"2.04","2.04","Crystal structure of the first RRM domain of heterogeneous nuclear ribonucleoprotein L (HnRNP L)","MGHHHHHHMENYDDPHKTPASPVVHIRGLIDGVVEADLVEALQEFGPISYVVVMPKKRQALVEFEDVLGACNAVNYAADNQIYIAGHPAFVNYSTSQKIS","Homo sapiens","HNRNPL, HNRPL, P/OKcl.14","Heterogeneous nuclear ribonucleoprotein L","1","3R27"
"3R28",,"X-RAY DIFFRACTION",2.01,38.76,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3R28",35.18,"1.75","1.75","CDK2 in complex with inhibitor KVR-1-140","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R28"
"3R2B",,"X-RAY DIFFRACTION",3.1,60.35,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris, 2.3 M AmSO4, pH 8.5, vapor diffusion, hanging drop, temperature 293K",293,"10.1016/j.bmcl.2011.04.018","05B","3R2B",441.75,"2.9","2.9","MK2 kinase bound to Compound 5b","HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMR","Homo sapiens","MAPKAPK2","MAP kinase-activated protein kinase 2","1","3R2B"
"3R2F",,"X-RAY DIFFRACTION",2.42,49.1,"VAPOR DIFFUSION, HANGING DROP",6.2,"14% PEG8000, 0.2 M ammonium sulfate, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2011.06.109","PB0","3R2F",203.51,"2.53","2.53","Crystal structure of beta-site app-cleaving enzyme 1 (BACE-WT) complex with BMS-693391 AKA (2S)-2-((3R)-3-acetamido-3-isobutyl-2-oxo-1-pyrrolidinyl)-N-((1S,2R)-1-(3,5-difluorobenzyl)-2-hydroxy-2-((2R,4R)-4-propoxy-2-pyrrolidinyl)ethyl)-4-phenylbutanamide","MASMTGGQQMGRGSAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","3R2F"
"3R2P",,"X-RAY DIFFRACTION",2.63,53.16,"VAPOR DIFFUSION, HANGING DROP",6.6,"0.15M potassium bromide, 30% PEG 2000 MME, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M111.260422",,"3R2P",21.66,"2.2045","2.2045","2.2 Angstrom Crystal Structure of C Terminal Truncated Human Apolipoprotein A-I Reveals the Assembly of HDL by Dimerization.","GDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGARQKLHELQEKLSPLGEEMRDRARAHVDALRTHLAPYSDELRQRLAARLEALKEN","Homo sapiens","APOA1","Apolipoprotein A-I","1","3R2P"
"3R2W",,"X-RAY DIFFRACTION",3.75,67.19,"VAPOR DIFFUSION, HANGING DROP",6.5,"MgSO4, 35.8% PEG3350, glycerol, HEPES, pH 6.5, vapor diffusion, hanging drop, temperature 290K",290,"10.1042/BJ20111598",,"3R2W",236.74,"3.6","3.6","Crystal Structure of UDP-glucose Pyrophosphorylase of Homo Sapiens","MGSSHHHHHHSSGLVPRGSHMSRFVQDLSKAMSQDGASQFQEVIRQELELSVKKELEKILTTASSHEFEHTKKDLDGFRKLFHRFLQEKGPSVDWGKIQRPPEDSIQPYEKIKARGLPDNISSVLNKLVVVKLNGGLGTSMGCKGPKSLIGVRNENTFLDLTVQQIEHLNKTYNTDVPLVLMNSFNTDEDTKKILQKYNHCRVKIYTFNQSRYPRINKESLLPVAKDVSYSGENTEAWYPPGHGDIYASFYNSGLLDTFIGEGKEYIFVSNIDNLGATVDLYILNHLMNPPNGKRCEFVMEVTNKTRADVKGGTLTQYEGKLRLVEIAQVPKAHVDEFKSVSKFKIFNTNNLWISLAAVKRLQEQNAIDMEIIVNAKTLDGGLNVIQLETAVGAAIKSFENSLGINVPRSRFLPVKTTSDLLLVMSNLYSLNAGSLTMSEKREFPTVPLVKLGSSFTKVQDYLRRFESIPDMLELDHLTVSGDVTFGKNVSLKGTVIIIANHGDRIDIPPGAVLENKIVSGNLRILDH","Homo sapiens","UGP2, UGP1","UTP--glucose-1-phosphate uridylyltransferase","1","3R2W"
"3R2Y",,"X-RAY DIFFRACTION",4.59,73.18,"VAPOR DIFFUSION, HANGING DROP",5,"1.6 M Sodium Malonate, pH 5.0, vapor diffusion, hanging drop, temperature 293K",293,"10.1016/j.bmcl.2011.04.018","P4O","3R2Y",37.44,"3","3","MK2 kinase bound to Compound 1","FHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMR","Homo sapiens","MAPKAPK2","MAP kinase-activated protein kinase 2","1","3R2Y"
"3R30",,"X-RAY DIFFRACTION",4.59,73.19,"VAPOR DIFFUSION, HANGING DROP",5,"1.8 M Sodium Malonate, pH 5.0, vapor diffusion, hanging drop, temperature 293K",293,"10.1016/j.bmcl.2011.04.018","CD2","3R30",37.25,"3.2","3.2","MK2 kinase bound to Compound 2","FHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMR","Homo sapiens","MAPKAPK2","MAP kinase-activated protein kinase 2","1","3R30"
"3R3G",,"X-RAY DIFFRACTION",2.23,44.78,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES, pH 6.5 and 20% PEG20000, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.bpc.2011.04.003",,"3R3G",33.88,"1.75","1.75","Structure of human thrombin with residues 145-150 of murine thrombin.","EADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Thrombin Light Chain","1","3R3G"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin Heavy Chain","2","3R3G"
"3R3I",,"X-RAY DIFFRACTION",3.78,67.48,"VAPOR DIFFUSION, HANGING DROP",6.5,"magnesium sulfate, PEG3350, glycerol, HEPES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,,,"3R3I",236.74,"3.57","3.57","Crystal Structure of C-terminal truncation of UDP-glucose Pyrophosphorylase of Homo sapiens","MGSSHHHHHHSSGLVPRGSHMSRFVQDLSKAMSQDGASQFQEVIRQELELSVKKELEKILTTASSHEFEHTKKDLDGFRKLFHRFLQEKGPSVDWGKIQRPPEDSIQPYEKIKARGLPDNISSVLNKLVVVKLNGGLGTSMGCKGPKSLIGVRNENTFLDLTVQQIEHLNKTYNTDVPLVLMNSFNTDEDTKKILQKYNHCRVKIYTFNQSRYPRINKESLLPVAKDVSYSGENTEAWYPPGHGDIYASFYNSGLLDTFIGEGKEYIFVSNIDNLGATVDLYILNHLMNPPNGKRCEFVMEVTNKTRADVKGGTLTQYEGKLRLVEIAQVPKAHVDEFKSVSKFKIFNTNNLWISLAAVKRLQEQNAIDMEIIVNAKTLDGGLNVIQLETAVGAAIKSFENSLGINVPRSRFLPVKTTSDLLLVMSNLYSLNAGSLTMSEKREFPTVPLVKLGSSFTKVQDYLRRFESIPDMLELDHLTVSGDVTFGKNVSLKGTVIIIANHGDRIDIPPGAVLENKIVSGNLRILDH","Homo sapiens","UGP2, UGP1","UTP--glucose-1-phosphate uridylyltransferase","1","3R3I"
"3R3M",,"X-RAY DIFFRACTION",3.43,64.15,"VAPOR DIFFUSION, SITTING DROP",8,"0.4 M NaH2PO4/1.6 M K2HPO4, 0.1 M imidazole, 0.2 M NaCl, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.str.2011.03.018",,"3R3M",40.07,"3","3","Crystal structure of the FAF1 UBX domain","MSENAEPVSKLRIRTPSGEFLERRFLASNKLQIVFDFVASKGFPWDEYKLLSTFPRRDVTQLDPNKSLLEVKLFPQETLFLEAKE","Homo sapiens","FAF1, UBXD12, UBXN3A, CGI-03","FAS-associated factor 1","1","3R3M"
"3R43",,"X-RAY DIFFRACTION",2.39,48.6,"VAPOR DIFFUSION, HANGING DROP",,"200 mM sodium acetate, 20% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 275K",275,"10.1371/journal.pone.0043965","ID8","3R43",39.21,"2","2","AKR1C3 complexed with mefenamic acid","MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","3R43"
"3R49",,"X-RAY DIFFRACTION",1.96,37.28,"VAPOR DIFFUSION, HANGING DROP",7.3,"30% PEG4000, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/ncomms12777",,"3R49",18.16,"1.77","1.77","Human cyclophilin D complexed with quinolin-8-amine","MSGNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","3R49"
"3R4G",,"X-RAY DIFFRACTION",2.01,38.91,"VAPOR DIFFUSION, HANGING DROP",7.3,"30% PEG4000, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/ncomms12777",,"3R4G",18.55,"1.05","1.05","Human Cyclophilin D Complexed with a Fragment","MSGNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","3R4G"
"3R4L",,"X-RAY DIFFRACTION",3.4,64,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.025M NACL, 27% TERT-BUTANOL, 0.050M TRIS-HCL, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.3892/ijmm.2011.798",,"3R4L",43.96,"2.7","2.7","Human very long half life Plasminogen Activator Inhibitor type-1","VHHPPSYVAHLASDFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDDKGMAPALRHLYKELMGPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIINDWVKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGCWKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAPYEKEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQADFTSLSDQEPLHVAQALQKVKIEVNESCTVASSSTAVIVSARMAPEEIIMDRPFLFVVRHNPTGTVLFMGQVMEP","Homo sapiens","PAI1, PLANH1, SERPINE1","Plasminogen activator inhibitor 1","1","3R4L"
"3R4M",,"X-RAY DIFFRACTION",2.24,45.03,"VAPOR DIFFUSION, HANGING DROP",5.2,"30 % PEG MME 550, 0.1 M CaCl2, 0.1 M cacodylate, pH 5.2, VAPOR DIFFUSION, HANGING DROP, temperature 286K",286,"10.1021/jm200128m","WOE","3R4M",25.89,"1.7","1.7","Optimization of Potent, Selective, and Orally Bioavailable Pyrrolodinopyrimidine-containing Inhibitors of Heat Shock Protein 90. Identification of Development Candidate 2-amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxamide","DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3R4M"
"3R4N",,"X-RAY DIFFRACTION",2.11,41.68,"VAPOR DIFFUSION, HANGING DROP",4.5,"20 % Ethylene glycol, 0.1 M citrate phosphate, 20 mM TCEP, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 286K",286,"10.1021/jm200128m","FU5","3R4N",51.86,"2","2","Optimization of Potent, Selective, and Orally Bioavailable Pyrrolodinopyrimidine-containing Inhibitors of Heat Shock Protein 90. Identification of Development Candidate 2-amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxamide","MDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKELEHHHHHH","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3R4N"
"3R4O",,"X-RAY DIFFRACTION",2.18,43.61,"VAPOR DIFFUSION, HANGING DROP",4.5,"5 % Ethylene glycol, 0.1 M phosphate-citrate, pH 4.5, 20 mM TCEP, VAPOR DIFFUSION, HANGING DROP, temperature 286K",286,"10.1021/jm200128m","FU3","3R4O",52.17,"2.65","2.65","Optimization of Potent, Selective, and Orally Bioavailable Pyrrolodinopyrimidine-containing Inhibitors of Heat Shock Protein 90. Identification of Development Candidate 2-amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxamide","MDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKELEHHHHHH","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3R4O"
"3R4P",,"X-RAY DIFFRACTION",2.13,42.36,"VAPOR DIFFUSION, HANGING DROP",4.3,"5 % Ethylene glycol, 0.1 M phosphate-citrate, pH 4.3, 20 mM TCEP, VAPOR DIFFUSION, HANGING DROP, temperature 286K",286,"10.1021/jm200128m","FU7","3R4P",52.48,"1.7","1.7","Optimization of potent, selective, and orally bioavailable pyrrolodinopyrimidine-containing inhibitors of heat shock protein 90. identification of development candidate 2-amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxamide","MDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKELEHHHHHH","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3R4P"
"3R54",,"X-RAY DIFFRACTION",2.03,39.27,"VAPOR DIFFUSION, HANGING DROP",7.3,"30% PEG4000, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/ncomms12777",,"3R54",17.97,"1.35","1.35","Human Cyclophilin D Complexed with a Fragment","MSGNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","3R54"
"3R56",,"X-RAY DIFFRACTION",1.99,38.3,"VAPOR DIFFUSION, HANGING DROP",7.3,"30% PEG4000, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/ncomms12777",,"3R56",18.33,"1.4","1.4","Human Cyclophilin D Complexed with a Fragment","MSGNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","3R56"
"3R57",,"X-RAY DIFFRACTION",2.04,39.84,"VAPOR DIFFUSION, HANGING DROP",7.3,"30% PEG4000, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/ncomms12777",,"3R57",18.68,"1.71","1.71","Human Cyclophilin D Complexed with a Fragment","MSGNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","3R57"
"3R58",,"X-RAY DIFFRACTION",2.42,49.13,"VAPOR DIFFUSION, HANGING DROP",,"200 mM sodium acetate, 20 % PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 275K",275,"10.1371/journal.pone.0043965","NPS","3R58",39.2,"2.3","2.3","AKR1C3 complex with naproxen","MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","3R58"
"3R59",,"X-RAY DIFFRACTION",2.04,39.6,"VAPOR DIFFUSION, HANGING DROP",7.3,"30% PEG4000, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/ncomms12777",,"3R59",18.01,"1.1","1.1","Human Cyclophilin D Complexed with a Fragment","MSGNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","3R59"
"3R5J",,"X-RAY DIFFRACTION",2.39,48.55,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M HEPES, 15% PEG 3350, 3mM DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M111.247627",,"3R5J",63.03,"1.77","1.77","Crystal structure of active caspase-2 bound with Ac-ADVAD-CHO","MQVKPCTPEFYQTHFQLAYRLQSRPRGLALVLSNVHFTGEKELEFRSGGDVDHSTLVTLFKLLGYDVHVLCDQTAQEMQEKLQNFAQLPAHRVTDSCIVALLSHGVEGAIYGVDGKLLQLQEVFQLFDNANCPSLQNKPKMFFIQACRGDETDRGVDQQD","Homo sapiens","CASP2, ICH1, NEDD2","Caspase-2 subunit p18","1","3R5J"
,,,,,,,,,,,,,,,,"GKEKLPKMRLPTRSDMICGYACLKGTAAMRNTKRGSWYIEALAQVFSERACDMHVADMLVKVNALIKDREGYAPGTEFHRCKEMSEYCSTLCRHLYLFPGHPPTLEHHHHHH","Homo sapiens","CASP2, ICH1, NEDD2","Caspase-2 subunit p12","2","3R5J"
,,,,,,,,,,,,,,,,"XADVAD",,,"Peptide Inhibitor (ACE)ADVAD-CHO","3","3R5J"
"3R5K",,"X-RAY DIFFRACTION",3.05,59.74,"VAPOR DIFFUSION, HANGING DROP",5,"2.1M Formate, 100mM Citrate, 1.25mM Cystamine, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/pro.673",,"3R5K",71.19,"2.86","2.86","A designed redox-controlled caspase-7","MADDQGCIEEQGVEDSANEDSVDAKPDRSSFVPSLFSKKKKNVTMRSIKTTRDRVPTYQYNMNFEKLGKCIIINNKNFDKVTGMGVRNGTDKDAEALFKCFRSLGFDVIVYNDCSCAKMQDLLKKASEEDHTNAACFACILLSHGEENVIYGKDGVTPIKDLTAHFRGDRCKTLLEKPKLFFIQACRGTELDDGIQADMSGPINDTDANPCYKIPVEADFLFAYSTVPGYYSWRSPGRGSWFVQALSSILEEHGKDLEIMQILTRVNDRVARHFESQSDDPHFHEKKQIPCVVSMLTKELYFSQLEHHHHHH","Homo sapiens","CASP7, MCH3","Caspase-7","1","3R5K"
"3R5N",,"X-RAY DIFFRACTION",2.7,54.48,"VAPOR DIFFUSION, HANGING DROP",7,"4 M sodium formate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1371/journal.pone.0028253","MLO","3R5N",31.85,"2","2","Crystal structure of PPARgammaLBD complexed with the agonist magnolol","LNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3R5N"
"3R62",,"X-RAY DIFFRACTION",2.34,47.51,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M Tris HCl, pH 8.5 and 12% polyethylene glycol 8000 , VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,,,"3R62",29.75,"1.52","1.52","Structure of complement regulator Factor H mutant, T1184R.","EAEFGKCGPPPPIDNGDITSFPLSVYAPASSVEYQCQNLYQLEGNKRITCRNGQWSEPPKCLHPCVISREIMENYNIALRWRAKQKLYSRTGESVEFVCKRGYRLSSRSHTLRTTCWDGKLEYPTCAKR","Homo sapiens","CFH, CFH complement factor H, HF, HF1, HF2","Complement factor H","1","3R62"
"3R6B",,"X-RAY DIFFRACTION",2.54,51.64,"VAPOR DIFFUSION, SITTING DROP",5,"0.9M sodium potassium phosphate, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 293.0K",293,"10.1016/j.pep.2011.07.010",,"3R6B",17.29,"2.4","2.4","Crystal Structure of Thrombospondin-1 TSR Domains 2 and 3","GAMDPEFELQDGGWSHWSPWSSCSVTCGDGVITRIRLCNSPSPQMNGKPCEGEARETKACKKDACPINGGWGPWSPWDICSVTCGGGVQKRSRLCNNPTPQFGGKDCVGDVTENQICNKQDCPLEPYTYRVRFLAKENVTQDAEDNTVSFLQP","Homo sapiens","THBS1, TSP, TSP1","Thrombospondin-1","1","3R6B"
"3R6G",,"X-RAY DIFFRACTION",2.37,48.2,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M HEPES, 15% PEG 3350, 3mM DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M111.247627",,"3R6G",63.08,"2.07","2.07","Crystal structure of active caspase-2 bound with Ac-VDVAD-CHO","MQVKPCTPEFYQTHFQLAYRLQSRPRGLALVLSNVHFTGEKELEFRSGGDVDHSTLVTLFKLLGYDVHVLCDQTAQEMQEKLQNFAQLPAHRVTDSCIVALLSHGVEGAIYGVDGKLLQLQEVFQLFDNANCPSLQNKPKMFFIQACRGDETDRGVDQQD","Homo sapiens","CASP2, ICH1, NEDD2","Caspase-2 subunit p18","1","3R6G"
,,,,,,,,,,,,,,,,"GKEKLPKMRLPTRSDMICGYACLKGTAAMRNTKRGSWYIEALAQVFSERACDMHVADMLVKVNALIKDREGYAPGTEFHRCKEMSEYCSTLCRHLYLFPGHPPTLEHHHHHH","Homo sapiens","CASP2, ICH1, NEDD2","Caspase-2 subunit p12","2","3R6G"
,,,,,,,,,,,,,,,,"XVDVAD",,,"Peptide Inhibitor (ACE)VDVAD-CHO","3","3R6G"
"3R6I",,"X-RAY DIFFRACTION",2.39,48.64,"VAPOR DIFFUSION, HANGING DROP",7.5,"200 mM sodium acetate, 20% PEG 3350, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 275K",275,"10.1371/journal.pone.0043965","JMS","3R6I",39.14,"1.95","1.95","AKR1C3 complex with meclofenamic acid","MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","3R6I"
"3R6L",,"X-RAY DIFFRACTION",2.38,48.32,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M HEPES, 15% PEG 3350, 3mM DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M111.247627",,"3R6L",63.02,"1.9","1.9","Caspase-2 T380A bound with Ac-VDVAD-CHO","MQVKPCTPEFYQTHFQLAYRLQSRPRGLALVLSNVHFTGEKELEFRSGGDVDHSTLVTLFKLLGYDVHVLCDQTAQEMQEKLQNFAQLPAHRVTDSCIVALLSHGVEGAIYGVDGKLLQLQEVFQLFDNANCPSLQNKPKMFFIQACRGDETDRGVDQQD","Homo sapiens","CASP2, ICH1, NEDD2","Caspase-2 subunit p18","1","3R6L"
,,,,,,,,,,,,,,,,"GKEKLPKMRLPTRSDMICGYACLKGTAAMRNAKRGSWYIEALAQVFSERACDMHVADMLVKVNALIKDREGYAPGTEFHRCKEMSEYCSTLCRHLYLFPGHPPTLEHHHHHH","Homo sapiens","CASP2, ICH1, NEDD2","Caspase-2 subunit p12","2","3R6L"
,,,,,,,,,,,,,,,,"XVDVAD",,,"Peptide Inhibitor (ACE)VDVAD-CHO","3","3R6L"
"3R6N",,"X-RAY DIFFRACTION",3.47,64.58,"VAPOR DIFFUSION, HANGING DROP",8.5,"16% PEG 8000, 0.1M Tris-Cl (pH 8.5), 4mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2011.04.046",,"3R6N",107.2,"2.95","2.95","Crystal structure of a rigid four spectrin repeat fragment of the human desmoplakin plakin domain","SGWDEFTKHVTSECLGWMRQQRAEMDMVAWGVDLASVEQHINSHRGIHNSIGDYRWQLDKIKADLREKSAIYQLEEEYENLLKASFERMDHLRQLQNIIQATSREIMWINDCEEEELLYDWSDKNTNIAQKQEAFSIRMSQLEVKEKELNKLKQESDQLVLNQHPASDKIEAYMDTLQTQWSWILQITKCIDVHLKENAAYFQFFEEAQSTEAYLKGLQDSIRKKYPCDKNMPLQHLLEQIKELEKEREKILEYKRQVQNLVNKSKKIVQLKPRNPDYRSNKPIILRALCDYKQDQKIVHKGDECILKDNNERSKWYVTGPGGVDMLVPSVGLIIPPPNPLAVDLSCKIEQYYEAILALWNQLYINMKSLVSWHYCMIDIEKIRAMTIAKLKTMRQEDYMKTIADLELHYQEFIRNSQGSEMFGDDDKRKIQSQFTDAQKHYQTLVIQLP","Homo sapiens","DSP","Desmoplakin","1","3R6N"
"3R6X",,"X-RAY DIFFRACTION",2.01,38.7,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3R6X",35.17,"1.75","1.75","CDK2 in complex with inhibitor KVR-1-158","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R6X"
"3R71",,"X-RAY DIFFRACTION",2.01,38.69,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3R71",35.18,"1.75","1.75","CDK2 in complex with inhibitor KVR-1-162","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R71"
"3R73",,"X-RAY DIFFRACTION",2,38.6,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3R73",35.17,"1.7","1.7","CDK2 in complex with inhibitor KVR-1-164","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R73"
"3R7B",,"X-RAY DIFFRACTION",2.39,48.58,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M HEPES (pH 7.0), 15% PEG 3350, 3mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M111.247627",,"3R7B",62.46,"1.8","1.8","Caspase-2 bound to one copy of Ac-DVAD-CHO","MQVKPCTPEFYQTHFQLAYRLQSRPRGLALVLSNVHFTGEKELEFRSGGDVDHSTLVTLFKLLGYDVHVLCDQTAQEMQEKLQNFAQLPAHRVTDSCIVALLSHGVEGAIYGVDGKLLQLQEVFQLFDNANCPSLQNKPKMFFIQACRGDETDRGVDQQD","Homo sapiens","CASP2, ICH1, NEDD2","Caspase-2 subunit p18","1","3R7B"
,,,,,,,,,,,,,,,,"GKEKLPKMRLPTRSDMICGYACLKGTAAMRNTKRGSWYIEALAQVFSERACDMHVADMLVKVNALIKDREGYAPGTEFHRCKEMSEYCSTLCRHLYLFPGHPPTLEHHHHHH","Homo sapiens","CASP2, ICH1, NEDD2","Caspase-2 subunit p12","2","3R7B"
,,,,,,,,,,,,,,,,"XDVAD",,,"Peptide Inhibitor (ACE)DVAD-CHO","3","3R7B"
"3R7E",,"X-RAY DIFFRACTION",2,38.51,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3R7E",35.1,"1.9","1.9","CDK2 in complex with inhibitor KVR-1-67","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R7E"
"3R7I",,"X-RAY DIFFRACTION",2,38.65,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3R7I",35.14,"1.85","1.85","CDK2 in complex with inhibitor KVR-1-74","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R7I"
"3R7M",,"X-RAY DIFFRACTION",2.4,48.75,"VAPOR DIFFUSION, HANGING DROP",,"200 mM sodium acetate, 20% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 275K",275,"10.1371/journal.pone.0043965",,"3R7M",39.2,"2.1","2.1","AKR1C3 complex with sulindac","MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","3R7M"
"3R7N",,"X-RAY DIFFRACTION",2.38,48.23,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M HEPES, 15% PEG 3350, 3mM DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M111.247627",,"3R7N",62.89,"2.33","2.33","Caspase-2 bound with two copies of Ac-DVAD-CHO","MQVKPCTPEFYQTHFQLAYRLQSRPRGLALVLSNVHFTGEKELEFRSGGDVDHSTLVTLFKLLGYDVHVLCDQTAQEMQEKLQNFAQLPAHRVTDSCIVALLSHGVEGAIYGVDGKLLQLQEVFQLFDNANCPSLQNKPKMFFIQACRGDETDRGVDQQD","Homo sapiens","CASP2, ICH1, NEDD2","Caspase-2 subunit p18","1","3R7N"
,,,,,,,,,,,,,,,,"GKEKLPKMRLPTRSDMICGYACLKGTAAMRNTKRGSWYIEALAQVFSERACDMHVADMLVKVNALIKDREGYAPGTEFHRCKEMSEYCSTLCRHLYLFPGHPPTLEHHHHHH","Homo sapiens","CASP2, ICH1, NEDD2","Caspase-2 subunit p12","2","3R7N"
,,,,,,,,,,,,,,,,"XDVAD",,,"Peptide Inhibitor (ACE)DVAD-CHO","3","3R7N"
"3R7O",,"X-RAY DIFFRACTION",2.19,43.77,"VAPOR DIFFUSION, HANGING DROP",7,"15.6 mg/ml protein mixed in 1:1 ratio with reservoir containing 150 mM malic acid, 20% PEG3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M110.204404","M61","3R7O",35.68,"2.3","2.3","Structure of dually phosphorylated c-MET receptor kinase in complex with an MK-2461 analog","QNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHHHHHHH","Homo sapiens","MET","Hepatocyte growth factor receptor","1","3R7O"
"3R7Q",,"X-RAY DIFFRACTION",2.27,45.9,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG 3350, 0.2M NH4SO4, 0.1M Tris-HCl 8.5, vapor diffusion, hanging drop, temperature 289K",289,"10.1016/j.bmcl.2011.04.124","FAV","3R7Q",111.08,"2.5","2.5","Structure-based design of thienobenzoxepin inhibitors of PI3- kinase","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","3R7Q"
"3R7R",,"X-RAY DIFFRACTION",2.27,45.9,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG 3350, 0.2M NH4SO4, 0.1M Tris-HCl 8.5, vapor diffusion, hanging drop, temperature 289K",289,"10.1016/j.bmcl.2011.04.124","FAZ","3R7R",111.15,"2.9","2.9","Structure-based design of thienobenzoxepin inhibitors of PI3-Kinase","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","3R7R"
"3R7S",,"X-RAY DIFFRACTION",2.77,55.63,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M HEPES, 15% PEG 3350, 3mM DTT, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M111.247627",,"3R7S",62.03,"2.252","2.252","Crystal Structure of Apo Caspase2","MQVKPCTPEFYQTHFQLAYRLQSRPRGLALVLSNVHFTGEKELEFRSGGDVDHSTLVTLFKLLGYDVHVLCDQTAQEMQEKLQNFAQLPAHRVTDSCIVALLSHGVEGAIYGVDGKLLQLQEVFQLFDNANCPSLQNKPKMFFIQACRGDETDRGVDQQD","Homo sapiens","CASP2, ICH1, NEDD2","Caspase-2 subunit p18","1","3R7S"
,,,,,,,,,,,,,,,,"GKEKLPKMRLPTRSDMICGYACLKGTAAMRNTKRGSWYIEALAQVFSERACDMHVADMLVKVNALIKDREGYAPGTEFHRCKEMSEYCSTLCRHLYLFPGHPPTLEHHHHHH","Homo sapiens","CASP2, ICH1, NEDD2","Caspase-2 subunit p12","2","3R7S"
"3R7U",,"X-RAY DIFFRACTION",2.01,38.78,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3R7U",35.12,"1.75","1.75","CDK2 in complex with inhibitor KVR-1-75","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R7U"
"3R7V",,"X-RAY DIFFRACTION",1.97,37.5,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3R7V",35.1,"1.95","1.95","CDK2 in complex with inhibitor KVR-1-9","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R7V"
"3R7X",,"X-RAY DIFFRACTION",2.11,41.78,"HANGING DROP",4.6,"100 mM sodium acetate, 200 mM ammonium acetate, 28% PEG4000, pH 4.6, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2011.04.017","QSN","3R7X",59.21,"2.1","2.1","Crystal Structure Analysis of a Quinazolinedione sulfonamide bound to human GluR2: A Novel Class of Competitive AMPA Receptor Antagonists with Oral Activity","GPNKTVVVTTILESPYVMMKKNHEMLEGNERYEGYCVDLAAEIAKHCGFKYKLTIVGDGKYGARDADTKIWNGMVGELVYGKADIAIAPLTITLVREEVIDFSKPFMSLGISIMIKKGTPIESAEDLSKQTEIAYGTLDSGSTKEFFRRSKIAVFDKMWTYMRSAEPSVFVRTTAEGVARVRKSKGKYAYLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGIATPKGSSLRNAVNLAVLKLNEQGLLDKLKNKWWYDKGECGS","Homo sapiens","GRIA2","Glutamate receptor 2","1","3R7X"
,,,,,,,,,,,,,,,,,"Homo sapiens","GRIA2"
"3R7Y",,"X-RAY DIFFRACTION",2.01,38.77,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3R7Y",35.2,"1.9","1.9","CDK2 in complex with inhibitor KVR-2-88","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R7Y"
"3R83",,"X-RAY DIFFRACTION",2.09,41.03,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3R83",35.21,"1.75","1.75","CDK2 in complex with inhibitor KVR-2-92","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R83"
"3R8A",,"X-RAY DIFFRACTION",2.58,52.28,"VAPOR DIFFUSION, HANGING DROP",8,"Apo crystals grown from Citrate/Imidazole, then soaked with 0.5 mM compound 2a, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm200409s","HIG","3R8A",65.53,"2.41","2.41","X-ray crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a compound with dual PPAR gamma agonism and Angiotensin II Type I receptor antagonism activity","MKKGHHHHHHGESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","NR1C3, PPARG","Peroxisome proliferator-activated receptor gamma","1","3R8A"
"3R8D",,"X-RAY DIFFRACTION",2.48,50.32,"VAPOR DIFFUSION, HANGING DROP",7.8,"50 mM imidazole, 16% 2-propanol (v/v), pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1002/pro.706",,"3R8D",36.59,"2.8","2.8","Activation of the Human Nuclear Xenobiotic Receptor PXR by the Reverse Transcriptase-Targeted Anti-HIV Drug PNU-142721","MKKGHHHHHHGSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGS","Homo sapiens","NR1I2, PXR","Nuclear receptor subfamily 1 group I member 2","1","3R8D"
"3R8G",,"X-RAY DIFFRACTION",2.36,47.91,"VAPOR DIFFUSION, HANGING DROP",,"200 mM sodium acetate, 20% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 275K",275,"10.1371/journal.pone.0043965",,"3R8G",38.99,"1.799","1.799","AKR1C3 complex with ibuprofen","MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","3R8G"
"3R8H",,"X-RAY DIFFRACTION",2.32,46.94,,,,,"10.1371/journal.pone.0043965",,"3R8H",39.14,"1.9","1.9","AKR1C3 complex with zomepirac","MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","3R8H"
"3R8I",,"X-RAY DIFFRACTION",2.58,52.41,,8,"0.8 M NA Citrate, 0.15 M Tris, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm201306q","XCX","3R8I",65.83,"2.3","2.3","Crystal Structure of PPARgamma with an achiral ureidofibrate derivative (RT86)","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3R8I"
"3R8J",,"X-RAY DIFFRACTION",2.81,56.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"KH2PO4 0.8M, NaH2PO4 0.8M, HEPES 0.08M, 1-butyl-3-methylimidazolium chloride 0.2M, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1042/BJ20110257",,"3R8J",47.42,"1.6","1.6","Crystal structure of human SOUL protein (orthorhombic form)","MRGSAEPLQPDPGAAEDAAAQAVETPGWKAPEDAGPQPGSYEIRHYGPAKWVSTSVESMDWDSAIQTGFTKLNSYIQGKNEKEMKIKMTAPVTSYVEPGSGPFSESTITISLYIPSEQQFDPPRPLESDVFIEDRAEMTVFVRSFDGFSSAQKNQEQLLTLASILREDGKVFDEKVYYTAGYNSPVKLLNRNNEVWLIQKNEPTKENELVPR","Homo sapiens","C6orf34, HEBP2, SOUL","Heme-binding protein 2","1","3R8J"
"3R8K",,"X-RAY DIFFRACTION",3.82,67.83,"VAPOR DIFFUSION, HANGING DROP",8.5,"2.0M ammonium sulphate, 0.1M Tris-HCl, 0.2M 1-butyl-3-methylimidazolium chloride, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1042/BJ20110257",,"3R8K",94.65,"2.85","2.85","Crystal structure of human SOUL protein (hexagonal form)","MRGSAEPLQPDPGAAEDAAAQAVETPGWKAPEDAGPQPGSYEIRHYGPAKWVSTSVESMDWDSAIQTGFTKLNSYIQGKNEKEMKIKMTAPVTSYVEPGSGPFSESTITISLYIPSEQQFDPPRPLESDVFIEDRAEMTVFVRSFDGFSSAQKNQEQLLTLASILREDGKVFDEKVYYTAGYNSPVKLLNRNNEVWLIQKNEPTKENELVPR","Homo sapiens","C6orf34, HEBP2, SOUL","Heme-binding protein 2","1","3R8K"
"3R8L",,"X-RAY DIFFRACTION",1.94,36.57,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate , pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3R8L",35,"1.9","1.9","CDK2 in complex with inhibitor L3-4","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R8L"
"3R8M",,"X-RAY DIFFRACTION",1.97,37.68,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate , pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3R8M",35.03,"1.8","1.8","CDK2 in complex with inhibitor L3-3","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R8M"
"3R8P",,"X-RAY DIFFRACTION",1.93,36.37,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3R8P",34.98,"1.8","1.8","CDK2 in complex with inhibitor NSK-MC1-6","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R8P"
"3R8Q",,"X-RAY DIFFRACTION",2.29,46.21,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M Na HEPES, 0.8 M sodium dihydrogen phosphate, 0.8 M potassium dihydrogen phosphate, supplemented with 35% glycerol for cryo-protection, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"3R8Q",31.77,"2.4","2.4","Structure of Fibronectin domain 12-14","MAHHHHHHSSGLEVLFQGPAIPAPTDLKFTQVTPTSLSAQWTPPNVQLTGYRVRVTPKEKTGPMKEINLAPDSSSVVVSGLMVATKYEVSVYALKDTLTSRPAQGVVTTLENVSPPRRARVTDATETTITISWRTKTETITGFQVDAVPANGQTPIQRTIKPDVRSYTITGLQPGTDYKIYLYTLNDNARSSPVVIDASTAIDAPSNLRFLATTPNSLLVSWQPPRARITGYIIKYEKPGSPPREVVPRPRPGVTEATITGLEPGTEYTIYVIALKNNQKSEPLIGRKKT","Homo sapiens","Fibronectin 1, FN, FN1","Fibronectin","1","3R8Q"
"3R8U",,"X-RAY DIFFRACTION",2.01,38.67,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate , pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","Z31","3R8U",35.07,"2","2","CDK2 in complex with inhibitor RC-1-132","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R8U"
"3R8V",,"X-RAY DIFFRACTION",1.99,38.21,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate , pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","Z62","3R8V",35.07,"1.9","1.9","CDK2 in complex with inhibitor RC-1-135","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R8V"
"3R8Z",,"X-RAY DIFFRACTION",1.94,36.68,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate , pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","Z63","3R8Z",35.02,"1.85","1.85","CDK2 in complex with inhibitor RC-1-136","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R8Z"
"3R90",,"X-RAY DIFFRACTION",2.4,49,"VAPOR DIFFUSION",7,"2.5M ammonium sulfate, 0.1M Bis-Tris propane, pH 7, VAPOR DIFFUSION, temperature 293K",293,,,"3R90",258.24,"1.7","1.7","Crystal structure of Malignant T cell-amplified sequence 1 protein","MFKKFDEKENVSNCIQLKTSVIKGIKNQLIEQFPGIEPWLNQIMPKKDPVKIVRCHEHIEILTVNGELLFFRQREGPFYPTLRLLHKYPFILPHQQVDKGAIKFVLSGANIMCPGLTSPGAKLYPAAVDTIVAIMAAGAAHALCVGVMKMSAEDIEKVNKGIGIENIHYLNDGLWHMKTYKAHHHHHH","Homo sapiens","MCTS1, MCT1","Malignant T cell-amplified sequence 1","1","3R90"
,,,,,"VAPOR DIFFUSION",7,"Se-Met derivative. 2.5M ammonium sulfate, 0.1M Bis-Tris propane, 2% PEG-3350, pH 7, VAPOR DIFFUSION, temperature 293K",293
"3R91",,"X-RAY DIFFRACTION",2.91,57.74,"VAPOR DIFFUSION, HANGING DROP",7.5,"22% PEG3350, 0.175 M MAGNESIUM NITRATE, pH 7.5, TEMPERATURE 277K; FROZEN BY 1-STEP TRANSFER TO 25% GLYCEROL, 17% PEG3350, 0.13M MAGNESIUM NITRATE, VAPOR DIFFUSION, HANGING DROP",277,"10.1016/j.bmcl.2011.03.112","06H","3R91",25.85,"1.579","1.579","Macrocyclic lactams as potent Hsp90 inhibitors with excellent tumor exposure and extended biomarker activity.","QPMEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90A, HSP90AA1, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3R91"
"3R92",,"X-RAY DIFFRACTION",2.95,58.32,"VAPOR DIFFUSION, HANGING DROP",6.5,"25% PEG3000, 0.1 M MES, pH 6.5, TEMPERATURE 277K; FROZEN BY 1-STEP TRANSFER TO 25% GLYCEROL, 19% PEG3000, 0.075M MES, VAPOR DIFFUSION, HANGING DROP",277,"10.1016/j.bmcl.2011.04.102","06J","3R92",25.85,"1.5801","1.5801","Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model.","QPMEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90A, HSP90AA1, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3R92"
"3R93",,"X-RAY DIFFRACTION",2.67,53.92,"VAPOR DIFFUSION, SITTING DROP",,"35% PEG2000-MME, 8-fold excess of H3K9Me3, vapor diffusion, sitting drop, temperature 293K",293,"10.1371/journal.pone.0025104",,"3R93",35.81,"2.057","2.057","Crystal structure of the chromo domain of M-phase phosphoprotein 8 bound to H3K9Me3 peptide","GEDVFEVEKILDMKTEGGKVLYKVRWKGYTSDDDTWEPEIHLEDCKEVLLEFRKKIAENKAK","Homo sapiens","MPHOSPH8, MPP8","M-phase phosphoprotein 8","1","3R93"
,,,,,,,,,,,,,,,,"ARTKQTARKSTGGKA",,,"H3K9Me3 peptide","2","3R93"
"3R94",,"X-RAY DIFFRACTION",2.28,46.14,"VAPOR DIFFUSION, HANGING DROP",,"200 mM sodium acetate, 20% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 275K",275,"10.1371/journal.pone.0043965",,"3R94",39.03,"2.013","2.013","AKR1C3 complex with flurbiprofen","MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","3R94"
"3R9D",,"X-RAY DIFFRACTION",2.01,38.84,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","X6B","3R9D",35.17,"1.95","1.95","CDK2 in complex with inhibitor RC-2-135","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R9D"
"3R9H",,"X-RAY DIFFRACTION",2.01,38.69,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","Z67","3R9H",35.19,"2.1","2.1","CDK2 in complex with inhibitor RC-2-142","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R9H"
"3R9M",,"X-RAY DIFFRACTION",6.03,79.59,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M MES, 1M sodium formate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2011.07.016",,"3R9M",43.46,"1.95","1.95","Crystal structure of the Brox Bro1 domain","GVDTHWFHRNPLKATAPVSFNYYGVVTGPSASKICNDLRSSRARLLELFTDLSCNPEMMKNAADSYFSLLQGFINSLDESTQESKLRYIQNFKWTDTLQGQVPSAQQDAVFELISMGFNVALWYTKYASRLAGKENITEDEAKEVHRSLKIAAGIFKHLKESHLPKLITPAEKGRDLESRLIEAYVIQCQAEAQEVTIARAIELKHAPGLIAALAYETANFYQKADHTLSSLEPAYSAKWRKYLHLKMCFYTAYAYCYHGETLLASDKCGEAIRSLQEAEKLYAKAEALCKEYGETKGPGPTVKPSGHLFFRKLGNLVKNTLEKCQRENGFIYFQKIPTEAPQLELKANYGLVEPIPFEFPPTSVQWTPETLAAFD","Homo sapiens","BROX, BROFTI, C1orf58","BRO1 domain-containing protein BROX","1","3R9M"
"3R9N",,"X-RAY DIFFRACTION",2,38.5,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","Z68","3R9N",35.11,"1.75","1.75","CDK2 in complex with inhibitor RC-2-21","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R9N"
"3R9O",,"X-RAY DIFFRACTION",2.01,38.67,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","Z71","3R9O",35.19,"1.9","1.9","CDK2 in complex with inhibitor RC-2-143","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3R9O"
"3RAH",,"X-RAY DIFFRACTION",2.01,38.83,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","O1Z","3RAH",35.11,"1.75","1.75","CDK2 in complex with inhibitor RC-2-22","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3RAH"
"3RAI",,"X-RAY DIFFRACTION",2.01,38.78,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3RAI",35.24,"1.7","1.7","CDK2 in complex with inhibitor KVR-1-160","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3RAI"
"3RAK",,"X-RAY DIFFRACTION",2,38.63,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k",,"3RAK",35.14,"1.75","1.75","CDK2 in complex with inhibitor RC-2-32","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3RAK"
"3RAL",,"X-RAY DIFFRACTION",2.01,38.94,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","04Z","3RAL",35.17,"1.75","1.75","CDK2 in complex with inhibitor RC-2-34","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3RAL"
"3RAP",,"X-RAY DIFFRACTION",2.2,44.05,,8,"PEG 8000 20-25% TRIS-HCL 100MM PH 8 100MM MGCL2",,"10.1002/(sici)1097-0134(19991115)37:3<465::aid-prot13>3.0.co;2-o",,"3RAP",38.99,"2.2","2.2","The small G protein Rap2 in a non catalytic complex with GTP","MREYKVVVLGSGGVGKSALTVQFVTGTFIEKYDPTIEDFYRKEIEVDSSPSVLEILDTAGTEQFASMRDLYIKNGQGFILVYSLVNQQSFQDIKPMRDQIIRVKRYEKVPVILVGNKVDLESEREVSSSEGRALAEEWGCPFMETSAKSKTMVDELFAEIVRQMNYA","Homo sapiens","RAP2A","PROTEIN (G protein RAP2A)","1","3RAP"
"3RAU",,"X-RAY DIFFRACTION",2.23,44.92,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1M MES pH5.5, 16% PEG3350, 0.3M Magnesium Acetate, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2011.07.016",,"3RAU",82.53,"1.95","1.95","Crystal structure of the HD-PTP Bro1 domain","GEFEAVPRMPMIWLDLKEAGDFHFQPAVKKFVLKNYGENPEAYNEELKKLELLRQNAVRVPRDFEGCSVLRKYLGQLHYLQSRVPMGSGQEAAVPVTWTEIFSGKSVAHEDIKYEQACILYNLGALHSMLGAMDKRVSEEGMKVSCTHFQCAAGAFAYLREHFPQAYSVDMSRQILTLNVNLMLGQAQECLLEKSMLDNRKSFLVARISAQVVDYYKEACRALENPDTASLLGRIQKDWKKLVQMKIYYFAAVAHLHMGKQAEEQQKFGERVAYFQSALDKLNEAIKLAKGQPDTVQDALRFTMDVIGGKYNSAKKDNDFIYHEAVPALDTLQPVKGAPLVKPLPVNPTDPAVTGPDIFAKLV","Homo sapiens","PTPN23, KIAA1471","Tyrosine-protein phosphatase non-receptor type 23","1","3RAU"
"3RAW",,"X-RAY DIFFRACTION",2.92,57.82,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.20M NaNO3 
0.1M BTProp pH 7.5 
20.0% PEG 3350 
10.0% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3RAW",90.19,"2.09","2.09","Crystal Structure of human CDC-like kinase 3 isoform in complex with leucettine L41","MHHHHHHSSGVDLGTENLYFQSMQSSKRSSRSVEDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT","Homo sapiens","CLK3","Dual specificity protein kinase CLK3","1","3RAW"
"3RAY",,"X-RAY DIFFRACTION",1.66,25.98,"VAPOR DIFFUSION, SITTING DROP",,"20%PEG 3350,       
0.2M KCl        
, VAPOR DIFFUSION, SITTING DROP, temperature 297K",297,,,"3RAY",27.62,"1.73","1.73","Crystal structure of Methyltransferase domain of human PR domain-containing protein 11","GDSSAMEVEPKKLKGKRDLIVPKSFQQVDFWFCESCQEYFVDECPNHGPPVFVSDTPVPVGIPDRAALTIPQGMEVVKDTSGESDVRCVNEVIPKGHIFGPYEGQISTQDKSAGFFSWLIVDKNNRYKSIDGSDETKANWMRYVVISREEREQNLLAFQHSERIYFRACRDIRPGEWLRVWYSEDYMKRLHSMSQETIHRNLARGEKRLQREKSEQVLDNPEDLRGPIHLSVLRQGK","Homo sapiens","PRDM11, PFM8","PR domain-containing protein 11","1","3RAY"
"3RBF",,"X-RAY DIFFRACTION",2.68,54.18,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M HEPES pH 7.0, 28-30% Jeffamine ED 2001 pH 7.0, vapor diffusion, hanging drop, temperature 294K",294,"10.1073/pnas.1111456108",,"3RBF",108.24,"2.9","2.9","Crystal structure of Human aromatic L-amino acid decarboxylase (AADC) in the apo form","MNASEFRRRGKEMVDYVANYMEGIEGRQVYPDVEPGYLRPLIPAAAPQEPDTFEDIINDVEKIIMPGVTHWHSPYFFAYFPTASSYPAMLADMLCGAIGCIGFSWAASPACTELETVMMDWLGKMLELPKAFLNEKAGEGGGVIQGSASEATLVALLAARTKVIHRLQAASPELTQAAIMEKLVAYSSDQAHSSVERAGLIGGVKLKAIPSDGNFAMRASALQEALERDKAAGLIPFFMVATLGTTTCCSFDNLLEVGPICNKEDIWLHVDAAYAGSAFICPEFRHLLNGVEFADSFNFNPHKWLLVNFDCSAMWVKKRTDLTGAFRLDPTYLKHSHQDSGLITDYRHWQIPLGRRFRSLKMWFVFRMYGVKGLQAYIRKHVQLSHEFESLVRQDPRFEICVEVILGLVCFRLKGSNKVNEALLQRINSAKKIHLVPCHLRDKFVLRFAICSRTVESAHVQRAWEHIKELAADVLRAERE","Homo sapiens","AADC, DDC, hCG_1811384, tcag7.584","Aromatic-L-amino-acid decarboxylase","1","3RBF"
"3RBG",,"X-RAY DIFFRACTION",2.34,47.4,"VAPOR DIFFUSION, SITTING DROP",6.9,"0.49 M Sodium Phosphate, 0.91M Potasium Phosphate pH 6.9, Vapor diffusion, Sitting drop, temperature 277K",277,"10.1016/j.str.2013.02.022",,"3RBG",57.36,"2.3","2.3","Crystal structure analysis of Class-I MHC restricted T-cell associated molecule","MGSLTNHTETITVEEGQTLTLKCVTSLRKNSSLQWLTPSGFTIFLNEYPVLKNSKYQLLHHSANQLSITVPNVTLQDEGVYKCLHYSDSVSTKEVKVIVLATMKGEFCRYPSHWRPLEHHHHHH","Homo sapiens","CRTAM","Cytotoxic and regulatory T-cell molecule","1","3RBG"
"3RBL",,"X-RAY DIFFRACTION",2.8,56.09,"vapor diffusion followed by soaking",7,"crystals obtained from holoAADC in 0.1 M HEPES pH 7.0, 28-30% Jeffamine ED 2001 pH 7.0 were transferred in a ML droplet to yield apoAADC, vapor diffusion followed by soaking, temperature 294K",294,"10.1073/pnas.1111456108",,"3RBL",107.96,"3.24","3.24","Crystal structure of Human aromatic L-amino acid decarboxylase (AADC) in the apo form","MNASEFRRRGKEMVDYVANYMEGIEGRQVYPDVEPGYLRPLIPAAAPQEPDTFEDIINDVEKIIMPGVTHWHSPYFFAYFPTASSYPAMLADMLCGAIGCIGFSWAASPACTELETVMMDWLGKMLELPKAFLNEKAGEGGGVIQGSASEATLVALLAARTKVIHRLQAASPELTQAAIMEKLVAYSSDQAHSSVERAGLIGGVKLKAIPSDGNFAMRASALQEALERDKAAGLIPFFMVATLGTTTCCSFDNLLEVGPICNKEDIWLHVDAAYAGSAFICPEFRHLLNGVEFADSFNFNPHKWLLVNFDCSAMWVKKRTDLTGAFRLDPTYLKHSHQDSGLITDYRHWQIPLGRRFRSLKMWFVFRMYGVKGLQAYIRKHVQLSHEFESLVRQDPRFEICVEVILGLVCFRLKGSNKVNEALLQRINSAKKIHLVPCHLRDKFVLRFAICSRTVESAHVQRAWEHIKELAADVLRAERE","Homo sapiens","AADC, DDC","aromatic L-amino acid decarboxylase","1","3RBL"
"3RBN",,"X-RAY DIFFRACTION",2.04,39.58,"VAPOR DIFFUSION, HANGING DROP",8,"22% PEG4000, 0.2 M sodium acetate, 0.1 M Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3RBN",66.06,"2.16","2.16","Crystal structure of MutL protein homolog 1 isoform 1 [Homo sapiens]","MHHHHHHSSGRENLYFQGSRKEMTAACTPRRRIINLTSVLSLQEEINEQGHEVLREMLHNHSFVGCVNPQWALAQHQTKLYLLNTTKLSEELFYQILIYDFANFGVLRLSEPAPLFDLAMLALDSPESGWTEEDGPKEGLAEYIVEFLKKKAEMLADYFSLEIDEEGNLIGLPLLIDNYVPPLEGLPIFILRLATEVNWDEEKECFESLSKECAMFYSIRKQYISEESTLSGQQSEVPGSIPNSWKWTVEHIVYKALRSHILPPKHFTEDGNILQLANLPDLYK","Homo sapiens","MLH1, COCA2","DNA mismatch repair protein Mlh1","1","3RBN"
"3RBS",,"X-RAY DIFFRACTION",2.63,53.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 M NaNO3, 18% w/v polyethylene glycol 3350, 5% w/w ethylene glycol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1371/journal.pbio.1001261",,"3RBS",24.58,"1.85","1.85","Crystal structure of the myomesin domains 10 and 11","GIDPFTKSELAVEILEKGQVRFWMQAEKLSGNAKVNYIFNEKEIFEGPKYKMHIDRNTGIIEMFMEKLQDEDEGTYTFQLQDGKATNHSTVVLVGDVFKKLQKEAEFQRQEWIRKQGPHFVEYLSWEVTGECNVLLKCKVANIKKETHIVWYKDEREISVDEKHDFKDGICTLLITEFSKKDAGIYEVILKDDRGKDKSRLKLVDEA","Homo sapiens","MYOM1","Myomesin-1","1","3RBS"
"3RBU",,"X-RAY DIFFRACTION",3.16,61.02,"VAPOR DIFFUSION, HANGING DROP",8,"33% pentaerythritol propoxylate, 1% PEG3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.pep.2011.11.016","G88","3RBU",86.48,"1.6","1.6","N-terminally AviTEV-tagged Human Glutamate Carboxypeptidase II in complex with 2-PMPA","RSGLNDIFEAQKIEWHEGSGSGSENLYFQGRSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH, FOLH1, GIG27, NAALAD1, PSM, PSMA","Glutamate carboxypeptidase 2","1","3RBU"
"3RBW",,"X-RAY DIFFRACTION",2.48,50.48,"VAPOR DIFFUSION",,"VAPOR DIFFUSION",,,,"3RBW",96.11,"3.2","3.2","Crystal structure of Spire KIND domain","GSGEGPREPGAAGGAAGGSRDALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAPAADDAGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLPTESDAPNHYQAVCRALFAETMELHTFLTK","Homo sapiens","SPIRE1, KIAA1135, SPIR1","Protein spire homolog 1","1","3RBW"
"3RC3",,"X-RAY DIFFRACTION",2.65,53.54,,6.5,"6% PEG 3350, 0.1 M Na citrate, 10 % glycerol, pH 6.5, vapor diffusion, hanging drop, temperature 277K",277,"10.1107/S0907444911040248",,"3RC3",77.33,"2.08","2.08","Human Mitochondrial Helicase Suv3","GTASSSASGGSKIPNTSLFVPLTVKPQGPSADGDVGAELTRPLDKNEVKKVLDKFYKRKEIQKLGADYGLDARLFHQAFISFRNYIMQSHSLDVDIHIVLNDICFGAAHADDLFPFFLRHAKQIFPVLDCKDDLRKISDLRIPPNWYPDARAMQRKIIFHSGPTNSGKTYHAIQKYFSAKSGVYCGPLKLLAHEIFEKSNAAGVPCDLVTGEERVTVQPNGKQASHVSCTVEMCSVTTPYEVAVIDEIQMIRDPARGWAWTRALLGLCAEEVHLCGEPAAIDLVMELMYTTGEEVEVRDYKRLTPISVLDHALESLDNLRPGDCIVCFSKNDIYSVSRQIEIRGLESAVIYGSLPPGTKLAQAKKFNDPNDPCKILVATDAIGMGLNLSIRRIIFYSLIKPSINEKGERELEPITTSQALQIAGRAGRFSSRFKEGEVTTMNHEDLSLLKEILKRPVDPIRAAGLHPTAEQIEMFAYHLPDATLSNLIDIFVDFSQVDGQYFVCNMDDFKFSAELIQHIPLSLRVRYVFCTAPINKKQPFVCSSLLQFARQYSRNEPLTFAWLRRYIKWPLLPPKNIKDLMDLEAVHDVLDLYLWLSYRFMDMFPDASLIRDLQKELDGIIQDGVHNITKLIKMSETHKLLNLEGFPSGSQSRLSGTLKSQARRTRGTKALGSKATE","Homo sapiens","SUPV3L1, SUV3","ATP-dependent RNA helicase SUPV3L1, mitochondrial","1","3RC3"
"3RC8",,"X-RAY DIFFRACTION",2.92,57.84,"VAPOR DIFFUSION, HANGING DROP",6.5,"6% PEG 3350, 0.1 M Na citrate, 10 % glycerol, pH 6.5, vapor diffusion, hanging drop, temperature 277K",277,"10.1107/S0907444911040248",,"3RC8",77.9,"2.9","2.9","Human Mitochondrial Helicase Suv3 in Complex with Short RNA Fragment","GTASSSASGGSKIPNTSLFVPLTVKPQGPSADGDVGAELTRPLDKNEVKKVLDKFYKRKEIQKLGADYGLDARLFHQAFISFRNYIMQSHSLDVDIHIVLNDICFGAAHADDLFPFFLRHAKQIFPVLDCKDDLRKISDLRIPPNWYPDARAMQRKIIFHSGPTNSGKTYHAIQKYFSAKSGVYCGPLKLLAHEIFEKSNAAGVPCDLVTGEERVTVQPNGKQASHVSCTVEMCSVTTPYEVAVIDEIQMIRDPARGWAWTRALLGLCAEEVHLCGEPAAIDLVMELMYTTGEEVEVRDYKRLTPISVLDHALESLDNLRPGDCIVCFSKNDIYSVSRQIEIRGLESAVIYGSLPPGTKLAQAKKFNDPNDPCKILVATDAIGMGLNLSIRRIIFYSLIKPSINEKGERELEPITTSQALQIAGRAGRFSSRFKEGEVTTMNHEDLSLLKEILKRPVDPIRAAGLHPTAEQIEMFAYHLPDATLSNLIDIFVDFSQVDGQYFVCNMDDFKFSAELIQHIPLSLRVRYVFCTAPINKKQPFVCSSLLQFARQYSRNEPLTFAWLRRYIKWPLLPPKNIKDLMDLEAVHDVLDLYLWLSYRFMDMFPDASLIRDLQKELDGIIQDGVHNITKLIKMSETHKLLNLEGFPSGSQSRLSGTLKSQARRTRGTKALGSKATE","Homo sapiens","SUPV3L1, SUV3","ATP-dependent RNA helicase SUPV3L1, mitochondrial","1","3RC8"
,,,,,,,,,,,,,,,,"CCGCCC",,,"RNA fragment","2","3RC8"
"3RCD",,"X-RAY DIFFRACTION",1.98,37.95,"VAPOR DIFFUSION, SITTING DROP",6.5,"20% PEG 3550, 200MM DI-AMMONIUM TARTRATE, 100 MM PIPES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/jm2008634","03P","3RCD",154.01,"3.21","3.21","HER2 Kinase Domain Complexed with TAK-285","MSGAAPNQALLRILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVSEFSRMARDPQRFVVIQNEDLGPASPLDSTFYRSLLEDDDMGDLVDAEEYLVPQQGAAASHHHHHH","Homo sapiens","ERBB2, HER2, MLN19, NEU, NGL","Receptor tyrosine-protein kinase erbB-2","1","3RCD"
"3RCF",,"X-RAY DIFFRACTION",2.03,39.3,"VAPOR DIFFUSION, HANGING DROP",7.3,"30% PEG4000, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/ncomms12777",,"3RCF",18.42,"1.15","1.15","Human cyclophilin D complexed with N-[(4-aminophenyl)sulfonyl]benzamide","MSGNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","3RCF"
"3RCG",,"X-RAY DIFFRACTION",2.01,38.87,"VAPOR DIFFUSION, HANGING DROP",7.3,"30% PEG4000, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/ncomms12777",,"3RCG",17.98,"0.97","0.97","Human cyclophilin D complexed with dimethylformamide","MSGNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","3RCG"
"3RCH",,"X-RAY DIFFRACTION",2.71,54.6,"vapor diffusion, soaking",7,"crystals obtained from holoAADC in 0.1 M HEPES pH 7.0, 28-30% Jeffamine ED 2001 pH 7.0 were transferred in a ML droplet containing 10mM PLP to yield crystals with PLP and LLP bound, vapor diffusion, soaking, temperature 294K",294,"10.1073/pnas.1111456108",,"3RCH",108.4,"2.8","2.8","Crystal structure of Human aromatic L-amino acid decarboxylase (AADC) in the open conformation with LLP and PLP bound to Chain-A and Chain-B respectively","MNASEFRRRGKEMVDYVANYMEGIEGRQVYPDVEPGYLRPLIPAAAPQEPDTFEDIINDVEKIIMPGVTHWHSPYFFAYFPTASSYPAMLADMLCGAIGCIGFSWAASPACTELETVMMDWLGKMLELPKAFLNEKAGEGGGVIQGSASEATLVALLAARTKVIHRLQAASPELTQAAIMEKLVAYSSDQAHSSVERAGLIGGVKLKAIPSDGNFAMRASALQEALERDKAAGLIPFFMVATLGTTTCCSFDNLLEVGPICNKEDIWLHVDAAYAGSAFICPEFRHLLNGVEFADSFNFNPHKWLLVNFDCSAMWVKKRTDLTGAFRLDPTYLKHSHQDSGLITDYRHWQIPLGRRFRSLKMWFVFRMYGVKGLQAYIRKHVQLSHEFESLVRQDPRFEICVEVILGLVCFRLKGSNKVNEALLQRINSAKKIHLVPCHLRDKFVLRFAICSRTVESAHVQRAWEHIKELAADVLRAERE","Homo sapiens","AADC, DDC","aromatic L-amino acid decarboxylase","1","3RCH"
,,,,,,,,,,,,,,,,"MNASEFRRRGKEMVDYVANYMEGIEGRQVYPDVEPGYLRPLIPAAAPQEPDTFEDIINDVEKIIMPGVTHWHSPYFFAYFPTASSYPAMLADMLCGAIGCIGFSWAASPACTELETVMMDWLGKMLELPKAFLNEKAGEGGGVIQGSASEATLVALLAARTKVIHRLQAASPELTQAAIMEKLVAYSSDQAHSSVERAGLIGGVKLKAIPSDGNFAMRASALQEALERDKAAGLIPFFMVATLGTTTCCSFDNLLEVGPICNKEDIWLHVDAAYAGSAFICPEFRHLLNGVEFADSFNFNPHKWLLVNFDCSAMWVKKRTDLTGAFRLDPTYLKHSHQDSGLITDYRHWQIPLGRRFRSLKMWFVFRMYGVKGLQAYIRKHVQLSHEFESLVRQDPRFEICVEVILGLVCFRLKGSNKVNEALLQRINSAKKIHLVPCHLRDKFVLRFAICSRTVESAHVQRAWEHIKELAADVLRAERE","Homo sapiens","AADC, DDC","aromatic L-amino acid decarboxylase","2","3RCH"
"3RCI",,"X-RAY DIFFRACTION",2,38.59,"VAPOR DIFFUSION, HANGING DROP",7.3,"30% PEG4000, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/ncomms12777",,"3RCI",18.26,"1.44","1.44","Human cyclophilin D complexed with 5-methyl-1,2-oxazol-3-amine","MSGNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","3RCI"
"3RCJ",,"X-RAY DIFFRACTION",2.16,43.01,"VAPOR DIFFUSION, HANGING DROP",7,"0,1 M HEPES; 1,4 M sodium citrate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1039/c1ob05586k","3RC","3RCJ",35.67,"1.7","1.7","Rapid preparation of triazolyl substituted NH-heterocyclic kinase inhibitors via one-pot Sonogashira coupling TMS-deprotection CuAAC sequence","GAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDPK1, PDK1","3-phosphoinositide-dependent protein kinase 1","1","3RCJ"
"3RCK",,"X-RAY DIFFRACTION",2.01,38.78,"VAPOR DIFFUSION, HANGING DROP",7.3,"30% PEG4000, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/ncomms12777",,"3RCK",18.44,"1.26","1.26","Human Cyclophilin D Complexed with a Fragment","MSGNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","3RCK"
"3RCL",,"X-RAY DIFFRACTION",1.99,38.24,"VAPOR DIFFUSION, HANGING DROP",7.3,"30% PEG4000, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/ncomms12777",,"3RCL",18.35,"1.7","1.7","Human Cyclophilin D Complexed with a Fragment","MSGNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","3RCL"
"3RCO",,"X-RAY DIFFRACTION",2.07,40.63,"VAPOR DIFFUSION, SITTING DROP",4.6,"0.1M NaOAc, 2.2-2.4M NaCl, VAPOR DIFFUSION, SITTING DROP, temperature 297K, pH 4.6",297,,,"3RCO",20.37,"1.8","1.8","Crystal structure of a conserved motif in human TDRD7","ENLYFQGMLEGDLVSKMLRAVLQSHKNGVALPRLQGEYRSLTGDWIPFKQLGFPTLEAYLRSVPAVVRIETSRSGEITCYAMACTETAR","Homo sapiens","TDRD7, PCTAIRE2BP","Tudor domain-containing protein 7","1","3RCO"
"3RCP",,"X-RAY DIFFRACTION",2.17,43.44,"VAPOR DIFFUSION, HANGING DROP",4.6,"precipitant solution containing 0.1 M NaAc, pH 4.6, 50mM (NH4)2SO4 and 15% PEG1000., VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1074/jbc.M111.233015",,"3RCP",12.08,"1.9","1.9","Crystal structure of the FAPP1 pleckstrin homology domain","MEGVLYKWTNYLTGWQPRWFVLDNGILSYYDSQDDVCKGSKGSIKMAVCEIKVHSADNTRMELIIPGEQHFYMKAVNAAERQRWLVALGSSKASLTDTRLVPR","Homo sapiens","FAPP1, PLEKHA3","Pleckstrin homology domain-containing family A member 3","1","3RCP"
"3RCW",,"X-RAY DIFFRACTION",2.26,45.55,"VAPOR DIFFUSION, SITTING DROP",4.8,"32.5% PEG3350, 5% EtGly, 0.1M Acetate, pH 4.8, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.cell.2012.02.013",,"3RCW",125.64,"2.21","2.21","Crystal Structure of the bromodomain of human BRD1","SMEQVAMELRLTPLTVLLRSVLDQLQDKDPARIFAQPVSLKEVPDYLDHIKHPMDFATMRKRLEAQGYKNLHEFEEDFDLIIDNCMKYNARDTVFYRAAVRLRDQGGVVLRQARREVDSIGLEEASGMHLPERPA","Homo sapiens","BRD1, BRL, BRPF2","Bromodomain-containing protein 1","1","3RCW"
"3RD2",,"X-RAY DIFFRACTION",1.84,33.23,"VAPOR DIFFUSION, SITTING DROP",9,"1.7 M ammonium 118 sulfate, 100 mM Bicine pH 9.0, VAPOR DIFFUSION, SITTING DROP, temperature 273K",273,"10.1128/MCB.05188-11",,"3RD2",9.37,"1.6","1.6","NIP45 SUMO-like Domain 2","MHHHHHHSQQLQLRVQGKEKHQTLEVSLSRDSPLKTLMSHYEEAMGLSGRKLSFFFDGTKLSGRELPADLGMESGDLIEVWG","Homo sapiens","NFATC2IP, NIP45","NFATC2-interacting protein","1","3RD2"
"3RD9",,"X-RAY DIFFRACTION",2,38.39,"VAPOR DIFFUSION, HANGING DROP",7.3,"30% PEG4000, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 100K, temperature 291K",291,"10.1038/ncomms12777",,"3RD9",18.23,"1.4","1.4","Human Cyclophilin D Complexed with a Fragment","MSGNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","3RD9"
"3RDA",,"X-RAY DIFFRACTION",1.99,38.28,"VAPOR DIFFUSION, HANGING DROP",7.3,"30% PEG4000, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/ncomms12777",,"3RDA",18.56,"1.07","1.07","Human Cyclophilin D Complexed with a Fragment","MSGNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","3RDA"
"3RDB",,"X-RAY DIFFRACTION",1.99,38.29,"VAPOR DIFFUSION, HANGING DROP",7.3,"30% PEG4000, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/ncomms12777",,"3RDB",18.4,"1.55","1.55","Human Cyclophilin D Complexed with a Fragment","MSGNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","3RDB"
"3RDC",,"X-RAY DIFFRACTION",1.94,36.56,"VAPOR DIFFUSION, HANGING DROP",7.3,"30% PEG4000, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1107/S1399004715010342",,"3RDC",18.12,"1.94","1.94","Human Cyclophilin D Complexed with an Inhibitor","MSGNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS","Homo sapiens","PPIF, CYP3","Peptidyl-prolyl cis-trans isomerase F, mitochondrial","1","3RDC"
"3RDD",,"X-RAY DIFFRACTION",2.29,46.24,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES, 20% PEG10000, 5% ethanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1038/ncomms12777",,"3RDD",20.55,"2.14","2.14","Human Cyclophilin A Complexed with an Inhibitor","MGHHHHHHSSGRENLYFQGMVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","3RDD"
"3RDH",,"X-RAY DIFFRACTION",2.75,55.21,"VAPOR DIFFUSION, HANGING DROP",8.5,"25% PEG3350, 100 mM Tris-HCl pH 8.5, 10 mM MgCl2, 1 mM NiCl2, 1% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1073/pnas.1100012108","3RD","3RDH",114.05,"2.39","2.39","X-ray induced covalent inhibition of 14-3-3","GSHMDKNELVQKAKLAEQAERYDDMAACMKSVTEQGAELSNEERNLLSVAYKNVVGARRSSWRVVSSIEQKTEGAEKKQQMAREYREKIETELRDICNDVLSLLEKFLIPNASQAESKVFYLKMKGDYYRYLAEVAAGDDKKGIVDQSQQAYQEAFEISKKEMQPTHPIRLGLALNFSVFYYEILNSPEKACSLAKTAFDEAIAELDTLSEESYKDSTLIMQLLRDNLTLWTSDTQGDEAEAGEGGEN","Homo sapiens","YWHAZ","14-3-3 protein zeta/delta","1","3RDH"
"3RE0",,"X-RAY DIFFRACTION",2.31,46.68,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 3350, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/ja211591n",,"3RE0",64.21,"2.28","2.28","Crystal structure of human apo Cu,Zn superoxide dismutase (SOD1) complexed with cisplatin","ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","3RE0"
"3REE",,"X-RAY DIFFRACTION",3.9,68.5,"VAPOR DIFFUSION, HANGING DROP",,"Crystals were grown by mixing 1 microliter of mitoNEET 23.3 mg/mL in 50 mM Tris HCl, 0.3 M NaCl, pH 8.5 with 1 microliter of 0.1 M Tris HCl, 1.5 ~ 1.8 M ammonium sulfate, pH 8.5 solution against the same solution. Crystals were appeared in 3 days and flash frozen by transfering into 0.1 M Tris HCl, 1.5 ~ 1.8 M amomnium acete, pH 8.5, 20% xylitol for a few minutes, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/bi200546s",,"3REE",9.95,"1.76","1.76","Crystal structure of mitoNEET","KRFYVKDHRNKAMINLHIQKDNPKIVHAFDMEDLGDKAVYCRCWRSKKFPFCDGAHTKHNEETGDNVGPLIIKKKETSSGLVPR","Homo sapiens","CISD1, C10orf70, ZCD1, MDS029","CDGSH iron-sulfur domain-containing protein 1","1","3REE"
"3REV",,"X-RAY DIFFRACTION",2.33,47.3,"VAPOR DIFFUSION, SITTING DROP",4,"22% PEG 4000, 0.2M AMMONIUM ACETATE, 0.1M CITRIC ACID, PH 4, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K",298,"10.1073/pnas.1108422109",,"3REV",49.67,"2.2","2.2","Crystal structure of human alloreactive tcr nb20","GVTQTPKFQVLKTGQSMTLQCAQDMNHEYMSWYRQDPGMGLRLIHYSVGAGITDQGEVPNGYNVSRSTTEDFPLRLLSAAPSQTSVYFCASSYVSQNNEQFFGPGTRLTVLEDLKNVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYSLSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRA","Homo sapiens",,"TCR NB20 BETA CHAIN","2","3REV"
,,,,,,,,,,,,,,,,"QSVAQPEDQVNVAEGNPLTVKCTYSVSGNPYLFWYVQYPNRGLQFLLKYITGDNLVKGSYGFEAEFNKSQTSFHLKKPSALVSDSALYFCAVRDMNSGNTPLVFGKGTRLSVIANIQKPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFP","Homo sapiens",,"TCR NB20 ALPHA CHAIN","1","3REV"
"3REY",,"X-RAY DIFFRACTION",5.495351,77.617447,"VAPOR DIFFUSION, SITTING DROP",8.2,"32-42% PEG1000, 0.25M MGCL2, 0.3% NG, 0.1%(W/V) 1-BUTANOL, 0.05% CYMAL-6, 0.1M TRIS-HCL(PH 8.1), VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.str.2011.06.014","XAC","3REY",36.91,"3.309","3.309","Thermostabilised adenosine A2A receptor in complex with XAC","MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADILVGVLAIPFAITISTGFCAACHGCLFIACFVLVLAQSSIFSLLAIAIDRYIAIAIPLRYNGLVTGTRAAGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFAAARRQLKQMESQPLPGERARSTLQKEVHAAKSAAIIAGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLAHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAAAHHHHHHHHHH","Homo sapiens","ADORA2A, ADORA2","Adenosine receptor A2a","1","3REY"
"3REZ",,"X-RAY DIFFRACTION",2.28,46.08,"VAPOR DIFFUSION, SITTING DROP",5,"0.1 M MMT buffer pH 5 (MMT buffer is a mixture of DL-malic acid, MES and Tris base in the molar ratios 1:2:2 DL-malic acid:MES:Tris base), 25% (w/v) PEG 1500, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1182/blood-2011-05-356253",,"3REZ",58.54,"2.35","2.35","glycoprotein GPIb variant","ADPCPAPCSCAGTLVDCGRRGLTALPALPARTTELVLTGNNLTSVPPGAFDHLPQLRTAHLGANPWRCDCSLTYLRLWLEDRPERAPYRDLRCVAPPALRGRLLPYLAEDELRAACAPGPLSSHHHHHH","Homo sapiens","GP1BB, GP9","Platelet glycoprotein Ib beta chain, Platelet glycoprotein IX","1","3REZ"
,,,,,,,,,,,,,,,,,"Homo sapiens","GP1BB, GP9"
,,,,,,,,,,,,,,,,,"Homo sapiens","GP1BB, GP9"
,,,,,,,,,,,,,,,,,"Homo sapiens","GP1BB, GP9"
,,,,,,,,,,,,,,,,,"Homo sapiens","GP1BB, GP9"
,,,,,,,,,,,,,,,,,"Homo sapiens","GP1BB, GP9"
,,,,,,,,,,,,,,,,,"Homo sapiens","GP1BB, GP9"
"3RFE",,"X-RAY DIFFRACTION",2.73,54.87,"VAPOR DIFFUSION, SITTING DROP",6.5,"1.6M(NH4)2SO4, 0.4M LiCl, 0.1M MES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1182/blood-2011-05-356253",,"3RFE",29.3,"1.245","1.245","Crystal structure of glycoprotein GPIb ectodomain","PCPAPCSCAGTLVDCGRRGLTWASLPTAFPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLVPLRAWLAGRPERAPYRDLRCVAPPALRGRLLPYLAEDELRAACAPGPLSSHHHHHH","Homo sapiens","GP1BB","Platelet glycoprotein Ib beta chain","1","3RFE"
"3RFM",,"X-RAY DIFFRACTION",5.64,78.19,"VAPOR DIFFUSION, SITTING DROP",8.2,"32-42% PEG1000, 0.25M MGCL2, 0.3% NG, 0.1%(W/V) 1-BUTANOL, 0.05% CYMAL-6, 0.1M TRIS-HCL,, pH 8.2, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.str.2011.06.014","CFF","3RFM",36.67,"3.598","3.598","Thermostabilised adenosine A2A receptor in complex with caffeine","MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADILVGVLAIPFAITISTGFCAACHGCLFIACFVLVLAQSSIFSLLAIAIDRYIAIAIPLRYNGLVTGTRAAGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFAAARRQLKQMESQPLPGERARSTLQKEVHAAKSAAIIAGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLAHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAAAHHHHHHHHHH","Homo sapiens","ADORA2A, ADORA2","Adenosine receptor A2a","1","3RFM"
"3RG3",,"X-RAY DIFFRACTION",2.13,42.32,"VAPOR DIFFUSION, HANGING DROP",8,"1.2-1.4 M sodium citrate, 100 mM Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1016/j.abb.2011.09.011",,"3RG3",29.3,"1.903","1.903","Crystal structure of the W5E mutant of human carbonic anhydrase II","MSHHEGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3RG3"
"3RG4",,"X-RAY DIFFRACTION",2.13,42.24,"VAPOR DIFFUSION, HANGING DROP",8,"1.2-1.4 M sodium citrate, 100 mM Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1016/j.abb.2011.09.011",,"3RG4",29.32,"1.5","1.5","Crystal structure of the W5F mutant of human carbonic anhydrase II","MSHHFGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3RG4"
"3RGE",,"X-RAY DIFFRACTION",2.13,42.34,"VAPOR DIFFUSION, HANGING DROP",8,"1.2-1.4 M sodium citrate, 100 mM Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1016/j.abb.2011.09.011",,"3RGE",29.31,"2.096","2.096","Crystal structure of the W5H mutant of human carbonic anhydrase II","MSHHHGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3RGE"
"3RGH",,"X-RAY DIFFRACTION",2.36,47.97,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.2 M ammonium acetate, 25%(w/v) PEG 3350, 0.1 M Bis-tris, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1744309111024249",,"3RGH",21,"2.44","2.44","Structure of filamin A immunoglobulin-like repeat 10 from Homo sapiens","GAMDPFDASKVKCSGPGLERATAGEVGQFQVDCSSAGSAELTIEICSEAGLPAEVYIQDHGDGTHTITYIPLCPGAYTVTIKYGGQPVPNFPSKLQVEPA","Homo sapiens","FLN, FLN1, FLNA","Filamin-A","1","3RGH"
"3RGK",,"X-RAY DIFFRACTION",2.24,45.07,"VAPOR DIFFUSION, HANGING DROP",7.5,"250 mM Tris-HCl, 80% Ammonium Sulfate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/S0022-2836(05)80181-0",,"3RGK",17.98,"1.65","1.65","Crystal Structure of Human Myoglobin Mutant K45R","GLSDGEWQLVLNVWGKVEADIPGHGQEVLIRLFKGHPETLEKFDRFKHLKSEDEMKASEDLKKHGATVLTALGGILKKKGHHEAEIKPLAQSHATKHKIPVKYLEFISEAIIQVLQSKHPGDFGADAQGAMNKALELFRKDMASNYKELGFQG","Homo sapiens","MB","Myoglobin","1","3RGK"
"3RH4",,"X-RAY DIFFRACTION",2.24,45.08,"VAPOR DIFFUSION, SITTING DROP",7.5,"16% PEG3350, 350 mM sodium acetate, 50 mM imidazole, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1074/jbc.M111.253401",,"3RH4",49.36,"1.918","1.918","DNA Polymerase Beta with a dideoxy-terminated primer with an incoming ribonucleotide (rCTP)","CCGACGCCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*GP*CP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","1","3RH4"
,,,,,,,,,,,,,,,,"GCTGATGCGG",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*(DDG))-3'","2","3RH4"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","3","3RH4"
,,,,,,,,,,,,,,,,"MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","4","3RH4"
"3RH5",,"X-RAY DIFFRACTION",2.25,45.42,"VAPOR DIFFUSION, SITTING DROP",7,"16% PEG3350, 350 mM sodium acetate, 50 mM imidazole, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1074/jbc.M111.253401",,"3RH5",49.14,"2.096","2.096","DNA Polymerase Beta Mutant (Y271) with a dideoxy-terminated primer with an incoming deoxynucleotide (dCTP)","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLAFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","3RH5"
,,,,,,,,,,,,,,,,"CCGACGCCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*GP*CP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","2","3RH5"
,,,,,,,,,,,,,,,,"GCTGATGCGG",,,"5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*(DDG))-3'","3","3RH5"
,,,,,,,,,,,,,,,,"GTCGG",,,"5'-D(P*GP*TP*CP*GP*G)-3'","4","3RH5"
"3RH6",,"X-RAY DIFFRACTION",2.25,45.22,"VAPOR DIFFUSION, SITTING DROP",7,"16% PEG3350, 350 mM sodium acetate, 50 mM imidazole, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1074/jbc.M111.253401",,"3RH6",49.05,"2.048","2.048","DNA Polymerase Beta Mutant (Y271) with a dideoxy-terminated primer with an incoming ribonucleotide (rCTP)","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLAFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","3RH6"
,,,,,,,,,,,,,,,,"CCGACGCCGCATCAGC",,,"5'-D(*CP*CP*GP*AP*CP*GP*CP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3'","2","3RH6"
,,,,,,,,,,,,,,,,"GCTGATGCGG",,,"(5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*(DDG))-3')","3","3RH6"
,,,,,,,,,,,,,,,,"GTCGG",,,"(5'-D(P*GP*TP*CP*GP*G)-3')","4","3RH6"
"3RHK",,"X-RAY DIFFRACTION",2.62,53.03,"VAPOR DIFFUSION, HANGING DROP",8.5,"13% ethanol, 12% ethylene glycol, 100mM imidazole, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M110.213801","M97","3RHK",72.71,"1.94","1.94","Crystal structure of the catalytic domain of c-Met kinase in complex with ARQ 197","MGHHHHHHMGDSDISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG","Homo sapiens","MET","Hepatocyte growth factor receptor","1","3RHK"
"3RHX",,"X-RAY DIFFRACTION",2.71,54.61,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 10000, 0.3M (NH4)2SO4, 5% ethylene glycol, 100mM MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M110.213736","3RH","3RHX",70.77,"2.01","2.01","Crystal structure of the catalytic domain of FGFR1 kinase in complex with ARQ 069","GSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, FGFBR, FLG, FLT2, BFGFR, CEK, HBGFR","Basic fibroblast growth factor receptor 1","1","3RHX"
"3RI1",,"X-RAY DIFFRACTION",2.8,56.06,"VAPOR DIFFUSION, HANGING DROP",7.5,"15% polyethylene glycol 4000 and 0.3M lithium sulfate and 100 mM HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M110.213736","3RH","3RI1",72.94,"2.1","2.1","Crystal structure of the catalytic domain of FGFR2 kinase in complex with ARQ 069","GSPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE","Homo sapiens","FGFR2, BEK, KGFR, KSAM","Fibroblast growth factor receptor 2","1","3RI1"
"3RI4",,"X-RAY DIFFRACTION",2.16,43.08,"sitting drop vapor diffusion and macroseeding",8.5,"200 mM ammonium chloride, 10 mM calcium chloride, 50 mM Tris-HCl buffer (pH 8.5), 18.5% v/v PEG MME 2000, 3% v/v glycerol, sitting drop vapor diffusion and macroseeding, temperature 295K",295,"10.1371/journal.pone.0033698",,"3RI4",57.47,"3","3","Ets1 cooperative binding to widely separated sites on promoter DNA","MVPSYDSFDYEDYPAALPNHKPKGTFKDYVRDRADLNKDKPVIPAAALAGYTGSGPIQLWQFLLELLTDKSCQSFISWTGDGWEFKLSDPDEVARRWGKRKNKPKMNYEKLSRGLRYYYDKNIIHKTAGKRYVYRFVCDLQSLLGYTPEELHAMLDVKPDADE","Homo sapiens","ETS1, EWSR2","Protein C-ets-1","1","3RI4"
,,,,,,,,,,,,,,,,"GGAAGCCACATCCTCT",,,"TCR alpha promoter DNA","2","3RI4"
,,,,,,,,,,,,,,,,"CAGAGGATGTGGCTTC",,,"TCR alpha promoter DNA","3","3RI4"
"3RIB",,"X-RAY DIFFRACTION",2.6,52.67,"hanging drop",6.5,"25% PEG 3350, 0.2M Lithium Sulfate, 0.1M Bis-Tris, pH 6.5, hanging drop, temperature 277K",277,"10.1093/jmcb/mjr015","SAH","3RIB",103.69,"2.79","2.79","Human lysine methyltransferase Smyd2 in complex with AdoHcy","MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESHLEHHHHHH","Homo sapiens","SMYD2, KMT3C","N-lysine methyltransferase SMYD2","1","3RIB"
"3RIC",,"X-RAY DIFFRACTION",2.22,44.61,,5.1,"15-20% PEG 3350, pH 5.1, VAPOR DIFFUSION, HANGING DROP, temperature 273K",273,"10.1016/j.str.2011.09.011",,"3RIC",24.8,"2.1","2.1","Crystal Structure of D48V||A47D mutant of Human Glycolipid Transfer Protein complexed with 3-O-sulfo-galactosylceramide containing nervonoyl acyl chain (24:1)","MALLAEHLLKPLPADKQIETGPFLEAVSHLPPFFDCLGSPVFTPIKDVISGNITKIKAVYDTNPAKFRTLQNILEVEKEMYGAEWPKVGATLALMWLKRGLRFIQVFLQSICDGERDENHPNLIRVNATKAYEMALKKYHGWIVQKIFQAALYAAPYKSDFLKALSKGQNVTEEECLEKIRLFLVNYTATIDVIYEMYTQMNAELNYKV","Homo sapiens","GLTP","Glycolipid transfer protein","1","3RIC"
"3RIG",,"X-RAY DIFFRACTION",2.26,45.48,"VAPOR DIFFUSION, HANGING DROP",9.5,"20% PEG 8000, 0.1M CHES, pH 9.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1126/science.1207861",,"3RIG",62.48,"2","2","Sirt5 is an NAD-dependent protein lysine demalonylase and desuccinylase","GSFTARPSSSMADFRKFFAKAKHIVIISGAGVSAESGVPTFRGAGGYWRKWQAQDLATPLAFAHNPSRVWEFYHYRREVMGSKEPNAGHRAIAECETRLGKQGRRVVVITQNIDELHRKAGTKNLLEIHGSLFKTRCTSCGVVAENYKSPICPALSGKGAPEPGTQDASIPVEKLPRCEEAGCGGLLRPHVVWFGENLDPAILEEVDRELAHCDLCLVVGTSSVVYPAAMFAPQVAARGVPVAEFNTETTPATNRFRFHFQGPCGTTLPEALA","Homo sapiens","SIR2L5, SIRT5","NAD-dependent deacetylase sirtuin-5","1","3RIG"
,,,,,,,,,,,,,,,,"KQTARXSTGGKA",,,"peptide of histone 3 thioacetyl-lysine 9","2","3RIG"
"3RII",,"X-RAY DIFFRACTION",2.04,39.77,"VAPOR DIFFUSION, HANGING DROP",8.5,"30% PEG 3350, 0.1M MgCl2, 0.1M Tris-HCl, pH 8.5, 3% Trimethyl amino oxide, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1111/j.1742-4658.2011.08393.x",,"3RII",52.81,"2.0008","2.0008","Crystal structure of the catalytic domain of UCHL5, a proteasome-associated human deubiquitinating enzyme, reveals an unproductive form of the enzyme","GPLGSMTGNAGEWCLMESDPGVFTELIKGFGCRGAQVEEIWSLEPENFEKLKPVHGLIFLFKWQPGEEPAGSVVQDSRLDTIFFAKQVINNASATQAIVSVLLNCTHQDVHLGETLSEFKEFSQSFDAAMKGLALSNSDVIRQVHNSFARQQMFEFDTKTSAKEEDAFHFVSYVPVNGRLYELDGLREGPIDLGACNQDDWISAVRPVIEKRIQKYSEGEIRFNLMAIVSDRK","Homo sapiens","AD-019, CGI-70, UCH37, UCHL5","Ubiquitin carboxyl-terminal hydrolase isozyme L5","1","3RII"
"3RIK",,"X-RAY DIFFRACTION",3.16,61.1,,4.6,"11-12% PEG 3350, 0.18-0.205 M ammonium sulfate, and 0.1 M acetate buffer, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1021/bi201619z","3RI","3RIK",227.13,"2.48","2.48","The acid beta-glucosidase active site exhibits plasticity in binding 3,4,5,6-tetrahydroxyazepane-based inhibitors: implications for pharmacological chaperone design for gaucher disease","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ","Homo sapiens","GBA, GC, GLUC","Glucosylceramidase","1","3RIK"
"3RIL",,"X-RAY DIFFRACTION",3.2,61.54,"VAPOR DIFFUSION, HANGING DROP",4.6,"11-12% PEG 3350, 0.18-0.205 M ammonium sulfate, and 0.1 M acetate buffer, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1021/bi201619z","3RK","3RIL",227.56,"2.4","2.4","The acid beta-glucosidase active site exhibits plasticity in binding 3,4,5,6-tetrahydroxyazepane-based inhibitors: implications for pharmacological chaperone design for gaucher disease","ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ","Homo sapiens","GBA, GC, GLUC","Glucosylceramidase","1","3RIL"
"3RIN",,"X-RAY DIFFRACTION",3.01,59.18,"VAPOR DIFFUSION, HANGING DROP",6.5,"22% PEG3350, 0.2 M sodium chloride, 1 mM THP, 0.1 M Bis-Tris, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2011.05.114","I2O","3RIN",41.7,"2.2","2.2","p38 kinase crystal structure in complex with small molecule inhibitor","MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","CSBP, CSBP1, CSBP2, CSPB1, MAPK14, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","3RIN"
"3RIP",,"X-RAY DIFFRACTION",5.56,77.87,"VAPOR DIFFUSION, HANGING DROP",8,"8-10% MPD (2-methyl-2,4-pentanediol), 0-20% glycerol (w/v), 300-400 mM Tris-Hcl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 285K",285,"10.1038/nsmb.2083",,"3RIP",78.35,"2.3","2.3","Crystal Structure of human gamma-tubulin complex protein 4 (GCP4)","MIHELLLALSGYPGSIFTWNKRSGLQVSQDFPFLHPSETSVLNRLCRLGTDYIRFTEFIEQYTGHVQQQDHHPSQQGQGGLHGIYLRAFCTGLDSVLQPYRQALLDLEQEFLGDPHLSISHVNYFLDQFQLLFPSVMVVVEQIKSQKIHGCQILETVYKHSCGGLPPVRSALEKILAVCHGVMYKQLSAWMLHGLLLDQHEEFFIKQGPSSGNVSAQPEEDEEDLGIGGLTGKQLRELQDLRLIEEENMLAPSLKQFSLRVEILPSYIPVRVAEKILFVGESVQMFENQNVNLTRKGSILKNQEDTFAAELHRLKQQPLFSLVDFEQVVDRIRSTVAEHLWKLMVEESDLLGQLKIIKDFYLLGRGELFQAFIDTAQHMLKTPPTAVTEHDVNVAFQQSAHKVLLDDDNLLPLLHLTIEYHGKEHKDATQAREGPSRETSPREAPASGWAALGLSYKVQWPLHILFTPAVLEKYNVVFKYLLSVRRVQAELQHCWALQMQRKHLKSNQTDAIKWRLRNHMAFLVDNLQYYLQVDVLESQFSQLLHQINSTRDFESIRLAHDHFLSNLLAQSFILLKPVFHCLNEILDLCHSFCSLVSQNLGPLDERGAAQLSILVKGFSRQSSLLFKILSSVRNHQINSDLAQLLLRLDYNKYYTQAGGTLGSFGMCGRLEHHHHHH","Homo sapiens","TUBGCP4, 76P, GCP4","Gamma-tubulin complex component 4","1","3RIP"
"3RIS",,"X-RAY DIFFRACTION",2.29,46.21,"VAPOR DIFFUSION, HANGING DROP",8.5,"1.6 M Ammonium sulfate, 0.1 M Tris-HCl, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1111/j.1742-4658.2011.08393.x",,"3RIS",110.85,"2.398","2.398","Crystal structure of the catalytic domain of UCHL5, a proteasome-associated human deubiquitinating enzyme, reveals an unproductive form of the enzyme","GPLGSMTGNAGEWCLMESDPGVFTELIKGFGCRGAQVEEIWSLEPENFEKLKPVHGLIFLFKWQPGEEPAGSVVQDSRLDTIFFAKQVINNACATQAIVSVLLNCTHQDVHLGETLSEFKEFSQSFDAAMKGLALSNSDVIRQVHNSFARQQMFEFDTKTSAKEEDAFHFVSYVPVNGRLYELDGLREGPIDLGACNQDDWISAVRPVIEKRIQKYSEGEIRFNLMAIVSDRKMIYEQKIAELQR","Homo sapiens","AD-019, CGI-70, UCH37, UCHL5","Ubiquitin carboxyl-terminal hydrolase isozyme L5","1","3RIS"
"3RIY",,"X-RAY DIFFRACTION",2.3,46.63,"VAPOR DIFFUSION, HANGING DROP",,"16% PEG 4000, 6% Glycerol, vapor diffusion, hanging drop, temperature 298K",298,"10.1126/science.1207861",,"3RIY",63.48,"1.55","1.55","Sirt5 is an NAD-dependent protein lysine demalonylase and desuccinylase","GSFTARPSSSMADFRKFFAKAKHIVIISGAGVSAESGVPTFRGAGGYWRKWQAQDLATPLAFAHNPSRVWEFYHYRREVMGSKEPNAGHRAIAECETRLGKQGRRVVVITQNIDELHRKAGTKNLLEIHGSLFKTRCTSCGVVAENYKSPICPALSGKGAPEPGTQDASIPVEKLPRCEEAGCGGLLRPHVVWFGENLDPAILEEVDRELAHCDLCLVVGTSSVVYPAAMFAPQVAARGVPVAEFNTETTPATNRFRFHFQGPCGTTLPEALA","Homo sapiens","SIR2L5, SIRT5","NAD-dependent deacetylase sirtuin-5","1","3RIY"
,,,,,,,,,,,,,,,,"KQTARXSTGGKA",,,"peptide of histone 3 N-succinyl lysine 9","2","3RIY"
"3RJ7",,"X-RAY DIFFRACTION",2.11,41.75,"VAPOR DIFFUSION, HANGING DROP",8,"2.4 M ammonium sulfate, 0.1 M Tris-HCl, pH 8.0, 1 mM 4-hydroxymercuribenzoic acid, 5% v/v DMSO, 4 weeks at 298K, 2 weeks at 277K, 4 weeks again at 298K, VAPOR DIFFUSION, HANGING DROP",,"10.1002/anie.201107333","RCS","3RJ7",30.63,"1.2","1.2","Human carbonic anhydrase II complexed with its inhibitor rhenium(I)triscarbonyl-cyclopentadienyl-carboxy-4-aminomethylbenzene-sulfonamide","HHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3RJ7"
"3RJC",,"X-RAY DIFFRACTION",1.97,37.55,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","06Z","3RJC",35.07,"1.85","1.85","CDK2 in complex with inhibitor L4-12","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3RJC"
"3RJD",,"X-RAY DIFFRACTION",3.83,67.9,"VAPOR DIFFUSION, HANGING DROP",,"10% PEG8000 and 10% PEG1000, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M111.257550",,"3RJD",32.35,"2.65","2.65","Crystal structure of Fc RI and its implication to high affinity immunoglobulin G binding","KAVITLQPPWVSVFQEETVTLHCEVLHLPGSSSTQWFLNGTATQTSTPSYRITSASVNDSGEYRCQRGLSGRSDPIQLEIHRGWLLLQVSSRVFTEGEPLALRCHAWKDKLVYNVLYYRNGKAFKFFHWNSNLTILKTNISHNGTYHCSGMGKHRYTSAGISVTVKELFPAPVLNASVTSPLLEGNLVTLSCETKLLLQRPGLQLYFSFYMGSKTLRGRNTSSEYQILTARREDSGLYWCEAATEDGNVLKRSPELELQVLG","Homo sapiens","FCGR1A, FCG1, FCGR1, IGFR1","High affinity immunoglobulin gamma Fc receptor I","1","3RJD"
"3RJE",,"X-RAY DIFFRACTION",2.39,48.53,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM Imidazole, pH 7.5 
350 mM Sodium Acetate 
18 % PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1073/pnas.1112235108",,"3RJE",47.81,"2.1","2.1","Ternary complex of DNA Polymerase Beta with a gapped DNA containing 8odG at template position","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","3RJE"
,,,,,,,,,,,,,,,,"CCGACGTCGCATCAGC",,,"DNA (5'-D(*CP*CP*GP*AP*CP*(8OG)P*TP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3')","2","3RJE"
,,,,,,,,,,,,,,,,"GCTGATGCGA",,,"DNA (5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*A)-3')","3","3RJE"
,,,,,,,,,,,,,,,,"GTCGG",,,"DNA (5'-D(P*GP*TP*CP*GP*G)-3')","4","3RJE"
"3RJF",,"X-RAY DIFFRACTION",2.24,45.1,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM Imidazole, pH 7.5 
350 mM Sodium Acetate 
18 % PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1073/pnas.1112235108","F2A","3RJF",48.45,"2.3","2.3","Ternary complex of DNA Polymerase Beta with a gapped DNA containing (syn)8odG at template position paired with non-hydrolyzable dATP analog (dApCPP)","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","3RJF"
,,,,,,,,,,,,,,,,"CCGACGTCGCATCAGC",,,"DNA (5'-D(*CP*CP*GP*AP*CP*(8OG)P*TP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3')","2","3RJF"
,,,,,,,,,,,,,,,,"GCTGATGCGA",,,"DNA (5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*A)-3')","3","3RJF"
,,,,,,,,,,,,,,,,"GTCGG",,,"DNA (5'-D(P*GP*TP*CP*GP*G)-3')","4","3RJF"
"3RJG",,"X-RAY DIFFRACTION",2.41,48.98,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM Imidazole, pH 7.5, 350 mM Sodium Acetate, 18 % PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1073/pnas.1112235108",,"3RJG",47.79,"2","2","Binary complex of DNA Polymerase Beta with a gapped DNA containing 8odG:dA base-pair at primer Terminus","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","3RJG"
,,,,,,,,,,,,,,,,"CCGACGGCGCATCAGC",,,"DNA (5'-D(*CP*CP*GP*AP*CP*GP*(8OG)P*CP*GP*CP*AP*TP*CP*AP*GP*C)-3')","2","3RJG"
,,,,,,,,,,,,,,,,"GCTGATGCGA",,,"DNA (5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*A)-3')","3","3RJG"
,,,,,,,,,,,,,,,,"GTCGG",,,"DNA (5'-D(P*GP*TP*CP*GP*G)-3')","4","3RJG"
"3RJH",,"X-RAY DIFFRACTION",2.23,44.84,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM Imidazole, pH 7.5, 350 mM Sodium Acetate, 18 % PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1073/pnas.1112235108",,"3RJH",48.49,"2.2","2.2","Ternary complex of DNA Polymerase Beta with a gapped DNA containing (syn)8odG:dA at primer terminus and dG:dCMP(CF2)PPin the active site","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","3RJH"
,,,,,,,,,,,,,,,,"CCGACGGCGCATCAGC",,,"DNA (5'-D(*CP*CP*GP*AP*CP*GP*(8OG)P*CP*GP*CP*AP*TP*CP*AP*GP*C)-3')","2","3RJH"
,,,,,,,,,,,,,,,,"GCTGATGCGA",,,"DNA (5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*A)-3')","3","3RJH"
,,,,,,,,,,,,,,,,"GTCGG",,,"DNA (5'-D(P*GP*TP*CP*GP*G)-3')","4","3RJH"
"3RJI",,"X-RAY DIFFRACTION",2.26,45.65,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM Imidazole, pH 7.5, 350 mM Sodium Acetate, 18 % PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1073/pnas.1112235108",,"3RJI",48.39,"2.3","2.3","Ternary complex of DNA Polymerase Beta with a gapped DNA containing 8odG at template position paired with non-hydrolyzable dCTP analog (dCMP(CF2)PP)","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","3RJI"
,,,,,,,,,,,,,,,,"CCGACGTCGCATCAGC",,,"DNA (5'-D(*CP*CP*GP*AP*CP*(8OG)P*TP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3')","2","3RJI"
,,,,,,,,,,,,,,,,"GCTGATGCGA",,,"DNA (5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*A)-3')","3","3RJI"
,,,,,,,,,,,,,,,,"GTCGG",,,"DNA (5'-D(P*GP*TP*CP*GP*G)-3')","4","3RJI"
"3RJJ",,"X-RAY DIFFRACTION",2.4,48.71,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM Imidazole, pH 7.5, 350 mM Sodium Acetate, 18 % PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1073/pnas.1112235108",,"3RJJ",47.77,"2","2","Ternary complex crystal structure of DNA Polymerase Beta with template 8odG provides insight into mutagenic lesion bypass","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","3RJJ"
,,,,,,,,,,,,,,,,"CCGACGGCGCATCAGC",,,"DNA (5'-D(*CP*CP*GP*AP*CP*GP*(8OG)P*CP*GP*CP*AP*TP*CP*AP*GP*C)-3')","2","3RJJ"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"DNA (5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*C)-3')","3","3RJJ"
,,,,,,,,,,,,,,,,"GTCGG",,,"DNA (5'-D(P*GP*TP*CP*GP*G)-3')","4","3RJJ"
"3RJK",,"X-RAY DIFFRACTION",2.24,45.17,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM Imidazole, pH 7.5, 350 mM Sodium Acetate, 18 % PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1073/pnas.1112235108",,"3RJK",48.43,"2.1","2.1","Ternary complex of DNA Polymerase Beta with a gapped DNA containing 8odG:dC base pair at primer terminus and dG:dCMP(CF2)PP in the active site","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","3RJK"
,,,,,,,,,,,,,,,,"CCGACGGCGCATCAGC",,,"DNA (5'-D(*CP*CP*GP*AP*CP*GP*(8OG)P*CP*GP*CP*AP*TP*CP*AP*GP*C)-3')","2","3RJK"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"DNA (5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*C)-3')","3","3RJK"
,,,,,,,,,,,,,,,,"GTCGG",,,"DNA (5'-D(P*GP*TP*CP*GP*G)-3')","4","3RJK"
"3RJO",,"X-RAY DIFFRACTION",2.74,55.12,,8.5,"12% PEG 6000, 0.2M MgCl, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/srep00186",,"3RJO",48.84,"2.3","2.3","Crystal Structure of ERAP1 Peptide Binding Domain","GFPLITITVRGRNVHMKQEHYMKGSDGAPDTGYLWHVPLTFITSKSDMVHRFLLKTKTDVLILPEEVEWIKFNVGMNGYYIVHYEDDGWDSLTGLLKGTHTAVSSNDRASLINNAFQLVSIGKLSIEKALDLSLYLKHETEIMPVFQGLNELIPMYKLMEKRDMNEVETQFKAFLIRLLRDLIDKQTWTDEGSVSERMLRSQLLLLACVHNYQPCVQRAEGYFRKWKESNGNLSLPVDVTLAVFAVGAQSTEGWDFLYSKYQFSLSSTEKSQIEFALCRTQNKEKLQWLLDESFKGDKIKTQEFPQILTLIGRNPVGYPLAWQFLRKNWNKLVQKFELGSSSIAHMVMGTTNQFSTRTRLEEVKGFFSSLKENGSQLRCVQQTIETIEENIGWMDKNFDKIRVWLQSEKLERMHHHHHH","Homo sapiens","ERAP1, APPILS, ARTS1, KIAA0525, UNQ584/PRO1154","Endoplasmic reticulum aminopeptidase 1","1","3RJO"
"3RJW",,"X-RAY DIFFRACTION",2.4,47.9,"VAPOR DIFFUSION",6.5,"0.2M SODIUM FORMATE, 10% ETHYLENE GLYCOL, 25% PEG-3350, 0.1M BIS-TRIS PROPANE, pH 6.5, vapor diffusion, temperature 291K",291,"10.1038/nchembio.599","CIQ, SAH","3RJW",67.52,"2.56","2.56","Crystal structure of histone lysine methyltransferase g9a with an inhibitor","GSNRAIRTEKIICRDVARGYENVPIPCVNGVDGEPCPEDYKYISENCETSTMNIDRNITHLQHCTCVDDCSSSNCLCGQLSIRCWYDKDGRLLQEFNKIEPPLIFECNQACSCWRNCKNRVVQSGIKVRLQLYRTAKMGWGVRALQTIPQGTFICEYVGELISDAEADVREDDSYLFDLDNKDGEVYCIDARYYGNISRFINHLCDPNIIPVRVFMLHQDLRFPRIAFFSSRDIRTGEELGFDYGDRFWDIKSKYFTCQCGSEKCKHSAEAIALEQSRLARLD","Homo sapiens","EHMT2, BAT8, C6orf30, G9A, KMT1C, NG36","Histone-lysine N-methyltransferase EHMT2","1","3RJW"
"3RK5",,"X-RAY DIFFRACTION",2,38.37,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","07Z","3RK5",35.1,"2","2","CDK2 in complex with inhibitor RC-2-72","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3RK5"
"3RK6",,"X-RAY DIFFRACTION",2.61,52.87,"VAPOR DIFFUSION, SITTING DROP",6.5,"18% PEG20000, 0.1 M MES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bbrc.2011.04.088",,"3RK6",52.96,"2","2","Crystal structure of the middle domain of human Paip1","GSHMASMTGGQQMGRGSTLSEYVQDFLNHLTEQPGSFETEIEQFAETLNGCVTTDDALQELVELIYQQATSIPNFSYMGARLCNYLSHHLTISPQSGNFRQLLLQRCRTEYEVKDQAAKGDEVTRKRFHAFVLFLGELYLNLEIKGTNGQVTRADILQVGLRELLNALFSNPMDDNLICAVKLLKLTGSVLEDAWKEKGKMDMEEIIQRIENVVLDANCSRDVKQMLLKLVELR","Homo sapiens","PAIP1","Polyadenylate-binding protein-interacting protein 1","1","3RK6"
"3RK7",,"X-RAY DIFFRACTION",2.01,38.7,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","08Z","3RK7",35.16,"1.8","1.8","CDK2 in complex with inhibitor RC-2-71","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3RK7"
"3RK9",,"X-RAY DIFFRACTION",2,38.58,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","09Z","3RK9",35.02,"1.85","1.85","CDK2 in complex with inhibitor RC-2-74","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3RK9"
"3RKB",,"X-RAY DIFFRACTION",2,38.65,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","12Z","3RKB",35.13,"2","2","CDK2 in complex with inhibitor RC-2-73","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3RKB"
"3RKQ",,"X-RAY DIFFRACTION",2.68,54.15,"VAPOR DIFFUSION, HANGING DROP",7,"50mM Tris pH 7.0, 5mM MgCl2, 15% polyethylene glycol monomethyl ether 550 , VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi300849c",,"3RKQ",25.93,"1.7","1.7","NKX2.5 Homeodomain dimer bound to ANF-242 DNA","GRRKPRVLFSQAQVYELERRFKQQRYLSAPERDQLASVLKLTSTQVKIWFQNRRYKSK","Homo sapiens","NKX2-5, CSX, NKX2.5, NKX2E","Homeobox protein Nkx-2.5","1","3RKQ"
,,,,,,,,,,,,,,,,"TGAAGTGGGGGCCTCTTGA",,,"ANF-242 DNA","2","3RKQ"
,,,,,,,,,,,,,,,,"TCAAGAGGCCCCCACTTCA",,,"ANF-242 DNA","3","3RKQ"
"3RKZ",,"X-RAY DIFFRACTION",2.91,57.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG3350, 0.200 M MAGNESIUM FORMATE, pH 7.5, TEMPERATURE 277K; FROZEN BY 1-STEP TRANSFER TO 25% GLYCEROL, 15% PEG3350, 0.15M MAGNESIUM FORMATE, VAPOR DIFFUSION, HANGING DROP",277,"10.1016/j.bmcl.2011.05.102","06T","3RKZ",25.91,"1.5693","1.5693","Discovery of a stable macrocyclic o-aminobenzamide Hsp90 inhibitor capable of significantly decreasing tumor volume in a mouse xenograft model.","QPMEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90A, HSP90AA1, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3RKZ"
"3RLD",,"X-RAY DIFFRACTION",2.15,42.89,"VAPOR DIFFUSION, HANGING DROP",8,"1.7 M sodium citrate, 100 mM Tris, droplet is 1:1 mixture of the protein and reservoir, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.abb.2010.12.004","SO4","3RLD",29.59,"1.5","1.5","Crystal structure of the Y7I mutant of human carbonic anhydrase II","MSHHWGIGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3RLD"
"3RLE",,"X-RAY DIFFRACTION",2.59,52.59,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M imidazole, 0.2M Ammonium Acetate, 25% PEG 400, 10% PEG 20000, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1074/jbc.C111.245324",,"3RLE",22.99,"1.649","1.649","Crystal Structure of GRASP55 GRASP domain (residues 7-208)","GMGSSQSVEIPGGGTEGYHVLRVQENSPGHRAGLEPFFDFIVSINGSRLNKDNDTLKDLLKANVEKPVKMLIYSSKTLELRETSVTPSNLWGGQGLLGVSIRFCSFDGANENVWHVLEVESNSPAALAGLRPHSDYIIGADTVMNESEDLFSLIETHEAKPLKLYVYNTDTDNCREVIITPNSAWGGEGSLGCGIGYGYLHRIPTRPFE","Homo sapiens","GORASP2, GOLPH6","Golgi reassembly-stacking protein 2","1","3RLE"
"3RLJ",,"X-RAY DIFFRACTION",2.21,44.3,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.5 M Sodium Citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm2000097",,"3RLJ",29.21,"1.9","1.9","Crystal structure of the androgen receptor ligand binding domain in complex with SARM S-22","PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFH","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","3RLJ"
"3RLL",,"X-RAY DIFFRACTION",2.2,44.01,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.5 M Sodium Citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm2000097",,"3RLL",29.23,"1.7","1.7","Crystal structure of the T877A androgen receptor ligand binding domain in complex with (S)-N-(4-Cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanonaphthalen-1-yloxy)-2-hydroxy-2-methylpropanamide","PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFAFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFH","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","3RLL"
"3RLN",,"X-RAY DIFFRACTION",2.41,48.94,"VAPOR DIFFUSION, HANGING DROP",7,"0.2 M KCl, 20% PEG3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.immuni.2012.02.014",,"3RLN",22.41,"2.251","2.251","Structural Basis of Cytosolic DNA Recognition by Innate Immune Receptors","GSVDDSAQSDLKEVMVLNATESFVYEPKEQKKMFHATVATENEVFRVKVFNIDLKEKFTPKKIIAIANYVCRNGFLEVYPFTLVADVNADRNMEIPAGLIASASVTPKINQLCSQTKGSFVNGVFEVHKKNVRGEFTYYEIQDATGKMEVVVHGRLTTINCEEGDKLKLTCFELAPKSGNTGELRSVIHSHIKVIKTRKN","Homo sapiens","IFI16, IFNGIP1","Gamma-interferon-inducible protein 16","1","3RLN"
"3RLO",,"X-RAY DIFFRACTION",2.4,48.67,"VAPOR DIFFUSION, HANGING DROP",6,"20% PEG1500, 10 mM MgCl2, 0.1 M MES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.immuni.2012.02.014",,"3RLO",23.5,"1.8","1.8","Structural Basis of Cytosolic DNA Recognition by Innate Receptors","GSVDDSAQSDLKEVMVLNATESFVYEPKEQKKMFHATVATENEVFRVKVFNIDLKEKFTPKKIIAIANYVCRNGFLEVYPFTLVADVNADRNMEIPKGLIRSASVTPKINQLCSQTKGSFVNGVFEVHKKNVRGEFTYYEIQDNTGKMEVVVHGRLTTINCEEGDKLKLTCFELAPKSGNTGELRSVIHSHIKVIKTRKNAAAS","Homo sapiens","IFI16, IFNGIP1","Gamma-interferon-inducible protein 16","1","3RLO"
"3RLP",,"X-RAY DIFFRACTION",2.09,41.22,"VAPOR DIFFUSION, HANGING DROP",4.3,"5% Ethylene glycol, 0.1 M phosphate-citrate, pH 4.3, 20 mM TCEP, 13 C, VAPOR DIFFUSION, HANGING DROP, temperature 286K",286,"10.1016/j.bmcl.2011.04.130","3RP","3RLP",51.83,"1.7","1.7","Co-crystal structure of the HSP90 ATP binding domain in complex with 4-(2,4-dichloro-5-methoxyphenyl)-6-methylpyrimidin-2-amine","MDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKELEHHHHHH","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3RLP"
"3RLQ",,"X-RAY DIFFRACTION",2.08,40.96,"VAPOR DIFFUSION, HANGING DROP",4.3,"30% Ethylene glycol, 0.1 M phosphate-citrate, pH 4.3, 20 mM TCEP, 13 C, VAPOR DIFFUSION, HANGING DROP, temperature 286K",286,"10.1016/j.bmcl.2011.04.130","3RQ","3RLQ",51.93,"1.9","1.9","Co-crystal structure of the HSP90 ATP binding domain in complex with 4-(2,4-dichloro-5-methoxyphenyl)-2-methyl-7H-pyrrolo[2,3-d]pyrimidine-5- carbonitrile","MDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKELEHHHHHH","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3RLQ"
"3RLR",,"X-RAY DIFFRACTION",2.05,40.13,"VAPOR DIFFUSION, HANGING DROP",4.3,"5% Ethylene glycol, 0.1 M phosphate-citrate, pH 4.3, 20 mM TCEP, 21 C, VAPOR DIFFUSION, HANGING DROP, temperature 286K",286,"10.1016/j.bmcl.2011.04.130","3RR","3RLR",51.96,"1.7","1.7","Co-crystal structure of the HSP90 ATP binding domain in complex with 4-(2,4-dichloro-5-methoxyphenyl)-2,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile","MDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKELEHHHHHH","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3RLR"
"3RM4",,"X-RAY DIFFRACTION",2.04,39.64,"VAPOR DIFFUSION, HANGING DROP",6.5,"pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm100533p","3RM","3RM4",89.14,"1.9","1.9","AMCase in complex with Compound 1","YQLTCYFTNWAQYRPGLGRFMPDDINPCLCTHLIYAFAGMQNNEITTIEWNDVTLYQAFNGLKNKNSQLKTLLAIGGWNFGTAPFTAMVSTPENRQTFITSVIKFLRQYEFDGLDFDWEYPGSRGSPPQDKHLFTVLVQEMREAFEQEAKQINKPRLMVTAAVAAGISNIQSGYEIPQLSQYLDYIHVMTYDLHGSWEGYTGENSPLYKYPTDTGSNAYLNVDYVMNYWKDNGAPAEKLIVGFPTYGHNFILSNPSNTGIGAPTSGAGPAGPYAKESGIWAYYEICTFLKNGATQGWDAPQEVPYAYQGNVWVGYDNVKSFDIKAQWLKHNKFGGAMVWAIDLDDFTGTFCNQGKFPLISTLKKALGLQSASCTAPAQPIEPITAAPGSHHHHHH","Homo sapiens","CHIA","Acidic mammalian chitinase","1","3RM4"
"3RM6",,"X-RAY DIFFRACTION",2.05,39.9,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3RM6",35.24,"1.6","1.6","CDK2 in complex with inhibitor KVR-2-80","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3RM6"
"3RM7",,"X-RAY DIFFRACTION",2,38.52,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3RM7",35.11,"1.85","1.85","CDK2 in complex with inhibitor KVR-1-91","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3RM7"
"3RM8",,"X-RAY DIFFRACTION",2.02,39.17,"VAPOR DIFFUSION, HANGING DROP",6.5,"pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm100533p","RM8","3RM8",89.02,"1.8","1.8","AMCase in complex with Compound 2","YQLTCYFTNWAQYRPGLGRFMPDDINPCLCTHLIYAFAGMQNNEITTIEWNDVTLYQAFNGLKNKNSQLKTLLAIGGWNFGTAPFTAMVSTPENRQTFITSVIKFLRQYEFDGLDFDWEYPGSRGSPPQDKHLFTVLVQEMREAFEQEAKQINKPRLMVTAAVAAGISNIQSGYEIPQLSQYLDYIHVMTYDLHGSWEGYTGENSPLYKYPTDTGSNAYLNVDYVMNYWKDNGAPAEKLIVGFPTYGHNFILSNPSNTGIGAPTSGAGPAGPYAKESGIWAYYEICTFLKNGATQGWDAPQEVPYAYQGNVWVGYDNVKSFDIKAQWLKHNKFGGAMVWAIDLDDFTGTFCNQGKFPLISTLKKALGLQSASCTAPAQPIEPITAAPGSHHHHHH","Homo sapiens","CHIA","Acidic mammalian chitinase","1","3RM8"
"3RM9",,"X-RAY DIFFRACTION",2.04,39.68,"VAPOR DIFFUSION, HANGING DROP",6.5,"pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm100533p","613","3RM9",88.88,"2.1","2.1","AMCase in complex with Compound 3","YQLTCYFTNWAQYRPGLGRFMPDDINPCLCTHLIYAFAGMQNNEITTIEWNDVTLYQAFNGLKNKNSQLKTLLAIGGWNFGTAPFTAMVSTPENRQTFITSVIKFLRQYEFDGLDFDWEYPGSRGSPPQDKHLFTVLVQEMREAFEQEAKQINKPRLMVTAAVAAGISNIQSGYEIPQLSQYLDYIHVMTYDLHGSWEGYTGENSPLYKYPTDTGSNAYLNVDYVMNYWKDNGAPAEKLIVGFPTYGHNFILSNPSNTGIGAPTSGAGPAGPYAKESGIWAYYEICTFLKNGATQGWDAPQEVPYAYQGNVWVGYDNVKSFDIKAQWLKHNKFGGAMVWAIDLDDFTGTFCNQGKFPLISTLKKALGLQSASCTAPAQPIEPITAAPGSHHHHHH","Homo sapiens","CHIA","Acidic mammalian chitinase","1","3RM9"
"3RME",,"X-RAY DIFFRACTION",2.03,39.53,"VAPOR DIFFUSION, HANGING DROP",6.5,"pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm100533p","RME","3RME",89.09,"1.8","1.8","AMCase in complex with Compound 5","YQLTCYFTNWAQYRPGLGRFMPDDINPCLCTHLIYAFAGMQNNEITTIEWNDVTLYQAFNGLKNKNSQLKTLLAIGGWNFGTAPFTAMVSTPENRQTFITSVIKFLRQYEFDGLDFDWEYPGSRGSPPQDKHLFTVLVQEMREAFEQEAKQINKPRLMVTAAVAAGISNIQSGYEIPQLSQYLDYIHVMTYDLHGSWEGYTGENSPLYKYPTDTGSNAYLNVDYVMNYWKDNGAPAEKLIVGFPTYGHNFILSNPSNTGIGAPTSGAGPAGPYAKESGIWAYYEICTFLKNGATQGWDAPQEVPYAYQGNVWVGYDNVKSFDIKAQWLKHNKFGGAMVWAIDLDDFTGTFCNQGKFPLISTLKKALGLQSASCTAPAQPIEPITAAPGSHHHHHH","Homo sapiens","CHIA","Acidic mammalian chitinase","1","3RME"
"3RMF",,"X-RAY DIFFRACTION",2.02,39.12,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","20Z","3RMF",35.19,"1.75","1.75","CDK2 in complex with inhibitor RC-2-33","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3RMF"
"3RMU",,"X-RAY DIFFRACTION",2.37,48.11,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% PEG smears (PEG400, PEG550 MME, PEG600, PEG1000), 0.1 M Tris, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,,,"3RMU",59.39,"1.8","1.8","Crystal structure of human Methylmalonyl-CoA epimerase, MCEE","SMLGRLNHVAIAVPDLEKAAAFYKNILGAQVSEAVPLPEHGVSVVFVNLGNTKMELLHPLGLDSPIAGFLQKNKAGGMHHICIEVDNINAAVMDLKKKKIRSLSEEVKIGAHGKPVIFLHPKDCGGVLVELEQA","Homo sapiens","MCEE","Methylmalonyl-CoA epimerase, mitochondrial","1","3RMU"
"3RMV",,"X-RAY DIFFRACTION",2.35,47.57,"VAPOR DIFFUSION, SITTING DROP",7.5,"28% PEG smears (PEG 2k, 3350, 4k, 5kMME), 0.05M MgSO4, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1073/pnas.1113921108",,"3RMV",30.25,"1.82","1.82","Crystal Structure of Human Glycogenin-1 (GYG1) T83M mutant complexed with manganese and UDP","SMTDQAFVTLTTNDAYAKGALVLGSSLKQHRTTRRLVVLATPQVSDSMRKVLETVFDEVIMVDVLDSGDSAHLTLMKRPELGVMLTKLHCWSLTQYSKCVFMDADTLVLANIDDLFDREELSAAPDPGWPDCFNSGVFVYQPSVETYNQLLHLASEQGSFDGGDQGILNTFFSSWATTDIRKHLPFIYNLSSISIYSYLPAFKVFGASAKVVHFLGRVKPWNYTYDPKTKSVKSEAHDPNMTHPEFLILWWNIFTTNVLPLLQ","Homo sapiens","GYG, GYG1","Glycogenin-1","1","3RMV"
"3RMW",,"X-RAY DIFFRACTION",2.36,47.89,"VAPOR DIFFUSION, SITTING DROP",8,"25% PEG smears (PEG 6k, 8k, 10k), 0.2M MgCl2, 10% glycerol, 0.1M Tris, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1073/pnas.1113921108",,"3RMW",31.03,"1.93","1.93","Crystal Structure of Human Glycogenin-1 (GYG1) T83M mutant complexed with manganese and UDP-glucose","SMTDQAFVTLTTNDAYAKGALVLGSSLKQHRTTRRLVVLATPQVSDSMRKVLETVFDEVIMVDVLDSGDSAHLTLMKRPELGVMLTKLHCWSLTQYSKCVFMDADTLVLANIDDLFDREELSAAPDPGWPDCFNSGVFVYQPSVETYNQLLHLASEQGSFDGGDQGILNTFFSSWATTDIRKHLPFIYNLSSISIYSYLPAFKVFGASAKVVHFLGRVKPWNYTYDPKTKSVKSEAHDPNMTHPEFLILWWNIFTTNVLPLLQ","Homo sapiens","GYG, GYG1","Glycogenin-1","1","3RMW"
"3RN2",,"X-RAY DIFFRACTION",2.42,49.21,"VAPOR DIFFUSION, HANGING DROP",6.5,"8% PEG1000, 0.1 M KCl, 10 mM MgCl2, 0.1 M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.immuni.2012.02.014",,"3RN2",59.6,"2.55","2.55","Structural Basis of Cytosolic DNA Recognition by Innate Immune Receptors","GSVDSIREGFQKRCLPVMVLKAKKPFTFETQEGKQEMFHATVATEKEFFFVKVFNTLLKDKFIPKRIIIIARYYRHSGFLEVNSASRVLDAESDQKVNVPLNIIRKAGETPKINTLQTQPLGTIVNGLFVVQKVTEKKKNILFDLSDNTGKMEVLGVRNEDTMKCKEGDKVRLTFFTLSKNGEKLQLTSGVHSTIKVIKAKKKTAAAS","Homo sapiens","AIM2","Interferon-inducible protein AIM2","1","3RN2"
,,,,,,,,,,,,,,,,"CCATCAAAGATCTTTGATGG",,,"DNA (5'-D(*CP*CP*AP*TP*CP*AP*AP*AP*GP*AP*TP*CP*TP*TP*TP*GP*AP*TP*GP*G)-3')","2","3RN2"
"3RN5",,"X-RAY DIFFRACTION",2.79,55.98,"VAPOR DIFFUSION, HANGING DROP",6.5,"8% PEG1000, 0.1 M KCl, 10 mM MgCl2, 0.1 M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.immuni.2012.02.014",,"3RN5",117.78,"2.5","2.5","Structural basis of cytosolic DNA recognition by innate immune receptors","GSVDSIREGFQKRCLPVMVLKAKKPFTFETQEGKQEMFHATVATEKEFFFVKVFNTLLKDKFIPKRIIIIARYYRHSGFLEVNSASRVLDAESDQKVNVPLNIIRKAGETPKINTLQTQPLGTIVNGLFVVQKVTEKKKNILFDLSDNTGKMEVLGVRNEDTMKCKEGDKVRLTFFTLSKNGEKLQLTSGVHSTIKVIKAKKKTAAAS","Homo sapiens","AIM2","Interferon-inducible protein AIM2","1","3RN5"
,,,,,,,,,,,,,,,,"CCATCAAAGAGAGAAAGAG",,,"DNA (5'-D(*CP*CP*AP*TP*CP*AP*AP*AP*GP*AP*GP*AP*GP*AP*AP*AP*GP*AP*G)-3')","2","3RN5"
,,,,,,,,,,,,,,,,"GCTCTTTCTCTCTTTGATG",,,"DNA (5'-D(*GP*CP*TP*CP*TP*TP*TP*CP*TP*CP*TP*CP*TP*TP*TP*GP*AP*TP*G)-3')","3","3RN5"
"3RN8",,"X-RAY DIFFRACTION",2.37,48.17,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG8000, Sodium Cacodylate, Zinc Acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1124/mol.110.070243",,"3RN8",94.6,"1.7","1.7","Crystal Structure of iGluR2 Ligand Binding Domain and Symmetrical Carboxyl Containing Potentiator","RGANKTVVVTTILESPYVMMKKNHEMLEGNERYEGYCVDLAAEIAKHCGFKYKLTIVGDGKYGARDADTKIWNGMVGELVYGKADIAIAPLTITLVREEVIDFSKPFMSLGISIMIKKGTPIESAEDLSKQTEIAYGTLDSGSTKEFFRRSKIAVFDKMWTYMRSAEPSVFVRTTAEGVARVRKSKGKYAYLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGIATPKGSSLGNAVNLAVLKLNEQGLLDKLKNKWWYDKGECGSGGGDSKEKTSALSLSN","Homo sapiens","GRIA2, GLUR2","Glutamate receptor 2","1","3RN8"
,,,,,,,,,,,,,,,,,"Homo sapiens","GRIA2, GLUR2"
"3RNI",,"X-RAY DIFFRACTION",1.99,38.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","21Z","3RNI",35.14,"1.95","1.95","CDK2 in complex with inhibitor RC-3-86","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3RNI"
"3RNJ",,"X-RAY DIFFRACTION",2.12,42.06,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M ammonium acetate, 0.1M Tris-HCl pH 8.5, 30% isopropanol, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"3RNJ",8.05,"1.5","1.5","Crystal structure of the SH3 domain from IRSp53 (BAIAP2)","GPLGSGRMRVKAIFSHAAGDNSTLLSFKEGDLITLLVPEARDGWHYGESEKTKMRGWFPFSYTRVLD","Homo sapiens","BAIAP2","Brain-specific angiogenesis inhibitor 1-associated protein 2","1","3RNJ"
"3RNN",,"X-RAY DIFFRACTION",2.31,46.76,,,,,"10.1124/mol.110.070243",,"3RNN",97.63,"1.75","1.75","Crystal Structure of iGluR2 Ligand Binding Domain with Symmetric Sulfonamide Containing Potentiator","RGSAMGSGNDTSRGANKTVVVTTILESPYVMMKKNHEMLEGNERYEGYCVDLAAEIAKHCGFKYKLTIVGDGKYGARDADTKIWNGMVGELVYGKADIAIAPLTITLVREEVIDFSKPFMSLGISIMIKKGTPIESAEDLSKQTEIAYGTLDSGSTKEFFRRSKIAVFDKMWTYMRSAEPSVFVRTTAEGVARVRKSKGKYAYLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGIATPKGSSLGNAVNLAVLKLNEQGLLDKLKNKWWYDKGECGSGGGDSKEKTSALSLSN","Homo sapiens","GRIA2, GLUR2","Glutamate receptor 2","1","3RNN"
,,,,,,,,,,,,,,,,,"Homo sapiens","GRIA2, GLUR2"
"3RNU",,"X-RAY DIFFRACTION",2.5,50.85,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG3350, 0.1 M K Formate, 0.1 M HEPES, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.immuni.2012.02.014",,"3RNU",101.74,"2.502","2.502","Structural Basis of Cytosolic DNA Sensing by Innate Immune Receptors","GSVDDSAQSDLKEVMVLNATESFVYEPKEQKKMFHATVATENEVFRVKVFNIDLKEKFTPKKIIAIANYVCRNGFLEVYPFTLVADVNADRNMEIPKGLIRSASVTPKINQLCSQTKGSFVNGVFEVHKKNVRGEFTYYEIQDNTGKMEVVVHGRLTTINCEEGDKLKLTCFELAPKSGNTGELRSVIHSHIKVIKTRKNAAAS","Homo sapiens","IFI16, IFNGIP1","Gamma-interferon-inducible protein 16","1","3RNU"
,,,,,,,,,,,,,,,,"GCCATCAAAGAGAGAG",,,"DNA (5'-D(*GP*CP*CP*AP*TP*CP*AP*AP*AP*GP*AP*GP*AP*GP*AP*G)-3')","2","3RNU"
,,,,,,,,,,,,,,,,"TCTCTCTTTGATGGCC",,,"DNA (5'-D(*TP*CP*TP*CP*TP*CP*TP*TP*TP*GP*AP*TP*GP*GP*CP*C)-3')","3","3RNU"
"3RNY",,"X-RAY DIFFRACTION",2.2,43.97,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 17.1%(w/v) PEG 3350, 4%(v/v) acetonitrile or 18%(w/v)
PEG 3350, 100 mM ammonium formate, 4%(v/v) acetonitrile, vapor diffusion, sitting drop, temperature 290K",290,"10.1107/S0907444912007457",,"3RNY",77.69,"2.7","2.7","Crystal structure of human RSK1 C-terminal kinase domain","MGSSHHHHHHSSGLVPRGSHMNLVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLVKGAMAATYSALNSSKPTPQLKPIESSILAQRRVRKLPSTTL","Homo sapiens","RPS6KA1, MAPKAPK1A, RSK1","Ribosomal protein S6 kinase alpha-1","1","3RNY"
"3RO4",,"X-RAY DIFFRACTION",3.69,66.65,"VAPOR DIFFUSION, SITTING DROP",4.5,"17% PEG 8k, 0.1M Na-Citrate, 0.2M Ammonium sulfate, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1016/j.bmcl.2011.06.067","LJ9","3RO4",68.68,"2.6","2.6","X-ray Structure of Ketohexokinase in complex with an indazole compound derivative","MGSSHHHHHHSSGLVPRGSQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV","Homo sapiens","KHK","Ketohexokinase","1","3RO4"
"3ROC",,"X-RAY DIFFRACTION",2.29,46.31,"VAPOR DIFFUSION, HANGING DROP",9,"20-30% PEG3000, 10MM CaCl2, 50MM CHES, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2011.05.006","29A","3ROC",42.03,"1.7","1.7","Crystal structure of human p38 alpha complexed with a pyrimidinone compound","MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","CSBP, CSBP1, CSBP2, CSPB1, MAPK14, MXI2, THP-1, SAPK2A","Mitogen-activated protein kinase 14","1","3ROC"
"3ROD",,"X-RAY DIFFRACTION",1.94,36.57,,,"25% PEG3350, 0.1 M BIS-TRIS; OR 25- 27% PEG3350, 0.2 M NACL, 0.1M BIS-TRIS OR IMIDAZOLE, PH 5.5 OR 6.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",,"10.1021/bi2007614",,"3ROD",127.89,"2.72","2.72","Methyltransferase","MGSSHHHHHHSSGLVPRGSMESGFTSKDTYLSHFNPRDYLEKYYKFGSRHSAESQILKHLLKNLFKIFCLDGVKGDLLIDIGSGPTIYQLLSACESFKEIVVTDYSDQNLQELEKWLKAAPAAFDWSPVVTYVCDLEGNRVKGPEKEEKLRQAVKQVLKCDVTQSQPLGAVPLPPADCVLSTLCLDAACPDLPTYCRALRNLGSLLKPGGFLVIMDALKSSYYMIGEQKFSSLPLGREAVEAAVKEAGYTIEWFEVISQSYSSTMANNEGLFSLVARKLSRPL","Homo sapiens","NNMT","Nicotinamide N-methyltransferase","1","3ROD"
"3ROK",,"X-RAY DIFFRACTION",2.27,45.75,"VAPOR DIFFUSION, HANGING DROP",4,"0.1M sodium acetate pH4.0, 0.2M ammonium acetate, 3% isopropanol, 15% PEG10000, vapor diffusion, hanging drop, temperature 298K",298,"10.1021/bi201509f",,"3ROK",59.66,"1.65","1.65","Crystal structure of human CD38 in complex with compound CZ-27","EFRWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVEVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSC","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","3ROK"
"3ROM",,"X-RAY DIFFRACTION",2.22,44.68,"VAPOR DIFFUSION, HANGING DROP",4,"0.1M sodium acetate pH4.0, 0.2M ammonium acetate, 3% isopropanol, 15% PEG 10000, vapor diffusion, hanging drop, temperature 298K",298,"10.1021/bi201509f",,"3ROM",59.58,"2.04","2.04","Crystal structure of human CD38 in complex with compound CZ-48","EFRWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVEVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSC","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","3ROM"
"3ROP",,"X-RAY DIFFRACTION",2.26,45.56,"VAPOR DIFFUSION, HANGING DROP",4,"0.1M sodium acetate pH4.0, 0.2M ammonium acetate, 3% isopropanol, 15% PEG 10000, vapor diffusion, hanging drop, temperature 298K",298,"10.1021/bi201509f",,"3ROP",59.79,"1.94","1.94","Crystal structure of human CD38 in complex with compound CZ-50b","EFRWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVEVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSC","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","3ROP"
"3ROQ",,"X-RAY DIFFRACTION",2.28,46,"VAPOR DIFFUSION, HANGING DROP",4,"0.1M sodium acetate pH4.0, 0.2M ammonium acetate, 3% isopropanol, 15% PEG 10000, vapor diffusion, hanging drop, temperature 298K",298,"10.1021/bi201509f",,"3ROQ",59.72,"2.1","2.1","Crystal structure of human CD38 in complex with compound CZ-46","EFRWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVEVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSC","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","3ROQ"
"3ROV",,"X-RAY DIFFRACTION",1.78,31.05,"VAPOR DIFFUSION, HANGING DROP",8.3,"0.05 M sodium citrate, 1% phenol, 0.04% zinc acetate, pH 8.3, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"3ROV",35.84,"2.3","2.3","Insulin's biosynthesis and activity have opposing structural requirements: a new factor in neonatal diabetes mellitus","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","3ROV"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCAERAFFYTKPT","Homo sapiens","INS","Insulin","2","3ROV"
"3ROY",,"X-RAY DIFFRACTION",2.01,38.68,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3ROY",35.19,"1.75","1.75","CDK2 in complex with inhibitor KVR-1-154","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3ROY"
"3RP1",,"X-RAY DIFFRACTION",2.13,42.18,"VAPOR DIFFUSION, SITTING DROP",7.5,"200mM calcium choloride, 28% PEG400, 100mM HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"3RP1",46.45,"2.6","2.6","Crystal structure of Human LAIR-1 in C2 space group","MQEEDLPRPSISAEPGTVIPLGSHVTFVCRGPVGVQTFRLERESRSTYNDTEDVSQASPSESEARFRIDSVSEGNAGPYRCIYYKPPKWSEQSDYLELLVKET","Homo sapiens","CD305, LAIR-1, LAIR1","Leukocyte-associated immunoglobulin-like receptor 1","1","3RP1"
"3RPI",,"X-RAY DIFFRACTION",3.61,65.96,"VAPOR DIFFUSION, SITTING DROP",5,"11.7% PEG20000, 0.1 M sodium acetate, pH 5.0, 100 mM potassium/sodium tartrate, 20 mM lithium sulfate, 10 mM CHES, pH 9.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1126/science.1207227",,"3RPI",96.41,"2.648","2.648","Crystal Structure of Fab from 3BNC60, Highly Potent anti-HIV Antibody","DIQMTQSPSSLSARVGDTVTITCQANGYLNWYQQRRGKAPKLLIYDGSKLERGVPARFSGRRWGQEYNLTINNLQPEDVATYFCQVYEFIVPGTRLDLKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Light chain from highly potent anti-HIV neutralizing antibody","1","3RPI"
,,,,,,,,,,,,,,,,"QVHLSQSGAAVTKPGASVRVSCEASGYKISDHFIHWWRQAPGQGLQWVGWINPKTGQPNNPRQFQGRVSLTRQASWDFDTYSFYMDLKAVRSDDTAIYFCARQRSDFWDFDVWGSGTQVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKT","Homo sapiens",,"Heavy chain from highly potent anti-HIV neutralizing antibody","2","3RPI"
"3RPN",,"X-RAY DIFFRACTION",2.49,50.6,"hanging drop",7,"20% polyethylene glycol 3350, 0.2M NaSCN, pH 7.0, hanging drop, temperature 293K",293,"10.1042/BJ20110753",,"3RPN",161.96,"1.9","1.9","Crystal structure of human kappa class glutathione transferase in complex with S-hexylglutathione","MGPLPRTVELFYDVLSPYSWLGFEILCRYQNIWNINLQLRPSLITGIMKDSGNKPPGLLPRKGLYMANDLKLLRHHLQIPIHFPKDFLSVMLEKGSLSAMRFLTAVNLEHPEMLEKASRELWMRVWSRNEDITEPQSILAAAEKAGMSAEQAQGLLEKIATPKVKNQLKETTEAACRYGAFGLPITVAHVDGQTHMLFGSDRMELLAHLLGEKWMGPIPPAVNARLLEHHHHHH","Homo sapiens","GSTK1, HDCMD47P","Glutathione S-transferase kappa 1","1","3RPN"
"3RPO",,"X-RAY DIFFRACTION",2.01,38.68,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3RPO",35.2,"1.75","1.75","CDK2 in complex with inhibitor KVR-1-156","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3RPO"
"3RPP",,"X-RAY DIFFRACTION",2.85,56.89,"hanging drop",7,"15% polyethylene glycol 3350, 0.2M Mg(NO3)2, pH 7.0, hanging drop, temperature 277K",277,"10.1042/BJ20110753",,"3RPP",79.8,"1.8","1.8","Crystal structure of human kappa class glutathione transferase in apo form","MGPLPRTVELFYDVLSPYSWLGFEILCRYQNIWNINLQLRPSLITGIMKDSGNKPPGLLPRKGLYMANDLKLLRHHLQIPIHFPKDFLSVMLEKGSLSAMRFLTAVNLEHPEMLEKASRELWMRVWSRNEDITEPQSILAAAEKAGMSAEQAQGLLEKIATPKVKNQLKETTEAACRYGAFGLPITVAHVDGQTHMLFGSDRMELLAHLLGEKWMGPIPPAVNARLLEHHHHHH","Homo sapiens","GSTK1, HDCMD47P","Glutathione S-transferase kappa 1","1","3RPP"
"3RPR",,"X-RAY DIFFRACTION",2.01,38.85,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","25Z","3RPR",35.12,"1.75","1.75","CDK2 in complex with inhibitor RC-2-49","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3RPR"
"3RPS",,"X-RAY DIFFRACTION",2.15,42.88,,,,,"10.1007/s11010-011-0948-5","4B0","3RPS",80.96,"2.3","2.3","Structure of human CK2alpha in complex with the ATP-competitive inhibitor 3-(4,5,6,7-tetrabromo-1H-benzotriazol-1-yl)propan-1-ol","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3RPS"
"3RPV",,"X-RAY DIFFRACTION",2,38.49,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","26Z","3RPV",35.21,"1.8","1.8","CDK2 in complex with inhibitor RC-2-88","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3RPV"
"3RPX",,"X-RAY DIFFRACTION",3.7,66.72,"VAPOR DIFFUSION, SITTING DROP",7.5,"25% peg1500, 0.2 M sodium chloride, 0.1 M HEPES, 5% glycerol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3RPX",66.38,"2.65","2.65","Crystal structure of complement component 1, q subcomponent binding protein, C1QBP","IQKHKTLPKMSGGWELELNGTEAKLVRKVAGEKITVTFNINNSIPPTFDGEEEPSQGQKVEEQEPELTSTPNFVVEVIKNDDGKKALVLDCHYPEDEVGQEDEAESDIFSIREVSFQSTGESEWKDTNYTLNTDSLDWALYDHLMDFLADRGVDNTFADELVELSTALEHQEYITFLEDLKSFVKSQAHHHHHH","Homo sapiens","C1QBP, GC1QBP, HABP1, SF2P32","Complement component 1 Q subcomponent-binding protein","1","3RPX"
"3RPY",,"X-RAY DIFFRACTION",2,38.63,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","27Z","3RPY",35.07,"1.9","1.9","CDK2 in complex with inhibitor RC-2-40","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3RPY"
"3RQ3",,"X-RAY DIFFRACTION",3.96,68.95,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.0M Ammonium Sulfate, 0.1M BIS-TRIS pH 5.5, 1% PEG3350, Vapor diffusion, Sitting drop, temperature 298K",298,,,"3RQ3",25.21,"2.7","2.7","Structure of T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT) in hexagonal crystal form","MMTGTIETTGNISAEKGGSIILQCHLSSTTAQVTQVNWEQQDQLLAICNADLGWHISPSFKDRVAPGPGLGLTLQSLTVNDTGEYFCIYHTYPDGTYTGRIFLEVLESSVAEHGAR","Homo sapiens","TIGIT, VSIG9, VSTM3","T cell immunoreceptor with Ig and ITIM domains","1","3RQ3"
"3RQ4",,"X-RAY DIFFRACTION",2.35,47.61,"VAPOR DIFFUSION, HANGING DROP",7.2,"12% PEG8K, 0.1MHepes, 12% Ethylene Glycol, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.febslet.2013.10.020",,"3RQ4",28.65,"1.8","1.8","Crystal structure of suppressor of variegation 4-20 homolog 2","GPDRVTARELCENDDLATSLVLDPYLGFRTHKMNVSPVPPLRRQQHLRSALETFLRQRDLEAAYRALTLGGWTARYFQSRGPRQEAALKTHVYRYLRAFLPESGFTILPCTRYSMETNGAKIVSTRAWKKNEKLELLVGCIAELREADEGLLRAGENDFSIMYSTRKRSAQLWLGPAAFINHDCKPNCKFVPADGNAACVKVLRDIEPGDEVTCFYGEGFFGEKNEHCECHTCERKGEGAFRTRPRE","Homo sapiens","SUV420H2, KMT5C, PP7130","Histone-lysine N-methyltransferase SUV420H2","1","3RQ4"
"3RQ7",,"X-RAY DIFFRACTION",1.85,33.57,"VAPOR DIFFUSION, HANGING DROP",,"PBD protein at 12 mg/mL in 10 mM Tris, pH 8.0, 0.5 M NaCl, 10 mM DTT, 2% DMSO and 2 mM compound 4j was mixed with an equal volume of reservoir solution consisting of 15% (w/v) PEG 3350, 0.1 M glycine, pH 9.0, 300 mM NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nchembio.614",,"3RQ7",28.13,"1.55","1.55","Polo-like kinase 1 Polo box domain in complex with a C6H5(CH2)8-derivatized peptide inhibitor","GAHMDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSRSASNRLKAS","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","3RQ7"
,,,,,,,,,,,,,,,,"XPLHSTX",,,"C6H5(CH2)8-derivatized peptide inhibitor","2","3RQ7"
"3RQS",,"X-RAY DIFFRACTION",2.45,49.76,"macrobatch under oil",4.2,"Protein solution: 100mM NaCl, 5mM DTT, 0.02% NaN3, 10mM Tris-HCl (pH 7.5), Reservoir solution: 0.1M Potassium phosphate dibasic (K2HPO4), 0.1M Sodium Citrate, 20% (w/v) PEG 4000, macrobatch under oil, temperature 277KK",277,,,"3RQS",72.72,"2.001","2.001","Crystal Structure of human L-3- Hydroxyacyl-CoA dehydrogenase (EC1.1.1.35) from mitochondria at the resolution 2.0 A, Northeast Structural Genomics Consortium Target HR487, Mitochondrial Protein Partnership","MGHHHHHHSHMAFVTRQFMRSVSSSSTASASAKKIIVKHVTVIGGGLMGAGIAQVAAATGHTVVLVDQTEDILAKSKKGIEESLRKVAKKKFAENPKAGDEFVEKTLSTIATSTDAASVVHSTDLVVEAIVENLKVKNELFKRLDKFAAEHTIFASNTSSLQITSIANATTRQDRFAGLHFFNPVPVMKLVEVIKTPMTSQKTFESLVDFSKALGKHPVSCKDTPGFIVNRLLVPYLMEAIRLYERGDASKEDIDTAMKLGAGYPMGPFELLDYVGLDTTKFIVDGWHEMDAENPLHQPSPSLNKLVAENKFGKKTGEGFYKYK","Homo sapiens","HADH, HAD, HADHSC, SCHAD, HAD1","Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial","1","3RQS"
"3RRQ",,"X-RAY DIFFRACTION",1.98,37.97,"VAPOR DIFFUSION, SITTING DROP",8.5,"3.5M Sodium formate, 0.1M Bis-Tris, pH 7.5, Vapor diffusion, Sitting drop, temperature 298K, VAPOR DIFFUSION, SITTING DROP",298,,,"3RRQ",14.45,"2.1","2.1","Crystal structure of the extracellular domain of human PD-1","WNPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRARRNDSGTYLCGAISLAPKLQIKESLRAELRVTERRAEVPTAHPSPSP","Homo sapiens","PD-1, PD1, PDCD1","Programmed cell death protein 1","1","3RRQ"
"3RRU",,"X-RAY DIFFRACTION",3.39,63.69,,6,"Protein solution: 10 mM Tris (pH 7.5), 100 mM sodium chloride, 5 mM DTT, and 0.02% NaN3. Reservoir solution: 100mM MES (pH 6), 40% PEG 8000, and 100mM Ammonium Sulfate, micro batch under oil, temperature 291K",291,,,"3RRU",34.97,"3","3","X-ray crystal structure of the VHS domain of human TOM1-like protein, Northeast Structural Genomics Consortium Target HR3050E","MGHHHHHHSHDPYATSVGHLIEKATFAGVQTEDWGQFMHICDIINTTQDGPKDAVKALKKRISKNYNHKEIQLTLSLIDMCVQNCGPSFQSLIVKKEFVKENLVKLLNPRYNLPLDIQNRILNFIKTWSQGFPGGVDVSEVKEVYLDLVKKG","Homo sapiens","hCG_32771, tom1-like, TOM1L1, SRCASM","TOM1L1 protein","1","3RRU"
"3RRY",,"X-RAY DIFFRACTION",2.71,54.61,"hanging drop",7.5,"20 % PEG 3350, 200mM Calcium Chloride, pH 7.5, hanging drop, temperature 298K",298,"10.1016/j.jmb.2011.09.011",,"3RRY",19.53,"1.6","1.6","H-Ras crosslinked control, soaked in aqueous solution: one of 10 in MSCS set","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","3RRY"
"3RRZ",,"X-RAY DIFFRACTION",2.74,55.06,"hanging drop",7.5,"20 % PEG 3350, 200mM Calcium Chloride, pH 7.5, hanging drop, temperature 298K",298,"10.1016/j.jmb.2011.09.011",,"3RRZ",20.26,"1.6","1.6","H-Ras in 70% glycerol: one of 10 in MSCS set","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","3RRZ"
"3RS0",,"X-RAY DIFFRACTION",2.63,53.19,"hanging drop",7.5,"20 % PEG 3350, 200mM Calcium Chloride, pH 7.5, hanging drop, temperature 298K",298,"10.1016/j.jmb.2011.09.011",,"3RS0",19.7,"1.4","1.4","H-Ras soaked in neat cyclopentanol: one of 10 in MSCS set","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","3RS0"
"3RS2",,"X-RAY DIFFRACTION",2.66,53.81,"hanging drop",7.5,"20 % PEG 3350, 200mM Calcium Chloride, pH 7.5, hanging drop, temperature 298K",298,"10.1016/j.jmb.2011.09.011",,"3RS2",19.73,"1.836","1.836","H-Ras soaked in 50% 2,2,2-trifluoroethanol: one of 10 in MSCS set","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","3RS2"
"3RS3",,"X-RAY DIFFRACTION",2.69,54.23,"hanging drop",7.5,"20 % PEG 3350, 200mM Calcium Chloride, pH 7.5, hanging drop, temperature 298K",298,"10.1016/j.jmb.2011.09.011",,"3RS3",19.71,"1.52","1.52","H-Ras soaked in neat hexane: 1 of 10 in MSCS set","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","3RS3"
"3RS4",,"X-RAY DIFFRACTION",2.71,54.69,"hanging drop",7.5,"20 % PEG 3350, 200mM Calcium Chloride, pH 7.5, hanging drop, temperature 298K",298,"10.1016/j.jmb.2011.09.011",,"3RS4",19.64,"1.7","1.7","H-Ras soaked in 60% 1,6-hexanediol: 1 of 10 in MSCS set","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","3RS4"
"3RS5",,"X-RAY DIFFRACTION",2.7,54.38,"hanging drop",7.5,"20 % PEG 3350, 200mM Calcium Chloride, pH 7.5, hanging drop, temperature 298K",298,"10.1016/j.jmb.2011.09.011",,"3RS5",19.82,"1.68","1.68","H-Ras soaked in 55% dimethylformamide: 1 of 10 in MSCS set","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","3RS5"
"3RS7",,"X-RAY DIFFRACTION",2.76,55.36,"hanging drop",7.5,"20 % PEG 3350, 200mM Calcium Chloride, pH 7.5, hanging drop, temperature 298K",298,"10.1016/j.jmb.2011.09.011",,"3RS7",19.5,"1.7","1.7","H-Ras soaked in 50% isopropanol: 1 of 10 in MSCS set","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","3RS7"
"3RSL",,"X-RAY DIFFRACTION",2.7,54.37,"hanging drop",7.5,"20 % PEG 3350, 200mM Calcium Chloride, pH 7.5, hanging drop, temperature 298K",298,"10.1016/j.jmb.2011.09.011",,"3RSL",21.23,"1.7","1.7","H-Ras soaked in 90% R,S,R-bisfuranol: one of 10 in MSCS set","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","3RSL"
"3RSN",,"X-RAY DIFFRACTION",2.89,57.51,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris-HCl pH8.5, 20% PEG8000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/embor.2011.101",,"3RSN",20.69,"2.1","2.1","Crystal Structure of the N-terminal region of Human Ash2L","SDTQAGSVDEENGRQLGEVELQCGICTKWFTADTFGIDTSSCLPFMTNYSFHCNVCHHSGNTYFLRKQANLKEMCLSALANLTWQSRTQDEHPKTMFSKDKDIIPFIDKYWECMTTRQRPGKMTWPNNIVKTMSKERDVFLVKEHPDPGSKDPEEDYPKFGLLDQDLSNIGPAYDNQ","Homo sapiens","ASH2L, ASH2L1","Set1/Ash2 histone methyltransferase complex subunit ASH2","1","3RSN"
"3RSO",,"X-RAY DIFFRACTION",2.68,54.05,"hanging drop",7.5,"20 % PEG 3350, 200mM Calcium Chloride, pH 7.5, hanging drop, temperature 298K",298,"10.1016/j.jmb.2011.09.011",,"3RSO",19.76,"1.6","1.6","H-Ras soaked in 20% S,R,S-bisfuranol: 1 of 10 in MSCS set","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","3RSO"
"3RSV",,"X-RAY DIFFRACTION",2.86,56.93,"VAPOR DIFFUSION, HANGING DROP",6.6,"20% (w/v) PEG 5000 monomethylethyl ether (MME), 200mM sodium citrate (pH 6.6) and 200mM sodium iodide, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm200544q","3RS","3RSV",47.04,"2.5","2.5","Structure of Bace-1 (Beta-Secretase) in complex with (R)-3-(2-amino-6-o-tolylquinolin-3-yl)-N-((R)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-2-methylpropanamide","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3RSV"
"3RSW",,"X-RAY DIFFRACTION",2.16,42.98,"VAPOR DIFFUSION, SITTING DROP",3.2,"0.1M Citric Acid, pH 3.2 and 32% PEG400, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"3RSW",35.3,"2.599","2.599","Crystal Structure of Heart Fatty Acid Binding Protein (FABP3)","MGSSHHHHHHSSGLVPRGSHMLQDLMVDAFLGTWKLVDSKNFDDYMKSLGVGFATRQVASMTKPTTIIEKNGDILTLKTHSTFKNTEISFKLGVEFDETTADDRKVKSIVTLDGGKLVHLQKWDGQETTLVRELIDGKLILTLTHGTAVCTRTYEKEA","Homo sapiens","FABP3, FABP11, MDGI","Fatty acid-binding protein, heart","1","3RSW"
"3RSX",,"X-RAY DIFFRACTION",2.8,56.09,"VAPOR DIFFUSION, HANGING DROP",6.6,"20% (w/v) PEG 5000 monomethylethyl ether (MME), 200mM sodium citrate (pH 6.6) and 200mM sodium iodide., VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm200544q","RSV","3RSX",46.56,"2.48","2.48","Structure of Bace-1 (Beta-Secretase) in Complex with 6-(Thiophen-3-yl)quinolin-2-amine","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3RSX"
"3RTH",,"X-RAY DIFFRACTION",2.77,55.64,"VAPOR DIFFUSION, HANGING DROP",6.6,"20% (w/v) PEG 5000 monomethylethyl ether (MME), 200mM sodium citrate (pH 6.6) and 200mM sodium iodide, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm200544q","RTH","3RTH",46.63,"2.7","2.7","Structure of Bace-1 (Beta-Secretase) in Complex with 6-(2-(3,3-Dimethylbut-1-ynyl)phenyl)quinolin-2-amine","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3RTH"
"3RTM",,"X-RAY DIFFRACTION",2.77,55.52,"VAPOR DIFFUSION, HANGING DROP",6.6,"20% (w/v) PEG 5000 monomethylethyl ether (MME), 200mM sodium citrate (pH 6.6) and 200mM sodium iodide, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm200544q","RTM","3RTM",46.7,"2.76","2.76","Structure of Bace-1 (Beta-Secretase) in Complex with 3-(2-Aminoquinolin-3-yl)-N-cyclohexyl-N-methylpropanamide","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3RTM"
"3RTN",,"X-RAY DIFFRACTION",2.86,57.05,"VAPOR DIFFUSION, HANGING DROP",6.6,"20% (w/v) PEG 5000 monomethylethyl ether (MME), 200mM sodium citrate (pH 6.6) and 200mM sodium iodide, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm200544q","RTN","3RTN",47.12,"2.7","2.7","Structure of Bace-1 (Beta-Secretase) in Complex with 3-(2-Amino-6-o-tolylquinolin-3-yl)-N-cyclohexylpropanamide","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3RTN"
"3RTP",,"X-RAY DIFFRACTION",2.33,47.26,"VAPOR DIFFUSION, SITTING DROP",7.5,"15% PEG 8K, 10% ethylene glycol, 0.1M Hepes pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2011.06.100","34I","3RTP",42.25,"2.4","2.4","Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration","ASKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNS","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","3RTP"
"3RTS",,"X-RAY DIFFRACTION",2.19,43.82,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M Tris-HCl, 30% PEG6000, 1M LiCl, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,"KLG","3RTS",17.99,"1.81","1.81","Human MMP-12 catalytic domain in complex with*N*-Hydroxy-2-(2-phenylethylsulfonamido)acetamide","GPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","3RTS"
"3RTT",,"X-RAY DIFFRACTION",2.18,43.63,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M Tris-HCl, 30% PEG6000, 1 M LiCl, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,"KLH","3RTT",18.03,"1.82","1.82","Human MMP-12 catalytic domain in complex with*(R)-N*-Hydroxy-1-(phenethylsulfonyl)pyrrolidine-2-carboxamide","GPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","MMP12, HME","Macrophage metalloelastase","1","3RTT"
"3RU0",,"X-RAY DIFFRACTION",2.83,56.48,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.75ul of protein 10mg/mL and 1mM Sinefungin in 25mM TrisHCl pH7.6, 150mM NaCl, 1mM TCEP and 0.75uL reservoir solution: 100mM HEPES pH 7.5, 16% PEG 3350, 200mM Magnesium Chloride , VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1371/journal.pone.0022290",,"3RU0",101.85,"1.849","1.849","Cocrystal structure of human SMYD3 with inhibitor Sinefungin bound","MALEPLKVEKFATANRGNGLRAVTPLRPGELLFRSDPLAYTVCKGSRGVVCDRCLLGKEKLMRCSQCRVAKYCSAKCQKKAWPDHKRECKCLKSCKPRYPPDSVRLLGRVVFKLMDGAPSESEKLYSFYDLESNINKLTEDKKEGLRQLVMTFQHFMREEIQDASQLPPAFDLFEAFAKVICNSFTICNAEMQEVGVGLYPSISLLNHSCDPNCSIVFNGPHLLLRAVRDIEVGEELTICYLDMLMTSEERRKQLRDQYCFECDCFRCQTQDKDADMLTGDEQVWKEVQESLKKIEELKAHWKWEQVLAMCQAIISSNSERLPDINIYQLKVLDCAMDACINLGLLEEALFYGTRTMEPYRIFFPGSHPVRGVQVMKVGKLQLHQGMFPQAMKNLRLAFDIMRVTHGREHSLIEDLILLLEECDANIRASEGHHHHHH","Homo sapiens","SMYD3, ZMYND1, ZNFN3A1","SET and MYND domain-containing protein 3","1","3RU0"
"3RU1",,"X-RAY DIFFRACTION",2.81,56.24,"VAPOR DIFFUSION, HANGING DROP",6.6,"20% (w/v) PEG 5000 monomethylethyl ether (MME), 200mM sodium citrate (pH 6.6) and 200mM sodium iodide, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm200544q","3RU","3RU1",47.1,"2.3","2.3","Structure of Bace-1 (Beta-Secretase) in Complex with 3-(2-Aminoquinolin-3-yl)-N-(cyclohexylmethyl)propanamide","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3RU1"
"3RUK",,"X-RAY DIFFRACTION",2.53,51.38,,8.5,"30% PEG 3350, 0.175 M Tris, 0.30 M ammonium sulfate, 3% glycerol, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nature10743","AER","3RUK",226.82,"2.6","2.6","Human Cytochrome P450 CYP17A1 in complex with Abiraterone","MAKKTGAKYPKSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTKTTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDIASNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHNGQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYKEKFRSDSITNMLDTLMQAKMNSDNGNAGPDQDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRTPTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPERFLNPAGTQLISPSVSYLPFGAGPRSCIGEILARQELFLIMAWLLQRFDLEVPDDGQLPSLEGIPKVVFLIDSFKVKIKVRQAWREAQAEGSTHHHH","Homo sapiens","CYP17, CYP17A1, S17AH","Steroid 17-alpha-hydroxylase/17,20 lyase","1","3RUK"
"3RUL",,"X-RAY DIFFRACTION",3.23,61.94,"VAPOR DIFFUSION, HANGING DROP",,"24% PEG3350, 0.2M ammonium tartrate, 0.015M CYMAL-7, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/ja208755j",,"3RUL",43.9,"2.5","2.5","New strategy to analyze structures of glycopeptide-target complexes","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGCKAA","Homo sapiens","UBC","Ubiquitin","1","3RUL"
,,,,,,,,,,,,,,,,"XYXGGYX",,,"Dalbavancin","2","3RUL"
"3RV5",,"X-RAY DIFFRACTION",2.56,51.96,"VAPOR DIFFUSION, SITTING DROP",8,"100 mM Tris-HCl (pH 8), 50 mM cadmium sulfate, 900 mM sodium acetate (reservoir) and 50 mM deoxycholic acid (additive), VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2011.08.049",,"3RV5",46.04,"2.2","2.2","Crystal structure of human cardiac troponin C regulatory domain in complex with cadmium and deoxycholic acid","MDDIYKAAVEQLTEEQKNEFKAAFDIFVLGAEDGCISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRCMKDDS","Homo sapiens","TNNC, TNNC1, TNNC1 (Amino acids 1-89)","Troponin C, slow skeletal and cardiac muscles","1","3RV5"
"3RVG",,"X-RAY DIFFRACTION",2.29,46.37,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 100mM Ammonium Sulfate, 33.5% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm200909u","17P","3RVG",36.18,"2.498","2.498","Crystals structure of Jak2 with a 1-amino-5H-pyrido[4,3-b]indol-4-carboxamide inhibitor","MAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAGLVPR","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","3RVG"
"3RVH",,"X-RAY DIFFRACTION",2.43,49.31,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M CITRATE, 4mM NiCl2, 20% PEG 3350, 2:1 Protein:Well, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3RVH",89.63,"2.251","2.251","Crystal Structure of JMJD2A Complexed with Inhibitor","MHHHHHHSSGVDLGTENLYFQSMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","JHDM3A, JMJD2, JMJD2A, KDM4A, KIAA0677","Lysine-specific demethylase 4A","1","3RVH"
"3RVI",,"X-RAY DIFFRACTION",2.85,56.88,"VAPOR DIFFUSION, HANGING DROP",6.6,"20% (w/v) PEG 5000 monomethylethyl ether (MME), 200mM sodium citrate (pH 6.6) and 200mM sodium iodide, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm200544q","RVI","3RVI",47.34,"2.65","2.65","Structure of Bace-1 (Beta-Secretase) in Complex with 2-((2-Amino-6-o-tolylquinolin-3-yl)methyl)-N-(cyclohexylmethyl)pentanamide","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3RVI"
"3RW6",,"X-RAY DIFFRACTION",2.6,52.62,"VAPOR DIFFUSION, HANGING DROP",4.8,"2 M ammonium acetate, 0.1 M Na acetate, pH 4.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nsmb.2094",,"3RW6",101.59,"2.3","2.3","Structure of nuclear RNA export factor TAP bound to CTE RNA","VRRDRAPPERGGAGTSQDGTSKNWFKITIPYGRKYDKAWLLSMIQSKCSVPFTPIEFHYENTRAQFFVEDASTASALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLDGHELPPPIAF","Homo sapiens","NXF1, TAP, TAP (NXF1)","Nuclear RNA export factor 1","1","3RW6"
,,,,,,,,,,,,,,,,"GGCACUAACCUAAGACAGGAGGGCCGGGAAACCUGCCUAAUCCAAUGACGGGUAAUAGUGUC",,,"constitutive transport element(CTE)of Mason-Pfizer monkey virus RNA","2","3RW6"
"3RW7",,"X-RAY DIFFRACTION",4.12,70.12,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.4 M sodium acetate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nsmb.2094",,"3RW7",122.04,"3","3","Structure of N-terminal domain of nuclear RNA export factor TAP","VRRDRAPPERGGAGTSQDGTSKNWFKITIPYGRKYDKAWLLSMIQSKCSVPFTPIEFHYENTRAQFFVEDASTASALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLDGHELPPPIAF","Homo sapiens","NXF1, TAP, TAP (NXF1)","Nuclear RNA export factor 1","1","3RW7"
"3RW9",,"X-RAY DIFFRACTION",2.15,42.77,"VAPOR DIFFUSION, HANGING DROP",8.4,"20% PEG 3350, 0.2 M sodium sulfate, pH 8.4, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1002/pro.717","DSH","3RW9",68.79,"2","2","Crystal Structure of human Spermidine Synthase in Complex with decarboxylated S-adenosylhomocysteine","GHMEPGPDGPAASGPAAIREGWFRETCSLWPGQALSLQVEQLLHHRRSRYQDILVFRSKTYGNVLVLDGVIQCTERDEFSYQEMIANLPLCSHPNPRKVLIIGGGDGGVLREVVKHPSVESVVQCEIDEDVIQVSKKFLPGMAIGYSSSKLTLHVGDGFEFMKQNQDAFDVIITDSSDPMGPAESLFKESYYQLMKTALKEDGVLCCQGECQWLHLDLIKEMRQFCQSLFPVVAYAYCTIPTYPSGQIGFMLCSKNPSTNFQEPVQPLTQQQVAQMQLKYYNSDVHRAAFVLPEFARKALNDVS","Homo sapiens","SRM, SPS1, SRML1","Spermidine synthase","1","3RW9"
"3RWP",,"X-RAY DIFFRACTION",2.91,57.76,"VAPOR DIFFUSION, HANGING DROP",7,"2.2M Ammonium Sulfate, 10mM EDTA, 5-10% glycerol,  0.1M HEPES, pH 7.0., VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm201019k","ABQ","3RWP",37.02,"1.92","1.92","Discovery of a Novel, Potent and Selective Inhibitor of 3-Phosphoinositide Dependent Kinase (PDK1)","ALMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDPK1, PDK1","3-phosphoinositide-dependent protein kinase 1","1","3RWP"
"3RWQ",,"X-RAY DIFFRACTION",2.92,57.91,"VAPOR DIFFUSION",7,"Ammonium Sulfate, pH 7.0, VAPOR DIFFUSION, temperature 293K",293,"10.1021/jm201019k","3RW","3RWQ",36.91,"2.55","2.55","Discovery of a Novel, Potent and Selective Inhibitor of 3-Phosphoinositide Dependent Kinase (PDK1)","GAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDPK1, PDK1","3-phosphoinositide-dependent protein kinase 1","1","3RWQ"
"3RWV",,"X-RAY DIFFRACTION",2.62,53.1,"VAPOR DIFFUSION, HANGING DROP",6.5,"15-20%PEG 8000, 0.1M MES pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 273K",273,"10.1016/j.str.2011.09.011",,"3RWV",47.85,"1.5","1.5","Crystal Structure of apo-form of Human Glycolipid Transfer Protein at 1.5 A resolution","MALLAEHLLKPLPADKQIETGPFLEAVSHLPPFFDCLGSPVFTPIKADISGNITKIKAVYDTNPAKFRTLQNILEVEKEMYGAEWPKVGATLALMWLKRGLRFIQVFLQSICDGERDENHPNLIRVNATKAYEMALKKYHGWIVQKIFQAALYAAPYKSDFLKALSKGQNVTEEECLEKIRLFLVNYTATIDVIYEMYTQMNAELNYKV","Homo sapiens","GLTP","Glycolipid transfer protein","1","3RWV"
"3RX2",,"X-RAY DIFFRACTION",2.05,40.02,"VAPOR DIFFUSION, HANGING DROP",5,"50mM ammonium citrate, pH5.0, 7.5% PEG 6000 , VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.febslet.2011.11.023",,"3RX2",39.19,"1.9","1.9","Crystal Structure of Human Aldose Reductase Complexed with Sulindac Sulfone","MGSSHHHHHHSSGLVPRGSHMASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","3RX2"
"3RX3",,"X-RAY DIFFRACTION",2.04,39.61,"VAPOR DIFFUSION, HANGING DROP",5,"50 mM ammonium citrate, pH5.0, 7.5% PEG 6000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.febslet.2011.11.023","SUZ","3RX3",39.17,"1.9","1.9","Crystal Structure of Human Aldose Reductase Complexed with Sulindac","MGSSHHHHHHSSGLVPRGSHMASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","3RX3"
"3RX4",,"X-RAY DIFFRACTION",2.07,40.7,"VAPOR DIFFUSION, HANGING DROP",5,"50mM ammonium citrate, pH5.0, 7.5% PEG 6000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.febslet.2011.11.023",,"3RX4",39.15,"2","2","Crystal Structure of Human Aldose Reductase complexed with Sulindac Sulfide","MGSSHHHHHHSSGLVPRGSHMASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","3RX4"
"3RY4",,"X-RAY DIFFRACTION",2.9,57.55,"VAPOR DIFFUSION",5.6,"30% (W/V) PEG 4000, 0.2M AMMONIUM ACETATE, 0.1M SODIUM CITRATE, PH 5.60, VAPOR DIFFUSION, TEMPERATURE 291.0K",,"10.4049/jimmunol.1101467",,"3RY4",19.5,"1.5","1.5","1.5 Angstrom resolution structure of glycosylated fcgammariia (low-responder polymorphism)","APPKAVLKLEPPWINVLQEDSVTLTCQGARSPESDSIQWFHNGNLIPTHTQPSYRFKANNNDSGEYTCQTGQTSLSDPVHLTVLFEWLVLQTPHLEFQEGETIMLRCHSWKDKPLVKVTFFQNGKSQKFSHLDPTFSIPQANHSHSGDYHCTGNIGYTLFSSKPVTITVQ","Homo sapiens","CD32, FCG2, FCGR2A, FCGR2A1, IGFR2","Low affinity immunoglobulin gamma Fc region receptor II-a","1","3RY4"
"3RY5",,"X-RAY DIFFRACTION",2.24,45.13,"VAPOR DIFFUSION",7.5,"30% (W/V) PEG 4000, 0.2M AMMONIUM SULFATE, PH 7.50, VAPOR DIFFUSION, TEMPERATURE 291.0K",,"10.4049/jimmunol.1101467",,"3RY5",19.15,"2.3","2.3","Three-dimensional structure of glycosylated fcgammariia (high-responder polymorphism)","APPKAVLKLEPPWINVLQEDSVTLTCQGARSPESDSIQWFHNGNLIPTHTQPSYRFKANNNDSGEYTCQTGQTSLSDPVHLTVLSEWLVLQTPHLEFQEGETIMLRCHSWKDKPLVKVTFFQNGKSQKFSRLDPTFSIPQANHSHSGDYHCTGNIGYTLFSSKPVTITVQ","Homo sapiens","FCGR2A, CD32, FCG2, FCGR2A1, IGFR2","LOW AFFINITY IMMUNOGLOBULIN GAMMA FC REGION RECEPTOR II-A","1","3RY5"
"3RYE",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, HANGING DROP",4.5,"0.2 M Ammonium Sulfate, 15% Isopropanol, 15% Ethylene Glycol, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"UNR","3RYE",40.58,"2.1","2.1","Human FDPS Synthase in Complex with a N-Methyl Pyridinum Bisphosphonate","SNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","3RYE"
"3RYJ",,"X-RAY DIFFRACTION",2.13,42.38,"VAPOR DIFFUSION, HANGING DROP",7.8,"100 mM Tris-Cl, 1.14 M sodium citrate, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/ja2045293","RYJ","3RYJ",29.51,"1.39","1.39","Carbonic Anhydrase complexed with 4-sulfamoyl-N-(2,2,2-trifluoroethyl)benzamide","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3RYJ"
"3RYV",,"X-RAY DIFFRACTION",2.1,41.56,"VAPOR DIFFUSION",7.8,"100 mM Tris-Cl, 1.15 M sodium citrate, pH 7.8, vapor diffusion, temperature 277K",277,"10.1021/ja2045293","RYV","3RYV",29.38,"1.2","1.2","Carbonic Anhydrase complexed with N-ethyl-4-sulfamoylbenzamide","SHHWGYGGHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3RYV"
"3RYX",,"X-RAY DIFFRACTION",2.15,42.67,"VAPOR DIFFUSION",7.8,"100 mM Tris-Cl, 1.15 M sodium citrate, pH 7.8, vapor diffusion, temperature 277K",277,"10.1021/ja2045293","RYX","3RYX",29.56,"1.6","1.6","Fluoroalkyl and Alkyl Chains Have Similar Hydrophobicities in Binding to the Hydrophobic Wall of Carbonic Anhydrase","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3RYX"
"3RYY",,"X-RAY DIFFRACTION",2.12,42.07,"VAPOR DIFFUSION",7.8,"100 mM Tris-Cl, 1.15 M sodium citrate, pH 7.8, vapor diffusion, temperature 277K",277,"10.1021/ja2045293","RYY","3RYY",29.64,"1.16","1.16","Fluoroalkyl and Alkyl Chains Have Similar Hydrophobicities in Binding to the Hydrophobic Wall of Carbonic Anhydrase","SHHWGYGGHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3RYY"
"3RYZ",,"X-RAY DIFFRACTION",2.12,42.02,"VAPOR DIFFUSION",7.8,"100 mM Tris-Cl, 1.15 M sodium citrate, pH 7.8, vapor diffusion, temperature 277K",277,"10.1021/ja2045293","RYZ","3RYZ",29.61,"1.37","1.37","Fluoroalkyl and Alkyl Chains Have Similar Hydrophobicities in Binding to the Hydrophobic Wall of Carbonic Anhydrase","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3RYZ"
"3RZ0",,"X-RAY DIFFRACTION",2.15,42.87,"VAPOR DIFFUSION",7.8,"100 mM Tris-Cl, 1.15 M sodium citrate, pH 7.8, vapor diffusion, temperature 277K",277,"10.1021/ja2045293","RZ0","3RZ0",29.48,"1.798","1.798","Fluoroalkyl and Alkyl Chains Have Similar Hydrophobicities in Binding to the Hydrophobic Wall of Carbonic Anhydrase","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3RZ0"
"3RZ1",,"X-RAY DIFFRACTION",2.11,41.83,"VAPOR DIFFUSION",7.8,"100 mM Tris-Cl, 1.15 M sodium citrate, pH 7.8, vapor diffusion, temperature 277K",277,"10.1021/ja2045293","RZ1","3RZ1",29.73,"1.51","1.51","Fluoroalkyl and Alkyl Chains Have Similar Hydrophobicities in Binding to the Hydrophobic Wall of Carbonic Anhydrase","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3RZ1"
"3RZ3",,"X-RAY DIFFRACTION",2.76,55.49,"VAPOR DIFFUSION, HANGING DROP",8,"0.5M NaH2PO4, 1.6M K2HPO4, 0.1 M Imidazole, 0.2 M NaCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.cell.2011.05.039","U94","3RZ3",84.81,"2.3","2.3","Human Cdc34 E2 in complex with CC0651 inhibitor","GAMGSPSSQKALLLELKGLQEEPVEGFRVTLVDEGDLYNWEVAIFGPPNTYYEGGYFKARLKFPIDYPYSPPAFRFLTKMWHPNIYETGDVCISILHPPVDDPQSGELPSERWNPTQNVRTILLSVISLLNEPNTFSPANVDASVMYRKWKESKGKDREYTDIIRKQVLGTKVDAERDGVKVP","Homo sapiens","CDC34, UBCH3, UBE2R1","Ubiquitin-conjugating enzyme E2 R1","1","3RZ3"
"3RZ5",,"X-RAY DIFFRACTION",2.11,41.8,"VAPOR DIFFUSION",7.8,"100 mM Tris-Cl, 1.15 M sodium citrate, pH 7.8, vapor diffusion, temperature 277K",277,"10.1021/ja2045293","RZ5","3RZ5",29.57,"1.65","1.65","Fluoroalkyl and Alkyl Chains Have Similar Hydrophobicities in Binding to the Hydrophobic Wall of Carbonic Anhydrase","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3RZ5"
"3RZ7",,"X-RAY DIFFRACTION",2.14,42.41,"VAPOR DIFFUSION",7.8,"100 mM Tris-Cl, 1.15 M sodium citrate, pH 7.8, vapor diffusion, temperature 277K",277,"10.1021/ja2045293","RZ7","3RZ7",29.71,"1.8","1.8","Fluoroalkyl and Alkyl Chains Have Similar Hydrophobicities in Binding to the Hydrophobic Wall of Carbonic Anhydrase","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3RZ7"
"3RZ8",,"X-RAY DIFFRACTION",2.1,41.46,"VAPOR DIFFUSION",7.8,"100 mM Tris-Cl, 1.15 M sodium citrate, pH 7.8, vapor diffusion, temperature 277K",277,"10.1021/ja2045293","RZ8","3RZ8",29.59,"1.7","1.7","Fluoroalkyl and Alkyl Chains Have Similar Hydrophobicities in Binding to the Hydrophobic Wall of Carbonic Anhydrase","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3RZ8"
"3RZB",,"X-RAY DIFFRACTION",2,38.52,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","02Z","3RZB",35,"1.9","1.9","CDK2 in complex with inhibitor RC-2-23","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3RZB"
"3RZG",,"X-RAY DIFFRACTION",2.84,56.7,"VAPOR DIFFUSION, HANGING DROP",6.5,"12% PEG 8000, 0.1M sodium chloride, 0.05M magnesium chloride, 0.1M cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nsmb.2320",,"3RZG",32.46,"1.62","1.62","Duplex Interrogation by a Direct DNA Repair Protein in the Search of Damage","GSMSWRHIRAEGLDSSYTVLFGKAEADEIFQELEKEVEYFTGALARVQVFGKWHSVPRKQATYGDAGLTYTFSGLTLSPKPWIPVLERIRDHVSGVTGQTFNFVLINRYKDGSDHICEHRDDERDLAPGSPIASVSFGASRDFVFRHKDSRGKSPSRRVAVVRLPLAHGSLLMMNHPTNTHWYHSLPVRKKVLAPRVNLTFRKILLTKK","Homo sapiens","ALKBH2, ABH2","Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2","1","3RZG"
,,,,,,,,,,,,,,,,"CTGTCATCACTGCG",,,"5'-D(*CP*TP*GP*TP*CP*AP*TP*CP*AP*CP*TP*GP*CP*G)-3'","2","3RZG"
,,,,,,,,,,,,,,,,"TCGCAGTGATGACA",,,"5'-D(*TP*CP*GP*CP*AP*GP*TP*GP*AP*TP*GP*AP*CP*A)-3'","3","3RZG"
"3RZH",,"X-RAY DIFFRACTION",3.19,61.48,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG 4000, 0.1M sodium chloride, 0.05M magnesium chloride, 0.1M cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1038/nsmb.2320",,"3RZH",31.79,"2.25","2.25","Duplex Interrogation by a Direct DNA Repair Protein in the Search of Damage","GSHSWRHIRAEGLDSSYTVLFGKAEADEIFQELEKEVEYFTGALARVQVFGKWHSVPRKQATYGDAGLTYTFSGLTLSPKPWIPVLERIRDHVSGVTGQTFNFVLINRYKDGSDHICEHRDDERELAPGSPIASVSFGASRDFVFRHKDSRGKSPSRRVAVVRLPLAHGSLLMMNHPTNTHWYHSLPVRKKVLAPRVNLTFRKILLTKK","Homo sapiens","ALKBH2, ABH2","Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2","1","3RZH"
,,,,,,,,,,,,,,,,"CTGTCTXACTGCG",,,"5'-D(*CP*TP*GP*TP*CP*TP*(ME6)P*AP*CP*TP*GP*CP*G)-3'","2","3RZH"
,,,,,,,,,,,,,,,,"TCGCAGTGAGACA",,,"5'-D(*TP*CP*GP*CP*AP*GP*TP*GP*AP*GP*AP*CP*A)-3'","3","3RZH"
"3RZJ",,"X-RAY DIFFRACTION",3.15,60.99,"VAPOR DIFFUSION, HANGING DROP",6.5,"12% PEG 5000, 0.1M sodium chloride, 0.05M magnesium chloride, 0.1M cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nsmb.2320",,"3RZJ",31.99,"2.5","2.5","Duplex Interrogation by a Direct DNA Repair Protein in the Search of Damage","GSHSWRHIRAEGLDSSYTVLFGKAEADEIFQELEKEVEYFTGALARVQVFGKWHSVPRKQATYGDAGLTYTFSGLTLSPKPWIPVLERIRDHVSGVTGQTFNFVLINRYKDGSDHICEHRDDERELAPGSPIASVSFGASRDFVFRHKDSRGKSPSRRVAVVRLPLAHGSLLMMNHPTNTHWYHSLPVRKKVLAPRVNLTFRKILLTKK","Homo sapiens","ALKBH2, ABH2","Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2","1","3RZJ"
,,,,,,,,,,,,,,,,"CTGTCTXACTGCG",,,"5'-D(*CP*TP*GP*TP*CP*TP*(ME6)P*AP*CP*TP*GP*CP*G)-3'","2","3RZJ"
,,,,,,,,,,,,,,,,"TCGCAGTGAGACA",,,"5'-D(*TP*CP*GP*CP*AP*GP*TP*GP*AP*GP*AP*CP*A)-3'","3","3RZJ"
"3RZK",,"X-RAY DIFFRACTION",3.22,61.76,"VAPOR DIFFUSION, HANGING DROP",6.5,"8% PEG 8000, 0.1M sodium chloride, 0.05M magnesium chloride, 0.1M cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nsmb.2320",,"3RZK",32,"2.78","2.78","Duplex Interrogation by a Direct DNA Repair Protein in the Search of Damage","GSHSWRHIRAEGLDSSYTVLFGKAEADEIFQELEKEVEYFTGALARVQVFGKWHSVPRKQATYGDAGLTYTFSGLTLSPKPWIPVLERIRDHVSGVTGQTFNFVLINRYKDGSDHICEHRDDERELAPGSPIASVSFGASRDFVFRHKDSRGKSPSRRVAVVRLPLAHGSLLMMNHPTNTHWYHSLPVRKKVLAPRVNLTFRKILLTKK","Homo sapiens","ALKBH2, ABH2","Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2","1","3RZK"
,,,,,,,,,,,,,,,,"CTGTCTAACTGCG",,,"5'-D(*CP*TP*GP*TP*CP*TP*(EDA)P*AP*CP*TP*GP*CP*G)-3'","2","3RZK"
,,,,,,,,,,,,,,,,"TCGCAGTTAGACA",,,"5'-D(*TP*CP*GP*CP*AP*GP*TP*TP*AP*GP*AP*CP*A)-3'","3","3RZK"
"3RZL",,"X-RAY DIFFRACTION",2.41,48.99,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG 8000, 0.1M SODIUM CHLORIDE, 0.05M magnesium chloride, 0.1M cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1038/nsmb.2320",,"3RZL",63.45,"2.6","2.6","Duplex Interrogation by a Direct DNA Repair Protein in the Search of Damage","SHSWRHIRAEGLDSSYTVLFGKAEADEIFQELEKEVEYFTGALARVQVFGKWHSVPRKQATYGDAGLTYTFSGLTLSPKPWIPVLERIRDHVSGVTGQTFNFVLINRYKDGSDHICEHRDDERELAPGSPIASVSFGASRDFVFRHKDSRGKSPSRRVAVVRLPLAHGSLLMMNHPTNTHWYHSLPVRKKVLAPRVNLTFRKILLTKK","Homo sapiens","ALKBH2, ABH2","Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2","1","3RZL"
,,,,,,,,,,,,,,,,"ATGTATCACTGCG",,,"5'-D(*AP*TP*GP*TP*AP*TP*CP*AP*CP*TP*GP*CP*G)-3'","2","3RZL"
,,,,,,,,,,,,,,,,"TCGCAGTIATACA",,,"5'-D(*TP*CP*GP*CP*AP*GP*TP*IP*AP*TP*AP*CP*A)-3'","3","3RZL"
"3RZM",,"X-RAY DIFFRACTION",3.81,67.69,"VAPOR DIFFUSION, HANGING DROP",6.5,"12% PEG 4000, 0.1M SODIUM CHLORIDE, 0.05M magnesium chloride, 0.1M cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nsmb.2320",,"3RZM",31.46,"3.06","3.06","Duplex Interrogation by a Direct DNA Repair Protein in the Search of Damage","HSWRHIRAEGLDSSYTVLFGKAEADEIFQELEKEVEYFTGALARVQVFGKWHSVPRKQATYGDAGLTYTFSGLTLSPKPWIPVLERIRDHVSGVTGQTFNFVLINRYKDGSDHICEHRDDERELAPGSPIASVSFGASRDFVFRHKDSRGKSPSRRVAVVRLPLAHGSLLMMNHPTNTHWYHSLPVRKKVLAPRVNLTFRKILLTA","Homo sapiens","ALKBH2, ABH2","Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2","1","3RZM"
,,,,,,,,,,,,,,,,"ATGTATAACTGCG",,,"5'-D(*AP*TP*GP*TP*AP*TP*AP*AP*CP*TP*GP*CP*G)-3'","2","3RZM"
,,,,,,,,,,,,,,,,"TCGCAGTTATACA",,,"5'-D(*TP*CP*GP*CP*AP*GP*TP*TP*AP*TP*AP*CP*A)-3'","3","3RZM"
"3RZN",,"X-RAY DIFFRACTION",2.26,45.47,,5.1,"20-25% PEG 8000, pH 5.1, VAPOR DIFFUSION, HANGING DROP, temperature 273K",273,"10.1016/j.str.2011.09.011",,"3RZN",24.77,"1.1","1.1","Crystal Structure of Human Glycolipid Transfer Protein complexed with 3-O-sulfo-galactosylceramide containing nervonoyl acyl chain (24:1)","MALLAEHLLKPLPADKQIETGPFLEAVSHLPPFFDCLGSPVFTPIKADISGNITKIKAVYDTNPAKFRTLQNILEVEKEMYGAEWPKVGATLALMWLKRGLRFIQVFLQSICDGERDENHPNLIRVNATKAYEMALKKYHGWIVQKIFQAALYAAPYKSDFLKALSKGQNVTEEECLEKIRLFLVNYTATIDVIYEMYTQMNAELNYKV","Homo sapiens","GLTP","Glycolipid transfer protein","1","3RZN"
"3RZU",,"X-RAY DIFFRACTION",2.48,50.48,"VAPOR DIFFUSION, SITTING DROP",7,"0.2M Sodium malonate, 20% PEG 3350, 5% PEG 400, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.jmb.2011.08.029",,"3RZU",145.23,"2.5","2.5","The Crystal Structure of the Catalytic Domain of AMSH","GPLGSSNSESIPTIDGLRHVVVPGRLCPQFLQLASANTARGVETCGILCGKLMRNEFTITHVLIPKQSAGSDYCNTENEEELFLIQDQQGLITLGWIHTHPTQTAFLSSVDLHTHCSYQMMLPESVAIVCSPKFQETGFFKLTDHGLEEISSCRQKGFHPHSKDPPLFCSCSHVTVVDRAVTITDLR","Homo sapiens","AMSH, STAMBP, STAMBP (AMSH)","STAM-binding protein","1","3RZU"
"3RZV",,"X-RAY DIFFRACTION",1.99,38.24,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M MES, 15% PEG 6000, 5% MPD, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.jmb.2011.08.029",,"3RZV",23.22,"1.67","1.67","The Crystal Structure of a E280A Mutant of the Catalytic Domain of AMSH","GPLGSSDCHTTVRPAKPPVVDRSLKPGALSNSESIPTIDGLRHVVVPGRLCPQFLQLASANTARGVATCGILCGKLMRNEFTITHVLIPKQSAGSDYCNTENEEELFLIQDQQGLITLGWIHTHPTQTAFLSSVDLHTHCSYQMMLPESVAIVCSPKFQETGFFKLTDHGLEEISSCRQKGFHPHSKDPPLFCSCSHVTVVDRAVTITDLR","Homo sapiens","AMSH, STAMBP, STAMBP (AMSH)","STAM-binding protein","1","3RZV"
"3RZW",,"X-RAY DIFFRACTION",2.56,51.88,"VAPOR DIFFUSION",8,"24% PEG-8000, 0.1M Imidazole, pH 8.0, VAPOR DIFFUSION, temperature 292K",292,"10.1016/j.jmb.2011.12.019",,"3RZW",43.32,"2.15","2.15","Crystal Structure of the Monobody ySMB-9 bound to human SUMO1","GSGSSVSSVPTKLEVVAATPTSLLISWDAGYWFIDYYRITYGETGGNSPVQEFTVPGYSSTATISGLSPGVDYTITVYAYYDNYGWSPISINYRT","Homo sapiens","SUMO1, SMT3C, SMT3H3, UBL1, OK/SW-cl.43","Monobody ySMB-9","1","3RZW"
,,,,,,,,,,,,,,,,"GSMSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYAQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGG","Homo sapiens","SUMO1, SMT3C, SMT3H3, UBL1, OK/SW-cl.43","Small ubiquitin-related modifier 1","2","3RZW"
"3RZY",,"X-RAY DIFFRACTION",2.1,41.5,"VAPOR DIFFUSION",6.5,"1.6 M sodium citrate, pH 6.5, vapor diffusion, temperature 293K",293,"10.1107/S2053230X14027897",,"3RZY",15.49,"1.08","1.08","Human adipocyte lipid-binding protein FABP4, Apo form at 1.08 Ang resolution.","QQMGRGSMCDAFVGTWKLVSSENFDDYMKEVGVGFATRKVAGMAKPNMIISVNGDVITIKSESTFKNTEISFILGQEFDEVTADDRKVKSTITLDGGVLVHVQKWDGKSTTIKRKREDDKLVVECVMKGVTSTRVYERA","Homo sapiens","FABP4","Fatty acid-binding protein, adipocyte","1","3RZY"
"3S00",,"X-RAY DIFFRACTION",1.97,37.71,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","Z60","3S00",35.06,"1.8","1.8","CDK2 in complex with inhibitor L4-14","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3S00"
"3S0I",,"X-RAY DIFFRACTION",2.01,38.68,,7,"20-25% PEG 3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 273K",273,"10.1016/j.str.2011.09.011",,"3S0I",24.75,"1.5","1.5","Crystal Structure of D48V mutant of Human Glycolipid Transfer Protein complexed with 3-O-sulfo galactosylceramide containing nervonoyl acyl chain","MALLAEHLLKPLPADKQIETGPFLEAVSHLPPFFDCLGSPVFTPIKAVISGNITKIKAVYDTNPAKFRTLQNILEVEKEMYGAEWPKVGATLALMWLKRGLRFIQVFLQSICDGERDENHPNLIRVNATKAYEMALKKYHGWIVQKIFQAALYAAPYKSDFLKALSKGQNVTEEECLEKIRLFLVNYTATIDVIYEMYTQMNAELNYKV","Homo sapiens","GLTP","Glycolipid transfer protein","1","3S0I"
"3S0K",,"X-RAY DIFFRACTION",2.2,44.03,,6.5,"20-25% PEG 3350 , 0.1M MES pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 273K",273,"10.1016/j.str.2011.09.011",,"3S0K",24.66,"1.4","1.4","Crystal Structure of Human Glycolipid Transfer Protein complexed with glucosylceramide containing oleoyl acyl chain (18:1)","MALLAEHLLKPLPADKQIETGPFLEAVSHLPPFFDCLGSPVFTPIKADISGNITKIKAVYDTNPAKFRTLQNILEVEKEMYGAEWPKVGATLALMWLKRGLRFIQVFLQSICDGERDENHPNLIRVNATKAYEMALKKYHGWIVQKIFQAALYAAPYKSDFLKALSKGQNVTEEECLEKIRLFLVNYTATIDVIYEMYTQMNAELNYKV","Homo sapiens","GLTP","Glycolipid transfer protein","1","3S0K"
"3S0N",,"X-RAY DIFFRACTION",2.64,53.44,"VAPOR DIFFUSION",8,"26 - 33% PEG8000, 0.1 M Tris pH 8.0, 2 mM ZnSO4 , VAPOR DIFFUSION, temperature 295K",295,"10.1016/j.bmcl.2011.05.126","0BB","3S0N",25.88,"1.95","1.95","Crystal Structure of Human Chymase with Benzimidazolone Inhibitor","IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRSITVTLGAHNITEEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTLPFPSQKNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNPRKTKSAFKGDSGGPLLCAGAAQGIVSYGRSDAKPPAVFTRISHYQPWINQILQAN","Homo sapiens","CMA1, CYH, CYM","Chymase","1","3S0N"
"3S0O",,"X-RAY DIFFRACTION",1.98,37.98,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","50Z","3S0O",35.02,"2","2","CDK2 in complex with inhibitor RC-1-138","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3S0O"
"3S1B",,"X-RAY DIFFRACTION",3.84,67.96,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M NaOAc, 0.02 M CaCl2, MPD 30.0% v/v, pH 6.0, vapor diffusion, hanging drop, temperature 289K",289,"10.1016/j.chembiol.2011.05.011",,"3S1B",15.26,"2.9","2.9","The Development of Peptide-based Tools for the Analysis of Angiogenesis","HEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPK","Homo sapiens","VEGF, VEGFA","Vascular endothelial growth factor A","1","3S1B"
,,,,,,,,,,,,,,,,"FNKECLLRYKEAALDPNLNLYQRIAKIVSIDDDC",,,"mini-Z","2","3S1B"
"3S1H",,"X-RAY DIFFRACTION",2.03,39.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","56Z","3S1H",35.17,"1.75","1.75","CDK2 in complex with inhibitor RC-2-39","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3S1H"
"3S1K",,"X-RAY DIFFRACTION",2.58,52.35,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2 M KI, 0.1 M MES, PEG 4000 25.0% v/v, pH 6.5, vapor diffusion, hanging drop, temperature 289K",289,"10.1016/j.chembiol.2011.05.011",,"3S1K",37.24,"2.55","2.55","The Development of Peptide-based Tools for the Analysis of Angiogenesis","VDNKFNKEMHNAYAIEIALLPNLNDQQFHAFIWSLIDDPSQSANLLAEAKKLNDAQAPK",,,"Z-domain","1","3S1K"
,,,,,,,,,,,,,,,,"GQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKD","Homo sapiens","VEGF, VEGFA","Vascular endothelial growth factor A","2","3S1K"
"3S24",,"X-RAY DIFFRACTION",2.57,52.07,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.7 M ammonium sulfate, 10% glucose, 5 mM 2-mercaptoethanol, 5 mM MgCl2, 5% isopropanol, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1106610108",,"3S24",280.4,"3.0137","3.0137","Crystal structure of human mRNA guanylyltransferase","GAIFLEGVTVKGVTQVTTQPKLGEVQQKCHQFCGWEGSGFPGAQPVSMDKQNIKLLDLKPYKVSWKADGTRYMMLIDGTNEVFMIDRDNSVFHVSNLEFPFRKDLRMHLSNTLLDGEMIIDRVNGQAVPRYLIYDIIKFNSQPVGDCDFNVRLQCIEREIISPRHEKMKTGLIDKTQEPFSVRNKPFFDICTSRKLLEGNFAKEVSHEMDGLIFQPTGKYKPGRCDDILKWKPPSLNSVDFRLKITRMGGEGLLPQNVGLLYVGGYERPFAQIKVTKELKQYDNKIIECKFENNSWVFMRQRTDKSFPNAYNTAMAVCNSISNPVTKEMLFEFIDRCTALEHHHHHH","Homo sapiens","RNGTT, CAP1A","mRNA-capping enzyme","1","3S24"
"3S2A",,"X-RAY DIFFRACTION",2.4,48.71,"VAPOR DIFFUSION, HANGING DROP",7.3,"22% w/v PEG3350, 245 mM ammonium sulfate, 100 mM Tris, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm200386s","2NQ","3S2A",110.61,"2.55","2.55","Crystal structure of PI3K-gamma in complex with a quinoline inhibitor","GSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA","Homo sapiens","PIK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","3S2A"
"3S2O",,"X-RAY DIFFRACTION",2.81,56.16,"VAPOR DIFFUSION, HANGING DROP",6.4,"22% PEG 5K MME 150MM AMMONIUM IODIDE AND 200MM SODIUM CITRATE PH6.4 , VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K",293,"10.1016/j.bmcl.2010.06.089","EV6","3S2O",46.09,"2.6","2.6","Fragment based discovery and optimisation of bace-1 inhibitors","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","3S2O"
"3S2P",,"X-RAY DIFFRACTION",1.99,38.2,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.2M HEPES, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2011.05.081","PMU","3S2P",34.31,"2.3","2.3","Crystal structure of CDK2 with a 2-aminopyrimidine compound","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3S2P"
"3S32",,"X-RAY DIFFRACTION",2.79,55.89,"VAPOR DIFFUSION, HANGING DROP",7,"0.2M MgAcetate and 17-20% PEG 3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nsmb.2093",,"3S32",22.1,"2.45","2.45","Crystal structure of Ash2L N-terminal domain","GAMGSMDTQAGSVDEENGRQLGEVELQCGICTKWFTADTFGIDTSSCLPFMTNYSFHCNVCHHSGNTYFLRKQANLKEMCLSALANLTWQSRTQDEHPKTMFSKDKDIIPFIDKYWECMTTRQRPGKMTWPNNIVKTMSKERDVFLVKEHPDPGSKDPEEDYPKFGLLDQDLSNIGPAYDNQKQSSAVSTS","Homo sapiens","ASH2L, ASH2L1","Set1/Ash2 histone methyltransferase complex subunit ASH2","1","3S32"
"3S3G",,"X-RAY DIFFRACTION",2.03,39.41,"VAPOR DIFFUSION, HANGING DROP",5,"7.5% PEG 6000, 0.05M ammonium citrate, pH5.0 , VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.febslet.2011.11.023","TLT","3S3G",39.07,"1.8","1.8","Crystal Structure of Human Aldose Reductase Complexed with Tolmetin","MGSSHHHHHHSSGLVPRGSHMASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","3S3G"
"3S3I",,"X-RAY DIFFRACTION",2.97,58.54,"VAPOR DIFFUSION, HANGING DROP",6.5,"22% PEG3350, 0.2 M sodium chloride, 0.1 M Bis-Tris, pH 6.5, 1 mM THP, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2012.03.099","CQ0","3S3I",40.38,"1.8","1.8","p38 kinase crystal structure in complex with small molecule inhibitor","ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPP","Homo sapiens","CSBP, CSBP1, CSBP2, CSPB1, MAPK14, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","3S3I"
"3S3V",,"X-RAY DIFFRACTION",2.54,51.6,"VAPOR DIFFUSION, HANGING DROP",6.9,"100 mM K2HPO4, 60% AS, 3% ETOH, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 287K",287,"10.1016/j.jsb.2011.06.001","TOP","3S3V",22.44,"1.53","1.53","human dihydrofolate reductase Q35K/N64F double mutant binary complex with trimethoprim","VGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFKRMTTTSSVEGKQNLVIMGKKTWFSIPEKFRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR, pds5","Dihydrofolate reductase","1","3S3V"
"3S41",,"X-RAY DIFFRACTION",2.24,45.12,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG 4000, PH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,"S41","3S41",53.57,"2.18","2.18","Glucokinase in complex with activator and glucose","MHHHHHHENLYFQGMKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ","Homo sapiens","GCK","Glucokinase","1","3S41"
"3S4E",,"X-RAY DIFFRACTION",2.15,42.68,"VAPOR DIFFUSION, SITTING DROP",7.4,"2.0M ammonium sulfate, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1002/prot.23156",,"3S4E",16.18,"1.26","1.26","Crystal Structrue of a Novel Mitogen-activated Protein Kinase Phosphatase, SKRP1","ASQVGVIKPWLLLGSQDAAHDLDTLKKNKVTHILNVAYGVENAFLSDFTYKSISILDLPETNILSYFPECFEFIEEAKRKDGVVLVHSNAGVSRAAAIVIGFLMNSEQTSFTSAFSLVKNARPSICPNSGFMEQLRTYQEGKES","Homo sapiens","DUSP19, DUSP17, LMWDSP3, SKRP1","Dual specificity protein phosphatase 19","1","3S4E"
"3S4J",,"X-RAY DIFFRACTION",2.68,54.13,"VAPOR DIFFUSION, HANGING DROP",4.5,"0.2 M Ammonium Sulfate, 15% Isopropanol, 15% Ethylene Glycol, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"3S4J",40.56,"1.95","1.95","Human FDPS Synthase in Complex with a Rigid Analog of Risedronate","SNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK","Homo sapiens","FDPS, FPS, KIAA1293","Farnesyl pyrophosphate synthase","1","3S4J"
"3S4M",,"X-RAY DIFFRACTION",2.34,47.38,"VAPOR DIFFUSION, HANGING DROP",5.6,"30% MPD, 0.1 M sodium citrate, 0.2 M ammonium acetate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/bi200666h",,"3S4M",14.2,"1.3","1.3","Crystal structure of wild-type human frataxin","GTLGHPGSLDETTYERLAEETLDSLAEFFEDLADKPYTFEDYDVSFGSGVLTVKLGGDLGTYVINKQTPNKQIWLSSPSSGPKRYDWTGKNWVYSHDGVSLHELLAAELTKALKTKLDLSSLAYSGKDA","Homo sapiens","FRDA, FXN, X25","Frataxin, mitochondrial","1","3S4M"
"3S4Q",,"X-RAY DIFFRACTION",2.09,41.02,,,"1-6% (W/V) PEG-4K 50 MM MES, PH 6.0, 5 MM MAGNESIUM SULFATE",,"10.1016/j.bmcl.2011.05.091","NK0","3S4Q",42.53,"2.27","2.27","P38 alpha kinase complexed with a pyrazolo-triazine based inhibitor","MAHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","CSBP, CSBP1, CSBP2, CSPB1, MAPK14, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","3S4Q"
"3S4R",,"X-RAY DIFFRACTION",3.49,64.79,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M Na cacodylate, MPD 20%, Mg acetate 0.45M, pH 6, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.1206836109",,"3S4R",22.36,"2.452","2.452","Crystal structure of vimentin coil1A/1B fragment with a stabilizing mutation","GSTRTNEKVELQELNDRFANLIDKVRFLEQQNKILLAELEQLKGQGKSRLGDLYEEEMRELRRQVDQLTNDKARVEVERDNLAEDIMRLREKL","Homo sapiens","FLJ36605, VIM","Vimentin","1","3S4R"
,,,,,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M MES, MPD 35%, 0.35M Li2SO4, pH 6, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277
"3S4Y",,"X-RAY DIFFRACTION",2.39,48.58,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% peg-3350, 0.2M ammonium sulfate, 0.1M sodium cacodylate. 0.02M ATP, 0.004M magnesium chloride were added to the protein stock solution, pH 5.5, vapor diffusion, sitting drop, temperature 293K",293,,,"3S4Y",57.26,"1.8","1.8","Crystal structure of human thiamin pyrophosphokinase 1","MHHHHHHSSGRENLYFQGGNLKYCLVILNQPLDNYFRHLWNKALLRACADGGANRLYDITEGERESFLPEFINGDFDSIRPEVREYYATKGCELISTPDQDHTDFTKCLKMLQKKIEEKDLKVDVIVTLGGLAGRFDQIMASVNTLFQATHITPFPIIIIQEESLIYLLQPGKHRLHVDTGMEGDWCGLIPVGQPCMQVTTTGLKWNLTNDVLAFGTLVSTSNTYDGSGVVTVETDHPLLWTMAIKS","Homo sapiens","TPK1","Thiamin pyrophosphokinase 1","1","3S4Y"
"3S57",,"X-RAY DIFFRACTION",2.86,57.04,"VAPOR DIFFUSION, HANGING DROP",6.5,"16% PEG 5000, 0.1M sodium chloride, 0.025M magnesium chloride, 0.1M cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nsmb.2320",,"3S57",32.27,"1.6","1.6","ABH2 cross-linked with undamaged dsDNA-1 containing cofactors","MSWRHIRAEGLDSSYTVLFGKAEADEIFQELEKEVEYFTGALARVQVFGKWHSVPRKQATYGDAGLTYTFSGLTLSPKPWIPVLERIRDHVSGVTGQTFNFVLINRYKDGSDHICEHRDDERELAPGSPIASVSFGASRDFVFRHKDSRGKSPSRRVAVVRLPLAHGSLLMMNHPTNTHWYHSLPVRKKVLAPRVNLTFRKILL","Homo sapiens","ABH2, ALKBH2","Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2","1","3S57"
,,,,,,,,,,,,,,,,"CTGTCATCACTGCG",,,"5'-D(*CP*TP*GP*TP*CP*AP*TP*CP*AP*CP*TP*GP*CP*G)-3'","2","3S57"
,,,,,,,,,,,,,,,,"TCGCAGTGATGACA",,,"5'-D(*TP*CP*GP*CP*AP*GP*TP*GP*AP*TP*GP*AP*CP*A)-3'","3","3S57"
"3S5A",,"X-RAY DIFFRACTION",2.87,57.18,"VAPOR DIFFUSION, HANGING DROP",6.1,"12% PEG 8000, 100mM sodium chloride, 50mM Magnesium chloride, 100mM cacodylate, pH 6.1, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nsmb.2320",,"3S5A",32.36,"1.7","1.7","ABH2 cross-linked to undamaged dsDNA-2 with cofactors","MSWRHIRAEGLDSSYTVLFGKAEADEIFQELEKEVEYFTGALARVQVFGKWHSVPRKQATYGDAGLTYTFSGLTLSPKPWIPVLERIRDHVSGVTGQTFNFVLINRYKDGSDHICEHRDDERELAPGSPIASVSFGASRDFVFRHKDSRGKSPSRRVAVVRLPLAHGSLLMMNHPTNTHWYHSLPVRKKVLAPRVNLTFRKILL","Homo sapiens","ABH2, ALKBH2","Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2","1","3S5A"
,,,,,,,,,,,,,,,,"CTGTCTCACTGTCG",,,"5'-D(*CP*TP*GP*TP*CP*TP*CP*AP*CP*TP*GP*TP*CP*G)-3'","2","3S5A"
,,,,,,,,,,,,,,,,"TCGACAGTGAGACA",,,"5'-D(*TP*CP*GP*AP*CP*AP*GP*TP*GP*AP*GP*AP*CP*A)-3'","3","3S5A"
"3S5D",,"X-RAY DIFFRACTION",2.24,45.21,"VAPOR DIFFUSION, HANGING DROP",5,"1.8 M ammonium sulfate, 0.2 M potassium sodium tartrate tetrahydrate, 0.1 M sodium citrate tribasic dihydrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/bi200666h",,"3S5D",14.18,"1.5","1.5","Crystal structure of human frataxin variant W155A","GTLGHPGSLDETTYERLAEETLDSLAEFFEDLADKPYTFEDYDVSFGSGVLTVKLGGDLGTYVINKQTPNKQIALSSPSSGPKRYDWTGKNWVYSHDGVSLHELLAAELTKALKTKLDLSSLAYSGKDA","Homo sapiens","FRDA, FXN, X25","Frataxin, mitochondrial","1","3S5D"
"3S5E",,"X-RAY DIFFRACTION",2.27,45.75,"VAPOR DIFFUSION, HANGING DROP",6,"16% PEG2000 MME, 0.1 M MES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/bi200666h",,"3S5E",14.19,"1.31","1.31","Crystal structure of human frataxin variant W155R, one of the Friedreich's ataxia point mutations","GTLGHPGSLDETTYERLAEETLDSLAEFFEDLADKPYTFEDYDVSFGSGVLTVKLGGDLGTYVINKQTPNKQIRLSSPSSGPKRYDWTGKNWVYSHDGVSLHELLAAELTKALKTKLDLSSLAYSGKDA","Homo sapiens","FRDA, FXN, X25","Frataxin, mitochondrial","1","3S5E"
"3S5F",,"X-RAY DIFFRACTION",2.01,38.69,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M sodium acetate trihydrate, 0.1 M Tris hydrochloride, 30% PEG4000, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/bi200666h",,"3S5F",28.36,"1.5","1.5","Crystal structure of human frataxin variant W155F","GTLGHPGSLDETTYERLAEETLDSLAEFFEDLADKPYTFEDYDVSFGSGVLTVKLGGDLGTYVINKQTPNKQIFLSSPSSGPKRYDWTGKNWVYSHDGVSLHELLAAELTKALKTKLDLSSLAYSGKDA","Homo sapiens","FRDA, FXN, X25","Frataxin, mitochondrial","1","3S5F"
"3S5J",,"X-RAY DIFFRACTION",2.4,48.85,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1371/journal.pone.0120304",,"3S5J",72.48,"2.02","2.02","2.0A Crystal structure of human phosphoribosyl pyrophosphate synthetase 1","MPNIKIFSGSSHQDLSQKIADRLGLELGKVVTKKFSNQETCVEIGESVRGEDVYIVQSGCGEINDNLMELLIMINACKIASASRVTAVIPCFPYARQDKKDKSRAPISAKLVANMLSVAGADHIITMDLHASQIQGFFDIPVDNLYAEPAVLKWIRENISEWRNCTIVSPDAGGAKRVTSIADRLNVDFALIHKERKKANEVDRMVLVGDVKDRVAILVDDMADTCGTICHAADKLLSAGATRVYAILTHGIFSGPAISRINNACFEAVVVTNTIPQEDKMKHCSKIQVIDISMILAEAIRRTHNGESVSYLFSHVPLLEHHHHHH","Homo sapiens","PRPS1","Ribose-phosphate pyrophosphokinase 1","1","3S5J"
"3S5N",,"X-RAY DIFFRACTION",4.81,74.43,"VAPOR DIFFUSION, HANGING DROP",8,"PEG 3350, KSCN, Bis tris Propane, TCEP, Ethelyene glycol, pH 8, vapor diffusion, hanging drop, temperature 298K",298,"10.1371/journal.pone.0026021",,"3S5N",33.09,"2.5","2.5","Crystal Structure of Human 4-hydroxy-2-oxoglutarate Aldolase","GPASGEGKKVDIAGIYPPVTTPFTATAEVDYGKLEENLHKLGTFPFRGFVVQGSNGEFPFLTSSERLEVVSRVRQAMPKNRLLLAGSGCESTQATVEMTVSMAQVGADAAMVVTPCYYRGRMSSAALIHHYTKVADLSPIPVVLYSVPANTGLDLPVDAVVTLSQHPNIVGMKDSGGDVTRIGLIVHKTRKQDFQVLAGSAGFLMASYALGAVGGVCALANVLGAQVCQLERLCCTGQWEDAQKLQHRLIEPNAAVTRRFGIPGLKKIMDWFGYYGGPCRAPLQELSPAEEEALRMDFTSNGWL","Homo sapiens","C10orf65, DHDPSL, HOGA1","4-hydroxy-2-oxoglutarate aldolase, mitochondrial","1","3S5N"
"3S5O",,"X-RAY DIFFRACTION",4.75,74.12,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG 3350, KSCN, Bis tris Propane, TCEP, Ethelyene glycol, pH 7.5, vapor diffusion, hanging drop, temperature 298K",298,"10.1371/journal.pone.0026021",,"3S5O",33.39,"1.97","1.97","Crystal Structure of Human 4-hydroxy-2-oxoglutarate Aldolase Bound to Pyruvate","GPLGSASGEGKKVDIAGIYPPVTTPFTATAEVDYGKLEENLHKLGTFPFRGFVVQGSNGEFPFLTSSERLEVVSRVRQAMPKNRLLLAGSGCESTQATVEMTVSMAQVGADAAMVVTPCYYRGRMSSAALIHHYTKVADLSPIPVVLYSVPANTGLDLPVDAVVTLSQHPNIVGMKDSGGDVTRIGLIVHKTRKQDFQVLAGSAGFLMASYALGAVGGVCALANVLGAQVCQLERLCCTGQWEDAQKLQHRLIEPNAAVTRRFGIPGLKKIMDWFGYYGGPCRAPLQELSPAEEEALRMDFTSNGWL","Homo sapiens","C10orf65, DHDPSL, HOGA1","4-hydroxy-2-oxoglutarate aldolase, mitochondrial","1","3S5O"
"3S5Y",,"X-RAY DIFFRACTION",3.28,62.55,"VAPOR DIFFUSION, HANGING DROP",5.1,"8-15% PEG 8000, 0.1 M Sodium Cacodylate, 0.02 M Magnesium Chloride, pH 5.1, vapor diffusion, hanging drop, temperature 293K, VAPOR DIFFUSION, HANGING DROP",293,"10.1016/j.chembiol.2011.10.012","DGJ","3S5Y",97.83,"2.105","2.105","Pharmacological Chaperoning in Human alpha-Galactosidase","LDNGLARTPTMGWLHWERFMCNLDCQEEPDSCISEKLFMEMAELMVSEGWKDAGYEYLCIDDCWMAPQRDSEGRLQADPQRFPHGIRQLANYVHSKGLKLGIYADVGNKTCAGFPGSFGYYDIDAQTFADWGVDLLKFDGCYCDSLENLADGYKHMSLALNRTGRSIVYSCEWPLYMWPFQKPNYTEIRQYCNHWRNFADIDDSWKSIKSILDWTSFNQERIVDVAGPGGWNDPDMLVIGNFGLSWNQQVTQMALWAIMAAPLFMSNDLRHISPQAKALLQDKDVIAINQDPLGKQGYQLRQGDNFEVWERPLSGLAWAVAMINRQEIGGPRSYTIAVASLGKGVACNPACFITQLLPVKRKLGFYEWTSRLRSHINPTGTVLLQLENTMQMSLKDLL","Homo sapiens","GLA","Alpha-galactosidase A","1","3S5Y"
"3S5Z",,"X-RAY DIFFRACTION",3.16,61.02,"VAPOR DIFFUSION, HANGING DROP",5.1,"PEG 8000, Sodium Cacodylate, Magnesium Chloride, pH 5.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.chembiol.2011.10.012","GLA","3S5Z",95.2,"2.001","2.001","Pharmacological Chaperoning in Human alpha-Galactosidase","LDNGLARTPTMGWLHWERFMCNLDCQEEPDSCISEKLFMEMAELMVSEGWKDAGYEYLCIDDCWMAPQRDSEGRLQADPQRFPHGIRQLANYVHSKGLKLGIYADVGNKTCAGFPGSFGYYDIDAQTFADWGVDLLKFDGCYCDSLENLADGYKHMSLALNRTGRSIVYSCEWPLYMWPFQKPNYTEIRQYCNHWRNFADIDDSWKSIKSILDWTSFNQERIVDVAGPGGWNDPDMLVIGNFGLSWNQQVTQMALWAIMAAPLFMSNDLRHISPQAKALLQDKDVIAINQDPLGKQGYQLRQGDNFEVWERPLSGLAWAVAMINRQEIGGPRSYTIAVASLGKGVACNPACFITQLLPVKRKLGFYEWTSRLRSHINPTGTVLLQLENTMQMSLKDLL","Homo sapiens","GLA","Alpha-galactosidase A","1","3S5Z"
"3S67",,"X-RAY DIFFRACTION",4.29,71.33,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Imidazole pH=6.5  
0.9M Sodium acetate,  
additive 2.0M NDSB-221, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444912051657",,"3S67",14.03,"2.26","2.26","Crystal structure of V57P mutant of human cystatin C","SSPGKPPRLVGGPMDASVEEEGVRRALDFAVGEYNKASNDMYHSRALQVVRARKQIPAGVNYFLDVELGRTTCTKTQPNLDNCPFHDQPHLKRKAFCSFQIYAVPWQGTMTLSKSTCQDA","Homo sapiens","CST3","Cystatin-C","1","3S67"
"3S6C",,"X-RAY DIFFRACTION",3.48,64.65,"VAPOR DIFFUSION, HANGING DROP",3.6,"10% PEG 6000, 0.2 M Sodium malonate, 0.1 M magnesium valerate, 0.1 M sodium borate , pH 3.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1105627108",,"3S6C",45.12,"2.9","2.9","Structure of human CD1e","IQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDMDDDDKGSSSSDDDDKEEQLSFRMLQTSSFANHSWAHSEGSGWLGDLQTHGWDTVLGTIRFLKPWSHGNFSKQELKNLQSLFQLYFHSFIRIVQASAGQFQLEYPFEIQILAGCRMNAPQIFLNMAYQGSDFLSFQGISWEPSPGAGIRAQNICKVLNRYLDIKEILQSLLGHTCPRFLAGLMEAGESELKRKVKPEAWLSCGPSPGPGRLQLVCHVSGFYPKPVWVMWMRGEQEQRGTQRGDVLPNADETWYLRATLDVAAGEAAGLSCRVKHSSLGGHDLIIHWGGENLYFQ","Homo sapiens","B2M, CD1E","Beta-2-microglobulin, T-cell surface glycoprotein CD1e, membrane-associated","1","3S6C"
,,,,,,,,,,,,,,,,,"Homo sapiens","B2M, CD1E"
"3S6W",,"X-RAY DIFFRACTION",2.47,50.13,"VAPOR DIFFUSION, HANGING DROP",4,"10% 2-propanol, 100mM Phosphate-Citrate, 0.2M Li2SO4, pH 4.0, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1371/journal.pone.0030375",,"3S6W",6.45,"1.78","1.78","Crystal structure of Tudor domain of human TDRD3","MWKPGDECFALYWEDNKFYRAEVEALHSSGMTAVVKFIDYGNYEEVLLSNIKPI","Homo sapiens","TDRD3","Tudor domain-containing protein 3","1","3S6W"
"3S70",,"X-RAY DIFFRACTION",2.16,43.11,"VAPOR DIFFUSION, SITTING DROP",6.5,"20%(w/v) PEG 8000, 0.2M magnesium acetate, 0.1M sodium cacodylate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1371/journal.pone.0024227",,"3S70",66.26,"1.625","1.625","Crystal structure of active caspase-6 bound with Ac-VEID-CHO solved by As-SAD","AFYKREMFDPAEKYKMDHRRRGIALIFNHERFFWHLTLPERRGTCADRDNLTRRFSDLGFEVKCFNDLKAEELLLKIHEVSTVSHADADCFVCVFLSHGEGNHIYAYDAKIEIQTLTGLFKGDKCHSLVGKPKIFIIQACRGNQHDVPVIPLDVVDNQTEKLDTNITEVDAASVYTLPAGADFLMCYSVAEGYYSHRETVNGSWYIQDLCEMLGKYGSSLEFTELLTLVNRKVSQRRVDFCKDPSAIGKKQVPCFASMLTKKLHFFPKSNLEHHHHHH","Homo sapiens","CASP6, MCH2","Caspase-6","1","3S70"
,,,,,,,,,,,,,,,,"XVEID",,,"aldehyde inhibitor Ac-VEID-CHO","2","3S70"
"3S71",,"X-RAY DIFFRACTION",2.11,41.83,"VAPOR DIFFUSION",7.8,"100 mM Tris-Cl, 1.15 M sodium citrate, pH 7.8, vapor diffusion, temperature 277K, VAPOR DIFFUSION",277,"10.1073/pnas.1114107108","EVD","3S71",29.53,"1.25","1.25","The origin of the hydrophobic effect in the molecular recognition of arylsulfonamides by carbonic anhydrase","HHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3S71"
"3S72",,"X-RAY DIFFRACTION",2.11,41.67,"VAPOR DIFFUSION",7.8,"100 mM Tris-Cl, 1.15 M sodium citrate, pH 7.8, vapor diffusion, temperature 277K, VAPOR DIFFUSION",277,"10.1073/pnas.1114107108","EVE","3S72",29.41,"1.6","1.6","The origin of the hydrophobic effect in the molecular recognition of arylsulfonamides by carbonic anhydrase","HHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3S72"
"3S73",,"X-RAY DIFFRACTION",2.18,43.61,"VAPOR DIFFUSION",7.8,"100 mM Tris-Cl, 1.15 M sodium citrate, pH 7.8, vapor diffusion, temperature 277K, VAPOR DIFFUSION",277,"10.1073/pnas.1114107108","EVF","3S73",29.56,"1.75","1.75","The origin of the hydrophobic effect in the molecular recognition of arylsulfonamides by carbonic anhydrase","HHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3S73"
"3S74",,"X-RAY DIFFRACTION",2.09,41.08,"VAPOR DIFFUSION",7.8,"100 mM Tris-Cl, 1.15 M sodium citrate, pH 7.8, vapor diffusion, temperature 277K",277,"10.1073/pnas.1114107108","03T","3S74",29.56,"1.4","1.4","The origin of the hydrophobic effect in the molecular recognition of arylsulfonamides by carbonic anhydrase","HHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3S74"
"3S75",,"X-RAY DIFFRACTION",2.12,41.92,"VAPOR DIFFUSION",7.8,"100 mM Tris-Cl, 1.15 M sodium citrate, pH 7.8, vapor diffusion, temperature 277K, VAPOR DIFFUSION",277,"10.1073/pnas.1114107108","EVG","3S75",29.43,"1.5","1.5","The origin of the hydrophobic effect in the molecular recognition of arylsulfonamides by carbonic anhydrase","HHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3S75"
"3S76",,"X-RAY DIFFRACTION",2.13,42.18,"VAPOR DIFFUSION",7.8,"100 mM Tris-Cl, 1.15 M sodium citrate, pH 7.8, vapor diffusion, temperature 277K, VAPOR DIFFUSION",277,"10.1073/pnas.1114107108","EVH","3S76",29.36,"1.6","1.6","The origin of the hydrophobic effect in the molecular recognition of arylsulfonamides by carbonic anhydrase","HHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3S76"
"3S77",,"X-RAY DIFFRACTION",2.08,40.75,"VAPOR DIFFUSION",7.8,"100 mM Tris-Cl, 1.15 M sodium citrate, pH 7.8, vapor diffusion, temperature 277K, VAPOR DIFFUSION",277,"10.1073/pnas.1114107108","EVI","3S77",29.46,"1.86","1.86","The origin of the hydrophobic effect in the molecular recognition of arylsulfonamides by carbonic anhydrase","HHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3S77"
"3S78",,"X-RAY DIFFRACTION",2.05,40.1,"VAPOR DIFFUSION",7.8,"100 mM Tris-Cl; 1.15 M sodium citrate, pH 7.8, vapor diffusion, temperature 277K",277,"10.1073/pnas.1114107108","EVJ","3S78",29.46,"1.98","1.98","The origin of the hydrophobic effect in the molecular recognition of arylsulfonamides by carbonic anhydrase","HHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3S78"
"3S79",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",7.4,"20-30% PEG 4000, phosphate buffer, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm300930n","ASD","3S79",59.14,"2.75","2.75","Human placental aromatase cytochrome P450 (CYP19A1) refined at 2.75 angstrom","MVLEMLNPIHYNITSIVPEAMPAATMPVLLLTGLFLLVWNYEGTSSIPGPGYCMGIGPLISHGRFLWMGIGSACNYYNRVYGEFMRVWISGEETLIISKSSSMFHIMKHNHYSSRFGSKLGLQCIGMHEKGIIFNNNPELWKTTRPFFMKALSGPGLVRMVTVCAESLKTHLDRLEEVTNESGYVDVLTLLRRVMLDTSNTLFLRIPLDESAIVVKIQGYFDAWQALLIKPDIFFKISWLYKKYEKSVKDLKDAIEVLIAEKRRRISTEEKLEECMDFATELILAEKRGDLTRENVNQCILEMLIAAPDTMSVSLFFMLFLIAKHPNVEEAIIKEIQTVIGERDIKIDDIQKLKVMENFIYESMRYQPVVDLVMRKALEDDVIDGYPVKKGTNIILNIGRMHRLEFFPKPNEFTLENFAKNVPYRYFQPFGFGPRGCAGKYIAMVMMKAILVTLLRRFHVKTLQGQCVESIQKIHDLSLHPDETKNMLEMIFTPRNSDRCLEH","Homo sapiens","CYP19A1, ARO1, CYAR, CYP19","Cytochrome P450 19A1","1","3S79"
"3S7A",,"X-RAY DIFFRACTION",2.28,46.14,"VAPOR DIFFUSION, HANGING DROP",6.9,"30% ammonium sulfate, 100 mM K2PO4, pH 6.9, VAPOR DIFFUSION, HANGING DROP, temperature 287K",287,"10.1107/S0907444911030071","684","3S7A",22.3,"1.8","1.8","Human dihydrofolate reductase binary complex with PT684","VGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR","Dihydrofolate reductase","1","3S7A"
"3S7B",,"X-RAY DIFFRACTION",3.22,61.79,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 0.1 M Tris-HCl, 5% ethanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2011.06.011","NH5","3S7B",51.45,"2.42","2.42","Structural Basis of Substrate Methylation and Inhibition of SMYD2","MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLEFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH","Homo sapiens","SMYD2, KMT3C","N-lysine methyltransferase SMYD2","1","3S7B"
"3S7D",,"X-RAY DIFFRACTION",3.04,59.61,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 0.1 M Tris-HCl, 5% ethanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2011.06.011","SAH","3S7D",52.07,"2.3","2.3","Structural Basis of Substrate Methylation and Inhibition of SMYD2","MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLEFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH","Homo sapiens","SMYD2, KMT3C","N-lysine methyltransferase SMYD2","1","3S7D"
,,,,,,,,,,,,,,,,"SSHLKSKKGQSTS",,,"Monomethylated p53 peptide","2","3S7D"
"3S7F",,"X-RAY DIFFRACTION",3.16,61.06,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 0.1 M Tris-HCl, 5% ethanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2011.06.011",,"3S7F",51.9,"2.85","2.85","Structural Basis of Substrate Methylation and Inhibition of SMYD2","MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLEFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH","Homo sapiens","SMYD2, KMT3C","N-lysine methyltransferase SMYD2","1","3S7F"
,,,,,,,,,,,,,,,,"SSHLKSKKGQSTS",,,"p53 peptide","2","3S7F"
"3S7G",,"X-RAY DIFFRACTION",2.78,55.82,"VAPOR DIFFUSION, SITTING DROP",7,"10% PEG 1000, 20% PEG 6000, 0.1M MAGNESIUM CHLORIDE, 0.2M TRIS, PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 295K",295,,,"3S7G",102.32,"3.13","3.13","Aglycosylated human igg1 fc fragment","DKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHG1, IGHM","Ig gamma-1 chain C region","1","3S7G"
"3S7H",,"X-RAY DIFFRACTION",2.95,58.34,,8,"0.1 M Tris and 8% PEG 8000 , pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/bi200878c",,"3S7H",34.11,"1.9","1.9","Structure of thrombin mutant Y225P in the E* form","FGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Prothrombin","1","3S7H"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKPGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Prothrombin","2","3S7H"
"3S7J",,"X-RAY DIFFRACTION",3.19,61.4,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 0.1 M Tris-HCl, 5% ethanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2011.06.011",,"3S7J",50.43,"3.04","3.04","Structural Basis of Substrate Methylation and Inhibition of SMYD2","MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLEFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH","Homo sapiens","SMYD2, KMT3C","N-lysine methyltransferase SMYD2","1","3S7J"
"3S7K",,"X-RAY DIFFRACTION",2.01,38.9,"VAPOR DIFFUSION, HANGING DROP",7.3,"0.2 M K Formate, 20 % PEG 3350, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/bi200878c",,"3S7K",67.74,"1.9","1.9","Structure of thrombin mutant Y225P in the E form","FGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Prothrombin","1","3S7K"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKPGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Prothrombin","2","3S7K"
"3S7L",,"X-RAY DIFFRACTION",2.04,39.81,"VAPOR DIFFUSION, HANGING DROP",5.4,"10-15% PEG 3350, 100 mM NaAcetate pH 5.4, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.bmcl.2011.07.057","591","3S7L",46.8,"2.162","2.162","Pyrazolyl and Thienyl Aminohydantoins as Potent BACE1 Inhibitors","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESTHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3S7L"
"3S7M",,"X-RAY DIFFRACTION",2.02,39.23,,,,,"10.1016/j.bmcl.2011.07.057","532","3S7M",46.79,"2.2","2.2","Pyrazolyl and Thienyl Aminohydantoins as Potent BACE1 Inhibitors","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESTHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3S7M"
"3S7R",,"X-RAY DIFFRACTION",2.54,51.49,"VAPOR DIFFUSION, SITTING DROP",9.5,"40.00% polyethylene glycol 600, 0.1M CHES pH 9.5, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3S7R",19.62,"2.15","2.15","Crystal structure of a Heterogeneous nuclear ribonucleoprotein A/B (HNRPAB) from HOMO SAPIENS at 2.15 A resolution","GINASKNEEDAGKMFVGGLSWDTSKKDLKDYFTKFGEVVDCTIKMDPNTGRSRGFGFILFKDAASVEKVLDQKEHRLDGRVIDPKKA","Homo sapiens","ABBP1, BC009359, HNRNPAB, HNRPAB","Heterogeneous nuclear ribonucleoprotein A/B","1","3S7R"
"3S7S",,"X-RAY DIFFRACTION",5.86,79.02,"VAPOR DIFFUSION, SITTING DROP",7.4,"24-32% PEG 4000, phosphate buffer, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm300930n","EXM","3S7S",58.87,"3.21","3.21","Crystal structure of human placental aromatase complexed with breast cancer drug exemestane","MVLEMLNPIHYNITSIVPEAMPAATMPVLLLTGLFLLVWNYEGTSSIPGPGYCMGIGPLISHGRFLWMGIGSACNYYNRVYGEFMRVWISGEETLIISKSSSMFHIMKHNHYSSRFGSKLGLQCIGMHEKGIIFNNNPELWKTTRPFFMKALSGPGLVRMVTVCAESLKTHLDRLEEVTNESGYVDVLTLLRRVMLDTSNTLFLRIPLDESAIVVKIQGYFDAWQALLIKPDIFFKISWLYKKYEKSVKDLKDAIEVLIAEKRRRISTEEKLEECMDFATELILAEKRGDLTRENVNQCILEMLIAAPDTMSVSLFFMLFLIAKHPNVEEAIIKEIQTVIGERDIKIDDIQKLKVMENFIYESMRYQPVVDLVMRKALEDDVIDGYPVKKGTNIILNIGRMHRLEFFPKPNEFTLENFAKNVPYRYFQPFGFGPRGCAGKYIAMVMMKAILVTLLRRFHVKTLQGQCVESIQKIHDLSLHPDETKNMLEMIFTPRNSDRCLEH","Homo sapiens","CYP19A1, ARO1, CYAR, CYP19","Cytochrome P450 19A1","1","3S7S"
"3S84",,"X-RAY DIFFRACTION",2.94,58.14,"Batch plate",7.5,"Crystal grew in pH 8.5 PEG and AmSO4, Dehydration in 60% PEG, Batch plate, temperature 293K",293,"10.1016/j.str.2012.02.020",,"3S84",63.33,"2.4","2.4","Dimeric apoA-IV","GATELHERLAKDSEKLKEEIGKELEELRARLLPHANEVSQKIGDNLRELQQRLEPYADQLRTQVNTQAEQLRRQLTPYAQRMERVLRENADSLQASLRPHADELKAKIDQNVEELKGRLTPYADEFKVKIDQTVEELRRSLAPYAQDTQEKLNHQLEGLTFQMKKNAEELKARISASAEELRQRLAPLAEDVRGNLRGNTEGLQKSLAELGGHLDQQVEEFRRRVEPYGENFNKALVQQMEQLRQKLGPHAGDVEGHLSFLEKDLRDKVNSFF","Homo sapiens","APOA4","Apolipoprotein A-IV","1","3S84"
"3S8E",,"X-RAY DIFFRACTION",2.32,46.9,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.1M HEPES, 0.1M NaCl, 1.5M Ammonium sulfate, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.str.2012.02.003",,"3S8E",255.77,"2.88","2.88","Phosphorylation regulates assembly of the caspase-6 substrate-binding groove","MAFYKREMFDPAEKYKMDHRRRGIALIFNHERFFWHLTLPERRGTCADRDNLTRRFSDLGFEVKCFNDLKAEELLLKIHEVSTVSHADADCFVCVFLSHGEGNHIYAYDAKIEIQTLTGLFKGDKCHSLVGKPKIFIIQACRGNQHDVPVIPLDVVDNQTEKLDTNITEVDAASVYTLPAGADFLMCYSVAEGYYSHRETVNGSWYIQDLCEMLGKYGSSLEFTELLTLVNRKVDQRRVDFCKDPSAIGKKQVPCFASMLTKKLHFFPKSNHHHHHH","Homo sapiens","CASP6, MCH2","Caspase-6","1","3S8E"
"3S8I",,"X-RAY DIFFRACTION",2.15,42.73,"VAPOR DIFFUSION, HANGING DROP",6,"21% PEG3350, 0.2 M AMMONIUM PHOSPHATE, 0.1 M BIS-TRIS, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3S8I",33.28,"1.7","1.7","The retroviral-like protease (RVP) domain of human DDI1","MGSSHHHHHHSSGLVPRGSGQVTMLYINCKVNGHPLKAFVDSGAQMTIMSQACAERCNIMRLVDRRWAGVAKGVGTQRIIGRVHLAQIQIEGDFLQCSFSILEDQPMDMLLGLDMLRRHQCSIDLKKNVLVIGTTGTQTYFLPEGELP","Homo sapiens","DDI1","Protein DDI1 homolog 1","1","3S8I"
"3S8L",,"X-RAY DIFFRACTION",1.69,27.06,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, 3.5 M sodium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/ja2068752",,"3S8L",14.38,"1.71","1.71","Protein-Ligand Interactions: Thermodynamic Effects Associated with Increasing Hydrophobic Surface Area","IEMKPHPWFFGKIPRAKAEEMLSKQRHDGAFLIRESESAPGDFSLSVKFGNDVQHFKVLRDGAGKYFLWVVKFNSLNELVDYHRSTSVSRNQQIFLRDIEQVPQQPTYVQAHHHHHH","Homo sapiens","GRB2, ASH","Growth factor receptor-bound protein 2","1","3S8L"
,,,,,,,,,,,,,,,,"XYXNX",,,"pYAc4cN","2","3S8L"
"3S8N",,"X-RAY DIFFRACTION",1.69,27.2,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, 4.3 M sodium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/ja2068752",,"3S8N",14.62,"1.71","1.71","Crystal Structure of the Grb2 SH2 Domain in Complex with a pYXN-Derived Tripeptide","IEMKPHPWFFGKIPRAKAEEMLSKQRHDGAFLIRESESAPGDFSLSVKFGNDVQHFKVLRDGAGKYFLWVVKFNSLNELVDYHRSTSVSRNQQIFLRDIEQVPQQPTYVQAHHHHHH","Homo sapiens","GRB2, ASH","Growth factor receptor-bound protein 2","1","3S8N"
,,,,,,,,,,,,,,,,"XYXNX",,,"pYAc5cN","2","3S8N"
"3S8O",,"X-RAY DIFFRACTION",1.7,27.78,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, 5.0 M sodium chloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/ja2068752",,"3S8O",14.34,"1.85","1.85","Crystal Structure of the Grb2 SH2 Domain in Complex with a pYXN-Derived Tripeptide","IEMKPHPWFFGKIPRAKAEEMLSKQRHDGAFLIRESESAPGDFSLSVKFGNDVQHFKVLRDGAGKYFLWVVKFNSLNELVDYHRSTSVSRNQQIFLRDIEQVPQQPTYVQAHHHHHH","Homo sapiens","GRB2, ASH","Growth factor receptor-bound protein 2","1","3S8O"
,,,,,,,,,,,,,,,,"XYANX",,,"pYAc6cN","2","3S8O"
"3S8P",,"X-RAY DIFFRACTION",2.55,51.67,"VAPOR DIFFUSION, SITTING DROP",7,"2.0 M sodium formate, 0.1 M BisTris propane, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1016/j.febslet.2013.10.020",,"3S8P",64.69,"1.85","1.85","Crystal Structure of the SET Domain of Human Histone-Lysine N-Methyltransferase SUV420H1 In Complex With S-Adenosyl-L-Methionine","QSRYVPSSGMSAKELCENDDLATSLVLDPYLGFQTHKMNTSAFPSRSSRHFSKSDSFSHNNPVRFRPIKGRQEELKEVIERFKKDEHLEKAFKCLTSGEWARHYFLNKNKMQEKLFKEHVFIYLRMFATDSGFEILPCNRYSSEQNGAKIVATKEWKRNDKIELLVGCIAELSEIEENMLLRHGENDFSVMYSTRKNCAQLWLGPAAFINHDCRPNCKFVSTGRDTACVKALRDIEPGEEISCYYGDGFFGENNEFCECYTCERRGTGAFKSR","Homo sapiens","CGI-85, KMT5B, SUV420H1","Histone-lysine N-methyltransferase SUV420H1","1","3S8P"
"3S8S",,"X-RAY DIFFRACTION",1.61,23.8,"VAPOR DIFFUSION",7,"1.5 M ammonium sulfate, 0.1 M bistris propane, pH 7.0, vapor diffusion, temperature 291K",291,,,"3S8S",12.49,"1.3","1.3","Crystal structure of the RRM domain of human SETD1A","GGQIPLKEVTFARLNDNVRETFLKDMCRKYGEVEEVEILLHPRTRKHLGLARVLFTSTRGAKETVKNLHLTSVMGNIIHAQLDIKGQQRMKYYELIVNGSYTPQTVPTGG","Homo sapiens","SETD1A, KIAA0339, KMT2F, SET1, SET1A","Histone-lysine N-methyltransferase SETD1A","1","3S8S"
"3S8W",,"X-RAY DIFFRACTION",3.07,59.99,,8.5,"31% (w/v) PEG 4000, 200 mM Li2SO4, 100 mM Tris pH 8.5, 5% (v/v) MPD, 10 mM Na acetate, 1.5% (w/v) PEG8000, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.cell.2011.06.048",,"3S8W",36.21,"2.6","2.6","D2 domain of human IFNAR2","ADPDMSFEPPEFEIVGFTNHINVMVKFPSIVEEELQFDLSLVIEEQSEGIVKKHKPEIKGNMSGNFTYIIDKLIPNTNYCVSVYLEHSDEQAVIKSPLKCTLLPP","Homo sapiens","IFNAR2, IFNABR, IFNARB","Interferon alpha/beta receptor 2","1","3S8W"
"3S8X",,"X-RAY DIFFRACTION",2.07,40.13,"VAPOR DIFFUSION",9,"Na-Bicine 0.1M pH 9, Na-Malonate 2.2M pH 7, VAPOR DIFFUSION, temperature 298K",298,"10.1016/j.ejmech.2012.02.050","E59","3S8X",30.01,"1.3","1.3","Crystal structure of human carbonic anhydrase isozyme II with 4-{[(4-methyl-6-oxo-1,6-dihydro-2-pyrimidinyl)sulfanyl]acetyl}benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3S8X"
"3S8Z",,"X-RAY DIFFRACTION",3.49,64.77,"VAPOR DIFFUSION, HANGING DROP",6.5,"100mM ADA pH 6.5, 100mM MgCl2, 12% PEG6000, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nsmb.2139",,"3S8Z",71.92,"2.8","2.8","Crystal structure of LRP6-E3E4","HHHHHHHHVPEAFLLFSRRADIRRISLETNNNNVAIPLTGVKEASALDFDVTDNRIYWTDISLKTISRAFMNGSALEHVVEFGLDYPEGMAVDWLGKNLYWADTGTNRIEVSKLDGQHRQVLVWKDLDSPRALALDPAEGFMYWTEWGGKPKIDRAAMDGSERTTLVPNVGRANGLTIDYAKRRLYWTDLDTNLIESSNMLGLNREVIADDLPHPFGLTQYQDYIYWTDWSRRSIERANKTSGQNRTIIQGHLDYVMDILVFHSSRQSGWNECASSNGHCSHLCLAVPVGGFVCGCPAHYSLNADNRTCSAPTTFLLFSQKSAINRMVIDEQQSPDIILPIHSLRNVRAIDYDPLDKQLYWIDSRQNMIRKAQEDGSQGFTVVVSSVPSQNLEIQPYDLSIDIYSRYIYWTCEATNVINVTRLDGRSVGVVLKGEQDRPRAIVVNPEKGYMYFTNLQERSPKIERAALDGTEREVLFFSGLSKPIALALDSRLGKLFWADSDLRRIESSDLSGANRIVLEDSNILQPVGLTVFENWLYWIDKQQQMIEKIDMTGREGRTKVQARIAQLSDIHAVKELNLQEYRQHPCAQDNGGCSHICLVKGDGTTRCSCPMHLVLLQDELSC","Homo sapiens","LRP6","Low-density lipoprotein receptor-related protein 6","1","3S8Z"
"3S91",,"X-RAY DIFFRACTION",2.85,56.85,"VAPOR DIFFUSION, SITTING DROP",4.6,"14% isopropanol, 0.14M CaCl2, 30% glycerol, 0.7M acetate, pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3S91",15.1,"2.06","2.06","Crystal Structure of the first bromodomain of human BRD3 in complex with the inhibitor JQ1","SMPEVSNPSKPGRKTNQLQYMQNVVVKTLWKHQFAWPFYQPVDAIKLNLPDYHKIIKNPMDMGTIKKRLENNYYWSASECMQDFNTMFTNCYIYNKPTDDIVLMAQALEKIFLQKVAQMPQEE","Homo sapiens","BRD3, KIAA0043, RING3L","Bromodomain-containing protein 3","1","3S91"
"3S92",,"X-RAY DIFFRACTION",2.04,39.83,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 3350, 0.2M (NH4)2Hcit, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3S92",13.83,"1.36","1.36","Crystal Structure of the second bromodomain of human BRD3 in complex with the inhibitor JQ1","SMGKLSEHLRYCDSILREMLSKKHAAYAWPFYKPVDAEALELHDYHDIIKHPMDLSTVKRKMDGREYPDAQGFAADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKMP","Homo sapiens","BRD3, KIAA0043, RING3L","Bromodomain-containing protein 3","1","3S92"
"3S93",,"X-RAY DIFFRACTION",2.59,52.54,,,"crystal used for final refinement: 1.5 M ammonium phosphate, 0.1 M bis-tris propane. 1:200 trypsin was also added., pH 8.5, vapor diffusion, temperature 291K",291,,,"3S93",22.72,"2.28","2.28","Crystal structure of conserved motif in TDRD5","GMSEQERIQECLRKEIRSLLISTKDGLSPQELEKEYLLMVGNHLPLRILGYRSTMELVLDMPDVVRVCPGAGGTVILKAIPDESTKGIASLVAKQRSSHKLR","Homo sapiens","TDRD5, TUDOR3","Tudor domain-containing protein 5","1","3S93"
,,,,,,,"Selenomethionyl derivative: 1.5 M ammonium phosphat
e, 0.1 M bis-tris propane. 1:200 trypsin was also added., pH 7, vapor diffusion, temperature 291K",291
,,,,,,,"crystal used for preliminary refinement: 25 w/v% PEG-3350, 0.2 M lithium sulfate, 0.1 M bis-tris propane. 1:200 trypsin was also added., pH 6.5, vapor diffusion, temperature 291K",291
"3S94",,"X-RAY DIFFRACTION",2.71,54.65,"VAPOR DIFFUSION, HANGING DROP",5.5,"80mM sodium citrate pH 5.5, 20-21% PEG3350, 40mM KSCN, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nsmb.2139",,"3S94",141.35,"2.8","2.8","Crystal structure of LRP6-E1E2","HHHHHHHHAPLLLYANRRDLRLVDATNGKENATIVVGGLEDAAAVDFVFSHGLIYWSDVSEEAIKRTEFNKTESVQNVVVSGLLSPDGLACDWLGEKLYWTDSETNRIEVSNLDGSLRKVLFWQELDQPRAIALDPSSGFMYWTDWGEVPKIERAGMDGSSRFIIINSEIYWPNGLTLDYEEQKLYWADAKLNFIHKSNLDGTNRQAVVKGSLPHPFALTLFEDILYWTDWSTHSILACNKYTGEGLREIHSDIFSPMDIHAFSQQRQPNATNPCGIDNGGCSHLCLMSPVKPFYQCACPTGVKLLENGKTCKDGATELLLLARRTDLRRISLDTPDFTDIVLQLEDIRHAIAIDYDPVEGYIYWTDDEVRAIRRSFIDGSGSQFVVTAQIAHPDGIAVDWVARNLYWTDTGTDRIEVTRLNGTMRKILISEDLEEPRAIVLDPMVGYMYWTDWGEIPKIERAALDGSDRVVLVNTSLGWPNGLALDYDEGKIYWGDAKTDKIEVMNTDGTGRRVLVEDKIPHIFGFTLLGDYVYWTDWQRRSIERVHKRSAEREVIIDQLPDLMGLKATNVHRVIGSNPCAEENGGCSHLCLYRPQGLRCACPIGFELISDMKTCIVP","Homo sapiens","LRP6","Low-density lipoprotein receptor-related protein 6","1","3S94"
"3S95",,"X-RAY DIFFRACTION",3.1,60.31,"VAPOR DIFFUSION, SITTING DROP",7.2,"24% MPD, 0.1M Tris pH 7.2, 10mM Phenol, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,,,"3S95",74.41,"1.65","1.65","Crystal structure of the human LIMK1 kinase domain in complex with staurosporine","SMPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWETYRRGES","Homo sapiens","LIMK, LIMK1","LIM domain kinase 1","1","3S95"
"3S98",,"X-RAY DIFFRACTION",2.59,52.42,,,"20% (w/v) PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.cell.2011.06.048",,"3S98",35.86,"1.9","1.9","human IFNAR1","ADPLKSPQKVEVDIIDDNFILRWNRSDESVGNVTFSFDYQKTGMDNWIKLSGCQNITSTKCNFSSLKLNVYEEIKLRIRAEKENTSSWYEVDSFTPFRKAQIGPPEVHLEAEDKAIVIHISPGTKDSVMWALDGLSFTYSLVIWKNSSGVEERIENIYSRHKIYKLSPETTYCLKVKAALLTSWKIGVYSPVHCIKTTVENELPPPENIEVSVQNQNYVLKWDYTYANMTFQVQWLHAFLKRNPGNHLYKWKQIPDCENVKTTQCVFPQNVFQKGIYLLRVQASDGNNTSFWSEEIKFDTEIQAFL","Homo sapiens","IFNAR1, IFNAR","Interferon alpha/beta receptor 1","1","3S98"
"3S9G",,"X-RAY DIFFRACTION",2.29,46.34,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M sodium cacodylate, 0.1 M calcium acetate, 4% PEG 8000, 5 mM magnesium chloride, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2011.10.022",,"3S9G",24.84,"2.1","2.1","Structure of human Hexim1 (delta stammer) coiled coil domain","GAMGGDGSEFLQRDFSETYERYHTESLQNMSKQELIKEYLELEKSLSRMEDENNRLRLESKRLDARVRELELELDRLRAENLQLLTENELHRQQERAPLSKFGD","Homo sapiens","CLP1, EDG1, HEXIM1, HIS1, MAQ1","Protein HEXIM1","1","3S9G"
"3S9O",,"X-RAY DIFFRACTION",4.54,72.93,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM Hepes, 3.3M NaCl, 1% glycerol, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1074/jbc.M114.593632",,"3S9O",54.39,"2.6","2.6","The Focal Adhesion Targeting (FAT) domain of the Focal Adhesion Kinase showing N-terminal interactions in cis","GPLSSPADSYNEGVKLQPQEISPPPTANLDRSNDKVYENVTGLVKAVIEMSSKIQPAPPEEYVPMVKEVGLALRTLLATVDETIPLLPASTHREIEMAQKLLNSDLGELINKMKLAQQYVMTSLQQEYKKQMLTAAHALAVDAKNLLDVIDQARLKMLGQTRPH","Homo sapiens","FAK, FAK1, PTK2","Focal adhesion kinase 1","1","3S9O"
"3S9T",,"X-RAY DIFFRACTION",2.1,39.6,"VAPOR DIFFUSION",7,"2.4M Na-Malonate, pH 7, VAPOR DIFFUSION, temperature 298K",298,"10.1016/j.ejmech.2012.02.050","E49","3S9T",30.05,"1.3","1.3","Crystal structure of human carbonic anhydrase isozyme II with 2-chloro-5-{[(4,6-dimethyl-2-pyrimidinyl)sulfanyl]acetyl}benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3S9T"
"3SA0",,"X-RAY DIFFRACTION",2.29,46.28,"VAPOR DIFFUSION, SITTING DROP",7.5,"Precipitant: 1.1 M - 1.3 M ammonium sulfate, 2% PEG 500 MME, 0.1 M Hepes, pH 7.5. The protein was in 80-120 mM Nacl, Tris 15 mM, pH 8.0, 10-20 mM b-ME 
Protein was mixed with precipitant at 1:1 ratio, VAPOR DIFFUSION, SITTING DROP, temperature 290K",290,"10.1158/0008-5472.CAN-11-2596",,"3SA0",42.03,"1.5947","1.5947","Complex of ERK2 with norathyriol","MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","ERK2, MAPK1, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","3SA0"
"3SAF",,"X-RAY DIFFRACTION",2.8,56.02,"VAPOR DIFFUSION, HANGING DROP",8,"6% PEG6000, 1.5 M sodium chloride, 0.4 mM yttrium(III) trichloride, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1261/rna.2763111",,"3SAF",100.94,"2.5","2.5","Crystal structure of the human RRP6 catalytic domain with D313N mutation in the active site","SIIRPQLKFREKIDNSNTPFLPKIFIKPNAQKPLPQALSKERRERPQDRPEDLDVPPALADFIHQQRTQQVEQDMFAHPYQYELNHFTPADAVLQKPQPQLYRPIEETPCHFISSLDELVELNEKLLNCQEFAVNLEHHSYRSFLGLTCLMQISTRTEDFIIDTLELRSDMYILNESLTDPAIVKVFHGADSDIEWLQKDFGLYVVNMFDTHQAARLLNLGRHSLDHLLKLYCNVDSNKQYQLADWRIRPLPEEMLSYARDDTHYLLYIYDKMRLEMWERGNGQPVQLQVVWQRSRDICLKKFIKPIFTDESYLELYRKQKKHLNTQQLTAFQLLFAWRDKTARREDESYGYVLPNHMMLKIAEELPKEPQGIIACCNPVPPLVRQQINEMHLLIQQAREMPLLKSEVAAGVKKSGPLPSAERLENVL","Homo sapiens","EXOSC10, PMSCL, PMSCL2, RRP6","Exosome component 10","1","3SAF"
"3SAG",,"X-RAY DIFFRACTION",2.88,57.35,"VAPOR DIFFUSION, HANGING DROP",8,"6% PEG6000, 1.5 M sodium chloride, 0.4 mM yttrium(III) trichloride, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1261/rna.2763111",,"3SAG",101,"2.7","2.7","Crystal structure of the human RRP6 catalytic domain with D313N mutation in the active site","SIIRPQLKFREKIDNSNTPFLPKIFIKPNAQKPLPQALSKERRERPQDRPEDLDVPPALADFIHQQRTQQVEQDMFAHPYQYELNHFTPADAVLQKPQPQLYRPIEETPCHFISSLDELVELNEKLLNCQEFAVNLEHHSYRSFLGLTCLMQISTRTEDFIIDTLELRSDMYILNESLTDPAIVKVFHGADSDIEWLQKDFGLYVVNMFDTHQAARLLNLGRHSLDHLLKLYCNVDSNKQYQLADWRIRPLPEEMLSYARDDTHYLLYIYDKMRLEMWERGNGQPVQLQVVWQRSRDICLKKFIKPIFTDESYLELYRKQKKHLNTQQLTAFQLLFAWRDKTARREDESYGYVLPNHMMLKIAEELPKEPQGIIACCNPVPPLVRQQINEMHLLIQQAREMPLLKSEVAAGVKKSGPLPSAERLENVL","Homo sapiens","EXOSC10, PMSCL, PMSCL2, RRP6","Exosome component 10","1","3SAG"
"3SAH",,"X-RAY DIFFRACTION",2.89,57.4,"VAPOR DIFFUSION, HANGING DROP",8,"6% PEG6000, 1.5 M sodium chloride, 0.4 mM yttrium(III) trichloride, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1261/rna.2763111",,"3SAH",100.84,"2.65","2.65","Crystal structure of the human RRP6 catalytic domain with Y436A mutation in the catalytic site","SIIRPQLKFREKIDNSNTPFLPKIFIKPNAQKPLPQALSKERRERPQDRPEDLDVPPALADFIHQQRTQQVEQDMFAHPYQYELNHFTPADAVLQKPQPQLYRPIEETPCHFISSLDELVELNEKLLNCQEFAVDLEHHSYRSFLGLTCLMQISTRTEDFIIDTLELRSDMYILNESLTDPAIVKVFHGADSDIEWLQKDFGLYVVNMFDTHQAARLLNLGRHSLDHLLKLYCNVDSNKQYQLADWRIRPLPEEMLSAARDDTHYLLYIYDKMRLEMWERGNGQPVQLQVVWQRSRDICLKKFIKPIFTDESYLELYRKQKKHLNTQQLTAFQLLFAWRDKTARREDESYGYVLPNHMMLKIAEELPKEPQGIIACCNPVPPLVRQQINEMHLLIQQAREMPLLKSEVAAGVKKSGPLPSAERLENVL","Homo sapiens","EXOSC10, PMSCL, PMSCL2, RRP6","Exosome component 10","1","3SAH"
"3SAK",,"SOLUTION NMR",,,,,,,,,"3SAK",19.79,,,"HIGH RESOLUTION SOLUTION NMR STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTI-DIMENSIONAL NMR (SAC STRUCTURES)","KKKPLDGEYFTLQIRGRERFEMFRELNEALELKDAQAGKEPG","Homo sapiens","TP53, P53","PROTEIN (TUMOR SUPPRESSOR P53)","1","3SAK"
"3SAP",,"X-RAY DIFFRACTION",2.1,40.2,"VAPOR DIFFUSION, SITTING DROP",7.5,"2.3M Na-bicine pH 9, 2.3M Na-malonate pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.ejmech.2012.02.050","E2I","3SAP",30.16,"1.75","1.75","Crystal structure of human carbonic anhydrase isozyme II with 4-{[(5-butyl-2-pyrimidinyl)sulfanyl]acetyl}benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3SAP"
"3SAX",,"X-RAY DIFFRACTION",2.08,40.78,"VAPOR DIFFUSION, SITTING DROP",9,"0.1M Na-bicine pH 9, 2.6M Na-malonate pH 7.55, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.ejmech.2012.02.050","E50","3SAX",30.05,"1.1","1.1","Crystal structure of human carbonic anhydrase isozyme II with 2-chloro-5-{[(5-ethyl-2-pyrimidinyl)sulfanyl]acetyl}benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3SAX"
"3SAY",,"X-RAY DIFFRACTION",2.61,52.93,"VAPOR DIFFUSION, SITTING DROP",7,"20% PEG3350, 0.1M sodium Hepes pH 7.0, 2% (v/v) Tacsimate pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 296K",296,,,"3SAY",97.65,"2.231","2.231","Crystal structure of human glycogen synthase kinase 3 beta (GSK3b) in complex with inhibitor 142","MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNSTLEHHHHHHHH","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","3SAY"
"3SBD",,"X-RAY DIFFRACTION",2.29,46.25,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG4000, 7% isopropanol, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1038/ng.2359",,"3SBD",42.76,"2.1","2.1","Crystal structure of RAC1 P29S mutant","GSHMENLYFQGQAIKCVVVGDGAVGKTCLLISYTTNAFSGEYIPTVFDNYSANVMVDGKPVNLGLWDTAGQEDYDRLRPLSYPQTDVFLICFSLVSPASFENVRAKWYPEVRHHCPNTPIILVGTKLDLRDDKDTIEKLKEKKLTPITYPQGLAMAKEIGAVKYLECSALTQRGLKTVFDEAIRAVL","Homo sapiens","RAC1, TC25, MIG5","Ras-related C3 botulinum toxin substrate 1","1","3SBD"
"3SBE",,"X-RAY DIFFRACTION",2.51,50.97,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG4000, 7% isopropanol, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1038/ng.2359",,"3SBE",21.38,"2.6","2.6","Crystal structure of RAC1 P29S mutant","GSHMENLYFQGQAIKCVVVGDGAVGKTCLLISYTTNAFSGEYIPTVFDNYSANVMVDGKPVNLGLWDTAGQEDYDRLRPLSYPQTDVFLICFSLVSPASFENVRAKWYPEVRHHCPNTPIILVGTKLDLRDDKDTIEKLKEKKLTPITYPQGLAMAKEIGAVKYLECSALTQRGLKTVFDEAIRAVL","Homo sapiens","RAC1, TC25, MIG5","Ras-related C3 botulinum toxin substrate 1","1","3SBE"
"3SBH",,"X-RAY DIFFRACTION",2.1,40.1,"VAPOR DIFFUSION, SITTING DROP",9,"0.1M Na-bicine pH 9, 2M Na-malonate pH 7.55, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.ejmech.2012.02.050","E65","3SBH",30.21,"1.65","1.65","Crystal structure of human carbonic anhydrase isozyme II with 4-{[(4,6-dimethyl-2-pyrimidinyl)sulfanyl]acetyl}benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3SBH"
"3SBI",,"X-RAY DIFFRACTION",2.1,41.2,"VAPOR DIFFUSION",9,"0.1M Na-bicine pH 9, 2M Na-malonate pH 7.55, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.ejmech.2012.02.050","E90","3SBI",29.98,"1.4","1.4","Crystal structure of human carbonic anhydrase isozyme II with 4-[(2-pyrimidinylsulfanyl)acetyl]benzenesulfonamide","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3SBI"
"3SBY",,"X-RAY DIFFRACTION",2.38,48.33,"VAPOR DIFFUSION, SITTING DROP",6.7,"0.96 M sodium malonate, 10% Jeffamine 600 pH 7.0, 0.1 M Hepes 6.7, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1074/jbc.M111.261370",,"3SBY",58.72,"2.71","2.71","Crystal Structure of SeMet-Substituted Apo-MMACHC (1-244), a human B12 processing enzyme","MEPKVAELKQKIEDTLCPFGFEVYPFQVAWYNELLPPAFHLPLPGPTMAFLVLSTPAMFDRALKPFLQSCHLRMLTDPVDQCMAYHLGRVRESLPELQIEIIADYEMHPNRRPKILAQTAAHVAGAAYYYQRQDVEADPWGNQRISGVCIHPRFGGWFAIRGVMLLPGIEVPDLPPRKPHDCVPTRADRIALLEGFNFHWRDWTYRDAVTPQERYSEEQKAYFSTPPAQRLALLGLAQPSEKPSLEHHHHHH","Homo sapiens","MMACHC","Methylmalonic aciduria and homocystinuria type C protein","1","3SBY"
"3SBZ",,"X-RAY DIFFRACTION",3.54,65.24,"VAPOR DIFFUSION, SITTING DROP",6.7,"0.9 M sodium malonate, 5% Jeffamine 600 pH 7.0, 0.1 M Hepes 6.7, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1074/jbc.M111.261370",,"3SBZ",29.31,"2","2","Crystal Structure of Apo-MMACHC (1-244), a human B12 processing enzyme","MEPKVAELKQKIEDTLCPFGFEVYPFQVAWYNELLPPAFHLPLPGPTLAFLVLSTPAMFDRALKPFLQSCHLRMLTDPVDQCVAYHLGRVRESLPELQIEIIADYEVHPNRRPKILAQTAAHVAGAAYYYQRQDVEADPWGNQRISGVCIHPRFGGWFAIRGVVLLPGIEVPDLPPRKPHDCVPTRADRIALLEGFNFHWRDWTYRDAVTPQERYSEEQKAYFSTPPAQRLALLGLAQPSEKPSLEHHHHHH","Homo sapiens","MMACHC","Methylmalonic aciduria and homocystinuria type C protein","1","3SBZ"
"3SC0",,"X-RAY DIFFRACTION",2.48,50.47,"VAPOR DIFFUSION",8.5,"2.0 M ammonium sulfate, and 0.1 M Tris.HCl pH 8.5, vapor diffusion, temperature 277K",277,"10.1074/jbc.M111.261370",,"3SC0",28.83,"1.95","1.95","Crystal Structure of MMACHC (1-238), a human B12 processing enzyme, complexed with MethylCobalamin","SNAMEPKVAELKQKIEDTLCPFGFEVYPFQVAWYNELLPPAFHLPLPGPTLAFLVLSTPAMFDRALKPFLQSCHLRMLTDPVDQCVAYHLGRVRESLPELQIEIIADYEVHPNRRPKILAQTAAHVAGAAYYYQRQDVEADPWGNQRISGVCIHPRFGGWFAIRGVVLLPGIEVPDLPPRKPHDCVPTRADRIALLEGFNFHWRDWTYRDAVTPQERYSEEQKAYFSTPPAQRLALLGLAQ","Homo sapiens","MMACHC","Methylmalonic aciduria and homocystinuria type C protein","1","3SC0"
"3SC1",,"X-RAY DIFFRACTION",2.94,58.14,"VAPOR DIFFUSION, HANGING DROP",7,"2.2M AMMONIUM SULFATE, 10MM EDTA, 5-% GLYCEROL, 0.1M HEPES, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1007/s10822-011-9456-7","3S1","3SC1",36.38,"2.7","2.7","Novel Isoquinolone PDK1 Inhibitors Discovered through Fragment-Based Lead Discovery","GAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDPK1, PDK1","3-phosphoinositide-dependent protein kinase 1","1","3SC1"
"3SD0",,"X-RAY DIFFRACTION",3.32,62.9,,,,,,"TSK","3SD0",81.11,"2.7","2.7","Identification of a Glycogen Synthase Kinase-3b Inhibitor that Attenuates Hyperactivity in CLOCK Mutant Mice","SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARI","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","3SD0"
"3SD4",,"X-RAY DIFFRACTION",2.34,47.36,"VAPOR DIFFUSION, HANGING DROP",4,"28% PEG 3000, 0.2 M ammonium acetate, 0.1 M cacodylic acid  
, pH 4.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nsmb.2353",,"3SD4",17.08,"1.928","1.928","Crystal structure of the first Tudor domain of human PHF20","GHMHPPNRRGISFEVGAQLEARDRLKNWYPAHIEDIDYEEGKVLIHFKRWNHRYDEWFCWDSPYLRPLE","Homo sapiens","PHF20, C20orf104, GLEA2, HCA58, NZF, TZP","PHD finger protein 20","1","3SD4"
"3SD5",,"X-RAY DIFFRACTION",2.34,47.49,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2M Sodium Acetate, 0.1M Sodium Citrate, 0.1M TRIS pH8.5, 16-19% (w/v)PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1158/1535-7163.MCT-11-0474","SD5","3SD5",111.17,"3.2","3.2","Crystal Structure of PI3K gamma with 5-(2,4-dimorpholinopyrimidin-6-yl)-4-(trifluoromethyl)pyridin-2-amine","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVRLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","3SD5"
"3SD6",,"X-RAY DIFFRACTION",2.04,39.82,"VAPOR DIFFUSION, SITTING DROP",7.5,"cadmium sulphate 0.05M, sodium acetate 1.0M, 0.1M Hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1107/S0907444913001182",,"3SD6",11.06,"1.37","1.37","Crystal structure of the amino-terminal domain of human cardiac troponin C in complex with cadmium at 1.4 resolution.","MDDIYKAAVEQLTEEQKNEFKAAFDIFVLGAEDGCISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRCMKDDS","Homo sapiens","TNNC, TNNC1","Troponin C, slow skeletal and cardiac muscles","1","3SD6"
"3SE2",,"X-RAY DIFFRACTION",2.4,48.85,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 0.2M KSCN, 0.1M Bis-Tris-Propane, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nbt.2121",,"3SE2",89.75,"2.3","2.3","Human poly(ADP-ribose) polymerase 14 (PARP14/ARTD8) - catalytic domain in complex with 6(5H)-phenanthridinone","SMDMKQQNFCVVELLPSDPEYNTVASKFNQTCSHFRIEKIERIQNPDLWNSYQAKKKTMDAKNGQTMNEKQLFHGTDAGSVPHVNRNGFNRSYAGKNAVAYGKGTYFAVNANYSANDTYSRPDANGRKHVYYVRVLTGIYTHGNHSLIVPPSKNPQNPTDLYDTVTDNVHHPSLFVAFYDYQAYPEYLITFRK","Homo sapiens","BAL2, KIAA1268, PARP14","Poly [ADP-ribose] polymerase 14","1","3SE2"
"3SE6",,"X-RAY DIFFRACTION",2.88,57.22,"VAPOR DIFFUSION, SITTING DROP",6.5,"10% PEG 8000, 20% ethylene glycol, 61 mM MES, 39 mM imidazole, 20 mM sodium-L-glutamate, 20 mM D-L-alanine, 20 mM glycine, 20 mM D-L-lysine, 20 mM D-L-serine, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/bi201230p",,"3SE6",226.11,"3.08","3.08","Crystal structure of the human Endoplasmic Reticulum Aminopeptidase 2","MVHSSAMVNSHRKPMFNIHRGFYCLTAILPQICICSQFSVPSSYHFTEDPGAFPVATNGERFPWQELRLPSVVIPLHYDLFVHPNLTSLDFVASEKIEVLVSNATQFIILHSKDLEITNATLQSEEDSRYMKPGKELKVLSYPAHEQIALLVPEKLTPHLKYYVAMDFQAKLGDGFEGFYKSTYRTLGGETRILAVTDFEPTQARMAFPCFDEPLFKANFSIKIRRESRHIALSNMPKVKTIELEGGLLEDHFETTVKMSTYLVAYIVCDFHSLSGFTSSGVKVSIYASPDKRNQTHYALQASLKLLDFYEKYFDIYYPLSKLDLIAIPDFAPGAMENWGLITYRETSLLFDPKTSSASDKLWVTRVIAHELAHQWFGNLVTMEWWNDIWLNEGFAKYMELIAVNATYPELQFDDYFLNVCFEVITKDSLNSSRPISKPAETPTQIQEMFDEVSYNKGACILNMLKDFLGEEKFQKGIIQYLKKFSYRNAKNDDLWSSLSNSCLESDFTSGGVCHSDPKMTSNMLAFLGENAEVKEMMTTWTLQKGIPLLVVKQDGCSLRLQQERFLQGVFQEDPEWRALQERYLWHIPLTYSTSSSNVIHRHILKSKTDTLDLPEKTSWVKFNVDSNGYYIVHYEGHGWDQLITQLNQNHTLLRPKDRVGLIHDVFQLVGAGRLTLDKALDMTYYLQHETSSPALLEGLSYLESFYHMMDRRNISDISENLKRYLLQYFKPVIDRQSWSDKGSVWDRMLRSALLKLACDLNHAPCIQKAAELFSQWMESSGKLNIPTDVLKIVYSVGAQTTAGWNYLLEQYELSMSSAEQNKILYALSTSKHQEKLLKLIELGMEGKVIKTQNLAALLHAIARRPKGQQLAWDFVRENWTHLLKKFDLGSYDIRMIISGTTAHFSSKDKLQEVKLFFESLEAQGSHLDIFQTVLETITKNIKWLEKNLPTLRTWLMVNTRHHHHHH","Homo sapiens","ERAP2, LRAP","Endoplasmic reticulum aminopeptidase 2","1","3SE6"
"3SEA",,"X-RAY DIFFRACTION",2.11,41.73,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM Tris hydrochloride, 200 mM Sodium acetate trihydrate, 30% w/v Polyethylene glycol 4,000, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2012.06.013",,"3SEA",38.59,"2","2","Structure of Rheb-Y35A mutant in GDP- and GMPPNP-bound forms","QSKSRKIAILGYRSVGKSSLTIQFVEGQFVDSADPTIENTFTKLITVNGQEYHLQLVDTAGQDEYSIFPQTYSIDINGYILVYSVTSIKSFEVIKVIHGKLLDMVGKVQIPIMLVGNKKDLHMERVISYEEGKALAESWNAAFLESSAKENQTAVDVFRRIILEAEK","Homo sapiens","RHEB, RHEB2","GTP-binding protein Rheb","1","3SEA"
"3SEI",,"X-RAY DIFFRACTION",2.53,51.45,"VAPOR DIFFUSION, HANGING DROP",8.9,"1.5 M ammonium sulfate, 75 mM Tris, 25 % glycerol, pH 8.9, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2011.09.018",,"3SEI",34.14,"2.4","2.4","Crystal Structure of Caskin1 Tandem SAMs","MEKTREGKSSEAVSQWLTAFQLQLYAPNFISAGYDLPTISRMTPEDLTAIGVTKPGHRKKIAAEISGLSIPDWLPEHKPANLAVWLSMIGLAQYYKVLVDNGYENIDFITDITWEDLQEIGITKLGHQKKLMLAVRKLAELRRHHHHHH","Homo sapiens","CASKIN1, KIAA1306","Caskin-1","1","3SEI"
"3SEN",,"X-RAY DIFFRACTION",3.62,65.98,"VAPOR DIFFUSION, HANGING DROP",6.2,"100 mM Na/K phosphate, 1-10% PEG 2K, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2011.09.018",,"3SEN",71.61,"3.1","3.1","Structure of Caskin1 Tandem SAMs","MKHHHHHHHMHAKEGKSSEAVSQWLTAFQLQLYAPNFISAGYDLPTISRMTPEDLTAIGVTKPGHRKKIAAEISGLSIPDWLPEHKPANLAVWLSMIGLAQYYKVLVDNGYENIDFITDITWEDLQEIGITKLGHQKKLMLAVRKLAELQKAEYAKY","Homo sapiens","CASKIN1, KIAA1306","Caskin-1","1","3SEN"
"3SF8",,"X-RAY DIFFRACTION",2.1,41.37,,6.5,"45% (v/v) polyproylene glycol 400, 0.1 M Bis-Tris, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jsb.2011.08.011",,"3SF8",40.33,"1.56","1.56","Structural insights into thiol stabilization of DJ-1","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKDLE","Homo sapiens","PARK7","Protein DJ-1","1","3SF8"
,,,,,,,,,,,,,,,,"MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKDLE","Homo sapiens","PARK7","Protein DJ-1","2","3SF8"
"3SFC",,"X-RAY DIFFRACTION",2.99,58.85,"VAPOR DIFFUSION, HANGING DROP",4.5,"0.05M CITRATE, 10-12% PEG3350, 0.6M NACL, 20 MG/ML RENIN, VAPOUR DIFFUSION, HANGING DROP, VAPOR DIFFUSION, HANGING DROP, temperature 298K, pH 4.5",298,"10.1016/j.bmcl.2011.06.114","S53","3SFC",76.91,"2.1","2.1","Structure-Based Optimization of Potent 4- and 6-Azaindole-3-Carboxamides as Renin Inhibitors","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","3SFC"
"3SFF",,"X-RAY DIFFRACTION",2.15,42.74,"VAPOR DIFFUSION, HANGING DROP",8,"100 mM Tris, pH 8.0, 500 mM NDSB-201, 12% PEG3350, 18% isopropanol, cryoprotectant: 15% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmc.2011.06.030","0DI","3SFF",42.44,"2","2","Crystal Structure of Human HDAC8 Inhibitor Complex, an Amino Acid Derived Inhibitor","SMEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGGYNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVV","Homo sapiens","HDAC8, HDACL1, CDA07","Histone deacetylase 8","1","3SFF"
"3SFH",,"X-RAY DIFFRACTION",2.11,41.65,"VAPOR DIFFUSION, HANGING DROP",8,"100 mM Tris, pH 8.0, 500 mM NDSB-201, 12% PEG3350, 18% isopropanol, cryoprotectant: 15% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmc.2011.06.030","1DI","3SFH",42.55,"2.7","2.7","Crystal Structure of Human HDAC8 Inhibitor Complex, an Amino Acid Derived Inhibitor","SMEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGGYNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVV","Homo sapiens","HDAC8, HDACL1, CDA07","Histone deacetylase 8","1","3SFH"
"3SFJ",,"X-RAY DIFFRACTION",2.37,48.18,"VAPOR DIFFUSION, HANGING DROP",6,"36% w/v PEG1000, 0.1 M ammonium thiocyanate, 0.1 M MES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3SFJ",25.44,"1.24","1.24","Crystal Structure of Tax-Interacting Protein-1 (TIP-1) PDZ domain bound to iCAL36 inhibitor peptide","VTAVVQRVEIHKLRQGENLILGFSIGGGIDQDPSQNPFSEDKTDKGIYVTRVSEGGPAEIAGLQIGDKIMQVNGWDMTMVTHDQARKRLTKRSEEVVRLLVTRQ","Homo sapiens","TAX1BP3, TIP1","Tax1-binding protein 3","1","3SFJ"
,,,,,,,,,,,,,,,,"ANSRWPTSII",,,"decameric peptide iCAL36","2","3SFJ"
"3SGM",,"X-RAY DIFFRACTION",2.34,47.52,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M TRIS pH 7.0, 35% MPD, 0.2M SODIUM CHLORIDE, vapor diffusion, hanging drop, temperature 298K",298,"10.1126/science.1213151",,"3SGM",5.23,"1.7006","1.7006","Bromoderivative-2 of amyloid-related segment of alphaB-crystallin residues 90-100","KXKVLGDVIEV","Homo sapiens","CRYAB, CRYA2, HSPB5","Alpha-crystallin B chain","1","3SGM"
"3SGN",,"X-RAY DIFFRACTION",5.68,78.3,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES pH 7.5, 30% MPD, 0.2M SODIUM CITRATE, vapor diffusion, hanging drop, temperature 298K",298,"10.1126/science.1213151",,"3SGN",2.55,"2.807","2.807","Bromoderivative-8 of amyloid-related segment of alphaB-crystallin residues 90-100","KVKVLGDXIEV","Homo sapiens","CRYAB, CRYA2, HSPB5","Alpha-crystallin B chain","1","3SGN"
"3SGO",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M BIS-TRIS pH 6.5, 45% MPD, 0.2M AMMONIUM ACETATE, vapor diffusion, hanging drop, temperature 298K",298,"10.1126/science.1213151",,"3SGO",1.2,"2.557","2.557","Amyloid-related segment of alphaB-crystallin residues 90-100","KVKVLGDVIEV","Homo sapiens","CRYAB, CRYA2, HSPB5","Alpha-crystallin B chain","1","3SGO"
"3SGP",,"X-RAY DIFFRACTION",2.43,49.39,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M TRIS pH 7.0, 35% MPD, 0.2M SODIUM CHLORIDE, vapor diffusion, hanging drop, temperature 298K",298,"10.1126/science.1213151",,"3SGP",5.21,"1.4016","1.4016","Amyloid-related segment of alphaB-crystallin residues 90-100 mutant V91L","KLKVLGDVIEV","Homo sapiens","CRYAB, CRYA2, HSPB5","Alpha-crystallin B chain","1","3SGP"
"3SGR",,"X-RAY DIFFRACTION",2.23,44.81,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M SODIUM CACODYLATE pH 6.5, 30% MPD, 0.2M MAGNESIUM ACETATE, vapor diffusion, hanging drop, temperature 298K",298,"10.1126/science.1213151",,"3SGR",15.73,"2.17","2.17","Tandem repeat of amyloid-related segment of alphaB-crystallin residues 90-100 mutant V91L","GKLKVLGDVIEVGGKLKVLGDVIEV","Homo sapiens","CRYAB","Tandem repeat of amyloid-related segment of alphaB-crystallin residues 90-100 mutant V91L","1","3SGR"
,,,,,,,,,,,,,,,,,"Homo sapiens","CRYAB"
"3SGS",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",7,"2.1M DL-MALIC ACID pH 7.0, vapor diffusion, hanging drop, temperature 298K",298,"10.1126/science.1213151",,"3SGS",0.63,"1.703","1.703","Amyloid-related segment of alphaB-crystallin residues 95-100","GDVIEV","Homo sapiens","CRYAB, CRYA2, HSPB5","Alpha-crystallin B chain","1","3SGS"
"3SH4",,"X-RAY DIFFRACTION",1.71,27.97,"VAPOR DIFFUSION, HANGING DROP",4.5,"3.5M sodium formate, 0.1 sodium acetate pH4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2011.09.048",,"3SH4",20.57,"1.5","1.5","Laminin G like domain 3 from human perlecan","DAPGQYGAYFHDDGFLAFPGHVFSRSLPEVPETIELEVRTSTASGLLLWQGVEVGEAGQGKDFISLGLQDGHLVFRYQLGSGEARLVSEDPINDGEWHRVTALREGRRGSIQVDGEELVSGRSPGPNVAVNAKGSVYIGGAPDVATLTGGRFSSGITGCVKNLVLHSARPGAPPPQPLDLQHRAQAGANTRPCPS","Homo sapiens","HSPG2","LG3 peptide","1","3SH4"
"3SH5",,"X-RAY DIFFRACTION",1.89,35.03,"VAPOR DIFFUSION, HANGING DROP",4.5,"20% PEG 8000, 200mM calcium acetate, 100mM MES pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2011.09.048",,"3SH5",20.61,"2.8","2.8","Calcium-bound Laminin G like domain 3 from human perlecan","DAPGQYGAYFHDDGFLAFPGHVFSRSLPEVPETIELEVRTSTASGLLLWQGVEVGEAGQGKDFISLGLQDGHLVFRYQLGSGEARLVSEDPINDGEWHRVTALREGRRGSIQVDGEELVSGRSPGPNVAVNAKGSVYIGGAPDVATLTGGRFSSGITGCVKNLVLHSARPGAPPPQPLDLQHRAQAGANTRPCPS","Homo sapiens","HSPG2","LG3 peptide","1","3SH5"
"3SHE",,"X-RAY DIFFRACTION",2.53,51.37,"VAPOR DIFFUSION, HANGING DROP",5,"0.1 M citrate/Bis-tris propane, 12% PEG3350, 10 mM DTT, 1 mM inhibitor, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2011.10.071",,"3SHE",36.9,"2.25","2.25","Novel ATP-competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series","EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWDEVKEEMTSALATMRVDYDQV","Homo sapiens","MAPKAPK3","MAP kinase-activated protein kinase 3","1","3SHE"
"3SHI",,"X-RAY DIFFRACTION",3.13,60.67,,8.5,"30% PEG8000, 0.1 M Tris-HCl, pH 8.5",,"10.1016/j.febslet.2011.09.020",,"3SHI",53.13,"2.2","2.2","Crystal structure of human MMP1 catalytic domain at 2.2 A resolution","NPRWEQTHLTYRIENYTPDLPRADVDHAIEKAFQLWSNVTPLTFTKVSEGQADIMISFVRGDHRDNSPFDGPGGNLAHAFQPGPGIGGDAHFDEDERWTNNFREYNLHRVAAHELGHSLGLSHSTDIGALMYPSYTFSGDVQLAQDDIDGIQAIYG","Homo sapiens","MMP1, CLG","Interstitial collagenase","1","3SHI"
"3SHT",,"X-RAY DIFFRACTION",2.87,57.14,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM HEPES, 10% PEG6000, 5% MPD, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 281K",281,"10.1016/j.jsb.2011.11.022",,"3SHT",68.62,"1.95","1.95","Crystal structure of human MCPH1 tandem BRCT domains","MGHHHHHHMKSGRGKKPTRTLVMTSMPSEKQNVVIQVVDKLKGFSIAPDVCETTTHVLSGKPLRTLNVLLGIARGCWVLSYDWVLWSLELGHWISEEPFELSHHFPAAPLCRSECHLSAGPYRGTLFADQPAMFVSPASSPPVAKLCELVHLCGGRVSQVPRQASIVIGPYSGKKKATVKYLSEKWVLDSITQHKVCAPENYLLSQ","Homo sapiens","MCPH1","Microcephalin","1","3SHT"
"3SHU",,"X-RAY DIFFRACTION",2.33,47.28,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% (w/v) PEG 4000, 10% (v/v) 2-Propanol,  0.1M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,,,"3SHU",20.76,"2.75","2.75","Crystal structure of ZO-1 PDZ3","GPGSMKLVKFRKGDSVGLRLAGGNDVGIFVAGVLEDSPAAKEGLEEGDQILRVNNVDFTNIIREEAVLFLLDLPKGEEVTILAQKKKDVYRRIVE","Homo sapiens","TJP1, ZO1","Tight junction protein ZO-1","1","3SHU"
"3SHW",,"X-RAY DIFFRACTION",2.79,55.85,"VAPOR DIFFUSION, HANGING DROP",5.5,"16% (w/v) PEG 8000, 0.1M Sodium Citrate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,,,"3SHW",54.06,"2.9","2.9","Crystal structure of ZO-1 PDZ3-SH3-Guk supramodule complex with Connexin-45 peptide","SMKLVKFRKGDSVGLRLAGGNDVGIFVAGVLEDSPAAKEGLEEGDQILRVNNVDFTNIIREEAVLFLLDLPKGEEVTILAQKKKDVYRRIVESDVGDSFYIRTHFEYEKESPYGLSFNKGEVFRVVDTLYNGKLGSWLAIRIGKNHKEVERGIIPNKNRAEQLASVQYTLPKTAGGDRADFWRFRGLRSSKRNLRKSREDLSAQPVQTKFPAYERVVLREAGFLRPVTIFGPIADVAREKLAREEPDIYQIAKSEPRDAGTDQRSSGIIRLHTIKQIIDQDKHALLDVTPNAVDRLNYAQWYPIVVFLNPDSKQGVKTMRMRLCPESRKSARKLYERSHKLRKNNHHLFTTTINLNSMNDGWYGALKEAIQQQQNQLVWVSEGKADGATSDDLDLHDDRLSYLSAPGSEYSMYSTDSRHTSDYEDTDTEGGAYTDQELDETLNDEVGTPPESAITRSSEPVREDSSGM","Homo sapiens","TJP1, ZO1","Tight junction protein ZO-1","1","3SHW"
,,,,,,,,,,,,,,,,"SGDGKTSVWI",,,"Gap junction gamma-1 protein","2","3SHW"
"3SHY",,"X-RAY DIFFRACTION",2.63,53.29,"VAPOR DIFFUSION, HANGING DROP",7.5,"19-20%(w/v) PEG 3350, 200mM MgSO4, 100mM Tris-HCl, pH 7.5, vapor diffusion, hanging drop, temperature 293K",293,"10.1021/jm200644r","5FO","3SHY",40.67,"2.647","2.647","Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors","MGSSHHHHHHSSGLVPRGSHMEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQ","Homo sapiens","PDE5, PDE5A","cGMP-specific 3',5'-cyclic phosphodiesterase","1","3SHY"
"3SHZ",,"X-RAY DIFFRACTION",2.65,53.5,"VAPOR DIFFUSION, HANGING DROP",7.5,"19-20%(w/v) PEG 3350, 200mM MgSO4, 100mM Tris-HCl, pH 7.5, vapor diffusion, hanging drop, temperature 293K",293,"10.1021/jm200644r","5CO","3SHZ",40.73,"2.449","2.449","Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors","MGSSHHHHHHSSGLVPRGSHMEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQ","Homo sapiens","PDE5, PDE5A","cGMP-specific 3',5'-cyclic phosphodiesterase","1","3SHZ"
"3SI0",,"X-RAY DIFFRACTION",2.57,52.21,"VAPOR DIFFUSION, HANGING DROP",8,"100 mM imidazole, 30% v/v MPD, 11% w/v PEG4000, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1021/bi200249h",,"3SI0",38.47,"2.1","2.1","Structure of glycosylated human glutaminyl cyclase","HHHHHHEEKNYHQPAILNSSALRQIAEGTSISEMWQNDLQPLLIERYPGSPGSYAARQHIMQRIQRLQADWVLEIDTFLSQTPYGYRSFSNIISTLNPTAKRHLVLACHYDSKYFSHWNNRVFVGATDSAVPCAMMLELARALDKKLLSLKTVSDSKPDLSLQLIFFDGEEAFLHWSPQDSLYGSRHLAAKMASTPHPPGARGTSQLHGMDLLVLLDLIGAPNPTFPNFFPNSARWFERLQAIEHELHELGLLKDHSLEGRYFQNYSYGGVIQDDHIPFLRRGVPVLHLIPSPFPEVWHTMDDNEENLDESTIDNLNKILQVFVLEYLHL","Homo sapiens","QPCT","Glutaminyl-peptide cyclotransferase","1","3SI0"
"3SI8",,"X-RAY DIFFRACTION",3.11,60.39,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M MES, 5 mM MgCl2, 19-21% (w/v) PEG 2K-MME, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1038/nature09196",,"3SI8",57.5,"2.15","2.15","Human DNA polymerase eta - DNA ternary complex with the 5'T of a CPD in the active site (TT2)","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","3SI8"
,,,,,,,,,,,,,,,,"TAACTATGACGC",,,"DNA (5'-D(*TP*A*AP*CP*(TTD)P*AP*TP*GP*AP*CP*GP*C)-3')","2","3SI8"
,,,,,,,,,,,,,,,,"TGCGTCATA",,,"DNA (5'-D(*TP*GP*CP*GP*TP*CP*AP*TP*A)-3')","3","3SI8"
"3SIE",,"X-RAY DIFFRACTION",2.19,43.72,"VAPOR DIFFUSION, HANGING DROP",4.6,"16% PEG 3350, 0.1M Sodium acetate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm200644r","5BO","3SIE",81.18,"1.93","1.93","Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors","MGSSHHHHHHSSGLVPRGSHMEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQ","Homo sapiens","PDE5, PDE5A","cGMP-specific 3',5'-cyclic phosphodiesterase","1","3SIE"
"3SJE",,"X-RAY DIFFRACTION",3.31,62.8,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 0.5 % (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm200807m",,"3SJE",83.02,"1.7","1.7","X-ray structure of human glutamate carboxypeptidase II (the E424A inactive mutant) in complex with N-acetyl-aspartyl-aminononanoic acid","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAAEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","3SJE"
"3SJF",,"X-RAY DIFFRACTION",3.3,62.72,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 0.5 % (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm200807m","JRG","3SJF",83.3,"1.65","1.65","X-ray structure of human glutamate carboxypeptidase II in complex with a urea-based inhibitor (A25)","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","3SJF"
"3SJG",,"X-RAY DIFFRACTION",3.31,62.88,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 0.5 % (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm200807m",,"3SJG",83.02,"1.65","1.65","Human glutamate carboxypeptidase II (E424A inactive mutant ) in complex with N-acetyl-aspartyl-aminooctanoic acid","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAAEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH, FOLH1, GIG27, NAALAD1, PSM, PSMA","Glutamate carboxypeptidase 2","1","3SJG"
"3SJM",,"X-RAY DIFFRACTION",2.17,43.43,"VAPOR DIFFUSION, HANGING DROP",7.5,"50 mM HEPES, pH 7.5, 1 mM spermine, 2 M ammonium sulfate and 40 mM Mg(OAc)2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3SJM",26.01,"1.35","1.35","Crystal Structure Analysis of TRF2-Dbd-DNA complex","CTCTAGGGTTAGGGTTAG",,,"DNA (5'-D(*CP*TP*CP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*G)-3')","1","3SJM"
,,,,,,,,,,,,,,,,"TCTAACCCTAACCCTAGA",,,"DNA (5'-D(*TP*CP*TP*AP*AP*CP*CP*CP*TP*AP*AP*CP*CP*CP*TP*AP*GP*A)-3')","2","3SJM"
,,,,,,,,,,,,,,,,"GSHMTTNITKKQKWTVEESEWVKAGVQKYGEGNWAAISKNYPFVNRTAVMIKDRWRTMKRLGMN","Homo sapiens","telomeric repeat binding factor 2, TERF2, TRBF2, TRF2","Telomeric repeat-binding factor 2","3","3SJM"
"3SJT",,"X-RAY DIFFRACTION",2.35,47.61,"VAPOR DIFFUSION, HANGING DROP",7.8,"3 uL of protein solution [3.5 mg/mL HAI, 50 mM bicine (pH 8.5), 2 mM MABH, 100   M MnCl2] and 3 uL of precipitant solution [0.1 M HEPES (pH 7.0), 22-28% Jeffamine] were equilibrated against a 1 mL reservoir of precipitant solution, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm200443b","5AB","3SJT",70.19,"1.597","1.597","Crystal structure of human arginase I in complex with the inhibitor Me-ABH, Resolution 1.60 A, twinned structure","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","3SJT"
"3SJX",,"X-RAY DIFFRACTION",3.29,62.61,"VAPOR DIFFUSION, HANGING DROP",8,"33% (v/v) pentaerythritol propoxylate PO/OH 5/4, 0.5 % (w/v) PEG 3350, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm200807m",,"3SJX",82.57,"1.66","1.66","X-ray structure of human glutamate carboxypeptidase II (the E424A inactive mutant) in complex with N-acetyl-aspartyl-methionine","RSKSSNEATNITPKHNMKAFLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYPNKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYARTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVKSYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYYDAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIGTLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFASWDAAEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKELKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKNWETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDYAVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIVLRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVDPSKAWGEVKRQIYVAAFTVQAAAETLSEVA","Homo sapiens","FOLH1, FOLH, NAALAD1, PSM, PSMA, GIG27","Glutamate carboxypeptidase 2","1","3SJX"
"3SKC",,"X-RAY DIFFRACTION",3.13,60.7,"VAPOR DIFFUSION, HANGING DROP",9,"PEG 10000, 100 mM Tris pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2011.06.097","BR2","3SKC",71.35,"3.2","3.2","Human B-Raf Kinase in Complex with an Amide Linked Pyrazolopyridine Inhibitor","MDRGSHHHHHHGSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","3SKC"
"3SKF",,"X-RAY DIFFRACTION",2.51,51.07,"VAPOR DIFFUSION, HANGING DROP",6.2,"pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2011.06.116","PB7","3SKF",101.98,"3","3","Crystal structure of beta-site app-cleaving enzyme 1 (BACE-WT) complex with (2S)-2-((3S)-3-(acetylamino)-3-(butan-2-yl)-2-oxopyrrolidin-1-yl)-N-((2S,3R)-3-hydroxy-4-((3-methoxybenzyl)amino)-1-phenylbutan-2-yl)-4-phenylbutanamide","MASMTGGQQMGRGSAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3SKF"
"3SKG",,"X-RAY DIFFRACTION",2.42,49.09,"VAPOR DIFFUSION, HANGING DROP",6.2,"pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2011.06.116","PB8","3SKG",203.53,"2.88","2.88","Crystal structure of beta-site app-cleaving enzyme 1 (BACE-WT) complex with (2S)-2-((3R)-3-acetamido-3-isobutyl-2-oxo-1-pyrrolidinyl)-N-((1S,2R)-1-(3,5-difluorobenzyl)-2-hydroxy-2-(1,2,3,4-tetrahydro-3-isoquinolinyl)ethyl)-4-phenylbutanamide","MASMTGGQQMGRGSAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3SKG"
"3SKK",,"X-RAY DIFFRACTION",2.34,47.36,"VAPOR DIFFUSION, HANGING DROP",7.8,"3 uL of protein solution [3.5 mg/mL HAI, 50 mM bicine (pH 8.5), 2 mM FABH, 100   M MnCl2] and 3 uL of precipitant solution [0.1 M HEPES (pH 7.0), 22-28% Jeffamine] were equilibrated against a 1 mL reservoir of precipitant solution, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm200443b","4U7","3SKK",70.26,"1.701","1.701","Crystal structure of human arginase I in complex with the inhibitor FABH, Resolution 1.70 A, twinned structure","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","3SKK"
"3SKP",,"X-RAY DIFFRACTION",3.08,60.11,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.2 M potassium sulfate, 2.2 M ammonium sulfate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1038/nature10823",,"3SKP",38.78,"1.7","1.7","The structure of apo-human transferrin C-lobe with bound sulfate ions","GCKPVKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGKCGLVPVLAENYNKSDNCEDTPEAGYFAVAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWNIPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAFRCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLARAPNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKLHDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP","Homo sapiens","TF, PRO1400","Serotransferrin","1","3SKP"
"3SL3",,"X-RAY DIFFRACTION",2.93,57.95,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 25% (v/v) ethylene glycol, 10% (v/v) isopropanol, 100 mM HEPES, pH 7.5, vapor diffusion, hanging drop, temperature 294K",294,"10.1016/j.bmcl.2011.09.109",,"3SL3",171.78,"2.1","2.1","Crystal structure of the apo form of the catalytic domain of PDE4D2","IPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLE","Homo sapiens","DPDE3, PDE4D","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","3SL3"
"3SL4",,"X-RAY DIFFRACTION",2.93,57.99,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 25% (v/v) ethylene glycol, 10% (v/v) isopropanol, 100 mM HEPES, pH 7.5, vapor diffusion, hanging drop, temperature 294K",294,"10.1016/j.bmcl.2011.09.109","JN4","3SL4",173.44,"1.9","1.9","Crystal structure of the catalytic domain of PDE4D2 with compound 10D","IPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLE","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","3SL4"
"3SL5",,"X-RAY DIFFRACTION",2.81,56.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 25% (v/v) ethylene glycol, 10% (v/v) isopropanol, 100 mM HEPES, pH 7.5, vapor diffusion, hanging drop, temperature 294K",294,"10.1016/j.bmcl.2011.09.109","J25","3SL5",168.47,"2.65","2.65","Crystal structure of the catalytic domain of PDE4D2 complexed with compound 10d","IPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDSPEEGRQGQTEKFELTLE","Homo sapiens","DPDE3, PDE4D","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","3SL5"
"3SL6",,"X-RAY DIFFRACTION",2.93,58.03,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 25% (v/v) ethylene glycol, 10% (v/v) isopropanol, 100 mM HEPES, pH 7.5, vapor diffusion, hanging drop, temperature 294K",294,"10.1016/j.bmcl.2011.09.109","JN8","3SL6",170.64,"2.44","2.44","Crystal structure of the catalytic domain of PDE4D2 with compound 12c","IPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLE","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","3SL6"
"3SL8",,"X-RAY DIFFRACTION",2.95,58.24,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 25% (v/v) ethylene glycol, 10% (v/v) isopropanol, 100 mM HEPES, pH 7.5, vapor diffusion, hanging drop, temperature 294K",294,"10.1016/j.bmcl.2011.09.109","JN7","3SL8",170.88,"2.6","2.6","Crystal structure of the catalytic domain of PDE4D2 with compound 10o","IPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLE","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","3SL8"
"3SLA",,"X-RAY DIFFRACTION",4.09,69.96,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.98M sodium acetate trihydrate, 30% glycerol, 0.07M sodium cacodylate, 30% w/v galactose
, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/ncomms1680",,"3SLA",92.48,"2.5","2.5","X-ray structure of first four repeats of human beta-catenin","GSNYQDDAELATRAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAY","Homo sapiens","Beta catenin, CTNNB, CTNNB1, OK/SW-cl.35, PRO2286","Catenin beta-1","1","3SLA"
"3SLS",,"X-RAY DIFFRACTION",2.55,51.72,"VAPOR DIFFUSION, SITTING DROP",,"18% PEG-3350, 200mM Ammonium fluoride, 4% Glycerol, 10mM DTT, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.jsb.2012.01.002","77D","3SLS",69.96,"2.3","2.3","Crystal Structure of human MEK-1 kinase in complex with UCB1353770 and AMPPNP","MTLQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQ","Homo sapiens","Human MEK-1 kinase, MAP2K1, MEK1, PRKMK1","Dual specificity mitogen-activated protein kinase kinase 1","1","3SLS"
"3SM9",,"X-RAY DIFFRACTION",3.84,67.96,"VAPOR DIFFUSION, HANGING DROP",7,"1.5 M Ammonium Sulfate 
0.1 M BisTris Propane pH 7.0 
, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,"Z99","3SM9",55.42,"2.26","2.26","Crystal Structure of Metabotropic glutamate receptor 3 precursor in presence of LY341495 antagonist","HNFLRREIKIEGDLVLGGLFPINEKGTGTEECGRINEDRGIQRLEAMLFAIDEINKDDYLLPGVKLGVHILDTCSRDTYALEQSLEFVRASLTKVDEAEYMCPDGSYAIQENIPLLIAGVIGGSYSSVSIQVANLLRLFQIPQISYASTSAKLSDKSRYDYFARTVPPDFYQAKAMAEILRFFNWTYVSTVASEGDYGETGIEAFEQEARLRNISIATAEKVGRSNIRKSYDSVIRELLQKPNARVVVLFMRSDDSRELIAAASRANASFTWVASDGWGAQESIIKGSEHVAYGAITLELASQPVRQFDRYFQSLNPYNNHRNPWFRDFWEQKFQCSLQNKRNHRRVCDKHLAIDSSNYEQESKIMFVVNAVYAMAHALHKMQRTLCPNTTKLCDAMKILDGKKLYKDYLLKINFTAPFNPNKDADSIVKFDTFGDGMGRYNVFNFQNVGGKYSYLKVGHWAETLSLDVNSIHWSRNSV","Homo sapiens","GPRC1C, GRM3, MGLUR3","Metabotropic glutamate receptor 3","1","3SM9"
"3SMB",,"X-RAY DIFFRACTION",2.7,54.51,"VAPOR DIFFUSION, HANGING DROP",7.5,"2 M ammonium sulfate, 3% isopropanol, 0.1 
M tris(hydroxymethyl)aminomethane; mixed with protein:inhibitor complex in a 1:1 ratio, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi3005494",,"3SMB",37.95,"1.6","1.6","Phenethylisothiocyanate Covalently Bound to Macrophage Migration Inhibitory Factor (MIF)","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","GLIF, MIF, MMIF","Macrophage migration inhibitory factor","1","3SMB"
"3SMC",,"X-RAY DIFFRACTION",3.69,66.64,"VAPOR DIFFUSION, HANGING DROP",7.5,"2 M ammonium sulfate, 3% isopropanol, 0.1 
M tris(hydroxymethyl)aminomethane; mixed with protein:inhibitor complex in a 1:1 ratio, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi3005494",,"3SMC",38.04,"1.8","1.8","Macrophage Migration Inhibitory Factor (MIF) with Covalently Bound L-sulforaphane","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","GLIF, MIF, MMIF","Macrophage migration inhibitory factor","1","3SMC"
"3SME",,"X-RAY DIFFRACTION",3.33,63.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"11-18 % PEG3000, 0.1M HEPES pH 7.0-8.0, 0.2 M magnesium acetate, and 2 mM TCEP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/ja2077137",,"3SME",34.94,"1.7","1.7","Structure of PTP1B inactivated by H2O2/bicarbonate","GHMEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHED","Homo sapiens","PTP1B, PTPN1","Tyrosine-protein phosphatase non-receptor type 1","1","3SME"
"3SMI",,"X-RAY DIFFRACTION",2.21,44.34,"VAPOR DIFFUSION, SITTING DROP",7.5,"25% PEG3350, 0.2M NaNO3, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nbt.2121",,"3SMI",44.81,"2.4","2.4","Human poly(ADP-ribose) polymerase 14 (Parp14/Artd8) - catalytic domain in complex with a quinazoline inhibitor","SMDMKQQNFCVVELLPSDPEYNTVASKFNQTCSHFRIEKIERIQNPDLWNSYQAKKKTMDAKNGQTMNEKQLFHGTDAGSVPHVNRNGFNRSYAGKNAVAYGKGTYFAVNANYSANDTYSRPDANGRKHVYYVRVLTGIYTHGNHSLIVPPSKNPQNPTDLYDTVTDNVHHPSLFVAFYDYQAYPEYLITFRK","Homo sapiens","BAL2, KIAA1268, PARP14","Poly [ADP-ribose] polymerase 14","1","3SMI"
"3SMJ",,"X-RAY DIFFRACTION",2.19,43.8,"VAPOR DIFFUSION, SITTING DROP",6.5,"20% PEG 3350, 0.1M Bis-tris, 0.2M Na2SO4, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nbt.2121",,"3SMJ",44.74,"1.5","1.5","Human poly(ADP-ribose) polymerase 14 (Parp14/Artd8) - catalytic domain in complex with a pyrimidine-like inhibitor","SMDMKQQNFCVVELLPSDPEYNTVASKFNQTCSHFRIEKIERIQNPDLWNSYQAKKKTMDAKNGQTMNEKQLFHGTDAGSVPHVNRNGFNRSYAGKNAVAYGKGTYFAVNANYSANDTYSRPDANGRKHVYYVRVLTGIYTHGNHSLIVPPSKNPQNPTDLYDTVTDNVHHPSLFVAFYDYQAYPEYLITFRK","Homo sapiens","BAL2, KIAA1268, PARP14","Poly [ADP-ribose] polymerase 14","1","3SMJ"
"3SMP",,"X-RAY DIFFRACTION",2.8,55.8,"VAPOR DIFFUSION, SITTING DROP",5.5,"20% peg-1500, 0.2 M magnesium chloride, 0.1 M sodium cacodylate, pH 5.5, vapor diffusion, sitting drop",,,,"3SMP",88.39,"1.9","1.9","Monoclinic crystal structure of human pantothenate kinase 1 alpha","MGSSHHHHHHSSGLVPRGSKNRPPFPWFGMDIGGTLVKLVYFEPKDITAEEEQEEVENLKSIRKYLTSNTAYGKTGIRDVHLELKNLTMCGRKGNLHFIRFPSCAMHRFIQMGSEKNFSSLHTTLCATGGGAFKFEEDFRMIADLQLHKLDELDCLIQGLLYVDSVGFNGKPECYYFENPTNPELCQKKPYCLDNPYPMLLVNMGSGVSILAVYSKDNYKRVTGTSLGGGTFLGLCCLLTGCETFEEALEMAAKGDSTNVDKLVKDIYGGDYERFGLQGSAVASSFGNMMSKEKRDSISKEDLARATLVTITNNIGSIARMCALNENIDRVVFVGNFLRINMVSMKLLAYAMDFWSKGQLKALFLEHEGYFGAVGALLELFKMTDD","Homo sapiens","PANK1, PANK","Pantothenate kinase 1","1","3SMP"
"3SMQ",,"X-RAY DIFFRACTION",2.8,56.12,"VAPOR DIFFUSION, SITTING DROP",6.5,"20.0% PEG 4K, 0.2M Mg OAc, 0.1M Na CaCo pH6.5, VAPOR DIFFUSION, SITTING DROP, temperature 297K",297,"10.1016/j.str.2012.06.001","TDU","3SMQ",38.62,"2","2","Crystal structure of protein arginine methyltransferase 3","MGSSHHHHHHSSGLVPRGSDLQEDEDGVYFSSYGHYGIHEEMLKDKIRTESYRDFIYQNPHIFKDKVVLDVGCGTGILSMFAAKAGAKKVLGVDQSEILYQAMDIIRLNKLEDTITLIKGKIEEVHLPVEKVDVIISEWMGYFLLFESMLDSVLYAKNKYLAKGGSVYPDICTISLVAVSDVNKHADRIAFWDDVYGFKMSCMKKAVIPEAVVEVLDPKTLISEPCGIKHIDCHTTSISDLEFSSDFTLKITRTSMCTAIAGYFDIYFEKNCHNRVVFSTGPQSTKTHWKQTVFLLEKPFSVKAGEALKGKVTVHKNKKDPRSLTVTLTLNNSTQTYGLQ","Homo sapiens","PRMT3, HRMT1L3","Protein arginine N-methyltransferase 3","1","3SMQ"
"3SMR",,"X-RAY DIFFRACTION",2.15,42.85,"VAPOR DIFFUSION, SITTING DROP",6.5,"24% PEG3350,9.2M NH4 Acetate, 0.1 Bis Tris pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 297K",297,"10.1042/BJ20121280","NP7","3SMR",140.09,"1.82","1.82","Crystal structure of human WD repeat domain 5 with compound","GTQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","3SMR"
"3SMS",,"X-RAY DIFFRACTION",2.35,47.76,"VAPOR DIFFUSION",7.5,"25% PEG3350, 0.2 M lithium sulfate, 0.1 M Hepes, 0.005 M of each of ATP, magnesium chloride and N-heptylpantothenamide were also added, pH 7.5, vapor diffusion, temperature 291K",291,,,"3SMS",43.1,"2.2","2.2","Human Pantothenate kinase 3 in complex with a pantothenate analog","MGSSHHHHHHSSGLVPRGSSFPWFGMDIGGTLVKLSYFEPIDITAEEEQEEVESLKSIRKYLTSNVAYGSTGIRDVHLELKDLTLFGRRGNLHFIRFPTQDLPTFIQMGRDKNFSTLQTVLCATGGGAYKFEKDFRTIGNLHLHKLDELDCLVKGLLYIDSVSFNGQAECYYFANASEPERCQKMPFNLDDPYPLLVVNIGSGVSILAVHSKDNYKRVTGTSLGGGTFLGLCSLLTGCESFEEALEMASKGDSTQADKLVRDIYGGDYERFGLPGWAVASSFGNMIYKEKRESVSKEDLARATLVTITNNIGSVARMCAVNEKINRVVFVGNFLRVNTLSMKLLAYALDYWSKGQLKALFLEHEGYFGAVGALLGLPNFSDD","Homo sapiens","PANK3","Pantothenate kinase 3","1","3SMS"
"3SMT",,"X-RAY DIFFRACTION",2.72,54.8,"VAPOR DIFFUSION, SITTING DROP",6.5,"20 % PEG4000, 0.2 M calcium Acetate, 0.1 M sodium cacodalyte, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 297K",297,,,"3SMT",58.33,"2.04","2.04","Crystal structure of human SET domain-containing protein3","GKKSRVKTQKSGTGATATVSPKEILNLTSELLQKCSSPAPGPGKEWEEYVQIRTLVEKIRKKQKGLSVTFDGKREDYFPDLMKWASENGASVEGFEMVNFKEEGFGLRATRDIKAEELFLWVPRKLLMTVESAKNSVLGPLYSQDRILQAMGNIALAFHLLCERASPNSFWQPYIQTLPSEYDTPLYFEEDEVRYLQSTQAIHDVFSQYKNTARQYAYFYKVIQTHPHANKLPLKDSFTYEDYRWAVSSVMTRQNQIPTEDGSRVTLALIPLWDMCNHTNGLITTGYNLEDDRCECVALQDFRAGEQIYIFYGTRSNAEFVIHSGFFFDNNSHDRVKIKLGVSKSDRLYAMKAEVLARAGIPTSSVFALHFTEPPISAQLLAFLRVFCMTEEELKEHLLGDSAIDRIFTLGNSEFPVSWDNEVKLWTFLEDRASLLLKTYKTTIEEDKSVLKNHDLSVRAKMAIKLRLGEKEILEKAVKSAAVNREYYRQQMEEKAP","Homo sapiens","SETD3, C14orf154","Histone-lysine N-methyltransferase setd3","1","3SMT"
"3SMZ",,"X-RAY DIFFRACTION",2.53,51.37,"VAPOR DIFFUSION, SITTING DROP",8.5,"100 mM Tris-HCl (pH 8.5), 24% PEG 3350, 200 mM Lithium sulfate, Vapor diffusion, sitting drop, temperature 298K, VAPOR DIFFUSION, SITTING DROP",298,"10.1002/pro.664",,"3SMZ",31.78,"1.99","1.99","Human raver1 RRM1-3 domains (residues 39-320)","HMLDPEEIRKRLEHTERQFRNRRKILIRGLPGDVTNQEVHDLLSDYELKYCFVDKYKGTAFVTLLNGEQAEAAINAFHQSRLRERELSVQLQPTDALLCVANLPPSLTQQQFEELVRPFGSLERCFLVYSERTGQSKGYGFAEYMKKDSAARAKSDLLGKPLGPRTLYVHWTDAGQLTPALLHSRCLCVDRLPPGFNDVDALCRALSAVHSPTFCQLACGQDGQLKGFAVLEYETAEMAEEAQQQADGLSLGGSHLRVSFCAPGPPGRSMLAALIAAQATALNR","Homo sapiens","KIAA1978, RAVER1","Ribonucleoprotein PTB-binding 1","1","3SMZ"
"3SN5",,"X-RAY DIFFRACTION",2.9,56.9,"VAPOR DIFFUSION, SITTING DROP",6,"18% PEG550 MME, 0.1 M MES, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3SN5",114.97,"2.75","2.75","Crystal structure of human CYP7A1 in complex with cholest-4-en-3-one","MAKKTSSRRRQTGEPPLENGLIPYLGCALQFGANPLEFLRANQRKHGHVFTCKLMGKYVHFITNPLSYHKVLCHGKYFDWKKFHFALSAKAFGHRSIDPMDGNTTENINDTFIKTLQGHALNSLTESMMENLQRIMRPPVSSNSKTAAWVTEGMYSFCYRVMFEAGYLTIFGRDLTRRDTQKAHILNNLDNFKQFDKVFPALVAGLPIHMFRTAHNAREKLAESLRHENLQKRESISELISLRMFLNDTLSTFDDLEKAKTHLVVLWASQANTIPATFWSLFQMIRNPEAMKAATEEVKRTLENAGQKVSLEGNPICLSQAELNDLPVLDSIIKESLRLSSASLNIRTAKEDFTLHLEDGSYNIRKDDIIALYPQLMHLDPEIYPDPLTFKYDRYLDENGKTKTTFYCNGLKLKYYYMPFGSGATICPGRLFAIHEIKQFLILMLSYFELELIEGQAKCPPLDQSRAGLGILPPLNDIEFKYKFKHHHHHH","Homo sapiens","CYP7A1, CYP7","Cholesterol 7-alpha-monooxygenase","1","3SN5"
"3SN7",,"X-RAY DIFFRACTION",2.06,40.23,"VAPOR DIFFUSION, HANGING DROP",7.1,"12-18% PEG 3350, 100 mM MES pH 7.1, 3-6% Methanol, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm2009138","540","3SN7",80.14,"1.82","1.82","Highly Potent, Selective, and Orally Active Phosphodiestarase 10A Inhibitors","GSHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","3SN7"
"3SNH",,"X-RAY DIFFRACTION",2.72,54.71,"VAPOR DIFFUSION, SITTING DROP",7.3,"9% PEG400, 6% isopropanol, 100 mM HEPES/NaOH (pH 7.3), 10 mM MgCl2, 10 mM KCl. , VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1038/nature10369",,"3SNH",85.07,"3.7","3.7","Crystal structure of nucleotide-free human dynamin1","GPMEDLIPLVNRLQDAFSAIGQNADLDLPQIAVVGGQSAGKSSVLENFVGRDFLPRGSGIVTRRPLVLQLVNATTEYAEFLHCKGKKFTDFEEVRLEIEAETDRVTGTNKGISPVPINLRVYSPHVLNLTLVDLPGMTKVPVGDQPPDIEFQIRDMLMQFVTKENCLILAVSPANSDLANSDALKVAKEVDPQGQRTIGVITKLDLMDEGTDARDVLENKLLPLRRGYIGVVNRSQKDIDGKKDITAALAAERKFFLSHPSYRHLADRMGTPYLQKVLNQQLTNHIRDTLPGLRNKLQSQLLSIEKEVEEYKNFRPDDPARKTKALLQMVQQFAVDFEKRIEGSGDQIDTYELSGGARINRIFHERFPFELVKMEFDEKELRREISYAIKNAAAAATGLFTPDMAFETIVKKQVKKIREPCLKCVDMVISELISTVRQCTKKLQQYPRLREEMERIVTTHIREREGRTKEQVMLLIDIELAYMNTNHEDFIGFANAQQRSNQMNKKKTSGNQDEILVIRKGWLTINNIGIMKGGSKEYWFVLTAENLSWYKDDEEKEKEYMLSVDNLKLRDVEKGFMSSKHIFALFNTEQRNVYKDYRQLELACETQEEVDSWKASFLRAGVYPERVGDKEKASETEENGSDSFMHSMDPQLERQVETIRNLVDSYMAIVNKTVRDLMPKTIMHLMINNTKEFIFSELLANLYSCGDQNTLMEESAEQAQRRDEMLRMYHALKEALSIIGDIN","Homo sapiens","DNM, DNM1","Dynamin-1","1","3SNH"
"3SNI",,"X-RAY DIFFRACTION",2.07,40.6,"VAPOR DIFFUSION, HANGING DROP",7.1,"12-18% PEG 3350, 100 mM MES pH 7.1, 3-6% methanol, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm2009138","546","3SNI",80.1,"1.9","1.9","Highly Potent, Selective, and Orally Active Phosphodiestarase 10A Inhibitors","GSHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","3SNI"
"3SNL",,"X-RAY DIFFRACTION",2.03,39.51,"VAPOR DIFFUSION, HANGING DROP",7.1,"12-18% PEG 3350, 100 mM MES pH 7.1, 3-6% methanol, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm2009138","548","3SNL",79.78,"2.4","2.4","Highly Potent, Selective, and Orally Active Phosphodiestarase 10A Inhibitors","GSHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","3SNL"
"3SNV",,"X-RAY DIFFRACTION",2.04,39.57,"VAPOR DIFFUSION, HANGING DROP",7,"1.9 M ammonium sulfate, 0.2 M lithium sulfate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"3SNV",33,"2.2","2.2","Crystal structure of Symfoil-4T Permutation #1: de novo designed beta-trefoil architecture with symmetric primary structure","MHHHHHHFNLPPGNYKKGGQYLRINPDGTVDGTRDRSDTHIQFQISPEGNGEVLLKSTETGQYLRINPDGTVDGTRDRSDTHIQFQISPEGNGEVLLKSTETGQYLRINPDGTVDGTRDRSDTHIQFQISPEGNGEVLLKSTE","Homo sapiens",,"Symfoil-4T/Permutation #1 synthetic protein","1","3SNV"
"3SO8",,"X-RAY DIFFRACTION",2.24,45.01,"VAPOR DIFFUSION, SITTING DROP",6,"Peg 3350, pH 6, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1126/scisignal.2002979",,"3SO8",17.67,"1.9","1.9","Crystal Structure of ANKRA","NSLSVHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGADPTIETDSGYNSMDLAVALGYRSVQQVIESHLLKLLQN","Homo sapiens","ANKRA2, ANKRA","Ankyrin repeat family A protein 2","1","3SO8"
"3SOA",,"X-RAY DIFFRACTION",3.67,66.53,"VAPOR DIFFUSION",5.5,"1.2 M Ammonium Tartrate, 100 mM bistrispropane, pH 5.5, VAPOR DIFFUSION, temperature 288.15K",288.15,"10.1016/j.cell.2011.07.038","DB8","3SOA",51.18,"3.5501","3.5501","Full-length human CaMKII","MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVMLATRNFSVRKQEIIKVTEQLIEAISNGDFESYTKMCDPGMTAFEPEALGNLVEGLDFHRFYFENLWSRNSKPVHTTILNPHIHLMGDESACIAYIRITQYLDAGGIPRTAQSEETRVWHRRDGKWQIVHFHRSGAPS","Homo sapiens","CAMK2A, CAMKA, KIAA0968, camk2b, camkb","Calcium/calmodulin-dependent protein kinase type II subunit alpha with a beta 7 linker","1","3SOA"
"3SOC",,"X-RAY DIFFRACTION",2.52,51.12,"VAPOR DIFFUSION, SITTING DROP",8.5,"20% PEG 3350, 0.1M Tris, pH 8.5, 0.2M Ammonium Acetate, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,,,"3SOC",74.54,"1.95","1.95","Crystal structure of Activin receptor type-IIA (ACVR2A) kinase domain in complex with a quinazolin","MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLTNI","Homo sapiens","ACVR2, ACVR2A","Activin receptor type-2A","1","3SOC"
"3SOE",,"X-RAY DIFFRACTION",2.79,55.85,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M Bis-tris pH 6.0 
0.25M Li2SO4 
35% PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3SOE",12.1,"1.6","1.6","Crystal Structure of the 3rd PDZ domain of the human Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 (MAGI3)","GAMATLYKKAGLLVTIPLIKGPKGFGFAIADSPTGQKVKMILDSQWCQGLQKGDIIKEIYHQNVQNLTHLQVVEVLKQFPVGADVPLLILRGGPPSPTKTAKMGSGSGQITKV","Homo sapiens","KIAA1634, MAGI3","Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3","1","3SOE"
"3SOG",,"X-RAY DIFFRACTION",3.16,61.06,"VAPOR DIFFUSION, SITTING DROP",6.2,"2.66% PEG 6000, 2.66% PEG 8000, 2.66% PEG 10,000, 0.02M Magnesium Acetate, 0.05M Potassium Chloride, 0.1M MES, pH 6.2, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,,,"3SOG",24.36,"2.3","2.3","Crystal structure of the BAR domain of human Amphiphysin, isoform 1","SMTKDEQFEEYVQNFKRQEAEGTRLQRELRGYLAAIKGMQEASMKLTESLHEVYEPDWYGREDVKMVGEKCDVLWEDFHQKLVDGSLLTLDTYLGQFPDIKNRIAKRSRKLVDYDSARHHLEALQSSKRKDESRISKAEEEFQKAQKVFEEFNVDLQEELPSLWSRRVGFYVNTFKNVSSLEAKFHKEIAVLCHKLYEVMTKLGD","Homo sapiens","AMPH, AMPH1","Amphiphysin","1","3SOG"
"3SOM",,"X-RAY DIFFRACTION",2.95,58.36,"VAPOR DIFFUSION",5,"10(w/v) PEG_3350, 0.2M ammonium citrate pH 5.0, VAPOR DIFFUSION, temperature 293K",293,"10.1021/bi300150y",,"3SOM",549.02,"2.4","2.4","crystal structure of human MMACHC","YFQSMEPKVAELKQKIEDTLCPFGFEVYPFQVAWYNELLPPAFHLPLPGPTLAFLVLSTPAMFDRALKPFLQSCHLRMLTDPVDQCVAYHLGRVRESLPELQIEIIADYEVHPNRRPKILAQTAAHVAGAAYYYQRQDVEADPWGNQRISGVCIHPRFGGWFAIRGVVLLPGIEVPDLPPRKPHDCVPTRADRIALLEGFNFHWRDWTYRDAVTPQERYSEEQKAYFSTPPAQRLALLGLAQPSEKPSSPSPDLPFTTPAPKKPGNPSRARSWLSPRVSPPASPGP","Homo sapiens","MMACHC","Methylmalonic aciduria and homocystinuria type C protein","1","3SOM"
"3SOO",,"X-RAY DIFFRACTION",3.27,62.39,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.2M potassium sodium tartrate, 2.0M ammonium sulfate, 0.1M sodium citrate pH 5.6, NANODROP', VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3SOO",31.63,"2.73","2.73","Crystal structure of a LINE-1 type transposase domain-containing protein 1 (L1TD1) from HOMO SAPIENS at 2.73 A resolution","GVLMDEGAVLTLAADLSSATLDISKQWSNVFNILRENDFEPKFLCEVKLAFKCDGEIKTFSDLQSLRKFASQKSSMKELLKDVLPQKE","Homo sapiens","BC111559, ECAT11, L1TD1","LINE-1 type transposase domain-containing protein 1","1","3SOO"
"3SOP",,"X-RAY DIFFRACTION",2.46,50.06,"VAPOR DIFFUSION, HANGING DROP",6.2,"100 mM Bis-Tris, pH 6.2, 200 mM magnesium formate, 18% PEG3350, 5% ethylene glycol, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1042/BJ20120851",,"3SOP",63.95,"2.885","2.885","Crystal Structure Of Human Septin 3 GTPase Domain","FDFNIMVVGQSGLGKSTLVNTLFKSQVSRKASSWNREEKIPKTVEIKAIGHVIEEGGVKMKLTVIDTPGFGDQINNENCWEPIEKYINEQYEKFLKEEVNIARKKRIPDTRVHCCLYFISPTGHSLRPLDLEFMKHLSKVVNIIPVIAKADTMTLEEKSEFKQRVRKELEVNGIEFYPQKEFDEDLEDKTENDKIRQESMPFAVVGSDKEYQVNGKRVLGRKTPWGIIEVENLNHCEFALLRDFVIRTHLQDLKEVTHNIHYETYRAKRL","Homo sapiens","SEP3, SEPT3, SEPTIN3","Neuronal-specific septin-3","1","3SOP"
"3SOR",,"X-RAY DIFFRACTION",2.26,45.68,"VAPOR DIFFUSION, HANGING DROP",,"Co-crystallization by adding seeds to the crystal drops using a Hampton seed hair. Incubation @ 20 C. crystal. solution: 0.1 M citrate pH 4.5-5.25, 22-24 % PEG4000. cryoprotectant: 75 % mother liquor + 25 % Glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S1744309112009037",,"3SOR",27.58,"1.8","1.8","Factor XIa in complex with a clorophenyl-tetrazole inhibitor","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","Coagulation factor XI","1","3SOR"
"3SOS",,"X-RAY DIFFRACTION",2.19,43.77,,,"Co-crystallization by adding seeds to the crystal drops using a Hampton seed hair. crystal. solutin: 0.1 M citrate pH 4.5 - 5.25, 22 - 24 % PEG4000. cryoprotectant: 75 % mother liquor + 25 % Glycerol, temperature 293K",293,"10.1107/S1744309112009037",,"3SOS",27.73,"2.58","2.58","Benzothiazinone inhibitor in complex with FXIa","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAV","Homo sapiens","F11","Coagulation factor XI","1","3SOS"
"3SOX",,"X-RAY DIFFRACTION",2.93,58.04,"VAPOR DIFFUSION, SITTING DROP",8.5,"2 M ammonium sulfate, 0.1 M Tris, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.molcel.2011.07.006",,"3SOX",16.37,"2.6501","2.6501","Structure of UHRF1 PHD finger in the free form","SGPSCKHCKDDVNRLCRVCACHLCGGRQDPDKQLMCDECDMAFHIYCLDPPLSSVPSEDEWYCPECRNDA","Homo sapiens","ICBP90, NP95, RNF106, UHRF1","E3 ubiquitin-protein ligase UHRF1","1","3SOX"
"3SP7",,"X-RAY DIFFRACTION",2.31,46.75,"VAPOR DIFFUSION",4.5,"4% PEG3000, 0.6 M zinc acetate, 0.1 M sodium acetate, pH 4.5, VAPOR DIFFUSION, temperature 293K",293,,,"3SP7",21.02,"1.4","1.4","Crystal Structure of Bcl-xL bound to BM903","SEFMSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQER","Homo sapiens","Bcl-xL, BCL2L, BCL2L1, BCLX","Bcl-2-like protein 1","1","3SP7"
,,,,,,,,,,,,,,,,,"Homo sapiens","Bcl-xL, BCL2L, BCL2L1, BCLX"
"3SP8",,"X-RAY DIFFRACTION",2.69,54.29,"VAPOR DIFFUSION, HANGING DROP",6,"50mM MES pH=6.0, 30% MPD, VAPOR DIFFUSION, HANGING DROP, temperature 21K, temperature 294K",294,,,"3SP8",64.15,"1.86","1.86","Crystal structure of NK2 in complex with fractionated Heparin DP10","GSYAEGQRKRRNTIHEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFDKARKQCLWFPFNSMSSGVKKEFGHEFDLYENKDYIRNCIIGKGRSYKGTVSITKSDIKCQPWSSMIPHEHSFLPSSYRGKDLQENYCRNPRGEEGGPWCFTSNPEVRYEVCDIPQCSEVECMTSNGESYRGLMDHTESGKICQRWDHQTPHRHKFLPERYPDKGFDDNYCRNPDGQPRPWCYTLDPHTRWEYCKIKTCK","Homo sapiens","HGF, HPTA","Hepatocyte growth factor alpha chain","1","3SP8"
"3SP9",,"X-RAY DIFFRACTION",2.34,47.49,"VAPOR DIFFUSION, HANGING DROP",6.5,"10% PEG3350, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M111.266023",,"3SP9",65.18,"2.3","2.3","Structural basis for iloprost as a dual PPARalpha/delta agonist","HHHHHHLVPRGSADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","3SP9"
"3SPA",,"X-RAY DIFFRACTION",2.6,52.77,"VAPOR DIFFUSION, HANGING DROP",6.5,"12% PEG4000, 10% Glycerol, 30mM Mes 6.5, 60mM (NH4)2SO4, 40mM Tris 8.0, 20mM DTT  
  
in situ proteolysed with ArgC (1:1000 w/w ratio) and micro-seeded, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature10435",,"3SPA",129.98,"2.5","2.5","Crystal Structure of Human Mitochondrial RNA Polymerase","MGHHHHHHRKVQMGAKDATPVPCGRWAKILEKDKRTQQMRMQRLKAKLQMPFQSGEFKALTRRLQVEPRLLSKQMAGCLEDCTRQAPESPWEEQLARLLQEAPGKLSLDVEQAPSGQHSQAQLSGQQQRLLAFFKCCLLTDQLPLAHHLLVVHHGQRQKRKLLTLDMYNAVMLGWARQGAFKELVYVLFMVKDAGLTPDLLSYAAALQCMGRQDQDAGTIERCLEQMSQEGLKLQALFTAVLLSEEDRATVLKAVHKVKPTFSLPPQLPPPVNTSKLLRDVYAKDGRVSYPKLHLPLKTLQCLFEKQLHMELASRVCVVSVEKPTLPSKEVKHARKTLKTLRDQWEKALCRALRETKNRLEREVYEGRFSLYPFLCLLDEREVVRMLLQVLQALPAQGESFTTLARELSARTFSRHVVQRQRVSGQVQALQNHYRKYLCLLASDAEVPEPCLPRQYWEALGAPEALREQPWPLPVQMELGKLLAEMLVQATQMPCSLDKPHRSSRLVPVLYHVYSFRNVQQIGILKPHPAYVQLLEKAAEPTLTFEAVDVPMLCPPLPWTSPHSGAFLLSPTKLMRTVEGATQHQELLETCPPTALHGALDALTQLGNCAWRVNGRVLDLVLQLFQAKGCPQLGVPAPPSEAPQPPEAHLPHSAAPARKAELRRELAHCQKVAREMHSLRAEALYRLSLAQHLRDRVFWLPHNMDFRGRTYPCPPHFNHLGSDVARALLEFAQGRPLGPHGLDWLKIHLVNLTGLKKREPLRKRLAFAEEVMDDILDSADQPLTGRKWWMGAEEPWQTLACCMEVANAVRASDPAAYVSHLPVHQDGSCNGLQHYAALGRDSVGAASVNLEPSDVPQDVYSGVAAQVEVFRRQDAQRGMRVAQVLEGFITRKVVKQTVMTVVYGVTRYGGRLQIEKRLRELSDFPQEFVWEASHYLVRQVFKSLQEMFSGTRAIQHWLTESARLISHMGSVVEWVTPLGVPVIQPYRLDSKVKQIGGGIQSITYTHNGDISRKPNTRKQKNGFPPNFIHSLDSSHMMLTALHCYRKGLTFVSVHDCYWTHAADVSVMNQVCREQFVRLHSEPILQDLSRFLVKRFCSEPQKILEASQLKETLQAVPKPGAFDLEQVKRSTYFFS","Homo sapiens","AAC06147.1, POLRMT","DNA-directed RNA polymerase, mitochondrial","1","3SPA"
,,,,,,,,,,,,,,,,"XXXXXXXXX","Homo sapiens","AAC06147.1, POLRMT","Nonamer peptide","2","3SPA"
"3SPF",,"X-RAY DIFFRACTION",2.43,49.37,"VAPOR DIFFUSION",9,"1.2 M sodium citrate, 25 mM CHES, pH 9.0, VAPOR DIFFUSION, temperature 293K",293,"10.1021/jm300178u","B50","3SPF",20.57,"1.7","1.7","Crystal Structure of Bcl-xL bound to BM501","SEFMSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQER","Homo sapiens","BCL2L1, BCL2L, BCLX","Bcl-2-like protein 1","1","3SPF"
,,,,,,,,,,,,,,,,,"Homo sapiens","BCL2L1, BCL2L, BCLX"
"3SQE",,"X-RAY DIFFRACTION",2.02,39.07,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris, 11% PEG8000, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/bi2015019",,"3SQE",33.58,"1.9","1.9","Crystal structure of prethrombin-2 mutant S195A in the alternative form","EADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin light chain, heavy chain","1","3SQE"
"3SQH",,"X-RAY DIFFRACTION",1.97,37.53,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris, 11% PEG8000, VAPOR DIFFUSION, HANGING DROP, temperature 295K, pH 8.5",295,"10.1021/bi2015019",,"3SQH",33.39,"2.2","2.2","Crystal structure of prethrombin-2 mutant S195A in the the open form","EADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2, human cDNA","Thrombin light chain, heavy chain","1","3SQH"
"3SQJ",,"X-RAY DIFFRACTION",2.46,50.02,"VAPOR DIFFUSION, HANGING DROP",7.5,"28% PEG 3350, 50mM phosphate, 150 mM KCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1073/pnas.1109736108",,"3SQJ",135.97,"2.05","2.05","Recombinant human serum albumin from transgenic plant","HKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALG","Homo sapiens","ALB, GIG20, GIG42, HSA, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","3SQJ"
"3SQP",,"X-RAY DIFFRACTION",2.54,51.63,,7.5,"660 MM AMMONIUM SULFATE, 100 MM POTASSIUM PHOSPHATE, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295.0K",,"10.1179/174329211X13049558293678","3J8","3SQP",105.83,"2.21","2.21","Structure of human glutathione reductase complexed with pyocyanin, an agent with antimalarial activity","ACRQEPQPQGPPPAAGAVASYDYLVIGGGSGGLASARRAAELGARAAVVESHKLGGTCVNVGCVPKKVMWNTAVHSEFMHDHADYGFPSCEGKFNWRVIKEKRDAYVSRLNAIYQNNLTKSHIEIIRGHAAFTSDPKPTIEVSGKKYTAPHILIATGGMPSTPHESQIPGASLGITSDGFFQLEELPGRSVIVGAGYIAVEMAGILSALGSKTSLMIRHDKVLRSFDSMISTNCTEELENAGVEVLKFSQVKEVKKTLSGLEVSMVTAVPGRLPVMTMIPDVDCLLWAIGRVPNTKDLSLNKLGIQTDDKGHIIVDEFQNTNVKGIYAVGDVCGKALLTPVAIAAGRKLAHRLFEYKEDSKLDYNNIPTVVFSHPPIGTVGLTEDEAIHKYGIENVKTYSTSFTPMYHAVTKRKTKCVMKMVCANKEEKVVGIHMQGLGCDEMLQGFAVAVKMGATKADFDNTVAIHPTSSEELVTLR","Homo sapiens","GSR, GLUR, GRD1","Glutathione reductase, mitochondrial","1","3SQP"
"3SQQ",,"X-RAY DIFFRACTION",2.02,39.04,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 3 mM inhibitor, 15% v/v PEG3350, 50 mM HEPES/NaOH, 50 mM Na/K phosphate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm301234k","99Z","3SQQ",35.21,"1.85","1.85","CDK2 in complex with inhibitor RC-3-96","GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3SQQ"
"3SR4",,"X-RAY DIFFRACTION",4.21,70.75,"VAPOR DIFFUSION, HANGING DROP",5.3,"PROTEIN SOLUTION: 20 mM Tris, pH 8.0, 200 mM NaCl, 1 mM EDTA, 10% glycerol, 3 mM inhibitor, 3 mM TCEP. RESERVOIR SOLUTION: 0.1 M HAC, pH 5.3, 1.25-1.7 M (NH4)2SO4. , VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/ja206312b","TT8","3SR4",41.4,"2.5","2.5","Crystal Structure of Human DOT1L in Complex with a Selective Inhibitor","MGEKLELRLKSPVGAEPAVYPWPLPVYDKHHDAAHEIIETIRWVCEEIPDLKLAMENYVLIDYDTKSFESMQRLCDKYNRAIDSIHQLWKGTTQPMKLNTRPSTGLLRHILQQVYNHSVTDPEKLNNYEPFSPEVYGETSFDLVAQMIDEIKMTDDDLFVDLGSGVGQVVLQVAAATNCKHHYGVEKADIPAKYAETMDREFRKWMKWYGKKHAEYTLERGDFLSEEWRERIANTSVIFVNNFAFGPEVDHQLKERFANMKEGGRIVSSKPFAPLNFRINSRNLSDIGTIMRVVELSPLKGSVSWTGKPVSYYLHTIDRTILENYFSSLKNPKLREEQEAARRRQQRESKS","Homo sapiens","DOT1L, KIAA1814, KMT4","Histone-lysine N-methyltransferase, H3 lysine-79 specific","1","3SR4"
"3SRD",,"X-RAY DIFFRACTION",2.35,47.57,"VAPOR DIFFUSION, HANGING DROP",7.2,"10-16% polyethyleneglycol 8000, 20 mM triethanolamine-HCl buffer (pH 7.2), 50 mM MgCl2, 100 mM KCl, 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,,,"3SRD",243.14,"2.902","2.902","Human M2 pyruvate kinase in complex with fructose 1-6 bisphosphate and Oxalate.","MGSSHHHHHHSSGLVPRGSHMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","OIP3, PK2, PK3, PKM, PKM2","Pyruvate kinase isozymes M1/M2","1","3SRD"
"3SRF",,"X-RAY DIFFRACTION",2.59,52.42,"VAPOR DIFFUSION, HANGING DROP",7.2,"10-16% polyethyleneglycol 8000, 20 mM triethanolamine-HCl buffer (pH 7.2), 50 mM MgCl2, 100 mM KCl, 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,,,"3SRF",485.22,"2.845","2.845","Human M1 pyruvate kinase","MGSSHHHHHHSSGLVPRGSHMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAMFHRKLFEELVRASSHSTDLMEAMAMGSVEASYKCLAAALIVLTESGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","OIP3, PK2, PK3, PKM, PKM1, PKM2","Pyruvate kinase isozymes M1/M2","1","3SRF"
"3SRH",,"X-RAY DIFFRACTION",2.47,50.23,"VAPOR DIFFUSION, HANGING DROP",7.2,"10-16% polyethyleneglycol 8000, 20 mM triethanolamine-HCl buffer (pH 7.2), 50 mM MgCl2, 100 mM KCl, 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,,,"3SRH",241.04,"2.6","2.6","Human M2 pyruvate kinase","MGSSHHHHHHSSGLVPRGSHMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","OIP3, PK2, PK3, PKM, PKM2","Pyruvate kinase isozymes M1/M2","1","3SRH"
"3SRV",,"X-RAY DIFFRACTION",2.25,45.22,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG3350, 0.2M Na-K-Phosphate, 0.1M Bis-Tris-Propane pH 6.5, 5mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2011.07.082","S19","3SRV",65.3,"1.95","1.95","Crystal structure of spleen tyrosine kinase (SYK) in complex with a diaminopyrimidine carboxamide inhibitor","GPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","3SRV"
,,,,,,,,,,,,,,,,"GPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN","Homo sapiens","SYK","Tyrosine-protein kinase SYK","2","3SRV"
"3SSG",,"X-RAY DIFFRACTION",2.35,47.56,"VAPOR DIFFUSION, HANGING DROP",6.5,"3% w/v PEG 8000, 0.1M cacodylate pH 6.5, 5 mM Zn acetate, VAPOR DIFFUSION, HANGING DROP, temperature 287K",287,"10.1107/S090744491104491X",,"3SSG",14.03,"2","2","Structure of transthyretin L55P in complex with Zn","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGEPHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3SSG"
"3SSU",,"X-RAY DIFFRACTION",2.55,51.68,"VAPOR DIFFUSION, HANGING DROP",6,"0.04M calcium acetate, 0.1M MES pH 6, isopropanol 6%, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1073/pnas.1206836109",,"3SSU",22.28,"2.603","2.603","Crystal structure of vimentin coil1A/1B fragment","GSTRTNEKVELQELNDRFANYIDKVRFLEQQNKILLAELEQLKGQGKSRLGDLYEEEMRELRRQVDQLTNDKARVEVERDNLAEDIMRLREKL","Homo sapiens","FLJ36605, VIM","Vimentin","1","3SSU"
,,,,,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.06M calcium acetate, 0.1M MES pH 5.5, isopropanol 6%, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277
"3STK",,"X-RAY DIFFRACTION",2.22,44.51,"VAPOR DIFFUSION, HANGING DROP",8,"0.15M potassium bromide, 30% polyethylene glycol monomethyl ether (PEG MME) 2000, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M111.270165",,"3STK",15.11,"1.55","1.55","Crystal Structure of human LFABP complex with two molecules of palmitic acid (holo-LFABP)","MAGSSFSGKYQLQSQENFEAFMKAIGLPEELIQKGKDIKGVSEIVQNGKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTMTLGDIVFKRISKRIGT","Homo sapiens","FABP1, FABPL","Fatty acid-binding protein, liver","1","3STK"
"3STM",,"X-RAY DIFFRACTION",2.21,44.37,"VAPOR DIFFUSION, HANGING DROP",8,"0.15 M potassium bromide and 30% polyethylene glycol monomethyl ether (PEG MME) 2000, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M111.270165",,"3STM",14.86,"2.216","2.216","Structure of human LFABP in complex with one molecule of palmitic acid","MAGSSFSGKYQLQSQENFEAFMKAIGLPEELIQKGKDIKGVSEIVQNGKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTMTLGDIVFKRISKRIGT","Homo sapiens","FABP1, FABPL","Fatty acid-binding protein, liver","1","3STM"
"3STN",,"X-RAY DIFFRACTION",2.25,45.36,"VAPOR DIFFUSION, HANGING DROP",8,"0.15M potassium bromide, 30% polyethylene glycol monomethyl ether (PEG MME) 2000, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M111.270165",,"3STN",14.6,"2.595","2.595","Structure of human LFABP (apo-LFABP)","MAGSSFSGKYQLQSQENFEAFMKAIGLPEELIQKGKDIKGVSEIVQNGKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTMTLGDIVFKRISKRIGT","Homo sapiens","FABP1, FABPL","Fatty acid-binding protein, liver","1","3STN"
"3SVA",,"X-RAY DIFFRACTION",4.29,71.3,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Imidazole pH 6.5,  0.1M sodium acetate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444912051657",,"3SVA",13.55,"3.02","3.02","Crystal structure of V57D mutant of human cystatin C","SSPGKPPRLVGGPMDASVEEEGVRRALDFAVGEYNKASNDMYHSRALQVVRARKQIDAGVNYFLDVELGRTTCTKTQPNLDNCPFHDQPHLKRKAFCSFQIYAVPWQGTMTLSKSTCQDA","Homo sapiens","CST3","Cystatin-C","1","3SVA"
"3SVF",,"X-RAY DIFFRACTION",2.13,42.24,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M Na(OAc), 0.1M BTProp, 20% PEG3350, 10% EtGly, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3SVF",15.42,"1.975","1.975","Crystal Structure of the first bromodomain of human BRD4 in complex with a dihydro-quinazolin ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","3SVF"
"3SVG",,"X-RAY DIFFRACTION",2.15,42.66,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2M Na2SO4, 0.1M BTProp, 20% PEG 3350, 10% EtGly, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,"ODR","3SVG",15.55,"1.68","1.68","Crystal Structure of the first bromodomain of human BRD4 in complex with a 3,5-dimethylisoxazol ligand","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","3SVG"
"3SVH",,"X-RAY DIFFRACTION",2.51,50.96,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.25M KSCN, 10% PEG 3350, 5% EtGly, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,"KRG","3SVH",29.55,"1.8","1.8","Crystal Structure of the bromdomain of human CREBBP in complex with a 3,5-dimethylisoxazol ligand","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CBP, CREBBP","CREB-binding protein","1","3SVH"
"3SW0",,"X-RAY DIFFRACTION",2.85,56.86,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.1M Sodium Acetate trihydrate, pH 4.6, 2% v/v Tacsimate, pH 4.0 (Hampton Research formulation containing: 1.8305 M Malonic acid, 0.25 M Ammonium citrate tribasic, 0.12 M Succinic acid, 0.3 M DL-Malic acid, 0.4 M Sodium acetate trihydrate, 0.5 M Sodium formate, 0.16 M Ammonium tartrate dibasic and pH adjusted using NaOH) and 16% w/v polyethylene glycol 3350 as the precipitant, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1371/journal.pone.0032187",,"3SW0",21.89,"1.8","1.8","Structure of the C-terminal region (modules 18-20) of complement regulator Factor H","AGTSCVNPPTVQNAYIVSRQMSKYPSGERVRYQCRSPYEMFGDEEVMCLNGNWTEPPQCKDSTGKCGPPPPIDNGDITSFPLSVYAPASSVEYQCQNLYQLEGNKRITCRNGQWSEPPKCLHPCVISREIMENYNIALRWTAKQKLYSRTGESVEFVCKRGYRLSSRSHTLRTTCWDGKLEYPTCAKR","Homo sapiens","CFH, HF, HF1, HF2","Complement factor H","1","3SW0"
"3SW2",,"X-RAY DIFFRACTION",2.17,43.39,"VAPOR DIFFUSION, HANGING DROP",6,"15-22% w/v PEG5000 MME, 0.01 M calcium acetate, 0.35 M sodium acetate, 0.1 M lithium sulfate, 0.1 M MES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2011.06.098","FI1","3SW2",37.81,"2.42","2.42","X-ray crystal structure of human FXA in complex with 6-chloro-N-((3S)-2-oxo-1-(2-oxo-2-((5S)-8-oxo-5,6-dihydro-1H-1,5-methanopyrido[1,2-a][1,5]diazocin-3(2H,4H,8H)-yl)ethyl)piperidin-3-yl)naphthalene-2-sulfonamide","KDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE","Homo sapiens","F10","Coagulation factor X","1","3SW2"
,,,,,,,,,,,,,,,,"IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLP","Homo sapiens","F10","Coagulation factor X","2","3SW2"
"3SW4",,"X-RAY DIFFRACTION",2.05,40.06,"VAPOR DIFFUSION, SITTING DROP",7.8,"15-20% PEG3350, 0.2M Ammonium Acetate, 0.1M HEPES pH 7.8, vapor diffusion, sitting drop, temperature 293.15K",293.15,,"18K","3SW4",34.39,"1.7","1.7","Crystal Structure of the CDK2 in complex with thiazolylpyrimidine inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3SW4"
"3SW7",,"X-RAY DIFFRACTION",2.06,40.22,"VAPOR DIFFUSION, SITTING DROP",7.8,"15-20% PEG3350, 0.2M Ammonium Acetate, 0.1M HEPES pH 7.8, vapor diffusion, sitting drop, temperature 293.15K",293.15,,"19K","3SW7",34.37,"1.8","1.8","Crystal Structure of the CDK2 in complex with thiazolylpyrimidine inhibitor","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3SW7"
"3SWB",,"X-RAY DIFFRACTION",2.09,41.07,"VAPOR DIFFUSION, SITTING DROP",8,"cadmium sulphate octahydrate 0.02M, sodium acetate 0.6M, 0.1M Tris , pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1107/S0907444913001182",,"3SWB",10.92,"1.67","1.67","Crystal structure of the amino-terminal domain of human cardiac troponin C in complex with cadmium at 1.7 A resolution","MDDIYKAAVEQLTEEQKNEFKAAFDIFVLGAEDGCISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRCMKDDS","Homo sapiens","TNNC, TNNC1","Troponin C, slow skeletal and cardiac muscles","1","3SWB"
"3SWK",,"X-RAY DIFFRACTION",2.18,43.62,"VAPOR DIFFUSION, SITTING DROP",6.6,"protein in 10 mM Tris pH 8, 38 mM NaCl + PEG 3350 25% w/v, 0.2M ammonium acetate, BIS-TRIS 0.1M pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1073/pnas.1206836109",,"3SWK",20.8,"1.7","1.7","Crystal structure of vimentin coil1B fragment","EMRELRRQVDQLTNDKARVEVERDNLAEDIMRLREKLQEEMLQREEAENTLQSFRQDVDNASLARLDLERKVESLQEEIAFLKKLH","Homo sapiens","FLJ36605, VIM","Vimentin","1","3SWK"
"3SWL",,"X-RAY DIFFRACTION",2.17,43.2,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris, 30% (v/v) PEG 550 monomethyl ether, 0.05 M calcium chloride, 2.5 mM DTT, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/bi201541w",,"3SWL",26.3,"2.35","2.35","Crystal Structure Analysis of H74A Mutant of Human CLIC1","PQVELFVKAGSDGAKIGNCPFSQRLFMVLWLKGVTFNVTTVDTKRRTETVQKLCPGGQLPFLLYGTEVATDTNKIEEFLEAVLCPPRYPKLAALNPESNTAGLDIFAKFSAYIKNSNPALNDNLEKGLLKALKVLDNYLTSPLPEEVDETSAEDEGVSQRKFLDGNELTLADCNLLPKLHIVQVVCKKYRGFTIPEAFRGVHRYLSNAYAREEFASTCPDDEEIELAYEQVAKALK","Homo sapiens","CLIC1, G6, NCC27","Chloride intracellular channel protein 1","1","3SWL"
"3SWR",,"X-RAY DIFFRACTION",2.92,57.94,,5.8,"5% PEG 4000, 5 mM MgSO4, 50 mM MES, pH 5.8, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,,,"3SWR",116.35,"2.49","2.49","Structure of human DNMT1 (601-1600) in complex with Sinefungin","HMRQTIRHSTREKDRGPTKATTTKLVYQIFDTFFAEQIEKDDREDKENAFKRRRCGVCEVCQQPECGKCKACKDMVKFGGSGRSKQACQERRCPNMAMKEADDDEEVDDNIPEMPSPKKMHQGKKKKQNKNRISWVGEAVKTDGKKSYYKKVCIDAETLEVGDCVSVIPDDSSKPLYLARVTALWEDSSNGQMFHAHWFCAGTDTVLGATSDPLELFLVDECEDMQLSYIHSKVKVIYKAPSENWAMEGGMDPESLLEGDDGKTYFYQLWYDQDYARFESPPKTQPTEDNKFKFCVSCARLAEMRQKEIPRVLEQLEDLDSRVLYYSATKNGILYRVGDGVYLPPEAFTFNIKLSSPVKRPRKEPVDEDLYPEHYRKYSDYIKGSNLDAPEPYRIGRIKEIFCPKKSNGRPNETDIKIRVNKFYRPENTHKSTPASYHADINLLYWSDEEAVVDFKAVQGRCTVEYGEDLPECVQVYSMGGPNRFYFLEAYNAKSKSFEDPPNHARSPGNKGKGKGKGKGKPKSQACEPSEPEIEIKLPKLRTLDVFSGCGGLSEGFHQAGISDTLWAIEMWDPAAQAFRLNNPGSTVFTEDCNILLKLVMAGETTNSRGQRLPQKGDVEMLCGGPPCQGFSGMNRFNSRTYSKFKNSLVVSFLSYCDYYRPRFFLLENVRNFVSFKRSMVLKLTLRCLVRMGYQCTFGVLQAGQYGVAQTRRRAIILAAAPGEKLPLFPEPLHVFAPRACQLSVVVDDKKFVSNITRLSSGPFRTITVRDTMSDLPEVRNGASALEISYNGEPQSWFQRQLRGAQYQPILRDHICKDMSALVAARMRHIPLAPGSDWRDLPNIEVRLSDGTMARKLRYTHHDRKNGRSSSGALRGVCSCVEAGKACDPAARQFNTLIPWCLPHTGNRHNHWAGLYGRLEWDGFFSTTVTNPEPMGKQGRVLHPEQHRVVSVRECARSQGFPDTYRLFGNILDKHRQVGNAVPPPLAKAIGLEIKLCMLAKA","Homo sapiens","DNMT1, AIM, CXXC9, DNMT","DNA (cytosine-5)-methyltransferase 1","1","3SWR"
"3SWV",,"X-RAY DIFFRACTION",2.67,53.99,,5,"15% PEG1000, 0.1M sodium citrate, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3SWV",23.79,"3","3","Crystal Structure of a domain of Brefeldin A-inhibited guanine nucleotide-exchange protein 2 (Brefeldin A-inhibited GEP 2) from Homo sapiens (Human), Northeast Structural Genomics Consortium target id HR5562A","EQFEVIKQQKEIIEHGIELFNKKPKRGIQFLQEQGMLGTSVEDIAQFLHQEERLDSTQVGDFLGDSARFNKEVMYAYVDQLDFCEKEFVSALRTFLEGFRLPGEAQKIDRLMEKFAARYIECNQGQTLFASADTAYVLAYSIIMLTTDLHSPQVKNKMTKEQYIKMNRGINDSKDLPEEYLSSIYEEIEGKKIAMKETKELT","Homo sapiens","ARFGEF2, ARFGEP2, BIG2","Brefeldin A-inhibited guanine nucleotide-exchange protein 2","1","3SWV"
"3SWW",,"X-RAY DIFFRACTION",2.69,54.35,"VAPOR DIFFUSION, HANGING DROP",8.5,"CRYSTALS GROWN IN 2 UL EQUIVOLUME MIXTURE OF PROTEIN SOLUTION (0.1 M NACL, 20 MM TRIS-HCL BUFFER PH 7.8, 9.8 MG/ML PROTEIN) AND  CRYSTALLIZATION SOLUTION (17% W/V PEG 3350, 15% W/V GLYCEROL, 200 MM MGCL2, 100 MM TRIS-HCL).  SUFFICIENT 100 MM LIGAND STOCK SOLUTION (NEAT DMSO) ADDED TO ACHIEVE 1 MM LIGAND CONCENTRATION.  SOAKED OVERNIGHT. HARVESTED DIRECTLY AND CRYO-STORED IN LN2 VAPOR DIFFUSION / HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2011.09.074","KXB","3SWW",178.72,"2","2","Crystal structure of human dpp-iv in complex with sa-(+)-3-(aminomethyl)-4-(2,4-dichlorophenyl)-6-(2-methoxyphenyl)- 2-methyl-5h-pyrrolo[3,4-b]pyridin-7(6h)-one","EFSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLPPLEQKLISEEDLNSAVDHHHHHH","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","3SWW"
"3SWY",,"X-RAY DIFFRACTION",2.04,39.59,"VAPOR DIFFUSION, SITTING DROP",6.2,"20% w/v PEG3350, 200 mM potassium acetate, pH 6.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/ncomms1466",,"3SWY",15.74,"1.9","1.9","CNGA3 626-672 containing CLZ domain","GALEEKVEQLGSSLDTLQTRFARLLAEYNATQMKMKQRLSQLESQV","Homo sapiens","CNCG3, CNGA3","Cyclic nucleotide-gated cation channel alpha-3","1","3SWY"
"3SWZ",,"X-RAY DIFFRACTION",2.61,52.94,,8.5,"30% PEG 3350, 0.175 M Tris, 0.30 M ammonium sulfate, 3% glycerol, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nature10743","TOK","3SWZ",226.98,"2.4","2.4","Human Cytochrome P450 17A1 in complex with TOK-001","MAKKTGAKYPKSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTKTTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDIASNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHNGQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYKEKFRSDSITNMLDTLMQAKMNSDNGNAGPDQDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRTPTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPERFLNPAGTQLISPSVSYLPFGAGPRSCIGEILARQELFLIMAWLLQRFDLEVPDDGQLPSLEGIPKVVFLIDSFKVKIKVRQAWREAQAEGSTHHHH","Homo sapiens","CYP17, CYP17A1, S17AH","Steroid 17-alpha-hydroxylase/17,20 lyase","1","3SWZ"
"3SX0",,"X-RAY DIFFRACTION",3.58,65.69,"VAPOR DIFFUSION",4.6,"1.5 M ammonium sulfate, 0.1 M sodium acetate, 0.0015 M ligand, pH 4.6, vapor diffusion, temperature 291K, VAPOR DIFFUSION",291,"10.1016/j.bmc.2013.01.049","SX0","3SX0",48.54,"2.28","2.28","Crystal structure of Dot1l in complex with a brominated SAH analog","GMGEKLELRLKSPVGAEPAVYPWPLPVYDKHHDAAHEIIETIRWVCEEIPDLKLAMENYVLIDYDTKSFESMQRLCDKYNRAIDSIHQLWKGTTQPMKLNTRPSTGLLRHILQQVYNHSVTDPEKLNNYEPFSPEVYGETSFDLVAQMIDEIKMTDDDLFVDLGSGVGQVVLQVAAATNCKHHYGVEKADIPAKYAETMDREFRKWMKWYGKKHAEYTLERGDFLSEEWRERIANTSVIFVNNFAFGPEVDHQLKERFANMKEGGRIVSSKPFAPLNFRINSRNLSDIGTIMRVVELSPLKGSVSWTGKPVSYYLHTIDRTILENYFSSLKNPKLREEQEAARRRQQRESKSNAATPTKGPEGKVAGPADAPMDSGAEEEKAGAATVKKPSPSKARKKKLNKKGRKMAGRKRGRPKKMNTA","Homo sapiens","DOT1L, KIAA1814, KMT4","Histone-lysine N-methyltransferase, H3 lysine-79 specific","1","3SX0"
"3SX3",,"X-RAY DIFFRACTION",2.27,45.75,,7,"1% PEG4000, 5% MPD, 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM ADA, pH 7.6, 30 mM sodium acetate, pH 4.6, 5 mM manganese chloride, with 30% Glycerol as cryoprotectant, HANGING DROP, temperature 298K",298,"10.1107/S0907444912001801",,"3SX3",35.06,"1.45","1.45","Crystal structure of AABB+UDP+Gal with glycerol as the cryoprotectant","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","3SX3"
"3SX4",,"X-RAY DIFFRACTION",2.7,54.41,"VAPOR DIFFUSION, HANGING DROP",8.5,"CRYSTALS GROWN IN 2 UL EQUIVOLUME MIXTURE OF PROTEIN SOLUTION (0.1 M NACL, 20 MM TRIS-HCL BUFFER PH 7.8, 9.8 MG/ML PROTEIN) AND 
CRYSTALLIZATION SOLUTION (17% W/V PEG 3350, 15% W/V GLYCEROL, 200 MM MGCL2, 100 MM TRIS-HCL BUFFER PH 8.5).  SUFFICIENT 100 MM LIGAND STOCK SOLUTION (NEAT DMSO) ADDED TO ACHIEVE 1 MM LIGAND CONCENTRATION.  SOAKED OVERNIGHT. 
                            HARVESTED DIRECTLY AND CRYO-STORED IN LN2. 
2. For crystal 2: 
<crystal_number =, VAPOR DIFFUSION / HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2011.09.074","KXA","3SX4",179.04,"2.6","2.6","Crystal structure of human dpp-iv in complex with sa-(+)-3-(aminomethyl)-4-(2,4-dichlorophenyl)-6-(2-methoxyphenyl)- 2-methyl-5h-pyrrolo[3,4-b]pyridin-7(6h)-one","EFSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLPPLEQKLISEEDLNSAVDHHHHHH","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","3SX4"
"3SX5",,"X-RAY DIFFRACTION",2.28,46.01,,7,"1% PEG4000, 5% MPD, 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM ADA, pH 7.6, 30 mM sodium acetate, pH 4.6, 5 mM manganese chloride, with 20% MPD as  cryoprotectant, HANGING DROP, temperature 298K",298,"10.1107/S0907444912001801",,"3SX5",34.97,"1.43","1.43","Crystal structure of AABB+UDP+Gal with MPD as the cryoprotectant","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","3SX5"
"3SX7",,"X-RAY DIFFRACTION",2.28,46.1,,7,"1% PEG4000, 5% MPD, 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM ADA, pH 7.6, 30 mM sodium acetate, pH 4.6, 5 mM manganese chloride, with 30% glycerol as cryoprotectant, HANGING DROP, temperature 298K",298,"10.1107/S0907444912001801",,"3SX7",35.08,"1.42","1.42","Crystal structure of ABBA+UDP+Gal with Glycerol as the cryoprotectant","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGGFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","3SX7"
"3SX8",,"X-RAY DIFFRACTION",2.28,46.15,,7,"1% PEG4000, 5% MPD, 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM ADA, pH 7.6, 30 mM sodium acetate, pH 4.6, 5 mM manganese chloride, with 20% MPD as cryoprotectant, HANGING DROP, temperature 298K",298,"10.1107/S0907444912001801",,"3SX8",34.99,"1.47","1.47","Crystal structure of ABBA+UDP+Gal with MPD as the cryoprotectant","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGGFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","3SX8"
"3SXA",,"X-RAY DIFFRACTION",2.28,46.12,,7,"1% PEG4000, 5% MPD, 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM ADA, pH 7.6, 30 mM sodium acetate, pH 4.6, 5 mM manganese chloride, with 30% glycerol as cryoprotectant, HANGING DROP, temperature 298K",298,"10.1107/S0907444912001801",,"3SXA",35.09,"1.5","1.5","Crystal structure of ABBB+UDP+Gal with Glycerol as the cryoprotectant","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","3SXA"
"3SXB",,"X-RAY DIFFRACTION",2.28,46.15,,7,"1% PEG4000, 5% MPD, 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM ADA, pH 7.6, 30 mM sodium acetate, pH 4.6, 5 mM manganese chloride, with 20% MPD as cryoprotectant, HANGING DROP, temperature 298K",298,"10.1107/S0907444912001801",,"3SXB",35,"1.49","1.49","Crystal structure of ABBB+UDP+Gal with MPD as the cryoprotectant","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","3SXB"
"3SXC",,"X-RAY DIFFRACTION",2.27,45.85,,7,"1% PEG4000, 5% MPD, 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM ADA, pH 7.6, 30 mM sodium acetate, pH 4.6, 5 mM manganese chloride, with 30% glycerol as cryoprotectant, HANGING DROP, temperature 298K",298,"10.1107/S0907444912001801",,"3SXC",34.9,"1.9","1.9","Crystal structure of BBBB+UDP+Gal with Glycerol as the cryoprotectant","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","3SXC"
"3SXD",,"X-RAY DIFFRACTION",2.28,45.96,,7,"1% PEG4000, 5% MPD, 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM ADA, pH 7.6, 30 mM sodium acetate, pH 4.6, 5 mM manganese chloride, with 20% MPD as cryoprotectant, HANGING DROP, temperature 298K",298,"10.1107/S0907444912001801",,"3SXD",34.9,"1.55","1.55","Crystal structure of BBBB+UDP+Gal with MPD as the cryoprotectant","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","3SXD"
"3SXE",,"X-RAY DIFFRACTION",2.29,46.35,"HANGING DROP",7,"1% PEG4000, 5% MPD, 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM ADA, pH 7.6, 30 mM sodium acetate, pH 4.6, 5 mM MnCl2, with 30% glycerol as the cryoprotectant, HANGING DROP, temperature 298K",298,"10.1107/S0907444912001801",,"3SXE",35.01,"1.49","1.49","Crystal structure of AAAA+UDP+Gal with Glycerol as the cryoprotectant","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYLGGFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","3SXE"
"3SXG",,"X-RAY DIFFRACTION",2.3,46.57,,7,"1% PEG4000, 5% MPD, 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM ADA, pH 7.6, 30 mM sodium acetate, pH 4.6, 5 mM manganese chloride, with 20% MPD as cryoprotectant, HANGING DROP, temperature 298K",298,"10.1107/S0907444912001801",,"3SXG",34.94,"1.86","1.86","Crystal structure of AAAA+UDP+Gal with MPD as the cryoprotectant","FMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYLGGFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","3SXG"
"3SXR",,"X-RAY DIFFRACTION",2.67,53.95,,,,,"10.1111/j.1747-0285.2011.01230.x","1N1","3SXR",63.68,"2.4","2.4","Crystal structure of BMX non-receptor tyrosine kinase complex with dasatinib","GHMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDKH","Homo sapiens","AGMX1, ATK, BMX, BPK, BTK","Cytoplasmic tyrosine-protein kinase BMX","1","3SXR"
"3SXS",,"X-RAY DIFFRACTION",2.35,47.7,,,,,"10.1111/j.1747-0285.2011.01230.x",,"3SXS",31.51,"1.89","1.89","Crystal structure of BMX non-receptor tyrosine kinase complexed with PP2","GHMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDKH","Homo sapiens","AGMX1, ATK, BMX, BPK, BTK","Cytoplasmic tyrosine-protein kinase BMX","1","3SXS"
"3SYX",,"X-RAY DIFFRACTION",3.29,62.67,"Microbatch crystallization under oil",6,"12% PEG 20000, 0.1 M potassium acetate, 10 mM yttrium(III) chloride, 0.1 M MES, pH 6.0, Microbatch crystallization under oil, temperature 277K",277,,,"3SYX",14.92,"2.453","2.453","Crystal Structure of the WH1 domain from human sprouty-related, EVH1 domain-containing protein. Northeast Structural Genomics Consortium Target HR5538B.","MGHHHHHHSHMSYARVRAVVMTRDDSSGGWLPLGGSGLSSVTVFKVPHQEENGCADFFIRGERLRDKMVVLECMLKKDLIYNKVTPTFHHWKIDDKKFGLTFQSPADARAFDRGIRRAIEDISQGCPESK","Homo sapiens","SPRED1","Sprouty-related, EVH1 domain-containing protein 1","1","3SYX"
"3SZ1",,"X-RAY DIFFRACTION",2.63,53.32,"VAPOR DIFFUSION, HANGING DROP",7,"Sodium Citrate 0.90 M, HEPES 0.1 M, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1124/mol.111.076216","MYR, LU2","3SZ1",64.3,"2.3","2.3","Human PPAR gamma ligand binding domain in complex with luteolin and myristic acid","GSHMLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3SZ1"
"3SZ9",,"X-RAY DIFFRACTION",2.15,42.91,"VAPOR DIFFUSION",6.4,"100 MM ACES (N-[2-ACETAMIDO]-2-AMINOETHANE SULFONIC ACID), 10MM MGCL2, 100 MM GUANIDINE HCL, 16-17% W/V PEG 6000, 4MM DTT, pH 6.4, vapor diffusion, temperature 292K",292,"10.1074/jbc.M111.293597","I3E","3SZ9",439.85,"2.1","2.1","Crystal structure of human ALDH2 modified with the beta-elimination product of Aldi-3; 1-(4-ethylbenzene)prop-2-en-1-one","SAAATQAVPAPNQQPEVFCNQIFINNEWHDAVSRKTFPTVNPSTGEVICQVAEGDKEDVDKAVKAARAAFQLGSPWRRMDASHRGRLLNRLADLIERDRTYLAALETLDNGKPYVISYLVDLDMVLKCLRYYAGWADKYHGKTIPIDGDFFSYTRHEPVGVCGQIIPWNFPLLMQAWKLGPALATGNVVVMKVAEQTPLTALYVANLIKEAGFPPGVVNIVPGFGPTAGAAIASHEDVDKVAFTGSTEIGRVIQVAAGSSNLKRVTLELGGKSPNIIMSDADMDWAVEQAHFALFFNQGQCCCAGSRTFVQEDIYDEFVERSVARAKSRVVGNPFDSKTEQGPQVDETQFKKILGYINTGKQEGAKLLCGGGIAADRGYFIQPTVFGDVQDGMTIAKEEIFGPVMQILKFKTIEEVVGRANNSTYGLAAAVFTKDLDKANYLSQALQAGTVWVNCYDVFGAQSPFGGYKMSGSGRELGEYGLQAYTEVKTVTVKVPQKNS","Homo sapiens","ALDH2, ALDM","Aldehyde dehydrogenase, mitochondrial","1","3SZ9"
"3SZA",,"X-RAY DIFFRACTION",2.16,42.93,"VAPOR DIFFUSION",,"0.2 M potassium acetate, 18% PEG 3350, vapor diffusion, temperature 298K",298,"10.1074/jbc.M111.293597",,"3SZA",104.77,"1.48","1.48","Crystal structure of human ALDH3A1 - apo form","HHHHHHSSGLVPRGSHMSKISEAVKRARAAFSSGRTRPLQFRIQQLEALQRLIQEQEQELVGALAADLHKNEWNAYYEEVVYVLEEIEYMIQKLPEWAADEPVEKTPQTQQDELYIHSEPLGVVLVIGTWNYPFNLTIQPMVGAIAAGNAVVLKPSELSENMASLLATIIPQYLDKDLYPVINGGVPETTELLKERFDHILYTGSTGVGKIIMTAAAKHLTPVTLELGGKSPCYVDKNCDLDVACRRIAWGKFMNSGQTCVAPDYILCDPSIQNQIVEKLKKSLKEFYGEDAKKSRDYGRIISARHFQRVMGLIEGQKVAYGGTGDAATRYIAPTILTDVDPQSPVMQEEIFGPVLPIVCVRSLEEAIQFINQREKPLALYMFSSNDKVIKKMIAETSSGGVAANDVIVHITLHSLPFGGVGNSGMGSYHGKKSFETFSHRRSCLVRPLMNDEGLKVRYPPSPAKMTQH","Homo sapiens","ALDH3, ALDH3A1","Aldehyde dehydrogenase, dimeric NADP-preferring","1","3SZA"
"3SZB",,"X-RAY DIFFRACTION",2.13,42.37,"VAPOR DIFFUSION",,"0.2 M potassium acetate, 18% PEG 3350, vapor diffusion, temperature 298K",298,"10.1074/jbc.M111.293597","I1E","3SZB",105.03,"1.51","1.51","Crystal structure of human ALDH3A1 modified with the beta-elimination product of Aldi-1; 1-phenyl- 2-propen-1-one","HHHHHHSSGLVPRGSHMSKISEAVKRARAAFSSGRTRPLQFRIQQLEALQRLIQEQEQELVGALAADLHKNEWNAYYEEVVYVLEEIEYMIQKLPEWAADEPVEKTPQTQQDELYIHSEPLGVVLVIGTWNYPFNLTIQPMVGAIAAGNAVVLKPSELSENMASLLATIIPQYLDKDLYPVINGGVPETTELLKERFDHILYTGSTGVGKIIMTAAAKHLTPVTLELGGKSPCYVDKNCDLDVACRRIAWGKFMNSGQTCVAPDYILCDPSIQNQIVEKLKKSLKEFYGEDAKKSRDYGRIISARHFQRVMGLIEGQKVAYGGTGDAATRYIAPTILTDVDPQSPVMQEEIFGPVLPIVCVRSLEEAIQFINQREKPLALYMFSSNDKVIKKMIAETSSGGVAANDVIVHITLHSLPFGGVGNSGMGSYHGKKSFETFSHRRSCLVRPLMNDEGLKVRYPPSPAKMTQH","Homo sapiens","ALDH3A1, ALDH3","Aldehyde dehydrogenase","1","3SZB"
"3SZR",,"X-RAY DIFFRACTION",4.24,70.97,"VAPOR DIFFUSION, HANGING DROP",7.6,"7% PEG3350, 100 mM HEPES (pH 7.6), 80 mM NaCl, 2.5% 2-methyl-2,4-pentandiol (MPD), 5% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.immuni.2011.07.012",,"3SZR",69.18,"3.5","3.5","Crystal structure of modified nucleotide-free human MxA","GPHMGGSPGSVAENNLCSQYEEKVRPCIDLIDSLRALGVEQDLALPAIAVIGDQSSGKSSVLEALSGVALPRGSGIVTRCPLVLKLKKLVNEDKWRGKVSYQDYEIEISDASEVEKEINKAQNAIAGEGMGISHELITLEISSRDVPDLTLIDLPGITRVAVGNQPADIGYKIKTLIKKYIQRQETISLVVVPSNVDIATTEALSMAQEVDPEGDRTIGILTKPDLVDKGTEDKVVDVVRNLVFHLKKGYMIVKCRGQQEIQDQLSLSEALQREKIFFENHPYFRDLLEEGKATVPCLAEKLTSELITHICKSLPLLENQIKETHQRITEELQKYGVDIPEDENEKMFFLIDKVNAFNQDITALMQGEETVGEEDIRLFTRLRHEFHKWSTIIENNFQEGHKILSRKIQKFENQAAAAELPGFVNYRTFETIVKQQIKALEEPAVDMLHTVTDMVRLAFTDVSIKNFEEFFNLHRTAKSKIEDIRAEQEREGEKLIRLHFQMEQIVYGAFQSSSATDSSMEEIFQHLMAYHQEASKRISSHIPLIIQFFMLQTYGQQLQKAMLQLLQDKDTYSWLLKERSDTSDKRKFLKERLARLTQARRRLAQFPG","Homo sapiens","MX1","Interferon-induced GTP-binding protein Mx1","1","3SZR"
"3T0H",,"X-RAY DIFFRACTION",2.82,56.38,"VAPOR DIFFUSION, HANGING DROP",6.5,"20-25% (w/v) PEG 2000 monomethyl ether, 200mM magnesium chloride, 100mM sodium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1093/abbs/gms001",,"3T0H",25.66,"1.2","1.2","Structure insights into mechanisms of ATP hydrolysis and the activation of human Hsp90","DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90A, HSP90AA1, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3T0H"
"3T0L",,"X-RAY DIFFRACTION",2.75,55.26,"VAPOR DIFFUSION, HANGING DROP",7.7,"0.095M HEPES Na salt, 0.19M calcium chloride, 5% glycerol, 28% PEG 400, pH 7.7, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1039/c3cc44612c","1CT","3T0L",27.2,"1.6","1.6","Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening","AMGSMERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSCEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTNPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWT","Homo sapiens","HME1, SFN","14-3-3 protein sigma","1","3T0L"
"3T0M",,"X-RAY DIFFRACTION",2.71,54.67,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.095M HEPES Na salt, 0.19M calcium chloride, 5% glycerol, 25.6% PEG 400, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1039/c3cc44612c","2CT","3T0M",27.18,"1.62","1.62","Small-molecule inhibitors of 14-3-3 protein-protein interactions from virtual screening","AMGSMERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSCEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTNPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWT","Homo sapiens","HME1, SFN","14-3-3 protein sigma","1","3T0M"
"3T0O",,"X-RAY DIFFRACTION",1.797959,31.589108,"VAPOR DIFFUSION, HANGING DROP",,"15% PEG3350, 0.2 M ammonium nitrate, macroseeding, no buffer, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1093/nar/gks614",,"3T0O",28.45,"1.59","1.59","Crystal Structure Analysis of Human RNase T2","DKRLRDNHEWKKLIMVQHWPETVCEKIQNDCRDPPDYWTIHGLWPDKSEGCNRSWPFNLEEIKDLLPEMRAYWPDVIHSFPNRSRFWKHEWEKHGTCAAQVDALNSQKKYFGRSLELYRELDLNSVLLKLGIKPSINYYQVADFKDALARVYGVIPKIQCLPPSQDEEVQTIGQIELCLTKQDQQLQNCTEPGEQPSPKQEVWLANGAAESRGLRVCEDGPVFYPPPKKTKHHHHHHH","Homo sapiens","RNASET2, RNASE6PL","Ribonuclease T2","1","3T0O"
"3T0V",,"X-RAY DIFFRACTION",2.27,45.75,"VAPOR DIFFUSION, SITTING DROP",7.5,"2M ammonium sulfate, 2% PEG 400, 0.1M Hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi201422g",,"3T0V",14.48,"1.451","1.451","Unliganded fluorogen activating protein M8VL","QPVLTQSPSVSGTPGQKVTIFCSGSSSNVEDNSVYWYQQFPGTTPKVLIYNDDRRSSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCLSWDDSLNGWVFGGGTKVTVLDAASGADHHHHHH","Homo sapiens",,"immunoglobulin variable lambda domain","1","3T0V"
"3T0W",,"X-RAY DIFFRACTION",2.05,40.11,"VAPOR DIFFUSION, SITTING DROP",,"35% PEG 1500, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi201422g","DIW","3T0W",27.56,"1.501","1.501","Fluorogen activating protein M8VL in complex with dimethylindole red","QPVLTQSPSVSGTPGQKVTIFCSGSSSNVEDNSVYWYQQFPGTTPKVLIYNDDRRSSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCLSWDDSLNGWVFGGGTKVTVLDAASGADHHHHHH","Homo sapiens",,"immunoglobulin variable lambda domain","1","3T0W"
"3T0X",,"X-RAY DIFFRACTION",2.52,51.14,"VAPOR DIFFUSION, SITTING DROP",,"0.25M ammonium sulfate, 30% PEG 4000, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/bi201422g","DIW","3T0X",27.41,"1.96","1.96","Fluorogen Activating Protein M8VLA4(S55P) in complex with dimethylindole red","QPVLTQSPSVSGTPGQKVTIFCSGSSSNVEDNSVYWYQQFPGTTPKVLIYNDDRRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCLSWDDSLNGWVFGGGTKVTVLDAASGADHHHHHH","Homo sapiens",,"Immunoglobulin variable lambda domain M8VLA4(S55P)","1","3T0X"
"3T0Z",,"X-RAY DIFFRACTION",2.29,46.21,"VAPOR DIFFUSION, HANGING DROP",6.5,"15~20% PEG 3350, 5mM magnesium chloride, 500mM ammonium phosphate, 100mM Bis-Tris pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1093/abbs/gms001",,"3T0Z",26.19,"2.192","2.192","Hsp90 N-terminal domain bound to ATP","DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90A, HSP90AA1, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3T0Z"
"3T10",,"X-RAY DIFFRACTION",2.27,45.82,"VAPOR DIFFUSION, HANGING DROP",6.5,"20~25% (w/v) PEG 2000 monomethyl ether, 200mM magnesium chloride, 100mM sodium cacodylate pH 6.5,, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1093/abbs/gms001",,"3T10",26.19,"1.24","1.24","HSP90 N-terminal domain bound to ACP","DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90A, HSP90AA1, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3T10"
"3T1D",,"X-RAY DIFFRACTION",2.92,57.86,"VAPOR DIFFUSION, HANGING DROP",4.5,"1.3M Ammonium sulfate, 0.2M Lithium sulfate, 50mM sodium chloride, 0.1M sodium acetate. Protein 10 mg/ml, Cryoprotection 15% glycerol. Target DB: HosaA.18070.a, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3T1D",68.86,"2.3","2.3","The mutant structure of human Siderocalin W79A, R81A, Y106F bound to Enterobactin","MPLGLLWLGLALLGALHAQAQDSTSDLIPAPPLSKVPLQQNFQDNQFQGKWYVVGLAGNAILREDKDPQKMYATIYELKEDKSYNVTSVLFRKKKCDYAIATFVPGSQPGEFTLGNIKSYPGLTSFLVRVVSTNYNQHAMVFFKKVSQNREYFKITLYGRTKELTSELKENFIRFSKSLGLPENHIVFPVPIDQCIDG","Homo sapiens","LCN2, HNL, NGAL","Neutrophil gelatinase-associated lipocalin","1","3T1D"
"3T1I",,"X-RAY DIFFRACTION",3.09,60.26,"VAPOR DIFFUSION, HANGING DROP",8.8,"14% PEG 3350, 0.1M Bicne, 0.5mM manganese chloride, 2mM Dithiothreitol, 4mM Glutathione, pH 8.8, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2011.09.010",,"3T1I",201.43,"3","3","Crystal Structure of Human Mre11: Understanding Tumorigenic Mutations","MGSSHHHHHHSSGLVPRGSHMSTADALDDENTFKILVATDIHLGFMEKDAVRGNDTFVTLDEILRLAQENEVDFILLGGDLFHENKPSRKTLHTCLELLRKYCMGDRPVQFEILSDQSVNFGFSKFPWVNYQDGNLNISIPVFSIHGNHDDPTGADALCALDILSCAGFVNHFGRSMSVEKIDISPVLLQKGSTKIALYGLGSIPDERLYRMFVNKKVTMLRPKEDENSWFNLFVIHQNRSKHGSTNFIPEQFLDDFIDLVIWGHEHECKIAPTKNEQQLFYISQPGSSVVTSLSPGEAVKKHVGLLRIKGRKMNMHKIPLHTVRQFFMEDIVLANHPDIFNPDNPKVTQAIQSFCLEKIEEMLENAERERLGNSHQPEKPLVRLRVDYSGGFEPFSVLRFSQKFVDRVANPKDIIHFFRHREQKEKTGEE","Homo sapiens","HNGS1, MRE11, MRE11A","Double-strand break repair protein MRE11A","1","3T1I"
"3T1K",,"X-RAY DIFFRACTION",2.61,52.87,,,,,,,"3T1K",52.37,"1.5","1.5","HSP90 N-terminal domain bound to ANP","DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90A, HSP90AA1, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3T1K"
"3T1L",,"X-RAY DIFFRACTION",2.12,41.86,"VAPOR DIFFUSION, HANGING DROP",7,"31% PEG 6000, 100mM MGCl2, 8mM beta merceptoethanol, 100mM Tris HCL, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1111/j.1747-0285.2011.01283.x","MQT","3T1L",16.44,"1.6","1.6","Crystal structure of human Galectin-3 in complex with methyl 2-O-acetyl-3-O-toluoyl-beta-D-talopyranoside","GAPAGPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","3T1L"
"3T1M",,"X-RAY DIFFRACTION",2.15,42.77,"VAPOR DIFFUSION, HANGING DROP",7,"31% PEG 6000, 100mM MGCl2, 8mM beta merceptoethanol, 100mM Tris-HCL, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1111/j.1747-0285.2011.01283.x","DQT","3T1M",16.52,"1.55","1.55","Crystal structure of human galectin-3 carbohydrate recognition domain in complex with methyl 3-deoxy-2-O-toluoyl-3-N-toluoyl-beta-D-talopyranoside","GAPAGPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","Galectin-3","1","3T1M"
"3T1P",,"X-RAY DIFFRACTION",4.37,71.84,"VAPOR DIFFUSION, SITTING DROP",8.5,"18% (w/w) ethanol, 0.1M Tris-HCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/embor.2011.171",,"3T1P",41.84,"3.9","3.9","Crystal structure of an alpha-1-antitrypsin trimer","NKITPNLAEFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHSKKLSSWVLLMKYLGNATAIFFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLCITGTYDLKSVLGQLGITKVFSNGADLSGVTEEAPLKLSKAVHKAVLCIDEKGTEAAGAMFLEAIPRSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK","Homo sapiens","SERPINA1, AAT, PI, PRO0684, PRO2209","Alpha-1-antitrypsin","1","3T1P"
"3T1W",,"X-RAY DIFFRACTION",2.88,57.34,"VAPOR DIFFUSION, SITTING DROP",9,"26 %(w/v) PEG3350, 0.1 M Tris-HCl, 0.2 M NaCl, 5 %(v/v) Isopropanol, pH 9.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M111.303131",,"3T1W",40.97,"2.4","2.4","Structure of the four-domain fragment Fn7B89 of oncofetal fibronectin","MPLSPPTNLHLEANPDTGVLTVSWERSTTPDITGYRITTTPTNGQQGNSLEEVVHADQSSCTFDNLSPGLEYNVSVYTVKDDKESVPISDTIIPEVPQLTDLSFVDITDSSIGLRWTPLNSSTIIGYRITVVAAGEGIPIFEDFVDSSVGYYTVTGLEPGIDYDISVITLINGGESAPTTLTQQTAVPPPTDLRFTNIGPDTMRVTWAPPPSIDLTNFLVRYSPVKNEEDVAELSISPSDNAVVLTNLLPGTEYVVSVSSVYEQHESTPLRGRQKTGLDSPTGIDFSDITANSFTVHWIAPRATITGYRIRHHPEHFSGRPREDRVPHSRNSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSAHHHHHH","Homo sapiens","DKFZp686O12165, NP_997647, FN1, FN","four-domain fibronectin fragment","1","3T1W"
"3T2S",,"X-RAY DIFFRACTION",2.6,52.78,"VAPOR DIFFUSION, HANGING DROP",8.5,"20~25% PEG 4000,  200mM magnesium chloride, 100mM Tris pH 8.5, VAPOR DIFFUSION, HANGING DROP",,,,"3T2S",52.41,"1.501","1.501","HSP90 N-terminal domain bound to AGS","DQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90A, HSP90AA1, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3T2S"
"3T2T",,"X-RAY DIFFRACTION",2.45,49.8,"VAPOR DIFFUSION, HANGING DROP",6.2,"0.2M ammonium sulphate, 25% w/v polyethylene glycol 4000, 0.1M sodium acetate trihydrate, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1111/j.1747-0285.2011.01283.x","MQT","3T2T",30.27,"1.9","1.9","Crystal structure of human galectin-1 in complex with methyl 2-O-acetyl-3-O-toluoyl-beta-D-talopyranoside","MACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","1","3T2T"
"3T30",,"X-RAY DIFFRACTION",2.25,45.35,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% v/v PEG 3350, 100 mM NaCl, 25 mM Tris-HCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/bi2006652",,"3T30",123.94,"1.9","1.9","Human nucleoplasmin (Npm2): a histone chaperone in oocytes and early embryos","MVTTVLWGCELSQERRTWTFRPQLEGKQSCRLLLHTICLGEKAKEEMHRVEILPPANQEDKKMQPVTIASLQASVLPMVSMVGVQLSPPVTFQLRAGSGPVFLSGQERYE","Homo sapiens","NPM2","Nucleoplasmin-2","1","3T30"
"3T3J",,"X-RAY DIFFRACTION",1.9,35.1,"VAPOR DIFFUSION, HANGING DROP",7,"28% PEG2000 MME, 0.1 M Tris, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/bi200895k",,"3T3J",14.21,"1.7","1.7","1.70 A structure of Friedreich's ataxia frataxin variant N146K","GTLGHPGSLDETTYERLAEETLDSLAEFFEDLADKPYTFEDYDVSFGSGVLTVKLGGDLGTYVIKKQTPNKQIWLSSPSSGPKRYDWTGKNWVYSHDGVSLHELLAAELTKALKTKLDLSSLAYSGKDA","Homo sapiens","FXN, FRDA, X25","Frataxin, mitochondrial","1","3T3J"
"3T3K",,"X-RAY DIFFRACTION",2.34,47.46,"VAPOR DIFFUSION, HANGING DROP",5.5,"20% PEG3000, 0.1 M sodium citrate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/bi200895k",,"3T3K",14.22,"1.24","1.24","1.24 A Structure of Friedreich's ataxia frataxin variant Q148R","GTLGHPGSLDETTYERLAEETLDSLAEFFEDLADKPYTFEDYDVSFGSGVLTVKLGGDLGTYVINKRTPNKQIWLSSPSSGPKRYDWTGKNWVYSHDGVSLHELLAAELTKALKTKLDLSSLAYSGKDA","Homo sapiens","FXN, FRDA, X25","Frataxin, mitochondrial","1","3T3K"
"3T3L",,"X-RAY DIFFRACTION",2.27,45.71,"VAPOR DIFFUSION, HANGING DROP",5.6,"2.0 M ammonium sulfate, 0.1 M sodium citrate tribasic dihydrate, 0.2 M potassium sodium tartrate tetrahydrate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/bi200895k",,"3T3L",14.23,"1.15","1.15","1.15 A structure of human frataxin variant Q153A","GTLGHPGSLDETTYERLAEETLDSLAEFFEDLADKPYTFEDYDVSFGSGVLTVKLGGDLGTYVINKQTPNKAIWLSSPSSGPKRYDWTGKNWVYSHDGVSLHELLAAELTKALKTKLDLSSLAYSGKDA","Homo sapiens","FXN, FRDA, X25","Frataxin, mitochondrial","1","3T3L"
"3T3Q",,"X-RAY DIFFRACTION",2.69,54.31,"VAPOR DIFFUSION, HANGING DROP",8.5,"30% PEG 3350, 0.100 M Tris, pH 8.5, and 0.200 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1111/j.1742-4658.2011.08412.x","9PL","3T3Q",221.95,"2.1","2.1","Human Cytochrome P450 2A6 I208S/I300F/G301A/S369G in complex with Pilocarpine","MAKKTSSKGKLPPGPTPLPFIGNYLQLNTEQMYNSLMKISERYGPVFTIHLGPRRVVVLCGHDAVREALVDQAEEFSGRGEQATFDWVFKGYGVVFSNGERAKQLRRFSIATLRDFGVGKRGIEERIQEEAGFLIDALRGTGGANIDPTFFLSRTVSNVISSIVFGDRFDYKDKEFLSLLRMMLGSFQFTSTSTGQLYEMFSSVMKHLPGPQQQAFQLLQGLEDFIAKKVEHNQRTLDPNSPRDFIDSFLIRMQEEEKNPNTEFYLKNLVMTTLNLFFAGTETVSTTLRYGFLLLMKHPEVEAKVHEEIDRVIGKNRQPKFEDRAKMPYMEAVIHEIQRFGDVIPMGLARRVKKDTKFRDFFLPKGTEVYPMLGSVLRDPSFFSNPQDFNPQHFLNEKGQFKKSDAFVPFSIGKRNCFGEGLARMELFLFFTTVMQNFRLKSSQSPKDIDVSPKHVGFATIPRNYTMSFLPRHHHH","Homo sapiens","CYP2A3, CYP2A6, CYP2A6 I208S/I300F/G301A/S369G","Cytochrome P450 2A6","1","3T3Q"
"3T3R",,"X-RAY DIFFRACTION",2.65,53.62,"VAPOR DIFFUSION, HANGING DROP",8.5,"30% PEG 3350, 0.175 M Tris, pH 8.5, 0.20 M ammomium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1111/j.1742-4658.2011.08412.x","9PL","3T3R",221.99,"2.4","2.4","Human Cytochrome P450 2A6 in complex with Pilocarpine","MAKKTSSKGKLPPGPTPLPFIGNYLQLNTEQMYNSLMKISERYGPVFTIHLGPRRVVVLCGHDAVREALVDQAEEFSGRGEQATFDWVFKGYGVVFSNGERAKQLRRFSIATLRDFGVGKRGIEERIQEEAGFLIDALRGTGGANIDPTFFLSRTVSNVISSIVFGDRFDYKDKEFLSLLRMMLGIFQFTSTSTGQLYEMFSSVMKHLPGPQQQAFQLLQGLEDFIAKKVEHNQRTLDPNSPRDFIDSFLIRMQEEEKNPNTEFYLKNLVMTTLNLFIGGTETVSTTLRYGFLLLMKHPEVEAKVHEEIDRVIGKNRQPKFEDRAKMPYMEAVIHEIQRFGDVIPMSLARRVKKDTKFRDFFLPKGTEVYPMLGSVLRDPSFFSNPQDFNPQHFLNEKGQFKKSDAFVPFSIGKRNCFGEGLARMELFLFFTTVMQNFRLKSSQSPKDIDVSPKHVGFATIPRNYTMSFLPRHHHH","Homo sapiens","CYP2A3, CYP2A6","Cytochrome P450 2A6","1","3T3R"
"3T3S",,"X-RAY DIFFRACTION",2.89,57.49,,8.5,"30% PEG 3350, 0.175 M Tris, pH 8.5, and 0.2 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1111/j.1742-4658.2011.08412.x","9PL","3T3S",444.62,"3","3","Human Cytochrome P450 2A13 in complex with Pilocarpine","MAKKTSSKGKLPPGPTPLPFIGNYLQLNTEQMYNSLMKISERYGPVFTIHLGPRRVVVLCGHDAVKEALVDQAEEFSGRGEQATFDWLFKGYGVAFSNGERAKQLRRFSIATLRGFGVGKRGIEERIQEEAGFLIDALRGTHGANIDPTFFLSRTVSNVISSIVFGDRFDYEDKEFLSLLRMMLGSFQFTATSTGQLYEMFSSVMKHLPGPQQQAFKELQGLEDFIAKKVEHNQRTLDPNSPRDFIDSFLIRMQEEEKNPNTEFYLKNLVMTTLNLFFAGTETVSTTLRYGFLLLMKHPEVEAKVHEEIDRVIGKNRQPKFEDRAKMPYTEAVIHEIQRFGDMLPMGLAHRVNKDTKFRDFFLPKGTEVFPMLGSVLRDPRFFSNPRDFNPQHFLDKKGQFKKSDAFVPFSIGKRYCFGEGLARMELFLFFTTIMQNFRFKSPQSPKDIDVSPKHVGFATIPRNYTMSFLPRHHHH","Homo sapiens","CYP2A13","Cytochrome P450 2A13","1","3T3S"
"3T3T",,"X-RAY DIFFRACTION",2.53,51.37,"VAPOR DIFFUSION, HANGING DROP",5.5,"2.0 M ammonium sulfate, 0.1 M citrate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/bi200895k",,"3T3T",56.88,"1.38","1.38","1.38 A structure of human frataxin variant Q148G","GTLGHPGSLDETTYERLAEETLDSLAEFFEDLADKPYTFEDYDVSFGSGVLTVKLGGDLGTYVINKGTPNKQIWLSSPSSGPKRYDWTGKNWVYSHDGVSLHELLAAELTKALKTKLDLSSLAYSGKDA","Homo sapiens","FXN, FRDA, X25","Frataxin, mitochondrial","1","3T3T"
"3T3X",,"X-RAY DIFFRACTION",2.25,45.3,"VAPOR DIFFUSION, HANGING DROP",5.5,"1.9 M ammonium sulfate, 0.1 M sodium citrate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/bi200895k",,"3T3X",28.48,"1.57","1.57","1.57 A structure of Friedreich's ataxia frataxin variant R165C","GTLGHPGSLDETTYERLAEETLDSLAEFFEDLADKPYTFEDYDVSFGSGVLTVKLGGDLGTYVINKQTPNKQIWLSSPSSGPKCYDWTGKNWVYSHDGVSLHELLAAELTKALKTKLDLSSLAYSGKDA","Homo sapiens","FXN, FRDA, X25","Frataxin, mitochondrial","1","3T3X"
"3T3Z",,"X-RAY DIFFRACTION",2.98,58.76,,7.5,"8% PEG MME 2000, 12% isopropanol, and 0.1 M NaHEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1111/j.1742-4658.2011.08412.x","9PL","3T3Z",224.9,"2.35","2.35","Human Cytochrome P450 2E1 in complex with pilocarpine","MAKKTSSKGKLPPGPFPLPIIGNLFQLELKNIPKSFTRLAQRFGPVFTLYVGSQRMVVMHGYKAVKEALLDYKDEFSGRGDLPAFHAHRDRGIIFNNGPTWKDIRRFSLTTLRNYGMGKQGNESRIQREAHFLLEALRKTQGQPFDPTFLIGCAPCNVIADILFRKHFDYNDEKFLRLMYLFNENFHLLSTPWLQLYNNFPSFLHYLPGSHRKVIKNVAEVKEYVSERVKEHHQSLDPNCPRDLTDCLLVEMEKEKHSAERLYTMDGITVTVADLFFAGTETTSTTLRYGLLILMKYPEIEEKLHEEIDRVIGPSRIPAIKDRQEMPYMDAVVHEIQRFITLVPSNLPHEATRDTIFRGYLIPKGTVVVPTLDSVLYDNQEFPDPEKFKPEHFLNENGKFKYSDYFKPFSTGKRVCAGEGLARMELFLLLCAILQHFNLKPLVDPKDIDLSPIHIGFGCIPPRYKLCVIPRSHHHH","Homo sapiens","CYP2E, CYP2E1","Cytochrome P450 2E1","1","3T3Z"
"3T42",,"X-RAY DIFFRACTION",2.18,43.49,,4.2,"The hanging drop method was used to obtain crystals (EasyXtal Tool 24 culture plates, Qiagen).  WT hALR2 was co-crystallized with the oxidized form of coenzyme NADP+ (Sigma) and inhibitor 2 at room temperature (ratios of protein / inhibitor / coenzyme = 1/2/2).  Hanging drops were made by the mixing mother liquor (0.06 M citric acid, 0.04 M Bis-tris propane, 12% (w/v) PEG 3350, pH 4.2) with holoenzyme solution (10 mg/mL, 20 mM hepes, pH 7.0).  Crystals were observed after three days of equilibration, EVAPORATION, temperature 298K",298,"10.1021/bi200930f","3T4","3T42",37.51,"1.28","1.28","Human aldose reductase in complex with a nitrile-containing IDD inhibitor","GSHMASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","3T42"
"3T54",,"X-RAY DIFFRACTION",2.71,54.55,"VAPOR DIFFUSION, HANGING DROP",7,"12% (w/v) PEG 3350, 20 mM MgCl2, 0.1 M HEPES, 1 mM ATP, 2 mM CdCl2, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nchembio.733",,"3T54",39.15,"1.9","1.9","Crystal structure of the catalytic domain of human diphosphoinositol pentakisphosphate kinase 2 (PPIP5K2) in complex with ATP and Cadmium","GSFTDSPPERQIVVGICSMAKKSKSKPMKEILERISLFKYITVVVFEEEVILNEPVENWPLCDCLISFHSKGFPLDKAVAYAKLRNPFVINDLNMQYLIQDRREVYSILQAEGILLPRYAILNRDPNNPKECNLIEGEDHVEVNGEVFQKPFVEKPVSAEDHNVYIYYPTSAGGGSQRLFRKIGSRSSVYSPESNVRKTGSYIYEEFMPTDGTDVKVYTVGPDYAHAEARKSPALDGKVERDSEGKEVRYPVILNAREKLIAWKVCLAFKQTVCGFDLLRANGQSYVCDVNGFSFVKNSMKYYDDCAKILGNIVMRELAPQFHIPWSIPLEAED","Homo sapiens","PPIP5K2, HISPPD1, KIAA0433, VIP2","Inositol Pyrophosphate Kinase","1","3T54"
"3T5D",,"X-RAY DIFFRACTION",3.29,62.6,"VAPOR DIFFUSION, HANGING DROP",9.5,"0.2M sodium chlorid, 1.1M ammonium sulfate, 0.1M CHES, pH 9.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1515/BC.2011.082",,"3T5D",63.59,"3.3","3.3","Crystal structure of Septin 7 in complex with GDP","GPLGSGFEFTLMVVGESGLGKSTLINSLFLTDLYSPEYPGPSHRIKKTVQVEQSKVLIKEGGVQLLLTIVDTPGFGDAVDNSNCWQPVIDYIDSKFEDYLNAESRVNRRQMPDNRVQCCLYFIAPSGHGLKPLDIEFMKRLHEKVNIIPLIAKADTLTPEECQQFKKQIMKEIQEHKIKIYEFPETDDEEENKLVKKIKDRLPLAVVGSNTIIEVNGKRVRGRQYPWGVAEVENGEHCDFTILRNMLIRTHMQDLKDVTNNVHYENYRSRKLAA","Homo sapiens","SEPT7, CDC10, SEPTIN7","Septin-7","1","3T5D"
"3T5I",,"X-RAY DIFFRACTION",2.25,45.25,"VAPOR DIFFUSION, HANGING DROP",7.2,"0.1 MES 6.5 and 30 % PEG 5000 MME , pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nchembio.686",,"3T5I",73.05,"2.1","2.1","Structure of Fully modified farnesylated Rheb Peptide in complex with PDE6D","GSMSAKDERAREILRGFKLNWMNLRDAETGKILWQGTEDLSVPGVEHEARVPKKILKCKAVSRELNFSSTEQMEKFRLEQKVYFKGQCLEEWFFEFGFVIPNSTNTWQSLIEAAPESQMMPASVLTGNVIIETKFFDDDLLVSTSRVRLFYV","Homo sapiens","PDE6D, PDED","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta","1","3T5I"
,,,,,,,,,,,,,,,,"CSQQGKSSC",,,"C-terminal Farnesylated Rheb peptide CSQQGKSS(CMT)","2","3T5I"
"3T5O",,"X-RAY DIFFRACTION",3.9,68.49,,5.8,"5 mM MES, 89 mM Sodium Chloride, 0.01 mM Cadmium Chloride, pH 5.8, EVAPORATION, temperature 284K",284,"10.1074/jbc.M111.327809",,"3T5O",104.29,"2.869","2.869","Crystal Structure of human Complement Component C6","CFCDHYAWTQWTSCSKTCNSGTQSRHRQIVVDKYYQENFCEQICSKQETRECNWQRCPINCLLGDFGPWSDCDPCIEKQSKVRSVLRPSQFGGQPCTAPLVAFQPCIPSKLCKIEEADCKNKFRCDSGRCIARKLECNGENDCGDNSDERDCGRTKAVCTRKYNPIPSVQLMGNGFHFLAGEPRGEVLDNSFTGGICKTVKSSRTSNPYRVPANLENVGFEVQTAEDDLKTDFYKDLTSLGHNENQQGSFSSQGGSSFSVPIFYSSKRSENINHNSAFKQAIQASHKKDSSFIRIHKVMKVLNFTTKAKDLHLSDVFLKALNHLPLEYNSALYSRIFDDFGTHYFTSGSLGGVYDLLYQFSSEELKNSGLTEEEAKHCVRIETKKRVLFAKKTKVEHRCTTNKLSEKHEGSFIQGAEKSISLIRGGRSEYGAALAWEKGSSGLEEKTFSEWLESVKENPAVIDFELAPIVDLVRNIPCAVTKRNNLRKALQEYAAKFDPCQCAPCPNNGRPTLSGTECLCVCQSGTYGENCEKQSPDYKSNAVDGQWGCWSSWSTCDATYKRSRTRECNNPAPQRGGKRCEGEKRQEEDCTFSIMENNGQPCINDDEEMKEVDLPEIEADSGCPQPVPPENGFIRNEKQLYLVGEDVEISCLTGFETVGYQYFRCLPDGTWRQGDVECQRTECIKPVVQEVLTITPFQRLYRIGESIELTCPKGFVVAGPSRYTCQGNSWTPPISNSLTCEKDTLTKLKGHCQLGQKQSGSECICMSPEEDCSHHSEDLCVFDTDSNDYFTSPACKFLAEKCLNNQQLHFLHIGSCQDGRQLEWGLERTRLSSNSTKKESCGYDTCYDWEKCSASTSKCVCLLPPQCFKGGNQLYCVKMGSSTSEKTLNICEVGTIRCANRKMEILHPGKCLA","Homo sapiens","C6","Complement component C6","1","3T5O"
"3T5U",,"X-RAY DIFFRACTION",2.1,41.47,"VAPOR DIFFUSION, HANGING DROP",8.5,"2.6 M ammonium sulfate, 0.3 M sodium chloride, 0.1 M Tris-HCl, pH 8.5, 5 mM 4-hydroxymercurybenzoate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1039/c1cc14575d","A09","3T5U",30.33,"1.75","1.75","Crystal structure of the human carbonic anhydrase II in complex with N-hydroxy benzenesulfonamide","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3T5U"
"3T5W",,"X-RAY DIFFRACTION",2.75,55.29,"VAPOR DIFFUSION, HANGING DROP",6,"15% PEG 3350, 300mM (NH4)2SO4, pH6.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1042/BSR20120029",,"3T5W",193.54,"1.8","1.8","2ME modified human SOD1","ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","3T5W"
"3T5Z",,"X-RAY DIFFRACTION",2.08,40.78,"VAPOR DIFFUSION, HANGING DROP",8.5,"2.6 M ammonium sulfate, 0.3 M sodium chloride, 0.1 M Tris-HCl, pH 8.5, 5 mM 4-hydroxymercurybenzoate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1039/c1cc14575d","B09","3T5Z",29.73,"1.65","1.65","Crystal structure of the human carbonic anhydrase II in complex with N-methoxy-benzenesulfonamide","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3T5Z"
"3T6A",,"X-RAY DIFFRACTION",2.47,50.11,"VAPOR DIFFUSION, SITTING DROP",6.4,"15-20 % PEG3350, 0.04 M citric acid and 0.06 M Bis-Tris propane (pH 6.4), VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1038/nsmb.2152",,"3T6A",152.89,"2.4","2.4","Structure of the C-terminal domain of BCAR3","MGEFVTPLLETVSSFRPNEFESKFLPPENKPLETALLKRAKELFTNNDPKVIAQHVLSMDCRVARILGVSEEMRRNMGVSSGLELITLPHGHQLRLDIIERHNTMAIGIAVDILGCTGTLEDRAATLSKIIQVAVELKDSMGDLYSFSALMKALEMPQITRLEKTWTALRHQYTQTAILYEKQLKPFSKLLHEGRESTCVPPNNVSVPLLMPLVTLMERQAVTFEGTDMWEKNDQSCEIMLNHLATARFMAEAADSYRMNAERILAGFQPDEEMNEICKTEFQMRLLWGSKGAQVNQTERYEKFNQILTALSRKLEPPPVKQAELLEHHHHHH","Homo sapiens","BCAR3, NSP2, SH2D3B, UNQ271/PRO308","Breast cancer anti-estrogen resistance protein 3","1","3T6A"
"3T6P",,"X-RAY DIFFRACTION",2.2,44.06,"VAPOR DIFFUSION, SITTING DROP",8,"200 mM lithium chloride, 100 mM Tris pH 8, 20% PEG 6000, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1126/science.1207862",,"3T6P",39.47,"1.897","1.897","IAP antagonist-induced conformational change in cIAP1 promotes E3 ligase activation via dimerization","GSMQTHAARMRTFMYWPSSVPVQPEQLASAGFYYVGRNDDVKCFSCDGGLRCWESGDDPWVEHAKWFPRCEFLIRMKGQEFVDEIQGRYPHLLEQLLSTPPIIHYGPGESSSEDAVMMNTPVVKSALEMGFNRDLVKQTVQSKILTTGENYKTVNDIVSALLNAEDEKREEEKEKQAEEMASDDLSLIRKNRMALFQQLTCVLPILDNLLKANVINKQEHDIIKQKTQIPLQARELIDTILVKGNAAANIFKNSLKEIDSTLYKNLFVDKNMKYIPTEDVSGLSLEEQLRRLQEERTCKVCMDKEVSVVFIPCGHLVVCQECAPSLRKCPICRGIIKGTVRTFLS","Homo sapiens","API1, BIRC2, IAP2, MIHB, RNF48","Baculoviral IAP repeat-containing protein 2","1","3T6P"
"3T7A",,"X-RAY DIFFRACTION",2.71,54.69,"VAPOR DIFFUSION, HANGING DROP",7,"12% (w/v) PEG 3350, 20 mM MgCl2, 0.1 M HEPES, 1 mM ATP, 2 mM CdCl2
Soaking under pH5.2 overnight 
, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nchembio.733",,"3T7A",38.56,"1.7","1.7","Crystal structure of the catalytic domain of human diphosphoinositol pentakisphosphate kinase 2 (PPIP5K2) in complex with ADP at pH 5.2","GSFTERQIVVGICSMAKKSKSKPMKEILERISLFKYITVVVFEEEVILNEPVENWPLCDCLISFHSKGFPLDKAVAYAKLRNPFVINDLNMQYLIQDRREVYSILQAEGILLPRYAILNRDPNNPKECNLIEGEDHVEVNGEVFQKPFVEKPVSAEDHNVYIYYPTSAGGGSQRLFRKIGSRSSVYSPESNVRKTGSYIYEEFMPTDGTDVKVYTVGPDYAHAEARKSPALDGKVERDSEGKEVRYPVILNAREKLIAWKVCLAFKQTVCGFDLLRANGQSYVCDVNGFSFVKNSMKYYDDCAKILGNIVMRELAPQFHIPWSIPLEAED","Homo sapiens","PPIP5K2, HISPPD1, KIAA0433, VIP2","Inositol Pyrophosphate Kinase","1","3T7A"
"3T7L",,"X-RAY DIFFRACTION",1.73,28.9,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 3350, 0.2 M NaNO3, 10% Ethylene glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,,,"3T7L",10.44,"1.09","1.09","Crystal structure of the FYVE domain of endofin (ZFYVE16) at 1.1A resolution","SMEGLVLGQKQPTWVPDSEAPNCMNCQVKFTFTKRRHHCRACGKVFCGVCCNRKCKLQYLEKEARVCVVCYETISKAQAFERMMSPTGSN","Homo sapiens","KIAA0305, ZFYVE16","Zinc finger FYVE domain-containing protein 16","1","3T7L"
"3T7M",,"X-RAY DIFFRACTION",2.5,50.76,"VAPOR DIFFUSION, SITTING DROP",6.5,"2.0M Ammonium Sulphate, 0.1 M Bis-Tris, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1073/pnas.1113921108",,"3T7M",61.57,"1.8","1.8","Crystal Structure of Human Glycogenin-1 (GYG1) complexed with manganese and UDP, in a triclinic closed form","SMTDQAFVTLTTNDAYAKGALVLGSSLKQHRTTRRLVVLATPQVSDSMRKVLETVFDEVIMVDVLDSGDSAHLTLMKRPELGVTLTKLHCWSLTQYSKCVFMDADTLVLANIDDLFDREELSAAPDPGWPDCFNSGVFVYQPSVETYNQLLHLASEQGSFDGGDQGILNTFFSSWATTDIRKHLPFIYNLSSISIYSYLPAFKVFGASAKVVHFLGRVKPWNYTYDPKTKSVKSEAHDPNMTHPEFLILWWNIFTTNVLPLLQ","Homo sapiens","GYG, GYG1","Glycogenin-1","1","3T7M"
"3T7N",,"X-RAY DIFFRACTION",2.2,44.03,"VAPOR DIFFUSION, SITTING DROP",8.5,"20% PEG 3350, 0.2M MgCl2, 0.1M Tris, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1073/pnas.1113921108",,"3T7N",60.14,"1.98","1.98","Crystal Structure of Human Glycogenin-1 (GYG1) complexed with manganese and UDP, in a monoclinic closed form","SMTDQAFVTLTTNDAYAKGALVLGSSLKQHRTTRRLVVLATPQVSDSMRKVLETVFDEVIMVDVLDSGDSAHLTLMKRPELGVTLTKLHCWSLTQYSKCVFMDADTLVLANIDDLFDREELSAAPDPGWPDCFNSGVFVYQPSVETYNQLLHLASEQGSFDGGDQGILNTFFSSWATTDIRKHLPFIYNLSSISIYSYLPAFKVFGASAKVVHFLGRVKPWNYTYDPKTKSVKSEAHDPNMTHPEFLILWWNIFTTNVLPLLQ","Homo sapiens","GYG, GYG1","Glycogenin-1","1","3T7N"
"3T7O",,"X-RAY DIFFRACTION",2.43,49.44,"VAPOR DIFFUSION, SITTING DROP",6.5,"2.0M Ammonium Sulphate, 0.1M Bis-Tris, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1073/pnas.1113921108",,"3T7O",61.83,"1.85","1.85","Crystal Structure of Human Glycogenin-1 (GYG1) complexed with manganese, UDP-Glucose and glucose","SMTDQAFVTLTTNDAYAKGALVLGSSLKQHRTTRRLVVLATPQVSDSMRKVLETVFDEVIMVDVLDSGDSAHLTLMKRPELGVTLTKLHCWSLTQYSKCVFMDADTLVLANIDDLFDREELSAAPDPGWPDCFNSGVFVYQPSVETYNQLLHLASEQGSFDGGDQGILNTFFSSWATTDIRKHLPFIYNLSSISIYSYLPAFKVFGASAKVVHFLGRVKPWNYTYDPKTKSVKSEAHDPNMTHPEFLILWWNIFTTNVLPLLQ","Homo sapiens","GYG, GYG1","Glycogenin-1","1","3T7O"
"3T7U",,"X-RAY DIFFRACTION",2.34,47.55,"VAPOR DIFFUSION, HANGING DROP",,"1.02M Sodium phosphate monobasic monohydrate, 0.18M Potassium phosphate dibasic, vapor diffusion, hanging drop, temperature 287K",287,"10.1016/j.bbrc.2011.08.044",,"3T7U",84.29,"2.9","2.9","A NeW Crystal structure of APC-ARM","MGHHHHHHMLHLLEQIRAYCETCWEWQEAHEPGMDQDKNPMPAPVEHQICPAVCVLMKLSFDEEHRHAMNELGGLQAIAELLQVDCEMYGLTNDHYSITLRRYAGMALTNLTFGDVANKATLCSMKGCMRALVAQLKSESEDLQQVIASVLRNLSWRADVNSKKTLREVGSVKALMECALEVKKESTLKSVLSALWNLSAHCTENKADICAVDGALAFLVGTLTYRSQTNTLAIIESGGGILRNVSSLIATNEDHRQILRENNCLQTLLQHLKSHSLTIVSNACGTLWNLSARNPKDQEALWDMGAVSMLKNLIHSKHKMIAMGSAAALRNLMANRPAKYKDANIMSPGSSLPSLHVRKQKALEAELDAQHLSETFDN","Homo sapiens","APC, DP2.5","Adenomatous polyposis coli protein","1","3T7U"
"3T82",,"X-RAY DIFFRACTION",2.1,41.35,"VAPOR DIFFUSION, HANGING DROP",9.5,"2.9M (NH4)2SO4, 0.1M Glycine, pH 9.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1021/ja207855c","SG4","3T82",29.7,"2.002","2.002","Human Carbonic Anhydrase II in complex with Acetylated Carbohydrate Sulfamates","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3T82"
"3T83",,"X-RAY DIFFRACTION",2.11,41.65,"VAPOR DIFFUSION, HANGING DROP",7.5,"2.9M (NH4)2SO4, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1021/ja207855c","SG5, MG5","3T83",30.21,"1.8","1.8","Human Carbonic Anhydrase II in complex with Acetylated Carbohydrate Sulfamates","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3T83"
"3T84",,"X-RAY DIFFRACTION",2.09,41.25,"VAPOR DIFFUSION, HANGING DROP",9.5,"2.9M (NH4)2SO4, 0.1M Glycine, pH 9.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1021/ja207855c","SG6","3T84",29.66,"2","2","Human Carbonic Anhydrase II in complex with Acetylated Carbohydrate Sulfamates","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3T84"
"3T85",,"X-RAY DIFFRACTION",2.1,41.3,"VAPOR DIFFUSION, HANGING DROP",9.5,"2.9M (NH4)2SO4, 0.1M Glycine, pH 9.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1021/ja207855c","SG7","3T85",29.7,"2.4","2.4","Human Carbonic Anhydrase II in complex with Acetylated Carbohydrate Sulfamates","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3T85"
"3T8M",,"X-RAY DIFFRACTION",2.32,47.02,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG 3350, 0.2M NH4SO4, 0.1M Tris-HCl 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,,,"3T8M",111.28,"2.5","2.5","Rational Design of PI3K-alpha Inhibitors that Exhibit Selectivity Over the PI3K-beta Isoform","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","3T8M"
"3T92",,"X-RAY DIFFRACTION",2.56,51.97,"Micro batch under oil",8.5,"200mM NaCl, 5mM TCEP and 20% isopropanol, pH 8.5, Micro batch under oil, temperature 277K",277,"10.1107/S1399004714009262",,"3T92",14.09,"1.5","1.5","Crystal structure of the Taz2:C/EBPepsilon-TAD chimera protein","ATQSPGDSRRLSIQRAIQSLVHAAQCRNANCSLPSCQKMKRVVQHTKGCKRKTNGGCPICKQLIALAAYHAKHCQENKCPVPFCLNIKQKLRQQQLEASIDLSAYIESGEEQLLSDLFAVK","Homo sapiens","EP300, P300","HISTONE ACETYLTRANSFERASE P300 TAZ2-CCAAT/ENHANCER-BINDING PROTEIN EPSILON","1","3T92"
,,,,,,,,,,,,,,,,,"Homo sapiens","EP300, P300"
"3T99",,"X-RAY DIFFRACTION",2.75,55.24,"VAPOR DIFFUSION, HANGING DROP",7,"12% (w/v) PEG 3350, 20 mM MgCl2, 0.1 M HEPES, 1 mM ATP, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nchembio.733",,"3T99",38.44,"2.1","2.1","Crystal structure of the catalytic domain of human diphosphoinositol pentakisphosphate kinase 2 (PPIP5K2) in complex with ADP and in the absence of cadmium at pH 7.0","GSFTDSPPERQIVVGICSMAKKSKSKPMKEILERISLFKYITVVVFEEEVILNEPVENWPLCDCLISFHSKGFPLDKAVAYAKLRNPFVINDLNMQYLIQDRREVYSILQAEGILLPRYAILNRDPNNPKECNLIEGEDHVEVNGEVFQKPFVEKPVSAEDHNVYIYYPTSAGGGSQRLFRKIGSRSSVYSPESNVRKTGSYIYEEFMPTDGTDVKVYTVGPDYAHAEARKSPALDGKVERDSEGKEVRYPVILNAREKLIAWKVCLAFKQTVCGFDLLRANGQSYVCDVNGFSFVKNSMKYYDDCAKILGNIVMRELAPQFHIPWSIPLEAED","Homo sapiens","PPIP5K2, HISPPD1, KIAA0433, VIP2","Inositol Pyrophosphate Kinase","1","3T99"
"3T9A",,"X-RAY DIFFRACTION",2.75,55.21,"VAPOR DIFFUSION, HANGING DROP",7,"12% (w/v) PEG 3350, 20 mM MgCl2, 0.1 M HEPES, 1 mM AMPPNP, 2 mM CdCl2, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nchembio.733",,"3T9A",38.4,"1.8","1.8","Crystal structure of the catalytic domain of human diphosphoinositol pentakisphosphate kinase 2 (PPIP5K2) in complex with AMPPNP at pH 7.0","GSFTERQIVVGICSMAKKSKSKPMKEILERISLFKYITVVVFEEEVILNEPVENWPLCDCLISFHSKGFPLDKAVAYAKLRNPFVINDLNMQYLIQDRREVYSILQAEGILLPRYAILNRDPNNPKECNLIEGEDHVEVNGEVFQKPFVEKPVSAEDHNVYIYYPTSAGGGSQRLFRKIGSRSSVYSPESNVRKTGSYIYEEFMPTDGTDVKVYTVGPDYAHAEARKSPALDGKVERDSEGKEVRYPVILNAREKLIAWKVCLAFKQTVCGFDLLRANGQSYVCDVNGFSFVKNSMKYYDDCAKILGNIVMRELAPQFHIPWSIPLEAED","Homo sapiens","PPIP5K2, HISPPD1, KIAA0433, VIP2","Inositol Pyrophosphate Kinase","1","3T9A"
"3T9B",,"X-RAY DIFFRACTION",2.69,54.35,"VAPOR DIFFUSION, HANGING DROP",,"12% (w/v) PEG 3350, 20 mM MgCl2, 0.1 M HEPES, pH 7.0, 1 mM AMPPNP, 2 mM CdCl2, Soaking under pH 5.2 for 2 days, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nchembio.733",,"3T9B",38.15,"1.85","1.85","Crystal structure of the catalytic domain of human diphosphoinositol pentakisphosphate kinase 2 (PPIP5K2) in complex with AMPPNP at pH 5.2","GSFTERQIVVGICSMAKKSKSKPMKEILERISLFKYITVVVFEEEVILNEPVENWPLCDCLISFHSKGFPLDKAVAYAKLRNPFVINDLNMQYLIQDRREVYSILQAEGILLPRYAILNRDPNNPKECNLIEGEDHVEVNGEVFQKPFVEKPVSAEDHNVYIYYPTSAGGGSQRLFRKIGSRSSVYSPESNVRKTGSYIYEEFMPTDGTDVKVYTVGPDYAHAEARKSPALDGKVERDSEGKEVRYPVILNAREKLIAWKVCLAFKQTVCGFDLLRANGQSYVCDVNGFSFVKNSMKYYDDCAKILGNIVMRELAPQFHIPWSIPLEAED","Homo sapiens","PPIP5K2, HISPPD1, KIAA0433, VIP2","Inositol Pyrophosphate Kinase","1","3T9B"
"3T9C",,"X-RAY DIFFRACTION",2.71,54.55,"VAPOR DIFFUSION, HANGING DROP",,"12% (w/v) PEG 3350, 20 mM MgCl2, 0.1 M HEPES, pH 7.0, 1 mM AMPPNP, 2 mM CdCl2, Soaking with 10mM IP6 and 10 mM NaF under pH 5.2 for 3 days, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nchembio.733",,"3T9C",38.83,"1.9","1.9","Crystal structure of the catalytic domain of human diphosphoinositol pentakisphosphate kinase 2 (PPIP5K2) in complex with AMPPNP and inositol hexakisphosphate (IP6)","GSFTERQIVVGICSMAKKSKSKPMKEILERISLFKYITVVVFEEEVILNEPVENWPLCDCLISFHSKGFPLDKAVAYAKLRNPFVINDLNMQYLIQDRREVYSILQAEGILLPRYAILNRDPNNPKECNLIEGEDHVEVNGEVFQKPFVEKPVSAEDHNVYIYYPTSAGGGSQRLFRKIGSRSSVYSPESNVRKTGSYIYEEFMPTDGTDVKVYTVGPDYAHAEARKSPALDGKVERDSEGKEVRYPVILNAREKLIAWKVCLAFKQTVCGFDLLRANGQSYVCDVNGFSFVKNSMKYYDDCAKILGNIVMRELAPQFHIPWSIPLEAED","Homo sapiens","PPIP5K2, HISPPD1, KIAA0433, VIP2","Inositol Pyrophosphate Kinase","1","3T9C"
"3T9D",,"X-RAY DIFFRACTION",2.72,54.78,"VAPOR DIFFUSION, HANGING DROP",,"12% (w/v) PEG 3350, 20 mM MgCl2, 0.1 M HEPES, pH 7.0, 1 mM AMPPNP, 2 mM CdCl2, Soaking with 5-IP7 under pH 5.2 for 2 days
, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nchembio.733",,"3T9D",38.94,"1.85","1.85","Crystal structure of the catalytic domain of human diphosphoinositol pentakisphosphate kinase 2 (PPIP5K2) in complex with AMPPNP and 5-(PP)-IP5 (5-IP7)","GSFTERQIVVGICSMAKKSKSKPMKEILERISLFKYITVVVFEEEVILNEPVENWPLCDCLISFHSKGFPLDKAVAYAKLRNPFVINDLNMQYLIQDRREVYSILQAEGILLPRYAILNRDPNNPKECNLIEGEDHVEVNGEVFQKPFVEKPVSAEDHNVYIYYPTSAGGGSQRLFRKIGSRSSVYSPESNVRKTGSYIYEEFMPTDGTDVKVYTVGPDYAHAEARKSPALDGKVERDSEGKEVRYPVILNAREKLIAWKVCLAFKQTVCGFDLLRANGQSYVCDVNGFSFVKNSMKYYDDCAKILGNIVMRELAPQFHIPWSIPLEAED","Homo sapiens","PPIP5K2, HISPPD1, KIAA0433, VIP2","Inositol Pyrophosphate Kinase","1","3T9D"
"3T9E",,"X-RAY DIFFRACTION",2.69,54.36,"VAPOR DIFFUSION, HANGING DROP",,"12% (w/v) PEG 3350, 20 mM MgCl2, 0.1 M HEPES, pH 7.0, 1 mM ATP, 2 mM CdCl2, Soaking with 2mM 5-IP7 and 10 mM NaF under pH 5.2 for 2 days
, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nchembio.733",,"3T9E",38.94,"1.9","1.9","Crystal structure of the catalytic domain of human diphosphoinositol pentakisphosphate kinase 2 (PPIP5K2) in complex with ADP, 5-(PP)-IP5 (5-IP7) and MgF3 (transition state mimic)","GSFTERQIVVGICSMAKKSKSKPMKEILERISLFKYITVVVFEEEVILNEPVENWPLCDCLISFHSKGFPLDKAVAYAKLRNPFVINDLNMQYLIQDRREVYSILQAEGILLPRYAILNRDPNNPKECNLIEGEDHVEVNGEVFQKPFVEKPVSAEDHNVYIYYPTSAGGGSQRLFRKIGSRSSVYSPESNVRKTGSYIYEEFMPTDGTDVKVYTVGPDYAHAEARKSPALDGKVERDSEGKEVRYPVILNAREKLIAWKVCLAFKQTVCGFDLLRANGQSYVCDVNGFSFVKNSMKYYDDCAKILGNIVMRELAPQFHIPWSIPLEAED","Homo sapiens","PPIP5K2, HISPPD1, KIAA0433, VIP2","Inositol Pyrophosphate Kinase","1","3T9E"
"3T9F",,"X-RAY DIFFRACTION",2.7,54.51,"VAPOR DIFFUSION, HANGING DROP",,"12% (w/v) PEG 3350, 20 mM MgCl2, 0.1 M HEPES, pH 7.0, 1 mM ATP, 2 mM CdCl2, Soaking with 5-IP7 under pH 5.2 for 2 days
, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/nchembio.733",,"3T9F",39.05,"2","2","Crystal structure of the catalytic domain of human diphosphoinositol pentakisphosphate kinase 2 (PPIP5K2) in complex with ADP and 1,5-(PP)2-IP4 (1,5-IP8)","GSFTERQIVVGICSMAKKSKSKPMKEILERISLFKYITVVVFEEEVILNEPVENWPLCDCLISFHSKGFPLDKAVAYAKLRNPFVINDLNMQYLIQDRREVYSILQAEGILLPRYAILNRDPNNPKECNLIEGEDHVEVNGEVFQKPFVEKPVSAEDHNVYIYYPTSAGGGSQRLFRKIGSRSSVYSPESNVRKTGSYIYEEFMPTDGTDVKVYTVGPDYAHAEARKSPALDGKVERDSEGKEVRYPVILNAREKLIAWKVCLAFKQTVCGFDLLRANGQSYVCDVNGFSFVKNSMKYYDDCAKILGNIVMRELAPQFHIPWSIPLEAED","Homo sapiens","PPIP5K2, HISPPD1, KIAA0433, VIP2","Inositol Pyrophosphate Kinase","1","3T9F"
"3T9I",,"X-RAY DIFFRACTION",2.85,56.87,,5.5,"RESERVOIR SOLUTION - 0.7M (NH4)2HPO4, 0.3M NACL, 0.1M NACITRATE, PH 5.5, PROTEIN SOLUTION - 7.5MG/ML IN 20MM HEPES, 100MM NACL, 5MM DTT, PH 8, compound was soaked in, temperature 298.0K",298,"10.1016/j.bmcl.2011.08.105",,"3T9I",37.91,"2.6","2.6","Pim1 complexed with a novel 3,6-disubstituted indole at 2.6 Ang Resolution","MAHHHHHHLEVLFQGPLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase pim-1","1","3T9I"
"3T9L",,"X-RAY DIFFRACTION",3.61,65.93,"VAPOR DIFFUSION",5.5,"2M ammonium sulphate, 100 mM Bis-Tris-Cl, pH 5.5, vapor diffusion, temperature 298K",298,"10.1021/bi200726e",,"3T9L",26.94,"1.5","1.5","Structure of N-terminal DUSP-UBL domains of human USP15","MAEGGAADLDTQRSDIATLLKTSLRKGDTWYLVDSRWFKQWKKYVGFDSWDKYQMGDQNVYPGPIDNSGLLKDGDAQSLKEHLIDELDYILLPTEGWNKLVSWYTLMEGQEPIARKVVEQGMFVKHCKVEVYLTELKLCENGNMNNVVTRRFSKADTIDTIEKEIRKIFSIPDEKETRLWNKYMSNTFEPLNKPDSTIQDAGLYQGQVLVIEQKNEDGTWPRLEHHHHHH","Homo sapiens","KIAA0529, USP15, USP15 (1-222)","Ubiquitin carboxyl-terminal hydrolase 15","1","3T9L"
"3T9T",,"X-RAY DIFFRACTION",2.25,45.26,"VAPOR DIFFUSION, HANGING DROP",7.2,"14% PEG3350, 0.1 M magnesium acetate, 0.1 M HEPES, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2011.09.008","IAQ","3T9T",31.08,"1.65","1.65","Crystal structure of BTK mutant (F435T,K596R) complexed with Imidazo[1,5-a]quinoxaline","GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","3T9T"
"3TB3",,"X-RAY DIFFRACTION",2.23,44.77,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2M Calcium Acetate hydrate, 0.1M Sodium Cacodylate, 18% w/v PEG 8000, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1042/BJ20110699",,"3TB3",51.45,"2.3","2.3","Crystal structure of the UCH domain of UCH-L5 with 6 residues deleted","GSMTGNAGEWCLMESDPGVFTELIKGFGCRGAQVEEIWSLEPENFEKLKPVHGLIFLFKWQPGEEPAGSVVQDSRLDTIFFAKQVINNAAATQAIVSVLLNCTHQDVHLGETLSEFKEFSQSFDAAMKGLALSNSDVIRQVHNSFARQQMFEFDTKTSAKEEDAFHFVSYVPVNGRLYELDGLREGPIDLGACNQDDWISAVRPVIEKRIQKYSEGEIRFNLMAIVSDR","Homo sapiens","AD-019, CGI-70, UCH-L5, UCH37, UCHL5","Ubiquitin carboxyl-terminal hydrolase isozyme L5","1","3TB3"
"3TBD",,"X-RAY DIFFRACTION",2.81,56.29,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG 3350, 0.2M Calcium acetate, 0.1M Sodium cacodylate pH6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1016/j.jmb.2011.10.030",,"3TBD",40.13,"1.8","1.8","Crystal Structure of domain VI and LE1 of human Netrin-G2","DYDICKSWVTTDEGPTWEFYACQPKVMRLKDYVKVKVEPSGITCGDPPERFCSHENPYLCSNECDASNPDLAHPPRLMFDKEEEGLATYWQSITWSRYPSPLEANITLSWNKTVELTDDVVMTFEYGRPTVMVLEKSLDNGRTWQPYQFYAEDCMEAFGMSARRARDMSSSSAHRVLCTEEYSRWAGSKKEKHVRFEVRDRFAIFAGPDLRNMDNLYTRLESAKGLKEFFTLTDLRMRLLRPALGGTYVQRENLYKYFYAISNIEVIGRCKCNLHANLCSMREGSLQCECEHNTTGPDCGKCKKNFRTRSWRAGSYLPLPHGSPNACAAAGSHHHHHH","Homo sapiens","NTNG2, KIAA1857, LMNT2, UNQ9381/PRO34206","Netrin-G2","1","3TBD"
"3TBG",,"X-RAY DIFFRACTION",3.19,61.39,"VAPOR DIFFUSION, HANGING DROP",7,"PEG3350, sodium acetate, sodium cacodylate, potassium phosphate, sodium chloride, zinc chloride, glycerol, beta-mercaptoethanol, thioridazine, HEGA-10, facial amphiphile 231_CHOL, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M114.627661",,"3TBG",221.55,"2.1","2.1","Human cytochrome P450 2D6 with two thioridazines bound in active site","MAKKTSSKGKLPPGPLPLPGLGNLLHVDFQNTPYCFDQLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVFLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDKAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKVLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVADLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVIHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHFLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGVFAFLVSPSPYELCAVPRHHHH","Homo sapiens","CYP2D6, CYP2DL1","Cytochrome P450 2D6","1","3TBG"
"3TC5",,"X-RAY DIFFRACTION",2.9,57.57,"VAPOR DIFFUSION, SITTING DROP",7.5,"2.2M Ammonium sulphate, 0.1M HEPES buffer, 1% PEG 400,pH 7.5, vapor diffusion, sitting drop, temperature 277K, VAPOR DIFFUSION, SITTING DROP",277,"10.1021/cb2001796","3T5","3TC5",19.22,"1.4","1.4","Selective targeting of disease-relevant protein binding domains by O-phosphorylated natural product derivatives","GSHMADEEKLPPGWEKAMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","3TC5"
"3TCL",,"X-RAY DIFFRACTION",2.54,51.6,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG 8000, 3% MPD, 0.1M imidazole, , pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature10696",,"3TCL",98.48,"1.906","1.906","Crystal Structure of HIV-1 Neutralizing Antibody CH04","EVQLVESGGGLIRPGGSLRLSCKGSGFIFENFGFGWVRQGPGKGLEWVSGTNWNGGDSRYGDSVKGRFTISRDNSNNFVYLQMNSLRPEDTAIYYCARGTDYTIDDQGIRYQGSGTFWYFDVWGRGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCD","Homo sapiens",,"CH04 Heavy Chain Fab","1","3TCL"
,,,,,,,,,,,,,,,,"EIVLTQSPDTLSLSPGERATLSCRASQSVHSRYFAWYQHKPGQPPRLLIYGGSTRATGIPNRFSAGGSGTQFTLTVNRLEAEDFAVYYCQQYGRSPYTFGQGTKVEIRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"CH04 Light Chain Fab","2","3TCL"
"3TCP",,"X-RAY DIFFRACTION",2.18,43.68,,8.5,"Protein: 32.5 mg/mL in 20 mM Tris pH 8.0, 500mM sodium chloride, 2mM beta-mercaptoethanol; incubated with inhibitor (2.5 mM final concentration) overnight; Mixed 1:1 with crystallization solution (27-33% (v/v) Peg400, 200 mM magnesium chloride, 100 mM Tris pH 8.5), VAPOR DIFFUSION, SITTING DROP, temperature 288K",288,"10.1021/ml200239k","CKJ","3TCP",72.8,"2.69","2.69","Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC569","MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPDV","Homo sapiens","MERTK, MER","Tyrosine-protein kinase Mer","1","3TCP"
"3TCT",,"X-RAY DIFFRACTION",2.12,42,,5.5,"THE WT-TTR WAS CONCENTRATED TO 4 MG/ML IN 10 MM NAPI, 100 MM KCL, AT PH 7.6 AND CO-CRYSTALLIZED AT ROOM TEMPERATURE WITH INHIBITORS USING THE VAPOR-DIFFUSION SITTING DROP METHOD, CRYSTALS WERE GROWN FROM 1.395 M SODIUM CITRATE, 3.5% V/V GLYCEROL AT PH 5.5. THE CRYSTALS WERE FROZEN USING A CRYO-PROTECTANT SOLUTION OF 1.395 M SODIUM CITRATE, PH 5.5, CONTAINING 10% V/V GLYCEROL, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298.0K",,"10.1073/pnas.1121005109","3MI","3TCT",28.17,"1.3","1.3","Structure of wild-type TTR in complex with tafamidis","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","PALB, TTR","Transthyretin","1","3TCT"
"3TCZ",,"X-RAY DIFFRACTION",3.14,60.85,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.9-2.2 M ammonium sulfate, 1% PEG400 at pH 7.5 in 50 mM HEPES buffer, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/cb3000887",,"3TCZ",18.41,"2.1","2.1","Human Pin1 bound to cis peptidomimetic inhibitor","KLPPGWEKAMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","3TCZ"
"3TDA",,"X-RAY DIFFRACTION",3.17,61.14,"VAPOR DIFFUSION, HANGING DROP",7,"PEG3350, sodium acetate, sodium cacodylate, potassium phosphate, sodium chloride, zinc chloride, glycerol, beta-mercaptoethanol, prinomastat, thioridazine, HEGA-10, facial amphiphile 231_CHOL, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K, prinomastat was added after protein crystallization",298,"10.1074/jbc.M114.627661",,"3TDA",219.41,"2.67","2.67","Competitive replacement of thioridazine by prinomastat in crystals of cytochrome P450 2D6","MAKKTSSKGKLPPGPLPLPGLGNLLHVDFQNTPYCFDQLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVFLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDKAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKVLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVADLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVIHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHFLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGVFAFLVSPSPYELCAVPRHHHH","Homo sapiens","CYP2D6, CYP2DL1","Cytochrome P450 2D6","1","3TDA"
"3TDB",,"X-RAY DIFFRACTION",3.13,60.74,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.9-2.2 M ammonium sulfate, 1% PEG400 at pH 7.5 in 50 mM HEPES buffer, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/cb3000887",,"3TDB",18.53,"2.267","2.267","Human Pin1 bound to trans peptidomimetic inhibitor","KLPPGWEKAMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","3TDB"
"3TDC",,"X-RAY DIFFRACTION",2.88,57.23,"VAPOR DIFFUSION, SITTING DROP",6,"6.8% PEG MME 2000, 0.0175M Ammonium Sulfate, 0.1M MES , pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2011.08.117","0EU","3TDC",87.1,"2.41","2.41","Crystal Structure of Human Acetyl-CoA carboxylase 2","MLINTPYVTKDLLQAKRFQAQTLGTTYIYDFPEMFRQALFKLWGSPDKYPKDILTYTELVLDSQGQLVEMNRLPGGNEVGMVAFKMRFKTQEYPEGRDVIVIGNDITFRIGSFGPGEDLLYLRASEMARAEGIPKIYVAANSGARIGMAEEIKHMFHVAWVDPEDPHKGFKYLYLTPQDYTRISSLNSVHCKHIEEGGESRYMITDIIGKDDGLGVENLRGSGMIAGESSLAYEEIVTISLVTCRAIGIGAYLVRLGQRVIQVENSHIILTGASALNKVLGREVYTSNNQLGGVQIMHYNGVSHITVPDDFEGVYTILEWLSYMPKDNHSPVPIITPTDPIDREIEFLPSRAPYDPRWMLAGRPHPTLKGTWQSGFFDHGSFKEIMAPWAQTVVTGRARLGGIPVGVIAVETRTVEVAVPADPANLDSEAKIIQQAGQVWFPDSAYKTAQAIKDFNREKLPLMIFANWRGFSGGMKDMYDQVLKFGAYIVDGLRQYKQPILIYIPPYAELRGGSWVVIDATINPLCIEMYADKESRGGVLEPEGTVEIKFRKKDLIKSMRRIDPAYKKLMEQLGEPDLSDKDRKDLEGRLKAREDLLLPIYHQVAVQFADFHDTPGRMLEKGVISDILEWKTARTFLYWRLRRLLLEDQVKQEILQASGELSHVHIQSMLRRWFVETEGAVKAYLWDNNQVVVQWLEQHWQAGDGPRSTIRENITYLKHDSVLKTIRGLVEENPEVAVDCVIYLSQHISPAERAQVHHHHHH","Homo sapiens","ACACB, ACC2, ACCB","Acetyl-CoA carboxylase 2 variant","1","3TDC"
"3TDK",,"X-RAY DIFFRACTION",2.87,57.11,"vapr diffusion",6.5,"0.2M Ammonium sulfate, 21% PEG 8000, 0.1M Sodium cacodylate, pH 6.5, vapr diffusion, temperature 298K",298,"10.1371/journal.pone.0025226",,"3TDK",666.34,"2.8","2.8","Crystal Structure of Human UDP-Glucose Dehydrogenase","MFEIKKICCIGAGYVGGPTCSVIAHMCPEIRVTVVDVNESRINAWNSPTLPIYEPGLKEVVESCRGKNLFFSTNIDDAIKEADLVFISVNTPTKTYGMGKGRAADLKYIEACARRIVQNSNGYKIVTEKSTVPVRAAESIRRIFDANTKPNLNLQVLSNPEFLAEGTAIKDLKNPDRVLIGGDETPEGQRAVQALCAVYEHWVPREKILTTNTWSSELSKLAANAFLAQRISSINSISALCEATGADVEEVATAIGMDQRIGNKFLKASVGFGGSCFQKDVLNLVYLCEALNLPEVARYWQQVIDMNDYQRRRFASRIIDSLFNTVTDKKIAILGFAFKKDTGDTRESSSIYISKYLMDEGAHLHIYDPKVPREQIVVDLSHPGVSEDDQVSRLVTISKDPYEACDGAHAVVICTEWDMFKELDYERIHKKMLKPAFIFDGRRVLDGLHNELQTIGFQIETIGKKVSSKRIPYAPSGEIPKFSLQDP","Homo sapiens","UGDH","UDP-glucose 6-dehydrogenase","1","3TDK"
"3TDL",,"X-RAY DIFFRACTION",2.15,42.86,"VAPOR DIFFUSION, SITTING DROP",7.4,"28-32% (w/v) polyethylene glycol 3350, 50mM potassium phosphate (pH 7.5), VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/pro.749",,"3TDL",68.35,"2.6","2.6","Structure of human serum albumin in complex with DAUDA","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","3TDL"
"3TE3",,"X-RAY DIFFRACTION",2.87,57.2,,,,,"10.1016/j.bbapap.2011.12.002",,"3TE3",25.99,"2.694","2.694","Coiled-coil oligomerization domain of the polycystin transient receptor potential channel PKD2L1","GGWVSGEEFYMLTRRVLQLETVLEGVVSQIDAVGSKLKM","Homo sapiens","PKD2L1, PKD2L, PKDL, TRPP3","Polycystic kidney disease 2-like 1 protein","1","3TE3"
"3TE7",,"X-RAY DIFFRACTION",2.48,50.47,"VAPOR DIFFUSION, SITTING DROP",,"VAPOR DIFFUSION, SITTING DROP",,"10.1021/jm200416e","TE7","3TE7",53.74,"1.7","1.7","Quinone Oxidoreductase (NQ02) bound to the imidazoacridin-6-one 5a1","GKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFG","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","3TE7"
"3TEG",,"X-RAY DIFFRACTION",2.48,50.31,"VAPOR DIFFUSION, HANGING DROP",7,"2 mM DTT, 100 mM Bis-Tris Propane,1.8 M Na-acetate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1016/j.chembiol.2011.08.008",,"3TEG",48.7,"2.2044","2.2044","Bacterial and Eukaryotic Phenylalanyl-tRNA Synthetases Catalyze Misaminoacylation of tRNAPhe with 3,4-Dihydroxy-L-Phenylalanine (L-Dopa)","MAAECATQRAPGSVVELLGKSYPQDDHSNLTRKVLTRVGRNLHNQQHHPLWLIKERVKEHFYKQYVGRFGTPLFSVYDNLSPVVTTWQNFDSLLIPADHPSRKKGDNYYLNRTHMLRAHTSAHQWDLLHAGLDAFLVVGDVYRRDQIDSQHYPIFHQLEAVRLFSKHELFAGIKDGESLQLFEQSSRSAHKQETHTMEAVKLVEFDLKQTLTRLMAHLFGDELEIRWVDCYFPFTHPSFEMEINFHGEWLEVLGCGVMEQQLVNSAGAQDRIGWAFGLGLERLAMILYDIPDIRLFWCEDERFLKQFCVSNINQKVKFQPLSKYPAVINDISFWLPSENYAENDFYDLVRTIGGDLVEKVDLIDKFVHPKTHKTSHCYRITYRHMERTLSQREVRHIHQALQEAAVQLLGVEGRF","Homo sapiens","FARS1, FARS2, HSPC320","Phenylalanyl-tRNA synthetase, mitochondrial","1","3TEG"
"3TEM",,"X-RAY DIFFRACTION",2.46,49.94,,,,,"10.1021/jm200416e","6A1","3TEM",53.79,"1.45","1.45","Quinone Oxidoreductase (NQ02) bound to the imidazoacridin-6-one 6a1","GKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFG","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","3TEM"
"3TEQ",,"X-RAY DIFFRACTION",2.3,46.45,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M Bis-Tris pH 6.5, 10% PEG3350, 0.2M Ammonium dibasic phosphate, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.1118947109",,"3TEQ",47.33,"1.9","1.9","Crystal structure of SOAR domain","PEALQKWLQLTHEVEVQYYNIKKQNAEKQLMVAKEGAEKIKKKRNTLFGTFHVAHSSSLDDVDHKILTAKQALSEATAALRERLHRWQQIEILTGFQIVNN","Homo sapiens","STIM1, GOK","Stromal interaction molecule 1","1","3TEQ"
"3TF2",,"X-RAY DIFFRACTION",2.4,49.1,"VAPOR DIFFUSION",,"20% PEG-3350, 0.2 M diammonium citrate, vapor diffusion, temperature 289K",289,"10.1016/j.jmb.2011.12.002",,"3TF2",100.52,"2.1","2.1","Crystal structure of the cap free human translation initiation factor eIF4E","MATVEPETTPTPNPPTTEEEKTESNQEVANPEHYIKHPLQNRWALWFFKNDKSKTWQANLRLISKFDTVEDFWALYNHIQLSSNLMPGCDYSLFKDGIEPMWEDEKNKRGGRWLITLNKQQRRSDLDRFWLETLLCLIGESFDDYSDDVCGAVVNVRAKGDKIAIWTTECENREAVTHIGRVYKERLGLPPKIVIGYQSHADTATKSGSTTKNRFVV","Homo sapiens","EIF4E, EIF4EL1, EIF4F","Eukaryotic translation initiation factor 4E","1","3TF2"
"3TF3",,"X-RAY DIFFRACTION",2.39,48.62,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M HEPES, 30% (v/v) Jeffamine ED-2001, 0.014 M thymine, 0.0001 M manganese chloride. following xtal growth, metal-free HAI crystals are prepared by soaking a single crystal in 0.015 M dipicolinic acid, 0.015 M EDTA, 30% (v/v) Jeffamine ED-2001 for 1 week, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi201101t",,"3TF3",69.56,"1.64","1.64","Crystal structure of metal-free Human Arginase I","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","3TF3"
"3TF5",,"X-RAY DIFFRACTION",2.76,55.49,"VAPOR DIFFUSION, HANGING DROP",9.4,"0.1 mM piperine, 12% PEG3350, 2% DMSO, 125 mM magnesium acetate, 0.1 M sodium glycine, pH 9.4, yielded triangular plates within one week, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/bi201381e",,"3TF5",164.98,"2.3","2.3","Structure of UDP-glucose dehydrogenase V132 deletion","MFEIKKICCIGAGYVGGPTCSVIAHMCPEIRVTVVDVNESRINAWNSPTLPIYEPGLKEVVESCRGKNLFFSTNIDDAIKEADLVFISVNTPTKTYGMGKGRAADLKYIEACARRIVQNSNGYKIVTEKSTPVRAAESIRRIFDANTKPNLNLQVLSNPEFLAEGTAIKDLKNPDRVLIGGDETPEGQRAVQALCAVYEHWVPREKILTTNTWSSELSKLAANAFLAQRISSINSISALCEATGADVEEVATAIGMDQRIGNKFLKASVGFGGSCFQKDVLNLVYLCEALNLPEVARYWQQVIDMNDYQRRRFASRIIDSLFNTVTDKKIAILGFAFKKDTGDTRESSSIYISKYLMDEGAHLHIYDPKVPREQIVVDLSHPGVSEDDQVSRLVTISKDPYEACDGAHAVVICTEWDMFKELDYERIHKKMLKPAFIFDGRRVLDGLHNELQTIGFQIETIGKKVSSKRIPYAPSGEIPKFSLQDPPNKKPKV","Homo sapiens","NM_003359, UGDH","UDP-glucose 6-dehydrogenase","1","3TF5"
"3TF6",,"X-RAY DIFFRACTION",3.2,61.6,"VAPOR DIFFUSION, HANGING DROP",4.5,"1.0-1.5 M Ammonium sulfate, 0.2M Lithium sulfate, 50mM sodium chloride, 0.1M sodium acetate, pH 4.5, SSGCID PROTEIN TRACKING DATA: HosaA.18070.a.BE13.PC00083, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,"DBH","3TF6",63.59,"2.35","2.35","Crystal structure of Neutrophil gelatinase-associated lipocalin (C87S mutant) in complex with Europium and the siderophore analog tren(cam)(1,2-hopo)2","GQDSTSDLIPAPPLSKVPLQQNFQDNQFQGKWYVVGLAGNAILREDKDPQKMYATIYELKEDKSYNVTSVLFRKKKCDYWIRTFVPGSQPGEFTLGNIKSYPGLTSYLVRVVSTNYNQHAMVFFKKVSQNREYFKITLYGRTKELTSELKENFIRFSKSLGLPENHIVFPVPIDQCIDG","Homo sapiens","LCN2, HNL, NGAL","Neutrophil gelatinase-associated lipocalin","1","3TF6"
"3TFB",,"X-RAY DIFFRACTION",2.32,47.02,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES, 200 mM CaCl2 and 28% PEG400, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/bi201365r",,"3TFB",25.47,"2.033","2.033","Transthyretin natural mutant A25T","CPLMVKVLDAVRGSPTINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNP","Homo sapiens","PALB, TTR","Transthyretin","1","3TFB"
"3TFQ",,"X-RAY DIFFRACTION",2.34,47.5,"VAPOR DIFFUSION, HANGING DROP",7.3,"200 mM potassium formate, pH 7.3, 22% (W/V) PEG3350, 1.5 mM Zwittergent 3-12, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2011.09.058","07M","3TFQ",129.75,"1.8","1.8","Crystal structure of 11b-hsd1 double mutant (l262r, f278e) complexed with 8-{[(2-CYANOPYRIDIN-3-YL)METHYL]SULFANYL}-6-HYDROXY-3,4-DIHYDRO-1H-PYRANO[3,4-C]PYRIDINE-5-CARBONITRILE","GSHMASMTGGQQMGRGSNEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPMVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSRWTTLLIRNPCRKILEELYSTSYNMDRFINK","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","Corticosteroid 11-beta-dehydrogenase isozyme 1","1","3TFQ"
"3TFR",,"X-RAY DIFFRACTION",2.25,45.25,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM Imidazole, 350 mM Sodium Acetate, 18 % PEG3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1002/cbic.201100738",,"3TFR",48.44,"2","2","Ternary complex structure of DNA polymerase beta with a gapped DNA substrate and a, b dAMP(CF2)PP in the active site","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","3TFR"
,,,,,,,,,,,,,,,,"CCGACTGCGCATCAGC",,,"DNA (5'-D(*CP*CP*GP*AP*CP*TP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3')","2","3TFR"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"DNA (5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*C)-3')","3","3TFR"
,,,,,,,,,,,,,,,,"GTCGG",,,"DNA (5'-D(P*GP*TP*CP*GP*G)-3')","4","3TFR"
"3TFS",,"X-RAY DIFFRACTION",2.25,45.29,"VAPOR DIFFUSION, SITTING DROP",7.5,"50 mM Imidazole, 350 mM Sodium Acetate, 18 % PEG3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1002/cbic.201100738",,"3TFS",48.43,"2","2","Ternary complex structure of DNA polymerase beta with a gapped DNA substrate and a, b dAMP(CFH)PP in the active site: Stereoselective binding of (S) isomer","MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE","Homo sapiens","POLB","DNA polymerase beta","1","3TFS"
,,,,,,,,,,,,,,,,"CCGACTGCGCATCAGC",,,"DNA (5'-D(*CP*CP*GP*AP*CP*TP*GP*CP*GP*CP*AP*TP*CP*AP*GP*C)-3')","2","3TFS"
,,,,,,,,,,,,,,,,"GCTGATGCGC",,,"DNA (5'-D(*GP*CP*TP*GP*AP*TP*GP*CP*GP*C)-3')","3","3TFS"
,,,,,,,,,,,,,,,,"GTCGG",,,"DNA (5'-D(P*GP*TP*CP*GP*G)-3')","4","3TFS"
"3TFY",,"X-RAY DIFFRACTION",2.68,54.09,"VAPOR DIFFUSION, HANGING DROP",5,"well solution: 16% PEG 8000, 20% glycerol, 40mM potassium phosphate (monobasic), pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 273K",273,"10.1074/jbc.M111.282863",,"3TFY",63.77,"2.75","2.75","Naa50p amino-terminal acetyltransferase bound to substrate peptide fragment and CoA","MKGSRIELGDVTPHNIKQLKRLNQVIFPVSYNDKFYKDVLEVGELAKLAYFNDIAVGAVCCRVDHSQNQKRLYIMTLGCLAPYRRLGIGTKMLNHVLNICEKDGTFDNIYLHVQISNESAIDFYRKFGFEIIETKKNYYKRIEPADAHVLQKNLKVPSGQNADVQKTDN","Homo sapiens","MAK3, NAA50, NAT13, NAT5","N-alpha-acetyltransferase 50, NatE catalytic subunit","1","3TFY"
,,,,,,,,,,,,,,,,"MLGPEGGRWG",,,"hnRNP F","2","3TFY"
"3TG3",,"X-RAY DIFFRACTION",1.91,35.57,"VAPOR DIFFUSION",6,"100mM Bis-Tris, pH 6.0, 26% [w/v] polyethylene glycol 3350, 0.1M Ammonium Sulfate, VAPOR DIFFUSION, temperature 293K",293,"10.1126/scisignal.2002241",,"3TG3",64.08,"2.675","2.675","Crystal structure of the MAPK binding domain of MKP7","MIGTQIVTERLVALLESGTEKVLLIDSRPFVEYNTSHILEAININCSKLMKRRLQQDKVLITELIQHSAKHKVDIDCSQKVVVYDQSSQDVASLSSDCFLTVLLGKLEKSFNSVHLLAGGFAEFSRCFPGLCEGLEHHHHHH","Homo sapiens","DUSP16, KIAA1700, MKP7","Dual specificity protein phosphatase 16","1","3TG3"
"3TG4",,"X-RAY DIFFRACTION",2.53,51.31,"VAPOR DIFFUSION",8.5,"0.8M lithium chloride, 0.1M Tris-HCl (pH 8.5), 32% PEG 4000, VAPOR DIFFUSION, temperature 293K",293,"10.1074/jbc.M111.262410",,"3TG4",50.82,"2","2","Structure of SMYD2 in complex with SAM","MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH","Homo sapiens","SMYD2, KMT3C","N-lysine methyltransferase SMYD2","1","3TG4"
"3TGD",,"X-RAY DIFFRACTION",2.32,47.07,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.8M potassium phosphate, 0.8M sodium phosphate, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3TGD",17.16,"1.8","1.8","Crystal structure of the human ubiquitin-conjugating enzyme (E2) UbcH5b","GAMGSMALKRIHKELNDLARDPPAQCSAGPVGDDMFHWQATIMGPNDSPYQGGVFFLTIHFPTDYPFKPPKVAFTTRIYHPNINSNGSICLDILRSQWSPALTISKVLLSICSLLCDPNPDDPLVPEIARIYKTDREKYNRIAREWTQKYAM","Homo sapiens","UBC4, UBC5B, UBCH4, UBCH5B, UBE2D2, PUBC1","Ubiquitin-conjugating enzyme E2 D2","1","3TGD"
"3TGE",,"X-RAY DIFFRACTION",2.16,42.93,"EVAPORATION",8.5,"0.2M MgSO4, 0.1M Tris, 10-15% PEG3350, pH 8.5, EVAPORATION, temperature 298K",298,"10.1016/j.bmcl.2011.08.106","TGE","3TGE",38.17,"1.96","1.96","A novel series of potent and selective PDE5 inhibitor1","EEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHPGVSNQFLINTNSELALMYNDESVLEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHEKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAE","Homo sapiens","PDE5A, PDE5","cGMP-specific 3',5'-cyclic phosphodiesterase","1","3TGE"
,,,,,,,,,,,,,,,,,"Homo sapiens","PDE5A, PDE5"
,,,,,,,,,,,,,,,,,"Homo sapiens","PDE5A, PDE5"
"3TGF",,"SOLUTION NMR",,,,,,,"10.1111/j.1432-1033.1991.tb16050.x",,"3TGF",5.56,,,"THE SOLUTION STRUCTURE OF HUMAN TRANSFORMING GROWTH FACTOR ALPHA","VVSHFNDCPDSHTQFCFHGTCRFLVQEDKPACVCHSGYVGARCEHADLLA","Homo sapiens","TGFA","TRANSFORMING GROWTH FACTOR-ALPHA","1","3TGF"
"3TGG",,"X-RAY DIFFRACTION",2.08,40.83,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2M MgSO4, 10-15%PEG3350, Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2011.08.106","0H3","3TGG",38.14,"1.91","1.91","A novel series of potent and selective PDE5 inhibitor2","EEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHPGVSNQFLINTNSELALMYNDESVLEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHEKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAE","Homo sapiens","PDE5A, PDE5","cGMP-specific 3',5'-cyclic phosphodiesterase","1","3TGG"
"3TGM",,"X-RAY DIFFRACTION",2.12,41.97,"VAPOR DIFFUSION, SITTING DROP",7.5,"100 mM HEPES (pH 7.5), 2.2 M ammonium sulfate, 0.95% 1,6-hexanediol, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1371/journal.pone.0029514",,"3TGM",55.73,"2.85","2.85","X-Ray Crystal Structure of Human Heme Oxygenase-1 in Complex with 1-(1H-imidazol-1-yl)-4,4-diphenyl-2 butanone","MERPQPDSMPQDLSEALKEATKEVHTQAENAEFMRNFQKGQVTRDGFKLVMASLYHIYVALEEEIERNKESPVFAPVYFPEELHRKAALEQDLAFWYGPRWQEVIPYTPAMQRYVKRLHEVGRTEPELLVAHAYTRYLGDLSGGQVLKKIAQKALDLPSSGEGLAFFTFPNIASATKFKQLYRSRMNSLEMTPAVRQRVIEEAKTAFLLNIQLFEELQELLTHDTKDQSPSRA","Homo sapiens","HMOX1, HO, HO1","Heme oxygenase 1","1","3TGM"
"3TGP",,"X-RAY DIFFRACTION",1.98,37.91,"MICROBATCH",7.6,"Protein was crystallized from 28 % PEG 400, 10mM MgCl 264 mM TRIS/HCl, PH 7.6, pH 7.60, micro-batch, temperature 291.0K",291,"10.1073/pnas.1111325108",,"3TGP",19.42,"1.3075","1.3075","Room temperature H-ras","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","3TGP"
"3TGZ",,"X-RAY DIFFRACTION",2.28,46.02,"hanging drop",6.5,"0.1 M Bis-Tris, 20% (v/v) PEG 3350 monomethyl ether, 0.2 M sodium acetate, 2.5 mM DTT, pH 6.5, hanging drop, temperature 293K",293,,,"3TGZ",53.92,"2.3","2.3","Crystal Structure Analysis of W35F/H207W Mutant of Human CLIC1","MAEEQPQVELFVKAGSDGAKIGNCPFSQRLFMVLFLKGVTFNVTTVDTKRRTETVQKLCPGGQLPFLLYGTEVHTDTNKIEEFLEAVLCPPRYPKLAALNPESNTAGLDIFAKFSAYIKNSNPALNDNLEKGLLKALKVLDNYLTSPLPEEVDETSAEDEGVSQRKFLDGNELTLADCNLLPKLHIVQVVCKKYRGFTIPEAFRGVWRYLSNAYAREEFASTCPDDEEIELAYEQVAKALK","Homo sapiens","CLIC1, G6, NCC27","Chloride intracellular channel protein 1","1","3TGZ"
"3TH5",,"X-RAY DIFFRACTION",2.26,45.65,"VAPOR DIFFUSION, HANGING DROP",7.5,"22% PEG4000, 7% isopropanol, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1038/ng.2359",,"3TH5",46.56,"2.3","2.3","Crystal structure of wild-type RAC1","MGSSHHHHHHSSGLVPRGSHMENLYFQGQAIKCVVVGDGAVGKTCLLISYTTNAFPGEYIPTVFDNYSANVMVDGKPVNLGLWDTAGQEDYDRLRPLSYPQTDVFLICFSLVSPASFENVRAKWYPEVRHHCPNTPIILVGTKLDLRDDKDTIEKLKEKKLTPITYPQGLAMAKEIGAVKYLECSALTQRGLKTVFDEAIRAVL","Homo sapiens","RAC1, TC25, MIG5","Ras-related C3 botulinum toxin substrate 1","1","3TH5"
"3TH7",,"X-RAY DIFFRACTION",2.37,48,"VAPOR DIFFUSION, HANGING DROP",7,"Metal-free HAI crystals were soaked in 20 mM CoCl2, 100 mM HEPES, 30% (v/v) Jeffamine ED-2001 for 25 hours, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi201101t",,"3TH7",69.8,"2.1","2.1","Crystal structure of unliganded Co2+2-HAI (pH 7.0)","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","3TH7"
"3THB",,"X-RAY DIFFRACTION",2.73,54.91,,,,,"10.1021/jm2011172","3TA","3THB",38,"2.5","2.5","Structure of PLK1 kinase domain in complex with a benzolactam-derived inhibitor","APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVLNK","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","3THB"
"3THC",,"X-RAY DIFFRACTION",2.62,53.03,"VAPOR DIFFUSION, SITTING DROP",8,"20% (w/v) PEG3350 
0.2M ammonium sulfate, 100mM Tris HCl pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M111.293795",,"3THC",300.33,"1.8","1.8","Crystal structure of human beta-galactosidase in complex with galactose","LRNATQRMFEIDYSRDSFLKDGQPFRYISGSIHYSRVPRFYWKDRLLKMKMAGLNAIQTYVPWNFHEPWPGQYQFSEDHDVEYFLRLAHELGLLVILRPGPYICAEWEMGGLPAWLLEKESILLRSSDPDYLAAVDKWLGVLLPKMKPLLYQNGGPVITVQVENEYGSYFACDFDYLRFLQKRFRHHLGDDVVLFTTDGAHKTFLKCGALQGLYTTVDFGTGSNITDAFLSQRKCEPKGPLINSEFYTGWLDHWGQPHSTIKTEAVASSLYDILARGASVNLYMFIGGTNFAYWNGANSPYAAQPTSYDYDAPLSEAGDLTEKYFALRNIIQKFEKVPEGPIPPSTPKFAYGKVTLEKLKTVGAALDILCPSGPIKSLYPLTFIQVKQHYGFVLYRTTLPQDCSNPAPLSSPLNGVHDRAYVAVDGIPQGVLERNNVITLNITGKAGATLDLLVENMGRVNYGAYINDFKGLVSNLTLSSNILTDWTIFPLDTEDAVRSHLGGWGHRDSGHHDEAWAHNSSNYTLPAFYMGNFSIPSGIPDLPQDTFIQFPGWTKGQVWINGFNLGRYWPARGPQLTLFVPQHILMTSAPNTITVLELEWAPCSSDDPELCAVTFVDRPVIGSSVTYDHPSKPVEKRLMPPPPQKNKDSWLDHV","Homo sapiens","GLB1, ELNR1","Beta-galactosidase","1","3THC"
"3THD",,"X-RAY DIFFRACTION",2.62,52.99,"VAPOR DIFFUSION, SITTING DROP",8,"20% (w/v) PEG3350 0.2M ammonium sulfate 100mM Tris HCl pH 8.0 , VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M111.293795","DGJ","3THD",300.26,"1.79","1.79","Crystal structure of human beta-galactosidase in complex with 1-deoxygalactonojirimycin","LRNATQRMFEIDYSRDSFLKDGQPFRYISGSIHYSRVPRFYWKDRLLKMKMAGLNAIQTYVPWNFHEPWPGQYQFSEDHDVEYFLRLAHELGLLVILRPGPYICAEWEMGGLPAWLLEKESILLRSSDPDYLAAVDKWLGVLLPKMKPLLYQNGGPVITVQVENEYGSYFACDFDYLRFLQKRFRHHLGDDVVLFTTDGAHKTFLKCGALQGLYTTVDFGTGSNITDAFLSQRKCEPKGPLINSEFYTGWLDHWGQPHSTIKTEAVASSLYDILARGASVNLYMFIGGTNFAYWNGANSPYAAQPTSYDYDAPLSEAGDLTEKYFALRNIIQKFEKVPEGPIPPSTPKFAYGKVTLEKLKTVGAALDILCPSGPIKSLYPLTFIQVKQHYGFVLYRTTLPQDCSNPAPLSSPLNGVHDRAYVAVDGIPQGVLERNNVITLNITGKAGATLDLLVENMGRVNYGAYINDFKGLVSNLTLSSNILTDWTIFPLDTEDAVRSHLGGWGHRDSGHHDEAWAHNSSNYTLPAFYMGNFSIPSGIPDLPQDTFIQFPGWTKGQVWINGFNLGRYWPARGPQLTLFVPQHILMTSAPNTITVLELEWAPCSSDDPELCAVTFVDRPVIGSSVTYDHPSKPVEKRLMPPPPQKNKDSWLDHV","Homo sapiens","GLB1, ELNR1","Beta-galactosidase","1","3THD"
"3THE",,"X-RAY DIFFRACTION",2.13,42.33,"VAPOR DIFFUSION, HANGING DROP",8.5,"A metal-free HAI crystal was soaked in 20 mM CoCl2, 100 mM Bicine, 32% (v/v) Jeffamine ED-2001 for 21 hours, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi201101t",,"3THE",70.12,"1.97","1.97","Crystal structure of Co2+2-HAI (pH 8.5)","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","3THE"
"3THH",,"X-RAY DIFFRACTION",2.36,47.8,"VAPOR DIFFUSION, HANGING DROP",7,"An unliganded Co2+2-HAI crystal was soaked in 20 mM ABH, 5 mM CoCl2, 100 mM HEPES, 30% (v/v) Jeffamine ED-2001 for 39 hours, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi201101t",,"3THH",70.18,"1.85","1.85","Crystal structure of the Co2+2-HAI-ABH complex","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","3THH"
"3THJ",,"X-RAY DIFFRACTION",2.37,48.06,"VAPOR DIFFUSION, HANGING DROP",7,"An unliganded Co2+2-HAI crystal was soaked in 20 mM L-Orn, 5 mM CoCl2, 0.1 M HEPES, 30% (v/v) Jeffamine ED-2001 for 24 hours, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi201101t",,"3THJ",70.19,"1.5","1.5","Crystal structure of the Co2+2-HAI-L-Orn complex","MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK","Homo sapiens","ARG1","Arginase-1","1","3THJ"
"3THP",,"X-RAY DIFFRACTION",2.54,51.61,"microbatch under oil",7,"30% PEG 3350 and 0.15 M D/L malic acid, 2.8 mM MnCl2, and 8.6 mM 2-oxyglutarate., pH 7, microbatch under oil, temperature 293K",293,"10.1074/jbc.M111.286187",,"3THP",39.95,"3.2","3.2","Crystal structure and RNA binding properties of the RRM/AlkB domains in human ABH8, an enzyme catalyzing tRNA hypermodification, Northeast Structural Genomics Consortium Target HR5601B","AKHTLLRHEGIETVSYATQSLVVANGGLGNGVSRNQLLPVLEKCGLVDALLMPPNKPYSFARYRTTEESKRAYVTLNGKEVVDDLGQKITLYLNFVEKVQWKELRPQALPPGLMVVEEIISSEEEKMLLESVDWTEDTDNQNSQKSLKHRRVKHFGYEFHYENNNVDKDKPLSGGLPDICESFLEKWLRKGYIKHKPDQMTINQYEPGQGIPAHIDTHSAFEDEIVSLSLGSEIVMDFKHPDGIAVPVMLPRRSLLVMTGESRYLWTHGITCRKFDTVQASESLKSGIITSDVGDLTLSKRGLRTSFTFRKVRQTPCNCSYPLVCDSQRKENLYFQGLEHHHHHH","Homo sapiens","ABH8, ALKBH8","Alkylated DNA repair protein alkB homolog 8","1","3THP"
"3THT",,"X-RAY DIFFRACTION",2.41,49.06,"microbatch under oil",5.6,"2.8 mM Mn2Cl and 8.6 mM 2OG and a precipitant containing 28.5-30.5% (w/v) PEG 4K, 15% (v/v) glycerol, 170 mM NH4(CH3COO), 85 mM Na-citrate, pH 5.6, microbatch under oil, temperature 293K",293,"10.1074/jbc.M111.286187",,"3THT",158.5,"3.01","3.01","Crystal structure and RNA binding properties of the RRM/AlkB domains in human ABH8, an enzyme catalyzing tRNA hypermodification, Northeast Structural Genomics Consortium Target HR5601B","AKHTLLRHEGIETVSYATQSLVVANGGLGNGVSRNQLLPVLEKCGLVDALLMPPNKPYSFARYRTTEESKRAYVTLNGKEVVDDLGQKITLYLNFVEKVQWKELRPQALPPGLMVVEEIISSEEEKMLLESVDWTEDTDNQNSQKSLKHRRVKHFGYEFHYENNNVDKDKPLSGGLPDICESFLEKWLRKGYIKHKPDQMTINQYEPGQGIPAHIDTHSAFEDEIVSLSLGSEIVMDFKHPDGIAVPVMLPRRSLLVMTGESRYLWTHGITCRKFDTVQASESLKSGIITSDVGDLTLSKRGLRTSFTFRKVRQTPCNCSYPLVCDSQRKENLYFQGLEHHHHHH","Homo sapiens","ABH8, ALKBH8","Alkylated DNA repair protein alkB homolog 8","1","3THT"
"3TI1",,"X-RAY DIFFRACTION",2.05,40.13,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 1.5 mM Sunitinib, 15% (v/v) PEG 3350, 50 mM HEPES/NaOH (pH 7.5), VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1002/cbic.201200316","B49","3TI1",34.87,"1.99","1.99","CDK2 in complex with SUNITINIB","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3TI1"
"3TIY",,"X-RAY DIFFRACTION",2.05,39.94,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 1.5 mM NSC 35676, 15% (v/v) Jeffamine ED-2001 (pH 7.5), 100 mM HEPES/NaOH VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K",291,"10.1002/cbic.201200316","TIY","3TIY",34.94,"1.84","1.84","CDK2 in complex with NSC 35676","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3TIY"
"3TIZ",,"X-RAY DIFFRACTION",2.03,39.45,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 1.5 mM NSC 111848, 15% (v/v) Jeffamine ED-2001 (pH 7.5) and 100 mM VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K",291,"10.1002/cbic.201200316","3TI","3TIZ",34.74,"2.02","2.02","CDK2 in complex with NSC 111848","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3TIZ"
"3TJ2",,"X-RAY DIFFRACTION",2.09,41.27,"VAPOR DIFFUSION, SITTING DROP",8,"0.15 M Potassium bromide, 30% Polyethylene glycol mono methyl ether 2000, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277.15K",277.15,,"TJ2","3TJ2",23.32,"2.1","2.1","Structure of a novel submicromolar MDM2 inhibitor","MQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","3TJ2"
"3TJB",,"X-RAY DIFFRACTION",2.44,49.63,"VAPOR DIFFUSION, SITTING DROP",7.3,"0.1 M HEPES, pH 7.3, 11% PEG8000, 8% ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1074/jbc.M111.298810",,"3TJB",144.18,"2.38","2.38","Crystal structure of wild-type human peroxiredoxin IV","MGSSHHHHHHSQDPLVPRGSWETEERPRTREEECHFYAGGQVYPGEASRVSVADHSLHLSKAKISKPAPYWEGTAVIDGEFKELKLTDYRGKYLVFFFYPLDFTFVCPTEIIAFGDRLEEFRSINTEVVACSVDSQFTHLAWINTPRRQGGLGPIRIPLLSDLTHQISKDYGVYLEDSGHTLRGLFIIDDKGILRQITLNDLPVGRSVDETLRLVQAFQYTDKHGEVCPAGWKPGSETIIPDPAGKLKYFDKLN","Homo sapiens","PRDX4","Peroxiredoxin-4","1","3TJB"
"3TJC",,"X-RAY DIFFRACTION",3.19,61.42,"VAPOR DIFFUSION, HANGING DROP",6,"0.5 or 1.0 M LiCl,  
22.5-35% PEG6000, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm200911r","0TP","3TJC",70.98,"2.4","2.4","Co-crystal structure of jak2 with thienopyridine 8","GSEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","3TJC"
"3TJD",,"X-RAY DIFFRACTION",3.16,61.13,"VAPOR DIFFUSION, HANGING DROP",6,"0.5M or 1.0 M LiCl, 
22.5-35% PEG6000, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm200911r","6TP","3TJD",71.08,"2.9","2.9","co-crystal structure of Jak2 with thienopyridine 19","GSEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","3TJD"
"3TJF",,"X-RAY DIFFRACTION",2.44,49.57,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.55 M ammonium sulfate, 12% glycerol, 0.1 M Tris, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1074/jbc.M111.298810",,"3TJF",145.46,"2.04","2.04","Crystal Structure of human peroxiredoxin IV C51A mutant in reduced form","MGSSHHHHHHSQDPLVPRGSWETEERPRTREEEAHFYAGGQVYPGEASRVSVADHSLHLSKAKISKPAPYWEGTAVIDGEFKELKLTDYRGKYLVFFFYPLDFTFVCPTEIIAFGDRLEEFRSINTEVVACSVDSQFTHLAWINTPRRQGGLGPIRIPLLSDLTHQISKDYGVYLEDSGHTLRGLFIIDDKGILRQITLNDLPVGRSVDETLRLVQAFQYTDKHGEVCPAGWKPGSETIIPDPAGKLKYFDKLN","Homo sapiens","PRDX4","Peroxiredoxin-4","1","3TJF"
"3TJG",,"X-RAY DIFFRACTION",2.4,48.85,"VAPOR DIFFUSION, SITTING DROP",7,"48% PEG200, 0.1 M Tris, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1074/jbc.M111.298810",,"3TJG",144.02,"2.24","2.24","Crystal Structure of human peroxiredoxin IV C51A mutant in oxidized form","MGSSHHHHHHSQDPLVPRGSWETEERPRTREEEAHFYAGGQVYPGEASRVSVADHSLHLSKAKISKPAPYWEGTAVIDGEFKELKLTDYRGKYLVFFFYPLDFTFVCPTEIIAFGDRLEEFRSINTEVVACSVDSQFTHLAWINTPRRQGGLGPIRIPLLSDLTHQISKDYGVYLEDSGHTLRGLFIIDDKGILRQITLNDLPVGRSVDETLRLVQAFQYTDKHGEVCPAGWKPGSETIIPDPAGKLKYFDKLN","Homo sapiens","PRDX4","Peroxiredoxin-4","1","3TJG"
"3TJJ",,"X-RAY DIFFRACTION",2.48,50.34,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES, 10% w/v PEG8000, 8% v/v ethylene glycol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1074/jbc.M111.298810",,"3TJJ",144.1,"1.91","1.91","Crystal structure of human peroxiredoxin IV C245A mutant in sulfenylated form","MGSSHHHHHHSQDPLVPRGSWETEERPRTREEECHFYAGGQVYPGEASRVSVADHSLHLSKAKISKPAPYWEGTAVIDGEFKELKLTDYRGKYLVFFFYPLDFTFVCPTEIIAFGDRLEEFRSINTEVVACSVDSQFTHLAWINTPRRQGGLGPIRIPLLSDLTHQISKDYGVYLEDSGHTLRGLFIIDDKGILRQITLNDLPVGRSVDETLRLVQAFQYTDKHGEVAPAGWKPGSETIIPDPAGKLKYFDKLN","Homo sapiens","PRDX4","Peroxiredoxin-4","1","3TJJ"
"3TJK",,"X-RAY DIFFRACTION",2.42,49.26,"VAPOR DIFFUSION, SITTING DROP",7,"1.0 M succinic acid, 1% w/v PEG2000 MME, 0.1 M HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1074/jbc.M111.298810",,"3TJK",144.02,"2.09","2.09","Crystal Structure of human peroxiredoxin IV C245A mutant in reduced form","MGSSHHHHHHSQDPLVPRGSWETEERPRTREEECHFYAGGQVYPGEASRVSVADHSLHLSKAKISKPAPYWEGTAVIDGEFKELKLTDYRGKYLVFFFYPLDFTFVCPTEIIAFGDRLEEFRSINTEVVACSVDSQFTHLAWINTPRRQGGLGPIRIPLLSDLTHQISKDYGVYLEDSGHTLRGLFIIDDKGILRQITLNDLPVGRSVDETLRLVQAFQYTDKHGEVAPAGWKPGSETIIPDPAGKLKYFDKLN","Homo sapiens","PRDX4","Peroxiredoxin-4","1","3TJK"
"3TJM",,"X-RAY DIFFRACTION",1.95,37.01,"VAPOR DIFFUSION",5.5,"18-23% PEG 3350, 0.1M Bis-Tris buffer, pH 5.5, VAPOR DIFFUSION, temperature 298K",298,"10.1073/pnas.1112334108","7FA","3TJM",31.32,"1.48","1.48","Crystal Structure of the Human Fatty Acid Synthase Thioesterase Domain with an Activate Site-Specific Polyunsaturated Fatty Acyl Adduct","NLRSLLVNPEGPTLMRLNSVQSSERPLFLVHPIEGSTTVFHSLASRLSIPTYGLQCTRAAPLDSIHSLAAYYIDCIRQVQPEGPYRVAGYSYGACVAFEMCSQLQAQQSPAPTHNSLFLFDGSPTYVLAYTGSYRAKLTPGCEAEAETEAICFFVQQFTDMEHNRVLEALLPLKGLEERVAAAVDLIIKSHQGLDRQELSFAARSFYYKLRAAEQYTPKAKYHGNVMLLRAKTGGAYGEAAGADYNLSQVCDGKVSVHVIEGDHATLLEGSGLESIISIIHSS","Homo sapiens","FAS, FASN","Fatty acid synthase","1","3TJM"
"3TJN",,"X-RAY DIFFRACTION",2.68,54.17,"VAPOR DIFFUSION, SITTING DROP",7,"ammonium acetate, pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1016/j.str.2012.03.021",,"3TJN",74.21,"3","3","HtrA1 catalytic domain, apo form","MGSSHHHHHHSSGLVPRGSHMDPNSLRHKYNFIADVVEKIAPAVVHIELFRKLPFSKREVPVASGSGFIVSEDGLIVTNAHVVTNKHRVKVELKNGATYEAKIKDVDEKADIALIKIDHQGKLPVLLLGRSSELRPGEFVVAIGSPFSLQNTVTTGIVSTTQRGGKELGLRNSDMDYIQTDAIINYGNSGGPLVNLDGEVIGINTLKVTAGISFAIPSDKIKKFLTES","Homo sapiens","HTRA, HTRA1, PRSS11","Serine protease HTRA1","1","3TJN"
"3TJO",,"X-RAY DIFFRACTION",3.35,63.28,"VAPOR DIFFUSION, SITTING DROP",6.5,"ammonium sulfate, LiCl, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1016/j.str.2012.03.021",,"3TJO",76.82,"2.301","2.301","HtrA1 catalytic domain, mutationally inactivated","MGSSHHHHHHSSGLVPRGSHMDPNSLRHKYNFIADVVEKIAPAVVHIELFRKLPFSKREVPVASGSGFIVSEDGLIVTNAHVVTNKHRVKVELKNGATYEAKIKDVDEKADIALIKIDHQGKLPVLLLGRSSELRPGEFVVAIGSPFSLQNTVTTGIVSTTQRGGKELGLRNSDMDYIQTDAIINYGNAGGPLVNLDGEVIGINTLKVTAGISFAIPSDKIKKFLTESHDR","Homo sapiens","HTRA, HTRA1, PRSS11","Serine protease HTRA1","1","3TJO"
"3TJP",,"X-RAY DIFFRACTION",2.28,46.08,"VAPOR DIFFUSION, HANGING DROP",8.5,"16-19% PEG 4000, 0.2M SODIUM ACETATE,0.1M SODIUM CITRATE, 0.1M TRIS PH 8.5, PROTEIN at 6MG/ML IN 20MM TRIS PH 7.2, 50MM AMMSO4, 1% BETAINE, 1% ETHYLENE GLYCOL, 0.02% CHAPS, 5MM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,"13K","3TJP",111.26,"2.7","2.7","Crystal Structure of PI3K gamma with N6-(3,4-dimethoxyphenyl)-2-morpholino-[4,5'-bipyrimidine]-2',6-diamine","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVRLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","3TJP"
"3TJQ",,"X-RAY DIFFRACTION",2.11,41.81,"VAPOR DIFFUSION, SITTING DROP",4.5,"potassium thiocyanate, sodium acetate, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 300K",300,"10.1016/j.str.2012.03.021",,"3TJQ",15.58,"2.001","2.001","N-domain of HtrA1","AHHHHHHGENLYFQGSAGCPDRCEPARCPPQPEHCEGGRARDACGCCEVCGAPEGAACGLQEGPCGEGLQCVVPFGVPASATVRRRAQAGLCVCASSEPVCGSDANTYANLCQLRAASRRSERLHRPPVIVLQRGACGNS","Homo sapiens","HTRA, HTRA1, PRSS11","Serine protease HTRA1","1","3TJQ"
"3TJS",,"X-RAY DIFFRACTION",2.19,43.81,"MICROBATCH UNDER OIL",6.4,"10% PEG3350, 80 mM malonate, pH 6.4, MICROBATCH UNDER OIL, temperature 293K",293,"10.1016/j.abb.2012.02.018",,"3TJS",56.95,"2.25","2.25","Crystal Structure of the complex between human cytochrome P450 3A4 and desthiazolylmethyloxycarbonyl ritonavir","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","3TJS"
"3TJU",,"X-RAY DIFFRACTION",2.81,56.26,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2M Li2SO4, 0.1M Bicine (pH 8.5), 25% (w/v) PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.4049/jimmunol.1101381",,"3TJU",26.03,"2.7","2.7","Crystal structure of human granzyme H with an inhibitor","IIGGHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHCQGSSINVTLGAHNIKEQERTQQFIPVKRPIPHPAYNPKNFSNNIMLLQLERKAKWTTAVRPLRLPSSKAQVKPGQLCSVAGWGYVSMSTLATTLQEVLLTVQKDCQCERLFHGNYSRATEICVGDPKKTQTGFKGDSGGPLVCKDVAQGILSYGNKKGTPPGVYIKVSHFLPWIKRTMKRL","Homo sapiens","GZMH, CGL2, CTSGL2","Granzyme H","1","3TJU"
,,,,,,,,,,,,,,,,"XPTSYX",,,"Ac-PTSY-CMK inhibitor","2","3TJU"
"3TJV",,"X-RAY DIFFRACTION",2.28,46.08,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2M Li2SO4, 0.1M Bicine (pH 8.5), 25% (w/v) PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.4049/jimmunol.1101381",,"3TJV",26.37,"2.4","2.4","Crystal structure of human granzyme H with a peptidyl substrate","IIGGHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHCQGSSINVTLGAHNIKEQERTQQFIPVKRPIPHPAYNPKNFSNNIMLLQLERKAKWTTAVRPLRLPSSKAQVKPGQLCSVAGWGYVSMSTLATTLQEVLLTVQKDCQCERLFHGNYSRATEICVGDPKKTQTGFKGDSGGPLVCKDVAQGILSYGNKKGTPPGVYIKVSHFLPWIKRTMKRL","Homo sapiens","GZMH, CGL2, CTSGL2","Granzyme H","1","3TJV"
,,,,,,,,,,,,,,,,"PTSYAGDDSG",,,"PTSYAGDDSG","2","3TJV"
"3TK0",,"X-RAY DIFFRACTION",2.06,40.17,"VAPOR DIFFUSION",6,"0.1 M MES, 20% PEG6000, PH 6.0, VAPOR DIFFUSION, temperature 293K",293,,,"3TK0",15.85,"1.611","1.611","mutation of sfALR","SMRTQQKRDTKFREDCPPDREELGRHSWAVLHTLAAYYPDLPTPEQQQDMAQFIHLFSKFYPSEECAEDLRKRLARNHPDTRTRAAFTQWLCHLHNEVNRKLGKPDFDCSKVDERWRDGWKDGSCD","Homo sapiens","GFER, ALR, HERV1, HPO","FAD-linked sulfhydryl oxidase ALR","1","3TK0"
"3TK5",,"X-RAY DIFFRACTION",2.48,50.33,"VAPOR DIFFUSION, HANGING DROP",5,"pH 5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,"D1Q","3TK5",32.8,"2.2","2.2","Factor Xa in complex with D102-4380","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMK","Homo sapiens","F10","Factor X heavy chain","1","3TK5"
,,,,,,,,,,,,,,,,"TRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE","Homo sapiens","F10","Factor X light chain","2","3TK5"
"3TK6",,"X-RAY DIFFRACTION",2.51,51.01,"VAPOR DIFFUSION, HANGING DROP",5,"pH 5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,"D46","3TK6",32.72,"1.8","1.8","factor Xa in complex with D46-5241","IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMK","Homo sapiens","F10","Factor X heavy chain","1","3TK6"
,,,,,,,,,,,,,,,,"TRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLE","Homo sapiens","F10","Factor X light chain","2","3TK6"
"3TK9",,"X-RAY DIFFRACTION",2.88,57.33,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2M Li2SO4, 0.1M Bicine (pH 8.5), 25% (w/v) PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.4049/jimmunol.1101381",,"3TK9",25.31,"2.2","2.2","Crystal structure of human granzyme H","IIGGHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHCQGSSINVTLGAHNIKEQERTQQFIPVKRPIPHPAYNPKNFSNNIMLLQLERKAKWTTAVRPLRLPSSKAQVKPGQLCSVAGWGYVSMSTLATTLQEVLLTVQKDCQCERLFHGNYSRATEICVGDPKKTQTGFKGDSGGPLVCKDVAQGILSYGNKKGTPPGVYIKVSHFLPWIKRTMKRL","Homo sapiens","GZMH, CGL2, CTSGL2","Granzyme H","1","3TK9"
"3TKB",,"X-RAY DIFFRACTION",2.19,43.77,"VAPOR DIFFUSION, HANGING DROP",7.8,"18% PEG 4000, 0.041M ammonium sulfate, 0.05M sodium chloride, 0.1M imidazole/maleate, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1016/j.cbpb.2011.09.007",,"3TKB",25.65,"1.5","1.5","crystal structure of human uracil-DNA glycosylase D183G/K302R mutant","MEFFGESWKKHLSGEFGKPYFIKLMGFVAEERKHYTVYPPPHQVFTWTQMCDIKDVKVVILGQDPYHGPNQAHGLCFSVQRPVPPPPSLENIYKELSTDIEGFVHPGHGDLSGWAKQGVLLLNAVLTVRAHQANSHKERGWEQFTDAVVSWLNQNSNGLVFLLWGSYAQKKGSAIDRKRHHVLQTAHPSPLSVYRGFFGCRHFSKTNELLQKSGKKPIDWREL","Homo sapiens","UNG, DGU, UNG1, UNG15","Uracil-DNA glycosylase","1","3TKB"
"3TKC",,"X-RAY DIFFRACTION",2.63,53.15,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M MES pH6.0, 1.4 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1002/chem.201102695",,"3TKC",30.02,"1.75","1.75","Design, Synthesis, Evaluation and Structure of Vitamin D Analogues with Furan Side Chains","DSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEIS","Homo sapiens","VDR, NR1I1","Vitamin D3 receptor","1","3TKC"
"3TKH",,"X-RAY DIFFRACTION",2.3,46.55,"VAPOR DIFFUSION, HANGING DROP",6.8,"13% PEG8K, 0.1M ammonium sulfate, 2% glycerol, 0.1M cacodylate buffer at pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2012.01.110","07S","3TKH",37.48,"1.79","1.79","Crystal structure of Chk1 in complex with inhibitor S01","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKEHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","3TKH"
"3TKI",,"X-RAY DIFFRACTION",2.3,46.41,"VAPOR DIFFUSION, HANGING DROP",6.8,"13% PEG8K, 0.1M amminium sulfate, 2% glycerol, 0.1M cacodylate buffer at pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bmcl.2012.01.110","S25","3TKI",37.44,"1.6","1.6","Crystal structure of Chk1 in complex with inhibitor S25","MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKEHHHHHH","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","3TKI"
"3TKJ",,"X-RAY DIFFRACTION",2.82,56.41,"VAPOR DIFFUSION, SITTING DROP",4.6,"19-30% PEG4000, 0.1M sodium acetate, pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/cb300232n",,"3TKJ",66.92,"2.3","2.3","Crystal Structure of Human Asparaginase-like Protein 1 Thr168Ala","MGGGHHHHHHGGNPIVVVHGGGAGPISKDRKERVHQGMVRAATVGYGILREGGSAVDAVEGAVVALEDDPEFNAGCGSVLNTNGEVEMDASIMDGKDLSAGAVSAVQCIANPIKLARLVMEKTPHCFLTDQGAAQFAAAMGVPEIPGEKLVTERNKKRLEKEKHEKGAQKTDCQKNLGAVGAVALDCKGNVAYATSTGGIVNKMVGRVGDSPCLGAGGYADNDIGAVSTTGHGESILKVNLARLTLFHIEQGKTVEEAADLSLGYMKSRVKGLGGLIVVSKTGDWVAKWTSTSMPWAAAKDGKLHFGIDPDDTTITDLP","Homo sapiens","ASRGL1, ALP, CRASH","L-asparaginase","1","3TKJ"
"3TKM",,"X-RAY DIFFRACTION",2.03,39.43,"VAPOR DIFFUSION, SITTING DROP",9.5,"14% (w/v) polyethylene glycol (PEG) 8000, 200 mM KCl, 40 mM bis-Tris-propane (pH 9.5), 6% propanol, and 1 mM CaCl2 and detergent n-Octyl-b-D-thioglucoside (0.5 microliters in 5 microliters drops), VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1371/journal.pone.0033643","GW0","3TKM",31.99,"1.953","1.953","Crystal structure PPAR delta binding GW0742","GSHMQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","3TKM"
"3TKP",,"X-RAY DIFFRACTION",2.75,55.34,"VAPOR DIFFUSION, HANGING DROP",8.2,"0.8M sodium phosphate monobasic monohydrate/potassium phosphate dibasic, 5mM DTT, pH 8.2, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1042/BJ20110380",,"3TKP",140.06,"2.49","2.49","Crystal structure of full-length human peroxiredoxin 4 in the reduced form","MRGSHHHHHHGSWETEERPRTREEECHFYAGGQVYPGEASRVSVADHSLHLSKAKISKPAPYWEGTAVIDGEFKELKLTDYRGKYLVFFFYPLDFTFVCPTEIIAFGDRLEEFRSINTEVVACSVDSQFTHLAWINTPRRQGGLGPIRIPLLSDLTHQISKDYGVYLEDSGHTLRGLFIIDDKGILRQITLNDLPVGRSVDETLRLVQAFQYTDKHGEVCPAGWKPGSETIIPDPAGKLKYFDKLN","Homo sapiens","PRDX4","Peroxiredoxin-4","1","3TKP"
"3TKQ",,"X-RAY DIFFRACTION",2.53,51.35,"VAPOR DIFFUSION, HANGING DROP",8.2,"0.8M sodium phosphate monobasic monohydrate/potassium phosphate dibasic, pH 8.2, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1042/BJ20110380",,"3TKQ",140.06,"2.22","2.22","Crystal structure of full-length human peroxiredoxin 4 with mixed conformation","MRGSHHHHHHGSWETEERPRTREEECHFYAGGQVYPGEASRVSVADHSLHLSKAKISKPAPYWEGTAVIDGEFKELKLTDYRGKYLVFFFYPLDFTFVCPTEIIAFGDRLEEFRSINTEVVACSVDSQFTHLAWINTPRRQGGLGPIRIPLLSDLTHQISKDYGVYLEDSGHTLRGLFIIDDKGILRQITLNDLPVGRSVDETLRLVQAFQYTDKHGEVCPAGWKPGSETIIPDPAGKLKYFDKLN","Homo sapiens","PRDX4","Peroxiredoxin-4","1","3TKQ"
"3TKR",,"X-RAY DIFFRACTION",2.72,54.83,"VAPOR DIFFUSION, HANGING DROP",8.2,"0.8M sodium phosphate monobasic monohydrate/potassium phosphate dibasic, 5mM DTT, pH 8.2, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1042/BJ20110380",,"3TKR",280.4,"2.1","2.1","Crystal structure of full-length human peroxiredoxin 4 with T118E mutation","MRGSHHHHHHGSWETEERPRTREEECHFYAGGQVYPGEASRVSVADHSLHLSKAKISKPAPYWEGTAVIDGEFKELKLTDYRGKYLVFFFYPLDFTFVCPTEIIAFGDRLEEFRSINTEVVACSVDSQFEHLAWINTPRRQGGLGPIRIPLLSDLTHQISKDYGVYLEDSGHTLRGLFIIDDKGILRQITLNDLPVGRSVDETLRLVQAFQYTDKHGEVCPAGWKPGSETIIPDPAGKLKYFDKLN","Homo sapiens","PRDX4","Peroxiredoxin-4","1","3TKR"
"3TKS",,"X-RAY DIFFRACTION",2.75,55.26,"VAPOR DIFFUSION, HANGING DROP",8.2,"0.8M sodium phosphate monobasic monohydrate/potassium phosphate dibasic, 5mM DTT, pH 8.2, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1042/BJ20110380",,"3TKS",140.25,"2.4","2.4","Crystal structure of full-length human peroxiredoxin 4 in three different redox states","MRGSHHHHHHGSWETEERPRTREEECHFYAGGQVYPGEASRVSVADHSLHLSKAKISKPAPYWEGTAVIDGEFKELKLTDYRGKYLVFFFYPLDFTFVCPTEIIAFGDRLEEFRSINTEVVACSVDSQFTHLAWINTPRRQGGLGPIRIPLLSDLTHQISKDYGVYLEDSGHTLRGLFIIDDKGILRQITLNDLPVGRSVDETLRLVQAFQYTDKHGEVCPAGWKPGSETIIPDPAGKLKYFDKLN","Homo sapiens","PRDX4","Peroxiredoxin-4","1","3TKS"
,,,,,,,,,,,,,,,,"MRGSHHHHHHGSWETEERPRTREEECHFYAGGQVYPGEASRVSVADHSLHLSKAKISKPAPYWEGTAVIDGEFKELKLTDYRGKYLVFFFYPLDFTFVCPTEIIAFGDRLEEFRSINTEVVACSVDSQFTHLAWINTPRRQGGLGPIRIPLLSDLTHQISKDYGVYLEDSGHTLRGLFIIDDKGILRQITLNDLPVGRSVDETLRLVQAFQYTDKHGEVCPAGWKPGSETIIPDPAGKLKYFDKLN","Homo sapiens","PRDX4","Peroxiredoxin-4","2","3TKS"
,,,,,,,,,,,,,,,,"MRGSHHHHHHGSWETEERPRTREEECHFYAGGQVYPGEASRVSVADHSLHLSKAKISKPAPYWEGTAVIDGEFKELKLTDYRGKYLVFFFYPLDFTFVCPTEIIAFGDRLEEFRSINTEVVACSVDSQFTHLAWINTPRRQGGLGPIRIPLLSDLTHQISKDYGVYLEDSGHTLRGLFIIDDKGILRQITLNDLPVGRSVDETLRLVQAFQYTDKHGEVCPAGWKPGSETIIPDPAGKLKYFDKLN","Homo sapiens","PRDX4","Peroxiredoxin-4","3","3TKS"
"3TKU",,"X-RAY DIFFRACTION",2.32,46.87,"VAPOR DIFFUSION, SITTING DROP",5.6,"10-20% PEG 3350, 0.1 M BISTRIS, 0.1 M SODIUM TARTRATE, 0.1 M AMMONIUM SULPHATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K, VAPOR DIFFUSION, SITTING DROP, pH 5.6",277,"10.1371/journal.pone.0024825","M77","3TKU",101.02,"2.15","2.15","MRCK beta in complex with fasudil","MHHHHHHSSGENLYFQGSAKVRLKKLEQLLLDGPWRNESALSVETLLDVLVCLYTECSHSALRRDKYVAEFLEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLNWENIRNLEAPYIPDVSSPSDTSNFDVDDDVLRNTEILPPGSHTGFSGLHLPFIGFTFTTESCFSDRGSLKS","Homo sapiens","CDC42BPB, KIAA1124","Serine/threonine-protein kinase MRCK beta","1","3TKU"
"3TKZ",,"X-RAY DIFFRACTION",2.48,50.4,"VAPOR DIFFUSION, HANGING DROP",5.5,"20% PEG 3350, 0.1M Bis-Tris, 0.2M Li2SO4, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/bi200439v",,"3TKZ",15.01,"1.8","1.8","Structure of the SHP-2 N-SH2 domain in a 1:2 complex with RVIpYFVPLNR peptide","GSHMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCAD","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","3TKZ"
,,,,,,,,,,,,,,,,"RVIYFVPLNR",,,"PROTEIN (RVIpYFVPLNR peptide)","2","3TKZ"
"3TL0",,"X-RAY DIFFRACTION",2.7,54.45,"VAPOR DIFFUSION, HANGING DROP",5.5,"20% PEG 3350, 0.1 M bis-Tris, 0.2 M Li2SO4, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1021/bi200439v",,"3TL0",13.82,"2.05","2.05","Structure of SHP2 N-SH2 domain in complex with RLNpYAQLWHR peptide","GSHMTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCAD","Homo sapiens","PTPN11, PTP2C, SHPTP2","Tyrosine-protein phosphatase non-receptor type 11","1","3TL0"
,,,,,,,,,,,,,,,,"RLNYAQLWHR",,,"RLNpYAQLWHR peptide","2","3TL0"
"3TL5",,"X-RAY DIFFRACTION",2.24,45.07,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG3350, 0.2 M ammonium sulfate, 0.1 M Tris-HCl, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1021/jm2009327","980","3TL5",111.23,"2.788","2.788","Discovery of GDC-0980: a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor for the Treatment of Cancer","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","3TL5"
"3TLP",,"X-RAY DIFFRACTION",2.34,47.47,"VAPOR DIFFUSION, SITTING DROP",8.5,"25% PEG_MME_2000, 0.015M NiCl, 0.1M Tris pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.cell.2012.02.013",,"3TLP",35.16,"2.13","2.13","Crystal structure of the fourth bromodomain of human poly-bromodomain containing protein 1 (PB1)","MGDSMISSATSDTGSAKRKSKKNIRKQRMKILFNVVLEAREPGSGRRLCDLFMVKPSKKDYPDYYKIILEPMDLKIIEHNIRNDKYAGEEGMIEDMKLMFRNARHYNEEGSQVYNDAHILEKLLKEKRKELGPLPDDDDMASPAENLYFQ","Homo sapiens","BAF180, PB1, PBRM1","Protein polybromo-1","1","3TLP"
"3TLR",,"X-RAY DIFFRACTION",2.2,44.06,"VAPOR DIFFUSION, SITTING DROP",7.7,"Hepes 0.1 M pH 7.7, CdSO4 0.12 M, sodium acetate 2.4 M, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1111/j.1742-4658.2012.08510.x",,"3TLR",48.75,"2.45","2.45","Crystal Structure of the tetrameric Beta-2 microglobulin DIMC20 mutant","MIQRTPKIQVYSRHPAENGKCNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM","Homo sapiens","B2M, CDABP0092, HDCMA22P","Beta-2-microglobulin","1","3TLR"
"3TM6",,"X-RAY DIFFRACTION",2.32,47.03,"VAPOR DIFFUSION, SITTING DROP",5.5,"imidazole-malate 0.2 M, pH 5.5, PEG 600 24%, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1111/j.1742-4658.2012.08510.x",,"3TM6",95.93,"2.7","2.7","Crystal structure of the beta-2 microglobulin DIMC50 disulphide-linked homodimer mutant","MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVCHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM","Homo sapiens","B2M, CDABP0092, HDCMA22P","Beta-2-microglobulin","1","3TM6"
"3TMJ",,"NEUTRON DIFFRACTION, X-RAY DIFFRACTION",2.17,43.26,"VAPOR DIFFUSION, SITTING DROP",7.8,"1.3 M sodium citrate, 100 mM Tris, pH 7.8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/bi201487b",,"3TMJ",29.14,"2","2","Joint X-ray/neutron structure of human carbonic anhydrase II at pH 7.8","HHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3TMJ"
"3TMM",,"X-RAY DIFFRACTION",2.54,51.49,"VAPOR DIFFUSION, HANGING DROP",4.2,"29% PEG 400, 0.15 M calcium acetate, 0.1 M sodium acetate,pH 4.2, 400 mM NDSB211, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nsmb.2159",,"3TMM",45.63,"2.5001","2.5001","TFAM imposes a U-turn on mitochondrial DNA","MGSSHHHHHHSSGLVPRGSHMASMTGGQQMGRGSSSVLASCPKKPVSSYLRFSKEQLPIFKAQNPDAKTTELIRRIAQRWRELPDSKKKIYQDAYRAEWQVYKEEISRFKEQLTPSQIMSLEKEIMDKHLKRKAMTKKKELTLLGKPKRPRSAYNVYVAERFQEAKGDSPQEKLKTVKENWKNLSDSEKELYIQHAKEDETRYHNEMKSWEEQMIEVGRKDLLRRTIKKQRKYGAEEC","Homo sapiens","TCF6, TCF6L2, TFAM","Transcription factor A, mitochondrial","1","3TMM"
,,,,,,,,,,,,,,,,"TGTTAGTTGGGGGGTGACTGTTAAAAGT",,,"DNA (28-MER)","2","3TMM"
,,,,,,,,,,,,,,,,"ACTTTTAACAGTCACCCCCCAACTAACA",,,"DNA (28-MER)","3","3TMM"
"3TMO",,"X-RAY DIFFRACTION",2.44,49.62,"VAPOR DIFFUSION, SITTING DROP",7,"0.8 M succinic acid, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nsmb.2206",,"3TMO",21.6,"2.2","2.2","The catalytic domain of human deubiquitinase DUBA","GSHMGAGYNSEDEYEAAAARIEAMDPATVEQQEHWFEKALRDKKGFIIKQMKEDGACLFRAVADQVYGDQDMHEVVRKHCMDYLMKNADYFSNYVTEDFTTYINRKRKNNCHGNHIEMQAMAEMYNRPVEVYQYSTGTSAVEPINTFHGIHQNEDEPIRVSYHRNIHYNSVVNPNKATIGVGLG","Homo sapiens","DUBA, OTUD5","OTU domain-containing protein 5","1","3TMO"
"3TN2",,"X-RAY DIFFRACTION",1.81,31.99,"EVAPORATION",5.5,"15% v/v ethanol, 0.1 M MES, pH 5.5, 0.2 M zinc acetate, EVAPORATION, temperature 298K",298,"10.1016/j.jmb.2015.01.012",,"3TN2",7.88,"1.6","1.6","structure analysis of MIP1-beta P8A","APMGSDPATACCFSYTARKLPRNFVVDYYETSSLCSQPAVVFQTKRSKQVCADPSESWVQEYVYDLEL","Homo sapiens","CCL4, LAG1, MIP1B, SCYA4","C-C motif chemokine 4","1","3TN2"
"3TNM",,"X-RAY DIFFRACTION",2.1,41.47,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES sodium pH 7.5, 10% 2-Propanol,  20% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 297K",297,"10.1073/pnas.1217609110",,"3TNM",95.36,"1.85","1.85","Crystal structure of A32 Fab, an ADCC mediating anti-HIV-1 antibody","QVQLQESGPGLVKPSQTLSLSCTVSGGSSSSGAHYWSWIRQYPGKGLEWIGYIHYSGNTYYNPSLKSRITISQHTSENQFSLKLNSVTVADTAVYYCARGTRLRTLRNAFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHT","Homo sapiens",,"Fab heavy chain of human anti-HIV-1 Env antibody A32","1","3TNM"
,,,,,,,,,,,,,,,,"QSVLTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQHHPGKAPKLIISEVNNRPSGVPDRFSGSKSGNTASLTVSGLQAEDEAEYYCSSYTDIHNFVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Fab light chain of human anti-HIV-1 Env antibody A32","2","3TNM"
"3TNN",,"X-RAY DIFFRACTION",2.33,47.24,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M Ammonium Sulfate, 30% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3TNN",188.38,"1.95","1.95","Crystal structure of N5-i5 Fab, an ADCC mediating and non-neutralizing CD4i anti-HIV- 1 antibody.","EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYAMSWVRQAPGKGLEWVSSINNSGRNTFSADSVKGRFTISRDNSKNTLFLVMNSLRAEDTAVYYCAKDLRLGGGSDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTH","Homo sapiens",,"Fab heavy chain of ADCC and non-neutralizing anti-HIV-1 antibody N5-i5","1","3TNN"
,,,,,,,,,,,,,,,,"QSALTQPASVSGSPGQSITISCTGTSSDVGSYNFVSWYQQHPGKAPKLMIYEVSERPSGISNRFSGSKSGNTASLTISGLQAEDEADYYCSSYAGSTTFRVFGGGTKLTVRGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Fab light chain of ADCC and non-neutralizing anti-HIV-1 antibody N5-i5","2","3TNN"
"3TO8",,"X-RAY DIFFRACTION",1.86,34,"VAPOR DIFFUSION, HANGING DROP",6.5,"30% v/v Pentaerythritol ethoxylate (15/4 EO/OH), 0.05M Ammonium sulfate, 0.05M BIS-TRIS pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 287K",287,,,"3TO8",25,"1.82","1.82","Crystal structure of the two C-terminal RRM domains of heterogeneous nuclear ribonucleoprotein L (hnRNP L)","MGHHHHHHDSPVLMVYGLDQSKMNCDRVFNVFCLYGNVEKVKFMKSKPGAAMVEMADGYAVDRAITHLNNNFMFGQKLNVCVSKQPAIMPGQSYGLEDGSCSYKDFSESRNNRFSTPEQAAKNRIQHPSNVLHFFNAPLEVTEENFFEICDELGVKRPSSVKVFSGKSERSSSGLLEWESKSDALETLGFLNHYQMKNPNGPYPYTLKLCFSTAQHAS","Homo sapiens","HNRNPL, HNRPL, P/OKcl.14","Heterogeneous nuclear ribonucleoprotein L","1","3TO8"
"3TOA",,"X-RAY DIFFRACTION",2.3,46.49,"VAPOR DIFFUSION, HANGING DROP",6.5,"25% PEG3350, 0.2 M magnesium chloride, 0.1 M Bis-Tris, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1038/emboj.2011.382",,"3TOA",36.04,"3.004","3.004","Human MOF crystal structure with active site lysine partially acetylated","HHHHHHDYDIPTTENLYFQGSKYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVYEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVACILTLPPYQRRGYGKFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSWVLLEILRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPPKHKQVKLSKK","Homo sapiens","MYST1, MOF, PP7073, KAT8","histone acetyltransferase MYST1","1","3TOA"
"3TOB",,"X-RAY DIFFRACTION",2.24,45.18,"VAPOR DIFFUSION, HANGING DROP",6.5,"25% PEG3350, 0.2 M magnesium chloride, 0.1 M Bis-Tris, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1038/emboj.2011.382",,"3TOB",35.88,"2.703","2.703","Human MOF E350Q crystal structure with active site lysine partially acetylated","HHHHHHDYDIPTTENLYFQGSKYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVYEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVACILTLPPYQRRGYGKFLIAFSYELSKLESTVGSPQKPLSDLGKLSYRSYWSWVLLEILRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPPKHKQVKLSKK","Homo sapiens","MYST1, MOF, PP7073, KAT8","histone acetyltransferase MYST1","1","3TOB"
"3TOJ",,"X-RAY DIFFRACTION",4.24,70.99,"VAPOR DIFFUSION, HANGING DROP",8.5,"20% PEG4000, 0.15 M Li2SO4, 0.1 M Tris, pH8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1038/cr.2012.9",,"3TOJ",47.87,"2.07","2.07","Structure of the SPRY domain of human Ash2L","SGDLYRACLYERVLLALHDRAPQLKISDDRLTVVGEKGYSMVRASHGVRKGAWYFEITVDEMPPDTAARLGWSQPLGNLQAPLGYDKFSYSWRSKKGTKFHQSIGKHYSSGYGQGDVLGFYINLPEDTISGRGSSEIIFYKNGVNQGVAYKDIFEGVYFPAISLYKSCTVSINFGPCFKYPPKDLTYRPMSDMGWGAVVEHTLADVLYHVETE","Homo sapiens","ASH2L, ASH2L1","Set1/Ash2 histone methyltransferase complex subunit ASH2","1","3TOJ"
,,,,,,,,,,,,,,,,,"Homo sapiens","ASH2L, ASH2L1"
"3TON",,"X-RAY DIFFRACTION",3.52,65.05,"VAPOR DIFFUSION, SITTING DROP",7,"0.3M MgSO4, 16% PEG 3350, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1007/s13238-011-1105-3",,"3TON",207.45,"2.953","2.953","Crystral Structure of the C-terminal Subunit of Human Maltase-Glucoamylase","WSHPQFEKDEEKIDCYPDENGASAENCTARGCIWEASNSSGVPFCYFVNDLYSVSDVQYNSHGATADISLKSSVYANAFPSTPVNPLRLDVTYHKNEMLQFKIYDPNKNRYEVPVPLNIPSMPSSTPEGQLYDVLIKKNPFGIEIRRKSTGTIIWDSQLLGFTFSDMFIRISTRLPSKYLYGFGETEHRSYRRDLEWHTWGMFSRDQPPGYKKNSYGVHPYYMGLEEDGSAHGVLLLNSNAMDVTFQPLPALTYRTTGGVLDFYVFLGPTPELVTQQYTELIGRPVMVPYWSLGFQLCRYGYQNDSEIASLYDEMVAAQIPYDVQYSDIDYMERQLDFTLSPKFAGFPALINRMKADGMRVILILDPAISGNETQPYPAFTRGVEDDVFIKYPNDGDIVWGKVWPDFPDVVVNGSLDWDSQVELYRAYVAFPDFFRNSTAKWWKREIEELYNNPQNPERSLKFDGMWIDMNEPSSFVNGAVSPGCRDASLNHPPYMPHLESRDRGLSSKTLCMESQQILPDGSLVQHYNVHNLYGWSQTRPTYEAVQEVTGQRGVVITRSTFPSSGRWAGHWLGDNTAAWDQLKKSIIGMMEFSLFGISYTGADICGFFQDAEYEMCVRWMQLGAFYPFSRNHNTIGTRRQDPVSWDVAFVNISRTVLQTRYTLLPYLYTLMHKAHTEGVTVVRPLLHEFVSDQVTWDIDSQFLLGPAFLVSPVLERNARNVTAYFPRARWYDYYTGVDINARGEWKTLPAPLDHINLHVRGGYILPWQEPALNTHLSRQKFMGFKIALDDEGTAGGWLFWDDGQSIDTYGKGLYYLASFSASQNTMQSHIIFNNYITGTNPLKLGYIEIWGVGSVPVTSVSISVSGMVITPSFNNDPTTQVLSIDVTDRNISLHNFTSLTWHHHHHH","Homo sapiens","MGAM, MGA, MGAML","Maltase-glucoamylase, intestinal","1","3TON"
"3TOP",,"X-RAY DIFFRACTION",3.46,64.5,"VAPOR DIFFUSION, SITTING DROP",7,"0.3 M MgSO4,16% PEG 3350, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1007/s13238-011-1105-3",,"3TOP",208.75,"2.881","2.881","Crystral Structure of the C-terminal Subunit of Human Maltase-Glucoamylase in Complex with Acarbose","WSHPQFEKDEEKIDCYPDENGASAENCTARGCIWEASNSSGVPFCYFVNDLYSVSDVQYNSHGATADISLKSSVYANAFPSTPVNPLRLDVTYHKNEMLQFKIYDPNKNRYEVPVPLNIPSMPSSTPEGQLYDVLIKKNPFGIEIRRKSTGTIIWDSQLLGFTFSDMFIRISTRLPSKYLYGFGETEHRSYRRDLEWHTWGMFSRDQPPGYKKNSYGVHPYYMGLEEDGSAHGVLLLNSNAMDVTFQPLPALTYRTTGGVLDFYVFLGPTPELVTQQYTELIGRPVMVPYWSLGFQLCRYGYQNDSEIASLYDEMVAAQIPYDVQYSDIDYMERQLDFTLSPKFAGFPALINRMKADGMRVILILDPAISGNETQPYPAFTRGVEDDVFIKYPNDGDIVWGKVWPDFPDVVVNGSLDWDSQVELYRAYVAFPDFFRNSTAKWWKREIEELYNNPQNPERSLKFDGMWIDMNEPSSFVNGAVSPGCRDASLNHPPYMPHLESRDRGLSSKTLCMESQQILPDGSLVQHYNVHNLYGWSQTRPTYEAVQEVTGQRGVVITRSTFPSSGRWAGHWLGDNTAAWDQLKKSIIGMMEFSLFGISYTGADICGFFQDAEYEMCVRWMQLGAFYPFSRNHNTIGTRRQDPVSWDVAFVNISRTVLQTRYTLLPYLYTLMHKAHTEGVTVVRPLLHEFVSDQVTWDIDSQFLLGPAFLVSPVLERNARNVTAYFPRARWYDYYTGVDINARGEWKTLPAPLDHINLHVRGGYILPWQEPALNTHLSRQKFMGFKIALDDEGTAGGWLFWDDGQSIDTYGKGLYYLASFSASQNTMQSHIIFNNYITGTNPLKLGYIEIWGVGSVPVTSVSISVSGMVITPSFNNDPTTQVLSIDVTDRNISLHNFTSLTWHHHHHH","Homo sapiens","MGAM, MGA, MGAML","Maltase-glucoamylase, intestinal","1","3TOP"
"3TOQ",,"X-RAY DIFFRACTION",3.44,64.26,"VAPOR DIFFUSION, SITTING DROP",8.2,"1.4 M Sodium Potassium, Phosphate pH 8.2 (Hampton Research, Index Screen B7 condition), 289 K , VAPOR DIFFUSION, SITTING DROP",289,,,"3TOQ",11.28,"2","2","Acylphosphatase with mesophilic surface and thermophilic core","MAEGNTLISADLEIFGKVQGVFFRKHMQAEAKKLGVVGWVQNTDRGTVQAQLQGPISKVRHLQEWAETRGSPKSHIDKANFNNEKVILKLDYSDFQIVK","Homo sapiens","ACYP1, ACYPE","Acylphosphatase-1","1","3TOQ"
"3TOW",,"X-RAY DIFFRACTION",1.76,30.28,"VAPOR DIFFUSION, HANGING DROP",8.5,"33% PEG 400, 0.1M Tris pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1073/pnas.1117597109",,"3TOW",17.23,"1.34","1.34","Crystal Structure of the MABP Domain of MVB12B of Human ESCRT-I Complex","MDPITGVGVVASRNRAPTGYDVVAQTADGVDADLWKDGLFKSKVTRYLCFTRSFSKENSHLGNVLVDMKLIDIKDTLPVGFIPIQETVDTQEVAFRKKRLCIKFIPRDSTEAAICDIRIMGRTKQAPPQYTFIGELNSMGIWYRMGHHHHHH","Homo sapiens","C9orf28, FAM125B, MVB12B","Multivesicular body subunit 12B","1","3TOW"
"3TPJ",,"X-RAY DIFFRACTION",2.67,53.94,"VAPOR DIFFUSION, HANGING DROP",6.4,"20-25%(w/v) PEG 5000, 200mM monomethyl ether, 200mM ammonium iodide, 200mM sodium citrate, pH 6.4, vapor diffusion, hanging drop, temperature 293K",293,"10.1107/S0907444911047251",,"3TPJ",49.27,"1.61","1.61","APO structure of BACE1","MGSSHHHHHHSAGENLYFQGTLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGAWAGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","3TPJ"
"3TPL",,"X-RAY DIFFRACTION",2.61,52.8,"VAPOR DIFFUSION, HANGING DROP",6.4,"20-25%(w/v)PEG 5000, 200mM monomethyl ether, 200mM ammonium iodide, 200mM sodium citrate, pH 6.4, vapor diffusion, hanging drop, temperature 293K",293,"10.1107/S0907444911047251",,"3TPL",144.99,"2.5","2.5","APO Structure of BACE1","MGSSHHHHHHSAGENLYFQGTLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGAWAGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","3TPL"
"3TPP",,"X-RAY DIFFRACTION",2.66,53.74,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5-1.8M Li2SO4, 100mM HEPES, pH 7.5, vapor diffusion, hanging drop, temperature 293K",293,"10.1107/S0907444911047251","5HA","3TPP",49.94,"1.6","1.6","Crystal structure of BACE1 complexed with an inhibitor","MGSSHHHHHHSAGENLYFQGTLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGAWAGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","3TPP"
"3TPR",,"X-RAY DIFFRACTION",2.75,55.27,"VAPOR DIFFUSION, HANGING DROP",7.5,"20-25% (w/v) PEG 5000, monomethyl ether, 200mM ammonium iodide, 200mM sodium citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1107/S0907444911047251","5HA","3TPR",48.95,"2.55","2.55","Crystal structure of BACE1 complexed with an inhibitor","MGSSHHHHHHSAGENLYFQGTLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","3TPR"
"3TPX",,"X-RAY DIFFRACTION",2.43,49.32,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M MES, pH 5.5, 25% PEG4000, 0.15 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm3005465",,"3TPX",35.58,"1.8","1.8","Crystal structure of human MDM2 in complex with a trifluoromethylated D-peptide inhibitor","ETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVV","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","3TPX"
,,,,,,,,,,,,,,,,"TAWYANXEKLLR",,,"D-peptide inhibitor DPMI-delta","2","3TPX"
"3TQ1",,"X-RAY DIFFRACTION",2.07,40.65,"VAPOR DIFFUSION, HANGING DROP",5.5,"20%-35% PEG 3350, 0.1M Bis-Tris pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2011.11.038",,"3TQ1",55.32,"2.556","2.556","Human DNA Polymerase eta in binary complex with DNA","GPHMATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNMNTSGIQTEWSPPLTMLFLCATKFSAS","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","3TQ1"
,,,,,,,,,,,,,,,,"TCATTATGACGCT",,,"DNA (5'-D(*TP*CP*AP*TP*TP*AP*TP*GP*AP*CP*GP*CP*T)-3')","2","3TQ1"
,,,,,,,,,,,,,,,,"TAGCGTCAT",,,"DNA (5'-D(*TP*AP*GP*CP*GP*TP*CP*AP*T)-3')","3","3TQ1"
"3TRT",,"X-RAY DIFFRACTION",2.48,50.47,"VAPOR DIFFUSION, HANGING DROP",8.5,"2M ammonium sulphate, 0.1M Tris pH8.5 + protein in 10 mM Tris pH 8, 38 mM NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.jsb.2011.11.014",,"3TRT",18.32,"2.3","2.3","Crystal structure of stabilised vimentin coil2 fragment","GGSKPDCTAAMRDVRQQYESVAAKNLQEAEEWYKSKFADLSEAANRNNDALRQAKQESTEYRRQVQSLTMEVDALKG","Homo sapiens","VIM","Vimentin","1","3TRT"
"3TRX",,"SOLUTION NMR",,,,,,,"10.1021/bi00224a017",,"3TRX",11.72,,,"HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF REDUCED RECOMBINANT HUMAN THIOREDOXIN IN SOLUTION","MVKQIESKTAFQEALDAAGDKLVVVDFSATWCGPCKMIKPFFHSLSEKYSNVIFLEVDVDDCQDVASECEVKCTPTFQFFKKGQKVGEFSGANKEKLEATINELV","Homo sapiens","TXN, TRDX, TRX, TRX1","THIOREDOXIN","1","3TRX"
"3TS4",,"X-RAY DIFFRACTION",2.37,48.01,"VAPOR DIFFUSION, SITTING DROP",9,"MMP12 AT 0.4 mM co-crystallization, with 100mM AHA and non-chelating inhibitor EEG at 1.1 mM with reservoir: 27% PEG 10K, 0.1M glycine. AHA removed during cryo-soak for 5 min in 30% MPEG2K, 10% ethylene glycol, 200 mM imidazole malate, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M112.380782","EEG","3TS4",18.59,"1.587","1.587","Human MMP12 in complex with L-glutamate motif inhibitor","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","HME, MMP12","Macrophage metalloelastase","1","3TS4"
"3TS8",,"X-RAY DIFFRACTION",3.13,60.67,"VAPOR DIFFUSION, HANGING DROP",7,"0.2 M potassium tartrate tetrahydrate, 20% Polyethylene Glycol 3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1158/1541-7786.MCR-11-0351",,"3TS8",122.71,"2.8","2.8","Crystal structure of a multidomain human p53 tetramer bound to the natural CDKN1A(p21) p53-response element","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFVQLAKTVPVQLYVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERSSDSDGLAPPQHLIRVEGNLRAEYLDDPNTFRHSVVVPYEPPEVGSDYTTIYFKFMCNSSCMGGMNRRPILVIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKTMDGEYFTLQIRGRERFEQFRERNEALELKDAQAT","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","3TS8"
,,,,,,,,,,,,,,,,,"Homo sapiens","TP53, P53"
,,,,,,,,,,,,,,,,"AGGAACATGTCCCAACATGTTGAGAA",,,"CDKN1A(p21) sense strand","2","3TS8"
,,,,,,,,,,,,,,,,"CTCAACATGTTGGGACATGTTCCTTT",,,"CDKN1A(p21) anti-sense strand","3","3TS8"
"3TSK",,"X-RAY DIFFRACTION",2.37,48.05,"VAPOR DIFFUSION, SITTING DROP",9.5,"MMP-12 at 0.4 mM  co-crystallized with 100 mM AHA and compound QEG at 1 mM against reservoir solution: 27% PEG 10000, 100 mM Tris-HCl, pH 9.5. 24h in cryoprotectant to remove AHA. 70 MICRO-M compound QEG in 10% di-ethylene glycol, 10% 1.2-propanediol, 10% glycerol, 10% PEG 10K, 200 mM NaCl, 33.3 mM sodium acetate, 33.3 mM ADA, 33.3 mM bicine, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M112.380782","QEG","3TSK",18.43,"2","2","Human MMP12 in complex with L-glutamate motif inhibitor","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDDHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYG","Homo sapiens","HME, MMP12","Macrophage metalloelastase","1","3TSK"
"3TSV",,"X-RAY DIFFRACTION",1.69,27.3,"VAPOR DIFFUSION, SITTING DROP",5,"25% PEG 1500, 0.1M MMT, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1074/jbc.M111.304089",,"3TSV",13.71,"1.989","1.989","crystal structure of the third PDZ domain of the human ZO-1 MAGUK protein","MGSSHHHHHHSSGGTENLYFQGHMILRPSMKLVKFRKGDSVGLRLAGGNDVGIFVAGVLEDSPAAKEGLEEGDQILRVNNVDFTNIIREEAVLFLLDLPKGEEVTILAQKKKDVYRRIVESDVG","Homo sapiens","TJP1, ZO1","Tight junction protein ZO-1","1","3TSV"
"3TSW",,"X-RAY DIFFRACTION",2.99,58.82,"VAPOR DIFFUSION, HANGING DROP",5,"1.2M AmSO4, 0.1M NaAc pH 5.0, 60mM NaF, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1074/jbc.M111.304089",,"3TSW",179.32,"2.847","2.847","crystal structure of the PDZ3-SH3-GUK core module of Human ZO-1","GSHMILRPSMKLVKFRKGDSVGLRLAGGNDVGIFVAGVLEDSPAAKEGLEEGDQILRVNNVDFTNIIREEAVLFLLDLPKGEEVTILAQKKKDVYRRIVESDVGDSFYIRTHFEYEKESPYGLSFNKGEVFRVVDTLYNGKLGSWLAIRIGKNHKEVERGIIPNKNRAEQLASVQYTLPKTAGGDRADFWRFRGLRSSKRNLRKSREDLSAQPVQTKFPAYERVVLREAGFLRPVTIFGPIADVAREKLAREEPDIYQIAKSEPRDAGTDQRSSGIIRLHTIKQIIDQDKHALLDVTPNAVDRLNYAQWYPIVVFLNPDSKQGVKTMRMRLCPESRKSARKLYERSHKLRKNNHHLFTTTINLNSMNDGWYGALKEAIQQQQNQLVWVSEG","Homo sapiens","TJP1, ZO1","Tight junction protein ZO-1","1","3TSW"
"3TT0",,"X-RAY DIFFRACTION",1.91,35.51,"VAPOR DIFFUSION, HANGING DROP",7.5,"CRYSTALLIZED FROM RESERVOIR CONTAINING 18-28% (V:V) PEG-MME 5000, 0.2 M AMSO4, AND     
0.1 M SODIUM CACODYLATE , pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm2006222","07J","3TT0",90.38,"2.8","2.8","Co-structure of Fibroblast Growth Factor Receptor 1 kinase domain with 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (BGJ398)","MGYYHHHHHHDYDIPTTENLYFNGMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHHHHHDYDIPTTENLYFNG","Homo sapiens","FGFR1, FGFBR, FLG, FLT2, BFGFR, CEK, HBGFR","Basic fibroblast growth factor receptor 1","1","3TT0"
"3TT4",,"X-RAY DIFFRACTION",2.25,45.3,"VAPOR DIFFUSION, SITTING DROP",5.5,"MMP-8 at 400 micro-M co-crystallization with peptidic inhibitor with reservoir solution 17.5% PEG 20K, 0.1 M MES, 0.125 M NACL. VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K. Inhibitor exchange: 24hr soak in 25% PEG 4K instead of 17.5% PEG20K with 100 micro-M E1S inhibitor in 6 micro-L volume cryoprotectant is 12% PEG10K, 13.75% MPEG2K, 5% di-ethylene glycol, 10% 1,2-propanediol, 10% glycerol, 0.025 M MES PH 5.5, 30 sec cryoprotectant soak",293,"10.1074/jbc.M112.380782","E1S","3TT4",18.45,"1.88","1.88","Human MMP8 in complex with L-glutamate motif inhibitor","GNPKWERTNLTYRIRNYTPQLSEAEVERAIKDAFELWSVASPLIFTRISQGEADINIAFYQRDHGDNSPFDGPNGILAHAFQPGQGIGGDAHFDAEETWTNTSANYNLFLVAAHEFGHSLGLAHSSDPGALMYPNYAFRETSNYSLPQDDIDGIQAIYG","Homo sapiens","CLG1, MMP8","Neutrophil collagenase","1","3TT4"
"3TT8",,"X-RAY DIFFRACTION",1.86,33.75,"VAPOR DIFFUSION, HANGING DROP",6.4,"1mM sodium citrate, volume fractions of acetone 10% and 7.5 mM cooper(II) acetate monohydrate, pH 6.4, VAPOR DIFFUSION, HANGING DROP",,,,"3TT8",11.76,"1.12","1.12","Crystal Structure Analysis of Cu Human Insulin Derivative","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A-CHAIN","1","3TT8"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","INSULIN B-CHAIN","2","3TT8"
"3TT9",,"X-RAY DIFFRACTION",2.09,41.11,"VAPOR DIFFUSION, HANGING DROP",7,"reservoir: 22% (w/v) PEG 3350, 75 M malonic acid pH 7.0, protein: 5 mg/mL in 20 mM HEPES, NaOH pH 7.5, 0.1 M NaCl, 3 mM DTT, mix 1:1, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1161/CIRCGENETICS.111.961854",,"3TT9",26.4,"1.55","1.55","Crystal structure of the stable degradation fragment of human plakophilin 2 isoform a (PKP2a) C752R variant","GSNADMEMTLERAVSMLEADHMLPSRISAAATFIQHECFQKSEARKRVNQLRGILKLLQLLKVQNEDVQRAVCGALRNLVFEDNDNKLEVAELNGVPRLLQVLKQTRDLETKKQITGLLWNLSSNDKLKNLMITEALLTLTENIIIPFSGWPEGDYPKANGLLDFDIFYNVTGCLRNMSSAGADGRKAMRRCDGLIDSLVHYVRGTIADYQPDDKATENCVCILHNLSYQLEA","Homo sapiens","PKP2","Plakophilin-2","1","3TT9"
"3TTI",,"X-RAY DIFFRACTION",1.88,34.74,"VAPOR DIFFUSION, SITTING DROP",6.5,"100mm MES, 25% PEG 400, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2011.12.027","KBI","3TTI",53.19,"2.2","2.2","Crystal Structure of JNK3 complexed with CC-930, an orally active anti-fibrotic JNK inhibitor","MSLHFLYYCSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSEEKTKNGVVKGQPSPSGAAVNSSESLPPSSSVNDISSMSTDQTLASDTDSSLEASAGPLGCCR","Homo sapiens","JNK3, JNK3A, MAPK10, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","3TTI"
"3TTJ",,"X-RAY DIFFRACTION",1.86,34.03,"VAPOR DIFFUSION, SITTING DROP",6.5,"100mm MES, 25% PEG 400, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2011.12.028","JBI","3TTJ",53.07,"2.1","2.1","Crystal Structure of JNK3 complexed with CC-359, a JNK inhibitor for the prevention of ischemia-reperfusion injury","MSLHFLYYCSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSEEKTKNGVVKGQPSPSGAAVNSSESLPPSSSVNDISSMSTDQTLASDTDSSLEASAGPLGCCR","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","3TTJ"
"3TU1",,"X-RAY DIFFRACTION",2.47,50.1,"VAPOR DIFFUSION, SITTING DROP",4.8,"0.1 M sodium acetate 
18% PEG 4000 
, pH 4.8, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1002/cmdc.201100428","07G","3TU1",12.93,"1.603","1.603","Exhaustive Fluorine Scanning towards Potent p53-MDM2 Antagonist","QIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSEN","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","3TU1"
"3TUB",,"X-RAY DIFFRACTION",2.03,39.51,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG 3350, 0.2M NaCl, 0.1M bis-Tris pH6.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1111/j.1747-0285.2012.01443.x","FPU","3TUB",34.51,"2.23","2.23","Crystal structure of SYK kinase domain with 1-(5-(6,7-dimethoxyquinolin-4-yloxy)pyridin-2-yl)-3-((1R,2S)-2-phenylcyclopropyl)urea","MDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","3TUB"
"3TUC",,"X-RAY DIFFRACTION",2,38.45,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG 1500, 0.1M bis-Tris pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1111/j.1747-0285.2012.01443.x","FPW","3TUC",35.39,"2.1","2.1","Crystal structure of SYK kinase domain with 1-benzyl-N-(5-(6,7-dimethoxyquinolin-4-yloxy)pyridin-2-yl)-2-oxo-1,2-dihydropyridine-3-carboxamide","MDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","3TUC"
"3TUD",,"X-RAY DIFFRACTION",1.89,34.93,"VAPOR DIFFUSION, SITTING DROP",6.6,"30% PEG MME 2000, 0.1M bis-Tris pH 6.6, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1111/j.1747-0285.2012.01443.x","FPX","3TUD",35.41,"2.33","2.33","Crystal structure of SYK kinase domain with N-(4-methyl-3-(8-methyl-7-oxo-2-(phenylamino)-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)phenyl)-3-(trifluoromethyl)benzamide","MDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","3TUD"
"3TUG",,"X-RAY DIFFRACTION",2.29,46.28,"VAPOR DIFFUSION, SITTING DROP",7.5,"30% PEG1500, 0.2M NaCl 0.1M HEPES pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 297K",297,,,"3TUG",47.53,"2.27","2.27","Crystal structure of the HECT domain of ITCH E3 ubiquitin ligase","MHHHHHHSSGRENLYFQGYVRDFKAKVQYFRFWCQQLAMPQHIKITVTRKTLFEDSFQQIMSFSPQDLRRRLWVIFPGEEGLDYGGVAREWFFLLSHEVSNPMYCLFEYAGKDNYCLQINPASYINPDHLKYFRFIGRFIAMALFHGKFIDTGFSLPFYKRILNKPVGLKDLESIDPEFYNSLIWVKENNIEECDLEMYFSVDKEILGEIKSHDLKPNGGNILVTEENKEEYIRMVAEWRLSRGVEEQTQAFFEGFNEILPQQYLQYFDAKELEVLLCGMQEIDLNDWQRHAIYRRYARTSKQIMWFWQFVKEIDNEKRMRLLQFVTGTCRLPVGGFADLMGSNGPQKFCIEKVGKENWLPRSHTCFNRLDLPPYKSYEQLKEKLLFAIEETEGFGQE","Homo sapiens","ITCH","E3 ubiquitin-protein ligase Itchy homolog","1","3TUG"
"3TUH",,"X-RAY DIFFRACTION",2.98,58.78,,,,,,,"3TUH",47.51,"1.8","1.8","Crystal Structure of the N-terminal domain of an HSP90 in the presence of an the inhibitor ganetespib","EVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEK","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3TUH"
"3TUO",,"X-RAY DIFFRACTION",2.1,41.47,"VAPOR DIFFUSION, SITTING DROP",7,"15% polyethylene glycol 3350, 0.15M ammonium citrite dibasic, 4% polypropylene glycol P400, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1093/nar/gkr1284",,"3TUO",46.63,"1.697","1.697","Crystal structure of N-terminal domain of DNA-binding protein satb1","GPGSGTMLPVFCVVEHYENAIEYDCKEEHAEFVLVRKDMLFNQLIEMALLSLGYSHSSAAQAKGLIQVGKWNPVPLSYVTDAPDATVADMLQDVYHVVTLKIQLH","Homo sapiens","SATB1","DNA-binding protein SATB1","1","3TUO"
"3TV0",,"X-RAY DIFFRACTION",2.19,43.79,"VAPOR DIFFUSION",3.6,"19% PEG 2000, 0.15 M Potassium phosphate, pH 3.6, VAPOR DIFFUSION, temperature 295K",295,,,"3TV0",42.17,"2.1492","2.1492","Structure of dynactin p27 subunit","GSSSMAEKTQKSVKIAPGAVVCVESEIRGDVTIGPRTVIHPKARIIAEAGPIVIGEGNLIEEQALIINAYPDNITPDTEDPEPKPMIIGTNNVFEVGCYSQAMKMGDNNVIESKAYVGRNVILTSGCIIGACCNLNTFEVIPENTVIYGADCLRRVQTERPQPQTLQLDFLMKILPNYHHLKKTMKGSSTPVKN","Homo sapiens","DCTN6, WS3","Dynactin subunit 6","1","3TV0"
"3TV4",,"X-RAY DIFFRACTION",3.17,61.17,"VAPOR DIFFUSION, HANGING DROP",9,"PEG 8000, Tris pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/ml200025q","TV4","3TV4",71.33,"3.4","3.4","Human B-Raf Kinase Domain in Complex with an Bromopyridine Benzamide Inhibitor","MDRGSHHHHHHGSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","3TV4"
"3TV6",,"X-RAY DIFFRACTION",3.14,60.89,"VAPOR DIFFUSION, HANGING DROP",9,"PEG 8000, Tris pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/ml200025q","B0R","3TV6",71.29,"3.3","3.3","Human B-Raf Kinase Domain in Complex with a Methoxypyrazolopyridinyl Benzamide Inhibitor","MDRGSHHHHHHGSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHR","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","3TV6"
"3TV7",,"X-RAY DIFFRACTION",2.78,55.81,"VAPOR DIFFUSION, SITTING DROP",7.4,"10 mg/ml ROCK1, 75 mm hepes pH 7.4, 2.5 % tacsimate ph 7.4, 5 % PEG 5000 MME, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1039/C2MD00320A","07Q","3TV7",191.55,"2.75","2.75","Human Rho-associated protein kinase 1 (ROCK 1) in COMPLEX WITH RKI1342","SFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNR","Homo sapiens","ROCK1","Rho-associated protein kinase 1","1","3TV7"
"3TV8",,"X-RAY DIFFRACTION",2.77,55.59,"VAPOR DIFFUSION, HANGING DROP",4.6,"20% PEG 4000, 200mM Ammonium Sulfate, 100mM Sodium Acetate, pH 4.6, vapor diffusion, hanging drop, temperature 293K",293,"10.1016/j.chembiol.2011.10.012","DGJ","3TV8",96.44,"2.639","2.639","Pharmacological Chaperoning in Human alpha-Galactosidase","LDNGLARTPTMGWLHWERFMCNLDCQEEPDSCISEKLFMEMAELMVSEGWKDAGYEYLCIDDCWMAPQRDSEGRLQADPQRFPHGIRQLANYVHSKGLKLGIYADVGNKTCAGFPGSFGYYDIDAQTFADWGVDLLKFAGCYCDSLENLADGYKHMSLALNRTGRSIVYSCEWPLYMWPFQKPNYTEIRQYCNHWRNFADIDDSWKSIKSILDWTSFNQERIVDVAGPGGWNDPDMLVIGNFGLSWNQQVTQMALWAIMAAPLFMSNDLRHISPQAKALLQDKDVIAINQDPLGKQGYQLRQGDNFEVWERPLSGLAWAVAMINRQEIGGPRSYTIAVASLGKGVACNPACFITQLLPVKRKLGFYEWTSRLRSHINPTGTVLLQLENTMQMSLKDLLHHHHHH","Homo sapiens","GLA","Alpha-galactosidase A","1","3TV8"
"3TVC",,"X-RAY DIFFRACTION",2.76,55.45,"VAPOR DIFFUSION, SITTING DROP",5.5,"PROTEIN-INHIBITOR SOLUTION: MMP13 AT 20 MG/ML CO-CRYSTALLIZED WITH E3P AT 1.1 MILLI-M. RESERVOIR SOLUTION: 17.5% PEG 20K, 0.1 M MES, 0.02 M NACL. CRYOPROTECTANT: 5% DIETHYLENE GLYCOL, 5% ETHYLENE GLYCOL, 5% MPD, 5% PROPYLENE GLYCOL, 5% DMSO, 5% GLYCEROL, 0.005 M 3-(-PYRIDINIO)-1-PROPANESULFONATE, 10% PEG 20K, 0.033 M SODIUM ACETATE, 0.033 M ADA, 0.033 M  BICINE, PH 5.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,"10.1074/jbc.M112.380782","E3P","3TVC",20.02,"2.43","2.43","Human MMP13 in complex with L-glutamate motif inhibitor","YNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYGPGDED","Homo sapiens","MMP13","Collagenase 3","1","3TVC"
"3TVL",,"X-RAY DIFFRACTION",1.93,36.38,"VAPOR DIFFUSION, HANGING DROP",4.2,"O.1 citrate, 0.2 Ammonium sulfate, triphosphate 0.1M, pH 4.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bbagen.2013.05.014","3PO","3TVL",51.89,"2.3","2.3","Complex between the human thiamine triphosphatase and triphosphate","MAQGLIEVERKFLPGPGTEERLQELGGTLEYRVTFRDTYYDTPELSLMQADHWLRRREDSGWELKCPGAAGVLGPHTEYKELTAEPTIVAQLCKVLRADGLGAGDVAAVLGPLGLQEVASFVTKRSAWKLVLLGADEEEPQLRVDLDTADFGYAVGEVEALVHEEAEVPTALEKIHRLSSMLGVPAQETAPAKLIVYLQRFRPQDYQRLLEVNSSRERPQETEDPDHCLG","Homo sapiens","THTPA","Thiamine-triphosphatase","1","3TVL"
"3TVN",,"X-RAY DIFFRACTION",2.08,40.82,"VAPOR DIFFUSION, HANGING DROP",8,"1.25 M sodium citrate, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi301099k",,"3TVN",29.15,"1.497","1.497","Human Carbonic Anhydrase II Proton Transfer Mutant","HHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFQVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3TVN"
"3TVO",,"X-RAY DIFFRACTION",2.08,40.84,"VAPOR DIFFUSION, HANGING DROP",8,"1.25 M sodium citrate, 100 mM Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi301099k",,"3TVO",29.23,"1.6","1.6","Human Carbonic Anhydrase II Proton Transfer Double Mutant","HHWGFGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFQVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3TVO"
"3TVX",,"X-RAY DIFFRACTION",2.9,57.66,"VAPOR DIFFUSION, HANGING DROP",7.25,"2ul of 34mg/ml protein in HEPES pH 7.5 150mM NaCl, 5mM DTT with 2ul of 1.5mM Ammonium sulfate, 0.1 M Bis/Tris propane , VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1177/1087057111430987","PNX","3TVX",78.47,"2.84","2.84","The structure of PDE4A with pentoxifylline at 2.84A resolution","GAGTMNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAI","Homo sapiens","PDE4A, DPDE2","cAMP-specific 3',5'-cyclic phosphodiesterase 4A","1","3TVX"
"3TW2",,"X-RAY DIFFRACTION",2.08,40.75,"VAPOR DIFFUSION, HANGING DROP",5.5,"19% PEG 8000, 0.1M sodium cacodylate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1107/S1744309112029491",,"3TW2",28,"1.38","1.38","High resolution structure of human histidine triad nucleotide-binding protein 1 (hHINT1)/AMP complex in a monoclinic space group","MADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLHVLGGRQMHWPPG","Homo sapiens","HINT1, HINT, PKCI1, PRKCNH1","Histidine triad nucleotide-binding protein 1","1","3TW2"
"3TW4",,"X-RAY DIFFRACTION",3.33,63.04,"VAPOR DIFFUSION, HANGING DROP",8.4,"100mM Tris pH 8.4; 16% Glycerol; 1.5M Amonium Sulphate; 500mM GDP; 12.5% Isopropanol and 7mg/mL SETPT7G, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.febslet.2011.10.043",,"3TW4",63.16,"3.35","3.35","Crystal Structure of Human Septin 7 GTPase Domain","GFEFTLMVVGESGLGKSTLINSLFLTDLYSPEYPGPSHRIKKTVQVEQSKVLIKEGGVQLLLTIVDTPGFGDAVDNSNCWQPVIDYIDSKFEDYLNAESRVNRRQMPDNRVQCCLYFIAPSGHGLKPLDIEFMKRLHEKVNIIPLIAKADTLTPEECQQFKKQIMKEIQEHKIKIYEFPETDDEEENKLVKKIKDRLPLAVVGSNTIIEVNGKRVRGRQYPWGVAEVENGEHCDFTILRNMLIRTHMQDLKDVTNNVHYENYRSRKLAAVT","Homo sapiens","SEPT7, CDC10, SEPTIN7","Septin-7","1","3TW4"
"3TWJ",,"X-RAY DIFFRACTION",2.97,58.55,"VAPOR DIFFUSION, SITTING DROP",7.4,"10 MG/ML ROCK1, 75 MM hepes ph 7.4, 2.5 % tacsimate pH 7.4, 5 % PEG 5000 MME, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1158/0008-5472.CAN-12-0954","07R","3TWJ",190.78,"2.9","2.9","Rho-associated protein kinase 1 (ROCK 1) IN COMPLEX WITH RKI1447","SFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNR","Homo sapiens","ROCK1","Rho-associated protein kinase 1","1","3TWJ"
"3TWQ",,"X-RAY DIFFRACTION",2.17,43.31,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M HEPES-NaOH pH 8.0, 0.2 M Li2SO4,  35% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.cell.2011.10.046",,"3TWQ",38.37,"2.151","2.151","Crystal structure of ARC4 from human Tankyrase 2 (apo form)","GAMGISLGNSEADRQLLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPLDLVKDGDTDIQDLLRGDAALLDAAKK","Homo sapiens","PARP5B, TANK2, TNKL, TNKS2","Tankyrase-2","1","3TWQ"
"3TXO",,"X-RAY DIFFRACTION",2.53,51.3,"FREE INTERFACE DIFUSION",7.8,"1 uL protein (18mg/ml in 0.25 M NaCl, 0.025 M Tris pH 7.8, 4mM TCEP, 1mM EDTA) with 3-4 uL crystallisation buffer (25 % PEG3350 w/v, 200 mM citrate), FREE INTERFACE DIFUSION, temperature 298K",298,"10.1016/j.bmcl.2011.10.025","07U","3TXO",40.79,"2.05","2.05","PKC eta kinase in complex with a naphthyridine","GPKESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGHLPMINQDEFRNFEYVSPELQP","Homo sapiens","PRKCH, PKCL, PRKCL","Protein kinase C eta type","1","3TXO"
"3TY0",,"X-RAY DIFFRACTION",2.62,53.12,,,,,"10.1021/jm201061j","082","3TY0",64.16,"2","2","Structure of PPARgamma ligand binding domain in complex with (R)-5-(3-((3-(6-methoxybenzo[d]isoxazol-3-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)methyl)phenyl)-5-methyloxazolidine-2,4-dione","GSQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3TY0"
"3TYY",,"X-RAY DIFFRACTION",2.68,54.11,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG3350, 0.2M LISO4, 0.1M BIS-TRIS pH 6.5, 0.1M CrCl3, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1016/j.febslet.2012.01.007",,"3TYY",23.14,"2.399","2.399","Crystal Structure of Human Lamin-B1 Coil 2 Segment","MHHHHHHSSRENLYFQGQKESRACLERIQELEDLLAKEKDNSRRMLTDKEREMAEIRDQMQQQLNDYEQLLDVKLALDMEISAYRKLLEGEEERL","Homo sapiens","LMN2, LMNB, LMNB1","Lamin-B1","1","3TYY"
"3TZB",,"X-RAY DIFFRACTION",2.23,44.91,"VAPOR DIFFUSION, SITTING DROP",,"VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1158/1535-7163.MCT-11-0543",,"3TZB",107.59,"2.1901","2.1901","Quinone Oxidoreductase (NQ02) bound to NSC13000","AMGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFG","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","3TZB"
"3TZM",,"X-RAY DIFFRACTION",2.08,40.73,"VAPOR DIFFUSION, HANGING DROP",8,"100 mM Imidazole 
10% PEG 8000, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.cellsig.2011.09.027","085","3TZM",35.61,"1.7","1.7","TGF-beta Receptor type 1 in complex with SB431542","GAMGSTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM","Homo sapiens","TGFBR1, ALK5, SKR4","TGF-beta receptor type-1","1","3TZM"
"3TZS",,"X-RAY DIFFRACTION",3.16,61.06,"VAPOR DIFFUSION, SITTING DROP",4.5,"HosaA.18070.a protein at 10 mg/mL against 1.3M Ammonium sulfate, 0.2M Lithium sulfate, 50mM sodium chloride, 0.1M sodium acetate with 15% glycerol as cryo-protectant, crystal tracking ID 224571a10, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,,,"3TZS",64.81,"2.45","2.45","Crystal structure of Neutrophil gelatinase-associated lipocalin NGAL (C87S mutant) in complex with fragment 1026, phenylurea","GQDSTSDLIPAPPLSKVPLQQNFQDNQFQGKWYVVGLAGNAILREDKDPQKMYATIYELKEDKSYNVTSVLFRKKKCDYWIRTFVPGSQPGEFTLGNIKSYPGLTSYLVRVVSTNYNQHAMVFFKKVSQNREYFKITLYGRTKELTSELKENFIRFSKSLGLPENHIVFPVPIDQCIDGIVTD","Homo sapiens","HNL, LCN2, NGAL, Oncogene 24p3","Neutrophil gelatinase-associated lipocalin","1","3TZS"
"3U0D",,"X-RAY DIFFRACTION",4.55,72.95,"VAPOR DIFFUSION, HANGING DROP",4.5,"HosaA.18070.a at 10mg/ml. 1.3M Ammonium sulfate, 0.2M Lithium sulfate, 50mM sodium chloride, 0.1M sodium acetate, pH 4.5. Cryo protection 15% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1371/journal.pone.0043696","DBH","3U0D",92.57,"2.51","2.51","The structure of human Siderocalin bound to the bacterial siderophore 2,3-DHBA","MPLGLLWLGLALLGALHAQAQDSTSDLIPAPPLSKVPLQQNFQDNQFQGKWYVVGLAGNAILREDKDPQKMYATIYELKEDKSYNVTSVLFRKKKCDYWIRTFVPGSQPGEFTLGNIKSYPGLTSYLVRVVSTNYNQHAMVFFKKVSQNREYFKITLYGRTKELTSELKENFIRFSKSLGLPENHIVFPVPIDQCIDG","Homo sapiens","LCN2, HNL, NGAL","Neutrophil gelatinase-associated lipocalin","1","3U0D"
"3U0R",,"X-RAY DIFFRACTION",2.45,49.87,"VAPOR DIFFUSION, HANGING DROP",9,"10% PEG 6000, 100mM, bicine pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M111.317594",,"3U0R",57.12,"2.5","2.5","Helical repeat structure of apoptosis inhibitor 5 reveals protein-protein interaction modules","GSHMPTVEELYRNYGILADATEQVGQHKDAYQVILDGVKGGTKEKRLAAQFIPKFFKHFPELADSAINAQLDLCEDEDVSIRRQAIKELPQFATGENLPRVADILTQLLQTDDSAEFNLVNNALLSIFKMDAKGTLGGLFSQILQGEDIVRERAIKFLSTKLKTLPDEVLTKEVEELILTESKKVLEDVTGEEFVLFMKILSGLKSLQTVSGRQQLVELVAEQADLEQTFNPSDPDCVDRLLQCTRQAVPLFSKNVHSTRFVTYFCEQVLPNLGTLTTPVEGLDIQLEVLKLLAEMSSFCGDMEKLETNLRKLFDKLLEYMPLPPEEAENGENAGNEEPKLQFSYVECLLYSFHQLGRKLPDFLTAKLNAEKLKDFKIRLQYFARGLQVYIRQLRLALQGKTGEALKTEENKIKVVALKITNNINVLIKDLFHIPPSYKSTVTLSWKPVQKVEIGQKRASEDTTSGSPPKKSSAGPKRDARQIYNPPSGKYSSNLGNFNYERSLQGK","Homo sapiens","API5, MIG8","Apoptosis inhibitor 5","1","3U0R"
"3U0V",,"X-RAY DIFFRACTION",2.1,41.36,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% w/v PEG 3350, 0.1M Bis-Tris pH 5.5, vapor diffusion, sitting drop, temperature 293K",293,"10.1194/jlr.M019851",,"3U0V",26.52,"1.72","1.72","Crystal Structure Analysis of human LYPLAL1","GPMAAASGSVLQRCIVSPAGRHSASLIFLHGSGDSGQGLRMWIKQVLNQDLTFQHIKIIYPTAPPRSYTPMKGGISNVWFDRFKITNDCPEHLESIDVMCQVLTDLIDEEVKSGIKKNRILIGGFSMGGCMAMHLAYRNHQDVAGVFALSSFLNKASAVYQALQKSNGVLPELFQCHGTADELVLHSWAEETNSMLKSLGVTTKFHSFPNVYHELSKTELDILKLWILTKLPGEMEKQK","Homo sapiens","LYPLAL1","Lysophospholipase-like protein 1","1","3U0V"
"3U0X",,"X-RAY DIFFRACTION",2.41,49,"VAPOR DIFFUSION, HANGING DROP",7,"23% PEG-3350, 300 mM Ammonium Sulfate, 50 mM MOPS, 50 mM MnCl2, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,,,"3U0X",71.3,"1.85","1.85","Crystal structure of the B-specific-1,3-galactosyltransferase (GTB) in complex with compound 382","MAIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","3U0X"
"3U0Y",,"X-RAY DIFFRACTION",2.34,47.37,"VAPOR DIFFUSION, HANGING DROP",7,"50 mM MOPS pH 7, 50-200 mM ammonium sulfate, 50 mM MnCl2, 6-9% PEG-3350, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,,,"3U0Y",71.19,"1.6","1.6","Crystal structure of the Fucosylgalactoside alpha N-acetylgalactosaminyltransferase (GTA, cisAB mutant L266G, G268A) in complex with compound 382 and UDP","MAIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYGGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","3U0Y"
"3U10",,"X-RAY DIFFRACTION",2.42,49.21,"VAPOR DIFFUSION",4.6,"20% PEG 8000, 0.5M NaCl, 0.1M Citrate buffer (pH 4.6), 10% glycerol, VAPOR DIFFUSION, temperature 278K",278,"10.1074/jbc.M111.297606","CMP","3U10",24.86,"2.3","2.3","Tetramerization dynamics of the C-terminus underlies isoform-specific cAMP-gating in HCN channels","QGPSSPMDSSRRQYQEKYKQVEQYMSFHKLPADFRQKIHDYYEHRYQGKMFDEDSILGELNGPLREEIVNFNCRKLVASMPLFANADPNFVTAMLTKLKFEVFQPGDYIIREGTIGKKMYFIQHGVVSVLTKGNKEMKLSDGSYFGEICLLTRGRRTASVRADTYCRLYSLSVDNFNEVLEEYPMMRRAFETVAIDRLDRIGKKNSILLH","Homo sapiens","HCN2, BCNG2","Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2","1","3U10"
"3U11",,"X-RAY DIFFRACTION",2.29,46.28,"VAPOR DIFFUSION",5,"25% PEG 3350, 0.4M Sodium Acetate buffer, pH 5.0, 0.5M dibasic Ammonium phosphate, VAPOR DIFFUSION, temperature 278K",278,"10.1074/jbc.M111.297606",,"3U11",50.37,"2.5","2.5","Tetramerization dynamics of the C-terminus underlies isoform-specific cAMP-gating in HCN channels","QGPSSPMDSSRRQYQEKYKQVEQYMSFHKLPPDTRQRIHDYYEHRYQGKMFDEESILGELSEPLREEIINFNCRKLVASMPLFANADPNFVTSMLTKLRFEVFQPGDYIIREGTIGKKMYFIQHGVVSVLTKGNKETKLADGSYFGEICLLTRGRRTASVRADTYCRLYSLSVDNFNEVLEEYPMMRRAFETVALDRLDRIGKKNSILLH","Homo sapiens","HCN4","Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4","1","3U11"
"3U12",,"X-RAY DIFFRACTION",2.05,39.91,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1 M Sodium acetate pH 5.6, 2.46 M ammonium sulfate,  
10 mM DTT 
, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,,,"3U12",32.31,"2.08","2.08","The pleckstrin homology (PH) domain of USP37","MGSSHHHHHHSSGLVPRGSLKIHGPIRIRSMQTGITKWKEGSFEIVEKENKVSLVVHYNTGGIPRIFQLSHNIKNVVLRPSGAKQSRLMLTLQDNSFLSIDKVPSKDAEEMRLFLDAVHQNRLPAAMKPSQGSGSFGAILG","Homo sapiens","USP37, KIAA1594","USP37 protein","1","3U12"
"3U15",,"X-RAY DIFFRACTION",2.37,48.02,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.4-2.0M ammonium sulfate  
1.4-2.0M NaCl, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1073/pnas.1203789109","03M","3U15",46.55,"1.8","1.8","Structure of hDMX with Dimer Inducing Indolyl Hydantoin RO-2443","GPDSASRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLAT","Homo sapiens","MDM4, MDMX","Protein Mdm4","1","3U15"
"3U18",,"X-RAY DIFFRACTION",2.69,54.29,"VAPOR DIFFUSION",8,"100 mM p425 dissolved in 2.0 M ammonium sulfate, 4% 2-propanol, 0.1 M Tris, VAPOR DIFFUSION, temperature 310K, pH 8",310,"10.1074/jbc.M112.385583","Y0X","3U18",39.51,"1.9","1.9","Chicago Sky Blue 6B, A Novel Inhibitor for Macrophage Migration Inhibitory Factor","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","3U18"
"3U1K",,"X-RAY DIFFRACTION",2.72,54.84,"VAPOR DIFFUSION, HANGING DROP",5,"10%(v/v) 2-Propanol, 0.1M Sodium citrate tribasic dihydrate, 26%(v/v) Polyethylene glycol 400 , pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/nar/gkr1281",,"3U1K",276.78,"2.13","2.13","Crystal structure of human PNPase","GSHMASAVAVDLGNRKLEISSGKLARFADGSAVVQSGDTAVMVTAVSKTKPSPSQFMPLVVDYRQKAAAAGRIPTNYLRREVGTSDKEILTSRIIDRSIRPLFPAGYFYDTQVLCNLLAVDGVNEPDVLAINGASVALSLSDIPWNGPVGAVRIGIIDGEYVVNPTRKEMSSSTLNLVVAGAPKSQIVMLEASAENILQQDFCHAIKVGVKYTQQIIQGIQQLVKETGVTKRTPQKLFTPSPEIVKYTHKLAMERLYAVFTDYEHDKVSRDEAVNKIRLDTEEQLKEKFPEADPYEIIESFNVVAKEVFRSIVLNEYKRCDGRDLTSLRNVSCEVDMFKTLHGSALFQRGQTQVLCTVTFDSLESGIKSDQVITAINGIKDKNFMLHYEFPPYATNEIGKVTGLNRRELGHGALAEKALYPVIPRDFPFTIRVTSEVLESNGSSSMASACGGSLALMDSGVPISSAVAGVAIGLVTKTDPEKGEIEDYRLLTDILGIEDYNGDMDFKIAGTNKGITALQADIKLPGIPIKIVMEAIQQASVAKKEILQIMNKTISKPRASRKENGPVVETVQVPLSKRAKFVGPGGYNLKKLQAETGVTISQVDEETFSVFAPTPSAMHEARDFITEICK","Homo sapiens","PNPT1, PNPASE","Polyribonucleotide nucleotidyltransferase 1, mitochondrial","1","3U1K"
"3U1N",,"X-RAY DIFFRACTION",2.57,52.23,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,"10.1038/nature10623",,"3U1N",246.73,"3.1","3.1","Structure of the catalytic core of human SAMHD1","ASWSHPQFEKGALEVLFQGPGDPIHGHIELHPLLVRIIDTPQFQRLRYIKQLGGGYYVFPGASHNRFEHSLGVGYLAGCLVHALGEKQPELQISERDVLCVQIAGLCHDLGHGPFSHMFDGRFIPLARPEVKWTHEQGSVMMFEHLINSNGIKPVMEQYGLIPEEDICFIKEQIVGPLESPVEDSLWPYKGRPENKSFLYEIVSNKRNGIDVDKWDYFARDCHHLGIQNNFDYKRFIKFARVCEVDNELRICARDKEVGNLYDMFHTRNSLHRRAYQHKVGNIIDTMITDAFLKADDYIEITGAGGKKYRISTAIDDMEAYTKLTDNIFLEILYSTDPKLKDAREILKQIEYRNLFKYVGETQPTGQIKIKREDYESLPKEVASAKPKVLLDVKLKAEDFIVDVINMDYGMQEKNPIDHVSFYCKTAPNRAIRITKNQVSQLLPEKFAEQLIRVYCKKVDRKSLYAARQYFVQWCADRNFTKPQDGDVIAPLITPQKKEWNDSTSVQNPTRLREASKSRVQLFKDDPM","Homo sapiens","MOP5, SAMHD1","SAM domain and HD domain-containing protein 1","1","3U1N"
"3U1S",,"X-RAY DIFFRACTION",3.24,62.05,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES, pH 7.5, 2 M ammonium sulfate and 20% PEG 400, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nature10696",,"3U1S",55.67,"2.3","2.3","Crystal structure of human Fab PGT145, a broadly reactive and potent HIV-1 neutralizing antibody","MRLPAQLLGLLMLWVSGSGAEVVITQSPLFLPVTPGEAASLSCKCSHSLQHSTGANYLAWYLQRPGQTPRLLIHLATHRASGVPDRFSGSGSGTDFTLKISRVESDDVGTYYCMQGLHSPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Fab PGT145 Light chain","1","3U1S"
,,,,,,,,,,,,,,,,"QASTMDWIWRILFLVAAATSAHSQVQLVQSGAEVKKPGSSVKVSCKASGNSFSNHDVHWVRQATGQGLEWMGWMSHEGDKTGLAQKFQGRVTITRDSGASTVYMELRGLTADDTAIYYCLTGSKHRLRDYFLYNEYGPNYEEWGDYLATLDVWGHGTAVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCD","Homo sapiens",,"Fab PGT145 Heavy chain","2","3U1S"
"3U1U",,"X-RAY DIFFRACTION",2.7,53.8,"sitting drop vapor diffusion",5.5,"25% PEG-3350, 0.2M ammonium sulfate, 0.1M sodium cacodylate, pH 5.5, sitting drop vapor diffusion, temperature 291K",291,,,"3U1U",32.31,"1.8","1.8","Crystal structure of RNA polymerase-associated protein RTF1 homolog Plus-3 domain","GPPKSQPVSLPEELNRVRLSRHKLERWCHMPFFAKTVTGCFVRIGIGNHNSKPVYRVAEITGVVETAKVYQLGGTRTNKGLQLRHGNDQRVFRLEFVSNQEFTESEFMKWKEAMFSAGMQLPTLDEINKKELSIKEA","Homo sapiens","RTF1, KIAA0252","RNA polymerase-associated protein RTF1 homolog","1","3U1U"
"3U21",,"X-RAY DIFFRACTION",2.09,41.26,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.09M HEPES pH 7.5, 10% glycerol, 1.26M tri-sodium citrate, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1371/journal.pone.0043761",,"3U21",29.03,"2.18","2.18","Crystal structure of a Fragment of Nuclear factor related to kappa-B-binding protein (residues 370-495) (NFRKB) from Homo sapiens at 2.18 A resolution","GLGINEISSSFFSLLLEILLLESQASLPMLEERVLDWQSSPASSLNSWFSAAPNWAELVLPALQYLAGESRAVPSSFSPFVEFKEKTQQWKLLGQSQDNEKELAALFQLWLETKDQAFCKQENEDSS","Homo sapiens","BC063280, INO80G, NFRKB","Nuclear factor related to kappa-B-binding protein","1","3U21"
"3U2C",,"X-RAY DIFFRACTION",2.18,43.49,"VAPOR DIFFUSION",5,"ammonium citrate, PEG4000, pH 5, VAPOR DIFFUSION, temperature 278K",278,"10.1002/cmdc.201100374","SUZ","3U2C",37.95,"1","1","Aldose reductase in complex with NSAID-type inhibitor at 1.0 A resolution","MASRILLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, aldose reductase, ALDR1, ALR2","Aldose reductase","1","3U2C"
"3U2I",,"X-RAY DIFFRACTION",2.39,48.54,"VAPOR DIFFUSION, HANGING DROP",7.4,"2.0M tri-ammonium citrate(pD7.4), 0.4M MgCl2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jsb.2011.12.022",,"3U2I",25.78,"1.7","1.7","X-ray crystal structure of human Transthyretin at room temperature","MLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3U2I"
"3U2J",,"NEUTRON DIFFRACTION",,,"VAPOR DIFFUSION, SITTING DROP",7.4,"1.85M tri-ammonium citrate, pD7.4, 0.4M MgCl2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jsb.2011.12.022",,"3U2J",25.78,"2","2","Neutron crystal structure of human Transthyretin","MLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3U2J"
"3U2L",,"X-RAY DIFFRACTION",2.23,44.76,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M MES, 20% PEG6000, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/ja209881f",,"3U2L",14.48,"1.95","1.95","Crystal structure of human ALR mutant C142S.","FREDCPPDREELGRHSWAVLHTLAAYYPDLPTPEQQQDMAQFIHLFSKFYPSEECAEDLRKRLARNHPDTRTRAAFTQWLCHLHNEVNRKLGKPDFDCSKVDERWRDGWKDGSCD","Homo sapiens","GFER, ALR, HERV1, HPO","FAD-linked sulfhydryl oxidase ALR","1","3U2L"
"3U2M",,"X-RAY DIFFRACTION",2.21,44.37,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M MES, 20% PEG6000 , pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1021/ja209881f",,"3U2M",14.47,"2","2","Crystal structure of human ALR mutant C142/145S","FREDCPPDREELGRHSWAVLHTLAAYYPDLPTPEQQQDMAQFIHLFSKFYPSEESAEDLRKRLARNHPDTRTRAAFTQWLCHLHNEVNRKLGKPDFDCSKVDERWRDGWKDGSCD","Homo sapiens","GFER, ALR, HERV1, HPO","FAD-linked sulfhydryl oxidase ALR","1","3U2M"
"3U2O",,"X-RAY DIFFRACTION",3.41,63.95,"VAPOR DIFFUSION",4.8,"ammonium sulfate, pH 4.8, vapor diffusion, temperature 293K",293,"10.1016/j.bmcl.2011.10.052","03U","3U2O",44.28,"2.18","2.18","Dihydroorotate Dehydrogenase (DHODH) crystal structure in complex with small molecule inhibitor","MAWRHLKKRAQDAVIILGGGGLLFASYLMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","3U2O"
"3U2P",,"X-RAY DIFFRACTION",2.48,50.37,"VAPOR DIFFUSION, HANGING DROP",6,"16% PEG8000,0.2M Calcium acetate, 0.1M Socium Cacodylate, VAPOR DIFFUSION, HANGING DROP, temperature 293K, pH 6.0",293,"10.1002/pro.753",,"3U2P",56.58,"2.57","2.57","Crystal structure of N-terminal three extracellular domains of ErbB4/Her4","QSVCAGTENKLSSLSDLEQQYRALRKYYENCEVVMGNLEITSIEHNRDLSFLRSVREVTGYVLVALNQFRYLPLENLRIIRGTKLYEDRYALAIFLNYRKDGNFGLQELGLKNLTEILNGGVYVDQNKFLCYADTIHWQDIVRNPWPSNLTLVSTNGSSGCGRCHKSCTGRCWGPTENHCQTLTRTVCAEQCDGRCYGPYVSDCCHRECAGGCSGPKDTDCFACMNFNDSGACVTQCPQTFVYNPTTFQLEHNFNAKYTYGAFCVKKCPHNFVVDSSSCVRACPSSKMEVEENGIKMCKPCTDICPKACDGIGTGSLMSAQTVDSSNIDKFINCTKINGNLIFLVTGIHGDPYNAIEAIDPEKLNVFRTVREITGFLNIQSWPPNMTDFSVFSNLVTIGGRVLYSGLSLLILKQQGITSLQFQSLKEISAGNIYITDNSNLCYYHTINWTTLFSTINQRIVIRDNRKAENCTAEGMVCNHLCSSDGCWGPGPDQCLS","Homo sapiens","ERBB4, HER4","Receptor tyrosine-protein kinase erbB-4","1","3U2P"
"3U2T",,"X-RAY DIFFRACTION",2.2,44.03,"VAPOR DIFFUSION, SITTING DROP",7.5,"22.5% PEG smears, 0.2M Li2(SO4), 0.05M ZnCl2, 0.1M Bis-Tris, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1073/pnas.1113921108",,"3U2T",32.39,"2.05","2.05","Crystal Structure of Human Glycogenin-1 (GYG1) complexed with manganese","MHHHHHHSSGVDLGTENLYFQSMTDQAFVTLTTNDAYAKGALVLGSSLKQHRTTRRLVVLATPQVSDSMRKVLETVFDEVIMVDVLDSGDSAHLTLMKRPELGVTLTKLHCWSLTQYSKCVFMDADTLVLANIDDLFDREELSAAPDPGWPDCFNSGVFVYQPSVETYNQLLHLASEQGSFDGGDQGILNTFFSSWATTDIRKHLPFIYNLSSISIYSYLPAFKVFGASAKVVHFLGRVKPWNYTYDPKTKSVKSEAHDPNMTHPEFLILWWNIFTTNVLPLLQ","Homo sapiens","GYG, GYG1","Glycogenin-1","1","3U2T"
"3U2U",,"X-RAY DIFFRACTION",2.48,50.32,"VAPOR DIFFUSION, SITTING DROP",5.6,"2.0M Ammonium Sulphate, 0.2M Na/K tartrate, 0.1M Na Citrate, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1073/pnas.1113921108",,"3U2U",62.12,"1.45","1.45","Crystal Structure of Human Glycogenin-1 (GYG1) complexed with manganese, UDP and maltotetraose","SMTDQAFVTLTTNDAYAKGALVLGSSLKQHRTTRRLVVLATPQVSDSMRKVLETVFDEVIMVDVLDSGDSAHLTLMKRPELGVTLTKLHCWSLTQYSKCVFMDADTLVLANIDDLFDREELSAAPDPGWPDCFNSGVFVYQPSVETYNQLLHLASEQGSFDGGDQGILNTFFSSWATTDIRKHLPFIYNLSSISIYSYLPAFKVFGASAKVVHFLGRVKPWNYTYDPKTKSVKSEAHDPNMTHPEFLILWWNIFTTNVLPLLQ","Homo sapiens","GYG, GYG1","Glycogenin-1","1","3U2U"
"3U2V",,"X-RAY DIFFRACTION",2.46,49.96,"VAPOR DIFFUSION, SITTING DROP",7.5,"2.0M Ammonium Sulphate, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1073/pnas.1113921108",,"3U2V",63.05,"1.5","1.5","Crystal Structure of Human Glycogenin-1 (GYG1) complexed with manganese, UDP and maltohexaose","SMTDQAFVTLTTNDAYAKGALVLGSSLKQHRTTRRLVVLATPQVSDSMRKVLETVFDEVIMVDVLDSGDSAHLTLMKRPELGVTLTKLHCWSLTQYSKCVFMDADTLVLANIDDLFDREELSAAPDPGWPDCFNSGVFVYQPSVETYNQLLHLASEQGSFDGGDQGILNTFFSSWATTDIRKHLPFIYNLSSISIYSYLPAFKVFGASAKVVHFLGRVKPWNYTYDPKTKSVKSEAHDPNMTHPEFLILWWNIFTTNVLPLLQ","Homo sapiens","GYG, GYG1","Glycogenin-1","1","3U2V"
"3U2W",,"X-RAY DIFFRACTION",2.19,43.8,"VAPOR DIFFUSION, SITTING DROP",8.5,"25% PEG 3350, 0.2M Li2(SO4), 0.1M Tris, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,"10.1073/pnas.1113921108",,"3U2W",60.91,"1.68","1.68","Crystal Structure of Human Glycogenin-1 (GYG1) complexed with manganese and glucose or a glucal species","SMTDQAFVTLTTNDAYAKGALVLGSSLKQHRTTRRLVVLATPQVSDSMRKVLETVFDEVIMVDVLDSGDSAHLTLMKRPELGVTLTKLHCWSLTQYSKCVFMDADTLVLANIDDLFDREELSAAPDPGWPDCFNSGVFVYQPSVETYNQLLHLASEQGSFDGGDQGILNTFFSSWATTDIRKHLPFIYNLSSISIFSYLPAFKVFGASAKVVHFLGRVKPWNYTYDPKTKSVKSEAHDPNMTHPEFLILWWNIFTTNVLPLLQ","Homo sapiens","GYG, GYG1","Glycogenin-1","1","3U2W"
"3U2X",,"X-RAY DIFFRACTION",2.47,50.2,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.4M tri-sodium citrate dihydrate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K",293.15,,,"3U2X",61.15,"1.77","1.77","Crystal Structure of Human Glycogenin-1 (GYG1) complexed with manganese, UDP and 1'-deoxyglucose","SMTDQAFVTLTTNDAYAKGALVLGSSLKQHRTTRRLVVLATPQVSDSMRKVLETVFDEVIMVDVLDSGDSAHLTLMKRPELGVTLTKLHCWSLTQYSKCVFMDADTLVLANIDDLFDREELSAAPDPGWPDCFNSGVFVYQPSVETYNQLLHLASEQGSFDGGDQGILNTFFSSWATTDIRKHLPFIYNLSSISIYSYLPAFKVFGASAKVVHFLGRVKPWNYTYDPKTKSVKSEAHDPNMTHPEFLILWWNIFTTNVLPLLQ","Homo sapiens","GYG, GYG1","Glycogenin-1","1","3U2X"
"3U2Z",,"X-RAY DIFFRACTION",2.4,49.3,"VAPOR DIFFUSION",6.5,"25% PEG-3350, 0.2M ammonium sulfate, 0.1M Bis-Tris. Activator concentration: 0.01M., pH 6.5, vapor diffusion, temperature 291K",291,"10.1038/nchembio.1060",,"3U2Z",234.75,"2.1","2.1","Activator-Bound Structure of Human Pyruvate Kinase M2","GSMSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM2, OIP3, PK2, PK3, PKM","Pyruvate kinase isozymes M1/M2","1","3U2Z"
"3U36",,"X-RAY DIFFRACTION",2.41,48.95,"VAPOR DIFFUSION, HANGING DROP",6.5,"25% (w/v) PEG 3350, 15% (v/v) 2-methyl-2,4-pentanediol, 0.2 M lithium sulfate, 0.1 M imidazole pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature10696",,"3U36",200.13,"3.281","3.281","Crystal Structure of PG9 Fab","QRLVESGGGVVQPGSSLRLSCAASGFDFSRQGMHWVRQAPGQGLEWVAFIKYDGSEKYHADSVWGRLSISRDNSKDTLYLQMNSLRVEDTATYFCVREAGGPDYRNGYNYYDFYDGYYNYHYMDVWGKGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKGLEVLFQ","Homo sapiens",,"PG9 Fab heavy chain","1","3U36"
,,,,,,,,,,,,,,,,"QSALTQPASVSGSPGQSITISCQGTSNDVGGYESVSWYQQHPGKAPKVVIYDVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEGDYYCKSLTSTRRRVFGTGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHKSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"PG9 Fab light chain","2","3U36"
"3U3A",,"X-RAY DIFFRACTION",2.08,40.78,"VAPOR DIFFUSION, HANGING DROP",8,"1.4 M Sodium Citrate 50 mM Tris pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"3U3A",29.55,"1.549","1.549","structure of Human Carbonic Anhydrase II V143I","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAILGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2, HCA2","Carbonic anhydrase 2","1","3U3A"
"3U3J",,"X-RAY DIFFRACTION",2.4,48.82,"VAPOR DIFFUSION",7.5,"Sodium chloride, HEPES, Polyethylene glycol 3,350, pH 7.5, VAPOR DIFFUSION, temperature 293K",293,"10.1371/journal.pone.0026794",,"3U3J",73.41,"2.7","2.7","Crystal structure of hSULT1A1 bound to PAP","MGSSHHHHHHSSGLVPRGSHMELIQDTSRPPLEYVKGVPLIKYFAEALGPLQSFQARPDDLLISTYPKSGTTWVSQILDMIYQGGDLEKCHRAPIFMRVPFLEFKAPGIPSGMETLKDTPAPRLLKTHLPLALLPQTLLDQKVKVVYVARNAKDVAVSYYHFYHMAKVHPEPGTWDSFLEKFMVGEVSYGSWYQHVQEWWELSRTHPVLYLFYEDMKENPKREIQKILEFVGHSLPEETVDFMVQHTSFKEMKKNPMTNYTTVPQEFMDHSISPFMRKGMAGDWKTTFTVAQNERFDADYAEKMAGCSLSFRSE","Homo sapiens","hSULT1A1, OK/SW-cl.88, STP, STP1, SULT1A1","Sulfotransferase 1A1","1","3U3J"
"3U3K",,"X-RAY DIFFRACTION",2.45,49.86,"VAPOR DIFFUSION",8.5,"Tris, Polyethylene glycol 3.350, pH 8.5, VAPOR DIFFUSION, temperature 293K",293,"10.1371/journal.pone.0026794",,"3U3K",73.93,"2.36","2.36","Crystal structure of hSULT1A1 bound to PAP and 2-Naphtol","MGSSHHHHHHSSGLVPRGSHMELIQDTSRPPLEYVKGVPLIKYFAEALGPLQSFQARPDDLLISTYPKSGTTWVSQILDMIYQGGDLEKCHRAPIFMRVPFLEFKAPGIPSGMETLKDTPAPRLLKTHLPLALLPQTLLDQKVKVVYVARNAKDVAVSYYHFYHMAKVHPEPGTWDSFLEKFMVGEVSYGSWYQHVQEWWELSRTHPVLYLFYEDMKENPKREIQKILEFVGHSLPEETVDFMVQHTSFKEMKKNPMTNYTTVPQEFMDHSISPFMRKGMAGDWKTTFTVAQNERFDADYAEKMAGCSLSFRSEL","Homo sapiens","hSULT1A1, OK/SW-cl.88, STP, STP1, SULT1A1","Sulfotransferase 1A1","1","3U3K"
"3U3M",,"X-RAY DIFFRACTION",2.74,55.15,"VAPOR DIFFUSION",6.7,"Magnesium chloride, BIS-TRIS, Polyethylene glycol 3,350, pH 6.7, vapor diffusion, temperature 293K",293,"10.1371/journal.pone.0026794",,"3U3M",37.01,"2.3","2.3","Crystal structure of Human SULT1A1 bound to PAP and 3-Cyano-7-hydroxycoumarin","MGSSHHHHHHSSGLVPRGSHMELIQDTSRPPLEYVKGVPLIKYFAEALGPLQSFQARPDDLLISTYPKSGTTWVSQILDMIYQGGDLEKCHRAPIFMRVPFLEFKAPGIPSGMETLKDTPAPRLLKTHLPLALLPQTLLDQKVKVVYVARNAKDVAVSYYHFYHMAKVHPEPGTWDSFLEKFMVGEVSYGSWYQHVQEWWELSRTHPVLYLFYEDMKENPKREIQKILEFVGHSLPEETVDFMVQHTSFKEMKKNPMTNYTTVPQEFMDHSISPFMRKGMAGDWKTTFTVAQNERFDADYAEKMAGCSLSFRSEL","Homo sapiens","hSULT1A1, OK/SW-cl.88, STP, STP1, SULT1A1","Sulfotransferase 1A1","1","3U3M"
"3U3O",,"X-RAY DIFFRACTION",2.7,54.46,"VAPOR DIFFUSION",6.5,"Magnesium chloride, BIS-TRIS, Polyethylene glycol 3,350, pH 6.5, vapor diffusion, temperature 293K",293,"10.1371/journal.pone.0026794",,"3U3O",37.19,"2","2","Crystal structure of Human SULT1A1 bound to PAP and two 3-Cyano-7-hydroxycoumarin","MGSSHHHHHHSSGLVPRGSHMELIQDTSRPPLEYVKGVPLIKYFAEALGPLQSFQARPDDLLISTYPKSGTTWVSQILDMIYQGGDLEKCHRAPIFMRVPFLEFKAPGIPSGMETLKDTPAPRLLKTHLPLALLPQTLLDQKVKVVYVARNAKDVAVSYYHFYHMAKVHPEPGTWDSFLEKFMVGEVSYGSWYQHVQEWWELSRTHPVLYLFYEDMKENPKREIQKILEFVGHSLPEETVDFMVQHTSFKEMKKNPMTNYTTVPQEFMDHSISPFMRKGMAGDWKTTFTVAQNERFDADYAEKMAGCSLSFRSEL","Homo sapiens","hSULT1A1, OK/SW-cl.88, STP, STP1, SULT1A1","Sulfotransferase 1A1","1","3U3O"
"3U3P",,"X-RAY DIFFRACTION",2.44,49.64,"VAPOR DIFFUSION, HANGING DROP",,"0.2M ammonium acetate, 0.1M sodium citrate tribasic dehydrate (pH5.0-6.0), 25-30% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1107/S0907444912004490",,"3U3P",34.21,"2.09","2.09","The S-SAD phased crystal structure of the ecto-domain of Death Receptor 6 (DR6)","QPEQKASNLIGTYRHVDRATGQVLTCDKCPAGTYVSEHCTNTSLRVCSSCPVGTFTRHENGIEKCHDCSQPCPWPMIEKLPCAALTDRECTCPPGMFQSNATCAPHTVCPVGWGVRKKGTETEDVRCKQCARGTFSDVPSSVMKCKAYTDCLSQNLVVIKPGTKETDNVCGTLPSFSSSTSPSPGTAIFPRPEHMETHEVPSSTYVPKGMNSTESNSSASVRPKVLSSIQEGTVPDNTSSARGKEDVNKTLPNLQVVNHQQGPHHRHILKLLPSMEATGGEKSSTPIKGPKRGHPRQNLHKHFDINEHHHHHH","Homo sapiens","TNFRSF21, DR6, UNQ437/PRO868","Tumor necrosis factor receptor superfamily member 21","1","3U3P"
"3U3Q",,"X-RAY DIFFRACTION",2.45,49.79,"VAPOR DIFFUSION, HANGING DROP",,"0.2M ammonium acetate, 0.1M sodium citrate tribasic dehydrate (pH5.0-6.0), 25-30% PEG 4000 , VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1107/S0907444912004490",,"3U3Q",34.21,"2.7","2.7","The S-SAD phased crystal structure of the ecto-domain of Death Receptor 6 (DR6)","QPEQKASNLIGTYRHVDRATGQVLTCDKCPAGTYVSEHCTNTSLRVCSSCPVGTFTRHENGIEKCHDCSQPCPWPMIEKLPCAALTDRECTCPPGMFQSNATCAPHTVCPVGWGVRKKGTETEDVRCKQCARGTFSDVPSSVMKCKAYTDCLSQNLVVIKPGTKETDNVCGTLPSFSSSTSPSPGTAIFPRPEHMETHEVPSSTYVPKGMNSTESNSSASVRPKVLSSIQEGTVPDNTSSARGKEDVNKTLPNLQVVNHQQGPHHRHILKLLPSMEATGGEKSSTPIKGPKRGHPRQNLHKHFDINEHHHHHH","Homo sapiens","TNFRSF21, DR6, UNQ437/PRO868","Tumor necrosis factor receptor superfamily member 21","1","3U3Q"
"3U3R",,"X-RAY DIFFRACTION",2.46,50.03,"VAPOR DIFFUSION",6.5,"Magnesium chloride, BIS-TRIS, Polyethylene glycol 3.350, pH 6.5, vapor diffusion, temperature 293K",293,"10.1371/journal.pone.0026794",,"3U3R",37.04,"2.36","2.36","Crystal structure of D249G mutated Human SULT1A1 bound to PAP and P-NITROPHENOL","MGSSHHHHHHSSGLVPRGSHMELIQDTSRPPLEYVKGVPLIKYFAEALGPLQSFQARPDDLLISTYPKSGTTWVSQILDMIYQGGDLEKCHRAPIFMRVPFLEFKAPGIPSGMETLKDTPAPRLLKTHLPLALLPQTLLDQKVKVVYVARNAKDVAVSYYHFYHMAKVHPEPGTWDSFLEKFMVGEVSYGSWYQHVQEWWELSRTHPVLYLFYEDMKENPKREIQKILEFVGHSLPEETVDFMVQHTSFKEMKKNPMTNYTTVPQEFMGHSISPFMRKGMAGDWKTTFTVAQNERFDADYAEKMAGCSLSFRSEL","Homo sapiens","hSULT1A1 D249G mutation, OK/SW-cl.88, STP, STP1, SULT1A1","Sulfotransferase 1A1","1","3U3R"
"3U3S",,"X-RAY DIFFRACTION",2.44,49.52,"VAPOR DIFFUSION, HANGING DROP",,"0.2M ammonium acetate, 0.1M sodium citrate tribasic dehydrate (pH5.0-6.0), 25-30% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1107/S0907444912004490",,"3U3S",34.21,"2.7","2.7","The S-SAD phased crystal structure of the ecto-domain of Death Receptor 6 (DR6)","QPEQKASNLIGTYRHVDRATGQVLTCDKCPAGTYVSEHCTNTSLRVCSSCPVGTFTRHENGIEKCHDCSQPCPWPMIEKLPCAALTDRECTCPPGMFQSNATCAPHTVCPVGWGVRKKGTETEDVRCKQCARGTFSDVPSSVMKCKAYTDCLSQNLVVIKPGTKETDNVCGTLPSFSSSTSPSPGTAIFPRPEHMETHEVPSSTYVPKGMNSTESNSSASVRPKVLSSIQEGTVPDNTSSARGKEDVNKTLPNLQVVNHQQGPHHRHILKLLPSMEATGGEKSSTPIKGPKRGHPRQNLHKHFDINEHHHHHH","Homo sapiens","TNFRSF21, DR6, UNQ437/PRO868","Tumor necrosis factor receptor superfamily member 21","1","3U3S"
"3U3T",,"X-RAY DIFFRACTION",2.43,49.4,"VAPOR DIFFUSION, HANGING DROP",,"0.2M ammonium acetate, 0.1M sodium citrate tribasic dehydrate (pH5.0-6.0), 25-30% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1107/S0907444912004490",,"3U3T",34.21,"3.21","3.21","The S-SAD phased crystal structure of the ecto-domain of Death Receptor 6 (DR6)","QPEQKASNLIGTYRHVDRATGQVLTCDKCPAGTYVSEHCTNTSLRVCSSCPVGTFTRHENGIEKCHDCSQPCPWPMIEKLPCAALTDRECTCPPGMFQSNATCAPHTVCPVGWGVRKKGTETEDVRCKQCARGTFSDVPSSVMKCKAYTDCLSQNLVVIKPGTKETDNVCGTLPSFSSSTSPSPGTAIFPRPEHMETHEVPSSTYVPKGMNSTESNSSASVRPKVLSSIQEGTVPDNTSSARGKEDVNKTLPNLQVVNHQQGPHHRHILKLLPSMEATGGEKSSTPIKGPKRGHPRQNLHKHFDINEHHHHHH","Homo sapiens","TNFRSF21, DR6, UNQ437/PRO868","Tumor necrosis factor receptor superfamily member 21","1","3U3T"
"3U3V",,"X-RAY DIFFRACTION",2.45,49.88,"VAPOR DIFFUSION, HANGING DROP",,"0.2M ammonium acetate, 0.1M sodium citrate tribasic dehydrate (pH5.0-6.0), 25-30% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1107/S0907444912004490",,"3U3V",34.21,"2.96","2.96","The S-SAD phased crystal structure of the ecto-domain of Death Receptor 6 (DR6)","QPEQKASNLIGTYRHVDRATGQVLTCDKCPAGTYVSEHCTNTSLRVCSSCPVGTFTRHENGIEKCHDCSQPCPWPMIEKLPCAALTDRECTCPPGMFQSNATCAPHTVCPVGWGVRKKGTETEDVRCKQCARGTFSDVPSSVMKCKAYTDCLSQNLVVIKPGTKETDNVCGTLPSFSSSTSPSPGTAIFPRPEHMETHEVPSSTYVPKGMNSTESNSSASVRPKVLSSIQEGTVPDNTSSARGKEDVNKTLPNLQVVNHQQGPHHRHILKLLPSMEATGGEKSSTPIKGPKRGHPRQNLHKHFDINEHHHHHH","Homo sapiens","TNFRSF21, DR6, UNQ437/PRO868","Tumor necrosis factor receptor superfamily member 21","1","3U3V"
"3U45",,"X-RAY DIFFRACTION",2.1,41.46,"VAPOR DIFFUSION, HANGING DROP",8,"1.4 M Sodium Citrate 50 mM Tris pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"3U45",29.42,"1.699","1.699","Human Carbonic Anhydrase II V143A","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAALGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2, HCA2","Carbonic anhydrase 2","1","3U45"
"3U46",,"X-RAY DIFFRACTION",3.1,60.36,"VAPOR DIFFUSION, HANGING DROP",4.5,"16% PEG 400,  8% PEG 8000, 0.1M Acetate pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature10696",,"3U46",98.44,"2.906","2.906","CH04H/CH02L P212121","EVQLVESGGGLIRPGGSLRLSCKGSGFIFENFGFGWVRQGPGKGLEWVSGTNWNGGDSRYGDSVKGRFTISRDNSNNFVYLQMNSLRPEDTAIYYCARGTDYTIDDQGIRYQGSGTFWYFDVWGRGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDK","Homo sapiens",,"CH04 Heavy chain Fab","1","3U46"
,,,,,,,,,,,,,,,,"EIVLTQSPATLSVSPGERATLSCRASQNVHPRYFAWYQQKRGQSPRLLIHSGSTRAAGIADRFSGGGSGMHFTLTITRVEPEDFAVYFCQQYGGSPYTFGQGTRVELRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"CH02 Light chain Fab","2","3U46"
"3U47",,"X-RAY DIFFRACTION",2.1,41.4,"VAPOR DIFFUSION, HANGING DROP",8,"1.4 M Sodium Citrate, 50 mM Tris pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"3U47",29.46,"1.6","1.6","Human Carbonic Anhydrase II V143L","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLALLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2, HCA2","Carbonic anhydrase 2","1","3U47"
"3U4B",,"X-RAY DIFFRACTION",3.5,64.89,"VAPOR DIFFUSION, HANGING DROP",6.5,"15% PEG 3350, 9% 2-Methyl-2,4-pentanediol, 0.1M Li2SO4, 0.1M Imidazole pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nature10696",,"3U4B",49.22,"2.893","2.893","CH04H/CH02L Fab P4","EVQLVESGGGLIRPGGSLRLSCKGSGFIFENFGFGWVRQGPGKGLEWVSGTNWNGGDSRYGDSVKGRFTISRDNSNNFVYLQMNSLRPEDTAIYYCARGTDYTIDDQGIRYQGSGTFWYFDVWGRGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDK","Homo sapiens",,"CH04 Heavy chain","1","3U4B"
,,,,,,,,,,,,,,,,"EIVLTQSPATLSVSPGERATLSCRASQNVHPRYFAWYQQKRGQSPRLLIHSGSTRAAGIADRFSGGGSGMHFTLTITRVEPEDFAVYFCQQYGGSPYTFGQGTRVELRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"CH02 Light chain","2","3U4B"
"3U4H",,"X-RAY DIFFRACTION",2.27,45.83,"VAPOR DIFFUSION, HANGING DROP",6,"100mM MES, 12% PEG 4000, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1371/journal.pone.0066247","C8R","3U4H",61.88,"1.878","1.878","CD38 structure-based inhibitor design using the N1-cyclic inosine 5'-diphosphate ribose template","KREAEARWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVEVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","3U4H"
"3U4I",,"X-RAY DIFFRACTION",2.4,48.74,"VAPOR DIFFUSION, HANGING DROP",6,"100mM MES, 12% PEG 4000, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1371/journal.pone.0066247","CVR","3U4I",61.3,"2.118","2.118","CD38 structure-based inhibitor design using the N1-cyclic inosine 5'-diphosphate ribose template","KREAEARWRQTWSGPGTTKRFPETVLARCVKYTEIHPEMRHVDCQSVWDAFKGAFISKHPCDITEEDYQPLMKLGTQTVPCNKILLWSRIKDLAHQFTQVQRDMFTLEDTLLGYLADDLTWCGEFDTSKINYQSCPDWRKDCSNNPVSVFWKTVSRRFAEAACDVVHVMLDGSRSKIFDKDSTFGSVEVHNLQPEKVQTLEAWVIHGGREDSRDLCQDPTIKELESIISKRNIQFSCKNIYRPDKFLQCVKNPEDSSCTSEI","Homo sapiens","CD38","ADP-ribosyl cyclase 1","1","3U4I"
"3U4N",,"X-RAY DIFFRACTION",3.48,64.63,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M Bis-Tris pH 6.5, 3.0 M NaCl, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1371/journal.pone.0030882",,"3U4N",5.67,"1.98","1.98","A novel covalently linked insulin dimer","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","3U4N"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFCYTPK","Homo sapiens","INS","Insulin B chain","2","3U4N"
"3U4S",,"X-RAY DIFFRACTION",2.32,46.92,"VAPOR DIFFUSION, SITTING DROP",5.5,"20% PEG 3350, 0.1M citrate, 2 mM NiCl2, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1002/anie.201107833",,"3U4S",90.99,"2.15","2.15","Histone Lysine demethylase JMJD2A in complex with T11C peptide substrate crosslinked to N-oxalyl-D-cysteine","MHHHHHHSSGVDLGTENLYFQSMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","JHDM3A, JMJD2, JMJD2A, KDM4A, KIAA0677","Lysine-specific demethylase 4A","1","3U4S"
,,,,,,,,,,,,,,,,"ARKSCGGK",,,"HISTONE 3 TAIL ANALOG (T11C Peptide)","2","3U4S"
"3U4U",,"X-RAY DIFFRACTION",2.23,44.86,"VAPOR DIFFUSION, HANGING DROP",6.5,"22-26% PEG 6K, 200 mM ammonium sulfate, 100 mM MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1021/ml200257n","LNH","3U4U",40.36,"2.2","2.2","Casein kinase 2 in complex with AZ-Inhibitor","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQAR","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3U4U"
"3U53",,"X-RAY DIFFRACTION",2.45,49.71,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1M Sodium citrate tribasic dihydrate, 1.2M Lithium sulfate, 0.2M Ammonium sulfate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bbrc.2013.01.095",,"3U53",73.41,"2.705","2.705","Crystal structure of human Ap4A hydrolase","MALRACGLIIFRRCLIPKVDNNAIEFLLLQASDGIHHWTPPKGHVEPGEDDLETALRETQEEAGIEAGQLTIIEGFKRELNYVARNKPKTVIYWLAEVKDYDVEIRLSHEHQAYRWLGLEEACQLAQFKEMKAALQEGHQFLCSIEALEHHHHHH","Homo sapiens","NUDT2, APAH1","Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]","1","3U53"
"3U5J",,"X-RAY DIFFRACTION",2.14,42.51,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2M Na2SO4, 0.1M BTProp pH 6.5, 20% PEG3350, 10% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmc.2011.10.080","08H","3U5J",15.66,"1.6","1.6","Crystal Structure of the first bromodomain of human BRD4 in complex with Alprazolam","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","3U5J"
"3U5K",,"X-RAY DIFFRACTION",2.47,50.18,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M MES pH 5.5, 0.1M MgCl, 15% PEG 6000, 10% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmc.2011.10.080",,"3U5K",61.7,"1.8","1.8","Crystal Structure of the first bromodomain of human BRD4 in complex with Midazolam","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","3U5K"
"3U5L",,"X-RAY DIFFRACTION",2.14,42.51,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.20M Na(malonate), 0.1M BTProp pH 7.5, 20.0% PEG 3350, 10.0% EtGly, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmc.2011.10.080","08K","3U5L",15.49,"1.39","1.39","Crystal Structure of the first bromodomain of human BRD4 in complex with a benzo-triazepine ligand (BzT-7)","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","3U5L"
"3U5M",,"X-RAY DIFFRACTION",2.58,52.27,"VAPOR DIFFUSION, HANGING DROP",,"0.2M CaCl2, 20% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 273K",273,"10.1016/j.cell.2011.11.032",,"3U5M",288.01,"3.08","3.08","Crystal structure of TRIM33 PHD-Bromo in the free state","SDDDPNEDWCAVCQNGGDLLCCEKCPKVFHLTCHVPTLLSFPSGDWICTFCRDIGKPEVEYDCDNLQHSKKGKTAQGLSPVDQRKCERLLLYLYCHELSIEFQEPVPASIPNYYKIIKKPMDLSTVKKKLQKKHSQHYQIPDDFVADVRLIFKNCERFNEMMKVVQVYADTQEINLKADSEVAQAGKAVALYFEDKLTEIYSDRTFA","Homo sapiens","TRIM33, KIAA1113, RFG7, TIF1G","E3 ubiquitin-protein ligase TRIM33","1","3U5M"
"3U5S",,"X-RAY DIFFRACTION",2.01,38.76,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.jmb.2012.11.011",,"3U5S",16.24,"1.5","1.5","Selenium Substituted Human Augmenter of Liver Regeneration","SMRTQQKRDTKFREDUPPDREELGRHSWAVLHTLAAYYPDLPTPEQQQDMAQFIHLFSKFYPUEEUAEDLRKRLARNHPDTRTRAAFTQWLUHLHNEVNRKLGKPDFDUSKVDERWRDGWKDGSUD","Homo sapiens","GFER, ALR, HERV1, HPO","FAD-linked sulfhydryl oxidase ALR","1","3U5S"
"3U69",,"X-RAY DIFFRACTION",2.62,53.04,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris, 50mM Bicine, 30mM NaF, 30mM NaBr, 30mM NaI, 11.5% MPD, 11.5% PEG 1000, 11.5% PEG 3350 , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1371/journal.pone.0034354",,"3U69",34.22,"1.55","1.55","Unliganded wild-type human thrombin","ADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Prothrombin","1","3U69"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Prothrombin","2","3U69"
"3U6A",,"X-RAY DIFFRACTION",2.94,58.22,"VAPOR DIFFUSION",8,"100mM Sodium Citrate  pH 5.4-6.0, 200mM NH4I, 16% PEG5000mme, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.bmcl.2011.10.050","18P","3U6A",132.13,"2.199","2.199","Rational Design and Synthesis of Aminopiperazinones as Beta Secretase (BACE) Inhibitors","AGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3U6A"
"3U6H",,"X-RAY DIFFRACTION",2.65,53.53,"VAPOR DIFFUSION",5,"12% PEG 6000, 1.0 M lithium chloride, 0.1 M sodium citrate, pH 5.0, VAPOR DIFFUSION, temperature 293K",293,"10.1021/jm201330u","03X","3U6H",35.74,"2","2","Crystal structure of c-Met in complex with pyrazolone inhibitor 26","QNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHHHHHH","Homo sapiens","MET","Hepatocyte growth factor receptor","1","3U6H"
"3U6I",,"X-RAY DIFFRACTION",2.67,53.86,"VAPOR DIFFUSION",5,"12% PEG 6000, 1.0 M lithium chloride, 0.1 M sodium citrate, pH 5.0, VAPOR DIFFUSION, temperature 293K",293,"10.1021/jm201330u","044","3U6I",35.76,"2.1","2.1","Crystal structure of c-Met in complex with pyrazolone inhibitor 58a","QNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHHHHHH","Homo sapiens","MET","Hepatocyte growth factor receptor","1","3U6I"
"3U6J",,"X-RAY DIFFRACTION",2.57,52.11,"VAPOR DIFFUSION, HANGING DROP",8,"17% PEG 5000 monomethyl ether, 75 mM ammonium sulfate, 25 mM sodium chloride, 100 mM HEPES, 8% isopropanol, 40 mM beta-mercaptoethanol, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm201330u","03X","3U6J",36.69,"2.15","2.15","Crystal structure of the VEGFR2 kinase domain in complex with a pyrazolone inhibitor","EHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDRHHHHHH","Homo sapiens","FLK1, KDR, VEGFR2","Vascular endothelial growth factor receptor 2","1","3U6J"
"3U6R",,"X-RAY DIFFRACTION",2.38,48.29,"VAPOR DIFFUSION, SITTING DROP",8.5,"1.54M ammonium sulfate, 0.2M lithium sulfate, 0.1M Tris/HCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1093/protein/gzr058",,"3U6R",61.99,"2.67","2.67","Three dimensional structure of broadly neutralizing anti - Hepatitis C virus (HCV) glycoprotein E2 single chain FV fragment 1:7","AMEVQLLEQSGAEVKKPGSSVKVSCQVFGDTFSRYTIQWLRQAPGQGPEWMGNIIPVYNTPNYAQKFQGRLSITADDSTSTAYMELSSLRSEDTAVYFCARVVIPNAIRHTMGYYFDYWGQGTLVTVSSGTGGSGGGGSGGGGSGGGAS","Homo sapiens",,"Antibody 1:7 (Heavy chain)","1","3U6R"
,,,,,,,,,,,,,,,,"AELTQSPATLSLSPGERATLSCRASQSVNKYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISNLEPEDFAVYYCQQRSDWVTFGGGTKVEIKAAADDDDKAGWSHPQFEKGGGSGGGSGGGSWSHPQFEK","Homo sapiens",,"Antibody 1:7 (Light chain)","2","3U6R"
"3U6V",,"X-RAY DIFFRACTION",2.37,48.1,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris, 20% PEG 3350, 2 mM DTT, 0.02% azide, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3U6V",51.26,"2.2","2.2","Crystal Structure Analysis of L23A mutant of human GST A1-1","MAEKPKLHYFNARGRMESTRWLAAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEIDGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYIEGIADLGEMILLLPVCPPEEKDAKLALIKEKIKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEEARKIFRF","Homo sapiens","GSTA1","Glutathione S-transferase A1","1","3U6V"
"3U74",,"X-RAY DIFFRACTION",2.97,58.64,"VAPOR DIFFUSION, SITTING DROP",7.4,"100 mM HEPES, pH 7.5, 2% (w/v) PEG400, 2 M ammonium sulfate, vapor diffusion, sitting drop, temperature 295.0K",295,"10.1016/j.jmb.2011.12.058",,"3U74",32.1,"2.39","2.39","Crystal structure of stabilized human uPAR mutant","LRCMQCKTNGDCRVEECALGQDLCRTTIVRLWEEGEELELVEKSCTCSEKTNRTLSYRTGLKITSLTEVVCGLDLCNQGNSGRAVTYSRSRYLECISCGSSDMSCERGRHQSLQCRSPEEQCLDVVTHWIQEGEEGRPKDDRHLRGCGYLPGCPGSNGFHNNDTFHFLKCCNTTKCNEGPILELENLPQNGRQCYSCKGNSTHGCSSEETFLIDCRGPMNQCLVATGTHEPKNQSYMVRGCATASMCQHAHLGDAFSMCHIDVSCCTKSGCNHPDLDVQYRSG","Homo sapiens","MO3, PLAUR, UPAR","Urokinase plasminogen activator surface receptor","1","3U74"
"3U78",,"X-RAY DIFFRACTION",2.72,54.75,"VAPOR DIFFUSION, HANGING DROP",6.4,"15-20% v/v PEG5000 MME, 0.2 M calcium chloride, 0.1 M Bis-Tris, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1016/j.jmb.2011.12.036","E67","3U78",47.09,"2.689","2.689","E67-2 selectively inhibits KIAA1718, a human histone H3 lysine 9 Jumonji demethylase","SLMKKRRNWHRHDYTEIDDGSKPVQAGTRTFIKELRSRVFPSADEIIIKMHGSQLTQRYLEKHGFDVPIMVPKLDDLGLRLPSPTFSVMDVERYVGGDKVIDVIDVARQADSKMTLHNYVKYFMNPNRPKVLNVISLEFSDTKMSELVEVPDIAKKLSWVENYWPDDSVFPKPFVQKYCLMGVQDSYTDFHIDFGGTSVWYHVLWGEKIFYLIKPTDENLARYESWSSSVTQSEVFFGDKVDKCYKCVVKQGHTLFVPTGWIHAVLTSQDCMAFGGNFLHNLNIGMQLRCYEMEKRLKTPDLFKFPFFEAICWFVAKNLLETLKELREDGFQPQTYLVQGVKALHTALKLWMKKELVSEHAFEIPDNVRPGHLIKELSKVIRAIEEENGKPVKSQGI","Homo sapiens","JHDM1D, KDM7, KIAA1718, KDM7A","Lysine-specific demethylase 7","1","3U78"
"3U79",,"X-RAY DIFFRACTION",2.4,48.72,"VAPOR DIFFUSION, HANGING DROP",8.21,"20% (w/v) polyethylene glycol monomethyl ether and 0.2M Sodium Acetate in 0.1 M MES buffer (pH 8.21), VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"3U79",99.25,"1.62","1.62","AL-103 Y32F Y96F","STDIQMTQSPSSLSASVGDRVTITCQASQDISNFLIWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYHNLPPFTFGPGTKLEIKR","Homo sapiens",,"Amyloidogenic immunoglobulin light chain protein AL-103 Y32F Y96F, variable domain","1","3U79"
"3U7A",,"X-RAY DIFFRACTION",2.54,51.49,"VAPOR DIFFUSION, HANGING DROP",7,"27% (w/v) polyethylene glycol 4000 and 0.15 M Li2SO4 in 0.1 M Tris HCl pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,,,"3U7A",12.1,"2","2","AL-09 Y32F Y96F","STDIQMTQSPSSLSASVGDRVTITCQASQDINNFLIWYQQKPGQAPKLLIYDASTLETGVPSRFSGSGSGTEFTFTISSLQPEDLATYHCQQYDNLPFTFGQGTKLEIKR","Homo sapiens",,"Amyloidogenic immunoglobulin light chain protein AL-09 Y32F Y96F, variable domain","1","3U7A"
"3U7C",,"X-RAY DIFFRACTION",2.09,41.18,"VAPOR DIFFUSION, HANGING DROP",8,"1.4 M citrate, 50 mM tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"BCT","3U7C",29.61,"0.93","0.93","crystal structure of the V143I mutant of human carbonic anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAILGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3U7C"
"3U83",,"X-RAY DIFFRACTION",4.04,69.52,"VAPOR DIFFUSION, HANGING DROP",8.5,"20% PEG 2000, 0.2M Trimethylamine N-oxidedihydrate, 0.1M Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1038/ncomms1571",,"3U83",37.2,"2.499","2.499","Crystal structure of nectin-1","MASMTGGQQMGRDPSQVVQVNDSMYGFIGTDVVLHCSFANPLPSVKITQVTWQKSTNGSKQNVAIYNPSMGVSVLAPYRERVEFLRPSFTDGTIRLSRLELEDEGVYICEFATFPTGNRESQLNLTVMAKPTNWIEGTQAVLRAKKGQDDKVLVATCTSANGKPPSVVSWETRLKGEAEYQEIRNPNGTVTVISRYRLVPSREAHQQSLACIVNYHMDRFKESLTLNVQYEPEVTIEGFDGNWYLQRMDVKLTCKADANPPATEYHWTTLNGSLPKGVEAQNRTLFFKGPINYSLAGTYICEATNPIGTRSGQVEVNITEAAALEHHHHHH","Homo sapiens","PVRL1, HVEC, PRR1, NECTIN1","Poliovirus receptor-related protein 1","1","3U83"
"3U84",,"X-RAY DIFFRACTION",2.17,43.3,"VAPOR DIFFUSION, SITTING DROP",6.5,"1.4 M sodium acetate, pH 6.5, vapor diffusion, sitting drop, temperature 277K",277,"10.1038/nature10806",,"3U84",122.12,"2.5","2.5","Crystal Structure of Human Menin","SGLKAAQKTLFPLRSIDDVVRLFAAELGREEPDLVLLSLVLGFVEHFLAVNRVIPTNVPELTFQPSPAPDPPGGLTYFPVADLSIIAALYARFTAQIRGAVDLSLYPREGGVSSRELVKKVSDVIWNSLSRSYFKDRAHIQSLFSFITGTKLDSSGVAFAVVGACQALGLRDVHLALSEDHAWVVFGPNGEQTAEVTWHGKGNEDRRGQTVNAGVAERSWLYLKGSYMRCDRKMEVAFMVCAINPSIDLHTDSLELLQLQQKLLWLLYDLGHLERYPMALGNLADLEELEPTPGRPDPLTLYHKGIASAKTYYRDEHIYPYMYLAGYHCRNRNVREALQAWADTATVIQDYNYCREDEEIYKEFFEVANDVIPNLLKEAASLLEAGEERPGEQSQGTQSQGSALQDPECFAHLLRFYDGICKWEEGSPTPVLHVGWATFLVQSLGRFEGQVRQKVRIVSGTVAGTARGPEGGSTAQVPAPTASPPPEGPVLTFQSEKMKGMKELLVATKINSSAIKLQLTAQSQVQMKKQKVSTPSDYTLSFLKRQRKGL","Homo sapiens","MEN1, SCG2","Menin","1","3U84"
,,,,,,,,,,,,,,,,,"Homo sapiens","MEN1, SCG2"
"3U87",,"X-RAY DIFFRACTION",3.1,60.28,"VAPOR DIFFUSION, SITTING DROP",6.2,"reservoir:    
15% polyethylene glycol 8000, 15% glycerol, 0.17 M ammonium sulfate, 0.1 M sodium cacodylate buffer;    
drop:   
0.8 uL reservoir solution, 0.8 uL protein solution (12.6 mg/ml), 0.5 uL 10% anapoe 305 (detergent), 1.5 uL 5 mM AMPPNP, 1.5 uL 10 mM magnesium chloride, 1.5 uL CK2 substrate peptide (sequence RRRADDSDDDDD), pH 6.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S0907444912016587",,"3U87",84.37,"2.9","2.9","Structure of a chimeric construct of human CK2alpha and human CK2alpha' in complex with a non-hydrolysable ATP-analogue","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYPVVKEQSQPCADNAVLSSGLTAAR","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3U87"
,,,,,,,,,,,,,,,,,"Homo sapiens","CSNK2A1, CK2A1"
"3U8B",,"X-RAY DIFFRACTION",2.57,52.21,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.1 M Tris HCl pH 7.4, 10 mM CaCl2, 0.5 mM Beta-octyl glucoside and 4 M NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M112.397893",,"3U8B",14.1,"2.299","2.299","Functionally selective inhibition of Group IIA phospholipase A2 reveals a role for vimentin in regulating arachidonic acid metabolism","NLVNFHRMIKLTTGKEAALSYGFYGCHCGVGGRGSPKDATDRCCVTHDCCYKRLEKRGCGTKFLSYKFSNSGSRITCAKQDSCRSQLCECDKAAATCFARNKTTYNKKYQYYSNKHCRGSTPRC","Homo sapiens","PLA2G2A, PLA2B, PLA2L, RASF-A","Phospholipase A2, membrane associated","1","3U8B"
"3U8D",,"X-RAY DIFFRACTION",2.68,54.1,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.1 M Tris-HCl pH 7.4, 10 mM CaCl2, 0.5 mM beta-octyl glucoside and 4 M NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M112.397893","U8D","3U8D",29.05,"1.805","1.805","Functionally selective inhibition of Group IIA phospholipase A2 reveals a role for vimentin in regulating arachidonic acid metabolism","NLVNFHRMIKLTTGKEAALSYGFYGCHCGVGGRGSPKDATDRCCVTHDCCYKRLEKRGCGTKFLSYKFSNSGSRITCAKQDSCRSQLCECDKAAATCFARNKTTYNKKYQYYSNKHCRGSTPRC","Homo sapiens","PLA2G2A, PLA2B, PLA2L, RASF-A","Phospholipase A2, membrane associated","1","3U8D"
"3U8H",,"X-RAY DIFFRACTION",2.89,57.45,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.1 M Tris HCl pH 7.4, 10 mM CaCl2, 0.5 mM Beta-octyl glucoside and 4 M NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M112.397893","BHP","3U8H",29.17,"2.3","2.3","Functionally selective inhibition of Group IIA phospholipase A2 reveals a role for vimentin in regulating arachidonic acid metabolism","NLVNFHRMIKLTTGKEAALSYGFYGCHCGVGGRGSPKDATDRCCVTHDCCYKRLEKRGCGTKFLSYKFSNSGSRITCAKQDSCRSQLCECDKAAATCFARNKTTYNKKYQYYSNKHCRGSTPRC","Homo sapiens","PLA2G2A, PLA2B, PLA2L, RASF-A","Phospholipase A2, membrane associated","1","3U8H"
"3U8I",,"X-RAY DIFFRACTION",2.07,40.69,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.1 M Tris HCl pH 7.4, 10 mM CaCl2, 0.5 mM Beta-octyl glucoside and 4 M NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M112.397893",,"3U8I",28.68,"1.1","1.1","Functionally selective inhibition of Group IIA phospholipase A2 reveals a role for vimentin in regulating arachidonic acid metabolism","NLVNFHRMIKLTTGKEAALSYGFYGCHCGVGGRGSPKDATDRCCVTXDCCYKRLEKRGCGTKFLSYKFSNSGSRITCAKQDSCRSQLCECDKAAATCFARNKTTYNKKYQYYSNKHCRGSTPRC","Homo sapiens","PLA2G2A, PLA2B, PLA2L, RASF-A","Phospholipase A2, membrane associated","1","3U8I"
"3U8T",,"X-RAY DIFFRACTION",2.49,50.55,"VAPOR DIFFUSION, SITTING DROP",8.5,"50mM Tris, 50mM Bicine, 30mM NaF, 30mM NaBr, 30mM NaI, 11.5% MPD, 11.5% PEG-1000, 11.5% PEG-3350, VAPOR DIFFUSION, SITTING DROP, temperature 293K, pH 8.5",293,"10.1371/journal.pone.0034354",,"3U8T",34.01,"1.861","1.861","Human thrombin complexed with D-Phe-Pro-D-Arg-Cys","ADCGLRPLFEKKSLEDKTERELLESYI","Homo sapiens","F2","Thrombin light chain","1","3U8T"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin heavy chain","2","3U8T"
,,,,,,,,,,,,,,,,"FPRCX",,,"D-PHE-PRO-D-ARG-CYS DIRECT THROMBIN INHIBITOR","3","3U8T"
"3U8U",,"X-RAY DIFFRACTION",2.88,57.34,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.05M MGCL2.6H2O, 0.1M HEPES PH 7.5, 30% PEG 550MME, 1 MICRO-MOLAR HYCANTHONE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 280K",280,,,"3U8U",213.93,"2.15","2.15","Crystal structure of Human Apurinic/Apyridinimic Endonuclease, Ape1 in a new crystal form","MPKRGKKGAVAEDGDELRTEPEAKKSKTAAKKNDKEAAGEGPALYEDPPDQKTSPSGKPATLKICSWNVDGLRAWIKKKGLDWVKEEAPDILCLQETKCSENKLPAELQELPGLSHQYWSAPSDKEGYSGVGLLSRQCPLKVSYGIGDEEHDQEGRVIVAEFDSFVLVTAYVPNAGRGLVRLEYRQRWDEAFRKFLKGLASRKPLVLCGDLNVAHEEIDLRNPKGNKKNAGFTPQERQGFGELLQAVPLADSFRHLYPNTPYAYTFWTYMMNARSKNVGWRLDYFLLSHSLLPALCDSKIRSKALGSDHCPITLYLAL","Homo sapiens","APEX1, APE, APE1, APEX, APX, HAP1, REF1","DNA-(apurinic or apyrimidinic site) lyase","1","3U8U"
"3U8W",,"X-RAY DIFFRACTION",2.78,55.75,"VAPOR DIFFUSION, HANGING DROP",5.5,"25% PEG3350, 0.2M Magnesium Chloride, 0.1M BIS-TRIS, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmcl.2011.11.067","09J","3U8W",42.46,"2.15","2.15","Crystal Structure of p38a Mitogen-Activated Protein Kinase in Complex with a Triazolopyridazinone inhibitor","GSHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","3U8W"
"3U8Z",,"X-RAY DIFFRACTION",3.28,62.45,"VAPOR DIFFUSION, HANGING DROP",8,"protein in 50 mM Tris, pH 8.0, 300 mM sodium chloride, reservoir:  4.5% PEG4000, 0.2 M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1002/pro.751",,"3U8Z",141.78,"2.64","2.64","human merlin FERM domain","GPLGSQPKTFTVRIVTMDAEMEFNCEMKWKGKDLFDLVCRTLGLRETWFFGLQYTIKDTVAWLKMDKKVLDHDVSKEEPVTFHFLAKFYPENAEEELVQEITQHLFFLQVKKQILDEKIYCPPEASVLLASYAVQAKYGDYDPSVHKRGFLAQEELLPKRVINLYQMTPEMWEERITAWYAEHRGRARDEAEMEYLKIAQDLEMYGVNYFAIRNKKGTELLLGVDALGLHIYDPENRLTPKISFPWNEIRNISYSDKEFTIKPLDKKIDVFKFNSSKLRVNKLILQLCIGNHDLFMRRRK","Homo sapiens","NF2, SCH","Merlin","1","3U8Z"
"3U9C",,"X-RAY DIFFRACTION",3.2,61.6,,6.5,"reservoir:  
30 % polyethylene glycol 8000, 0.2 M ammonium sulfate, 0.1 M sodium cacodylate buffer;  
drop:  
2 microliters preincubated CK2alpha/resorufin mixture (5 mM resorufin, 5 mg/ml Ck2alpha), 1 reservoir solution , pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S0907444912016587","04G","3U9C",81.73,"3.2","3.2","Structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit with the ATP-competitive inhibitor resorufin","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3U9C"
"3U9H",,"X-RAY DIFFRACTION",2.43,49.45,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LiSO4, 0.1 M Tris HCl  
22 % PEG3350, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm201510p",,"3U9H",55.66,"1.75","1.75","Complex structure of human tankyrase 2 with nicotinamide","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","3U9H"
"3U9J",,"X-RAY DIFFRACTION",2.13,42.22,"VAPOR DIFFUSION, HANGING DROP",7.5,"15% PEG 3350, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1002/cbic.201200043",,"3U9J",39.34,"1.603","1.603","Crystal structure of oxidized human FBXL5 hemerythrin like domain","MAPFPEEVDVFTAPHWRMKQLVGLYCDKLSKTNFSNNNDFRALLQSLYATFKEFKMHEQIENEYIIGLLQQRSQTIYNVHSDNKLSEMLSLFEKGLKNVKNEYEQLNYAKQLKERLEAFTRDFLPHMKEEEEVFQPMLMEYFTYEELKDIKKKVIAQHCS","Homo sapiens","FBXL5, FBL4, FBL5, FLR1","F-box/LRR-repeat protein 5","1","3U9J"
"3U9M",,"X-RAY DIFFRACTION",2.02,39.07,"VAPOR DIFFUSION, HANGING DROP",7.5,"15% PEG 3350, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1002/cbic.201200043",,"3U9M",77.37,"1.95","1.95","Structure of reduced human FBXL5 hemerythrin like domain","MAPFPEEVDVFTAPHWRMKQLVGLYCDKLSKTNFSNNNDFRALLQSLYATFKEFKMHEQIENEYIIGLLQQRSQTIYNVHSDNKLSEMLSLFEKGLKNVKNEYEQLNYAKQLKERLEAFTRDFLPHMKEEEEVFQPMLMEYFTYEELKDIKKKVIAQHCS","Homo sapiens","FBXL5, FBL4, FBL5, FLR1","F-box/LRR-repeat protein 5","1","3U9M"
"3U9N",,"X-RAY DIFFRACTION",2.52,51.2,"VAPOR DIFFUSION, HANGING DROP",7.5,".1 M Tris-Cl pH 7.5, 1% v/v n-butanol, 2.5% v/v DMSO, 25% v/v Glycerol, 6-12% PEG 3.25K, 2.5 mM TCEP-Cl, 10 mM Na2-Dithionite, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"09H","3U9N",31.86,"1.85","1.85","X-ray crystal structure of compound 1 bound to human CHK1 kinase domain","AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAK","Homo sapiens","CHEK1, CHK1","Serine/threonine-protein kinase Chk1","1","3U9N"
"3U9W",,"X-RAY DIFFRACTION",2.43,49.47,"LIQUID-LIQUID DIFFUSION, CAPILLARIES",6.8,"28% PEG8000, 0.1 mM sodium acetate, 0.1 mM imidazole, 5 mM ytterbium(III) chloride, pH 6.8, LIQUID-LIQUID DIFFUSION, CAPILLARIES, temperature 298K",298,,"28P","3U9W",71.21,"1.25","1.25","Structure of human Leukotriene A4 hydrolase in complex with inhibitor sc57461A","IVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD","Homo sapiens","LTA4H, LTA4","Leukotriene A-4 hydrolase","1","3U9W"
"3U9X",,"X-RAY DIFFRACTION",2.7,54.47,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.095M HEPES Na, 26.6% PEG400, 0.1M Calcium chloride, 5% Glycerol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1073/pnas.1116592109",,"3U9X",26.98,"1.8","1.8","Covalent attachment of pyridoxal-phosphate derivatives to 14-3-3 proteins","AMGSMERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSCEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTNPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWT","Homo sapiens","HME1, NM_006142, SFN","14-3-3 protein sigma","1","3U9X"
"3U9Y",,"X-RAY DIFFRACTION",2.35,47.69,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LiSO4, 0.1 M Tris-HCl    
24 % PEG3350 , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm201510p","09L","3U9Y",28.08,"2.3","2.3","Crystal structure of human tankyrase 2 catalytic domain in complex with olaparib","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","3U9Y"
"3UA1",,"X-RAY DIFFRACTION",2.2,43.97,"MICROBATCH UNDER OIL",6.4,"2% tacsimate, 6% PEG3350, pH 6.4, MICROBATCH UNDER OIL, temperature 293K",293,"10.1074/jbc.M111.317081","08Y","3UA1",57.03,"2.15","2.15","Crystal structure of the cytochrome P4503A4-bromoergocryptine complex","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","3UA1"
"3UA5",,"X-RAY DIFFRACTION",2.57,52.13,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M sodium acetate trihydrate, 0.1M TRIS Hcl pH 8.5 and 30% w/v PEG4000, VAPOR DIFFUSION, SITTING DROP, temperature 291K",291,"10.1021/bi300894z",,"3UA5",112.16,"2.8","2.8","Crystal Structure of P450 2B6 (Y226H/K262R) in complex with two molecules of Amlodipine","MAKKTSSKGKLPPGPRPLPLLGNLLQMDRRGLLKSFLRFREKYGDVFTVHLGPRPVVMLCGVEAIREALVDKAEAFSGRGKIAMVDPFFRGYGVIFANGNRWKVLRRFSVTTMRDFGMGKRSVEERIQEEAQCLIEELRKSKGALMDPTFLFQSITANIICSIVFGKRFHYQDQEFLKMLNLFYQTFSLISSVFGQLFELFSGFLKHFPGAHRQVYKNLQEINAYIGHSVEKHRETLDPSAPRDLIDTYLLHMEKEKSNAHSEFSHQNLNLNTLSLFFAGTETTSTTLRYGFLLMLKYPHVAERVYREIEQVIGPHRPPELHDRAKMPYTEAVIYEIQRFSDLLPMGVPHIVTQHTSFRGYIIPKDTEVFLILSTALHDPHYFEKPDAFNPDHFLDANGALKKTEAFIPFSLGKRICLGEGIARAELFLFFTTILQNFSMASPVAPEDIDLTPQECGVGKIPPTYQIRFLPRHHHH","Homo sapiens","CYP2B6","Cytochrome P450 2B6","1","3UA5"
"3UA6",,"X-RAY DIFFRACTION",2.49,50.62,"VAPOR DIFFUSION, HANGING DROP",6,"5.5 M sodium formate, 0.1 M MES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S0907444912019798",,"3UA6",14.87,"1.85","1.85","Crystal Structure of the Human Fyn SH3 domain","MGTGVTLFVALYDYEARTEDDLSFHKGEKFQILNSSEGDWWEARSLTTGETGYIPSNYVAPVDS","Homo sapiens","FYN","Tyrosine-protein kinase Fyn","1","3UA6"
"3UA8",,"X-RAY DIFFRACTION",2.25,45.42,"HANGING DROP",7.5,"20% w/v 2-propanol, 10% w/v PEG4000, 100 mM HEPES, pH 7.5, HANGING DROP, temperature 277K",277,"10.1016/j.bmcl.2011.12.009","08W","3UA8",29.79,"1.9","1.9","Crystal Structure Analysis of a 6-Amino Quinazolinedione Sulfonamide bound to human GluR2","GPNKTVVVTTILESPYVMMKKNHEMLEGNERYEGYCVDLAAEIAKHCGFKYKLTIVGDGKYGARDADTKIWNGMVGELVYGKADIAIAPLTITLVREEVIDFSKPFMSLGISIMIKKGTPIESAEDLSKQTEIAYGTLDSGSTKEFFRRSKIAVFDKMWTYMRSAEPSVFVRTTAEGVARVRKSKGKYAYLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGIATPKGSSLRNAVNLAVLKLNEQGLLDKLKNKWWYDKGECGS","Homo sapiens","GRIA2, GLUR2","Glutamate receptor 2","1","3UA8"
,,,,,,,,,,,,,,,,,"Homo sapiens","GRIA2, GLUR2"
"3UA9",,"X-RAY DIFFRACTION",2.43,49.33,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LiSO4, 0.1 M Tris HCl 26 % PEG3350 , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm201510p","IWR","3UA9",56.15,"2.15","2.15","Crystal structure of human tankyrase 2 in complex with a selective inhibitor","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","Tankyrase-2","1","3UA9"
"3UB2",,"X-RAY DIFFRACTION",4.9,74.88,"VAPOR DIFFUSION, HANGING DROP",9.5,"0.1M CHES, 12-20% Glycerol, 150-300mM sodium chloride, 10mM DTT, pH 9.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1371/journal.pone.0034202",,"3UB2",16.12,"2.4","2.4","TIR domain of Mal/TIRAP","GPGSSRWSKDYDVCVCHSEEDLVAAQDLVSYLEGSTASLRCFLQLRDATPGGAIVSELCQALSSSHCRVLLITPGFLQDPWCKYQMLQALTEAPGAEGCTIPLLSGLSRAAYPPELRFMYYVDGRGPDGGFRQVKEAVMRYLQTLS","Homo sapiens","TIRAP, MAL","Toll/interleukin-1 receptor domain-containing adapter protein","1","3UB2"
"3UB3",,"X-RAY DIFFRACTION",4.8,74.37,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris, 12-15% Glycerol, 0.2-0.3M sodium chloride, 10mM DTT, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1371/journal.pone.0034202",,"3UB3",16.12,"2.75","2.75","D96N variant of TIR domain of Mal/TIRAP","GPGSSRWSKDYDVCVCHSEENLVAAQDLVSYLEGSTASLRCFLQLRDATPGGAIVSELCQALSSSHCRVLLITPGFLQDPWCKYQMLQALTEAPGAEGCTIPLLSGLSRAAYPPELRFMYYVDGRGPDGGFRQVKEAVMRYLQTLS","Homo sapiens","TIRAP, MAL","Toll/interleukin-1 receptor domain-containing adapter protein","1","3UB3"
"3UB4",,"X-RAY DIFFRACTION",4.81,74.42,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris, 12-15% Glycerol, 0.2-0.3M sodium chloride, 10mM DTT, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1371/journal.pone.0034202",,"3UB4",16.15,"3.1","3.1","S180L variant of TIR domain of Mal/TIRAP","GPGSSRWSKDYDVCVCHSEEDLVAAQDLVSYLEGSTASLRCFLQLRDATPGGAIVSELCQALSSSHCRVLLITPGFLQDPWCKYQMLQALTEAPGAEGCTIPLLLGLSRAAYPPELRFMYYVDGRGPDGGFRQVKEAVMRYLQTLS","Homo sapiens","TIRAP, MAL","Toll/interleukin-1 receptor domain-containing adapter protein","1","3UB4"
"3UBY",,"X-RAY DIFFRACTION",1.97,37.46,"VAPOR DIFFUSION, HANGING DROP",,"An equimolar ratio of delta79AAG and 13-mer single-stranded (ss) EDC DNA were mixed to form a protein-DNA complex concentration of 0.3 mM in the complex buffer (20 mM HEPES-NaOH, pH 7.5, 100 mM NaCl, 0.1 mM EDTA, 5% v/v glycerol and 1 mM DTT). The complex was incubated on ice for 15 min and used for crystallization. Crystals were obtained upon mixing 1 uL of protein-DNA complex and 1 uL of reservoir solution (100 mM BIS-TRIS, pH 5.5, 200 mM cesium chloride and 20% polyethylene glycol (PEG) 3350) over 0.5 ml of reservoir solution. Crystals appeared after incubation for 14 days at 22 degrees C, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi201484k",,"3UBY",56.56,"2","2","Crystal structure of human alklyadenine DNA glycosylase in a lower and higher-affinity complex with DNA","GPHMTRLGLEFFDQPAVPLARAFLGQVLVRRLPNGTELRGRIVETEAYLGPEDEAAHSRGGRQTPRNRGMFMKPGTLYVYIIYGMYFCMNISSQGDGACVLLRALEPLEGLETMRQLRSTLRKGTASRVLKDRELCSGPSKLCQALAINKSFDQRDLAQDEAVWLERGPLEPSEPAVVAAARVGVGHAGEWARKPLRFYVRGSPWVSVVDRVAEQDTQA","Homo sapiens","MPG, AAG, ANPG, MID1","DNA-3-methyladenine glycosylase","1","3UBY"
,,,,,,,,,,,,,,,,"GACATGXTTGCCT",,,"DNA (5'-D(*GP*AP*CP*AP*TP*GP*(EDC)P*TP*TP*GP*CP*CP*T)-3')","2","3UBY"
"3UCC",,"X-RAY DIFFRACTION",2.43,49.42,"VAPOR DIFFUSION, HANGING DROP",8.5,"20% PEG4K, 0.2M MgCl2, 0.1M Tris-HCl, pH 8.5, vapor diffusion, hanging drop, temperature 298K, VAPOR DIFFUSION, HANGING DROP",298,"10.1016/j.jinorgbio.2012.02.011",,"3UCC",96.63,"1.5","1.5","Asymmetric complex of human neuron specific enolase-1-PGA/PEP","SIQKIWAREILDSRGNPTVEVDLYTAKGLFRAAVPSGASTGIYEALELRDGDKQRYLGKGVLKAVDHINSTIAPALISSGLSVVEQEKLDNLMLELDGTENKSKFGANAILGVSLAVCKAGAAERELPLYRHIAQLAGNSDLILPVPAFNVINGGSHAGNKLAMQEFMILPVGAESFRDAMRLGAEVYHTLKGVIKDKYGKDATNVGDEGGFAPNILENSEALELVKEAIDKAGYTEKIVIGMDVAASEFYRDGKYDLDFKSPTDPSRYITGDQLGALYQDFVRDYPVVSIEDPFDQDDWAAWSKFTANVGIQIVGDDLTVTNPKRIERAVEEKACNCLLLKVNQIGSVTEAIQACKLAQENGWGVMVSHRSGETEDTFIADLVVGLCTGQIKTGAPCRSERLAKYNQLMRIEEELGDEARFAGHNFRNPSVLHHHHHH","Homo sapiens","ENO2","Gamma-enolase","1","3UCC"
"3UCD",,"X-RAY DIFFRACTION",2.21,44.24,"VAPOR DIFFUSION, HANGING DROP",8.5,"20% PEG4K, 0.2M MgCl2, 0.1M Tris-HCl, pH 8.5, vapor diffusion, hanging drop, temperature 298K, VAPOR DIFFUSION, HANGING DROP",298,"10.1016/j.jinorgbio.2012.02.011",,"3UCD",96.49,"1.41","1.41","Asymmetric complex of human neuron specific enolase-2-PGA/PEP","SIQKIWAREILDSRGNPTVEVDLYTAKGLFRAAVPSGASTGIYEALELRDGDKQRYLGKGVLKAVDHINSTIAPALISSGLSVVEQEKLDNLMLELDGTENKSKFGANAILGVSLAVCKAGAAERELPLYRHIAQLAGNSDLILPVPAFNVINGGSHAGNKLAMQEFMILPVGAESFRDAMRLGAEVYHTLKGVIKDKYGKDATNVGDEGGFAPNILENSEALELVKEAIDKAGYTEKIVIGMDVAASEFYRDGKYDLDFKSPTDPSRYITGDQLGALYQDFVRDYPVVSIEDPFDQDDWAAWSKFTANVGIQIVGDDLTVTNPKRIERAVEEKACNCLLLKVNQIGSVTEAIQACKLAQENGWGVMVSHRSGETEDTFIADLVVGLCTGQIKTGAPCRSERLAKYNQLMRIEEELGDEARFAGHNFRNPSVLHHHHHH","Homo sapiens","ENO2","Gamma-enolase","1","3UCD"
"3UCG",,"X-RAY DIFFRACTION",3.35,63.31,"VAPOR DIFFUSION, SITTING DROP",7.5,"2.0M (NH4)2SO4, 2.0% PEG-400, 0.1M HEPES pH 7.5, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3UCG",10.37,"1.95","1.95","Crystal structure of a RNA binding domain of polyadenylate-binding protein (PABPN1) from Homo sapiens at 1.95 A resolution","GMEADARSIYVGNVDYGATAEELEAHFHGCGSVNRVTILCDKFSGHPKGFAYIEFSDKESVRTSLALDESLFRGRQIKVIPKRTNRPGI","Homo sapiens","BC010939, PAB2, PABP2, PABPN1","Polyadenylate-binding protein 2","1","3UCG"
"3UCH",,"X-RAY DIFFRACTION",3.39,63.68,"VAPOR DIFFUSION, SITTING DROP",7,"20.0% PEG-1000, 0.1M TRIS pH 7.0, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3UCH",19.32,"2.5","2.5","Crystal structure of a peptidyl-prolyl cis-trans isomerase E (PPIE) from Homo sapiens at 2.50 A resolution","GGEPIAKKARSNPQVYMDIKIGNKPAGRIQMLLRSDVVPMTAENFRCLCTHEKGFGFKGSSFHRIIPQFMCQGGDFTNHNGTGGKSIYGKKFDDENFILKHTGPGLLSMANSGPNTNGSQFFLTCDKTDWLDGKHVVFGEVTEGLDVLRQIEAQGSKDGKPKQKVIIADCGEYV","Homo sapiens","BC008451, CYP33, PPIE","Peptidyl-prolyl cis-trans isomerase E","1","3UCH"
"3UCR",,"X-RAY DIFFRACTION",3.54,65.23,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.5 M (NH4)2SO4 and 0.1M HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.1120606109",,"3UCR",48.19,"2.627","2.627","Crystal structure of the immunoreceptor TIGIT IgV domain","GSHHMTGTIETTGNISAEKGGSIILQCHLSSTTAQVTQVNWEQQDQLLAICNADLGWHISPSFKDRVAPGPGLGLTLQSLTVNDTGEYFCIYHTYPDGTYTGRIFLEVLE","Homo sapiens","TIGIT, VSIG9, VSTM3","T cell immunoreceptor with Ig and ITIM domains","1","3UCR"
"3UCT",,"X-RAY DIFFRACTION",2.13,42.25,"VAPOR DIFFUSION, HANGING DROP",6.5,"100MM TRIS-CACODYLATE, 25MM ZNCL2, 16% PEG8000, 100MM MNCL2, 20% ETHYLENE GLYCOL, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi300698h",,"3UCT",18.19,"1.9","1.9","Structure of Mn2+-bound N-terminal domain of calmodulin in the presence of Zn2+","ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDT","Homo sapiens","CALM, CALM1, CALM2, CALM3, CALML2, CAM, CAM1, CAM2, CAM3, CAMB, CAMC, CAMIII","Calmodulin","1","3UCT"
"3UCU",,"X-RAY DIFFRACTION",2.04,39.66,"VAPOR DIFFUSION, HANGING DROP",6,"24% PEG550mme, 50 mM MES, pH 6.0, 5 mM MgSO4, 300 mM NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi2016662",,"3UCU",41.95,"2.8","2.8","The c-di-GMP-I riboswitch bound to pGpG","MAVPETRPNHTIYINNLNEKIKKDELKKSLHAIFSRFGQILDILVSRSLKMRGQAFVIFKEVSSATNALRSMQGFPFYDKPMRIQYAKTDSDIIAKMK","Homo sapiens","SNRPA","U1 small nuclear ribonucleoprotein A","1","3UCU"
,,,,,,,,,,,,,,,,"GGUCACGCACAGGGCAAACCAUUCGAAAGAGUGGGACGCAAAGCCUCCGGCCUAAACCAUUGCACUCCGGUAGGUAGCGGGGUUACCGAUGG",,,"RNA (92-MER)","2","3UCU"
,,,,,,,,,,,,,,,,"GG",,,"diguanosine monophosphate","3","3UCU"
"3UCW",,"X-RAY DIFFRACTION",2.06,40.42,"VAPOR DIFFUSION, HANGING DROP",7,"20MM TRIS CACODYLATE, 32% PEG8000, 25MM MGAC, 1MM EGTA, 50MM KCL, 25% ETHYLENE GLYCOL, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi300698h",,"3UCW",35.44,"1.76","1.76","Structure of MG2+ bound N-Terminal domain of Calmodulin","ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDT","Homo sapiens","CALM, CALM1, CALM2, CALM3, CALML2, CAM, CAM1, CAM2, CAM3, CAMB, CAMC, CAMIII","Calmodulin","1","3UCW"
"3UCY",,"X-RAY DIFFRACTION",2.53,51.38,"VAPOR DIFFUSION, HANGING DROP",6.5,"100MM TRIS CACODYLATE, 25MM ZNCL2, 16% PEG8000, 100MM MGCL2, 20% ETHYLENE GLYCOL, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi300698h",,"3UCY",9.11,"1.8","1.8","Structure of Mg2+ bound N-terminal domain of calmodulin in the presence of Zn2+","ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDT","Homo sapiens","CALM, CALM1, CALM2, CALM3, CALML2, CAM, CAM1, CAM2, CAM3, CAMB, CAMC, CAMIII","Calmodulin","1","3UCY"
"3UCZ",,"X-RAY DIFFRACTION",2.07,40.66,"VAPOR DIFFUSION, HANGING DROP",6,"24% PEG550mme, 50 mM MES, pH 6.0, 5 mM MgSO4, 300 mM NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi2016662",,"3UCZ",42,"2.8","2.8","The c-di-GMP-I riboswitch bound to GpG","MAVPETRPNHTIYINNLNEKIKKDELKKSLHAIFSRFGQILDILVSRSLKMRGQAFVIFKEVSSATNALRSMQGFPFYDKPMRIQYAKTDSDIIAKMK","Homo sapiens","SNRPA","U1 small nuclear ribonucleoprotein A","1","3UCZ"
,,,,,,,,,,,,,,,,"GGUCACGCACAGGGCAAACCAUUCGAAAGAGUGGGACGCAAAGCCUCCGGCCUAAACCAUUGCACUCCGGUAGGUAGCGGGGUUACCGAUGG",,,"RNA (92-MER)","2","3UCZ"
,,,,,,,,,,,,,,,,"GG",,,"RNA (5'-R(*GP*G)-3')","3","3UCZ"
"3UD1",,"X-RAY DIFFRACTION",2.46,50.01,"VAPOR DIFFUSION, SITTING DROP",7,"25% ethanol, 0.1 M Tris pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 283.15K",283.15,"10.1016/j.jmb.2012.01.041",,"3UD1",108.81,"2","2","Crystal structure of ZU5A-ZU5B domains of human erythrocyte ankyrin","SNATGFLVSFMVDARGGSMRGSRHNGLRVVIPPRTCAAPTRITCRLVKPQKLSTPPPLAEEEGLASRIIALGPTGAQFLSPVIVEIPHFASHGRGDRELVVLRSENGSVWKEHRSRYGESYLDQILNGMDEELGSLEELEKKRVCRIITTDFPLYFVIMSRLCQDYDIIGPEGGSLKSKLVPLVQATFPENAVTKRVKLALQAQPVPDELVTKLLGNQATFSPIVTVEPRRRKFHRPIGLRIPLPPSWTDNPRDSGEGDTTSLRLLCSVIGGTDQAQWEDITGTTKLVYANECANFTTNVSARFWLSDCPRTAEAVNFATLLYKEL","Homo sapiens","ANK1, ANK","Ankyrin-1","1","3UD1"
"3UD2",,"X-RAY DIFFRACTION",2.5,50.76,"VAPOR DIFFUSION, SITTING DROP",7,"25% ethanol, 0.1 M Tris pH 7, VAPOR DIFFUSION, SITTING DROP, temperature 283.15K",283.15,"10.1016/j.jmb.2012.01.041",,"3UD2",109.57,"2.21","2.21","Crystal structure of Selenomethionine ZU5A-ZU5B protein domains of human erythrocyte ankyrin","SNATGFLVSFMVDARGGSMRGSRHNGLRVVIPPRTCAAPTRITCRLVKPQKLSTPPPLAEEEGLASRIIALGPTGAQFLSPVIVEIPHFASHGRGDRELVVLRSENGSVWKEHRSRYGESYLDQILNGMDEELGSLEELEKKRVCRIITTDFPLYFVIMSRLCQDYDIIGPEGGSLKSKLVPLVQATFPENAVTKRVKLALQAQPVPDELVTKLLGNQATFSPIVTVEPRRRKFHRPIGLRIPLPPSWTDNPRDSGEGDTTSLRLLCSVIGGTDQAQWEDITGTTKLVYANECANFTTNVSARFWLSDCPRTAEAVNFATLLYKEL","Homo sapiens","ANK1, ANK","Ankyrin-1","1","3UD2"
"3UD3",,"X-RAY DIFFRACTION",2.12,42.09,"VAPOR DIFFUSION, HANGING DROP",6,"26% PEG550mme, 50 mM MES, pH 6.0, 5 mM MgSO4, 300 mM NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi2016662",,"3UD3",41.94,"3.1","3.1","The C92U mutant c-di-GMP-I riboswitch bound to pGpA","MAVPETRPNHTIYINNLNEKIKKDELKKSLHAIFSRFGQILDILVSRSLKMRGQAFVIFKEVSSATNALRSMQGFPFYDKPMRIQYAKTDSDIIAKMK","Homo sapiens","SNRPA","U1 small nuclear ribonucleoprotein A","1","3UD3"
,,,,,,,,,,,,,,,,"GGUCACGCACAGGGCAAACCAUUCGAAAGAGUGGGACGCAAAGCCUCCGGCCUAAACCAUUGCACUCCGGUAGGUAGCGGGGUUAUCGAUGG",,,"RNA (92-MER)","2","3UD3"
,,,,,,,,,,,,,,,,"GA",,,"RNA (5'-R(P*GP*A)-3')","3","3UD3"
"3UD4",,"X-RAY DIFFRACTION",2.02,39.09,"VAPOR DIFFUSION, HANGING DROP",6,"24% PEG550mme, 50 mM MES, pH 6.0, 5 mM MgSO4, 300 mM NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi2016662",,"3UD4",41.94,"2.7","2.7","The C92U mutant c-di-GMP-I riboswitch bound to GpA","MAVPETRPNHTIYINNLNEKIKKDELKKSLHAIFSRFGQILDILVSRSLKMRGQAFVIFKEVSSATNALRSMQGFPFYDKPMRIQYAKTDSDIIAKMK","Homo sapiens","SNRPA","U1 small nuclear ribonucleoprotein A","1","3UD4"
,,,,,,,,,,,,,,,,"GGUCACGCACAGGGCAAACCAUUCGAAAGAGUGGGACGCAAAGCCUCCGGCCUAAACCAUUGCACUCCGGUAGGUAGCGGGGUUAUCGAUGG",,,"RNA (92-MER)","2","3UD4"
,,,,,,,,,,,,,,,,"GA",,,"RNA (5'-R(*GP*A)-3')","3","3UD4"
"3UD7",,"X-RAY DIFFRACTION",2.28,46.04,"VAPOR DIFFUSION, HANGING DROP",7,"2M (NH4)HPO4, 0.1M sodium acetate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/ja3090065",,"3UD7",49.07,"2.8","2.8","Crystal Structure Analysis of FGF1-Disaccharide(NI21) complexes","MFNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","3UD7"
"3UD8",,"X-RAY DIFFRACTION",2.14,42.46,"VAPOR DIFFUSION, HANGING DROP",7,"2 M (NH4)HPO4, 0.1 M sodium acetate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/ja3090065",,"3UD8",48.77,"2.37","2.37","Crystal Structure Analysis of FGF1-Disaccharide(NI22) complex","MFNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","3UD8"
"3UD9",,"X-RAY DIFFRACTION",2.18,43.61,"VAPOR DIFFUSION, HANGING DROP",7,"2M (NH4)HPO4, 0.1M sodium acetate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/ja3090065",,"3UD9",48.96,"2.34","2.34","Crystal Structure Analysis of FGF1-Disaccharide(NI23) complex","MFNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","3UD9"
"3UDA",,"X-RAY DIFFRACTION",2.14,42.41,"VAPOR DIFFUSION, HANGING DROP",7,"2M (NH4)HPO4, 0.1M sodium acetate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/ja3090065",,"3UDA",48.94,"2.51","2.51","Crystal Structure Analysis of FGF1-Disaccharide(NI24) complex","MFNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD","Homo sapiens","FGF1, FGFA","Heparin-binding growth factor 1","1","3UDA"
"3UDD",,"X-RAY DIFFRACTION",2.41,48.98,"VAPOR DIFFUSION, HANGING DROP",5.8,"15% PEG3350, 100MM BIS-TRIS PH5.8, 300MM AMMONIUM SULFATE, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm2011222","34M","3UDD",52.71,"1.95","1.95","Tankyrase-1 in complex with small molecule inhibitor","GGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTIKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEAPSQTATAAEQKT","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","3UDD"
"3UDH",,"X-RAY DIFFRACTION",2.14,42.51,"VAPOR DIFFUSION",,"protein in sodium borate, pH 8.5, reservoir: 30% PEG200, 0.1 M sodium acetate, pH 5.2-5.4, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm201715d","091","3UDH",45.78,"1.7","1.7","Crystal Structure of BACE with Compound 1","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3UDH"
"3UDJ",,"X-RAY DIFFRACTION",2.18,43.6,"VAPOR DIFFUSION",,"protein in sodium borate, pH 8.5, reservoir: 30% PEG200, 0.1 M sodium acetate, pH 5.2-5.4, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm201715d","092","3UDJ",45.7,"1.8","1.8","Crystal Structure of BACE with Compound 5","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3UDJ"
"3UDK",,"X-RAY DIFFRACTION",2.19,43.86,"VAPOR DIFFUSION",,"protein in sodium borate, pH 8.5, reservoir: 30% PEG200, 0.1 M sodium acetate, pH 5.2-5.4, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm201715d","095","3UDK",45.83,"2.51","2.51","Crystal Structure of BACE with Compound 6","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3UDK"
"3UDM",,"X-RAY DIFFRACTION",2.12,42.07,"VAPOR DIFFUSION",,"protein in sodium borate, pH 8.5, reservoir: 30% PEG200, 0.1 M sodium acetate, pH 5.2-5.4, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm201715d","09A","3UDM",45.71,"1.94","1.94","Crystal Structure of BACE with Compound 8","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3UDM"
"3UDN",,"X-RAY DIFFRACTION",2.1,41.41,"VAPOR DIFFUSION",,"protein in sodium borate, pH 8.5, reservoir: 30% PEG200, 0.1 M sodium acetate, pH 5.2-5.4, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm201715d","09B","3UDN",45.8,"2.193","2.193","Crystal Structure of BACE with Compound 9","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3UDN"
"3UDP",,"X-RAY DIFFRACTION",2.11,41.68,"VAPOR DIFFUSION",,"protein in sodium borate, pH 8.5, reservoir: 30% PEG200, 0.1 M sodium acetate, pH 5.2-5.4, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm201715d","09D","3UDP",45.98,"1.95","1.95","Crystal Structure of BACE with Compound 12","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3UDP"
"3UDQ",,"X-RAY DIFFRACTION",2.14,42.56,"VAPOR DIFFUSION",,"protein in sodium borate, pH 8.5, reservoir: 30% PEG200, 0.1 M sodium acetate, pH 5.2-5.4, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm201715d","09E","3UDQ",45.65,"2.73","2.73","Crystal Structure of BACE with Compound 13","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3UDQ"
"3UDR",,"X-RAY DIFFRACTION",2.14,42.46,"VAPOR DIFFUSION",,"protein in sodium borate, pH 8.5, reservoir: 30% PEG200, 0.1 M sodium acetate, pH 5.2-5.4, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm201715d","09F","3UDR",45.79,"1.95","1.95","Crystal Structure of BACE with Compound 14","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3UDR"
"3UDY",,"X-RAY DIFFRACTION",2.14,42.43,"VAPOR DIFFUSION",,"protein in sodium borate, pH 8.5, reservoir: 30% PEG200, 0.1 M sodium acetate, pH 5.2-5.4, VAPOR DIFFUSION, temperature 298K",298,"10.1021/jm201715d","09G","3UDY",46,"2","2","Crystal Structure of BACE with Compound 11","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESRSHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3UDY"
"3UE2",,"X-RAY DIFFRACTION",1.87,34.1,"VAPOR DIFFUSION, SITTING DROP",6,"2.4 M ammonium sulfate, 0.1M MES pH 6.0, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3UE2",13.72,"1.23","1.23","Crystal structure of a RNA binding domain of poly-U binding splicing factor 60KDa (PUF60) from Homo sapiens at 1.23 A resolution","GSGSSARHMVMQKLLRKQESTVMVLRNMVDPKDIDDDLEGEVTEECGKFGAVNRVIIYQEKQGEEEDAEIIVKIFVEFSIASETHKAIQALNGRWFAGRKVVAEVYDQERFDNSDLSA","Homo sapiens","BC008875, FIR, PUF60, ROBPI, SIAHBP1","Poly(U)-binding-splicing factor PUF60","1","3UE2"
"3UE4",,"X-RAY DIFFRACTION",3.12,60.64,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1M Ammonium Acetate 
0.1M BisTris pH 5.5 
11% PEG 10K, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1371/journal.pone.0029828","DB8","3UE4",67.51,"2.424","2.424","Structural and spectroscopic analysis of the kinase inhibitor bosutinib binding to the Abl tyrosine kinase domain","GHMSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGK","Homo sapiens","ABL1, ABL, JTK7","Tyrosine-protein kinase ABL1","1","3UE4"
"3UE8",,"X-RAY DIFFRACTION",2.44,49.63,,,,,"10.1021/ml200204m",,"3UE8",99.05,"3.22","3.22","Kynurenine Aminotransferase II Inhibitors","MNYARFITAASAARNPSPIRTMTDILSRGPKSMISLAGGLPNPNMFPFKTAVITVENGKTIQFGEEMMKRALQYSPSAGIPELLSWLKQLQIKLHNPPTIHYPPSQGQMDLCVTSGSQQGLCKVFEMIINPGDNVLLDEPAYSGTLQSLHPLGCNIINVASDESGIVPDSLRDILSRWKPEDAKNPQKNTPKFLYTVPNGNNPTGNSLTSERKKEIYELARKYDFLIIEDDPYYFLQFNKFRVPTFLSMDVDGRVIRADSFSKIISSGLRIGFLTGPKPLIERVILHIQVSTLHPSTFNQLMISQLLHEWGEEGFMAHVDRVIDFYSNQKDAILAAADKWLTGLAEWHVPAAGMFLWIKVKGINDVKELIEEKAVKMGVLMLPGNAFYVDSSAPSPYLRASFSSASPEQMDVAFQVLAQLIKESLLVPRGSLEHHHHHH","Homo sapiens","AADAT, KAT2, KYAT2","Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial","1","3UE8"
"3UEC",,"X-RAY DIFFRACTION",3.11,60.41,"VAPOR DIFFUSION, HANGING DROP",7.5,"12% peg 8000; O.1 M MOPS 7.5; 0.1 M Magnesium acetate tetrahydrate , VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1091/mbc.E11-11-0904",,"3UEC",18.17,"2.18","2.18","Crystal structure of human Survivin bound to histone H3 phosphorylated on threonine-3.","GSHEMGAPTLPPAWQPFLKDHRISTFKNWPFLEGCACTPERMAEAGFIHCPTENEPDLAQCFFCFKELEGWEPDDDPIEEHKKHSSGCAFLSVKKQFEELTLGEFLKLDRERAKNKIAKETNNKKKEFEETAKKVRRAIEQLAAMD","Homo sapiens","API4, BIRC5, IAP4","Baculoviral IAP repeat-containing protein 5","1","3UEC"
,,,,,,,,,,,,,,,,"ARTK",,,"N-TERMINAL FRAGMENT OF HISTONE H3","2","3UEC"
"3UED",,"X-RAY DIFFRACTION",3.54,65.23,"VAPOR DIFFUSION, HANGING DROP",7.5,"15% PEG 3350, 0.16 M sodium citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1091/mbc.E11-11-0904",,"3UED",36.56,"2.7","2.7","Crystal structure of human Survivin bound to histone H3 phosphorylated on threonine-3 (C2 space group).","GSHEMGAPTLPPAWQPFLKDHRISTFKNWPFLEGCACTPERMAEAGFIHCPTENEPDLAQCFFCFKELEGWEPDDDPIEEHKKHSSGCAFLSVKKQFEELTLGEFLKLDRERAKNKIAKETNNKKKEFEETAKKVRRAIEQLAAMD","Homo sapiens","API4, BIRC5, IAP4","Baculoviral IAP repeat-containing protein 5","1","3UED"
,,,,,,,,,,,,,,,,"ARTKQTARKSTG",,,"N-terminal fragment of histone H3","2","3UED"
"3UEE",,"X-RAY DIFFRACTION",3.53,65.18,"VAPOR DIFFUSION, HANGING DROP",7,"12% PEG 3350, 0.12 M succinic acid, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1091/mbc.E11-11-0904",,"3UEE",36.28,"2.61","2.61","Crystal structure of human Survivin K62A mutant bound to N-terminal histone H3","GSHEMGAPTLPPAWQPFLKDHRISTFKNWPFLEGCACTPERMAEAGFIHCPTENEPDLAQCFFCFAELEGWEPDDDPIEEHKKHSSGCAFLSVKKQFEELTLGEFLKLDRERAKNKIAKETNNKKKEFEETAKKVRRAIEQLAAMD","Homo sapiens","API4, BIRC5, IAP4","Baculoviral IAP repeat-containing protein 5","1","3UEE"
,,,,,,,,,,,,,,,,"ARTKQTARKSTG",,,"N-terminal fragment of histone H3","2","3UEE"
"3UEF",,"X-RAY DIFFRACTION",3.55,65.31,"VAPOR DIFFUSION, HANGING DROP",7.5,"12% PEG 3350, 0.2 M potassium/sodium tartate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1091/mbc.E11-11-0904",,"3UEF",36.52,"2.45","2.45","Crystal structure of human Survivin bound to histone H3 (C2 space group).","GSHEMGAPTLPPAWQPFLKDHRISTFKNWPFLEGCACTPERMAEAGFIHCPTENEPDLAQCFFCFKELEGWEPDDDPIEEHKKHSSGCAFLSVKKQFEELTLGEFLKLDRERAKNKIAKETNNKKKEFEETAKKVRRAIEQLAAMD","Homo sapiens","API4, BIRC5, IAP4","Baculoviral IAP repeat-containing protein 5","1","3UEF"
,,,,,,,,,,,,,,,,"ARTKQTARKSTG",,,"N-terminal fragment of histone H3","2","3UEF"
"3UEG",,"X-RAY DIFFRACTION",3.81,67.69,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES-Na, 20% PEG 3350, 
0.18 M AMMONIUM SULFATE, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1091/mbc.E11-11-0904",,"3UEG",33.92,"2.8","2.8","Crystal structure of human Survivin K62A mutant","GSHEMGAPTLPPAWQPFLKDHRISTFKNWPFLEGCACTPERMAEAGFIHCPTENEPDLAQCFFCFAELEGWEPDDDPIEEHKKHSSGCAFLSVKKQFEELTLGEFLKLDRERAKNKIAKETNNKKKEFEETAKKVRRAIEQLAAMD","Homo sapiens","API4, BIRC5, IAP4","Baculoviral IAP repeat-containing protein 5","1","3UEG"
"3UEH",,"X-RAY DIFFRACTION",3.79,67.51,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 0.2 M SODIUM FORMATE, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1091/mbc.E11-11-0904",,"3UEH",34.07,"2.6","2.6","Crystal structure of human Survivin H80A mutant","GSHEMGAPTLPPAWQPFLKDHRISTFKNWPFLEGCACTPERMAEAGFIHCPTENEPDLAQCFFCFKELEGWEPDDDPIEEHKKASSGCAFLSVKKQFEELTLGEFLKLDRERAKNKIAKETNNKKKEFEETAKKVRRAIEQLAAMD","Homo sapiens","API4, BIRC5, IAP4","Baculoviral IAP repeat-containing protein 5","1","3UEH"
"3UEI",,"X-RAY DIFFRACTION",3.86,68.15,"VAPOR DIFFUSION, HANGING DROP",7.5,"5% Tacsimate, 0.1 M HEPES-Na, 12% PEG monomethyl eter, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1091/mbc.E11-11-0904",,"3UEI",33.67,"2.7","2.7","Crystal structure of human Survivin E65A mutant","GSHEMGAPTLPPAWQPFLKDHRISTFKNWPFLEGCACTPERMAEAGFIHCPTENEPDLAQCFFCFKELAGWEPDDDPIEEHKKHSSGCAFLSVKKQFEELTLGEFLKLDRERAKNKIAKETNNKKKEFEETAKKVRRAIEQLAAMD","Homo sapiens","API4, BIRC5, IAP4","Baculoviral IAP repeat-containing protein 5","1","3UEI"
"3UEM",,"X-RAY DIFFRACTION",2.36,47.97,"VAPOR DIFFUSION, HANGING DROP",8.5,"25%(w/v) PEG3350, 0.1M Tris-HCl, 0.2M ammonium acetate, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1074/jbc.M111.303149",,"3UEM",40.9,"2.29","2.29","Crystal structure of human PDI bb'a' domains","HHHSSGLEVLFQGPGSEFATTLPDGAAAESLVESSEVAVIGFFKDVESDSAKQFLQAAEAIDDIPFGITSNSDVFSKYQLDKDGVVLFKKFDEGRNNFEGEVTKENLLDFIKHNQLPLVIEFTEQTAPKIFGGEIKTHILLFLPKSVSDYDGKLSNFKTAAESFKGKILFIFIDSDHTDNQRILEFFGLKKEECPAVRLITLEEEMTKYKPESEELTAERITEFCHRFLEGKIKPHLMSQELPEDWDKQPVKVLVGKNFEDVAFDEKKNVFVEFYAPWCGHCKQLAPIWDKLGETYKDHENIVIAKMDSTANEVEAVKVHSFPTLKFFPASADRTVIDYNGERTLDGFKKFLESGGQDGAG","Homo sapiens","PDI, P4HB, ERBA2L, PDIA1, PO4DB","Protein disulfide-isomerase","1","3UEM"
"3UEN",,"X-RAY DIFFRACTION",2.48,50.47,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG 3350, NaSCN, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2013.06.015",,"3UEN",22.76,"1.9","1.9","Crystal structure of TopBP1 BRCT4/5 domains","GPLGSEEGLFSQKSFLVLGFSNENESNIANIIKENAGKIMSLLSRTVADYAVVPLLGCEVEATVGEVVTNTWLVTCIDYQTLFDPKSNPLFTPVPVMTGMTPLEDCVISFSQCAGAEKESLTFLANLLGASVQEYFVRKSNAKKGMFASTHLILKERGGSKYEAAKKWNLPAVTIAWLLETARTGKRADESHFLIENSTKEER","Homo sapiens","KIAA0259, TOPBP1","DNA topoisomerase 2-binding protein 1","1","3UEN"
"3UEO",,"X-RAY DIFFRACTION",2.55,51.77,"VAPOR DIFFUSION, HANGING DROP",5.5,"PEG 10000, Ammonium acetate, bis-Tris, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.str.2013.06.015",,"3UEO",91.98,"2.6","2.6","Crystal structure of TopBP1 BRCT4/5 domains in complex with a phospho-peptide","GPLGSEEGLFSQKSFLVLGFSNENESNIANIIKENAGKIMSLLSRTVADYAVVPLLGCEVEATVGEVVTNTWLVTCIDYQTLFDPKSNPLFTPVPVMTGMTPLEDCVISFSQCAGAEKESLTFLANLLGASVQEYFVRKSNAKKGMFASTHLILKERGGSKYEAAKKWNLPAVTIAWLLETARTGKRADESHFLIENSTKEER","Homo sapiens","KIAA0259, TOPBP1","DNA topoisomerase 2-binding protein 1","1","3UEO"
,,,,,,,,,,,,,,,,"GFIDSDTDVEEE",,,"phospho-peptide","2","3UEO"
"3UF1",,"X-RAY DIFFRACTION",2.51,51.08,"VAPOR DIFFUSION, HANGING DROP",7.5,"Protein solution: 100mM NaCl, 5mM DTT, 0.02% NaN3, 10mM Tris-HCl (pH 7.5). Reservoir solution:NH4SO4 0.15M, TRISHCL 0.1M, PEG3350 18%, VAPOR DIFFUSION, HANGING DROP,",,"10.1074/jbc.M111.334011",,"3UF1",58.55,"2.81","2.81","Crystal Structure of Vimentin (fragment 144-251) from Homo sapiens, Northeast Structural Genomics Consortium Target HR4796B","MGHHHHHHSHMSRLGDLYEEEMRELRRQVDQLTNDKARVEVERDNLAEDIMRLREKLQEEMLQREEAENTLQSFRQDVDNASLARLDLERKVESLQEEIAFLKKLHEEEIQELQAQIQE","Homo sapiens","VIM","Vimentin","1","3UF1"
"3UF2",,"X-RAY DIFFRACTION",2,38.65,"VAPOR DIFFUSION, SITTING DROP",5,"0.1M magnesium chloride, 0.1M sodium citrate pH 5.0, 15% w/v PEG 4000, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/nsmb.2367",,"3UF2",178.68,"2.75","2.75","Crystal structure of the human Colony-Stimulating Factor 1 (hCSF-1) cytokine","GSHMEEVSEYCSHMIGSGHLQSLQRLIDSQMETSCQITFEFVDQEQLKDPVCYLKKAFLLVQDIMEDTMRFRDNTPNAIAIVQLQELSLRLKSCFTKDYEEHDKACVRTFYETPLQLLEKVKNVFNETKNLLDKDWNIFSKNCNNSFAECSSQ","Homo sapiens","CSF1","Macrophage colony-stimulating factor 1","1","3UF2"
"3UFJ",,"X-RAY DIFFRACTION",2.82,56.32,"VAPOR DIFFUSION, SITTING DROP",7.3,"20% PEG3350, 0.2 M potassium sodium tartrate tetrahydrate, pH 7.3, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1073/pnas.1201010109",,"3UFJ",74.43,"2.967","2.967","Human Thymine DNA Glycosylase Bound to Substrate Analog 2'-fluoro-2'-deoxyuridine","GSHMASFNGVSEAELLTKTLPDILTFNLDIVIIGINPGLMAAYKGHHYPGPGNHFWKCLFMSGLSEVQLNHMDDHTLPGKYGIGFTNMVERTTPGSKDLSSKEFREGGRILVQKLQKYQPRIAVFNGKCIYEIFSKEVFGVKVKNLEFGLQPHKIPDTETLCYVMPSSSARCAQFPRAQDKVHYYIKLKDLRDQLKGIERNMDV","Homo sapiens","TDG","G/T mismatch-specific thymine DNA glycosylase","1","3UFJ"
,,,,,,,,,,,,,,,,"CAGCTCTGTACGTGAGCAGTGGA",,,"5'-D(*CP*AP*GP*CP*TP*CP*TP*GP*TP*AP*CP*GP*TP*GP*AP*GP*CP*AP*GP*TP*GP*GP*A)-3'","2","3UFJ"
,,,,,,,,,,,,,,,,"CCACTGCTCAXGTACAGAGCTGT",,,"5'-D(*CP*CP*AP*CP*TP*GP*CP*TP*CP*AP*(UF2)P*GP*TP*AP*CP*AP*GP*AP*GP*CP*TP*GP*T)-3'","3","3UFJ"
"3UFL",,"X-RAY DIFFRACTION",2.99,58.81,"VAPOR DIFFUSION, HANGING DROP",7,"pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 273K",273,"10.1016/j.bmcl.2011.11.024","508","3UFL",44.33,"1.9","1.9","Discovery of Pyrrolidine-based b-Secretase Inhibitors: Lead Advancement through Conformational Design for Maintenance of Ligand Binding Efficiency","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3UFL"
"3UFN",,"X-RAY DIFFRACTION",2.06,40.47,"VAPOR DIFFUSION, HANGING DROP",3.8,"0.93M sodium chloride and 30mM citrate-phosphate buffer, pH 3.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/bi2018317","ROC","3UFN",22.95,"1.45","1.45","Crystal Structure of Multidrug Resistant HIV-1 Protease Clinical Isolate PR20 in Complex with Saquinavir","PQITLWKRPFVTVKVGGQLKEALLDTGADNTIFEDINLPGRWKPKMVGGIGGFLKVREYDQVPIEIAGHKVIGTVLVGPTPVNVIGRDTMTQIGATLNF","Homo sapiens",,"HIV-1 protease","1","3UFN"
"3UFY",,"X-RAY DIFFRACTION",2.4,48.83,"VAPOR DIFFUSION, HANGING DROP",7.5,"200mM sodium acetate, 20% mPEG 5000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1371/journal.pone.0043965",,"3UFY",39.26,"1.9","1.9","AKR1C3 complex with R-naproxen","MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","3UFY"
"3UG1",,"X-RAY DIFFRACTION",3.09,60.23,"Counter Diffusion",7.1,"COUNTER DIFFUSION IN MICROGRAVITY CONDITIONS; COUNTER-DIFFUSION METHOD USING JAXA CRYSTALLISATION BOX (JCB). 40mm X 0.5mm CAPILLARIES WERE FILLED WITH 8.1mg/ml PROTEIN SOLUTION AND INSTALLED INTO JCB SYRINGE CASE FILLED WITH MOTHER LIQUOUR (1.7M Sodium CITRATE, 0.1M MES, 7.1). CRYSTALS WERE IN ORBIT FOR 2.5 MONTHS IN THE PROTEIN CRYSTALLISATION RESEARCH FACILITY ON THE JAPANESE EXPERIMENT MODULE OF THE INTERNATIONAL SPACE STATION., Counter Diffusion, temperature 293K",293,"10.1038/onc.2012.21",,"3UG1",38.23,"2.75","2.75","Crystal structure of the mutated EGFR kinase domain (G719S/T790M) in the apo form","GAMGIRSGEAPNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB1, ERBB, HER1","Epidermal growth factor receptor","1","3UG1"
"3UG2",,"X-RAY DIFFRACTION",3.25,62.14,"VAPOR DIFFUSION, HANGING DROP",7.1,"1.1M Sodium citrate, 0.1M MES PH 7.1, 5mg/ml protein, incubated overnight at 4deg with final concentration of 0.5mM gefitinib and 1% DMSO , VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/onc.2012.21","IRE","3UG2",38.68,"2.5","2.5","Crystal structure of the mutated EGFR kinase domain (G719S/T790M) in complex with gefitinib","GAMGIRSGEAPNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB1, ERBB, HER1","Epidermal growth factor receptor","1","3UG2"
"3UG8",,"X-RAY DIFFRACTION",2.3,46.57,"VAPOR DIFFUSION, HANGING DROP",7.5,"200mM sodium acetate, 20% MPEG 5000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1371/journal.pone.0043965","IMN","3UG8",39.14,"1.73","1.73","AKR1C3 complex with indomethacin at pH 7.5","MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","3UG8"
"3UGC",,"X-RAY DIFFRACTION",2.7,54.39,"VAPOR DIFFUSION, HANGING DROP",,"1.8M SODIUM MALONATE PH 6.0, 0.1M GLYCINE-PH 8.2, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1158/2159-8290.CD-11-0324",,"3UGC",35.2,"1.34","1.34","Structural basis of Jak2 inhibition by the type II inhibtor NVP-BBT594","GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","3UGC"
"3UGR",,"X-RAY DIFFRACTION",2.25,45.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"200mM sodium acetate, 20% MPEG 5000, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1371/journal.pone.0043965","IMN","3UGR",39.28,"1.65","1.65","AKR1C3 complex with indomethacin at pH 6.8","MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","3UGR"
"3UH2",,"X-RAY DIFFRACTION",2.36,47.92,"VAPOR DIFFUSION, SITTING DROP",5.8,"16% PEG3350, 100mM Bis-Tris pH5.8, 300mM Ammonium Sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1107/S1744309111051219","P34","3UH2",52.61,"2","2","Tankyrase-1 in complexed with PJ34","GGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTIKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEAPSQTATAAEQKT","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","3UH2"
"3UH4",,"X-RAY DIFFRACTION",2.43,49.39,"VAPOR DIFFUSION, SITTING DROP",5.8,"15% PEG3350, 290 mM Ammonium Sulfate, 100mM Bis-Tris pH5.8, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1107/S1744309111051219","XAV","3UH4",52.52,"2","2","TANKYRASE-1 complexed with NVP-XAV939","GGTILLDLAPEDKEYQSVEEEMQSTIREHRDGGNAGGIFNRYNVIRIQKVVNKKLRERFCHRQKEVSEENHNHHNERMLFHGSPFINAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPTHKDRSCYICHRQMLFCRVTLGKSFLQFSTIKMAHAPPGHHSVIGRPSVNGLAYAEYVIYRGEQAYPEYLITYQIMKPEAPSQTATAAEQKT","Homo sapiens","TNKS, PARP5A, PARPL, TIN1, TINF1, TNKS1","Tankyrase-1","1","3UH4"
"3UI4",,"X-RAY DIFFRACTION",1.86,33.73,"VAPOR DIFFUSION",8,"0.1 M Tris, 2.5 M (NH4)2SO4, 3-20 mM Ala-Pro, pH 8.0, vapor diffusion, temperature 298K",298,"10.1021/ja2086195",,"3UI4",11.62,"0.8","0.8","0.8 A resolution crystal structure of human Parvulin 14","GPMGSNAVKVRHILCEKHGKIMEAMEKLKSGMRFNEVAAQYSEDKARQGGDLGWMTRGSMVGPFQEAAFALPVSGMDKPVFTDPPVKTKFGYHIIMVEGRK","Homo sapiens","PIN4, Q9Y237","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4","1","3UI4"
"3UI5",,"X-RAY DIFFRACTION",1.88,34.53,"VAPOR DIFFUSION",8,"0.1 M Tris, 2.5 M (NH4)2SO4, 3-20 mM Ala-Pro, pH 8.0, vapor diffusion, temperature 298K",298,"10.1021/ja2086195",,"3UI5",11.74,"1.4","1.4","Crystal structure of human Parvulin 14","GPMGSNAVKVRHILCEKHGKIMEAMEKLKSGMRFNEVAAQYSEDKARQGGDLGWMTRGSMVGPFQEAAFALPVSGMDKPVFTDPPVKTKFGYHIIMVEGRK","Homo sapiens","PIN4, Q9Y237","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4","1","3UI5"
"3UI6",,"X-RAY DIFFRACTION",1.87,34.22,"VAPOR DIFFUSION",8,"0.1 M Tris, 2.5 M (NH4)2SO4, 3-20 mM Ala-Pro, pH 8.0, vapor diffusion, temperature 298K",298,,,"3UI6",11.84,"0.89","0.89","0.89 A resolution crystal structure of human Parvulin 14 in complex with oxidized DTT","GPMGSNAVKVRHILCEKHGKIMEAMEKLKSGMRFNEVAAQYSEDKARQGGDLGWMTRGSMVGPFQEAAFALPVSGMDKPVFTDPPVKTKFGYHIIMVEGRK","Homo sapiens","PIN4, Q9Y237","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4","1","3UI6"
"3UI7",,"X-RAY DIFFRACTION",2.08,40.76,"VAPOR DIFFUSION, HANGING DROP",7.4,"100mM Hepes, 16% PEG 3350, 25 mM MgCl2, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.bmcl.2011.11.023","C1L","3UI7",78.02,"2.28","2.28","Discovery of orally active pyrazoloquinoline as a potent PDE10 inhibitor for the management of schizophrenia","GMEKLSYHSHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEE","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","3UI7"
"3UIG",,"X-RAY DIFFRACTION",3.64,66.2,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M DL-malic acid, pH 7.0, 12% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2011.12.001",,"3UIG",36.37,"2.4","2.4","crystal structure of human Survivin in complex with T3 phosphorylated H3(1-15) peptide","GMGAPTLPPAWQPFLKDHRISTFKNWPFLEGCACTPERMAEAGFIHCPTENEPDLAQCFFCFKELEGWEPDDDPIEEHKKHSSGCAFLSVKKQFEELTLGEFLKLDRERAKNKIAKETNNKKKEFEETAKKVRRAIEQLAAMD","Homo sapiens","BIRC5, API4, IAP4","Baculoviral IAP repeat-containing protein 5","1","3UIG"
,,,,,,,,,,,,,,,,"ARTKQTARKSTGGKA",,,"T3 phosphorylated H3(1-15) peptide","2","3UIG"
"3UII",,"X-RAY DIFFRACTION",3.72,66.97,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M ammonium citrate tribasic, pH 7.0, 12% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2011.12.001",,"3UII",35.38,"2.6","2.6","crystal structure of human Survivin in complex with H3(1-10) peptide","GMGAPTLPPAWQPFLKDHRISTFKNWPFLEGCACTPERMAEAGFIHCPTENEPDLAQCFFCFKELEGWEPDDDPIEEHKKHSSGCAFLSVKKQFEELTLGEFLKLDRERAKNKIAKETNNKKKEFEETAKKVRRAIEQLAAMD","Homo sapiens","BIRC5, API4, IAP4","Baculoviral IAP repeat-containing protein 5","1","3UII"
,,,,,,,,,,,,,,,,"ARTKQTARKS",,,"histone H3(1-10) peptide","2","3UII"
"3UIK",,"X-RAY DIFFRACTION",3.72,66.92,"VAPOR DIFFUSION, HANGING DROP",7,"0.2 M succinic acid, pH 7.0, 12% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2011.12.001",,"3UIK",35.54,"2.701","2.701","crystal structure of human Survivin mutant K62Y/H80W in complex with H3(1-10) peptide","GMGAPTLPPAWQPFLKDHRISTFKNWPFLEGCACTPERMAEAGFIHCPTENEPDLAQCFFCFYELEGWEPDDDPIEEHKKWSSGCAFLSVKKQFEELTLGEFLKLDRERAKNKIAKETNNKKKEFEETAKKVRRAIEQLAAMD","Homo sapiens","BIRC5, API4, IAP4","Baculoviral IAP repeat-containing protein 5","1","3UIK"
,,,,,,,,,,,,,,,,"ARTKQTARKS",,,"histone H3(1-10) peptide","2","3UIK"
"3UIU",,"X-RAY DIFFRACTION",2.25,45.43,"VAPOR DIFFUSION, SITTING DROP",6.5,"20% PEG 3350, 0.2M NaF, 0.1M MES pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3UIU",71.14,"2.903","2.903","Crystal structure of Apo-PKR kinase domain","ETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTCVLHHHHHH","Homo sapiens","EIF2AK2, PKR, PRKR","Interferon-induced, double-stranded RNA-activated protein kinase","1","3UIU"
"3UIV",,"X-RAY DIFFRACTION",2.46,49.94,"VAPOR DIFFUSION, SITTING DROP",7.5,"32% (w/v) polyethylene glycol 3350, 50mM potassium phosphate (pH 7.5), 5% glycerol, 3% DMSO, 2% MPD, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"3UIV",136.26,"2.2","2.2","Human serum albumin-myristate-amantadine hydrochloride complex","DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","3UIV"
"3UIX",,"X-RAY DIFFRACTION",3.21,61.73,"VAPOR DIFFUSION, HANGING DROP",5.5,"100mM CITRATE BUFFER PH 5.5, 200mM NACL, 1M NH4HPO4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2012.01.036","Q17","3UIX",34.78,"2.2","2.2","Crystal structure of Pim1 kinase in complex with small molecule inhibitor","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKSGPSSGENLYFQ","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase pim-1","1","3UIX"
"3UJ1",,"X-RAY DIFFRACTION",3.27,62.34,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES, 20 % (w/v) PEG 10.000, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 288K",288,"10.1016/j.jmb.2013.01.029",,"3UJ1",12.27,"2.651","2.651","Crystal structure of the third thioredoxin domain of human ERp46","TVLALTENNFDDTIAEGITFIKFYAPWCGHCKTLAPTWEELSKKEFPGLAGVKIAEVDCTAERNICSKYSVRGYPTLLLFRGGKKVSEHSGGRDLDSLHRFVLSQAKDEL","Homo sapiens","TLP46, TXNDC5, UNQ364/PRO700","Thioredoxin domain-containing protein 5","1","3UJ1"
"3UJE",,"X-RAY DIFFRACTION",2.3,46.47,"VAPOR DIFFUSION, HANGING DROP",8.5,"20% PEG4K, 0.2M MgCl2, 0.1M Tris-HCl, pH 8.5, vapor diffusion, hanging drop, temperature 298K",298,"10.1016/j.jinorgbio.2012.02.011",,"3UJE",97.71,"1.55","1.55","Asymmetric complex of human neuron specific enolase-3-PGA/PEP","SIEKIWAREILDSRGNPTVEVDLYTAKGLFRAAVPSGASTGIYEALELRDGDKQRYLGKGVLKAVDHINSTIAPALISSGLSVVEQEKLDNLMLELDGTENKSKFGANAILGVSLAVCKAGAAERELPLYRHIAQLAGNSDLILPVPAFNVINGGSHAGNKLAMQEFMILPVGAESFRDAMRLGAEVYHTLKGVIKDKYGKDATNVGDEGGFAPNILENSEALELVKEAIDKAGYTEKIVIGMDVAASEFYRDGKYDLDFKSPTDPSRYITGDQLGALYQDFVRDYPVVSIEDPFDQDDWAAWSKFTANVGIQIVGDDLTVTNPKRIERAVEEKACNCLLLKVNQIGSVTEAIQACKLAQENGWGVMVSHRSGETEDTFIADLVVGLCTGQIKTGAPCRSERLAKYNQLMRIEEELGDEARFAGHNFRNPSVLHHHHHHHHHH","Homo sapiens","ENO2","Gamma-enolase","1","3UJE"
"3UJF",,"X-RAY DIFFRACTION",2.3,46.5,"VAPOR DIFFUSION, HANGING DROP",8.5,"20% PEG4K, 0.2M MgCl2, 0.1M Tris-HCl, pH 8.5, vapor diffusion, hanging drop, temperature 298K",298,"10.1016/j.jinorgbio.2012.02.011",,"3UJF",97.59,"2.1","2.1","Asymmetric complex of human neuron specific enolase-4-PGA/PEP","SIEKIWAREILDSRGNPTVEVDLYTAKGLFRAAVPSGASTGIYEALELRDGDKQRYLGKGVLKAVDHINSTIAPALISSGLSVVEQEKLDNLMLELDGTENKSKFGANAILGVSLAVCKAGAAERELPLYRHIAQLAGNSDLILPVPAFNVINGGSHAGNKLAMQEFMILPVGAESFRDAMRLGAEVYHTLKGVIKDKYGKDATNVGDEGGFAPNILENSEALELVKEAIDKAGYTEKIVIGMDVAASEFYRDGKYDLDFKSPTDPSRYITGDQLGALYQDFVRDYPVVSIEDPFDQDDWAAWSKFTANVGIQIVGDDLTVTNPKRIERAVEEKACNCLLLKVNQIGSVTEAIQACKLAQENGWGVMVSHRSGETEDTFIADLVVGLCTGQIKTGAPCRSERLAKYNQLMRIEEELGDEARFAGHNFRNPSVLHHHHHHHHHH","Homo sapiens","ENO2","Gamma-enolase","1","3UJF"
"3UJR",,"X-RAY DIFFRACTION",2.32,47.05,"VAPOR DIFFUSION, HANGING DROP",8.5,"20% PEG4K, 0.2M MgCl2, 0.1M Tris-HCl, pH 8.5, vapor diffusion, hanging drop, temperature 298K",298,"10.1016/j.jinorgbio.2012.02.011",,"3UJR",97.71,"1.4","1.4","Asymmetric complex of human neuron specific enolase-5-PGA/PEP","SIEKIWAREILDSRGNPTVEVDLYTAKGLFRAAVPSGASTGIYEALELRDGDKQRYLGKGVLKAVDHINSTIAPALISSGLSVVEQEKLDNLMLELDGTENKSKFGANAILGVSLAVCKAGAAERELPLYRHIAQLAGNSDLILPVPAFNVINGGSHAGNKLAMQEFMILPVGAESFRDAMRLGAEVYHTLKGVIKDKYGKDATNVGDEGGFAPNILENSEALELVKEAIDKAGYTEKIVIGMDVAASEFYRDGKYDLDFKSPTDPSRYITGDQLGALYQDFVRDYPVVSIEDPFDQDDWAAWSKFTANVGIQIVGDDLTVTNPKRIERAVEEKACNCLLLKVNQIGSVTEAIQACKLAQENGWGVMVSHRSGETEDTFIADLVVGLCTGQIKTGAPCRSERLAKYNQLMRIEEELGDEARFAGHNFRNPSVLHHHHHHHHHH","Homo sapiens","ENO2","Gamma-enolase","1","3UJR"
"3UJS",,"X-RAY DIFFRACTION",2.41,48.91,"VAPOR DIFFUSION, HANGING DROP",8.5,"20% PEG4K, 0.2M MgCl2, 0.1M Tris-HCl, pH 8.5, vapor diffusion, hanging drop, temperature 298K",298,"10.1016/j.jinorgbio.2012.02.011","0V5, XSP","3UJS",97.71,"1.65","1.65","Asymmetric complex of human neuron specific enolase-6-PGA/PEP","SIEKIWAREILDSRGNPTVEVDLYTAKGLFRAAVPSGASTGIYEALELRDGDKQRYLGKGVLKAVDHINSTIAPALISSGLSVVEQEKLDNLMLELDGTENKSKFGANAILGVSLAVCKAGAAERELPLYRHIAQLAGNSDLILPVPAFNVINGGSHAGNKLAMQEFMILPVGAESFRDAMRLGAEVYHTLKGVIKDKYGKDATNVGDEGGFAPNILENSEALELVKEAIDKAGYTEKIVIGMDVAASEFYRDGKYDLDFKSPTDPSRYITGDQLGALYQDFVRDYPVVSIEDPFDQDDWAAWSKFTANVGIQIVGDDLTVTNPKRIERAVEEKACNCLLLKVNQIGSVTEAIQACKLAQENGWGVMVSHRSGETEDTFIADLVVGLCTGQIKTGAPCRSERLAKYNQLMRIEEELGDEARFAGHNFRNPSVLHHHHHHHHHH","Homo sapiens","ENO2","Gamma-enolase","1","3UJS"
"3UK3",,"X-RAY DIFFRACTION",2.54,51.57,"VAPOR DIFFUSION, HANGING DROP",6,"0.01M Zinc chloride, 0.1M MES, 20% PEG 6000, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3UK3",26.52,"2.1","2.1","Crystal structure of ZNF217 bound to DNA","TTTGCAGAATCGATTCTGCA",,,"5'-D(*TP*TP*TP*GP*CP*AP*GP*AP*AP*TP*CP*GP*AP*TP*TP*CP*TP*GP*CP*A)-3'","1","3UK3"
,,,,,,,,,,,,,,,,"AATGCAGAATCGATTCTGCA",,,"5'-D(*AP*AP*TP*GP*CP*AP*GP*AP*AP*TP*CP*GP*AP*TP*TP*CP*TP*GP*CP*A)-3'","2","3UK3"
,,,,,,,,,,,,,,,,"GSSSRECSYCGKFFRSNYYLNIHLRTHTGEKPYKCEFCEYAAAQKTSLRYHLERHHK","Homo sapiens","ZNF217, ZABC1","Zinc finger protein 217","3","3UK3"
"3UK6",,"X-RAY DIFFRACTION",2.64,53.45,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M Tris-HCL, pH 8.0, 20% PEG 3000, 5% glucose, galactose or trehalose, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.str.2012.05.012",,"3UK6",494.69,"2.95","2.95","Crystal Structure of the Tip48 (Tip49b) hexamer","MATVTATTKVPEIRDVTRIERIGAHSHIRGLGLDDALEPRQASQGMVGQLAARRAAGVVLEMIREGKIAGRAVLIAGQPGTGKTAIAMGMAQALGPDTPFTAIAGSEIFSLEMSKTEALTQAFRRSIGVRIKAGAVHTVSLHEIDVINSRTQGFLALFSGDTGEIKSEVREQINAKVAEWREEGKAEIIPGVLFIDEVHMLDIESFSFLNRALESDMAPVLIMATNRGITRIRGTSYQSPHGIPIDLLDRLLIVSTTPYSEKDTKQILRIRCEEEDVEMSEDAYTVLTRIGLETSLRYAIQLITAASLVCRKRKGTEVQVDDIKRVYSLFLDESRSTQYMKEYQDAFLFNELKGETMDTSLEHHHHHH","Homo sapiens","CGI-46, INO80J, RUVBL2, TIP48, TIP49B","RuvB-like 2","1","3UK6"
,,,,,,,,,,,,,,,,,"Homo sapiens","CGI-46, INO80J, RUVBL2, TIP48, TIP49B"
"3UKM",,"X-RAY DIFFRACTION",4.71,73.87,"VAPOR DIFFUSION, HANGING DROP",8,"20% Peg 400, 150 mM KCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1126/science.1213274",,"3UKM",128.66,"3.4","3.4","Crystal structure of the human two pore domain potassium ion channel K2P1 (TWIK-1)","GPSREASNSATMFGFLVLGYLLYLVFGAVVFSSVELPYEDLLRQELRKLKRRFLEEHECLSEQQLEQFLGRVLEASNYGVSVLSQASGNWNWDFTSALFFASTVLSTTGYGHTVPLSDGGKAFCIIYSVIGIPFTLLFLTAVVQRITVHVTRRPVLYFHIRWGFSKQVVAIVHAVLLGFVTVSCFFFIPAAVFSVLEDDWNFLESFYFCFISLSTIGLGDYVPGEGYNQKFRELYKIGITCYLLLGLIAMLVVLETFCELHELKKFRKMFYVKKDKDEVD","Homo sapiens","HOHO1, K2P1 (TWIK-1), KCNK1, KCNO1, TWIK1","Potassium channel subfamily K member 1","1","3UKM"
"3ULH",,"X-RAY DIFFRACTION",3.7,66.74,"VAPOR DIFFUSION, SITTING DROP",7.5,"25.0% Glycerol, 0.6M di-sodium hydrogen phosphate, 0.6M potassium dihydrogen phosphate, 0.1M HEPES pH 7.5, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3ULH",11.85,"2.54","2.54","Crystal structure of a RNA binding domain of THO complex subunit 4 protein (THOC4) from Homo sapiens at 2.54 A resolution","GSRPKQLPDKWQHDLFDSGFGGGAGVETGGKLLVSNLDFGVSDADIQELFAEFGTLKKAAVHYDRSGRSLGTADVHFERKADALKAMKQYNGVPLDGRPMNIQLVTS","Homo sapiens","ALY, BC052302, BEF, THOC4, ALYREF","THO complex subunit 4","1","3ULH"
"3ULI",,"X-RAY DIFFRACTION",2.01,38.88,"VAPOR DIFFUSION, HANGING DROP",7.4,"50MM AMMONIUM ACETATE, 10-12% PEG4K, 0.1M HEPES PH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1016/j.bmcl.2012.01.018","1N3","3ULI",34.45,"2","2","Human Cyclin Dependent Kinase 2 (CDK2) bound to azabenzimidazole derivative","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3ULI"
"3ULL",,"X-RAY DIFFRACTION",2.03,39.48,,7.5,"pH 7.5",,"10.1038/nsb0297-153",,"3ULL",30.43,"2.4","2.4","HUMAN MITOCHONDRIAL SINGLE-STRANDED DNA BINDING PROTEIN","ESETTTSLVLERSLNRVHLLGRVGQDPVLRQVEGKNPVTIFSLATNEMWRSGDSEVYQLGDVSQKTTWHRISVFRPGLRDVAYQYVKKGSRIYLEGKIDYGEYMDKNNVRRQATTIIADNIIFLSDQTKEKE","Homo sapiens","SSBP1, SSBP","DNA BINDING PROTEIN","1","3ULL"
"3ULS",,"X-RAY DIFFRACTION",2.41,48.89,"VAPOR DIFFUSION, HANGING DROP",4.5,"18% PEG8000, 0.1 M sodium acetate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2012.05.006",,"3ULS",94.62,"2.495","2.495","Crystal structure of Fab12","ESVLTQPPSVSVAPGQTARISCSGDNIGSYYVHWYQQKPGQAPVLVIYEDSERPSGIPERFSGSNSGNTATLTISGTQAEDEADYYCSSYDDPNFQVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Fab12 light chain","1","3ULS"
,,,,,,,,,,,,,,,,"QVQLQQSGPGLVKPSQTLSLTCAISGDSVSSNSAAWGWIRQSPGRGLEWLGIIQKRSKWYNNYAVSVKSRITINPDTSKNQFSLQLNSVTPEDTAVYYCARYSYPFYSIDYWGQGTLVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVHHHHHH","Homo sapiens",,"Fab12 heavy chain","2","3ULS"
"3UM7",,"X-RAY DIFFRACTION",5.69,78.37,"VAPOR DIFFUSION, HANGING DROP",,"21-24% PEG400, 1 mM Fos-choline-12, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1126/science.1213808",,"3UM7",67.37,"3.31","3.31","Crystal structure of the human two pore domain K+ ion channel TRAAK (K2P4.1)","MTTAPQEPPARPLQAGSGAGPAPGRAMRSTTLLALLALVLLYLVSGALVFRALEQPHEQQAQRELGEVREKFLRAHPCVSDQELGLLIKEVADALGGGADPETQSTSQSSHSAWDLGSAFFFSGTIITTIGYGNVALRTDAGRLFCIFYALVGIPLFGILLAGVGDRLGSSLRHGIGHIEAIFLKWHVPPELVRVLSAMLFLLIGCLLFVLTPTFVFCYMEDWSKLEAIYFVIVTLTTVGFGDYVAGADPRQDSPAYQPLVWFWILLGLAYFASVLTTIGNWLRVVSRRTRAEMGGLTAQSNSLEVLFQ","Homo sapiens","KCNK4, TRAAK","Potassium channel subfamily K member 4","1","3UM7"
"3UMH",,"X-RAY DIFFRACTION",1.98,37.99,"VAPOR DIFFUSION, SITTING DROP",6.4,"0.1 mM HEPES, 1 M sodium acetate, 10 mM MgCl2, 50 mM CdSO4, pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2011.12.057",,"3UMH",26.19,"2","2","X-ray structure of the E2 domain of the human amyloid precursor protein (APP) in complex with cadmium","MSTPDAVDKYLETPGDENEHAHFQKAKERLEAKHRERMSQVMREWEEAERQAKNLPKADKKAVIQHFQEKVESLEQEAANERQQLVETHMARVEAMLNDRRRLALENYITALQAVPPRPRHVFNMLKKYVRAEQKDRQHTLKHFEHVRMVDPKKAAQIRSQVMTHLRVIYERMNQSLSLLYNVPAVAEEIQDEVDELLQKEQNYSDDIEGR","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","3UMH"
"3UMI",,"X-RAY DIFFRACTION",1.99,38.29,"VAPOR DIFFUSION, SITTING DROP",6.4,"0.1 mM HEPES, 1 M sodium acetate, 10 mM MgCl2, 50 mM CdSO4, pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2011.12.057",,"3UMI",26.09,"2.4","2.4","X-ray structure of the E2 domain of the human amyloid precursor protein (APP) in complex with zinc","MSTPDAVDKYLETPGDENEHAHFQKAKERLEAKHRERMSQVMREWEEAERQAKNLPKADKKAVIQHFQEKVESLEQEAANERQQLVETHMARVEAMLNDRRRLALENYITALQAVPPRPRHVFNMLKKYVRAEQKDRQHTLKHFEHVRMVDPKKAAQIRSQVMTHLRVIYERMNQSLSLLYNVPAVAEEIQDEVDELLQKEQNYSDDIEGR","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","3UMI"
"3UMK",,"X-RAY DIFFRACTION",1.99,38.3,"VAPOR DIFFUSION, SITTING DROP",6.4,"0.1 mM HEPES, 1 M sodium acetate, 10 mM MgCl2, 50 mM CdSO4, pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2011.12.057",,"3UMK",26.04,"2.6","2.6","X-ray structure of the E2 domain of the human amyloid precursor protein (APP) in complex with copper","MSTPDAVDKYLETPGDENEHAHFQKAKERLEAKHRERMSQVMREWEEAERQAKNLPKADKKAVIQHFQEKVESLEQEAANERQQLVETHMARVEAMLNDRRRLALENYITALQAVPPRPRHVFNMLKKYVRAEQKDRQHTLKHFEHVRMVDPKKAAQIRSQVMTHLRVIYERMNQSLSLLYNVPAVAEEIQDEVDELLQKEQNYSDDIEGR","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","3UMK"
"3UMN",,"X-RAY DIFFRACTION",3.04,59.55,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 300.0K",300,"10.1016/j.febslet.2012.01.007",,"3UMN",40.28,"2","2","Crystal Structure of Lamin-B1","SSVSISHSASATGNVCIEEIDVDGKFIRLKNTSEQDQPMGGWEMIRKIGDTSVSYKYTSRYVLKAGQTVTIWAANAGVTASPPTDLIWKNQNSWGTGEDVKVILKNSQGEEVAQRSTVFKTTI","Homo sapiens","LMNB1, LMN2, LMNB","Lamin-B1","1","3UMN"
"3UMR",,"X-RAY DIFFRACTION",3.1,60.34,"VAPOR DIFFUSION",6.5,"Protein: 10-20 mg/mL in 50 mM HEPES, pH 8.0, 1 mM EDTA, 100 microM GDP, 5 mM DTT; well solution: 1.9M ammonium sulfite, 0.1M sodium acetate, pH 6.0, VAPOR DIFFUSION, temperature 291K",291,,,"3UMR",41.13,"2.04","2.04","Crystal structure of the G202D mutant of human G-alpha-i1","MGCTLSAEDKAAVERSKMIDRNLREDGEKAAREVKLLLLGAGESGKSTIVKQMKIIHEAGYSEEECKQYKAVVYSNTIQSIIAIIRAMGRLKIDFGDSARADDARQLFVLAGAAEEGFMTAELAGVIKRLWKDSGVQACFNRSREYQLNDSAAYYLNDLDRIAQPNYIPTQQDVLRTRVKTTGIVETHFTFKDLHFKMFDVDGQRSERKKWIHCFEGVTAIIFCVALSDYDLVLAEDEEMNRMHESMKLFDSICNNKCFTDTSIILFLNKKDLFEEKIKKSPLTICYPEYAGSNTYEEAAAYIQCQFEDLNKRKDTKEIYTHFTCATDTKNVQFVFDAVTDVIIKNNLKDCGLF","Homo sapiens","GNAI1","Guanine nucleotide-binding protein G(i) subunit alpha-1","1","3UMR"
"3UMS",,"X-RAY DIFFRACTION",3.1,60.34,"VAPOR DIFFUSION",6.5,"Protein: 10-20 mg/mL in 50 mM HEPES, pH 8.0, 1 mM EDTA, 100 microM GDP, 5 mM DTT, well solution: 1.8-2.2 M ammonium sulfate, 0.1M sodium acetate, pH 6.0, VAPOR DIFFUSION, temperature 291K",291,,,"3UMS",41,"2.343","2.343","Crystal structure of the G202A mutant of human G-alpha-i1","MGCTLSAEDKAAVERSKMIDRNLREDGEKAAREVKLLLLGAGESGKSTIVKQMKIIHEAGYSEEECKQYKAVVYSNTIQSIIAIIRAMGRLKIDFGDSARADDARQLFVLAGAAEEGFMTAELAGVIKRLWKDSGVQACFNRSREYQLNDSAAYYLNDLDRIAQPNYIPTQQDVLRTRVKTTGIVETHFTFKDLHFKMFDVAGQRSERKKWIHCFEGVTAIIFCVALSDYDLVLAEDEEMNRMHESMKLFDSICNNKWFTDTSIILFLNKKDLFEEKIKKSPLTICYPEYAGSNTYEEAAAYIQCQFEDLNKRKDTKEIYTHFTCATDTKNVQFVFDAVTDVIIKNNLKDCGLF","Homo sapiens","GNAI1","Guanine nucleotide-binding protein G(i) subunit alpha-1","1","3UMS"
"3UMW",,"X-RAY DIFFRACTION",3.29,62.6,"VAPOR DIFFUSION, HANGING DROP",5.5,"100mM Citrate buffer pH 5.5, 200mM NaCl, 1M NH4HPO4, vapor diffusion, hanging drop, temperature 293K",293,"10.1021/jm3001289","596","3UMW",34.77,"2.08","2.08","Crystal structure of Pim1 kinase in complex with inhibitor (Z)-2-[(1H-indazol-3-yl)methylene]-6-methoxy-7-(piperazin-1-ylmethyl)benzofuran-3(2H)-one","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKSGPSSGENLYFQ","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase pim-1","1","3UMW"
"3UMX",,"X-RAY DIFFRACTION",3.29,62.66,"VAPOR DIFFUSION, HANGING DROP",5.5,"100mM Citrate buffer pH 5.5, 200mM NaCl, 1M NH4HPO4, vapor diffusion, hanging drop, temperature 293K",293,"10.1107/S1744309112027108","Q18","3UMX",34.67,"2.55","2.55","Crystal structure of Pim1 kinase in complex with inhibitor (Z)-2-[(1H-indol-3-yl)methylene]-7-(azepan-1-ylmethyl)-6-hydroxybenzofuran-3(2H)-one","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKSGPSSGENLYFQ","Homo sapiens","PIM1","Proto-oncogene serine/threonine-protein kinase pim-1","1","3UMX"
"3UMZ",,"X-RAY DIFFRACTION",2.29,46.2,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 0.1M HEPES (pH 7.5), 50mM KCl, vapor diffusion, hanging drop, temperature 293K",293,"10.1093/nar/gkr1296",,"3UMZ",25.02,"1.65","1.65","Crystal Structure of the human MDC1 FHA Domain","SNVEPVGRLHIFSGAHGPEKDFPLHLGKNVVGRMPDCSVALPFPSISKQHAEIEILAWDKAPILRDCGSLNGTQILRPPKVLSPGVSHRLRDQELILFADLLCQYHRLDVSLP","Homo sapiens","MDC1, KIAA0170, NFBD1","Mediator of DNA damage checkpoint protein 1","1","3UMZ"
"3UN0",,"X-RAY DIFFRACTION",1.87,34.08,"MICROBATCH",4.6,"1.32M ammonium sulfate, 0.05M sodium acetate pH 4.6, 5% v/v methyl-pentanediol, Microbatch, temperature 291K",291,"10.1093/nar/gkr1300",,"3UN0",26.01,"2.3","2.3","Crystal Structure of MDC1 FHA Domain","GSCNVEPVGRLHIFSGAHGPEKDFPLHLGKNVVGRMPDCSVALPFPSISKQHAEIEILAWDKAPILRDCGSLNGTQILRPPKVLSPGVSHRLRDQELILFADLLCQYHRLDVSLP","Homo sapiens","MDC1, KIAA0170, NFBD1","Mediator of DNA damage checkpoint protein 1","1","3UN0"
"3UN9",,"X-RAY DIFFRACTION",1.83,32.75,"VAPOR DIFFUSION, SITTING DROP",8,"18% PEG 1000 and 200 mM Tris, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 296.0K",296,"10.1016/j.immuni.2011.12.018",,"3UN9",122.63,"2.65","2.65","Crystal structure of an immune receptor","MLLVGLLSAHNRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEFQNQRFSAEVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSGSPSGSWSHPQFEKGAGHHHHHH","Homo sapiens","NLRX1, NOD26, NOD5, NOD9","NLR family member X1","1","3UN9"
"3UNJ",,"X-RAY DIFFRACTION",2.05,39.92,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 1.5 mM YL1-038-31, 5 % (v/v) PEG 3350, 50 mM HEPES/NaOH (pH 7.5), 50 mM phosphate (Na/K, pH 7.5), VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb200508b","0BX","3UNJ",34.38,"1.9001","1.9001","CDK2 in complex with inhibitor YL1-038-31","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3UNJ"
"3UNK",,"X-RAY DIFFRACTION",2.03,39.43,"VAPOR DIFFUSION, HANGING DROP",7.5,"5 mg/mL CDK2 protein, 1.5 mM YL5-83, 5 % (v/v) PEG 3350, 50 mM HEPES/NaOH (pH 7.5), 50 mM phosphate (Na/K, pH 7.5), VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb200508b","0BY","3UNK",34.41,"2.1","2.1","CDK2 in complex with inhibitor YL5-083","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3UNK"
"3UNM",,"X-RAY DIFFRACTION",2.21,44.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 0.1M HEPES (pH 7.5), 50mM KCl, vapor diffusion, hanging drop, temperature 293K",293,"10.1093/nar/gkr1296",,"3UNM",25.02,"1.8","1.8","Crystal Structure of The Human MDC1 FHA Domain","SNVEPVGRLHIFSGAHGPEKDFPLHLGKNVVGRMPDCSVALPFPSISKQHAEIEILAWDKAPILRDCGSLNGTQILRPPKVLSPGVSHRLRDQELILFADLLCQYHRLDVSLP","Homo sapiens","MDC1, KIAA0170, NFBD1","Mediator of DNA damage checkpoint protein 1","1","3UNM"
"3UNP",,"X-RAY DIFFRACTION",2.59,52.53,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M imidazole, 1.0M sodium acetate, 10 mM YCl3, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 290K",290,"10.1074/jbc.M111.304543",,"3UNP",22.93,"2.39","2.39","Structure of human SUN2 SUN domain","VIGVTEEQVHHIVKQALQRYSEDRIGLADYALESGGASVISTRCSETYETKTALLSLFGIPLWYHSQSPRVILQPDVHPGNCWAFQGPQGFAVVRLSARIRPTAVTLEHVPKALSPNSTISSAPKDFAIFGFDEDLQQEGTLLGKFTYDQDGEPIQTFHFQAPTMATYQVVELRILTNWGHPEYTCIYRFRVHGEPAHHHHHH","Homo sapiens","SUN2, FRIGG, KIAA0668, RAB5IP, UNC84B","SUN domain-containing protein 2","1","3UNP"
"3UNW",,"X-RAY DIFFRACTION",2.67,53.91,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.3 M magnesium chloride, 0.1 M Tris, and 12% (w/v) PEG  
179 4000, VAPOR DIFFUSION, HANGING DROP, temperature 291.15K, pH 8.5",291.15,"10.1021/bi201613d",,"3UNW",236.34,"2.56","2.56","Crystal Structure of Human GAC in Complex with Glutamate","GLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRHSFGPLDYESLQQELALKETVWKKVSPESNEDISTTVVYRMESLGEKSHHHHHH","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","3UNW"
"3UNZ",,"X-RAY DIFFRACTION",2.51,51.05,"VAPOR DIFFUSION, HANGING DROP",7.5,"10 mg/mL AURORA A protein, 1 mM RPM1679, 10 % (v/v) PEG 3350, 25 mM phosphate(Na/K pH 7.4), 5 % Tacismate pH 7.0 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K",291,"10.1021/cb200508b","0BZ","3UNZ",65.62,"2.8","2.8","Aurora A in Complex with RPM1679","SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","3UNZ"
"3UO4",,"X-RAY DIFFRACTION",2.66,53.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"10 mg/mL AURORA A protein, 1 mM RPM1680, 10 % (v/v) PEG 3350, 25 mM phosphate(Na/K pH 7.4), 100 mM sodium tartrate pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb200508b","0C0","3UO4",32.93,"2.45","2.45","Aurora A in complex with RPM1680","SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","3UO4"
"3UO5",,"X-RAY DIFFRACTION",2.6,52.67,,7.5,"10 mg/mL AURORA A protein, 1 mM YL1-038-31, 10 % (v/v) PEG 3350, 25 mM phosphate(Na/K pH 7.4), 100 mM sodium tartrate pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb200508b","0BX","3UO5",32.67,"2.7012","2.7012","Aurora A in complex with YL1-038-31","SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Serine/Threonine-Protein Kinase 6","1","3UO5"
"3UO6",,"X-RAY DIFFRACTION",2.51,51.02,"VAPOR DIFFUSION, HANGING DROP",7.5,"10 mg/mL AURORA A protein, 1 mM YL5-083, 10 % (v/v) PEG 3350, 25 mM phosphate(Na/K pH 7.4), 5 % Tacismate pH 7.0 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K",291,"10.1021/cb200508b","0BY","3UO6",65.65,"2.8002","2.8002","Aurora A in complex with YL5-083","SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","3UO6"
"3UO7",,"X-RAY DIFFRACTION",3.77,67.33,"VAPOR DIFFUSION, HANGING DROP",7,"25% PEG3350, 0.2 M tripotassium citrate monohydrate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nchembio.914",,"3UO7",59.61,"3.002","3.002","Crystal structure of Human Thymine DNA Glycosylase Bound to Substrate 5-carboxylcytosine","CAGCTCTGTACATGAGCAGTGGA",,,"5'-D(*CP*AP*GP*CP*TP*CP*TP*GP*TP*AP*CP*AP*TP*GP*AP*GP*CP*AP*GP*TP*GP*GP*A)-3'","1","3UO7"
,,,,,,,,,,,,,,,,"CCACTGCTCAXGTACAGAGCTGT",,,"5'-D(*CP*CP*AP*CP*TP*GP*CP*TP*CP*AP*(1CC)P*GP*TP*AP*CP*AP*GP*AP*GP*CP*TP*GP*T)-3'","2","3UO7"
,,,,,,,,,,,,,,,,"SNAFNGVSEAELLTKTLPDILTFNLDIVIIGIAPGLMAAYKGHHYPGPGNHFWKCLFMSGLSEVQLNHMDDHTLPGKYGIGFTNMVERTTPGSKDLSSKEFREGGRILVQKLQKYQPRIAVFNGKCIYEIFSKEVFGVKVKNLEFGLQPHKIPDTETLCYVMPSSSARCAQFPRAQDKVHYYIKLKDLRDQLKGIERNMDV","Homo sapiens","TDG","G/T mismatch-specific thymine DNA glycosylase","3","3UO7"
"3UO8",,"X-RAY DIFFRACTION",2.36,47.78,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES (pH 6.0), 0.2M calcium acetate, 2% benzamidine, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1111708108",,"3UO8",90.26,"1.9","1.9","Crystal structure of the MALT1 paracaspase (P1 form)","MLAKDKVALLIGNMNYREHPKLKAPLVDVYELTNLLRQLDFKVVSLLDLTEYEMRNAVDEFLLLLDKGVYGLLYYAGHGYENFGNSFMVPVDAPNPYRSENCLCVQNILKLMQEKETGLNVFLLDMCRKRNDYDDTIPILDALKVTANIVFGYATCQGAEAFEIQHSGLANGIFMKFLKDRLLEDKKITVLLDEVAEDMGKCHLTKGKQALEIRSSLSEKRALTDPIQGTEYSAESLVRNLQWAKAHELPESMCLKFDCGVQIQLGFAAEFSNVMIIYTSIVYKPPEIIMCDAYVTDFPLDLDIDPKDANKGTPEETGSYLVSKDLPKHCLYTRLSSLQKLKEHLVFTVCLSYQYSGLEDTVEDKQEVNVGKPLIAKLDMHRLEHHHHHH","Homo sapiens","MALT1, MLT","Mucosa-associated lymphoid tissue lymphoma translocation protein 1","1","3UO8"
,,,,,,,,,,,,,,,,"XVRPRX",,,"Z-Val-Arg-Pro-DL-Arg-fluoromethylketone","2","3UO8"
"3UO9",,"X-RAY DIFFRACTION",2.63,53.2,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M magnesium chloride, 0.1 M Tris, and 12% (w/v) PEG 179 4000, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/bi201613d","04A","3UO9",237.17,"2.3","2.3","Crystal Structure of Human GAC in Complex with Glutamate and BPTES","GLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRHSFGPLDYESLQQELALKETVWKKVSPESNEDISTTVVYRMESLGEKSHHHHHH","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","3UO9"
"3UOA",,"X-RAY DIFFRACTION",2.34,47.43,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M MES (pH 6.0), 0.2M calcium acetate, 2% benzamidine, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1111708108",,"3UOA",90.31,"1.75","1.75","Crystal structure of the MALT1 paracaspase (P21 form)","MLAKDKVALLIGNMNYREHPKLKAPLVDVYELTNLLRQLDFKVVSLLDLTEYEMRNAVDEFLLLLDKGVYGLLYYAGHGYENFGNSFMVPVDAPNPYRSENCLCVQNILKLMQEKETGLNVFLLDMCRKRNDYDDTIPILDALKVTANIVFGYATCQGAEAFEIQHSGLANGIFMKFLKDRLLEDKKITVLLDEVAEDMGKCHLTKGKQALEIRSSLSEKRALTDPIQGTEYSAESLVRNLQWAKAHELPESMCLKFDCGVQIQLGFAAEFSNVMIIYTSIVYKPPEIIMCDAYVTDFPLDLDIDPKDANKGTPEETGSYLVSKDLPKHCLYTRLSSLQKLKEHLVFTVCLSYQYSGLEDTVEDKQEVNVGKPLIAKLDMHRLEHHHHHH","Homo sapiens","MALT1, MLT","Mucosa-associated lymphoid tissue lymphoma translocation protein 1","1","3UOA"
,,,,,,,,,,,,,,,,"XVRPRX",,,"Z-Val-Arg-Pro-DL-Arg-fluoromethylketone","2","3UOA"
"3UOB",,"X-RAY DIFFRACTION",3.53,65.16,"VAPOR DIFFUSION, HANGING DROP",7,"25% PEG3350, 0.2 M tripotassium citrate monohydrate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nchembio.914",,"3UOB",59.73,"3.011","3.011","Crystal structure of Human Thymine DNA Glycosylase Bound to Substrate Analog 2'-deoxy-2'-beta-fluoro-cytidine","CAGCTCTGTACGTGAGCAGTGGA",,,"5'-D(*CP*AP*GP*CP*TP*CP*TP*GP*TP*AP*CP*GP*TP*GP*AP*GP*CP*AP*GP*TP*GP*GP*A)-3'","1","3UOB"
,,,,,,,,,,,,,,,,"CCACTGCTCAXGTACAGAGCTGT",,,"5'-D(*CP*CP*AP*CP*TP*GP*CP*TP*CP*AP*(1FC)P*GP*TP*AP*CP*AP*GP*AP*GP*CP*TP*GP*T)-3'","2","3UOB"
,,,,,,,,,,,,,,,,"SNAFNGVSEAELLTKTLPDILTFNLDIVIIGINPGLMAAYKGHHYPGPGNHFWKCLFMSGLSEVQLNHMDDHTLPGKYGIGFTNMVERTTPGSKDLSSKEFREGGRILVQKLQKYQPRIAVFNGKCIYEIFSKEVFGVKVKNLEFGLQPHKIPDTETLCYVMPSSSARCAQFPRAQDKVHYYIKLKDLRDQLKGIERNMDV","Homo sapiens","TDG","G/T mismatch-specific thymine DNA glycosylase","3","3UOB"
"3UOD",,"X-RAY DIFFRACTION",2.61,52.79,"VAPOR DIFFUSION, HANGING DROP",7.5,"10 mg/mL AURORA A protein, 1 mM RPM1693, 10 % (v/v) PEG 3350, 25 mM phosphate(Na/K pH 7.4), 100 mM sodium tartrate pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb200508b","0C3","3UOD",32.9,"2.5002","2.5002","Aurora A in complex with RPM1693","SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","3UOD"
"3UOH",,"X-RAY DIFFRACTION",2.52,51.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"10 mg/mL AURORA A protein, 1 mM RPM1722, 10 % (v/v) PEG 3350, 25 mM phosphate(Na/K pH 7.4), 5 % Tacismate pH 7.0 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K",291,"10.1021/cb200508b","0C4","3UOH",65.8,"2.8002","2.8002","Aurora A in complex with RPM1722","SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","3UOH"
"3UOJ",,"X-RAY DIFFRACTION",2.53,51.3,"VAPOR DIFFUSION, HANGING DROP",7.5,"10 mg/mL AURORA A protein, 1 mM RPM1715, 10 % (v/v) PEG 3350, 25 mM phosphate(Na/K pH 7.4), 5 % Tacismate pH 7.0 VAPOR DIFFUSION, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb200508b","0C5","3UOJ",65.38,"2.9003","2.9003","Aurora A in complex with RPM1715","SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","3UOJ"
"3UOK",,"X-RAY DIFFRACTION",2.52,51.11,"VAPOR DIFFUSION, HANGING DROP",7.5,"10 mg/mL AURORA A protein, 1 mM YL5-81-1, 10 % (v/v) PEG 3350, 25 mM phosphate(Na/K pH 7.4), 5 % Tacismate pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb200508b","0C6","3UOK",65.44,"2.9506","2.9506","Aurora A in complex with YL5-81-1","SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","3UOK"
"3UOL",,"X-RAY DIFFRACTION",2.52,51.12,"VAPOR DIFFUSION, HANGING DROP",7.5,"10 mg/mL AURORA A protein, 1 mM SO2-162, 10 % (v/v) PEG 3350, 25 mM phosphate(Na/K pH 7.4), 5 % Tacismate pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb200508b","0C7","3UOL",66.19,"2.4","2.4","Aurora A in complex with SO2-162","SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","3UOL"
"3UOM",,"X-RAY DIFFRACTION",3.33,63.01,"VAPOR DIFFUSION, HANGING DROP",5.5,"50 mM Bis-tris propane, 50 mM CaCl2, 40% MPD, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 278K",278,"10.1074/jbc.M111.335075",,"3UOM",258.75,"2.02","2.02","Ca2+ complex of Human skeletal calsequestrin","QEGLDFPEYDGVDRVINVNAKNYKNVFKKYEVLALLYHEPPEDDKASQRQFEMEELILELAAQVLEDKGVGFGLVDSEKDAAVAKKLGLTEVDSMYVFKGDEVIEYDGEFSADTIVEFLLDVLEDPVELIEGERELQAFENIEDEIKLIGYFKSKDSEHYKAFEDAAEEFHPYIPFFATFDSKVAKKLTLKLNEIDFYEAFMEEPVTIPDKPNSEEEIVNFVEEHRRSTLRKLKPESMYETWEDDMDGIHIVAFAEEADPDGFEFLETLKAVAQDNTENPDLSIIWIDPDDFPLLVPYWEKTFDIDLSAPQIGVVNVTDADSVWMEMDDEEDLPSAEELEDWLEDVLEGEINTEDDDDDDDD","Homo sapiens","CASQ1, CASQ","Calsequestrin-1","1","3UOM"
"3UP1",,"X-RAY DIFFRACTION",3.05,59.65,,8.5,"1.26M (NH4)2SO4, 0.1 M Tris-HCl pH 8.5, 0.2 M Li2SO4, VAPOR DIFFUSION, SITTING DROP, temperature 292K",292,"10.1073/pnas.1116582109",,"3UP1",53.63,"2.15","2.15","Crystal structure of the unliganded human interleukin-7 receptor extracellular domain","GSHMESGYAQNGDLEDAELDDYSFSCYSQLEVNGSQHSLTCAFEDPDVNTTNLEFEICGALVEVKCLNFRKLQEIYFIETKKFLLIGKSNICVKVGEKSLTCKKIDLTTIVKPEAPFDLSVVYREGANDFVVTFNTSHLQKKYVKVLMHDVAYRQEKDENKWTHVNLSSTKLTLLQRKLQPAAMYEIKVRSIPDHYFKGFWSEWSPSYYFRTPEINNSSGEMD","Homo sapiens","IL7R","Interleukin-7 receptor subunit alpha","1","3UP1"
"3UP2",,"X-RAY DIFFRACTION",2.62,53.13,"VAPOR DIFFUSION, HANGING DROP",7.5,"10 mg/mL AURORA A protein, 1 mM RPM1686, 10 % (v/v) PEG 3350, 25 mM phosphate(Na/K pH 7.4), 100 mM sodium tartrate pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/cb200508b","0C8","3UP2",32.87,"2.3001","2.3001","Aurora A in complex with RPM1686","SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","3UP2"
"3UP7",,"X-RAY DIFFRACTION",2.62,53.08,"VAPOR DIFFUSION, HANGING DROP",7.5,"10 mg/mL AURORA A protein, 1 mM YL1-038-09, 10 % (v/v) PEG 3350, 25 mM phosphate(Na/K pH 7.4), 100 mM sodium tartrate pH 7.0 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K",,"10.1021/jm300334d","0C9","3UP7",32.71,"3.05","3.05","Aurora A in complex with YL1-038-09","SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","3UP7"
"3UPA",,"X-RAY DIFFRACTION",1.89,34.81,"VAPOR DIFFUSION, HANGING DROP",7.5,"26% PEG 10000, 100mM Tris, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1202866109",,"3UPA",23.28,"1.8","1.8","A general strategy for the generation of human antibody variable domains with increased aggregation resistance","DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYDADDLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPNTFGQGTKVEIK","Homo sapiens","IGKV1-39","kappa light chain variable domain","1","3UPA"
"3UPC",,"X-RAY DIFFRACTION",3.55,65.39,"counter diffusion in Crystal Harp capillary",5.5,"20% PEG 3350, 100mM Citrate, pH 5.5, counter diffusion in Crystal Harp capillary, temperature 293K",293,"10.1073/pnas.1202866109",,"3UPC",122.43,"2.8","2.8","A general strategy for the generation of human antibody variable domains with increased aggregation resistance","QLLESGGGLVQPGGSLRLSCAASGFTFSDEDMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKSYGAFDYWGQGTLVTVS","Homo sapiens","IGHV3-23","heavy chain variable domain","1","3UPC"
"3UPQ",,"X-RAY DIFFRACTION",2.89,57.5,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM Na HEPES pH 7.5, 1.0M lithium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1093/nar/gks413",,"3UPQ",44.16,"1.95","1.95","Crystal structure of the pre-catalytic ternary complex of polymerase lambda with an rATP analog opposite a templating T.","AQPSSQKATNHNLHITEKLEVLAKAYSVQGDKWRALGYAKAINALKSFHKPVTSYQEACSIPGIGKRMAEKIIEILESGHLRKLDHISESVPVLELFSNIWGAGTKTAQMWYQQGFRSLEDIRSQASLTTQQAIGLKHYSDFLERMPREEATEIEQTVQKAAQAFNSGLLCVACGSYRRGKATCGDVDVLITHPDGRSHRGIFSRLLDSLRQEGFLTDDLVKGETKYLGVCRLPGPGRRHRRLDIIVVPYSEFACALLYFTGSAHFNRSMRALAKTKGMSLSEHALSTAVVRNTHGCKVGPGRVLPTPTEKDVFRLLGLPYREPAERDW","Homo sapiens","POLL","DNA polymerase lambda","1","3UPQ"
,,,,,,,,,,,,,,,,"CGGCTGTACTG",,,"5'-D(*CP*GP*GP*CP*TP*GP*TP*AP*CP*TP*G)-3'","2","3UPQ"
,,,,,,,,,,,,,,,,"CAGTAC",,,"5'-D(*CP*AP*GP*TP*AP*C)-3'","3","3UPQ"
,,,,,,,,,,,,,,,,"GCCG",,,"5'-D(P*GP*CP*CP*G)-3'","4","3UPQ"
"3UQ0",,"X-RAY DIFFRACTION",2.88,57.25,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM Na HEPES pH 7.5, 1.0M lithium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1093/nar/gks413",,"3UQ0",43.92,"2.14","2.14","Crystal structure of the post-catalytic product complex of polymerase lambda with an rAMP at the primer terminus.","AQPSSQKATNHNLHITEKLEVLAKAYSVQGDKWRALGYAKAINALKSFHKPVTSYQEACSIPGIGKRMAEKIIEILESGHLRKLDHISESVPVLELFSNIWGAGTKTAQMWYQQGFRSLEDIRSQASLTTQQAIGLKHYSDFLERMPREEATEIEQTVQKAAQAFNSGLLCVACGSYRRGKATCGDVDVLITHPDGRSHRGIFSRLLDSLRQEGFLTDDLVKGETKYLGVCRLPGPGRRHRRLDIIVVPYSEFACALLYFTGSAHFNRSMRALAKTKGMSLSEHALSTAVVRNTHGCKVGPGRVLPTPTEKDVFRLLGLPYREPAERDW","Homo sapiens","POLL","DNA polymerase lambda","1","3UQ0"
,,,,,,,,,,,,,,,,"CGGCTGTACTG",,,"5'-D(*CP*GP*GP*CP*TP*GP*TP*AP*CP*TP*G)-3'","2","3UQ0"
,,,,,,,,,,,,,,,,"CAGTACA",,,"5'-D(*CP*AP*GP*TP*AP*CP)-R(P*A)-3'","3","3UQ0"
,,,,,,,,,,,,,,,,"GCCG",,,"5'-D(P*GP*CP*CP*G)-3'","4","3UQ0"
"3UQ2",,"X-RAY DIFFRACTION",2.79,55.95,"VAPOR DIFFUSION, SITTING DROP",5.6,"170mM ammonium acetate, 85mM sodium citrate tribasic dihydrate pH 5.6, 25.5% (w/v) PEG4000, 15% (v/v) glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1093/nar/gks413",,"3UQ2",43.61,"2.25","2.25","Crystal structure of the post-catalytic product complex of polymerase lambda with an rCMP inserted opposite a templating G and dAMP inserted opposite a templating T at the primer terminus.","AQPSSQKATNHNLHITEKLEVLAKAYSVQGDKWRALGYAKAINALKSFHKPVTSYQEACSIPGIGKRMAEKIIEILESGHLRKLDHISESVPVLELFSNIWGAGTKTAQMWYQQGFRSLEDIRSQASLTTQQAIGLKHYSDFLERMPREEATEIEQTVQKAAQAFNSGLLCVACGSYRRGKATCGDVDVLITHPDGRSHRGIFSRLLDSLRQEGFLTDDLVKGETKYLGVCRLPGPGRRHRRLDIIVVPYSEFACALLYFTGSAHFNRSMRALAKTKGMSLSEHALSTAVVRNTHGAKVGPGRVLPTPTEKDVFRLLGLPYREPAERDW","Homo sapiens","POLL","DNA polymerase lambda","1","3UQ2"
,,,,,,,,,,,,,,,,"CGGCTGTACTG",,,"5'-D(*CP*GP*GP*CP*TP*GP*TP*AP*CP*TP*G)-3'","2","3UQ2"
,,,,,,,,,,,,,,,,"CAGTACA",,,"5'-D(*CP*AP*GP*TP*AP)-R(P*CP*A)-3'","3","3UQ2"
,,,,,,,,,,,,,,,,"GCCG",,,"5'-D(P*GP*CP*CP*G)-3'","4","3UQ2"
"3UQU",,"X-RAY DIFFRACTION",2.65,53.5,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.6M Li2SO4, 100mM HEPES, 25% PEG3350, pH 7.5, vapor diffusion, hanging drop, temperature 293K",293,,,"3UQU",49.27,"1.7","1.7","Crystal structure of BACE1 with its inhibitor","MGSSHHHHHHSAGENLYFQGTLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGAWAGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3UQU"
"3UQW",,"X-RAY DIFFRACTION",2.87,57.2,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.6M Li2SO4, 100mM HEPES, 25% PEG3350, pH 7.5, vapor diffusion, hanging drop, temperature 293K",293,,,"3UQW",49.09,"2.2","2.2","Crystal structure of BACE1 with its inhibitor","MGSSHHHHHHSAGENLYFQGTLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGAWAGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3UQW"
"3UQX",,"X-RAY DIFFRACTION",2.66,53.68,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.6M Li2SO4, 100mM HEPES, 25% PEG3350, pH 7.5, vapor diffusion, hanging drop, temperature 293K",293,,,"3UQX",49.66,"1.7","1.7","Crystal structure of BACE1 with its inhibitor","MGSSHHHHHHSAGENLYFQGTLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGAWAGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3UQX"
"3UR4",,"X-RAY DIFFRACTION",2.31,46.64,"VAPOR DIFFUSION, SITTING DROP",6,"22% PEG 3350,0.1M A.S. ,0.1M Bis Tris pH 6.0 
, VAPOR DIFFUSION, SITTING DROP, temperature 297K",297,"10.1042/BJ20121280","0BW","3UR4",70.34,"1.8","1.8","Crystal structure of human WD repeat domain 5 with compound","GTQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","3UR4"
"3URO",,"X-RAY DIFFRACTION",4.28,71.23,"VAPOR DIFFUSION, HANGING DROP",8.5,"100 mM MgSO4, 6.8 M NH4NO3, 100 mM Tris buffer, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.0807848105",,"3URO",24.36,"3.5005","3.5005","Poliovirus receptor CD155 D1D2","VVVQAPTQVPGFLGDSVTLPCYLQVPNMEVTHVSQLTWARHGESGSMAVFHQTQGPSYSESKRLEFVAARLGAELRDASLRMFGLRVEDEGSYTCLFVTFPQGSRSVDIWLRVLAKPQNTAEVQKVQLTGEPVPMARCVSTGGRPPAQITWHSDLGGMPQTSQVPGFLSGTVTVTSLWILVPSSQVDGKQVTCKVEHESFEKPQLLTVSLTVYYPHHHHHH","Homo sapiens","PVR, PVS","Poliovirus receptor","1","3URO"
"3US0",,"X-RAY DIFFRACTION",3.33,63.07,"VAPOR DIFFUSION, HANGING DROP",6.8,"14% PEG3350, 0.2 M ammonium acetate, 0.1 M Bis-Tris, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M111.315820",,"3US0",104.49,"2.5","2.5","Structure of p63 DNA Binding Domain in Complex with a 22 Base Pair A/T Rich Response Element Containing a Two Base Pair ""AT"" Spacer Between Half Sites","GSHMASPSNTDYPGPHSFDVSFQQSSTAKSATWTYSTELKKLYCQIAKTCPIQIKVMTPPPQGAVIRAMPVYKKAEHVTEVVKRCPNHELSREFNEGQIAPPSHLIRVEGNSHAQYVEDPITGRQSVLVPYEPPQVGTEFTTVLYNFMCNSSCVGGMNRRPILIIVTLETRDGQVLGRRCFEARICACPGRDRKADEDSIRKQ","Homo sapiens","KET, P63, P73H, P73L, TP63, TP73L","Tumor protein 63","1","3US0"
,,,,,,,,,,,,,,,,"AAACATGTTTATAAACATGTTT",,,"5'-D(*AP*AP*AP*CP*AP*TP*GP*TP*TP*TP*AP*TP*AP*AP*AP*CP*AP*TP*GP*TP*TP*T)-3'","2","3US0"
"3US1",,"X-RAY DIFFRACTION",2.48,50.4,"VAPOR DIFFUSION, HANGING DROP",6.8,"0.2 M ammonium phosphate monobasic, 0.1 M Bis-Tris, pH 6.8, 14% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M111.315820",,"3US1",52.25,"2.8","2.8","Structure of p63 DNA Binding Domain in Complex with a 22 Base Pair Response Element Containing a Two Base Pair ""GC"" Spacer Between Half Sites","GSHMASPSNTDYPGPHSFDVSFQQSSTAKSATWTYSTELKKLYCQIAKTCPIQIKVMTPPPQGAVIRAMPVYKKAEHVTEVVKRCPNHELSREFNEGQIAPPSHLIRVEGNSHAQYVEDPITGRQSVLVPYEPPQVGTEFTTVLYNFMCNSSCVGGMNRRPILIIVTLETRDGQVLGRRCFEARICACPGRDRKADEDSIRKQ","Homo sapiens","KET, P63, P73H, P73L, TP63, TP73L","Tumor protein 63","1","3US1"
,,,,,,,,,,,,,,,,"AAACATGTTTGCAAACATGTTT",,,"5'-D(*AP*AP*AP*CP*AP*TP*GP*TP*TP*TP*GP*CP*AP*AP*AP*CP*AP*TP*GP*TP*TP*T)-3'","2","3US1"
"3US2",,"X-RAY DIFFRACTION",2.59,52.53,"VAPOR DIFFUSION, HANGING DROP",6.8,"0.2 M ammonium formate, 0.1 M Bis-Tris, pH 6.8, 12% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M111.315820",,"3US2",205.28,"4.2","4.2","Structure of p63 DNA Binding Domain in Complex with a 19 Base Pair A/T Rich Response Element Containing Two Half Sites with a Single Base Pair Overlap","GSHMASPSNTDYPGPHSFDVSFQQSSTAKSATWTYSTELKKLYCQIAKTCPIQIKVMTPPPQGAVIRAMPVYKKAEHVTEVVKRCPNHELSREFNEGQIAPPSHLIRVEGNSHAQYVEDPITGRQSVLVPYEPPQVGTEFTTVLYNFMCNSSCVGGMNRRPILIIVTLETRDGQVLGRRCFEARICACPGRDRKADEDSIRKQ","Homo sapiens","KET, P63, P73H, P73L, TP63, TP73L","Tumor protein 63","1","3US2"
,,,,,,,,,,,,,,,,"AAACATGTTAAACATGTTT",,,"5'-D(*AP*AP*AP*CP*AP*TP*GP*TP*TP*AP*AP*AP*CP*AP*TP*GP*TP*TP*T)-3'","2","3US2"
,,,,,,,,,,,,,,,,"AAACATGTTTAACATGTTT",,,"5'-D(*AP*AP*AP*CP*AP*TP*GP*TP*TP*TP*AP*AP*CP*AP*TP*GP*TP*TP*T)-3'","3","3US2"
"3US4",,"X-RAY DIFFRACTION",2.08,40.85,"VAPOR DIFFUSION, SITTING DROP",6,"2.40M (NH4)2SO4, 0.1M MES pH 6.0, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3US4",11.59,"1.5","1.5","Crystal structure of a SH2 domain of a megakaryocyte-associated tyrosine kinase (MATK) from Homo sapiens at 1.50 A resolution","GLSLMPWFHGKISGQEAVQQLQPPEDGLFLVRESARHPGDYVLCVSFGRDVIHYRVLHRDGHLTIDEAVFFCNLMDMVEHYSKDKGAICTKLVRPKRK","Homo sapiens","CTK, HYL, MATK, NM_139355","Megakaryocyte-associated tyrosine-protein kinase","1","3US4"
"3US5",,"X-RAY DIFFRACTION",2.21,44.42,"VAPOR DIFFUSION, SITTING DROP",8,"2.40M ammonium sulfate, 0.1M TRIS pH 8.0, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3US5",13.56,"1.38","1.38","Crystal structure of a RNA-binding domain of a poly-U binding splicing factor 60KDa (PUF60) from Homo sapiens at 1.38 A resolution","GSGSSARHMVMQKLLRKQESTVMVLRNMVDPKDIDDDLEGEVTEECGKFGAVNRVIIYQEKQGEEEDAEIIVKIFVEFSIASETHKAIQALNGRWFAGRKVVAEVYDQERFDNSDLSA","Homo sapiens","BC011265, FIR, PUF60, ROBPI, SIAHBP1","Poly(U)-binding-splicing factor PUF60","1","3US5"
"3USN",,"SOLUTION NMR",,,,,,,"10.1002/pro.5560071105","ATT","3USN",19.48,,,"STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE THIADIAZOLE INHIBITOR IPNU-107859, NMR, 1 STRUCTURE","FRTFPGIPKWRKTHLTYRIVNYTPDLPKDAVDSAVEKALKVWEEVTPLTFSRLYEGEADIMISFAVREHGDFYPFDGPGNVLAHAYAPGPGINGDAHFDDDEQWTKDTTGTNLFLVAAHEIGHSLGLFHSANTEALMYPLYHSLTDLTRFRLSQDDINGIQSLYGPPP","Homo sapiens","MMP3, STMY1","STROMELYSIN-1","1","3USN"
"3UT1",,"X-RAY DIFFRACTION",2.3,45.8,"VAPOR DIFFUSION",5.5,"27% PEG-3350, 0.1M ammonium sulfate, 0.2M cobaltous chloride, 0.1M Bis-tris, pH 5.5, vapor diffusion, temperature 291K",291,,,"3UT1",37.98,"2.05","2.05","Crystal structure of the 3-MBT repeat domain of L3MBTL3","GKKAWCWASYLEEEKAVAVPAKLFKEHQSFPYNKNGFKVGMKLEGVDPEHQSVYCVLTVAEVCGYRIKLHFDGYSDCYDFWVNADALDIHPVGWCEKTGHKLHPPKGYKEEEFNWQTYLKTCKAQAAPKSLFENQNITVIPSGFRVGMKLEAVDKKNPSFICVATVTDMVDNRFLVHFDNWDESYDYWCEASSPHIHPVGWCKEHRRTLITPPGYPNVKHFSWDKYLEETNSLPAPARAFKVKPPHGFQKKMKLEVVDKRNPMFIRVATVADTDDHRVKVHFDGWNNCYDYWIDADSPDIHPVGWCSKTGHPLQPPLSPLELME","Homo sapiens","L3MBTL3, KIAA1798, MBT1","Lethal(3)malignant brain tumor-like protein 3","1","3UT1"
"3UT3",,"X-RAY DIFFRACTION",2.69,54.35,"VAPOR DIFFUSION",6.1,"ammonium sulfate, pH 6.1, vapor diffusion, temperature 293K",293,,,"3UT3",169.53,"2.42","2.42","A novel PAI-I inhibitor and its structural mechanism","PSYVAHLASDFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDDKGMAPALRHLYKELMGPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIINDWVKTHTKGMISHLLGTGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAPYEKEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQADFTSLSDQEPLHVALALQKVKIEVNESGTVASSSTAVIVSARMAPEEIIIDRPFLFVVRHNPTGTVLFMGQVMEP","Homo sapiens","SERPINE1, PAI1, PLANH1","Plasminogen activator inhibitor 1","1","3UT3"
"3UTL",,"X-RAY DIFFRACTION",2.41,48.93,"VAPOR DIFFUSION",5.2,"16-30 mg/ml protein purified from gastric juice. 30% saturated ammonium sulphate buffered with 200 mM formate, pH 5.2, VAPOR DIFFUSION, temperature 298K",298,"10.1107/S0907444912004817",,"3UTL",34.63,"2.61","2.61","Human pepsin 3b","VDEQPLENYLDMEYFGTIGIGTPAQDFTVVFDTGSSNLWVPSVYCSSLACTNHNRFNPEDSSTYQSTSETVSITYGTGSMTGILGYDTVQVGGISDTNQIFGLSETEPGSFLYYAPFDGILGLAYPSISSSGATPVFDNIWNQGLVSQDLFSVYLSADDQSGSVVIFGGIDSSYYTGSLNWVPVTVEGYWQITVDSITMNGEAIACAEGCQAIVDTGTSLLTGPTSPIANIQSDIGASENSDGDMVVSCSAISSLPDIVFTINGVQYPVPPSAYILQSEGSCISGFQGMNLPTESGELWILGDVFIRQYFTVFDRANNQVGLAPVA","Homo sapiens","PGA4","Pepsin A","1","3UTL"
"3UTP",,"X-RAY DIFFRACTION",2.51,50.96,"VAPOR DIFFUSION",7.5,"20% w/v PEG3350, 0.2 M sodium iodide, 0.1 M Bis-tris propane, pH 7.5, VAPOR DIFFUSION, temperature 291K",291,"10.1038/ni.2206",,"3UTP",102.54,"2.574","2.574","1E6 TCR specific for HLA-A*0201-ALWGPDPAAA","KEVEQDPGPLSVPEGAIVSLNCTYSNSAFQYFMWYRQYSRKGPELLMYTYSSGNKEDGRFTAQVDKSSKYISLFIRDSQPSDSATYLCAMRGDSSYKLIFGSGTRLLVRPDIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSP","Homo sapiens",,"1E6 TCR alpha chain","1","3UTP"
,,,,,,,,,,,,,,,,"DAGVIQSPRHEVTEMGQQVTLRCKPISGHDYLFWYRQTMMRGLELLIYFNNNVPIDDSGMPEDRFSAKMPNASFSTLKIQPSEPRDSAVYFCASSLWEKLAKNIQYFGAGTRLSVLEDLKNVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYALSSRLRVSATFWQDPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"1E6 TCR beta chain","2","3UTP"
"3UUC",,"X-RAY DIFFRACTION",2.16,42.99,"VAPOR DIFFUSION, HANGING DROP",5.5,"200 mM MgCl2, 100 mM BisTris pH 5.5, 25% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1073/pnas.1203574109",,"3UUC",115.99,"2.1","2.1","Crystal structure of hERa-LBD (wt) in complex with bisphenol-C","KKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPLYDLLLEMLDAHRLHAP","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","3UUC"
"3UUN",,"X-RAY DIFFRACTION",2.03,39.52,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1M Tris HCl, 2.0M Ammonium sulphate, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 294.15K",294.15,"10.1371/journal.pone.0040066",,"3UUN",27.28,"2.3","2.3","Crystal Structure of N-terminal first spectrin repeat of dystrophin","EVNLDRYQTALEEVLSWLLSAEDTLQAQGEISNDVEVVKDQFHTHEGYMMDLTAHQGRVGNILQLGSKLIGTGKLSEDEETEVQEQMNLLNSRWECLRVASMEKQSNLHRVLMDLQNQK","Homo sapiens","DMD","Dystrophin","1","3UUN"
"3UUO",,"X-RAY DIFFRACTION",2.15,42.78,"VAPOR DIFFUSION, HANGING DROP",7.4,"100MM HEPES, 16% PEG 3350, 25 MM MGCL2, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.bmcl.2011.11.127","0CV","3UUO",79.01,"2.11","2.11","The discovery of potent, selectivity, and orally bioavailable pyrozoloquinolines as PDE10 inhibitors for the treatment of Schizophrenia","GSHMGMEKLSYHSHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEE","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","3UUO"
"3UV2",,"X-RAY DIFFRACTION",2.31,46.7,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.10M Na/KPO4, 20.0% PEG 3350, 10.0% EtGly, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.cell.2012.02.013",,"3UV2",15.13,"1.58","1.58","Crystal structure of the bromodomain of human nucleosome-remodeling factor subunit BPTF","SMQCQSTEDAMTVLTPLTEKDYEGLKRVLRSLQAHKMAWPFLEPVDPNDAPDYYGVIKEPMDLATMEERVQRRYYEKLTEFVADMTKIFDNCRYYNPSDSPFYQCAEVLESFFVQKLKGFKASRSH","Homo sapiens","BPTF, FAC1, FALZ","bromodomain of human nucleosome-remodeling factor subunit BPTF","1","3UV2"
"3UV4",,"X-RAY DIFFRACTION",2.79,55.98,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.056M NaH2PO4 
1.344M K2HPO4, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.cell.2012.02.013",,"3UV4",37.08,"1.89","1.89","Crystal Structure of the second bromodomain of human Transcription initiation factor TFIID subunit 1 (TAF1)","MHHHHHHSSGVDLGTENLYFQSMDDDQVAFSFILDNIVTQKMMAVPDSWPFHHPVNKKFVPDYYKVIVNPMDLETIRKNISKHKYQSRESFLDDVNLILANSVKYNGPESQYTKTAQEIVNVCYQTLTEYDEHLTQLEKDICTAKEAALEEAELESLD","Homo sapiens","BA2R, CCG1, CCGS, TAF1, TAF2A","second bromodomain of human Transcription initiation factor TFIID subunit 1 (TAF1)","1","3UV4"
"3UV5",,"X-RAY DIFFRACTION",4.1,70.03,"VAPOR DIFFUSION, SITTING DROP",9,"0.1M Tris-HCl, 1.1M (NH4)2SO4, pH 9.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.cell.2012.02.013",,"3UV5",31.09,"2.03","2.03","Crystal Structure of the tandem bromodomains of human Transcription initiation factor TFIID subunit 1 (TAF1)","SMSIHRRRTDPMVTLSSILESIINDMRDLPNTYPFHTPVNAKVVKDYYKIITRPMDLQTLRENVRKRLYPSREEFREHLELIVKNSATYNGPKHSLTQISQSMLDLCDEKLKEKEDKLARLEKAINPLLDDDDQVAFSFILDNIVTQKMMAVPDSWPFHHPVNKKFVPDYYKVIVNPMDLETIRKNISKHKYQSRESFLDDVNLILANSVKYNGPESQYTKTAQEIVNVCYQTLTEYDEHLTQLEKDICTAKEAALEEAELESLD","Homo sapiens","BA2R, CCG1, CCGS, TAF1, TAF2A","Transcription initiation factor TFIID subunit 1","1","3UV5"
"3UVC",,"X-RAY DIFFRACTION",1.87,34.38,"VAPOR DIFFUSION, HANGING DROP",7.5,"50mM imidazole pH 7.5, 200-400mM CaCl, 20% PEG 1k, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"3UVC",38.27,"1.3","1.3","MMP12 in a complex with the dimeric adduct: 5-(5-phenylhydantoin)-5-phenylhydantoin","MGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDFHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHAIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYGHHHHH","Homo sapiens","4321, HME, MMP12","Macrophage metalloelastase","1","3UVC"
"3UVD",,"X-RAY DIFFRACTION",2.08,40.83,"VAPOR DIFFUSION, SITTING DROP",8.5,"28% MMW PEG smear 
0.1M Tris.HCl pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.cell.2012.02.013",,"3UVD",14.66,"1.85","1.85","Crystal Structure of the bromodomain of human Transcription activator BRG1 (SMARCA4) in complex with N-Methyl-2-pyrrolidone","SMAEKLSPNPPNLTKKMKKIVDAVIKYKDSSSGRQLSEVFIQLPSRKELPEYYELIRKPVDFKKIKERIRNHKYRSLNDLEKDVMLLCQNAQTFNLEGSLIYEDSIVLQSVFTSVRQKIEKEDD","Homo sapiens","BRG1, SMARCA4, BAF190A, SNF2B, SNF2L4","Transcription activator BRG1","1","3UVD"
"3UVH",,"X-RAY DIFFRACTION",2.28,46.11,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris, 0.2 M ammonium acetate, 25% (w/v) PEG 3350, 0.02% azide, 5 mM DTT, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3UVH",53.91,"1.84","1.84","Crystal Structure Analysis of E81M mutant of human CLIC1","MAEEQPQVELFVKAGSDGAKIGNCPFSQRLFMVLWLKGVTFNVTTVDTKRRTETVQKLCPGGQLPFLLYGTEVHTDTNKIMEFLEAVLCPPRYPKLAALNPESNTAGLDIFAKFSAYIKNSNPALNDNLEKGLLKALKVLDNYLTSPLPEEVDETSAEDEGVSQRKFLDGNELTLADCNLLPKLHIVQVVCKKYRGFTIPEAFRGVHRYLSNAYAREEFASTCPDDEEIELAYEQVAKALK","Homo sapiens","CLIC1, G6, NCC27","Chloride intracellular channel protein 1","1","3UVH"
"3UVP",,"X-RAY DIFFRACTION",2,38.35,"VAPOR DIFFUSION, HANGING DROP",6.2,"100mM MES, 25% PEG 4000, 50mM n-BOG, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm300951u","048","3UVP",42.24,"2.4","2.4","Human p38 MAP Kinase in Complex with a Benzamide Substituted Benzosuberone","GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","3UVP"
"3UVQ",,"X-RAY DIFFRACTION",2.31,46.8,"VAPOR DIFFUSION, HANGING DROP",6.1,"100mM MES, 24 % PEG 4000, 50mM n-BOG, pH 6.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm301539x","FS8","3UVQ",42.09,"2.2","2.2","Human p38 MAP Kinase in Complex with a Dibenzosuberone Derivative","GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","3UVQ"
"3UVR",,"X-RAY DIFFRACTION",1.92,35.78,"VAPOR DIFFUSION, HANGING DROP",6,"100mM MES, 22% PEG 4000, 50mM n-BOG, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3UVR",42.38,"2.1","2.1","Human p38 MAP Kinase in Complex with KM064","GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","3UVR"
"3UVT",,"X-RAY DIFFRACTION",2.35,47.76,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.2 M ammonium sulfate, 0.1 M Bis-Tris (pH 5.5), 25% (w/v) PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 294K",294,"10.1107/S1744309112005866",,"3UVT",61.45,"2","2","Crystal structure of the third catalytic domain of ERp46","GPLGSTVLALTENNFDDTIAEGITFIKFYAPWCGHCKTLAPTWEELSKKEFPGLAGVKIAEVDCTAERNICSKYSVRGYPTLLLFRGGKKVSEHSGGRDLDSLHRFVLSQA","Homo sapiens","TXNDC5, TLP46, UNQ364/PRO700","Thioredoxin domain-containing protein 5","1","3UVT"
"3UW4",,"X-RAY DIFFRACTION",1.81,32.4,"VAPOR DIFFUSION, HANGING DROP",8.6,"Protein Solution (4mg/mL cIAP with 1 mM GDC-0152, 50 mM HEPES pH 7.2, 300 mM NaCl, 0.2 mM TCEP) was mixed with equal volumes of resevoir solution (0.1 M Tris-HCl pH 8.6, 0.5 M Magnesium Formate)., VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1021/jm300060k",,"3UW4",11.25,"1.79","1.79","Crystal structure of cIAP1 BIR3 bound to GDC0152","GSHMQTHAARMRTFMYWPSSVPVQPEQLAAAGFYYVGRNDDVKCFSCDGGLRCWESGDDPWVEHAKWFPGCEFLIRMKGQEYINNIHLTHSL","Homo sapiens","API1, BIRC2, cIAP1, IAP2, MIHB, RNF48, API3, BIRC4, IAP3, XIAP","Baculoviral IAP repeat-containing protein 2, Baculoviral IAP repeat-containing protein 4","1","3UW4"
,,,,,,,,,,,,,,,,,"Homo sapiens","API1, BIRC2, cIAP1, IAP2, MIHB, RNF48, API3, BIRC4, IAP3, XIAP"
,,,,,,,,,,,,,,,,"AXPX",,,"GDC0152","2","3UW4"
"3UW5",,"X-RAY DIFFRACTION",2.58,52.4,"VAPOR DIFFUSION",6,"Protein at 25 mg/mL in 10 mM MES was mixed with peptide (AVPW)n a 1:2 protein/peptide ratio. The MLIAP   peptide complex was mixed with crystallization well solution (100 mM Bis   tris(hydroxymethyl)aminomethane (tris), pH 6; 200 mM lithium sulfate; 20   25% (w/v) poly(ethylene glycol) 3350) in a ratio of 1 uL of protein complex to 1 uL of well solution, VAPOR DIFFUSION, temperature 292K",292,"10.1021/jm300060k",,"3UW5",27.47,"1.71","1.71","Crystal structure of the BIR domain of MLIAP bound to GDC0152","GSHMLETEEEEEEGAGATLSRGPAFPGMGSEELRLASFYDWPLTAEVPPELLAAAGFFHTGHQDKVRCFFCYGGLQSWKRGDDPWTEHAKWFPGCQFLLRSKGQEYINNIHLTHSL","Homo sapiens","BIRC7, KIAP, LIVIN, MLIAP, RNF50, UNQ5800/PRO19607/PRO21344, API3, BIRC4, IAP3, XIAP","Baculoviral IAP repeat-containing protein 7, Baculoviral IAP repeat-containing protein 4","1","3UW5"
,,,,,,,,,,,,,,,,,"Homo sapiens","BIRC7, KIAP, LIVIN, MLIAP, RNF50, UNQ5800/PRO19607/PRO21344, API3, BIRC4, IAP3, XIAP"
,,,,,,,,,,,,,,,,"AXPX",,,"GDC-0152","2","3UW5"
"3UWE",,"X-RAY DIFFRACTION",2.41,49.04,"VAPOR DIFFUSION, HANGING DROP",7.5,"200mM sodium acetate, 20% PEG 3350, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1107/S1744309112009049","VJJ","3UWE",39.2,"1.68","1.68","AKR1C3 complexed with 3-phenoxybenzoic acid","MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEYLEHHHHHH","Homo sapiens","AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS","Aldo-keto reductase family 1 member C3","1","3UWE"
"3UWN",,"X-RAY DIFFRACTION",3.3,62.3,"VAPOR DIFFUSION, SITTING DROP",5.5,"25% PEG-3350, 0.1 M ammonium sulfate, 0.1 M bis-tris. Crystal was soaked for 2 days in a 0.001 M solution of the ligand., pH 5.5, vapor diffusion, sitting drop, temperature 291K",291,,"UWN","3UWN",38.28,"2.15","2.15","The 3-MBT repeat domain of L3MBTL1 in complex with a methyl-lysine mimic","GEKKECWSWESYLEEQKAITAPVSLFQDSQAVTHNKNGFKLGMKLEGIDPQHPSMYFILTVAEVCGYRLRLHFDGYSECHDFWVNANSPDIHPAGWFEKTGHKLQPPKGYKEEEFSWSQYLRSTRAQAAPKHLFVSQSHSPPPLGFQVGMKLEAVDRMNPSLVCVASVTDVVDSRFLVHFDNWDDTYDYWCDPSSPYIHPVGWCQKQGKPLTPPQDYPDPDNFCWEKYLEETGASAVPTWAFKVRPPHSFLVNMKLEAVDRRNPALIRVASVEDVEDHRIKIHFDGWSHGYDFWIDADHPDIHPAGWCSKTGHPLQPPLGPREPSSASPGG","Homo sapiens","L3MBTL1, KIAA0681, L3MBT, L3MBTL","Lethal(3)malignant brain tumor-like protein 1","1","3UWN"
"3UWP",,"X-RAY DIFFRACTION",3.46,64.43,"VAPOR DIFFUSION",4.6,"3.5M sodium formate, 0.1M sodium acetate, pH 4.6, vapor diffusion, temperature 291K",291,"10.1038/ncomms2304","5ID","3UWP",50.79,"2.05","2.05","Crystal structure of Dot1l in complex with 5-iodotubercidin","MHHHHHHSSGRENLYFQGMGEKLELRLKSPVGAEPAVYPWPLPVYDKHHDAAHEIIETIRWVCEEIPDLKLAMENYVLIDYDTKSFESMQRLCDKYNRAIDSIHQLWKGTTQPMKLNTRPSTGLLRHILQQVYNHSVTDPEKLNNYEPFSPEVYGETSFDLVAQMIDEIKMTDDDLFVDLGSGVGQVVLQVAAATNCKHHYGVEKADIPAKYAETMDREFRKWMKWYGKKHAEYTLERGDFLSEEWRERIANTSVIFVNNFAFGPEVDHQLKERFANMKEGGRIVSSKPFAPLNFRINSRNLSDIGTIMRVVELSPLKGSVSWTGKPVSYYLHTIDRTILENYFSSLKNPKLREEQEAARRRQQRESKSNAATPTKGPEGKVAGPADAPMDSGAEEEKAGAATVKKPSPSKARKKKLNKKGRKMAGRKRGRPKKMNTA","Homo sapiens","DOT1L, KIAA1814, KMT4","Histone-lysine N-methyltransferase, H3 lysine-79 specific","1","3UWP"
"3UWT",,"X-RAY DIFFRACTION",2.14,42.62,"VAPOR DIFFUSION, SITTING DROP",9.5,"0.2M sodium chloride, 1.26M ammonium sulfate, 0.1M CHES pH 9.5, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3UWT",22.31,"2.5","2.5","Crystal structure of a RNA binding domain of poly-U binding splicing factor 60KDa (PUF60) from Homo sapiens at 2.50 A resolution","GAAQRQRALAIMCRVYVGSIYYELGEDTIRQAFAPFGPIKSIDMSWDSVTMKHKGFAFVEYEVPEAAQLALEQMNSVMLGGRNIKVGRPSNIGQAQPIIDQLAEEARAFNRIYVASVHQDLSDDDIKSVFEAFGKIKSCTLARDPTTGKHKGYGFIEYEKAQSSQDAVSSMNLFDLGGQYLRVGKAVTPPMPLLTPATPG","Homo sapiens","BC008875, FIR, PUF60, ROBPI, SIAHBP1","Poly(U)-binding-splicing factor PUF60","1","3UWT"
"3UX2",,"X-RAY DIFFRACTION",1.99,38.3,"VAPOR DIFFUSION",7.5,"HEPES, ammonium acetate, PEG 3350, pH 7.5, VAPOR DIFFUSION, temperature 278K",278,"10.1107/S0907444912006592",,"3UX2",15.12,"1.8","1.8","Crystal Structure of Domain-Swapped Fam96a Major dimer","SNARIMEEKALEVYDLIRTIRDPEKPNTLEELEVVSESCVEVQEINEEEYLVIIRFTPTVPHCSLATLIGLCLRVKLQRCLPFKHKLEIYISEGTHSTEEDINKQINDKERVAAAMENPNLREIVEQCVL","Homo sapiens","FAM96A, CIAO2A, CIA2A","MIP18 family protein FAM96A","1","3UX2"
"3UX3",,"X-RAY DIFFRACTION",2.73,54.89,"VAPOR DIFFUSION",4.7,"sodium acetate, sodium malonate, DMSO, PEG3350, zinc zcetate, pH 4.7, VAPOR DIFFUSION, temperature 278K",278,"10.1107/S0907444912006592",,"3UX3",30.31,"1.8","1.8","Crystal Structure of Domain-Swapped Fam96a minor dimer","SNARIMEEKALEVYDLIRTIRDPEKPNTLEELEVVSESCVEVQEINEEEYLVIIRFTPTVPHCSLATLIGLCLRVKLQRCLPFKHKLEIYISEGTHSTEEDINKQINDKERVAAAMENPNLREIVEQCVL","Homo sapiens","FAM96A, CIAO2A, CIA2A","MIP18 family protein FAM96A","1","3UX3"
"3UXE",,"X-RAY DIFFRACTION",2.45,49.84,"VAPOR DIFFUSION, HANGING DROP",6.7,"1.7M Ammonium Sulfate, 0.1M BisTris, 0.1M NaCl, 5mM DTT, 12uM FAD, pH 6.7, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/jm201251c","465","3UXE",54.1,"1.5","1.5","Design, Synthesis and Biological Evaluation of Potent Quinoline and Pyrroloquinoline Ammosamide Analogues as Inhibitors for Quinone Reductase 2","AGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","3UXE"
"3UXH",,"X-RAY DIFFRACTION",2.45,49.75,"VAPOR DIFFUSION, HANGING DROP",6.7,"1.7M Ammonium Sulfate, 0.1M BisTris, 0.1M NaCl, 5mM DTT, 12uM FAD, pH 6.7, VAPOR DIFFUSION, HANGING DROP",,"10.1021/jm201251c","UXH","3UXH",53.98,"1.53","1.53","Design, Synthesis and Biological Evaluation of Potetent Quinoline and Pyrroloquinoline Ammosamide Analogues as Inhibitors of Quinone Reductase 2","AGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNFEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ","Homo sapiens","NQO2, NMOR2","Ribosyldihydronicotinamide dehydrogenase [quinone]","1","3UXH"
"3UYJ",,"X-RAY DIFFRACTION",3.14,60.81,"EVAPORATION",7.5,"8% PEG3350, 0.1M HepesNa pH 7.5, EVAPORATION, temperature 291K",291,,,"3UYJ",57.78,"2.351","2.351","Crystal structure of JMJD5 catalytic core domain in complex with nickle and alpha-KG","GSHMGLIPDVKLEKTVPRLHRPSLQHFREQFLVPGRPVILKGVADHWPCMQKWSLEYIQEIAGCRTVPVEVGSRYTDEEWSQTLMTVNEFISKYIVNEPRDVGYLAQHQLFDQIPELKQDISIPDYCSLGDGEEEEITINAWFGPQGTISPLHQDPQQNFLVQVMGRKYIRLYSPQESGALYPHDTHLLHNTSQVDVENPDLEKFPKFAKAPFLSCILSPGEILFIPVKYWHYVRALDLSFSVSFWWS","Homo sapiens","JMJD5, KDM8","Lysine-specific demethylase 8","1","3UYJ"
"3UYN",,"X-RAY DIFFRACTION",2.3,46.45,"VAPOR DIFFUSION",5.8,"0.2 M AMMONIUM ACETATE  0.1 M  SODIUM ACETATE 30% PEG 4K, PH 5.8, VAPOR DIFFUSION, temperature 277K",277,"10.1002/prot.21403",,"3UYN",29.63,"2.6","2.6","HCA 3","MAKEWGYASHNGPDHWHELFPNAKGENQSPIELHTKDIRHDPSLQPWSVSYDGGSAKTILNNGKTCHVVFDDTYDRSMLRGGPLPGPYRLRQFHLHWGSSDDHGSEHTVDGVKYAAELHLVHWNPKYNTFKEALKQRDGIAVIGIFLKIGHENGEFQIFLDALDKIKTKGKEAPFTKFDPSSLFPASRDYWTYQGSFTTPPCEECIVWLLLKEPMTVSSDQMAKLRSLLSSAENEPPVPLVSNWRPPQPINNRVVRASFK","Homo sapiens","CA3","Carbonic anhydrase 3","1","3UYN"
"3UYQ",,"X-RAY DIFFRACTION",2.11,41.78,"VAPOR DIFFUSION",5.8,"0.2 M AMMONIUM ACETATE, 0.1 M  SODIUM ACETATE, 30% PEG 4K, pH 5.8, VAPOR DIFFUSION, temperature 277K",277,"10.1002/prot.21403",,"3UYQ",29.66,"1.7","1.7","HCA 3","MAKEWGYASHNGPDHWHELFPNAKGENQSPIELHTKDIRHDPSLQPWSVSYDGGSAKTILNNGHTCRVVFDDTYDRSMLRGGPLPGPYRLRQFHLHWGSSDDHGSEHTVDGVKYAAELHLVHWNPKYNTFKEALKQRDGIAVIGIFLKIGHENGEFQIFLDALDKIKTKGKEAPFTKFDPSSLFPASRDYWTYQGSFTTPPCEECIVWLLLKEPMTVSSDQMAKLRSLLSSAENEPPVPLVSNWRPPQPINNRVVRASFK","Homo sapiens","CA3, hca3","Carbonic anhydrase 3","1","3UYQ"
"3UYS",,"X-RAY DIFFRACTION",2.48,50.47,"VAPOR DIFFUSION, HANGING DROP",5,"100 mM Citrate,  
0.2 or 0.4 M Na2SO4,  
15-20% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 5.0",277,"10.1021/jm201387s",,"3UYS",138.36,"2.3","2.3","Crystal structure of apo human ck1d","GSMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","3UYS"
"3UYT",,"X-RAY DIFFRACTION",2.5,50.85,"VAPOR DIFFUSION, HANGING DROP",5,"100 mM Citrate pH5.0, 
0.2 or 0.4 M Na2SO4,  
15-20% PEG3350, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm201387s","0CK","3UYT",139.42,"2","2","crystal structure of ck1d with PF670462 from P1 crystal form","GSMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","3UYT"
"3UZA",,"X-RAY DIFFRACTION",5.395047,77.201309,"VAPOR DIFFUSION, SITTING DROP",8,"32-42% PEG1000, 0.25M MGCL2, 0.3% NG, 0.1%(W/V) 1-BUTANOL, 0.05% CYMAL-6, 0.1M TRIS-HCL, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm201376w","T4G","3UZA",36.76,"3.273","3.273","Thermostabilised Adenosine A2A receptor in complex with 6-(2,6-Dimethylpyridin-4-yl)-5-phenyl-1,2,4-triazin-3-amine","MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADILVGVLAIPFAITISTGFCAACHGCLFIACFVLVLAQSSIFSLLAIAIDRYIAIAIPLRYNGLVTGTRAAGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFAAARRQLKQMESQPLPGERARSTLQKEVHAAKSAAIIAGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLAHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAAAHHHHHHHHHH","Homo sapiens","ADORA2A, ADORA2","Adenosine receptor A2a","1","3UZA"
"3UZC",,"X-RAY DIFFRACTION",5.39,77.2,"VAPOR DIFFUSION, SITTING DROP",8,"32-42% PEG1000, 0.25M MGCL2, 0.3% NG, 0.1%(W/V) 1-BUTANOL, 0.05% CYMAL-6, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm201376w","T4E","3UZC",36.78,"3.341","3.341","Thermostabilised Adenosine A2A receptor in complex with 4-(3-amino-5-phenyl-1,2,4-triazin-6-yl)-2-chlorophenol","MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADILVGVLAIPFAITISTGFCAACHGCLFIACFVLVLAQSSIFSLLAIAIDRYIAIAIPLRYNGLVTGTRAAGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFAAARRQLKQMESQPLPGERARSTLQKEVHAAKSAAIIAGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLAHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAAAHHHHHHHHHH","Homo sapiens","ADORA2A, ADORA2","Adenosine A2A Receptor","1","3UZC"
"3UZP",,"X-RAY DIFFRACTION",2.25,45.31,"VAPOR DIFFUSION, HANGING DROP",5,"100 mM Citrate, 1.0 M LiCl,  
22.5-35% PEG6000, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 5.0",277,"10.1021/jm201387s","0CK","3UZP",69.38,"1.94","1.94","crystal structure of ck1d with PF670462 from P21 crystal form","GSMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","3UZP"
"3UZW",,"X-RAY DIFFRACTION",2.25,45.44,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris-HCl, 14-20% polyethylene glycol 4000, 10% isopropanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M111.338780",,"3UZW",80.81,"1.892","1.892","Crystal structure of 5beta-reductase (AKR1D1) E120H mutant in complex with NADP+","MGSSHHHHHHSSGLVPRGSHMDLSAASHRIPLSDGNSIPIIGLGTYSEPKSTPKGACATSVKVAIDTGYRHIDGAYIYQNEHEVGEAIREKIAEGKVRREDIFYCGKLWATNHVPEMVRPTLERTLRVLQLDYVDLYIIHVPMAFKPGDEIYPRDENGKWLYHKSNLCATWEAMEACKDAGLVKSLGVSNFNRRQLELILNKPGLKHKPVSNQVECHPYFTQPKLLKFCQQHDIVITAYSPLGTSRNPIWVNVSSPPLLKDALLNSLGKRYNKTAAQIVLRFNIQRGVVVIPKSFNLERIKENFQIFDFSLTEEEMKDIEALNKNVRFVELLMWRDHPEYPFHDEY","Homo sapiens","AKR1D1, SRD5B1","3-oxo-5-beta-steroid 4-dehydrogenase","1","3UZW"
"3UZX",,"X-RAY DIFFRACTION",2.24,45.1,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris-HCl, 14-20% polyethylene glycol 4000, 10% isopropanol, pH 7.5, vapor diffusion, hanging drop, temperature 277K",277,"10.1074/jbc.M111.338780",,"3UZX",81.43,"1.637","1.637","Crystal structure of 5beta-reductase (AKR1D1) E120H mutant in complex with NADP+ and epiandrosterone","MGSSHHHHHHSSGLVPRGSHMDLSAASHRIPLSDGNSIPIIGLGTYSEPKSTPKGACATSVKVAIDTGYRHIDGAYIYQNEHEVGEAIREKIAEGKVRREDIFYCGKLWATNHVPEMVRPTLERTLRVLQLDYVDLYIIHVPMAFKPGDEIYPRDENGKWLYHKSNLCATWEAMEACKDAGLVKSLGVSNFNRRQLELILNKPGLKHKPVSNQVECHPYFTQPKLLKFCQQHDIVITAYSPLGTSRNPIWVNVSSPPLLKDALLNSLGKRYNKTAAQIVLRFNIQRGVVVIPKSFNLERIKENFQIFDFSLTEEEMKDIEALNKNVRFVELLMWRDHPEYPFHDEY","Homo sapiens","AKR1D1, SRD5B1","3-oxo-5-beta-steroid 4-dehydrogenase","1","3UZX"
"3UZY",,"X-RAY DIFFRACTION",2.25,45.41,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris-HCl, 14-20% polyethylene glycol 4000, 10% isopropanol, pH 7.5, vapor diffusion, hanging drop, temperature 277K",277,"10.1074/jbc.M111.338780","BDT","3UZY",81.36,"1.832","1.832","Crystal structure of 5beta-reductase (AKR1D1) E120H mutant in complex with NADP+ and 5beta-dihydrotestosterone","MGSSHHHHHHSSGLVPRGSHMDLSAASHRIPLSDGNSIPIIGLGTYSEPKSTPKGACATSVKVAIDTGYRHIDGAYIYQNEHEVGEAIREKIAEGKVRREDIFYCGKLWATNHVPEMVRPTLERTLRVLQLDYVDLYIIHVPMAFKPGDEIYPRDENGKWLYHKSNLCATWEAMEACKDAGLVKSLGVSNFNRRQLELILNKPGLKHKPVSNQVECHPYFTQPKLLKFCQQHDIVITAYSPLGTSRNPIWVNVSSPPLLKDALLNSLGKRYNKTAAQIVLRFNIQRGVVVIPKSFNLERIKENFQIFDFSLTEEEMKDIEALNKNVRFVELLMWRDHPEYPFHDEY","Homo sapiens","AKR1D1, SRD5B1","3-oxo-5-beta-steroid 4-dehydrogenase","1","3UZY"
"3UZZ",,"X-RAY DIFFRACTION",2.25,45.42,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris-HCl, 14-20% polyethylene glycol 4000, 10% isopropanol, pH 7.5, vapor diffusion, hanging drop, temperature 277K",277,"10.1074/jbc.M111.338780",,"3UZZ",81.31,"1.82","1.82","Crystal structure of 5beta-reductase (AKR1D1) E120H mutant in complex with NADP+ and delta4-androstenedione","MGSSHHHHHHSSGLVPRGSHMDLSAASHRIPLSDGNSIPIIGLGTYSEPKSTPKGACATSVKVAIDTGYRHIDGAYIYQNEHEVGEAIREKIAEGKVRREDIFYCGKLWATNHVPEMVRPTLERTLRVLQLDYVDLYIIHVPMAFKPGDEIYPRDENGKWLYHKSNLCATWEAMEACKDAGLVKSLGVSNFNRRQLELILNKPGLKHKPVSNQVECHPYFTQPKLLKFCQQHDIVITAYSPLGTSRNPIWVNVSSPPLLKDALLNSLGKRYNKTAAQIVLRFNIQRGVVVIPKSFNLERIKENFQIFDFSLTEEEMKDIEALNKNVRFVELLMWRDHPEYPFHDEY","Homo sapiens","AKR1D1, SRD5B1","3-oxo-5-beta-steroid 4-dehydrogenase","1","3UZZ"
"3V01",,"X-RAY DIFFRACTION",3.28,62.54,"VAPOR DIFFUSION, HANGING DROP",7.2,"16-20% w/v PEG8K, 0.1M HEPES, 250mM NH4H2PO4, 1mM TCEP, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 286K",286,"10.1021/jm2017094","3V0","3V01",38.95,"2.705","2.705","Discovery of Novel Allosteric MEK Inhibitors Possessing Classical and Non-classical Bidentate Ser212 Interactions.","MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGVLEHHHHHH","Homo sapiens","MAP2K1, MEK1, PRKMK1","Dual specificity mitogen-activated protein kinase kinase 1","1","3V01"
"3V04",,"X-RAY DIFFRACTION",3.32,62.92,"VAPOR DIFFUSION, HANGING DROP",7.2,"16-20 %w/v PEG8K, 0.1M HEPES, 250mM NH4H2PO4, 1mM TCEP, pH 7.2, VAPOR DIFFUSION, HANGING DROP, temperature 286K",286,"10.1021/jm2017094","V04","3V04",38.92,"2.7","2.7","Discovery of Novel Allosteric MEK Inhibitors Possessing Classical and Non-classical Bidentate Ser212 Interactions.","MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGVLEHHHHHH","Homo sapiens","MAP2K1, MEK1, PRKMK1","Dual specificity mitogen-activated protein kinase kinase 1","1","3V04"
"3V0L",,"X-RAY DIFFRACTION",2.21,44.45,"VAPOR DIFFUSION, HANGING DROP",7,"50 mM MOPS pH 7, 50-200 mM AMMONIUM SULFATE, 50 mM MnCl2, AND 6-9% PEG-3350, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M113.465963","2GW","3V0L",35.45,"1.75","1.75","Crystal structure of the Fucosylgalactoside alpha N-acetylgalactosaminyltransferase (GTA, cisAB mutant L266G, G268A) in complex with a novel UDP-Gal derived inhibitor (2GW)","MAIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYGGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","AB0, ABO","Histo-blood group ABO system transferase","1","3V0L"
"3V0M",,"X-RAY DIFFRACTION",2.28,46.01,"VAPOR DIFFUSION, HANGING DROP",7,"50 mM MOPS pH 7, 50-200 mM AMMONIUM SULFATE, 50 mM MnCl2, AND 6-9% PEG-3350 , VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M113.465963",,"3V0M",71.35,"1.68","1.68","Crystal structure of the Fucosylgalactoside alpha N-acetylgalactosaminyltransferase (GTA, cisAB mutant L266G, G268A) in complex with a novel UDP-Gal derived inhibitor (5GW) and H-antigen acceptor","MAIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYGGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","AB0, ABO","Histo-blood group ABO system transferase","1","3V0M"
"3V0N",,"X-RAY DIFFRACTION",2.27,45.9,"VAPOR DIFFUSION, HANGING DROP",7,"50 mM MOPS pH 7, 50-200 mM AMMONIUM SULFATE, 50 mM MnCl2, 6-9% PEG-3350 , VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M113.465963",,"3V0N",71.64,"1.75","1.75","Crystal structure of the Fucosylgalactoside alpha N-acetylgalactosaminyltransferase (GTA, cisAB mutant L266G, G268A) in complex with a novel UDP-GalNAc derived inhibitor (3GW and 4GW)","MAIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYGGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","AB0, ABO","Histo-blood group ABO system transferase","1","3V0N"
"3V0O",,"X-RAY DIFFRACTION",2.12,41.96,"VAPOR DIFFUSION, HANGING DROP",7,"50 mM MOPS pH 7, 50-200 mM AMMONIUM SULFATE, 50 mM MnCl2, AND 6-9% PEG-3350 , VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M113.465963",,"3V0O",71.42,"1.65","1.65","Crystal structure of the Fucosylgalactoside alpha N-acetylgalactosaminyltransferase (GTA, cisAB mutant L266G, G268A) in complex with a novel UDP-GalNAc derived inhibitor (4GW) and H-antigen acceptor","MAIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYGGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","AB0, ABO","Histo-blood group ABO system transferase","1","3V0O"
"3V0P",,"X-RAY DIFFRACTION",2.29,46.3,"VAPOR DIFFUSION, HANGING DROP",7,"50 mM MOPS pH 7, 50-200 mM AMMONIUM SULFATE, 50 mM MnCl2, AND 6-9% PEG-3350 , VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M113.465963","4GW","3V0P",71.42,"1.9","1.9","Crystal structure of the Fucosylgalactoside alpha N-acetylgalactosaminyltransferase (GTA, cisAB mutant L266G, G268A) in complex with a novel UDP-Gal derived inhibitor (4GW) and H-antigen acceptor","MAIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYGGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","AB0, ABO","Histo-blood group ABO system transferase","1","3V0P"
"3V0Q",,"X-RAY DIFFRACTION",2.27,45.88,"VAPOR DIFFUSION, HANGING DROP",7,"50 mM MOPS pH 7, 50-200 mM AMMONIUM SULFATE, 50 mM MnCl2, AND 6-9% PEG-3350 , VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1074/jbc.M113.465963",,"3V0Q",71.57,"1.8","1.8","Crystal structure of the Fucosylgalactoside alpha N-acetylgalactosaminyltransferase (GTA, cisAB mutant L266G, G268A) in complex with UDP and H-antigen acceptor","MAIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYGGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","AB0, ABO","Histo-blood group ABO system transferase","1","3V0Q"
"3V19",,"X-RAY DIFFRACTION",1.82,32.44,"VAPOR DIFFUSION",8,"0.02 M Tris, 0.05 M sodium citrate, 5% acetone, 0.03% phenol, 0.01% zinc acetate, pH 8.0, VAPOR DIFFUSION, temperature 298K",298,,,"3V19",12.03,"2","2","Forestalling insulin fibrillation by insertion of a chiral clamp mechanism-based application of protein engineering to global health","GLLEQCCHSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","3V19"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin","2","3V19"
"3V1G",,"X-RAY DIFFRACTION",1.93,36.41,"VAPOR DIFFUSION",8,"0.02 M Tris, 0.05 M sodium citrate, 5% 
acetone, 0.03% phenol, 0.01% zinc acetate, pH 8.0, VAPOR DIFFUSION, temperature 298K",298,,,"3V1G",11.9,"2.2","2.2","Forestalling insulin fibrillation by insertion of a chiral clamp mechanism-based application of protein engineering to global health","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","3V1G"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin","2","3V1G"
"3V2B",,"X-RAY DIFFRACTION",2.26,45.57,"VAPOR DIFFUSION, SITTING DROP",5,"20% PEG6000, 0.1M NA-ACETATE, 0.2M NaCl, pH 5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.str.2012.12.019",,"3V2B",22.15,"2.2","2.2","Human poly(adp-ribose) polymerase 15 (ARTD7, BAL3), macro domain 2 in complex with adenosine-5-diphosphoribose","MHHHHHHSSGVDLGTENLYFQSMTAYEMKIGAITFQVATGDIATEQVDVIVNSTARTFNRKSGVSRAILEGAGQAVESECAVLAAQPHRDFIITPGGCLKCKIIIHVPGGKDVRKTVTSVLEECEQRKYTSVSLPAIGTGNAGKNPITVADNIIDAIVDFSSQHSTPSLKTVKVVIFQPELLNIFYDSMKKRDLSASLN","Homo sapiens","BAL3, PARP15","Poly [ADP-ribose] polymerase 15","1","3V2B"
"3V2J",,"X-RAY DIFFRACTION",2.15,42.85,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M Na-Citrate, 50mM Tris-Cl as precipitant solution. DMSO to dissolve AZM. 10 uL drops of CA II-AZM in 50% precipitant solution, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"AZM","3V2J",29.58,"1.699","1.699","Effect of Sucrose and Glycerol as Cryoprotectans, on the Inhibition of Human Carbonic Anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3V2J"
"3V2M",,"X-RAY DIFFRACTION",2.09,41.06,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M Na-Citrate, 50mM Tris-Cl as precipitant solution. DMSO to dissolve AZM. 10 uL drops of CA II-AZM in 50% precipitant solution, pH 7.8, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,"AZM","3V2M",29.73,"1.471","1.471","Effect of Sucrose and Glycerol as Cryoprotectans, on the Inhibition of Human Carbonic Anhydrase II","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3V2M"
"3V32",,"X-RAY DIFFRACTION",2.11,41.74,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1M Bis-Tris, 7% PEG 3350, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1093/nar/gks359",,"3V32",42.58,"2","2","Crystal structure of MCPIP1 N-terminal conserved domain","GGGTPKAPNLEPPLPEEEKEGSDLRPVVIDGSNVAMSHGNKEVFSCRGILLAVNWFLERGHTDITVFVPSWRKEQPRPDVPITDQHILRELEKKKILVFTPSRRVGGKRVVCYDDRFIVKLAYESDGIVVSNDTYRDLQGERQEWKRFIEERLLMYSFVNDKFMPPDDPLGRHGPSLDNFLRKKP","Homo sapiens","MCPIP1, ZC3H12A, MCPIP","Ribonuclease ZC3H12A","1","3V32"
"3V33",,"X-RAY DIFFRACTION",2.82,56.32,"VAPOR DIFFUSION, HANGING DROP",5,"4% Tacsimate, 6% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1093/nar/gks359",,"3V33",51.55,"2.005","2.005","Crystal structure of MCPIP1 conserved domain with zinc-finger motif","GGGTPKAPNLEPPLPEEEKEGSDLRPVVIDGSNVAMSHGNKEVFSCRGILLAVNWFLERGHTDITVFVPSWRKEQPRPDVPITDQHILRELEKKKILVFTPSRRVGGKRVVCYDDRFIVKLAYESDGIVVSNDTYRDLQGERQEWKRFIEERLLMYSFVNDKFMPPDDPLGRHGPSLDNFLRKKPLTLEHRKQPCPYGRKCTYGIKCRFFHPERPSCPQRSVA","Homo sapiens","MCPIP1, ZC3H12A, MCPIP","Ribonuclease ZC3H12A","1","3V33"
"3V34",,"X-RAY DIFFRACTION",2.12,41.91,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Bis-Tris, 7% PEG 3350, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1093/nar/gks359",,"3V34",42.63,"2.003","2.003","Crystal structure of MCPIP1 conserved domain with magnesium ion in the catalytic center","GGGTPKAPNLEPPLPEEEKEGSDLRPVVIDGSNVAMSHGNKEVFSCRGILLAVNWFLERGHTDITVFVPSWRKEQPRPDVPITDQHILRELEKKKILVFTPSRRVGGKRVVCYDDRFIVKLAYESDGIVVSNDTYRDLQGERQEWKRFIEERLLMYSFVNDKFMPPDDPLGRHGPSLDNFLRKKP","Homo sapiens","MCPIP1, ZC3H12A, MCPIP","Ribonuclease ZC3H12A","1","3V34"
"3V35",,"X-RAY DIFFRACTION",2.05,40.03,"VAPOR DIFFUSION, HANGING DROP",5,"120mM ammonium citrate pH 5.0, 20% (m/V) PEG 6000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1002/cmdc.201200333","NTI","3V35",40.8,"1.9","1.9","Aldose reductase complexed with a nitro compound","MGSSHHHHHHSSGLVPRGSHMASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","3V35"
"3V36",,"X-RAY DIFFRACTION",2.04,39.69,"VAPOR DIFFUSION, HANGING DROP",5,"120mM ammonium citrate pH 5.0, 20% (m/V) PEG 6000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1002/cmdc.201200333","3GR","3V36",38.98,"2","2","Aldose reductase complexed with glceraldehyde","MGSSHHHHHHSSGLVPRGSHMASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF","Homo sapiens","AKR1B1, ALDR1, ALR2","Aldose reductase","1","3V36"
"3V3B",,"X-RAY DIFFRACTION",1.93,36.15,"VAPOR DIFFUSION, SITTING DROP",4.75,"100 mM Na-acetate, 2.5M NaCl, pH 4.75, VAPOR DIFFUSION, SITTING DROP, temperature 290K",290,"10.1021/ja2090367",,"3V3B",25.24,"2","2","Structure of the Stapled p53 Peptide Bound to Mdm2","MQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVV","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","3V3B"
,,,,,,,,,,,,,,,,"QSQQTFXNLWRLLLQN",,,"SAH-p53-8 stapled-peptide","2","3V3B"
"3V3E",,"X-RAY DIFFRACTION",3.2,61.61,"VAPOR DIFFUSION, HANGING DROP",4.8,"7% PEG 6000, pH 4.8, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1038/nchembio.1069",,"3V3E",57.77,"2.06","2.06","Crystal Structure of the Human Nur77 Ligand-binding Domain","MSKPKQPPDASPANLLTSLVRAHLDSGPSTAKLDYSKFQELVLPHFGKEDAGDVQQFYDLLSGSLEVIRKWAEKIPGFAELSPADQDLLLESAFLELFILRLAYRSKPGEGKLIFCSGLVLHRLQCARGFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITDRHGLQEPRRVEELQNRIASCLKEHVAAVAGEPQPASCLSRLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPPIIDKIFMDTLPFLEHHHHHH","Homo sapiens","NR4A1, GFRP1, HMR, NAK1","Nuclear receptor subfamily 4 group A member 1","1","3V3E"
"3V3F",,"X-RAY DIFFRACTION",1.93,36.21,"VAPOR DIFFUSION, HANGING DROP",8.5,"30% w/v PEG 4000, 0.2M magnesium chloride hexahydrate, 0.1M TRIS hydrochloride, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/protein/gzs027","CL","3V3F",29.39,"2","2","Kinetic and structural studies of thermostabilized mutants of HCA II.","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSHDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVSKFRKLNFNGEGEPEEPMVDNWRPAQPLKQRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3V3F"
"3V3G",,"X-RAY DIFFRACTION",1.93,36.41,"VAPOR DIFFUSION, HANGING DROP",8.5,"30% w/v PEG 4000, 0.2M magnesium chloride hexahydrate, 0.1M TRIS hydrochloride, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/protein/gzs027","CL","3V3G",29.36,"1.5581","1.5581","Kinetic and structural studies of thermostabilized mutants of HCA II.","MSHHWGFGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSHDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVSKFRKLNFNGEGEPEEPMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3V3G"
"3V3H",,"X-RAY DIFFRACTION",1.93,36.33,"VAPOR DIFFUSION, HANGING DROP",8.5,"30% w/v PEG 4000 
0.2M Magnesium chloride hexahydrate 
0.1M TRIS hydrochloride, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/protein/gzs027","CL","3V3H",29.36,"1.85","1.85","Kinetic and structural studies of thermostabilized mutants of HCA II.","MSHHWGFGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNLGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSHDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVSKFRKLNFNGEGEPEEPMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3V3H"
"3V3I",,"X-RAY DIFFRACTION",1.91,35.74,"VAPOR DIFFUSION, HANGING DROP",8.5,"30% w/v PEG 4000 
0.2M Magnesium chloride 
0.1M TRIS hydrochloride, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/protein/gzs027","CL","3V3I",29.37,"1.73","1.73","Kinetic and structural studies of thermostabilized mutants of HCA II.","MSHHWGFGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFQVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSHDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVSKFRKLNFNGEGEPEEPMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3V3I"
"3V3J",,"X-RAY DIFFRACTION",1.9,35.23,"VAPOR DIFFUSION, HANGING DROP",8.5,"30% w/v PEG 4000, 0.2M magnesium chloride hexahydrate, 0.1M TRIS hydrochloride, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1093/protein/gzs027",,"3V3J",29.35,"1.63","1.63","Kinetic and structural studies of thermostabilized mutants of HCA II.","MSHHWGFGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNLGHAFQVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSHDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVSKFRKLNFNGEGEPEEPMVDNWRPAQPLKQRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3V3J"
"3V3L",,"X-RAY DIFFRACTION",3.16,61.04,,8,"45% PEG 400, 100 mM  Tris  HCl pH 8.0, 10 mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1101/gad.182618.111","V3L","3V3L",21.63,"1.65","1.65","Crystal structure of human RNF146 WWE domain in complex with iso-ADPRibose","GNGEYAWYYEGRNGWWQYDERTSRELEDAFSKGKKNTEMLIAGFLYVADLENMVQYRRNEHGRRRKIKRDIIDIPKKGVAGLRLD","Homo sapiens","RNF146","E3 ubiquitin-protein ligase RNF146","1","3V3L"
"3V3Q",,"X-RAY DIFFRACTION",3.2,61.59,"VAPOR DIFFUSION, HANGING DROP",4.8,"7% PEG 6000, pH 4.8, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1038/nchembio.1069","TMY","3V3Q",58.64,"2.22","2.22","Crystal Structure of Human Nur77 Ligand-binding Domain in Complex with Ethyl 2-[2,3,4 trimethoxy-6(1-octanoyl)phenyl]acetate","MSKPKQPPDASPANLLTSLVRAHLDSGPSTAKLDYSKFQELVLPHFGKEDAGDVQQFYDLLSGSLEVIRKWAEKIPGFAELSPADQDLLLESAFLELFILRLAYRSKPGEGKLIFCSGLVLHRLQCARGFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITDRHGLQEPRRVEELQNRIASCLKEHVAAVAGEPQPASCLSRLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPPIIDKIFMDTLPFLEHHHHHH","Homo sapiens","NR4A1, GFRP1, HMR, NAK1","Nuclear receptor subfamily 4 group A member 1","1","3V3Q"
"3V42",,"X-RAY DIFFRACTION",2.27,45.83,"VAPOR DIFFUSION, HANGING DROP",5.5,"100 MM BIS-TRIS, PH5.5, 200 MM LISO4, 25% PEG 3350, VAPOR DIFFUSION, TEMPERATURE 293K, VAPOR DIFFUSION, HANGING DROP",293,"10.1098/rsob.120071",,"3V42",50.93,"2","2","Crystal structure of renal tumor suppressor protein, folliculin","RKLPVFKSLRHMRQVLGAPSFRMLAWHVLMGNQVIWKSRDVDLVQSAFEVLRTMLPVGCVRIIPYSSQYEEAYRCNFLGLSPHVQIPPHVLSSEFAVIVEVHAAARSTLHPVGAEDDQSLSKYEFVVTSGSPVAADRVGPTILNKIEAALTNQNLSVDVVDQALVALKEEWMNKVKVLFKFTKVDSRPKEDTQKLLSILGASEEDNVKLLKFWMTGLSKTYKSHLM","Homo sapiens","BHD, FLCN","Folliculin","1","3V42"
"3V4J",,"X-RAY DIFFRACTION",2.3,46.45,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES, pH 7.5, 10% PEG 4000, 0.1M Magnesium Chloride, vapor diffusion, sitting drop, temperature 277K",277,"10.1021/cb200440y","PQR","3V4J",48.77,"2.04","2.04","First-In-Class Small Molecule Inhibitors of the Single-strand DNA Cytosine Deaminase APOBEC3G","GPLGSPEFELGTTEILRHSMDPPTFTFNFNNEPWVRGRHETYLCYEVERMHNDTWVKLNQRRGFLANQAPHKHGFLEGRHAELCFLDVIPFWKLDLDQDYRVTCFTSWSPCFSCAQEMAKFISKNKHVSLCIKTARIYDDQGRAQEGLRTLAEAGAKISIMTYSEFKHCWDTFVDHQGAPFQPWDGLDEHSQDLSGRLRAILQNQEN","Homo sapiens","APOBEC3G, MDS019","DNA dC->dU-editing enzyme APOBEC-3G","1","3V4J"
"3V4K",,"X-RAY DIFFRACTION",2.52,51.19,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES, pH 7.5, 10% PEG 4000, 0.1M Magnesium Chloride, vapor diffusion, sitting drop, temperature 277K",277,"10.1021/cb200440y",,"3V4K",47.65,"1.38","1.38","First-In-Class Small Molecule Inhibitors of the Single-strand DNA Cytosine Deaminase APOBEC3G","GPLGSPEFELGTTEILRHSMDPPTFTFNFNNEPWVRGRHETYLCYEVERMHNDTWVKLNQRRGFLANQAPHKHGFLEGRHAELCFLDVIPFWKLDLDQDYRVTCFTSWSPCFSCAQEMAKFISKNKHVSLCIKTARIYDDQGRCQEGLRTLAEAGAKISIMTYSEFKHCWDTFVDHQGAPFQPWDGLDEHSQDLSGRLRAILQ","Homo sapiens","APOBEC3G, MDS019","DNA dC->dU-editing enzyme APOBEC-3G","1","3V4K"
"3V4O",,"X-RAY DIFFRACTION",2.76,55.4,"VAPOR DIFFUSION",7,"20% PeG3550, 0.4 Ammonium nitrate, 0.1M Bis-tris propane, VAPOR DIFFUSION, temperature 298K, pH 7.0",298,"10.1016/j.jmb.2012.02.018",,"3V4O",28.41,"2.1","2.1","Human MALT1 (caspase domain) in complex with an irreversible peptidic inhibitor","GPGSDNKEQTTDQPLAKDKVALLIGNMNYREHPKLKAPLVDVYELTNLLRQLDFKVVSLLDLTEYEMRNAVDEFLLLLDKGVYGLLYYAGHGYENFGNSFMVPVDAPNPYRSENCLCVQNILKLMQEKETGLNVFLLDMCRKRNDYDDTIPILDALKVTANIVFGYATCQGAEAFEIQHSGLANGIFMKFLKDRLLEDKKITVLLDEVAEDMGKCHLTKGKQALEIRSSLSEKRALTDPIQGTEY","Homo sapiens","MALT1, MLT","Mucosa-associated lymphoid tissue lymphoma translocation protein 1","1","3V4O"
,,,,,,,,,,,,,,,,"XVRPRX",,,"MALT1 Inhibitor","2","3V4O"
"3V4Q",,"X-RAY DIFFRACTION",4.99,75.35,"VAPOR DIFFUSION, SITTING DROP",5.5,"15% Ethanol, 0.1M Citrate pH 5.5, 0.2 M Litium Sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bbrc.2011.12.136",,"3V4Q",8.93,"3.06","3.06","Structure of R335W mutant of human Lamin","LAAKEAKLRDLEDSLARERDTSWRLLAEKEREMAEMRARMQQQLDEYQELLDIKLALDMEIHAYRKLLEGEEER","Homo sapiens","Lamin A/C, LMN1, LMNA","Prelamin-A/C","1","3V4Q"
"3V4W",,"X-RAY DIFFRACTION",4.95,75.13,"VAPOR DIFFUSION, SITTING DROP",4.6,"30% 2-methyl-2,4-pentanediol, 0.1 M Sodium Acetate pH 4.6, 0.2 M Sodium Chloride, VAPOR DIFFUSION, SITTING DROP",,"10.1016/j.bbrc.2011.12.136",,"3V4W",8.91,"3.7","3.7","Structure of E347K mutant of Lamin","LAAKEAKLRDLEDSLARERDTSRRLLAEKEREMAKMRARMQQQLDEYQELLDIKLALDMEIHAYRKLLEGEEER","Homo sapiens","LMNA, LMN1","Prelamin-A/C","1","3V4W"
"3V53",,"X-RAY DIFFRACTION",2.48,50.32,"VAPOR DIFFUSION, HANGING DROP",5.65,"pH 5.65, VAPOR DIFFUSION, HANGING DROP, temperature 281K",281,"10.1042/BJ20121382",,"3V53",69.98,"2.9","2.9","Crystal structure of human RBM25","MGHHHHHHMKRKHIKSLIEKIPTAKPELFAYPLDWSIVDSILMERRIRPWINKKIIEYIGEEEATLVDFVCSKVMAHSSPQSILDDVAMVLDEEAEVFIVKMWRLLIYETEAKKIGLVK","Homo sapiens","RBM25, RNPC7","RNA-binding protein 25","1","3V53"
"3V55",,"X-RAY DIFFRACTION",2.13,42.17,"VAPOR DIFFUSION",,"0.2M magnesium formate, 20% PEG3350, VAPOR DIFFUSION, temperature 298K",298,"10.1016/j.jmb.2012.02.018",,"3V55",43.98,"1.81","1.81","Human MALT1 (334-719) in its ligand free form","GPGTTDQPLAKDKVALLIGNMNYREHPKLKAPLVDVYELTNLLRQLDFKVVSLLDLTEYEMRNAVDEFLLLLDKGVYGLLYYAGHGYENFGNSFMVPVDAPNPYRSENCLCVQNILKLMQEKETGLNVFLLDMCRKRNDYDDTIPILDALKVTANIVFGYATCQGAEAFEIQHSGLANGIFMKFLKDRLLEDKKITVLLDEVAEDMGKCHLTKGKQALEIRSSLSEKRALTDPIQGTEYSAESLVRNLQWAKAHELPESMCLKFDCGVQIQLGFAAEFSNVMIIYTSIVYKPPEIIMCDAYVTDFPLDLDIDPKDANKGTPEETGSYLVSKDLPKHCLYTRLSSLQKLKEHLVFTVCLSYQYSGLEDTVEDKQEVNVGKPLIAKLDMHR","Homo sapiens","MALT1, MLT","Mucosa-associated lymphoid tissue lymphoma translocation protein 1","1","3V55"
"3V56",,"X-RAY DIFFRACTION",2.27,45.91,,,,,"10.1107/S0907444911056058",,"3V56",147.83,"3","3","Re-refinement of PDB entry 1OSG - Complex between BAFF and a BR3 derived peptide presented in a beta-hairpin scaffold - reveals an additonal copy of the peptide.","GSHMELQGHHAEKLPAGAGAPKAGLEEAPAVTAGLKIFEPPAPGEGNSSQNSRNKRAVQGPEETVTQDCLQLIADSETPTIQKGSYTFVPWLLSFKRGSALEEKENKILVKETGYFFIYGQVLYTDKTYAMGHLIQRKKVHVFGDELSLVTLFRCIQNMPETLPNNSCYSAGIAKLEEGDELQLAIPRENAQISLDGDVTFFGALKLL","Homo sapiens","TNFSF13B, BAFF, BLYS, TALL1, TNFSF20, ZTNF4, UNQ401/PRO738","Tumor necrosis factor ligand superfamily member 13B","1","3V56"
,,,,,,,,,,,,,,,,"XCHWDLLVRHWVCX",,,"BR3 derived peptive","2","3V56"
"3V5B",,"X-RAY DIFFRACTION",4.91,74.93,"VAPOR DIFFUSION, SITTING DROP",7.5,"30% 2-methyl-2,4-pentanediol, 0.1 M Hepes pH 7.5, 0.5 M Ammonium Sulfate, VAPOR DIFFUSION, SITTING DROP",,"10.1016/j.bbrc.2011.12.136",,"3V5B",8.91,"3","3","Structure of Coil 2b of human lamin","LAAKEAKLRDLEDSLARERDTSRRLLAEKEREMAEMRARMQQQLDEYQELLDIKLALDMEIHAYRKLLEGEEER","Homo sapiens","LMNA, LMN1","Prelamin-A/C","1","3V5B"
"3V5G",,"X-RAY DIFFRACTION",2.08,40.84,"VAPOR DIFFUSION, HANGING DROP",8.4,"2.6M Ammonium Sulphate, 0.3M Sodium Chloride, 0.1M Tris-HCl pH 8.4, 5mM mercury para-hydroxybenzoate, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K",293,"10.1021/jm300818k","0F3","3V5G",30.77,"1.5","1.5","Crystal structure of human carbonic anhydrase II in complex with the 4-sulfamido-benzenesulfonamide inhibitor","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3V5G"
"3V5J",,"X-RAY DIFFRACTION",2.73,55.02,"VAPOR DIFFUSION",6.5,"18% PEG3350, 0.1 M Bis-Tris, 0.12 M Li-sulfate, 4% propanol, 10 mM DTT, pH 6.5, VAPOR DIFFUSION, temperature 294K",294,"10.1016/j.bmcl.2012.03.016","0F2","3V5J",61.6,"2.59","2.59","Crystal Structure of Interleukin-2 Inducible T-cell Kinase Itk Catalytic Domain with Thienopyrazolylindole Inhibitor 090","GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","3V5J"
"3V5L",,"X-RAY DIFFRACTION",2.7,54.51,"VAPOR DIFFUSION",6,"0.8M Ammonium-sulfate, 0.1 M Na-citrate, 0.225 M Mg-acetate, 4% acetone, 10 mM DTT, pH 6.0, VAPOR DIFFUSION, temperature 294K",294,"10.1016/j.bmcl.2012.03.016","0G1","3V5L",122.82,"1.86","1.86","Crystal Structure of Interleukin-2 Inducible T-cell Kinase Itk Catalytic Domain with Thienopyrazolylindole Inhibitor 542","GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","3V5L"
"3V5Q",,"X-RAY DIFFRACTION",3.29,62.66,"VAPOR DIFFUSION, SITTING DROP",6.2,"2.5 M NaCl, 0.1 M Na/K phosphate, pH 6.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/ml200261d","0F4","3V5Q",68.92,"2.2001","2.2001","Discovery of a selective TRK Inhibitor with efficacy in rodent cancer tumor models","GAMHSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKATP","Homo sapiens","NTRK3, TRKC","NT-3 growth factor receptor","1","3V5Q"
"3V5X",,"X-RAY DIFFRACTION",2.2,44.1,"VAPOR DIFFUSION, HANGING DROP",6.5,"10% PEG 6000, 0.1 M HEPES, 25% ethylene glycol, pH 6.5, vapor diffusion, hanging drop, temperature 293K",293,"10.1074/jbc.M111.308684",,"3V5X",38.97,"1.85","1.85","Structure of FBXL5 hemerythrin domain, C2 cell","MAPFPEEVDVFTAPHWRMKQLVGLYCDKLSKTNFSNNNDFRALLQSLYATFKEFKMHEQIENEYIIGLLQQRSQTIYNVHSDNKLSEMLSLFEKGLKNVKNEYEQLNYAKQLKERLEAFTRDFLPHMKEEEEVFQPMLMEYFTYEELKDIKKKVIAQHCSQ","Homo sapiens","FBL4, FBL5, FBXL5, FLR1","F-box/LRR-repeat protein 5","1","3V5X"
"3V5Y",,"X-RAY DIFFRACTION",2.16,43.01,"VAPOR DIFFUSION, HANGING DROP",7.4,"25% PEG 3350, 0.1 M HEPES, 20% ethylene glycol, pH 7.4, vapor diffusion, hanging drop, temperature 293K",293,"10.1074/jbc.M111.308684",,"3V5Y",77.94,"2.1","2.1","Structure of FBXL5 hemerythrin domain, P2(1) cell","MAPFPEEVDVFTAPHWRMKQLVGLYCDKLSKTNFSNNNDFRALLQSLYATFKEFKMHEQIENEYIIGLLQQRSQTIYNVHSDNKLSEMLSLFEKGLKNVKNEYEQLNYAKQLKERLEAFTRDFLPHMKEEEEVFQPMLMEYFTYEELKDIKKKVIAQHCSQ","Homo sapiens","FBL4, FBL5, FBXL5, FLR1","F-box/LRR-repeat protein 5","1","3V5Y"
"3V5Z",,"X-RAY DIFFRACTION",2.18,43.51,"VAPOR DIFFUSION, HANGING DROP",6.5,"12% PEG 6000, 0.1 M HEPES, 30% ethylene glycol, 2M Na(2)S(2)O(4), pH 6.5, vapor diffusion, hanging drop, temperature 293K",293,"10.1074/jbc.M111.308684",,"3V5Z",38.97,"2.1847","2.1847","Structure of FBXL5 hemerythrin domain, C2 cell, grown anaerobically","MAPFPEEVDVFTAPHWRMKQLVGLYCDKLSKTNFSNNNDFRALLQSLYATFKEFKMHEQIENEYIIGLLQQRSQTIYNVHSDNKLSEMLSLFEKGLKNVKNEYEQLNYAKQLKERLEAFTRDFLPHMKEEEEVFQPMLMEYFTYEELKDIKKKVIAQHCSQ","Homo sapiens","FBL4, FBL5, FBXL5, FLR1","F-box/LRR-repeat protein 5","1","3V5Z"
"3V66",,"X-RAY DIFFRACTION",2.56,52.01,"VAPOR DIFFUSION",5,"CO-CRYSTALLIZED USING SEEDING METHOD., pH 5, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.bmc.2012.02.054","D3A","3V66",39.8,"1.8","1.8","HUMAN SQUALENE SYNTHASE IN COMPLEX WITH 2-(1-{2-[(4R,6S)-8-chloro-6-(2,3-dimethoxyphenyl)-4H,6H-pyrrolo[1,2-a][4,1]benzoxazepin-4-yl]acetyl}-4-piperidinyl)acetic acid","MDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFAKPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKGAVKIRKGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSDPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3V66"
"3V6A",,"X-RAY DIFFRACTION",2.63,53.17,"VAPOR DIFFUSION, HANGING DROP",9,"10% PEG 6000, 100mM bicine pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1074/jbc.M111.317594",,"3V6A",53.59,"2.6","2.6","Helical repeat structure of apoptosis inhibitor 5 reveals protein-protein interaction modules","MGSSHHHHHHSSGLVPRGSHMPTVEELYRNYGILADATEQVGQHKDAYQVILDGVKGGTKEKRLAAQFIPKFFKHFPELADSAINAQLDLCEDEDVSIRRQAIKELPQFATGENLPRVADILTQLLQTDDSAEFNLVNNALLSIFKMDAKGTLGGLFSQILQGEDIVRERAIKFLSTKLKTLPDEVLTKEVEELILTESKKVLEDVTGEEFVLFMKILSGLKSLQTVSGRQQLVELVAEQADLEQTFNPSDPDCVDRLLQCTRQAVPLFSQNVHSTRFVTYFCEQVLPNLGTLTTPVEGLDIQLEVLKLLAEMSSFCGDMEKLETNLRKLFDKLLEYMPLPPEEAENGENAGNEEPKLQFSYVECLLYSFHQLGRKLPDFLTAKLNAEKLKDFKIRLQYFARGLQVYIRQLRLALQGKTGEALKTEENKIKVVALKITNNINVLIKDLFHIPPSYKSTVTLSWKPVQKVEIGQK","Homo sapiens","API5, MIG8","Apoptosis inhibitor 5","1","3V6A"
"3V6L",,"X-RAY DIFFRACTION",2.93,58.06,"VAPOR DIFFUSION, SITTING DROP",6.6,"0.1M MES, 10% PEG3350, 0.2M sodium chloride, pH 6.6, VAPOR DIFFUSION, SITTING DROP, temperature 293.0K",293,"10.1074/jbc.M112.351213",,"3V6L",65.15,"2.2","2.2","Crystal Structure of caspase-6 inactivation mutation","METDAFYKREMFDPAEKYKMDHRRRGIALIFNHERFFWHLTLPERRGTCADRDNLTRRFSDLGFEVKCFNDLKAEELLLKIHEVSTVSHADADCFVCVFLSHGEGNHIYAYDAKIEIQTLTGLFKGDKCHSLVGKPKIFIIQACRGNQHDVPVIPLDVVDNQTEKLDTNITEVDAASVYTLPAGADFLMCYSVAEGYYSHRETVNGSWYIQDLCEMLGKYGSSLEFTELLTLVNRKVEQRRVDFCKDPSAIGKKQVPCFASMLTKKLHFFPKSNLEHHHHHH","Homo sapiens","CASP6, MCH2","Caspase-6","1","3V6L"
"3V6M",,"X-RAY DIFFRACTION",2.27,45.88,"VAPOR DIFFUSION, SITTING DROP",7.5,"20mM HEPES, 2.0M sodium chloride, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.0K",293,"10.1074/jbc.M112.351213",,"3V6M",257.82,"2.692","2.692","Inhibition of caspase-6 activity by single mutation outside the active site","MAFYKREMFDPAEKYKMDHRRRGIALIFNHERFFWHLTLPERRGTCADRDNLTRRFSDLGFEVKCFNDLKAEELLLKIHEVSTVSHADADCFVCVFLSHGEGNHIYAYDAKIEIQTLTGLFKGDKCHSLVGKPKIFIIQACRGNQHDVPVIPLDVVDNQTEKLDTNITEVDAASVYTLPAGADFLMCYSVAEGYYSHRETVNGSWYIQDLCEMLGKYGSSLEFTELLTLVNRKVEQRRVDFCKDPSAIGKKQVPCFASMLTKKLHFFPKSNLEHHHHHH","Homo sapiens","CASP6, MCH2","Caspase-6","1","3V6M"
"3V6R",,"X-RAY DIFFRACTION",2.25,45.42,"VAPOR DIFFUSION, SITTING DROP",7,"50 mM HEPES, 100 mM NaCl, 5% glycerol, 5 mM TCEP, 0.4 mM Zwittergent 3-14), pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.chembiol.2011.11.010","CQQ","3V6R",85.11,"2.6","2.6","Discovery of potent and selective covalent inhibitors of JNK","MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","3V6R"
"3V6S",,"X-RAY DIFFRACTION",2.22,44.68,,7,"50 mM HEPES pH 7.0, 100 mM NaCl, 5% glycerol, 5 mM TCEP, 0.4 mM Zwittergent 3-14), VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.chembiol.2011.11.010","0F0","3V6S",85.11,"2.97","2.97","Discovery of potent and selective covalent inhibitors of JNK","MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE","Homo sapiens","MAPK10, JNK3, JNK3A, PRKM10, SAPK1B","Mitogen-activated protein kinase 10","1","3V6S"
"3V70",,"X-RAY DIFFRACTION",2.06,47.9,"VAPOR DIFFUSION",7.5,"25% w/v PEG3350, 0.2M sodium chloride, 0.1M HEPES. GDP and 1:100 dispase were also added., pH 7.5, vapor diffusion, temperature 293K",293,,,"3V70",56.38,"2.206","2.206","Crystal Structure of Human GTPase IMAP family member 1","MHHHHHHSSGRENLYFQGESTRRLILVGRTGAGKSATGNSILGQRRFFSRLGATSVTRACTTGSRRWDKCHVEVVDTPDIFSSQVSKTDPGCEERGHCYLLSAPGPHALLLVTQLGRFTAQDQQAVRQVRDMFGEDVLKWMVIVFTRKEDLAGGSLHDYVSNTENRALRELVAECGGRVCAFDNRATGREQEAQVVQLLGMVEGLVLEHKGAHYSNEVYELAQVLRWAGPEERLRRVAERVAARVQR","Homo sapiens","GIMAP1, IMAP1","GTPase IMAP family member 1","1","3V70"
"3V7M",,"X-RAY DIFFRACTION",2.96,58.46,,5.1,"8% MPEG 5000, 300 MICRO-M ZNCL2, 100 MICRO-M       
NICL2, 0.1 M SODIUM CACODYLATE, pH 5.1, VAPOR DIFFUSION, SITTING DROP, temperature 316KK",316,"10.1016/j.imlet.2012.02.002",,"3V7M",25.67,"2.02","2.02","Crystal structure of monoclonal human anti-Rhesus D Fc IgG1 T125(YB2/0) in the presence of Zn2+","GGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLS","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","3V7M"
"3V7T",,"X-RAY DIFFRACTION",2.59,52.53,"hanging drop",5,"NaAC 0.1M, NaCl 2M, glycerol 10%, PEG3350 20%, hanging drop, temperature 291K",291,"10.1016/j.bmcl.2011.12.127","0GX","3V7T",112.07,"2.09","2.09","Crystal Structure of Human Beta-Tryptase Complexed with a Synthetic Inhibitor with a Tropanylamide Scaffold","IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYVPKKP","Homo sapiens","TPSB2, TPS2","TPSB2 protein","1","3V7T"
"3V7X",,"X-RAY DIFFRACTION",2.09,41.11,"VAPOR DIFFUSION, HANGING DROP",7.5,"3 M ammonium sulfate, 50 mM Tris-HCl, 2 mM 4-(Hydroxymercuri)benzoate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm300112w","D7A","3V7X",31.33,"1.03","1.03","Complex of human carbonic anhydrase II with N-[2-(3,4-dimethoxyphenyl)ethyl]-4-sulfamoylbenzamide","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3V7X"
"3V83",,"X-RAY DIFFRACTION",2.99,58.8,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM HEPES, pH 7.5, 1.6 M ammonium sulfate, and 2% PEG 1000, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1038/nature10823",,"3V83",472.51,"2.102","2.102","The 2.1 angstrom crystal structure of diferric human transferrin","MRLAVGALLVCAVLGLCLAVPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVKKASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVVKKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPCADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRDQYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKEFQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKPVKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGKCGLVPVLAENYNKSDNCEDTPEAGYFAVAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWNIPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAFRCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLARAPNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKLHDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP","Homo sapiens","TF, PRO1400","Serotransferrin","1","3V83"
"3V8C",,"X-RAY DIFFRACTION",2.87,57.08,"VAPOR DIFFUSION, SITTING DROP",5.1,"17% MPEG 5000; 21.5% ETHYLENE GLYCOL, 0.1M SODIUM CACODYLATE, pH 5.1, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.imlet.2012.02.002",,"3V8C",51.38,"2.77","2.77","Crystal structure of monoclonal human anti-rhesus D Fc IgG1 t125(yb2/0) double mutant (H310 and H435 in K)","GGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLKQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNKYTQKSLSLSPGK","Homo sapiens","HUMAN, IGHG1","Ig gamma-1 chain C region","1","3V8C"
"3V8D",,"X-RAY DIFFRACTION",2.8,55.7,,5.6,"30% PEG-400, 0.2M lithium sulfate, 0.1M trisodium citrate, pH 5.6, temperature 291K",291,,,"3V8D",115.57,"1.9","1.9","Crystal structure of human CYP7A1 in complex with 7-ketocholesterol","MAKKTSSRRRQTGEPPLENGLIPYLGCALQFGANPLEFLRANQRKHGHVFTCKLMGKYVHFITNPLSYHKVLCHGKYFDWKKFHFALSAKAFGHRSIDPMDGNTTENINDTFIKTLQGHALNSLTESMMENLQRIMRPPVSSNSKTAAWVTEGMYSFCYRVMFEAGYLTIFGRDLTRRDTQKAHILNNLDNFKQFDKVFPALVAGLPIHMFRTAHNAREKLAESLRHENLQKRESISELISLRMFLNDTLSTFDDLEKAKTHLVVLWASQANTIPATFWSLFQMIRNPEAMKAATEEVKRTLENAGQKVSLEGNPICLSQAELNDLPVLDSIIKESLRLSSASLNIRTAKEDFTLHLEDGSYNIRKDDIIALYPQLMHLDPEIYPDPLTFKYDRYLDENGKTKTTFYCNGLKLKYYYMPFGSGATICPGRLFAIHEIKQFLILMLSYFELELIEGQAKCPPLDQSRAGLGILPPLNDIEFKYKFKHHHHHH","Homo sapiens","CYP7A1, CYP7","Cholesterol 7-alpha-monooxygenase","1","3V8D"
"3V8O",,"X-RAY DIFFRACTION",3.67,66.46,"VAPOR DIFFUSION, HANGING DROP",8,"1.6M Sodium Potassium Phosphate, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1074/jbc.M113.537456",,"3V8O",41.25,"2.8","2.8","Human Filamin C Ig - like Domains 4 and 5","QAGVQKVRAWGPGLETGQVGKSADFVVEAIGTEVGTLGFSIEGPSQAKIECDDKGDGSCDVRYWPTEPGEYAVHVICDDEDIRDSPFIAHILPAPPDCFPDKVKAFGPGLEPTGCIVDKPAEFTIDARAAGKGDLKLYAQDADGCPIDIKVIPNGDGTFRCSYVPTKPIKHTIIISWGGVNVPKSPFRVNVGEG","Homo sapiens","ABPL, FLN2, FLNC","Filamin-C","1","3V8O"
"3V8S",,"X-RAY DIFFRACTION",2.83,56.49,"VAPOR DIFFUSION, HANGING DROP",7.4,"10 MG/ML ROCK1, 25 MM HEPES PH 7.4, 50 MM MES PH 6.5, 2.5% TACSIMATE PH 7.0, 5% PEG 5000 MME, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K",291,"10.1021/jm201289r","0HD","3V8S",191.06,"2.286","2.286","Human RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH INDAZOLE DERIVATIVE (COMPOUND 18)","SFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNR","Homo sapiens","ROCK1","Rho-associated protein kinase 1","1","3V8S"
"3V8T",,"X-RAY DIFFRACTION",2.73,54.87,"VAPOR DIFFUSION",6.2,"0.8M Ammonium-sulfate, 0.1 M Na-citrate, 0.15 M Mg-acetate, 10 mM DTT, pH 6.2, VAPOR DIFFUSION, temperature 294K",294,"10.1016/j.bmcl.2012.03.016","477","3V8T",61.34,"2","2","Crystal Structure of Interleukin-2 Inducible T-cell Kinase Itk Catalytic Domain with Thienopyrazolylindole Inhibitor 477","GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","3V8T"
"3V8W",,"X-RAY DIFFRACTION",2.73,54.9,"VAPOR DIFFUSION",5.8,"0.8M Ammonium-sulfate, 0.1 M Na-citrate, 0.2 M Mg-acetate, 10 mM DTT, pH 5.8, VAPOR DIFFUSION, temperature 294K",294,"10.1016/j.bmcl.2012.03.016","0G2","3V8W",61.4,"2.27","2.27","Crystal Structure of Interleukin-2 Inducible T-cell Kinase Itk Catalytic Domain with Thienopyrazolylindole Inhibitor 469","GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL","Homo sapiens","ITK, EMT, LYK","Tyrosine-protein kinase ITK/TSK","1","3V8W"
"3V92",,"X-RAY DIFFRACTION",2.54,51.67,"VAPOR DIFFUSION, HANGING DROP",6,"10% tacsimate, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1096/fj.12-205286",,"3V92",158.95,"2.74","2.74","S663A Stable-5-LOX","MGSSHHHHHHSSGLVPRGSHMPSYTVTVATGSQEHAGTDDYIYLSLVGSAGCSEKHLLDKGSFERGAVDSYDVTVDEELGEIQLVRIEKRKYGSNDDWYLKYITLKTPHGDYIEFPCYRWITGDVEVVLRDGRAKLARDDQIHILKQHRRKELETRQKQYRWMEWNPGFPLSIDAKCHKDLPRDIQFDSEKGVDFVLNYSKAMENLFINRFMHMFQSSWNDFADFEKIFVKISNTISERVMNHWQEDLMFGYQFLNGANPVLIRRCTELPEKLPVTTEMVECSLERQLSLEQEVQQGNIFIVDFELLDGIDANKTDPCTLQFLAAPICLLYKNLANKIVPIAIQLNQIPGDENPIFLPSDAKYDWLLAKIWVRSSDFHVHQTITHLLRTHLVSEVFGIAMYRQLPAVHPIFKLLVAHVRFTIAINTKAREQLICECGLFDKANATGGGGHVQMVQRAMKDLTYASLCFPEAIKARGMESKEDIPYYFYRDDGLLVWEAIRTFTAEVVDIYYEGDQVVEEDPELQDFVNDVYVYGMRGRKSSGFPKSVKSREQLSEYLTVVIFTASAQHAAVNFGQYDWASWIPNAPPTMRAPPPTAKGVVTIEQIVDTLPDRGRSCWHLGAVWALSQFQENELFLGMYPEEHFIEKPVKEAMARFRKNLEAIVSVIAERNENLQLPYYYLAPDRIPNSVAI","Homo sapiens","ALOX5, LOG5","Arachidonate 5-lipoxygenase","1","3V92"
"3V95",,"X-RAY DIFFRACTION",2.83,56.53,,5.1,"12.8% MPEG 5000, 21.5% ETHYLENE GLYCOL, 0.002M EDTA, 0.1 M SODIUM CACODYLATE, pH 5.1, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.imlet.2012.02.002",,"3V95",51.09,"2.7","2.7","Crystal structure of monoclonal human anti-rhesus D Fc and IgG1 t125(yb2/0) in the presence of EDTA","GGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","3V95"
"3V98",,"X-RAY DIFFRACTION",2.56,51.88,"VAPOR DIFFUSION, HANGING DROP",6,"10% tacsimate , pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1096/fj.12-205286",,"3V98",159.04,"2.07","2.07","S663D Stable-5-LOX","MGSSHHHHHHSSGLVPRGSHMPSYTVTVATGSQEHAGTDDYIYLSLVGSAGCSEKHLLDKGSFERGAVDSYDVTVDEELGEIQLVRIEKRKYGSNDDWYLKYITLKTPHGDYIEFPCYRWITGDVEVVLRDGRAKLARDDQIHILKQHRRKELETRQKQYRWMEWNPGFPLSIDAKCHKDLPRDIQFDSEKGVDFVLNYSKAMENLFINRFMHMFQSSWNDFADFEKIFVKISNTISERVMNHWQEDLMFGYQFLNGANPVLIRRCTELPEKLPVTTEMVECSLERQLSLEQEVQQGNIFIVDFELLDGIDANKTDPCTLQFLAAPICLLYKNLANKIVPIAIQLNQIPGDENPIFLPSDAKYDWLLAKIWVRSSDFHVHQTITHLLRTHLVSEVFGIAMYRQLPAVHPIFKLLVAHVRFTIAINTKAREQLICECGLFDKANATGGGGHVQMVQRAMKDLTYASLCFPEAIKARGMESKEDIPYYFYRDDGLLVWEAIRTFTAEVVDIYYEGDQVVEEDPELQDFVNDVYVYGMRGRKSSGFPKSVKSREQLSEYLTVVIFTASAQHAAVNFGQYDWASWIPNAPPTMRAPPPTAKGVVTIEQIVDTLPDRGRSCWHLGAVWALSQFQENELFLGMYPEEHFIEKPVKEAMARFRKNLEAIVSVIAERNENLQLPYYYLDPDRIPNSVAI","Homo sapiens","ALOX5, LOG5","Arachidonate 5-lipoxygenase","1","3V98"
"3V99",,"X-RAY DIFFRACTION",2.27,45.89,"VAPOR DIFFUSION, HANGING DROP",6,"10% tacsimate, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1096/fj.12-205286",,"3V99",159.34,"2.252","2.252","S663D Stable-5-LOX in complex with Arachidonic Acid","MGSSHHHHHHSSGLVPRGSHMPSYTVTVATGSQEHAGTDDYIYLSLVGSAGCSEKHLLDKGSFERGAVDSYDVTVDEELGEIQLVRIEKRKYGSNDDWYLKYITLKTPHGDYIEFPCYRWITGDVEVVLRDGRAKLARDDQIHILKQHRRKELETRQKQYRWMEWNPGFPLSIDAKCHKDLPRDIQFDSEKGVDFVLNYSKAMENLFINRFMHMFQSSWNDFADFEKIFVKISNTISERVMNHWQEDLMFGYQFLNGANPVLIRRCTELPEKLPVTTEMVECSLERQLSLEQEVQQGNIFIVDFELLDGIDANKTDPCTLQFLAAPICLLYKNLANKIVPIAIQLNQIPGDENPIFLPSDAKYDWLLAKIWVRSSDFHVHQTITHLLRTHLVSEVFGIAMYRQLPAVHPIFKLLVAHVRFTIAINTKAREQLICECGLFDKANATGGGGHVQMVQRAMKDLTYASLCFPEAIKARGMESKEDIPYYFYRDDGLLVWEAIRTFTAEVVDIYYEGDQVVEEDPELQDFVNDVYVYGMRGRKSSGFPKSVKSREQLSEYLTVVIFTASAQHAAVNFGQYDWASWIPNAPPTMRAPPPTAKGVVTIEQIVDTLPDRGRSCWHLGAVWALSQFQENELFLGMYPEEHFIEKPVKEAMARFRKNLEAIVSVIAERNENLQLPYYYLDPDRIPNSVAI","Homo sapiens","ALOX5, LOG5","Arachidonate 5-lipoxygenase","1","3V99"
"3V9B",,"X-RAY DIFFRACTION",2.65,53.64,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 25%(v/v) ethylene glycol, 10%(v/v) isopropanol, 100mM HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1039/c2ob06495b","IHM","3V9B",168.24,"2.1","2.1","Crystal structure of the catalytic domain of PDE4D2 with (S)-N-(3-{1-[1-(3-Cyclopropylmethoxy-4-difluoromethoxyphenyl)-2-(1-oxypyridin-4-yl)-ethyl]-1H-pyrazl-3-yl}phenyl)acetamide","IPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTL","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","3V9B"
"3V9G",,"X-RAY DIFFRACTION",2.54,51.52,"VAPOR DIFFUSION, SITTING DROP",7.5,"reservoir: 22.5% PEG3350, 0.2 M ammonium sulfate, 0.1 M HEPES, cryoprotectant: 25% PEG3350, 0.2 M ammonium sulfate, 0.1 M HEPES, 25% glycerol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.jmb.2012.04.010",,"3V9G",248.08,"2.5","2.5","Crystal structure of human 1-pyrroline-5-carboxylate dehydrogenase","MGSSHHHHHHSSGLVPRGSHTGAGLRWKHTSSLKVANEPVLAFTQGSPERDALQKALKDLKGRMEAIPCVVGDEEVWTSDVQYQVSPFNHGHKVAKFCYADKSLLNKAIEAALAARKEWDLKPIADRAQIFLKAADMLSGPRRAEILAKTMVGQGKTVIQAEIDAAAELIDFFRFNAKYAVELEGQQPISVPPSTNSTVYRGLEGFVAAISPFNFTAIGGNLAGAPALMGNVVLWKPSDTAMLASYAVYRILREAGLPPNIIQFVPADGPLFGDTVTSSEHLCGINFTGSVPTFKHLWKQVAQNLDRFHTFPRLAGECGGKNFHFVHRSADVESVVSGTLRSAFEYGGQKCSACSRLYVPHSLWPQIKGRLLEEHSRIKVGDPAEDFGTFFSAVIDAKSFARIKKWLEHARSSPSLTILAGGKCDDSVGYFVEPCIVESKDPQEPIMKEEIFGPVLSVYVYPDDKYKETLQLVDSTTSYGLTGAVFSQDKDVVQEATKVLRNAAGNFYINDKSTGSIVGQQPFGGARASGTNDKPGGPHYILRWTSPQVIKETHKPLGDWSYAYMQ","Homo sapiens","ALDH4, ALDH4A1, P5CDH","Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial","1","3V9G"
"3V9H",,"X-RAY DIFFRACTION",2.47,50.16,"VAPOR DIFFUSION, SITTING DROP",7.5,"reservoir: 22.5% PEG3350, 0.2 M ammonium sulfate, 0.1 M HEPES, pH 7.5, cryoprotectant: 25% glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2012.04.010",,"3V9H",248.69,"2.4","2.4","Crystal structure of human 1-pyrroline-5-carboxylate dehydrogenase mutant S352A","MGSSHHHHHHSSGLVPRGSHTGAGLRWKHTSSLKVANEPVLAFTQGSPERDALQKALKDLKGRMEAIPCVVGDEEVWTSDVQYQVSPFNHGHKVAKFCYADKSLLNKAIEAALAARKEWDLKPIADRAQIFLKAADMLSGPRRAEILAKTMVGQGKTVIQAEIDAAAELIDFFRFNAKYAVELEGQQPISVPPSTNSTVYRGLEGFVAAISPFNFTAIGGNLAGAPALMGNVVLWKPSDTAMLASYAVYRILREAGLPPNIIQFVPADGPLFGDTVTSSEHLCGINFTGSVPTFKHLWKQVAQNLDRFHTFPRLAGECGGKNFHFVHRSADVESVVSGTLRSAFEYGGQKCSACARLYVPHSLWPQIKGRLLEEHSRIKVGDPAEDFGTFFSAVIDAKSFARIKKWLEHARSSPSLTILAGGKCDDSVGYFVEPCIVESKDPQEPIMKEEIFGPVLSVYVYPDDKYKETLQLVDSTTSYGLTGAVFSQDKDVVQEATKVLRNAAGNFYINDKSTGSIVGQQPFGGARASGTNDKPGGPHYILRWTSPQVIKETHKPLGDWSYAYMQ","Homo sapiens","ALDH4, ALDH4A1, P5CDH","Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial","1","3V9H"
"3V9I",,"X-RAY DIFFRACTION",2.53,51.42,"VAPOR DIFFUSION, SITTING DROP",7.5,"reservoir: 22.5% PEG3350, 0.2 M ammonium sulfate, 0.1 M HEPES, pH 7.5, cryoprotectant: 25% glycerol, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.jmb.2012.04.010",,"3V9I",248.18,"2.85","2.85","Crystal structure of human 1-pyrroline-5-carboxylate dehydrogenase mutant S352L","MGSSHHHHHHSSGLVPRGSHTGAGLRWKHTSSLKVANEPVLAFTQGSPERDALQKALKDLKGRMEAIPCVVGDEEVWTSDVQYQVSPFNHGHKVAKFCYADKSLLNKAIEAALAARKEWDLKPIADRAQIFLKAADMLSGPRRAEILAKTMVGQGKTVIQAEIDAAAELIDFFRFNAKYAVELEGQQPISVPPSTNSTVYRGLEGFVAAISPFNFTAIGGNLAGAPALMGNVVLWKPSDTAMLASYAVYRILREAGLPPNIIQFVPADGPLFGDTVTSSEHLCGINFTGSVPTFKHLWKQVAQNLDRFHTFPRLAGECGGKNFHFVHRSADVESVVSGTLRSAFEYGGQKCSACLRLYVPHSLWPQIKGRLLEEHSRIKVGDPAEDFGTFFSAVIDAKSFARIKKWLEHARSSPSLTILAGGKCDDSVGYFVEPCIVESKDPQEPIMKEEIFGPVLSVYVYPDDKYKETLQLVDSTTSYGLTGAVFSQDKDVVQEATKVLRNAAGNFYINDKSTGSIVGQQPFGGARASGTNDKPGGPHYILRWTSPQVIKETHKPLGDWSYAYMQ","Homo sapiens","ALDH4, ALDH4A1, P5CDH","Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial","1","3V9I"
"3VAF",,"X-RAY DIFFRACTION",2.89,57.46,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M Ammonium sulfate, 10% Dioxane, 0.1M MES pH 6.5, Deoxy-Big Chap, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1093/nar/gkt046",,"3VAF",44.32,"2.49","2.49","Structure of U2AF65 variant with BrU3 DNA","GPLGSARRLYVGNIPFGITEEAMMDFFNAQMRLGGLTQAPGNPVLAVQINQDKNFAFLEFRSVDETTQAMAFDGIIFQGQSLKIRRPHDYQPLPGAHKLFIGGLPNYLNDDQVKELLTSFGPLKAFNLVKDSATGLSKGYAFCEYVDINVTDQAIAGLNGMQLGDKKLLVQRAS","Homo sapiens","U2AF2, U2AF65","Splicing factor U2AF 65 kDa subunit","1","3VAF"
,,,,,,,,,,,,,,,,,"Homo sapiens","U2AF2, U2AF65"
,,,,,,,,,,,,,,,,"UUUUUUU",,,"DNA 5'-D(*UP*UP*(BRU)P*(BRU)P*UP*UP*U)-3'","2","3VAF"
"3VAG",,"X-RAY DIFFRACTION",3.04,59.61,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M Ammonium sulfate, 10% Dioxane, 0.1M MES pH 6.5, Deoxy-Big Chap, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1093/nar/gkt046",,"3VAG",44.53,"2.19","2.19","Structure of U2AF65 variant with BrU3C2 DNA","GPLGSARRLYVGNIPFGITEEAMMDFFNAQMRLGGLTQAPGNPVLAVQINQDKNFAFLEFRSVDETTQAMAFDGIIFQGQSLKIRRPHDYQPLPGAHKLFIGGLPNYLNDDQVKELLTSFGPLKAFNLVKDSATGLSKGYAFCEYVDINVTDQAIAGLNGMQLGDKKLLVQRAS","Homo sapiens","U2AF2, U2AF65","Splicing factor U2AF 65 kDa subunit","1","3VAG"
,,,,,,,,,,,,,,,,,"Homo sapiens","U2AF2, U2AF65"
,,,,,,,,,,,,,,,,"UCUUUUU",,,"DNA 5'-D(*U*CP*(BRU)P*UP*UP*UP*U)-3'","2","3VAG"
"3VAH",,"X-RAY DIFFRACTION",3.02,59.27,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M Ammonium sulfate, 10% Dioxane, 0.1M MES pH 6.5, Deoxy-Big Chap, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1093/nar/gkt046",,"3VAH",44.07,"2.5","2.5","Structure of U2AF65 variant with BrU3C4 DNA","GPLGSARRLYVGNIPFGITEEAMMDFFNAQMRLGGLTQAPGNPVLAVQINQDKNFAFLEFRSVDETTQAMAFDGIIFQGQSLKIRRPHDYQPLPGAHKLFIGGLPNYLNDDQVKELLTSFGPLKAFNLVKDSATGLSKGYAFCEYVDINVTDQAIAGLNGMQLGDKKLLVQRAS","Homo sapiens","U2AF2, U2AF65","Splicing factor U2AF 65 kDa subunit","1","3VAH"
,,,,,,,,,,,,,,,,,"Homo sapiens","U2AF2, U2AF65"
,,,,,,,,,,,,,,,,"UUUCUUU",,,"DNA 5'-D(P*UP*UP*(BRU)P*CP*UP*UP*U)-3'","2","3VAH"
"3VAI",,"X-RAY DIFFRACTION",3.01,59.12,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M M Ammonium sulfate, 10% Dioxane, 0.1M MES pH 6.5, Deoxy-Big Chap, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1093/nar/gkt046",,"3VAI",44.35,"2.2","2.2","Structure of U2AF65 variant with BrU3C5 DNA","GPLGSARRLYVGNIPFGITEEAMMDFFNAQMRLGGLTQAPGNPVLAVQINQDKNFAFLEFRSVDETTQAMAFDGIIFQGQSLKIRRPHDYQPLPGAHKLFIGGLPNYLNDDQVKELLTSFGPLKAFNLVKDSATGLSKGYAFCEYVDINVTDQAIAGLNGMQLGDKKLLVQRAS","Homo sapiens","U2AF2, U2AF65","Splicing factor U2AF 65 kDa subunit","1","3VAI"
,,,,,,,,,,,,,,,,,"Homo sapiens","U2AF2, U2AF65"
,,,,,,,,,,,,,,,,"UUUUCUU",,,"DNA 5'-D(*UP*UP*(BRU)P*UP*CP*UP*U)-3'","2","3VAI"
"3VAJ",,"X-RAY DIFFRACTION",2.91,57.73,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M Ammonium sulfate, 10% Dioxane, 0.1M MES pH 6.5, Deoxy-Big Chap, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1093/nar/gkt046",,"3VAJ",44.34,"1.9","1.9","Structure of U2AF65 variant with BrU5C6 DNA","GPLGSARRLYVGNIPFGITEEAMMDFFNAQMRLGGLTQAPGNPVLAVQINQDKNFAFLEFRSVDETTQAMAFDGIIFQGQSLKIRRPHDYQPLPGAHKLFIGGLPNYLNDDQVKELLTSFGPLKAFNLVKDSATGLSKGYAFCEYVDINVTDQAIAGLNGMQLGDKKLLVQRAS","Homo sapiens","U2AF2, U2AF65","Splicing factor U2AF 65 kDa subunit","1","3VAJ"
,,,,,,,,,,,,,,,,,"Homo sapiens","U2AF2, U2AF65"
,,,,,,,,,,,,,,,,"UUUUUCU",,,"DNA (5'-D(*UP*UP*UP*UP*(BRU)P*CP*U)-3')","2","3VAJ"
"3VAL",,"X-RAY DIFFRACTION",2.49,50.65,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M Ammonium sulfate, 10% Dioxane, 0.1M MES pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1093/nar/gkt046",,"3VAL",85.97,"2.5","2.5","Structure of U2AF65 variant with BrU5C1 DNA","GPLGSARRLYVGNIPFGITEEAMMDFFNAQMRLGGLTQAPGNPVLAVQINQDKNFAFLEFRSVDETTQAMAFDGIIFQGQSLKIRRPHDYQPLPGAHKLFIGGLPNYLNDDQVKELLTSFGPLKAFNLVKDSATGLSKGYAFCEYVDINVTDQAIAGLNGMQLGDKKLLVQRAS","Homo sapiens","U2AF2, U2AF65","Splicing factor U2AF 65 kDa subunit","1","3VAL"
,,,,,,,,,,,,,,,,,"Homo sapiens","U2AF2, U2AF65"
,,,,,,,,,,,,,,,,"CUUUUUU",,,"DNA (5'-D(*C*UP*UP*UP*(BRU)P*UP*U)-3')","2","3VAL"
"3VAM",,"X-RAY DIFFRACTION",3.1,60.28,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M Ammonium sulfate, 10% Dioxane, 0.1M MES pH 6.5, Deoxy-Big Chap, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1093/nar/gkt046",,"3VAM",44.25,"2.4","2.4","Structure of U2AF65 variant with BrU5C2 DNA","GPLGSARRLYVGNIPFGITEEAMMDFFNAQMRLGGLTQAPGNPVLAVQINQDKNFAFLEFRSVDETTQAMAFDGIIFQGQSLKIRRPHDYQPLPGAHKLFIGGLPNYLNDDQVKELLTSFGPLKAFNLVKDSATGLSKGYAFCEYVDINVTDQAIAGLNGMQLGDKKLLVQRAS","Homo sapiens","U2AF2, U2AF65","Splicing factor U2AF 65 kDa subunit","1","3VAM"
,,,,,,,,,,,,,,,,,"Homo sapiens","U2AF2, U2AF65"
,,,,,,,,,,,,,,,,"UCUUUUU",,,"DNA (5'-D(*UP*CP*UP*UP*(BRU)P*UP*U)-3')","2","3VAM"
"3VAP",,"X-RAY DIFFRACTION",2.51,51.06,"VAPOR DIFFUSION, HANGING DROP",8.3,"0.1M TRIS, 0.2M LISO4, 33% PEG 400, 0.001M COMPOUND, 1% DMSO, pH 8.3, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.bmcl.2012.03.051","0FY","3VAP",32,"2.66","2.66","Synthesis and SAR Studies of imidazo-[1,2-a]-pyrazine Aurora kinase inhibitors with improved off target kinase selectivity","GAMGSKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","3VAP"
"3VBB",,"X-RAY DIFFRACTION",3.55,65.32,"VAPOR DIFFUSION, SITTING DROP",7,"20% PEG 3350, 0.2 M tri-sodium citrate pH 7.0, 5mM ATP, 10mM MgCl2, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1038/ncomms1686",,"3VBB",360.22,"2.891","2.891","Crystal Structure of Seryl-tRNA Synthetase from Human at 2.9 angstroms","MVLDLDLFRVDKGGDPALIRETQEKRFKDPGLVDQLVKADSEWRRCRFRADNLNKLKNLCSKTIGEKMKKKEPVGDDESVPENVLSFDDLTADALANLKVSQIKKVRLLIDEAILKCDAERIKLEAERFENLREIGNLLHPSVPISNDEDVDNKVERIWGDCTVRKKYSHVDLVVMVDGFEGEKGAVVAGSRGYFLKGVLVFLEQALIQYALRTLGSRGYIPIYTPFFMRKEVMQEVAQLSQFDEELYKVIGKGSEKSDDNSYDEKYLIATSEQPIAALHRDEWLRPEDLPIKYAGLSTCFRQEVGSHGRDTRGIFRVHQFEKIEQFVYSSPHDNKSWEMFEEMITTAEEFYQSLGIPYHIVNIVSGSLNHAASKKLDLEAWFPGSGAFRELVSCSNCTDYQARRLRIRYGQTKKMMDKVEFVHMLNATMCATTRTICAILENYQTEKGITVPEKLKEFMPPGLQELIPFVKPAPIEQEPSKKQKKQHEGSKKKAAARDVTLENRLQNMEVTDALEHHHHHH","Homo sapiens","SARS, SERS, SARS1","Seryl-tRNA synthetase, cytoplasmic","1","3VBB"
"3VBD",,"X-RAY DIFFRACTION",2.06,40.37,"VAPOR DIFFUSION, HANGING DROP",7.5,"3 M ammonium sulfate, 50 mM Tris-HCl, 2 mM 4-(Hydroxymercuri)benzoate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1021/jm300112w","0FZ","3VBD",30.37,"1.05","1.05","Complex of human carbonic anhydrase II with 4-(6-methoxy-3,4-dihydroisoquinolin-1-yl)benzenesulfonamide","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","3VBD"
"3VBG",,"X-RAY DIFFRACTION",4.98,75.32,"VAPOR DIFFUSION, HANGING DROP",6.5,"54% saturated ammonium sulfate, 0.1M Tris, 5% PEG 550 mme, VAPOR DIFFUSION, HANGING DROP, temperature 277K, pH 6.5",277,"10.1073/pnas.1203789109","03M","3VBG",41.85,"2.8","2.8","Structure of hDM2 with Dimer Inducing Indolyl Hydantoin RO-2443","ETLVRPKPELLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVV","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","3VBG"
"3VBQ",,"X-RAY DIFFRACTION",3.24,62.08,"VAPOR DIFFUSION, SITTING DROP",6.4,"0.1M Imidazole, 1M Sodium acetate , pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm2014698","0F5","3VBQ",34.88,"1.85","1.85","Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in Pim-1 kinase needle screening and inhibitor design","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKAAALEHHHHHHHH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","3VBQ"
"3VBT",,"X-RAY DIFFRACTION",3.19,61.44,"VAPOR DIFFUSION, SITTING DROP",6.4,"0.1M Imidazole 
1M Sodium Acetate, pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm2014698","0F9","3VBT",34.68,"2.23","2.23","Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in Pim-1 kinase needle screening and inhibitor design","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKAAALEHHHHHHHH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","3VBT"
"3VBV",,"X-RAY DIFFRACTION",3.19,61.44,"VAPOR DIFFUSION, SITTING DROP",6.4,"0.1M Imidazole 
1M Sodium Acetate, pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm2014698","0FK","3VBV",34.67,"2.08","2.08","Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in Pim-1 kinase needle screening and inhibitor design","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKAAALEHHHHHHHH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","3VBV"
"3VBW",,"X-RAY DIFFRACTION",3.19,61.44,"VAPOR DIFFUSION, SITTING DROP",6.4,"0.1M Imidazole, 1M Na Acetate, pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm2014698","0FN","3VBW",34.65,"2.48","2.48","Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in Pim-1 kinase needle screening and inhibitor design","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKAAALEHHHHHHHH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","3VBW"
"3VBX",,"X-RAY DIFFRACTION",3.19,61.44,,,,,"10.1021/jm2014698","0FO","3VBX",34.72,"2.03","2.03","Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in Pim-1 kinase needle screening and inhibitor design","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKAAALEHHHHHHHH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","3VBX"
"3VBY",,"X-RAY DIFFRACTION",3.19,61.44,,,,,"10.1021/jm2014698","0FR","3VBY",34.83,"2.27","2.27","Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in Pim-1 kinase needle screening and inhibitor design","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKAAALEHHHHHHHH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","3VBY"
"3VC4",,"X-RAY DIFFRACTION",3.29,62.62,"VAPOR DIFFUSION, SITTING DROP",6.4,"0.1M Imidazole 
1M Na Acetate, pH 6.4, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/jm2014698","0FS","3VC4",34.89,"2.23","2.23","Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in Pim-1 kinase needle screening and inhibitor design","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKAAALEHHHHHHHH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","3VC4"
"3VCM",,"X-RAY DIFFRACTION",3.86,68.15,"VAPOR DIFFUSION, SITTING DROP",7,"1.5 M sodium malonate, 0.1 M Bis-Tris-propane, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.jmb.2012.05.003",,"3VCM",83.89,"2.93","2.93","Crystal structure of human prorenin","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","prorenin","1","3VCM"
,,,,,,,,,,,,,,,,"LPTDTTTFKRIFLKRMPSIRESLKERGVDMARLGPEWSQPMKR","Homo sapiens","REN","prorenin","2","3VCM"
"3VD0",,"X-RAY DIFFRACTION",2.39,48.53,,6.1,"0.1M MES, 0.1M Na acetate, pH 6.1, temperature 298.0K",298,"10.1073/pnas.1115463109",,"3VD0",220.04,"2.95","2.95","structure of p73 DNA binding domain tetramer modulates p73 transactivation","MGHHHHHHHHEFIPSNTDYPGPHHFEVTFQQSSTAKSATWTYSPLLKKLYCQIAKTCPIQIKVSTPPPPGTAIRAMPVYKKAEHVTDVVKRCPNHELGRDFNEGQSAPASHLIRVEGNNLSQYVDDPVTGRQSVVVPYEPPQVGTEFTTILYNFMCNSSCVGGMNRRPILIIITLEMRDGQVLGRRSFEGRICACPGRDRKADEDHYREQ","Homo sapiens","TP73, P73","Tumor protein p73","1","3VD0"
,,,,,,,,,,,,,,,,"CAGGCATGCCTG",,,"DNA (5'-D(*CP*AP*GP*GP*CP*AP*TP*GP*CP*CP*TP*G)-3')","2","3VD0"
"3VD1",,"X-RAY DIFFRACTION",2.4,48.71,,6.1,"0.1M MES, 0.1M Na acetate, pH 6.1, temperature 298.0K",298,"10.1073/pnas.1115463109",,"3VD1",220.05,"2.95","2.95","structure of p73 DNA binding domain tetramer modulates p73 transactivation","MGHHHHHHHHEFIPSNTDYPGPHHFEVTFQQSSTAKSATWTYSPLLKKLYCQIAKTCPIQIKVSTPPPPGTAIRAMPVYKKAEHVTDVVKRCPNHELGRDFNEGQSAPASHLIRVEGNNLSQYVDDPVTGRQSVVVPYEPPQVGTEFTTILYNFMCNSSCVGGMNRRPILIIITLEMRDGQVLGRRSFEGRICACPGRDRKADEDHYREQ","Homo sapiens","TP73, P73","Tumor protein p73","1","3VD1"
,,,,,,,,,,,,,,,,"CGGGCATGCCCG",,,"DNA (5'-D(*CP*GP*GP*GP*CP*AP*TP*GP*CP*CP*CP*G)-3')","2","3VD1"
"3VD2",,"X-RAY DIFFRACTION",2.95,58.26,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Bis-tris, 0.1M Ammonium acetate, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K, pH 6.5",298,"10.1073/pnas.1115463109",,"3VD2",168.73,"4","4","structure of p73 DNA binding domain tetramer modulates p73 transactivation","MGHHHHHHHHEFIPSNTDYPGPHHFEVTFQQSSTAKSATWTYSPLLKKLYCQIAKTCPIQIKVSTPPPPGTAIRAMPVYKKAEHVTDVVKRCPNHELGRDFNEGQSAPASHLIRVEGNNLSQYVDDPVTGRQSVVVPYEPPQVGTEFTTILYNFMCNSSCVGGMNRRPILIIITLEMRDGQVLGRRSFEGRICACPGRDRKADEDHYREQ","Homo sapiens","TP73, P73","Tumor protein p73","1","3VD2"
,,,,,,,,,,,,,,,,"ATGGACATGTCCAT",,,"DNA (5'-D(*AP*TP*GP*GP*AP*CP*AP*TP*GP*TP*CP*CP*AP*T)-3')","2","3VD2"
"3VEU",,"X-RAY DIFFRACTION",2.07,40.63,"VAPOR DIFFUSION, HANGING DROP",6,"15% PEG 1,500, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 292K",292,"10.1021/jm300069y","0GO","3VEU",45.33,"1.52","1.52","Crystal Structure of Human Beta Secretase in Complex with NVP-AVI326","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3VEU"
"3VEV",,"X-RAY DIFFRACTION",2.24,45.17,"VAPOR DIFFUSION, HANGING DROP",7,"Protein was in 25 mM HEPES pH 7.0, 0.5 mM TCEP, 0.05 M NaCl, 40 mM glucose at 20 mg/mL and 1 mM a GKA.  Crystallization drops in a 1:1 ratio were set up over wells containing 0.1 M Tris HCl, pH 7.0, 80-200 mM glucose, and 19-26% PEG-4000, VAPOR DIFFUSION, HANGING DROP",,"10.1074/jbc.M111.274126",,"3VEV",53.59,"1.8","1.8","Glucokinase in complex with an activator and glucose","MGHHHHHHENLYFQGMKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ","Homo sapiens","GCK","Glucokinase","1","3VEV"
"3VEY",,"X-RAY DIFFRACTION",2.97,58.52,"VAPOR DIFFUSION, HANGING DROP",7,"Protein at 10 mg/ml in 25 mM 
HEPES pH 7.0, 0.5 mM TCEP, 0.05 M NaCl, 40 mM glucose and 1 mM activator at an 1:1 ratio with well solution of 0.2 M ammonium acetate, 0.1 M 
Bis-Tris pH 6.5, and 19-26% PEG-4000.  1mM ATPgS*Mg was soaked overnight in reformed crystal., VAPOR DIFFUSION, HANGING DROP",,"10.1074/jbc.M111.274126",,"3VEY",51.99,"2.25","2.25","glucokinase in complex with glucose and ATPgS","MALTLVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ","Homo sapiens","GCK","Glucokinase","1","3VEY"
"3VF3",,"X-RAY DIFFRACTION",2.13,42.31,"VAPOR DIFFUSION, HANGING DROP",5.5,"15% PEG 1,500, in water, pH 5.5, vapor diffusion, hanging drop, temperature 292K",292,"10.1021/jm300069y","0GS","3VF3",45.3,"1.48","1.48","Crystal Structure of Human Beta Secretase in Complex with NVP-BQQ711","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3VF3"
"3VF6",,"X-RAY DIFFRACTION",2.24,45.06,"VAPOR DIFFUSION, HANGING DROP",7,"20mg/ml protein in 25 mM HEPES pH 7.0, 0.5 mM TCEP, 0.05 M NaCl, 40 mM glucose, 1 mM of activator,  Crystallization drops in a 1:1 ratio were set up over wells containing 0.1 M Tris HCl, pH 7.0, 80-200 mM 
glucose, and 19-26% PEG-4000, VAPOR DIFFUSION, HANGING DROP",,"10.1074/jbc.M111.274126","0H6","3VF6",53.6,"1.86","1.86","Glucokinase in complex with glucose and activator","MGHHHHHHENLYFQGMKKEKVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ","Homo sapiens","GCK","Glucokinase","1","3VF6"
"3VF8",,"X-RAY DIFFRACTION",2.17,43.35,"VAPOR DIFFUSION",4.7,"20% PEG3350, 0.1 M Na-citrate, 0.175 M K-phosphate, pH 4.7, VAPOR DIFFUSION, temperature 292K",292,"10.1016/j.bmcl.2012.03.016","0JE","3VF8",35.24,"2.08","2.08","Crystal Structure of Spleen Tyrosine Kinase Syk Catalytic Domain with Pyrazolylbenzimidazole Inhibitor 416","MDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","3VF8"
"3VF9",,"X-RAY DIFFRACTION",2.18,43.59,"VAPOR DIFFUSION",4.7,"19% PEG3350, 0.1 M Na-citrate, 0.175 M K-phosphate, pH 4.7, VAPOR DIFFUSION, temperature 292K",292,"10.1016/j.bmcl.2012.03.016","477","3VF9",35.26,"2.3","2.3","Crystal Structure of Spleen Tyrosine Kinase Syk Catalytic Domain with Thienopyrazolylindole Inhibitor 027","MDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","3VF9"
"3VFD",,"X-RAY DIFFRACTION",2.35,47.72,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.6M (NH3)2SO4, 0.1M MES monohydrate (pH 6.5),10% 1,4-dioxane and 4% benzamidine HCl, 1mM ATP, VAPOR DIFFUSION, HANGING DROP, temperature 296K",296,"10.1016/j.jsb.2012.03.002",,"3VFD",42.67,"3.301","3.301","Human spastin AAA domain","ESGAVPKRKDPLTHTSNSLPRSKTVMKTGSAGLSGHHRAPSYSGLSMVSGVKQGSGPAPTTHKGTPKTNRTNKPSTPTTATRKKKDLKNFRNVDSNLANLIMNEIVDNGTAVKFDDIAGQDLAKQALQEIVILPSLRPELFTGLRAPARGLLLFGPPGNGKTMLAKAVAAESNATFFNISAASLTSKYVGEGEKLVRALFAVARELQPSIIFIDQVDSLLCERREGEHDASRRLKTEFLIEFDGVQSAGDDRVLVMGATNRPQELDEAVLRRFIKRVYVSLPNEETRLLLLKNLLCKQGSPLTQKELAQLARMTDGYSGSDLTALAKDAALGPIRELKPEQVKNMSASEMRNIRLSDFTESLKKIKRSVSPQTLEAYIRWNKDFGDTTV","Homo sapiens","ADPSP, FSP2, KIAA1083, SPAST, SPG4","Spastin","1","3VFD"
"3VFE",,"X-RAY DIFFRACTION",2.32,46.94,"hanging drop",8.5,"0.20 M trimethylamine N-oxide, 0.1 M Tris-HCl pH8.5, 20% PEG MME 2000 and 10 mM benzamidine, hanging drop, temperature 291K",291,"10.1016/j.bmcl.2012.02.014",,"3VFE",24.97,"1.88","1.88","Virtual Screening and X-Ray Crystallography for Human Kallikrein 6 Inhibitors with an Amidinothiophene P1 Group","LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHCKKPNLQVFLGKHNLGQQESSQEQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLERDCSAQTTSCHILGWGKTADGDFPDTIQCAYIHLVSREECEHAYPGQITQNMLCAGDEKYGKDSCQGDSGGPLVCGDHLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQAK","Homo sapiens","KLK6, PRSS18, PRSS9","Kallikrein-6","1","3VFE"
"3VFQ",,"X-RAY DIFFRACTION",2.26,45.47,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3350, 0.2M SODIUM-THIOCYANATE, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.str.2012.12.019","AR6","3VFQ",45.27,"2.8","2.8","Human PARP14 (ARTD8, BAL2) - macro domains 1 and 2 in complex with adenosine-5-diphosphoribose","SMGGSPAGQKCFSRTVLAPGVVLIVQQGDLARLPVDVVVNASNEDLKHYGGLAAALSKAAGPELQADCDQIVKREGRLLPGNATISKAGKLPYHHVIHAVGPRWSGYEAPRCVYLLRRAVQLSLCLAEKYKYRSIAIPAISSGVFGFPLGRCVETIVSAIKENFQFKKDGHCLKEIYLVDVSEKTVEAFAEAVKTVFKATLPDTAAPPGLPPAAAGPGKTSWEKGSLVSPGGLQMLLVKEGVQNAKTDVVVNSVPLDLVLSRGPLSKSLLEKAGPELQEELDTVGQGVAVSMGTVLKTSSWNLDCRYVLHVVAPEWRNGSTSSLKIMEDIIRECMEITESLSLKSIAFPAIGTGNLGFPKNIFAELIISEVFKFSSKNQLKTLQEVHFLLHPSDHENIQAFSDEFARRANGNLVS","Homo sapiens","BAL2, KIAA1268, PARP14","Poly [ADP-ribose] polymerase 14","1","3VFQ"
"3VG1",,"X-RAY DIFFRACTION",2.05,40.13,"VAPOR DIFFUSION, HANGING DROP",5.2,"15% PEG 1,500, in water, pH 5.2, vapor diffusion, hanging drop, temperature 292K",292,"10.1021/jm300069y","0GT","3VG1",45.28,"1.77","1.77","Crystal Structure of Human Beta Secretase in Complex with NVP-BUR436, derived from a soaking experiment","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE, BACE1, KIAA1149","Beta-secretase 1","1","3VG1"
"3VG2",,"X-RAY DIFFRACTION",2.15,42.7,"hanging drop",8,"30% PEG MME 2000, 0.15M KBr, pH 8.0, hanging drop, temperature 293K",293,"10.1007/s10969-012-9137-3",,"3VG2",15.75,"2.4","2.4","Iodide derivative of human LFABP","MAGSSFSGKYQLQSQENFEAFMKAIGLPEELIQKGKDIKGVSEIVQNGKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTMTLGDIVFKRISKRIGT","Homo sapiens","FABP1, FABPL","Fatty acid-binding protein, liver","1","3VG2"
"3VG3",,"X-RAY DIFFRACTION",2.16,43.15,"hanging drop",8,"30% PEG MME 2000, 0.15M KBr, pH 8.0, hanging drop, temperature 293K",293,"10.1007/s10969-012-9137-3",,"3VG3",15.34,"2.22","2.22","Cadmium derivative of human LFABP","MAGSSFSGKYQLQSQENFEAFMKAIGLPEELIQKGKDIKGVSEIVQNGKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTMTLGDIVFKRISKRIGT","Homo sapiens","FABP1, FABPL","Fatty acid-binding protein, liver","1","3VG3"
"3VG4",,"X-RAY DIFFRACTION",2.15,42.81,"hanging drop",8,"30% PEG MME 2000, 0.15M KBr, pH 8.0, hanging drop, temperature 293K",293,"10.1007/s10969-012-9137-3",,"3VG4",15.34,"2.5","2.5","Cadmium derivative of human LFABP","MAGSSFSGKYQLQSQENFEAFMKAIGLPEELIQKGKDIKGVSEIVQNGKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTMTLGDIVFKRISKRIGT","Homo sapiens","FABP1, FABPL","Fatty acid-binding protein, liver","1","3VG4"
"3VG5",,"X-RAY DIFFRACTION",2.2,43.99,"hanging drop",8,"30% PEG MME 2000, 0.15M KBr, pH 8.0, hanging drop, temperature 293K",293,"10.1007/s10969-012-9137-3",,"3VG5",15.39,"2","2","Barium derivative of human LFABP","MAGSSFSGKYQLQSQENFEAFMKAIGLPEELIQKGKDIKGVSEIVQNGKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTMTLGDIVFKRISKRIGT","Homo sapiens","FABP1, FABPL","Fatty acid-binding protein, liver","1","3VG5"
"3VG6",,"X-RAY DIFFRACTION",2.21,44.25,"hanging drop",8,"30% PEG MME 2000, 0.15M KBr, pH 8.0, hanging drop, temperature 293K",293,"10.1007/s10969-012-9137-3",,"3VG6",15.89,"2.22","2.22","Barium derivative of human LFABP","MAGSSFSGKYQLQSQENFEAFMKAIGLPEELIQKGKDIKGVSEIVQNGKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTMTLGDIVFKRISKRIGT","Homo sapiens","FABP1, FABPL","Fatty acid-binding protein, liver","1","3VG6"
"3VG7",,"X-RAY DIFFRACTION",1.94,44.22,"hanging drop",8,"30% PEG MME 2000, 0.15M KBr, pH 8.0, hanging drop, temperature 293K",293,"10.1007/s10969-012-9137-3",,"3VG7",15.11,"1.44","1.44","Structure of human LFABP at high resolution from S-SAD","MAGSSFSGKYQLQSQENFEAFMKAIGLPEELIQKGKDIKGVSEIVQNGKHFKFTITAGSKVIQNEFTVGEECELETMTGEKVKTVVQLEGDNKLVTTFKNIKSVTELNGDIITNTMTLGDIVFKRISKRIGT","Homo sapiens","FABP1, FABPL","Fatty acid-binding protein, liver","1","3VG7"
"3VGO",,"X-RAY DIFFRACTION",2.17,43.27,"VAPOR DIFFUSION, SITTING DROP",8.4,"25% PEG 3350, 0.1M bicine, 0.8M KNO3, pH 8.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1073/pnas.1110712108",,"3VGO",136.91,"3.1","3.1","Crystal structure of the N-terminal fragment of Cbl-b","GPHMGSAAADRRTVEKTWKLMDKVVRLCQNPKLQLKNSPPYILDILPDTYQHLRLILSKYDDNQKLAQLSENEYFKIYIDSLMKKSKRAIRLFKEGKERMYEEQSQDRRNLTKLSLIFSHMLAEIKAIFPNGQFQGDNFRITKADAAEFWRKFFGDKTIVPWKVFRQCLHEVHQISSGLEAMALKSTIDLTCNDYISVFEFDIFTRLFQPWGSILRNWNFLAVTHPGYMAFLTYDEVKARLQKYSTKPGSYIFRLSCTRLGQWAIGYVTGDGNILQTIPHNKPLFQALIDGSREGFYLYPDGRSYNPDLTGLCEPTPHDHIKVTQEQYELYCEMGSTFQLCKICAENDKDVKIEPCGHLMCTSCLTAWQESDGQGCPFCRCEIKGTEPIIVDPF","Homo sapiens","CBLB, RNF56, Nbla00127","E3 ubiquitin-protein ligase CBL-B","1","3VGO"
"3VHA",,"X-RAY DIFFRACTION",2.2,44,"VAPOR DIFFUSION, HANGING DROP",6,"32%(w/v) PEG 3350, 0.3M KCl, 0.1M Na-MES, pH 6.0, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2011.11.100","VHA","3VHA",26.36,"1.39","1.39","Hsp90 alpha N-terminal domain in complex with a macrocyclic inhibitor","MDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3VHA"
"3VHC",,"X-RAY DIFFRACTION",2.2,44,"VAPOR DIFFUSION, HANGING DROP",8.5,"33%(w/v) PEG 2000 MME, 0.1M MgCl2, 0.1M Tris-Cl, pH 8.5, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2011.11.100","VHC","3VHC",26.22,"1.41","1.41","Hsp90 alpha N-terminal domain in complex with a macrocyclic inhibitor","MDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3VHC"
"3VHD",,"X-RAY DIFFRACTION",2.1,40.4,"VAPOR DIFFUSION, HANGING DROP",6.5,"31%(w/v) PEG 5000 MME, 0.2M MgCl2, 5%(v/v) Glycerol, 0.1M Na-MES, pH 6.5, vapor diffusion, hanging drop, temperature 277K",277,"10.1016/j.bmcl.2011.11.100","VHE","3VHD",52.35,"1.52","1.52","Hsp90 alpha N-terminal domain in complex with a macrocyclic inhibitor, CH5164840","MDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3VHD"
"3VHE",,"X-RAY DIFFRACTION",2.4,48.73,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.3M tri-sodium citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.bmc.2010.08.017","42Q","3VHE",41.29,"1.55","1.55","Crystal structure of human VEGFR2 kinase domain with a novel pyrrolopyrimidine inhibitor.","LPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ","Homo sapiens","FLK1, KDR, VEGFR2","Vascular endothelial growth factor receptor 2","1","3VHE"
"3VHK",,"X-RAY DIFFRACTION",2.36,47.91,"VAPOR DIFFUSION, SITTING DROP",7,"100mM HEPES, 880-1440mM tri-sodium citrate, pH 7.0-8.0, vapor diffusion, sitting drop, temperature 293K",293,"10.1021/ml3000403","BPK","3VHK",42.16,"2.49","2.49","Crystal structure of the VEGFR2 kinase domain in complex with a back pocket binder","GAMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD","Homo sapiens","KDR, FLK1, VEGFR2","Vascular endothelial growth factor receptor 2","1","3VHK"
"3VHS",,"X-RAY DIFFRACTION",1.79,31.25,"VAPOR DIFFUSION, SITTING DROP",7.5,"28% PEG 400, 0.1M HEPES, 0.2M calcium chrolide, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293.0K",293,"10.1111/febs.13734",,"3VHS",6.66,"1.9","1.9","Crystal structure of UBZ of human WRNIP1","GSPEFQVQCPVCQQMMPAAHINSHLDRCL","Homo sapiens","WRNIP1, WHIP","ATPase WRNIP1","1","3VHS"
"3VHU",,"X-RAY DIFFRACTION",2.44,49.67,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M HEPES pH 7.0, 1.26M Lithium sulfate, 6% PEG MME 2000, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm2011645","SNL","3VHU",34.42,"2.11","2.11","Mineralocorticoid receptor ligand-binding domain with spironolactone","MGSDKIIHHHHHHENLYFQGSAPAKEPSVNTALVPQLSTISRALTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPGFKNLPLEDQITLIQYSWMSLLSFALSWRSYKHTNSQFLYFAPDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMRTNYIKELRKMVTKCPNNSGQSWQRFYQLTKLLDSMHDLVSDLLEFCFYTFRESHALKVEFPAMLVEIISDQLPKVESGNAKPLYFHRK","Homo sapiens","NR3C2, MCR, MLR","Mineralocorticoid receptor","1","3VHU"
"3VHV",,"X-RAY DIFFRACTION",2.83,56.58,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.1M HEPES pH 7.4, 0.88M potassium/sodium tartrate, 5% ethylene glycol, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm2011645","LD1","3VHV",31.05,"1.35","1.35","Mineralocorticoid receptor ligand-binding domain with non-steroidal antagonist","GSLSTISRALTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPGFKNLPLEDQITLIQYSWMSLLSFALSWRSYKHTNSQFLYFAPDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMRTNYIKELRKMVTKCPNNSGQSWQRFYQLTKLLDSMHDLVSDLLEFCFYTFRESHALKVEFPAMLVEIISDQLPKVESGNVKPLYFHRK","Homo sapiens","NR3C2, MCR, MLR","Mineralocorticoid receptor","1","3VHV"
"3VHW",,"X-RAY DIFFRACTION",2.55,51.74,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M MES, 1.2-1.6M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jsbmb.2013.02.004",,"3VHW",30.38,"2.43","2.43","Crystal structure of the human vitamin D receptor ligand binding domain complexed with 4-MP","GSHMDSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEIS","Homo sapiens","VDR","Vitamin D3 receptor","1","3VHW"
,,,,,,,,,,,,,,,,,"Homo sapiens","VDR"
"3VI5",,"X-RAY DIFFRACTION",2.28,45.96,"VAPOR DIFFUSION, HANGING DROP",8.4,"PEG 4000, Tris-HCl, DTT, GSH, 1,4-dioxane, pH 8.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1093/jb/mvs024","M4M","3VI5",94.76,"2","2","Human hematopoietic prostaglandin D synthase inhibitor complex structures","PNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELLTYNAPHLMQDLDTYLGGREWLIGMSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKKVQAIPAVANWIKRRPQTKL","Homo sapiens","HPGDS, GSTS, PGDS, PTGDS2","Hematopoietic prostaglandin D synthase","1","3VI5"
"3VI6",,"X-RAY DIFFRACTION",2.23,44.84,"VAPOR DIFFUSION, SITTING DROP",8,"0.3M potassium chrolide, 1mM EDTA, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S1744309111045131",,"3VI6",13.96,"1.59","1.59","Crystal Structure of human ribosomal protein L30e","GMVAAKKTKKSLESINSRLQLVMKSGKYVLGYKQTLKMIRQGKAKLVILANNCPALRKSEIEYYAMLAKTGVHHYSGNNIELGTACGKYYRVCTLAIIDPGDSDIIRSMPEQTGEKGAPHHHHHH","Homo sapiens","RPL30","60S ribosomal protein L30","1","3VI6"
"3VI7",,"X-RAY DIFFRACTION",2.29,46.28,"VAPOR DIFFUSION, HANGING DROP",8.4,"PEG6000, Tris-HCl, CaCl2, GSH, DTT, 1,4-dioxane,, pH 8.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1093/jb/mvs024","CBD","3VI7",95.88,"2","2","Human hematopoietic prostaglandin D synthase inhibitor complex structures","PNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELLTYNAPHLMQDLDTYLGGREWLIGMSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKKVQAIPAVANWIKRRPQTKL","Homo sapiens","HPGDS, GSTS, PGDS, PTGDS2","Hematopoietic prostaglandin D synthase","1","3VI7"
"3VI8",,"X-RAY DIFFRACTION",2.24,45.14,"VAPOR DIFFUSION, HANGING DROP",7.5,"25% PEG3350, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm2014293","13M","3VI8",31.32,"1.75","1.75","Human PPAR alpha ligand binding domain in complex with a synthetic agonist APHM13","GSHMTADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","Peroxisome proliferator-activated receptor alpha","1","3VI8"
"3VIA",,"X-RAY DIFFRACTION",1.98,37.95,"VAPOR DIFFUSION, SITTING DROP",6.5,"20% PEG MME 5000, 0.1M bis-tris-HCl, 13% ethylene glycol, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 289K",289,"10.1107/S0907444911051626",,"3VIA",26.19,"1.75","1.75","Crystal structure of the PH domain of Evectin-2 from human","GSMAFVKSGWLLRQSTILKRWKKNWFDLWSDGHLIYYDDQTRQNIEDKVHMPMDCINIRTGQECRDTQPPDGKSKDCMLQIVCRDGKTISLCAESTDDCLAWKFTLQDSRTN","Homo sapiens","PLEKHB2, EVT2","Pleckstrin homology domain-containing family B member 2","1","3VIA"
"3VID",,"X-RAY DIFFRACTION",2.15,42.84,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.3M TRI-SODIUM CITRATE, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/ml3000403","4TT","3VID",40.73,"2.3","2.3","Crystal structure of human VEGFR2 kinase domain with Compound A.","LDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA","Homo sapiens","KDR, FLK1, VEGFR2","Vascular endothelial growth factor receptor 2","1","3VID"
"3VJ8",,"X-RAY DIFFRACTION",2.35,47.6,"VAPOR DIFFUSION, HANGING DROP",8.5,"20% PEG 2000 MME, 0.01M NiCl2, 0.1M Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M112.351254",,"3VJ8",39.45,"1.52","1.52","Crystal structure of the human squalene synthase","GSHMDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFAKPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKGAVKIRKGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSDPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3VJ8"
"3VJ9",,"X-RAY DIFFRACTION",2.08,40.73,"VAPOR DIFFUSION, HANGING DROP",8.5,"20% PEG 2000 MME, 0.01M NiCl2, 0.1M Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M112.351254",,"3VJ9",39.55,"1.52","1.52","Crystal structure of the human squalene synthase","GSHMDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFAKPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKGAVKIRKGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSDPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3VJ9"
"3VJA",,"X-RAY DIFFRACTION",2.09,41.25,"VAPOR DIFFUSION, HANGING DROP",8.5,"20% PEG 2000 MME, 0.01M NiCl2, 0.1M Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M112.351254",,"3VJA",79.02,"1.76","1.76","Crystal structure of the human squalene synthase","GSHMDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFAKPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKGAVKIRKGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSDPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3VJA"
"3VJB",,"X-RAY DIFFRACTION",2.55,51.68,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.4M sodium citrate tribasic dihydrate, 0.1M HEPES sodium, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M112.351254",,"3VJB",236.69,"2.05","2.05","Crystal structure of the human squalene synthase","GSHMDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFAKPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKGAVKIRKGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSDPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3VJB"
"3VJC",,"X-RAY DIFFRACTION",2.55,51.78,"VAPOR DIFFUSION, HANGING DROP",6.5,"2% PEG 400, 2M K2HPO4/NaH2PO4, 0.5mM zaragozic acid A, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M112.351254","ZGA","3VJC",241.46,"1.89","1.89","Crystal structure of the human squalene synthase in complex with zaragozic acid A","GSHMDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFAKPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKGAVKIRKGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSDPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3VJC"
"3VJH",,"X-RAY DIFFRACTION",2.48,50.41,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.8M Sodium citrate, 0.1M HEPES (pH7.5), VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1021/jm2014293",,"3VJH",65.48,"2.22","2.22","Human PPAR GAMMA ligand binding domain in complex with JKPL35","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3VJH"
"3VJI",,"X-RAY DIFFRACTION",2.5,50.85,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.8M Sodium Citrate, 0.1M HEPES (pH7.5), VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm2014293",,"3VJI",65.58,"2.61","2.61","Human PPAR gamma ligand binding domain in complex with JKPL53","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3VJI"
"3VJK",,"X-RAY DIFFRACTION",3,58.94,"VAPOR DIFFUSION, SITTING DROP",8.8,"20% PEG 4000, 0.18M sodium acetate, 0.18M glycine-sodium hydroxide , pH 8.8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmc.2012.08.012","M51","3VJK",176.28,"2.49","2.49","Crystal structure of human depiptidyl peptidase IV (DPP-4) in complex with MP-513","DDATADSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLPHHHHHH","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","3VJK"
"3VJL",,"X-RAY DIFFRACTION",2.96,58.43,"VAPOR DIFFUSION, SITTING DROP",8.8,"20% PEG 4000, 0.18M sodium acetate, 0.18M  glycine-sodium hydroxide, pH 8.8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmc.2012.08.012","W94","3VJL",176.17,"2.393","2.393","Crystal structure of human depiptidyl peptidase IV (DPP-4) in complex with a prolylthiazolidine inhibitor #2","DDATADSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLPHHHHHH","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","3VJL"
"3VJM",,"X-RAY DIFFRACTION",2.97,58.54,"VAPOR DIFFUSION, SITTING DROP",8.8,"20% PEG 4000, 0.18M sodium acetate, 0.18M  glycine-sodium hydroxide, pH 8.8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmc.2012.06.033","W61","3VJM",176.36,"2.1","2.1","Crystal structure of human depiptidyl peptidase IV (DPP-4) in complex with a prolylthiazolidine inhibitor #1","DDATADSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLPHHHHHH","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","3VJM"
"3VJN",,"X-RAY DIFFRACTION",3.27,62.35,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M Tris-HCl(pH 7.0), 0.2M NaCl, 1M Sodium citrate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/onc.2012.21",,"3VJN",38.54,"2.34","2.34","Crystal structure of the mutated EGFR kinase domain (G719S/T790M) in complex with AMPPNP.","GAMGIRSGEAPNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB1, ERBB, HER1","Epidermal growth factor receptor","1","3VJN"
"3VJO",,"X-RAY DIFFRACTION",3.23,61.95,"VAPOR DIFFUSION, SITTING DROP",7,"0.1M Tris-HCl(pH 7.0), 0.2M NaCl, 1M Sodium citrate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/onc.2012.21",,"3VJO",38.48,"2.64","2.64","Crystal structure of the wild-type EGFR kinase domain in complex with AMPPNP.","GAMGIRSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB1, ERBB, HER1","Epidermal growth factor receptor","1","3VJO"
"3VKE",,"X-RAY DIFFRACTION",2.35,47.77,"VAPOR DIFFUSION, HANGING DROP",4.2,"0.1M phosphate-citrate, 40%(v/v) PEG 300, pH 4.2, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1093/nar/gks058",,"3VKE",40.8,"1.77","1.77","Contribution of the first K-homology domain of poly(C)-binding protein 1 to its affinity and specificity for C-rich oligonucleotides","HMLTIRLLMHGKEVGSIIGKKGESVKRIREESGARINISEGNSPERIITLTGPTNAIFKAFAMIIDKLEEDINSSW","Homo sapiens","PCBP1","Poly(rC)-binding protein 1","1","3VKE"
,,,,,,,,,,,,,,,,"ACCCCA",,,"DNA (5'-D(P*AP*CP*CP*CP*CP*A)-3')","2","3VKE"
"3VKK",,"X-RAY DIFFRACTION",2.32,47,"VAPOR DIFFUSION, HANGING DROP",8.5,"27.5% PEG3350, 0.2M MgCl2, 0.1M Tris-HCl, 15% glycerol, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293.4K",293.4,,,"3VKK",54.84,"2","2","Crystal Structure Of The Covalent Intermediate Of Human Cytosolic Beta-Glucosidase-mannose complex","MAFPAGFGWAAATAAYQVEGGWDADGKGPCVWDTFTHQGGERVFKNQTGDVACGSYTLWEEDLKCIKQLGLTHYRFSLSWSRLLPDGTTGFINQKGIDYYNKIIDDLLKNGVTPIVTLYHFDLPQTLEDQGGWLSEAIIESFDKYAQFCFSTFGDRVKQWITINQANVLSVMSYDLGMFPPGIPHFGTGGYQAAHNLIKAHARSWHSYDSLFRKKQKGMVSLSLFAVWLEPADPNSVSDQEAAKRAITFHLDLFAKPIFIDGDYPEVVKSQIASMSQKQGYPSSRLPEFTEEEKKMIKGTADFFAVQYYTTRLIKYQENKKGELGILQDAEIEFFPDPSWKNVDWIYVVPWGVCKLLKYIKDTYNNPVIYITENGFPQSDPAPLDDTQRWEYFRQTFQELFKAIQLDKVNLQVYCAWSLLDNFEWNQGYSSRFGLFHVDFEDPARPRVPYTSAKEYAKIIRNNGLEAHL","Homo sapiens","GBA3, CBG, CBGL1","Cytosolic beta-glucosidase","1","3VKK"
"3VKL",,"X-RAY DIFFRACTION",2.48,50.43,"VAPOR DIFFUSION, HANGING DROP",9,"2-3%(v/v) 1,4-dioxane, 9-10%(w/v) PEG20000, 0.1M bicine, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1111/j.1742-4658.2012.08753.x",,"3VKL",68.83,"2.55","2.55","Protease-resistant mutant form of human Galectin-8 in complex with two lactose molecules","MMLSLNNLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSMKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSFSSHMRLPFAARLNTPMGPGRTVVVKGEVNANAKSFNVDLLAGKSKDIALHLNPRLNIKAFVRNSFLQESWGEEERNITSFPFSPGMYFEMIIYCDVREFKVAVNGVHSLEYKHRFKELSSIDTLEINGDIHLLEVRSW","Homo sapiens","LGALS8","Galectin-8","1","3VKL"
,,,,,,,,,,,,,,,,,"Homo sapiens","LGALS8"
"3VKM",,"X-RAY DIFFRACTION",2.96,58.39,"VAPOR DIFFUSION, HANGING DROP",9,"2-3%(v/v) 1,4-dioxane, 9-10%(w/v) PEG20000, 0.1M bicine, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1111/j.1742-4658.2012.08753.x",,"3VKM",69.66,"2.98","2.98","Protease-resistant mutant form of Human Galectin-8 in complex with sialyllactose and lactose","MMLSLNNLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSMKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSFSSHMRLPFAARLNTPMGPGRTVVVKGEVNANAKSFNVDLLAGKSKDIALHLNPRLNIKAFVRNSFLQESWGEEERNITSFPFSPGMYFEMIIYCDVREFKVAVNGVHSLEYKHRFKELSSIDTLEINGDIHLLEVRSW","Homo sapiens","LGALS8","Galectin-8","1","3VKM"
,,,,,,,,,,,,,,,,,"Homo sapiens","LGALS8"
"3VKN",,"X-RAY DIFFRACTION",1.99,38.08,"VAPOR DIFFUSION, SITTING DROP",9.5,"30%(v/v) PEG 400, 0.1M CHES, pH 9.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1111/j.1742-4658.2012.08753.x",,"3VKN",34.77,"1.98","1.98","Galectin-8 N-terminal domain in free form","MMLSLNNLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSMKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSF","Homo sapiens","LGALS8","Galectin-8","1","3VKN"
"3VKO",,"X-RAY DIFFRACTION",2.04,39.58,"VAPOR DIFFUSION, SITTING DROP",9.5,"30%(v/v) PEG400, 0.1M CHES, pH 9.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1111/j.1742-4658.2012.08753.x",,"3VKO",36.12,"2.08","2.08","Galectin-8 N-terminal domain in complex with sialyllactosamine","MMLSLNNLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSMKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSF","Homo sapiens","LGALS8","Galectin-8","1","3VKO"
"3VKX",,"X-RAY DIFFRACTION",4.24,71,,,,,"10.1074/jbc.M112.353201","T3","3VKX",30.06,"2.1","2.1","Structure of PCNA","MFEARLVQGSILKKVLEALKDLINEACWDISSSGVNLQSMDSSHVSLVQLTLRSEGFDTYRCDRNLAMGVNLTSMSKILKCAGNEDIITLRAEDNADTLALVFEAPNQEKVSDYEMKLMDLDVEQLGIPEQEYSCVVKMPSGEFARICRDLSHIGDAVVISCAKDGVKFSASGELGNGNIKLSQTSNVDKEEEAVTIEMNEPVQLTFALRYLNFFTKATPLSSTVTLSMSADVPLVVEYKIADMGHLKYYLAPKIEDEEGS","Homo sapiens","PCNA","Proliferating cell nuclear antigen","1","3VKX"
"3VLG",,"X-RAY DIFFRACTION",2.28,45.94,"VAPOR DIFFUSION, SITTING DROP",5,"20% PEG8000, 0.1M sodium citrate, 0.2M ammonium sulfate, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bbapap.2012.02.003",,"3VLG",16.32,"2.3","2.3","Crystal structure of the W150A mutant LOX-1 CTLD showing impaired OxLDL binding","GPHMTLKRVANCSAPCPQDWIAHGENCYLFSSGSFNWEKSQEKCLSLDAKLLKINSTADLDFIQQAISYSSFPFWMGLSRRNPSYPWLWEDGSPLMPHLFRVRGAVSQTYPSGTCAYIQRGAVYAENCILAAFSICQKKANLRAQ","Homo sapiens","OLR1, CLEC8A, LOX1","Oxidized low-density lipoprotein receptor 1","1","3VLG"
"3VLN",,"X-RAY DIFFRACTION",2.38,48.36,"VAPOR DIFFUSION, HANGING DROP",4.75,"2.2M ammonium sulfate, 0.1M sodium acetate pH 4.75, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.jmb.2012.04.014",,"3VLN",28.35,"1.7","1.7","Human Glutathione Transferase O1-1 C32S Mutant in Complex with Ascorbic Acid","MSGESARSLGKGSAPPGPVPEGSIRIYSMRFSPFAERTRLVLKAKGIRHEVININLKNKPEWFFKKNPFGLVPVLENSQGQLIYESAITCEYLDEAYPGKKLLPDDPYEKACQKMILELFSKVPSLVGSFIRSQNKEDYAGLKEEFRKEFTKLEEVLTNKKTTFFGGNSISMIDYLIWPWFERLEAMKLNECVDHTPKLKLWMAAMKEDPTVSALLTSEKDWQGFLELYLQNSPEACDYGL","Homo sapiens","GSTO1, GSTTLP28","Glutathione S-transferase omega-1","1","3VLN"
"3VM8",,"X-RAY DIFFRACTION",2.57,52.05,"VAPOR DIFFUSION, HANGING DROP",9,"Bicine, PEG 6000, L-Arginine HCl, pH 9.0, vapor diffusion, hanging drop, temperature 293K",293,,,"3VM8",45.83,"3","3","Crystal structure of the human APOBEC3C having HIV-1 Vif-binding interface","MNPQIRNPMKAMYPGTFYFQFKNLWEANDRNETWLCFTVEGIKRRSVVSWKTGVFRNQVDSETHCHAERCFLSWFCDDILSPNTKYQVTWYTSWSPCPDCAGEVAEFLARHSNVNLTIFTARLYYFQYPCYQEGLRSLSQEGVAVEIMDYEDFKYCWENFVYNDNEPFKPWKGLKTNFRLLKRRLRESLQ","Homo sapiens","APOBEC3C, APOBEC1L, PBI","Probable DNA dC->dU-editing enzyme APOBEC-3C","1","3VM8"
"3VN4",,"X-RAY DIFFRACTION",3.21,61.66,"VAPOR DIFFUSION, SITTING DROP",6,"20% PEG1500, 0.1M MES, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3VN4",46.49,"2.8","2.8","Crystal structure of the exosite-containing fragment of human ADAMTS13 (P475S mutant)","GRRPQPGSAGHPPDAQPGLYYSANEQCRVAFGPKAVACTFAREHLDMCQALSCHTDPLDQSSCSRLLVPLLDGTECGVEKWCSKGRCRSLVELTPIAAVHGRWSSWGPRSPCSRSCGGGVVTRRRQCNNPRPAFGGRACVGADLQAEMCNTQACEKTQLEFMSQQCARTDGQPLRSSPGGASFYHWGAAVSHSQGDALCRHMCRAIGESFIMKRGDSFLDGTRCMPSGPREDGTLSLCVSGSCRTFGCDGRMDSQQVWDRCQVCGGDNSTCSPRKGSFTAGRAREYVTFLTVTPNLTSVYIANHRPLFTHLAVRIGGRYVVAGKMSISPNTTYPSLLEDGRVEYRVALTEDRLPRLEEIRIWGPLQEDADIQVYRRYGEEYGNLTRPDITFTYFQPKPRQASRLENLYFQ","Homo sapiens","ADAMTS13, C9orf8, UNQ6102/PRO20085","A disintegrin and metalloproteinase with thrombospondin motifs 13","1","3VN4"
"3VN9",,"X-RAY DIFFRACTION",2.65,53.59,"VAPOR DIFFUSION, SITTING DROP",6,"20% PEG4000, 10% 2-propanol, 0.1mol/L Na-HEPES-HCl, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1093/jb/mvs023",,"3VN9",38.9,"2.6","2.6","Rifined Crystal structure of non-phosphorylated MAP2K6 in a putative auto-inhibition state","MSQSKGKKRNPGLKIPKEAFEQPQTSSTPPRDLDSKACISIGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDVASFVKLILGDHHHHHH","Homo sapiens","MAP2K6, MEK6, MKK6, PRKMK6, SKK3","Dual specificity mitogen-activated protein kinase kinase 6","1","3VN9"
"3VNG",,"X-RAY DIFFRACTION",1.96,37.31,"VAPOR DIFFUSION, HANGING DROP",7.5,"10% PEG 3350, 0.1M calcium acetate hydrate(pH 7.5), VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"3VNG",34.18,"2.1","2.1","Crystal Structure of Keap1 in Complex with Synthetic Small Molecular based on a co-crystallization","GSSHHHHHHSSGLVPRGSHMAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","3VNG"
"3VNH",,"X-RAY DIFFRACTION",2.27,45.78,"VAPOR DIFFUSION, HANGING DROP",7,"0.2M HEPES (pH 7.0), 10mM Magnesium chloride, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"3VNH",34.18,"2.1","2.1","Crystal Structure of Keap1 Soaked with Synthetic Small Molecular","GSSHHHHHHSSGLVPRGSHMAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","3VNH"
"3VNN",,"X-RAY DIFFRACTION",2.33,47.15,"VAPOR DIFFUSION, HANGING DROP",5.6,"7.5% PEG 6000, 100mM MES, 0.01mg/ml papain, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2012.04.012",,"3VNN",16.2,"2.903","2.903","Crystal Structure of a sub-domain of the nucleotidyltransferase (adenylation) domain of human DNA ligase IV","FYIETKLDGERMQMHKDGDVYKYFSRNGYNYTDQFGASPTEGSLTPFIHNAFKADIQICILDGEMMAYNPNTQTFMQKGTKFDIKRMVEDSDLQTCYCVFDVLMVNNKKLGHETLRKRYEILSSIFTPIPGRIEIVQKT","Homo sapiens","LIG4","DNA ligase 4","1","3VNN"
"3VNT",,"X-RAY DIFFRACTION",2.73,54.88,"VAPOR DIFFUSION, SITTING DROP",,"100mM HEPES, 880-1440mM tri-sodium citrate, pH 7.0-8.0, vapor diffusion, sitting drop, temperature 293K",293,"10.1021/jm300126x","0JA","3VNT",37.09,"1.64","1.64","Crystal Structure of the Kinase domain of Human VEGFR2 with a [1,3]thiazolo[5,4-b]pyridine derivative","GAMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD","Homo sapiens","KDR, FLK1, VEGFR2","Vascular endothelial growth factor receptor 2","1","3VNT"
"3VO3",,"X-RAY DIFFRACTION",2.64,53.49,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M trisHCl pH 8.5, 1.2M tri-sodium citrate, vapor diffusion, sitting drop, temperature 293K",293,"10.1016/j.bmc.2013.01.074","0KF","3VO3",36.85,"1.52","1.52","Crystal Structure of the Kinase domain of Human VEGFR2 with imidazo[1,2-b]pyridazine derivative","GAMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD","Homo sapiens","KDR, FLK1, VEGFR2","Vascular endothelial growth factor receptor 2","1","3VO3"
"3VOQ",,"X-RAY DIFFRACTION",3.44,64.26,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M Bis-Tris, 1.26M ammonium sulfate, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S1744309112007178",,"3VOQ",28.23,"2","2","Crystal structure of the pleckstrin homology domain of human Sin1, a TORC2 subunit","GAMATVQDMLSSHHYKSFKVSMIHRLRFTTDVQLGISGDKVEIDPVTNQKASTKFWIKQKPISIDSDLLCACDLAEEKSPSHAIFKLTYLSNHDYKHLYFESDAATVNEIVLKVNYILESRASTA","Homo sapiens","SIN1, MAPKAP1, MIP1","Target of rapamycin complex 2 subunit MAPKAP1","1","3VOQ"
"3VOW",,"X-RAY DIFFRACTION",2.44,49.61,"VAPOR DIFFUSION, HANGING DROP",9,"Bicine, PEG 6000, L-Arginine HCl, pH 9.0, vapor diffusion, hanging drop, temperature 293K",293,"10.1038/nsmb.2378",,"3VOW",45.87,"2.15","2.15","Crystal Structure of the Human APOBEC3C having HIV-1 Vif-binding Interface","MNPQIRNPMKAMYPGTFYFQFKNLWEANDRNETWLCFTVEGIKRRSVVSWKTGVFRNQVDSETHCHAERCFLSWFCDDILSPNTKYQVTWYTSWSPCPDCAGEVAEFLARHSNVNLTIFTARLYYFQYPCYQEGLRSLSQEGVAVEIMDYEDFKYCWENFVYNDNEPFKPWKGLKTNFRLLKRRLRESLQ","Homo sapiens","APOBEC3C, APOBEC1L, PBI","Probable DNA dC->dU-editing enzyme APOBEC-3C","1","3VOW"
"3VOY",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.4M Lithium sulfate, 100mM Bis-tris-propane pH 7.0, 5% DMSO, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.1116573109",,"3VOY",34.88,"2.2","2.2","Crystal structure of human glutaminase in apo form","SMIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNL","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","3VOY"
"3VOZ",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",7,"1.8M Lithium sulfate, 100mM Bis-tris-propane pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K",293,"10.1073/pnas.1116573109","04A","3VOZ",35.41,"2.4","2.4","Crystal structure of human glutaminase in complex with BPTES","SMIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNL","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","3VOZ"
"3VP0",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",7,"1.4M Lithium sulfate, 100mM Bis-tris-propane pH 7.0, 10mM L-glutamine, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1116573109",,"3VP0",35.03,"2.4","2.4","Crystal structure of human glutaminase in complex with L-glutamine","SMIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNL","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","3VP0"
"3VP1",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",7,"1.6M Lithium sulfate, 100mM Bis-tris-propane pH 7.0, 10mM L-glutamate, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1116573109","04A","3VP1",35.55,"2.3","2.3","Crystal structure of human glutaminase in complex with L-glutamate and BPTES","SMIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNL","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","3VP1"
"3VP2",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",7,"1.6M Lithium sulfate, 100mM Bis-tris-propane pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1116573109","BP0","3VP2",35.07,"2.7","2.7","Crystal structure of human glutaminase in complex with inhibitor 2","SMIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNL","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","3VP2"
"3VP3",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",7,"1.7M Lithium sulfate, 100mM Bis-tris-propane pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1116573109","BP8","3VP3",35.06,"2.7","2.7","Crystal structure of human glutaminase in complex with inhibitor 3","SMIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNL","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","3VP3"
"3VP4",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",7,"1.65M Lithium sulfate, 100mM Bis-tris-propane pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1116573109","BP9","3VP4",35.07,"2.45","2.45","Crystal structure of human glutaminase in complex with inhibitor 4","QSMIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNL","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","3VP4"
"3VP6",,"X-RAY DIFFRACTION",2.3,46.53,"VAPOR DIFFUSION, HANGING DROP",6,"25% PEG 3500, 100mM Bis-Tris, pH 6.0, vapor diffusion, hanging drop, temperature 298K",298,"10.1042/BSR20120111",,"3VP6",117.41,"2.1","2.1","Structural characterization of Glutamic Acid Decarboxylase; insights into the mechanism of autoinactivation","RTETDFSNLFARDLLPAKNGEEQTVQFLLEVVDILLNYVRKTFDRSTKVLDFHHPHQLLEGMEGFNLELSDHPESLEQILVDCRDTLKYGVRTGHPRFFNQLSTGLDIIGLAGEWLTSTANTNMFTYEIAPVFVLMEQITLKKMREIVGWSSKDGDGIFSPGGAISNMYSIMAARYKYFPEVKTKGMAAVPKLVLFTSEQSHYSIKKAGAALGFGTDNVILIKCNERGKIIPADFEAKILEAKQKGYVPFYVNATAGTTVYGAFDPIQEIADICEKYNLWLHVDAAWGGGLLMSRKHRHKLNGIERANSVTWNPHKMMGVLLQCSAILVKEKGILQGCNQMHASYLFQQDKHYDVSYDTGDKAIQCGRHVDIFKFWLMWKAKGTVGFENQINKCLELAEYLYAKIKNREEFEMVFNGEPEHTNVCFWYIPQSLRGVPDSPQRREKLHKVAPKIKALMMESGTTMVGYQPQGDKANFFRMVISNPAATQSDIDFLIEEIERLGQDLHHHHHH","Homo sapiens","GAD1, GAD, GAD67","Glutamate decarboxylase 1","1","3VP6"
"3VPM",,"X-RAY DIFFRACTION",3.87,68.22,"VAPOR DIFFUSION, HANGING DROP",7.5,"50mM Tris-HCl, 0.1mM KCl, pH 7.5, temperature 293K, VAPOR DIFFUSION, HANGING DROP",293,,,"3VPM",67.28,"2.7","2.7","Crystal structure of human ribonucleotide reductase subunit M2 (hRRM2) mutant","MGVEDEPLLRENPRRFVIFPIEYHDIWQMYKKAEASFWTAEAVDLSKDIQHWESLKPEERYFISHVLAFFAASDGIVNENLVERFSQEVQITEARCFYGFQIAMENIHSEMYSLLIDTYIKDPKEREFLFNAIETMPCVKKKADWALRWIGDKEATYGERVVAFAAVEGIFFSGSFASIFWLKKRGLMPGLTFSNELISRDEGLHCDFACLMFKHLVHKPSEERVREIIINAVRIEQEFLTEALPVKLIGMNCTLMKQYIEFVADRLMLELGFSKVFRVENPFDFM","Homo sapiens","RR2, RRM2","Ribonucleoside-diphosphate reductase subunit M2","1","3VPM"
"3VPN",,"X-RAY DIFFRACTION",3.91,68.51,"VAPOR DIFFUSION, HANGING DROP",7.5,"50mM Tris-HCl, 0.1mM KCl, pH 7.5, temperature 293K, VAPOR DIFFUSION, HANGING DROP",293,,,"3VPN",67.37,"2.25","2.25","Crystal structure of human ribonucleotide reductase subunit M2 (hRRM2) mutant","MGVEDEPLLRENPRRFVIFPIEYHDIWQMYKKAEASFWTAEDVDLSKDIQHWESLKPEERYFISHVLAFFAASDGIVNENLVERFSQEVQITEARCFYGFQIAMENIHSEMYSLLIDTYIKDPKEREFLFNAIETMPCVKKKADWALRWIGDKEATYGERVVAFAAVEGIFFSGSFASIFWLKKRGLMPGLTFSNELISRDEGLHCDFACLMFKHLVHKPSEERVREIIINAVRIEQEFLTEALPVKLIGMNCTLMKQYIEFVADRLMLELGFSKVFRVENPFDFM","Homo sapiens","RR2, RRM2","Ribonucleoside-diphosphate reductase subunit M2","1","3VPN"
"3VPO",,"X-RAY DIFFRACTION",3.89,68.36,"VAPOR DIFFUSION, HANGING DROP",7.5,"50mM Tris-HCl, 0.1mM KCl, pH 7.5, temperature 293K, VAPOR DIFFUSION, HANGING DROP",293,,,"3VPO",67.4,"2.3","2.3","Crystal structure of human ribonucleotide reductase subunit M2 (hRRM2) mutant","MGVEDEPLLRENPRRFVIFPIEYHDIWQMYKKAEASFWTAEQVDLSKDIQHWESLKPEERYFISHVLAFFAASDGIVNENLVERFSQEVQITEARCFYGFQIAMENIHSEMYSLLIDTYIKDPKEREFLFNAIETMPCVKKKADWALRWIGDKEATYGERVVAFAAVEGIFFSGSFASIFWLKKRGLMPGLTFSNELISRDEGLHCDFACLMFKHLVHKPSEERVREIIINAVRIEQEFLTEALPVKLIGMNCTLMKQYIEFVADRLMLELGFSKVFRVENPFDFM","Homo sapiens","RR2, RRM2","Ribonucleoside-diphosphate reductase subunit M2","1","3VPO"
"3VPP",,"X-RAY DIFFRACTION",2.04,39.77,"VAPOR DIFFUSION, HANGING DROP",8,"30% PEG 8000, 0.2M MgCl2, 0.1M Tris pH8.0, VAPOR DIFFUSION, HANGING DROP, temperature 310K",310,"10.1016/j.immuni.2012.03.009",,"3VPP",30.2,"1.642","1.642","Crystal Structure of the Human CLEC9A C-type Lectin-Like Domain","SSPCPNNWIQNRESCYYVSEIWSIWHTSQENCLKEGSTLLQIESKEEMDFITGSLRKIKGSYDYWVGLSQDGHSGRWLWQDGSSPSPGLLPAERSQSANQVCGYVKSNSLLSSNCDTWKYFICEKYALRSSV","Homo sapiens","CLEC9A, UNQ9341/PRO34046","C-type lectin domain family 9 member A","1","3VPP"
"3VQU",,"X-RAY DIFFRACTION",2.89,57.47,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M MES pH 6, 13.8% w/v PEG 4000, 0.3M ammonium iodide, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/ml3000879","O22","3VQU",38.04,"2.4","2.4","CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-[(4-amino-5-cyano-6-ethoxypyridin-2- yl)amino]benzamide","ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNLVPRGSAAGHHHHHH","Homo sapiens","TTK, MPS1, MPS1L1","Dual specificity protein kinase TTK","1","3VQU"
"3VRN",,"X-RAY DIFFRACTION",1.87,34.3,"VAPOR DIFFUSION, HANGING DROP",7,"16% PEG3350, 0.1M ammonium formate, 0.2M NDSB-201, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1093/jb/mvs085",,"3VRN",36.73,"1.64","1.64","Crystal structure of the tyrosine kinase binding domain of Cbl-c","GPLGSPEFMALAVAPWGRQWEEARALGRAVRMLQRLEEQCVDPRLSVSPPSLRDLLPRTAQLLREVAHSRRAAGGGGPGGPGGSGDFLLIYLANLEAKSRQVAALLPPRGRRSANDELFRAGSRLRRQLAKLAIIFSHMHAELHALFPGGKYCGHMYQLTKAPAHTFWRESCGARCVLPWAEFESLLGTCHPVEPGCTALALRTTIDLTCSGHVSIFEFDVFTRLFQPWPTLLKNWQLLAVNHPGYMAFLTYDEVQERLQACRDKPGSYIFRPSCTRLGQWAIGYVSSDGSILQTIPANKPLSQVLLEGQKDGFYLYPDGKTHNPDLTELG","Homo sapiens","CBLC, CBL3, RNF57","Signal transduction protein CBL-C","1","3VRN"
"3VRQ",,"X-RAY DIFFRACTION",2.21,44.42,"VAPOR DIFFUSION, HANGING DROP",7,"22% PEG3350, 0.1M Magnesium Nitrate, 0.6M NDSB-201, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 288K",288,"10.1093/jb/mvs085",,"3VRQ",73.49,"2.39","2.39","Crystal structure of the tyrosine kinase binding domain of Cbl-c (PL mutant)","GPLGSPEFMALAVAPWGRQWEEARALGRAVRMLQRLEEQCVDPRLSVSPPSLRDLLPRTAQLLREVAHSRRAAGGGGPGGPGGSGDFLLIYLANLEAKSRQVAALLPPRGRRSANDELFRAGSRLRRQLAKLAIIFSHMHAELHALFPGGKYCGHMYQLTKAPAHTFWRESCGARCVLPWAEFESLLGTCHPVEPGCTALALRTTIDLTCSGHVSIFEFDVFTRLFQPWPTLLKNWQLLAVNHPGYMAFLTYDEVQERLQACRDKPGSYIFRLSCTRLGQWAIGYVSSDGSILQTIPANKPLSQVLLEGQKDGFYLYPDGKTHNPDLTELG","Homo sapiens","CBLC, CBL3, RNF57","Signal transduction protein CBL-C","1","3VRQ"
"3VRY",,"X-RAY DIFFRACTION",3.06,59.86,"VAPOR DIFFUSION, SITTING DROP",8,"21% PEG 6000, 180mM calcium acetate, 18% glycerol, 100mM Tris, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1126/scitranslmed.3004387","B43","3VRY",104.89,"2.481","2.481","Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 4-Amino-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl-cyclopentane","GAMGSGIRIIVVALYDYEAIHHEDLSFQKGDQMVVLEESGEWWKARSLATRKEGYIPSNYVARVDSLETEEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP","Homo sapiens","HCK","Tyrosine-protein kinase HCK","1","3VRY"
"3VRZ",,"X-RAY DIFFRACTION",3.09,60.19,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M Tris, 0.1M calcium acetate, 20% glycerol, 21% PEG6000, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 288K",288,"10.1126/scitranslmed.3004387",,"3VRZ",105,"2.218","2.218","Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-benzylurea","GAMGSGIRIIVVALYDYEAIHHEDLSFQKGDQMVVLEESGEWWKARSLATRKEGYIPSNYVARVDSLETEEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP","Homo sapiens","HCK","Tyrosine-protein kinase HCK","1","3VRZ"
"3VS0",,"X-RAY DIFFRACTION",3.09,60.22,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M Tris, 0.1M calcium acetate, 20% glycerol, 21% PEG6000, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1126/scitranslmed.3004387",,"3VS0",104.95,"2.934","2.934","Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor N-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]benzamide","GAMGSGIRIIVVALYDYEAIHHEDLSFQKGDQMVVLEESGEWWKARSLATRKEGYIPSNYVARVDSLETEEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP","Homo sapiens","HCK","Tyrosine-protein kinase HCK","1","3VS0"
"3VS1",,"X-RAY DIFFRACTION",3.09,60.17,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M Tris, 0.1M calcium acetate, 20% glycerol, 21% PEG6000, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 288K",288,"10.1126/scitranslmed.3004387",,"3VS1",104.98,"2.464","2.464","Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 1-[4-(4-amino-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)phenyl]-3-phenylurea","GAMGSGIRIIVVALYDYEAIHHEDLSFQKGDQMVVLEESGEWWKARSLATRKEGYIPSNYVARVDSLETEEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP","Homo sapiens","HCK","Tyrosine-protein kinase HCK","1","3VS1"
"3VS2",,"X-RAY DIFFRACTION",3.07,59.89,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M Tris, 0.1M calcium acetate, 20% glycerol, 21% PEG6000, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 288K",288,"10.1126/scitranslmed.3004387",,"3VS2",105.12,"2.609","2.609","Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 7-[cis-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine","GAMGSGIRIIVVALYDYEAIHHEDLSFQKGDQMVVLEESGEWWKARSLATRKEGYIPSNYVARVDSLETEEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP","Homo sapiens","HCK","Tyrosine-protein kinase HCK","1","3VS2"
"3VS3",,"X-RAY DIFFRACTION",3.08,60.05,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M Tris, 0.1M calcium acetate, 20% glycerol, 21% PEG6000, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 288K",288,"10.1126/scitranslmed.3004387","VSE","3VS3",105.12,"2.17","2.17","Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine","GAMGSGIRIIVVALYDYEAIHHEDLSFQKGDQMVVLEESGEWWKARSLATRKEGYIPSNYVARVDSLETEEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP","Homo sapiens","HCK","Tyrosine-protein kinase HCK","1","3VS3"
"3VS4",,"X-RAY DIFFRACTION",3.1,60.34,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M Tris, 0.1M calcium acetate, 20% glycerol, 21% PEG6000, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1126/scitranslmed.3004387","VSF","3VS4",104.92,"2.747","2.747","Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 5-(4-phenoxyphenyl)-7-(tetrahydro-2H-pyran-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine","GAMGSGIRIIVVALYDYEAIHHEDLSFQKGDQMVVLEESGEWWKARSLATRKEGYIPSNYVARVDSLETEEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP","Homo sapiens","HCK","Tyrosine-protein kinase HCK","1","3VS4"
"3VS5",,"X-RAY DIFFRACTION",3.01,59.2,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M Tris, 0.1M calcium acetate, 20% glycerol, 21% PEG6000, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1126/scitranslmed.3004387",,"3VS5",104.88,"2.851","2.851","Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor 7-(1-methylpiperidin-4-yl)-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine","GAMGSGIRIIVVALYDYEAIHHEDLSFQKGDQMVVLEESGEWWKARSLATRKEGYIPSNYVARVDSLETEEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP","Homo sapiens","HCK","Tyrosine-protein kinase HCK","1","3VS5"
"3VS6",,"X-RAY DIFFRACTION",3.15,60.94,"VAPOR DIFFUSION, SITTING DROP",9,"0.1M Tris, 0.1M calcium acetate, 20% glycerol, 21% PEG6000, pH 9, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1126/scitranslmed.3004387",,"3VS6",105.03,"2.373","2.373","Crystal structure of HCK complexed with a pyrazolo-pyrimidine inhibitor tert-butyl {4-[4-amino-1-(propan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-2-methoxyphenyl}carbamate","GAMGSGIRIIVVALYDYEAIHHEDLSFQKGDQMVVLEESGEWWKARSLATRKEGYIPSNYVARVDSLETEEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP","Homo sapiens","HCK","Tyrosine-protein kinase HCK","1","3VS6"
"3VS7",,"X-RAY DIFFRACTION",3.07,59.98,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M Tris, 0.1M calcium acetate, 20% glycerol, 21% PEG6000, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1126/scitranslmed.3004387",,"3VS7",104.79,"3.001","3.001","Crystal structure of HCK complexed with a pyrazolo-pyrimidine inhibitor 1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine","GAMGSGIRIIVVALYDYEAIHHEDLSFQKGDQMVVLEESGEWWKARSLATRKEGYIPSNYVARVDSLETEEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP","Homo sapiens","HCK","Tyrosine-protein kinase HCK","1","3VS7"
"3VSO",,"X-RAY DIFFRACTION",2.57,52.1,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.8M SODIUM CITRATE, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmc.2013.02.003","EK1","3VSO",65.57,"2","2","Human PPAR gamma ligand binding domain in complex with a gamma selective agonist mekt21","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3VSO"
"3VSP",,"X-RAY DIFFRACTION",2.53,51.29,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.8M SODIUM CITRATE, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,"EK8","3VSP",65.58,"2.4","2.4","Human PPAR gamma ligand binding domain in complex with a gamma selective agonist mekt28","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3VSP"
"3VSW",,"X-RAY DIFFRACTION",3.12,60.56,"VAPOR DIFFUSION, HANGING DROP",3,"5-12% PEG 3350, 0.6M NaCl, 0.1M citrate (pH3.0-4.5), VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.bmcl.2012.05.092","R31","3VSW",76.08,"3","3","Human renin in complex with compound 8","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","3VSW"
"3VSX",,"X-RAY DIFFRACTION",2.95,58.31,"VAPOR DIFFUSION, HANGING DROP",3,"5-12% PEG3 350, 0.6M NaCl, 0.1M citrate (pH 3.0-4.5), VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.bmcl.2012.05.092","R32","3VSX",76.02,"2.8","2.8","Human renin in complex with compound 18","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","3VSX"
"3VTU",,"X-RAY DIFFRACTION",1.95,36.89,"VAPOR DIFFUSION, SITTING DROP",5.6,"2.0M Ammonium sulfate, 0.1M Tri-sodium citrate, 0.2M Potassium sodium tartrate, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1042/BJ20121907",,"3VTU",14.96,"1.6","1.6","Crystal structure of human LC3B_2-119","GSPEFPSEKTFKQRRTFEQRVEDVRLIREQHPTKIPVIIERYKGEKQLPVLDKTKFLVPDHVNMSELIKIIRRRLQLNANQAFFLLVNGHSMVSVSTPISEVYESEKDEDGFLYMVYASQETF","Homo sapiens","MAP1LC3B, MAP1ALC3","Microtubule-associated proteins 1A/1B light chain 3B","1","3VTU"
"3VTV",,"X-RAY DIFFRACTION",1.82,32.27,"VAPOR DIFFUSION, HANGING DROP",5.6,"2.0M Ammonium sulfate, 0.05M Tri-sodium citrate, 0.1M Potassium sodium tartrate, 10% PEG 3350, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1042/BJ20121907",,"3VTV",15.75,"1.7","1.7","Crystal structure of Optineurin LIR-fused human LC3B_2-119","GSEEGEEEDEFVEIGGPSEKTFKQRRTFEQRVEDVRLIREQHPTKIPVIIERYKGEKQLPVLDKTKFLVPDHVNMSELIKIIRRRLQLNANQAFFLLVNGHSMVSVSTPISEVYESEKDEDGFLYMVYASQETF","Homo sapiens","MAP1LC3B, MAP1ALC3","Optineurin, microtubule-associated proteins 1A/1B light chain 3B","1","3VTV"
,,,,,,,,,,,,,,,,,"Homo sapiens","MAP1LC3B, MAP1ALC3"
"3VTW",,"X-RAY DIFFRACTION",2.85,56.84,"VAPOR DIFFUSION, HANGING DROP",5.6,"2.0M Ammonium sulfate, 0.05M Tri-sodium citrate, 0.1M Potassium sodium tartrate, 5% Glycerol, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 289K",289,"10.1042/BJ20121907",,"3VTW",51.91,"2.52","2.52","Crystal structure of T7-tagged Optineurin LIR-fused human LC3B_2-119","GSHMASMTGGQQMGRGSEEGEEEDEFVEIGGPSEKTFKQRRTFEQRVEDVRLIREQHPTKIPVIIERYKGEKQLPVLDKTKFLVPDHVNMSELIKIIRRRLQLNANQAFFLLVNGHSMVSVSTPISEVYESEKDEDGFLYMVYASQETF","Homo sapiens","MAP1LC3B, MAP1ALC3","Optineurin, microtubule-associated proteins 1A/1B light chain 3B","1","3VTW"
,,,,,,,,,,,,,,,,,"Homo sapiens","MAP1LC3B, MAP1ALC3"
"3VUC",,"X-RAY DIFFRACTION",3.15,61,"VAPOR DIFFUSION, HANGING DROP",3,"5-12% PEG 3350, 0.6M NaCl, 0.1M citrate pH3.0-4.5, vapor diffusion, hanging drop, temperature 295K",295,"10.1021/ml300168e","HHE","3VUC",76.1,"2.6","2.6","Human renin in complex with compound 5","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","3VUC"
"3VUT",,"X-RAY DIFFRACTION",2.34,47.39,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M ammonium acetate, 22-25%(w/v) PEG3350, 0.1M HEPES-NaOH pH7.0, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bbrc.2012.07.066",,"3VUT",74.94,"3.5","3.5","Crystal structures of non-phosphorylated MAP2K4","MSIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQMPATPSSPMYVDHHHHHH","Homo sapiens","MAP2K4, JNKK1, MEK4, MKK4, PRKMK4, SEK1, SERK1, SKK1","Dual specificity mitogen-activated protein kinase kinase 4","1","3VUT"
"3VUZ",,"X-RAY DIFFRACTION",2.3,46.55,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Tris-HCl pH8.3-8.5, 28-30% PEG 6000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1107/S0907444912052092",,"3VUZ",29.53,"2.5","2.5","Crystal structure of histone methyltransferase SET7/9 in complex with AAM-1","GSSGSSGKDNIRHGVCWIYYPDGGSLVGEVNEDGEMTGEKIAYVYPDERTALYGKFIDGEMIEGKLATLMSTEEGRPHFELMPGNSVYHFDKSTSSCISTNALLPDPYESERVYVAESLISSAGEGLFSKVAVGPNTVMSFYNGVRITHQEVDSRDWALNGNTLSLDEETVIDVPEPYNHVSKYCASLGHKANHSFTPNCIYDMFVHPRFGPIKCIRTLRAVEADEELTVAYGYDHSPPGKSGPEAPEWYQVELKAFQATQQK","Homo sapiens","SETD7, KIAA1717, KMT7, SET7, SET9","Histone-lysine N-methyltransferase SETD7","1","3VUZ"
"3VV0",,"X-RAY DIFFRACTION",2.31,46.66,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Tris-HCl pH8.3-8.5, 28-30% PEG 6000, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1107/S0907444912052092",,"3VV0",29.58,"2.001","2.001","Crystal structure of histone methyltransferase SET7/9 in complex with DAAM-3","GSSGSSGKDNIRHGVCWIYYPDGGSLVGEVNEDGEMTGEKIAYVYPDERTALYGKFIDGEMIEGKLATLMSTEEGRPHFELMPGNSVYHFDKSTSSCISTNALLPDPYESERVYVAESLISSAGEGLFSKVAVGPNTVMSFYNGVRITHQEVDSRDWALNGNTLSLDEETVIDVPEPYNHVSKYCASLGHKANHSFTPNCIYDMFVHPRFGPIKCIRTLRAVEADEELTVAYGYDHSPPGKSGPEAPEWYQVELKAFQATQQK","Homo sapiens","SETD7, KIAA1717, KMT7, SET7, SET9","Histone-lysine N-methyltransferase SETD7","1","3VV0"
"3VV6",,"X-RAY DIFFRACTION",2.78,55.76,"VAPOR DIFFUSION, SITTING DROP",6.5,"120mM sodium citrate, 200mM ammonium iodide, 30%(w/v) polyethylene glycol 5000 monomethyl ether, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm3011405","B00","3VV6",47.64,"2.05","2.05","Crystal Structure of beta secetase in complex with 2-amino-3-methyl-6-((1S, 2R)-2-phenylcyclopropyl)pyrimidin-4(3H)-one","GSHMLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3VV6"
"3VV7",,"X-RAY DIFFRACTION",2.83,56.48,"VAPOR DIFFUSION, SITTING DROP",6.5,"120mM sodium citrate, 200mM ammonium iodide, 30%(w/v) polyethylene glycol 5000 monomethyl ether, pH 6.5, VAPOR DIFFUSION, SITTING DROP",,"10.1021/jm3011405","0B1","3VV7",47.69,"2.1","2.1","Crystal Structure of beta secetase in complex with 2-amino-6-((1S,2R)-2-(3'-methoxybiphenyl-3-yl)cyclopropyl)-3-methylpyrimidin-4(3H)-one","GSHMLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3VV7"
"3VV8",,"X-RAY DIFFRACTION",2.74,55.03,"VAPOR DIFFUSION, SITTING DROP",6.5,"120mM sodium citrate, 200mM ammonium iodide, 30%(w/v) polyethylene glycol 5000 monomethyl ether, pH 6.5, VAPOR DIFFUSION, SITTING DROP",,"10.1021/jm3011405","B02","3VV8",46.82,"2.5","2.5","Crystal structure of beta secetase in complex with 2-amino-3-methyl-6-((1S,2R)-2-(3'-methylbiphenyl-4-yl)cyclopropyl)pyrimidin-4(3H)-one","GSHMLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3VV8"
"3VVH",,"X-RAY DIFFRACTION",2.27,45.75,"VAPOR DIFFUSION, HANGING DROP",8.8,"PEG 4000, pH 8.8, VAPOR DIFFUSION, HANGING DROP, temperature 279K",279,,"4BM","3VVH",116.83,"2","2","X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in complex with an inhibitor and MgATP","MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGVLEHHHHHH","Homo sapiens","MAP2K1, MEK1, PRKMK1","Dual specificity mitogen-activated protein kinase kinase 1","1","3VVH"
"3VVV",,"X-RAY DIFFRACTION",2.12,42.07,"VAPOR DIFFUSION",8.5,"24% PEG4000, 0.1M Tris , pH 8.5, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.molcel.2012.08.024",,"3VVV",14.6,"1.35","1.35","Skich domain of NDP52","GPSQVIFNSVEKFYIPGGDVTCHYTFTQHFIPRRKDWIGIFRVGWKTTREYYTFMWVTLPIDLNNKSAKQQEVQFKAYYLPKDDEYYQFCYVDEDGVVRGASIPFQFRPENEEDILVVTTQGE","Homo sapiens","CALCOCO2, NDP52","Calcium-binding and coiled-coil domain-containing protein 2","1","3VVV"
"3VW6",,"X-RAY DIFFRACTION",3.08,60.12,"VAPOR DIFFUSION, SITTING DROP",7,"10% PEG 6000, 1M lithium chloride, 0.1M HEPES, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 277.0K",277,"10.1016/j.bmcl.2012.10.084","IM6","3VW6",61.31,"2.4","2.4","Crystal structure of human apoptosis signal-regulating kinase 1 (ASK1) with imidazopyridine inhibitor","LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK","Homo sapiens","MAP3K5, ASK1, MAPKKK5, MEKK5","Mitogen-activated protein kinase kinase kinase 5","1","3VW6"
"3VW8",,"X-RAY DIFFRACTION",2.04,39.7,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES, 25% PEG2000, 8% isopropanol, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmc.2013.10.028","DF6","3VW8",37.59,"2.1","2.1","Crystal structure of human c-Met kinase domain with its inhibitor","VQYPLTDMSPILTSGDSDISSPLLQNTVHIDLSLNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHV","Homo sapiens","MET","Hepatocyte growth factor receptor","1","3VW8"
"3VW9",,"X-RAY DIFFRACTION",2.3,47.1,"VAPOR DIFFUSION, HANGING DROP",7,"25%(w/v) PEG 2000 MME, 10%(v/v) Glycerol, 0.1M Na-HEPES (pH 7.0), vapor diffusion, hanging drop, temperature 293K",293,"10.1016/j.bmcl.2012.10.045","HPJ","3VW9",43.29,"1.47","1.47","Human Glyoxalase I with an N-hydroxypyridone inhibitor","GSHMAEPQPPSGGLTDEAALSCCSDADPSTKDFLLQQTMLRVKDPKKSLDFYTRVLGMTLIQKCDFPIMKFSLYFLAYEDKNDIPKEKDEKIAWALSRKATLELTHNWGTEDDETQSYHNGNSDPRGFGHIGIAVPDVYSACKRFEELGVKFVKKPDDGKMKGLAFIQDPDGYWIEILNPNKMATLM","Homo sapiens","GLO1","Lactoylglutathione lyase","1","3VW9"
"3VWD",,"X-RAY DIFFRACTION",2.16,43.12,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1M Bis-tris propane, 20% PEG 3350, 0.2M sodium formate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3VWD",23.91,"1.25","1.25","Crystal structure of alpha-tubulin acetyltransferase domain of human Mec-17 in complex with acetoacetyl-CoA (P21212 form)","GPGSMEFPFDVDALFPERITVLDQHLRPPARRPGTTTPARVDLQQQIMTIIDELGKASAKAQNLSAPITSASRMQSNRHVVYILKDSSARPAGKGAIIGFIKVGYKKLFVLDDREAHNEVEPLCILDFYIHESVQRHGHGRELFQYMLQKERVEPHQLAIDRPSQKLLKFLNKHYNLETTVPQVNNFVIFEGFFAHQHEFG","Homo sapiens","ATAT1, C6orf134, MEC17, Nbla00487","Alpha-tubulin N-acetyltransferase","1","3VWD"
"3VWE",,"X-RAY DIFFRACTION",2.08,40.81,"VAPOR DIFFUSION, HANGING DROP",9,"0.1M Tris, 26% PEG 3350, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3VWE",23.7,"1.956","1.956","Crystal structure of alpha-tubulin acetyltransferase domain of human Mec-17 in complex with CoA (P21 form)","GPGSMEFPFDVDALFPERITVLDQHLRPPARRPGTTTPARVDLQQQIMTIIDELGKASAKAQNLSAPITSASRMQSNRHVVYILKDSSARPAGKGAIIGFIKVGYKKLFVLDDREAHNEVEPLCILDFYIHESVQRHGHGRELFQYMLQKERVEPHQLAIDRPSQKLLKFLNKHYNLETTVPQVNNFVIFEGFFAHQHEFG","Homo sapiens","ATAT1, C6orf134, MEC17, Nbla00487","Alpha-tubulin N-acetyltransferase","1","3VWE"
"3VWW",,"X-RAY DIFFRACTION",2.28,46.15,"VAPOR DIFFUSION",6.7,"5% PEG 4000, 50mM sodium phosphate (pH 6.7), VAPOR DIFFUSION, temperature 293K",293,"10.1038/srep02456",,"3VWW",25.9,"1.93","1.93","Crystal structure of a0-domain of P5 from H. sapiens","DDVIELTPSNFNREVIQSDSLWLVEFYAPWCGHCQRLTPEWKKAATALKDVVKVGAVDADKHHSLGGQYGVQGFPTIKIFGSNKNRPEDYQGGRTGEAIVDAALSALRQLVKDRLG","Homo sapiens","PDIA6, ERP5, P5, TXNDC7","Protein disulfide-isomerase A6","1","3VWW"
"3VXE",,"X-RAY DIFFRACTION",2.69,54.22,"VAPOR DIFFUSION, HANGING DROP",5,"10% W/V PEG 4000, 100mm sodium acetate pD5.0 at room temperature, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.bbapap.2013.05.014",,"3VXE",36.3,"1.25","1.25","Human alpha-thrombin-Bivalirudin complex at PD5.0","TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR","Homo sapiens","F2","Thrombin light chain","1","3VXE"
,,,,,,,,,,,,,,,,"IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE","Homo sapiens","F2","Thrombin heavy chain","2","3VXE"
,,,,,,,,,,,,,,,,"PGGGGNGDFEEIPEEYL",,,"BIVALIRUDIN","3","3VXE"
,,,,,,,,,,,,,,,,"FPR",,,"BIVALIRUDIN","4","3VXE"
"3VXQ",,"X-RAY DIFFRACTION",2.29,46.4,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M Bis-Tris, 20% PEG8000, 0.5M magnesium chloride, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/srep03097",,"3VXQ",101.11,"2","2","H27-14 TCR specific for HLA-A24-Nef134-10","MDTGVSQNPRHKITKRGQNVTFRCDPISEHNRLYWYRQTLGQGPEFLTYFQNEAQLEKSRLLSDRFSAERPKGSFSTLEIQRTEQGDSAMYLCASSSWDTGELFFGEGSRLTVLEDLKNVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYALSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"H27-14 TCR beta chain","2","3VXQ"
,,,,,,,,,,,,,,,,"MKQEVTQIPAALSVPEGENLVLNCSFTDSAIYNLQWFRQDPGKGLTSLLLIQSSQREQTSGRLNASLDKSSGRSTLYIAASQPGDSATYLCAVRMDSSYKLIFGSGTRLLVRPDIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSPE","Homo sapiens",,"H27-14 TCR alpha chain","1","3VXQ"
"3VXT",,"X-RAY DIFFRACTION",2.63,53.18,"VAPOR DIFFUSION, SITTING DROP",6,"0.2M potassium sulfate, 0.1M MES, 15% PEG8000, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/srep03097",,"3VXT",100.69,"2.5","2.5","T36-5 TCR specific for HLA-A24-Nef134-10","MQKEVEQNSGPLSVPEGAIASLNCTYSDRGSQSFFWYRQYSGKSPELIMSIYSNGDKEDGRFTAQLNKASQYVSLLIRDSQPSDSATYLWGTYNQGGKLIFGQGTELSVKPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSPESS","Homo sapiens",,"T36-5 TCR alpha chain","1","3VXT"
,,,,,,,,,,,,,,,,"MEAQVTQNPRYLITVTGKKLTVTCSQNMNHEYMSWYRQDPGLGLRQIYYSMNVEVTDKGDVPEGYKVSRKEKRNFPLILESPSPNQTSLYFCASSGASHEQYFGPGTRLTVTEDLKNVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYALSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"T36-5 TCR beta chain","2","3VXT"
"3VY6",,"X-RAY DIFFRACTION",2.09,41.22,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.09M MES (pH 6.5), 0.09M sodium phosphate, 0.09M potassium phosphate, 1.8M sodium chloride , VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M113.539114",,"3VY6",15.91,"2","2","Crystal structure of human pancreatic secretory protein ZG16p with laminaribiose","GSARSSSYSGEYGSGGGKRFSHSGNQLDGPITALRVRVNTYYIVGLQVRYGKVWSDYVGGRNGDLEEIFLHPGESVIQVSGKYKWYLKKLVFVTDKGRYLSFGKDSGTSFNAVPLHPNTVLRFISGRSGSLIDAIGLHWDV","Homo sapiens","ZG16","Zymogen granule membrane protein 16","1","3VY6"
"3VY7",,"X-RAY DIFFRACTION",2.1,41.36,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.09M MES (pH 6.5), 0.09M sodium phosphate, 0.09M potassium phosphate, 1.8M sodium chloride , VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M113.539114",,"3VY7",15.86,"2.14","2.14","Crystal structure of human pancreatic secretory protein ZG16p with O-(alpha-D-mannosyl)-L-serine","GSARSSSYSGEYGSGGGKRFSHSGNQLDGPITALRVRVNTYYIVGLQVRYGKVWSDYVGGRNGDLEEIFLHPGESVIQVSGKYKWYLKKLVFVTDKGRYLSFGKDSGTSFNAVPLHPNTVLRFISGRSGSLIDAIGLHWDV","Homo sapiens","ZG16","Zymogen granule membrane protein 16","1","3VY7"
"3VYD",,"X-RAY DIFFRACTION",3.14,60.78,"VAPOR DIFFUSION, HANGING DROP",,"5-12% PEG 3350, 0.6M NaCl, 0.1M citrate pH3.0-4.5, vapor diffusion, hanging drop, temperature 295K, VAPOR DIFFUSION, HANGING DROP",295,"10.1016/j.bmcl.2012.09.103","VYD","3VYD",75.87,"2.81","2.81","Human renin in complex with inhibitor 6","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","3VYD"
"3VYE",,"X-RAY DIFFRACTION",3.16,61.12,"VAPOR DIFFUSION, HANGING DROP",,"5-12% PEG 3350, 0.6M NaCl, 0.1M citrate pH3.0-4.5, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1016/j.bmcl.2012.09.103","VYE","3VYE",75.85,"2.7","2.7","Human renin in complex with inhibitor 7","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","3VYE"
"3VYF",,"X-RAY DIFFRACTION",3.16,61.11,"VAPOR DIFFUSION, HANGING DROP",,"5-12% PEG 3350, 0.6M NaCl, 0.1M citrate pH3.0-4.5, vapor diffusion, hanging drop, temperature 295K, VAPOR DIFFUSION, HANGING DROP",295,"10.1016/j.bmcl.2012.09.103","VYF","3VYF",75.96,"2.8","2.8","Human renin in complex with inhibitor 9","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","3VYF"
"3VYX",,"X-RAY DIFFRACTION",2.76,55.38,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 4000, KNO3, Tris, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1093/nar/gkt042",,"3VYX",19.49,"2.29","2.29","Structural insights into RISC assembly facilitated by dsRNA binding domains of human RNA helicase (DHX9)","MKEEQEVQATLESEEVDLNAGLHGNWTLENAKARLNQYFQKEKIQGEYKYTQVGPDHNRSFIAEMTIYIKQLGRRIFAREHGSNKKLAAQSCALSLVRQLYHLGVVEAYSGLTK","Homo sapiens","DHX9, DDX9, LKP, NDH2","ATP-dependent RNA helicase A","1","3VYX"
,,,,,,,,,,,,,,,,"GCGCGCGCGC",,,"RNA (5'-R(P*GP*CP*GP*CP*GP*CP*GP*CP*GP*C)-3')","2","3VYX"
"3VZB",,"X-RAY DIFFRACTION",2.57,52.05,"sitting drop",6,"1.0-1.4M ammonium sulfate, 0.3-1.3M NaCl, 0.1M Bis-Tris,, pH 6.0, sitting drop, temperature 289K",289,"10.1016/j.str.2013.02.025",,"3VZB",121.4,"2","2","Crystal structure of Sphingosine Kinase 1","AMGSGVLPRPCRVLVLLNPRGGKGKALQLFRSHVQPLLAEAEISFTLMLTERRNHARELVRSEELGRWDALVVMSGDGLMHEVVNGLMERPDWETAIQKPLCSLPAGSGNALAASLNHYAGYEQVTNEDLLTNCTLLLCRRLLSPMNLLSLHTASGLRLFSVLSLAWGFIADVDLESEKYRRLGEMRFTLGTFLRLAALRTYRGRLAYLPVGRVGSKTPASPVVVQQGPVDAHLVPLEEPVPSHWTVVPDEDFVLVLALLHSHLGSEMFAAPMGRCAAGVMHLFYVRAGVSRAMLLRLFLAMEKGRHMEYECPYLVYVPVVAFRLEPKDGKGVFAVDGELMVSEAVQGQVHPNYFWMVSG","Homo sapiens","SPHK1, SPHK, SPK, SK1","Sphingosine kinase 1","1","3VZB"
"3VZC",,"X-RAY DIFFRACTION",2.57,52.16,"sitting drop",6,"1.0-1.4M ammonium sulfate, 0.3-1.3M NaCl, 0.1M Bis-Tris, pH 6.0, sitting drop, temperature 289K",289,"10.1016/j.str.2013.02.025","UUL","3VZC",241.45,"2.3","2.3","Crystal structure of Sphingosine Kinase 1 with inhibitor","GAMGSGVLPRPCRVLVLLNPRGGKGKALQLFRSHVQPLLAEAEISFTLMLTERRNHARELVRSEELGRWDALVVMSGDGLMHEVVNGLMERPDWETAIQKPLCSLPAGSGNALAASLNHYAGYEQVTNEDLLTNCTLLLCRRLLSPMNLLSLHTASGLRLFSVLSLAWGFIADVDLESEKYRRLGEMRFTLGTFLRLAALRTYRGRLAYLPVGRVGSKTPASPVVVQQGPVDAHLVPLEEPVPSHWTVVPDEDFVLVLALLHSHLGSEMFAAPMGRCAAGVMHLFYVRAGVSRAMLLRLFLAMEKGRHMEYECPYLVYVPVVAFRLEPKDGKGVFAVDGELMVSEAVQGQVHPNYFWMVSG","Homo sapiens","SPHK1, SPHK, SPK, SK1","Sphingosine kinase 1","1","3VZC"
"3VZD",,"X-RAY DIFFRACTION",2.57,52.13,"sitting drop",6,"1.0-1.4M ammonium sulfate, 0.3-1.3M NaCl, 0.1M Bis-Tris, pH 6.0, sitting drop, temperature 289K",289,"10.1016/j.str.2013.02.025","UUL","3VZD",242.83,"2.3","2.3","Crystal structure of Sphingosine Kinase 1 with inhibitor and ADP","GAMGSGVLPRPCRVLVLLNPRGGKGKALQLFRSHVQPLLAEAEISFTLMLTERRNHARELVRSEELGRWDALVVMSGDGLMHEVVNGLMERPDWETAIQKPLCSLPAGSGNALAASLNHYAGYEQVTNEDLLTNCTLLLCRRLLSPMNLLSLHTASGLRLFSVLSLAWGFIADVDLESEKYRRLGEMRFTLGTFLRLAALRTYRGRLAYLPVGRVGSKTPASPVVVQQGPVDAHLVPLEEPVPSHWTVVPDEDFVLVLALLHSHLGSEMFAAPMGRCAAGVMHLFYVRAGVSRAMLLRLFLAMEKGRHMEYECPYLVYVPVVAFRLEPKDGKGVFAVDGELMVSEAVQGQVHPNYFWMVSG","Homo sapiens","SPHK1, SPHK, SPK, SK1","Sphingosine kinase 1","1","3VZD"
"3VZE",,"X-RAY DIFFRACTION",2.1,41.41,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.09M MES(pH 6.5), 0.09M Sodium phosphate, 0.09M Potassium phosphate, 1.8M Sodium chloride, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M113.539114",,"3VZE",15.91,"1.9","1.9","Crystal structure of human pancreatic secretory protein ZG16p with alpha1,3-mannobiose","GSARSSSYSGEYGSGGGKRFSHSGNQLDGPITALRVRVNTYYIVGLQVRYGKVWSDYVGGRNGDLEEIFLHPGESVIQVSGKYKWYLKKLVFVTDKGRYLSFGKDSGTSFNAVPLHPNTVLRFISGRSGSLIDAIGLHWDV","Homo sapiens","ZG16","Zymogen granule membrane protein 16","1","3VZE"
"3VZF",,"X-RAY DIFFRACTION",2.09,41.14,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.09M MES(pH 6.5), 0.09M Sodium phosphate, 0.09M Potassium phosphate, 1.8M Sodium chloride, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M113.539114",,"3VZF",15.77,"2.8","2.8","Crystal structure of human pancreatic secretory protein ZG16p with methyl alpha-D-mannopyranoside","GSARSSSYSGEYGSGGGKRFSHSGNQLDGPITALRVRVNTYYIVGLQVRYGKVWSDYVGGRNGDLEEIFLHPGESVIQVSGKYKWYLKKLVFVTDKGRYLSFGKDSGTSFNAVPLHPNTVLRFISGRSGSLIDAIGLHWDV","Homo sapiens","ZG16","Zymogen granule membrane protein 16","1","3VZF"
"3VZG",,"X-RAY DIFFRACTION",2.09,41.15,,5.6,"0.09M MES(pH 6.5), 0.09M Sodium phosphate, 0.09M Potassium phosphate, 1.8M Sodium chloride, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1074/jbc.M113.539114",,"3VZG",15.87,"2.7","2.7","Crystal structure of human pancreatic secretory protein ZG16p with O-(alpha-D-mannosyl)-L-threonine","GSARSSSYSGEYGSGGGKRFSHSGNQLDGPITALRVRVNTYYIVGLQVRYGKVWSDYVGGRNGDLEEIFLHPGESVIQVSGKYKWYLKKLVFVTDKGRYLSFGKDSGTSFNAVPLHPNTVLRFISGRSGSLIDAIGLHWDV","Homo sapiens","ZG16","Zymogen granule membrane protein 16","1","3VZG"
"3VZV",,"X-RAY DIFFRACTION",3.79,67.56,"VAPOR DIFFUSION, SITTING DROP",8.1,"2.4M Ammonium sulfate, 5% PEG 200, 0.1M Tris HCl, pH 8.1, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmcl.2012.11.091","VZV","3VZV",21.55,"2.8","2.8","Crystal structure of human mdm2 with a dihydroimidazothiazole inhibitor","GSETLVRPKPELLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVV","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","3VZV"
"3W0A",,"X-RAY DIFFRACTION",2.66,53.82,"VAPOR DIFFUSION, HANGING DROP",,"VAPOR DIFFUSION, HANGING DROP",,,,"3W0A",29.32,"1.8","1.8","Crystal Structure Analysis of Vitamin D receptor","LRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFG","Homo sapiens","VDR, NR1I1","Vitamin D3 receptor","1","3W0A"
,,,,,,,,,,,,,,,,,"Homo sapiens","VDR, NR1I1"
"3W0C",,"X-RAY DIFFRACTION",2.65,53.52,"VAPOR DIFFUSION, HANGING DROP",6,"pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"3W0C",29.32,"1.9","1.9","Crystal Structure Analysis of Vitamin D receptor","LRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFG","Homo sapiens","VDR, NR1I1","Vitamin D3 receptor","1","3W0C"
,,,,,,,,,,,,,,,,,"Homo sapiens","VDR, NR1I1"
"3W0T",,"X-RAY DIFFRACTION",2.19,43.94,"VAPOR DIFFUSION, HANGING DROP",7,"33% (w/v) PEG 2000 MME, 0.1M Na-HEPES (pH 7.0), vapor diffusion, hanging drop, temperature 293K",293,,,"3W0T",86.75,"1.351","1.351","Human Glyoxalase I with an N-hydroxypyridone derivative inhibitor","GSHMAEPQPPSGGLTDEAALSCCSDADPSTKDFLLQQTMLRVKDPKKSLDFYTRVLGMTLIQKCDFPIMKFSLYFLAYEDKNDIPKEKDEKIAWALSRKATLELTHNWGTEDDETQSYHNGNSDPRGFGHIGIAVPDVYSACKRFEELGVKFVKKPDDGKMKGLAFIQDPDGYWIEILNPNKMATLM","Homo sapiens","GLO1","Lactoylglutathione lyase","1","3W0T"
"3W0U",,"X-RAY DIFFRACTION",2.4,47.5,"VAPOR DIFFUSION, HANGING DROP",7,"25% (w/v) PEG 2000 MME, 10%(v/v) Glycerol, 0.1M Na-HEPES (pH 7.0), vapor diffusion, hanging drop, temperature 293K",293,,,"3W0U",43.2,"1.7","1.7","human Glyoxalase I with an N-hydroxypyridone inhibitor","GSHMAEPQPPSGGLTDEAALSCCSDADPSTKDFLLQQTMLRVKDPKKSLDFYTRVLGMTLIQKCDFPIMKFSLYFLAYEDKNDIPKEKDEKIAWALSRKATLELTHNWGTEDDETQSYHNGNSDPRGFGHIGIAVPDVYSACKRFEELGVKFVKKPDDGKMKGLAFIQDPDGYWIEILNPNKMATLM","Homo sapiens","GLO1","Lactoylglutathione lyase","1","3W0U"
"3W0Y",,"X-RAY DIFFRACTION",2.67,53.88,"VAPOR DIFFUSION, HANGING DROP",6.3,"pH 6.3, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"3W0Y",29.34,"1.98","1.98","Crystal Structure Analysis of Vitamin D receptor","LRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFG","Homo sapiens","VDR, NR1I1","Vitamin D3 receptor","1","3W0Y"
,,,,,,,,,,,,,,,,,"Homo sapiens","VDR, NR1I1"
"3W10",,"X-RAY DIFFRACTION",2.98,58.78,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 3350, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,,,"3W10",32.49,"2.7","2.7","Aurora kinase A complexed to pyrazole aminoquinoline I","RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","3W10"
"3W16",,"X-RAY DIFFRACTION",2.62,53.02,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"3W16",32.53,"2.8","2.8","Structure of Aurora kinase A complexed to pyrazole-aminoquinoline inhibitor III","RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","3W16"
"3W18",,"X-RAY DIFFRACTION",2.16,43,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"3W18",65.33,"2.5","2.5","Structure of Aurora kinase A complexed to benzoimidazole-indazole inhibitor XIII","RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","3W18"
"3W1F",,"X-RAY DIFFRACTION",2.94,58.1,"VAPOR DIFFUSION, SITTING DROP",,"11.5% w/v PEG 4000, 0.15M Magnesium formate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm4000215","1O5","3W1F",37.27,"2.7","2.7","Crystal structure of Human MPS1 catalytic domain in complex with 5-(5-ethoxy-6-(1-methyl-1H-pyrazol-4-yl)-1H-indazol-3-yl)-2-methylbenzenesulfonamide","MECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNLVPRGSAAGHHHHHH","Homo sapiens","TTK, MPS1, MPS1L1","Dual specificity protein kinase TTK","1","3W1F"
"3W1W",,"X-RAY DIFFRACTION",2.65,53.57,"VAPOR DIFFUSION, SITTING DROP",4.8,"0.1M PCB, 10% PEG1500, pH 4.8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1124/mol.113.087940",,"3W1W",89.18,"2.006","2.006","Protein-drug complex","MAHHHHHHQPQKRKPKTGILMLNMGGPETLGDVHDFLLRLFLDRDLMTLPIQNKLAPFIAKRLTPKIQEQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERDGLERAIAFTQYPQYSCSTTGSSLNAIYRYYNQVGRKPTMKWSTIDRWPTHHLLIQCFADHILKELDHFPLEKRSEVVILFSAHSLPMSVVNRGDPYPQEVSATVQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIAFTSDHIETLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSCPLCVNPVCRETKSFFTSQQL","Homo sapiens","FECH","Ferrochelatase, mitochondrial","1","3W1W"
"3W2C",,"X-RAY DIFFRACTION",2.11,41.74,"VAPOR DIFFUSION, SITTING DROP",7,"PEG 3350, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,,,"3W2C",122.95,"2.45","2.45","Structure of Aurora kinase A complexed to benzoimidazole-indazole inhibitor XV","WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","Aurora kinase A","1","3W2C"
"3W2O",,"X-RAY DIFFRACTION",3.27,62.37,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M Bis-tris propane pH 6.5, 35% Tacsimate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/ml300327z","03P","3W2O",38.57,"2.35","2.35","EGFR Kinase domain T790M/L858R Mutant with TAK-285","HHHHHHAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","3W2O"
"3W2P",,"X-RAY DIFFRACTION",3.34,63.17,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M Bis-tris propane pH 6.5, 35% Tacsimate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/ml300327z","W2P","3W2P",38.58,"2.05","2.05","EGFR Kinase domain T790M/L858R mutant with compound 2","HHHHHHAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","3W2P"
"3W2Q",,"X-RAY DIFFRACTION",3.28,62.5,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M Bis-tris propane pH 6.5, 35% Tacsimate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/ml300327z","HKI","3W2Q",38.78,"2.2","2.2","EGFR kinase domain T790M/L858R mutant with HKI-272","HHHHHHAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","3W2Q"
"3W2R",,"X-RAY DIFFRACTION",2.09,41.07,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M Mes pH 5.5, 24% PEG 3350 , VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/ml300327z","W2R","3W2R",38.65,"2.05","2.05","EGFR Kinase domain T790M/L858R mutant with compound 4","HHHHHHAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","3W2R"
"3W2S",,"X-RAY DIFFRACTION",2.24,45.01,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M Bis-tris pH 6.5, 0.2M lithium sulfate, 24% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/ml300327z","W2R","3W2S",38.32,"1.9","1.9","EGFR kinase domain with compound4","GAMGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","3W2S"
"3W2T",,"X-RAY DIFFRACTION",2.98,58.69,"VAPOR DIFFUSION, SITTING DROP",8.8,"20% PEG 4000, 0.18M sodium acetate, 0.18M glycine-sodium hydroxide, pH 8.8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bbrc.2013.03.010","LF7","3W2T",176.94,"2.36","2.36","Crystal structure of human depiptidyl peptidase IV (DPP-4) in complex with vildagliptin","DDATADSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLPHHHHHH","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","3W2T"
"3W32",,"X-RAY DIFFRACTION",2.18,43.59,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M MES, 0.2M lithium sulfate, 25% PEG 3350, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.bmc.2013.02.014","W32","3W32",38.24,"1.8","1.8","EGFR kinase domain complexed with compound 20a","GAMGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","3W32"
"3W33",,"X-RAY DIFFRACTION",2.25,45.42,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M MES, 0.2M lithium sulfate, 25% PEG 3350, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K",298,"10.1016/j.bmc.2013.02.014","W19","3W33",38.17,"1.7","1.7","EGFR kinase domain complexed with compound 19b","GAMGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","3W33"
"3W3B",,"X-RAY DIFFRACTION",2.04,39.72,"VAPOR DIFFUSION, HANGING DROP",7,"pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3W3B",27.55,"1.9","1.9","Crystal structure of wild-type human transthyretin","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","3W3B"
"3W3G",,"X-RAY DIFFRACTION",2.58,52.34,"VAPOR DIFFUSION, SITTING DROP",8.2,"11.75% PEG8000, 0.2M NaCl, 0.1M Tris, pH 8.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1126/science.1229159",,"3W3G",191.33,"2.3","2.3","Crystal structure of human TLR8 (unliganded form)","RSPWEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTEFLVPR","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","3W3G"
"3W3J",,"X-RAY DIFFRACTION",2.39,48.44,"VAPOR DIFFUSION, SITTING DROP",5.1,"14%(w/v) PEG3350, 0.2M potassium formate, 0.1M sodium citrate, pH 5.1, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1126/science.1229159",,"3W3J",193.07,"2","2","Crystal structure of human TLR8 in complex with CL097","RSPWEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTEFLVPR","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","3W3J"
"3W3K",,"X-RAY DIFFRACTION",2.54,51.6,"VAPOR DIFFUSION, SITTING DROP",5.1,"14%(w/v) PEG3350, 0.2M potassium formate, 0.1M sodium citrate, pH 5.1, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1126/science.1229159","L07","3W3K",192.14,"2.3","2.3","Crystal structure of human TLR8 in complex with CL075","RSPWEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTEFLVPR","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","3W3K"
"3W3L",,"X-RAY DIFFRACTION",2.74,55.12,"VAPOR DIFFUSION, SITTING DROP",5.2,"14%(w/v) PEG3350, 0.1M MES, 0.15M ammonium sulfate, pH 5.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1126/science.1229159","RX8","3W3L",386.32,"2.33","2.33","Crystal structure of human TLR8 in complex with Resiquimod (R848) crystal form 1","RSPWEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTEFLVPR","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","3W3L"
"3W3M",,"X-RAY DIFFRACTION",2.7,54.46,"VAPOR DIFFUSION, SITTING DROP",5.1,"12%(w/v) PEG3350, 0.2M potassium formate, 0.1M sodium citrate, pH 5.1, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1126/science.1229159","RX8","3W3M",96.54,"2.7","2.7","Crystal structure of human TLR8 in complex with Resiquimod (R848) crystal form 2","RSPWEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTEFLVPR","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","3W3M"
"3W3N",,"X-RAY DIFFRACTION",3.11,60.4,"VAPOR DIFFUSION, SITTING DROP",5.1,"12% (w/v) PEG3350, 0.2 M potassium formate, 0.1 M sodium citrate, and 20% glycerol, pH 5.1, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1126/science.1229159","RX8","3W3N",194.08,"2.1","2.1","Crystal structure of human TLR8 in complex with Resiquimod (R848) crystal form 3","RSPWEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTEFLVPR","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","3W3N"
"3W4I",,"X-RAY DIFFRACTION",2.16,43.07,"sitting drop vapor diffusion",8,"10-15% (w/v) PEG 4000, 0.1M sodium citrate pH8.0, 0.2M ammonium dihydrogen phosphate, 10% (v/v) glycerol, sitting drop vapor diffusion, temperature 298K",298,"10.1021/jm400095b","8LG","3W4I",161.67,"2.5","2.5","Crystal Structure of human DAAO in complex with coumpound 8","MRVVVIGAGVIGLSTALCIHERYHSVLQPLDIKVYADRFTPLTTTDVAAGLWQPYLSDPNNPQEADWSQQTFDYLLSHVHSPNAENLGLFLISGYNLFHEAIPDPSWKDTVLGFRKLTPRELDMFPDYGYGWFHTSLILEGKNYLQWLTERLTERGVKFFQRKVESFEEVAREGADVIVNCTGVWAGALQRDPLLQPGRGQIMKVDAPWMKHFILTHDPERGIYNSPYIIPGTQTVTLGGIFQLGNWSELNNIQDHNTIWEGCCRLEPTLKNARIIGERTGFRPVRPQIRLEREQLRTGPSNTEVIHNYGHGGYGLTIHWGCALEAAKLFGRILEEKKLSRMPPSHL","Homo sapiens","DAO, DAMOX","D-amino-acid oxidase","1","3W4I"
"3W4J",,"X-RAY DIFFRACTION",2.18,43.6,"sitting drop vapor diffusion",8,"10-15% (w/v) PEG 4000, 0.1M sodium citrate pH 8.0, 0.2M ammonium dihydrogen phosphate, 10% (v/v) glycerol, sitting drop vapor diffusion, temperature 298K",298,"10.1021/jm400095b","2LD","3W4J",162.09,"2.74","2.74","Crystal Structure of human DAAO in complex with coumpound 12","MRVVVIGAGVIGLSTALCIHERYHSVLQPLDIKVYADRFTPLTTTDVAAGLWQPYLSDPNNPQEADWSQQTFDYLLSHVHSPNAENLGLFLISGYNLFHEAIPDPSWKDTVLGFRKLTPRELDMFPDYGYGWFHTSLILEGKNYLQWLTERLTERGVKFFQRKVESFEEVAREGADVIVNCTGVWAGALQRDPLLQPGRGQIMKVDAPWMKHFILTHDPERGIYNSPYIIPGTQTVTLGGIFQLGNWSELNNIQDHNTIWEGCCRLEPTLKNARIIGERTGFRPVRPQIRLEREQLRTGPSNTEVIHNYGHGGYGLTIHWGCALEAAKLFGRILEEKKLSRMPPSHL","Homo sapiens","DAO, DAMOX","D-amino-acid oxidase","1","3W4J"
"3W4K",,"X-RAY DIFFRACTION",2.2,43.98,"sitting drop vapor diffusion",8,"10-15% (w/v) PEG 4000, 0.1M sodium citrate pH8.0, 0.2M ammonium dihydrogen phosphate, 10% (v/v) glycerol, sitting drop vapor diffusion, temperature 298K",298,"10.1021/jm400095b","3LD","3W4K",162.09,"2.86","2.86","Crystal Structure of human DAAO in complex with coumpound 13","MRVVVIGAGVIGLSTALCIHERYHSVLQPLDIKVYADRFTPLTTTDVAAGLWQPYLSDPNNPQEADWSQQTFDYLLSHVHSPNAENLGLFLISGYNLFHEAIPDPSWKDTVLGFRKLTPRELDMFPDYGYGWFHTSLILEGKNYLQWLTERLTERGVKFFQRKVESFEEVAREGADVIVNCTGVWAGALQRDPLLQPGRGQIMKVDAPWMKHFILTHDPERGIYNSPYIIPGTQTVTLGGIFQLGNWSELNNIQDHNTIWEGCCRLEPTLKNARIIGERTGFRPVRPQIRLEREQLRTGPSNTEVIHNYGHGGYGLTIHWGCALEAAKLFGRILEEKKLSRMPPSHL","Homo sapiens","DAO, DAMOX","D-amino-acid oxidase","1","3W4K"
"3W51",,"X-RAY DIFFRACTION",2.72,54.76,"VAPOR DIFFUSION, HANGING DROP",8.5,"17% PEG 3350, 0.2M Ammoniumsulphate, 0.1M Tris pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1021/jm400211f","AJ2","3W51",48.82,"2","2","Tankyrase in complex with 2-hydroxy-4-methylquinoline","GTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPE","Homo sapiens","PARP5B, TANK2, TNKL, TNKS2","Tankyrase-2","1","3W51"
"3W55",,"X-RAY DIFFRACTION",2.24,44.97,"VAPOR DIFFUSION, SITTING DROP",6.5,"PEG 5000, AMMONIUM SULPHATE, DITHIOTHREITOL, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bbrc.2006.12.083","FRR, 1FM","3W55",42.59,"3","3","The structure of ERK2 in complex with FR148083","GDLGSDELMAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","3W55"
"3W58",,"X-RAY DIFFRACTION",3.14,60.82,"VAPOR DIFFUSION, HANGING DROP",5.1,"2.0M ammonium sulfate, 1% 2-Mercaptoethanol, pH 5.1, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"3W58",59.79,"1.58","1.58","Crystal structure of Galectin-1 in the lactose-unbound state(P21)","ACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","1","3W58"
"3W59",,"X-RAY DIFFRACTION",3.25,62.2,"VAPOR DIFFUSION, HANGING DROP",5.1,"2.0M ammonium sulfate, 1% 2-Mercaptoethanol, pH 5.1, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"3W59",59.2,"2.1","2.1","Crystal structure of Galectin-1 in the lactose-unbound state(P212121)","ACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD","Homo sapiens","LGALS1","Galectin-1","1","3W59"
"3W5E",,"X-RAY DIFFRACTION",2.15,42.8,"VAPOR DIFFUSION, HANGING DROP",8,"10-20% PEG 3350, 0.2-0.4M CaCl2, 0.1M Tris/HCl (pH8.0), vapor diffusion, hanging drop, temperature 295K",295,"10.1016/j.bmcl.2013.03.104","NVW","3W5E",87.85,"2.3","2.3","Crystal structure of phosphodiesterase 4B in complex with compound 31e","SISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHS","Homo sapiens","DPDE4, PDE4B","cAMP-specific 3',5'-cyclic phosphodiesterase 4B","1","3W5E"
"3W5O",,"X-RAY DIFFRACTION",3.07,59.91,"VAPOR DIFFUSION, HANGING DROP",5.7,"2M ammonium sulfate, 10mM YCl, 100mM MES, pH 5.7, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1016/j.str.2013.02.014",,"3W5O",142.4,"2.84","2.84","Crystal Structure of Human DNA ligase IV","TMAASQTSQTVASHVPFADLCSTLERIQKSKGRAEKIRHFREFLDSWRKFHDALHKNHKDVTDSFYPAMRLILPQLERERMAYGIKETMLAKLYIELLNLPRDGKDALKLLNYRTPTGTHGDAGDFAMIAYFVLKPRCLQKGSLTIQQVNDLLDSIASNNSAKRKDLIKKSLLQLITQSSALEQKWLIRMIIKDLKLGVSQQTIFSVFHNDAAELHNVTTDLEKVCRQLHDPSVGLSDISITLFSAFKPMLAAIADIEHIEKDMKHQSFYIETKLDGERMQMHKDGDVYKYFSRNGYNYTDQFGASPTEGSLTPFIHNAFKADIQICILDGEMMAYNPNTQTFMQKGTKFDIKRMVEDSDLQTCYCVFDVLMVNNKKLGHETLRKRYEILSSIFTPIPGRIEIVQKTQAHTKNEVIDALNEAIDKREEGIMVKQPLSIYKPDKRGEGWLKIKPEYVSGLMDELDILIVGGYWGKGSRGGMMSHFLCAVAEKPPPGEKPSVFHTLSRVGSGCTMKELYDLGLKLAKYWKPFHRKAPPSSILCGTEKPEVYIEPCNSVIVQIKAAEIVPSDMYKTGCTLRFPRIEKIRDDKEWHECMTLDDLEQLRGKASGK","Homo sapiens","LIG4","DNA ligase 4","1","3W5O"
"3W69",,"X-RAY DIFFRACTION",3.51,64.99,"VAPOR DIFFUSION, SITTING DROP",8.1,"2.4M Ammonium sulfate, 5% PEG 200, 0.1M Tris HCl, pH 8.1 , VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmc.2013.04.056","LTZ","3W69",22.09,"1.9","1.9","Crystal structure of human mdm2 with a dihydroimidazothiazole inhibitor","GSETLVRPKPELLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVV","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","3W69"
"3W6H",,"X-RAY DIFFRACTION",2.12,41.97,"VAPOR DIFFUSION, HANGING DROP",6.3,"23 or 25% polyethylene glycol (PEG) 3350, 200mM NaCl, 100mM MES (pH 6.3), VAPOR DIFFUSION, HANGING DROP, temperature 297K",297,,"AZM","3W6H",58.73,"2.964","2.964","Crystal structure of 19F probe-labeled hCAI in complex with acetazolamide","ASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","3W6H"
"3W6I",,"X-RAY DIFFRACTION",2.27,45.71,"VAPOR DIFFUSION, HANGING DROP",6.3,"23-25% PEG 3350, 200mM NaCl, 100mM MES (pH 6.3)., VAPOR DIFFUSION, HANGING DROP, temperature 297K",297,,,"3W6I",58.29,"2.693","2.693","Crystal structure of 19F probe-labeled hCAI","ASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF","Homo sapiens","CA1","Carbonic anhydrase 1","1","3W6I"
"3W6N",,"X-RAY DIFFRACTION",2.22,44.67,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG 550 MME, 0.05M calcium chloride, 0.1M Bis-Tris-HCl, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3W6N",82.64,"2","2","Crystal structure of human Dlp1 in complex with GMP-PN.Pi","GPMEALIPVINKLQDVFNTVGADIIQLPQIVVVGTQSSGKSSVLESLVGRDLLPRGTGIVTRRPLILQLVHVSQEDKRKTTGEENGVEAEEWGKFLHTKNKLYTDFDEIRQEIENETERISGNNKGVSPEPIHLKIFSPNVVNLTLVDLPGMTKVPVGDQPKDIELQIRELILRFISNPNSIILAVTAANTDMATSEALKISREVDPDGRRTLAVITKLDLMDAGTDAMDVLMGRVIPVKLGIIGVVNRSQLDINNKKSVTDSIRDEYAFLQKKYPSLANRNGTKYLARTLNRLLMHHIRDCLPELKTRINVLAAQYQSLLNSYGEPVDDKHGTDSRRKEAADMLKALQGASQIIAEIRETHLW","Homo sapiens","DNM1L, DLP1, DRP1","Dynamin-1-like protein","1","3W6N"
,,,,,,,,,,,,,,,,,"Homo sapiens","DNM1L, DLP1, DRP1"
"3W6O",,"X-RAY DIFFRACTION",2.21,44.36,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG 550 MME, 0.05M calcium chloride, 0.1M Bis-Tris-HCl, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3W6O",82.6,"1.9","1.9","Crystal structure of human Dlp1 in complex with GMP-PCP","GPMEALIPVINKLQDVFNTVGADIIQLPQIVVVGTQSSGKSSVLESLVGRDLLPRGTGIVTRRPLILQLVHVSQEDKRKTTGEENGVEAEEWGKFLHTKNKLYTDFDEIRQEIENETERISGNNKGVSPEPIHLKIFSPNVVNLTLVDLPGMTKVPVGDQPKDIELQIRELILRFISNPNSIILAVTAANTDMATSEALKISREVDPDGRRTLAVITKLDLMDAGTDAMDVLMGRVIPVKLGIIGVVNRSQLDINNKKSVTDSIRDEYAFLQKKYPSLANRNGTKYLARTLNRLLMHHIRDCLPELKTRINVLAAQYQSLLNSYGEPVDDKHGTDSRRKEAADMLKALQGASQIIAEIRETHLW","Homo sapiens","DNM1L, DLP1, DRP1","Dynamin-1-like protein","1","3W6O"
,,,,,,,,,,,,,,,,,"Homo sapiens","DNM1L, DLP1, DRP1"
"3W6P",,"X-RAY DIFFRACTION",2.23,44.76,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG 550 MME, 0.05M calcium chloride, 0.1M Bis-Tris-HCl, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3W6P",82.7,"1.7","1.7","Crystal structure of human Dlp1 in complex with GDP.AlF4","GPMEALIPVINKLQDVFNTVGADIIQLPQIVVVGTQSSGKSSVLESLVGRDLLPRGTGIVTRRPLILQLVHVSQEDKRKTTGEENGVEAEEWGKFLHTKNKLYTDFDEIRQEIENETERISGNNKGVSPEPIHLKIFSPNVVNLTLVDLPGMTKVPVGDQPKDIELQIRELILRFISNPNSIILAVTAANTDMATSEALKISREVDPDGRRTLAVITKLDLMDAGTDAMDVLMGRVIPVKLGIIGVVNRSQLDINNKKSVTDSIRDEYAFLQKKYPSLANRNGTKYLARTLNRLLMHHIRDCLPELKTRINVLAAQYQSLLNSYGEPVDDKHGTDSRRKEAADMLKALQGASQIIAEIRETHLW","Homo sapiens","DNM1L, DLP1, DRP1","Dynamin-1-like protein","1","3W6P"
,,,,,,,,,,,,,,,,,"Homo sapiens","DNM1L, DLP1, DRP1"
"3W6R",,"X-RAY DIFFRACTION",2.13,42.21,"VAPOR DIFFUSION, SITTING DROP",5.7,"100mM sodium cacodylate buffer, 13% polyethylene glycol 6000, 25% glycerol, pH 5.7, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,"10.1016/j.bbrc.2013.04.094",,"3W6R",22.79,"1.9","1.9","Crystal structure of the GAP domain of human MgcRacGAP","GAMEGMLADFVSQTSPMIPSIVVHCVNEIEQRGLTETGLYRISGCDRTVKELKEKFLRVKTVPLLSKVDDIHAICSLLKDFLRNLKEPLLTFRLNRAFMEAAEITDEDNSIAAMYQAVGELPQANRDTLAFLMIHLQRVAQSPHTKMDVANLAKVFGPTIVAHAVPNPDPVTMLQDIKRQPKVVERLLSLPLEYWSQFMMVE","Homo sapiens","RACGAP1, KIAA1478, MGCRACGAP","Rac GTPase-activating protein 1","1","3W6R"
"3W7R",,"X-RAY DIFFRACTION",3.41,63.91,"VAPOR DIFFUSION, HANGING DROP",4.9,"100mM SODIUM ACETATE, 1.8-1.9M AMMONIUM SULPHATE, 40mM C11DAO, 20.8mM DDAO, 2mM DIHYDROOROTATE, pH 4.9, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3W7R",47.65,"1.68","1.68","Structure of Human dihydroorotate dehydrogenase in complex with mii-4-097","MGHHHHHHHHHHSSGHIDDDDKHMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","PyrD, DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","3W7R"
"3W7Y",,"X-RAY DIFFRACTION",1.85,33.39,"VAPOR DIFFUSION, HANGING DROP",8.67,"10mg/ml protein, 0.1M Sodium Citrate, 22% DMF(v/v) and 0.08% Zinc chloride(w/v), pH 8.67, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3W7Y",11.77,"0.92","0.92","0.92A structure of 2Zn human insulin at 100K","FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin","2","3W7Y"
,,,,,,,,,,,,,,,,"GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","3W7Y"
"3W7Z",,"X-RAY DIFFRACTION",1.93,36.41,"VAPOR DIFFUSION, HANGING DROP",8.67,"10mg/ml protein, 0.1M Sodium Citrate, 22%(v/v) DMF, 0.08%(w/v) Zinc chloride, pH 8.67, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3W7Z",11.77,"1.15","1.15","1.15A structure of human 2Zn insulin at 293K","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","3W7Z"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin","2","3W7Z"
"3W80",,"X-RAY DIFFRACTION",1.93,36.2,"VAPOR DIFFUSION, HANGING DROP",8.67,"10mg/ml protein, 0.1M Sodium Citrate, 22%(v/v) DMF, 0.08%(w/v) Zinc chloride, pH 8.67, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3W80",23.53,"1.4","1.4","Crystal structure of dodecamer human insulin with double C-axis length of the hexamer 2 Zn insulin cell","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin","1","3W80"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin","2","3W80"
"3W81",,"X-RAY DIFFRACTION",3.31,62.86,"VAPOR DIFFUSION, HANGING DROP",6.5,"18%(w/v) PEG 3350, 0.18M K/Na tartrate, 3%(w/v) PEG MME 5000, 0.02M ammonium sulfate, 0.01M MES-Na, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 288K",288,"10.1073/pnas.1306939110",,"3W81",147.61,"2.3","2.3","Human alpha-l-iduronidase","EAPHLVHVDAARALWPLRRFWRSTGFCPPLPHSQADQYVLSWDQQLNLAYVGAVPHRGIKQVRTHWLLELVTTRGSTGRGLSYNFTHLDGYLDLLRENQLLPGFELMGSASGHFTDFEDKQQVFEWKDLVSSLARRYIGRYGLAHVSKWNFETWNEPDHHDFDNVSMTMQGFLNYYDACSEGLRAASPALRLGGPGDSFHTPPRSPLSWGLLRHCHDGTNFFTGEAGVRLDYISLHRKGARSSISILEQEKVVAQQIRQLFPKFADTPIYNDEADPLVGWSLPQPWRADVTYAAMVVKVIAQHQNLLLANTTSAFPYALLSNDNAFLSYHPHPFAQRTLTARFQVNNTRPPHVQLLRKPVLTAMGLLALLDEEQLWAEVSQAGTVLDSNHTVGVLASAHRPQGPADAWRAAVLIYASDDTRAHPNRSVAVTLRLRGVPPGPGLVYVTRYLDNGLCSPDGEWRRLGRPVFPTAEQFRRMRAAEDPVAAAPRPLPAGGRLTLRPALRLPSLLLVHVCARPEKPPGQVTRLRALPLTQGQLVLVWSDEHVGSKCLWTYEIQFSQDGKAYTPVSRKPSTFNLFVFSPDTGAVSGSYRVRALDYWARPGPFSDPVPYLEVPVPRGPPSPGNP","Homo sapiens","IDUA","Alpha-L-iduronidase","1","3W81"
"3W82",,"X-RAY DIFFRACTION",3.03,59.38,"VAPOR DIFFUSION, HANGING DROP",6.5,"18%(w/v) PEG 3350, 0.18M K/Na tartrate, 3% (w/v)PEG MME 5000, 0.02M ammonium sulfate, 0.01M MES-Na, 7mM IdoA, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 288K",288,"10.1073/pnas.1306939110",,"3W82",146.06,"2.76","2.76","Human alpha-L-iduronidase in complex with iduronic acid","EAPHLVHVDAARALWPLRRFWRSTGFCPPLPHSQADQYVLSWDQQLNLAYVGAVPHRGIKQVRTHWLLELVTTRGSTGRGLSYNFTHLDGYLDLLRENQLLPGFELMGSASGHFTDFEDKQQVFEWKDLVSSLARRYIGRYGLAHVSKWNFETWNEPDHHDFDNVSMTMQGFLNYYDACSEGLRAASPALRLGGPGDSFHTPPRSPLSWGLLRHCHDGTNFFTGEAGVRLDYISLHRKGARSSISILEQEKVVAQQIRQLFPKFADTPIYNDEADPLVGWSLPQPWRADVTYAAMVVKVIAQHQNLLLANTTSAFPYALLSNDNAFLSYHPHPFAQRTLTARFQVNNTRPPHVQLLRKPVLTAMGLLALLDEEQLWAEVSQAGTVLDSNHTVGVLASAHRPQGPADAWRAAVLIYASDDTRAHPNRSVAVTLRLRGVPPGPGLVYVTRYLDNGLCSPDGEWRRLGRPVFPTAEQFRRMRAAEDPVAAAPRPLPAGGRLTLRPALRLPSLLLVHVCARPEKPPGQVTRLRALPLTQGQLVLVWSDEHVGSKCLWTYEIQFSQDGKAYTPVSRKPSTFNLFVFSPDTGAVSGSYRVRALDYWARPGPFSDPVPYLEVPVPRGPPSPGNP","Homo sapiens","IDUA","Alpha-L-iduronidase","1","3W82"
"3W8L",,"X-RAY DIFFRACTION",2.35,47.72,"VAPOR DIFFUSION, SITTING DROP",7.5,"17% polyethylene glycol 4000, 15% glycerol, 8.5% isopropanol, 0.085M Sodium HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 296K",296,"10.1073/pnas.1304670110",,"3W8L",81.43,"2.4","2.4","Crystal structure of human CK2 in complex with inositol hexakisphosphate","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAVNITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3W8L"
"3W8Q",,"X-RAY DIFFRACTION",2.03,39.44,"VAPOR DIFFUSION, SITTING DROP",6,"16%(w/v) PEG 3350, 0.1M ammonium citrate, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 277.0K",277,"10.1107/S2053230X21011687",,"3W8Q",39.76,"2.2","2.2","Structure of the Human Mitogen-Activated Protein Kinase Kinase 1 (MEK1)","ELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRAPGRPLASYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNHHHHHH","Homo sapiens","MAP2K1, MEK1, PRKMK1","Dual specificity mitogen-activated protein kinase kinase 1","1","3W8Q"
"3W9D",,"X-RAY DIFFRACTION",2.54,51.63,"VAPOR DIFFUSION",5.8,"25%(w/v) PEG 4000, 10mM calcium chloride dihydrate, 100mM sodium citrate tribasic dihydrate, pH 5.8, VAPOR DIFFUSION, temperature 298K",298,"10.1107/S0907444913016776",,"3W9D",93.5,"2.32","2.32","Structure of Human Monoclonal Antibody E317 Fab","QVTLKQSGAEVKKPGSSVKVSCTASGGTLRTYGVSWVRQAPGQGLEWLGRTIPLFGKTDYAQKFQGRVTITADKSMDTSFMELTSLTSEDTAVYYCARDLTTLTSYNWWDLWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEP","Homo sapiens",,"Antibody Fab heavy chain","1","3W9D"
,,,,,,,,,,,,,,,,"EIVLTQSPGTLSLSPGERATLSCRASQSVTSSQLAWYQQKPGQAPRLLISGASNRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKLYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Antibody Fab light chain","2","3W9D"
"3W9Y",,"X-RAY DIFFRACTION",2.39,48.56,"VAPOR DIFFUSION, SITTING DROP",,"0.2M sodium thiocyanate, 22% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bbrc.2013.04.056",,"3W9Y",23.4,"2.2","2.2","Crystal structure of the human DLG1 guanylate kinase domain","GSSGSSGNYTRPVIILGPMKDRINDDLISEFPDKFGSCVPHTTRPKRDYEVDGRDYHFVTSREQMEKDIQEHKFIEAGQYNNHLYGTSVQSVREVAEKGKHCILDVSGNAIKRLQIAQLYPISIFIKPKSMENIMEMNKRLTEEQARKTFERAMKLEQEFTEHFTAIVQGDTLEDIYNQVKQIIEEQSGSYIWVPAKEKL","Homo sapiens","DLG1","Disks large homolog 1","1","3W9Y"
"3WAL",,"X-RAY DIFFRACTION",2.44,49.51,"VAPOR DIFFUSION, SITTING DROP",5,"0.2M Sodium malonate, 20% PEG 3350, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.str.2013.09.023",,"3WAL",14.81,"2","2","Crystal structure of human LC3A_2-121","GSPEFPSDRPFKQRRSFADRCKEVQQIRDQHPSKIPVIIERYKGEKQLPVLDKTKFLVPDHVNMSELVKIIRRRLQLNPTQAFFLLVNQHSMVSVSTPIADIYEQEKDEDGFLYMVYASQETFGF","Homo sapiens","MAP1LC3A","Microtubule-associated proteins 1A/1B light chain 3A","1","3WAL"
"3WAM",,"X-RAY DIFFRACTION",2.96,58.46,"VAPOR DIFFUSION, HANGING DROP",5,"0.5M di-Ammonium hydrogen citrate, 10% PEG 3350, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.str.2013.09.023",,"3WAM",14.14,"1.75","1.75","Crystal structure of human LC3C_8-125","GSPSVRPFKQRKSLAIRQEEVAGIRAKFPNKIPVVVERYPRETFLPPLDKTKFLVPQELTMTQFLSIIRSRMVLRATEAFYLLVNNKSLVSMSATMAEIYRDYKDEDGFVYMTYASQETF","Homo sapiens","MAP1LC3C","Microtubule-associated proteins 1A/1B light chain 3C","1","3WAM"
"3WAN",,"X-RAY DIFFRACTION",2.03,39.36,"VAPOR DIFFUSION, SITTING DROP",4.6,"12% MPD, 0.1M Sodium chloride, 0.1M Sodium acetate trihydrate, pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.str.2013.09.023",,"3WAN",31.63,"1.77","1.77","Crystal structure of Atg13 LIR-fused human LC3A_2-121","GSSSGNTHDDFVMIGSPSDRPFKQRRSFADRCKEVQQIRDQHPSKIPVIIERYKGEKQLPVLDKTKFLVPDHVNMSELVKIIRRRLQLNPTQAFFLLVNQHSMVSVSTPIADIYEQEKDEDGFLYMVYASQETFGF","Homo sapiens","MAP1LC3A","Autophagy-related protein 13, Microtubule-associated proteins 1A/1B light chain 3A","1","3WAN"
,,,,,,,,,,,,,,,,,"Homo sapiens","MAP1LC3A"
"3WAO",,"X-RAY DIFFRACTION",2.18,43.66,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Sodium citrate tribasic dihydrate 10% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.str.2013.09.023",,"3WAO",62.22,"2.6","2.6","Crystal structure of Atg13 LIR-fused human LC3B_2-119","GSSSGNTHDDFVMIGSPSEKTFKQRRTFEQRVEDVRLIREQHPTKIPVIIERYKGEKQLPVLDKTKFLVPDHVNMSELIKIIRRRLQLNANQAFFLLVNGHSMVSVSTPISEVYESEKDEDGFLYMVYASQETF","Homo sapiens","MAP1LC3B, MAP1ALC3","Autophagy-related protein 13, Microtubule-associated proteins 1A/1B light chain 3B","1","3WAO"
,,,,,,,,,,,,,,,,,"Homo sapiens","MAP1LC3B, MAP1ALC3"
"3WAP",,"X-RAY DIFFRACTION",3.42,64.08,"VAPOR DIFFUSION, SITTING DROP",4.6,"0.1M Sodium acetate trihydrate, 8% PEG 4000, pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.str.2013.09.023",,"3WAP",15.4,"3.1","3.1","Crystal structure of Atg13 LIR-fused human LC3C_8-125","GSSSGNTHDDFVMIGSPSVRPFKQRKSLAIRQEEVAGIRAKFPNKIPVVVERYPRETFLPPLDKTKFLVPQELTMTQFLSIIRSRMVLRATEAFYLLVNNKSLVSMSATMAEIYRDYKDEDGFVYMTYASQETF","Homo sapiens","MAP1LC3C","Autophagy-related protein 13, Microtubule-associated proteins 1A/1B light chain 3C","1","3WAP"
,,,,,,,,,,,,,,,,,"Homo sapiens","MAP1LC3C"
"3WAR",,"X-RAY DIFFRACTION",1.97,37.5,"VAPOR DIFFUSION, SITTING DROP",8,"25% ethylene glycol, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1107/S0909049513020785",,"3WAR",41.78,"1.04","1.04","Crystal structure of human CK2a","GPLGSMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3WAR"
"3WB4",,"X-RAY DIFFRACTION",2.76,55.47,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.164M Na3-citrate, 0.15M ammonium iodide, 22.8%(w/v) PEG5000MME, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmc.2013.08.036","0B3","3WB4",47.26,"2.25","2.25","Crystal Structure of beta secetase in complex with 2-amino-3,6-dimethyl-6-(2-phenylethyl)-3,4,5,6-tetrahydropyrimidin-4-one","GSHMLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3WB4"
"3WB5",,"X-RAY DIFFRACTION",2.73,54.95,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.191M Na3-citrate, 0.133M ammonium iodide, 20.6%(w/v) PEG5000MME, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmc.2013.08.036","0B4","3WB5",47.29,"2.501","2.501","Crystal Structure of beta secetase in complex with (6S)-2-amino-3,6-dimethyl-6-[(1R,2R)-2-phenylcyclopropyl]-3,4,5,6-tetrahydropyrimidin-4-one","GSHMLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","3WB5"
"3WBG",,"X-RAY DIFFRACTION",1.78,30.86,"VAPOR DIFFUSION, SITTING DROP",6,"100mM MES, 30% PEG3350, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S0909049513021298",,"3WBG",69.4,"2.15","2.15","Structure of the human heart fatty acid-binding protein in complex with 1-anilinonaphtalene-8-sulphonic acid","MGSSHHHHHHSSGLVPRGSHMVDAFLGTWKLVDSKNFDDYMKSLGVGFATRQVASMTKPTTIIEKNGDILTLKTHSTFKNTEISFKLGVEFDETTADDRKVKSIVTLDGGKLVHLQKWDGQETTLVRELIDGKLILTLTHGTAVCTRTYEKEA","Homo sapiens","FABP3, FABP11, MDGI","Fatty acid-binding protein, heart","1","3WBG"
"3WBL",,"X-RAY DIFFRACTION",2.07,40.48,"VAPOR DIFFUSION, SITTING DROP",7.4,"PEG3350, Ammonium Acetate, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1107/S0909049513020736","PDY","3WBL",34.4,"2","2","Crystal structure of CDK2 in complex with pyrazolopyrimidine inhibitor","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","Cyclin-dependent kinase 2","1","3WBL"
"3WBP",,"X-RAY DIFFRACTION",2.08,40.99,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES, 1.5M lithium sulfate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/prot.24504",,"3WBP",36.3,"1.8","1.8","Crystal structure of carbohydrate recognition domain of Blood Dendritic Cell Antigen-2 (BDCA2) lectin (crystal form-1)","MNHKVHHHHHHIEGRHMENLYFQGSCPTPWTSFQSSCYFISTGMQSWTKSQKNCSVMGADLVVINTREEQDFIIQNLKRNSSYFLGLSDPGGRRHWQWVDQTPYNENVTFWHSGEPNNLDERCAIINFRSSEEWGWNDIHCHVPQKSICKMKK","Homo sapiens","BDCA2, CLEC4C, CLECSF11, CLECSF7, DLEC, HECL, UNQ9361/PRO34150","C-type lectin domain family 4 member C","1","3WBP"
"3WBQ",,"X-RAY DIFFRACTION",2.29,46.2,"VAPOR DIFFUSION, HANGING DROP",8,"0.2M ammonium phosphate dibasic, 20%(w/v) PEG3350, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/prot.24504",,"3WBQ",30.26,"2.3","2.3","Crystal structure of carbohydrate recognition domain of Blood Dendritic Cell Antigen-2 (BDCA2) lectin (crystal form-2)","GSCPTPWTSFQSSCYFISTGMQSWTKSQKNCSVMGADLVVINTREEQDFIIQNLKRNSSYFLGLSDPGGRRHWQWVDQTPYNENVTFWHSGEPNNLDERCAIINFRSSEEWGWNDIHCHVPQKSICKMKK","Homo sapiens","BDCA2, CLEC4C, CLECSF11, CLECSF7, DLEC, HECL, UNQ9361/PRO34150","C-type lectin domain family 4 member C","1","3WBQ"
"3WBR",,"X-RAY DIFFRACTION",3.31,62.82,"VAPOR DIFFUSION, HANGING DROP",8.3,"0.2M potassium citrate tribasic, 20%(w/v) PEG3350, pH 8.3, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1002/prot.24504",,"3WBR",121.02,"2.2","2.2","Crystal structure of carbohydrate recognition domain of Blood Dendritic Cell Antigen-2 (BDCA2) lectin (crystal form-3)","GSCPTPWTSFQSSCYFISTGMQSWTKSQKNCSVMGADLVVINTREEQDFIIQNLKRNSSYFLGLSDPGGRRHWQWVDQTPYNENVTFWHSGEPNNLDERCAIINFRSSEEWGWNDIHCHVPQKSICKMKK","Homo sapiens","BDCA2, CLEC4C, CLECSF11, CLECSF7, DLEC, HECL, UNQ9361/PRO34150","C-type lectin domain family 4 member C","1","3WBR"
"3WC9",,"X-RAY DIFFRACTION",2.4,48.7,"VAPOR DIFFUSION",8.2,"0.2M sodium citrate, 28% PEG 3350, pH 8.2, VAPOR DIFFUSION, temperature 298K",298,"10.1371/journal.ppat.1004114",,"3WC9",250.52,"2.82","2.82","The complex structure of HsSQS wtih ligand, FSPP","MGSSHHHHHHSSGLVPRGSHMDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFALPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKGAVLIRLGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSNPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3WC9"
"3WCD",,"X-RAY DIFFRACTION",2.43,49.42,"VAPOR DIFFUSION",8.2,"0.2M sodium citrate, 28% PEG 3350, pH 8.2, VAPOR DIFFUSION, temperature 298K",298,"10.1371/journal.ppat.1004114",,"3WCD",248.82,"2.75","2.75","The complex structure of HsSQS wtih ligand, WC-9","MGSSHHHHHHSSGLVPRGSHMDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFALPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKGAVLIRLGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSNPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3WCD"
"3WCF",,"X-RAY DIFFRACTION",2.37,48.13,"VAPOR DIFFUSION",8.2,"0.2M sodium citrate, 28% PEG 3350, pH 8.2, VAPOR DIFFUSION, temperature 298K",298,"10.1371/journal.ppat.1004114","BH8","3WCF",250.11,"2.22","2.22","The complex structure of HsSQS wtih ligand,BPH1218","MGSSHHHHHHSSGLVPRGSHMDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFALPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKGAVLIRLGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSNPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3WCF"
"3WCH",,"X-RAY DIFFRACTION",2.4,48.72,"VAPOR DIFFUSION",8.2,"0.2M sodium citrate, 28% PEG 3350, pH 8.2, VAPOR DIFFUSION, temperature 298K",298,"10.1371/journal.ppat.1004114","8PH","3WCH",251.86,"2.5","2.5","The complex structure of HsSQS wtih ligand BPH1237","MGSSHHHHHHSSGLVPRGSHMDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFALPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKGAVLIRLGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSNPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3WCH"
"3WCI",,"X-RAY DIFFRACTION",2.41,49.03,"VAPOR DIFFUSION",8.2,"0.2M sodium citrate, 28% PEG 3350, pH 8.2, VAPOR DIFFUSION, temperature 298K",298,"10.1371/journal.ppat.1004114","BH5","3WCI",250.63,"2.3","2.3","The complex structure of HsSQS wtih ligand,BPH1325","MGSSHHHHHHSSGLVPRGSHMDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFALPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKGAVLIRLGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSNPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3WCI"
"3WCJ",,"X-RAY DIFFRACTION",2.44,49.53,"VAPOR DIFFUSION",8.2,"0.2M sodium citrate, 28% PEG 3350, pH 8.2, VAPOR DIFFUSION, temperature 298K",298,"10.1371/journal.ppat.1004114","E5S","3WCJ",250.34,"2.2","2.2","The complex structure of HsSQS wtih ligand,E5700","MGSSHHHHHHSSGLVPRGSHMDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFALPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKGAVLIRLGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSNPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3WCJ"
"3WCL",,"X-RAY DIFFRACTION",2.4,48.7,"VAPOR DIFFUSION",8.2,"0.2M sodium citrate, 28% PEG 3350, pH 8.2, VAPOR DIFFUSION, temperature 298K",298,"10.1371/journal.ppat.1004114","BH3","3WCL",248.2,"2.24","2.24","The complex structure of HsSQS wtih ligand,BPH1344","MGSSHHHHHHSSGLVPRGSHMDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFALPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKGAVLIRLGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSNPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3WCL"
"3WCM",,"X-RAY DIFFRACTION",2.44,49.64,"VAPOR DIFFUSION",8.2,"0.2 M sodium citrate, 28% PEG 3350, pH 8.2, VAPOR DIFFUSION, temperature 298K",298,"10.1371/journal.ppat.1004114","ER4","3WCM",250.17,"2.06","2.06","The complex structure of HsSQS wtih ligand, ER119884","MGSSHHHHHHSSGLVPRGSHMDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFALPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKGAVLIRLGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSNPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3WCM"
"3WD9",,"X-RAY DIFFRACTION",2.14,42.57,"VAPOR DIFFUSION, SITTING DROP",8,"10-20% PEG 3350, 0.2-0.4M CaCl2, 0.1M Tris/HCl (pH8.0), VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmc.2013.09.013","QPC","3WD9",87.75,"2.5","2.5","Crystal structure of phosphodiesterase 4B in complex with compound 10f","SISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHS","Homo sapiens","DPDE4, PDE4B","cAMP-specific 3',5'-cyclic phosphodiesterase 4B","1","3WD9"
"3WE2",,"X-RAY DIFFRACTION",2.83,56.48,"VAPOR DIFFUSION",8.4,"20-25% PEG 4000, 50mM sodium phosphate, 150mM sodium acetate, 100mM Tris-HCl, 15%(v/v) glycerol, pH 8.4, VAPOR DIFFUSION, temperature 293K",293,"10.1038/srep03294",,"3WE2",32.75,"2.7","2.7","Structure of BLM RQC domain bound to a phosphate ion","GPLGSKTKDYKTRDVTDDVKSIVRFVQEHSSSQGMRNIKHVGPSGRFTMNMLVDIFLGSKSAKIQSGIFGKGSAYSRHNAERLFKKLILDKILDEDLYINANDQAIAYVMLGNKAQTVLNGNLKVDFMETENSSSVKKQKALVAKVS","Homo sapiens","BLM, RECQ2, RECQL3","Bloom syndrome protein","1","3WE2"

"3WE3",,"X-RAY DIFFRACTION",2.87,57.11,"VAPOR DIFFUSION",8.4,"20-25% PEG 4000, 50mM sodium phosphate, 150mM sodium acetate, 100mM Tris-HCl, 15%(v/v) glycerol, pH 8.4, VAPOR DIFFUSION, temperature 293K",293,"10.1038/srep03294",,"3WE3",32.79,"2.9","2.9","Structure of BLM RQC domain bound to an arsenate ion","GPLGSKTKDYKTRDVTDDVKSIVRFVQEHSSSQGMRNIKHVGPSGRFTMNMLVDIFLGSKSAKIQSGIFGKGSAYSRHNAERLFKKLILDKILDEDLYINANDQAIAYVMLGNKAQTVLNGNLKVDFMETENSSSVKKQKALVAKVS","Homo sapiens","BLM, RECQ2, RECQL3","Bloom syndrome protein","1","3WE3"
"3WE4",,"X-RAY DIFFRACTION",2.48,50.49,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M Tris-HCl, 3.7-3.9M sodium formate, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1007/s10969-014-9188-8","5FI","3WE4",37.63,"1.995","1.995","Crystal structure of S6K1 kinase domain in complex with a pyrimidine derivative PF-4708671 2-{[4-(5-ethylpyrimidin-4-yl)piperazin-1-yl]methyl}-5-(trifluoromethyl)-1H-benzimidazole","GSFTSSGSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDST","Homo sapiens","RPS6KB1, STK14A","Ribosomal protein S6 kinase beta-1","1","3WE4"
"3WE8",,"X-RAY DIFFRACTION",3.56,65.47,"VAPOR DIFFUSION, HANGING DROP",7,"100mM Bis-Tris Propan, 200mM Li-sulphate, 12% PEG 3350, 10% EG, pH 7, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1002/open.201300031",,"3WE8",31.9,"1.954","1.954","Pim-1 kinase in complex with Ruthenium-based inhibitor","PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","3WE8"
"3WEF",,"X-RAY DIFFRACTION",2.56,51.86,"VAPOR DIFFUSION, HANGING DROP",6.5,"2% PEG 400, 2M K2HPO4/NaH2PO4, 3mM farnesyl thiopyrophosphate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S1399004713026230",,"3WEF",239.88,"2.35","2.35","Crystal structure of the human squalene synthase in complex with farnesyl thiopyrophosphate","GSHMDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFAKPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKGAVKIRKGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSDPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3WEF"
"3WEG",,"X-RAY DIFFRACTION",2.14,42.59,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 4000, 10% 2-propanol, 0.1M HEPES, 3mM farnesyl thiopyrophosphate, 1mM MgCl2, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S1399004713026230",,"3WEG",40.32,"1.75","1.75","Crystal structure of the human squalene synthase in complex with farnesyl thiopyrophosphate and magnesium ion","GSHMDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFAKPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKGAVKIRKGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSDPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3WEG"
"3WEH",,"X-RAY DIFFRACTION",2.35,47.56,"VAPOR DIFFUSION, HANGING DROP",8.5,"20% PEG 2000 MME, 0.01M NiCl2, 0.1M Tris, 1mM presqualene pyrophosphate, 1mM MgCl2, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S1399004713026230",,"3WEH",40.08,"1.87","1.87","Crystal structure of the human squalene synthase in complex with presqualene pyrophosphate","GSHMDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFAKPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKGAVKIRKGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSDPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3WEH"
"3WEI",,"X-RAY DIFFRACTION",2.11,41.59,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 4000, 10% 2-propanol, 0.1M HEPES, 1mM presqualene pyrophosphate, 3mM MnCl2, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S1399004713026230",,"3WEI",40.11,"1.79","1.79","Crystal structure of the human squalene synthase Y73A mutant in complex with presqualene pyrophosphate","GSHMDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFALVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFAKPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKGAVKIRKGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSDPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3WEI"
"3WEJ",,"X-RAY DIFFRACTION",2.26,45.5,"VAPOR DIFFUSION, HANGING DROP",8.5,"20% PEG 2000 MME, 0.01 M NiCl2, 0.1M Tris, 1mM presqualene pyrophosphate, 1mM MgCl2, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S1399004713026230",,"3WEJ",40.01,"2","2","Crystal structure of the human squalene synthase F288A mutant in complex with presqualene pyrophosphate","GSHMDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFAKPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNACAIPQVMAIATLAACYNNQQVFKGAVKIRKGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSDPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3WEJ"
"3WEK",,"X-RAY DIFFRACTION",2.1,41.4,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 4000, 10% 2-propanol, 0.1M HEPES, 1mM presqualene pyrophosphate, 1mM MgCl2, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1107/S1399004713026230",,"3WEK",40.03,"1.85","1.85","Crystal structure of the human squalene synthase F288L mutant in complex with presqualene pyrophosphate","GSHMDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFAKPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNLCAIPQVMAIATLAACYNNQQVFKGAVKIRKGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSDPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3WEK"
"3WEZ",,"X-RAY DIFFRACTION",2.62,53.08,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350, Ammonium sulfate, HEPES, pH 7.5, vapor diffusion, sittingdrop, temperature 277K",277,,"N8V","3WEZ",312.57,"2.11","2.11","Crystal structure of human beta-galactosidase in complex with NOEV","EAEAYVEFHHHHHHDYKDDDDKTSLRNATQRMFEIDYSRDSFLKDGQPFRYISGSIHYSRVPRFYWKDRLLKMKMAGLNAIQTYVPWNFHEPWPGQYQFSEDHDVEYFLRLAHELGLLVILRPGPYICAEWEMGGLPAWLLEKESILLRSSDPDYLAAVDKWLGVLLPKMKPLLYQNGGPVITVQVENEYGSYFACDFDYLRFLQKRFRHHLGDDVVLFTTDGAHKTFLKCGALQGLYTTVDFGTGSNITDAFLSQRKCEPKGPLINSEFYTGWLDHWGQPHSTIKTEAVASSLYDILARGASVNLYMFIGGTNFAYWNGANSPYAAQPTSYDYDAPLSEAGDLTEKYFALRNIIQKFEKVPEGPIPPSTPKFAYGKVTLEKLKTVGAALDILCPSGPIKSLYPLTFIQVKQHYGFVLYRTTLPQDCSNPAPLSSPLNGVHDRAYVAVDGIPQGVLERNNVITLNITGKAGATLDLLVENMGRVNYGAYINDFKGLVSNLTLSSNILTDWTIFPLDTEDAVRSHLGGWGHRDSGHHDEAWAHNSSNYTLPAFYMGNFSIPSGIPDLPQDTFIQFPGWTKGQVWINGFNLGRYWPARGPQLTLFVPQHILMTSAPNTITVLELEWAPCSSDDPELCAVTFVDRPVIGSSVTYDHPSKPVEKRLMPPPPQKNKDSWLDHV","Homo sapiens","ELNR1, GLB1","Beta-galactosidase","1","3WEZ"
"3WF0",,"X-RAY DIFFRACTION",2.64,53.33,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350, Ammonium sulfate, HEPES, pH 7.5, vapor diffusion, sittingdrop, temperature 277K",277,,"6DJ","3WF0",312.46,"2.2","2.2","Crystal structure of human beta-galactosidase in complex with 6S-NBI-DGJ","EAEAYVEFHHHHHHDYKDDDDKTSLRNATQRMFEIDYSRDSFLKDGQPFRYISGSIHYSRVPRFYWKDRLLKMKMAGLNAIQTYVPWNFHEPWPGQYQFSEDHDVEYFLRLAHELGLLVILRPGPYICAEWEMGGLPAWLLEKESILLRSSDPDYLAAVDKWLGVLLPKMKPLLYQNGGPVITVQVENEYGSYFACDFDYLRFLQKRFRHHLGDDVVLFTTDGAHKTFLKCGALQGLYTTVDFGTGSNITDAFLSQRKCEPKGPLINSEFYTGWLDHWGQPHSTIKTEAVASSLYDILARGASVNLYMFIGGTNFAYWNGANSPYAAQPTSYDYDAPLSEAGDLTEKYFALRNIIQKFEKVPEGPIPPSTPKFAYGKVTLEKLKTVGAALDILCPSGPIKSLYPLTFIQVKQHYGFVLYRTTLPQDCSNPAPLSSPLNGVHDRAYVAVDGIPQGVLERNNVITLNITGKAGATLDLLVENMGRVNYGAYINDFKGLVSNLTLSSNILTDWTIFPLDTEDAVRSHLGGWGHRDSGHHDEAWAHNSSNYTLPAFYMGNFSIPSGIPDLPQDTFIQFPGWTKGQVWINGFNLGRYWPARGPQLTLFVPQHILMTSAPNTITVLELEWAPCSSDDPELCAVTFVDRPVIGSSVTYDHPSKPVEKRLMPPPPQKNKDSWLDHV","Homo sapiens","ELNR1, GLB1","Beta-galactosidase","1","3WF0"
"3WF1",,"X-RAY DIFFRACTION",2.62,53.13,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350, Ammonium sulfate, pH 7.5, vapor diffusion, sittingdrop, temperature 277K",277,,,"3WF1",312.52,"2","2","Crystal structure of human beta-galactosidase in complex with 6S-NBI-GJ","EAEAYVEFHHHHHHDYKDDDDKTSLRNATQRMFEIDYSRDSFLKDGQPFRYISGSIHYSRVPRFYWKDRLLKMKMAGLNAIQTYVPWNFHEPWPGQYQFSEDHDVEYFLRLAHELGLLVILRPGPYICAEWEMGGLPAWLLEKESILLRSSDPDYLAAVDKWLGVLLPKMKPLLYQNGGPVITVQVENEYGSYFACDFDYLRFLQKRFRHHLGDDVVLFTTDGAHKTFLKCGALQGLYTTVDFGTGSNITDAFLSQRKCEPKGPLINSEFYTGWLDHWGQPHSTIKTEAVASSLYDILARGASVNLYMFIGGTNFAYWNGANSPYAAQPTSYDYDAPLSEAGDLTEKYFALRNIIQKFEKVPEGPIPPSTPKFAYGKVTLEKLKTVGAALDILCPSGPIKSLYPLTFIQVKQHYGFVLYRTTLPQDCSNPAPLSSPLNGVHDRAYVAVDGIPQGVLERNNVITLNITGKAGATLDLLVENMGRVNYGAYINDFKGLVSNLTLSSNILTDWTIFPLDTEDAVRSHLGGWGHRDSGHHDEAWAHNSSNYTLPAFYMGNFSIPSGIPDLPQDTFIQFPGWTKGQVWINGFNLGRYWPARGPQLTLFVPQHILMTSAPNTITVLELEWAPCSSDDPELCAVTFVDRPVIGSSVTYDHPSKPVEKRLMPPPPQKNKDSWLDHV","Homo sapiens","ELNR1, GLB1","Beta-galactosidase","1","3WF1"
"3WF2",,"X-RAY DIFFRACTION",2.66,53.72,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350, Ammonium sulfate, HEPES, pH 7.5, vapor diffusion, sittingdrop, temperature 277K",277,,,"3WF2",312.53,"2.3","2.3","Crystal structure of human beta-galactosidase in complex with NBT-DGJ","EAEAYVEFHHHHHHDYKDDDDKTSLRNATQRMFEIDYSRDSFLKDGQPFRYISGSIHYSRVPRFYWKDRLLKMKMAGLNAIQTYVPWNFHEPWPGQYQFSEDHDVEYFLRLAHELGLLVILRPGPYICAEWEMGGLPAWLLEKESILLRSSDPDYLAAVDKWLGVLLPKMKPLLYQNGGPVITVQVENEYGSYFACDFDYLRFLQKRFRHHLGDDVVLFTTDGAHKTFLKCGALQGLYTTVDFGTGSNITDAFLSQRKCEPKGPLINSEFYTGWLDHWGQPHSTIKTEAVASSLYDILARGASVNLYMFIGGTNFAYWNGANSPYAAQPTSYDYDAPLSEAGDLTEKYFALRNIIQKFEKVPEGPIPPSTPKFAYGKVTLEKLKTVGAALDILCPSGPIKSLYPLTFIQVKQHYGFVLYRTTLPQDCSNPAPLSSPLNGVHDRAYVAVDGIPQGVLERNNVITLNITGKAGATLDLLVENMGRVNYGAYINDFKGLVSNLTLSSNILTDWTIFPLDTEDAVRSHLGGWGHRDSGHHDEAWAHNSSNYTLPAFYMGNFSIPSGIPDLPQDTFIQFPGWTKGQVWINGFNLGRYWPARGPQLTLFVPQHILMTSAPNTITVLELEWAPCSSDDPELCAVTFVDRPVIGSSVTYDHPSKPVEKRLMPPPPQKNKDSWLDHV","Homo sapiens","ELNR1, GLB1","Beta-galactosidase","1","3WF2"
"3WF3",,"X-RAY DIFFRACTION",2.62,53.02,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350, Ammonium sulfate, HEPES, pH 7.5, vapor diffusion, sittingdrop, temperature 277K",277,,,"3WF3",312.09,"2.15","2.15","Crystal structure of human beta-galactosidase mutant I51T in complex with Galactose","EAEAYVEFHHHHHHDYKDDDDKTSLRNATQRMFEIDYSRDSFLKDGQPFRYTSGSIHYSRVPRFYWKDRLLKMKMAGLNAIQTYVPWNFHEPWPGQYQFSEDHDVEYFLRLAHELGLLVILRPGPYICAEWEMGGLPAWLLEKESILLRSSDPDYLAAVDKWLGVLLPKMKPLLYQNGGPVITVQVENEYGSYFACDFDYLRFLQKRFRHHLGDDVVLFTTDGAHKTFLKCGALQGLYTTVDFGTGSNITDAFLSQRKCEPKGPLINSEFYTGWLDHWGQPHSTIKTEAVASSLYDILARGASVNLYMFIGGTNFAYWNGANSPYAAQPTSYDYDAPLSEAGDLTEKYFALRNIIQKFEKVPEGPIPPSTPKFAYGKVTLEKLKTVGAALDILCPSGPIKSLYPLTFIQVKQHYGFVLYRTTLPQDCSNPAPLSSPLNGVHDRAYVAVDGIPQGVLERNNVITLNITGKAGATLDLLVENMGRVNYGAYINDFKGLVSNLTLSSNILTDWTIFPLDTEDAVRSHLGGWGHRDSGHHDEAWAHNSSNYTLPAFYMGNFSIPSGIPDLPQDTFIQFPGWTKGQVWINGFNLGRYWPARGPQLTLFVPQHILMTSAPNTITVLELEWAPCSSDDPELCAVTFVDRPVIGSSVTYDHPSKPVEKRLMPPPPQKNKDSWLDHV","Homo sapiens","ELNR1, GLB1","Beta-galactosidase","1","3WF3"
"3WF4",,"X-RAY DIFFRACTION",2.63,53.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"PEG 3350, Ammonium sulfate, pH 7.5, vapor diffusion, sittingdrop, temperature 277K",277,,"6DJ","3WF4",312.41,"2.3","2.3","Crystal structure of human beta-galactosidase mutant I51T in complex with 6S-NBI-DGJ","EAEAYVEFHHHHHHDYKDDDDKTSLRNATQRMFEIDYSRDSFLKDGQPFRYTSGSIHYSRVPRFYWKDRLLKMKMAGLNAIQTYVPWNFHEPWPGQYQFSEDHDVEYFLRLAHELGLLVILRPGPYICAEWEMGGLPAWLLEKESILLRSSDPDYLAAVDKWLGVLLPKMKPLLYQNGGPVITVQVENEYGSYFACDFDYLRFLQKRFRHHLGDDVVLFTTDGAHKTFLKCGALQGLYTTVDFGTGSNITDAFLSQRKCEPKGPLINSEFYTGWLDHWGQPHSTIKTEAVASSLYDILARGASVNLYMFIGGTNFAYWNGANSPYAAQPTSYDYDAPLSEAGDLTEKYFALRNIIQKFEKVPEGPIPPSTPKFAYGKVTLEKLKTVGAALDILCPSGPIKSLYPLTFIQVKQHYGFVLYRTTLPQDCSNPAPLSSPLNGVHDRAYVAVDGIPQGVLERNNVITLNITGKAGATLDLLVENMGRVNYGAYINDFKGLVSNLTLSSNILTDWTIFPLDTEDAVRSHLGGWGHRDSGHHDEAWAHNSSNYTLPAFYMGNFSIPSGIPDLPQDTFIQFPGWTKGQVWINGFNLGRYWPARGPQLTLFVPQHILMTSAPNTITVLELEWAPCSSDDPELCAVTFVDRPVIGSSVTYDHPSKPVEKRLMPPPPQKNKDSWLDHV","Homo sapiens","ELNR1, GLB1","Beta-galactosidase","1","3WF4"
"3WF5",,"X-RAY DIFFRACTION",2.31,46.67,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M Tris-HCl, 2.9-3.3M sodium formate, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1007/s10969-014-9188-8","FZ8","3WF5",37.56,"2.099","2.099","Crystal structure of S6K1 kinase domain in complex with a pyrazolopyrimidine derivative 4-[4-(1H-benzimidazol-2-yl)piperidin-1-yl]-1H-pyrazolo[3,4-d]pyrimidine","GSFTSSGSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDST","Homo sapiens","RPS6KB1, STK14A","Ribosomal protein S6 kinase beta-1","1","3WF5"
"3WF6",,"X-RAY DIFFRACTION",2.33,47.11,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M Tris-HCl, 2.9-3.3M sodium formate, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1007/s10969-014-9188-8","FZ9","3WF6",37.56,"2.031","2.031","Crystal structure of S6K1 kinase domain in complex with a pyrazolopyrimidine derivative 4-[4-(1H-indol-3-yl)-3,6-dihydropyridin-1(2H)-yl]-1H-pyrazolo[3,4-d]pyrimidine","GSFTSSGSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDST","Homo sapiens","RPS6KB1, STK14A","Ribosomal protein S6 kinase beta-1","1","3WF6"
"3WF7",,"X-RAY DIFFRACTION",2.36,47.91,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M Tris-HCl, 3.7-3.9M sodium formate, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1007/s10969-014-9188-8","FS9","3WF7",37.73,"1.85","1.85","Crystal structure of S6K1 kinase domain in complex with a purine derivative 1-(9H-purin-6-yl)-N-[3-(trifluoromethyl)phenyl]piperidine-4-carboxamide","GSFTSSGSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDST","Homo sapiens","RPS6KB1, STK14A","Ribosomal protein S6 kinase beta-1","1","3WF7"
"3WF8",,"X-RAY DIFFRACTION",3.23,61.89,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M Tris-HCl, 2.9M sodium formate, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1007/s10969-014-9188-8","F76","3WF8",37.79,"1.975","1.975","Crystal structure of S6K1 kinase domain in complex with a quinoline derivative 2-oxo-2-[(4-sulfamoylphenyl)amino]ethyl 7,8,9,10-tetrahydro-6H-cyclohepta[b]quinoline-11-carboxylate","GSFTSSGSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDST","Homo sapiens","RPS6KB1, STK14A","Ribosomal protein S6 kinase beta-1","1","3WF8"
"3WF9",,"X-RAY DIFFRACTION",3.2,61.57,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1M Tris-HCl, 2.9M sodium formate, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1007/s10969-014-9188-8","FS7","3WF9",37.8,"2.035","2.035","Crystal structure of S6K1 kinase domain in complex with a quinoline derivative 1-oxo-1-[(4-sulfamoylphenyl)amino]propan-2-yl-2-methyl-1,2,3,4-tetrahydroacridine-9-carboxylate","GSFTSSGSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDST","Homo sapiens","RPS6KB1, STK14A","Ribosomal protein S6 kinase beta-1","1","3WF9"
"3WFF",,"X-RAY DIFFRACTION",2.53,51.34,"VAPOR DIFFUSION, SITTING DROP",7.2,"0.04M potassium dihydrogen phosphate, 16% PEG 8000, 20% glycerol, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmc.2013.07.043","WFF","3WFF",32.1,"2.05","2.05","Mineralocorticoid receptor ligand-binding domain with compound 2b","GSAPAKEPSVNTALVPQLSTISRALTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPGFKNLPLEDQITLIQYSWMSLLSFALSWRSYKHTNSQFLYFAPDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMRTNYIKELRKMVTKCPNNSGQSWQRFYQLTKLLDSMHDLVSDLLEFCFYTFRESHALKVEFPAMLVEIISDQLPKVESGNVKPLYFHRK","Homo sapiens","NR3C2, MCR, MLR","Mineralocorticoid receptor","1","3WFF"
"3WFG",,"X-RAY DIFFRACTION",2.32,46.94,"VAPOR DIFFUSION, SITTING DROP",7.8,"0.1M Tris, 23% ethanol, pH 7.8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmc.2013.07.043","WFG","3WFG",32.81,"1.4","1.4","Mineralocorticoid receptor ligand-binding domain with compuond 2e","GSAPAKEPSVNTALVPQLSTISRALTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPGFKNLPLEDQITLIQYSWMSLLSFALSWRSYKHTNSQFLYFAPDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMRTNYIKELRKMVTKCPNNSGQSWQRFYQLTKLLDSMHDLVSDLLEFCFYTFRESHALKVEFPAMLVEIISDQLPKVESGNVKPLYFHRK","Homo sapiens","NR3C2, MCR, MLR","Mineralocorticoid receptor","1","3WFG"
"3WGD",,"X-RAY DIFFRACTION",2.93,57.96,"VAPOR DIFFUSION, SITTING DROP",7.8,"0.092M Sodium phosphate, 1.308M Potassium phosphate, pH 7.8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.str.2013.12.013",,"3WGD",118.52,"2.5","2.5","Crystal structure of ERp46 Trx1","GSHMSKHLYTADMFTHGIQSAAHFVMFFAPWCGHCQRLQPTWNDLGDKYNSMEDAKVYVAKVDCTAHSDVCSAQGVRGYPTLKLFKPGQEAVKYQGPRDFQTLENWMLQTLNE","Homo sapiens","TXNDC5, TLP46, UNQ364/PRO700","Thioredoxin domain-containing protein 5","1","3WGD"
"3WGE",,"X-RAY DIFFRACTION",2.13,42.33,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.1M HEPES, 2.2M Ammonium sulfate, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.str.2013.12.013",,"3WGE",13.1,"0.95","0.95","Crystal structure of ERp46 Trx2","GSHMGLYELSASNFELHVAQGDHFIKFFAPWCGHCKALAPTWEQLALGLEHSETVKIGKVDCTQHYELCSGNQVRGYPTLLWFRDGKKVDQYKGKRDLESLREYVESQLQRTE","Homo sapiens","TXNDC5, TLP46, UNQ364/PRO700","Thioredoxin domain-containing protein 5","1","3WGE"
"3WGP",,"X-RAY DIFFRACTION",2.64,53.35,,,,,,,"3WGP",29.24,"2","2","Crystal Structure Analysis of Vitamin D receptor","LRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFG","Homo sapiens","VDR, NR1I1","Vitamin D3 receptor","1","3WGP"
"3WGW",,"X-RAY DIFFRACTION",5.13,76.04,,,,,"10.1074/jbc.M113.520429","T2B","3WGW",59.32,"2.8","2.8","Structure of PCNA bound to a small molecule inhibitor","MFEARLVQGSILKKVLEALKDLINEACWDISSSGVNLQSMDSSHVSLVQLTLRSEGFDTYRCDRNLAMGVNLTSMSKILKCAGNEDIITLRAEDNADTLALVFEAPNQEKVSDYEMKLMDLDVEQLGIPEQEYSCVVKMPSGEFARICRDLSHIGDAVVISCAKDGVKFSASGELGNGNIKLSQTSNVDKEEEAVTIEMNEPVQLTFALRYLNFFTKATPLSSTVTLSMSADVPLVVEYKIADMGHLKYYLAPKIEDEEGS","Homo sapiens","PCNA","Proliferating cell nuclear antigen","1","3WGW"
"3WH0",,"X-RAY DIFFRACTION",2.99,58.8,"VAPOR DIFFUSION, SITTING DROP",7.5,"2.0-2.5M ammonium sulfate, 0.1M HEPES (pH 7.5), 1mM DTT, 25mM crown ether, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1002/anie.201405664",,"3WH0",18.96,"1.6","1.6","Structure of Pin1 Complex with 18-crown-6","MADEEKLPPGWEKAMSRSSGRVYYFNHITNASQWERPSGNSSSGGKNGQGEPARVRCSHLLVKHSQSRRPSSWRQEKITRTKEEALELINGYIQKIKSGEEDFESLASQFSDCSSAKARGDLGAFSRGQMQKPFEDASFALRTGEMSGPVFTDSGIHIILRTE","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","3WH0"
"3WH2",,"X-RAY DIFFRACTION",1.8,31.82,"VAPOR DIFFUSION, SITTING DROP",4,"1.0M lithium chloride, 0.1M citric acid, 20%(w/v) PEG3350, pH 4.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1073/pnas.1312649110",,"3WH2",17.15,"1.3","1.3","Human Mincle in complex with citrate","MGSVKNCCPLNWEYFQSSCYFFSTDTKSWALSLKNCSAMGAHLVVINSQEEQEFLSYKKPKMREFFIGLSDQVVEGQWQWVDGTPLTKSLSFWDVGEPNNIATLEDCATMRDSSNPRQNWNDVTCFLNYFRICEMVGINPLNKGKSL","Homo sapiens","CLEC4E, CLECSF9, MINCLE, UNQ218/PRO244","C-type lectin domain family 4 member E","1","3WH2"
"3WH3",,"X-RAY DIFFRACTION",1.77,30.62,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M Bis-tris propane, 0.2M potassium thiocyanate, 20%(w/v) PEG3350, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1073/pnas.1312649110",,"3WH3",16.96,"1.32","1.32","human Mincle, ligand free form","MGSVKNCCPLNWEYFQSSCYFFSTDTKSWALSLKNCSAMGAHLVVINSQEEQEFLSYKKPKMREFFIGLSDQVVEGQWQWVDGTPLTKSLSFWDVGEPNNIATLEDCATMRDSSNPRQNWNDVTCFLNYFRICEMVGINPLNKGKSL","Homo sapiens","CLEC4E, CLECSF9, MINCLE, UNQ218/PRO244","C-type lectin domain family 4 member E","1","3WH3"
"3WHA",,"X-RAY DIFFRACTION",2.7,54.5,"VAPOR DIFFUSION, SITTING DROP",6.5,"22%(w/v) PEG 3350, 0.2M MgCl2, 0.1M Na-MES, pH 6.5, vapor diffusion, sitting drop, temperature 278K",278,"10.1016/j.bmc.2013.11.036","WHA","3WHA",52.52,"1.3","1.3","Hsp90 alpha N-terminal domain in complex with a tricyclic inhibitor","MDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3WHA"
"3WHD",,"X-RAY DIFFRACTION",2.93,58.09,,,,,"10.1073/pnas.1312649110",,"3WHD",36.61,"2.29","2.29","C-type lectin, human MCL","MHAKLKCIKEKSELKSAEGSTWNCCPIDWRAFQSNCYFPLTDNKTWAESERNCSGMGAHLMTISTEAEQNFIIQFLDRRLSYFLGLRDENAKGQWRWVDQTPFNPRRVFWHKNEPDNSQGENCVVLVYNQDKWAWNDVPCNFEASRICKIPGTTLN","Homo sapiens","CLEC4D, CLECSF8, MCL","C-type lectin domain family 4 member D","1","3WHD"
"3WHW",,"X-RAY DIFFRACTION",2.24,45.01,"VAPOR DIFFUSION",4,"26% PEG 6000, 100mM Naacetate, 100mM Li-sulphate, pH 4, VAPOR DIFFUSION, temperature 293K",293,"10.1002/anie.201307849",,"3WHW",37.83,"2.701","2.701","MTH1 in complex with Ruthenium-based inhibitor","MGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-dihydro-8-oxoguanine triphosphatase","1","3WHW"
"3WI2",,"X-RAY DIFFRACTION",2.04,39.74,"VAPOR DIFFUSION, SITTING DROP",6,"50mM Bis-tris propane pH6.0, 50mM Magnesium sulfate, 15% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 296K",296,"10.1016/j.bmc.2013.10.035","P98","3WI2",80.18,"2.26","2.26","Crystal structure of PDE10A in complex with inhibitor","GSHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","3WI2"
"3WI6",,"X-RAY DIFFRACTION",4.56,73.05,"VAPOR DIFFUSION, HANGING DROP",5,"0.1M Na-Acetate, 1.6M Ammonium Sulphate, 200mM NaCl, 1.4mM Deoxi Big Chap, pH 5.0, VAPOR DIFFUSION, HANGING DROP, temperature 293.0K",293,"10.1107/S1744309113030534","YRZ","3WI6",226.68,"2.99","2.99","Crystal structure of MAPKAP Kinase-2 (MK2) in complex with non-selective inhibitor","QQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMR","Homo sapiens","MAPKAPK2","MAP kinase-activated protein kinase 2","1","3WI6"
"3WIG",,"X-RAY DIFFRACTION",4.68,73.75,"VAPOR DIFFUSION, SITTING DROP",4.2,"7.5-10% PEG 8000, 0.2M NaCl, 0.2M Ammonium sulfate, 0.1M citrate buffer, pH 4.2, vapor diffusion, sitting drop, temperature 277K",277,"10.1016/j.ccr.2014.03.011",,"3WIG",35.61,"2.7","2.7","Human MEK1 kinase in complex with CH5126766 and MgAMP-PNP","MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGVHHHHHH","Homo sapiens","MAP2K1, MEK1, PRKMK1","Dual specificity mitogen-activated protein kinase kinase 1","1","3WIG"
,,,,,,,,,,,,,,,,,"Homo sapiens","MAP2K1, MEK1, PRKMK1"
"3WIK",,"X-RAY DIFFRACTION",1.93,36.38,"VAPOR DIFFUSION, SITTING DROP",8,"25% ethyleneglycol, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,"LCT","3WIK",40.74,"1.995","1.995","Crystal structure of the CK2alpha/compound10 complex","GPLGSMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3WIK"
"3WIL",,"X-RAY DIFFRACTION",1.94,36.47,"VAPOR DIFFUSION, SITTING DROP",8,"25% ethyleneglycol, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3WIL",40.83,"2.9","2.9","Crystal structure of the CK2alpha/compound3 complex","GPLGSMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3WIL"
"3WIX",,"X-RAY DIFFRACTION",2.04,39.79,"VAPOR DIFFUSION, SITTING DROP",8,"0.1M Tris pH 8.0, 0.2M sodium isothiocyanate, 20% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm401170c","LC3","3WIX",74.68,"1.9","1.9","Crystal structure of Mcl-1 in complex with compound 4","GPLGSDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","3WIX"
"3WIY",,"X-RAY DIFFRACTION",2.11,41.71,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M Bis-tris pH 6.5, 22% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm401170c","LC6","3WIY",114.55,"2.15","2.15","Crystal structure of Mcl-1 in complex with compound 10","GPLGSDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","3WIY"
"3WIZ",,"X-RAY DIFFRACTION",3.64,66.17,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M Na-K phosphate pH 6.5, 0.72M sodium malonate, 0.84% MEGA-8, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm401170c","LC6","3WIZ",42.73,"2.45","2.45","Crystal structure of Bcl-xL in complex with compound 10","MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERLEHHHHHH","Homo sapiens","BCL2L1, BCL2L, BCLX","Bcl-2-like protein 1","1","3WIZ"
,,,,,,,,,,,,,,,,,"Homo sapiens","BCL2L1, BCL2L, BCLX"
"3WJ4",,"X-RAY DIFFRACTION",2.28,45.97,"VAPOR DIFFUSION, SITTING DROP",8.5,"100mM Tris-HCl pH 8.5, 160mM CH3COONH4, 19-23% PEG 4000, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3WJ4",63.4,"1.95","1.95","Crystal structure of PPARgamma ligand binding domain in complex with tributyltin","GPLGSESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3WJ4"
"3WJ5",,"X-RAY DIFFRACTION",2.31,46.67,"VAPOR DIFFUSION, SITTING DROP",8.5,"100mM Tris-HCl pH 8.5, 160mM CH3COONH4, 19-23% PEG 4000, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3WJ5",63.52,"1.89","1.89","Crystal structure of PPARgamma ligand binding domain in complex with triphenyltin","GPLGSESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3WJ5"
"3WJA",,"X-RAY DIFFRACTION",2.85,56.8,"VAPOR DIFFUSION, HANGING DROP",7.4,"250mM LiCl, 19% (w/v) PEG 3350, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K",298,"10.1016/j.bbapap.2014.06.019",,"3WJA",130.59,"2.548","2.548","The crystal structure of human cytosolic NADP(+)-dependent malic enzyme in apo form","MEPEAPRRRHTHQRGYLLTRNPHLNKDLAFTLEERQQLNIHGLLPPSFNSQEIQVLRVVKNFEHLNSDFDRYLLLMDLQDRNEKLFYRVLTSDIEKFMPIVYTPTVGLACQQYSLVFRKPRGLFITIHDRGHIASVLNAWPEDVIKAIVVTDGERILGLGDLGCNGMGIPVGKLALYTACGGMNPQECLPVILDVGTENEELLKDPLYIGLRQRRVRGSEYDDFLDEFMEAVSSKYGMNCLIQFEDFANVNAFRLLNKYRNQYCTFNDDIQGTASVAVAGLLAALRITKNKLSDQTILFQGAGEAALGIAHLIVMALEKEGLPKEKAIKKIWLVDSKGLIVKGRASLTQEKEKFAHEHEEMKNLEAIVQEIKPTALIGVAAIGGAFSEQILKDMAAFNERPIIFALSNPTSKAECSAEQCYKITKGRAIFASGSPFDPVTLPNGQTLYPGQGNNSYVFPGVALGVVACGLRQITDNIFLTTAEVIAQQVSDKHLEEGRLYPPLNTIRDVSLKIAEKIVKDAYQEKTATVYPEPQNKEAFVRSQMYSTDYDQILPDCYSWPEEVQKIQTKVDQLEHHHHHH","Homo sapiens","ME1","NADP-dependent malic enzyme","1","3WJA"
"3WK4",,"X-RAY DIFFRACTION",2.41,48.89,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M Potassium phosphate, 0.2M Ammonium dihydrogen phosphate, 25%w/v PEG 3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1016/j.bmc.2014.03.001","S0A","3WK4",63.84,"2.11","2.11","Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","3WK4"
"3WK5",,"X-RAY DIFFRACTION",2.34,47.47,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M Potassium phosphate, 0.2M Ammonium dihydrogen phosphate, 25%w/v PEG 3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1016/j.bmc.2014.03.001","S0C","3WK5",63.84,"2.77","2.77","Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","3WK5"
"3WK6",,"X-RAY DIFFRACTION",2.39,48.61,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M Potassium phosphate, 0.2M Ammonium dihydrogen phosphate, 25%w/v PEG 3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1016/j.bmc.2014.03.001","S0B","3WK6",63.85,"2.1","2.1","Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","3WK6"
"3WK7",,"X-RAY DIFFRACTION",2.39,48.47,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M Potassium phosphate, 0.2M Ammonium dihydrogen phosphate, 25%w/v PEG 3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1016/j.bmc.2014.03.001","S0D","3WK7",63.83,"2.2","2.2","Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","3WK7"
"3WK8",,"X-RAY DIFFRACTION",2.37,48.1,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M Potassium phosphate, 0.2M Ammonium dihydrogen phosphate, 25%w/v PEG 3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1016/j.bmc.2014.03.001","S0E","3WK8",63.85,"2.2","2.2","Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","3WK8"
"3WK9",,"X-RAY DIFFRACTION",2.38,48.39,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M Potassium phosphate, 0.2M Ammonium dihydrogen phosphate, 25%w/v PEG 3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1016/j.bmc.2014.03.001","S0F","3WK9",63.9,"2.2","2.2","Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","3WK9"
"3WKA",,"X-RAY DIFFRACTION",2.35,47.75,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M Potassium phosphate, 0.2M Ammonium dihydrogen phosphate, 25%w/v PEG 3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1016/j.bmc.2014.03.001","S0G","3WKA",63.86,"2.01","2.01","Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","3WKA"
"3WKB",,"X-RAY DIFFRACTION",2.38,48.32,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M Potassium phosphate, 0.2M Ammonium dihydrogen phosphate, 25%w/v PEG 3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1016/j.bmc.2014.03.001","S0I","3WKB",63.87,"2.2","2.2","Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","3WKB"
"3WKC",,"X-RAY DIFFRACTION",2.37,48.05,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M Potassium phosphate, 0.2M Ammonium dihydrogen phosphate, 25%w/v PEG 3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1016/j.bmc.2014.03.001","S0J","3WKC",63.91,"2.2","2.2","Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","3WKC"
"3WKD",,"X-RAY DIFFRACTION",2.4,48.73,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M Potassium phosphate, 0.2M Ammonium dihydrogen phosphate, 25%w/v PEG 3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1016/j.bmc.2014.03.001","S0K","3WKD",63.92,"2.48","2.48","Crystal structure of soluble epoxide hydrolase in complex with fragment inhibitor","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","3WKD"
"3WKE",,"X-RAY DIFFRACTION",2.34,47.51,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M Potassium phosphate, 0.2M Ammonium dihydrogen phosphate, 25%w/v PEG 3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K",298,"10.1016/j.bmc.2014.03.001","AUB","3WKE",64.05,"2.75","2.75","Crystal structure of soluble epoxide hydrolase in complex with t-AUCB","MTLRAAVFDLDGVLALPAVFGVLGRTEEALALPRGLLNDAFQKGGPEGATTRLMKGEITLSQWIPLMEENCRKCSETAKVCLPKNFSIKEIFDKAISARKINRPMLQAALMLRKKGFTTAILTNTWLDDRAERDGLAQLMCELKMHFDFLIESCQVGMVKPEPQIYKFLLDTLKASPSEVVFLDDIGANLKPARDLGMVTILVQDTDTALKELEKVTGIQLLNTPAPLPTSCNPSDMSHGYVTVKPRVRLHFVELGSGPAVCLCHGFPESWYSWRYQIPALAQAGYRVLAMDMKGYGESSAPPEIEEYCMEVLCKEMVTFLDKLGLSQAVFIGHDWGGMLVWYMALFYPERVRAVASLNTPFIPANPNMSPLESIKANPVFDYQLYFQEPGVAEAELEQNLSRTFKSLFRASDESVLSMHKVCEAGGLFVNSPEEPSLSRMVTEEEIQFYVQQFKKSGFRGPLNWYRNMERNWKWACKSLGRKILIPALMVTAEKDFVLVPQMSQHMEDWIPHLKRGHIEDCGHWTQMDKPTEVNQILIKWLDSDARNPPVVSKMHHHHHH","Homo sapiens","EPHX2","Bifunctional epoxide hydrolase 2","1","3WKE"
"3WLU",,"X-RAY DIFFRACTION",2.14,42.61,"VAPOR DIFFUSION",7.5,"PEG 6000, 100mM Tris-HCl, pH 7.5, VAPOR DIFFUSION, temperature 289K",289,"10.1016/j.bmc.2014.02.023",,"3WLU",65.77,"1.4","1.4","Crystal Structure of human galectin-9 NCRD with Selenolactose","GSQAPYLSPAVPFSGTIQGGLQDGLQITVNGTVLSSSGTRFAVNFQTGFSGNDIAFHFNPRFEDGGYVVCNTRQNGSWGPEERKTHMPFQKGMPFDLCFLVQSSDFKVMVNGILFVQYFHRVPFHRVDTISVNGSVQLSYISFQ","Homo sapiens","LGALS9","Galectin-9","1","3WLU"
"3WMH",,"X-RAY DIFFRACTION",2.54,51.65,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.8M SODIUM CITRATE, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3WMH",66.12,"2.1","2.1","Human PPAR gamma ligand binding domain in complex with a gammma selective synthetic partial agonist MEKT75","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDL","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3WMH"
"3WN4",,"X-RAY DIFFRACTION",2.61,52.92,"VAPOR DIFFUSION, SITTING DROP",4.4,"10% (w/v) PEG 3350, 0.1M sodium citrate pH 4.4, 0.3M potassium formate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/cmdc.201300573","D87","3WN4",97.15,"1.81","1.81","Crystal structure of human TLR8 in complex with DS-877","RSPWEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTEFLVPR","Homo sapiens","TLR8, UNQ249/PRO286","Toll-like receptor 8","1","3WN4"
"3WNR",,"X-RAY DIFFRACTION",2.74,55.13,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.9M ammonium sulfate, 100mM Tris pH 8.0, 200mM NaCl, 4%(v/v) 2-propanol, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.ejmech.2015.02.012",,"3WNR",38.5,"2.008","2.008","Multiple binding modes of benzyl isothiocyanate inhibitor complexed with Macrophage Migration Inhibitory Factor","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","GLIF, MIF, MMIF","Macrophage migration inhibitory factor","1","3WNR"
"3WNS",,"X-RAY DIFFRACTION",2.73,55.03,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.9M ammonium sulfate, 100mM Tris pH 8.0, 200mM NaCl, 4%(v/v) 2-propanol, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.ejmech.2015.02.012",,"3WNS",38.32,"1.658","1.658","Allyl isothiocyanate inhibitor complexed with Macrophage Migration Inhibitory Factor","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","GLIF, MIF, MMIF","Macrophage migration inhibitory factor","1","3WNS"
"3WNT",,"X-RAY DIFFRACTION",2.8,56,"VAPOR DIFFUSION, HANGING DROP",6.5,"1.9M ammonium sulfate, 100mM Tris pH 8.0, 200mM NaCl, 4%(v/v) 2-propanol, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1016/j.ejmech.2015.02.012",,"3WNT",38.06,"2.074","2.074","Multiple binding modes of benzyl isothiocyanate inhibitor complexed with Macrophage Migration Inhibitory Factor","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","GLIF, MIF, MMIF","Macrophage migration inhibitory factor","1","3WNT"
"3WO2",,"X-RAY DIFFRACTION",2.68,54.07,"VAPOR DIFFUSION, HANGING DROP",7,"100mM Bis-Tris-HCl, 2.5M ammonium sulfate, 0.2%(w/v) CHAPS, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K",277,"10.1038/ncomms6340",,"3WO2",80.72,"2.33","2.33","Crystal structure of human interleukin-18","YFGKLESKLSVIRNLNDQVLFIDQGNRPLFEDMTDSDCRDNAPRTIFIISMYKDSQPRGMAVTISVKCEKISTLSCENKIISFKEMNPPDNIKDTKSDIIFFQRSVPGHDNKMQFESSSYEGYFLACEKERDLFKLILKKEDELGDRSIMFTVQNED","Homo sapiens","IL18, IGIF, IL1F4","Interleukin-18","1","3WO2"
"3WOW",,"X-RAY DIFFRACTION",1.93,36.14,"VAPOR DIFFUSION, SITTING DROP",8,"25% ethylene glycol, pH 8, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,,,"3WOW",41.41,"2.5","2.5","Crystal structure of human CK2a with AMPPNP","GPLGSMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMG","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","3WOW"
"3WOY",,"X-RAY DIFFRACTION",2.78,55.8,"VAPOR DIFFUSION, HANGING DROP",8.5,"20mM Tris, 3%(w/v) PEG10K , pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.jmb.2015.05.012",,"3WOY",28.18,"2.1","2.1","Crystal structure of CLASP2 TOG domain (TOG2)","GGAGAVDEDDFIKAFTDVPSIQIYSSRELEETLNKIREILSDDKHDWDQRANALKKIRSLLVAGAAQYDCFFQHLRLLDGALKLSAKDLRSQVVREACITVAHLSTVLGNKFDHGAEAIVPTLFNLVPNSAKVMATSGCAAIRFIIRHTHVPRLIPLITSNCTSKSVPVRRRSFEFLDLLLQEWQTHSLERHAAVLVETIKKGIHDADAEARVEARKTYMGLRNHFPGEAETLYNSLEPSYQKSLQTYLKS","Homo sapiens","CLASP2, KIAA0627","CLIP-associating protein 2","1","3WOY"
"3WPN",,"X-RAY DIFFRACTION",2.36,47.91,"VAPOR DIFFUSION, SITTING DROP",6,"19% PEG3350, 0.1M MES, 0.2M NaNO3, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1021/cb500939x","B4S","3WPN",43.19,"2.8","2.8","Kinesin spindle protein Eg5 in complex with ATP-competitive inhibitor PVZB1194","MNHKVHMASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQKLQHHHHHH","Homo sapiens","EG5, KIF11, KNSL1, TRIP5","Kinesin-like protein KIF11","1","3WPN"
"3WPQ",,"X-RAY DIFFRACTION",2.43,49.33,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.0M Na Citrate, 0.1M Hepes, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3WPQ",46.35,"1.84","1.84","crystal structure of the GAP domain of MgcRacGAP(S387A)","GSSGSSGIGEGMLADFVSQTSPMIPSIVVHCVNEIEQRGLTETGLYRIAGCDRTVKELKEKFLRVKTVPLLSKVDDIHAICSLLKDFLRNLKEPLLTFRLNRAFMEAAEITDEDNSIAAMYQAVGELPQANRDTLAFLMIHLQRVAQSPHTKMDVANLAKVFGPTIVAHAVPNPDPVTMSQDIKRQPKVVERLLSLPLEYWSQFMMVE","Homo sapiens","RACGAP1, KIAA1478, MGCRACGAP","Rac GTPase-activating protein 1","1","3WPQ"
"3WPS",,"X-RAY DIFFRACTION",3.97,69.01,"VAPOR DIFFUSION, SITTING DROP",6.5,"2.0M magnesium sulfate, 0.1M MES, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3WPS",47.48,"2.7","2.7","crystal structure of the GAP domain of MgcRacGAP(S387D)","GSSGSSGIGEGMLADFVSQTSPMIPSIVVHCVNEIEQRGLTETGLYRIDGCDRTVKELKEKFLRVKTVPLLSKVDDIHAICSLLKDFLRNLKEPLLTFRLNRAFMEAAEITDEDNSIAAMYQAVGELPQANRDTLAFLMIHLQRVAQSPHTKMDVANLAKVFGPTIVAHAVPNPDPVTMSQDIKRQPKVVERLLSLPLEYWSQFMMVE","Homo sapiens","RACGAP1, KIAA1478, MGCRACGAP","Rac GTPase-activating protein 1","1","3WPS"
"3WPT",,"X-RAY DIFFRACTION",3.74,67.14,"VAPOR DIFFUSION, SITTING DROP",5.5,"50MM MES, 100MM AMMONIUM SULFATE, 10MM MGCL, 15-20%(w/v) PEG8000, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,,,"3WPT",93.35,"2.629","2.629","Crystal structure of closed dimer of human importin-alpha1 (Rch1)","NWSVDDIVKGINSSNVENQLQATQAARKLLSREKQPPIDNIIRAGLIPKFVSFLGRTDCSPIQFESAWALTNIASGTSEQTKAVVDGGAIPAFISLLASPHAHISEQAVWALGNIAGDGSVFRDLVIKYGAVDPLLALLAVPDMSSLACGYLRNLTWTLSNLCRNKNPAPPIDAVEQILPTLVRLLHHDDPEVLADTCWAISYLTDGPNERIGMVVKTGVVPQLVKLLGASELPIVTPALRAIGNIVTGTDEQTQVVIDAGALAVFPSLLTNPKTNIQKEATWTMSNITAGRQDQIQQVVNHGLVPFLVSVLSKADFKTQKEAVWAVTNYTSGGTVEQIVYLVHCGIIEPLMNLLTAKDTKIILVILDAISNIFQAAEKLGETEKLSIMIEECGGLDKIEALQNHENESVYKASLSLIEKYFS","Homo sapiens","KPNA2, RCH1, SRP1","Importin subunit alpha-1","1","3WPT"
"3WQ9",,"X-RAY DIFFRACTION",2.26,45.56,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG 6000, 200mM NaCl, 50mM Tris pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"3WQ9",27.24,"1.8","1.8","Crystal structure of Hsp90-alpha N-terminal domain in complex with 2-(4-Hydroxy-cyclohexylamino)-4-[5-(4-phenyl-imidazol-1-yl)-isoquinolin-1-yl]-benzamide","HMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","3WQ9"
"3WQH",,"X-RAY DIFFRACTION",2.79,55.86,,6.5,"18% PEG 4000, 15% PEG 1000, 0.15M Na/K-Phosphate, pH 6.5, VAPOR DIFFUSION, temperature 293K",293,"10.3109/14756366.2014.1002402","SKK","3WQH",172.88,"2.85","2.85","Crystal Structure of human DPP-IV in complex with Anagliptin","GPSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","3WQH"
"3WS8",,"X-RAY DIFFRACTION",2.03,39.27,"VAPOR DIFFUSION, SITTING DROP",6,"50mM Bis-tris propane pH6.0, 50mM Magnesium sulfate, 15% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 296K",296,"10.1016/j.bmc.2014.04.023","X4C","3WS8",80.13,"2.6","2.6","Crystal structure of PDE10A in complex with a benzimidazole inhibitor","GSHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","3WS8"
"3WS9",,"X-RAY DIFFRACTION",2.09,41.22,"VAPOR DIFFUSION, SITTING DROP",6,"50mM Bis-tris propane pH6.0, 50mM Magnesium sulfate, 15% PEG 3350, VAPOR DIFFUSION, VAPOR DIFFUSION, SITTING DROP, temperature 296K",296,"10.1016/j.bmc.2014.04.023","X4D","3WS9",80.1,"2.99","2.99","Crystal structure of PDE10A in complex with a benzimdazole inhibitor","GSHMSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","3WS9"
"3WSA",,"X-RAY DIFFRACTION",2.44,49.5,"VAPOR DIFFUSION, SITTING DROP",8.2,"0.2M sodium citrate, pH 8.2, 28% PEG 3350, VAPOR DIFFUSION, SITTING DROP, temperature 295K",295,,,"3WSA",249.06,"2.9","2.9","The Tuberculosis Drug SQ109 Inhibits Trypanosoma cruzi Cell Proliferation and acts Synergistically with Posaconazole","MGSSHHHHHHSSGLVPRGSHMDQDSLSSSLKTCYKYLNQTSRSFAAVIQALDGEMRNAVCIFYLVLRALDTLEDDMTISVEKKVPLLHNFHSFLYQPDWRFMESKEKDRQVLEDFPTISLEFRNLAEKYQTVIADICRRMGIGMAEFLDKHVTSEQEWDKYCHYVAGLVGIGLSRLFSASEFEDPLVGEDTERANSMGLFLQKTNIIRDYLEDQQGGREFWPQEVWSRYVKKLGDFALPENIDLAVQCLNELITNALHHIPDVITYLSRLRNQSVFNFCAIPQVMAIATLAACYNNQQVFKGAVLIRLGQAVTLMMDATNMPAVKAIIYQYMEEIYHRIPDSNPSSSKTRQIISTIRTQN","Homo sapiens","FDFT1","Squalene synthase","1","3WSA"
"3WSX",,"X-RAY DIFFRACTION",4.04,69.54,"VAPOR DIFFUSION, HANGING DROP",4.5,"0.1M Sodium Acetate, 1.2M Sodium dihydrogen phosphate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/nsmb.2954",,"3WSX",84.26,"2.35","2.35","SorLA Vps10p domain in ligand-free form","EVWTQRLHGGSAPLPQDRGFLVVQGDPRELRLWARGDARGASRADEKPLRRKRSAALQPEPIKVYGQVSLNDSHNQMVVHWAGEKSNVIVALARDSLALARPKSSDVYVSYDYGKSFKKISDKLNFGLGNRSEAVIAQFYHSPADNKRYIFADAYAQYLWITFDFCNTLQGFSIPFRAADLLLHSKASNLLLGFDRSHPNKQLWKSDDFGQTWIMIQEHVKSFSWGIDPYDKPNTIYIERHEPSGYSTVFRSTDFFQSRENQEVILEEVRDFQLRDKYMFATKVVHLLGSEQQSSVQLWVSFGRKPMRAAQFVTRHPINEYYIADASEDQVFVCVSHSNNRTNLYISEAEGLKFSLSLENVLYYSPGGAGSDTLVRYFANEPFADFHRVEGLQGVYIATLINGSMNEENMRSVITFDKGGTWEFLQAPAFTGYGEKINCELSQGCSLHLAQRLSQLLNLQLRRMPILSKESAPGLIIATGSVGKNLASKTNVYISSSAGARWREALPGPHYYTWGDHGGIITAIAQGMETNELKYSTNEGETWKTFIFSEKPVFVYGLLTEPGEKSTVFTIFGSNKENVHSWLILQVNATDALGVPCTENDYKLWSPSDERGNECLLGHKTVFKRRTPHATCFNGEDFDRPVVVSNCSCTREDYECDFGFKMSEDLSLEVCVPDPEFSGKSYSPPVPCPVGSTYRRTRGYRKISGDTCSGGDVEARLEGELVPCPSRLENLYFQ","Homo sapiens","SORL1, C11orf32","Sortilin-related receptor","1","3WSX"
"3WTD",,"X-RAY DIFFRACTION",2.62,53,"VAPOR DIFFUSION, HANGING DROP",8.5,"1.5M ammonium sulfate, 12%(v/v) glycerol, 0.1M Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1126/science.1261971",,"3WTD",35.71,"2.35","2.35","Structure of PAXX","GSMDPLSPPLCTLPPGPEPPRFVCYCEGEESGEGDRGGFNLYVTDAAELWSTCFTPDSLAALKARFGLSAAEDITPRFRAACEQQAVALTLQEDRASLTLSGGPSALAFDLSKVPGPEAAPRLRALTLGLAKRVWSLERRLAAAEETAVSPRKSPRPAGPQLFLPDPD","Homo sapiens","C9orf142, PAXX, XLS","Uncharacterized protein C9orf142","1","3WTD"
"3WTF",,"X-RAY DIFFRACTION",2.01,38.81,"VAPOR DIFFUSION, HANGING DROP",6,"1M sodium malonate, 1% (v/v) 1,4-Dioxane, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K",291,"10.1126/science.1261971",,"3WTF",43.62,"3.451","3.451","Structure of PAXX","GSMDPLSPPLCTLPPGPEPPRFVCYCEGEESGEGDRGGFNLYVTDAAELWSTCFTPDSLAALKARFGLSAAEDITPRFRAACEQQAVALTLQEDRASLTLSGGPSALAFDLSKVPGPEAAPRLRALTLGLAKRVWSLERRLAAAEETAVSPRKSPRPAGPQLFLPDPDPQRGGPGPGVRRRCPGESLINPGFKSKKPAGGVDFDET","Homo sapiens","C9orf142, PAXX, XLS","Uncharacterized protein C9orf142","1","3WTF"
"3WTZ",,"X-RAY DIFFRACTION",2.65,53.62,"VAPOR DIFFUSION, SITTING DROP",7.8,"9% MPD, 6% PEG 6000, 0.1M HEPES, pH 7.8, VAPOR DIFFUSION, SITTING DROP",,"10.1016/j.jmb.2014.07.020",,"3WTZ",38.43,"2.61","2.61","Crystal structure of ETS-1 DNA binding and autoinhibitory domains (276-441)","SLQRVPSYDSFDSEDYPAALPNHKPKGTFKDYVRDRADLNKDKPVIPAAALAGYTGSGPIQLWQFLLELLTDKSCQSFISWTGDGWEFKLSDPDEVARRWGKRKNKPKMNYEKLSRGLRYYYDKNIIHKTAGKRYVYRFVCDLQSLLGYTPEELHAMLDVKPDADE","Homo sapiens","ETS1, EWSR2","Protein C-ets-1","1","3WTZ"
"3WU0",,"X-RAY DIFFRACTION",2.56,51.95,"VAPOR DIFFUSION, SITTING DROP",7.5,"5% PEG 3000, 25% MPD, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP",,"10.1016/j.jmb.2014.07.020",,"3WU0",38.43,"2.6","2.6","Crystal structure of phosphorylated ETS-1 DNA binding and autoinhibitory domains (276-441)","SLQRVPSYDSFDSEDYPAALPNHKPKGTFKDYVRDRADLNKDKPVIPAAALAGYTGSGPIQLWQFLLELLTDKSCQSFISWTGDGWEFKLSDPDEVARRWGKRKNKPKMNYEKLSRGLRYYYDKNIIHKTAGKRYVYRFVCDLQSLLGYTPEELHAMLDVKPDADE","Homo sapiens","ETS1, EWSR2","Protein C-ets-1","1","3WU0"
"3WUP",,"X-RAY DIFFRACTION",2.25,45.44,"VAPOR DIFFUSION, SITTING DROP",7.5,"4.3M sodium chloride, 0.1M HEPES , pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1111/febs.13734",,"3WUP",4.61,"1.6","1.6","Crystal Structure of the Ubiquitin-Binding Zinc Finger (UBZ) Domain of the Human DNA Polymerase Eta","GSEDQVPCEKCGSLVPVWDMPEHMDYHFALELQKSFLQ","Homo sapiens","POLH, RAD30, RAD30A, XPV","DNA polymerase eta","1","3WUP"
"3WUS",,"X-RAY DIFFRACTION",3.43,64.12,"VAPOR DIFFUSION, HANGING DROP",9,"8.5% PEG 20000, 2% Dioxane, 300mM L-Arginine HCl, 85mM Na BICINE, pH 9, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1128/JVI.02369-15",,"3WUS",45.87,"2.54","2.54","Crystal Structure of the Vif-Binding Domain of Human APOBEC3F","MNPILRNPMEAMYPHIFYFHFKNLRKAYGRNESWLCFTMEVVKHHSPVSWKRGVFRNQVDPETHCHAERCFLSWFCDDILSPNTNYEVTWYTSWSPCPECAGEVAEFLARHSNVNLTIFTARLYYFWDTDYQEGLRSLSQEGASVEIMGYKDFKYCWENFVYNDDEPFKPWKGLKYNFLFLDSKLQEILE","Homo sapiens","APOBEC3F","DNA dC->dU-editing enzyme APOBEC-3F","1","3WUS"
"3WUZ",,"X-RAY DIFFRACTION",1.85,33.34,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1 M trisodium citrate pH 5.6, 20% 2-propanol, 20% PEG 4000, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1073/pnas.1324105111",,"3WUZ",14.41,"1.3","1.3","Crystal structure of the Ig V-set domain of human paired immunoglobulin-like type 2 receptor alpha","MLYGVTQPKHLSASMGGSVEIPFSFYYPWELATAPDVRISWRRGHFHGQSFYSTRPPSIHKDYVNRLFLNWTEGQKSGFLRISNLQKQDQSVYFCRVELDTRSSGRQQWQSIEGTKLSIT","Homo sapiens","PILRA","Paired immunoglobulin-like type 2 receptor alpha","1","3WUZ"
"3WV1",,"X-RAY DIFFRACTION",2.27,45.77,"VAPOR DIFFUSION, HANGING DROP",8.5,"8-16%(w/v) PEG8000, 1.0-1.5M ammonium formate, 0.1M Tris HCl, pH 8.5, vapor diffusion, hanging drop, temperature 293K",293,"10.1021/jm500981k","WHH","3WV1",40.01,"1.98","1.98","Crystal structure of the catalytic domain of MMP-13 complexed with 4-(2-((6-fluoro-2-((3-methoxybenzyl)carbamoyl)-4-oxo-3,4-dihydroquinazolin-5-yl)oxy)ethyl)benzoic acid","YNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYGPGDEDPN","Homo sapiens","MMP13","Collagenase 3","1","3WV1"
"3WV2",,"X-RAY DIFFRACTION",2.22,44.62,"VAPOR DIFFUSION, HANGING DROP",8.5,"5uM Zn(OAc)2, 5mM CaCl2, 50mM NaCl, 20mM Tris HCl, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.bmc.2014.07.025","WGG","3WV2",39.56,"2.3","2.3","Crystal structure of the catalytic domain of MMP-13 complexed with N-(3-methoxybenzyl)-4-oxo-3,4-dihydroquinazoline-2-carboxamide","YNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYGPGDEDPN","Homo sapiens","MMP13","Collagenase 3","1","3WV2"
"3WV3",,"X-RAY DIFFRACTION",2.33,47.19,"VAPOR DIFFUSION, HANGING DROP",8.5,"100mM TrisHCl, 1500mM ammonium formate, 17.7% PEG8000, pH 8.5, vapor diffusion, hanging drop, temperature 293K",293,"10.1016/j.bmc.2014.07.025","WLL","3WV3",39.79,"1.6","1.6","Crystal structure of the catalytic domain of MMP-13 complexed with N-(3-methoxybenzyl)-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidine-2-carboxamide","YNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYGPGDEDPN","Homo sapiens","MMP13","Collagenase 3","1","3WV3"
"3WV6",,"X-RAY DIFFRACTION",2.48,50.34,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M L-proline, 4%(w/v) PEG3350, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bbrc.2017.07.009",,"3WV6",68.34,"1.95","1.95","Crystal Structure of a protease-resistant mutant form of human galectin-9","MAFSGSQAPYLSPAVPFSGTIQGGLQDGLQITVNGTVLSSSGTRFAVNFQTGFSGNDIAFHFNPRFEDGGYVVCNTRQNGSWGPEERKTHMPFQKGMPFDLCFLVQSSDFKVMVNGILFVQYFHRVPFHRVDTISVNGSVQLSYISFQHMTPAIPPMMYPHPAYPMPFITTILGGLYPSKSILLSGTVLPSAQSFHINLCSGNHIAFHLNPRFDENAVVRNTQIDNSWGSEERSLPRKMPFVRGQSFSVWILCEAHCLKVAVDGQHLFEYYHRLRNLPTINRLEVGGDIQLTHVQT","Homo sapiens","LGALS9","Galectin-9","1","3WV6"
"3WVM",,"X-RAY DIFFRACTION",2.15,42.83,"VAPOR DIFFUSION, SITTING DROP",8.5,"55%(v/v) PEG400, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1002/anie.201409830",,"3WVM",15.73,"0.88","0.88","The 0.88 angstrom X-ray structure of the human heart fatty acid-binding protein complexed with stearic acid","MVDAFLGTWKLVDSKNFDDYMKSLGVGFATRQVASMTKPTTIIEKNGDILTLKTHSTFKNTEISFKLGVEFDETTADDRKVKSIVTLDGGKLVHLQKWDGQETTLVRELIDGKLILTLTHGTAVCTRTYEKEA","Homo sapiens","FABP3, FABP11, MDGI","Fatty acid-binding protein, heart","1","3WVM"
"3WVZ",,"X-RAY DIFFRACTION",2.35,47.6,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.1M Tris-HCl (pH 7.4), 1M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1107/S1399004714026881",,"3WVZ",43.94,"1.88","1.88","Crystal structure of Hikeshi, a new nuclear transport receptor of Hsp70","ALGSMFGCLVAGRLVQTAAQQVAEDKFVFDLPDYESINHVVVFMLGTIPFPEGMGGSVYFSYPDSNGMPVWQLLGFVTNGKPSAIFKISGLKSGEGSQHPFGAMNIVRTPSVAQIGISVELLDSMAQQTPVGNAAVSSVDSFTQFTQKMLDNFYNFASSFAVSQAQMTPSPSEMFIPANVVLKWYENFQRRLAQNPLFWKT","Homo sapiens","C11orf73, HSPC138, HSPC179, HSPC248, HIKESHI","Protein Hikeshi","1","3WVZ"
"3WW0",,"X-RAY DIFFRACTION",3.35,63.33,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.1M Tris-HCl (pH 7.4), 1M ammonium sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K",293.15,"10.1107/S1399004714026881",,"3WW0",43.36,"2.5","2.5","Crystal structure of F97A mutant, a new nuclear transport receptor of Hsp70","GSMFGCLVAGRLVQTAAQQVAEDKFVFDLPDYESINHVVVFMLGTIPFPEGMGGSVYFSYPDSNGMPVWQLLGFVTNGKPSAIFKISGLKSGEGSQHPAGAMNIVRTPSVAQIGISVELLDSMAQQTPVGNAAVSSVDSFTQFTQKMLDNFYNFASSFAVSQAQMTPSPSEMFIPANVVLKWYENFQRRLAQNPLFWKT","Homo sapiens","C11orf73, HSPC138, HSPC179, HSPC248, HIKESHI","Protein Hikeshi","1","3WW0"
,,,,,,,,,,,,,,,,"SMFGCLVAGRLVQTAAQQVAEDKFVFDLPDYESINHVVVFMLGTIPFPEGMGGSVYFSYPDSNGMPVWQLLGFVTNGKPSAIFKISGLKSGEGSQHPAGAMNIVRTPSVAQIGISVELLDSMAQQTPVGNAAVSSVDSFTQFTQKMLDNFYNFASSFAVSQAQMTPSPSEMFIPANVVLKWYENFQRRLAQNPLFWKT","Homo sapiens","C11orf73, HSPC138, HSPC179, HSPC248, HIKESHI","Protein Hikeshi","2","3WW0"
"3WWR",,"X-RAY DIFFRACTION",2.6,52.68,"VAPOR DIFFUSION",6.5,"0.1M MES, pH6.5, 1.2-1.6M ammonium sulfate, VAPOR DIFFUSION, temperature 293K",293,"10.1016/j.jsbmb.2014.12.004",,"3WWR",30.32,"3.18","3.18","Crystal structure of the human vitamin D receptor ligand binding domain complexed with 1-((((1S,2R,6R,Z)-2,6-dihydroxy-4-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-3-methylenecyclohexyl)oxy)methyl)cyclopropanecarbonitrile","GSHMDSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEIS","Homo sapiens","VDR, NR1I1","Vitamin D3 receptor","1","3WWR"
,,,,,,,,,,,,,,,,,"Homo sapiens","VDR, NR1I1"
"3WWS",,"X-RAY DIFFRACTION",2.24,45.12,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.1M Tris-HCl pH 7.4. 10%(m/v) PEG3350, 0.1M (NH4)3PO4, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,,,"3WWS",24.69,"2.01","2.01","Crystal structure of Serine/threonine-protein kinase 3","AADFDFLKNLSLEELQMRLKALDPMMEREIEELRQRYTAKRQPILDAMDAK","Homo sapiens","STK3, KRS1, MST2","Serine/threonine-protein kinase 3","1","3WWS"
,,,,,,,,,,,,,,,,"DFDFLKNLSLEELQMRLKALDPMMEREIEELRQRYTAKRQPILDAMDAK","Homo sapiens","STK3, KRS1, MST2","Serine/threonine-protein kinase 3","2","3WWS"
"3WXQ",,"X-RAY DIFFRACTION",2.19,43.96,"batch method",8,"73mM Tris-HCl, 43% PEG400, 33mM NaCl, pH 8.0, batch method, temperature 293K",293,"10.1038/nmeth.3172",,"3WXQ",15.16,"1.6","1.6","Serial femtosecond X-ray structure of human fatty acid-binding protein type-3 (FABP3) in complex with stearic acid (C18:0) determined using X-ray free-electron laser at SACLA","MVDAFLGTWKLVDSKNFDDYMKSLGVGFATRQVASMTKPTTIIEKNGDILTLKTHSTFKNTEISFKLGVEFDETTADDRKVKSIVTLDGGKLVHLQKWDGQETTLVRELIDGKLILTLTHGTAVCTRTYEKEA","Homo sapiens","FABP3, FABP11, MDGI","Fatty acid-binding protein, heart","1","3WXQ"
"3WYK",,"X-RAY DIFFRACTION",2.1,41.53,"VAPOR DIFFUSION, HANGING DROP",7.52,"200mM  magnesium chloride hexahydrate, 25.7% PEG3350, pH 7.52, vapor diffusion, hanging drop, temperature 277K",277,"10.1021/jm5013648",,"3WYK",78.72,"2.5","2.5","Crystal structure of the catalytic domain of PDE10A complexed with 3-(1-phenyl-1H-pyrazol-5-yl)-1-(3-(trifluoromethyl)phenyl)pyridazin-4(1H)-one","TSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","3WYK"
"3WYL",,"X-RAY DIFFRACTION",2.13,42.19,"VAPOR DIFFUSION, HANGING DROP",7.52,"200 mM  magnesium chloride hexahydrate, 27.4% PEG3350, pH 7.52, vapor diffusion, hanging drop, temperature 277K",277,"10.1021/jm5013648",,"3WYL",78.78,"2.68","2.68","Crystal structure of the catalytic domain of PDE10A complexed with 5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)-1-(3-(trifluoromethyl)phenyl)pyridazin-4(1H)-one","TSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","3WYL"
"3WYM",,"X-RAY DIFFRACTION",2.11,41.66,"VAPOR DIFFUSION, HANGING DROP",,"200mM  magnesium chloride hexahydrate, 25.7% PEG3350, vapor diffusion, hanging drop, temperature 277K",277,"10.1021/jm5013648",,"3WYM",78.82,"2","2","Crystal structure of the catalytic domain of PDE10A complexed with 1-(2-fluoro-4-(1H-pyrazol-1-yl)phenyl)-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one","TSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","3WYM"
"3WYR",,"X-RAY DIFFRACTION",2.23,44.85,"VAPOR DIFFUSION, HANGING DROP",6,"16% PEG 3350, 4% tacsimate, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1074/jbc.M114.612291",,"3WYR",46.27,"2.8","2.8","Crystal structure of Killer cell immunoglobulin-like receptor 2DL4","HHHHHHDDDDKHVGGQDKPFCSAWPSAVVPQGGHVTLRCHYRRGFNIFTLYKKDGVPVPELYNRIFWNSFLISPVTPAHAGTYRCRGFHPHSPTEWSAPSNPLVIMVTGLYEKPSLTARPGPTVRTGENVTLSCSSQSSFDIYHLSREGEAHELRLPAVPSINGTFQADFPLGPATHGETYRCFGSFHGSPYEWSDASDPLPVSVT","Homo sapiens","KIR2DL4, CD158D, KIR103AS","Killer cell immunoglobulin-like receptor 2DL4","1","3WYR"
"3WYX",,"X-RAY DIFFRACTION",2.85,56.87,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M ADA pH6.5, 0.3M potassium iodide, 12%(w/v) PEG8000, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmc.2015.02.042",,"3WYX",37.41,"2.9","2.9","CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 6-((3-(cyanomethoxy)-4-(1-methyl-1H-pyrazol-4-yl)phenyl)amino)-2-(cyclohexylamino)nicotinonitrile","MECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNLVPRGSAAGHHHHHH","Homo sapiens","TTK, MPS1, MPS1L1","Dual specificity protein kinase TTK","1","3WYX"
"3WYY",,"X-RAY DIFFRACTION",2.91,57.76,"VAPOR DIFFUSION, SITTING DROP",,"0.35M sodium malonate, 7%(w/v) PEG3350, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1016/j.bmc.2015.02.042",,"3WYY",37.4,"3.05","3.05","CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH (E)-3-(4-((6-(((3s,5s,7s)-adamantan-1-yl)amino)-4-amino-5-cyanopyridin-2-yl)amino)-2-(cyanomethoxy)phenyl)-N-(2-methoxyethyl)acrylamide","MECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNLVPRGSAAGHHHHHH","Homo sapiens","TTK, MPS1, MPS1L1","Dual specificity protein kinase TTK","1","3WYY"
"3WZD",,"X-RAY DIFFRACTION",2.45,49.91,"VAPOR DIFFUSION",9.5,"0.1M CHES,5-20% PEG 8000, pH 9.5, VAPOR DIFFUSION, temperature 277K",277,"10.1021/ml500394m","LEV","3WZD",36.82,"1.57","1.57","KDR in complex with ligand lenvatinib","DEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDG","Homo sapiens","KDR, FLK1, VEGFR2","Vascular endothelial growth factor receptor 2","1","3WZD"
"3WZE",,"X-RAY DIFFRACTION",2.97,58.68,"VAPOR DIFFUSION",8,"10-25% PEG 3350, Na3Citrate, 0.1M Bis-Tris propane, pH 8.0, VAPOR DIFFUSION, temperature 277K",277,"10.1021/ml500394m","BAX","3WZE",36.02,"1.9","1.9","KDR in complex with ligand sorafenib","DEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDG","Homo sapiens","KDR, FLK1, VEGFR2","Vascular endothelial growth factor receptor 2","1","3WZE"
"3WZF",,"X-RAY DIFFRACTION",2.54,51.5,"VAPOR DIFFUSION, HANGING DROP",6,"0.1M Bis-Tris 21%(w/v) PEG 3350, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,,,"3WZF",46.17,"2.991","2.991","Crystal structure of human cytoplasmic aspartate aminotransferase","APPSVFAEVPQAQPVLVFKLTADFREDPDPRKVNLGVGAYRTDDCHPWVLPVVKKVEQKIANDNSLNHEYLPILGLAEFRSCASRLALGDDSPALKEKRVGGVQSLGGTGALRIGADFLARWYNGTNNKNTPVYVSSPTWENHNAVFSAAGFKDIRSYRYWDAEKRGLDLQGFLNDLENAPEFSIVVLHACAHNPTGIDPTPEQWKQIASVMKHRFLFPFFDSAYQGFASGNLERDAWAIRYFVSEGFEFFCAQSFSKNFGLYNERVGNLTVVGKEPESILQVLSQMEKIVRITWSNPPAQGARIVASTLSNPELFEEWTGNVKTMADRILTMRSELRARLEALKTPGTWNHITDQIGMFSFTGLNPKQVEYLVNEKHIYLLPSGRINVSGLTTKNLDYVATSIHEAVTKIQ","Homo sapiens","GOT1","Aspartate aminotransferase, cytoplasmic","1","3WZF"
"3WZJ",,"X-RAY DIFFRACTION",3.04,59.51,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M Tris hydrochloride pH7.5, 0.12M magnesium chloride, 8%(w/v) triethylene glycol 
, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm501599u","O43","3WZJ",37.35,"2.75","2.75","CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-(6-(cyclohexylamino)-8-(((tetrahydro-2H-pyran-4-yl)methyl)amino)imidazo[1,2-b]pyridazin-3-yl)-N-cyclopropylbenzamide","MECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNLVPRGSAAGHHHHHH","Homo sapiens","TTK, MPS1, MPS1L1","Dual specificity protein kinase TTK","1","3WZJ"
"3WZK",,"X-RAY DIFFRACTION",2.98,58.67,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M PIPES pH6.5, 12.3%(w/v) PEG3350, 0.0818M magnesium sulfate, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1021/jm501599u","O23","3WZK",37.28,"2.3","2.3","CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH N-cyclopropyl-4-(8-((thiophen-2-ylmethyl)amino)imidazo[1,2-a]pyrazin-3-yl)benzamide","MECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNLVPRGSAAGHHHHHH","Homo sapiens","TTK, MPS1, MPS1L1","Dual specificity protein kinase TTK","1","3WZK"
"3WZU",,"X-RAY DIFFRACTION",2.67,53.98,"VAPOR DIFFUSION, SITTING DROP",7,"25W/V PEG3350, 0.2M SODIUM CITRATE, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2014.12.011","1FM","3WZU",37.36,"3.01","3.01","THE STRUCTURE OF MAP2K7 IN COMPLEX WITH 5Z-7-oxozeaenol","MTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRTSGVLSQPHLPFFRHHHHHH","Homo sapiens","MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4","Dual specificity mitogen-activated protein kinase kinase 7","1","3WZU"
"3WZZ",,"X-RAY DIFFRACTION",2.87,57.07,"VAPOR DIFFUSION, SITTING DROP",5.5,"100MM NA-CITRATE, 10MM MG-ACETATE, 100MM LI-ACETATE CONTAININ, 8-14%(V/V) PEG4000, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.molcel.2015.12.011",,"3WZZ",89.86,"2.6","2.6","Crystal structure of PIP4KIIBETA","GPNCAPGQKVKLFRASEPILSVLMWGVNHTINELSNVPVPVMLMPDDFKAYSKIKVDNHLFNKENLPSRFKFKEYCPMVFRNLRERFGIDDQDYQNSVTRSAPINSDSQGRCGTRFLTTYDRRFVIKTVSSEDVAEMHNILKKYHQFIVECHGNTLLPQFLGMYRLTVDGVETYMVVTRNVFSHRLTVHRKYDLKGSTVAREASDKEKAKDLPTFKDNDFLNEGQKLHVGEESKKNFLEKLKRDVEFLAQLKIMDYSLLVGIHDVDRAEQEEMEVEERAEDEECENDGVGGNLLCSYGTPPDSPGNLLSFPRFFGPGEFDPSVDVYAMKSHESSPKKEVYFMAIIDILTPYDTKKKAAHAAKTVKHGAGAEISTVNPEQYSKRFNEFMSNILT","Homo sapiens","PIP4K2B, PIP5K2B","Phosphatidylinositol 5-phosphate 4-kinase type-2 beta","1","3WZZ"
"3X01",,"X-RAY DIFFRACTION",2.95,58.3,"VAPOR DIFFUSION, SITTING DROP",5.5,"100MM NA-CITRATE, 10MM MG-ACETATE, 100MM LI-ACETATE CONTAINING 8-14%(V/V) PEG4000, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.molcel.2015.12.011",,"3X01",91.25,"2.15","2.15","Crystal structure of PIP4KIIBETA complex with AMP","GPNCAPGQKVKLFRASEPILSVLMWGVNHTINELSNVPVPVMLMPDDFKAYSKIKVDNHLFNKENLPSRFKFKEYCPMVFRNLRERFGIDDQDYQNSVTRSAPINSDSQGRCGTRFLTTYDRRFVIKTVSSEDVAEMHNILKKYHQFIVECHGNTLLPQFLGMYRLTVDGVETYMVVTRNVFSHRLTVHRKYDLKGSTVAREASDKEKAKDLPTFKDNDFLNEGQKLHVGEESKKNFLEKLKRDVEFLAQLKIMDYSLLVGIHDVDRAEQEEMEVEERAEDEECENDGVGGNLLCSYGTPPDSPGNLLSFPRFFGPGEFDPSVDVYAMKSHESSPKKEVYFMAIIDILTPYDTKKKAAHAAKTVKHGAGAEISTVNPEQYSKRFNEFMSNILT","Homo sapiens","PIP4K2B, PIP5K2B","Phosphatidylinositol 5-phosphate 4-kinase type-2 beta","1","3X01"
"3X02",,"X-RAY DIFFRACTION",2.96,58.46,"VAPOR DIFFUSION, SITTING DROP",5.5,"100MM NA-CITRATE, 10MM MG-ACETATE, 100MM LI-ACETATE CONTAINING 8-14%(V/V) PEG4000, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.molcel.2015.12.011",,"3X02",91.67,"2.45","2.45","Crystal structure of PIP4KIIBETA complex with GMP","GPNCAPGQKVKLFRASEPILSVLMWGVNHTINELSNVPVPVMLMPDDFKAYSKIKVDNHLFNKENLPSRFKFKEYCPMVFRNLRERFGIDDQDYQNSVTRSAPINSDSQGRCGTRFLTTYDRRFVIKTVSSEDVAEMHNILKKYHQFIVECHGNTLLPQFLGMYRLTVDGVETYMVVTRNVFSHRLTVHRKYDLKGSTVAREASDKEKAKDLPTFKDNDFLNEGQKLHVGEESKKNFLEKLKRDVEFLAQLKIMDYSLLVGIHDVDRAEQEEMEVEERAEDEECENDGVGGNLLCSYGTPPDSPGNLLSFPRFFGPGEFDPSVDVYAMKSHESSPKKEVYFMAIIDILTPYDTKKKAAHAAKTVKHGAGAEISTVNPEQYSKRFNEFMSNILT","Homo sapiens","PIP4K2B, PIP5K2B","Phosphatidylinositol 5-phosphate 4-kinase type-2 beta","1","3X02"
"3X03",,"X-RAY DIFFRACTION",2.93,58.04,"VAPOR DIFFUSION, SITTING DROP",5.5,"100MM NA-CITRATE, 10MM MG-ACETATE, 100MM LI-ACETATE, 8-14%(V/V) PEG4000, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.molcel.2015.12.011",,"3X03",91.38,"2.7","2.7","Crystal structure of PIP4KIIBETA complex with AMPPNP","GPNCAPGQKVKLFRASEPILSVLMWGVNHTINELSNVPVPVMLMPDDFKAYSKIKVDNHLFNKENLPSRFKFKEYCPMVFRNLRERFGIDDQDYQNSVTRSAPINSDSQGRCGTRFLTTYDRRFVIKTVSSEDVAEMHNILKKYHQFIVECHGNTLLPQFLGMYRLTVDGVETYMVVTRNVFSHRLTVHRKYDLKGSTVAREASDKEKAKDLPTFKDNDFLNEGQKLHVGEESKKNFLEKLKRDVEFLAQLKIMDYSLLVGIHDVDRAEQEEMEVEERAEDEECENDGVGGNLLCSYGTPPDSPGNLLSFPRFFGPGEFDPSVDVYAMKSHESSPKKEVYFMAIIDILTPYDTKKKAAHAAKTVKHGAGAEISTVNPEQYSKRFNEFMSNILT","Homo sapiens","PIP4K2B, PIP5K2B","Phosphatidylinositol 5-phosphate 4-kinase type-2 beta","1","3X03"
"3X04",,"X-RAY DIFFRACTION",3.01,59.16,"VAPOR DIFFUSION, SITTING DROP",5.5,"100MM NA-CITRATE, 10MM MG-ACETATE, 100MM LI-ACETATE, 8-14%(V/V) PEG4000, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.molcel.2015.12.011",,"3X04",91.95,"2.6","2.6","Crystal structure of PIP4KIIBETA complex with GMPPNP","GPNCAPGQKVKLFRASEPILSVLMWGVNHTINELSNVPVPVMLMPDDFKAYSKIKVDNHLFNKENLPSRFKFKEYCPMVFRNLRERFGIDDQDYQNSVTRSAPINSDSQGRCGTRFLTTYDRRFVIKTVSSEDVAEMHNILKKYHQFIVECHGNTLLPQFLGMYRLTVDGVETYMVVTRNVFSHRLTVHRKYDLKGSTVAREASDKEKAKDLPTFKDNDFLNEGQKLHVGEESKKNFLEKLKRDVEFLAQLKIMDYSLLVGIHDVDRAEQEEMEVEERAEDEECENDGVGGNLLCSYGTPPDSPGNLLSFPRFFGPGEFDPSVDVYAMKSHESSPKKEVYFMAIIDILTPYDTKKKAAHAAKTVKHGAGAEISTVNPEQYSKRFNEFMSNILT","Homo sapiens","PIP4K2B, PIP5K2B","Phosphatidylinositol 5-phosphate 4-kinase type-2 beta","1","3X04"
"3X05",,"X-RAY DIFFRACTION",2.95,58.25,"VAPOR DIFFUSION, HANGING DROP",5.5,"100MM NA-CITRATE, 10MM MG-ACETATE, 100MM LI-ACETATE, 8-14%(V/V) PEG4000, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K",277,"10.1016/j.molcel.2015.12.011",,"3X05",91.31,"2.5","2.5","Crystal structure of PIP4KIIBETA T201M complex with AMP","GPNCAPGQKVKLFRASEPILSVLMWGVNHTINELSNVPVPVMLMPDDFKAYSKIKVDNHLFNKENLPSRFKFKEYCPMVFRNLRERFGIDDQDYQNSVTRSAPINSDSQGRCGTRFLTTYDRRFVIKTVSSEDVAEMHNILKKYHQFIVECHGNTLLPQFLGMYRLTVDGVETYMVVMRNVFSHRLTVHRKYDLKGSTVAREASDKEKAKDLPTFKDNDFLNEGQKLHVGEESKKNFLEKLKRDVEFLAQLKIMDYSLLVGIHDVDRAEQEEMEVEERAEDEECENDGVGGNLLCSYGTPPDSPGNLLSFPRFFGPGEFDPSVDVYAMKSHESSPKKEVYFMAIIDILTPYDTKKKAAHAAKTVKHGAGAEISTVNPEQYSKRFNEFMSNILT","Homo sapiens","PIP4K2B, PIP5K2B","Phosphatidylinositol 5-phosphate 4-kinase type-2 beta","1","3X05"
"3X06",,"X-RAY DIFFRACTION",2.95,58.32,"VAPOR DIFFUSION, SITTING DROP",5.5,"100MM NA-CITRATE, 10MM MG-ACETATE, 100MM LI-ACETATE, 8-14%(V/V) PEG4000, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.molcel.2015.12.011",,"3X06",91.73,"2.65","2.65","Crystal structure of PIP4KIIBETA T201M complex with GMP","GPNCAPGQKVKLFRASEPILSVLMWGVNHTINELSNVPVPVMLMPDDFKAYSKIKVDNHLFNKENLPSRFKFKEYCPMVFRNLRERFGIDDQDYQNSVTRSAPINSDSQGRCGTRFLTTYDRRFVIKTVSSEDVAEMHNILKKYHQFIVECHGNTLLPQFLGMYRLTVDGVETYMVVMRNVFSHRLTVHRKYDLKGSTVAREASDKEKAKDLPTFKDNDFLNEGQKLHVGEESKKNFLEKLKRDVEFLAQLKIMDYSLLVGIHDVDRAEQEEMEVEERAEDEECENDGVGGNLLCSYGTPPDSPGNLLSFPRFFGPGEFDPSVDVYAMKSHESSPKKEVYFMAIIDILTPYDTKKKAAHAAKTVKHGAGAEISTVNPEQYSKRFNEFMSNILT","Homo sapiens","PIP4K2B, PIP5K2B","Phosphatidylinositol 5-phosphate 4-kinase type-2 beta","1","3X06"
"3X07",,"X-RAY DIFFRACTION",2.98,58.79,"VAPOR DIFFUSION, SITTING DROP",5.5,"100MM NA-CITRATE, 10MM MG-ACETATE, 100MM LI-ACETATE, 8-14%(V/V) PEG4000, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.molcel.2015.12.011",,"3X07",90.81,"2.6","2.6","Crystal structure of PIP4KIIBETA N203A complex with AMP","GPNCAPGQKVKLFRASEPILSVLMWGVNHTINELSNVPVPVMLMPDDFKAYSKIKVDNHLFNKENLPSRFKFKEYCPMVFRNLRERFGIDDQDYQNSVTRSAPINSDSQGRCGTRFLTTYDRRFVIKTVSSEDVAEMHNILKKYHQFIVECHGNTLLPQFLGMYRLTVDGVETYMVVTRAVFSHRLTVHRKYDLKGSTVAREASDKEKAKDLPTFKDNDFLNEGQKLHVGEESKKNFLEKLKRDVEFLAQLKIMDYSLLVGIHDVDRAEQEEMEVEERAEDEECENDGVGGNLLCSYGTPPDSPGNLLSFPRFFGPGEFDPSVDVYAMKSHESSPKKEVYFMAIIDILTPYDTKKKAAHAAKTVKHGAGAEISTVNPEQYSKRFNEFMSNILT","Homo sapiens","PIP4K2B, PIP5K2B","Phosphatidylinositol 5-phosphate 4-kinase type-2 beta","1","3X07"
"3X08",,"X-RAY DIFFRACTION",2.93,58.03,"VAPOR DIFFUSION, SITTING DROP",5.5,"100MM NA-CITRATE, 10MM MG-ACETATE, 100MM LI-ACETATE, 8-14%(V/V) PEG4000, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.molcel.2015.12.011",,"3X08",90.86,"2.75","2.75","Crystal structure of PIP4KIIBETA N203A complex with GMP","GPNCAPGQKVKLFRASEPILSVLMWGVNHTINELSNVPVPVMLMPDDFKAYSKIKVDNHLFNKENLPSRFKFKEYCPMVFRNLRERFGIDDQDYQNSVTRSAPINSDSQGRCGTRFLTTYDRRFVIKTVSSEDVAEMHNILKKYHQFIVECHGNTLLPQFLGMYRLTVDGVETYMVVTRAVFSHRLTVHRKYDLKGSTVAREASDKEKAKDLPTFKDNDFLNEGQKLHVGEESKKNFLEKLKRDVEFLAQLKIMDYSLLVGIHDVDRAEQEEMEVEERAEDEECENDGVGGNLLCSYGTPPDSPGNLLSFPRFFGPGEFDPSVDVYAMKSHESSPKKEVYFMAIIDILTPYDTKKKAAHAAKTVKHGAGAEISTVNPEQYSKRFNEFMSNILT","Homo sapiens","PIP4K2B, PIP5K2B","Phosphatidylinositol 5-phosphate 4-kinase type-2 beta","1","3X08"
"3X09",,"X-RAY DIFFRACTION",2.97,58.53,"VAPOR DIFFUSION, SITTING DROP",5.5,"100MM NA-CITRATE, 10MM MG-ACETATE, 100MM LI-ACETATE, 8-14%(V/V) PEG4000, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.molcel.2015.12.011",,"3X09",91.18,"2.7","2.7","Crystal structure of PIP4KIIBETA F205L complex with AMP","GPNCAPGQKVKLFRASEPILSVLMWGVNHTINELSNVPVPVMLMPDDFKAYSKIKVDNHLFNKENLPSRFKFKEYCPMVFRNLRERFGIDDQDYQNSVTRSAPINSDSQGRCGTRFLTTYDRRFVIKTVSSEDVAEMHNILKKYHQFIVECHGNTLLPQFLGMYRLTVDGVETYMVVTRNVLSHRLTVHRKYDLKGSTVAREASDKEKAKDLPTFKDNDFLNEGQKLHVGEESKKNFLEKLKRDVEFLAQLKIMDYSLLVGIHDVDRAEQEEMEVEERAEDEECENDGVGGNLLCSYGTPPDSPGNLLSFPRFFGPGEFDPSVDVYAMKSHESSPKKEVYFMAIIDILTPYDTKKKAAHAAKTVKHGAGAEISTVNPEQYSKRFNEFMSNILT","Homo sapiens","PIP4K2B, PIP5K2B","Phosphatidylinositol 5-phosphate 4-kinase type-2 beta","1","3X09"
"3X0A",,"X-RAY DIFFRACTION",2.94,58.19,"VAPOR DIFFUSION, SITTING DROP",5.5,"100MM NA-CITRATE, 10MM MG-ACETATE, 100MM LI-ACETATE, 8-14%(V/V) PEG4000, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.molcel.2015.12.011",,"3X0A",91.61,"2.6","2.6","Crystal structure of PIP4KIIBETA F205L complex with GMP","GPNCAPGQKVKLFRASEPILSVLMWGVNHTINELSNVPVPVMLMPDDFKAYSKIKVDNHLFNKENLPSRFKFKEYCPMVFRNLRERFGIDDQDYQNSVTRSAPINSDSQGRCGTRFLTTYDRRFVIKTVSSEDVAEMHNILKKYHQFIVECHGNTLLPQFLGMYRLTVDGVETYMVVTRNVLSHRLTVHRKYDLKGSTVAREASDKEKAKDLPTFKDNDFLNEGQKLHVGEESKKNFLEKLKRDVEFLAQLKIMDYSLLVGIHDVDRAEQEEMEVEERAEDEECENDGVGGNLLCSYGTPPDSPGNLLSFPRFFGPGEFDPSVDVYAMKSHESSPKKEVYFMAIIDILTPYDTKKKAAHAAKTVKHGAGAEISTVNPEQYSKRFNEFMSNILT","Homo sapiens","PIP4K2B, PIP5K2B","Phosphatidylinositol 5-phosphate 4-kinase type-2 beta","1","3X0A"
"3X0B",,"X-RAY DIFFRACTION",2.95,58.33,"VAPOR DIFFUSION, SITTING DROP",5.5,"100MM NA-CITRATE, 10MM MG-ACETATE, 100MM LI-ACETATE, 8-14%(V/V) PEG4000, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.molcel.2015.12.011",,"3X0B",91.16,"2.6","2.6","Crystal structure of PIP4KIIBETA I368A complex with AMP","GPNCAPGQKVKLFRASEPILSVLMWGVNHTINELSNVPVPVMLMPDDFKAYSKIKVDNHLFNKENLPSRFKFKEYCPMVFRNLRERFGIDDQDYQNSVTRSAPINSDSQGRCGTRFLTTYDRRFVIKTVSSEDVAEMHNILKKYHQFIVECHGNTLLPQFLGMYRLTVDGVETYMVVTRNVFSHRLTVHRKYDLKGSTVAREASDKEKAKDLPTFKDNDFLNEGQKLHVGEESKKNFLEKLKRDVEFLAQLKIMDYSLLVGIHDVDRAEQEEMEVEERAEDEECENDGVGGNLLCSYGTPPDSPGNLLSFPRFFGPGEFDPSVDVYAMKSHESSPKKEVYFMAIADILTPYDTKKKAAHAAKTVKHGAGAEISTVNPEQYSKRFNEFMSNILT","Homo sapiens","PIP4K2B, PIP5K2B","Phosphatidylinositol 5-phosphate 4-kinase type-2 beta","1","3X0B"
"3X0C",,"X-RAY DIFFRACTION",2.97,58.56,"VAPOR DIFFUSION, SITTING DROP",5.5,"100MM NA-CITRATE, 10MM MG-ACETATE, 100MM LI-ACETATE, 8-14%(V/V) PEG4000, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.molcel.2015.12.011",,"3X0C",91.23,"2.55","2.55","Crystal structure of PIP4KIIBETA I368A complex with GMP","GPNCAPGQKVKLFRASEPILSVLMWGVNHTINELSNVPVPVMLMPDDFKAYSKIKVDNHLFNKENLPSRFKFKEYCPMVFRNLRERFGIDDQDYQNSVTRSAPINSDSQGRCGTRFLTTYDRRFVIKTVSSEDVAEMHNILKKYHQFIVECHGNTLLPQFLGMYRLTVDGVETYMVVTRNVFSHRLTVHRKYDLKGSTVAREASDKEKAKDLPTFKDNDFLNEGQKLHVGEESKKNFLEKLKRDVEFLAQLKIMDYSLLVGIHDVDRAEQEEMEVEERAEDEECENDGVGGNLLCSYGTPPDSPGNLLSFPRFFGPGEFDPSVDVYAMKSHESSPKKEVYFMAIADILTPYDTKKKAAHAAKTVKHGAGAEISTVNPEQYSKRFNEFMSNILT","Homo sapiens","PIP4K2B, PIP5K2B","Phosphatidylinositol 5-phosphate 4-kinase type-2 beta","1","3X0C"
"3X0E",,"X-RAY DIFFRACTION",2.15,42.86,"VAPOR DIFFUSION, HANGING DROP",,"0.2M Magnesium acetate  20% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 295K",295,"10.1096/fj.15-272880",,"3X0E",20.62,"1.844","1.844","Crystal structure of the ectodomain of human CD81 large extracellular loop (hCD81-LEL)","SHMFVNKDQIAKDVKQFYDQALQQAVVDDDANNAKAVVKTFHETLDCCGSSTLTALTTSVLKNNLCPSGSNIISNLFKEDCHQKIDDLFSGKL","Homo sapiens","CD81, TAPA1, TSPAN28","CD81 antigen","1","3X0E"
"3X0W",,"X-RAY DIFFRACTION",2.26,45.48,"VAPOR DIFFUSION, HANGING DROP",5,"0.1M Acetate, pH 5.0, 1.4M Ammonium Sulfate, 0.1M NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1016/j.molcel.2014.11.006",,"3X0W",31.46,"2.71","2.71","Crystal structure of PLEKHM1 LIR-fused human LC3B_2-119","GSVRPQQEDEWVNVGSPSEKTFKQRRTFEQRVEDVRLIREQHPTKIPVIIERYKGEKQLPVLDKTKFLVPDHVNMSELIKIIRRRLQLNANQAFFLLVNGHSMVSVSTPISEVYESEKDEDGFLYMVYASQETF","Homo sapiens","MAP1LC3B, MAP1ALC3","Microtubule-associated proteins 1A/1B light chain 3B","1","3X0W"
"3X1H",,"X-RAY DIFFRACTION",2.66,53.79,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris-HCl PH 8, 0.7M sodium citrate, 1MM TCEP, 0.5MM EDTA, UNDER NITROGEN, temperature 293K, VAPOR DIFFUSION, HANGING DROP",293,"10.1021/acs.bioconjchem.5b00021",,"3X1H",63.62,"2.3","2.3","hPPARgamma Ligand binding domain in complex with 5-oxo-tricosahexaenoic acid","GALNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3X1H"
"3X1I",,"X-RAY DIFFRACTION",2.66,53.8,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.1M Tris-HCl PH 7.4, 0.7M sodium citrate, 1MM TCEP, 0.5MM EDTA, UNDER NITROGEN, temperature 293K, VAPOR DIFFUSION, HANGING DROP",293,"10.1021/acs.bioconjchem.5b00021",,"3X1I",63.64,"2.4","2.4","hPPARgamma Ligand binding domain in complex with 6-oxo-tetracosahexaenoic acid","GALNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","3X1I"
"3X1O",,"X-RAY DIFFRACTION",2.08,41,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2M lithium chloride, 20% Glycol3350, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K",293,"10.1038/ncomms7253",,"3X1O",50.21,"2.201","2.201","Crystal structure of the ROQ domain of human Roquin","MLVEEEGRIRAMRAARSLGERTVTELILQHQNPQQLSSNLWAAVRARGCQFLGPAMQEEALKLVLLALEDGSALSRKVLVLFVVQRLEPRFPQASKTSIGHVVQLLYRASCFKVTKRDEDSSLMQLKEEFRTYEALRREHDSQIVQIAMEAGLRIAPDQWSSLLYGDQSHKSHMQSIIDKLQTPASFAQSVQELTIALQRTKHHHHHH","Homo sapiens","RC3H1, KIAA2025, RNF198","Roquin-1","1","3X1O"
"3X31",,"X-RAY DIFFRACTION",2.52,51.21,"VAPOR DIFFUSION",6.5,"0.1M MES, pH6.5, 1.2-1.6M ammonium sulfate, VAPOR DIFFUSION, temperature 293K, temperature 293.0K",293,,,"3X31",30.21,"2.11","2.11","Crystal structure of the human vitamin D receptor ligand binding domain complexed with 7,8-cis-14-epi-1a,25-Dihydroxy-19-norvitamin D3","GSHMDSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEIS","Homo sapiens","NR1I1, VDR","Vitamin D3 receptor","1","3X31"
,,,,,,,,,,,,,,,,,"Homo sapiens","NR1I1, VDR"
"3X36",,"X-RAY DIFFRACTION",2.55,51.71,"VAPOR DIFFUSION",6.5,"0.1M MES, pH6.5, 1.2-1.6M ammonium sulfate, VAPOR DIFFUSION, temperature 293.0K",293,,,"3X36",30.21,"1.93","1.93","Crystal structure of the human vitamin D receptor ligand binding domain complexed with 7,8-cis-1a,25-Dihydroxy-19-norvitamin D3","GSHMDSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEIS","Homo sapiens","NR1I1, VDR","Vitamin D3 receptor","1","3X36"
,,,,,,,,,,,,,,,,,"Homo sapiens","NR1I1, VDR"
"3X3G",,"X-RAY DIFFRACTION",4.28,71.26,"VAPOR DIFFUSION, HANGING DROP",6.6,"20% PEG3350, 0.2M sodium sulfate, pH 6.6, VAPOR DIFFUSION, HANGING DROP, temperature 293K",293,"10.1038/srep17936",,"3X3G",48.77,"2.51","2.51","Fab fragment from anti TRAIL-R2 Human Agonist Antibody KMTR2","QVQLVQSGAEMKKPGASVKVSCKTSGYTFTNYKINWVRQAPGQGLEWMGWMNPDTDSTGYPQKFQGRVTMTRNTSISTAYMELSSLRSEDTAVYYCARSYGSGSYYRDYYYGMDVWGQGTTVTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTKTYTCNVDHKPSNTKVDKRVESKYG","Homo sapiens",,"Heavy chain of KMTR2","1","3X3G"
,,,,,,,,,,,,,,,,"EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPLTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Light chain of KMTR2","2","3X3G"
"3ZBF",,"X-RAY DIFFRACTION",2.74,55.1,"VAPOR DIFFUSION, HANGING DROP",5.6,"CRYSTALS WERE OBTAINED BY THE HANGING DROP VAPOR DIFFUSION METHOD AT 13 DEGREES C BY MIXING 1.5 MICROLITERS OF SOLUTION CONTAINING A 1:3 MOLAR RATIO OF PHOSPHORYLATED ROS1 KD (12.2MG/ML) TO CRIZOTINIB AND 1.5 MICROLITERS OF RESERVOIR SOLUTION CONTAINING 25% (W/V) PEG 3350, 0.6M POTASSIUM THIOCYANATE AND 0.1M SODIUM CITRATE TRIBASIC DIHYDRATE, PH5.6. CRYSTALS WERE FLASH-FROZEN IN LIQUID NITROGEN AFTER TRANSFER TO 2 MICROLITERS OF RESERVOIR SOLUTION CONTAINING 25% (V/V) GLYCEROL AS A CRYOPROTECTANT.",286,"10.1056/NEJMoa1215530","VGH","3ZBF",37.46,"2.2","2.2","Structure of Human ROS1 Kinase Domain in Complex with Crizotinib","MAHHHHHHDYGIPTTENLYFQGSIENLPAFPREKLTLRLLLGSGAFGEVYEGTAVDILGVGSGEIKVAVKTLKKGSTDQEKIEFLKEAHLMSKFNHPNILKQLGVCLLNEPQYIILELMEGGDLLTYLRKARMATFYGPLLTLVDLVDLCVDISKGCVYLERMHFIHRDLAARNCLVSVKDYTSPRIVKIGDFGLARDIYKNDYYRKRGEGLLPVRWMAPESLMDGIFTTQSDVWSFGILIWEILTLGHQPYPAHSNLDVLNYVQTGGRLEPPRNCPDDLWNLMTQCWAQEPDQRPTFHRIQDQLQLFRNFFLNSIYKSRDE","Homo sapiens","ROS1, MCF3, ROS","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS","1","3ZBF"
"3ZBX",,"X-RAY DIFFRACTION",2.41,49,"VAPOR DIFFUSION, HANGING DROP",4.2,"C-MET COCRYSTALS WERE OBTAINED AT 13 DEGREES C BY THE HANGING DROP VAPOR DIFFUSION METHOD BY MIXING 1.2 MICROLITERS OF PROTEIN SOLUTION (CONTAINING 7-13 MG/ML C-MET KD (RESIDUES 1051-1348) WITH A 5 FOLD MOLAR EXCESS OF C-MET INHIBITOR COMPOUND) WITH 1.2 MICROLITERS OF SOLUTION CONTAINING (0.05M CITRATE-PHOSPHATE PH 4.2, 200M NACL, AND 17.4% POLYETHYLENE GLYCOL MW=3350)",286,"10.1021/jm400926x","6XE","3ZBX",35.24,"2.2","2.2","X-ray Structure of c-Met kinase in complex with inhibitor 6-((6-(4- fluorophenyl)-(1,2,4)triazolo(4,3-b)(1,2,4)triazin-3-yl)methyl) quinoline.","MVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHHHHHHHH","Homo sapiens","MET","HEPATOCYTE GROWTH FACTOR RECEPTOR","1","3ZBX"
"3ZC5",,"X-RAY DIFFRACTION",2.4,48.84,"VAPOR DIFFUSION, HANGING DROP",4.6,"C-MET COCRYSTALS WERE OBTAINED AT 13 DEGREES C BY THE HANGING DROP VAPOR DIFFUSION METHOD BY MIXING 1.2 MICROL OF PROTEIN SOLUTION (CONTAINING 7-13 MG/ML C-MET KD (RESIDUES 1051-1348) WITH A 5 FOLD MOLAR EXCESS OF SELECTED C-MET INHIBITOR) WITH 1.2 MICROL OF SOLUTION CONTAINING (0.05 M CITRATE-PHOSPHATE PH 4.6, 0-0.275 M NACL, AND 17-21% POLYETHYLENE GLYCOL MW=3350).",286,"10.1021/jm400926x","W9Z","3ZC5",35.23,"2.2","2.2","X-ray Structure of c-Met kinase in complex with inhibitor (S)-6-(1-(6- (1-methyl-1H-pyrazol-4-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-yl)ethyl) quinoline.","MVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHHHHHHHH","Homo sapiens","MET","HEPATOCYTE GROWTH FACTOR RECEPTOR","1","3ZC5"
"3ZC6",,"X-RAY DIFFRACTION",2.73,55.02,,,,,"10.1016/j.bmcl.2013.02.012","VFC","3ZC6",134.42,"2.42","2.42","Crystal structure of JAK3 kinase domain in complex with an indazole substituted pyrrolopyrazine inhibitor","DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS","Homo sapiens","JAK3","TYROSINE-PROTEIN KINASE JAK3","1","3ZC6"
"3ZCF",,"X-RAY DIFFRACTION",2.31,46.7,,7,"26 TO 31 % W/V POLYETHYLENE GLYCOL 1000 AND 40 MM KH2PO4, PH 7.0",,"10.1042/BJ20130758",,"3ZCF",49.04,"1.65","1.65","Structure of recombinant human cytochrome c","GDVEKGKKIFIMKCSQCHTVEKGGKHKTGPNLHGLFGRKTGQAPGYSYTAANKNKGIIWGEDTLMEYLENPKKYIPGTKMIFVGIKKKEERADLIAYLKKATNE","Homo sapiens","CYCS, CYC","CYTOCHROME C","1","3ZCF"
"3ZCL",,"X-RAY DIFFRACTION",2.4,48,"VAPOR DIFFUSION, HANGING DROP",4.6,"C-MET COCRYSTALS WERE OBTAINED AT 13 DEGREES C BY THE HANGING DROP VAPOR DIFFUSION METHOD BY MIXING 1.2 MICROL OF PROTEIN SOLUTION (CONTAINING 7-13 MG/ML C-MET KD (RESIDUES 1051-1348) WITH A 5 FOLD MOLAR EXCESS OF SELECTED C-MET INHIBITOR) WITH 1.2 MICROL OF SOLUTION CONTAINING (0.05 M CITRATE-PHOSPHATE PH 4.6, 0-0.275 M NACL, AND 17-21% POLYETHYLENE GLYCOL MW=3350).",286,"10.1021/jm400926x","5TF","3ZCL",35.2,"1.4","1.4","X-ray Structure of c-Met kinase in complex with inhibitor (S)-3-(1-(1H-pyrrolo(2,3-b)pyridin-3-yl)ethyl)-N-isopropyl-(1,2,4)triazolo(4,3- b)pyridazin-6-amine","MVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHHHHHHHH","Homo sapiens","MET","HEPATOCYTE GROWTH FACTOR RECEPTOR","1","3ZCL"
"3ZCW",,"X-RAY DIFFRACTION",2.76,55.41,,6.9,"20% PEG3350, 2MM MAGNESIUM CHLORIDE, 100MM HEPES PH 7.5",,"10.1021/ja310377d","4A2","3ZCW",40.52,"1.691","1.691","Eg5 - New allosteric binding site","GKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKP","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","KINESIN-LIKE PROTEIN KIF11","1","3ZCW"
"3ZD1",,"X-RAY DIFFRACTION",2.23,44.96,,,"30% (W/V) PEG 8000, 0.2M AMMONIUM SULPHATE",,"10.1073/pnas.1219260110",,"3ZD1",29.23,"2","2","STRUCTURE OF THE TWO C-TERMINAL DOMAINS OF COMPLEMENT FACTOR H RELATED PROTEIN 2","MGEKCGPPPPIDNGDITSFLLSVYAPGSSVEYQCQNLYQLEGNNQITCRNGQWSEPPKCLDPCVISQEIMEKYNIKLKWTNQQKLYSRTGDIVEFVCKSGYHPTKSHSFRAMCQNGKLVYPSCEEK","Homo sapiens","CFHR2, CFHL2, FHR2, HFL3","COMPLEMENT FACTOR H-RELATED PROTEIN 2","1","3ZD1"
"3ZD2",,"X-RAY DIFFRACTION",2.06,40.3,,6.5,"36% (W/V) PEG 2000 MME, 0.1M MES PH 6.5",,"10.1073/pnas.1219260110",,"3ZD2",29.79,"1.99","1.99","THE STRUCTURE OF THE TWO N-TERMINAL DOMAINS OF COMPLEMENT FACTOR H RELATED PROTEIN 1 SHOWS FORMATION OF A NOVEL DIMERISATION INTERFACE","EATFCDFPKINHGILYDEEKYKPFSQVPTGEVFYYSCEYNFVSPSKSFWTRITCTEEGWSPTPKCLRLCFFPFVENGHSESSGQTHLEGDTVQIICNTGYRLQNNENNISCVERGWSTPPKCRST","Homo sapiens","CFHR1, CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, HFL1, HFL2","COMPLEMENT FACTOR H-RELATED PROTEIN 1","1","3ZD2"
"3ZDQ",,"X-RAY DIFFRACTION",3.53,65.22,,9.25,"0.1M SODIUM CHLORIDE, 0.1M GLYCINE PH 9.25, 30%(V/V) PEG 300",,"10.1073/pnas.1217042110",,"3ZDQ",69.35,"2.85","2.85","STRUCTURE OF THE HUMAN MITOCHONDRIAL ABC TRANSPORTER, ABCB10 (NUCLEOTIDE-FREE FORM)","MAGLPEARKLLGLAYPERRRLAAAVGFLTMSSVISMSAPFFLGKIIDVIYTNPTVDYSDNLTRLCLGLSAVFLCGAAANAIRVYLMQTSGQRIVNRLRTSLFSSILRQEVAFFDKTRTGELINRLSSDTALLGRSVTENLSDGLRAGAQASVGISMMFFVSPNLATFVLSVVPPVSIIAVIYGRYLRKLTKVTQDSLAQATQLAEERIGNVRTVRAFGKEMTEIEKYASKVDHVMQLARKEAFARAGFFGATGLSGNLIVLSVLYKGGLLMGSAHMTVGELSSFLMYAFWVGISIGGLSSFYSELMKGLGAGGRLWELLEREPKLPFNEGVILNEKSFQGALEFKNVHFAYPARPEVPIFQDFSLSIPSGSVTALVGPSGSGKSTVLSLLLRLYDPASGTISLDGHDIRQLNPVWLRSKIGTVSQEPILFSCSIAENIAYGADDPSSVTAEEIQRVAEVANAVAFIRNFPQGFNTVVGEKGVLLSGGQKQRIAIARALLKNPKILLLDEATSALDAENEYLVQEALDRLMDGRTVLVIAHRLSTIKNANMVAVLDQGKITEYGKHEELLSKPNGIYRKLMNKQSFISAAENLYFQ","Homo sapiens","ABCB10","ATP-BINDING CASSETTE SUB-FAMILY B MEMBER 10, MITOCHONDRIAL","1","3ZDQ"
"3ZDU",,"X-RAY DIFFRACTION",2.72,54.8,,,"0.03M ZN CL, 30% PEG_6000, 5% ETHYLENE GLYCOL, MES PH5.5",,"10.1016/j.celrep.2017.12.083",,"3ZDU",37.99,"2.2","2.2","Crystal structure of the human CDKL3 kinase domain","SMEMYETLGKVGEGSYGTVMKCKHKNTGQIVAIKIFYERPEQSVNKIAMREIKFLKQFHHENLVNLIEVFRQKKKIHLVFEFIDHTVLDELQHYCHGLESKRLRKYLFQILRAIDYLHSNNIIHRDIKPENILVSQSGITKLCDFGFARTLAAPGDIYDDEVATRWYRAPELVLKDTSYGKPVDIWALGCMIIEMATGNPYLPSSSDLDLLHKIVLKVGNLSPHLQNIFSKSPIFAGVVLPQVQHPKNARKKYPKLNGLLADIVHACLQIDPADRISSSDLLHHEYFTRDGFIEKFMPELKAKLLQEAKVNSLIKPKESSKENEL","Homo sapiens","CDKL3, NKIAMRE","CYCLIN-DEPENDENT KINASE-LIKE 3","1","3ZDU"
"3ZEH",,"SOLUTION NMR",,,,,,,"10.1186/1756-8935-6-12",,"3ZEH",11.9,,,"Solution structure of the Hs. PSIP1 PWWP domain","GSHMAMARDFKPGDLIFAKMKGYPHWPARVDEVPDGAVKPPTNKLPIFFFGTHETAFLGPKDIFPYSENKEKYGKPNKRKGFNEGLWEIDNNPKVKFSSQQAATK","Homo sapiens","PSIP1, DFS70, LEDGF, PSIP2","PC4 AND SFRS1-INTERACTING PROTEIN","1","3ZEH"
"3ZEP",,"X-RAY DIFFRACTION",2.65,53.58,,,,,"10.1016/j.bmcl.2013.03.015","1NX","3ZEP",133.66,"2.35","2.35","Crystal Structure of JAK3 Kinase Domain in Complex with a Pyrrolopyrazine-2-phenyl Ether Inhibitor","DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS","Homo sapiens","JAK3","TYROSINE-PROTEIN KINASE JAK3","1","3ZEP"
"3ZEW",,"X-RAY DIFFRACTION",3.09,60.26,,,,,"10.1002/pro.2445",,"3ZEW",68.52,"2.5","2.5","Crystal structure of EphB4 in complex with staurosporine","GSSDPNEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKIVARENG","Homo sapiens","EPHB4, HTK, MYK1, TYRO11","EPHRIN TYPE-B RECEPTOR 4","1","3ZEW"
"3ZFB",,"X-RAY DIFFRACTION",2.25,45.43,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M TRIS, 17% PEG 4000, 2 MM DTT, 0.02% AZIDE, PH 7.5, VAPOUR DIFFUSION, HANGING DROP, TEMPERATURE 293K",293,,,"3ZFB",51.26,"1.86","1.86","Crystal structure of the I75A mutant of human class alpha glutathione transferase in the apo form","MAEKPKLHYFNARGRMESTRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEIDGMKLVQTRAILNYAASKYNLYGKDIKERALIDMYIEGIADLGEMILLLPVCPPEEKDAKLALIKEKIKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEEARKIFRF","Homo sapiens","GSTA1","GLUTATHIONE S-TRANSFERASE A1","1","3ZFB"
"3ZFL",,"X-RAY DIFFRACTION",2.31,45.43,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M TRIS, 19% PEG 3350, 2 MM DTT, 0.02% AZIDE, PH 7.5, VAPOUR DIFFUSION, HANGING DROP, TEMPERATURE 293K",293,,,"3ZFL",51.28,"1.88","1.88","Crystal structure of the V58A mutant of human class alpha glutathione transferase in the apo form","MAEKPKLHYFNARGRMESTRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMAEIDGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYIEGIADLGEMILLLPVCPPEEKDAKLALIKEKIKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEEARKIFRF","Homo sapiens","GSTA1","GLUTATHIONE S-TRANSFERASE A1","1","3ZFL"
"3ZFM",,"X-RAY DIFFRACTION",1.99,38,,,,,"10.1002/pro.2445",,"3ZFM",33.6,"2.27","2.27","Crystal structure of EphB2","GSSDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMAPLSS","Homo sapiens","EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5","EPHRIN TYPE-B RECEPTOR 2","1","3ZFM"
"3ZFX",,"X-RAY DIFFRACTION",1.88,38,,,,,"10.1002/pro.2445",,"3ZFX",303.32,"2.5","2.5","Crystal structure of EphB1","GSSDPNEAVREFAKEIDVSFVKIEEVIGAGEFGEVYKGRLKLPGKREIYVAIKTLKAGYSEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAEMNYVHRDLAARNILVNSNLVCKVSDFGLSRYLQDDTSDPTYTSSLGGKIPVRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPMDCPAALHQLMLDCWQKDRNSRPRFAEIVNTLDKMIRNPASLKTVATITA","Homo sapiens","EPHB1, ELK, EPHT2, HEK6, NET","EPHRIN TYPE-B RECEPTOR 1","1","3ZFX"
"3ZFY",,"X-RAY DIFFRACTION",2.32,47,,,,,"10.1002/pro.2445",,"3ZFY",67.53,"2.2","2.2","Crystal structure of EphB3","GSSDPNEAVREFAKEIDVSCVKIEEVIGAGEFGEVCRGRLKQPGRREVFVAIKTLKVGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTKSRPVMILTEFMENCALDSFLRLNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDPSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAVEQDYRLPPPMDCPTALHQLMLDCWVRDRNLRPKFSQIVNTLDKLIRNPASLKVIASAQS","Homo sapiens","EPHB3, ETK2, HEK2, TYRO6","EPHRIN TYPE-B RECEPTOR 3","1","3ZFY"
"3ZGD",,"X-RAY DIFFRACTION",4.44,72.3,,5,"4.0 M AMMONIUM ACETATE, 0.1 M SODIUM ACETATE TRIHYDRATE PH 4.6",,"10.1107/S174430911301124X",,"3ZGD",68.3,"1.98","1.98","crystal structure of a KEAP1 mutant","MGSSHHHHHHSSGLVPRGSHMAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVATATWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVT","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","KELCH-LIKE ECH-ASSOCIATED PROTEIN 1","1","3ZGD"
"3ZGF",,"X-RAY DIFFRACTION",2.3,46,,7,"7-12% POLYETHYLENE GLYCOL 3350, 0.1 - 0.3 M AMMONIUM SULPHATE, 0.05 M MNCL2, 0.05 M MOPS PH 7.0",,"10.1107/S2053230X1401259X",,"3ZGF",70.72,"1.701","1.701","Crystal structure of the Fucosylgalactoside alpha N- acetylgalactosaminyltransferase (GTA, cisAB mutant L266G, G268A) in complex with in complex with NPE caged UDP-Gal (P2(1)2(1)2(1) space group)","MAIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYGGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","HISTO-BLOOD GROUP ABO SYSTEM TRANSFERASE","1","3ZGF"
"3ZGG",,"X-RAY DIFFRACTION",2.28,46,,7,"7-12% POLYETHYLENE GLYCOL 3350, 0.1 - 0.3 M AMMONIUM SULPHATE, 0.05 M MNCL2, 0.05 M MOPS PH 7.0",,"10.1107/S2053230X1401259X",,"3ZGG",35.5,"1.9","1.9","Crystal structure of the Fucosylgalactoside alpha N- acetylgalactosaminyltransferase (GTA, cisAB mutant L266G, G268A) in complex with NPE caged UDP-Gal (C222(1) space group)","MAIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYGGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","HISTO-BLOOD GROUP ABO SYSTEM TRANSFERASE","1","3ZGG"
"3ZGO",,"X-RAY DIFFRACTION",2.33,47.24,,,,,"10.1016/j.jsb.2013.02.012",,"3ZGO",111.62,"1.63","1.63","Re-refined structure of the human Sirt2 apoform","GSGEADMDFLRNLFSQTLSLGSQKERLLDELTLEGVARYMQSERCRRVICLVGAGISTSAGIPDFRSPSTGLYDNLEKYHLPYPEAIFEISYFKKHPEPFFALAKELYPGQFKPTICHYFMRLLKDKGLLLRCYTQNIDTLERIAGLEQEDLVEAHGTFYTSHCVSASCRHEYPLSWMKEKIFSEVTPKCEDCQSLVKPDIVFFGESPPARFFSCMQSDFLKVDLLLVMGTSLQVQPFASLISKAPLSTPRLLINKEKAGQSDPFLGMIMGLGGGMDFDSKKAYRDVAWLGECDQGCLALAELLGWKKELEDLVRREHASIDAQS","Homo sapiens","SIRT2, SIR2L, SIR2L2","NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-2","1","3ZGO"
"3ZGQ",,"X-RAY DIFFRACTION",2.39,48.61,,6.5,"pH 6.5",,"10.1016/j.molcel.2012.12.015",,"3ZGQ",56.04,"2.203","2.203","Crystal structure of human interferon-induced protein IFIT5","MSEIRKDTLKAILLELECHFTWNLLKEDIDLFEVEDTIGQQLEFLTTKSRLALYNLLAYVKHLKGQNKDALECLEQAEEIIQQEHSDKEEVRSLVTWGNYAWVYYHMDQLEEAQKYTGKIGNVCKKLSSPSNYKLECPETDCEKGWALLKFGGKYYQKAKAAFEKALEVEPDNPEFNIGYAITVYRLDDSDREGSVKSFSLGPLRKAVTLNPDNSYIKVFLALKLQDVHAEAEGEKYIEEILDQISSQPYVLRYAAKFYRRKNSWNKALELLKKALEVTPTSSFLHHQMGLCYRAQMIQIKKATHNRPKGKDKLKVDELISSAIFHFKAAMERDSMFAFAYTDLANMYAEGGQYSNAEDIFRKALRLENITDDHKHQIHYHYGRFQEFHRKSENTAIHHYLEALKVKDRSPLRTKLTSALKKLSTKRLCHNALDVQSLSALGFVYKLEGEKRQAAEYYEKAQKIDPENAEFLTALCELRLSI","Homo sapiens","IFIT5, ISG58, RI58","INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 5","1","3ZGQ"
"3ZGV",,"X-RAY DIFFRACTION",2.6,52,,5.5,"20% PEG 10 000, 100 MM AMMONIUM ACETATE, 100 MM BIS-TRIS PH 5.5",,"10.1016/j.jsb.2013.02.012",,"3ZGV",75.2,"2.27","2.27","Structure of human SIRT2 in complex with ADP-ribose","GSGEADMDFLRNLFSQTLSLGSQKERLLDELTLEGVARYMQSERCRRVICLVGAGISTSAGIPDFRSPSTGLYDNLEKYHLPYPEAIFEISYFKKHPEPFFALAKELYPGQFKPTICHYFMRLLKDKGLLLRCYTQNIDTLERIAGLEQEDLVEAHGTFYTSHCVSASCRHEYPLSWMKEKIFSEVTPKCEDCQSLVKPDIVFFGESLPARFFSCMQSDFLKVDLLLVMGTSLQVQPFASLISKAPLSTPRLLINKEKAGQSDPFLGMIMGLGGGMDFDSKKAYRDVAWLGECDQGCLALAELLGWKKELEDLVRREHASIDAQS","Homo sapiens","SIRT2, SIR2L, SIR2L2","NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-2","1","3ZGV"
"3ZH8",,"X-RAY DIFFRACTION",2.56,51.9,,,"0.2M AMMONIUM IODIDE AND 20%(W/V) PEG3350.",,"10.1042/BJ20121871","C58","3ZH8",124.45,"2.739","2.739","A novel small molecule aPKC inhibitor","SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINPLLMSAEESV","Homo sapiens","PRKCI, DXS1179E","PROTEIN KINASE C IOTA TYPE","1","3ZH8"
"3ZHD",,"X-RAY DIFFRACTION",2.23,44.79,,4.6,"27% PEG4000, 0.1M SODIUM ACETATE, PH4.6, 0.2M AMMONIUM SULFATE",,"10.1371/journal.pone.0098178",,"3ZHD",27.53,"1.962","1.962","The crystal structure of single domain antibody 8-4 scaffold.","EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMGWVRQAPGKGPEVVSLISGSGGSTWYDDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARHAPSTEAPDYWGQGTLVTVSSLEHHHHHH","Homo sapiens","IGHV3-23","MG8-4 SCAFFOLD ANTIBODY","1","3ZHD"
"3ZHK",,"X-RAY DIFFRACTION",3.35,63.34,,,"37% PEG8K, 0.2M AMMONIUM SULFATE",,"10.1371/journal.pone.0098178",,"3ZHK",27.7,"1.962","1.962","The crystal structure of single domain antibody 2x1 scaffold","EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNLLYLQMNSLRAEDTAVYYCARHAPSTEAPDYWGQGTLVTVSSLEHHHHHH","Homo sapiens","IGHV3-23","MG2X1 SCAFFOLD ANTIBODY","1","3ZHK"
"3ZHL",,"X-RAY DIFFRACTION",2.71,54.7,,5.5,"0.1M BIS-TRIS;PH5.5, 3M SODIUM CHLORIDE, 5% ETHYL ACETATE",,"10.1371/journal.pone.0098178",,"3ZHL",13.91,"2.47","2.47","The crystal structure of single domain antibody 8-14 scaffold","EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMGWVRQAPGKGPEWVSLISGSGGSTWYDDSVKGRFTISRDNSKNLLYLQMNSLRAEDTAVYYCARHAPSTEAPDYWGQGTLVTVSSLEHHHHHH","Homo sapiens","IGHV3-23","MG8-14 SCAFFOLD ANTIBODY","1","3ZHL"
"3ZI1",,"X-RAY DIFFRACTION",2.37,48.11,,,"0.2M MAGNESIUM CHLORIDE, 0.1M HEPES PH 7.5, 25%(W/V) PEG 3350",,,,"3ZI1",37.16,"1.9","1.9","Crystal structure of human glyoxalase domain-containing protein 4 (GLOD4)","MHHHHHHSSGVDLGTENLYFQSMAARRALHFVFKVGNRFQTARFYRDVLGMKVLRHEEFEEGCKAACNGPYDGKWSKTMVGFGPEDDHFVAELTYNYGVGDYKLGNDFMGITLASSQAVSNARKLEWPLTEVAEGVFETEAPGGYKFYLQNRSLPQSDPVLKVTLAVSDLQKSLNYWCNLLGMKIYENDEEKQRALLGYADNQCKLELQGVKGGVDHAAAFGRIAFSCPQKELPDLEDLMKRENQKILTPLVSLDTPGKATVQVVILADPDGHEICFVGDEAFRELSKMDPEGSNCWIDSKGGYGSEFELRRQACGRTRAPPPPPLRSGC","Homo sapiens","GLOD4, C17orf25, CGI-150, My027","GLYOXALASE DOMAIN-CONTAINING PROTEIN 4","1","3ZI1"
"3ZI3",,"X-RAY DIFFRACTION",2.07,41,,3,"0.075 M LI2SO4, PH 3.0",,"10.1074/jbc.M112.448050",,"3ZI3",5.9,"1.7","1.7","Crystal structure of the B24His-insulin - human analogue","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN","1","3ZI3"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGHFYTPKT","Homo sapiens","INS","INSULIN","2","3ZI3"
"3ZIM",,"X-RAY DIFFRACTION",2.71,54.59,,,,,"10.1021/jm3008745","KKR","3ZIM",109.98,"2.85","2.85","Discovery of a potent and isoform-selective targeted covalent inhibitor of the lipid kinase PI3Kalpha","NREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDA","Homo sapiens","PIK3CA","PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT ALPHA ISOFORM","1","3ZIM"
"3ZJB",,"X-RAY DIFFRACTION",2.02,39.2,,7,"15% PEG 4000, 0.1M HEPES PH 7.0",,"10.1371/journal.pbio.1001726",,"3ZJB",68.29,"1.84","1.84","The structure of the TRAF domain of human TRAF4","MALVSRQRQELQELRRELEELSVGSDGVLIWKIGSYGRRLQEAKAKPNLECFSPAFYTHKYGYKLQVSAFLNGNGSGEGTHLSLYIRVLPGAFDNLLEWPFARRVTFSLLDQSDPGLAKPQHVTETFHPDPNWKNFQKPGTWRGSLDESSLGFGYPKFISHQDIRKRNYVRDDAVFIRAAVELPRKILSLEHHHHHH","Homo sapiens","TRAF4, CART1, MLN62, RNF83","TNF RECEPTOR-ASSOCIATED FACTOR 4","1","3ZJB"
"3ZJC",,"X-RAY DIFFRACTION",2.24,45.16,,7.5,"19% PEG 3350, 100 MM MOPS PH 6.5.",,"10.1016/j.str.2013.01.014","GNP","3ZJC",213.23,"3.15","3.15","Crystal structure of GMPPNP-bound human GIMAP7 L100Q variant","GPLGSMAESEDRSLRIVLVGKTGSGKSATANTILGEEIFDSRIAAQAVTKNCQKASREWQGRDLLVVDTPGLFDTKESLDTTCKEISRCIISSCPGPHAIVLVLQLGRYTEEEQKTVALIKAVFGKSAMKHMVILFTRKEELEGQSFHDFIADADVGLKSIVKECGNRCCAFSNSKKTSKAEKESQVQELVELIEKMVQCNEGAYFSDDIYKDTEERLKQREEVLRKIYTDQLNEEIKLVEEDKHKSEEEKEKEIKLLKLKYDEKIKNIREEAERNIFKDVFNRIWKMLSEIWHRFLSKCKFYSS","Homo sapiens","GIMAP7, IAN7","GTPASE IMAP FAMILY MEMBER 7","1","3ZJC"
"3ZJD",,"X-RAY DIFFRACTION",2.84,56,,6.2,"2-2.5 M NACL, 0.1 M MES [PH 6-6.7], 10 MM DTT.",,"10.1038/ncomms2567",,"3ZJD",86.51,"1.87","1.87","A20 OTU domain in reduced, active state at 1.87 A resolution","MAEQVLPQALYLSNMRKAVKIRERTPEDIFKPTNGIIHHFKTMHRYTLEMFRTCQFCPQFREIIHKALIDRNIQATLESQKKLNWCREVRKLVALKTNGDGNCLMHATSQYMWSVQDTDLVLRKALFSTLKETDTRNFKFRWQLESLKSQEFVETGLCYDTRNWNDEWDNLIKMASTDTPMARSGLQYNSLEEIHIFVLCNILRRPIIVISDKMLRSLESGSNFAPLKVGGIYLPLHWPAQECYRYPIVLGYDSHHFVPLVTLKDSGPEIRAVPLVNRDRGRFEDLKVHFLTDPENEMKEKLLKEYLMVIEIPVQGWDHGTTHLINAAKLDEANLPKEINLVDDYFELVQHEYKKWQENSEQGRRE","Homo sapiens","TNFAIP3, OTUD7C","A20P50","1","3ZJD"
"3ZJE",,"X-RAY DIFFRACTION",2.85,56,,6.2,"2-2.5 M NACL, 0.1 M MES [PH 6-6.7]",,"10.1038/ncomms2567",,"3ZJE",86.64,"1.84","1.84","A20 OTU domain in reversibly oxidised (SOH) state","MAEQVLPQALYLSNMRKAVKIRERTPEDIFKPTNGIIHHFKTMHRYTLEMFRTCQFCPQFREIIHKALIDRNIQATLESQKKLNWCREVRKLVALKTNGDGNCLMHATSQYMWSVQDTDLVLRKALFSTLKETDTRNFKFRWQLESLKSQEFVETGLCYDTRNWNDEWDNLIKMASTDTPMARSGLQYNSLEEIHIFVLCNILRRPIIVISDKMLRSLESGSNFAPLKVGGIYLPLHWPAQECYRYPIVLGYDSHHFVPLVTLKDSGPEIRAVPLVNRDRGRFEDLKVHFLTDPENEMKEKLLKEYLMVIEIPVQGWDHGTTHLINAAKLDEANLPKEINLVDDYFELVQHEYKKWQENSEQGRRE","Homo sapiens","TNFAIP3, OTUD7C","A20P50","1","3ZJE"
"3ZJF",,"X-RAY DIFFRACTION",2.85,56,,6.2,"2-2.5 M NACL, 0.1 M MES [PH 6-6.7]. CRYSTALS WERE SOAKED IN 50 UM H2O2 FOR 270 MIN PRIOR TO FREEZING AND DATA COLLECTION.",,"10.1038/ncomms2567",,"3ZJF",86.42,"2.2","2.2","A20 OTU domain with irreversibly oxidised Cys103 from 270 min H2O2 soak.","MAEQVLPQALYLSNMRKAVKIRERTPEDIFKPTNGIIHHFKTMHRYTLEMFRTCQFCPQFREIIHKALIDRNIQATLESQKKLNWCREVRKLVALKTNGDGNCLMHATSQYMWSVQDTDLVLRKALFSTLKETDTRNFKFRWQLESLKSQEFVETGLCYDTRNWNDEWDNLIKMASTDTPMARSGLQYNSLEEIHIFVLCNILRRPIIVISDKMLRSLESGSNFAPLKVGGIYLPLHWPAQECYRYPIVLGYDSHHFVPLVTLKDSGPEIRAVPLVNRDRGRFEDLKVHFLTDPENEMKEKLLKEYLMVIEIPVQGWDHGTTHLINAAKLDEANLPKEINLVDDYFELVQHEYKKWQENSEQGRRE","Homo sapiens","TNFAIP3, OTUD7C","A20P50","1","3ZJF"
,,,,,,,,,,,,,,,,"MAEQVLPQALYLSNMRKAVKIRERTPEDIFKPTNGIIHHFKTMHRYTLEMFRTCQFCPQFREIIHKALIDRNIQATLESQKKLNWCREVRKLVALKTNGDGNCLMHATSQYMWSVQDTDLVLRKALFSTLKETDTRNFKFRWQLESLKSQEFVETGLCYDTRNWNDEWDNLIKMASTDTPMARSGLQYNSLEEIHIFVLCNILRRPIIVISDKMLRSLESGSNFAPLKVGGIYLPLHWPAQECYRYPIVLGYDSHHFVPLVTLKDSGPEIRAVPLVNRDRGRFEDLKVHFLTDPENEMKEKLLKEYLMVIEIPVQGWDHGTTHLINAAKLDEANLPKEINLVDDYFELVQHEYKKWQENSEQGRRE","Homo sapiens","TNFAIP3, OTUD7C","A20P50","2","3ZJF"
"3ZJG",,"X-RAY DIFFRACTION",2.85,56,,6.2,"2-2.5 M NACL, 0.1 M MES [PH 6-6.7] CRYSTALS WERE SOAKED IN 50 UM H2O2 FOR 60 MIN PRIOR TO FREEZING AND DATA COLLECTION.",,"10.1038/ncomms2567",,"3ZJG",86.45,"1.92","1.92","A20 OTU domain with irreversibly oxidised Cys103 from 60 min H2O2 soak.","MAEQVLPQALYLSNMRKAVKIRERTPEDIFKPTNGIIHHFKTMHRYTLEMFRTCQFCPQFREIIHKALIDRNIQATLESQKKLNWCREVRKLVALKTNGDGNCLMHATSQYMWSVQDTDLVLRKALFSTLKETDTRNFKFRWQLESLKSQEFVETGLCYDTRNWNDEWDNLIKMASTDTPMARSGLQYNSLEEIHIFVLCNILRRPIIVISDKMLRSLESGSNFAPLKVGGIYLPLHWPAQECYRYPIVLGYDSHHFVPLVTLKDSGPEIRAVPLVNRDRGRFEDLKVHFLTDPENEMKEKLLKEYLMVIEIPVQGWDHGTTHLINAAKLDEANLPKEINLVDDYFELVQHEYKKWQENSEQGRRE","Homo sapiens","TNFAIP3, OTUD7C","TUMOR NECROSIS FACTOR ALPHA-INDUCED PROTEIN 3","1","3ZJG"
,,,,,,,,,,,,,,,,"MAEQVLPQALYLSNMRKAVKIRERTPEDIFKPTNGIIHHFKTMHRYTLEMFRTCQFCPQFREIIHKALIDRNIQATLESQKKLNWCREVRKLVALKTNGDGNCLMHATSQYMWSVQDTDLVLRKALFSTLKETDTRNFKFRWQLESLKSQEFVETGLCYDTRNWNDEWDNLIKMASTDTPMARSGLQYNSLEEIHIFVLCNILRRPIIVISDKMLRSLESGSNFAPLKVGGIYLPLHWPAQECYRYPIVLGYDSHHFVPLVTLKDSGPEIRAVPLVNRDRGRFEDLKVHFLTDPENEMKEKLLKEYLMVIEIPVQGWDHGTTHLINAAKLDEANLPKEINLVDDYFELVQHEYKKWQENSEQGRRE","Homo sapiens","TNFAIP3, OTUD7C","TUMOR NECROSIS FACTOR ALPHA-INDUCED PROTEIN 3","2","3ZJG"
"3ZK6",,"X-RAY DIFFRACTION",3,59.96,,,"2.2 M (NH4)2 SO4, 0.1 M BIS TRIS, PH 5.5",,"10.1038/nchembio.1246","H1I","3ZK6",42.72,"2.48","2.48","Crystal structure of Bcl-xL in complex with inhibitor (Compound 2).","MSMAMSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERLEHHHHHH","Homo sapiens","BCL2L1, BCL2L, BCLX","BCL-2-LIKE PROTEIN 1","1","3ZK6"
"3ZKG",,"X-RAY DIFFRACTION",2.54,51.5,,8,"0.1M TRIS PH8, 25% PEG3350, pH 8.0",,"10.1107/S0907444913006574",,"3ZKG",84.38,"1.9","1.9","BACE2 MUTANT APO STRUCTURE","ANFLAMVDNLQGDSGRGYYLEMLIGTPPQKLQILVDTGSSNFAVAGTPHSYIDTYFDTERSSTYRSKGFDVTVKYTQGSWTGFVGEDLVTIPKGFNTSFLVNIATIFESENFFLPGIKWNGILGLAYATLAKPSSSLETFFDSLVTQANIPNVFSMQMCGAGLPVAGSGTNGGSLVLGGIEPSLYKGDIWYTPIKEEWYYQIEILKLEIGGQSLNLDCREYNADKAIVDSGTTLLRLPQKVFDAVVEAVARASLIPAFSDGFWTGSQLACWTNSETPWSYFPKISIYLRDENSSRSFRITILPQLYIQPMMGAGLNYECYRFGISPSTNALVIGATVMEGFYVIFDRAQKRVGFAASPCAEIAGAAVSEISGPFSTEDVASNCVPA","Homo sapiens","BACE2, AEPLC, ALP56, ASP21, CDA13, UNQ418/PRO852","BETA-SECRETASE 2","1","3ZKG"
"3ZKI",,"X-RAY DIFFRACTION",2.58,52.4,,8,"0.1M TRIS PH8.0, 25% PEG3350",,"10.1107/S0907444913006574","WZV","3ZKI",84.97,"2.4","2.4","BACE2 MUTANT STRUCTURE WITH LIGAND","ANFLAMVDNLQGDSGRGYYLEMLIGTPPQKLQILVDTGSSNFAVAGTPHSYIDTYFDTERSSTYRSKGFDVTVKYTQGSWTGFVGEDLVTIPKGFNTSFLVNIATIFESENFFLPGIKWNGILGLAYATLAKPSSSLETFFDSLVTQANIPNVFSMQMCGAGLPVAGSGTNGGSLVLGGIEPSLYKGDIWYTPIKEEWYYQIEILKLEIGGQSLNLDCREYNADKAIVDSGTTLLRLPQKVFDAVVEAVARASLIPAFSDGFWTGSQLACWTNSETPWSYFPKISIYLRDENSSRSFRITILPQLYIQPMMGAGLNYECYRFGISPSTNALVIGATVMEGFYVIFDRAQKRVGFAASPCAEIAGAAVSEISGPFSTEDVASNCVPA","Homo sapiens","BACE2, AEPLC, ALP56, ASP21, CDA13, UNQ418/PRO852","BETA-SECRETASE 2","1","3ZKI"
"3ZLI",,"X-RAY DIFFRACTION",2.69,54.31,"VAPOR DIFFUSION, SITTING DROP",,"0.2M TRIMETHYLAMINE N-OXIDE; 0.1M HEPES PH 7.5; 10%(W/V) PEG 3350",277,"10.1074/jbc.M114.555052",,"3ZLI",111.42,"1.8","1.8","Crystal structure of JmjC domain of human histone demethylase UTY","MLPKDKLNPPTPSIYLENKRDAFFPPLHQFCTNPKNPVTVIRGLAGALKLDLGLFSTKTLVEANNEHMVEVRTQLLQPADENWDPTGTKKIWRCESNRSHTTIAKYAQYQASSFQESLREENEKRTQHKDHSDNESTSSENSGRRRKGPFKTIKFGTNIDLSDNKKWKLQLHELTKLPAFARVVSAGNLLTHVGHTILGMNTVQLYMKVPGSRTPGHQENNNFCSVNINIGPGDCEWFVVPEDYWGVLNDFCEKNNLNFLMSSWWPNLEDLYEANVPVYRFIQRPGDLVWINAGTVHWVQAVGWCNNIAWNVGPLTACQYKLAVERYEWNKLKSVKSPVPMVHLSWNMARNIKVSDPKLFEMIKYCLLKILKQYQTLREALVAAGKEVIWHGRTNDEPAHYCSICEVEVFNLLFVTNESNTQKTYIVHCHDCARKTSKSLENFVVLEQYKMEDLIQVYDQFTLALSLSSSSAENLYFQ","Homo sapiens","UTY, KDM6C","HISTONE DEMETHYLASE UTY","1","3ZLI"
"3ZLN",,"X-RAY DIFFRACTION",3.01,59.01,,8,"1.8 M (NH4)2 SO4, 40 MM MG2 SO4, 10 MM TRIS PH 8.0",,"10.1038/nchembio.1246","H0Y","3ZLN",21.63,"2.288","2.288","Crystal structure of BCL-XL in complex with inhibitor (Compound 3)","MSMAMSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERLEHHHHHH","Homo sapiens","BCL2L1, BCL2L, BCLX","BCL-2-LIKE PROTEIN 1","1","3ZLN"
"3ZLO",,"X-RAY DIFFRACTION",2.15,47.76,,6,"2 M (NH4)2SO4, 0.5 M GUANADINE HCL, 0.1 M MES PH 6.0",,"10.1038/nchembio.1246","X8U","3ZLO",21.36,"2.601","2.601","Crystal structure of BCL-XL in complex with inhibitor (Compound 6)","MSMAMSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERLEHHHHHH","Homo sapiens","BCL2L1, BCL2L, BCLX","BCL-2-LIKE PROTEIN 1","1","3ZLO"
"3ZLR",,"X-RAY DIFFRACTION",2.34,47.36,,5.5,"1.6 M (NH4)2 SO4, 100 MM MES PH 5.5",,"10.1038/nchembio.1246","X0B","3ZLR",37.42,"2.026","2.026","Crystal structure of BCL-XL in complex with inhibitor (WEHI-539)","GPLGSMSQSNRELVVDFLSYKLSQKGYSWSQMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQER","Homo sapiens","BCL2L1, BCL2L, BCLX","BCL-2-LIKE PROTEIN 1","1","3ZLR"
"3ZLS",,"X-RAY DIFFRACTION",2.42,49.19,,7.7,"pH 7.7",,"10.1016/j.bmcl.2013.04.003","92P","3ZLS",39.12,"2.5","2.5","Crystal structure of MEK1 in complex with fragment 6","GLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKKGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQ","Homo sapiens","MAP2K1, MEK1, PRKMK1","DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1","1","3ZLS"
"3ZLW",,"X-RAY DIFFRACTION",2.44,49.62,,7.7,"pH 7.7",,"10.1016/j.bmcl.2013.04.003","MT8","3ZLW",39.17,"2.12","2.12","Crystal structure of MEK1 in complex with fragment 3","GLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAANGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQ","Homo sapiens","MAP2K1, MEK1, PRKMK1","DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 MAPK/ERK KINASE 1, MEK 1, MEK1","1","3ZLW"
"3ZLX",,"X-RAY DIFFRACTION",2.43,49.46,,7.7,"Appropriate single crystals were grown using this set-up in PEG 4000 18%, Tris 100mM pH7.7, DMSO 2% and CaCl2 0.2M and were extracted from the low volume drops, cryo-protected in mother liquor with 20% glycerol and flash cooled for synchrotron collection",,"10.1016/j.bmcl.2013.04.003","5EZ","3ZLX",39.2,"2.2","2.2","Crystal structure of MEK1 in complex with fragment 18","GLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKKGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQ","Homo sapiens","MAP2K1, MEK1, PRKMK1","DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1","1","3ZLX"
"3ZLY",,"X-RAY DIFFRACTION",2.43,49.28,,7.7,"Appropriate single crystals were grown using this set-up in PEG 4000 18%, Tris 100mM pH7.7, DMSO 2% and CaCl2 0.2M and were extracted from the low volume drops, cryo-protected in mother liquor with 20% glycerol and flash cooled for synchrotron collection",,"10.1016/j.bmcl.2013.04.003","YSO","3ZLY",39.08,"2.11","2.11","Crystal structure of MEK1 in complex with fragment 8","GLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNNKGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQ","Homo sapiens","MAP2K1, MEK1, PRKMK1","DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1","1","3ZLY"
"3ZLZ",,"X-RAY DIFFRACTION",2.83,57,,7.4,"20% (V/V) PEG3350 AND 0.2 M ZINC ACETATE, pH 7.4",,"10.1038/nsmb.2547",,"3ZLZ",17.54,"2.9","2.9","Lys6-linked tri-ubiquitin","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGRQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBB","UBIQUITIN","1","3ZLZ"
"3ZM0",,"X-RAY DIFFRACTION",2.32,46.92,,,"16-22 % (W/V) PEG3350, 0.1-0.2 M SODIUM CITRATE",,"10.1002/cmdc.201500015",,"3ZM0",33.11,"1.5","1.5","Catalytic domain of human SHP2","GAHMWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQR","Homo sapiens","PTPN11, PTP2C, SHPTP2","TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 11","1","3ZM0"
"3ZM1",,"X-RAY DIFFRACTION",2.29,46.29,,,"16-22% (W/V) PEG3350, 0.1-0.2 M SODIUM CITRATE",,"10.1002/cmdc.201500015",,"3ZM1",33.11,"1.4","1.4","Catalytic domain of human SHP2","GAHMWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQR","Homo sapiens","PTPN11, PTP2C, SHPTP2","TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 11","1","3ZM1"
"3ZM2",,"X-RAY DIFFRACTION",2.29,46.39,,,"16-22% (W/V) PEG3350 0.1-0.2 M SODIUM CITRATE",,"10.1002/cmdc.201500015",,"3ZM2",33.11,"1.5","1.5","Catalytic domain of human SHP2","GAHMWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQR","Homo sapiens","PTPN11, PTP2C, SHPTP2","TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 11","1","3ZM2"
"3ZM3",,"X-RAY DIFFRACTION",2.31,46.84,,,"16-22% (W/V) PEG3350, 0.1-0.2 M SODIUM CITRATE",,"10.1002/cmdc.201500015",,"3ZM3",33.16,"1.5","1.5","Catalytic domain of human SHP2","GAHMWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDRDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQR","Homo sapiens","PTPN11, PTP2C, SHPTP2","TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 11","1","3ZM3"
"3ZM4",,"X-RAY DIFFRACTION",2.5,50.85,,7.7,"Appropriate single crystals were grown using this set-up in PEG 4000 18%, Tris 100mM pH7.7, DMSO 2% and CaCl2 0.2M and were extracted from the low volume drops, cryo-protected in mother liquor with 20% glycerol and flash cooled for synchrotron collection",,"10.1016/j.bmcl.2013.04.003","22T","3ZM4",39.18,"2.37","2.37","Crystal structure of MEK1 in complex with fragment 1","GLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKKGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQ","Homo sapiens","MAP2K1, MEK1, PRKMK1","DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1","1","3ZM4"
"3ZM9",,"X-RAY DIFFRACTION",2.48,50.39,,,,,"10.1002/anie.201209660","QMQ","3ZM9",90.89,"1.9","1.9","The mechanism of allosteric coupling in choline kinase a1 revealed by a rationally designed inhibitor","PQPPADEQPEPRTRRRAYLWCKEFLPGAWRGLREDEFHISVIRGGLSNMLFQCSLPDTTATLGDEPRKVLLRLYGAILQMRSCNKEGSEQAQKENEFQGAEAMVLESVMFAILAERSLGPKLYGIFPQGRLEQFIPSRRLDTEELSLPDISAEIAEKMATFHGMKMPFNKEPKWLFGTMEKYLKEVLRIKFTEESRIKKLHKLLSYNLPLELENLRSLLESTPSPVVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNYRGFDIGNHFCEWMYDYSYEKYPFFRANIRKYPTKKQQLHFISSYLPAFQNDFENLSTEEKSIIKEEMLLEVNRFALASHFLWGLWSIVQAKISSIEFGYMDYAQARFDAYFHQKRKLGV","Homo sapiens","CHKA, CHK, CKI","CHOLINE KINASE ALPHA","1","3ZM9"
"3ZME",,"X-RAY DIFFRACTION",2.5,51,"VAPOR DIFFUSION, SITTING DROP",7.2,"CRYSTALLIZATION CONDITIONS: SITTING-DROP VAPOR DIFFUSION AT 21 DEGREE C. PROTEIN SOLUTION: 6 MG/ML PROTEIN IN 25 MM SODIUM PHOSPHATE, PH 7.2, 150 MM KCL, 5 MM DTT. RESERVOIR BUFFER: 100 MM HEPES, PH 7.2, 19% (W/V) POLYETHYLENE GLYCOL 4000, 5 MM DTT. SOAKING BUFFER: 40 MM COMPOUND (PK7204) IN 100 MM HEPES, PH 7.2, 10 MM SODIUM PHOSPHATE, PH 7.2, 19% (W/V) POLYETHYLENE GLYCOL 4000, 20 % (V/V) GLYCEROL, 150 MM KCL. SOAKING TIME: 3 HOURS.",294,"10.1093/nar/gkt305",,"3ZME",49.79,"1.35","1.35","Structure of the p53 core domain mutant Y220C bound to the small molecule PhiKan7242","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPCEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","Cellular tumor antigen p53","1","3ZME"
"3ZMG",,"X-RAY DIFFRACTION",2.87,57.3,"VAPOR DIFFUSION, SITTING DROP",7,"2.5M SODIUM FORMATE, 100MM HEPES, PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K",298,"10.1021/jm400225m","6Z0","3ZMG",46.07,"1.74","1.74","CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVASIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","3ZMG"
"3ZMM",,"X-RAY DIFFRACTION",2.7,54.47,,7.4,"pH 7.4",,"10.1016/j.bmcl.2013.02.111","F9J","3ZMM",71.16,"2.51","2.51","Inhibitors of Jak2 Kinase domain","AFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMAG","Homo sapiens","JAK2","TYROSINE-PROTEIN KINASE JAK2","1","3ZMM"
"3ZNF",,"SOLUTION NMR",,,,,,,"10.1021/bi00492a004",,"3ZNF",3.63,,,"HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF A SINGLE ZINC FINGER FROM A HUMAN ENHANCER BINDING PROTEIN IN SOLUTION","RPYHCSYCNFSFKTKGNLTKHMKSKAHSKK","Homo sapiens","HIVEP1, ZNF40","ZINC FINGER","1","3ZNF"
"3ZNN",,"X-RAY DIFFRACTION",2.23,44.78,,,,,"10.1021/jm4002583","4WL","3ZNN",81.96,"1.9","1.9","IN VITRO AND IN VIVO INHIBITION OF HUMAN D-AMINO ACID OXIDASE: REGULATION OF D-SERINE CONCENTRATION IN THE BRAIN","MRVVVIGAGVIGLSTALCIHERYHSVLQPLDIKVYADRFTPLTTTDVAAGLWQPYLSDPNNPQEADWSQQTFDYLLSHVHSPNAENLGLFLISGYNLFHEAIPDPSWKDTVLGFRKLTPRELDMFPDYGYGWFHTSLILEGKNYLQWLTERLTERGVKFFQRKVESFEEVAREGADVIVNCTGVWAGALQRDPLLQPGRGQIMKVDAPWMKHFILTHDPERGIYNSPYIIPGTQTVTLGGIFQLGNWSELNNIQDHNTIWEGCCRLEPTLKNARIIGERTGFRPVRPQIRLEREQLRTGPSNTEVIHNYGHGGYGLTIHWGCALEAAKLFGRILEEKKLSRMPPSHL","Homo sapiens","DAO, DAMOX","D-AMINO-ACID OXIDASE","1","3ZNN"
"3ZNO",,"X-RAY DIFFRACTION",2.21,44.3,,,,,"10.1021/jm4002583","SE5","3ZNO",81.2,"2.3","2.3","IN VITRO AND IN VIVO INHIBITION OF HUMAN D-AMINO ACID OXIDASE: REGULATION OF D-SERINE CONCENTRATION IN THE BRAIN","MRVVVIGAGVIGLSTALCIHERYHSVLQPLDIKVYADRFTPLTTTDVAAGLWQPYLSDPNNPQEADWSQQTFDYLLSHVHSPNAENLGLFLISGYNLFHEAIPDPSWKDTVLGFRKLTPRELDMFPDYGYGWFHTSLILEGKNYLQWLTERLTERGVKFFQRKVESFEEVAREGADVIVNCTGVWAGALQRDPLLQPGRGQIMKVDAPWMKHFILTHDPERGIYNSPYIIPGTQTVTLGGIFQLGNWSELNNIQDHNTIWEGCCRLEPTLKNARIIGERTGFRPVRPQIRLEREQLRTGPSNTEVIHNYGHGGYGLTIHWGCALEAAKLFGRILEEKKLSRMPPSHL","Homo sapiens","DAO, DAMOX","D-AMINO-ACID OXIDASE","1","3ZNO"
"3ZNP",,"X-RAY DIFFRACTION",2.44,49.62,,,,,"10.1021/jm4002583","SE2","3ZNP",81.42,"2.4","2.4","IN VITRO AND IN VIVO INHIBITION OF HUMAN D-AMINO ACID OXIDASE: REGULATION OF D-SERINE CONCENTRATION IN THE BRAIN","MRVVVIGAGVIGLSTALCIHERYHSVLQPLDIKVYADRFTPLTTTDVAAGLWQPYLSDPNNPQEADWSQQTFDYLLSHVHSPNAENLGLFLISGYNLFHEAIPDPSWKDTVLGFRKLTPRELDMFPDYGYGWFHTSLILEGKNYLQWLTERLTERGVKFFQRKVESFEEVAREGADVIVNCTGVWAGALQRDPLLQPGRGQIMKVDAPWMKHFILTHDPERGIYNSPYIIPGTQTVTLGGIFQLGNWSELNNIQDHNTIWEGCCRLEPTLKNARIIGERTGFRPVRPQIRLEREQLRTGPSNTEVIHNYGHGGYGLTIHWGCALEAAKLFGRILEEKKLSRMPPSHL","Homo sapiens","DAO, DAMOX","D-AMINO-ACID OXIDASE","1","3ZNP"
"3ZNQ",,"X-RAY DIFFRACTION",2.46,49.97,,,,,"10.1021/jm4002583",,"3ZNQ",80.87,"2.75","2.75","IN VITRO AND IN VIVO INHIBITION OF HUMAN D-AMINO ACID OXIDASE: REGULATION OF D-SERINE CONCENTRATION IN THE BRAIN","MRVVVIGAGVIGLSTALCIHERYHSVLQPLDIKVYADRFTPLTTTDVAAGLWQPYLSDPNNPQEADWSQQTFDYLLSHVHSPNAENLGLFLISGYNLFHEAIPDPSWKDTVLGFRKLTPRELDMFPDYGYGWFHTSLILEGKNYLQWLTERLTERGVKFFQRKVESFEEVAREGADVIVNCTGVWAGALQRDPLLQPGRGQIMKVDAPWMKHFILTHDPERGIYNSPYIIPGTQTVTLGGIFQLGNWSELNNIQDHNTIWEGCCRLEPTLKNARIIGERTGFRPVRPQIRLEREQLRTGPSNTEVIHNYGHGGYGLTIHWGCALEAAKLFGRILEEKKLSRMPPSHL","Homo sapiens","DAO, DAMOX","D-AMINO-ACID OXIDASE","1","3ZNQ"
"3ZNR",,"X-RAY DIFFRACTION",2.09,41.16,,7.5,"pH 7.5",,"10.1038/nchembio.1223","NU9","3ZNR",137.7,"2.4","2.4","HDAC7 bound with inhibitor TMP269","GSRAQSSPAAPASLSAPEPASQARVLSSSETPARTLPFTTGLIYDSVMLKHQCSCGDNSRHPEHAGRIQSIWSRLQERGLRSQCECLRGRKASLEELQSVHSERHVLLYGTNPLSRLKLDNGKLAGLLAQRMFVMLPCGGVGVDTDTIWNELHSSNAARWAAGSVTDLAFKVASRELKNGFAVVRPPGHHADHSTAMGFCFFNSVAIACRQLQQQSKASKILIVDWDVHHGNGTQQTFYQDPSVLYISLHRHDDGNFFPGSGAVDEVGAGSGEGFNVNVAWAGGLDPPMGDPEYLAAFRIVVMPIAREFSPDLVLVSAGFDAAEGHPAPLGGYHVSAKCFGYMTQQLMNLAGGAVVLALEGGHDLTAICDASEACVAALLGNRVDPLSEEGWKQKPNLNAIRSLEAVIRVHSKYWGCMQRLAS","Homo sapiens","HDAC7, HDAC7A","HISTONE DEACETYLASE 7","1","3ZNR"
"3ZNS",,"X-RAY DIFFRACTION",2.11,41.74,,7.4,"10% PEG 3350, 3% ISOPROPANAL, HEPES PH7.5, pH 7.4",,"10.1038/nchembio.1223","NU7","3ZNS",138.76,"2.45","2.45","HDAC7 bound with TFMO inhibitor tmp942","GSRAQSSPAAPASLSAPEPASQARVLSSSETPARTLPFTTGLIYDSVMLKHQCSCGDNSRHPEHAGRIQSIWSRLQERGLRSQCECLRGRKASLEELQSVHSERHVLLYGTNPLSRLKLDNGKLAGLLAQRMFVMLPCGGVGVDTDTIWNELHSSNAARWAAGSVTDLAFKVASRELKNGFAVVRPPGHHADHSTAMGFCFFNSVAIACRQLQQQSKASKILIVDWDVHHGNGTQQTFYQDPSVLYISLHRHDDGNFFPGSGAVDEVGAGSGEGFNVNVAWAGGLDPPMGDPEYLAAFRIVVMPIAREFSPDLVLVSAGFDAAEGHPAPLGGYHVSAKCFGYMTQQLMNLAGGAVVLALEGGHDLTAICDASEACVAALLGNRVDPLSEEGWKQKPNLNAIRSLEAVIRVHSKYWGCMQRLAS","Homo sapiens","HDAC7, HDAC7A","HISTONE DEACETYLASE 7","1","3ZNS"
"3ZNV",,"X-RAY DIFFRACTION",2.32,47.02,,6.5,"100 MM MES/IMIDAZOLE PH 6.5, 30 MM MGCL2, 30 MM CACL2, 10% PEG 4000, 20% GLYCEROL",,"10.1016/j.cell.2013.05.014",,"3ZNV",32.37,"1.3","1.3","Crystal structure of the OTU domain of OTULIN at 1.3 Angstroms.","GPLSVAPEMDIMDYCKKEWRGNTQKATCMKMGYEEVSQKFTSIRRVRGDNYCALRATLFQAMSQAVGLPPWLQDPELMLLPEKLISKYNWIKQWKLGLKFDGKNEDLVDKIKESLTLLRKKWAGLAEMRTAEARQIACDELFTNEAEEYSLYEAVKFLMLNRAIELYNDKEKGKEVPFFSVLLFARDTSNDPGQLLRNHLNQVGHTGGLEQVEMFLLAYAVRHTIQVYRLSKYNTEEFITVYPTDPPKDWPVVTLIAEDDRHYNIPVRVCEETSL","Homo sapiens","OTULIN, FAM105B","PROTEIN FAM105B","1","3ZNV"
"3ZNX",,"X-RAY DIFFRACTION",2.45,49.84,,6.5,"100 MM MES/IMIDAZOLE PH 6.5, 30 MM MGCL2, 30 MM CACL2, 10% PEG 4,000, 20% GLYCEROL",,"10.1016/j.cell.2013.05.014",,"3ZNX",32.23,"1.35","1.35","Crystal structure of the OTU domain of OTULIN D336A mutant","GPLSVAPEMDIMDYCKKEWRGNTQKATCMKMGYEEVSQKFTSIRRVRGDNYCALRATLFQAMSQAVGLPPWLQDPELMLLPEKLISKYNWIKQWKLGLKFDGKNEDLVDKIKESLTLLRKKWAGLAEMRTAEARQIACDELFTNEAEEYSLYEAVKFLMLNRAIELYNDKEKGKEVPFFSVLLFARDTSNDPGQLLRNHLNQVGHTGGLEQVEMFLLAYAVRHTIQVYRLSKYNTEEFITVYPTDPPKDWPVVTLIAEADRHYNIPVRVCEETSL","Homo sapiens","OTULIN, FAM105B","PROTEIN FAM105B","1","3ZNX"
"3ZON",,"X-RAY DIFFRACTION",2.44,49.69,,6.5,"0.1M MES PH 6.5, 12%(W/V) PEG 20000",,,,"3ZON",37.67,"2.15","2.15","Human TYK2 pseudokinase domain bound to a kinase inhibitor","SMGDDCFSLRRCCLPQPGETSNLIIMRGARASPRTLNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRLQPHN","Homo sapiens","TYK2","NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2","1","3ZON"
"3ZOO",,"X-RAY DIFFRACTION",2.3,46.7,,7,"26-31% (W/V) PEG 1000, 40 MM KH2PO4 PH 7.0",,"10.1042/BJ20130758",,"3ZOO",49.16,"1.35","1.35","Structure of the Y46F mutant of human cytochrome c","GDVEKGKKIFIMKCSQCHTVEKGGKHKTGPNLHGLFGRKTGQAPGFSYTAANKNKGIIWGEDTLMEYLENPKKYIPGTKMIFVGIKKKEERADLIAYLKKATNE","Homo sapiens","CYCS, CYC","CYTOCHROME C","1","3ZOO"
"3ZOS",,"X-RAY DIFFRACTION",2.31,46.89,,,"0.1M BIS-TRIS PH 5.5, 25% PEG 3350",,"10.1016/j.jmb.2014.04.014",,"3ZOS",73.29,"1.92","1.92","Structure of the DDR1 kinase domain in complex with ponatinib","SMPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDGQAAQGPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTV","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","1","3ZOS"
"3ZOV",,"X-RAY DIFFRACTION",3.16,61.1,"VAPOR DIFFUSION, SITTING DROP",7,"2.5M SODIUM FORMATE, 100MM HEPES, PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K",298,"10.1107/S0907444913006574","WZV","3ZOV",46.11,"2.1","2.1","CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVASIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","3ZOV"
"3ZOZ",,"X-RAY DIFFRACTION",2.32,47,,6.5,"35% PEG2000MME, 0.1M BIS-TRIS PH 6.5",,,"3PG","3ZOZ",45.47,"1.95","1.95","The structure of human phosphoglycerate kinase with bound bromide, a stimulating anion.","MSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI","Homo sapiens","PGK1, PGKA, MIG10, OK/SW-cl.110","PHOSPHOGLYCERATE KINASE 1","1","3ZOZ"
"3ZP9",,"X-RAY DIFFRACTION",2.2,42.7,"VAPOR DIFFUSION, HANGING DROP",7.9,"2.1 M AMSO4, 50 MM TRIS-SO4, 0.2 MM 4-CHLOROMERCURIBENZOIC ACID, 4 MG/ML PROTEIN, PH 7.9, 293 K",293,,"9TH","3ZP9",30.63,"1.31","1.31","Human Carbonic Anhydrase II as a Scaffold for an Artificial Transfer Hydrogenase","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","CARBONIC ANHYDRASE 2","1","3ZP9"
"3ZPO",,"X-RAY DIFFRACTION",2.75,55.28,,,"15%(W/V) PEG 3350, 0.1M MAGNESIUM FORMATE",,"10.1074/jbc.M114.555052","K0I","3ZPO",112.09,"2","2","Crystal structure of JmjC domain of human histone demethylase UTY with bound GSK J1","MLPKDKLNPPTPSIYLENKRDAFFPPLHQFCTNPKNPVTVIRGLAGALKLDLGLFSTKTLVEANNEHMVEVRTQLLQPADENWDPTGTKKIWRCESNRSHTTIAKYAQYQASSFQESLREENEKRTQHKDHSDNESTSSENSGRRRKGPFKTIKFGTNIDLSDNKKWKLQLHELTKLPAFARVVSAGNLLTHVGHTILGMNTVQLYMKVPGSRTPGHQENNNFCSVNINIGPGDCEWFVVPEDYWGVLNDFCEKNNLNFLMSSWWPNLEDLYEANVPVYRFIQRPGDLVWINAGTVHWVQAVGWCNNIAWNVGPLTACQYKLAVERYEWNKLKSVKSPVPMVHLSWNMARNIKVSDPKLFEMIKYCLLKILKQYQTLREALVAAGKEVIWHGRTNDEPAHYCSICEVEVFNLLFVTNESNTQKTYIVHCHDCARKTSKSLENFVVLEQYKMEDLIQVYDQFTLALSLSSSSAENLYFQ","Homo sapiens","UTY, KDM6C","HISTONE DEMETHYLASE UTY","1","3ZPO"
"3ZQK",,"X-RAY DIFFRACTION",1.9,35.3,,,"PROTEIN BUFFER: 0.015 M HEPES PH 7.5, 0.02 M NACL, 0.001 M CACL2. RESERVOIR BUFFER: 0.1 M MMT (PH 4.0-5.5), 0.15 M (NH4)2SO4, 18-23% (W/V) PEG2000 MME.",,"10.1038/ncomms1385",,"3ZQK",67.41,"1.7","1.7","Von Willebrand Factor A2 domain with calcium","GSVGPGLLGVSTLGPKRNSMVLDVAFVLEGSDKIGEADFNRSKEFMEEVIQRMDVGQDSIHVTVLQYSYMVTVEYPFSEAQSKGDILQRLREIRYQGGNRTNTGLALRYLSDHSFLVSQGDREQAPNLVYMVTGNPASDEIKRLPGDIQVVPIGVGPNANVQELERIGWPNAPILIQDFETLPREAPDLVLQRCCSGEG","Homo sapiens","VWF, F8VWF","VON WILLEBRAND FACTOR","1","3ZQK"
"3ZQR",,"X-RAY DIFFRACTION",2.4,48,,8.2,"0.6 M NA2SO4, 0.3 M TRIS PH 8.2, 0.6 M ZN(AC)2, 0.06% PHENOL.",,"10.1074/jbc.M111.265249",,"3ZQR",35.76,"1.9","1.9","NMePheB25 insulin analogue crystal structure","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","3ZQR"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","INSULIN B CHAIN","2","3ZQR"
"3ZQS",,"X-RAY DIFFRACTION",5.9,79,,5.5,"0.2M L-PROLINE, 0.1M SODIUM TRI CITRATE PH5.5, 2% PEG 3,350",,"10.1074/jbc.M111.244632",,"3ZQS",45.31,"2","2","Human FANCL central domain","QFYSSLIEEIGTLGWDKLVYADTCFSTIKLKAEDASGREHLITLKLKAKYPAESPDYFVDFPVPFCASWTPQSSLISIYSQFLAAIESLKAFWDVMDEIDEKTWVLEPEKPPRSATARRIALGNNVSINIEVDPRHPTMLPECFFLGADHVVKPLGIKLSRNIHLWDPENSVLQNLKDVLEIDFPA","Homo sapiens","FANCL, PHF9","E3 UBIQUITIN-PROTEIN LIGASE FANCL","1","3ZQS"
"3ZR0",,"X-RAY DIFFRACTION",2.28,46,,,"26 % PEG6000, 0.1 M SODIUM ACETATE TRIHYDRATE PH 4.0, 0.2 M LI2SO4",,"10.1016/j.febslet.2011.07.017",,"3ZR0",37.15,"1.8","1.8","Crystal structure of human MTH1 in complex with 8-oxo-dGMP","MGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE","1","3ZR0"
"3ZR1",,"X-RAY DIFFRACTION",2.28,46,,,"26 % PEG6000, 0.1 M SODIUM ACETATE TRIHYDRATE PH 4.0, 0.2 M LI2SO4",,"10.1016/j.febslet.2011.07.017",,"3ZR1",36.45,"1.9","1.9","Crystal structure of human MTH1","MGASRLYTLVLVLQPQRVLLGMKKRGFGAGRWNGFGGKVQEGETIEDGARRELQEESGLTVDALHKVGQIVFEFVGEPELMDVHVFCTDSIQGTPVESDEMRPCWFQLDQIPFKDMWPDDSYWFPLLLQKKKFHGYFKFQGQDTILDYTLREVDTV","Homo sapiens","NUDT1, MTH1","7,8-DIHYDRO-8-OXOGUANINE TRIPHOSPHATASE","1","3ZR1"
"3ZR7",,"X-RAY DIFFRACTION",2.24,45,,6.5,"20-30%POLYETHYLENE GLYCOL 3350, 0.1M HEPES PH 6.5, 100 MM MG2SO4, 10% GLYCEROL",,"10.1074/jbc.M111.273029",,"3ZR7",61.65,"1.65","1.65","Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators","GSHMGQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK","Homo sapiens","PGR, NR3C3","PROGESTERONE RECEPTOR","1","3ZR7"
"3ZRA",,"X-RAY DIFFRACTION",2.18,43,,6.5,"20-30% POLYETHYLENE GLYCOL 3350, 0.1M HEPES PH 6.5, 100 MM MG2SO4, 10% GLYCEROL.",,"10.1074/jbc.M111.273029",,"3ZRA",60.85,"1.9","1.9","Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators","GSHMGQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK","Homo sapiens","PGR, NR3C3","PROGESTERONE RECEPTOR","1","3ZRA"
"3ZRB",,"X-RAY DIFFRACTION",2.16,43,,6.5,"20-30%POLYETHYLENE GLYCOL 3350, 0.1M HEPES PH 6.5, 100 MM MG2SO4, 10% GLYCEROL",,"10.1074/jbc.M111.273029",,"3ZRB",61.17,"1.8","1.8","Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators","GSHMGQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK","Homo sapiens","PGR, NR3C3","PROGESTERONE RECEPTOR","1","3ZRB"
"3ZRH",,"X-RAY DIFFRACTION",2.77,55,,5.9,"150 MM NACL, 100 MM NAOAC, 5 MM MGCL2, 50 MM MES [PH 5.9]",,"10.1038/nsmb.2169",,"3ZRH",52.54,"2.23","2.23","Crystal structure of the Lys29, Lys33-linkage-specific TRABID OTU deubiquitinase domain reveals an Ankyrin-repeat ubiquitin binding domain (AnkUBD)","ALEVDFKKLKQIKNRMKKTDWLFLNACVGVVEGDLAAIEAYKSSGGDIARQLTADEVRLLNRPSAFDVGYTLVHLAIRFQRQDMLAILLTEVSQQAAKCIPAMVCPELTEQIRREIAASLHQRKGDFACYFLTDLVTFTLPADIEDLPPTVQEKLFDEVLDRDVQKELEEESPIINWSLELATRLDSRLYALWNRTAGDCLLDSVLQATWGIYDKDSVLRKALHDSLHDCSHWFYTRWKDWESWYSQSFGLHFSLREEQWQEDWAFILSLASQPGASLEQTHIFVLAHILRRPIIVYGVKYYKSFRGETLGYTRFQGVYLPLLWEQSFCWKSPIALGYTRGHFSALVAMENDGYGNRGAGANLNTDDDVTITFLPLVDSERKLLHVHFLSAQELGNEEQQEKLLREWLDCCVTEGGVLVAMQKSSRRRNHPLVTQMVEKWLDRYRQIRPCTSLS","Homo sapiens","ZRANB1, TRABID","UBIQUITIN THIOESTERASE ZRANB1","1","3ZRH"
"3ZRT",,"X-RAY DIFFRACTION",2.5,51,,4.5,"0.1 M SODIUM ACETATE TRIHYDRATE PH 6.0, 2.0 M SODIUM FORMATE AND 5 % PEG 4000 (DROP SIZE: 1 UL SAMPLE AND 1UL RESERVOIR SOLUTION)",,"10.1073/pnas.1113761109",,"3ZRT",85.39,"3.398","3.398","Crystal structure of human PSD-95 PDZ1-2","MHHHHHPRGSMEYEEITLERGNSGLGFSIAGGTDNPHIGDDPSIFITKIIPGGAAAQDGRLRVNDSILFVNEVDVREVTHSAAVEALKEAGSIVRLYVMRRKPPAEKVMEIKLIKGPKGLGFSIAGGVGNQHIPGDNSIYVTKIIEGGAAHKDGRLQIGDKILAVNSVGLEDVMHEDAVAALKNTYDVVYLKVAKPSNA","Homo sapiens","DLG4, PSD95","DISKS LARGE HOMOLOG 4","1","3ZRT"
"3ZS0",,"X-RAY DIFFRACTION",2.5,51,,5.5,"pH 5.5",,"10.1074/jbc.M111.266981","ZS0","3ZS0",136.72,"2.3","2.3","Human Myeloperoxidase inactivated by TX2","VTCPEQDKYRTITGMCNNRRSPTLGASNRAFVRWLPAEYEDGFSLPYGWTPGVKRNGFPVALARAVSNEIVRFPTDQLTPDQERSLMFMQWGQLLDHDLDFTPEPAAR","Homo sapiens","MPO","MYELOPEROXIDASE LIGHT CHAIN","1","3ZS0"
,,,,,,,,,,,,,,,,"VNCETSCVQQPPCFPLKIPPNDPRIKNQADCIPFFRSCPACPGSNITIRNQINALTSFVDASMVYGSEEPLARNLRNMSNQLGLLAVNQRFQDNGRALLPFDNLHDDPCLLTNRSARIPCFLAGDTRSSEMPELTSMHTLLLREHNRLATELKSLNPRWDGERLYQEARKIVGAMVQIITYRDYLPLVLGPTAMRKYLPTYRSYNDSVDPRIANVFTNAFRYGHTLIQPFMFRLDNRYQPMEPNPRVPLSRVFFASWRVVLEGGIDPILRGLMATPAKLNRQNQIAVDEIRERLFEQVMRIGLDLPALNMQRSRDHGLPGYNAWRRFCGLPQPETVGQLGTVLRNLKLARKLMEQYGTPNNIDIWMGGVSEPLKRKGRVGPLLACIIGTQFRKLRDGDRFWWENEGVFSMQQRQALAQISLPRIICDNTGITTVSKNNIFMSNSYPRDFVNCSTLPALNLASWREAS","Homo sapiens","MPO","MYELOPEROXIDASE HEAVY CHAIN","2","3ZS0"
"3ZS1",,"X-RAY DIFFRACTION",2.5,51,,5.5,"16-17% PEG3350, 100 MM NACL, pH 5.5",,"10.1074/jbc.M111.266981","PVW","3ZS1",137.11,"2.6","2.6","Human Myeloperoxidase inactivated by TX5","VTCPEQDKYRTITGMCNNRRSPTLGASNRAFVRWLPAEYEDGFSLPYGWTPGVKRNGFPVALARAVSNEIVRFPTDQLTPDQERSLMFMQWGQLLDHDLDFTPEPAARASFVTG","Homo sapiens","MPO","MYELOPEROXIDASE LIGHT CHAIN","1","3ZS1"
,,,,,,,,,,,,,,,,"VNCETSCVQQPPCFPLKIPPNDPRIKNQADCIPFFRSCPACPGSNITIRNQINALTSFVDASMVYGSEEPLARNLRNMSNQLGLLAVNQRFQDNGRALLPFDNLHDDPCLLTNRSARIPCFLAGDTRSSEMPELTSMHTLLLREHNRLATELKSLNPRWDGERLYQEARKIVGAMVQIITYRDYLPLVLGPTAMRKYLPTYRSYNDSVDPRIANVFTNAFRYGHTLIQPFMFRLDNRYQPMEPNPRVPLSRVFFASWRVVLEGGIDPILRGLMATPAKLNRQNQIAVDEIRERLFEQVMRIGLDLPALNMQRSRDHGLPGYNAWRRFCGLPQPETVGQLGTVLRNLKLARKLMEQYGTPNNIDIWMGGVSEPLKRKGRVGPLLACIIGTQFRKLRDGDRFWWENEGVFSMQQRQALAQISLPRIICDNTGITTVSKNNIFMSNSYPRDFVNCSTLPALNLASWREAS","Homo sapiens","MPO","MYELOPEROXIDASE HEAVY CHAIN","2","3ZS1"
"3ZS2",,"X-RAY DIFFRACTION",2.4,48,,8.2,"0.1 M NACITRATE, 0.3 M TRIS PH 8.2, 0.6 MM ZN(AC)2, 0.06% PHENOL",,"10.1074/jbc.M111.265249",,"3ZS2",35.76,"1.97","1.97","TyrB25,NMePheB26,LysB28,ProB29-insulin analogue crystal structure","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","3ZS2"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFYFTKPT","Homo sapiens","INS","INSULIN B CHAIN","2","3ZS2"
"3ZS5",,"X-RAY DIFFRACTION",2.33,47,"VAPOR DIFFUSION, HANGING DROP",6.5,"HANGING DROP, ROOM TEMP, 20 MM HEPES PH7.1, 50 MM NACL, 10 MM DTT, 5% GLYCEROL, 0.1 G/L METHIONINE, 28% PEG 4K,0.1 M MES PH=6.5, 50 MM N-OCTYL-BETAGLUCOSIDE. CRYOPROTECTANT 28% PEG 4K, 0.1M MES PH5.9, 50 MM N-OCTYL-BETAGLUCOSIDE, 20% ETHYLENE GLYCOL.",,"10.1107/S090744491201997X",,"3ZS5",42.64,"1.6","1.6","Structural basis for kinase selectivity of three clinical p38alpha inhibitors","GSHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","MITOGEN-ACTIVATED PROTEIN KINASE 14","1","3ZS5"
"3ZSG",,"X-RAY DIFFRACTION",2.17,43.22,,6.5,"pH 6.5",,"10.1107/S090744491201997X","T75","3ZSG",42.19,"1.89","1.89","X-ray structure of p38alpha bound to TAK-715","GSHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","MITOGEN-ACTIVATED PROTEIN KINASE 14","1","3ZSG"
"3ZSH",,"X-RAY DIFFRACTION",2.16,42.94,,6.5,"pH 6.5",,"10.1107/S090744491201997X","469","3ZSH",42.3,"2.05","2.05","X-ray structure of p38alpha bound to SCIO-469","GSHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","MITOGEN-ACTIVATED PROTEIN KINASE 14","1","3ZSH"
"3ZSI",,"X-RAY DIFFRACTION",2.23,44.77,,6.5,"pH 6.5",,"10.1107/S090744491201997X","52P","3ZSI",42.22,"2.4","2.4","X-ray structure of p38alpha bound to VX-745","GSHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","MITOGEN-ACTIVATED PROTEIN KINASE 14","1","3ZSI"
"3ZSJ",,"X-RAY DIFFRACTION",1.81,32.2,,7.5,"30% PEG 4000, 0.1M MGCL2, 0.008M BETA MERCAPTOETHANOL, 0.1M TRIS-HCL, PH 7.5, 0.4M NASCN",,"10.1021/bi201459p",,"3ZSJ",16.04,"0.86","0.86","Crystal structure of Human Galectin-3 CRD in complex with Lactose at 0.86 angstrom resolution","PLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","GALECTIN-3","1","3ZSJ"
"3ZSK",,"X-RAY DIFFRACTION",1.79,31.4,,7.5,"30% PEG 4000, 0.1M MGCL2, 0.008M BETA MERCAPTOETHANOL, 0.1M TRIS-HCL, PH 7.5, 0.4M NASCN",,"10.1021/bi201459p",,"3ZSK",15.92,"0.9","0.9","Crystal structure of Human Galectin-3 CRD with glycerol bound at 0.90 angstrom resolution","MLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","GALECTIN-3","1","3ZSK"
"3ZSL",,"X-RAY DIFFRACTION",1.8,31.6,,7.5,"30% PEG 4000, 0.1M MGCL2, 0.008M BETA MERCAPTOETHANOL, 0.1M TRIS-HCL, PH 7.5, 0.4M NASCN",,"10.1021/bi201459p",,"3ZSL",15.74,"1.08","1.08","Crystal structure of Apo Human Galectin-3 CRD at 1.08 angstrom resolution, at cryogenic temperature","MLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","GALECTIN-3","1","3ZSL"
"3ZSM",,"X-RAY DIFFRACTION",1.86,33.9,,7.5,"30% PEG 4000, 0.1M MGCL2, 0.008M BETA MERCAPTOETHANOL, 0.1M TRIS-HCL, PH 7.5, 0.4M NASCN",,"10.1021/bi201459p",,"3ZSM",15.74,"1.25","1.25","Crystal structure of Apo Human Galectin-3 CRD at 1.25 angstrom resolution, at room temperature","MLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","GALECTIN-3","1","3ZSM"
"3ZTG",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M110.217059",,"3ZTG",20.74,,,"Solution structure of the RING finger-like domain of Retinoblastoma Binding Protein-6 (RBBP6)","GPLGSEDDPIPDELLCLICKDIMTDAVVIPCCGNSYCDECIRTALLESDEHTCPTCHQNDVSPDALIANKFLRQAVNNFKNETGYTKRLRKQ","Homo sapiens","RBBP6, P2PR, PACT, RBQ1, My038","E3 UBIQUITIN-PROTEIN LIGASE RBBP6","1","3ZTG"
"3ZU1",,"X-RAY DIFFRACTION",2.14,40,,7.5,"100MM HEPES, 300MM NA-CITRATE, 24% 2-PROPANOL PH 7.5",,,,"3ZU1",12.06,"1.6","1.6","Structure of LysB29(Nepsilon omega-carboxyheptadecanoyl) des(B30) Human Insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","3ZU1"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","INSULIN B CHAIN","2","3ZU1"
"3ZV2",,"X-RAY DIFFRACTION",3.15,60,,7.5,"0.1 M HEPES (PH 7.5), 200 MM MAGNESIUM ACETATE, 12-16% PEG 8K",,"10.1016/j.cell.2011.08.036",,"3ZV2",37.2,"2.8","2.8","Human protein-tyrosine phosphatase 1b C215A, S216A mutant","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHAAAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPH","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","3ZV2"
"3ZVV",,"X-RAY DIFFRACTION",2.33,47.25,,,,,"10.1016/j.bmcl.2011.07.117","XAZ","3ZVV",110.89,"2.5","2.5","Fragment Bound to PI3Kinase gamma","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","1","3ZVV"
"3ZVZ",,"X-RAY DIFFRACTION",2.42,49.09,,,,,"10.1371/journal.pone.0027599",,"3ZVZ",6.63,"1.449","1.449","PHD finger of human UHRF1","GHMRVCACHLCGGRQDPDKQLMCDECDMAFHIYCLDPPLSSVPSEDEWYCPECRNDA","Homo sapiens","UHRF1, ICBP90, NP95, RNF106","E3 UBIQUITIN-PROTEIN LIGASE UHRF1","1","3ZVZ"
"3ZW3",,"X-RAY DIFFRACTION",2.35,47.55,,,,,"10.1016/j.bmcl.2011.07.117","ZW3","3ZW3",111.03,"2.8","2.8","Fragment based discovery of a novel and selective PI3 Kinase inhibitor","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","1","3ZW3"
"3ZW5",,"X-RAY DIFFRACTION",1.94,36.51,,,"2M AMMONIUM SULFATE, 2.5W/V PEG 400, PH7 HEPES",,,,"3ZW5",34.11,"1.6","1.6","Crystal structure of the human Glyoxalase domain-containing protein 5","MHHHHHHSSGVDLGTENLYFQSMLIRRLDHIVMTVKSIKDTTMFYSKILGMEVMTFKEDRKALCFGDQKFNLHEVGKEFEPKAAHPVPGSLDICLITEVPLEEMIQHLKACDVPIEEGPVPRTGAKGPIMSIYFRDPDRNLIEVSNY","Homo sapiens","GLOD5","GLYOXALASE DOMAIN-CONTAINING PROTEIN 5","1","3ZW5"
"3ZWF",,"X-RAY DIFFRACTION",2,38.5,,7,"15% PEG 3350 0.2M NA NITRATE, pH 7",,,,"3ZWF",82.54,"1.7","1.7","Crystal structure of Human tRNase Z, short form (ELAC1).","MDVTFLGTGAAYPSPTRGASAVVLRCEGECWLFDCGEGTQTQLMKSQLKAGRITKIFITHLHGDHFFGLPGLLCTISLQSGSMVSKQPIEIYGPVGLRDFIWRTMELSHTELVFHYVVHELVPTADQCPAEELKEFAHVNRADSPPKEEQGRTILLDSEENSYLLFDDEQFVVKAFRLFHRIPSFGFSVVEKKRPGKLNAQKLKDLGVPPGPAYGKLKNGISVVLENGVTISPQDVLKKPIVGRKICILGDCSGVVGDGGVKLCFEADLLIHEATLDDAQMDKAKEHGHSTPQMAATFAKLCRAKRLVLTHFSQRYKPVALAREGETDGIAELKKQAESVLDLQEVTLAEDFMVISIPIKKAENLYFQ","Homo sapiens","ELAC1, D29","ZINC PHOSPHODIESTERASE ELAC PROTEIN 1","1","3ZWF"
"3ZWS",,"X-RAY DIFFRACTION",3.67,66.47,,,"0.1 M SODIUM ACETATE (PH 4.8), 2.4-2.6 M AMMONIUM SULPHATE, 40 MM C11DAO, 20 MM DDAO.",,"10.1021/jm300157n","AVQ","3ZWS",41.16,"1.6","1.6","Structure of Human Dihydroorotate Dehydrogenase with a Bound Inhibitor","MATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","DIHYDROOROTATE DEHYDROGENASE (QUINONE), MITOCHONDRIAL","1","3ZWS"
"3ZWT",,"X-RAY DIFFRACTION",3.69,66.63,,,"0.1 M SODIUM ACETATE (PH 4.8), 2.4-2.6 M AMMONIUM SULPHATE, 40 MM C11DAO, 20 MM DDAO.",,"10.1021/jm300157n","KFZ","3ZWT",41.17,"1.55","1.55","Structure of Human Dihydroorotate Dehydrogenase with a Bound Inhibitor","MATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR","Homo sapiens","DHODH","DIHYDROOROTATE DEHYDROGENASE (QUINONE), MITOCHONDRIAL","1","3ZWT"
"3ZXE",,"X-RAY DIFFRACTION",2.2,44,,8.5,"0.1M BISTRISPROPANE, 20% PEG3350, pH 8.5",,"10.1111/j.1742-4658.2011.08414.x","PGZ","3ZXE",30.52,"1.67","1.67","Crystal structure of Human Galectin-7 in complex with a galactose- benzylphosphate inhibitor","VPHKSSLPEGIRPGTVLRIRGLVPPNASRFHVNLLCGEEQGSDAALHFNPRLDTSEVVFNSKEQGSWGREERGPGVPFQRGQPFEVLIIASDDGFKAVVGDAQYHHFRHRLPLARVRLVEVGGDVQLDSVRIF","Homo sapiens","LGALS7, PIG1, LGALS7B","GALECTIN-7","1","3ZXE"
"3ZXF",,"X-RAY DIFFRACTION",2.2,43,,8.1,"50MM SODIUM PHOSPHATE, 300 MM NACL, 15% PEG3350, 20MM IMIDAZOLE, pH 8.1",,"10.1111/j.1742-4658.2011.08414.x",,"3ZXF",30.62,"1.38","1.38","High resolution structure of Human Galectin-7","PAMSNVPHKSSLPEGIRPGTVLRIRGLVPPNASRFHVNLLCGEEQGSDAALHFNPRLDTSEVVFNSKEQGSWGREERGPGVPFQRGQPFEVLIIASDDGFKAVVGDAQYHHFRHRLPLARVRLVEVGGDVQLDSVRIF","Homo sapiens","LGALS7, PIG1, LGALS7B","GALECTIN-7","1","3ZXF"
"3ZXH",,"X-RAY DIFFRACTION",1.83,32.43,,8.2,"15% PEG 6K, 0.1M TRIS PH 8.2, 0.9 M HCOONA, 4 DEG. CELSIUS.",277,"10.1016/j.bmcl.2011.08.087","E41","3ZXH",40.26,"1.3","1.3","MMP-13 complexed with 2-Napthylsulfonamide hydroxamic acid inhibitor","YNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYGPGDEDPN","Homo sapiens","MMP13","COLLAGENASE 3","1","3ZXH"
"3ZXI",,"X-RAY DIFFRACTION",2.1,41,"VAPOR DIFFUSION, SITTING DROP",,"THE PROTEIN (20 MG/ML STOCK SOLUTION) WAS CRYSTALLIZED AT 293K BY VAPOR DIFFUSION (SITTING DROP) WITH A RESERVOIR SOLUTION CONTAINING 30% (M/V) PEG-4000, 0.1 M NA ACETATE PH 4.6, 0.2 M NH4 ACETATE, 0.1 M TRIS-HCL PH 7.5, 1.2 M NA MALONATE.",293,,,"3ZXI",80.92,"2.75","2.75","Crystal structure of human mitochondrial tyrosyl-tRNA synthetase in complex with a tyrosyl-adenylate analog","MRGSHSGAQGLLAAQKARGLFKDFFPETGTKIELPELFDRGTASFPQTIYCGFDPTADSLHVGHLLALLGLFHLQRAGHNVIALVGGATARLGDPSGRTKEREALETERVRANARALRLGLEALAANHQQLFTDGRSWGSFTVLDNSAWYQKQHLVDFLAAVGGHFRMGTLLSRQSVQLRLKSPEGMSLAEFFYQVLQAYDFYYLFQRYGCRVQLGGSDQLGNIMSGYEFINKLTGEDVFGITVPLITSTTGAKLGKSAGNAVWLNRDKTSPFELYQFFVRQPDDSVERYLKLFTFLPLPEIDHIMQLHVKEPERRGPQKRLAAEVTKLVHGREGLDSAKRCTQALYHRSHHHHHH","Homo sapiens","YARS2, CGI-04","TYROSYL-TRNA SYNTHETASE, MITOCHONDRIAL","1","3ZXI"
"3ZXP",,"X-RAY DIFFRACTION",2.9,38.3,,6.6,"22% PEG 1500, 0.1M MMT 6.6",,"10.1371/journal.pone.0027466",,"3ZXP",138.22,"2.495","2.495","Structural and Functional Analyses of the Bro1 Domain Protein BROX","GIDPFTMTHWFHRNPLKATAPVSFNYYGVVTGPSASKICNDLRSSRARLLELFTDLSCNPEMMKNAADSYFSLLQGFINSLDESTQESKLRYIQNFKWTDTLQGQVPSAQQDAVFELISMGFNVALWYTKYASRLAGKENITEDEAKEVHRSLKIAAGIFKHLKESHLPKLITPAEKGRDLESRLIEAYVIQCQAEAQEVTIARAIELKHAPGLIAALAYETANFYQKADHTLSSLEPAYSAKWRKYLHLKMCFYTAYAYCYHGETLLASDKCGEAIRSLQEAEKLYAKAEALCKEYGETKGPGPTVKPSGHLFFRKLGNLVKNTLEKCQRENGFIYFQKIPTEAPQLELKANYGLVEPIPFEFPPTSVQWTPETLAAFDLTKRPKDDSTKPKPEEEVKPVKEPDIK","Homo sapiens","BROX, BROFTI, C1orf58","BRO1 DOMAIN-CONTAINING PROTEIN BROX","1","3ZXP"
"3ZXT",,"X-RAY DIFFRACTION",2.95,58.39,,,"0.1 M HEPES PH7.0, 0.1M MGCL2, 15% PEG4000",,,,"3ZXT",133.07,"2.65","2.65","Dimeric structure of DAPK-1 catalytic domain in complex with AMPPCP- Mg","MTVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS","Homo sapiens","DAPK1, DAPK","DEATH-ASSOCIATED PROTEIN KINASE 1","1","3ZXT"
"3ZXZ",,"X-RAY DIFFRACTION",2.39,48.59,"VAPOR DIFFUSION, HANGING DROP",4.6,"CRYSTALS WERE OBTAINED AT 13 DEGREES C BY THE HANGING DROP VAPOR DIFFUSION METHOD USING 1.2 MICROLITERS OF PROTEIN SOLUTION (CONTAINING 7-13 MG/ML C-MET KD PLUS A 5 FOLD MOLAR EXCESS OF PF-04217903) AND 1.2 MICROLITERS OF MOTHER LIQUOR SOLUTION (0.05 M CITRATE-PHOSHPHATE 4.6, 0-0.275 M NACL, AND 21% W/V PEG 3350).",286,"10.1021/jm300967g","KRW","3ZXZ",35.25,"1.8","1.8","X-ray Structure of PF-04217903 bound to the kinase domain of c-Met","MVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHHHHHHHH","Homo sapiens","MET","HEPATOCYTE GROWTH FACTOR RECEPTOR","1","3ZXZ"
"3ZY0",,"X-RAY DIFFRACTION",1.9,36,"VAPOR DIFFUSION, SITTING DROP",,"SITTING DROP VAPOR DIFFUSION AT 17 DEGREE C. PROTEIN SOLUTION: 12-15 MG/ML IN 20 MM TRIS PH 8.5, 50 MM NACL CRYSTALLIZATION BUFFER: 30% PEG 400, 0.1 M HEPES PH 7.5, 0.2 M MG CHLORIDE.",290,"10.1016/j.jmb.2011.11.007",,"3ZY0",15.72,"1.9","1.9","Crystal structure of a truncated variant of the human p63 tetramerization domain lacking the C-terminal helix","GSDELLYLPVRGRETYEMLLKIKESLELMQYL","Homo sapiens","TP63, KET, P63, P73H, P73L, TP73L","TUMOR PROTEIN P63","1","3ZY0"
"3ZY1",,"X-RAY DIFFRACTION",3,59,"VAPOR DIFFUSION, SITTING DROP",,"SITTING DROP VAPOR DIFFUSION AT 17 DEGREE C. PROTEIN SOLUTION: 12-15 MG/ML IN 20 MM TRIS PH 8.5, 50 MM NACL CRYSTALLIZATION BUFFER: 10% PEG 8000, 0.1 M HEPES PH 7.5, AND 0.2 M CA ACETATE",290,"10.1016/j.jmb.2011.11.007",,"3ZY1",5.6,"2.15","2.15","Crystal structure of the human p63 tetramerization domain","GSDELLYLPVRGRETYEMLLKIKESLELMQYLPQHTIETYRQQQQQ","Homo sapiens","TP63, KET, P63, P73H, P73L, TP73L","TUMOR PROTEIN 63","1","3ZY1"
"3ZYA",,"X-RAY DIFFRACTION",2.45,49.7,,,"100 MM HEPES (PH 7.4), 20 % PEG 8000, 1 MM MGCL2",,"10.1038/nchembio.761","2A8","3ZYA",42.31,"1.9","1.9","Human p38 MAP Kinase in Complex with 2-amino-phenylamino- dibenzosuberone","GSHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","MITOGEN-ACTIVATED PROTEIN KINASE 14","1","3ZYA"
"3ZYC",,"X-RAY DIFFRACTION",2.19,43.71,"VAPOR DIFFUSION, SITTING DROP",7,"GGGMPPCP WAS CRYSTALLIZED BY SITTING DROP VAPOR DIFFUSION IN 0.1M HEPES PH 7.0, 200 MM MGCL2, AND 24-30% PEG 2000 MME USING A DROP SIZE OF 3 MICROL AND RESERVOIR VOLUME OF 65 MICROL. CRYSTALS GREW IN 3-5 DAYS AT 20C. THE ADDITION OF 200 MM LICL, NACL, KCL, OR NH4CL TO THE RESERVOIR SOLUTION DRAMATICALLY IMPROVED THE CRYSTALS. CRYSTALS GROWN IN THE PRESENCE OF KCL SHOWED THE BEST DIFFRACTION.",293,"10.1016/j.cell.2011.09.003",,"3ZYC",79.87,"2.2","2.2","DYNAMIN 1 GTPASE GED FUSION DIMER COMPLEXED WITH GMPPCP","GPEFSMEDLIPLVNRLQDAFSAIGQNADLDLPQIAVVGGQSAGKSSVLENFVGRDFLPRGSGIVTRRPLVLQLVNATTEYAEFLHCKGKKFTDFEEVRLEIEAETDRVTGTNKGISPVPINLRVYSPHVLNLTLVDLPGMTKVPVGDQPPDIEFQIRDMLMQFVTKENCLILAVSPANSDLANSDALKVAKEVDPQGQRTIGVITKLDLMDEGTDARDVLENKLLPLRRGYIGVVNRSQKDIDGKKDITAALAAERKFFLSHPSYRHLADRMGTPYLQKVLNQQLTNHIRDTLPGLRNKLQSQLLSIEKEVEEYKNFRPDKHGTDSRVDEMLRMYHALKEALSIIGNINTTTV","Homo sapiens","DNM1, DNM","DYNAMIN-1","1","3ZYC"
"3ZYG",,"X-RAY DIFFRACTION",2.6,52.69,,,"20% MME550, 0.1M NACL, 0.1M BICINE PH9",,"10.1038/emboj.2011.346",,"3ZYG",82.34,"2.2","2.2","NETRING2 LAM AND EGF1 DOMAINS","MLHLLALFLHCLPLASGDYDICKSWVTTDEGPTWEFYACQPKVMRLKDYVKVKVEPSGITCGDPPERFCSHENPYLCSNECDASNPDLAHPPRLMFDKEEEGLATYWQSITWSRYPSPLEANITLSWNKTVELTDDVVMTFEYGRPTVMVLEKSLDNGRTWQPYQFYAEDCMEAFGMSARRARDMSSSSAHRVLCTEEYSRWAGSKKEKHVRFEVRDRFAIFAGPDLRNMDNLYTRLESAKGLKEFFTLTDLRMRLLRPALGGTYVQRENLYKYFYAISNIEVIGRCKCNLHANLCSMREGSLQCECEHNTTGPDCGKCKKNFRTRSWRAGSYLPLPHGSPNACAGTHHHHHH","Homo sapiens","NTNG2, KIAA1857, LMNT2, UNQ9381/PRO34206","NETRIN-G2","1","3ZYG"
"3ZYQ",,"X-RAY DIFFRACTION",2.15,42.81,,,,,,,"3ZYQ",26.4,"1.48","1.48","Crystal structure of the tandem VHS and FYVE domains of Hepatocyte growth factor-regulated tyrosine kinase substrate (HGS-Hrs) at 1.48 A resolution","SMGRGSGTFERLLDKATSQLLLETDWESILQICDLIRQGDTQAKYAVNSIKKKVNDKNPHVALYALEVMESVVKNCGQTVHDEVANKQTMEELKDLLKRQVEVNVRNKILYLIQAWAHAFRNEPKYKVVQDTYQIMKVEGHVFPEFKESDAMFAAERAPDWVDAEECHRCRVQFGVMTRKHHCRACGQIFCGKCSSKYSTIPKFGIEKEVRVCEPCYEQLNRKAEG","Homo sapiens","HGS, HRS","HEPATOCYTE GROWTH FACTOR-REGULATED TYROSINE KINASE SUBSTRATE","1","3ZYQ"
"3ZYU",,"X-RAY DIFFRACTION",2.25,45.45,,,,,"10.1038/nature10509","1GH","3ZYU",31.46,"1.5","1.5","Crystal Structure of the first bromodomain of human BRD4 in complex with I-BET151(GSK1210151A)","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","BROMODOMAIN-CONTAINING PROTEIN 4","1","3ZYU"
"3ZYW",,"X-RAY DIFFRACTION",2.69,54.22,,,"0.1M BIS-TRIS PH 5.5, 25% PEG3350",,,,"3ZYW",25.8,"1.84","1.84","Crystal structure of the first glutaredoxin domain of human glutaredoxin 3 (GLRX3)","MKEDLNLRLKKLTHAAPCMLFMKGTPQEPRCGFSKQMVEILHKHNIQFSSFDIFSDEEVRQGLKAYSSWPTYPQLYVSGELIGGLDIIKELEASEELDTICPKAAENLYFQ","Homo sapiens","GLRX3, PICOT, TXNL2, HUSSY-22","GLUTAREDOXIN-3","1","3ZYW"
"3ZYX",,"X-RAY DIFFRACTION",2.74,52,,6.5,"12% PEG4000, 100 MM ADA PH 6.5, 70 MM LITHIUM SULPHATE, 8.5 MM ZWITTERGENT 3-12",,"10.1111/j.1742-4658.2011.08386.x","MBT","3ZYX",119.28,"2.2","2.2","Crystal structure of human monoamine oxidase B in complex with methylene blue and bearing the double mutation I199A-Y326A","SNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIASTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAATLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","AMINE OXIDASE [FLAVIN-CONTAINING] B","1","3ZYX"
"3ZZE",,"X-RAY DIFFRACTION",2.38,48.31,"VAPOR DIFFUSION, HANGING DROP",4.6,"CRYSTALS WERE OBTAINED AT 13 DEGREES C BY THE HANGING DROP VAPOR DIFFUSION METHOD USING 1.2 MICROLITERS OF PROTEIN SOLUTION (CONTAINING 7-13 MG/ML C-MET KD PLUS A 5 FOLD MOLAR EXCESS OF THE C-MET INHIBITOR COMPOUND) AND 1.2 MICROLITERS OF MOTHER LIQUOR SOLUTION (0.05 M CITRATE-PHOSHPHATE 4.6, 0-0.275 M NACL, AND 21% W/V PEG 3350).",286,"10.1021/jm300967g","6XP","3ZZE",35.24,"1.87","1.87","Crystal structure of C-MET kinase domain in complex with N'-((3Z)-4- chloro-7-methyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-2-(4- hydroxyphenyl)propanohydrazide","MVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHHHHHHHH","Homo sapiens","MET","HEPATOCYTE GROWTH FACTOR RECEPTOR","1","3ZZE"
"3ZZW",,"X-RAY DIFFRACTION",1.97,40.7,,7.5,"0.2M AMMONIUM ACETATE, 2.2M AMMONIUM SULFATE, pH 7.5",,,,"3ZZW",66.56,"2.9","2.9","Crystal structure of the kinase domain of ROR2","GKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN","Homo sapiens","ROR2, NTRKR2","TYROSINE-PROTEIN KINASE TRANSMEMBRANE RECEPTOR ROR2","1","3ZZW"
"41BI",,"X-RAY DIFFRACTION",3.35,63.33,,,,,,,"41BI",17.36,"2.9","2.9","INTERLEUKIN-1 BETA (IL-1 BETA) (MUTANT WITH CYS 8 REPLACED BY ALA (C8A)","APVRSLNATLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","INTERLEUKIN-1 BETA","1","41BI"
"421P",,"X-RAY DIFFRACTION",2.01,38.91,,,,,"10.1016/0092-8674(90)90018-a",,"421P",19.52,"2.2","2.2","THREE-DIMENSIONAL STRUCTURES OF H-RAS P21 MUTANTS: MOLECULAR BASIS FOR THEIR INABILITY TO FUNCTION AS SIGNAL SWITCH MOLECULES","MTEYKLVVVGARGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","H-RAS P21 PROTEIN","1","421P"
"456C",,"X-RAY DIFFRACTION",2.25,45.37,,8,"pH 8.0",,"10.1038/6657","CBP","456C",39.01,"2.4","2.4","CRYSTAL STRUCTURE OF COLLAGENASE-3 (MMP-13) COMPLEXED TO A DIPHENYL-ETHER SULPHONE BASED HYDROXAMIC ACID","YNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYGPGDE","Homo sapiens","MMP13","MMP-13","1","456C"
"4A06",,"X-RAY DIFFRACTION",2.3,47,,7.5,"1.2 M NA CITRATE, 0.1 M HEPES PH 7.5, 10 MM DTT.",,"10.1016/j.chembiol.2011.08.010",,"4A06",36.61,"2","2","Human PDK1 Kinase Domain in Complex with Allosteric Activator PS114 Bound to the PIF-Pocket","GAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDPK1, PDK1","3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1","1","4A06"
"4A07",,"X-RAY DIFFRACTION",2.3,47,,7.5,"1.2 M NA CITRATE 0.1 M HEPES PH 7.5 10 M DTT.",,"10.1016/j.chembiol.2011.08.010",,"4A07",36.9,"1.85","1.85","Human PDK1 Kinase Domain in Complex with Allosteric Activator PS171 Bound to the PIF-Pocket","GAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDPK1, PDK1","3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1","1","4A07"
"4A0D",,"X-RAY DIFFRACTION",2.49,50.54,,,"25% PEG 3350, 36.4MM PCTP 4, 63.6MM PCTP 10, 0.2M MG(SO4)2",,"10.1371/journal.pone.0050889",,"4A0D",61.73,"1.75","1.75","Structure of unliganded human PARG catalytic domain","GSSPDKKWLGTPIEEMRRMPRCGIRLPLLRPSANHTVTIRVDLLRAGEVPKPFPTHYKDLWDNKHVKMPCSEQNLYPVEDENGERTAGSRWELIQTALLNKFTRPQNLKDAILKYNVAYSKKWDFTALIDFWDKVLEEAEAQHLYQSILPDMVKIALCLPNICTQPIPLLAAAMNHSITMSQEQIASLLANAFFCTFPRRNAKMKSEYSSYPDINFNRLFEGRSSRKPEKLKTLFCYFRRVTAAAPTGLVTFTRQSLEDFPEWERCEKPLTRLHVTYEGTIEENGQGMLQVDFANRFVGGGVTSAGLVQEEIRFLINPELIISRLFTEVLDHNECLIITGTEQYSEYTGYAETYRWSRSHEDGSERDDWQRRCTEIVAIDALHFRRYLDQFVPEKMRRELNKAYCGFLRPGVSSENLSAVATGNWGCGAFGGDARLKALIQILAAAAAERDVVYFTFGDSELMRDIYSMHIFLTERKLTVGDVYKLLLRYYNEECRNCSTPGPDIKLYPFIYHAVESCAETADHSGQRTGT","Homo sapiens","PARG","POLY(ADP-RIBOSE) GLYCOHYDROLASE","1","4A0D"
"4A0P",,"X-RAY DIFFRACTION",3.03,59.37,,,,,"10.1016/j.devcel.2011.09.007",,"4A0P",72.81,"1.9","1.9","Crystal structure of LRP6P3E3P4E4","ETGVPEAFLLFSRRADIRRISLETNNNNVAIPLTGVKEASALDFDVTDNRIYWTDISLKTISRAFMNGSALEHVVEFGLDYPEGMAVDWLGKNLYWADTGTNRIEVSKLDGQHRQVLVWKDLDSPRALALDPAEGFMYWTEWGGKPKIDRAAMDGSERTTLVPNVGRANGLTIDYAKRRLYWTDLDTNLIESSNMLGLNREVIADDLPHPFGLTQYQDYIYWTDWSRRSIERANKTSGQNRTIIQGHLDYVMDILVFHSSRQSGWNECASSNGHCSHLCLAVPVGGFVCGCPAHYSLNADNRTCSAPTTFLLFSQKSAINRMVIDEQQSPDIILPIHSLRNVRAIDYDPLDKQLYWIDSRQNMIRKAQEDGSQGFTVVVSSVPSQNLEIQPYDLSIDIYSRYIYWTCEATNVINVTRLDGRSVGVVLKGEQDRPRAVVVNPEKGYMYFTNLQERSPKIERAALDGTEREVLFFSGLSKPIALALDSRLGKLFWADSDLRRIESSDLSGANRIVLEDSNILQPVGLTVFENWLYWIDKQQQMIEKIDMTGREGRTKVQARIAQLSDIHAVKELNLQEYRQHPCAQDNGGCSHICLVKGDGTTRCSCPMHLVLLQDELSCGGTKHHHHHH","Homo sapiens","LRP6","LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 6","1","4A0P"
"4A0Q",,"X-RAY DIFFRACTION",2.26,45.5,,,"PROTEIN WAS CRYSTALLIZED FROM 1.6 M TRI-SODIUM CITRATE.",,"10.1074/jbc.M111.261909",,"4A0Q",44.78,"1.9","1.9","Activated Conformation of Integrin alpha1 I-Domain mutant","ESSTQLDIVIVLDGSNSIYPWDSVTAFLNDLLERMDIGPKQTQVGIVQYGENVTHEFNLNKYSSTEEVLVAAKKIVQRGGRQTMTALGTDTARKEAFTEARGARRGVKKVMVIVTDGESHDNHRLKKVIQDCEDENIQRFSIAILGSYNRGNLSTEKFVEEIKSIASEPTEKHFFNVSDALALVTIVKTLGERIFALEATA","Homo sapiens","ITGA1","INTEGRIN ALPHA-1","1","4A0Q"
"4A14",,"X-RAY DIFFRACTION",2.33,47.34,,,"20% POLYETHYLENE GLYCOL 3350, 0.20 M LITHIUM ACETATE.",,"10.1107/S0907444911053042",,"4A14",37.9,"1.6","1.6","HUMAN KIF7, A KINESIN INVOLVED IN HEDGEHOG SIGNALLING","GAMGLPGAEEAPVRVALRVRPLLPKELLHGHQSCLQVEPGLGRVTLGRDRHFGFHVVLAEDAGQEAVYQACVQPLLEAFFEGFNATVFAYGQTGSGKTYTMGEASVASLLEDEQGIVPRAMAEAFKLIDENDLLDCLVHVSYLEVYKEEFRDLLEVGTASRDIQLREDERGNVVLCGVKEVDVEGLDEVLSLLEMGNAARHTGATHLNHLSSRSHTVFTVTLEQRGRAPSRLPRPAPGQLLVSKFHFVDLAGSERVLKTGSTGERLKESIQINSSLLALGNVISALGDPQRRGSHIPYRDSKITRILKDSLGGNAKTVMIACVSPSSSDFDETLNTLNYASRAQ","Homo sapiens","KIF7, UNQ340/PRO539","KINESIN-LIKE PROTEIN KIF7","1","4A14"
"4A1H",,"X-RAY DIFFRACTION",2.75,55.31,,4.5,"pH 4.5",,,,"4A1H",45.82,"2.201","2.201","Human myelin P2 protein, K45S mutant","GMSNKFLGTWKLVSSENFDDYMKALGVGLATRKLGNLAKPTVIISKSGDIITIRTESTFKNTEISFKLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGKMVAECKMKGVVCTRIYEKV","Homo sapiens","PMP2","MYELIN P2 PROTEIN","1","4A1H"
"4A1N",,"X-RAY DIFFRACTION",3.39,63.76,,,,,,,"4A1N",38.1,"2.8","2.8","Human Mitochondrial endo-exonuclease","MQGAEGALTGKQPDGSAEKAVLEQFGFPLTGTEARCYTNHALSYDQAKRVPRWVLEHISKSKIMGDADRKHCKFKPDPNIPPTFSAFNEDYVGSGWSRGHMAPAGNNKFSSKAMAETFYLSNIVPQDFDNNSGYWNRIEMYCRELTERFEDVWVVSGPLTLPQTRGDGKKIVSYQVIGEDNVAVPSHLYKVILARRSSVSTEPLALGAFVVPNEAIGFQPQLTEFQVSLQDLEKLSGLVFFPHLDRTSDIRNICSVDTCKLLDFQEFTLYLSTRKIEGARSVLRLEKIMVNLKNAEIEPDDYFMSRYEKKLEELKAKEQSGTQIRKPSAHHHHHH","Homo sapiens","EXOG, ENDOGL1, ENDOGL2, ENGL","NUCLEASE EXOG, MITOCHONDRIAL","1","4A1N"
"4A1Y",,"X-RAY DIFFRACTION",2.24,45.07,,,,,,,"4A1Y",61.09,"1.2","1.2","Human myelin P2 protein, K65Q mutant","GMSNKFLGTWKLVSSENFDDYMKALGVGLATRKLGNLAKPTVIISKKGDIITIRTESTFKNTEISFQLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGKMVAECKMKGVVCTRIYEKV","Homo sapiens","PMP2","MYELIN P2 PROTEIN","1","4A1Y"
"4A1Z",,"X-RAY DIFFRACTION",2.29,42.35,,6.8,"14% PEG 3350 0.2 M NA NO3 0.1 M MES (PH 5.6).",,"10.1021/jm4006274",,"4A1Z",83.11,"2.8","2.8","Eg5-1","MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEVPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","KINESIN-LIKE PROTEIN KIF11","1","4A1Z"
"4A24",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0054715",,"4A24",5.41,,,"Structural and functional analysis of the DEAF-1 and BS69 MYND domains","GAMEQSCVNCGREAMSECTGCHKVNYCSTFCQRKDWKDHQHICGQSA","Homo sapiens","DEAF1, SPN, ZMYND5","DEFORMED EPIDERMAL AUTOREGULATORY FACTOR 1 HOMOLOG","1","4A24"
"4A27",,"X-RAY DIFFRACTION",2.26,45.6,,,"0.20 M NABR, 0.1 M BISTRISPROPANE PH 6.5, 20.0% PEG 3350, 10.0% ETHYLENE GLYCOL.",,,,"4A27",77.35,"2.1","2.1","Crystal structure of human synaptic vesicle membrane protein VAT-1 homolog-like protein","SMEMRAVVLAGFGGLNKLRLFRKAMPEPQDGELKIRVKACGLNFIDLMVRQGNIDNPPKTPLVPGFECSGIVEALGDSVKGYEIGDRVMAFVNYNAWAEVVCTPVEFVYKIPDDMSFSEAAAFPMNFVTAYVMLFEVANLREGMSVLVHSAGGGVGQAVAQLCSTVPNVTVFGTASTFKHEAIKDSVTHLFDRNADYVQEVKRISAEGVDIVLDCLCGDNTGKGLSLLKPLGTYILYGSSNMVTGETKSFFSFAKSWWQVEKVNPIKLYEENKVIAGFSLLNLLFKQGRAGLIRGVVEKLIGLYNQKKIKPVVDSLWALEEVKEAMQRIHDRGNIGKLILDVEKTPTPL","Homo sapiens","VAT1L, KIAA1576","SYNAPTIC VESICLE MEMBRANE PROTEIN VAT-1 HOMOLOG-LIKE","1","4A27"
"4A28",,"X-RAY DIFFRACTION",2.34,47.48,,5.5,"pH 5.5",,"10.1021/jm4006274",,"4A28",83.1,"2.55","2.55","Eg5-2","MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLDGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","KINESIN-LIKE PROTEIN KIF11","1","4A28"
"4A2J",,"X-RAY DIFFRACTION",2.2,44.17,,6.5,"20-30% POLYETHYLENE GLYCOL 3350, 0.1 M HEPES PH 6.5, 100 MM MG2SO4, 10% GLYCEROL.",,"10.1074/jbc.M111.308403",,"4A2J",60.93,"2","2","PR X-Ray structures in agonist conformations reveal two different mechanisms for partial agonism in 11beta-substituted steroids","GSHMGQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK","Homo sapiens","PGR, NR3C3","PROGESTERONE RECEPTOR","1","4A2J"
"4A2O",,"X-RAY DIFFRACTION",1.63,24.17,,8.5,"pH 8.5",,"10.1016/j.jsb.2012.04.023",,"4A2O",32.54,"1.69","1.69","STRUCTURE OF THE HUMAN EOSINOPHIL CATIONIC PROTEIN IN COMPLEX WITH SULFATE ANIONS","RPPQFTRAQWFAIQHISLNPPRCTIAMRAINNYRWRCKNQNTFLRTTFANVVNVCGNQSIRCPHNRTLNNCHRSRFRVPLLHCDLINPGAQNISNCRYADRPGRRFYVVACDNRDPRDSPRYPVVPVHLDTTI","Homo sapiens","RNASE3, ECP, RNS3","EOSINOPHIL CATIONIC PROTEIN","1","4A2O"
"4A2Y",,"X-RAY DIFFRACTION",2.72,47.4,,5.2,"0.1 M NA CITRATE, PH 5.2, 6% JEFFAMINE M-600, 10 MM KH2PO4/K2HPO4, PH 7, 10 MM FECL3.",,"10.1016/j.jsb.2012.04.023",,"4A2Y",32.28,"1.7","1.7","STRUCTURE OF THE HUMAN EOSINOPHIL CATIONIC PROTEIN IN COMPLEX WITH CITRATE ANIONS","RPPQFTRAQWFAIQHISLNPPRCTIAMRAINNYRWRCKNQNTFLRTTFANVVNVCGNQSIRCPHNRTLNNCHRSRFRVPLLHCDLINPGAQNISNCRYADRPGRRFYVVACDNRDPRDSPRYPVVPVHLDTTI","Homo sapiens","RNASE3, ECP, RNS3","EOSINOPHIL CATIONIC PROTEIN","1","4A2Y"
"4A35",,"X-RAY DIFFRACTION",3.32,62.97,,,"25% PEG 3350, 0.1 M BIS-TRIS 5.5",,"10.1021/bi500349e",,"4A35",50.05,"1.74","1.74","Crystal structure of human Mitochondrial enolase superfamily member 1 (ENOSF1)","SMVRGRISRLSVRDVRFPTSLGGHGADAMHTDPDYSAAYVVIETDAEDGIKGCGITFTLGKGTEVVVCAVNALAHHVLNKDLKDIVGDFRGFYRQLTSDGQLRWIGPEKGVVHLATAAVLNAVWDLWAKQEGKPVWKLLVDMDPRMLVSCIDFRYITDVLTEEDALEILQKGQIGKKEREKQMLAQGYPAYTTSCAWLGYSDDTLKQLCAQALKDGWTRFKVKVGADLQDDMRRCQIIRDMIGPEKTLMMDANQRWDVPEAVEWMSKLAKFKPLWIEEPTSPDDILGHATISKALVPLGIGIATGEQCHNRVIFKQLLQAKALQFLQIDSCRLGSVNENLSVLLMAKKFEIPVCPHAGGVGLCELVQHLIIFDYISVSASLENRVCEYVDHLHEHFKYPVMIQRASYMPPKDPGYSTEMKEESVKKHQYPDGEVWKKLLPA","Homo sapiens","ENOSF1, RTS, TYMSAS","MITOCHONDRIAL ENOLASE SUPERFAMILY MEMBER 1","1","4A35"
"4A3N",,"X-RAY DIFFRACTION",3.25,62.19,,,,,,,"4A3N",8.64,"2.4","2.4","Crystal Structure of HMG-BOX of Human SOX17","GSIRRPMNAFMVWAKDERKRLAQQNPDLHNAELSKMLGKSWKALTLAEKRPFVEEAERLRVQHMQDHPNYK","Homo sapiens","SOX17","TRANSCRIPTION FACTOR SOX-17","1","4A3N"
"4A3O",,"X-RAY DIFFRACTION",4.1,70,,7,"1.9 M (NH4)2SO4, 100 MM HEPES PH 7.0, 200 MM KI",,"10.1016/j.febslet.2011.09.040",,"4A3O",51.21,"2.2","2.2","Crystal structure of the USP15 DUSP-UBL monomer","GAAADLDTQRSDIATLLKTSLRKGDTWYLVDSRWFKQWKKYVGFDSWDKYQMGDQNVYPGPIDNSGLLKDGDAQSLKEHLIDELDYILLPTEGWNKLVSWYTLMEGQEPIARKVVEQGMFVKHCKVEVYLTELKLCENGNMNNVVTRRFSKADTIDTIEKEIRKIFSIPDEKETRLWNKYMSNTFEPLNKPDSTIQDAGLYQGQVLVIEQKNEDGTWPRG","Homo sapiens","USP15, KIAA0529","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 15","1","4A3O"
"4A3P",,"X-RAY DIFFRACTION",2.19,43.7,,7,"1.9 M (NH4)2SO4, 100 MM HEPES PH 7.0, 200 MM KI.",,"10.1016/j.febslet.2011.09.040",,"4A3P",25.33,"1.4","1.4","Structure of USP15 DUSP-UBL deletion mutant","GAAADLDTQRSDIATLLKTSLRKGDTWYLVDSRWFKQWKKYVGFDSWDKYQMGDQNVYPGPIDNSGLLKDGDAQSLKEHLIDELDYILLPTEGWNKLVSWYTLMEGQEPIARKVVEQGMFCKVEVYLTELKLCENGNMNNVVTRRFSKADTIDTIEKEIRKIFSIPDEKETRLWNKYMSNTFEPLNKPDSTIQDAGLYQGQVLVIEQKNEDGTWPRG","Homo sapiens","USP15, KIAA0529","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 15","1","4A3P"
"4A4D",,"X-RAY DIFFRACTION",2.33,47.31,,6.5,"2% (V/V) TACSIMATE PH 4.0, 0.1 M BIS-TRIS PH 6.5, AND 20% (W/V) POLYETHYLENE GLYCOL 3350",,"10.1042/BJ20120001",,"4A4D",28.7,"2.7","2.7","Crystal structure of the N-terminal domain of the Human DEAD-BOX RNA helicase DDX5 (P68)","PKFEKNFYQEHPDLARRTAQEVETYRRSKEITVRGHNCPKPVLNFYEANFPANVMDVIARQNFTEPTAIQAQGWPVALSGLDMVGVAQTGSGKTLSYLLPAIVHINHQPFLERGDGPICLVLAPTRELAQQVQQVAAEYCRACRLKSTCIYGGAPKGPQIRDLERGVEICIATPGRLIDFLECGKTNLRRTTYLVLDEADRMLDMGFEPQIRKIVDQIRPDRQTLMWSATWPKEVRQLAEDFLKDYIHINIGA","Homo sapiens","DDX5, G17P1, HELR, HLR1","PROBABLE ATP-DEPENDENT RNA HELICASE DDX5","1","4A4D"
"4A4E",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.2185","2MR","4A4E",7.3,,,"Solution structure of SMN Tudor domain in complex with symmetrically dimethylated arginine","NTAASLQQWKVGDKCSAIWSEDGCIYPATIASIDFKRETCVVVYTGYGNREEQNLSDLLSPICE","Homo sapiens","SMN1, SMN, SMNT, SMN2, SMNC","SURVIVAL MOTOR NEURON PROTEIN","1","4A4E"
"4A4F",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.2185","2MR","4A4F",7.14,,,"Solution structure of SPF30 Tudor domain in complex with symmetrically dimethylated arginine","ASTQPTHSWKVGDKCMAVWSEDGQCYEAEIEEIDEENGTAAITFAGYGNAEVTPLLNLKPVEEG","Homo sapiens","SMNDC1, SMNR, SPF30","SURVIVAL OF MOTOR NEURON-RELATED-SPLICING FACTOR 30","1","4A4F"
"4A4G",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.2185","DA2","4A4G",7.3,,,"Solution structure of SMN Tudor domain in complex with asymmetrically dimethylated arginine","NTAASLQQWKVGDKCSAIWSEDGCIYPATIASIDFKRETCVVVYTGYGNREEQNLSDLLSPICE","Homo sapiens","SMN1, SMN, SMNT, SMN2, SMNC","SURVIVAL MOTOR NEURON PROTEIN","1","4A4G"
"4A4H",,"SOLUTION NMR",,,,,,,"10.1038/nsmb.2185","DA2","4A4H",7.14,,,"Solution structure of SPF30 Tudor domain in complex with asymmetrically dimethylated arginine","ASTQPTHSWKVGDKCMAVWSEDGQCYEAEIEEIDEENGTAAITFAGYGNAEVTPLLNLKPVEEG","Homo sapiens","SMNDC1, SMNR, SPF30","SURVIVAL OF MOTOR NEURON-RELATED-SPLICING FACTOR 30","1","4A4H"
"4A4I",,"X-RAY DIFFRACTION",2.88,57.3,,6.5,"2 M AMMONIUM SULFATE, 0.2 M NACL, 0.1 M MES PH 6.5",,"10.1093/nar/gks355",,"4A4I",19.95,"1.95","1.95","Crystal structure of the human Lin28b cold shock domain","GSESQVLRGTGHCKWFNVRMGFGFISMINREGSPLDIPVDVFVHQSKLFMEGFRSLKEGEPVEFTFKKSSKGLESIRVTGPGGSPCLGSE","Homo sapiens","LIN28B, CSDD2","PROTEIN LIN-28 HOMOLOG B","1","4A4I"
"4A4L",,"X-RAY DIFFRACTION",2.8,56.1,"VAPOR DIFFUSION, SITTING DROP",6,"1.2 M NA/K TARTRATE, 25 MM ZN ACETATE, 0.10 M MES PH 6.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277 K",277,"10.1016/j.bmcl.2011.11.065","939","4A4L",36.34,"2.35","2.35","CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A 5-(2-AMINO- PYRIMIDIN-4-YL)-1H-PYRROLE INHIBITOR","GPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVLNK","Homo sapiens","PLK1, PLK","SERINE/THREONINE-PROTEIN KINASE PLK1","1","4A4L"
"4A4O",,"X-RAY DIFFRACTION",2.82,56.3,"VAPOR DIFFUSION, SITTING DROP",6,"1.2 M NA/K TARTRATE, 25 MM ZN ACETATE, 0.10 M MES PH 6.0, VAPOR DIFFUSION, SITTING-DROP, TEMPERATURE 277 K",277,"10.1016/j.bmcl.2011.11.065","664","4A4O",36.36,"2.7","2.7","CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A 2-(2-AMINO- PYRIMIDIN-4-YL)-1,5,6,7-TETRAHYDRO-PYRROLOPYRIDIN-4-ONE INHIBITOR","GPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVLNK","Homo sapiens","PLK1, PLK","SERINE/THREONINE-PROTEIN KINASE PLK1","1","4A4O"
"4A4P",,"X-RAY DIFFRACTION",2.14,48,,7,"PEG 3350 12%, AMMONIUM ACETATE 0.4M. GLYCEROL CRYO-PROTECTANT., pH 7",,,,"4A4P",44.9,"2","2","crystal structure of the Sec7 domain from human cytohesin1","HHHHHHNKQVAMGRKKFNMDPKKGIQFLIENDLLKNTCEDIAQFLYKGEGLNKTAIGDYLGERDEFNIQVLHAFVELHEFTDLNLVQALRQFLWSFRLPGEAQKIDRMMEAFAQRYCQCNNGVFQSTDTCYVLSFAIIMLNTSLHNPNVKDKPTVERFIAMNRGINDGGDLPEELLRNLYESIKNEPFKIPE","Homo sapiens","CYTH1, D17S811E, PSCD1","CYTOHESIN1","1","4A4P"
"4A4V",,"X-RAY DIFFRACTION",2.48,50.39,,8,"0.8 M TRI-SODIUM CITRATE, 0.1 M IMIDAZOLE, PH 8.0",,"10.1021/jm3013272","YFD","4A4V",66,"2","2","Ligand binding domain of human PPAR gamma in complex with amorfrutin 2","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","1","4A4V"
"4A4W",,"X-RAY DIFFRACTION",2.46,50.11,,8,"0.8 M TRI-SODIUM CITRATE 0.1 M IMIDAZOLE, PH 8.0",,"10.1021/jm3013272","YFB","4A4W",66.2,"2","2","Ligand binding domain of human PPAR gamma in complex with amorfrutin B","GSHMAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","1","4A4W"
"4A4X",,"X-RAY DIFFRACTION",2.88,57.29,,,,,"10.1021/jm201683b","JUP","4A4X",33.29,"2.4","2.4","NEK2-EDE bound to CCT248662","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","SERINE/THREONINE-PROTEIN KINASE NEK2","1","4A4X"
"4A50",,"X-RAY DIFFRACTION",4.06,69.69,,5.5,"23 % POLYETHYLENE GLYCOL-3350, 0.25 M AMMONIUM SULPHATE AND 0.1 M MES PH 5.5",,"10.1021/jm201195m","DQ7, DQ6","4A50",42.23,"2.75","2.75","Crystal structure of human kinesin Eg5 in complex with 2-Amino-5-(3-methylphenyl)-5,5-diphenylpentanoic acid","MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","KINESIN-LIKE PROTEIN KIF11","1","4A50"
"4A51",,"X-RAY DIFFRACTION",3.37,63.53,,5.8,"22 % POLYETHYLENE GLYCOL-3350, 0.25 M AMMONIUM SULPHATE, 0.1 M POTASSIUM SODIUM TARTRATE TETRAHYDRATE AND 0.1 M MES PH 5.8",,"10.1021/jm201195m","DQ8","4A51",293.67,"2.75","2.75","Crystal structure of human kinesin Eg5 in complex with 1-(3-(((2-Aminoethyl)thio)diphenylmethyl)phenyl)ethanone hydrochloride","MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","KINESIN-LIKE PROTEIN KIF11","1","4A51"
"4A5S",,"X-RAY DIFFRACTION",3.28,58.2,,,"2 UL PROTEIN, 0.4 UL RESERVOIR, 0.25 UL WATER; PROTEIN SOLUTION: 5.2 MG/ML DPP4, 25 MM TRIS PH 8, 25 MM NACL, 2 MM NVP-BIV988-AA-1, 2% DMSO; RESERVOIR SOLUTION: 40% PEG 1000, 200 MM TRIS PH 9.0, 200 MM AMMONIUM SULFATE, 5% GLYCEROL",,"10.1016/j.bmcl.2011.11.054","N7F","4A5S",176.78,"1.62","1.62","CRYSTAL STRUCTURE OF HUMAN DPP4 IN COMPLEX WITH A NOVAL HETEROCYCLIC DPP4 INHIBITOR","SRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLIDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLPAAASWSHPQFEK","Homo sapiens","DPP4, ADCP2, CD26","DIPEPTIDYL PEPTIDASE 4 SOLUBLE FORM","1","4A5S"
"4A5T",,"X-RAY DIFFRACTION",3.65,66.27,,,,,"10.1111/j.1538-7836.2012.04765.x",,"4A5T",89.29,"3.49","3.49","STRUCTURAL BASIS FOR THE CONFORMATIONAL MODULATION","EPLDDYVNTQGASLFSVTKKQLGAGSIEECAAKCEEDEEFTCRAFQYHSKEQQCVIMAENRKSSIIIRMRDVVLFEKKVYLSECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILECEEECMHCSGENYDGKISKTMSGLECQAWDSQSPHAHGYIPSKFPNKNLKKNYCRNPDRELRPWCFTTDPNKRWELCDIPRCTTPPPSSGPTYQCLKGTGENYRGNVAVTVSGHTCQHWSAQTPHTHNRTPENFPCKNLDENYCRNPDGKRAPWCHTTNSQVRWEYCKIPSCDSSPVSTEQLAPTAPPELTPVVQDCYHGDGQSYRGTSSTTTTGKKCQSWSSMTPHRHQKTPENYPNAGLTMNYCRNPDADKGPWCFTTDPSVRWEYCNLKKCSGTEASVVAPPPVVLLPDVETPSEEDCMFGNGKGYRGKRATTVTGTPCQDWAAQEPHRHSIFTPETNPRAGLEKNYCRNPDGDVGGPWCYTTNPRKLYDYCDVPQCAAPSFDCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVMRNN","Homo sapiens","PLG","PLASMINOGEN","1","4A5T"
"4A5Y",,"X-RAY DIFFRACTION",2.62,53.13,,6.8,"14 % POLYETHYLENE GLYCOL-3350, 0.18 M AMMONIUM PHOSPHATE, pH 6.8",,"10.1074/jbc.M113.462648","G7X","4A5Y",126.28,"2.45","2.45","Intermediate state of human kinesin Eg5 in complex with Ispinesib","MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","KINESIN-LIKE PROTEIN KIF11","1","4A5Y"
"4A5Z",,"X-RAY DIFFRACTION",2.5,50.9,,6.5,"200 MM NACL, 100 MM BISTRIS PH6.5",,"10.1073/pnas.1206839109",,"4A5Z",79.26,"2.3","2.3","Structures of MITD1","MAHHHHHHMDQIKIEENATGFSYESLFREYLNETVTEVWIEDPYIRHTHQLYNFLRFCEMLIKRPCKVKTIHLLTSLDEGIEQVQQSRGLQEIEESLRSHGVLLEVQYSSSIHDREIRFNNGWMIKIGRGLDYFKKPQSRFSLGYCDFDLRPCHETTVDIFHD","Homo sapiens","MITD1","MIT DOMAIN-CONTAINING PROTEIN 1","1","4A5Z"
"4A60",,"X-RAY DIFFRACTION",4.61,73.06,,,,,,,"4A60",17.88,"1.53","1.53","Crystal structure of human testis-specific fatty acid binding protein 9 (FABP9)","MHHHHHHSSGVDLGTENLYFQSMVEPFLGTWKLVSSENFEDYMKELGVNFAARNMAGLVKPTVTISVDGKMMTIRTESSFQDTKISFKLGEEFDETTADNRKVKSTITLENGSMIHVQKWLGKETTIKRKIVDEKMVVECKMNNIVSTRIYEKV","Homo sapiens","FABP9","FATTY ACID-BINDING PROTEIN 9 TESTIS LIPID-BINDING PROTEIN, TLBP, TESTIS-TYPE FATTY ACID-BINDING PROTEIN, T-FABP","1","4A60"
"4A64",,"X-RAY DIFFRACTION",2.79,55.92,,,"24% PEG4000, 100 MM LISO4, 100 MM TRIS (PH 8.2)",,,,"4A64",168.24,"2.57","2.57","Crystal structure of the N-terminal domain of human Cul4B at 2.57A resolution","SMPKLPENYTDETWQKLKEAVEAIQNSTSIKYNLEELYQAVENLCSYKISANLYKQLRQICEDHIKAQIHQFREDSLDSVLFLKKIDRCWQNHCRQMIMIRSIFLFLDRTYVLQNSMLPSIWDMGLELFRAHIISDQKVQNKTIDGILLLIERERNGEAIDRSLLRSLLSMLSDLQIYQDSFEQRFLEETNRLYAAEGQKLMQEREVPEYLHHVNKRLEEEADRLITYLDQTTQKSLIATVEKQLLGEHLTAILQKGLNNLLDENRIQDLSLLYQLFSRVRGGVQVLLQQWIEYIKAFGSTIVINPEKDKTMRQELDDFKDKVDHIIDICFLKNEKFINAMKEAFETFINKRPN","Homo sapiens","CUL4B, KIAA0695","CULLIN-4B","1","4A64"
"4A6D",,"X-RAY DIFFRACTION",4.36,68,,6.5,"30% PEG400, 0.1M CACODYLATE PH6.5, 0.2M LISO4",,"10.1111/j.1600-079X.2012.01020.x",,"4A6D",40.48,"2.4","2.4","Crystal structure of human N-acetylserotonin methyltransferase (ASMT) in complex with SAM","MGSSEDQAYRLLNDYANGFMVSQVLFAACELGVFDLLAEAPGPLDVAAVAAGVRASAHGTELLLDICVSLKLLKVETRGGKAFYRNTELSSDYLTTVSPTSQCSMLKYMGRTSYRCWGHLADAVREGRNQYLETFGVPAEELFTAIYRSEGERLQFMQALQEVWSVNGRSVLTAFDLSVFPLMCDLGGGAGALAKECMSLYPGCKITVFDIPEVVWTAKQHFSFQEEEQIDFQEGDFFKDPLPEADLYILARVLHDWADGKCSHLLERIYHTCKPGGGILVIESLLDEDRRGPLLTQLYSLNMLVQTEGQERTPTHYHMLLSSAGFRDFQFKKTGAIYDAILARKGTHHHHHH","Homo sapiens","ASMT","HYDROXYINDOLE O-METHYLTRANSFERASE","1","4A6D"
"4A6E",,"X-RAY DIFFRACTION",4.52,68,,6.5,"30% PEG400, 0.1M CACODYLATE PH6.5, 0.2M LISO4",,"10.1111/j.1600-079X.2012.01020.x",,"4A6E",40.83,"2.7","2.7","Crystal structure of human N-acetylserotonin methyltransferase (ASMT) in complex with SAM and N-acetylserotonin","MGSSEDQAYRLLNDYANGFMVSQVLFAACELGVFDLLAEAPGPLDVAAVAAGVRASAHGTELLLDICVSLKLLKVETRGGKAFYRNTELSSDYLTTVSPTSQCSMLKYMGRTSYRCWGHLADAVREGRNQYLETFGVPAEELFTAIYRSEGERLQFMQALQEVWSVNGRSVLTAFDLSVFPLMCDLGGGAGALAKECMSLYPGCKITVFDIPEVVWTAKQHFSFQEEEQIDFQEGDFFKDPLPEADLYILARVLHDWADGKCSHLLERIYHTCKPGGGILVIESLLDEDRRGPLLTQLYSLNMLVQTEGQERTPTHYHMLLSSAGFRDFQFKKTGAIYDAILARKGTHHHHHH","Homo sapiens","ASMT","HYDROXYINDOLE O-METHYLTRANSFERASE","1","4A6E"
"4A6L",,"X-RAY DIFFRACTION",2.53,51.1,,5,"PEG 3000 10%, NAACETATE 100 MM PH 5, GLYCEROL 5%, NACL 1.7 M",,"10.1016/j.bmcl.2011.11.119","P43","4A6L",111.58,"2.05","2.05","beta-tryptase inhibitor","IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYVPKKP","Homo sapiens","TPSB2, TPS2","TRYPTASE ALPHA/BETA-1","1","4A6L"
"4A79",,"X-RAY DIFFRACTION",2.72,52,,6.5,"12% PEG 4000, 100 MM ADA PH 6.5, 70 MM LITHIUM SULPHATE",,"10.1021/ml200196p","P1B","4A79",119.96,"1.89","1.89","Crystal structure of human monoamine oxidase B (MAO B) in complex with pioglitazone","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","AMINE OXIDASE [FLAVIN-CONTAINING] B","1","4A79"
"4A7A",,"X-RAY DIFFRACTION",2.7,52,,6.5,"12% PEG4000, 100 MM ADA PH 6.5, 70 MM LITHIUM SULPHATE",,"10.1021/ml200196p","RGZ","4A7A",119.96,"1.7","1.7","Crystal structure of human monoamine oxidase B (MAO B) in complex with rosiglitazone","MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV","Homo sapiens","MAOB","AMINE OXIDASE [FLAVIN-CONTAINING] B","1","4A7A"
"4A7B",,"X-RAY DIFFRACTION",2.32,46.93,,8.5,"10-27% PEG 3350, 1.5 M AMMONIUM FORMATE, 0.1 M TRIS/HCL PH 8.5",,"10.1016/j.bmcl.2011.11.034","3W4","4A7B",39.84,"2.2","2.2","MMP13 IN COMPLEX WITH A NOVEL SELECTIVE NON ZINC BINDING INHIBITOR CMPD22","YNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYGPGDED","Homo sapiens","MMP13","COLLAGENASE 3","1","4A7B"
"4A7C",,"X-RAY DIFFRACTION",3.21,61.69,,7,"0.1 M IMIDAZOLE PH 7.0, 1 M NA ACETATE.",,"10.1016/j.bmcl.2011.12.130","E46","4A7C",35.97,"2.3","2.3","Crystal structure of PIM1 kinase with ETP46546","MGSSHHHHHHSSGLEVLFQGPHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE PIM-1","1","4A7C"
"4A7G",,"X-RAY DIFFRACTION",1.9,34,,5,"100MM SODIUM ACETATE PH 5, 150 MM SODIUM CHLORIDE, 2.5 M AMMONIUM SULPHATE",,"10.2174/0929867311320040008",,"4A7G",33.1,"1.24","1.24","Structure of human I113T SOD1 mutant complexed with 4-methylpiperazin- 1-yl)quinazoline in the p21 space group.","ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSTEDSVISLSGDHCITGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","1","4A7G"
,,,,,,,,,,,,,,,,"ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCITGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","2","4A7G"
"4A7I",,"X-RAY DIFFRACTION",2.44,49.7,,5.7,"PROTEIN SOLUTION: 8 MG/ML PROTEIN, 5 MM MES (PH 5.7), 5 MM CACL2, 100 MM BENZAMIDINE. RESERVOIR: 18-20% PEG-600, 50 MM MES (PH 5.7). SOAKING: ADD 10 MM INHIBITOR.",,"10.1002/anie.201107091","A7I","4A7I",39.52,"2.4","2.4","Factor Xa in complex with a potent 2-amino-ethane sulfonamide inhibitor","YKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","FACTOR X LIGHT CHAIN","1","4A7I"
,,,,,,,,,,,,,,,,"IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","ACTIVATED FACTOR XA HEAVY CHAIN XA","2","4A7I"
"4A7Q",,"X-RAY DIFFRACTION",1.79,31.32,,5,"100 MM SODIUM ACETATE PH 5, 150 MM SODIUM CHLORIDE, 2.5 AMMONIUM SULPHATE",,"10.2174/0929867311320040008",,"4A7Q",32.95,"1.22","1.22","Structure of human I113T SOD1 mutant complexed with 4-(4-methyl-1,4- diazepan-1-yl)quinazoline in the p21 space group.","ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCITGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","1","4A7Q"
"4A7S",,"X-RAY DIFFRACTION",1.79,31.32,,5,"100 MM SODIUM ACETATE, 150 MM SODIUM CHLORIDE, 2.5 AMMONIUM SULPHATE PH 5",,"10.1038/ncomms2750",,"4A7S",33.01,"1.06","1.06","Structure of human I113T SOD1 mutant complexed with 5-Fluorouridine in the p21 space group","ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCITGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","1","4A7S"
"4A7T",,"X-RAY DIFFRACTION",1.79,31.38,,5,"100 MM SODIUM ACETATE PH 5, 150 MM SODIUM CHLORIDE, 2.5 AMMONIUM SULPHATE",,"10.1038/ncomms2750",,"4A7T",33.45,"1.45","1.45","Structure of human I113T SOD1 mutant complexed with isoproteranol in the p21 space group","ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCITGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","1","4A7T"
"4A7U",,"X-RAY DIFFRACTION",1.84,33.17,,5,"100 MM SODIUM ACETATE, 150 MM SODIUM CHLORIDE, 2.5 AMMONIUM SULPHATE PH 5",,"10.1038/ncomms2750",,"4A7U",32.7,"0.98","0.98","Structure of human I113T SOD1 complexed with adrenaline in the p21 space group.","ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCITGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","1","4A7U"
"4A7V",,"X-RAY DIFFRACTION",1.83,32.77,,5,"100 MM SODIUM ACETATE, 150 MM SODIUM CHLORIDE, 2.5 M AMMONIUM SULPHATE PH 5",,"10.1038/ncomms2750",,"4A7V",32.43,"1","1","Structure of human I113T SOD1 mutant complexed with dopamine in the p21 space group","ATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCITGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","1","4A7V"
"4A82","9","ELECTRON CRYSTALLOGRAPHY",,,,8,"pH 8.0",,"10.1074/jbc.M111.292268",,"4A82",259.74,"2, 9","2","Fitted model of staphylococcus aureus sav1866 model ABC transporter in the human cystic fibrosis transmembrane conductance regulator volume map EMD-1966.","MIKRYLQFVKPYKYRIFATIIVGIIKFGIPMLIPLLIKYAIDGVINNHALTTDEKVHHLTIAIGIALFIFVIVRPPIEFIRQYLAQWTSNKILYDIRKKLYNHLQALSARFYANNQVGQVISRVINDVEQTKDFILTGLMNIWLDCITIIIALSIMFFLDVKLTLAALFIFPFYILTVYVFFGRLRKLTRERSQALAEVQGFLHERVQGISVVKSFAIEDNEAKNFDKKNTNFLTRALKHTRWNAYSFAAINTVTDIGPIIVIGVGAYLAISGSITVGTLAAFVGYLELLFGPLRRLVASFTTLTQSFASMDRVFQLIDEDYDIKNGVGAQPIEIKQGRIDIDHVSFQYNDNEAPILKDINLSIEKGETVAFVGMSGGGKSTLINLIPRFYDVTSGQILIDGHNIKDFLTGSLRNQIGLVQQDNILFSDTVKENILLGRPTATDEEVVEAAKMANAHDFIMNLPQGYDTEVGERGVKLSGGQKQRLSIARIFLNNPPILILDEATSALDLESESIIQEALDVLSKDRTTLIVAHRLSTITHADKIVVIENGHIVETGTHRELIAKQGAYEHLYSIQNL","Homo sapiens",,"CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR","1","4A82"
"4A8Z",,"X-RAY DIFFRACTION",3.64,66.24,,,,,,,"4A8Z",15.91,"1.801","1.801","Human myelin P2 protein, K112Q mutant","GMSNKFLGTWKLVSSENFDDYMKALGVGLATRKLGNLAKPTVIISKKGDIITIRTESTFKNTEISFKLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGQMVAECKMKGVVCTRIYEKV","Homo sapiens","PMP2","MYELIN P2 PROTEIN","1","4A8Z"
"4A9C",,"X-RAY DIFFRACTION",2.2,44.14,,4.8,"1.5 MM BIPHENYL 2,3,4,5, 6-PENTAKISPHOSPHATE, 2 MM MGSO4, 11% PEG 6000, 0.1 M CITRIC ACID PH 4.8",,"10.1021/cb200494d","B5F","4A9C",73.12,"2.1","2.1","Crystal structure of human SHIP2 in complex with biphenyl 2,3',4,5',6- pentakisphosphate","SMDEPDMISVFIGTWNMGSVPPPKNVTSWFTSKGLGKTLDEVTVTIPHDIYVFGTQENSVGDREWLDLLRGGLKELTDLDYRPIAMQSLWNIKVAVLVKPEHENRISHVSTSSVKTGIANTLGNKGAVGVSFMFNGTSFGFVNCHLTSGNEKTARRNQNYLDILRLLSLGDRQLNAFDISLRFTHLFWFGDLNYRLDMDIQEILNYISRKEFEPLLRVDQLNLEREKHKVFLRFSEEEISFPPTYRYERGSRDTYAWHKQKPTGVRTNVPSWCDRILWKSYPETHIICNSYGCTDDIVTSDHSPVFGTFEVGVTSQ","Homo sapiens","INPPL1, SHIP2","PHOSPHATIDYLINOSITOL-3,4,5-TRISPHOSPHATE 5-PHOSPHATASE 2","1","4A9C"
"4A9E",,"X-RAY DIFFRACTION",2.01,38.92,,7,"0.1 M HEPES PH 7, 24-28% PEG 3350, 0.2 M (NH4)2SO4, 20 DEGREES CELSIUS.",293,"10.1021/jm201320w",,"4A9E",54.75,"1.91","1.91","N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3-methyl-1,2,3,4- tetrahydroquinazolin-2-one","GSSHHHHHHSSGLVPRGSHMSNPKKPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKNSHKKGA","Homo sapiens","BRD2, KIAA9001, RING3","BROMODOMAIN-CONTAINING PROTEIN 2","1","4A9E"
"4A9F",,"X-RAY DIFFRACTION",2.01,38.92,,7,"0.1M HEPES PH 7, 24-28% PEG 3350, 0.2 M (NH4)2SO4, 20 DEGREES CELSIUS",293,"10.1021/jm201320w",,"4A9F",54.37,"1.73","1.73","N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-METHYLPYRROLIDIN-2-ONE","GSSHHHHHHSSGLVPRGSHMSNPKKPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKNSHKKGA","Homo sapiens","BRD2, KIAA9001, RING3","BROMODOMAIN-CONTAINING PROTEIN 2","1","4A9F"
"4A9H",,"X-RAY DIFFRACTION",2.01,38.82,,8,"0.1M HEPES, PH 8.0 30% PEG3350, 0.2M (NH4)2SO4, 20C",293,"10.1021/jm201320w",,"4A9H",54.61,"2.05","2.05","N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-(2-methyl-1,2,3,4-tetrahydroquinolin-1-yl)ethan-1-one","GSSHHHHHHSSGLVPRGSHMSNPKKPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKNSHKKGA","Homo sapiens","BRD2, KIAA9001, RING3","BROMODOMAIN-CONTAINING PROTEIN 2","1","4A9H"
"4A9I",,"X-RAY DIFFRACTION",2,38.48,,7,"0.1 M HEPES PH 7.0, 28% PEG 3350, 0.2 M (NH4)2SO4, 20 DEGREES CELSIUS",293,"10.1021/jm201320w","P9I","4A9I",54.79,"2.25","2.25","N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3-methyl-1,2,3,4- tetrahydroquinazolin-2-one","GSSHHHHHHSSGLVPRGSHMSNPKKPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKNSHKKGA","Homo sapiens","BRD2, KIAA9001, RING3","BROMODOMAIN CONTAINING 2","1","4A9I"
"4A9J",,"X-RAY DIFFRACTION",2,38.48,,7,"0.1 M HEPES PH 7.0, 24-28% PEG 3350, 0.2 M (NH4)2SO4, 20 DEGREES CELSIUS.",293,"10.1021/jm201320w",,"4A9J",54.65,"1.9","1.9","N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-(4-hydroxyphenyl) acetamide","GSSHHHHHHSSGLVPRGSHMSNPKKPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKNSHKKGA","Homo sapiens","BRD2, KIAA9001, RING3","BROMODOMAIN CONTAINING 2","1","4A9J"
"4A9K",,"X-RAY DIFFRACTION",2,38.58,,,"150 MM KSCN, 20% PEG 3350, 4 DEGREES CELSIUS.",277,"10.1021/jm201320w",,"4A9K",28.97,"1.81","1.81","BROMODOMAIN OF HUMAN CREBBP WITH N-(4-hydroxyphenyl)acetamide","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-BINDING PROTEIN","1","4A9K"
"4A9L",,"X-RAY DIFFRACTION",2.12,41.99,,8.5,"20-30% PEG 3350, 0.2 M NACL, 0.1 HEPES PH 8.5, 10% ETHYLGLYCOL.",,"10.1021/jm201320w","P9L","4A9L",15.73,"1.6","1.6","N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH 1,3-DIMETHYL-6-(MORPHOLINE- 4-SULFONYL)-1,2,3,4-TETRAHYDROQUINAZOLIN-2-ONE","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","BROMODOMAIN-CONTAINING PROTEIN 4","1","4A9L"
"4A9M",,"X-RAY DIFFRACTION",2.03,39.39,,8.5,"0.1 M HEPES, PH 8.5, 24-34% PEG 3350, 0.2 M (NH4)2SO4.",,"10.1021/jm201283q","P9M","4A9M",55.02,"2.06","2.06","N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-cyclopentyl-5-(3,5- dimethyl-1,2-oxazol-4-yl)-2-methylbenzene-1-sulfonamide","GSSHHHHHHSSGLVPRGSHMSNPKKPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKNSHKKGA","Homo sapiens","BRD2, KIAA9001, RING3","BROMODOMAIN CONTAINING 2","1","4A9M"
"4A9N",,"X-RAY DIFFRACTION",2.01,38.67,,7,"0.1 M HEPES PH 7.0, 22-28% PEG 3350, 0.2 M (NH4)2SO4, 20 DEGREES CELSIUS.",293,"10.1021/jm201283q","A9N","4A9N",55.17,"1.85","1.85","N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-cyclopropyl-5-(3,5- dimethyl-1,2-oxazol-4-yl)-2-methylbenzene-1-sulfonamide","GSSHHHHHHSSGLVPRGSHMSNPKKPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKNSHKKGA","Homo sapiens","BRD2, KIAA9001, RING3","BROMODOMAIN CONTAINING 2","1","4A9N"
"4A9O",,"X-RAY DIFFRACTION",2,38.49,,7,"0.1 M HEPES PH 7.0, 22-26% PEG 3350, 0.2 M (NH4)2SO4",,"10.1021/jm201283q",,"4A9O",54.7,"1.78","1.78","N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 5 ethyl-3-methyl-4-phenyl-1, 2-oxazole","GSSHHHHHHSSGLVPRGSHMSNPKKPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKNSHKKGA","Homo sapiens","BRD2, KIAA9001, RING3","BROMODOMAIN CONTAINING 2","1","4A9O"
"4A9R",,"X-RAY DIFFRACTION",3.5,64.84,,,"0.1M HEPES PH 7.5, 0.2M MAGNESIUM NITRATE, 8-16% (W/V) PEG 3350",,"10.1016/j.bmc.2012.09.024","RU5","4A9R",37.6,"2.85","2.85","CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH BENZIMIDAZOLE CARBOXAMIDE INHIBITOR","GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","4A9R"
"4A9S",,"X-RAY DIFFRACTION",3.29,62.7,,,"0.1M HEPES PH 7.5, 0.2M MAGNESIUM NITRATE, 8-16% (W/V) PEG 3350",,"10.1016/j.bmc.2012.09.024","RU9","4A9S",37.52,"2.66","2.66","CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH BENZIMIDAZOLE CARBOXAMIDE INHIBITOR","GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","4A9S"
"4A9T",,"X-RAY DIFFRACTION",3.31,62.9,,,"0.1 M HEPES PH 7.5, 0.2 M MAGNESIUM NITRATE, 8-16% (W/V) PEG 3350.",,"10.1016/j.bmc.2012.09.024","A9T","4A9T",37.84,"2.7","2.7","CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH BENZIMIDAZOLE CARBOXAMIDE INHIBITOR","GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","4A9T"
"4A9U",,"X-RAY DIFFRACTION",3.3,62.9,,,"0.1 M HEPES PH 7.5, 0.2 M MAGNESIUM NITRATE, 8-16% (W/V) PEG 3350",,"10.1016/j.bmc.2012.09.024","A9U","4A9U",38.21,"2.48","2.48","CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH BENZIMIDAZOLE CARBOXAMIDE INHIBITOR","GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","4A9U"
"4A9Y",,"X-RAY DIFFRACTION",2.4,48.6,"VAPOR DIFFUSION, HANGING DROP",6.5,"6-10% PEG-MME 5000, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K",298,"10.1016/j.bmcl.2012.04.116","AQZ","4A9Y",42.62,"2.2","2.2","P38ALPHA MAP KINASE BOUND TO CMPD 8","HHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","MITOGEN-ACTIVATED PROTEIN KINASE 14","1","4A9Y"
"4A9Z",,"X-RAY DIFFRACTION",2.2,44.01,,,,,,,"4A9Z",29.88,"2.29","2.29","CRYSTAL STRUCTURE OF HUMAN P63 TETRAMERIZATION DOMAIN","GSDDELLYLPVRGRETYEMLLKIKESLELMQYLPQHTIETYRQQQQQQHQHLLQKQTSIQS","Homo sapiens","TP63, KET, P63, P73H, P73L, TP73L","TUMOR PROTEIN 63","1","4A9Z"
"4AA0",,"X-RAY DIFFRACTION",2.4,49.1,"VAPOR DIFFUSION, HANGING DROP",6.5,"6-10% PEG-MME 5000, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K",298,"10.1016/j.bmcl.2012.04.116","AA0","4AA0",42.58,"1.8","1.8","P38ALPHA MAP KINASE BOUND TO CMPD 2","HHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","MITOGEN-ACTIVATED PROTEIN KINASE 14","1","4AA0"
"4AA4",,"X-RAY DIFFRACTION",2.34,47.51,"VAPOR DIFFUSION, HANGING DROP",6.5,"6-10% PEG-MME 5000, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K",298,"10.1016/j.bmcl.2012.04.116","QC0","4AA4",42.48,"2.3","2.3","P38ALPHA MAP KINASE BOUND TO CMPD 22","HHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","MITOGEN-ACTIVATED PROTEIN KINASE 14","1","4AA4"
"4AA5",,"X-RAY DIFFRACTION",2.24,45.1,"VAPOR DIFFUSION, HANGING DROP",6.5,"6-10% PEG-MME 5000, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K",298,"10.1016/j.bmcl.2012.04.116","NQB","4AA5",42.49,"2.38","2.38","P38ALPHA MAP KINASE BOUND TO CMPD 33","HHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","MITOGEN-ACTIVATED PROTEIN KINASE 14","1","4AA5"
"4AAA",,"X-RAY DIFFRACTION",2.6,52.7,,,"0.2M NACL, 0.1M TRIS PH 8.5; 25% PEG 3350.",,"10.1016/j.celrep.2017.12.083",,"4AAA",39.19,"1.53","1.53","Crystal structure of the human CDKL2 kinase domain","MGHHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQELQLKVQKDA","Homo sapiens","CDKL2","CYCLIN-DEPENDENT KINASE-LIKE 2","1","4AAA"
"4AAC",,"X-RAY DIFFRACTION",2.27,45.79,"VAPOR DIFFUSION, HANGING DROP",6.5,"6-10% PEG-MME 5000, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K",298,"10.1016/j.bmcl.2012.04.116","AAV","4AAC",42.52,"2.5","2.5","P38ALPHA MAP KINASE BOUND TO CMPD 29","HHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","MITOGEN-ACTIVATED PROTEIN KINASE 14","1","4AAC"
"4AAP",,"X-RAY DIFFRACTION",3.3,62.73,,,"16% PEG_3350, 0.007M NICL, 0M CDCL, 0.007M MGCL, 0.1M HEPES PH 7.3",,,,"4AAP",56.08,"2.6","2.6","Crystal structure of JMJD5 domain of human Lysine-specific demethylase 8 (KDM8) in complex with N-oxalylglycine (NOG)","SMLEKTVPRLHRPSLQHFREQFLVPGRPVILKGVADHWPCMQKWSLEYIQEIAGCRTVPVEVGSRYTDEEWSQTLMTVNEFISKYIVNEPRDVGYLAQHQLFDQIPELKQDISIPDYCSLGDGEEEEITINAWFGPQGTISPLHQDPQQNFLVQVMGRKYIRLYSPQESGALYPHDTHLLHNTSQVDVENPDLEKFPKFAKAPFLSCILSPGEILFIPVKYWHYVRALDLSFSVSFWWS","Homo sapiens","KDM8, JMJD5","LYSINE-SPECIFIC DEMETHYLASE 8","1","4AAP"
"4AB1",,"X-RAY DIFFRACTION",2.83,56.14,,5.5,"DROP WAS 45% PROTEIN SOLUTION (11MG/ML) OF 50 MM TRIS, PH7.6, 150 MM NACL, MIXED WITH 45% 2 M AMMONIUM SULFATE, 0.1 M BIS-TRIS, PH 5.5, AND 10% 2 M NASCN.",,"10.1107/S1744309112003326",,"4AB1",59.07,"2.2","2.2","Recombinant Human Carboxylesterase 1 from whole Cabbage Loopers","SSPPVVDTVHGKVLGKFVSLEGFAQPVAIFLGIPFAKPPLGPLRFTPPQPAEPWSFVKNATSYPPMCTQDPKAGQLLSELFTNRKENIPLKLSEDCLYLNIYTPADLTKKNRLPVMVWIHGGGLMVGAASTYDGLALAAHENVVVVTIQYRLGIWGFFSTGDEHSRGNWGHLDQVAALRWVQDNIASFGGNPGSVTIFGESAGGESVSVLVLSPLAKNLFHRAISESGVALTSVLVKKGDVKPLAEQIAITAGCKTTTSAVMVHCLRQKTEEELLETTLKMKFLSLDLQGDPRESQPLLGTVIDGMLLLKTPEELQAERNFHTVPYMVGINKQEFGWLIPMLMSYPLSEGQLDQKTAMSLLWKSYPLVCIAKELIPEATEKYLGGTDDTVKKKDLFLDLIADVMFGVPSVIVARNHRDAGAPTYMYEFQYRPSFSSDMKPKTVIGDHGDELFSVFGAPFLKEGASEEEIRLSKMVMKFWANFARNGNPNGEGLPHWPEYNQKEGYLQIGANTQAAQKLKDKEVAFWTNLFAK","Homo sapiens","CES1, CES2, SES1","LIVER CARBOXYLESTERASE 1","1","4AB1"
"4ABK",,"X-RAY DIFFRACTION",1.86,33.94,,,"1.4M TRI-SODIUM CITRATE, 0.1M HEPES PH 7.5",,"10.1016/j.str.2012.12.019","AR6","4ABK",20.37,"1.6","1.6","HUMAN PARP14 (ARTD8, BAL2) - MACRO DOMAIN 3 IN COMPLEX WITH ADENOSINE- 5-DIPHOSPHORIBOSE","SMFYGTVSSPDSGVYEMKIGSIIFQVASGDITKEEADVIVNSTSNSFNLKAGVSKAILECAGQNVERECSQQAQQRKNDYIITGGGFLRCKNIIHVIGGNDVKSSVSSVLQECEKKNYSSICLPAIGTGNAKQHPDKVAEAIIDAIEDFVQKGSAQSVKKVKVVIFLPQVLDVFYANMKKREG","Homo sapiens","PARP14, BAL2, KIAA1268","POLY [ADP-RIBOSE] POLYMERASE 14","1","4ABK"
"4ABL",,"X-RAY DIFFRACTION",1.9,35.35,,,"30% PEGMME2000, 0.05M POTASSIUM BROMIDE",,"10.1016/j.str.2012.12.019",,"4ABL",19.89,"1.15","1.15","HUMAN PARP14 (ARTD8, BAL2) - MACRO DOMAIN 3","SMFYGTVSSPDSGVYEMKIGSIIFQVASGDITKEEADVIVNSTSNSFNLKAGVSKAILECAGQNVERECSQQAQQRKNDYIITGGGFLRCKNIIHVIGGNDVKSSVSSVLQECEKKNYSSICLPAIGTGNAKQHPDKVAEAIIDAIEDFVQKGSAQSVKKVKVVIFLPQVLDVFYANMKKREG","Homo sapiens","PARP14, BAL2, KIAA1268","POLY [ADP-RIBOSE] POLYMERASE 14","1","4ABL"
"4ABM",,"X-RAY DIFFRACTION",2.24,45.19,,,,,"10.1016/j.jmb.2012.02.044",,"4ABM",37,"1.8","1.8","Crystal Structure of CHMP4B hairpin","GAMEQEAIQRLRDTEEMLSKKQEFLEKKIEQELTAAKKHGTKNKRAALQALKRKKRYEKQLAQIDGTLSTIEFQREALE","Homo sapiens","CHMP4B, C20orf178, SHAX1","CHARGED MULTIVESICULAR BODY PROTEIN 4B","1","4ABM"
"4ABQ",,"X-RAY DIFFRACTION",2.4,49.5,"VAPOR DIFFUSION, HANGING DROP",7.4,"POTASSIUM CHLORIDE, POTASSIUM PHOSPHATE, AMMONIUM SULFATE, PH 7.4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K",298,"10.1371/journal.pone.0043522",,"4ABQ",27.23,"1.7","1.7","CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-1","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN","Homo sapiens","TTR, PALB","TRANSTHYRETIN","1","4ABQ"
"4ABU",,"X-RAY DIFFRACTION",2.4,49.1,"VAPOR DIFFUSION, HANGING DROP",7.4,"POTASSIUM CHLORIDE, POTASSIUM PHOSPHATE, AMMONIUM SULFATE, PH 7.4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K",298,"10.1371/journal.pone.0043522","FT1","4ABU",27.41,"1.86","1.86","CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-2","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN","Homo sapiens","TTR, PALB","TRANSTHYRETIN","1","4ABU"
"4ABV",,"X-RAY DIFFRACTION",2.47,50.1,"VAPOR DIFFUSION, HANGING DROP",7.4,"POTASSIUM CHLORIDE, POTASSIUM PHOSPHATE, AMMONIUM SULFATE, PH 7.4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K",298,"10.1371/journal.pone.0043522","FT2","4ABV",27.45,"1.8","1.8","CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-3","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN","Homo sapiens","TTR, PALB","TRANSTHYRETIN","1","4ABV"
"4ABW",,"X-RAY DIFFRACTION",2.48,50.5,"VAPOR DIFFUSION, HANGING DROP",7.4,"POTASSIUM CHLORIDE, POTASSIUM PHOSPHATE, AMMONIUM SULFATE, PH 7.4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K",298,"10.1371/journal.pone.0043522",,"4ABW",27.49,"1.7","1.7","Crystal Structure of Transthyretin in Complex With Ligand C-6","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN","Homo sapiens","TTR, PALB","TRANSTHYRETIN","1","4ABW"
"4AC2",,"X-RAY DIFFRACTION",2.44,49.6,"VAPOR DIFFUSION, HANGING DROP",7.4,"POTASSIUM CHLORIDE, POTASSIUM PHOSPHATE, AMMONIUM SULFATE, PH 7.4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K",298,"10.1371/journal.pone.0043522","43F","4AC2",27.48,"1.81","1.81","CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-7","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTN","Homo sapiens","TTR, PALB","TRANSTHYRETIN","1","4AC2"
"4AC4",,"X-RAY DIFFRACTION",2.45,49.8,"VAPOR DIFFUSION, HANGING DROP",7.4,"POTASSIUM CHLORIDE, POTASSIUM PHOSPHATE, AMMONIUM SULFATE, PH 7.4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K",298,"10.1371/journal.pone.0043522","HKA","4AC4",28.04,"1.8","1.8","CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-18","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","TRANSTHYRETIN","1","4AC4"
"4ACC",,"X-RAY DIFFRACTION",3.04,59.49,,,,,"10.1021/jm201724m","7YG","4ACC",105.27,"2.21","2.21","GSK3b in complex with inhibitor","MSYYHHHHHHDYDIPTTENLYFQGAMGSSHHHHHHSSGLVPRGSHMSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST","Homo sapiens","GSK3B","GLYCOGEN SYNTHASE KINASE-3 BETA","1","4ACC"
"4ACD",,"X-RAY DIFFRACTION",3.02,59.25,,,,,"10.1021/jm201724m","GR9","4ACD",105.06,"2.6","2.6","GSK3b in complex with inhibitor","MSYYHHHHHHDYDIPTTENLYFQGAMGSSHHHHHHSSGLVPRGSHMSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST","Homo sapiens","GSK3B","GLYCOGEN SYNTHASE KINASE-3 BETA","1","4ACD"
"4ACG",,"X-RAY DIFFRACTION",2.99,57.99,,,,,"10.1021/jm201724m","6LQ","4ACG",105.22,"2.6","2.6","GSK3b in complex with inhibitor","MSYYHHHHHHDYDIPTTENLYFQGAMGSSHHHHHHSSGLVPRGSHMSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST","Homo sapiens","GSK3B","GLYCOGEN SYNTHASE KINASE-3 BETA","1","4ACG"
"4ACH",,"X-RAY DIFFRACTION",3.06,59.8,,,,,"10.1021/jm201724m","KDI","4ACH",105.05,"2.6","2.6","GSK3b in complex with inhibitor","MSYYHHHHHHDYDIPTTENLYFQGAMGSSHHHHHHSSGLVPRGSHMSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST","Homo sapiens","GSK3B","GLYCOGEN SYNTHASE KINASE-3 BETA","1","4ACH"
"4ACM",,"X-RAY DIFFRACTION",2,39.7,,,"8% PEG 3350, 0.1M HEPES PH 7.5, 0.05M AMMONIUM ACETATE",,"10.1021/jm201724m","7YG","4ACM",34.63,"1.63","1.63","CDK2 IN COMPLEX WITH 3-AMINO-6-(4-{[2-(DIMETHYLAMINO)ETHYL]SULFAMOYL}-PHENYL)-N-PYRIDIN-3-YLPYRAZINE-2-CARBOXAMIDE","XMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CYCLIN-DEPENDENT KINASE 2","1","4ACM"
"4ACP",,"X-RAY DIFFRACTION",3.15,60,,4,"25% W/V POLYETHYLENE GLYCOL 1500, 0.1 M SPG SYSTEM BUFFER PH 4",,"10.1016/j.jmb.2012.04.002",,"4ACP",54.25,"2.49","2.49","Deactivation of human IgG1 Fc by endoglycosidase treatment","GTKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKATPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGGTKHHHHHH","Homo sapiens","IGHG1","IG GAMMA-1 CHAIN C REGION","1","4ACP"
"4ACR",,"X-RAY DIFFRACTION",2.7,54,,8,"12-14% PEG 6000, 0.1 M TRIS-HCL, 0.2 M CACL2, PH 8.0",,"10.1074/jbc.M111.322487",,"4ACR",216.19,"2.55","2.55","Crystal structure of N-glycosylated, C-terminally truncated human glypican-1","APQLHHHHHHDLYENLYFQGKLDPASKSRSCGEVRQIYGAKGFSLSDVPQAEISGEHLRICPQGYTCCTSEMEENLANRSHAELETALRDSSRVLQAMLATQLRSFDDHFQHLLNDSERTLQATFPGAFGELYTQNARAFRDLYSELRLYYRGANLHLEETLAEFWARLLERLFKQLHPQLLLPDDYLDCLGKQAEALRPFGEAPRELRLRATRAFVAARSFVQGLGVASDVVRKVAQVPLGPECSRAVMKLVYCAHCLGVPGARPCPDYCRNVLKGCLANQADLDAEWRNLLDSMVLITDKFWGTSGVESVIGSVHTWLAEAINALQDNRDTLTAKVIQGCGNPKVNPQGPGPEEKRRRGKLAPRERPPSGTLEKLVSEAKAQLRDVQDFWISLPGTLCSEKMALSTASDDRCWNGMARGRYLPEVMGDGLANQINNPEVEVDITKPDMTIRQQIMQLKIMTNRLRSAYNGNDVDFQ","Homo sapiens","GPC1","GLYPICAN-1","1","4ACR"
"4ACS",,"X-RAY DIFFRACTION",2.6,54,"VAPOR DIFFUSION, HANGING DROP",7.8,"CRYSTALS WERE GROWN BY HANING DROP METHOD BY MIXING EQUAL VOLUMES (4 UL) OF PROTEIN (10 MG/ML)AND GLUTATHIONE S-CONJUGATE (5 MM) MIXTURE AND RESERVOIR SOLUTION CONTAINING 9-14% PEG 4000 AND 2 MM DTT IN 100 MM TRIS-HCL (PH 7.8) WITH ADDITIONAL OCTYL D-BETA- GLUCOPYRANOSIDE TO A FINAL CONCENTRATION OF 0.1% (W/V)",,"10.1016/j.chembiol.2012.01.021",,"4ACS",103.74,"2.1","2.1","Crystal structure of mutant GST A2-2 with enhanced catalytic efficiency with azathioprine","MAEKPKLHYSNIRGRMESIRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEIDGMKLVQTRAILNYIASKYNLYGKDIKEKALIDMYIEGIADLGEMIGDLSFSQPEEQDAKLALIQEKTKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEESRKIFRH","Homo sapiens","GSTA2, GST2","GLUTATHIONE S-TRANSFERASE A2","1","4ACS"
"4ACT",,"X-RAY DIFFRACTION",2.47,50.1,"VAPOR DIFFUSION, HANGING DROP",7.4,"POTASSIUM CHLORIDE, POTASSIUM PHOSPHATE, AMMONIUM SULFATE, PH 7.4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K",298,,,"4ACT",27.98,"1.8","1.8","CRYSTAL STRUCTURE OF TRANSTHYRETIN IN COMPLEX WITH LIGAND C-17","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","TRANSTHYRETIN","1","4ACT"
"4ACU",,"X-RAY DIFFRACTION",2.05,40,,5,"11% PEG6K, 90 MM NAAC PH 5.0, 18 MM TRIS PH 8.5, 135 MM NACL.",,"10.1016/j.bmcl.2012.01.079","QN7","4ACU",46.45,"1.75","1.75","Aminoimidazoles as BACE-1 Inhibitors. X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 14","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","4ACU"
"4ACX",,"X-RAY DIFFRACTION",2.07,41,,5,"11% PEG6K, 90 MM NAAC PH 5.0, 18 MM TRIS PH 8.5, 135 MM NACL",,"10.1016/j.bmcl.2012.01.079","S8Z","4ACX",46.34,"2","2","Aminoimidazoles as BACE-1 Inhibitors. X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 23","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","4ACX"
"4AD7",,"X-RAY DIFFRACTION",2.7,54,,8,"12-14% PEG 6000, 0.1 M TRIS-HCL, 0.2 M CACL2, PH 8.0",,"10.1074/jbc.M111.322487",,"4AD7",236.47,"2.945","2.945","Crystal structure of full-length N-glycosylated human glypican-1","APQLHHHHHHDLYENLYFQGKLDPASKSRSCGEVRQIYGAKGFSLSDVPQAEISGEHLRICPQGYTCCTSEMEENLANRSHAELETALRDSSRVLQAMLATQLRSFDDHFQHLLNDSERTLQATFPGAFGELYTQNARAFRDLYSELRLYYRGANLHLEETLAEFWARLLERLFKQLHPQLLLPDDYLDCLGKQAEALRPFGEAPRELRLRATRAFVAARSFVQGLGVASDVVRKVAQVPLGPECSRAVMKLVYCAHCLGVPGARPCPDYCRNVLKGCLANQADLDAEWRNLLDSMVLITDKFWGTSGVESVIGSVHTWLAEAINALQDNRDTLTAKVIQGCGNPKVNPQGPGPEEKRRRGKLAPRERPPSGTLEKLVSEAKAQLRDVQDFWISLPGTLCSEKMALSTASDDRCWNGMARGRYLPEVMGDGLANQINNPEVEVDITKPDMTIRQQIMQLKIMTNRLRSAYNGNDVDFQDASDDGSGSGSGDGCLDDLCSRKVSRKSSSSRTPLTHALPGLSEQEGQKT","Homo sapiens","GPC1","GLYPICAN-1","1","4AD7"
"4AD9",,"X-RAY DIFFRACTION",3.38,63,,7,"0.20M NABR, 0.1 M BTPROP PH 6.5, 20.0% PEG 3350, 10.0% ETHYLENE GLYCOL",,"10.1093/nar/gkw050",,"4AD9",198.67,"2.6","2.6","Crystal structure of human LACTB2.","SMAAVLQRVERLSNRVVRVLGCNPGPMTLQGTNTYLVGTGPRRILIDTGEPAIPEYISCLKQALTEFNTAIQEIVVTHWHRDHSGGIGDICKSINNDTTYCIKKLPRNPQREEIIGNGEQQYVYLKDGDVIKTEGATLRVLYTPGHTDDHMALLLEEENAIFSGDCILGEGTTVFEDLYDYMNSLKELLKIKADIIYPGHGPVIHNAEAKIQQYISHRNIREQQILTLFRENFEKSFTVMELVKIIYKNTPENLHEMAKHNLLLHLKKLEKEGKIFSNTDPDKKWKAHL","Homo sapiens","LACTB2, CGI-83","BETA-LACTAMASE-LIKE PROTEIN 2","1","4AD9"
"4AE2",,"X-RAY DIFFRACTION",2,39.9,,6.5,"20% PEG 3350, 0.1 M BIS TRIS PROPANE PH 6.5, POTASSIUM NITRATE 0.2 M",,"10.1038/nsmb.2389",,"4AE2",86.88,"1.68","1.68","Crystal structure of Human fibrillar procollagen type III C- propeptide trimer","ETGHHHHHHSADEPMDFKINTDEIMTSLKSVNGQIESLISPDGSRKNPARNCRDLKFCHPELKSGEYWVDPNQGCKLDAIKVFCNMETGETCISANPLNVPRKHWWTDSSAEKKHVWFGESMDGGFQFSYGNPELPEDVLDVQLAFLRLLSSRASQQITYHCKNSIAYMDQASGNVKKALKLMGSNEGEFKAEGNSKFTYTVLEDGCTKHTGEWSKTVFEYRTRKAVRLPIVDIAPYDIGGPDQEFGVDVGPVCFL","Homo sapiens","COL3A1","COLLAGEN ALPHA-1(III) CHAIN","1","4AE2"
"4AE4",,"X-RAY DIFFRACTION",2.81,56.3,,9.5,"645 MM NA/K TARTRATE, 271 MM LISO4, 100 MM CHES PH 9.5, 2 MM TCEP, 5% GLYCEROL",,"10.1016/j.str.2011.12.013",,"4AE4",28.32,"1.65","1.65","The UBAP1 subunit of ESCRT-I interacts with ubiquitin via a novel SOUBA domain","GSHMSPSERQCVETVVNMGYSYECVLRAMKAAGANIEQILDYLFAHGQLCEKGFDPLLVEEALEMHQCSEEKMMEFLQLMSKFKEMGFELKDIKEVLLLHNNDQDNALEDLMARAGAS","Homo sapiens","UBAP1, NAG20","UBIQUITIN-ASSOCIATED PROTEIN 1","1","4AE4"
,,,,,,,,,,,,,,,,"GSHMSPSERQCVETVVNMGYSYECVLRAMKAAGANIEQILDYLFAHGQLCEKGFDPLLVEEALEMHQCSEEKMMEFLQLMSKFKEMGFELKDIKEVLLLHNNDQDNALEDLMARAGAS","Homo sapiens","UBAP1, NAG20","UBIQUITIN-ASSOCIATED PROTEIN 1","2","4AE4"
"4AE6",,"X-RAY DIFFRACTION",2.53,51.51,,,"20 % PEG 3350, 0.2 M POTASSIUM ACETATE, 5 % POLYPROPYLENE GLYCOL P400",,"10.1016/j.jsb.2012.03.013",,"4AE6",80.14,"2.1","2.1","Structure and Function of the Human Sperm-Specific Isoform of Protein Kinase A (PKA) Catalytic Subunit Calpha 2","MASNSSDVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF","Homo sapiens","PRKACA, PKACA","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 2","1","4AE6"
"4AE7",,"X-RAY DIFFRACTION",2.5,51,,,"10% PEG 3000, 0.2 M NACL, 0.1 M PHOSPHATE-CITRATE PH 4.2",,"10.1128/MCB.00312-12",,"4AE7",24.54,"1.45","1.45","Crystal structure of human THEM5","GAHMSGRGSSTDSMFSRFLPEKTDLKDYALPNASWCSDMLSLYQEFLEKTKSSGWIKLPSFKSNRDHIRGLKLPSGLAVSSDKGDCRIFTRCIQVEGQGFEYVIFFQPTQKKSVCLFQPGSYLEGPPGFAHGGSLAAMMDETFSKTAFLAGEGLFTLSLNIRFKNLIPVDSLVVMDVEVDKIEDQKLYMSCIAHSRDQQTVYAKSSGVFLQLQLEEESPQ","Homo sapiens","THEM5, ACOT15","THIOESTERASE SUPERFAMILY MEMBER 5","1","4AE7"
"4AE8",,"X-RAY DIFFRACTION",1.9,34,,,"30% PEG3000, 0.2M NACL, 0.1M TRIS PH 7.0",,"10.1128/MCB.00312-12",,"4AE8",95.57,"1.594","1.594","Crystal structure of human THEM4","GAHMSGRSSEEVILKDCSVPNPSWNKDLRLLFDQFMKKCEDGSWKRLPSYKRTPTEWIQDFKTHFLDPKLMKEEQMSQAQLFTRSFDDGLGFEYVMFYNDIEKRMVCLFQGGPYLEGPPGFIHGGAIATMIDATVGMCAMMAGGIVMTANLNINYKRPIPLCSVVMINSQLDKVEGRKFFVSCNVQSVDEKTLYSEATSLFIKLNPAKSLT","Homo sapiens","THEM4, CTMP","THIOESTERASE SUPERFAMILY MEMBER 4","1","4AE8"
"4AE9",,"X-RAY DIFFRACTION",2.58,52.42,,,"20 % PEG 3350, 0.2 M POTASSIUM ACETATE, 5 % POLYPROPYLENE GLYCOL P400",,"10.1016/j.jsb.2012.03.013",,"4AE9",80.24,"2.3","2.3","Structure and function of the Human Sperm-Specific Isoform of Protein Kinase A (PKA) Catalytic Subunit C alpha 2","MASNSSDVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF","Homo sapiens","PRKACA, PKACA","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA","1","4AE9"
"4AEJ",,"X-RAY DIFFRACTION",2.3,46.5,,,"20% PEG 3350, 0.2 M NACL",,"10.1038/nsmb.2389",,"4AEJ",88.06,"2.21","2.21","Crystal structure of Human fibrillar procollagen type III C- propeptide trimer","ETGHHHHHHSADEPMDFKINTDEIMTSLKSVNGQIESLISPDGSRKNPARNCRDLKFCHPELKSGEYWVDPNQGCKLDAIKVFCNMETGETCISANPLNVPRKHWWTDSSAEKKHVWFGESMDGGFQFSYGNPELPEDVLDVQLAFLRLLSSRASQQITYHCKNSIAYMDQASGNVKKALKLMGSNEGEFKAEGNSKFTYTVLEDGCTKHTGEWSKTVFEYRTRKAVRLPIVDIAPYDIGGPDQEFGVDVGPVCFL","Homo sapiens","COL3A1","COLLAGEN ALPHA-1(III) CHAIN","1","4AEJ"
"4AEL",,"X-RAY DIFFRACTION",2.14,42.4,,7.5,"20 MM TRIS PH 7.5, 100 MM NACL AND 10 MM BETA MERCAPTOETHANOL",,"10.1016/j.bmcl.2012.01.046","4HN","4AEL",79.84,"2.2","2.2","PDE10A in complex with the inhibitor AZ5","SNASICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE 10A","1","4AEL"
"4AFE",,"X-RAY DIFFRACTION",2.61,52.85,,,,,"10.1021/jm201683b","GGY","4AFE",33.22,"2.597","2.597","Nek2 bound to hybrid compound 21","MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH","Homo sapiens","NEK2, NEK2A, NLK1","SERINE/THREONINE-PROTEIN KINASE NEK2","1","4AFE"
"4AFL",,"X-RAY DIFFRACTION",2.66,53,,7.5,"24% PEG 3350, 0.1 M BISTRIS- PROPANE PH:7.5, 0.4 M SODIUM NITRATE, 10% OPTISALT SOLUTION 6, SILVER BULLET ADDITIVE 3.",,"10.1074/jbc.M111.330001",,"4AFL",74.41,"2.275","2.275","The crystal structure of the ING4 dimerization domain reveals the functional organization of the ING family of chromatin binding proteins.","AAGMYLEHYLDSIENLPFELQRNFQLMRDLDQRTEDLKAEIDKLATEYMSSARSLSSEEKLALLKQIQEAYGKCKEFGDDKVQLAMQTYEMVDKHIRRLDTDLA","Homo sapiens","ING4, My036","INHIBITOR OF GROWTH PROTEIN 4","1","4AFL"
"4AFX",,"X-RAY DIFFRACTION",3.25,45,,5,"1.8M NAK PHOSPHATE, PH5",,"10.1182/blood-2012-03-419598",,"4AFX",48.9,"2.09","2.09","Crystal structure of the reactive loop cleaved ZPI in I2 space group","SAPSPQSPETPAPQNQTSRVVQAPKEEEEDEQEASEEKASEEEKAWLMASRQQLAKETSNFGFSLLRKISMRHDGNMVFSPFGMSLAMTGLMLGATGPTETQIKRGLHLQALKPTKPGLLPSLFKGLRETLSRNLELGLTQGSFAFIHKDFDVKETFFNLSKRYFDTECVPMNFRNASQAKRLMNHYINKETRGKIPKLFDEINPETKLILVDYILFKGKWLTPFDPVFTEVDTFHLDKYKTIKVPMMYGAGKFASTFDKNFRCHVLKLPYQGNATMLVVLMEKMGDHLALEDYLTTDLVETWLRNMKTRNMEVFFPKFKLDQKYEMHELLRQMGIRRIFSPFADLSELSATGRNLQVSRVLQRTVIEVDERGTEAVAGILSEITAR","Homo sapiens","SERPINA10, ZPI, UNQ707/PRO1358","PROTEIN Z DEPENDENT PROTEASE INHIBITOR","1","4AFX"
,,,,,,,,,,,,,,,,"SMPPVIKIDRPFHFMIYEETSGMLLFLGRVVNPTLL","Homo sapiens","SERPINA10, ZPI, UNQ707/PRO1358","PROTEIN Z DEPENDENT PROTEASE INHIBITOR","2","4AFX"
"4AG8",,"X-RAY DIFFRACTION",2.87,57.14,"VAPOR DIFFUSION, HANGING DROP",7.5,"CRYSTALS WERE GROWN AT 4 OR 13 C BY THE HANGING DROP VAPOR DIFFUSION BY MIXING 2 MICORLITERS OF PROTEIN-INHIBITOR COMPLEX SOLUTION WITH 2 MICROLITERS OF MOTHER LIQUOR (100 MM HEPES (PH 7.5), 200 MM AMMONIUM SULFATE, 5% (V/V) MPD, AND 15-20% (W/V) POLYETHYLENE GLYCOL (MW = 6000)). BEFORE SEALING THE COVERSLIPS ABOVE THE RESERVOIRS, BETA-MERCAPTOETHANOL WAS ADDED TO THE RESERVOIRS TO A FINAL CONCENTRATION OF 60 MM. THIS PROCEDURE PRODUCED MICROCRYSTALS THAT WERE SUBSEQUENTLY USED TO SEED MORE CRYSTALLIZATION DROPS AFTER 12-18 HOURS OF EQUILIBRATION.",,"10.1073/pnas.1207759109","AXI","4AG8",36.58,"1.95","1.95","CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH AXITINIB (AG-013736) (N-Methyl-2-(3-((E)-2-pyridin-2-yl-vinyl)-1H- indazol-6-ylsulfanyl)-benzamide)","MDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD","Homo sapiens","KDR, FLK1, VEGFR2","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","1","4AG8"
"4AGC",,"X-RAY DIFFRACTION",2.74,55.05,"VAPOR DIFFUSION, HANGING DROP",,"CRYSTALS WERE GROWN AT 13 DEGREES C BY THE HANGING DROP VAPOR DIFFUSION METHOD USING PRECIPITANT SOLUTIONS CONTAINING: 0.2M SODIUM CITRATE (PH 6.0 -6.5) AND 14-21% (W/V) POLYETHYLENE GLYCOL MW = 3350",286,"10.1073/pnas.1207759109","AXI","4AGC",40.64,"2","2","CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH AXITINIB (AG-013736) (N-Methyl-2-(3-((E)-2-pyridin-2-yl- vinyl)-1H-indazol-6-ylsulfanyl)-benzamide)","MGGHHHHHHGLEVLFQGPRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD","Homo sapiens","KDR, FLK1, VEGFR2","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","1","4AGC"
"4AGD",,"X-RAY DIFFRACTION",2.6,53.2,"VAPOR DIFFUSION, HANGING DROP",6.2,"CRYSTALS WERE GROWN AT 13 DEGREES C BY THE HANGING DROP VAPOR DIFFUSION METHOD USING PRECIPITANT SOLUTIONS CONTAINING: 0.222 M SODIUM CITRATE (PH 6.3) AND 17% (W/V) POLYETHYLENE GLYCOL 3350",286,"10.1073/pnas.1207759109","B49","4AGD",40.66,"2.81","2.81","CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH SUNITINIB (SU11248) (N-2-diethylaminoethyl)-5-((Z)-(5- fluoro-2-oxo-1H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3- carboxamide)","MGGHHHHHHGLEVLFQGPRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD","Homo sapiens","KDR, FLK1, VEGFR2","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","1","4AGD"
"4AGL",,"X-RAY DIFFRACTION",2.5,51,"VAPOR DIFFUSION, SITTING DROP",,"SITTING-DROP VAPOR DIFFUSION AT 21 DEGREE C. PROTEIN SOLUTION: 6 MG/ML PROTEIN IN 25 MM SODIUM PHOSPHATE, PH 7.2, 150 MM KCL, 5 MM DTT. RESERVOIR BUFFER: 100 MM HEPES, PH 7.2, 19% (W/V) POLYETHYLENE GLYCOL 4000, 5 MM DTT. SOAKING BUFFER: 30 MM COMPOUND IN 100 MM HEPES, PH 7.2, 10 MM SODIUM PHOSPHATE, PH 7.2, 19% (W/V) POLYETHYLENE GLYCOL 4000, 20 % (V/V) GLYCEROL, 150 MM KCL.",294,"10.1021/ja301056a","P84","4AGL",50.16,"1.7","1.7","Structure of the p53 core domain mutant Y220C bound to the stabilizing small molecule PhiKan784","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPCEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","CELLULAR TUMOR ANTIGEN P53","1","4AGL"
"4AGM",,"X-RAY DIFFRACTION",2.5,51,"VAPOR DIFFUSION, SITTING DROP",,"SITTING-DROP VAPOR DIFFUSION AT 21 DEGREE C. PROTEIN SOLUTION: 6 MG/ML PROTEIN IN 25 MM SODIUM PHOSPHATE, PH 7.2, 150 MM KCL, 5 MM DTT. RESERVOIR BUFFER: 100 MM HEPES, PH 7.2, 19% (W/V) POLYETHYLENE GLYCOL 4000, 5 MM DTT. SOAKING BUFFER: 30 MM COMPOUND IN 100 MM HEPES, PH 7.2, 10 MM SODIUM PHOSPHATE, PH 7.2, 19% (W/V) POLYETHYLENE GLYCOL 4000, 20 % (V/V) GLYCEROL, 150 MM KCL.",294,"10.1021/ja301056a","P86","4AGM",50.22,"1.52","1.52","Structure of the p53 core domain mutant Y220C bound to the stabilizing small molecule PhiKan5086","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPCEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","CELLULAR TUMOR ANTIGEN P53","1","4AGM"
"4AGN",,"X-RAY DIFFRACTION",2.5,51,"VAPOR DIFFUSION, SITTING DROP",,"SITTING-DROP VAPOR DIFFUSION AT 21 DEGREE C. PROTEIN SOLUTION: 6 MG/ML PROTEIN IN 25 MM SODIUM PHOSPHATE, PH 7.2, 150 MM KCL, 5 MM DTT. RESERVOIR BUFFER: 100 MM HEPES, PH 7.2, 19% (W/V) POLYETHYLENE GLYCOL 4000, 5 MM DTT. SOAKING BUFFER: 30 MM COMPOUND IN 100 MM HEPES, PH 7.2, 10 MM SODIUM PHOSPHATE, PH 7.2, 19% (W/V) POLYETHYLENE GLYCOL 4000, 20 % (V/V) GLYCEROL, 150 MM KCL.",294,"10.1021/ja301056a","NXG","4AGN",50.08,"1.6","1.6","Structure of the p53 core domain mutant Y220C bound to the stabilizing small molecule PhiKan5116","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPCEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","CELLULAR TUMOR ANTIGEN P53","1","4AGN"
"4AGO",,"X-RAY DIFFRACTION",2.5,51,"VAPOR DIFFUSION, SITTING DROP",,"SITTING-DROP VAPOR DIFFUSION AT 21 DEGREE C. PROTEIN SOLUTION: 6 MG/ML PROTEIN IN 25 MM SODIUM PHOSPHATE, PH 7.2, 150 MM KCL, 5 MM DTT. RESERVOIR BUFFER: 100 MM HEPES, PH 7.2, 19% (W/V) POLYETHYLENE GLYCOL 4000, 5 MM DTT. SOAKING BUFFER: 30 MM COMPOUND IN 100 MM HEPES, PH 7.2, 10 MM SODIUM PHOSPHATE, PH 7.2, 19% (W/V) POLYETHYLENE GLYCOL 4000, 20 % (V/V) GLYCEROL, 150 MM KCL.",294,"10.1021/ja301056a","P74","4AGO",50.28,"1.45","1.45","Structure of the p53 core domain mutant Y220C bound to the stabilizing small molecule PhiKan5174","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPCEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","CELLULAR TUMOR ANTIGEN P53","1","4AGO"
"4AGP",,"X-RAY DIFFRACTION",2.5,51,"VAPOR DIFFUSION, SITTING DROP",,"SITTING-DROP VAPOR DIFFUSION AT 21 DEGREE C. PROTEIN SOLUTION: 6 MG/ML PROTEIN IN 25 MM SODIUM PHOSPHATE, PH 7.2, 150 MM KCL, 5 MM DTT. RESERVOIR BUFFER: 100 MM HEPES, PH 7.2, 19% (W/V) POLYETHYLENE GLYCOL 4000, 5 MM DTT. SOAKING BUFFER: 30 MM COMPOUND IN 100 MM HEPES, PH 7.2, 10 MM SODIUM PHOSPHATE, PH 7.2, 19% (W/V) POLYETHYLENE GLYCOL 4000, 20 % (V/V) GLYCEROL, 150 MM KCL.",294,"10.1021/ja301056a","P51","4AGP",50.23,"1.5","1.5","Structure of the p53 core domain mutant Y220C bound to the stabilizing small molecule PhiKan5176","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPCEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","CELLULAR TUMOR ANTIGEN P53","1","4AGP"
"4AGQ",,"X-RAY DIFFRACTION",2.5,51,"VAPOR DIFFUSION, SITTING DROP",,"SITTING-DROP VAPOR DIFFUSION AT 21 DEGREE C. PROTEIN SOLUTION: 6 MG/ML PROTEIN IN 25 MM SODIUM PHOSPHATE, PH 7.2, 150 MM KCL, 5 MM DTT. RESERVOIR BUFFER: 100 MM HEPES, PH 7.2, 19% (W/V) POLYETHYLENE GLYCOL 4000, 5 MM DTT. SOAKING BUFFER: 13 MM COMPOUND IN 100 MM HEPES, PH 7.2, 10 MM SODIUM PHOSPHATE, PH 7.2, 19% (W/V) POLYETHYLENE GLYCOL 4000, 20 % (V/V) GLYCEROL, 150 MM KCL.",294,"10.1021/ja301056a","P96","4AGQ",50.23,"1.42","1.42","Structure of the p53 core domain mutant Y220C bound to the stabilizing small molecule PhiKan5196","SSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKLFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRAEYLDDRNTFRHSVVVPCEPPEVGSDCTTIHYNYMCYSSCMGGMNRRPILTIITLEDSSGNLLGRDSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNT","Homo sapiens","TP53, P53","CELLULAR TUMOR ANTIGEN P53","1","4AGQ"
"4AGU",,"X-RAY DIFFRACTION",2.08,41,,,"17.5% PEG 3350, 0.1 M (NH4)CL PH 6.3, 0.05 M MG FORMATE",,"10.1016/j.celrep.2017.12.083",,"4AGU",110.26,"2.4","2.4","CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN","MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKEHDKPAENLYFQ","Homo sapiens","CDKL1","CYCLIN-DEPENDENT KINASE-LIKE 1","1","4AGU"
"4AH6",,"X-RAY DIFFRACTION",3.25,62,"VAPOR DIFFUSION, SITTING DROP",7.5,"SITTING DROPLETS WERE PREPARED BY MIXING 0.5 UL HSADRS2 AT 10.6 MG/ML (IN 50 MM HEPES-NA PH 7.5, 150 MM NACL, 0.1 MM EDTA, 10% (V/V) GLYCEROL AND 1 MM DTT) WITH 0.5 UL BOTTOM PHASE OF A BIPHASIC MIXTURE OF 50 MM BIS-TRIS PH 5.5, 20% (M/V) PEG-3350 AND 1 M AMMONIUM SULFATE AND EQUILIBRATED BY VAPOR DIFFUSION OVER 50 UL OF THE LATTER SOLUTION.",,"10.1093/nar/gks1322",,"4AH6",281.51,"3.7","3.7","Human mitochondrial aspartyl-tRNA synthetase","MIPEFSSFVVRTNTCGELRSSHLGQEVTLCGWIQYRRQNTFLVLRDFDGLVQVIIPQDESAASVKKILCEAPVESVVQVSGTVISRPAGQENPKMPTGEIEIKVKTAELLNACKKLPFEIKNFVKKTEALRLQYRYLDLRSFQMQYNLRLRSQMVMKMREYLCNLHGFVDIETPTLFKRTPGGAKEFLVPSREPGKFYSLPQSPQQFKQLLMVGGLDRYFQVARCYRDEGSRPDRQPEFTQIDIEMSFVDQTGIQSLIEGLLQYSWPNDKDPVVVPFPTMTFAEVLATYGTDKPDTRFGMKIIDISDVFRNTEIGFLQDALSKPHGTVKAICIPEGAKYLKRKDIESIRNFAADHFNQEILPVFLNANRNWNSPVANFIMESQRLELIRLMETQEEDVVLLTAGEHNKACSLLGKLRLECADLLETRGVVLRDPTLFSFLWVVDFPLFLPKEENPRELESAHHPFTAPHPSDIHLLYTEPKKARSQHYDLVLNGNEIGGGSIRIHNAELQRYILATLLKEDVKMLSHLLQALDYGAPPHGGIALGLDRLICLVTGSPSIRDVIAFPKSFRGHDLMSNTPDSVPPEELKPYHIRVSKPTDSKAERAHVMYLEHHHHHH","Homo sapiens","DARS2","ASPARTATE--TRNA LIGASE, MITOCHONDRIAL","1","4AH6"
"4AHD",,"X-RAY DIFFRACTION",1.93,35,,,"20 % PEG 4K, 0.05 M NA/K TARTRATE, 0.1 M NACL, 0.1 M HEPES PH 7.0",,"10.1038/ncomms2126",,"4AHD",28.31,"2.47","2.47","Q12L - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis","QDNSRYTHFLTLHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP","Homo sapiens","ANG, RNASE5","ANGIOGENIN","1","4AHD"
"4AHE",,"X-RAY DIFFRACTION",3.19,61.52,,,"20 % PEG 4K, 0.4 M NA/K TARTRATE, 0.1 M NA CITRATE PH 5.5",,"10.1038/ncomms2126",,"4AHE",14.3,"2.08","2.08","K17I - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis","QDNSRYTHFLTQHYDAIPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP","Homo sapiens","ANG, RNASE5","ANGIOGENIN","1","4AHE"
"4AHF",,"X-RAY DIFFRACTION",2.4,48.3,,,"20 % PEG 4K, 0.05 M NA/K TARTRATE, 0.1 M NACL, 0.1 M HEPES PH 7.0",,"10.1038/ncomms2126",,"4AHF",14.52,"2.115","2.115","K17E - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis","QDNSRYTHFLTQHYDAEPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP","Homo sapiens","ANG, RNASE5","ANGIOGENIN","1","4AHF"
"4AHG",,"X-RAY DIFFRACTION",3.25,62.1,,,"20 % PEG 4K, 0.4 M NA/K TARTRATE, 0.1 M NA CITRATE PH 5.5",,"10.1038/ncomms2126",,"4AHG",14.35,"2.448","2.448","S28N - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis","QDNSRYTHFLTQHYDAKPQGRDDRYCENIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP","Homo sapiens","ANG, RNASE5","ANGIOGENIN","1","4AHG"
"4AHH",,"X-RAY DIFFRACTION",3.25,62.1,,,"20 % PEG 4K, 0.05 M NA/K TARTRATE, 0.1 M NACL, 0.1 M HEPES PH 7.0",,"10.1038/ncomms2126",,"4AHH",14.29,"2.498","2.498","R31K - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis","QDNSRYTHFLTQHYDAKPQGRDDRYCESIMKRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP","Homo sapiens","ANG, RNASE5","ANGIOGENIN","1","4AHH"
"4AHI",,"X-RAY DIFFRACTION",3.35,63,,,"20 % PEG 4K, 0.05 M NA/K TARTRATE, 0.1 M NACL, 0.1 M HEPES PH 7.0",,"10.1038/ncomms2126",,"4AHI",14.15,"2.798","2.798","K40I - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis","QDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCIDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP","Homo sapiens","ANG, RNASE5","ANGIOGENIN","1","4AHI"
"4AHJ",,"X-RAY DIFFRACTION",3.3,62,,,"20 % PEG 4K, 0.05 M NA/K TARTRATE, 0.1 M NACL, 0.1 M HEPES PH 7.0",,"10.1038/ncomms2126",,"4AHJ",14.3,"2.032","2.032","I46V - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis","QDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFVHGNKRSIKAICENKNGNPHRQNLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP","Homo sapiens","ANG, RNASE5","ANGIOGENIN","1","4AHJ"
"4AHK",,"X-RAY DIFFRACTION",3,58.9,,,"20 % PEG 4K, 0.4 M NA/K TARTRATE, 0.1 M NA CITRATE PH 5.5",,"10.1038/ncomms2126",,"4AHK",28.64,"1.97","1.97","K54E - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis","QDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIEAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP","Homo sapiens","ANG, RNASE5","ANGIOGENIN","1","4AHK"
"4AHL",,"X-RAY DIFFRACTION",2.51,51.1,,,"20 % PEG 4K, 0.4 M NA/K TARTRATE, 0.1 M NA CITRATE PH 5.5",,"10.1038/ncomms2126",,"4AHL",14.34,"2.053","2.053","P112L - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis","QDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLLVHLDQSIFRRP","Homo sapiens","ANG, RNASE5","ANGIOGENIN","1","4AHL"
"4AHM",,"X-RAY DIFFRACTION",3.3,62,,,"20 % PEG 4K, 0.4 M NA/K TARTRATE, 0.1 M NA CITRATE PH 5.5",,"10.1038/ncomms2126",,"4AHM",14.33,"1.96","1.96","V113I - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis","QDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPIHLDQSIFRRP","Homo sapiens","ANG, RNASE5","ANGIOGENIN","1","4AHM"
"4AHN",,"X-RAY DIFFRACTION",3.3,62,,,"20 % PEG 4K, 0.05 M NA/K TARTRATE, 0.1 M NACL, 0.1 M HEPES PH 7.0",,"10.1038/ncomms2126",,"4AHN",14.19,"2.977","2.977","R121H - Angiogenin mutants and amyotrophic lateral sclerosis - a biochemical and biological analysis","QDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFHRP","Homo sapiens","ANG, RNASE5","ANGIOGENIN","1","4AHN"
"4AI8",,"X-RAY DIFFRACTION",3.1,63,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES PH7.5, 1.6 M AMMONIUM SULFATE, 6% PEG400, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,"10.1021/jm300677j","DZA","4AI8",41.59,"2.4","2.4","FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH DAMINOZIDE","GSHMAATAAEAVASGSGEPREEAGALGPAWDESQLRSYSFPTRPIPRLSQSDPRAEELIENEEPVVLTDTNLVYPALKWDLEYLQENIGNGDFSVYSASTHKFLYYDEKKMANFQNFKPRSNREEMKFHEFVEKLQDIQQRGGEERLYLQQTLNDTVGRKIVMDFLGFNWNWINKQQGKRGWGQLTSNLLLIGMEGNVTPAHYDEQQNFFAQIKGYKRCILFPPDQFECLYPYPVHHPCDRQSQVDFDNPDYERFPNFQNVVGYETVVGPGDVLYIPMYWWHHIESLLNGGITITVNFWYKGAPTPKRIEYPLKAHQKVAIMRNIEKMLGEALGNPQEVGPLLNTMIKGRYN","Homo sapiens","HIF1AN, FIH1","HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR","1","4AI8"
"4AI9",,"X-RAY DIFFRACTION",2.4,49,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M CITRATE PH 5.5, 4MM NICL2, 20% PEG 3350, VAPOUR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1021/jm300677j","DZA","4AI9",89.54,"2.25","2.25","JMJD2A Complexed with Daminozide","MHHHHHHSSGVDLGTENLYFQSMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","LYSINE-SPECIFIC DEMETHYLASE 4A","1","4AI9"
"4AIW",,"X-RAY DIFFRACTION",2.1,41,"VAPOR DIFFUSION, HANGING DROP",,"15% PEG 3350, 100 MM MMT, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K",293,"10.1016/j.bbamem.2012.04.016",,"4AIW",17.95,"1.5","1.5","GAPR-1 with bound inositol hexakisphosphate","MGKSASKQFHNEVLKAHNEYRQKHGVPPLKLCKNLNREAQQYSEALASTRILKHSPESSRGQCGENLAWASYDQTGKEVADRWYSEIKNYNFQQPGFTSGTGHFTAMVWKNTKKMGVGKASASDGSSFVVARYFPAGNVVNEGFFEENVLPPKK","Homo sapiens","GLIPR2, C9orf19, GAPR1","GOLGI-ASSOCIATED PLANT PATHOGENESIS-RELATED PROTEIN 1","1","4AIW"
"4AIX",,"X-RAY DIFFRACTION",1.86,33.96,,3,"2.3 M AMMONIUM SULFATE, 40 % TREHALOSE",,"10.1074/jbc.M114.629550",,"4AIX",45.61,"1.8","1.8","Crystallographic structure of an amyloidogenic variant, 3rC34Y, of the germinal line lambda 3","SYELTQPPSVSVSPGQTASITCSGDKLGDKYAYWYQQKPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAWDSSTAVVFGGGTKLTVL","Homo sapiens",,"IG LAMBDA CHAIN V-IV REGION BAU","1","4AIX"
"4AIZ",,"X-RAY DIFFRACTION",2.1,41.33,,7.5,"0.2 M SODIUM CITRATE, 0.1 M HEPES, 30 % MPD, pH 7.5",,"10.1074/jbc.M114.629550",,"4AIZ",46.72,"1.75","1.75","Crystallographic structure of 3mJL2 from the germinal line lambda 3","SYELMQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTYVVFGGGTKLTVL","Homo sapiens","V2-17","V2-17 PROTEIN","1","4AIZ"
,,,,,,,,,,,,,,,,"SYELMQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTYVVFGGGTKLVVL","Homo sapiens","V2-17","V2-17 PROTEIN","2","4AIZ"
"4AJ0",,"X-RAY DIFFRACTION",1.85,33.65,,3,"1.6 M AMMONIUM SULFATE, 40 % TREHALOSE, pH 3",,"10.1074/jbc.M114.629550",,"4AJ0",45.45,"1.7","1.7","Crystallographic structure of an amyloidogenic variant, 3rCW, of the germinal line lambda 3","SYELTQPPSVSVSPGQTASITCSGDKLGDKYAYWYQQKPGQSPVLVIYQDSKRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCQAADSSTAVVFGGGTKLTVL","Homo sapiens",,"GERMINAL LINE LAMBDA 3 3RCW VARIANT","1","4AJ0"
"4AJD",,"X-RAY DIFFRACTION",2.16,43.15,,7,"13-18% PEG3350, 4-10 MM TCEP, 100 MM HEPES PH 7.5 AND 200MM MGCL2",,,,"4AJD",76.43,"2.3","2.3","Identification and structural characterization of PDE10 fragment inhibitors","NASICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATW","Homo sapiens","PDE10A","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE 10A, PDE10","1","4AJD"
"4AJF",,"X-RAY DIFFRACTION",2.16,43.15,,7,"13-18% PEG3350, 4-10 MM TCEP, 100 MM HEPES PH 7.5 AND 200 MM MGCL2",,,,"4AJF",76.25,"1.9","1.9","Identification and structural characterization of PDE10 fragment inhibitors","NASICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATW","Homo sapiens","PDE10A","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE 10A","1","4AJF"
"4AJG",,"X-RAY DIFFRACTION",2.16,43.15,,7,"13-18% PEG3350, 4-10 MM TCEP, 100 MM HEPES PH 7.5 AND 200MM MGCL2",,,,"4AJG",76.42,"2.3","2.3","Identification and structural characterization of PDE10 fragment inhibitors","NASICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATW","Homo sapiens","PDE10A","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE 10A","1","4AJG"
"4AJM",,"X-RAY DIFFRACTION",2.16,43.15,,,,,,,"4AJM",76.5,"2.4","2.4","Development of a plate-based optical biosensor methodology to identify PDE10 fragment inhibitors","NASICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATW","Homo sapiens","PDE10A","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE 10A","1","4AJM"
"4AJP",,"X-RAY DIFFRACTION",2.32,47,,6.5,"1.6M AMMONIUM SULPHATE, 0.1M MES PH 6.5, 10% 1, 4-DIOXANE",,"10.1021/jm201734r","88N","4AJP",153.05,"2.38","2.38","Human LDHA in complex with 2-((4-(4-((3-((2-methyl-1,3-benzothiazol- 6yl)amino)-3-oxo-propyl)amino)-4-oxo-butyl)phenyl)methyl)propanedioic acid","ATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQFHHHHHH","Homo sapiens","LDHA, PIG19","L-LACTATE DEHYDROGENASE A CHAIN","1","4AJP"
"4AJU",,"X-RAY DIFFRACTION",2.07,45,,4.5,"10% 2-PROPANOL, 0.2M LI2SO4, 0.1M NAAC, PH4.5",,"10.1182/blood-2012-03-419598",,"4AJU",48.97,"2.65","2.65","Crystal structure of the reactive loop cleaved ZPI in P41 space group","SAPSPQSPETPAPQNQTSRVVQAPKEEEEDEQEASEEKASEEEKAWLMASRQQLAKETSNFGFSLLRKISMRHDGNMVFSPFGMSLAMTGLMLGATGPTETQIKRGLHLQALKPTKPGLLPSLFKGLRETLSRNLELGLTQGSFAFIHKDFDVKETFFNLSKRYFDTECVPMNFRNASQAKRLMNHYINKETRGKIPKLFDEINPETKLILVDYILFKGKWLTPFDPVFTEVDTFHLDKYKTIKVPMMYGAGKFASTFDKNFRCHVLKLPYQGNATMLVVLMEKMGDHLALEDYLTTDLVETWLRNMKTRNMEVFFPKFKLDQKYEMHELLRQMGIRRIFSPFADLSELSATGRNLQVSRVLQRTVIEVDERGTEAVAGILSEITAR","Homo sapiens","SERPINA10, ZPI, UNQ707/PRO1358","PROTEIN Z-DEPENDENT PROTEASE INHIBITOR","1","4AJU"
,,,,,,,,,,,,,,,,"SMPPVIKIDRPFHFMIYEETSGMLLFLGRVVNPTLL","Homo sapiens","SERPINA10, ZPI, UNQ707/PRO1358","PROTEIN Z-DEPENDENT PROTEASE INHIBITOR","2","4AJU"
"4AJX",,"X-RAY DIFFRACTION",2.29,46.33,,7,"0.6 M IMIDAZOLE/MALONIC ACID PH 7.0",,"10.1021/bi3008609",,"4AJX",36.18,"1.2","1.2","Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engineered acylated insulin","FVNQHLCGSHLVEALYLVCGERGFFYTPK","Homo sapiens","INS","INSULIN","2","4AJX"
,,,,,,,,,,,,,,,,"GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN","1","4AJX"
"4AJZ",,"X-RAY DIFFRACTION",2.08,40.74,"MICROBATCH",7.5,"MICROBATCH METHOD 5MM PHENOL, 0.4M NACL; 6% (V/V) ETHANOL, 100MM HEPES PH 7.5",,"10.1021/bi3008609",,"4AJZ",11.69,"1.8","1.8","Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engineered acylated insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","4AJZ"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPK","Homo sapiens","INS","INSULIN B CHAIN","2","4AJZ"
"4AK0",,"X-RAY DIFFRACTION",3.43,64.16,,7.8,"pH 7.8",,"10.1021/bi3008609",,"4AK0",5.72,"2.28","2.28","Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engineered acylated insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","4AK0"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPK","Homo sapiens","INS","INSULIN B CHAIN","2","4AK0"
"4AK3",,"X-RAY DIFFRACTION",2.83,56.5,,,,,"10.1038/nsmb.2389",,"4AK3",28.86,"3.5","3.5","Crystal structure of Human fibrillar procollagen type III C- propeptide trimer","ETGHHHHHHSADEPMDFKINTDEIMTSLKSVNGQIESLISPDGSRKNPARNCRDLKFCHPELKSGEYWVDPNQGCKLDAIKVFCNMETGETCISANPLNVPRKHWWTDSSAEKKHVWFGESMDGGFQFSYGNPELPEDVLDVQLAFLRLLSSRASQQITYHCKNSIAYMDQASGNVKKALKLMGSNEGEFKAEGNSKFTYTVLEDGCTKHTGEWSKTVFEYRTRKAVRLPIVDIAPYDIGGPDQEFGVDVGPVCFL","Homo sapiens","COL3A1","COLLAGEN ALPHA-1(III) CHAIN","1","4AK3"
"4AK8",,"X-RAY DIFFRACTION",2.02,39.2,"VAPOR DIFFUSION, HANGING DROP",6,"HANGING DROP METHOD 100 MM MES PH 6.0, 200 MM MGCL2 AND 17% PEG 3350",,"10.1016/j.bpj.2014.10.075",,"4AK8",71.85,"1.4","1.4","Structure of F241L mutant of langerin carbohydrate recognition domain.","MWSHPQFEKIEGRMQNDILQVVSQGWKYFKGNFYYFSLIPKTWYSAEQFCVSRNSHLTSVTSESEQELLYKTAGGLIYWIGLTKAGMEGDWSWVDDTPFNKVQSARFWIPGEPNNAGNNEHCGNIKAPSLQAWNDAPCDKTFLFICKRPYVPSEP","Homo sapiens","CD207, CLEC4K","C-TYPE LECTIN DOMAIN FAMILY 4 MEMBER K","1","4AK8"
"4AKJ",,"X-RAY DIFFRACTION",2.11,41.84,,7.5,"pH 7.5",,"10.1021/bi3008609",,"4AKJ",12.24,"2.01","2.01","Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engineered acylated insulin","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","INSULIN A CHAIN","1","4AKJ"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPK","Homo sapiens","INS","INSULIN B CHAIN","2","4AKJ"
"4AKM",,"X-RAY DIFFRACTION",3.28,62.5,,5,"PROTEIN WAS CRYSTALLIZED FROM 5% PEG 6000, 0.1 M CITRIC ACID, PH 5.0; THEN SOAKED IN 0.014 M AMMONIUM HEXACHLOROIRIDATE(III)HYDRATE AND CRYO-PROTECTED IN 30% PEG 6000.",,"10.1186/1741-7007-10-62",,"4AKM",38.52,"2.687","2.687","Crystal structure of the human lysosome-associated membrane protein LAMP-3 (aka DC-LAMP)","SVKTGIYQVLNGSRLCIKAEMGIQLIVQDKESVFSPRRYFNIDPNATQASGNCGTRKSNLLLNFQGGFVNLTFTKDEESYYISEVGAYLTVSDPETVYQGIKHAVVMFQTAVGHSFKCVSEQSLQLSAHLQVKTTDVQLQAFDFEDDHFGNVDECSSDYTHHHHHH","Homo sapiens","LAMP3, DCLAMP, TSC403","LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEIN 3","1","4AKM"
"4AKN",,"X-RAY DIFFRACTION",2.02,39.24,,7,"20-26 % PEG3350, 0.2 M (NH4)2SO4, 100 MM HEPES PH 7.0. AT 20C",293,"10.1016/j.bmcl.2012.02.041","S5B","4AKN",54.6,"1.82","1.82","N-Terminal Bromodomain of Human BRD2 With tbutyl-phenyl-amino- dimethyl-oxazolyl-quinoline-carboxylic acid","GSSHHHHHHSSGLVPRGSHMSNPKKPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPNSHKKGA","Homo sapiens","BRD2, KIAA9001, RING3","BROMODOMAIN-CONTAINING PROTEIN 2","1","4AKN"
"4AKV",,"X-RAY DIFFRACTION",2.38,48.31,,,,,,,"4AKV",91.33,"2.651","2.651","Crystal structure of human sorting nexin 33 (SNX33)","MHHHHHHSSGVDLGTENLYFQSMYSIEMGPRGPQWKANPHPFACSVEDPTKQTKFKGIKSYISYKLTPTHAASPVYRRYKHFDWLYNRLLHKFTVISVPHLPEKQATGRFEEDFIEKRKRRLILWMDHMTSHPVLSQYEGFQHFLSCLDDKQWKMGKRRAEKDEMVGASFLLTFQIPTEHQDLQDVEDRVDTFKAFSKKMDDSVLQLSTVASELVRKHVGGFRKEFQKLGSAFQAISHSFQMDPPFCSEALNSAISHTGRTYEAIGEMFAEQPKNDLFQMLDTLSLYQGLLSNFPDIIHLQKGAFAKVKESQRMSDEGRMVQDEADGIRRRCRVVGFALQAEMNHFHQRRELDFKHMMQNYLRQQILFYQRVGQQLEKTLRMYDNL","Homo sapiens","SNX33, SH3PX3, SH3PXD3C, SNX30","SORTING NEXIN-33","1","4AKV"
"4AL0",,"X-RAY DIFFRACTION",4.1,69.99,,8,"pH 8",,"10.1073/pnas.1218504110",,"4AL0",18.78,"1.16","1.16","Crystal structure of Human PS-1","MPAHSLVMSSPALPAFLLCSTLLVIKMYVVAIITGQVRLRKKAFANPEDALRHGGPQYCRSDPDVERCLRAHRNDMETIYPFLFLGFVYSFLGPNPFVAWMHFLVFLVGRVAHTVAYLGKLRAPIRSVTYTLAQLPCASMALQILWEAARHL","Homo sapiens","PTGES, MGST1L1, MPGES1, PGES, PIG12","PROSTAGLANDIN E SYNTHASE","1","4AL0"
"4AL1",,"X-RAY DIFFRACTION",4.1,69.99,,8,"pH 8",,"10.1073/pnas.1218504110",,"4AL1",18.53,"1.95","1.95","Crystal structure of Human PS-1 GSH-analog complex","MPAHSLVMSSPALPAFLLCSTLLVIKMYVVAIITGQVRLRKKAFANPEDALRHGGPQYCRSDPDVERCLRAHRNDMETIYPFLFLGFVYSFLGPNPFVAWMHFLVFLVGRVAHTVAYLGKLRAPIRSVTYTLAQLPCASMALQILWEAARHL","Homo sapiens","PTGES, MGST1L1, MPGES1, PGES, PIG12","PROSTAGLANDIN E SYNTHASE","1","4AL1"
"4ALD",,"X-RAY DIFFRACTION",2.88,56.9,,7.5,"pH 7.5",,"10.1110/ps.8.2.291",,"4ALD",39.68,"2.8","2.8","HUMAN MUSCLE FRUCTOSE 1,6-BISPHOSPHATE ALDOLASE COMPLEXED WITH FRUCTOSE 1,6-BISPHOSPHATE","PYQYPALTPEQKKELSDIAHRIVAPGKGILAADESTGSIAKRLQSIGTENTEENRRFYRQLLLTADDRVNPCIGGVILFHETLYQKADDGRPFPQVIKSKGGVVGIKVDKGVVPLAGTNGETTTQGLDGLSERCAQYKKDGADFAKWRCVLKIGEHTPSALAIMENANVLARYASICQQNGIVPIVEPEILPDGDHDLKRCQYVTEKVLAAVYKALSDHHIYLEGTLLKPNMVTPGHACTQKFSHEEIAMATVTALRRTVPPAVTGITFLSGGQSEEEASINLNAINKCPLLKPWALTFSYGRALQASALKAWGGKKENLKAAQEEYVKRALANSLACQGKYTPSGQAGAAASESLFVSNHAY","Homo sapiens","ALDOA, ALDA","FRUCTOSE-BISPHOSPHATE ALDOLASE","1","4ALD"
"4ALG",,"X-RAY DIFFRACTION",2.05,40.03,,4.7,"150MM NH4SO4, 25%MME, 100MM NAAC PH 4.7, 20C",293,"10.1016/j.bmcl.2012.02.041","1GH","4ALG",18.48,"1.6","1.6","N-Terminal Bromodomain of Human BRD2 With IBET-151","GSSHHHHHHSSGLVPRGSHMSNPKKPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKNSHKKGA","Homo sapiens","BRD2, KIAA9001, RING3","BROMODOMAIN-CONTAINING PROTEIN 2","1","4ALG"
"4ALH",,"X-RAY DIFFRACTION",2.04,39.78,,7,"0.1M HEPES PH 7.0, 26% PEG3350, 0.2M (NH4)2SO4, 20C",293,"10.1021/jm201283q",,"4ALH",54.75,"1.97","1.97","N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3,5 dimethyl-4-phenyl-1,2- oxazole","GSSHHHHHHSSGLVPRGSHMSNPKKPGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKNSHKKGA","Homo sapiens","BRD2, KIAA9001, RING3","BROMODOMAIN CONTAINING 2","1","4ALH"
"4ALU",,"X-RAY DIFFRACTION",3.45,64.4,,7.2,"pH 7.2",,"10.1016/j.bmcl.2012.04.025","79O","4ALU",37.94,"2.6","2.6","Benzofuropyrimidinone Inhibitors of Pim-1","MHHHHHHGENLYFQGSLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGSGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","SERINE/THREONINE-PROTEIN KINASE PIM-1","1","4ALU"
"4ALV",,"X-RAY DIFFRACTION",3.9,63,,7.2,"pH 7.2",,"10.1016/j.bmcl.2012.04.025","R9P","4ALV",38.11,"2.59","2.59","Benzofuropyrimidinone Inhibitors of Pim-1","MHHHHHHGENLYFQGSLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","SERINE/THREONINE-PROTEIN KINASE PIM-1","1","4ALV"
"4ALW",,"X-RAY DIFFRACTION",2.9,64,,7.2,"pH 7.2",,"10.1016/j.bmcl.2012.04.025","HY7","4ALW",38.07,"1.92","1.92","Benzofuropyrimidinone Inhibitors of Pim-1","MHHHHHHGENLYFQGSLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","PIM-1 KINASE","1","4ALW"
"4AMH",,"X-RAY DIFFRACTION",2.6,52,"VAPOR DIFFUSION, SITTING DROP",7.5,"SITTING DROP VAPOR DIFFUSION, 0.1 M MES PH 6.0, 2.4 M AMMONIUM SULFATE",,"10.1371/journal.pone.0050055",,"4AMH",22.96,"2.3","2.3","Influence of circular permutation on the folding pathway of a PDZ domain","MHHHHHLVPRGSKGLGFSIAGGVGNQHWPGDNSIYVTKIIEGGAAHKDGKLQIGDKLLAVNNVALEEVTHEEAVTALKNTSDFVYLKVAKPGSGEKIMEIKLIKGP","Homo sapiens","DLG1","DISKS LARGE HOMOLOG 1","1","4AMH"
"4AMT",,"X-RAY DIFFRACTION",4.21,70.82,,,"1.0 M LITHIUM SULFATE, 0.1 M CITRATE PH 5.6, 0.5 M AMMONIUM SULFATE",,,,"4AMT",43.58,"2.6","2.6","Crystal structure at 2.6A of human prorenin","LPTDTTTFKRIFLKRMPSIRESLKERGVDMARLGPEWSQPMKRLTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","RENIN","1","4AMT"
"4AN2",,"X-RAY DIFFRACTION",2.32,47,,8.9,"MEK1 (8 MG/ML) WAS INCUBATED WITH INHIBITOR (300 MICROMOLAR FINAL CONCENTRATION) AND AMPPCP (2.8 MM FINAL CONCENTRATION) FOR TWO HOURS ON ICE, FOLLOWED BY CRYSTALLIZION VS. 26.5% PEG-2000 MME, 0.1 M TRIMETHYLAMINE N- OXIDE AND 0.1 M TRIS (PH 8.9)",,"10.1021/ml300049d","EUI","4AN2",34.68,"2.5","2.5","Crystal structures of human MEK1 with carboxamide-based allosteric inhibitor XL518 (GDC-0973), or related analogs.","MALGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGEGHHHHHH","Homo sapiens","MAP2K1, MEK1, PRKMK1","DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1","1","4AN2"
"4AN3",,"X-RAY DIFFRACTION",2.32,47,"VAPOR DIFFUSION, SITTING DROP",7.9,"SITTING DROP VAPOR DIFFUSION VS. 26.5 % PEG-2000 MME, 0.1 M TRIMETHYLAMINE N-OXIDE, 0.1 M TRIS (PH 8.9)",,"10.1021/ml300049d","5Y0","4AN3",34.63,"2.1","2.1","Crystal structures of human MEK1 with carboxamide-based allosteric inhibitor XL518 (GDC-0973), or related analogs.","MALGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGEGHHHHHH","Homo sapiens","MAP2K1, MEK1, PRKMK1","DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1","1","4AN3"
"4AN9",,"X-RAY DIFFRACTION",2.32,47,"VAPOR DIFFUSION, SITTING DROP",8.9,"SITTING DROP VAPOR-DIFFUSION VS. 26.5 % PEG-2000 MME, 0.1 M TRIMETHYLAMINE N-OXIDE, 0.1 M TRIS (PH 8.9)",,"10.1021/ml300049d","2P7","4AN9",34.59,"2.8","2.8","Crystal structures of human MEK1 with carboxamide-based allosteric inhibitor XL518 (GDC-0973), or related analogs.","MALGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGEGHHHHHH","Homo sapiens","MAP2K1, MEK1, PRKMK1","DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1","1","4AN9"
"4ANB",,"X-RAY DIFFRACTION",2.32,47,"VAPOR DIFFUSION, SITTING DROP",8.9,"SITTING DROP VAPOR DIFFUSION VS. 26.5 % PEG-2000 MME, 0.1 M TRIMETHYLAMINE N-OXIDE, 0.1 M TRIS (PH 8.9)",,"10.1021/ml300049d","YQY","4ANB",34.62,"2.2","2.2","Crystal structures of human MEK1 with carboxamide-based allosteric inhibitor XL518 (GDC-0973), or related analogs.","MALGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGEGHHHHHH","Homo sapiens","MAP2K1, MEK1, PRKMK1","DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1","1","4ANB"
"4ANK",,"X-RAY DIFFRACTION",2.44,49.6,"VAPOR DIFFUSION, HANGING DROP",7.4,"POTASSIUM CHLORIDE, POTASSIUM PHOSPHATE, AMMONIUM SULFATE, PH 7.4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K",298,"10.1371/journal.pone.0043522",,"4ANK",31.81,"1.7","1.7","Crystallographic study of novel transthyretin ligands exhibiting negative-cooperativity between two T4 binding sites.","MASHRLLLLCLAGLVFVSEAGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","TRANSTHYRETIN","1","4ANK"
"4ANL",,"X-RAY DIFFRACTION",2.18,43.54,"VAPOR DIFFUSION, HANGING DROP",8.5,"CRYSTALS WERE GROWN BY THE HANGING DROP VAPOR DIFFUSION METHOD AT 13 DEGRESS CELCIUS BY MIXING 2 MICROLITERS OF PROTEIN SOLUTION WITH A RESERVOIR SOLUTION CONTAINING: 19% (W/V) PEG 3350, 0.1 M TRIS PH 8.5, 0.2 M LITHIUM SULFATE, AND 0.1 (W/V) BETA-OCTYLGLCOSIDE",286,"10.1021/jm401805h",,"4ANL",38.61,"1.7","1.7","Structure of G1269A Mutant Anaplastic Lymphoma Kinase","MAHHHHHHDYGIPTTENLYFQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIADFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKV","Homo sapiens","ALK","ALK TYROSINE KINASE RECEPTOR","1","4ANL"
"4ANP",,"X-RAY DIFFRACTION",2.77,55,,,"40 MM PIPES, 20% PEG 2000, PH 6.8",,"10.1002/cbic.201200188","3QI","4ANP",37.9,"2.11","2.11","Crystal structure of human phenylalanine hydroxylase in complex with a pharmacological chaperone","ATVHELSRDKKKDTVPWFPRTIQELDRFANQILSYGAELDADHPGFKDPVYRARRKQFADIAYNYRHGQPIPRVEYMEEEKKTWGTVFKTLKSLYKTHACYEYNHIFPLLEKYCGFHEDNIPQLEDVSQFLQTCTGFRLRPVAGLLSSRDFLGGLAFRVFHCTQYIRHGSKPMYTPEPDICHELLGHVPLFSDRSFAQFSQEIGLASLGAPDEYIEKLATIYWFTVEFGLCKQGDSIKAYGAGLLSSFGELQYCLSEKPKLLPLELEKTAIQNYTVTEFQPLYYVAESFNDAKEKVRNFAATIPRPFSVRYDPYTQRIEVLDNT","Homo sapiens","PAH","PHENYLALANINE-4-HYDROXYLASE","1","4ANP"
"4ANQ",,"X-RAY DIFFRACTION",2.18,38.8,"VAPOR DIFFUSION, HANGING DROP",8.5,"CRYSTALS WERE GROWN BY THE HANGING DROP VAPOR DIFFUSION METHOD AT 13 DEGREES CELSIUS BY MIXING 2 MICROLITERS OF PROTEIN SOLUTION WITH A RESERVOIR SOLUTION CONTAINING: 18% (W/V) PEG 3350, 0.1 M TRIS PH 8.5, 0.2M LITHIUM SULFATE, AND 0.1(W/V) BETA-OCTYLGLCOSIDE.",286,"10.1021/jm401805h","VGH","4ANQ",39.06,"1.76","1.76","Structure of G1269A Mutant Anaplastic Lymphoma Kinase in Complex with Crizotinib","MAHHHHHHDYGIPTTENLYFQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIADFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKV","Homo sapiens","ALK","ALK TYROSINE KINASE RECEPTOR","1","4ANQ"
"4ANS",,"X-RAY DIFFRACTION",2.15,42.9,"VAPOR DIFFUSION, HANGING DROP",8.5,"CRYSTALS WERE GROWN BY THE HANGING DROP VAPOR DIFFUSION METHOD AT 13 DEGRESS CELSIUS BY MIXING 2 MICROLITERS OF PROTEIN SOLUTION WITH A RESERVOIR SOLUTION CONTAINING: 18% (W/V) PEG 3350, 0.1 M TRIS PH 8.5, 0.2M LITHIUM SULFATE, 0.1(W/V) BETA-OCTYLGLCOSIDE.",286,,"VGH","4ANS",39.08,"1.85","1.85","Structure of L1196M,G1269A Double Mutant Anaplastic Lymphoma Kinase in Complex with Crizotinib","MAHHHHHHDYGIPTTENLYFQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIADFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKV","Homo sapiens","ALK","ALK TYROSINE KINASE RECEPTOR","1","4ANS"
"4ANU",,"X-RAY DIFFRACTION",2.32,49,,7.2,"pH 7.2",,"10.1021/jm300403a","EM7","4ANU",112.49,"2.81","2.81","Complexes of PI3Kgamma with isoform selective inhibitors.","MLLGSSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAEFGLVPRGSGHHHHHH","Homo sapiens","PIK3CG","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","1","4ANU"
"4ANV",,"X-RAY DIFFRACTION",2.4,49,,7.2,"pH 7.2",,"10.1021/jm300403a","751","4ANV",112.71,"2.13","2.13","Complexes of PI3Kgamma with isoform selective inhibitors.","MLLGSSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPELTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAEFGLVPRGSGHHHHHH","Homo sapiens","PIK3CG","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","1","4ANV"
"4ANW",,"X-RAY DIFFRACTION",2.32,47,"VAPOR DIFFUSION, HANGING DROP",7.5,"CRYSTALS WERE GROWN AT 19C IN HANGING DROPS USING VAPOR DIFFUSION. THE COMPLEX WAS FORMED BY INCUBATING 49.5UL OF PI3KG-HIS6 (7.2 MG/ML IN 20 MM TRIS-HCL, PH 7.2, 50 MM (NH4)2SO4, AND 1 MM TCEP) WITH 0.5UL OF LIGAND (100 MM STOCK IN 100% DMSO) FOR 30 MINUTES AT 4C. CRYSTALS OF THE BINARY COMPLEX WERE OBTAINED BY MIXING 1.0UL OF THE PI3KG:INHIBITOR COMPLEX WITH 1.0UL OF A RESERVOIR SOLUTION CONSISTING OF 16-21% PEG 4K, 0.25 M (NH4)2SO4, AND 0.1 M TRIS-HCL, PH 7.5.",292,"10.1021/jm300403a","O92","4ANW",112.65,"2.31","2.31","Complexes of PI3Kgamma with isoform selective inhibitors.","MLLGSSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAEFGLVPRGSGHHHHHH","Homo sapiens","PIK3CG","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","1","4ANW"
"4ANX",,"X-RAY DIFFRACTION",2.32,47,"VAPOR DIFFUSION, HANGING DROP",7.5,"CRYSTALS WERE GROWN AT 19C IN HANGING DROPS USING VAPOR DIFFUSION. THE COMPLEX WAS FORMED BY INCUBATING 49.5UL OF PI3KG-HIS6 (7.2 MG/ML IN 20 MM TRIS-HCL, PH 7.2, 50 MM (NH4)2SO4, AND 1 MM TCEP) WITH 0.5UL OF LIGAND (100 MM STOCK IN 100% DMSO) FOR 30 MINUTES AT 4C. CRYSTALS OF THE BINARY COMPLEX WERE OBTAINED BY MIXING 1.0UL OF THE PI3KG:INHIBITOR COMPLEX WITH 1.0UL OF A RESERVOIR SOLUTION CONSISTING OF 16-21% PEG 4K, 0.25 M (NH4)2SO4, AND 0.1 M TRIS-HCL, PH 7.5.",292,"10.1021/jm300403a","534","4ANX",112.62,"2.73","2.73","Complexes of PI3Kgamma with isoform selective inhibitors.","MLLGSSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHINGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAEFGLVPRGSGHHHHHH","Homo sapiens","PIK3CG","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","1","4ANX"
"4AOF",,"X-RAY DIFFRACTION",2.52,51.22,,7.6,"19% PEG 3350, 0.2 M AMMONIUM SULFATE, 0.1 M TRIS-HCL PH 7.6",,"10.1038/nchembio.957","7L0","4AOF",110.23,"3.3","3.3","Selective small molecule inhibitor discovered by chemoproteomic assay platform reveals regulation of Th17 cell differentiation by PI3Kgamma","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA","Homo sapiens","PIK3CG","PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM","1","4AOF"
"4AOH",,"X-RAY DIFFRACTION",2.15,42.8,,7,"20 % PEG 4K, 0.05 M NA/K TARTRATE, 0.1 M NACL, 0.1 M HEPES PH 7.0",,"10.1038/ncomms2126",,"4AOH",14.54,"1.041","1.041","Structural snapshots and functional analysis of human angiogenin variants associated with Amyotrophic Lateral Sclerosis (ALS)","AQDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP","Homo sapiens","ANG, RNASE5","ANGIOGENIN","1","4AOH"
"4AOI",,"X-RAY DIFFRACTION",2.4,48.7,"VAPOR DIFFUSION, HANGING DROP",,"CRYSTALS WERE OBTAINED AT 13 DEGREES CELCIUS FROM HANGING DROPS CONTAINING 1.2 MICROLITERS OF PROTEIN: COMPOUND SOLUTION (1:5 MOLAR RATIO) AND 1.2 MICROLITERS OF PRECIPITATING SOLUTION (0.05 M CITRATE-PHOSPHATE, PH 4.6, 0-25 MM NACL, 21 % (W/V) PEG-3350). TO OBTAIN LARGER CRYSTALS, STREAK SEEDING WAS EMPLOYED USING THE CRYSTALS JUST MENTIONED AS DONORS, UNDER THE SAME CONDITIONS EXCEPT 275 MM NACL WAS USED AND THE DROPS WERE EQUILIBRATED OVERNIGHT BEFORE SEEDING WAS PERFORMED.",286,"10.1021/jm300967g","4K0","4AOI",35.23,"1.9","1.9","Crystal structure of C-MET kinase domain in complex with 4-(3-((1H- pyrrolo(2,3-b)pyridin-3-yl)methyl)-(1,2,4)triazolo(4,3-b)(1,2,4) triazin-6-yl)benzonitrile","MVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHHHHHHHH","Homo sapiens","MET","HEPATOCYTE GROWTH FACTOR RECEPTOR","1","4AOI"
"4AOJ",,"X-RAY DIFFRACTION",3.56,65,"VAPOR DIFFUSION, HANGING DROP",8,"HANGING DROP METHOD. 1 UL TRKA AT 10 MG/ML IN 10 MG/ML IN 20 MM TRIS PH 8.5, 0.1% CHAPS, 1MM TCEP, 8.7% GLYCEROL MIXED WITH 1 UL MOTHER LIQUOR CONTAINING 35% W/V GLYCEROL, 140 MM NA/K TARTRATE, 100 MM HEPES PH 8.0 SUPPLEMENTED WITH 40 MM ZINC CHLORIDE.",,"10.1021/ml300074j","V4Z","4AOJ",112.26,"2.75","2.75","Human TrkA in complex with the inhibitor AZ-23","GAMGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG","Homo sapiens","NTRK1, MTC, TRK, TRKA","HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR","1","4AOJ"
"4AOT",,"X-RAY DIFFRACTION",2.64,53.4,,6.5,"0.2M NAI, 0.1M BISTRISPROPANE PH 6.5, 20% PEG3350, 10% ETHYLENE GLYCOL",,,,"4AOT",70.07,"2.33","2.33","Crystal Structure of Human Serine Threonine Kinase-10 (LOK) Bound to GW830263A","SMRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAEVMEE","Homo sapiens","STK10, LOK","Serine/threonine-protein kinase 10","1","4AOT"
"4AOW",,"X-RAY DIFFRACTION",2.69,54.36,,8.5,"pH 8.5",,"10.1107/S1744309112027480",,"4AOW",113.6,"2.45","2.45","Crystal structure of the human Rack1 protein at a resolution of 2.45 angstrom","MHHHHHHSSGVDLGTENLYFQSMMTEQMTLRGTLKGHNGWVTQIATTPQFPDMILSASRDKTIIMWKLTRDETNYGIPQRALRGHSHFVSDVVISSDGQFALSGSWDGTLRLWDLTTGTTTRRFVGHTKDVLSVAFSSDNRQIVSGSRDKTIKLWNTLGVCKYTVQDESHSEWVSCVRFSPNSSNPIIVSCGWDKLVKVWNLANCKLKTNHIGHTGYLNTVTVSPDGSLCASGGKDGQAMLWDLNEGKHLYTLDGGDIINALCFSPNRYWLCAATGPSIKIWDLEGKIIVDELKQEVISTSSKAEPPQCTSLAWSADGQTLFAGYTDNLVRVWQVTIGTR","Homo sapiens","RACK1, GNB2L1, HLC7, PIG21","GUANINE NUCLEOTIDE-BINDING PROTEIN SUBUNIT BETA-2-LIKE 1","1","4AOW"
"4AP0",,"X-RAY DIFFRACTION",2.21,44,,8.5,"0.1M TRIS, PH 8.5; 0.02M MGCL2; 20%(W/V) POLYETHYLENE GLYCOL 8000; 4DEGC",277,"10.1107/S0907444912027965","G7X","4AP0",168.93,"2.594","2.594","The mitotic kinesin Eg5 in complex with Mg-ADP and ispinesib","GPMASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","KINESIN-LIKE PROTEIN KIF11","1","4AP0"
"4AP5",,"X-RAY DIFFRACTION",4.2,70,,,"12% PEG 20000, 0.02 M TRIS PH 8.5",,"10.1038/emboj.2012.143",,"4AP5",96.71,"3.003","3.003","Crystal structure of human POFUT2","SGQEFWPGQSAADILSGAASRRRYLLYDVNPPEGFNLRRDVYIRIASLLKTLLKTEEWVLVLPPWGRLYHWQSPDIHQVRIPWSEFFDLPSLNKNIPVIEYEQFIAESGGPFIDQVYVLQSYAEGWKEGTWEEKVDERPCIDQLLYSQDKHEYYRGWFWGYEETRGLNVSCLSVQGSASIVAPLLLRNTSARSVMLDRAENLLHDHYGGKEYWDTRRSMVFARHLREVGDEFRSRHLNSTDDADRIPFQEDWMKMKVKLGSALGGPYLGVHLRRKDFIWGHRQDVPSLEGAVRKIRSLMKTHRLDKVFVATDAVRKEYEELKKLLPEMVRFEPTWEELELYKDGGVAIIDQWICAHARFFIGTSVSTFSFRIHEEREILGLDPKTTYNRFCGDQEKACEQPTHWKITY","Homo sapiens","POFUT2, C21orf80, FUT13, KIAA0958","GDP-FUCOSE PROTEIN O-FUCOSYLTRANSFERASE 2","1","4AP5"
"4AP6",,"X-RAY DIFFRACTION",3.2,63,,,"20% PEG 3350, 0.2M NASCN",,"10.1038/emboj.2012.143",,"4AP6",202.04,"3.401","3.401","Crystal structure of human POFUT2 E54A mutant in complex with GDP- fucose","SMASHHHHHHSSGDYKDDDDKLEVLFQGPSGAASRRRYLLYDVNPPAGFNLRRDVYIRIASLLKTLLKTEEWVLVLPPWGRLYHWQSPDIHQVRIPWSEFFDLPSLNKNIPVIEYEQFIAESGGPFIDQVYVLQSYAEGWKEGTWEEKVDERPCIDQLLYSQDKHEYYRGWFWGYEETRGLNVSCLSVQGSASIVAPLLLRNTSARSVMLDRAENLLHDHYGGKEYWDTRRSMVFARHLREVGDEFRSRHLNSTDDADRIPFQEDWMKMKVKLGSALGGPYLGVHLRRKDFIWGHRQDVPSLEGAVRKIRSLMKTHRLDKVFVATDAVRKEYEELKKLLPEMVRFEPTWEELELYKDGGVAIIDQWICAHARFFIGTSVSTFSFRIHEEREILGLDPKTTYNRFCGDQEKACEQPTHWKITY","Homo sapiens","POFUT2, C21orf80, FUT13, KIAA0958","GDP-FUCOSE PROTEIN O-FUCOSYLTRANSFERASE 2","1","4AP6"
"4AP7",,"X-RAY DIFFRACTION",2.38,48.4,"VAPOR DIFFUSION, HANGING DROP",4.6,"CRYSTALS WERE OBTAINED AT 13 DEGRESS C IN 1-5 DAYS FROM HANGING DROPS CONTAINING 1.2 MICROLITERS OF PROTEIN: COMPOUND SOLUTION (1:5 MOLAR RATIO) AND 1.2 MICROLITERS OF PRECIPITATING SOLUTION (0.05 M CITRATE-PHOSPHATE, PH 4.6, 0-25 MM NACL, 21 % (W/V) PEG-3350). TO OBTAIN LARGER CRYSTALS, STREAK SEEDING WAS EMPLOYED USING THE CRYSTALS JUST MENTIONED AS DONORS, UNDER THE SAME CONDITIONS EXCEPT 275 MM NACL WAS USED AND THE DROPS WERE EQUILIBRATED OVERNIGHT BEFORE SEEDING WAS PERFORMED",286,"10.1021/jm300967g","F47","4AP7",35.2,"1.8","1.8","Crystal structure of C-MET kinase domain in complex with 4-((6-(4- fluorophenyl)-(1,2,4)triazolo(4,3-b)(1,2,4)triazin-3-yl)methyl)phenol","MVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHHHHHHHH","Homo sapiens","MET","HEPATOCYTE GROWTH FACTOR RECEPTOR","1","4AP7"
"4AP8",,"X-RAY DIFFRACTION",6.28,80.42,,,"0.1M HEPES PH 7.3, 0.8M POTASSIUM/SODIUM TARTRATE",,,,"4AP8",60.87,"2.78","2.78","Crystal structure of human Molybdopterin synthase catalytic subunit (MOCS2B)","EVEEKSKDVINFTAEKLSVDEVSQLVISPLCGAISLFVGTTRNNFEGKKVISLEYEAYLPMAENEVRKICSDIRQKWPVKHIAVFHRLGLVPVSEASIIIAVSSAHRAASLEAVSYAIDTLKAKVPIWKKEIYEE","Homo sapiens","MOCS2, MCBPE, MOCO1","MOLYBDOPTERIN SYNTHASE CATALYTIC SUBUNIT","1","4AP8"
"4APC",,"X-RAY DIFFRACTION",2.15,42.71,,7.5,"0.2 M AMMONIUM CHLORIDE, 20 %(W/V) PEG 3350, pH 7.5",,"10.1038/s41598-017-05325-w",,"4APC",80.07,"2.1","2.1","Crystal Structure of Human NIMA-related Kinase 1 (NEK1)","MHHHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYKKYGDKK","Homo sapiens","NEK1, KIAA1901","SERINE/THREONINE-PROTEIN KINASE NEK1","1","4APC"
"4APD",,"SOLUTION NMR",,,,,,,,,"4APD",3.77,,,"Liraglutide","HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG","Homo sapiens","GCG","LIRAGLUTIDE","1","4APD"
"4APP",,"X-RAY DIFFRACTION",2.15,42.87,"VAPOR DIFFUSION, HANGING DROP",6.2,"CRYSTALS WERE GROWN FROM THE HANGING DROP VAPOR DIFFUSION METHOD AT 21 DEGREES CELCIUS BY MIXING 3.6 MICROLITERS OF A 10 MG/ML PROTEIN SOLUTION WITH A RESERVIOR SOLUTION CONTAINING: 5% (W/V) MEPEG 5K, 0.1 M IMIDAZOLE AT PH 6.2, 0.1 M (NH4)2HPO4 AND 5MM DTT",294,"10.1021/jm300204j","N53","4APP",34.08,"2.2","2.2","Crystal Structure of the Human p21-Activated Kinase 4 in Complex with (S)-N-(5-(3-benzyl-1-methylpiperazine-4-carbonyl)-6,6-dimethyl-1,4,5, 6-tetrahydropyrrolo(3,4-c)pyrazol-3-yl)-3-phenoxybenzamide","GSHMSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","PAK4, KIAA1142","SERINE/THREONINE-PROTEIN KINASE PAK 4","1","4APP"
"4APT",,"X-RAY DIFFRACTION",2.13,42.3,,,"PROTEIN SAMPLES AT 20 MG/ML CRYSTALLISED IN 0.4 M POTASSIUM SODIUM TARTRATE AT ROOM TEMPERATURE.",,"10.1016/j.bpj.2013.01.048",,"4APT",55.13,"2.5","2.5","The structure of the AXH domain of ataxin-1.","GAMAPPTLPPYFMKGSIIQLANGELKKVEDLKTEDFIQSAEISNDLKIDSSTVERIEDSHSPGVAVIQFAVGEHRAQVSVEVLVEYPFFVFGQGWSSCCPERTSQLFDLPCSKLSVGDVCISLTLK","Homo sapiens","ATXN1, ATX1, SCA1","ATAXIN-1","1","4APT"
"4APU",,"X-RAY DIFFRACTION",2.31,46.8,,6.5,"20-30% POLYETHYLENE GLYCOL 3350, 0.1 M HEPES PH 6.5, 100 MM MG2SO4, 10% GLYCEROL",,"10.1074/jbc.M111.308403","A2K","4APU",60.93,"1.9","1.9","PR X-Ray structures in agonist conformations reveal two different mechanisms for partial agonism in 11beta-substituted steroids","GSHMGQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK","Homo sapiens","PGR, NR3C3","PROGESTERONE RECEPTOR","1","4APU"
"4AQ3",,"X-RAY DIFFRACTION",2.3,47,,,,,"10.1016/j.bmcl.2012.04.103","398","4AQ3",122.26,"2.4","2.4","HUMAN BCL-2 WITH PHENYLACYLSULFONAMIDE INHIBITOR","GSHMAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDDVEENRTEAPEGTESEVVHLALRQAGDDFSRRYRGDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMR","Homo sapiens","BCL2L1, BCL2L, BCLX, BCL2","APOPTOSIS REGULATOR BCL-2, BCL-2-LIKE PROTEIN 1","1","4AQ3"
"4AQB",,"X-RAY DIFFRACTION",6.51,81.1,,6.5,"0.2 M CALCIUM ACETATE, 0.1 M SODIUM CACODYLATE PH 6.5, 40% W/V PEG 400",,"10.1074/jbc.M112.386680",,"4AQB",43.36,"4.2","4.2","MBL-Ficolin Associated Protein-1, MAP-1 aka MAP44","HTVELNNMFGQIQSPGYPDSYPSDSEVTWNITVPDGFRIKLYFMHFNLESSYLCEYDYVKVETEDQVLATFCGRETTDTEQTPGQEVVLSPGSFMSITFRSDFSNEERFTGFDAHYMAVDVDECKEREDEELSCDHYCHNYIGGYYCSCRFGYILHTDNRTCRVECSDNLFTQRTGVITSPDFPNPYPKSSECLYTIELEEGFMVNLQFEDIFDIEDHPEVPCPYDYIKIKVGPKVLGPFCGEKAPEPISTQSHSVLILFHSDNSGENRGWRLSYRAAGNECPELQPPVHGKIEPSQAKYFFKDQVLVSCDTGYKVLKDNVEMDTFQIECLKDGTWSNKIPTCKKNEIDLESELKSEQVTE","Homo sapiens","MASP1, CRARF, CRARF1, PRSS5","MANNAN-BINDING LECTIN SERINE PROTEASE 1","1","4AQB"
"4AQC",,"X-RAY DIFFRACTION",3.1,60.28,"VAPOR DIFFUSION, HANGING DROP",,"32% PEG 3350, 0.2 M AMMONIUM SULFATE, 0.1 M BIS-TRIS, PH 6.8, HANGING DROP VAPOUR DIFFUSION",,"10.1021/jm300248q","88A","4AQC",72.29,"1.9","1.9","Triazolopyridine-based Inhibitor of Janus Kinase 2","GAMAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","TYROSINE-PROTEIN KINASE JAK2","1","4AQC"
"4AQD",,"X-RAY DIFFRACTION",2.7,55,,7.4,"PROTEIN WAS CRYSTALLIZED FROM 20% PEG 3350, 0.2 M NH4OAC PH 7.4, AT 293 K",293,"10.1111/j.1742-4658.2012.08672.x",,"4AQD",128.35,"2.5","2.5","Crystal structure of fully glycosylated human butyrylcholinesterase","RSEDDIIIATKNGKVRGMNLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDNYTKAEEILSRSIVKRWANFAKYGNPNETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","BUTYRYLCHOLINESTERASE","1","4AQD"
"4AQH",,"X-RAY DIFFRACTION",3.2,61,"VAPOR DIFFUSION, HANGING DROP",5.6,"PAI-1 WAS CONCENTRATED TO ABOUT 4 G/L IN A BUFFER CONTAINING 10 MM SODIUM ACETATE PH 5.6, 150 MM SODIUM CHLORIDE AND 1 MM EDTA. AZ3976 WAS DISSOLVED IN DEUTERATED DMSO AND ADDED TO THE PROTEIN SAMPLE TO A FINAL CONCENTRATION OF 0.3 MM. CRYSTALS WERE OBTAINED BY THE HANGING DROP VAPOR DIFFUSION TECHNIQUE: 2.5 UL PROTEIN SAMPLE WAS MIXED WITH 1 UL OF A WELL SOLUTION CONTAINING 2.0 M SODIUM CHLORIDE, 100 MM BIS-TRIS PH 6.8",,"10.1074/jbc.M112.371732","TB7","4AQH",130.65,"2.4","2.4","Plasminogen activator inhibitor type-1 in complex with the inhibitor AZ3976","GSHMVHHPPSYVAHLASDFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDDKGMAPALRHLYKELMGPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIINDWVKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAPYEKEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQADFTSLSDQEPLHVAQALQKVKIEVNESGTVASSSTAVIVSARMAPEEIIMDRPFLFVVRHNPTGTVLFMGQVMEP","Homo sapiens","SERPINE1, PAI1, PLANH1","PLASMINOGEN ACTIVATOR INHIBITOR 1","1","4AQH"
"4AQI",,"X-RAY DIFFRACTION",2.34,47.45,,,"45-50 MM ZINC ACETATE DIHYDRATE, 18-20% PEG 3350",,"10.1186/1472-6807-12-16",,"4AQI",12.15,"1.7","1.7","Structure of human S100A15 bound to zinc and calcium","GSAMGMSNTQAERSIIGMIDMFHKYTGRDGKIEKPSLLTMMKENFPNFLSACDKKGIHYLATVFEKKDKNEDKKIDFSEFLSLLGDIAADYHKQSHGAAPCSGGSQAAA","Homo sapiens","S100A7A, S100A15, S100A7L1","PROTEIN S100-A7A","1","4AQI"
"4AQJ",,"X-RAY DIFFRACTION",3.36,63.43,,,"0.2M AMMONIUM SULFATE, 0.1M BISTRIS PH 5.5, 20-25% PEG 3350",,"10.1186/1472-6807-12-16",,"4AQJ",12.17,"1.6","1.6","Structure of human S100A7 D24G bound to zinc and calcium","GSAMGMSNTQAERSIIGMIDMFHKYTRRDGKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLGDIATDYHKQSHGAAPCSGGSQAAA","Homo sapiens","S100A7, PSOR1, S100A7C","PROTEIN S100-A7","1","4AQJ"
"4AQL",,"X-RAY DIFFRACTION",2.43,49.4,,7,"20% PEG 6000 100 MM HEPES PH 7.0 200 MM MGCL2",,"10.1371/journal.pone.0037724",,"4AQL",54.01,"1.99","1.99","HUMAN GUANINE DEAMINASE IN COMPLEX WITH VALACYCLOVIR","MHHHHHHSSGVDLGTENLYFQSMCAAQMPPLAHIFRGTFVHSTWTCPMEVLRDHLLGVSDSGKIVFLEEASQQEKLAKEWCFKPCEIRELSHHEFFMPGLVDTHIHASQYSFAGSSIDLPLLEWLTKYTFPAEHRFQNIDFAEEVYTRVVRRTLKNGTTTACYFATIHTDSSLLLADITDKFGQRAFVGKVCMDLNDTFPEYKETTEESIKETERFVSEMLQKNYSRVKPIVTPRFSLSCSETLMGELGNIAKTRDLHIQSHISENRDEVEAVKNLYPSYKNYTSVYDKNNLLTNKTVMAHGCYLSAEELNVFHERGASIAHCPNSNLSLSSGFLNVLEVLKHEVKIGLGTDVAGGYSYSMLDAIRRAVMVSNILLINKVNEKSLTLKEVFRLATLGGSQALGLDGEIGNFEVGKEFDAILINPKASDSPIDLFYGDFFGDISEAVIQKFLYLGDDRNIEEVYVGGKQVVPFSSSV","Homo sapiens","GDA, KIAA1258","GUANINE DEAMINASE","1","4AQL"
"4AQP",,"X-RAY DIFFRACTION",2.45,49.78,,6.5,"PROTEIN SAMPLES AT 20 MG/ML CRYSTALLISED IN 0.1 M MES, PH 6.5, 10% W/V PWG 20000 AT ROOM TEMPERATURE.",,"10.1016/j.bpj.2013.01.048",,"4AQP",55.28,"2.452","2.452","The structure of the AXH domain of ataxin-1.","GAMAPPTLPPYFMKGSIIQLANGELKKVEDLKTEDFIQSAEISNDLKIDSSTVERIEDSHSPGVAVIQFAVGEHRAQVSVEVLVEYPFFVFGQGWSSCCPERTSQLFDLPCSKLSVGDVCISLTLK","Homo sapiens","ATXN1, ATX1, SCA1","ATAXIN-1","1","4AQP"
"4ARK",,"X-RAY DIFFRACTION",3.55,65.34,,,"0.1 M IMIDAZOLE-MALATE, 300 MM(NH4)H2PO4, 13% PEG 8000, PH 5.8",,"10.1016/j.bmcl.2013.02.028","M3K","4ARK",38.86,"2.6","2.6","CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MAP KINASE KINASE 1 (MEK1) IN COMPLEX WITH A SMALL MOLECULE INHIBITOR AND ADP","MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGVLEHHHHHH","Homo sapiens","MAP2K1, MEK1, PRKMK1","DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1","1","4ARK"
"4AS0",,"X-RAY DIFFRACTION",3.37,63.49,,7.5,"200 MM SODIUM CITRATE, 100 MM HEPES, 30 % MPD, PH 7.5",,"10.1039/c2dt30940h",,"4AS0",31.95,"2.3","2.3","Cyclometalated Phthalimides as Protein Kinase Inhibitors","PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH","Homo sapiens","PIM1","SERINE/THREONINE-PROTEIN KINASE PIM-1","1","4AS0"
"4AS4",,"X-RAY DIFFRACTION",2.28,46.05,,7,"40% W/V PEG 3350 AND 0.2 M MAGNESIUM FORMATE, pH 7",,"10.1107/S1744309112035191",,"4AS4",61.42,"1.7","1.7","Structure of human inositol monophosphatase 1","MADPWQECMDYAVTLARQAGEVVCEAIKNEMNVMLKSSPVDLVTATDQKVEKMLISSIKEKYPSHSFIGEESVAAGEKSILTDNPTWIIDPIDGTTNFVHRFPFVAVSIGFAVNKKIEFGVVYSCVEGKMYTARKGKGAFCNGQKLQVSQQEDITKSLLVTELGSSRTPETVRMVLSNMEKLFCIPVHGIRSVGTAAVNMCLVATGGADAYYEMGIHCWDVAGAGIIVTEAGGVLMDVTGGPFDLMSRRVIAANNRILAERIAKEIQVIPLQRDDED","Homo sapiens","IMPA1, IMPA","INOSITOL MONOPHOSPHATASE 1","1","4AS4"
"4AS7",,"X-RAY DIFFRACTION",2.87,57.14,,,"0.02 M CACL2 DEHYDRATE, 0.02 M CADMIUM CHLORIDE HYDRATE, 0.02 M COBALT(II) CHLORIDE HEXAHYDRATE, 20% W/V PEG-3350",,"10.1021/jm4006274","6LX","4AS7",42.92,"2.4","2.4","Eg5 complex 1","MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLDGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","KINESIN-LIKE PROTEIN KIF11","1","4AS7"
"4ASC",,"X-RAY DIFFRACTION",2.52,51.31,,,"0.1 M CITRATE PH 5.3, 20%(W/V) PEG 6000",,"10.1074/jbc.M112.437996",,"4ASC",35.38,"1.78","1.78","Crystal structure of the Kelch domain of human KBTBD5","MFLQDLIFMISEEGAVAYDPAANECYCASLSSQVPKNHVSLVTKENQVFVAGGLFYNEDNKEDPMSAYFLQFDHLDSEWLGMPPLPSPRCLFGLGEALNSIYVVGGREIKDGERCLDSVMCYDRLSFKWGESDPLPYVVYGHTVLSHMDLVYVIGGKGSDRKCLNKMCVYDPKKFEWKELAPMQTARSLFGATVHDGRIIVAAGVTDTGLTSSAEVYSITDNKWAPFEAFPQERSSLSLVSLVGTLYAIGGFATLETESGELVPTELNDIWRYNEEEKKWEGVLREIAYAAGATFLPVRLNVLRLTKMAENLYFQ","Homo sapiens","KLHL40, KBTBD5, SRYP","KELCH REPEAT AND BTB DOMAIN-CONTAINING PROTEIN 5","1","4ASC"
"4ASD",,"X-RAY DIFFRACTION",2.6,53,"VAPOR DIFFUSION, HANGING DROP",6.2,"CRYSTALS WERE OBTAINED BY THE HANGING DROP VAPOR DIFFUSION METHOD AT 13 DEGREES C USING PRECIPITANT SOLUTIONS CONTAINING APPROXIMATELY: 0.2M SODIUM CITRATE AND 14-21% (W/V) POLYETHYLENE GLYCOL 3350., pH 6.2",286,"10.1073/pnas.1207759109","BAX","4ASD",40.72,"2.03","2.03","Crystal Structure of VEGFR2 (Juxtamembrane and Kinase Domains) in Complex with SORAFENIB (BAY 43-9006)","MGGHHHHHHGLEVLFQGPRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD","Homo sapiens","KDR, FLK1, VEGFR2","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","1","4ASD"
"4ASE",,"X-RAY DIFFRACTION",2.6,53,"VAPOR DIFFUSION, HANGING DROP",6.2,"CRYSTALS WERE OBTAINED BY THE HANGING DROP VAPOR DIFFUSION METHOD AT 13 DEGREES C BY THE USING PRECIPITANT SOLUTIONS CONTAINING APPROXIMATELY: 0.2M SODIUM CITRATE AND 14-21% (W/V) POLYETHYLENE GLYCOL 3350., pH 6.2",286,"10.1073/pnas.1207759109","AV9","4ASE",40.71,"1.83","1.83","CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH TIVOZANIB (AV-951)","MGGHHHHHHGLEVLFQGPRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD","Homo sapiens","KDR, FLK1, VEGFR2","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","1","4ASE"
"4ASI",,"X-RAY DIFFRACTION",4.07,69.83,,,"0.05M NA MALONATE; 19% (W/V) PEG3350",,,,"4ASI",525.01,"2.8","2.8","Crystal structure of human ACACA C-terminal domain","SMLINTPYVTKDLLQSKRFQAQSLGTTYIYDIPEMFRQSLIKLWESMSTQAFLPSPPLPSDMLTYTELVLDDQGQLVHMNRLPGGNEIGMVAWKMTFKSPEYPEGRDIIVIGNDITYRIGSFGPQEDLLFLRASELARAEGIPRIYVSANSGARIGLAEEIRHMFHVAWVDPEDPYKGYRYLYLTPQDYKRVSALNSVHCEHVEDEGESRYKITDIIGKEEGIGPENLRGSGMIAGESSLAYNEIITISLVTCRAIGIGAYLVRLGQRTIQVENSHLILTGAGALNKVLGREVYTSNNQLGGIQIMHNNGVTHCTVCDDFEGVFTVLHWLSYMPKSVHSSVPLLNSKDPIDRIIEFVPTKTPYDPRWMLAGRPHPTQKGQWLSGFFDYGSFSEIMQPWAQTVVVGRARLGGIPVGVVAVETRTVELSIPADPANLDSEAKIIQQAGQVWFPDSAFKTYQAIKDFNREGLPLMVFANWRGFSGGMKDMYDQVLKFGAYIVDGLRECCQPVLVYIPPQAELRGGSWVVIDSSINPRHMEMYADRESRGSVLEPEGTVEIKFRRKDLVKTMRRVDPVYIHLAERLGTPELSTAERKELENKLKEREEFLIPIYHQVAVQFADLHDTPGRMQEKGVISDILDWKTSRTFFYWRLRRLLLEDLVKKKIHNANPELTDGQIQAMLRRWFVEVEGTVKAYVWDNNKDLAEWLEKQLTEEDGVHSVIEENIKCISRDYVLKQIRSLVQANPEVAMDSIIHMTQHISPTQRAEVIRIL","Homo sapiens","ACACA, ACAC, ACC1, ACCA","ACETYL-COA CARBOXYLASE 1","1","4ASI"
"4ASK",,"X-RAY DIFFRACTION",2.3,46.5,,8.5,"0.1M TRIS HCL, BICINE PH 8.5, 37.5% MPD, PEG1K, PEG3350, 0.03M MGCL2, 0.03M CACL2",,"10.1038/nature11262","K0I","4ASK",117.13,"1.86","1.86","CRYSTAL STRUCTURE OF JMJD3 WITH GSK-J1","MDVVRASRNAKVKGKFRESYLSPAQSVKPKINTEEKLPREKLNPPTPSIYLESKRDAFSPVLLQFCTDPRNPITVIRGLAGSLRLNLGLFSTKTLVEASGEHTVEVRTQVQQPSDENWDLTGTRQIWPCESSRSHTTIAKYAQYQASSFQESLQEEKESEDEESEEPDSTTGTPPSSAPDPKNHHIIKFGTNIDLSDAKRWKPQLQELLKLPAFMRVTSTGNMLSHVGHTILGMNTVQLYMKVPGSRTPGHQENNNFCSVNINIGPGDCEWFAVHEHYWETISAFCDRHGVDYLTGSWWPILDDLYASNIPVYRFVQRPGDLVWINAGTVHWVQATGWCNNIAWNVGPLTAYQYQLALERYEWNEVKNVKSIVPMIHVSWNVARTVKISDPDLFKMIKFCLLQSMKHCQVQRESLVRAGKKIAYQGRVKDEPAYYCNECDVEVFNILFVTSENGSRNTYLVHCEGCARRRSAGLQGVVVLEQYRTEELAQAYDAFTLAPASTSRHHHHHH","Homo sapiens","KDM6B, JMJD3, KIAA0346","LYSINE-SPECIFIC DEMETHYLASE 6B","1","4ASK"
"4ASX",,"X-RAY DIFFRACTION",2.62,53.07,,,"20 % PEG 3350 0.20 M NA(MALONATE)",,,,"4ASX",74.19,"2.05","2.05","Crystal structure of Activin receptor type-IIA (ACVR2A) kinase domain in complex with dihydro-Bauerine C","MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLTNI","Homo sapiens","ACVR2A, ACVR2","ACTIVIN RECEPTOR TYPE-2A","1","4ASX"
"4ASZ",,"X-RAY DIFFRACTION",2.93,58,,8,"THE APO-TRKB PROTEIN WAS CONCENTRATED TO 6 MG/ML AND CRYSTALLIZED IN 3 M NA-FORMATE, PH 8.0 AT 4 DEGREES C.",277,"10.1016/j.jmb.2012.08.002",,"4ASZ",34.35,"1.7","1.7","Crystal structure of apo TrkB kinase domain","GAMDTFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPVYLDILG","Homo sapiens","NTRK2, TRKB","BDNF/NT-3 GROWTH FACTORS RECEPTOR","1","4ASZ"
"4AT3",,"X-RAY DIFFRACTION",2.83,56,,6,"THE TRKB-CPD5N COMPLEX WAS OBTAINED BY COCRYSTALLIZATION IN 1.6 M AMMONIUM SULFATE, 50 MM MES, PH 6.0 AT 4 DEGREESC IN PRESENCE OF 2 MM OF INHIBITOR.",277,"10.1016/j.jmb.2012.08.002","LTI","4AT3",34.71,"1.77","1.77","CRYSTAL STRUCTURE OF TRKB KINASE DOMAIN IN COMPLEX WITH CPD5N","GAMDTFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPVYLDILG","Homo sapiens","NTRK2, TRKB","BDNF/NT-3 GROWTH FACTORS RECEPTOR","1","4AT3"
"4AT4",,"X-RAY DIFFRACTION",2.83,56,,8,"THE TRKB-EX429 COMPLEX WAS OBTAINED BY COCRYSTALLIZATION IN 2.1 M NA-FORMATE, 50 MM HEPES, PH 8.0 AT 4 DEGREES C IN PRESENCE OF 1 MM OF INHIBITOR.",277,"10.1016/j.jmb.2012.08.002","T6E","4AT4",34.8,"2.36","2.36","CRYSTAL STRUCTURE OF TRKB KINASE DOMAIN IN COMPLEX WITH EX429","GAMDTFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPVYLDILG","Homo sapiens","NTRK2, TRKB","BDNF/NT-3 GROWTH FACTORS RECEPTOR","1","4AT4"
"4AT5",,"X-RAY DIFFRACTION",2.83,56,,8,"THE TRKB-GW2580 COMPLEX WAS OBTAINED BY COCRYSTALLIZATION IN 2.4 M NA-FORMATE, 50 MM HEPES, PH 8.0 AT 4 DEGREES C IN PRESENCE OF 2 MM OF INHIBITOR.",277,"10.1016/j.jmb.2012.08.002","MUJ","4AT5",34.81,"1.71","1.71","CRYSTAL STRUCTURE OF TRKB KINASE DOMAIN IN COMPLEX WITH GW2580","GAMDTFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPVYLDILG","Homo sapiens","NTRK2, TRKB","BDNF/NT-3 GROWTH FACTORS RECEPTOR","1","4AT5"
"4ATM",,"X-RAY DIFFRACTION",2.99,58.82,,7,"20% PEG 3350, 0.1 M CITRATE PH 5.5",,,,"4ATM",29.04,"1.783","1.783","Crystal structure of the BAR domain of human Amphiphysin, isoform 1 at 1.8 Angstrom resolution featuring increased order at the N- terminus.","SMADIKTGIFAKNVQKRLNRAQEKVLQKLGKADETKDEQFEEYVQNFKRQEAEGTRLQRELRGYLAAIKGMQEASMKLTESLHEVYEPDWYGREDVKMVGEKCDVLWEDFHQKLVDESLLTLDTYLGQFPDIKNRIAKRSRKLVDYDSARHHLEALQSSKRKDESRISKAEEEFQKAQKVFEEFNVDLQEELPSLWSRRVGFYVNTFKNVSSLEAKFHKEIAVLCHKLYEVMTKLGDQHADKA","Homo sapiens","AMPH, AMPH1","AMPHIPHYSIN","1","4ATM"
"4AU8",,"X-RAY DIFFRACTION",2.5,51,,5.4,"pH 5.4",,"10.1016/j.bmcl.2012.07.068","Z3R","4AU8",68.48,"1.9","1.9","Crystal structure of compound 4a in complex with cdk5, showing an unusual binding mode to the hinge region via a water molecule","GAMGSQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP","Homo sapiens","CDK5, CDKN5, PSSALRE","CYCLIN-DEPENDENT KINASE 5","1","4AU8"
"4AUA",,"X-RAY DIFFRACTION",2.18,43.68,,5.7,"5MG/ML 0.1 M MES/NAOH PH 5.7,, 4.5% W/V PEG 3350, 25 MM SODIUM NITRATE, 10% V/V GLYCEROL, 10 DEGREES CELSIUS",287,"10.1021/ml200241a","4AU","4AUA",35.23,"2.31","2.31","Liganded X-ray crystal structure of cyclin dependent kinase 6 (CDK6)","MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQHHHHHH","Homo sapiens","CDK6, CDKN6","CYCLIN-DEPENDENT KINASE 6","1","4AUA"
"4AUV",,"X-RAY DIFFRACTION",2.33,47.2,,4.3,"0.1 M SODIUM ACETATE PH 4.3, 0.2 M AMMONIUM SULPHATE, 2 % PEG 4000",,"10.1016/j.jmb.2013.03.005",,"4AUV",35.19,"1.999","1.999","Crystal Structure of the BRMS1 N-terminal region","SEDYERRRSECVSEMLDLEKQFSELKEKLFRERLS","Homo sapiens","BRMS1","BREAST CANCER METASTASIS SUPPRESSOR 1","1","4AUV"
"4AVM",,"X-RAY DIFFRACTION",1.95,36.38,,7.5,"30% JEFFAMINE 2001, 0.1M HEPES PH 7.0, 100 MM NAI.",,,,"4AVM",28.66,"1.91","1.91","Crystal structure of the N-BAR domain of human bridging integrator 2.","SMGLFAKQVQKKFSRAQEKVLQKLGKAVETKDERFEQSASNFYQQQAEGHKLYKDLKNFLSAVKVMHESSKRVSETLQEIYSSEWDGHEELKAIVWNNDLLWEDYEEKLADQAVRTMEIYVAQFSEIKERIAKRGRKLVDYDSARHHLEAVQNAKKKDEAKTAKAEEEFNKAQTVFEDLNQELLEELPILYNSRIGCYVTIFQNISNLRDVFYREMSKLNHNLYEVMSKLERQHSNK","Homo sapiens","BIN2, BRAP1","BRIDGING INTEGRATOR 2","1","4AVM"
"4AVP",,"X-RAY DIFFRACTION",1.72,28.55,,7.5,"2.5M SODIUM FORMATE, pH 7.5",,"10.1074/jbc.M115.646737",,"4AVP",49.87,"1.82","1.82","Crystal structure of the DNA-binding domain of human ETV1.","SMGPTSQRRGSLQLWQFLVALLDDPSNSHFIAWTGRGMEFKLIEPEEVARRWGIQKNRPAMNYDKLSRSLRYYYEKGIMQKVAGERYVYKFVCDPEALFSMAFSDN","Homo sapiens","ETV1, ER81","ETS TRANSLOCATION VARIANT 1","1","4AVP"
"4AVS",,"X-RAY DIFFRACTION",2.7,55,,8,"0.06 M TRIS-HCL, PH 8, 16% PEG 550 MME, 0.01 M CACL2, 0.08 M NACL AND 0.1% NAN3",,"10.1107/S1399004714013455",,"4AVS",118.7,"1.399","1.399","Structure of N-Acetyl-L-Proline bound to Serum Amyloid P Component","HTDLSGKVFVFPRESVTDHVNLITPLEKPLQNFTLCFRAYSDLSRAYSLFSYNTQGRDNELLVYKERVGEYSLYIGRHKVTSKVIEKFPAPVHICVSWESSSGIAEFWINGTPLVKKGLRQGYFVEAQPKIVLGQEQDSYGGKFDRSQSFVGEIGDLYMWDSVLPPENILSAYQGTPLPANILDWQALNYEIRGYVIIKPLVWV","Homo sapiens","APCS, PTX2","SERUM AMYLOID P-COMPONENT","1","4AVS"
"4AVT",,"X-RAY DIFFRACTION",7.5,83.61,,7.6,"60MM TRIS-HCL, 80MM NACL, 15% PEG550 MME, pH 7.6",,"10.1107/S1399004714013455",,"4AVT",237.54,"3.2","3.2","Structure of CPHPC bound to Serum Amyloid P Component","HTDLSGKVFVFPRESVTDHVNLITPLEKPLQNFTLCFRAYSDLSRAYSLFSYNTQGRDNELLVYKERVGEYSLYIGRHKVTSKVIEKFPAPVHICVSWESSSGIAEFWINGTPLVKKGLRQGYFVEAQPKIVLGQEQDSYGGKFDRSQSFVGEIGDLYMWDSVLPPENILSAYQGTPLPANILDWQALNYEIRGYVIIKPLVWV","Homo sapiens","APCS, PTX2","SERUM AMYLOID P-COMPONENT","1","4AVT"
"4AVU",,"X-RAY DIFFRACTION",2.4,49,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1021/ml400292s","LDR","4AVU",55.9,"2.4","2.4","Crystal structure of human tankyrase 2 in complex with 6(5H)- phenanthridinone","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4AVU"
"4AVV",,"X-RAY DIFFRACTION",2.67,54,,4.6,"PH 4.6",,"10.1107/S1399004714013455","GHE","4AVV",126.14,"1.6","1.6","Structure of CPHPC bound to Serum Amyloid P Component","HTDLSGKVFVFPRESVTDHVNLITPLEKPLQNFTLCFRAYSDLSRAYSLFSYNTQGRDNELLVYKERVGEYSLYIGRHKVTSKVIEKFPAPVHICVSWESSSGIAEFWINGTPLVKKGLRQGYFVEAQPKIVLGQEQDSYGGKFDRSQSFVGEIGDLYMWDSVLPPENILSAYQGTPLPANILDWQALNYEIRGYVIIKPLVWV","Homo sapiens","APCS, PTX2","SERUM AMYLOID P-COMPONENT","1","4AVV"
"4AVW",,"X-RAY DIFFRACTION",2.4,49,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22 % PEG 3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1021/ml400292s","G18","4AVW",55.91,"2.15","2.15","Crystal structure of human tankyrase 2 in complex with TIQ-A","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4AVW"
"4AVX",,"X-RAY DIFFRACTION",2.01,38.94,,,"0.1 M BIS-TRIS PH 5.5; 25% PEG 3350",,,,"4AVX",27.02,"1.68","1.68","Hepatocyte Growth Factor-Regulated Tyrosine Kinase Substrate (Hgs-Hrs) bound to an IP2 compound at 1.68 A Resolution","SMGRGSGTFERLLDKATSQLLLETDWESILQICDLIRQGDTQAKYAVNSIKKKVNDKNPHVALYALEVMESVVKNCGQTVHDEVANKQTMEELKDLLKRQVEVNVRNKILYLIQAWAHAFRNEPKYKVVQDTYQIMKVEGHVFPEFKESDAMFAAERAPDWVDAEECHRCRVQFGVMTRKHHCRACGQIFCGKCSSKYSTIPKFGIEKEVRVCEPCYEQLNRKAEG","Homo sapiens","HGS, HRS","HEPATOCYTE GROWTH FACTOR-REGULATED TYROSINE KINASE SUBSTRATE","1","4AVX"
"4AW0",,"X-RAY DIFFRACTION",2.3,47,,7.5,"1.2 M NA CITRATE, 0.1 M HEPES PH 7.5, 0.01 M DTT",,"10.1016/j.chembiol.2012.07.017","MJF","4AW0",36.6,"1.43","1.43","Human PDK1 Kinase Domain in Complex with Allosteric Compound PS182 Bound to the PIF-Pocket","GAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDPK1, PDK1","3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1","1","4AW0"
"4AW1",,"X-RAY DIFFRACTION",2.3,47,,7.5,"1.2 M NA CITRATE, 0.1 M HEPES PH 7.5, 0.01 M DTT",,"10.1016/j.chembiol.2012.07.017","21O","4AW1",36.64,"1.68","1.68","Human PDK1 Kinase Domain in Complex with Allosteric Compound PS210 Bound to the PIF-Pocket","GAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT","Homo sapiens","PDPK1, PDK1","3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1","1","4AW1"
"4AW5",,"X-RAY DIFFRACTION",2.42,48.8,,8,"pH 8.0",,"10.1016/j.bmcl.2012.06.029","30K","4AW5",33.39,"2.33","2.33","Complex of the EphB4 kinase domain with an oxindole inhibitor","PWGSMEFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKIVARE","Homo sapiens","EPHB4, HTK, MYK1, TYRO11","EPHRIN TYPE-B RECEPTOR 4","1","4AW5"
"4AW6",,"X-RAY DIFFRACTION",3.17,61.21,,7.5,"0.1 M HEPES, PH 7.5, 0.1 M CALCIUM CHLORIDE, 41.5%(V/V) PEG 400",,"10.1126/science.1231513",,"4AW6",226.25,"3.4","3.4","Crystal structure of the human nuclear membrane zinc metalloprotease ZMPSTE24 (FACE1)","MGMWASLDALWEMPAEKRIFGAVLLFSWTVYLWETFLAQRQRRIYKTTTHVPPELGQIMDSETFEKSRLYQLDKSTFSFWSGLYSETEGTLILLFGGIPYLWRLSGRFCGYAGFGPEYEITQSLVFLLLATLFSALAGLPWSLYNTFVIEEKHGFNQQTLGFFMKDAIKKFVVTQCILLPVSSLLLYIIKIGGDYFFIYAWLFTLVVSLVLVTIYADYIAPLFDKFTPLPEGKLKEEIEVMAKSIDFPLTKVYVVEGSKRSSHSNAYFYGFFKNKRIVLFDTLLEEYSVLNKDIQEDSGMEPRNEEEGNSEEIKAKVKNKKQGCKNEEVLAVLGHELGHWKLGHTVKNIIISQMNSFLCFFLFAVLIGRKELFAAFGFYDSQPTLIGLLIIFQFIFSPYNEVLSFCLTVLSRRFEFQADAFAKKLGKAKDLYSALIKLNKDNLGFPVSDWLFSMWHYSHPPLLERLQALKTMKQHAENLYFQ","Homo sapiens","ZMPSTE24, FACE1, STE24","CAAX PRENYL PROTEASE 1 HOMOLOG","1","4AW6"
"4AWI",,"X-RAY DIFFRACTION",2.38,48.26,,6.5,"0.05 M AMMONIUM SULFATE, 0.05 M BIS-TRIS PH 6.5, 30% V/V PENTAERYTHRITOL (15/4 EO/OH)",,"10.1016/j.bmcl.2012.06.065","AQ2","4AWI",43.15,"1.91","1.91","Human Jnk1alpha kinase with 4-phenyl-7-azaindole IKK2 inhibitor.","GPLGSMSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLE","Homo sapiens","MAPK8, JNK1, PRKM8, SAPK1, SAPK1C","MITOGEN-ACTIVATED PROTEIN KINASE 8","1","4AWI"
"4AWN",,"X-RAY DIFFRACTION",2.03,39.5,"VAPOR DIFFUSION, HANGING DROP",,"HANGING DROP VAPOR DIFFUSION, 0.2 M MGCL2, 0.1 M BIS-TRIS AT PH 5.5, 25% V/V PEG 3350",,"10.1021/bi300873f",,"4AWN",30.33,"1.95","1.95","Structure of recombinant human DNase I (rhDNaseI) in complex with Magnesium and Phosphate.","LKIAAFNIQTFGETKMSNATLVSYIVQILSRYDIALVQEVRDSHLTAVGKLLDNLNQDAPDTYHYVVSEPLGRNSYKERYLFVYRPDQVSAVDSYYYDDGCEPCGNDTFNREPAIVRFFSRFTEVREFAIVPLHAAPGDAVAEIDALYDVYLDVQEKWGLEDVMLMGDFNAGCSYVRPSQWSSIRLWTSPTFQWLIPDSADTTATPTHCAYDRIVVAGMLLRGAVVPDSALPFNFQAAYGLSDQLAQAISDHYPVEVMLK","Homo sapiens","DNASE1, DNL1, DRNI","DEOXYRIBONUCLEASE-1","1","4AWN"
"4AWO",,"X-RAY DIFFRACTION",2.58,51.92,,8,"pH 8.0",,"10.1016/j.bmcl.2012.07.052","99B","4AWO",52.61,"1.7","1.7","Complex of HSP90 ATPase domain with tropane derived inhibitors","GSDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","4AWO"
"4AWP",,"X-RAY DIFFRACTION",2.54,51.1,,8,"pH 8",,"10.1016/j.bmcl.2012.07.052","99A","4AWP",52.63,"1.82","1.82","Complex of HSP90 ATPase domain with tropane derived inhibitors","GSDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","4AWP"
"4AWQ",,"X-RAY DIFFRACTION",2.54,51.1,,8,"pH 8.0",,"10.1016/j.bmcl.2012.07.052","592","4AWQ",52.57,"1.6","1.6","Complex of HSP90 ATPase domain with tropane derived inhibitors","GSDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","4AWQ"
"4AXB",,"X-RAY DIFFRACTION",3.09,60.14,,7.4,"PROTEIN WAS CRYSTALLIZED FROM 2.1 M AMMONIUM SULFATE, 100 MM MES BUFFER PH 6.5. THEN SOAKED IN 20% GLYCEROL",,"10.1016/j.cbi.2012.08.005",,"4AXB",62.36,"2.4","2.4","Crystal structure of soman-aged human butyrylcholinesterase in complex with 2-PAM","DIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGEXAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPEQYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","4AXB"
"4AXL",,"X-RAY DIFFRACTION",3.06,59.8,,,,,"10.1002/cmdc.201300112",,"4AXL",24.41,"1.92","1.92","HUMAN CATHEPSIN L APO FORM WITH ZN","APRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV","Homo sapiens","CTSL, CTSL1","CATHEPSIN L1","1","4AXL"
"4AXM",,"X-RAY DIFFRACTION",2.76,55.4,,,,,"10.1002/cmdc.201300112","V65","4AXM",148.29,"2.8","2.8","TRIAZINE CATHEPSIN INHIBITOR COMPLEX","APRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDNGGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSEDMDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV","Homo sapiens","CTSL, CTSL1","CATHEPSIN L1","1","4AXM"
"4AXX",,"X-RAY DIFFRACTION",2.13,0.39,,6.5,"32% PEG2000MME, 0.1M BIS/TRIS PH 6.5",,,"3PG","4AXX",45.43,"1.74","1.74","The catalytically active fully closed conformation of human phosphoglycerate kinase in complex with ADP 3-phosphoglycerate and beryllium trifluoride","MSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKAKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI","Homo sapiens","PGK1, PGKA, MIG10, OK/SW-cl.110","PHOSPHOGLYCERATE KINASE 1","1","4AXX"
"4AY1",,"X-RAY DIFFRACTION",2.8,56,,6,"23% PEG 3000, 0.1 M SODIUM CITRATE PH 6",,"10.1042/BJ20120377",,"4AY1",501.82,"1.95","1.95","Human YKL-39 is a pseudo-chitinase with retained chitooligosaccharide binding properties","AYKLVCYFTNWSQDRQEPGKFTPENIDPFLCSHLIYSFASIENNKVIIKDKSEVMLYQTINSLKTKNPKLKILLSIGGYLFGSKGFHPMVDSSTSRLEFINSIILFLRNHNFDGLDVSWIYPDQKENTHFTVLIHELAEAFQKDFTKSTKERLLLTAGVSAGRQMIDNSYQVEKLAKDLDFINLLSFDFHGSWEKPLITGHNSPLSKGWQDRGPSSYYNVEYAVGYWIHKGMPSEKVVMGIPTYGHSFTLASAETTVGAPASGPGAAGPITESSGFLAYYEICQFLKGAKITRLQDQQVPYAVKGNQWVGYDDVKSMETKVQFLKNLNLGGAMIWSIDMDDFTGKSCNQGPYPLVQAVKRSLGSL","Homo sapiens","CHI3L2","CHITINASE-3-LIKE PROTEIN 2","1","4AY1"
"4AY2",,"X-RAY DIFFRACTION",2.34,53,,,,,"10.1016/j.str.2012.08.029",,"4AY2",85.78,"2.8","2.8","Capturing 5' tri-phosphorylated RNA duplex by RIG-I","SPFKPRNYQLELALPAMKGKNTIICAPTGCGKTFVSLLICEHHLKKFPQGQKGKVVFFANQIPVYEQNKSVFSKYFERHGYRVTGISGATAENVPVEQIVENNDIIILTPQILVNNLKKGTIPSLSIFTLMIFDECHNTSKQHPYNMIMFNYLDQKLGGSSGPLPQVIGLTASVGVGDAKNTDEALDYICKLCASLDASVIATVKHNLEELEQVVYKPQKFFRKVESRISDKFKYIIAQLMRDTESLAKRICKDLENLSQIQNREFGTQKYEQWIVTVQKACMVFQMPDKDEESRICKALFLYTSHLRKYNDALIISEHARMKDALDYLKDFFSNVRAAGFDEIEQDLTQRFEEKLQELESVSRDPSNENPKLEDLCFILQEEYHLNPETITILFVKTRALVDALKNWIEGNPKLSFLKPGILTGRGKTNQNTGMTLPAQKCILDAFKASGDHNILIATSVADEGIDIAQCNLVILYEYVGNVIKMIQTRGRGRARGSKCFLLTSNAGVIEKEQINMYKEKMMNDSILRLQTWDEAVFREKILHIQTHEKFIRDSQEKPKPVPDKENKKLLCRKCKALACYTADVRVIEDCHYTVLGDAFKECFVSRPHPKPKQFSSFEKRAKIFCARQNCSHDWGIHVKYKTFEIPVIKIESFVVEDIATGVQTLYSKWKDFHFEKIPFDPAEMSK","Homo sapiens","DDX58","PROBABLE ATP-DEPENDENT RNA HELICASE DDX58","1","4AY2"
,,,,,,,,,,,,,,,,"GGCGCGGCUUCGGCCGCGCC",,,"5'-R-PPP(GP*GP*CP*GP*CP*GP*GP*CP*UP*UP*CP*GP*GP*CP *CP*GP*CP*GP*CP*C)-3'","2","4AY2"
"4AYA",,"X-RAY DIFFRACTION",1.98,37.8,,6.5,"PROTEIN WAS CRYSTALLIZED FROM 0.1 M MES PH6.5, 2.0 M POTASSIUM ACETATE",,"10.1371/journal.pone.0048591",,"4AYA",21.83,"2.103","2.103","Crystal structure of ID2 HLH homodimer at 2.1A resolution","GMKAFSPVRSVRKNSLSDHSLGISRSKTPVDDPMSLLYNMNDCYSKLKELVPSIPQNKKVSKMEILQHVIDYILDLQIALDSHLKPSFLVQSGDIAS","Homo sapiens","ID2, BHLHB26","DNA-BINDING PROTEIN INHIBITOR ID-2","1","4AYA"
"4AYC",,"X-RAY DIFFRACTION",2.8,56.1,,6.9,"0.1 M NA CACODYLATE, PH 6.9, 2.5 M AMMONIUM SULPHATE, 0.8 MM N,N-BIS(3-D-GLUCONAMIDOPROPYL)DEOXYCHOLAMIDE",,"10.1016/j.cell.2012.08.005",,"4AYC",34.26,"1.9","1.9","RNF8 RING domain structure","LGSMEELNRSKKDFEAIIQAKNKELEQTKEEKEKMQAQKEEVLSHMNDVLENELQCIICSEYFIEAVTLNCAHSFCSYCINEWMKRKIECPICRKDIKSKTYSLVLDNCINKMVNNLSSEVKERRIVLIRERKAKRLF","Homo sapiens","RNF8, KIAA0646","E3 UBIQUITIN-PROTEIN LIGASE RNF8","1","4AYC"
,,,,,,,,,,,,,,,,"LGSMEELNRSKKDFEAIIQAKNKELEQTKEEKEKMQAQKEEVLSHMNDVLENELQCIICSEYFIEAVTLNCAHSFCSYCINEWMKRKIECPICRKDIKSKTYSLVLDNCINKMVNNLSSEVKERRIVLIRERKAKRLF","Homo sapiens","RNF8, KIAA0646","E3 UBIQUITIN-PROTEIN LIGASE RNF8","2","4AYC"
"4AYK",,"SOLUTION NMR",,,,,,,"10.1021/bi982576v","CGS","4AYK",19.43,,,"CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH CGS-27023A, NMR, 30 STRUCTURES","VLTEGNPRWEQTHLTYRIENYTPDLPRADVDHAIEKAFQLWSNVTPLTFTKVSEGQADIMISFVRGDHRDNSPFDGPGGNLAHAFQPGPGIGGDAHFDEDERWTNNFREYNLHRVAAHELGHSLGLSHSTDIGALMYPSYTFSGDVQLAQDDIDGIQAIYGRSQNPVQP","Homo sapiens","MMP1, CLG","PROTEIN (COLLAGENASE)","1","4AYK"
"4AYT",,"X-RAY DIFFRACTION",3.39,63.71,,9.5,"0.1 M SODIUM CHLORIDE, 0.1 M GLYCINE PH 9.5, 37% (V/V) PEG 300.",,"10.1073/pnas.1217042110","ACP","4AYT",69.88,"2.85","2.85","STRUCTURE OF THE HUMAN MITOCHONDRIAL ABC TRANSPORTER, ABCB10","MAGLPEARKLLGLAYPERRRLAAAVGFLTMSSVISMSAPFFLGKIIDVIYTNPTVDYSDNLTRLCLGLSAVFLCGAAANAIRVYLMQTSGQRIVNRLRTSLFSSILRQEVAFFDKTRTGELINRLSSDTALLGRSVTENLSDGLRAGAQASVGISMMFFVSPNLATFVLSVVPPVSIIAVIYGRYLRKLTKVTQDSLAQATQLAEERIGNVRTVRAFGKEMTEIEKYASKVDHVMQLARKEAFARAGFFGATGLSGNLIVLSVLYKGGLLMGSAHMTVGELSSFLMYAFWVGISIGGLSSFYSELMKGLGAGGRLWELLEREPKLPFNEGVILNEKSFQGALEFKNVHFAYPARPEVPIFQDFSLSIPSGSVTALVGPSGSGKSTVLSLLLRLYDPASGTISLDGHDIRQLNPVWLRSKIGTVSQEPILFSCSIAENIAYGADDPSSVTAEEIQRVAEVANAVAFIRNFPQGFNTVVGEKGVLLSGGQKQRIAIARALLKNPKILLLDEATSALDAENEYLVQEALDRLMDGRTVLVIAHRLSTIKNANMVAVLDQGKITEYGKHEELLSKPNGIYRKLMNKQSFISAAENLYFQ","Homo sapiens","ABCB10","ATP-BINDING CASSETTE SUB-FAMILY B MEMBER 10 MITOCHONDRIAL","1","4AYT"
"4AYU",,"X-RAY DIFFRACTION",2.62,53,,8,"60 MM TRIS-HCL PH 8.0, 10 MM CACL2, 84 MM NACL, 20% GLYCEROL V/V, 17% PEG550 MME V/V",,"10.1107/S1399004714013455","N8P","4AYU",119.17,"1.5","1.5","Structure of N-Acetyl-D-Proline bound to serum amyloid P component","HTDLSGKVFVFPRESVTDHVNLITPLEKPLQNFTLCFRAYSDLSRAYSLFSYNTQGRDNELLVYKERVGEYSLYIGRHKVTSKVIEKFPAPVHICVSWESSSGIAEFWINGTPLVKKGLRQGYFVEAQPKIVLGQEQDSYGGKFDRSQSFVGEIGDLYMWDSVLPPENILSAYQGTPLPANILDWQALNYEIRGYVIIKPLVWV","Homo sapiens","APCS, PTX2","SERUM AMYLOID P-COMPONENT","1","4AYU"
"4AYW",,"X-RAY DIFFRACTION",3.28,62.52,,9.5,"0.1 M SODIUM CHLORIDE, 5%(V/V)JEFFAMINE M-600, 0.1 M GLYCINE PH 9.5, 34%(V/V) PEG 400 CRYSTAL SOAKED BRIEFLY IN 10MM LUTETIUM CHLORIDE PRIOR TO DATA COLLECTION",,"10.1073/pnas.1217042110","ANP","4AYW",68.65,"3.3","3.3","STRUCTURE OF THE HUMAN MITOCHONDRIAL ABC TRANSPORTER, ABCB10 (PLATE FORM)","SMRGPPAWAGDEAWRRGPAAPPGDKGRLRPAAAGLPEARKLLGLAYPERRRLAAAVGFLTMSSVISMSAPFFLGKIIDVIYTNPTVDYSDNLTRLCLGLSAVFLCGAAANAIRVYLMQTSGQRIVNRLRTSLFSSILRQEVAFFDKTRTGELINRLSSDTALLGRSVTENLSDGLRAGAQASVGISMMFFVSPNLATFVLSVVPPVSIIAVIYGRYLRKLTKVTQDSLAQATQLAEERIGNVRTVRAFGKEMTEIEKYASKVDHVMQLARKEAFARAGFFGATGLSGNLIVLSVLYKGGLLMGSAHMTVGELSSFLMYAFWVGISIGGLSSFYSELMKGLGAGGRLWELLEREPKLPFNEGVILNEKSFQGALEFKNVHFAYPARPEVPIFQDFSLSIPSGSVTALVGPSGSGKSTVLSLLLRLYDPASGTISLDGHDIRQLNPVWLRSKIGTVSQEPILFSCSIAENIAYGADDPSSVTAEEIQRVAEVANAVAFIRNFPQGFNTVVGEKGVLLSGGQKQRIAIARALLKNPKILLLDEATSALDAENEYLVQEALDRLMDGRTVLVIAHHLSTIKNANMVAVLDQGKITEYGKHEELLSKPNGIYRKLMNKQSFISA","Homo sapiens","ABCB10","ATP-BINDING CASSETTE SUB-FAMILY B MEMBER 10","1","4AYW"
"4AYX",,"X-RAY DIFFRACTION",3.56,65.44,,9.5,"0.1 M SODIUM CHLORIDE, 0.1 M GLYCINE PH 9.5, 33% (V/V) PEG 300.",,"10.1073/pnas.1217042110","ACP","4AYX",69.37,"2.9","2.9","STRUCTURE OF THE HUMAN MITOCHONDRIAL ABC TRANSPORTER, ABCB10 (ROD FORM B)","MAGLPEARKLLGLAYPERRRLAAAVGFLTMSSVISMSAPFFLGKIIDVIYTNPTVDYSDNLTRLCLGLSAVFLCGAAANAIRVYLMQTSGQRIVNRLRTSLFSSILRQEVAFFDKTRTGELINRLSSDTALLGRSVTENLSDGLRAGAQASVGISMMFFVSPNLATFVLSVVPPVSIIAVIYGRYLRKLTKVTQDSLAQATQLAEERIGNVRTVRAFGKEMTEIEKYASKVDHVMQLARKEAFARAGFFGATGLSGNLIVLSVLYKGGLLMGSAHMTVGELSSFLMYAFWVGISIGGLSSFYSELMKGLGAGGRLWELLEREPKLPFNEGVILNEKSFQGALEFKNVHFAYPARPEVPIFQDFSLSIPSGSVTALVGPSGSGKSTVLSLLLRLYDPASGTISLDGHDIRQLNPVWLRSKIGTVSQEPILFSCSIAENIAYGADDPSSVTAEEIQRVAEVANAVAFIRNFPQGFNTVVGEKGVLLSGGQKQRIAIARALLKNPKILLLDEATSALDAENEYLVQEALDRLMDGRTVLVIAHRLSTIKNANMVAVLDQGKITEYGKHEELLSKPNGIYRKLMNKQSFISAAENLYFQ","Homo sapiens","ABCB10","ATP-BINDING CASSETTE SUB-FAMILY B MEMBER 10","1","4AYX"
"4AYZ",,"X-RAY DIFFRACTION",4.4,72,,5.6,"1.8 M NA/K PHOSPHATE BUFFER 5.6",,,,"4AYZ",46.79,"3.5","3.5","X-ray Structure of human SOUL","AGHMAEPLQPDPGAAEDAAAQAVETPGWKAPEDAGPQPGSYEIRHYGPAKWVSTSVESMDWDSAIQTGFTKLNSYIQGKNEKEMKIKMTAPVTSYVEPGSGPFSESTITISLYIPSEQQFDPPRPLESDVFIEDRAEMTVFVRSFDGFSSAQKNQEQLLTLASILREDGKVFDEKVYYTAGYNSPVKLLNRNNEVWLIQKNEPTKENE","Homo sapiens","HEBP2, C6orf34, SOUL","HEME-BINDING PROTEIN 2","1","4AYZ"
,,,,,,,,,,,,,,,,"AGHMAEPLQPDPGAAEDAAAQAVETPGWKAPEDAGPQPGSYEIRHYGPAKWVSTSVESMDWDSAIQTGFTKLNSYIQGKNEKEMKIKMTAPVTSYVEPGSGPFESSTITISLYIPSEQQFDPPRPLESDVFIEDRAEMTVFVRSFDGFSSAQKNQEQLLTLASILREDGKVFDEKVYYTAGYNSPVKLLNRNNEVWLIQKNEPTKENE","Homo sapiens","HEBP2, C6orf34, SOUL","HEME-BINDING PROTEIN 2","2","4AYZ"
"4AZ0",,"X-RAY DIFFRACTION",2.3,46.6,"VAPOR DIFFUSION, HANGING DROP",4.6,"CATA WAS CRYSTALLIZED USING THE HANGING DROP METHOD: 1 UL OF PROTEIN SOLUTION, CONTAINING 6.5 MG/ML CATHEPSIN A, 25 MM TRIS-HCL (PH 8.0) AND 300 MM NACL, WAS MIXED WITH 1 UL RESERVOIR SOLUTION, CONTAINING 100 MM NAACETATE (PH 4.5), 18-20% PEG400 AND 100 MM CDCL2, AND SET TO EQUILIBRATE AT 4 DEG. C. ROD-SHAPED CRYSTALS APPEARED IN ABOUT ONE WEEK.",277,"10.1021/jm300663n","S61","4AZ0",53.75,"2.17","2.17","crystal structure of cathepsin a, complexed with 8a.","SRAPDQDEIQRLPGLAKQPSFRQYSGYLKGSGSKHLHYWFVESQKDPENSPVVLWLNGGPGCSSLDGLLTEHGPFLVQPDGVTLEYNPYSWNLIANVLYLESPAGVGFSYSDDKFYATNDTEVAQSNFEALQDFFRLFPEYKNNKLFLTGESYAGIYIPTLAVLVMQDPSMNLQGLAVGNGLSSYEQNDNSLVYFAYYHGLLGNRLWSSLQTHCCSQNKCNFYDNKDLECVTNLQEVARIVGNSGLNIYNLYAPCAGGVPSHFRYEKDTVVVQDLGNIFTRLPLKRMWHQALLRSGDKVR","Homo sapiens","CTSA, PPGB","LYSOSOMAL PROTECTIVE PROTEIN 32 KDA CHAIN","1","4AZ0"
,,,,,,,,,,,,,,,,"MDPPCTNTTAASTYLNNPYVRKALNIPEQLPQWDMCNFLVNLQYRRLYRSMNSQYLKLLSSQKYQILLYNGDVDMACNFMGDEWFVDSLNQKMEVQRRPWLVKYGDSGEQIAGFVKEFSHIAFLTIKGAGHMVPTDKPLAAFTMFSRFLNKQPYE","Homo sapiens","CTSA, PPGB","LYSOSOMAL PROTECTIVE PROTEIN 20 KDA CHAIN","2","4AZ0"
"4AZ3",,"X-RAY DIFFRACTION",2.4,48.7,"VAPOR DIFFUSION, HANGING DROP",4.6,"CATA WAS CRYSTALLIZED USING THE HANGING DROP METHOD: 1 UL OF PROTEIN SOLUTION, CONTAINING 6.5 MG/ML CATHEPSIN A, 25 MM TRIS-HCL (PH 8.0) AND 300 MM NACL, WAS MIXED WITH 1 UL RESERVOIR SOLUTION, CONTAINING 100 MM NAACETATE (PH 4.5), 18-20% PEG400 AND 100 MM CDCL2, AND SET TO EQUILIBRATE AT 4 DEG. C. ROD-SHAPED CRYSTALS APPEARED IN ABOUT ONE WEEK.",277,"10.1021/jm300663n","S35","4AZ3",53.63,"2.04","2.04","crystal structure of cathepsin a, complexed with 15a","SRAPDQDEIQRLPGLAKQPSFRQYSGYLKGSGSKHLHYWFVESQKDPENSPVVLWLNGGPGCSSLDGLLTEHGPFLVQPDGVTLEYNPYSWNLIANVLYLESPAGVGFSYSDDKFYATNDTEVAQSNFEALQDFFRLFPEYKNNKLFLTGESYAGIYIPTLAVLVMQDPSMNLQGLAVGNGLSSYEQNDNSLVYFAYYHGLLGNRLWSSLQTHCCSQNKCNFYDNKDLECVTNLQEVARIVGNSGLNIYNLYAPCAGGVPSHFRYEKDTVVVQDLGNIFTRLPLKRMWHQALLRSGDKVR","Homo sapiens","CTSA, PPGB","LYSOSOMAL PROTECTIVE PROTEIN 32 KDA CHAIN","1","4AZ3"
,,,,,,,,,,,,,,,,"MDPPCTNTTAASTYLNNPYVRKALNIPEQLPQWDMCNFLVNLQYRRLYRSMNSQYLKLLSSQKYQILLYNGDVDMACNFMGDEWFVDSLNQKMEVQRRPWLVKYGDSGEQIAGFVKEFSHIAFLTIKGAGHMVPTDKPLAAFTMFSRFLNKQPYE","Homo sapiens","CTSA, PPGB","LYSOSOMAL PROTECTIVE PROTEIN 20 KDA CHAIN","2","4AZ3"
"4AZ9",,"X-RAY DIFFRACTION",2.33,47.3,,,,,,,"4AZ9",31.14,"1.75","1.75","Crystal structure of phox homology domain of human sorting nexin 24","MHHHHHHSSGVDLGTENLYFQSMEVYIPSFRYEESDLERGYTVFKIEVLMNGRKHFVEKRYSEFHALHKKLKKCIKTPEIPSKHVRNWVPKVLEQRRQGLETYLQAVILENEELPKLFLDFLNVRHLPS","Homo sapiens","SNX24, SBBI31, UNQ654/PRO1284","SORTING NEXIN-24","1","4AZ9"
"4AZF",,"X-RAY DIFFRACTION",2.7,54.4,,7.5,"0.2 M NA/KPO4, 20% PEG 3350, 10% ETHYLENE GLYCOL, pH 7.5",,"10.1021/jm301034u","3RA","4AZF",48.75,"2.55","2.55","Human DYRK2 in complex with Leucettine L41","MHHHHHHSSGVDLGTENLYFQSMGKVKATPMTPEQAMKQYMQKLTAFEHHEIFSYPEIYFLGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLP","Homo sapiens","DYRK2","DYRK2 DUAL-SPECIFICITY TYROSINE-PHOSPHORYLATION REGULATED KINASE 2","1","4AZF"
"4AZM",,"X-RAY DIFFRACTION",2.6,52,"VAPOR DIFFUSION, HANGING DROP",7,"1.32 M SODIUM CITRATE, 0.1 M HEPES PH 7.0, SATURATED WITH RESPECT TO BMS-309403, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K. CRYOPROTECTION: 28% GLYCEROL IN MOTHER LIQUOR.",293,"10.1107/S1399004713026795","T4B","4AZM",31.98,"2.75","2.75","Human epidermal fatty acid-binding protein (FABP5) in complex with the inhibitor BMS-309413","GSHMATVQQLEGRWRLVDSKGFDEYMKELGVGIALRKMGAMAKPDCIITCDGKNLTIKTESTLKTTQFSCTLGEKFEETTADGRKTQTVCNFTDGALVQHQEWDGKESTITRKLKDGKLVVECVMNNVTCTRIYEKVE","Homo sapiens","FABP5","FATTY ACID-BINDING PROTEIN, EPIDERMAL","1","4AZM"
"4AZR",,"X-RAY DIFFRACTION",3.3,63,,7.5,"25% PEG 3350, 0.1 M HEPES PH 7.5. FABP INCUBATED IN A SOLUTION SATURATED WITH RESPECT TO ANANDAMIDE PRIOR TO CRYSTALLIZATION. CRYPROTECTION: 25% GLYCEROL IN MOTHER LIQUOR.",,"10.1107/S1399004713026795",,"4AZR",31.65,"2.95","2.95","Human epidermal fatty acid-binding protein (FABP5) in complex with the endocannabinoid anandamide","GSHMATVQQLEGRWRLVDSKGFDEYMKELGVGIALRKMGAMAKPDCIITCDGKNLTIKTESTVKTTQFSCTLGEKFEETTADGRKTQTVCNFTDGALVQHQEWDGKESTITRKLKDGKLVVECVMNNVTCTRIYEKVE","Homo sapiens","FABP5","FATTY ACID-BINDING PROTEIN, EPIDERMAL","1","4AZR"
"4AZY",,"X-RAY DIFFRACTION",2.05,40,,5,"11% PEG6K, 90 MM NAAC PH 5.0, 18 MM TRIS PH 8.5, 135 MM NACL",,"10.1021/jm3009025","7F3","4AZY",46.49,"1.79","1.79","Design and Synthesis of BACE1 Inhibitors with In Vivo Brain Reduction of beta-Amyloid Peptides (COMPOUND 10)","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","4AZY"
"4B00",,"X-RAY DIFFRACTION",2.06,40,,5,"11% PEG6K, 90 MM NAAC PH 5.0, 18 MM TRIS PH 8.5, 135 MM NACL",,"10.1021/jm3009025","I6X","4B00",46.54,"1.83","1.83","Design and Synthesis of BACE1 Inhibitors with In Vivo Brain Reduction of beta-Amyloid Peptides (COMPOUND (R)-41)","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","4B00"
"4B04",,"X-RAY DIFFRACTION",2.15,43,,,,,"10.1107/S0907444913004770",,"4B04",72.95,"2.205","2.205","Crystal structure of the Catalytic Domain of Human DUSP26 (C152S)","MHADEVWPGLYLGDQDMANNRRELRRLGITHVLNASHSRWRGTPEAYEGLGIRYLGVEAHDSPAFDMSIHFQTAADFIHRALSQPGGKILVHSAVGVSRSATLVLAYLMLYHHLTLVEAIKKVKDHRGIIPNRGFLRQLLALDRRLRQGLEALEHHHHHH","Homo sapiens","DUSP26, DUSP24, LDP4, MKP8, NATA1, SKRP3","DUAL SPECIFICITY PROTEIN PHOSPHATASE 26","1","4B04"
"4B05",,"X-RAY DIFFRACTION",2.05,40,,5,"11% PEG6K, 90 MM NAAC PH 5.0, 18 MM TRIS PH 8.5, 135 MM NACL",,"10.1074/jbc.M112.409110","32D","4B05",46.57,"1.8","1.8","Preclinical characterization of AZD3839, a novel clinical candidate BACE1 inhibitor for the treatment of Alzheimer Disease","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","4B05"
"4B0F",,"X-RAY DIFFRACTION",2.68,54.1,,,"46.5 % (V/V) PEG 400, 5 % (V/V) MPD, 0.1 M TRIS PH. 7.3 WITH 13.7 MG/ML C4BP",,"10.1016/j.jmb.2012.12.017",,"4B0F",51.78,"2.8","2.8","Heptameric core complex structure of C4b-binding (C4BP) protein from human","SAGAHAGWETPEGCEQVLTGKRLMQCLPNPEDVKMALEVYKLSLEIEQLELQRDSARQSTLDKEL","Homo sapiens","C4BPA, C4BP","C4B-BINDING PROTEIN ALPHA CHAIN","1","4B0F"
"4B0G",,"X-RAY DIFFRACTION",2.03,39.26,,,,,"10.1021/jm300952s","VEK","4B0G",33.66,"2.5","2.5","Complex of Aurora-A bound to an Imidazopyridine-based inhibitor","MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","AURORA KINASE A","1","4B0G"
"4B0O",,"X-RAY DIFFRACTION",3.16,61,,6.5,"2.1 M AMMONIUM SULFATE, 0.1 M MES BUFFER PH 6.5",,"10.1016/j.cbi.2012.08.005","15F","4B0O",62.62,"2.35","2.35","Crystal structure of soman-aged human butyrylcholinesterase in complex with benzyl pyridinium-4-methyltrichloroacetimidate","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGEXAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPEQYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","4B0O"
"4B0P",,"X-RAY DIFFRACTION",3.16,61,,6.5,"2.1 M AMMONIUM SULFATE, 0.1 M MES BUFFER PH 6.5",,"10.1016/j.cbi.2012.08.005","MF5","4B0P",62.6,"2.5","2.5","Crystal structure of soman-aged human butyrylcholinesterase in complex with methyl 2-(pentafluorobenzyloxyimino)pyridinium","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGEXAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPEQYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","4B0P"
"4B0Q",,"X-RAY DIFFRACTION",2.3,46,,,,,,,"4B0Q",43.32,"1.87","1.87","Lead Generation of BACE1 Inhibitors by Coupling Non-amidine New Warheads to a Known Binding Scaffold","EMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGY","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","4B0Q"
"4B0Y",,"X-RAY DIFFRACTION",3.6,66,,6.5,"2 M AMMONIUM SULPHATE, 0.1 M MES 6.5",,,,"4B0Y",25.55,"3.5","3.5","Determination of X-ray Structure of human SOUL by Molecular Replacement","MSYYHHHHHHLESTSLYKKAGTMAEPLQPDPGAAEDAAAQAVETPGWKAPEDAGPQPGSYEIRHYGPAKWVSTSVESMDWDSAIQTGFTKLNSYIQGKNEKEMKIKMTAPVTSYVEPGSGPFSESTITISLYIPSEQQFDPPRPLESDVFIEDRAEMTVFVRSFDGFSSAQKNQEQLLTLASILREDGKVFDEKVYYTAGYNSPVKLLNRNNEVWLIQKNEPTKENE","Homo sapiens","HEBP2, C6orf34, SOUL","HEME-BINDING PROTEIN 2","1","4B0Y"
"4B1C",,"X-RAY DIFFRACTION",2.3,46,,,,,"10.1021/jm300991n","1B1","4B1C",42.32,"1.95","1.95","New Aminoimidazoles as BACE-1 Inhibitors: From Rational Design to Ab- lowering in Brain","KKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLEDCGYN","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","4B1C"
"4B1D",,"X-RAY DIFFRACTION",2.3,46,,7,"pH 7",,"10.1021/jm300991n","6TG","4B1D",43.7,"1.95","1.95","New Aminoimidazoles as BACE-1 Inhibitors: From Rational Design to Ab- lowering in Brain","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGY","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","4B1D"
"4B1E",,"X-RAY DIFFRACTION",2.3,46,,7,"pH 7",,"10.1021/jm300991n",,"4B1E",43.53,"1.95","1.95","New Aminoimidazoles as BACE-1 Inhibitors: From Rational Design to Ab- lowering in Brain","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGY","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","4B1E"
"4B1G",,"X-RAY DIFFRACTION",2.36,47.81,,,"28% PEG3350, 0.2M MAGNESIUM CHLORIDE, 0.1M PCTP (0.04M SODIUM PROPIONATE, 0.02M SODIUM CACODYLATE, 0.04M BIS-TRIS PROPANE) PH 7.5; 1:1 RATIO; 4 MICROLITRE DROP; ROOM TEMPERATURE",,"10.1371/journal.pone.0050889",,"4B1G",61.71,"1.83","1.83","Structure of unliganded human PARG catalytic domain","GSSPDKKWLGTPIEEMRRMPRCGIRLPLLRPSANHTVTIRVDLLRAGEVPKPFPTHYKDLWDNKHVKMPCSEQNLYPVEDENGERTAGSRWELIQTALLNKFTRPQNLKDAILKYNVAYSKKWDFTALIDFWDKVLEEAEAQHLYQSILPDMVKIALCLPNICTQPIPLLAAAMNHSITMSQEQIASLLANAFFCTFPRRNAKMKSEYSSYPDINFNRLFEGRSSRKPEKLKTLFCYFRRVTAAAPTGLVTFTRQSLEDFPEWERCEKPLTRLHVTYEGTIEENGQGMLQVDFANRFVGGGVTSAGLVQEEIRFLINPELIISRLFTEVLDHNECLIITGTEQYSEYTGYAETYRWSRSHEDGSERDDWQRRCTEIVAIDALHFRRYLDQFVPEKMRRELNKAYCGFLRPGVSSENLSAVATGNWGCGAFGGDARLKALIQILAAAAAERDVVYFTFGDSELMRDIYSMHIFLTERKLTVGDVYKLLLRYYNEECRNCSTPGPDIKLYPFIYHAVESCAETADHSGQRTGT","Homo sapiens","PARG","POLY(ADP-RIBOSE) GLYCOHYDROLASE","1","4B1G"
"4B1H",,"X-RAY DIFFRACTION",2.48,50.47,,,"25% PEG 3350, 36.4MM PCTP-4, 63.6MM PCTP-10, 0.2M AMMONIUM SULPHATE",,"10.1371/journal.pone.0050889",,"4B1H",62.69,"2","2","Structure of human PARG catalytic domain in complex with ADP-ribose","GSSPDKKWLGTPIEEMRRMPRCGIRLPLLRPSANHTVTIRVDLLRAGEVPKPFPTHYKDLWDNKHVKMPCSEQNLYPVEDENGERTAGSRWELIQTALLNKFTRPQNLKDAILKYNVAYSKKWDFTALIDFWDKVLEEAEAQHLYQSILPDMVKIALCLPNICTQPIPLLAAAMNHSITMSQEQIASLLANAFFCTFPRRNAKMKSEYSSYPDINFNRLFEGRSSRKPEKLKTLFCYFRRVTAAAPTGLVTFTRQSLEDFPEWERCEKPLTRLHVTYEGTIEENGQGMLQVDFANRFVGGGVTSAGLVQEEIRFLINPELIISRLFTEVLDHNECLIITGTEQYSEYTGYAETYRWSRSHEDGSERDDWQRRCTEIVAIDALHFRRYLDQFVPEKMRRELNKAYCGFLRPGVSSENLSAVATGNWGCGAFGGDARLKALIQILAAAAAERDVVYFTFGDSELMRDIYSMHIFLTERKLTVGDVYKLLLRYYNEECRNCSTPGPDIKLYPFIYHAVESCAETADHSGQRTGT","Homo sapiens","PARG","POLY(ADP-RIBOSE) GLYCOHYDROLASE","1","4B1H"
"4B1I",,"X-RAY DIFFRACTION",2.44,49.57,,,"25% PEG 3350, 36.4MM PCTP-4, 63.6MM PCTP-10, 0.2M AMMONIUM SULPHATE",,"10.1371/journal.pone.0050889",,"4B1I",62.3,"2.14","2.14","Structure of human PARG catalytic domain in complex with OA-ADP-HPD","GSSPDKKWLGTPIEEMRRMPRCGIRLPLLRPSANHTVTIRVDLLRAGEVPKPFPTHYKDLWDNKHVKMPCSEQNLYPVEDENGERTAGSRWELIQTALLNKFTRPQNLKDAILKYNVAYSKKWDFTALIDFWDKVLEEAEAQHLYQSILPDMVKIALCLPNICTQPIPLLAAAMNHSITMSQEQIASLLANAFFCTFPRRNAKMKSEYSSYPDINFNRLFEGRSSRKPEKLKTLFCYFRRVTAAAPTGLVTFTRQSLEDFPEWERCEKPLTRLHVTYEGTIEENGQGMLQVDFANRFVGGGVTSAGLVQEEIRFLINPELIISRLFTEVLDHNECLIITGTEQYSEYTGYAETYRWSRSHEDGSERDDWQRRCTEIVAIDALHFRRYLDQFVPEKMRRELNKAYCGFLRPGVSSENLSAVATGNWGCGAFGGDARLKALIQILAAAAAERDVVYFTFGDSELMRDIYSMHIFLTERKLTVGDVYKLLLRYYNEECRNCSTPGPDIKLYPFIYHAVESCAETADHSGQRTGT","Homo sapiens","PARG","POLY(ADP-RIBOSE) GLYCOHYDROLASE","1","4B1I"
"4B1J",,"X-RAY DIFFRACTION",2.47,50.19,,,"25% PEG 3350, 36.4 MM PCTP-4, 63.6 MM PCTP-10, 0.2 M AMMONIUM SULPHATE",,"10.1371/journal.pone.0050889","A1R","4B1J",61.99,"2.08","2.08","Structure of human PARG catalytic domain in complex with ADP-HPD","GSSPDKKWLGTPIEEMRRMPRCGIRLPLLRPSANHTVTIRVDLLRAGEVPKPFPTHYKDLWDNKHVKMPCSEQNLYPVEDENGERTAGSRWELIQTALLNKFTRPQNLKDAILKYNVAYSKKWDFTALIDFWDKVLEEAEAQHLYQSILPDMVKIALCLPNICTQPIPLLAAAMNHSITMSQEQIASLLANAFFCTFPRRNAKMKSEYSSYPDINFNRLFEGRSSRKPEKLKTLFCYFRRVTAAAPTGLVTFTRQSLEDFPEWERCEKPLTRLHVTYEGTIEENGQGMLQVDFANRFVGGGVTSAGLVQEEIRFLINPELIISRLFTEVLDHNECLIITGTEQYSEYTGYAETYRWSRSHEDGSERDDWQRRCTEIVAIDALHFRRYLDQFVPEKMRRELNKAYCGFLRPGVSSENLSAVATGNWGCGAFGGDARLKALIQILAAAAAERDVVYFTFGDSELMRDIYSMHIFLTERKLTVGDVYKLLLRYYNEECRNCSTPGPDIKLYPFIYHAVESCAETADHSGQRTGT","Homo sapiens","PARG","POLY(ADP-RIBOSE) GLYCOHYDROLASE","1","4B1J"
"4B2D",,"X-RAY DIFFRACTION",2.28,46.16,,7,"PROTEIN SOLUTION 10 MG/ML, 25 MM TRIS/HCL PH 7.5, 0.1 M KCL, 5 MM MGCL2, 10% (V/V) GLYCEROL WAS MIXED IN A (1:1) RATIO WITH RESERVOIR SOLUTION CONTAINING 0.1 M KCL, 0.2 M AMMONIUM TARTRATE, 24% (W/V) PEG3350",,"10.1038/nature11540","SER","4B2D",241.16,"2.3","2.3","human PKM2 with L-serine and FBP bound.","MGSSHHHHHHSSGLVPRGSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","PYRUVATE KINASE ISOZYMES M1/M2","1","4B2D"
,,,,,,,,,,,,,,,,"MGSSHHHHHHSSGLVPRGSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKLTLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP","Homo sapiens","PKM, OIP3, PK2, PK3, PKM2","PYRUVATE KINASE ISOZYMES M1/M2","2","4B2D"
"4B2R",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2012.09.013",,"4B2R",14.19,,,"Solution structure of CCP modules 10-11 of complement factor H","EAAGERECELPKIDVHLVPDRKKDQYKVGEVLKFSCKPGFTIVGPNSVQCYHFGLSPDLPICKEQVQSCGPPPELLNGNVKEKTKEEYGHSEVVEYYCNPRFLMKGPNKIQCVDGEWTTLPVCIVE","Homo sapiens","CFH, HF, HF1, HF2","COMPLEMENT FACTOR H","1","4B2R"
"4B2S",,"SOLUTION NMR",,,,,,,"10.1016/j.jmb.2012.09.013",,"4B2S",14.11,,,"Solution structure of CCP modules 11-12 of complement factor H","EAEAAGVQSCGPPPELLNGNVKEKTKEEYGHSEVVEYYCNPRFLMKGPNKIQCVDGEWTTLPVCIVEESTCGDIPELEHGWAQLSSPPYYYGDSVEFNCSESFTMIGHRSITCIHGVWTQLPQCVAI","Homo sapiens","CFH, HF, HF1, HF2","COMPLEMENT FACTOR H","1","4B2S"
"4B36",,"X-RAY DIFFRACTION",1.81,32.2,,,"1.75-2.5 M NACL",,"10.1016/j.fob.2012.12.003",,"4B36",29.12,"1.76","1.76","Crystal Structure of Human Angiogenin with an Engineered Loop Exhibits Conformational Flexibility at the Functional Regions of the Molecule","MQDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLTTPSPQNISNCQYRATAGFRNVVVACENGLPVHLDQSIFRRP","Homo sapiens","ANG, RNASE5","ANGIOGENIN, EOSINOPHIL CATIONIC-RELATED PROTEIN","1","4B36"
"4B3E",,"X-RAY DIFFRACTION",3.8,68,,7.5,"1 M AMMONIUM SULPHATE, 50 MM TRIS PH 8.0 AND 50 MM NACL",,"10.1371/journal.pone.0044811",,"4B3E",161.96,"2.15","2.15","Structure of copper-zinc superoxide dismutase complexed with bicarbonate.","MATKAVCVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHEFGDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHCIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","1","4B3E"
"4B3F",,"X-RAY DIFFRACTION",2.64,53.37,,,,,"10.1093/nar/gks792",,"4B3F",71.72,"2.5","2.5","crystal structure of Ighmbp2 helicase","SAAVESFVTKQLDLLELERDAEVEERRSWQENISLKELQSRGVCLLKLQVSSQRTGLYGRLLVTFEPRRYGSAAALPSNSFTSGDIVGLYDAANEGSQLATGILTRVTQKSVTVAFDESHDFQLSLDRENSYRLLKLANDVTYRRLKKALIALKKYHSGPASSLIEVLFGRSAPSPASEIHPLTFFNTCLDTSQKEAVLFALSQKELAIIHGPPGTGKTTTVVEIILQAVKQGLKVLCCAPSNIAVDNLVERLALCKQRILRLGHPARLLESIQQHSLDAVLARSDSAQIVADIRKDIDQVFVKNKKTQDKREKSNFRNEIKLLRKELKEREEAAMLESLTSANVVLATNTGASADGPLKLLPESYFDVVVIDECAQALEASCWIPLLKARKCILAGDHKQLPPTTVSHKAALAGLSLSLMERLAEEYGARVVRTLTVQYRMHQAIMRWASDTMYLGQLTAHSSVARHLLRDLPGVAATEETGVPLLLVDTAGCGLFELEEEDEQSKGNPGEVRLVSLHIQALVDAGVPARDIAVVSPYNLQVDLLRQSLVHRHPELEIKSVDGFQGREKEAVILSFVRSNRKGEVGFLAEDRRINVAVTRARRHVAVICDSRTVNNHAFLKTLVEYFTQHGEVRTAFEYLDDIVP","Homo sapiens","IGHMBP2, SMBP2, SMUBP2","DNA-BINDING PROTEIN SMUBP-2","1","4B3F"
"4B3G",,"X-RAY DIFFRACTION",2.75,55.25,,,,,"10.1093/nar/gks792",,"4B3G",149.12,"2.85","2.85","crystal structure of Ighmbp2 helicase in complex with RNA","SAAVESFVTKQLDLLELERDAEVEERRSWQENISLKELQSRGVCLLKLQVSSQRTGLYGRLLVTFEPRRYGSAAALPSNSFTSGDIVGLYDAANEGSQLATGILTRVTQKSVTVAFDESHDFQQSLDRENSYRLLKLANDVTYRRLKKALIALKKYHSGPASSLIEVLFGRSAPSPASEIHPLTFFNTCLDTSQKEAVLFALSQKELAIIHGPPGTGKTTTVVEIILQAVKQGLKVLCCAPSNIAVDNLVERLALCKQRILRLGHPARLLESIQQHSLDAVLARSDSAQIVADIRKDIDQVFVKNKKTQDKREKSNFRNEIKLLRKELKEREEAAMLESLTSANVVLATNTGASADGPLKLLPESYFDVVVIDECAQALEASCWIPLLKARKCILAGDHKQLPPTTVSHKAALAGLSLSLMERLAEEYGARVVRTLTVQYRMHQAIMRWASDTMYLGQLTAHSSVARHLLRDLPGVAATEETGVPLLLVDTAGCGLFELEEEDEQSKGNPGEVRLVSLHIQALVDAGVPARDIAVVSPYNLQVDLLRQSLVHRHPELEIKSVDGFQGREKEAVILSFVRSNRKGEVGFLAEDRRINVAVTRARRHVAVICDSRTVNNHAFLKTLVEYFTQHGEVRTAFEYLDDIVP","Homo sapiens","IGHMBP2, SMBP2, SMUBP2","DNA-BINDING PROTEIN SMUBP-2","1","4B3G"
,,,,,,,,,,,,,,,,"AAAAAAAAA",,,"RNA (5'-(AP*AP*AP*AP*AP*AP*AP*AP*AP)-3')","2","4B3G"
"4B3W",,"X-RAY DIFFRACTION",2.04,40,,4.5,"18% PEG 4000, 0.2M NACL, 0.05M NA-ACETATE (PH 4.1-4.6), 0.01M K-FERRICYANIDE, 1MM KCN",,"10.1371/journal.pone.0049770",,"4B3W",44.55,"2.8","2.8","Crystal structure of human cytoglobin H(E7)Q mutant","MEKVPGEMEIERRERSEELSEAERKAVQAMWARLYANSEDVGVAILVRFFVNFPSAKQYFSQFKHMEDPLEMERSPQLRKQASRVMGALNTVVENLHDPDKVSSVLALVGKAHALKHKVEPVYFKILSGVILEVVAEEFASDFPPETQRAWAKLRGLIYSHVTAAYKEVGWVQQVPNATTPPATLPSSGP","Homo sapiens","CYGB, STAP","CYTOGLOBIN","1","4B3W"
"4B3Z",,"X-RAY DIFFRACTION",2.15,42.9,,7.5,"PROTEIN SOLUTION AT 10 MG/ML IN 20 MM TRIS-HCL WITH 150 MM NACL, PH 7.5 AND THE WELL SOLUTION (50 MM AMMONIUM SULFATE, 50 MM SODIUM CITRATE, 12-15% PEG 8000) IN A 1:1 RATIO",,"10.1107/S2053230X15009243",,"4B3Z",249.03,"3.05","3.05","Structure of the human collapsin response mediator protein-1, a lung cancer suppressor","MSYQGKKSIPHITSDRLLIKGGRIINDDQSLYADVYLEDGLIKQIGENLIVPGGVKTIEANGRMVIPGGIDVNTYLQKPSQGMTAADDFFQGTRAALVGGTTMIIDHVVPEPGSSLLTSFEKWHEAADTKSCCDYSLHVDITSWYDGVREELEVLVQDKGVNSFQVYMAYKDVYQMSDSQLYEAFTFLKGLGAVILVHAENGDLIAQEQKRILEMGITGPEGHALSRPEELEAEAVFRAITIAGRINCPVYITKVMSKSAADIIALARKKGPLVFGEPIAASLGTDGTHYWSKNWAKAAAFVTSPPLSPDPTTPDYLTSLLACGDLQVTGSGHCPYSTAQKAVGKDNFTLIPEGVNGIEERMTVVWDKAVATGKMDENQFVAVTSTNAAKIFNLYPRKGRIAVGSDADVVIWDPDKLKTITAKSHKSAVEYNIFEGMECHGSPLVVISQGKIVFEDGNINVNKGMGRFIPRKAFPEHLYQRVKIRNKVFGLQGVSRGMYDGPVYEVPATPKYATPAPSAKSSPSKHQPPPIRNLHQSNFSLSGAQIDDNNPRRTGHRIVAPPGGRSNITSLG","Homo sapiens","CRMP1, DPYSL1, ULIP3","DIHYDROPYRIMIDINASE-RELATED PROTEIN 1","1","4B3Z"
"4B4C",,"X-RAY DIFFRACTION",2.35,47.77,,7.5,"2M AMMONIUM SULFATE, 0.1M CITRATE PH 3.5",,,,"4B4C",24.33,"1.62","1.62","Crystal structure of the DNA-binding domain of human CHD1.","SMPRENIKGFSDAEIRRFIKSYKKFGGPLERLDAIARDAELVDKSETDLRRLGELVHNGCIKALKDSSSGTERTGGRLGKVKGPTFRISGVQVNAKLVISHEEELIPLHKSIPSDPEERKQYTIPCHTKAAHFDIDWGKEDDSNLLIGIYEYGYGSWEMIKMDPDLSLTHKILPDDPDKKPQAKQLQTRADYLIKLLSRDLAKKEALSGAG","Homo sapiens","CHD1","CHROMODOMAIN-HELICASE-DNA-BINDING PROTEIN 1","1","4B4C"
"4B4L",,"X-RAY DIFFRACTION",2.32,47,,5.5,"0.2M AMMONIUM SULFATE, 0.1M BIS-TRIS PH 5.5, 25%(W/V) POLYETHYLENE GLYCOL 3350",,"10.1016/j.chembiol.2013.12.008",,"4B4L",39.88,"1.75","1.75","CRYSTAL STRUCTURE OF AN ARD DAP-KINASE 1 MUTANT","GAMTVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAAAKKWKQSVRLISLCQRLSRSFLSRSNMSVARSD","Homo sapiens","DAPK1, DAPK","DEATH-ASSOCIATED PROTEIN KINASE 1","1","4B4L"
"4B4O",,"X-RAY DIFFRACTION",2.42,49.2,,,"0.2M NA FORMATE 15W/V PEG 3350",,,,"4B4O",265.24,"2.7","2.7","Crystal Structure of human epimerase family protein SDR39U1 (isoform2) with NADPH","MRVLVGGGTGFIGTALTQLLNARGHEVTLVSRKPGPGRITWDELAASGLPSCDAAVNLAGENILNPLRRWNETFQKEVLGSRLETTQLLAKAITKAPQPPKAWVLVTGVAYYQPSLTAEYDEDSPGGDFDFFSNLVTKWEAAARLPGDSTRQVVVRSGVVLGRGGGAMGHMLLPFRLGLGGPIGSGHQFFPWIHIGDLAGILTHALEANHVHGVLNGVAPSSATNAEFAQTFGAALGRRAFIPLPSAVVQAVFGRQRAIMLLEGQKVIPRRTLATGYQYSFPELGAALKEIAENLYFQ","Homo sapiens","SDR39U1, C14orf124, HCDI","EPIMERASE FAMILY PROTEIN SDR39U1","1","4B4O"
"4B53",,"X-RAY DIFFRACTION",2.34,47.38,"VAPOR DIFFUSION, SITTING DROP",,"SITTING DROP AT 291K. RESERVOIR OF 100 MICROLITRE 22% PEG 3350 AND 150MM CALCIUM ACETATE. DROP SIZE 100 NANOLITRE PROTEIN AND 100 NANOLITRE RESERVOIR. PROTEIN CONCENTRATION OF 1.5MG/ML",291,"10.1016/j.molimm.2012.10.029",,"4B53",25.04,"1.8","1.8","Crystal structure of the isolated IgG4 CH3 domain","QPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLGK","Homo sapiens","IGHG4","IG GAMMA-4 CHAIN C REGION","1","4B53"
"4B5O",,"X-RAY DIFFRACTION",2.1,41.42,,8,"50 MM TRIS PH 8.0, 200 MM NAC, 15% PEG8000",,"10.1073/pnas.1209343109",,"4B5O",23.67,"1.05","1.05","Crystal structure of human alpha tubulin acetyltransferase catalytic domain","GAASMEFPFDVDALFPERITVLDQHLRPPARRPGTTTPARVDLQQQIMTIIDELGKASAKAQNLSAPITSASRMQSNRHVVYILKDSSARPAGKGAIIGFIKVGYKKLFVLDDREAHNEVEPLCILDFYIHESVQRHGHGRELFQYMLQKERVEPHQLAIDRPSQKLLKFLNKHYNLETTVPQVNNFVIFEGFFAHQHRP","Homo sapiens","ATAT1, C6orf134, MEC17, Nbla00487","ALPHA-TUBULIN N-ACETYLTRANSFERASE","1","4B5O"
"4B5P",,"X-RAY DIFFRACTION",2.54,51.57,,7,"2.8 M NA ACETATE PH 7.0",,"10.1073/pnas.1209343109",,"4B5P",47.25,"1.6","1.6","Crystal structure of human alpha tubulin acetyltransferase catalytic domain Q58A variant","GAASMEFPFDVDALFPERITVLDQHLRPPARRPGTTTPARVDLQQQIMTIIDELGKASAKAANLSAPITSASRMQSNRHVVYILKDSSARPAGKGAIIGFIKVGYKKLFVLDDREAHNEVEPLCILDFYIHESVQRHGHGRELFQYMLQKERVEPHQLAIDRPSQKLLKFLNKHYNLETTVPQVNNFVIFEGFFAHQHRP","Homo sapiens","ATAT1, C6orf134, MEC17, Nbla00487","ALPHA-TUBULIN N-ACETYLTRANSFERASE","1","4B5P"
,,,,,,,,,,,,,,,,"GAASMEFPFDVDALFPERITVLDQHLRPPARRPGTTTPARVDLQQQIMTIIDELGKASAKAANLSAPITSASRMQSNRHVVYILKDSSARPAGKAAIIGFIKVGYKKLFVLDDREAHNEVEPLCILDFYIHESVQRHGHGRELFQYMLQKERVEPHQLAIDRPSQKLLKFLNKHYNLETTVPQVNNFVIFEGFFAHQHRP","Homo sapiens","ATAT1, C6orf134, MEC17, Nbla00487","ALPHA-TUBULIN N-ACETYLTRANSFERASE","2","4B5P"
"4B6D",,"X-RAY DIFFRACTION",3.35,63.26,,7.1,"1.3 M SODIUM CITRATE, PH 7.1 AND 0.3 M DIMETHYLETHYLAMMONIUM PROPANE SULFONATE",,"10.1038/nature11773",,"4B6D",41.82,"2.2","2.2","Structure of the atypical C1 domain of MgcRacGAP","GPLGSMRLHDFVSKTVIKPESCVPCGKRIKFGKLSLKCRDCRVVSHPECRDRCPLPCIPTL","Homo sapiens","RACGAP1, KIAA1478, MGCRACGAP","RAC GTPASE-ACTIVATING PROTEIN 1","1","4B6D"
"4B6L",,"X-RAY DIFFRACTION",2.57,50,,,"0.8M NAH2PO4, 1.2M K2HPO4, 0.1M MES PH 5.2, 10MM DTT",,,,"4B6L",32.79,"1.9","1.9","Discovery of Oral Polo-Like Kinase (PLK) Inhibitors with Enhanced Selectivity Profile using Residue Targeted Drug Design","LITDPRSGRTYLKGRLLGKGGFARCYEATDTETGSAYAVKVIPQSRVAKPHQREKILNEIELHRDLQHRHIVRFSHHFEDADNIYIFLELCSRKSLAHIWKARHTLLEPEVRYYLRQILSGLKYLHQRGILHRDLKLGNFFITENMELKVGDFGLAARLEPPEQRKKTICGTPNYVAPEVLLRQGHGPEADVWSLGCVMYTLLCGSPPFETADLKETYRCIKQVHYTLPASLSLPARQLLAAILRASPRDRPSIDQILRHDFFTKGYTPDRLPISSCVTVP","Homo sapiens","PLK3, CNK, FNK, PRK","SERINE/THREONINE-PROTEIN KINASE PLK3","1","4B6L"
"4B70",,"X-RAY DIFFRACTION",2.3,46,,7,"pH 7",,"10.1021/jm3011349","WM9","4B70",43.21,"1.6","1.6","Aminoimidazoles as BACE-1 Inhibitors: From De Novo Design to Ab- lowering in Brain","VEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGY","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","4B70"
"4B72",,"X-RAY DIFFRACTION",2.3,46,,7,"pH 7",,"10.1021/jm3011349","2FB","4B72",43.61,"1.6","1.6","Aminoimidazoles as BACE-1 Inhibitors: From De Novo Design to Ab- lowering in Brain","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGY","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","4B72"
"4B77",,"X-RAY DIFFRACTION",2.3,46,,7,"pH 7",,"10.1021/jm3011349","54M","4B77",43.62,"1.8","1.8","Aminoimidazoles as BACE-1 Inhibitors: From De Novo Design to Ab- lowering in Brain","GSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGY","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","4B77"
"4B78",,"X-RAY DIFFRACTION",2.3,46,,7,"pH 7",,"10.1021/jm3011349","KGG","4B78",43.18,"1.5","1.5","Aminoimidazoles as BACE-1 Inhibitors: From De Novo Design to Ab- lowering in Brain","EMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGY","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","4B78"
"4B7B",,"X-RAY DIFFRACTION",2.69,54.26,,5.6,"0.02 M CACL2 DEHYDRATE, 0.02 M CADMIUM CHLORIDE HYDRATE, 0.02 M COBALT(II) CHLORIDE HEXAHYDRATE, 20% W/V PEG 3350, PH 5.6",,"10.1021/jm4006274",,"4B7B",43.44,"2.5","2.5","Eg5-3","MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEVPLDGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","KINESIN-LIKE PROTEIN KIF11","1","4B7B"
"4B7I",,"X-RAY DIFFRACTION",2.8,56,,5.5,"20% W/V PEG 3350 PH 5.5, 0.2 M SODIUM/POTASSIUM PHOSPHATE",,"10.1021/ja306068g",,"4B7I",51.05,"2.36","2.36","Crystal Structure of Human IgG Fc Bearing Hybrid-type Glycans","GPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKATPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGTKHHHHHH","Homo sapiens","IGHG1","IG GAMMA-1 CHAIN C REGION","1","4B7I"
"4B7L",,"X-RAY DIFFRACTION",2.2,44.3,,8.5,"30% PEG 4000, 0.1 M TRIS HCL PH 8.5, 0.2 M SODIUM ACETATE",,"10.1016/j.jmb.2012.09.016",,"4B7L",78.57,"2.05","2.05","Crystal Structure of Human Filamin B Actin Binding Domain with 1st Filamin Repeat","MPVTEKDLAEDAPWKKIQQNTFTRWCNEHLKSVNKRIGNLQTDLSDGLRLIALLEVLSQKRMYRKYHQRPTFRQMQLENVSVALEFLDRESIKLVSIDSKAIVDGNLKLILGLVWTLILHYSISMPVWEDEGDDDAKKQTPKQRLLGWIQNKIPYLPITNFNQNWQDGKALGALVDSCAPGLCPDWESWDPQKPVDNAREAMQQADDWLGVPQVITPEEIIHPDVDEHSVMTYLSQFPKAKLKPGAPLKPKLNPKKARAYGRGIEPTGNMVKQPAKFTVDTISAGQGDVMVFVEDPEGNKEEAQVTPDSDKNKTYSVEYLPKVTGLHKVTVLFAGQHISKSPFEVSV","Homo sapiens","FLNB, FLN1L, FLN3, TABP, TAP","FILAMIN-B","1","4B7L"
"4B7P",,"X-RAY DIFFRACTION",2.18,43.48,,,,,"10.1158/1078-0432.CCR-12-3512","9UN","4B7P",26.27,"1.7","1.7","Structure of HSP90 with NMS-E973 inhibitor bound","GPDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","4B7P"
"4B7W",,"X-RAY DIFFRACTION",2.83,56.6,,8,"0.7 M AMMONIUM ACETATE, 0.1 M SODIUM CITRATE, 10 MM DTT, 16% MPD IN 0.1 M TRIS, PH 8.0",,,,"4B7W",107.68,"4","4","Ligand binding domain human hepatocyte nuclear factor 4alpha: Apo form","GAMSSYEDSSLPSINALLQAEVLSRQITSPVSGINGDIRAKKIASIADVCESMKEQLLVLVEWAKYIPAFCELPLDDQVALLRAHAGEHLLLGATKRSMVFKDVLLLGNDYIVPRHCPELAEMSRVSIRILDELVLPFQELQIDDNEYAYLKAIIFFDPDAKGLSDPGKIKRLRSQVQVSLEDYINDRQYDSRGRFGELLLLLPTLQSITWQMIEQIQFIKLFGMAKIDNLLQEMLLGG","Homo sapiens","HNF4A, HNF4, NR2A1, TCF14","HEPATOCYTE NUCLEAR FACTOR 4-ALPHA","1","4B7W"
"4B87",,"X-RAY DIFFRACTION",3.1,60,,7.5,"17.5% PEG 3350, 0.2M KCSN PH 8.2, 5% ETHYLENE GLYCOL",,,,"4B87",41.69,"2.16","2.16","Crystal structure of human DNA cross-link repair 1A","SMAHGGLQRGNKKIPESSNVGGSRKKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DNA CROSS-LINK REPAIR 1A PROTEIN","1","4B87"
"4B8W",,"X-RAY DIFFRACTION",1.93,36.41,,,"0.2 M NACL, 0.1 M BIS-TRIS PH 5.5, 25% PEG 3350",,,,"4B8W",74.12,"2.75","2.75","Crystal structure of human GDP-L-fucose synthase with bound NADP and GDP, tetragonal crystal form","NLYFQSMRILVTGGSGLVGKAIQKVVADGAGLPGEDWVFVSSKDADLTDTAQTRALFEKVQPTHVIHLAAMVGGLFRNIKYNLDFWRKNVHMNDNVLHSAFEVGARKVVSCLSTCIFPDKTTYPIDETMIHNGPPHNSNFGYSYAKRMIDVQNRAYFQQYGCTFTAVIPTNVFGPHDNFNIEDGHVLPGLIHKVHLAKSSGSALTVWGTGNPRRQFIYSLDLAQLFIWVLREYNEVEPIILSVGEEDEVSIKEAAEAVVEAMDFHGEVTFDTTKSDGQFKKTASNSKLRTYLPDFRFTPFKQAVKETCAWFTDNYEQAR","Homo sapiens","GFUS, SDR4E1, TSTA3","GDP-L-FUCOSE SYNTHASE","1","4B8W"
"4B8Z",,"X-RAY DIFFRACTION",2.35,47.8,,,"0.3M NABR, 0.1M BIS-TRIS-PROPANE (PH 7.5), 23% PEG3350, 10% ETHYLENE GLYCOL",,,,"4B8Z",148.75,"2.75","2.75","Crystal structure of human GDP-L-fucose synthase with bound NADP and GDP, rhombohedral crystal form","ENLYFQSMRILVTGGSGLVGKAIQKVVADGAGLPGEDWVFVSSKDADLTDTAQTRALFEKVQPTHVIHLAAMVGGLFRNIKYNLDFWRKNVHMNDNVLHSAFEVGARKVVSCLSTCIFPDKTTYPIDETMIHNGPPHNSNFGYSYAKRMIDVQNRAYFQQYGCTFTAVIPTNVFGPHDNFNIEDGHVLPGLIHKVHLAKSSGSALTVWGTGNPRRQFIYSLDLAQLFIWVLREYNEVEPIILSVGEEDEVSIKEAAEAVVEAMDFHGEVTFDTTKSDGQFKKTASNSKLRTYLPDFRFTPFKQAVKETCAWFTDNYEQAR","Homo sapiens","GFUS, SDR4E1, TSTA3","GDP-L-FUCOSE SYNTHASE","1","4B8Z"
"4B90",,"X-RAY DIFFRACTION",1.97,37.45,,6,"25% (W/V) PEG 1500 SPG PH 6.0",,"10.1111/jnc.12188",,"4B90",128.25,"2.2","2.2","Crystal structure of WT human CRMP-5","MHHHHHHSSGVDLGTENLYFQSMLANSASVRILIKGGKVVNDDCTHEADVYIENGIIQQVGRELMIPGGAKVIDATGKLVIPGGIDTSTHFHQTFMNATCVDDFYHGTKAALVGGTTMIIGHVLPDKETSLVDAYEKCRGLADPKVCCDYALHVGITWWAPKVKAEMETLVREKGVNSFQMFMTYKDLYMLRDSELYQVLHACKDIGAIARVHAENGELVAEGAKEALDLGITGPEGIEISRPEELEAEATHRVITIANRTHCPIYLVNVSSISAGDVIAAAKMQGKVVLAETTTAHATLTGLHYYHQDWSHAAAYVTVPPLRLDTNTSTYLMSLLANDTLNIVASDHRPFTTKQKAMGKEDFTKIPHGVSGVQDRMSVIWERGVVGGKMDENRFVAVTSSNAAKLLNLYPRKGRIIPGADADVVVWDPEATKTISASTQVQGGDFNLYENMRCHGVPLVTISRGRVVYENGVFMCAEGTGKFCPLRSFPDTVYKKLVQREKTLKVRGVDRTPYLGDVAVVVHPGKKEMGTPLADTPTRPVTRHGGMRDLHESSFSLSGSQIDDHVPKRASARILAPPGGRSSGIW","Homo sapiens","DPYSL5, CRMP5, ULIP6","DIHYDROPYRIMIDINASE-RELATED PROTEIN 5","1","4B90"
"4B91",,"X-RAY DIFFRACTION",2.28,46.08,,5,"23% (V/V) PEG 400 MMT PH 5.0",,"10.1111/jnc.12188",,"4B91",105.91,"1.7","1.7","Crystal structure of truncated human CRMP-5","SMLANSASVRILIKGGKVVNDDCTHEADVYIENGIIQQVGRELMIPGGAKVIDATGKLVIPGGIDTSTHFHQTFMNATCVDDFYHGTKAALVGGTTMIIGHVLPDKETSLVDAYEKCRGLADPKVCCDYALHVGITWWAPKVKAEMETLVREKGVNSFQMFMTYKDLYMLRDSELYQVLHACKDIGAIARVHAENGELVAEGAKEALDLGITGPEGIEISRPEELEAEATHRVITIANRTHCPIYLVNVSSISAGDVIAAAKMQGKVVLAETTTAHATLTGLHYYHQDWSHAAAYVTVPPLRLDTNTSTYLMSLLANDTLNIVASDHRPFTTKQKAMGKEDFTKIPHGVSGVQDRMSVIWERGVVGGKMDENRFVAVTSSNAAKLLNLYPRKGRIIPGADADVVVWDPEATKTISASTQVQGGDFNLYENMRCHGVPLVTISRGRVVYENGVFMCAEGTGKFCPLRSFPDTVYKKLVQREKTLK","Homo sapiens","DPYSL5, CRMP5, ULIP6","DIHYDROPYRIMIDINASE-RELATED PROTEIN 5","1","4B91"
"4B92",,"X-RAY DIFFRACTION",2.28,46.08,,5,"23% (V/V) PEG 400 MMT PH 5.0",,"10.1111/jnc.12188",,"4B92",106.17,"2.9","2.9","Crystal structure of truncated human CRMP-5 soaked with Zn","SMLANSASVRILIKGGKVVNDDCTHEADVYIENGIIQQVGRELMIPGGAKVIDATGKLVIPGGIDTSTHFHQTFMNATCVDDFYHGTKAALVGGTTMIIGHVLPDKETSLVDAYEKCRGLADPKVCCDYALHVGITWWAPKVKAEMETLVREKGVNSFQMFMTYKDLYMLRDSELYQVLHACKDIGAIARVHAENGELVAEGAKEALDLGITGPEGIEISRPEELEAEATHRVITIANRTHCPIYLVNVSSISAGDVIAAAKMQGKVVLAETTTAHATLTGLHYYHQDWSHAAAYVTVPPLRLDTNTSTYLMSLLANDTLNIVASDHRPFTTKQKAMGKEDFTKIPHGVSGVQDRMSVIWERGVVGGKMDENRFVAVTSSNAAKLLNLYPRKGRIIPGADADVVVWDPEATKTISASTQVQGGDFNLYENMRCHGVPLVTISRGRVVYENGVFMCAEGTGKFCPLRSFPDTVYKKLVQREKTLK","Homo sapiens","DPYSL5, CRMP5, ULIP6","DIHYDROPYRIMIDINASE-RELATED PROTEIN 5","1","4B92"
"4B94",,"X-RAY DIFFRACTION",3.6,66,,5,"0.1M MIB PH 5.0, 25% PEG1500",,"10.1083/jcb.201210033",,"4B94",83.19,"2.2","2.2","Crystal structure of human Mps1 TPR domain","GPGPEDWLSLLLKLEKNSVPLSDALLNKLIGRYSQAIEALPPDKYGQNESFARIQVRFAELKAIQEPDDARDYFQMARANCKKFAFVHISFAQFELSQGNVKKSKQLLQKAVERGAVPLEMLEIALRNLNLQKKQLLSEEEKKNLSASTVLTAQESFSGSLGHLQNRNNSCDSRGQTTKAR","Homo sapiens","TTK, MPS1, MPS1L1","DUAL SPECIFICITY PROTEIN KINASE TTK","1","4B94"
"4B99",,"X-RAY DIFFRACTION",3,59,,6,"0.05M CACL2, 0.1M MES PH 6.0, 20% PEG 6000, 10% ETHYLENE GLYCOL",,"10.1021/jm4000837","R4L","4B99",45.63,"2.8","2.8","Crystal Structure of MAPK7 (ERK5) with inhibitor","SMAEPLKEEDGEDGSAEPPGPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFHARREGIRQ","Homo sapiens","MAPK7, BMK1, ERK5, PRKM7","MITOGEN-ACTIVATED PROTEIN KINASE 7","1","4B99"
"4B9D",,"X-RAY DIFFRACTION",2.2,43,,7.5,"0.2M NA/KPO4, 20% PEG 3350, 10% ETHYLENE GLYCOL, pH 7.5",,"10.1038/s41598-017-05325-w",,"4B9D",80.65,"1.9","1.9","Crystal Structure of Human NIMA-related Kinase 1 (NEK1) with inhibitor.","MHHHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYKKYGDKK","Homo sapiens","NEK1, KIAA1901","SERINE/THREONINE-PROTEIN KINASE NEK1","1","4B9D"
"4BA9",,"X-RAY DIFFRACTION",2.92,57.84,,,"100 MM HEPES.NAOH PH 8.0, 10 MM MGCL2, 5 MM NICL2, 7-9% (W/V) PEG 3350, 4% (V/V) 2,2,2-TRIFLUOROETHANOL.",,,,"4BA9",79.03,"2.73","2.73","The structural basis for the coordination of Y-family Translesion DNA Polymerases by Rev1","GPHMHKKSFFDKKRSERGSDAGSAGDGASNLAGAVEFNDVKTLLREWITTISDPMEEDILQVVKYCTDLIEEKDLEKLDLVIKYMKRLMQQSVESVWNMAFDFILDNVQVVLQQ","Homo sapiens","REV1","DNA POLYMERASE KAPPA, DNA REPAIR PROTEIN REV1","1","4BA9"
,,,,,,,,,,,,,,,,,"Homo sapiens","REV1"
"4BB2",,"X-RAY DIFFRACTION",2.68,54.07,,7.5,"0.1 M HEPES 7.5, 2 % PEG 400, 2 M AMMONIUM SULFATE",,"10.1371/journal.pone.0052759","STR","4BB2",42.33,"2.48","2.48","Crystal structure of cleaved corticosteroid-binding globulin in complex with progesterone","GSNHHRGLASANVDFAFSLYKHLVALSPKKNIFISPVSISMALAMLSLGTCGHTRAQLLQGLGFNLTERSETEIHQGFQHLHQLFAKSDTSLEMTMGNALFLDGSLELLESFSADIAHYYESEVLAMNFQDWATASRQINSYVKNKTQGKIVDLFSGLDSPAILVLVNYIFFKGTWTQPFDLASTREENFYVDETTVVKVPMMLQSSTISYLHDSELPCQLVQMNYVGNGTVFFILPDKGKMNTVIAALSRDTINRWSAGLTSSQVDLYIPKVTISGVYDLGDVLEEMGIADLFTNQANFSRITQDAQLKSSKVVHKAVLQLNEEGVDTAGSTGVTLNLT","Homo sapiens","SERPINA6, CBG","CORTICOSTEROID-BINDING GLOBULIN","1","4BB2"
,,,,,,,,,,,,,,,,"SKPIILRFNQPFIIMIFDHFTWSSLFLARVMNPV","Homo sapiens","SERPINA6, CBG","CORTICOSTEROID-BINDING GLOBULIN","2","4BB2"
"4BB4",,"X-RAY DIFFRACTION",2.08,40.79,,7.4,"pH 7.4",,"10.1021/jm301658d","32W","4BB4",34.38,"1.65","1.65","ephB4 kinase domain inhibitor complex","DPNEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKIVARENGGASHPLL","Homo sapiens","EPHB4, HTK, MYK1, TYRO11","EPHRIN TYPE-B RECEPTOR 4","1","4BB4"
"4BB5",,"X-RAY DIFFRACTION",2.2,44,,7,"pH 7",,"10.1021/jm3013163","HD2","4BB5",134.4,"2.2","2.2","Free-Wilson and Structural Approaches to Co-optimising Human and Rodent Isoform Potency for 11b-Hydroxysteroid Dehydrogenase Type 1 11b-HSD1 Inhibitors","MAFMKKYLLPILGLFMAYYYYSANEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPLVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSRWTTLLIRNPSRKILEELYSTSYNMDRFINK","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","CORTICOSTEROID 11-BETA-DEHYDROGENASE ISOZYME 1","1","4BB5"
"4BB6",,"X-RAY DIFFRACTION",4.02,69.4,,,,,"10.1021/jm3013163",,"4BB6",67.38,"2.55","2.55","Free-Wilson and Structural Approaches to Co-optimising Human and Rodent Isoform Potency for 11b-Hydroxysteroid Dehydrogenase Type 1 11b-HSD1 Inhibitors","MAFMKKYLLPILGLFMAYYYYSANEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPLVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSRWTTLLIRNPSRKILEELYSTSYNWDRFINK","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","CORTICOSTEROID 11-BETA-DEHYDROGENASE ISOZYME 1","1","4BB6"
"4BB9",,"X-RAY DIFFRACTION",2.16,43.11,,,"12-16 MG/ML IN 25 MM HEPES PH 7.4, 50 MM KCL, 1 MM MGCL2, 2 MM DTT AND 5 MM FRUCTOSE-1-PHOSPHATE 14 % PEG 8000, 20% GLYCEROL, 0.16 M CALCIUM ACETATE AND 0.08 M CACODYLATE PH 6.5",,"10.1021/bi4000782","F1P","4BB9",70.08,"1.47","1.47","Crystal structure of glucokinase regulatory protein complexed to fructose-1-phosphate","MPGTKRFQHVIETPEPGKWELSGYEAAVPITEKSNPLTQDLDKADAENIVRLLGQCDAEIFQEEGQALSTYQRLYSESILTTMVQVAGKVQEVLKEPDGGLVVLSGGGTSGRMAFLMSVSFNQLMKGLGQKPLYTYLIAGGDRSVVASREGTEDSALHGIEELKKVAAGKKRVIVIGISVGLSAPFVAGQMDCCMNNTAVFLPVLVGFNPVSMARNDPIEDWSSTFRQVAERMQKMQEKQKAFVLNPAIGPEGLSGSSRMKGGSATKILLETLLLAAHKTVDQGIAASQRCLLEILRTFERAHQVTYSQSPKIATLMKSVSTSLETTGHVYLVGWQTLGIIAIMDGVECIHTFGADFRDVRGFLIGDHSDMFNQKAELTNQGPQFTFSQEDFLTSILPSLTEIDTVVFIFTLDDNLTEVQTIVEQVKEKTNHIQALAHSTVGQTLPIPLKKLFPSIISITWPLLFFEYEGNFIQKFQRELSTKWVLNTVSTGAHVLLGKILQNHMLDLRISNSKLFWRALAMLQRFSGQSKARCIESLLRAIHFPQPLSDDIRAAPISCHVQVAHEKEQVIPIALLSLLFRCSITEAQAHLAAAPSVCEAVRSALAGPGQKRTADPLEILEPDVQLEHHHHHH","Homo sapiens","GCKR","GLUCOKINASE REGULATORY PROTEIN","1","4BB9"
"4BBA",,"X-RAY DIFFRACTION",2.2,43.98,,,"12-16MG/ML IN 25 MM HEPES PH 7.4, 50 MM KCL, 1 MM MGCL2, 2 MM DTT. 20% PEG 3350, 0.1 M TRIS PH 8.0",,"10.1021/bi4000782",,"4BBA",69.87,"1.92","1.92","Crystal structure of glucokinase regulatory protein complexed to phosphate","MPGTKRFQHVIETPEPGKWELSGYEAAVPITEKSNPLTQDLDKADAENIVRLLGQCDAEIFQEEGQALSTYQRLYSESILTTMVQVAGKVQEVLKEPDGGLVVLSGGGTSGRMAFLMSVSFNQLMKGLGQKPLYTYLIAGGDRSVVASREGTEDSALHGIEELKKVAAGKKRVIVIGISVGLSAPFVAGQMDCCMNNTAVFLPVLVGFNPVSMARNDPIEDWSSTFRQVAERMQKMQEKQKAFVLNPAIGPEGLSGSSRMKGGSATKILLETLLLAAHKTVDQGIAASQRCLLEILRTFERAHQVTYSQSPKIATLMKSVSTSLETTGHVYLVGWQTLGIIAIMDGVECIHTFGADFRDVRGFLIGDHSDMFNQKAELTNQGPQFTFSQEDFLTSILPSLTEIDTVVFIFTLDDNLTEVQTIVEQVKEKTNHIQALAHSTVGQTLPIPLKKLFPSIISITWPLLFFEYEGNFIQKFQRELSTKWVLNTVSTGAHVLLGKILQNHMLDLRISNSKLFWRALAMLQRFSGQSKARCIESLLRAIHFPQPLSDDIRAAPISCHVQVAHEKEQVIPIALLSLLFRCSITEAQAHLAAAPSVCEAVRSALAGPGQKRTADPLEILEPDVQLEHHHHHH","Homo sapiens","GCKR","GLUCOKINASE REGULATORY PROTEIN","1","4BBA"
"4BBE",,"X-RAY DIFFRACTION",2.8,56,,7,"pH 7",,"10.1016/j.bmcl.2012.10.007","3O4","4BBE",141.54,"1.9","1.9","Aminoalkylpyrimidine Inhibitor Complexes with JAK2","GSRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAGEF","Homo sapiens","JAK2","TYROSINE-PROTEIN KINASE JAK2","1","4BBE"
"4BBF",,"X-RAY DIFFRACTION",2.8,56,,7,"pH 7",,"10.1016/j.bmcl.2012.10.007","O19","4BBF",141.76,"2","2","Aminoalkylpyrimidine Inhibitor Complexes with JAK2","GSRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAGEF","Homo sapiens","JAK2","TYROSINE-PROTEIN KINASE JAK2","1","4BBF"
"4BBG",,"X-RAY DIFFRACTION",4.02,69.44,,5.5,"22 % POLYETHYLENE GLYCOL-3350, 0.3 M AMMONIUM SULPHATE, 0.1 M MES PH 5.5 AND 0.01 M TRIMETHYLAMINE HYDROCHLORIDE",,"10.1021/jm3014597","V02","4BBG",42.05,"2.75","2.75","Crystal structure of human kinesin Eg5 in complex with 3-(((2-Aminoethyl)sulfanyl)(3-ethylphenyl) phenylmethyl)phenol","MASQPNSSAKKKEEKGKNIQVVVRCRPFNLAERKASAHSIVECDPVRKEVSVRTGGLADKSSRKTYTFDMVFGASTKQIDVYRSVVCPILDEVIMGYNCTIFAYGQTGTGKTFTMEGERSPNEEYTWEEDPLAGIIPRTLHQIFEKLTDNGTEFSVKVSLLEIYNEELFDLLNPSSDVSERLQMFDDPRNKRGVIIKGLEEITVHNKDEVYQILEKGAAKRTTAATLMNAYSSRSHSVFSVTIHMKETTIDGEELVKIGKLNLVDLAGSENIGRSGAVDKRAREAGNINQSLLTLGRVITALVERTPHVPYRESKLTRILQDSLGGRTRTSIIATISPASLNLEETLSTLEYAHRAKNILNKPEVNQK","Homo sapiens","KIF11, EG5, KNSL1, TRIP5","KINESIN-LIKE PROTEIN KIF11","1","4BBG"
"4BBM",,"X-RAY DIFFRACTION",2.19,43.85,,,"0.2M (NH4)2SO4, 0.1M CACODYLATE PH 6.5, 30% PEG 8K",,"10.1016/j.celrep.2017.12.083",,"4BBM",77.93,"2","2","CRYSTAL STRUCTURE OF THE HUMAN CDKL2 KINASE DOMAIN WITH BOUND TCS 2312","MGHHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQELQLKVQKDA","Homo sapiens","CDKL2","CYCLIN-DEPENDENT KINASE-LIKE 2","1","4BBM"
"4BBQ",,"X-RAY DIFFRACTION",2.51,51,,7.5,"0.1M BIS-TRIS, PH 6.5, 20%(W/V) PEG METHYL ETHER 5000",,,,"4BBQ",27.22,"2.24","2.24","Crystal structure of the CXXC and PHD domain of Human Lysine-specific Demethylase 2A (KDM2A)(FBXL11)","SMRRVRCRKCKACVQGECGVCHYCRDMKKFGGPGRMKQSCVLRQCLAPRLPHSVTCSLCGEVDQNEETQDFEKKLMECCICNEIVHPGCLQMDGEGLLNEELPNCWECPKCYQEDSS","Homo sapiens","KDM2A, CXXC8, FBL11, FBL7, FBXL11, JHDM1A, KIAA1004","LYSINE-SPECIFIC DEMETHYLASE 2A","1","4BBQ"
"4BBX",,"X-RAY DIFFRACTION",2,40,,8.9,"18% W/V PEG3350, 0.1 M TRIS-HCL PH 8.9, 5 MM CALCIUM CHLORIDE",,"10.1021/jm500073h","LKF","4BBX",78.87,"2.5","2.5","Discovery of a potent, selective and orally active PDE10A inhibitor for the treatment of schizophrenia","MGSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSRHHHHHH","Homo sapiens","PDE10A","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE 10A","1","4BBX"
"4BBZ",,"X-RAY DIFFRACTION",3.18,61,,6.5,"PROTEIN WAS CRYSTALLIZED FROM 2.1 M AMMONIUM SULFATE, 0.1 M MES BUFFER PH 6.5.",,"10.1021/tx3004505",,"4BBZ",62.58,"2.7","2.7","Structure of human butyrylcholinesterase inhibited by CBDP (2-min soak): Cresyl-phosphoserine adduct","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","4BBZ"
"4BC2",,"X-RAY DIFFRACTION",2.8,55,,,"200 MM MES/KOH PH 5.9, 15% (W/V) PEG 6000",,"10.1074/jbc.M112.427997",,"4BC2",179.32,"1.97","1.97","Crystal structure of human D-xylulokinase in complex with D-xylulose and adenosine diphosphate","GAMAEHAPRRCCLGWDFSTQQVKVVAVDAELNVFYEESVHFDRDLPEFGTQGGVHVHKDGLTVTSPVLMWVQALDIILEKMKASGFDFSQVLALSGAGQQHGSIYWKAGAQQALTSLSPDLRLHQQLQDCFSISDCPVWMDSSTTAQCRQLEAAVGGAQALSCLTGSRAYERFTGNQIAKIYQQNPEAYSHTERISLVSSFAASLFLGSYSPIDYSDGSGMNLLQIQDKVWSQACLGACAPHLEEKLSPPVPSCSVVGAISSYYVQRYGFPPGCKVVAFTGDNPASLAGMRLEEGDIAVSLGTSDTLFLWLQEPMPALEGHIFCNPVDSQHYMALLCFKNGSLMREKIRNESVSRSWSDFSKALQSTEMGNGGNLGFYFDVMEITPEIIGRHRFNTENHKVAAFPGDVEVRALIEGQFMAKRIHAEGLGYRVMSKTKILATGGASHNREILQVLADVFDAPVYVIDTANSACVGSAYRAFHGLAGGTDVPFSEVVKLAPNPRLAATPSPGASQVYEALLPQYAKLEQRILSQTRGPPE","Homo sapiens","XYLB","XYLULOSE KINASE","1","4BC2"
"4BC3",,"X-RAY DIFFRACTION",2.8,55,,,"200 MM MES/KOH, PH 5.9, 13% PEG 6000",,"10.1074/jbc.M112.427997",,"4BC3",178.15,"1.68","1.68","Crystal structure of human D-xylulokinase","GAMAEHAPRRCCLGWDFSTQQVKVVAVDAELNVFYEESVHFDRDLPEFGTQGGVHVHKDGLTVTSPVLMWVQALDIILEKMKASGFDFSQVLALSGAGQQHGSIYWKAGAQQALTSLSPDLRLHQQLQDCFSISDCPVWMDSSTTAQCRQLEAAVGGAQALSCLTGSRAYERFTGNQIAKIYQQNPEAYSHTERISLVSSFAASLFLGSYSPIDYSDGSGMNLLQIQDKVWSQACLGACAPHLEEKLSPPVPSCSVVGAISSYYVQRYGFPPGCKVVAFTGDNPASLAGMRLEEGDIAVSLGTSDTLFLWLQEPMPALEGHIFCNPVDSQHYMALLCFKNGSLMREKIRNESVSRSWSDFSKALQSTEMGNGGNLGFYFDVMEITPEIIGRHRFNTENHKVAAFPGDVEVRALIEGQFMAKRIHAEGLGYRVMSKTKILATGGASHNREILQVLADVFDAPVYVIDTANSACVGSAYRAFHGLAGGTDVPFSEVVKLAPNPRLAATPSPGASQVYEALLPQYAKLEQRILSQTRGPPE","Homo sapiens","XYLB","XYLULOSE KINASE","1","4BC3"
"4BC4",,"X-RAY DIFFRACTION",2.8,55,,,"200 MM MES/KOH, PH 5.9, 15% PEG 6000",,"10.1074/jbc.M112.427997",,"4BC4",178.16,"1.79","1.79","Crystal structure of human D-xylulokinase in complex with D-xylulose","GAMAEHAPRRCCLGWDFSTQQVKVVAVDAELNVFYEESVHFDRDLPEFGTQGGVHVHKDGLTVTSPVLMWVQALDIILEKMKASGFDFSQVLALSGAGQQHGSIYWKAGAQQALTSLSPDLRLHQQLQDCFSISDCPVWMDSSTTAQCRQLEAAVGGAQALSCLTGSRAYERFTGNQIAKIYQQNPEAYSHTERISLVSSFAASLFLGSYSPIDYSDGSGMNLLQIQDKVWSQACLGACAPHLEEKLSPPVPSCSVVGAISSYYVQRYGFPPGCKVVAFTGDNPASLAGMRLEEGDIAVSLGTSDTLFLWLQEPMPALEGHIFCNPVDSQHYMALLCFKNGSLMREKIRNESVSRSWSDFSKALQSTEMGNGGNLGFYFDVMEITPEIIGRHRFNTENHKVAAFPGDVEVRALIEGQFMAKRIHAEGLGYRVMSKTKILATGGASHNREILQVLADVFDAPVYVIDTANSACVGSAYRAFHGLAGGTDVPFSEVVKLAPNPRLAATPSPGASQVYEALLPQYAKLEQRILSQTRGPPE","Homo sapiens","XYLB","XYLULOSE KINASE","1","4BC4"
"4BC5",,"X-RAY DIFFRACTION",2.8,55,,,"200 MM MES/KOH PH 5.9, 13% PEG 6000",,"10.1074/jbc.M112.427997","5FX","4BC5",176.22,"1.98","1.98","Crystal structure of human D-xylulokinase in complex with inhibitor 5- deoxy-5-fluoro-D-xylulose","GAMAEHAPRRCCLGWDFSTQQVKVVAVDAELNVFYEESVHFDRDLPEFGTQGGVHVHKDGLTVTSPVLMWVQALDIILEKMKASGFDFSQVLALSGAGQQHGSIYWKAGAQQALTSLSPDLRLHQQLQDCFSISDCPVWMDSSTTAQCRQLEAAVGGAQALSCLTGSRAYERFTGNQIAKIYQQNPEAYSHTERISLVSSFAASLFLGSYSPIDYSDGSGMNLLQIQDKVWSQACLGACAPHLEEKLSPPVPSCSVVGAISSYYVQRYGFPPGCKVVAFTGDNPASLAGMRLEEGDIAVSLGTSDTLFLWLQEPMPALEGHIFCNPVDSQHYMALLCFKNGSLMREKIRNESVSRSWSDFSKALQSTEMGNGGNLGFYFDVMEITPEIIGRHRFNTENHKVAAFPGDVEVRALIEGQFMAKRIHAEGLGYRVMSKTKILATGGASHNREILQVLADVFDAPVYVIDTANSACVGSAYRAFHGLAGGTDVPFSEVVKLAPNPRLAATPSPGASQVYEALLPQYAKLEQRILSQTRGPPE","Homo sapiens","XYLB","XYLULOSE KINASE","1","4BC5"
"4BC6",,"X-RAY DIFFRACTION",2.86,57.04,,,"0.1M SPG PH 7.0; 60% MPD",,,,"4BC6",33.72,"2.2","2.2","Crystal structure of human serine threonine kinase-10 bound to novel Bosutinib Isoform 1, previously thought to be Bosutinib","EHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAEVME","Homo sapiens","STK10, LOK","SERINE/THREONINE-PROTEIN KINASE 10","1","4BC6"
"4BCR",,"X-RAY DIFFRACTION",2.92,57.92,,,"100 MM TRIS-HCL PH 7.5, 25% PEG 20 K",,"10.1016/j.jmb.2013.05.010","WY1","4BCR",63.45,"2.497","2.497","Structure of PPARalpha in complex with WY14643","IEDSETADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY","Homo sapiens","PPARA, NR1C1, PPAR","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA","1","4BCR"
"4BCW",,"X-RAY DIFFRACTION",2.27,46,,8,"3M AMMONIUM SULPHATE, 100 MM TRIS-HCL PH 8.0",,"10.1021/jm301625s","TU0","4BCW",29.31,"1.5","1.5","Carbonic anhydrase IX mimic in complex with (E)-2-(5-bromo-2- hydroxyphenyl)ethenesulfonic acid","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","CARBONIC ANHYDRASE 2","1","4BCW"
"4BCX",,"X-RAY DIFFRACTION",2.57,52.21,,6.5,"100 MM MES/IMIDAZOLE BUFFER PH 6.5, 0.03 M EACH OF DI-, TRI-, TETRA- AND PENTA-ETHYLENEGLYCOL, 10% (W/V) PEG 20000 AND 24% (V/V) PEG400 (USING A 2:1 RATIO OF PROTEIN TO MOTHER LIQUOR)",,"10.1038/nchembio.1294",,"4BCX",13.91,"2","2","gamma 2 adaptin EAR domain crystal structure","GGSAPIPDLKVFEREGVQLNLSFIRPPENPALLLITITATNFSEGDVTHFICQAAVPKSLQLQLQAPSGNTVPARGGLPITQLFRILNPNKAPLRLKLRLTYDHFHQSVQEIFEVNNLPVESWQ","Homo sapiens","AP1G2","AP-1 COMPLEX SUBUNIT GAMMA-LIKE 2","1","4BCX"
"4BCY",,"X-RAY DIFFRACTION",2.32,47,,,"25% PEG 400, 0.1M NA ACETATE PH 4.6, 0.1 M CDCL2, 20 C",293,"10.1073/pnas.1217306110",,"4BCY",16.76,"1.272","1.272","Monomeric Human Cu,Zn Superoxide dismutase, mutation H43F","ATKAVAVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLFGFHVHEEEDNTAGCTSAGPHFNPLSRKHGGPKDEERHVGDLGNVTADKDGVADVSIEDSVISLSGDHAIIGRTLVVHEKADDLGKGGNEESTKTGNAGSRLACGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","1","4BCY"
"4BCZ",,"X-RAY DIFFRACTION",2.17,43.4,,,"30% PEG 1500, 0.1M MIB BUFFER, PH 4.0, 20 C",293,"10.1073/pnas.1217306110",,"4BCZ",21.98,"1.93","1.93","Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form.","ATKAVAVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLHGFHVHGAGGDLGNVTADKDGVADVSIEDSVISLSGDHSIIGRTLVVHEKAGAGAGSRLASGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","1","4BCZ"
"4BD4",,"X-RAY DIFFRACTION",3.01,51.15,,,"18 % PEG 1500, 15% GLYCEROL",,"10.1073/pnas.1217306110",,"4BD4",99.36,"2.78","2.78","Monomeric Human Cu,Zn Superoxide dismutase, loops IV and VII deleted, apo form, mutant H43F","ATKAVAVLKGDGPVQGIINFEQKESNGPVKVWGSIKGLTEGLFGFHVHGAGGDLGNVTADKDGVADVSIEDSVISLSGDHSIIGRTLVVHEKAGAGAGSRLASGVIGIAQ","Homo sapiens","SOD1","SUPEROXIDE DISMUTASE [CU-ZN]","1","4BD4"
"4BD7",,"X-RAY DIFFRACTION",3.07,59.98,,,"1.8 M NH4SO4, 0.1 M HEPES PH 6.5, 10 MM PRCL3",,"10.1016/j.cell.2012.12.031",,"4BD7",77.05,"2.801","2.801","Bax domain swapped dimer induced by octylmaltoside","MDGSGEQPRGGGPTSSEQIMKTGALLLQGFIQDRAGRMGGEAPELALDPVPQDASTKKLSESLKRIGDELDSNMELQRMIAAVDTDSPREVFFRVAADMFSDGNFNWGRVVALFYFASKLVLKALSTKVPELIRTIMGWTLDFLRERLLGWIQDQGGWDGLLSYFGTPTWQGSS","Homo sapiens","BAX, BCL2L4","APOPTOSIS REGULATOR BAX","1","4BD7"
"4BD8",,"X-RAY DIFFRACTION",2.96,58.49,,,"1.8 M NH4SO4, 0.1 M HEPES PH 6.5, 10 MM PRCL3",,"10.1016/j.cell.2012.12.031",,"4BD8",77.51,"2.22","2.22","Bax domain swapped dimer induced by BimBH3 with CHAPS","MDGSGEQPRGGGPTSSEQIMKTGALLLQGFIQDRAGRMGGEAPELALDPVPQDASTKKLSESLKRIGDELDSNMELQRMIAAVDTDSPREVFFRVAADMFSDGNFNWGRVVALFYFASKLVLKALSTKVPELIRTIMGWTLDFLRERLLGWIQDQGGWDGLLSYFGTPTWQGSS","Homo sapiens","BAX, BCL2L4","APOPTOSIS REGULATOR BAX","1","4BD8"
"4BDA",,"X-RAY DIFFRACTION",3.42,63.74,,,"0.1 M HEPES 7.5, 0.2 M MG(NO3)2, 10% (V/V) ETHYLENE GLYCOL, 1 MM TCEP AND 8-14% (W/V) PEG 3350",,"10.1371/journal.pone.0065689","VFB","4BDA",37.8,"2.6","2.6","Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (CHK2)","GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","4BDA"
"4BDB",,"X-RAY DIFFRACTION",3.4,63.55,,,"0.1 M HEPES 7.5, 0.2 M MG(NO3)2, 10% (V/V) ETHYLENE GLYCOL, 1 MM TCEP AND 8-14% (W/V) PEG 3350",,"10.1371/journal.pone.0065689","ODO","4BDB",37.9,"2.5","2.5","Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (CHK2)","GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","4BDB"
"4BDC",,"X-RAY DIFFRACTION",3.01,59.13,,,"0.1 M HEPES 7.5, 0.2 M MG(NO3)2, 10% (V/V) ETHYLENE GLYCOL, 1 MM TCEP AND 8-14% (W/V) PEG 3350",,"10.1371/journal.pone.0065689","ODH","4BDC",37.52,"3","3","Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (CHK2)","GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","4BDC"
"4BDD",,"X-RAY DIFFRACTION",3,58.99,,,"0.1 M HEPES 7.5, 0.2 M MG(NO3)2, 10% (V/V) ETHYLENE GLYCOL, 1 MM TCEP AND 8-14% (W/V) PEG 3350",,"10.1371/journal.pone.0065689","Z0O","4BDD",37.6,"2.67","2.67","Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (CHK2)","GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","4BDD"
"4BDE",,"X-RAY DIFFRACTION",3.46,64.21,,,"0.1 M HEPES 7.5, 0.2 M MG(NO3)2, 10% (V/V) ETHYLENE GLYCOL, 1 MM TCEP AND 8-14% (W/V) PEG 3350",,"10.1371/journal.pone.0065689","CWS","4BDE",37.58,"2.55","2.55","Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (CHK2)","GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","4BDE"
"4BDF",,"X-RAY DIFFRACTION",2.99,58.92,,,"0.1 M HEPES 7.5, 0.2 M MG(NO3)2, 10% (V/V) ETHYLENE GLYCOL, 1 MM TCEP AND 8-14% (W/V) PEG 3350",,"10.1371/journal.pone.0065689","H3R","4BDF",37.46,"2.7","2.7","Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (CHK2)","GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","4BDF"
"4BDG",,"X-RAY DIFFRACTION",2.96,58.41,,,"0.1 M HEPES 7.5, 0.2 M MG(NO3)2, 10% (V/V) ETHYLENE GLYCOL, 1 MM TCEP AND 8-14% (W/V) PEG 3350",,"10.1371/journal.pone.0065689","P3J","4BDG",37.43,"2.84","2.84","Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (CHK2)","GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","4BDG"
"4BDH",,"X-RAY DIFFRACTION",3,59,,,"0.1 M HEPES 7.5, 0.2 M MG(NO3)2, 10% (V/V) ETHYLENE GLYCOL, 1 MM TCEP AND 8-14% (W/V) PEG 3350",,"10.1371/journal.pone.0065689","WVI","4BDH",37.57,"2.7","2.7","Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (CHK2)","GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","4BDH"
"4BDI",,"X-RAY DIFFRACTION",2.94,58.2,,,"0.1 M HEPES 7.5, 0.2 M MG(NO3)2, 10% (V/V) ETHYLENE GLYCOL, 1 MM TCEP AND 8-14% (W/V) PEG 3350",,"10.1371/journal.pone.0065689","HAU","4BDI",37.91,"2.32","2.32","Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (CHK2)","GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","SERINE/THREONINE-PROTEIN KINASE CHK2","1","4BDI"
"4BDJ",,"X-RAY DIFFRACTION",3.62,65.79,,,"0.1 M HEPES 7.5, 0.2 M MG(NO3)2, 10% (V/V) ETHYLENE GLYCOL, 1 MM TCEP AND 8-14% (W/V) PEG 3350",,"10.1371/journal.pone.0065689","Z2M","4BDJ",37.4,"3.01","3.01","Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (CHK2)","GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","CHECKPOINT KINASE 2","1","4BDJ"
"4BDK",,"X-RAY DIFFRACTION",3.54,64.99,,,"0.1 M HEPES 7.5, 0.2 M MG(NO3)2, 10% (V/V) ETHYLENE GLYCOL, 1 MM TCEP AND 8-14% (W/V) PEG 3350",,"10.1371/journal.pone.0065689","RQQ","4BDK",37.65,"3.3","3.3","Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (CHK2)","GPLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPREGEAEGAE","Homo sapiens","CHEK2, CDS1, CHK2, RAD53","CHECKPOINT KINASE 2","1","4BDK"
"4BDS",,"X-RAY DIFFRACTION",3.2,62,,6.5,"0.1 M MES PH 6.5, 2.1 M AMMONIUM SULFATE, 293 K",293,"10.1042/BJ20130013","THA","4BDS",62.6,"2.1","2.1","Human butyrylcholinesterase in complex with tacrine","EDDIIIATKNGKVRGMQLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDQYTKAEEILSRSIVKRWANFAKYGNPQETQNQSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKV","Homo sapiens","BCHE, CHE1","CHOLINESTERASE","1","4BDS"
"4BDV",,"X-RAY DIFFRACTION",4.8,74,,7.5,"3% PEG550, 0.100 M NACL, 0.100 M TRIS-HCL PH 7.5, 10% ETHANOL",,"10.1515/hsz-2012-0298",,"4BDV",167.98,"3.98","3.98","CRYSTAL STRUCTURE OF A TRUNCATED B-DOMAIN HUMAN FACTOR VIII","ATRRYYLGAVELSWDYMQSDLGELPVDARFPPRVPKSFPFNTSVVYKKTLFVEFTDHLFNIAKPRPPWMGLLGPTIQAEVYDTVVITLKNMASHPVSLHAVGVSYWKASEGAEYDDQTSQREKEDDKVFPGGSHTYVWQVLKENGPMASDPLCLTYSYLSHVDLVKDLNSGLIGALLVCREGSLAKEKTQTLHKFILLFAVFDEGKSWHSETKNSLMQDRDAASARAWPKMHTVNGYVNRSLPGLIGCHRKSVYWHVIGMGTTPEVHSIFLEGHTFLVRNHRQASLEISPITFLTAQTLLMDLGQFLLFCHISSHQHDGMEAYVKVDSCPEEPQLRMKNNEEAEDYDDDLTDSEMDVVRFDDDNSPSFIQIRSVAKKHPKTWVHYIAAEEEDWDYAPLVLAPDDRSYKSQYLNNGPQRIGRKYKKVRFMAYTDETFKTREAIQHESGILGPLLYGEVGDTLLIIFKNQASRPYNIYPHGITDVRPLYSRRLPKGVKHLKDFPILPGEIFKYKWTVTVEDGPTKSDPRCLTRYYSSFVNMERDLASGLIGPLLICYKESVDQRGNQIMSDKRNVILFSVFDENRSWYLTENIQRFLPNPAGVQLEDPEFQASNIMHSINGYVFDSLQLSVCLHEVAYWYILSIGAQTDFLSVFFSGYTFKHKMVYEDTLTLFPFSGETVFMSMENPGLWILGCHNSDFRNRGMTALLKVSSCDKNTGDYYEDSYEDISAYLLSKNNAIEPRSFSQNSRHPSQNPPVLKRHQ","Homo sapiens","F8, F8C","FACTOR VIIIA HEAVY CHAIN, 92 KDA ISOFORM, B DOMAIN","1","4BDV"
,,,,,,,,,,,,,,,,"REITRTTLQSDQEEIDYDDTISVEMKKEDFDIYDEDENQSPRSFQKKTRHYFIAAVERLWDYGMSSSPHVLRNRAQSGSVPQFKKVVFQEFTDGSFTQPLYRGELNEHLGLLGPYIRAEVEDNIMVTFRNQASRPYSFYSSLISYEEDQRQGAEPRKNFVKPNETKTYFWKVQHHMAPTKDEFDCKAWAYFSDVDLEKDVHSGLIGPLLVCHTNTLNPAHGRQVTVQEFALFFTIFDETKSWYFTENMERNCRAPCNIQMEDPTFKENYRFHAINGYIMDTLPGLVMAQDQRIRWYLLSMGSNENIHSIHFSGHVFTVRKKEEYKMALYNLYPGVFETVEMLPSKAGIWRVECLIGEHLHAGMSTLFLVYSNKCQTPLGMASGHIRDFQITASGQYGQWAPKLARLHYSGSINAWSTKEPFSWIKVDLLAPMIIHGIKTQGARQKFSSLYISQFIIMYSLDGKKWQTYRGNSTGTLMVFFGNVDSSGIKHNIFNPPIIARYIRLHPTHYSIRSTLRMELMGCDLNSCSMPLGMESKAISDAQITASSYFTNMFATWSPSKARLHLQGRSNAWRPQVNNPKEWLQVDFQKTMKVTGVTTQGVKSLLTSMYVKEFLISSSQDGHQWTLFFQNGKVKVFQGNQDSFTPVVNSLDPPLLTRYLRIHPQSWVHQIALRMEVLGCEAQDLY","Homo sapiens","F8, F8C","FACTOR VIIIA LIGHT CHAIN","2","4BDV"
"4BDW",,"X-RAY DIFFRACTION",2.89,57.4,,8.5,"0.1 M TRIS, 16-18% PEG4,000, 0.2 M POTASSIUM ACETATE SOAKED IN SAME BUFFER WITH 10 MM HOLMIUM CHLORIDE, pH 8.5",,"10.1107/S1744309113000286",,"4BDW",9.9,"2.501","2.501","The structure of the FnI-EGF tandem domain of coagulation factor XII in complex with Holmium","GSEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGPFCDVDTAA","Homo sapiens","F12","COAGULATION FACTOR XIIA HEAVY CHAIN","1","4BDW"
"4BDX",,"X-RAY DIFFRACTION",2.93,58,,8.5,"0.1 M TRIS PH 8.5 16-18% PEG4, 0.2 M POTASSIUM ACETATE",,"10.1107/S1744309113000286",,"4BDX",9.6,"1.62","1.62","The structure of the FnI-EGF tandem domain of coagulation factor XII","GSEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGPFCDVDTAA","Homo sapiens","F12","COAGULATION FACTOR XIIA HEAVY CHAIN","1","4BDX"
"4BE8",,"X-RAY DIFFRACTION",2.7,54.5,,9,"1.15 M POTASSIUM SODIUM TARTRATE, 0.1 M TRIS-HCL, PH 9.0",,"10.1038/nsmb.2566",,"4BE8",45.71,"2.996","2.996","NEDD4 HECT A889F structure","GPLGSRDYKRKYEFFRRKLKKQNDIPNKFEMKLRRATVLEDSYRRIMGVKRADFLKARLWIEFDGEKGLDYGGVAREWFFLISKEMFNPYYGLFEYSATDNYTLQINPNSGINPDHLSYFKFIGRVAGMAVYHGKLLDGFFIRPFYKMMLHKPITLHDMESVDSEYYNSLRWILENDPTELDLRFIIDEELFGQTHQHELKNGGSEIVVTNKNKKEYIYLVIQWRFVNRIQKQMAAFKEGFFELIPQDLIKIFDENELELLMSGLGDVDVNDWREHTKYKNGYSANHQVIQWFWKAVLMMDSEKRIRLLQFVTGTSRVPMNGFAELYGSNGPQSFTVEQWGTPEKLPRAHTCFNRLDLPPYESFEELWDKLQMFIENTQGFDGVD","Homo sapiens","NEDD4, KIAA0093, NEDD4-1, PIG53","E3 UBIQUITIN-PROTEIN LIGASE NEDD4","1","4BE8"
"4BEJ",,"X-RAY DIFFRACTION",2.66,53.83,,7.5,"12% PEG3350, 50 MM K(HCOO), pH 7.5",,"10.1038/emboj.2013.74",,"4BEJ",276.84,"3.483","3.483","Nucleotide-free Dynamin 1-like protein (DNM1L, DRP1, DLP1)","GPHMGGSMEALIPVINKLQDVFNTVGADIIQLPQIVVVGTQSSGKSSVLESLVGRDLLPRGTGIVTRRPLILQLVHVSQEDKRKTTGEENGVEAEEWGKFLHTKNKLYTDFDEIRQEIENETERISGNNKGVSPEPIHLKIFSPNVVNLTLVDLPGMTKVPVGDQPKDIELQIRELILRFISNPNSIILAVTAANTDMATSEALKISREVDPDGRRTLAVITKLDLMDAGTDAMDVLMGRVIPVKLGIIGVVNRSQLDINNKKSVTDSIRDEYAFLQKKYPSLANRNGTKYLARTLNRLLMHHIRDCLPELKTRINVLAAQYQSLLNSYGEPVDDKSATLLQLITKFATEYCNTIEGTAKYIETSELCGGARICYIFHETFGRTLESVDPLGGLNTIDILTAIRNATAAAAALFVPEVSFELLVKRQIKRLEEPSLRCVELVHEEMQRIIQHCSNYSTQELLRFPKLHDAIVEVVTCLLRKRLPVTNEMVHNLVAIELAYINTKHPDFADACGLMNNNIEEQRDCEVIERLIKSYFLIVRKNIQDSVPKAVMHFLVNHVKDTLQSELVGQLYKSSLLDDLLTESEDMAQRRKEAADMLKALQGASQIIAEIRETHLW","Homo sapiens","DNM1L, DLP1, DRP1","DYNAMIN 1-LIKE PROTEIN","1","4BEJ"
"4BEK",,"X-RAY DIFFRACTION",3.16,61.2,"VAPOR DIFFUSION, SITTING DROP",7,"CRYSTALLIZATION CONDITIONS: 2.5M SODIUM FORMATE, 100MM HEPES, PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K",298,"10.1016/j.bmcl.2013.05.003","XK0","4BEK",45.91,"2.39","2.39","CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVASIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","4BEK"
"4BEX",,"X-RAY DIFFRACTION",4.92,75.04,,7,"2.4 M SODIUM MALONATE PH 7.0 THE CRYSTALS WERE AIR-DRIED BEFORE FREEZING TO DEHYDRATE.",,"10.1107/S0907444913014418",,"4BEX",19.71,"2.8","2.8","Structure of human Cofilin1","GSPGISGGGGGILDSMASGVAVSDGVIKVFNDMKVRKSSTPEEVKKRKKAVLFCLSEDKKNIILEEGKEILVGDVGQTVDDPYATFVKMLPDKDCRYALYDATYETKESKKEDLVFIFWAPESAPLKSKMIYASSKDAIKKKLTGIKHELQANCYEEVKDRATLAEKLGGSAVISLEGKPL","Homo sapiens","CFL1, CFL","COFILIN-1","1","4BEX"
"4BF1",,"X-RAY DIFFRACTION",2.1,42,"VAPOR DIFFUSION, SITTING DROP",9,"1,5 M SODIUM CITRATE 80 MM TRIS- HCL, PH 9.0, PROTEIN 10,8 MG/ML 5-10 MM INHIBITOR (STOCK SOLUTION WAS 100 MM INHIBITOR DISSOLVED IN 100% DIMETHYL SULFOXIDE) VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K, TIME 2-5 DAYS",294,"10.1016/j.bmc.2013.06.041","9FK","4BF1",29.6,"1.35","1.35","Three dimensional structure of human carbonic anhydrase II in complex with 5-(1-naphthalen-1-yl-1,2,3-triazol-4-yl)thiophene-2-sulfonamide","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","CARBONIC ANHYDRASE 2","1","4BF1"
"4BF2",,"X-RAY DIFFRACTION",2.48,50.43,,6.5,"18% PEG 3.4K, 0.2M NA ACETATE, 0.1M BIS-TRIS BUFFER PH 6.5, 0.2% ISOPROPANOL",,"10.1002/pro.2298",,"4BF2",76.12,"2.11","2.11","Crystal Structures of Ask1-inhibitor Complexes","MDYKDDDDKENLYFQGSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTEEFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKLSALSAGSNEYLRSISLPVPVLVEDTS","Homo sapiens","MAP3K5, ASK1, MAPKKK5, MEKK5","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5","1","4BF2"
"4BF6",,"X-RAY DIFFRACTION",2.1,42,"VAPOR DIFFUSION, SITTING DROP",8,"3,2 M (NH4)2SO4 100 MM TRIS- HCL, PH 8.0, PROTEIN 10.8 MG/ML, 5-10 MM INHIBITOR (STOCK SOLUTION WAS 100 MM INHIBITOR DISSOLVED IN 100% DIMETHYL SULFOXIDE), VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K, TIME 7-14 DAYS",294,"10.1016/j.bmc.2013.06.041","X0Q","4BF6",29.65,"1.82","1.82","Three dimensional structure of human carbonic anhydrase II in complex with 5-(1-(3-Cyanophenyl)-1H-1,2,3-triazol-4-yl)thiophene-2- sulfonamide","SHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","CARBONIC ANHYDRASE 2","1","4BF6"
"4BFD",,"X-RAY DIFFRACTION",3.11,60.5,"VAPOR DIFFUSION, SITTING DROP",7.5,"2.5M SODIUM FORMATE, 100MM HEPES, PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K",298,"10.1016/j.bmcl.2013.05.003","8T3","4BFD",46.05,"2.3","2.3","CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVASIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","BETA-SECRETASE 1","1","4BFD"
"4BFP",,"X-RAY DIFFRACTION",2.2,45,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1371/journal.pone.0065404","SWY","4BFP",56.16,"2.4","2.4","Crystal structure of human tankyrase 2 in complex with WIKI4","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BFP"
"4BG1",,"X-RAY DIFFRACTION",2.5,52,"VAPOR DIFFUSION, SITTING DROP",7,"20 % PEG 3350, 1.5 % 1.6-DIAMINOHEXANE, 200 MM AMMONIUM CITRATE PH 7.0, 10 MM ZNSO4, 8 MM N-OXALYLGLYCINE, 4 MM INHIBITOR, PROTEIN 6.5 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K, TIME 2-7 DAYS",294,"10.1021/jm401603e","IVL","4BG1",45.47,"1.89","1.89","Three dimensional structure of human gamma-butyrobetaine hydroxylase in complex with 1-(3-Carboxypropyl)-1-methylpyrrolidin-1-ium chloride","MACTIQKAEALDGAHLMQILWYDEEESLYPAVWLRDNCPCSDCYLDSAKARKLLVEALDVNIGIKGLIFDRKKVYITWPDEHYSEFQADWLKKRCFSKQARAKLQRELFFPECQYWGSELQLPTLDFEDVLRYDEHAYKWLSTLKKVGIVRLTGASDKPGEVSKLGKRMGFLYLTFYGHTWQVQDKIDANNVAYTTGKLSFHTDYPALHHPPGVQLLHCIKQTVTGGDSEIVDGFNVCQKLKKNNPQAFQILSSTFVDFTDIGVDYCDFSVQSKHKIIELDDKGQVVRINFNNATRDTIFDVPVERVQPFYAALKEFVDLMNSKESKFTFKMNPGDVITFDNWRLLHGRRSYEAGTEISRHLEGAYADWDVVMSRLRILRQRVENGN","Homo sapiens","BBOX1, BBH, BBOX","GAMMA-BUTYROBETAINE DIOXYGENASE","1","4BG1"
"4BGC",,"X-RAY DIFFRACTION",2.2,43.7,,6.5,"WE WANTED TO USE THE PROTEIN IN 150 MM POTASSIUM PHOSPHATE BUFFER PH 6.5 IN 5 MM NMR TUBES FOR CHARACTERIZATION USING NMR SPECTROSCOPY. DURING TESTING, WE OBSERVED THE FORMATION OF CRYSTALS IN THE NMR TUBES. AN INITIAL TEST OF THE CRYSTALS SHOWED AN EXCELLENT DIFFRACTION PATTERN, SO WE DECIDED TO CONTINUE WITH CRYSTALLIZATION OPTIMIZATION IN NMR TUBES, RESULTING IN VERY GOOD CRYSTALS",,"10.1007/s10930-013-9513-2",,"4BGC",12.42,"1.2","1.2","T1 domain of the renal potassium channel Kv1.3","MERVVINISGLRFETQLKTLCQFPETLLGDPKRRMRYFDPLRNEYFFDRNRPSFDAILYYYQSGGRIRRPVNVPIDIFSEEIRFYQLGEEAMEKFREDEGFL","Homo sapiens","KCNA3, HGK5","POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY A MEMBER 3","1","4BGC"
"4BGG",,"X-RAY DIFFRACTION",2.89,57.49,,,"0.2M AMMONIUM CITRATE, 20%(W/V) PEG 3350",,"10.1021/jm501177w","844","4BGG",141.16,"2.56","2.56","Crystal structure of the ACVR1 kinase in complex with LDN-213844","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","ACTIVIN RECEPTOR TYPE-1","1","4BGG"
"4BGH",,"X-RAY DIFFRACTION",2.03,39.44,,,,,"10.1002/cmdc.201300096","3I6","4BGH",34.38,"1.95","1.95","Crystal Structure of CDK2 in complex with pan-CDK Inhibitor","MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL","Homo sapiens","CDK2, CDKN2","CYCLIN-DEPENDENT KINASE 2","1","4BGH"
"4BGJ",,"X-RAY DIFFRACTION",4.12,70.16,,,"20%(W/V) PEG 3350, 0.2M SODIUM MALONATE",,,,"4BGJ",17.4,"2.55","2.55","Crystal structure of the phox-homology domain of human sorting nexin 14","SMTPRNLAAWKISIPYVDFFEDPSSERKEKKERIPVFCIDVERNDRRAVGHEPEHWSVYRRYLEFYVLESKLTEFHGAFPDAQLPSKRIIGPKNYEFLKSKREEFQEYLQKLLQHPELSNSQLLADFLSPNGGETQFLDKILPDVNL","Homo sapiens","SNX14","SORTING NEXIN-14","1","4BGJ"
"4BGK",,"X-RAY DIFFRACTION",2.5,52,"VAPOR DIFFUSION, SITTING DROP",7,"20 % PEG 3350, 1.5 % 1.6-DIAMINOHEXANE, 200 MM AMMONIUM CITRATE PH 7.0, 10 MM ZNSO4, 8 MM N-OXALYLGLYCINE, 4 MM INHIBITOR, PROTEIN 6.5 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K, TIME 2-7 DAYS",,"10.1021/jm401603e","RTK","4BGK",45.34,"2.18","2.18","Three dimensional structure of human gamma-butyrobetaine hydroxylase in complex with (3-(Trimethylammonio)propyl)phosphinate","MACTIQKAEALDGAHLMQILWYDEEESLYPAVWLRDNCPCSDCYLDSAKARKLLVEALDVNIGIKGLIFDRKKVYITWPDEHYSEFQADWLKKRCFSKQARAKLQRELFFPECQYWGSELQLPTLDFEDVLRYDEHAYKWLSTLKKVGIVRLTGASDKPGEVSKLGKRMGFLYLTFYGHTWQVQDKIDANNVAYTTGKLSFHTDYPALHHPPGVQLLHCIKQTVTGGDSEIVDGFNVCQKLKKNNPQAFQILSSTFVDFTDIGVDYCDFSVQSKHKIIELDDKGQVVRINFNNATRDTIFDVPVERVQPFYAALKEFVDLMNSKESKFTFKMNPGDVITFDNWRLLHGRRSYEAGTEISRHLEGAYADWDVVMSRLRILRQRVENGN","Homo sapiens","BBOX1, BBH, BBOX","GAMMA-BUTYROBETAINE DIOXYGENASE","1","4BGK"
"4BGM",,"X-RAY DIFFRACTION",2.5,52,"VAPOR DIFFUSION, SITTING DROP",7,"20 % PEG 3350, 1.5 % 1.6-DIAMINOHEXANE, 200 MM AMMONIUM CITRATE PH 7.0, 10 MM ZNSO4, 8 MM N-OXALYLGLYCINE, 4 MM INHIBITOR, PROTEIN 6.5 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K, TIME 2-7 DAYS",294,"10.1021/jm401603e","DLT","4BGM",45.35,"2.4","2.4","Three dimensional structure of human gamma-butyrobetaine hydroxylase in complex with 3-Carboxy-N-(2-fluoroethyl)-N,N-dimethylpropan-1- aminium chloride","MACTIQKAEALDGAHLMQILWYDEEESLYPAVWLRDNCPCSDCYLDSAKARKLLVEALDVNIGIKGLIFDRKKVYITWPDEHYSEFQADWLKKRCFSKQARAKLQRELFFPECQYWGSELQLPTLDFEDVLRYDEHAYKWLSTLKKVGIVRLTGASDKPGEVSKLGKRMGFLYLTFYGHTWQVQDKIDANNVAYTTGKLSFHTDYPALHHPPGVQLLHCIKQTVTGGDSEIVDGFNVCQKLKKNNPQAFQILSSTFVDFTDIGVDYCDFSVQSKHKIIELDDKGQVVRINFNNATRDTIFDVPVERVQPFYAALKEFVDLMNSKESKFTFKMNPGDVITFDNWRLLHGRRSYEAGTEISRHLEGAYADWDVVMSRLRILRQRVENGN","Homo sapiens","BBOX1, BBH, BBOX","GAMMA-BUTYROBETAINE DIOXYGENASE","1","4BGM"
"4BGQ",,"X-RAY DIFFRACTION",2.49,50.59,,,"15% PEG SMEAR MEDIUM, 0.1M TRIS PH 8.0, 0.075M SODIUM ACETATE, 0.15M SODIUM CHLORIDE",,"10.1016/j.celrep.2017.12.083",,"4BGQ",35.86,"2","2","Crystal structure of the human CDKL5 kinase domain","SMKIPNIGNVMNKFEILGVVGEGAYGVVLKCRHKETHEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVKSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGNNANYDEEVATRWYRSPELLLGAPYGKSVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPSEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILNSVLLDLMKNLLKLDPADRYLTEQCLNHPTFQTQRLL","Homo sapiens","CDKL5, STK9","CYCLIN-DEPENDENT KINASE-LIKE 5","1","4BGQ"
"4BHF",,"X-RAY DIFFRACTION",2.5,52,"VAPOR DIFFUSION, SITTING DROP",7,"20 % PEG 3350, 1.5 % 1.6-DIAMINOHEXANE, 200 MM AMMONIUM CITRATE PH 7.0, 10 MM ZNSO4, 8 MM N-OXALYLGLYCINE, 4 MM INHIBITOR, PROTEIN 6.5 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K, TIME 2-7 DAYS",294,"10.1021/jm401603e","MZT","4BHF",45.46,"2.05","2.05","Three dimensional structure of human gamma-butyrobetaine hydroxylase in complex with 4-(Trimethylammonio)pentanoate","MACTIQKAEALDGAHLMQILWYDEEESLYPAVWLRDNCPCSDCYLDSAKARKLLVEALDVNIGIKGLIFDRKKVYITWPDEHYSEFQADWLKKRCFSKQARAKLQRELFFPECQYWGSELQLPTLDFEDVLRYDEHAYKWLSTLKKVGIVRLTGASDKPGEVSKLGKRMGFLYLTFYGHTWQVQDKIDANNVAYTTGKLSFHTDYPALHHPPGVQLLHCIKQTVTGGDSEIVDGFNVCQKLKKNNPQAFQILSSTFVDFTDIGVDYCDFSVQSKHKIIELDDKGQVVRINFNNATRDTIFDVPVERVQPFYAALKEFVDLMNSKESKFTFKMNPGDVITFDNWRLLHGRRSYEAGTEISRHLEGAYADWDVVMSRLRILRQRVENGN","Homo sapiens","BBOX1, BBH, BBOX","GAMMA-BUTYROBETAINE DIOXYGENASE","1","4BHF"
"4BHG",,"X-RAY DIFFRACTION",2.5,52,"VAPOR DIFFUSION, SITTING DROP",7,"15 % PEG 3350, 1 % 1.6-DIAMINOHEXANE, 200 MM AMMONIUM CITRATE PH 7.0, 10 MM ZNSO4, 8 MM N-OXALYLGLYCINE, 4 MM INHIBITOR, PROTEIN 6.5 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K, TIME 2-7 DAYS",294,,,"4BHG",45.46,"1.85","1.85","Three dimensional structure of human gamma-butyrobetaine hydroxylase in complex with 3-(1-Ethyl-1,1-dimethylhydrazin-1-ium-2-yl)propanoate","MACTIQKAEALDGAHLMQILWYDEEESLYPAVWLRDNCPCSDCYLDSAKARKLLVEALDVNIGIKGLIFDRKKVYITWPDEHYSEFQADWLKKRCFSKQARAKLQRELFFPECQYWGSELQLPTLDFEDVLRYDEHAYKWLSTLKKVGIVRLTGASDKPGEVSKLGKRMGFLYLTFYGHTWQVQDKIDANNVAYTTGKLSFHTDYPALHHPPGVQLLHCIKQTVTGGDSEIVDGFNVCQKLKKNNPQAFQILSSTFVDFTDIGVDYCDFSVQSKHKIIELDDKGQVVRINFNNATRDTIFDVPVERVQPFYAALKEFVDLMNSKESKFTFKMNPGDVITFDNWRLLHGRRSYEAGTEISRHLEGAYADWDVVMSRLRILRQRVENGN","Homo sapiens","BBOX1, BBH, BBOX","GAMMA-BUTYROBETAINE DIOXYGENASE","1","4BHG"
"4BHI",,"X-RAY DIFFRACTION",2.5,52,"VAPOR DIFFUSION, SITTING DROP",7,"20 % PEG 3350, 1.5 % 1.6-DIAMINOHEXANE, 200 MM AMMONIUM CITRATE PH 7.0, 10 MM ZNSO4, 8 MM N-OXALYLGLYCINE, 4 MM INHIBITOR, PROTEIN 6.5 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K, TIME 2-7 DAYS",294,"10.1021/jm401603e","RUJ","4BHI",45.33,"2.15","2.15","Three dimensional structure of human gamma-butyrobetaine hydroxylase in complex with 3-(1,1,1,2-Tetramethylhydrazin-1-ium-2-yl)propanoate","MACTIQKAEALDGAHLMQILWYDEEESLYPAVWLRDNCPCSDCYLDSAKARKLLVEALDVNIGIKGLIFDRKKVYITWPDEHYSEFQADWLKKRCFSKQARAKLQRELFFPECQYWGSELQLPTLDFEDVLRYDEHAYKWLSTLKKVGIVRLTGASDKPGEVSKLGKRMGFLYLTFYGHTWQVQDKIDANNVAYTTGKLSFHTDYPALHHPPGVQLLHCIKQTVTGGDSEIVDGFNVCQKLKKNNPQAFQILSSTFVDFTDIGVDYCDFSVQSKHKIIELDDKGQVVRINFNNATRDTIFDVPVERVQPFYAALKEFVDLMNSKESKFTFKMNPGDVITFDNWRLLHGRRSYEAGTEISRHLEGAYADWDVVMSRLRILRQRVENGN","Homo sapiens","BBOX1, BBH, BBOX","GAMMA-BUTYROBETAINE DIOXYGENASE","1","4BHI"
"4BHN",,"X-RAY DIFFRACTION",2.45,49.75,,6.5,"18% PEG3.4K, 0.2M NA ACETATE, 0.1M BIS-TRIS BUFFER PH6.5, 0.2% ISOPROPANOL",,"10.1002/pro.2298","BH9","4BHN",75.94,"2.3","2.3","Crystal Structures of Ask1-inhibitor Complexes","MDYKDDDDKENLYFQGSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTEEFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKLSALSAGSNEYLRSISLPVPVLVEDTS","Homo sapiens","MAP3K5, ASK1, MAPKKK5, MEKK5","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5","1","4BHN"
"4BHW",,"X-RAY DIFFRACTION",3,62,,7.5,"100 MM HEPES, PH 7.5, 20% PEG3350, 0.2M NACL",,"10.1038/nsmb.2642",,"4BHW",136.65,"2.799","2.799","Structural basis for autoinhibition of the acetyltransferase activity of p300","GAMAGKAVPMQSKKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKSPMDLSTIKRKLDTGQYQEPWQYVDDIWLMFNNAWLYNRKTSRVYKYCSKLSEVFEQEIDPVMQSLGYCCGRKLEFSPQTLCCYGKQLCTIPRDATYYSYQNRYHFCEKCFNEIQGESVSLGDDPSQPQTTINKEQFSKRKNDTLDPELFVECTECGRKMHQICVLHHEIIWPAGFVCDGCLKKSARTRKENKFSAKRLPSTRLGTFLENRVNDFLRRQNHPESGEVTVRVVHASDKTVEVKPGMKARFVDSGEMAESFPYRTKALFAFEEIDGVDLCFFGMHVQEYGSDCPPPNQRRVYISYLDSVHFFRPKCLRTAVYHEILIGYLEYVKKLGYTTGHIWACPPSEGDDYIFHCHPPDQKIPKPKRLQEWFKKMLDKAVSERIVHDYKDIFKQATEDRLTSAKELPYFEGDFWPNVLEESIKESGGSGSQKLYATMEKHKEVFFVIRLIAGPAANSLPPIVDPDPLIPCDLMDGRDAFLTLARDKHLEFSSLRRAQWSTMCMLVELHTQSQDRF","Homo sapiens","EP300, P300","HISTONE ACETYLTRANSFERASE P300","1","4BHW"
"4BHX",,"X-RAY DIFFRACTION",2.44,49,,,"CRYSTALLIZATION WAS OBSERVED DURING PROTEIN CONCENTRATION USING VIVASPIN 20 CONCENTRATORS (SARTORIUS STEDIM BIOTECH) IN 50 MM TRIS-HCL PH 7.5, 150 MM NACL.",,"10.1371/journal.pone.0069538",,"4BHX",24.93,"1.95","1.95","Crystal structure of the SCAN domain from human paternally expressed gene 3 protein","GHMTDSEFFHQRFRNLIYVEFVGPRKTLIKLRNLCLDWLQPETRTKEEIIELLVLEQYLTIIPEKLKPWVRAKKPENCEKLVTLLENYKEMYQP","Homo sapiens","PEG3, KIAA0287, ZSCAN24","PATERNALLY-EXPRESSED GENE 3 PROTEIN","1","4BHX"
"4BHZ",,"X-RAY DIFFRACTION",3.12,60.66,"VAPOR DIFFUSION, SITTING DROP",7.5,"30-45% (V/V) PEG300, SITTING DROP VAPOUR DIFFUSION, 291K, pH 7.5",291,"10.1021/ci400100c","Z0B","4BHZ",36.98,"2.85","2.85","Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor","MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE","Homo sapiens","TTK, MPS1, MPS1L1","DUAL SPECIFICITY PROTEIN KINASE TTK","1","4BHZ"
"4BI0",,"X-RAY DIFFRACTION",3.15,60.97,"VAPOR DIFFUSION, SITTING DROP",7.5,"30-45% (V/V) PEG300, SITTING DROP VAPOUR DIFFUSION, 291K, pH 7.5",291,"10.1021/ci400100c","Z0W","4BI0",36.97,"2.84","2.84","Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor","MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE","Homo sapiens","TTK, MPS1, MPS1L1","DUAL SPECIFICITY PROTEIN KINASE TTK","1","4BI0"
"4BI1",,"X-RAY DIFFRACTION",3.13,60.67,"VAPOR DIFFUSION, SITTING DROP",7.5,"30-45% (V/V) PEG300, SITTING DROP VAPOUR DIFFUSION, 291K, pH 7.5",291,"10.1021/ci400100c","ZO6","4BI1",37.79,"2.7","2.7","Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor","MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE","Homo sapiens","TTK, MPS1, MPS1L1","DUAL SPECIFICITY PROTEIN KINASE TTK","1","4BI1"
"4BI2",,"X-RAY DIFFRACTION",3.13,59.97,"VAPOR DIFFUSION, SITTING DROP",7.5,"30-45% (V/V) PEG300, SITTING DROP VAPOUR DIFFUSION, 291K, pH 7.5",291,"10.1021/ci400100c","ZO8","4BI2",36.74,"3.11","3.11","Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor","MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE","Homo sapiens","TTK, MPS1, MPS1L1","DUAL SPECIFICITY PROTEIN KINASE TTK","1","4BI2"
"4BIB",,"X-RAY DIFFRACTION",2.58,52.35,,6.5,"18% PEG3.4K, 0.2M NA ACETATE, 0.1M BIS-TRIS PH6.5, 0.2% ISOPROPANOL",,"10.1002/pro.2298","IEO","4BIB",72.01,"2.43","2.43","Crystal Structures of Ask1-inhibitor Complexes","STEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTEEFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKLSALSAGSNEYLRSISLPVPVLVEDTS","Homo sapiens","MAP3K5, ASK1, MAPKKK5, MEKK5","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5","1","4BIB"
"4BIC",,"X-RAY DIFFRACTION",2.58,52.35,,6.5,"18% PEG3.4K, 0.2M NA ACETATE, 0.1M BIS-TRIS PH6.5, 0.2% ISOPROPANOL",,"10.1002/pro.2298","IE4","4BIC",71.91,"2.62","2.62","Crystal Structures of Ask1-inhibitor Complexes","STEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTEEFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKLSALSAGSNEYLRSISLPVPVLVEDTS","Homo sapiens","MAP3K5, ASK1, MAPKKK5, MEKK5","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5","1","4BIC"
"4BID",,"X-RAY DIFFRACTION",2.58,52.35,,6.5,"18% PEG3.4K, 0.2M NA ACETATE, 0.1M BIS-TRIS PH6.5, 0.2% ISOPROPANOL",,"10.1002/pro.2298","IE8","4BID",71.99,"2.8","2.8","Crystal Structures of Ask1-inhibitor Complexes","STEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTEEFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKLSALSAGSNEYLRSISLPVPVLVEDTS","Homo sapiens","MAP3K5, ASK1, MAPKKK5, MEKK5","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5","1","4BID"
"4BIE",,"X-RAY DIFFRACTION",2.58,52.35,,6.5,"18% PEG3.4K, 0.2M NA ACETATE, 0.1M BIS-TRIS PH6.5, 0.2% ISOPROPANOL",,"10.1002/pro.2298","IE6","4BIE",71.93,"2.36","2.36","Crystal Structures of Ask1-inhibitor Complexes","STEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTEEFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKLSALSAGSNEYLRSISLPVPVLVEDTS","Homo sapiens","MAP3K5, ASK1, MAPKKK5, MEKK5","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 5","1","4BIE"
"4BIO",,"X-RAY DIFFRACTION",3.08,63,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.2M AMMONIUM SULPHATE, 3% PEG400, PEG400, 0.001M FECL2, 0.1M HEPES PH7.5, VAPOR DIFFUSION, SITTING DROP",,"10.1039/C3SC51122G","8XQ","4BIO",41.7,"2.45","2.45","FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH 8-HYDROXYQUINOLINE-5- CARBOXYLIC ACID","GSHMAATAAEAVASGSGEPREEAGALGPAWDESQLRSYSFPTRPIPRLSQSDPRAEELIENEEPVVLTDTNLVYPALKWDLEYLQENIGNGDFSVYSASTHKFLYYDEKKMANFQNFKPRSNREEMKFHEFVEKLQDIQQRGGEERLYLQQTLNDTVGRKIVMDFLGFNWNWINKQQGKRGWGQLTSNLLLIGMEGNVTPAHYDEQQNFFAQIKGYKRCILFPPDQFECLYPYPVHHPCDRQSQVDFDNPDYERFPNFQNVVGYETVVGPGDVLYIPMYWWHHIESLLNGGITITVNFWYKGAPTPKRIEYPLKAHQKVAIMRNIEKMLGEALGNPQEVGPLLNTMIKGRYN","Homo sapiens","HIF1AN, FIH1","HYPOXIA-INDUCIBLE FACTOR 1-ALPHA INHIBITOR","1","4BIO"
"4BIS",,"X-RAY DIFFRACTION",2.4,48.8,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M BIS-TRIS PROPANE PH 7.5, 0.02M NA/K PHOSPHATE, 20% W/V PEG 3350, SITTING DROP, 277K",277,"10.1039/C3SC51122G","8HQ","4BIS",89.44,"2.493","2.493","JMJD2A COMPLEXED WITH 8-HYDROXYQUINOLINE-4-CARBOXYLIC ACID","MHHHHHHSSGVDLGTENLYFQSMASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","LYSINE-SPECIFIC DEMETHYLASE 4A","1","4BIS"
"4BIT",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M115.662254",,"4BIT",18.35,,,"solution structure of cerebral dopamine neurotrophic factor (CDNF)","QEAGGRPGADCEVCKEFLNRFYKSLIDRGVNFSLDTIEKELISFCLDTKGKENRLCYYLGATKDAATKILSEVTRPMSVHMPAMKICEKLKKLDSQICELKYEKTLDLASVDLRKMRVAELKQILHSWGEECRACAEKTDYVNLIQELAPKYAATHPKTEL","Homo sapiens","CDNF, ARMETL1","CEREBRAL DOPAMINE NEUROTROPHIC FACTOR","1","4BIT"
"4BJ9",,"X-RAY DIFFRACTION",2.4,49,,8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22 % PEG 3350, PH 8.5",,"10.1021/ml400292s","UHB","4BJ9",56.37,"2.05","2.05","Crystal structure of human tankyrase 2 in complex with EB-47","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BJ9"
"4BJB",,"X-RAY DIFFRACTION",2.5,50,,8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22 % PEG 3350, PH 8.5",,"10.1021/ml400292s","P34","4BJB",27.94,"2.3","2.3","Crystal structure of human tankyrase 2 in complex with PJ-34","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BJB"
"4BJC",,"X-RAY DIFFRACTION",2.4,49,,8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5",,"10.1021/ml400292s","RPB","4BJC",27.88,"2.2","2.2","Crystal structure of human tankyrase 2 in complex with Rucaparib","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BJC"
"4BJL",,"X-RAY DIFFRACTION",2.39,48.56,,,,,"10.1073/pnas.93.14.7017",,"4BJL",45.54,"2.4","2.4","LOCW, A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN DISTILLED WATER","QSVLTQPPSASGTPGQRVTISCSGSSSNIGENSVTWYQHLSGTAPKLLIYEDNSRASGVSDRFSASKSGTSASLAISGLQPEDETDYYCAAWDDSLDVAVFGTGTKVTVLGQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADGSPVKAGVETTKPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"LOC - LAMBDA 1 TYPE LIGHT-CHAIN DIMER","1","4BJL"
"4BJO",,"X-RAY DIFFRACTION",2.79,55.9,,8.1,"100 MM HEPES PH 8.1, 25.4% PEG 4000, 225 MM MGNO3 AT 281K.",281,"10.1107/S1399004713031052",,"4BJO",79.07,"2.06","2.06","Nitrate in the active site of PTP1b is a putative mimetic of the transition state","MGHHHHHHGTENLYFQGSEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 1","1","4BJO"
"4BJX",,"X-RAY DIFFRACTION",1.59,22.07,,6.5,"20% PEG3350, 0.2M NAK,TARTRATE, 0.1M BISTRISPROPANE PH 6.5, 20C",293,"10.1371/journal.pone.0072967","73B","4BJX",18.37,"1.59","1.59","N-TERMINAL BROMODOMAIN OF HUMAN BRD4 WITH GSK1324726A (I-BET726)","GSSHHHHHHSSSMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEEQELVVTIPNSHKKGA","Homo sapiens","BRD4, HUNK1","BROMODOMAIN-CONTAINING PROTEIN 4","1","4BJX"
"4BK0",,"X-RAY DIFFRACTION",2.53,51.5,,6.2,"0.2 M NACL, 0.1 M SODIUM/POTASSIUM PHOSPHATE PH 6.2, 50% PEG 200",,"10.1038/nsmb.2596",,"4BK0",25.25,"1.9","1.9","Crystal structure of the KIX domain of human RECQL5 (domain-swapped dimer)","GPLGSRKGKDPKIEEFVPPDENCPLKEASSRRIPRLTVKAREHCLRLLEEALSSNRQSTRTADEADLRAKAVELEHETFRNAKVANLYKASVLKKVADIHRASKDGQPYDM","Homo sapiens","RECQL5, RECQ5","ATP-DEPENDENT DNA HELICASE Q5","1","4BK0"
"4BK4",,"X-RAY DIFFRACTION",6.16,76.7,,,"1.8 M AMMONIUM PHOSPHATE, 100 MM HEPES PH 7.4, ADDITIVE = EPHRINB2 IN A 1:1 MOLAR RATIO. WE SAW NO SIGN OF EPHRINB2 IN THE CRYSTAL STRUCTURE. THE USUAL BINDING SITE ON HEPHA4 WAS OCCUPIED BY AN EPHA4-EPHA4 CRYSTAL CONTACT.",,"10.1038/nsmb.2617",,"4BK4",125.3,"3.65","3.65","crystal structure of the human EphA4 ectodomain","MGILPSPGMPALLSLVSLLSVLLMGCVAETGVTGSRVYPANEVTLLDSRSVQGELGWIASPLEGGWEEVSIMDEKNTPIRTYQVCNVMEPSQNNWLRTDWITREGAQRVYIEIKFTLRDCNSLPGVMGTCKETFNLYYYESDNDKERFIRENQFVKIDTIAADESFTQVDIGDRIMKLNTEIRDVGPLSKKGFYLAFQDVGACIALVSVRVFYKKCPLTVRNLAQFPDTITGADTSSLVEVRGSCVNNSEEKDVPKMYCGADGEWLVPIGNCLCNAGHEERSGECQACKIGYYKALSTDATCAKCPPHSYSVWEGATSCTCDRGFFRADNDAASMPCTRPPSAPLNLISNVNETSVNLEWSSPQNTGGRQDISYNVVCKKCGAGDPSKCRPCGSGVHYTPQQNGLKTTKVSITDLLAHTNYTFEIWAVNGVSKYNPNPDQSVSVTVTTNQAAPSSIALVQAKEVTRYSVALAWLEPDRPNGVILEYEVKYYEKDQNERSYRIVRTAARNTDIKGLNPLTSYVFHVRARTAAGYGDFSEPLEVTTNTVPSRIIGDGANSTGTKHHHHHH","Homo sapiens","EPHA4, HEK8, SEK, TYRO1","EPHRIN TYPE-A RECEPTOR 4","1","4BK4"
"4BKE",,"X-RAY DIFFRACTION",2.47,50.13,,7.2,"26 % PEG 3350, 50 MM KH2PO4 PH 7.2; 120 MG/ML IN 20 MM KH2PO4 AT PH 7.5 CONTAINING NOMINAL 0.1 MM PALMITIC ACID STREAK SEEDED SEEDING",,"10.1186/1472-6807-14-4",,"4BKE",71.26,"2.35","2.35","Recombinant human serum albumin with palmitic acid. Synthetic cationic antimicrobial peptides bind with their hydrophobic parts to drug site II of human serum albumin","MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","SERUM ALBUMIN","1","4BKE"
"4BKG",,"X-RAY DIFFRACTION",1.89,34.91,,8,"0.1 M TRIS/HCL PH 8.0, 28% PEG 350MME,0.05% DIOXANE",,"10.1042/BJ20130753",,"4BKG",19.19,"2.11","2.11","crystal structure of human diSUMO-2","GSTENNDHINLKVAGQDGSVVQFKIKRHTPLSKLMKAYCERQGLSMRQIRFRFDGQPINETDTPAQLEMEDEDTIDVFQQQTGGRSTENNDHINLKVAGQDGSVVQFKIKRHTPLSKLMKAYCERQGLSMRQIRFRFDGQPINETDTPAQLEMEDEDTIDVFQQQTGG","Homo sapiens","SUMO2, SMT3B, SMT3H2","SMALL UBIQUITIN-RELATED MODIFIER 2","1","4BKG"
"4BKJ",,"X-RAY DIFFRACTION",2.28,46.11,,,"0.1M BIS-TRIS PH 6.3, 34% PEG 3350",,"10.1016/j.jmb.2014.04.014","STI","4BKJ",73.67,"1.7","1.7","Crystal structure of the human DDR1 kinase domain in complex with imatinib","SMPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDGQAAQGPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTV","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","1","4BKJ"
"4BKN",,"X-RAY DIFFRACTION",2.27,45.9,,8.5,"0.2M KSCN; 0.1M BISTRISPROPANE PH 8.5; 20% PEG 3350 10% ETHYLENE GLYCOL",,,,"4BKN",124.27,"2.1","2.1","Human Dihydropyrimidinase-related protein 3 (DPYSL3)","SMSYQGKKNIPRITSDRLLIKGGRIVNDDQSFYADIYMEDGLIKQIGDNLIVPGGVKTIEANGKMVIPGGIDVHTHYQMPYKGMTTVDDFFQGTKAALAGGTTMIIDHVVPEPESSLTEAYEKWREWADGKSCCDYALHVDITHWNDSVKQEVQNLIKDKGVNSFMVYMAYKDLYQVSNTELYEIFTCLGELGAIAQVHAENGDIIAQEQTRMLEMGITGPEGHVLSRPEELEAEAVFRAITIASQTNCPLYVTKVMSKSAADLISQARKKGNVVFGEPITASLGIDGTHYWSKNWAKAAAFVTSPPLSPDPTTPDYINSLLASGDLQLSGSAHCTFSTAQKAIGKDNFTAIPEGTNGVEERMSVIWDKAVATGKMDENQFVAVTSTNAAKIFNLYPRKGRISVGSDSDLVIWDPDAVKIVSAKNHQSAAEYNIFEGMELRGAPLVVICQGKIMLEDGNLHVTQGAGRFIPCSPFSDYVYKRIKARRKMADLHAVPRGMYDGPVFDLTTTPKGGTPAGSARGSPTRPNPPVRNLHQSGFSLSGTQVDEGVRSASKRIVAPPGGRSNITSLS","Homo sapiens","DPYSL3, CRMP4, DRP3, ULIP, ULIP1","DIHYDROPYRIMIDINASE-RELATED PROTEIN 3","1","4BKN"
"4BKP",,"X-RAY DIFFRACTION",2.85,56.82,,,"20% PEG 3350, 0.1M CITRATE PH 5.5",,,,"4BKP",154.46,"2.7","2.7","Crystal structure of human GDP-L-fucose synthase with bound NADP","MHHHHHHSSGVDLGTENLYFQSMRILVTGGSGLVGKAIQKVVADGAGLPGEDWVFVSSKDADLTDTAQTRALFEKVQPTHVIHLAAMVGGLFRNIKYNLDFWRKNVHMNDNVLHSAFEVGARKVVSCLSTCIFPDKTTYPIDETMIHNGPPHNSNFGYSYAKRMIDVQNRAYFQQYGCTFTAVIPTNVFGPHDNFNIEDGHVLPGLIHKVHLAKSSGSALTVWGTGNPRRQFIYSLDLAQLFIWVLREYNEVEPIILSVGEEDEVSIKEAAEAVVEAMDFHGEVTFDTTKSDGQFKKTASNSKLRTYLPDFRFTPFKQAVKETCAWFTDNYEQARK","Homo sapiens","GFUS, SDR4E1, TSTA3","GDP-L-FUCOSE SYNTHASE","1","4BKP"
"4BKW",,"X-RAY DIFFRACTION",2.46,50,,6.5,"0.1M BIS-TRIS PH 6.5, 0.15M MAGNESIUM CHLORIDE, 30% PEG 3350",,,,"4BKW",59.77,"2.53","2.53","Crystal structure of the C-terminal region of human ZFYVE9","AMNLIPEDGLPPILISTGVKGDYAVEEKPSQISVMQQLEDGGPDPLVFVLNANLLSMVKIVNYVNRKCWCFTTKGMHAVGQSEIVILLQCLPDEKCLPKDIFNHFVQLYRDALAGNVVSNLGHSFFSQSFLGSKEHGGFLYVTSTYQSLQDLVLPTPPYLFGILIQKWETPWAKVFPIRLMLRLGAEYRLYPCPLFSVRFRKPLFGETGHTIMNLLADFRNYQYTLPVVQGLVVDMEVRKTSIKIPSNRYNEMMKAMNKSNEHVLAGGACFNEKADSHLVCVQNDDGNYQTQAISIHNQPRKVTGASFFVFSGALKSSSGYLAKSSIVEDGVMVQITAENMDSLRQALREMKDFTITCGKADAEEPQEHIHIQWVDDDKNVSKGVVSPIDGKSMETITNVKIFHGSEYKANGKVIRWTEVFFLENDDQHNCLSDPADHSRLTEHVAKAFCLALCPHLKLLKEDGMTKLGLRVTLDSDQVGYQAGSNGQPLPSQYMNDLDSALVPVIHGGACQLSEGPVVMELIFYILENIV","Homo sapiens","ZFYVE9, MADHIP, SARA, SMADIP","ZINC FINGER FYVE DOMAIN-CONTAINING PROTEIN 9","1","4BKW"
"4BKY",,"X-RAY DIFFRACTION",2.29,46.31,,,"10% PEG 3350, 0.1M BIS-TRIS PH 6.5, 0.2M SODIUM CHLORIDE",,"10.1021/bi4005864","82B","4BKY",40.77,"1.83","1.83","Crystal structure of unphosphorylated Maternal Embryonic Leucine zipper Kinase (MELK) in complex with pyrrolopyrazole inhibitor","GPKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELIQGKSYLGSEADVWSMGILLYVLMCGFLPFDDDNVMALYKKIMRGKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLLNHPWIMQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQTMEDLISLWQYDHLTATYLLLLAKKARGKPVRLRLSSFSCGHHHHHH","Homo sapiens","MELK, KIAA0175","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","1","4BKY"
"4BKZ",,"X-RAY DIFFRACTION",2.33,47.29,,,"10% PEG 3350, 0.1M BIS-TRIS PH 6.5, 0.2M SODIUM CHLORIDE",,"10.1021/bi4005864","1WS","4BKZ",40.59,"2.2","2.2","Crystal structure of unphosphorylated Maternal Embryonic Leucine zipper Kinase (MELK) in complex with a benzodipyrazole inhibitor","GPKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELIQGKSYLGSEADVWSMGILLYVLMCGFLPFDDDNVMALYKKIMRGKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLLNHPWIMQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQTMEDLISLWQYDHLTATYLLLLAKKARGKPVRLRLSSFSCGHHHHHH","Homo sapiens","MELK, KIAA0175","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","1","4BKZ"
"4BL1",,"X-RAY DIFFRACTION",2.26,45.61,,,"10% PEG 3350, 0.1M BIS-TRIS PH 6.5, 0.2M SODIUM CHLORIDE",,,,"4BL1",40.73,"2.6","2.6","Crystal structure of unphosphorylated Maternal Embryonic Leucine zipper Kinase (MELK) in complex with AMP-PNP","GPKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELIQGKSYLGSEADVWSMGILLYVLMCGFLPFDDDNVMALYKKIMRGKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLLNHPWIMQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQTMEDLISLWQYDHLTATYLLLLAKKARGKPVRLRLSSFSCGHHHHHH","Homo sapiens","MELK, KIAA0175","MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE","1","4BL1"
"4BL5",,"X-RAY DIFFRACTION",2.17,43.36,,,"0.1M BIS-TRIS-PROPANE PH 7.5, 0.15M SODIUM CHLORIDE, 25% PEG 3350",,,,"4BL5",469.75,"2.6","2.6","Crystal structure of human GDP-L-fucose synthase with bound NADP and product GDP-L-fucose","MHHHHHHSSGVDLGTENLYFQSMRILVTGGSGLVGKAIQKVVADGAGLPGEDWVFVSSKDADLTDTAQTRALFEKVQPTHVIHLAAMVGGLFRNIKYNLDFWRKNVHMNDNVLHSAFEVGARKVVSCLSTCIFPDKTTYPIDETMIHNGPPHNSNFGYSYAKRMIDVQNRAYFQQYGCTFTAVIPTNVFGPHDNFNIEDGHVLPGLIHKVHLAKSSGSALTVWGTGNPRRQFIYSLDLAQLFIWVLREYNEVEPIILSVGEEDEVSIKEAAEAVVEAMDFHGEVTFDTTKSDGQFKKTASNSKLRTYLPDFRFTPFKQAVKETCAWFTDNYEQARK","Homo sapiens","GFUS, SDR4E1, TSTA3","GDP-L-FUCOSE SYNTHASE","1","4BL5"
"4BLI",,"X-RAY DIFFRACTION",2.1,41,,7.5,"19 MG/ML GALECTIN-3C, 100MM NACL, 0.1 M TRIS/HCL PH 7.5, 29 % PEG 4000, 0.4 M NASCN, 18 MM BETA-MERCAPTOETHANOL, 5 MM COMPOUND GMK",,,,"4BLI",16.44,"1.08","1.08","Galectin-3c in complex with Bisamido-thiogalactoside derivate 1","MLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","GALECTIN-3","1","4BLI"
"4BLJ",,"X-RAY DIFFRACTION",1.74,29.5,,7.5,"19 MG/ML GALECTIN-3C, 100MM NACL,100 MM LACTOSE, 29 % W/V PEG 4000, 0.4 M NASCN, 18 MM BETA-MERCAPTOETHANOL,0.02 % NAN3, 10 MM PHOSHATE, 100 MM MGCL2, 100 MM TRIS/HCL PH 7.5, 5 MM LIGAND",,,"70B","4BLJ",16.36,"1.2","1.2","Galectin-3c in complex with Bisamido-thiogalactoside derivate 2","MLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","GALECTIN-3","1","4BLJ"
"4BM7",,"X-RAY DIFFRACTION",2.75,55,,6.5,"28% POLYETHYLENE GLYCOL MONOMETHYL ETHER 2,000 IN 0.1M BIS-TRIS BUFFER AT PH 6.5",,"10.1021/ja4014375",,"4BM7",53.85,"1.95","1.95","Crystal Structure of IgG Fc F241A mutant with native glycosylation","GTHTCPPCPAPELLGGPSVALFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGTKHHHHHH","Homo sapiens","IGHG1","IG GAMMA-1 CHAIN C REGION","1","4BM7"
"4BM8",,"X-RAY DIFFRACTION",1.73,29.5,,7.5,"19 MG/ML GALECTIN-3C, 100MM NACL, 29 % W/V PEG 4000, 0.4 M NASCN, 18 MM BETA-MERCAPTOETHANOL,0.02 % NAN3, 10 MM PHOSHATE, 100 MM MGCL2, 100 MM TRIS/HCL PH 7.5, 2.5 MM LIGAND",,,,"4BM8",16.52,"0.96","0.96","Galectin-3c in complex with Bisamido-thiogalactoside derivate 3","ALIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI","Homo sapiens","LGALS3, MAC2","GALECTIN-3","1","4BM8"
"4BM9",,"X-RAY DIFFRACTION",3,58.8,,7,"1.6 M LITHIUM SULPHATE, 10 MM MAGNESIUM CHLORIDE, 50 MM MES (PH 5.4)",,"10.1038/emboj.2013.125",,"4BM9",37.72,"2.25","2.25","Structure of the autoinhibited Parkin catalytic domain","PAGRSIYNSFYVYCKGPCQRVQPGKLRVQCSTCRQATLTLTQGPSCWDDVLIPNRMSGECQSPHCPGTSAEFFFKCGAHPTSDKETSVALHLIATNSRNITCITCTDVRSPVLVFQCNSRHVICLDCFHLYCVTRLNDRQFVHDPQLGYSLPCVAGCPNSLIKELHHFRILGEEQYNRYQQYGAEECVLQMGGVLCPRPGCGAGLLPEPDQRKVTCEGGNGLGCGFAFCRECKEAYHEGECSAVFEASGTTTQAYRVDERAAEQARWEAASKETIKKTTKPCPRCHVPVEKNGGCMHMKCPQPQCRLEWCWNCGCEWNRVCMGDHWFDV","Homo sapiens","PRKN, PARK2","E3 UBIQUITIN-PROTEIN LIGASE PARKIN","1","4BM9"
"4BMB",,"X-RAY DIFFRACTION",2.74,55.2,,,"20% W/V PEG 4000, 100 MM HEPES SODIUM SALT (PH 7.2) AND 10 MM ZINC CHLORIDE",,"10.1111/febs.12716",,"4BMB",17.52,"1.351","1.351","Crystal structure of the N terminal domain of human Galectin 8","SLNNLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSMKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSF","Homo sapiens","LGALS8","GALECTIN-8","1","4BMB"
"4BME",,"X-RAY DIFFRACTION",2.15,42.7,,,"30% W/V PEG 4000, 100 MM MES SODIUM SALT (PH 6.5)",,"10.1111/febs.12716",,"4BME",35.05,"2","2","Crystal structure of the N terminal domain of human Galectin 8, F19Y mutant","SLNNLQNIIYNPVIPYVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSMKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSFSS","Homo sapiens","LGALS8","GALECTIN-8","1","4BME"
"4BMJ",,"X-RAY DIFFRACTION",3.65,66.3,,8.5,"0.1 M TRIS PH 8.5, 1 M LISO4",,"10.1016/j.jmb.2013.11.006",,"4BMJ",93.52,"2.75","2.75","Structure of the UBZ1and2 tandem of the ubiquitin-binding adaptor protein TAX1BP1","GPHMDVHKKCPLCELMFPPNYDQSKFEEHVESHWKVCPMCSEQFPPDYDQQVFERHVQTHFDQNVLNFD","Homo sapiens","TAX1BP1, T6BP, PRO0105","TAX1-BINDING PROTEIN 1","1","4BMJ"
"4BN1",,"X-RAY DIFFRACTION",2.54,51.65,,,"0.1 M HEPES PH 7.5, 10 % PEG 6000, 5 % MPD AND 0.1 M CALCIUM CHLORIDE DIHYDRATE",,"10.1021/cb400425t",,"4BN1",33.65,"2.499","2.499","Crystal structure of V174M mutant of Aurora-A kinase","GAMESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGMEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQS","Homo sapiens","AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6","AURORA KINASE A","1","4BN1"
"4BN2",,"X-RAY DIFFRACTION",2.74,57.22,,6,"25% POLYETHYLENE GLYCOL-3350 0.20 M MAGNESIUM CHLORIDE 0.1 M TRIS-HC; PH 8.5",292,"10.1107/S1399004713028721",,"4BN2",119.48,"2.695","2.695","The crystal structure of kinesin-like protein KIF15","GAMGQPSNEGDAIKVFVRIRPPAERSGSADGEQNLCLSVLSSTSLRLHSNPEPKTFTFDHVADVDTTQESVFATVAKSIVESCMSGYNGTIFAYGQTGSGKTFTMMGPSESDNFSHNLRGVIPRSFEYLFSLIDREKEKAGAGKSFLCKCSFIEIYNEQIYDLLDSASAGLYLREHIKKGVFVVGAVEQVVTSAAEAYQVLSGGWRNRRVASTSMNRESSRSHAVFTITIESMEKSNEIVNIRTSLLNLVDLAGSERQKDTHAEGMRLKEAGNINRSLSCLGQVITALVDVGNGKQRHVCYRDSKLTFLLRDSLGGNAKTAIIANVHPGSRCFGETLSTLNFAQRAKLIKNKAVVNEDTQG","Homo sapiens","KIF15, KLP2, KNSL7","KINESIN-LIKE PROTEIN KIF15","1","4BN2"
"4BN4",,"X-RAY DIFFRACTION",2.54,51.7,,,"30% (V/V) PEG600, 5%(W/V) PEG1000, 10% (V/V) GLYCEROL, 0.1 M MES, PH 6.0",,"10.1107/S0907444913015448",,"4BN4",32.43,"1.3","1.3","Structure of human SIRT3 in complex with ADP-ribose","GSSDKGKLSLQDVAELIRARACQRVVVMVGAGISTPSGIPDFRSPGSGLYSNLQQYDLPYPEAIFELPFFFHNPKPFFTLAKELYPGNYKPNVTHYFLRLLHDKGLLLRLYTQNIDGLERVSGIPASKLVEAHGTFASATCTVCQRPFPGEDIRADVMADRVPRCPVCTGVVKPDIVFFGEPLPQRFLLHVVDFPMADLLLILGTSLEVEPFASLTEAVRSSVPRLLINRDLVGPLAWHPRSRDVAQLGDVVHGVESLVELLGWTEEMRDLVQRETGKLDGPDK","Homo sapiens","SIRT3, SIR2L3","NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL","1","4BN4"
"4BN5",,"X-RAY DIFFRACTION",4.41,72.1,,,"20% (W/V) PEG3350, 0.2 M SODIUM FLUORIDE",,"10.1107/S0907444913015448","SR7","4BN5",389.77,"3.25","3.25","Structure of human SIRT3 in complex with SRT1720 inhibitor","DKGKLSLQDVAELIRARACQRVVVMVGAGISTPSGIPDFRSPGSGLYSNLQQYDLPYPEAIFELPFFFHNPKPFFTLAKELYPGNYKPNVTHYFLRLLHDKGLLLRLYTQNIDGLERVSGIPASKLVEAHGTFASATCTVCQRPFPGEDIRADVMADRVPRCPVCTGVVKPDIVFFGEPLPQRFLLHVVDFPMADLLLILGTSLEVEPFASLTEAVRSSVPRLLINRDLVGPLAWHPRSRDVAQLGDVVHGVESLVELLGWTEEMRDLVQRETGKLDGPDK","Homo sapiens","SIRT3, SIR2L3","NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL","1","4BN5"
"4BOP",,"X-RAY DIFFRACTION",2.54,51.66,,,"10% PEG 4K, 20% GLYCEROL, 0.09M NPS",,"10.1016/j.cell.2013.05.046",,"4BOP",34.72,"2.1","2.1","Structure of OTUD1 OTU domain","DEKLALYLAEVEKQDKYLRQRNKYRFHIIPDGNCLYRAVSKTVYGDQSLHRELREQTVHYIADHLDHFSPLIEGDVGEFIIAAAQDGAWAGYPELLAMGQMLNVNIHLTTGGRLESPTVSTMIHYLGPEDSLRPSIWLSWLSNGHYDAVFD","Homo sapiens","OTUD1, DUBA7, OTDC1","OTU DOMAIN-CONTAINING PROTEIN 1","1","4BOP"
"4BOQ",,"X-RAY DIFFRACTION",2.24,45.03,,,"0.8M SODIUM PHOSPHATE MONOBASIC MONOHYDRATE, 0.1 M TRIS PH 7.5",,"10.1016/j.cell.2013.05.046",,"4BOQ",21.1,"1.47","1.47","Structure of OTUD2 OTU domain","AFTKRGASSYVRETLPVLTRTVVPADNSCLFTSVYYVVEGGVLNPACAPEMRRLIAQIVASDPDFYSEAILGKTNQEYCDWIKRDDTWGGAIEISILSKFYQCEICVVDTQTVRIDRFGEDAGYTKRVLLIYDGIHYDPLQRNFPDPDTPPLTIFSSNDDIVLVQALELADEARRRRQFTDVN","Homo sapiens","YOD1, DUBA8, HIN7, OTUD2, PRO0907","UBIQUITIN THIOESTERASE OTU1","1","4BOQ"
"4BOU",,"X-RAY DIFFRACTION",2.26,45.6,,,"10% PEG 4K, 0.1 M KCL, 0.01 M MGCL2, 50 MM MES PH 6.0",,"10.1016/j.cell.2013.05.046",,"4BOU",18.35,"1.55","1.55","Structure of OTUD3 OTU domain","GPEFVSFANQLQALGLKLREVPGDGNCLFRALGDQLEGHSRNHLKHRQETVDYMIKQREDFEPFVEDDIPFEKHVASLAKPGTFAGNDAIVAFARNHQLNVVIHQLNAPLWQIRGTEKSSVRELHIAYRYGEHYDSVRRINDNSEAPAHLQTDFQMLHQD","Homo sapiens","OTUD3, KIAA0459","OTU DOMAIN-CONTAINING PROTEIN 3","1","4BOU"
"4BPC",,"X-RAY DIFFRACTION",2.46,49.96,"VAPOR DIFFUSION, SITTING DROP",,"0.8M SUCCINIC ACID, PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K",291,"10.1007/s10059-013-0033-x",,"4BPC",66.93,"2.1","2.1","Structure of the Catalytic Domain of Protein Tyrosine Phosphatase Sigma in the Sulfenic Acid Form","MLSHPPIPIADMAEHTERLKANDSLKLSQEYESIDPGQQFTWEHSNLEVNKPKNRYANVIAYDHSRVILQPIEGIMGSDYINANYVDGYRRQNAYIATQGPLPETFGDFWRMVWEQRSATIVMMTRLEEKSRIKCDQYWPNRGTETYGFIQVTLLDTIELATFAVRTFSLHKNGSSEKREVRQFQFTAWPDHGVPEYPTPFLAFLRRVKTANPPDAGPIVVHCSAGVGRTGAFIVIDAMLERIKPEKTVDVYGHVTLMRSQRNYMVQTEDQYSFIHEALLEAVGAGNTEVPARSLYAYIQKLAQVEPGEHVTGMELEFKRLANSKAHTSRFISANLPANKFKNRLVNIMPYESTRVALQPIRGVEGSDYINASFIDGYRQQKAYIATQGPLAETTEDFWRMLWENNSTIVVMLTKLREMGREKCHQYWPAERSARYQYFVVDPMAEYNMPQYILREFKVTDARDGQSRTVRQFQFTDWPEQGVPKSGEGFIDFIGQVHKTKEQFGQDGPISVHCSAGVGRTGVFITLSIVLERMRYEGVVDIFQTVKMLRTQRPAMVQTEDEYQFAYQAALEYLGSFDHYAT","Homo sapiens","PTPRS","RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE S","1","4BPC"
"4BQG",,"X-RAY DIFFRACTION",2.99,58.48,,,,,"10.1016/j.bmc.2013.09.018","50Q","4BQG",26.08,"1.9","1.9","structure of HSP90 with an inhibitor bound","GPDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HSP90AA1 PROTEIN","1","4BQG"
"4BQJ",,"X-RAY DIFFRACTION",2.1,40.7,,,,,"10.1016/j.bmc.2013.09.018","XKL","4BQJ",26.2,"2","2","structure of HSP90 with an inhibitor bound","GPDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","HEAT SHOCK PROTEIN HSP 90-ALPHA","1","4BQJ"
"4BQM",,"X-RAY DIFFRACTION",2.57,52.22,,,"0.1M TRIS PH 8.5, 0.2M SODIUM CHLORIDE, 25%(W/V) PEG 3350",,,,"4BQM",77.33,"2.18","2.18","Crystal structure of human liver-type glutaminase, catalytic domain","MHHHHHHSSGVDLGTENLYFQSMIPDFEEFTGHVDRIFEDVKELTGGKVAAYIPQLAKSNPDLWGVSLCTVDGQRHSVGHTKIPFCLQSCVKPLTYAISISTLGTDYVHKFVGKEPSGLRYNKLSLNEEGIPHNPMVNAGAIVVSSLIKMDCNKAEKFDFVLQYLNKMAGNEYMGFSNATFQSEKETGDRNYAIGYYLKEKKCFPKGVDMMAALDLYFQLCSVEVTCESGSVMAATLANGGICPITGESVLSAEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSAVSGAILLVVPNVMGMMCLSPPLDKLGNSHRGTSFCQKLVSLFNFHNYDNLRHCARKLDPRREG","Homo sapiens","GLS2, GA","GLUTAMINASE LIVER ISOFORM, MITOCHONDRIAL","1","4BQM"
"4BQW",,"X-RAY DIFFRACTION",2.6,52.3,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M MES PH6.5, 1.7M AMMONIUM SULFATE, 1% DIOXANE, 0.002M MNCL2, SITTING DROP, 293K",293,"10.1021/cb400088q","QNM","4BQW",28.43,"1.79","1.79","HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with Mn(II) and 2-(4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid","GSHMASPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF","Homo sapiens","EGLN1, C1orf12, PNAS-118, PNAS-137","EGL NINE HOMOLOG 1","1","4BQW"
"4BQX",,"X-RAY DIFFRACTION",2.6,52.3,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M MES PH6.5, 1.7M AMMONIUM SULFATE, 1% DIOXANE, 0.002M MNCL2, SITTING DROP, 293K",293,"10.1021/cb400088q","UN9","4BQX",28.43,"1.79","1.79","HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with Mn(II) and N-[(1-chloro-4-hydroxyisoquinolin-3-yl)carbonyl]glycine (IOX3/UN9)","GSHMASPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF","Homo sapiens","EGLN1, C1orf12, PNAS-118, PNAS-137","EGL NINE HOMOLOG 1","1","4BQX"
"4BQY",,"X-RAY DIFFRACTION",2.6,52.3,,6.5,"0.1M MES PH6.5, 1.6M AMMONIUM SULFATE, 3% DIOXANE, 0.002M FECL2, NEAR ANAEROBIC",,"10.1021/cb400088q","FNT","4BQY",28.45,"1.53","1.53","HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with Fe(II) and N-[(1-chloro-4-hydroxyisoquinolin-3-yl)carbonyl]alanine","GSHMASPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF","Homo sapiens","EGLN1, C1orf12, PNAS-118, PNAS-137","EGL NINE HOMOLOG 1","1","4BQY"
"4BR1",,"X-RAY DIFFRACTION",2.3,47,,8.5,"100 MM TRIS PH 8.5, 30% POLYETHYLENE GLYCOL 4000, 200 MM SODIUM ACETATE TRIHYDRATE",,,,"4BR1",52.8,"1.9","1.9","Protease-induced heterodimer of human triosephosphate isomerase.","SRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQQAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPEFVDIINAKQ","Homo sapiens","TPI1, TPI","TRIOSEPHOSPHATE ISOMERASE","1","4BR1"
"4BR3",,"X-RAY DIFFRACTION",2.5,50.89,,,,,"10.1002/cbic.201300195","U85","4BR3",91.33,"2.2","2.2","Determination of potential scaffolds for human choline kinase alpha 1 by chemical deconvolution studies","PQPPADEQPEPRTRRRAYLWCKEFLPGAWRGLREDEFHISVIRGGLSNMLFQCSLPDTTATLGDEPRKVLLRLYGAILQMRSCNKEGSEQAQKENEFQGAEAMVLESVMFAILAERSLGPKLYGIFPQGRLEQFIPSRRLDTEELSLPDISAEIAEKMATFHGMKMPFNKEPKWLFGTMEKYLKEVLRIKFTEESRIKKLHKLLSYNLPLELENLRSLLESTPSPVVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNYRGFDIGNHFCEWMYDYSYEKYPFFRANIRKYPTKKQQLHFISSYLPAFQNDFENLSTEEKSIIKEEMLLEVNRFALASHFLWGLWSIVQAKISSIEFGYMDYAQARFDAYFHQKRKLGV","Homo sapiens","CHKA, CHK, CKI","CHOLINE KINASE ALPHA","1","4BR3"
"4BS4",,"X-RAY DIFFRACTION",2.4,49,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1021/jm401463y","A64","4BS4",55.95,"1.89","1.89","Crystal structure of human tankyrase 2 in complex with 4'-isopropylflavone","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BS4"
"4BSJ",,"X-RAY DIFFRACTION",4.74,74.1,"VAPOR DIFFUSION, SITTING DROP",8,"VAPOUR DIFFUSION, SITTING DROP, TEMPERATURE 298 K, PHOSPHATE BUFFER 0.1 M, PH 7.5 - 8.5, PEG 400 25%.",298,"10.1073/pnas.1301415110",,"4BSJ",26.96,"2.5","2.5","Crystal structure of VEGFR-3 extracellular domains D4-5","DHNPFISVEWLKGPILEATAGDELVKLPVKLAAYPPPEFQWYKDGKALSGRHSPHALVLKEVTEASTGTYTLALWNSAAGLRRNISLELVVNVPPQIHEKEASSPSIYSRHSRQALTCTAYGVPLPLSIQWHWRPWTPCKMFAQRSLRRRQQQDLMPQCRDWRAVTTQDAVNPIESLDTWTEFVEGKNKTVSKLVIQNANVSAMYKCVVSNKVGQDERLIYFYVTTHHHHHH","Homo sapiens","FLT4, VEGFR3","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3","1","4BSJ"
"4BSM",,"X-RAY DIFFRACTION",4.26,71.15,,8,"BY MIXING EQUAL VOLUMES OF PROTEIN (8-10 MG/ML) AND RESERVOIR SOLUTION 0.5 M DISODIUM TARTRATE, 50 MM TRIS PH 8.0",,"10.1016/j.str.2013.06.003",,"4BSM",118.86,"4.5","4.5","Crystal structure of the Nuclear Export Receptor CRM1 (exportin-1) lacking the C-terminal helical extension at 4.5A","MPAIMTMLADHAARQLLDFSQKLDINLLDNVVNCLYHGEGAQQRMAQEVLTHLKEHPDAWTRVDTILEFSQNMNTKYYGLQILENVIKTRWKILPRNQCEGIKKYVVGLIIKTSSDPTCVEKEKVYIGKLNMILVQILKQEWPKHWPTFISDIVGASRTSESLCQNNMVILKLLSEEVFDFSSGQITQVKSKHLKDSMCNEFSQIFQLCQFVMENSQNAPLVHATLETLLRFLNWIPLGYIFETKLISTLIYKFLNVPMFRNVSLKCLTEIAGVSVSQYEEQFVTLFTLTMMQLKQMLPLNTNIRLAYSNGKDDEQNFIQNLSLFLCTFLKEHDQLIEKRLNLRETLMEALHYMLLVSEVEETEIFKICLEYWNHLAAELYRESPFSTSASPLLSGSQHFDVPPRRQLYLPMLFKVRLLMVSRMAKPEEVLVVENDQGEVVREFMKDTDSINLYKNMRETLVYLTHLDYVDTERIMTEKLHNQVNGTEWSWKNLNTLCWAIGSISGAMHEEDEKRFLVTVIKDLLGLCEQKRGKDNKAIIASNIMYIVGQYPRFLRAHWKFLKTVVNKLFEFMHETHDGVQDMACDTFIKIAQKCRRHFVQVQVGEVMPFIDEILNNINTIICDLQPQQVHTFYEAVGYMIGAQTDQTVQEHLIEKYMLLPNQVWDSIIQQATKNVDILKDPETVKQLGSILKTNVRACKAVGHPFVIQLGRIYLDMLNVYKCLSENISAAIQANGEMVTKQPLIRSMRTVKRETLKLISGWVSRSNDPQMVAENFVPPLLDAVLIDYQRNVPAAREPEVLSTMAIIVNKLGGHITAEIPQIFDAVFECTLNMINKDFEEYPEHRTNFFLLLQAVNSHCFPAFLAIPPTQFKLVLDSIIWAFKHTMRNVADTGLQILFTLLQNVAQEEAAAQSFYQTYFCDILQHIFSVVTDTSHTAGLTMHASILAYMFNLVEEGKISTSLNPGNPVNNQIFLQEYVANLLKSAFPHLQDAQVKLFVTGLFSLNQDIPAFKEHLRDFLVQIKEFAGEDTSD","Homo sapiens","XPO1, CRM1","EXPORTIN-1","1","4BSM"
"4BSN",,"X-RAY DIFFRACTION",4.15,70.38,,7.5,"BY MIXING EQUAL VOLUMES OF PROTEIN (8-10 MG/ML) AND RESERVOIR SOLUTION 0.8 M SODIUM ACETATE, 50 MM TRIS PH 7.5",,"10.1016/j.str.2013.06.003",,"4BSN",118.86,"4.1","4.1","Crystal structure of the Nuclear Export Receptor CRM1 (exportin-1) lacking the C-terminal helical extension at 4.1A","MPAIMTMLADHAARQLLDFSQKLDINLLDNVVNCLYHGEGAQQRMAQEVLTHLKEHPDAWTRVDTILEFSQNMNTKYYGLQILENVIKTRWKILPRNQCEGIKKYVVGLIIKTSSDPTCVEKEKVYIGKLNMILVQILKQEWPKHWPTFISDIVGASRTSESLCQNNMVILKLLSEEVFDFSSGQITQVKSKHLKDSMCNEFSQIFQLCQFVMENSQNAPLVHATLETLLRFLNWIPLGYIFETKLISTLIYKFLNVPMFRNVSLKCLTEIAGVSVSQYEEQFVTLFTLTMMQLKQMLPLNTNIRLAYSNGKDDEQNFIQNLSLFLCTFLKEHDQLIEKRLNLRETLMEALHYMLLVSEVEETEIFKICLEYWNHLAAELYRESPFSTSASPLLSGSQHFDVPPRRQLYLPMLFKVRLLMVSRMAKPEEVLVVENDQGEVVREFMKDTDSINLYKNMRETLVYLTHLDYVDTERIMTEKLHNQVNGTEWSWKNLNTLCWAIGSISGAMHEEDEKRFLVTVIKDLLGLCEQKRGKDNKAIIASNIMYIVGQYPRFLRAHWKFLKTVVNKLFEFMHETHDGVQDMACDTFIKIAQKCRRHFVQVQVGEVMPFIDEILNNINTIICDLQPQQVHTFYEAVGYMIGAQTDQTVQEHLIEKYMLLPNQVWDSIIQQATKNVDILKDPETVKQLGSILKTNVRACKAVGHPFVIQLGRIYLDMLNVYKCLSENISAAIQANGEMVTKQPLIRSMRTVKRETLKLISGWVSRSNDPQMVAENFVPPLLDAVLIDYQRNVPAAREPEVLSTMAIIVNKLGGHITAEIPQIFDAVFECTLNMINKDFEEYPEHRTNFFLLLQAVNSHCFPAFLAIPPTQFKLVLDSIIWAFKHTMRNVADTGLQILFTLLQNVAQEEAAAQSFYQTYFCDILQHIFSVVTDTSHTAGLTMHASILAYMFNLVEEGKISTSLNPGNPVNNQIFLQEYVANLLKSAFPHLQDAQVKLFVTGLFSLNQDIPAFKEHLRDFLVQIKEFAGEDTSD","Homo sapiens","XPO1, CRM1","EXPORTIN-1","1","4BSN"
"4BSO",,"X-RAY DIFFRACTION",2,38.57,,,,,"10.1016/j.celrep.2013.06.009",,"4BSO",14.09,"2.2","2.2","Crystal structure of R-spondin 1 (Fu1Fu2) - Native","GSRISAEGSQACAKGCELCSEVNGCLKCSPKLFILLERNDIRQVGVCLPSCPPGYFDARNPDMNKCIKCKIEHCEACFSHNFCTKCKEGLYLHKGRCYPACPEGSSAANGTMECSSPAAAHHHHHH","Homo sapiens","RSPO1","R-SPONDIN-1","1","4BSO"
"4BSP",,"X-RAY DIFFRACTION",1.94,36.52,,,,,"10.1016/j.celrep.2013.06.009",,"4BSP",14.13,"2","2","Crystal structure of R-spondin 1 (Fu1Fu2) - Holmium soak","GSRISAEGSQACAKGCELCSEVNGCLKCSPKLFILLERNDIRQVGVCLPSCPPGYFDARNPDMNKCIKCKIEHCEACFSHNFCTKCKEGLYLHKGRCYPACPEGSSAANGTMECSSPAAAHHHHHH","Homo sapiens","RSPO1","R-SPONDIN-1","1","4BSP"
"4BSV",,"X-RAY DIFFRACTION",2.55,51.82,"VAPOR DIFFUSION, HANGING DROP",,"VIA HANGING DROP VAPOR DIFFUSION METHOD AT A RATIO OF 2:1 OF 8.5 MG/ML OF AZYMETRIC VARIANT ABOVE A MOTHER LIQUOR SOLUTION COMPOSED OF 5% (V/V) ETHYLENE GLYCOL, 18% (W/V) POLYETHYLENE GLYCOL 3350, AND 0.15 M AMMONIUM IODIDE WITH AID OF MICROSEEDING.",,"10.4161/mabs.25632",,"4BSV",55.02,"1.75","1.75","Heterodimeric Fc Antibody Azymetric Variant 1","GTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYVYPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFALVSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHG1","HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2","1","4BSV"
,,,,,,,,,,,,,,,,"GTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYVLPPSRDELTKNQVSLLCLVKGFYPSDIAVEWESNGQPENNYMTWPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHG1","HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2","2","4BSV"
"4BSW",,"X-RAY DIFFRACTION",2.55,51.82,"VAPOR DIFFUSION, HANGING DROP",,"VIA HANGING DROP VAPOR DIFFUSION METHOD AT A RATIO OF 2:1 OF 8.5 MG/ML OF AZYMETRIC VARIANT 2 ABOVE A MOTHER LIQUOR SOLUTION COMPOSED OF 5% (V/V) ETHYLENE GLYCOL, 18% (W/V) POLYETHYLENE GLYCOL 3350, AND 0.15 M AMMONIUM IODIDE WITH AID OF MICROSEEDING.",,"10.4161/mabs.25632",,"4BSW",54.72,"2.15","2.15","Heterodimeric Fc Antibody Azymetric Variant 2","GTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYVYPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFALVSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHG1","HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2","1","4BSW"
,,,,,,,,,,,,,,,,"GTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYVLPPSRDELTKNQVSLLCLVKGFYPSDIAVEWESNGQPENNYLTWPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHG1","HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2","2","4BSW"
"4BSX",,"X-RAY DIFFRACTION",2.32,47,,,"0.1M BIS-TRIS PH 6.6, 150MM NACL, 28% PEG 3350",,"10.1107/S0907444913022385",,"4BSX",69.15,"2.229","2.229","Crystal Structure of the N terminal domain of TRIF (TIR-domain- containing adapter-inducing interferon-beta)","SNAMACTGPSLPSAFDILGAAGQDKLLYLKHKLKTPRPGCQGQDLLHAMVLLKLGQETEARISLEALKMDAVARLVARQWAGVDSTEDPEEPPDVSWAVARLYHLLAEEKLCPASMRDVAYQEAVRTLSSRDDHRLGELQDEARNRCGWDIAGDPG","Homo sapiens","TICAM1, PRVTIRB, TRIF","TIR DOMAIN-CONTAINING ADAPTER MOLECULE 1","1","4BSX"
"4BT8",,"X-RAY DIFFRACTION",2.34,47.3,,7.5,"25-30% PEG400, 10% ISOPROPANOL, 100MM HEPES PH 7.5, 5MM SPERMINE HCL",,"10.1016/j.str.2013.09.005",,"4BT8",55.04,"2.198","2.198","CRYSTAL STRUCTURE OF THE APO FORM OF N-TERMINAL DOMAIN AND PEPTIDE SUBSTRATE BINDING DOMAIN OF PROLYL-4 HYDROXYLASE TYPE I FROM HUMAN","MHPGFFTSIGQMTDLIHTEKDLVTSLKDYIKAEEDKLEQIKKWAEKLDRLTSTATKDPEGFVGHPVNAFKLMKRLNTEWSELENLVLKDMSDGFISNLTIQRQYFPNDEDQVGAAKALLRLQDTYNLDTDTISKGNLPGVKHKSFLTAEDCFELGKVAYTEADYYHTELWMEQALRQLDEGEISTIDKVSVLDYLSYAVYQQGDLDKALLLTKKLLELDPEHQRANGNLKYFEYIMAKE","Homo sapiens","P4HA1, P4HA","PROLYL 4-HYDROXYLASE SUBUNIT ALPHA-1","1","4BT8"
"4BTE",,"X-RAY DIFFRACTION",3.14,61,,,,,"10.1021/ja406010m",,"4BTE",19.98,"1.38","1.38","DJ-1 Cu(I) complex","MASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","PROTEIN DJ-1","1","4BTE"
"4BTI",,"X-RAY DIFFRACTION",2.4,49,"VAPOR DIFFUSION, HANGING DROP",5.7,"PROTEIN SOLUTION: 8 MG/ML DESGLA FACTOR XA, 5 MM MES (PH 6.0), 5 MM CACL2, 100 MM BENZAMIDINE. RESERVOIR SOLUTION: 18-20% PEG600, 50 MM MES (PH 5.7). HANGING DROP SETUP.",,"10.1021/jm4005835","7R9","4BTI",79.55,"2.3","2.3","factor Xa in complex with the dual thrombin-FXa inhibitor 58.","YKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","COAGULATION FACTOR X HEAVY CHAIN","1","4BTI"
,,,,,,,,,,,,,,,,"IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","COAGULATION FACTOR X LIGHT CHAIN","2","4BTI"
"4BTJ",,"X-RAY DIFFRACTION",4.93,78.8,,,,,"10.1002/cmdc.201300274","ATP","4BTJ",78.81,"2.16","2.16","TTBK1 in complex with ATP","MHHHHHHSSGVDLGTENLYFQSNAMQCLAAALKDETNMSGGGEQADILPANYVVKDRWKVLKKIGGGGFGEIYEAMDLLTRENVALKVESAQQPKQVLKMEVAVLKKLQGKDHVCRFIGCGRNEKFNYVVMQLQGRNLADLRRSQPRGTFTLSTTLRLGKQILESIEAIHSVGFLHRDIKPSNFAMGRLPSTYRKCYMLDFGLARQYTNTTGDVRPPRNVAGFRGTVRYASVNAHKNREMGRHDDLWSLFYMLVEFAVGQLPWRKIKDKEQVGMIKEKYEHRMLLKHMPSEFHLFLDHIASLDYFTKPDYQLIMSVFENSMKERGIAENEAFDWEKA","Homo sapiens","TTBK1, BDTK, KIAA1855","TAU-TUBULIN KINASE 1","1","4BTJ"
"4BTK",,"X-RAY DIFFRACTION",2.35,47.15,,,,,"10.1002/cmdc.201300274","DTQ","4BTK",39.12,"2","2","TTBK1 in complex with inhibitor","MHHHHHHSSGVDLGTENLYFQSNAMQCLAAALKDETNMSGGGEQADILPANYVVKDRWKVLKKIGGGGFGEIYEAMDLLTRENVALKVESAQQPKQVLKMEVAVLKKLQGKDHVCRFIGCGRNEKFNYVVMQLQGRNLADLRRSQPRGTFTLSTTLRLGKQILESIEAIHSVGFLHRDIKPSNFAMGRLPSTYRKCYMLDFGLARQYTNTTGDVRPPRNVAGFRGTVRYASVNAHKNREMGRHDDLWSLFYMLVEFAVGQLPWRKIKDKEQVGMIKEKYEHRMLLKHMPSEFHLFLDHIASLDYFTKPDYQLIMSVFENSMKERGIAENEAFDWEKA","Homo sapiens","TTBK1, BDTK, KIAA1855","TAU-TUBULIN KINASE 1","1","4BTK"
"4BTM",,"X-RAY DIFFRACTION",4.93,78.8,,,,,"10.1002/cmdc.201300274","F8E","4BTM",78.74,"2.54","2.54","TTBK1 in complex with inhibitor","MHHHHHHSSGVDLGTENLYFQSNAMQCLAAALKDETNMSGGGEQADILPANYVVKDRWKVLKKIGGGGFGEIYEAMDLLTRENVALKVESAQQPKQVLKMEVAVLKKLQGKDHVCRFIGCGRNEKFNYVVMQLQGRNLADLRRSQPRGTFTLSTTLRLGKQILESIEAIHSVGFLHRDIKPSNFAMGRLPSTYRKCYMLDFGLARQYTNTTGDVRPPRNVAGFRGTVRYASVNAHKNREMGRHDDLWSLFYMLVEFAVGQLPWRKIKDKEQVGMIKEKYEHRMLLKHMPSEFHLFLDHIASLDYFTKPDYQLIMSVFENSMKERGIAENEAFDWEKA","Homo sapiens","TTBK1, BDTK, KIAA1855","TAU-TUBULIN KINASE 1","1","4BTM"
"4BTT",,"X-RAY DIFFRACTION",2.6,53.4,"VAPOR DIFFUSION, HANGING DROP",5.7,"PROTEIN SOLUTION: 8 MG/ML DESGLA FACTOR XA, 5 MM MES (PH 6.0), 5 MM CACL2, 100 MM BENZAMIDINE. RESERVOIR SOLUTION: 18-20% PEG600, 50 MM MES (PH 5.7). HANGING DROP SETUP.",,"10.1021/jm4005835","VYR","4BTT",79.52,"2.59","2.59","factor Xa in complex with the dual thrombin-FXa inhibitor 31.","YKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","COAGULATION FACTOR X LIGHT CHAIN","1","4BTT"
,,,,,,,,,,,,,,,,"IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","COAGULATION FACTOR X","2","4BTT"
"4BTU",,"X-RAY DIFFRACTION",2.42,49,"VAPOR DIFFUSION, HANGING DROP",5.7,"PROTEIN SOLUTION: 8 MG/ML REMARK 280 DESGLA FACTOR XA, 5 MM MES (PH 6.0), 5 MM CACL2, 100 MM REMARK 280 BENZAMIDINE. RESERVOIR SOLUTION: 18-20% PEG600, 50 MM MES REMARK 280 (PH 5.7). HANGING DROP SETUP.",,"10.1021/jm4005835","6XS","4BTU",79.49,"2.37","2.37","Factor Xa in complex with the dual thrombin-FXa inhibitor 57.","YKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLER","Homo sapiens","F10","COAGULATION FACTOR X LIGHT CHAIN","1","4BTU"
,,,,,,,,,,,,,,,,"IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK","Homo sapiens","F10","COAGULATION FACTOR X HEAVY CHAIN","2","4BTU"
"4BTW",,"X-RAY DIFFRACTION",5.01,75.26,,,"0.6-0.75 M NA/K TARTRATE, 0.2 M NACL, 0.1 M HEPES PH 7.4-7.6",,"10.1021/jm401372d","JW7","4BTW",168.43,"2.8","2.8","Crystal structure of human vascular adhesion protein-1 in complex with pyridazinone inhibitors","GRGGDGGEPSQLPHCPSVSPSAQPWTHPGQSQLFADLSREELTAVMRFLTQRLGPGLVDAAQARPSDNCVFSVELQLPPKAAALAHLDRGSPPPAREALAIVFFGRQPQPNVSELVVGPLPHPSYMRDVTVERHGGPLPYHRRPVLFQEYLDIDQMIFNRELPQASGLLHHCCFYKHRGRNLVTMTTAPRGLQSGDRATWFGLYYNISGAGFFLHHVGLELLVNHKALDPARWTIQKVFYQGRYYDSLAQLEAQFEAGLVNVVLIPDNGTGGSWSLKSPVPPGPAPPLQFYPQGPRFSVQGSRVASSLWTFSFGLGAFSGPRIFDVRFQGERLVYEISLQEALAIYGGNSPAAMTTRYVDGGFGMGKYTTPLTRGVDCPYLATYVDWHFLLESQAPKTIRDAFCVFEQNQGLPLRRHHSDLYSHYFGGLAETVLVVRSMSTLLNYDYVWDTVFHPSGAIEIRFYATGYISSAFLFGATGKYGNQVSEHTLGTVHTHSAHFKVDLDVAGLENWVWAEDMVFVPMAVPWSPEHQLQRLQVTRKLLEMEEQAAFLVGSATPRYLYLASNHSNKWGHPRGYRIQMLSFAGEPLPQNSSMARGFSWERYQLAVTQRKEEEPSSSSVFNQNDPWAPTVDFSDFINNETIAGKDLVAWVTAGFLHIPHAEDIPNTVTVGNGVGFFLRPYNFFDEDPSFYSADSIYFRGDQDAGACEVNPLACLPQAAACAPDLPAFSHGGFSHN","Homo sapiens","AOC3, VAP1","MEMBRANE PRIMARY AMINE OXIDASE","1","4BTW"
"4BTX",,"X-RAY DIFFRACTION",4.91,74.75,,,"0.6-0.75 M NA/K TARTRATE, 0.2 M NACL, 0.1 M HEPES PH 7.4-7.6",,"10.1021/jm401372d","WF8","4BTX",167.58,"2.78","2.78","Crystal structure of human vascular adhesion protein-1 in complex with pyridazinone inhibitors","GRGGDGGEPSQLPHCPSVSPSAQPWTHPGQSQLFADLSREELTAVMRFLTQRLGPGLVDAAQARPSDNCVFSVELQLPPKAAALAHLDRGSPPPAREALAIVFFGRQPQPNVSELVVGPLPHPSYMRDVTVERHGGPLPYHRRPVLFQEYLDIDQMIFNRELPQASGLLHHCCFYKHRGRNLVTMTTAPRGLQSGDRATWFGLYYNISGAGFFLHHVGLELLVNHKALDPARWTIQKVFYQGRYYDSLAQLEAQFEAGLVNVVLIPDNGTGGSWSLKSPVPPGPAPPLQFYPQGPRFSVQGSRVASSLWTFSFGLGAFSGPRIFDVRFQGERLVYEISLQEALAIYGGNSPAAMTTRYVDGGFGMGKYTTPLTRGVDCPYLATYVDWHFLLESQAPKTIRDAFCVFEQNQGLPLRRHHSDLYSHYFGGLAETVLVVRSMSTLLNYDYVWDTVFHPSGAIEIRFYATGYISSAFLFGATGKYGNQVSEHTLGTVHTHSAHFKVDLDVAGLENWVWAEDMVFVPMAVPWSPEHQLQRLQVTRKLLEMEEQAAFLVGSATPRYLYLASNHSNKWGHPRGYRIQMLSFAGEPLPQNSSMARGFSWERYQLAVTQRKEEEPSSSSVFNQNDPWAPTVDFSDFINNETIAGKDLVAWVTAGFLHIPHAEDIPNTVTVGNGVGFFLRPYNFFDEDPSFYSADSIYFRGDQDAGACEVNPLACLPQAAACAPDLPAFSHGGFSHN","Homo sapiens","AOC3, VAP1","MEMBRANE PRIMARY AMINE OXIDASE","1","4BTX"
"4BTY",,"X-RAY DIFFRACTION",5.03,75.37,,,"0.6-0.75 M NA/K TARTRATE, 0.2 M NACL, 0.1 M HEPES PH 7.4-7.6",,"10.1021/jm401372d","JWF","4BTY",168.09,"3.1","3.1","Crystal structure of human vascular adhesion protein-1 in complex with pyridazinone inhibitors","GRGGDGGEPSQLPHCPSVSPSAQPWTHPGQSQLFADLSREELTAVMRFLTQRLGPGLVDAAQARPSDNCVFSVELQLPPKAAALAHLDRGSPPPAREALAIVFFGRQPQPNVSELVVGPLPHPSYMRDVTVERHGGPLPYHRRPVLFQEYLDIDQMIFNRELPQASGLLHHCCFYKHRGRNLVTMTTAPRGLQSGDRATWFGLYYNISGAGFFLHHVGLELLVNHKALDPARWTIQKVFYQGRYYDSLAQLEAQFEAGLVNVVLIPDNGTGGSWSLKSPVPPGPAPPLQFYPQGPRFSVQGSRVASSLWTFSFGLGAFSGPRIFDVRFQGERLVYEISLQEALAIYGGNSPAAMTTRYVDGGFGMGKYTTPLTRGVDCPYLATYVDWHFLLESQAPKTIRDAFCVFEQNQGLPLRRHHSDLYSHYFGGLAETVLVVRSMSTLLNYDYVWDTVFHPSGAIEIRFYATGYISSAFLFGATGKYGNQVSEHTLGTVHTHSAHFKVDLDVAGLENWVWAEDMVFVPMAVPWSPEHQLQRLQVTRKLLEMEEQAAFLVGSATPRYLYLASNHSNKWGHPRGYRIQMLSFAGEPLPQNSSMARGFSWERYQLAVTQRKEEEPSSSSVFNQNDPWAPTVDFSDFINNETIAGKDLVAWVTAGFLHIPHAEDIPNTVTVGNGVGFFLRPYNFFDEDPSFYSADSIYFRGDQDAGACEVNPLACLPQAAACAPDLPAFSHGGFSHN","Homo sapiens","AOC3, VAP1","MEMBRANE PRIMARY AMINE OXIDASE","1","4BTY"
"4BU2",,"X-RAY DIFFRACTION",5.14,76.1,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1M BIS-TRIS PROPANE PH 6.5, 19-22% (W/V) PEG 3350, 0.2M AMMONIUM SULPHATE, 0.005M NICL2, TEMPERATURE 293K. VAPOR DIFFUSION, SITTING DROP",293,"10.1038/nature13263",,"4BU2",51.35,"2.78","2.78","60S ribosomal protein L27A histidine hydroxylase (MINA53) in complex with Ni(II) and 2-oxoglutarate (2OG)","SMAAGGPSALNFDSPSSLFESLISPIKTETFFKEFWEQKPLLIQRDDPALATYYGSLFKLTDLKSLCSRGMYYGRDVNVCRCVNGKKKVLNKDGKAHFLQLRKDFDQKRATIQFHQPQRFKDELWRIQEKLECYFGSLVGSNVYITPAGSQGLPPHYDDVEVFILQLEGEKHWRLYHPTVPLAREYSVEAEERIGRPVHEFMLKPGDLLYFPRGTIHQADTPAGLAHSTHVTISTYQNNSWGDFLLDTISGLVFDTAKEDVELRTGIPRQLLLQVESTTVATRRLSGFLRTLADRLEGTKELLSSDMKKDFIMHRLPPYSAGDGAELSTPGGKLPRLDSVVRLQFKDHIVLTVLPDQDQSDETQEKMVYIYHSLKNSRETHMMGNEEETEFHGLRFPLSHLDALKQIWNSPAISVKDLKLTTDEEKESLVLSLWTECLIQVV","Homo sapiens","RIOX2, MDIG, MINA, MINA53, NO52","BIFUNCTIONAL LYSINE-SPECIFIC DEMETHYLASE AND HISTIDYL-HYDROXYLASE MINA","1","4BU2"
"4BU3",,"X-RAY DIFFRACTION",2.42,49.2,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1002/cmdc.201300337","F40","4BU3",55.65,"2.15","2.15","Crystal structure of human tankyrase 2 in complex with 2-phenyl-3,4- dihydroquinazolin-4-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BU3"
"4BU5",,"X-RAY DIFFRACTION",2.43,49.46,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1002/cmdc.201300337","3F4","4BU5",55.99,"1.8","1.8","Crystal structure of human tankyrase 2 in complex with 2-(4- hydroxyphenyl)-3,4-dihydroquinazolin-4-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BU5"
"4BU6",,"X-RAY DIFFRACTION",2.42,49.33,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1002/cmdc.201300337","RGK","4BU6",55.68,"1.8","1.8","Crystal structure of human tankyrase 2 in complex with 2-(4- aminophenyl)-3,4-dihydroquinazolin-4-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BU6"
"4BU7",,"X-RAY DIFFRACTION",2.42,49.26,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1002/cmdc.201300337","25F","4BU7",55.81,"2.05","2.05","Crystal structure of human tankyrase 2 in complex with 2-(4- bromophenyl)-3,4-dihydroquinazolin-4-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BU7"
"4BU8",,"X-RAY DIFFRACTION",2.43,49.32,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1002/cmdc.201300337","27F","4BU8",55.7,"1.85","1.85","Crystal structure of human tankyrase 2 in complex with 4-(4-oxo-1,4- dihydroquinazolin-2-yl)benzonitrile","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BU8"
"4BU9",,"X-RAY DIFFRACTION",2.46,49.99,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1002/cmdc.201300337","08C","4BU9",56.09,"1.65","1.65","Crystal structure of human tankyrase 2 in complex with 2-(4- methoxyphenyl)-3,4-dihydroquinazolin-4-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BU9"
"4BUA",,"X-RAY DIFFRACTION",2.44,49.67,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1002/cmdc.201300337","91F","4BUA",55.85,"1.85","1.85","Crystal structure of human tankyrase 2 in complex with 2-(4-(methylsulfanyl)phenyl)-3,4-dihydroquinazolin-4-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BUA"
"4BUD",,"X-RAY DIFFRACTION",2.42,49.21,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1002/cmdc.201300337","29F","4BUD",55.86,"2.5","2.5","Crystal structure of human tankyrase 2 in complex with 2-(4-tert- butylphenyl)-1,4-dihydroquinazolin-4-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BUD"
"4BUE",,"X-RAY DIFFRACTION",2.43,49.38,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1002/cmdc.201300337","JQF","4BUE",56.05,"1.6","1.6","Crystal structure of human tankyrase 2 in complex with 3-methyl-N-(4-(4-oxo-3,4-dihydroquinazolin-2-yl)phenyl)butanamide","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BUE"
"4BUF",,"X-RAY DIFFRACTION",2.4,48.79,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1002/cmdc.201300337","F36","4BUF",55.83,"2.5","2.5","Crystal structure of human tankyrase 2 in complex with 2-(4- acetylphenyl)-3,4-dihydroquinazolin-4-one","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BUF"
"4BUH",,"X-RAY DIFFRACTION",2.05,39.99,,7.5,"0.1M MES PH6.5, 25% PEG 4000, pH 7.5",,"10.1111/cea.12230",,"4BUH",57.79,"1.3","1.3","Human IgE against the major allergen Bet v 1 - Crystal structure of clone M0418 scFv","QVQLVQSGAEVKKPGESLKISCKGSEYSFPNYWIAWVRQMPGKGLEWMGMIYPGDSDTRYSPSFQGQVNISADKSSRTAFLEWSSLKASDSATYFCARLGGQLWNSYYYYYYMDVWGKGTTVTVSSGGGGSGGGGSGGGGSSYELTQPPSASGTPGQRVTISCSGSSSNIGGNTVNWYQQVPGTAPRLLIYKNNQRPSGVPDRFSGSKSGTSASLAISGLRSEDEADYYCEAWDGGLRGGVFGGGTKLTVLGDYKDDDDKAAAHHHHHH","Homo sapiens",,"CLONE M0418 SCFV","1","4BUH"
"4BUI",,"X-RAY DIFFRACTION",2.44,49.54,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1002/cmdc.201300337","W2E","4BUI",55.86,"1.95","1.95","Crystal structure of human tankyrase 2 in complex with methyl 4-(4- oxo-3,4-dihydroquinazolin-2-yl)benzoate","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BUI"
"4BUR",,"X-RAY DIFFRACTION",3.47,64.63,,,"16-20% PEG 4K, 0.2 M LI2SO4 AND 0.1 M TRIS-HCL PH 8.5",,"10.1021/bi500343r",,"4BUR",231.63,"2.88","2.88","Crystal structure of the reduced human Apoptosis inducing factor complexed with NAD","GLTPEQKQKKAALSASEGEEVPQDKAPSHVPFLLIGGGTAAFAAARSIRARDPGARVLIVSEDPELPYMRPPLSKELWFSDDPNVTKTLRFKQWNGKERSIYFQPPSFYVSAQDLPHIENGGVAVLTGKKVVQLDVRDNMVKLNDGSQITYEKCLIATGGTPRSLSAIDRAGAEVKSRTTLFRKIGDFRSLEKISREVKSITIIGGGFLGSELACALGRKARALGTEVIQLFPEKGNMGKILPEYLSNWTMEKVRREGVKVMPNAIVQSVGVSSGKLLIKLKDGRKVETDHIVAAVGLEPNVELAKTGGLEIDSDFGGFRVNAELQARSNIWVAGDAACFYDIKLGRRRVEHHDHAVVSGRLAGENMTGAAKPYWHQSMFWSDLGPDVGYEAIGLVDSSLPTVGVFAKATAQDNPKSATEQSGTGIRSESETESEASEITIPPSTPAVPQAPVQGEDYGKGVIFYLRDKVVVGIVLWNIFNRMPIARKIIKDGEQHEDLNEVAKLFNIHED","Homo sapiens","AIFM1, AIF, PDCD8","APOPTOSIS INDUCING FACTOR 1, MITOCHONDRIAL","1","4BUR"
"4BUS",,"X-RAY DIFFRACTION",2.41,48.94,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M LISO4, 0.1 M TRIS HCL, 22% PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K",277,"10.1002/cmdc.201300337","32F","4BUS",55.89,"1.9","1.9","Crystal structure of human tankyrase 2 in complex with 2-(4-(4-oxo-3, 4-dihydroquinazolin-2-yl)phenoxy)acetic acid","MHHHHHHSSGVDLGTENLYFQSMLNTSGSGTILIDLSPDDKEFQSVEEEMQSTVREHRDGGHAGGIFNRYNILKIQKVCNKKLWERYTHRRKEVSEENHNHANERMLFHGSPFVNAIIHKGFDERHAYIGGMFGAGIYFAENSSKSNQYVYGIGGGTGCPVHKDRSCYICHRQLLFCRVTLGKSFLQFSAMKMAHSPPGHHSVTGRPSVNGLALAEYVIYRGEQAYPEYLITYQIMRPEG","Homo sapiens","TNKS2, PARP5B, TANK2, TNKL","TANKYRASE-2","1","4BUS"
